PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Winkler, EA; Kim, CN; Ross, JM; Garcia, JH; Gil, E; Oh, I; Chen, LQ; Wu, D; Catapano, JS; Raygor, K; Narsinh, K; Kim, H; Weinsheimer, S; Cooke, DL; Walcott, BP; Lawton, MT; Gupta, N; Zlokovic, BV; Chang, EF; Abla, AA; Lim, DA; Nowakowski, TJ				Winkler, Ethan A.; Kim, Chang N.; Ross, Jayden M.; Garcia, Joseph H.; Gil, Eugene; Oh, Irene; Chen, Lindsay Q.; Wu, David; Catapano, Joshua S.; Raygor, Kunal; Narsinh, Kazim; Kim, Helen; Weinsheimer, Shantel; Cooke, Daniel L.; Walcott, Brian P.; Lawton, Michael T.; Gupta, Nalin; Zlokovic, Berislav, V; Chang, Edward F.; Abla, Adib A.; Lim, Daniel A.; Nowakowski, Tomasz J.			A single-cell atlas of the normal and malformed human brain vasculature	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; ARTERIOVENOUS-MALFORMATION; RETINOIC ACID; EXPRESSION; PERICYTES; BARRIER; IDENTIFICATION; DIVERSITY; INTEGRITY; PATHWAYS	Cerebrovascular diseases are a leading cause of death and neurologic disability. Further understanding of disease mechanisms and therapeutic strategies requires a deeper knowledge of cerebrovascular cells in humans. We profiled transcriptomes of 181,388 cells to define a cell atlas of the adult human cerebrovasculature, including endothelial cell molecular signatures with arteriovenous segmentation and expanded perivascular cell diversity. By leveraging this reference, we investigated cellular and molecular perturbations in brain arteriovenous malformations, which are a leading cause of stroke in young people, and identified pathologic endothelial transformations with abnormal vascular patterning and the ontology of vascularly derived inflammation. We illustrate the interplay between vascular and immune cells that contributes to brain hemorrhage and catalog opportunities for targeting angiogenic and inflammatory programs in vascular malformations.	[Winkler, Ethan A.; Ross, Jayden M.; Garcia, Joseph H.; Gil, Eugene; Wu, David; Raygor, Kunal; Gupta, Nalin; Chang, Edward F.; Abla, Adib A.; Lim, Daniel A.; Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Winkler, Ethan A.; Kim, Chang N.; Ross, Jayden M.; Gil, Eugene; Wu, David; Lim, Daniel A.; Nowakowski, Tomasz J.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Winkler, Ethan A.; Kim, Chang N.; Ross, Jayden M.; Cooke, Daniel L.; Chang, Edward F.; Abla, Adib A.; Lim, Daniel A.; Nowakowski, Tomasz J.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Winkler, Ethan A.; Catapano, Joshua S.; Lawton, Michael T.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA; [Kim, Chang N.; Ross, Jayden M.; Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kim, Chang N.; Ross, Jayden M.; Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Oh, Irene; Chen, Lindsay Q.] Rebus Biosyst, Santa Clara, CA USA; [Narsinh, Kazim; Cooke, Daniel L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Kim, Helen; Weinsheimer, Shantel] Univ Calif San Francisco, Ctr Cerebrovasc Res, Dept Anesthesia & Perioperat Care, San Francisco, CA USA; [Walcott, Brian P.] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL USA; [Zlokovic, Berislav, V] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA USA; [Zlokovic, Berislav, V] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Lim, Daniel A.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Nowakowski, Tomasz J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Barrow Neurological Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; NorthShore University Health System; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lim, DA; Nowakowski, TJ (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.; Lim, DA; Nowakowski, TJ (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Lim, DA; Nowakowski, TJ (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Nowakowski, TJ (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.; Nowakowski, TJ (corresponding author), Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA.; Lim, DA (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Nowakowski, TJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	adib.abla@ucsf.edu; daniel.lim@ucsf.edu; tomasz.nowakowski@gmail.com		Wu, David/0000-0002-9030-3667; Kim, Helen/0000-0002-1937-354X; Kim, Chang/0000-0001-7921-4447; Cooke, Daniel/0000-0002-3694-413X				Andreatta M, 2021, COMPUT STRUCT BIOTEC, V19, P3796, DOI 10.1016/j.csbj.2021.06.043; [Anonymous], 2019, LANCET NEUROL; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bernstein NJ, 2020, CELL SYST, V11, P95, DOI 10.1016/j.cels.2020.05.010; Bhaduri A, 2021, NATURE, V598, P200, DOI 10.1038/s41586-021-03910-8; Bonney S, 2016, J NEUROSCI, V36, P7786, DOI 10.1523/JNEUROSCI.3952-15.2016; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Bunis DG, 2020, BIOINFORMATICS, V36, P5535, DOI 10.1093/bioinformatics/btaa1011; Chen MB, 2020, CELL REP, V30, P4418, DOI 10.1016/j.celrep.2020.03.012; Chen WQ, 2013, ARTERIOSCL THROM VAS, V33, P305, DOI 10.1161/ATVBAHA.112.300485; Crist AM, 2019, CIRCULATION, V139, P2049, DOI 10.1161/CIRCULATIONAHA.118.036952; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; DeSisto J, 2020, DEV CELL, V54, P43, DOI 10.1016/j.devcel.2020.06.009; Duan LH, 2018, NEURON, V100, P183, DOI 10.1016/j.neuron.2018.08.030; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Fish JE, 2020, CIRC RES, V127, P727, DOI 10.1161/CIRCRESAHA.119.316500; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Frosen J, 2018, CARDIOVASC RES, V114, P501, DOI 10.1093/cvr/cvy002; Gaal EI, 2013, BLOOD, V122, P658, DOI 10.1182/blood-2012-07-441527; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; He LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35108; Hendriks-Balk MC, 2009, EUR J PHARMACOL, V606, P25, DOI 10.1016/j.ejphar.2009.01.018; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hupe M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2476; Jabbour MN, 2009, NEUROSURGERY, V64, P139, DOI 10.1227/01.NEU.0000334417.56742.24; Jiang H, 2020, NEURON, V107, P306, DOI 10.1016/j.neuron.2020.04.020; Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Kim C., 2022, ZENODO, DOI [10.5281/ zenodo.5826205, DOI 10.5281/ZENODO.5826205]; Kim YH, 2020, CIRC RES, V127, P1122, DOI 10.1161/CIRCRESAHA.119.316267; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kubikova T, 2018, J CHEM NEUROANAT, V88, P22, DOI 10.1016/j.jchemneu.2017.11.005; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lawton MT, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.8; Li XY, 2017, BIOCHEM BIOPH RES CO, V493, P291, DOI 10.1016/j.bbrc.2017.09.028; Li YM, 2020, CIRCULATION, V142, P1374, DOI 10.1161/CIRCULATIONAHA.120.046528; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Majumdar M, 2016, J NEUROINTERV SURG, V8, P163, DOI 10.1136/neurintsurg-2014-011517; Marsh S. E, 2020, SINGLE CELL SEQUENCI, DOI 10.1101/2020.12.03.408542; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Mishra S, 2016, DEV BIOL, V420, P148, DOI 10.1016/j.ydbio.2016.09.019; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Murphy PA, 2014, P NATL ACAD SCI USA, V111, P18007, DOI 10.1073/pnas.1415316111; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Nowakowski TJ, 2017, SCIENCE, V358, P1318, DOI 10.1126/science.aap8809; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Pan HZ, 2020, CIRCULATION, V142, P2060, DOI 10.1161/CIRCULATIONAHA.120.048378; Pardridge WM, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00373; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Rajan AM, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008800; Ratelade J, 2020, CIRCULATION, V141, P2078, DOI 10.1161/CIRCULATIONAHA.119.040963; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross JM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.600767; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schaeffer S, 2021, NAT NEUROSCI, V24, P1198, DOI 10.1038/s41593-021-00904-7; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shoemaker LD, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.99; Smyth LCD, 2018, J CHEM NEUROANAT, V92, P48, DOI 10.1016/j.jchemneu.2018.06.001; Sokolowski DJ, 2021, NAR GENOM BIOINFORM, V3, DOI 10.1093/nargab/lqab011; Soneson C, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008585; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Srivastava A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1670-y; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5; Wright R, 2020, ACTA NEUROCHIR, V162, P1741, DOI 10.1007/s00701-020-04328-3; Zbinden S, 2010, ARTERIOSCL THROM VAS, V30, P477, DOI 10.1161/ATVBAHA.109.200949; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhu W, 2017, STROKE, V48, P1420, DOI 10.1161/STROKEAHA.116.015713	86	26	27	8	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2022	375	6584			SI		992	+	eabi7377	10.1126/science.abi7377	http://dx.doi.org/10.1126/science.abi7377			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM3BK	35084939	Green Accepted, Green Published			2022-12-28	WOS:000764236900038
J	Hameed, I; Cifu, AS; Geirsson, A				Hameed, Irbaz; Cifu, Adam S.; Geirsson, Arnar			Blood Management in High-risk Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							UPDATE		[Hameed, Irbaz; Geirsson, Arnar] Yale Sch Med, Dept Surg, Div Cardiac Surg, 330 Cedar St, New Haven, CT 06510 USA; [Cifu, Adam S.] Univ Chicago, Chicago, IL 60637 USA	Yale University; University of Chicago	Geirsson, A (corresponding author), Yale Sch Med, Dept Surg, Div Cardiac Surg, 330 Cedar St, New Haven, CT 06510 USA.	arnar.geirsson@yale.edu						Corredor C, 2015, ANAESTHESIA, V70, P715, DOI 10.1111/anae.13083; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Frietsch T, 2019, BLOOD TRANSFUS-ITALY, V17, P331, DOI 10.2450/2019.0126-19; Mueller MM, 2019, JAMA-J AM MED ASSOC, V321, P983, DOI 10.1001/jama.2019.0554; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Shehata N, 2019, EUR HEART J, V40, P1081, DOI 10.1093/eurheartj/ehy435; Tibi P, 2021, J CARDIOTHOR VASC AN, V35, P2569, DOI 10.1053/j.jvca.2021.03.011	7	0	0	4	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					578	579						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35133425				2022-12-28	WOS:000758257900016
J	Kong, YM; Cao, L; Deikus, G; Fan, Y; Mead, EA; Lai, WY; Zhang, YZ; Yong, R; Sebra, R; Wang, HL; Zhang, XS; Fang, G				Kong, Yimeng; Cao, Lei; Deikus, Gintaras; Fan, Yu; Mead, Edward A.; Lai, Weiyi; Zhang, Yizhou; Yong, Raymund; Sebra, Robert; Wang, Hailin; Zhang, Xue-Song; Fang, Gang			Critical assessment of DNA adenine methylation in eukaryotes using quantitative deconvolution	SCIENCE			English	Article							SINGLE-MOLECULE; RESTRICTION; N-6-ADENINE; GENES; N-6-METHYLADENINE; DATABASE	The discovery of N-6-methyldeoxyadenine (6mA) across eukaryotes led to a search for additional epigenetic mechanisms. However, some studies have highlighted confounding factors that challenge the prevalence of 6mA in eukaryotes. We developed a metagenomic method to quantitatively deconvolve 6mA events from a genomic DNA sample into species of interest, genomic regions, and sources of contamination. Applying this method, we observed high-resolution 6mA deposition in two protozoa. We found that commensal or soil bacteria explained the vast majority of 6mA in insect and plant samples. We found no evidence of high abundance of 6mA in Drosophila, Arabidopsis, or humans. Plasmids used for genetic manipulation, even those from Dam methyltransferase mutant Escherichia coli, could carry abundant 6mA, confounding the evaluation of candidate 6mA methyltransferases and demethylases. On the basis of this work, we advocate for a reassessment of 6mA in eukaryotes.	[Kong, Yimeng; Cao, Lei; Deikus, Gintaras; Fan, Yu; Mead, Edward A.; Sebra, Robert; Fang, Gang] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kong, Yimeng; Cao, Lei; Deikus, Gintaras; Fan, Yu; Mead, Edward A.; Sebra, Robert; Fang, Gang] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Lai, Weiyi; Wang, Hailin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Zhang, Yizhou; Yong, Raymund] Icahn Sch Med Mt Sinai, Dept Neurosurg & Oncol Sci, New York, NY 10029 USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Sebra, Robert] Sema4, Stamford, CT 06902 USA; [Zhang, Xue-Song] Rutgers State Univ, Ctr Adv Biotechnol & Med, New Brunswick, NJ 08854 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick	Fang, G (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Fang, G (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	gang.fang@mssm.edu		Fan, Yu/0000-0002-5978-5004; Mead, Edward/0000-0002-4588-8096; Fang, Gang/0000-0002-2462-9124	NIH [R35 GM139655, R01 HG011095, R56 AG071291]; Irma T. Hirschl/Monique Weill-Caulier Trust; Nash Family Foundation; Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB2004]; National Natural Science Foundation of China [22021003]; Icahn Institute for Genomics and Multiscale Biology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl/Monique Weill-Caulier Trust; Nash Family Foundation; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Icahn Institute for Genomics and Multiscale Biology	Supported by the Icahn Institute for Genomics and Multiscale Biology, NIH grants R35 GM139655, R01 HG011095, and R56 AG071291, the Irma T. Hirschl/Monique Weill-Caulier Trust, and the Nash Family Foundation (G.F.). UHPLC-MS/MS analyses of 6mA were supported by Strategic Priority Research Program of the Chinese Academy of Sciences grant XDPB2004 and National Natural Science Foundation of China grant 22021003 (H.W.).	Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Beaulaurier J, 2019, NAT REV GENET, V20, P157, DOI 10.1038/s41576-018-0081-3; Beaulaurier J, 2018, NAT BIOTECHNOL, V36, P61, DOI 10.1038/nbt.4037; Beaulaurier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8438; Bian C, 2020, P NATL ACAD SCI USA, V117, P13127, DOI 10.1073/pnas.1912075117; Blow MJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005854; Bulanenkova S, 2007, GENETICA, V130, P83, DOI 10.1007/s10709-006-0026-1; Castro-Diaz N, 2014, GENE DEV, V28, P1397, DOI 10.1101/gad.241661.114; Chen WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5909; Corkum CP, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0113-0; Deamer D, 2016, NAT BIOTECHNOL, V34, P518, DOI 10.1038/nbt.3423; Douvlataniotis K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3335; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gomes RJ, 2018, FOOD TECHNOL BIOTECH, V56, P139, DOI 10.17113/ftb.56.02.18.5593; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Guiblet WM, 2018, GENOME RES, V28, P1767, DOI 10.1101/gr.241257.118; Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018; Koh CWQ, 2018, NUCLEIC ACIDS RES, V46, P11659, DOI 10.1093/nar/gky1104; Kong Y., 2022, CRITICAL ASSESSMENT, DOI [10.5281/zenodo.5838427, DOI 10.5281/ZENODO.5838427]; Lai WY, 2018, ANAL CHEM, V90, P6859, DOI 10.1021/acs.analchem.8b01041; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lentini A, 2018, NAT METHODS, V15, P499, DOI 10.1038/s41592-018-0038-7; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Liang Z, 2018, DEV CELL, V45, P406, DOI [10.1016/j.devicel.2018.03.012, 10.1016/j.devcel.2018.03.012]; Liu XL, 2021, CELL RES, V31, P94, DOI 10.1038/s41422-020-0317-6; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Luo GZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11301; Ma CC, 2019, NAT CELL BIOL, V21, P319, DOI 10.1038/s41556-018-0238-5; Mondo SJ, 2017, NAT GENET, V49, P964, DOI 10.1038/ng.3859; Murgier J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45140-z; Musheev MU, 2020, NAT CHEM BIOL, V16, P630, DOI 10.1038/s41589-020-0504-2; O'Brown ZK, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5754-6; Oliveira PH, 2020, NAT MICROBIOL, V5, P166, DOI 10.1038/s41564-019-0613-4; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sanchez-Romero MA, 2020, NAT REV MICROBIOL, V18, P7, DOI 10.1038/s41579-019-0286-2; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Tourancheau A, 2021, NAT METHODS, V18, P491, DOI 10.1038/s41592-021-01109-3; Wang YY, 2017, NUCLEIC ACIDS RES, V45, P11594, DOI 10.1093/nar/gkx883; Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Yao B, 2018, MOL CELL, V71, P848, DOI 10.1016/j.molcel.2018.07.005; Ye PH, 2017, NUCLEIC ACIDS RES, V45, pD85, DOI 10.1093/nar/gkw950; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zhang XS, 2012, J BACTERIOL, V194, P3407, DOI 10.1128/JB.00113-12; Zhu SJ, 2018, GENOME RES, V28, P1067, DOI 10.1101/gr.231068.117	55	12	12	29	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					515	+		10.1126/science.abe7489	http://dx.doi.org/10.1126/science.abe7489			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113693	Green Accepted			2022-12-28	WOS:000753965100035
J	Paulsen, B; Velasco, S; Kedaigle, AJ; Pigoni, M; Quadrato, G; Deo, AJ; Adiconis, X; Uzquiano, A; Sartore, R; Yang, SM; Simmons, SK; Symvoulidis, P; Kim, K; Tsafou, K; Podury, A; Abbate, C; Tucewicz, A; Smith, SN; Albanese, A; Barrett, L; Sanjana, NE; Shi, X; Chung, K; Lage, K; Boyden, ES; Regev, A; Levin, JZ; Arlotta, P				Paulsen, Bruna; Velasco, Silvia; Kedaigle, Amanda J.; Pigoni, Martina; Quadrato, Giorgia; Deo, Anthony J.; Adiconis, Xian; Uzquiano, Ana; Sartore, Rafaela; Yang, Sung Min; Simmons, Sean K.; Symvoulidis, Panagiotis; Kim, Kwanho; Tsafou, Kalliopi; Podury, Archana; Abbate, Catherine; Tucewicz, Ashley; Smith, Samantha N.; Albanese, Alexandre; Barrett, Lindy; Sanjana, Neville E.; Shi, Xi; Chung, Kwanghun; Lage, Kasper; Boyden, Edward S.; Regev, Aviv; Levin, Joshua Z.; Arlotta, Paola			Autism genes converge on asynchronous development of shared neuron classes	NATURE			English	Article							CALCIUM WAVES; SPECTRUM; ARCHITECTURE; PENETRANCE; DIVERSITY; PROTEOME; BALANCE; MODELS	Genetic risk for autism spectrum disorder (ASD) is associated with hundreds of genes spanning a wide range of biological functions(1-6). The alterations in the human brain resulting from mutations in these genes remain unclear. Furthermore, their phenotypic manifestation varies across individuals(7,8). Here we used organoid models of the human cerebral cortex to identify cell-type-specific developmental abnormalities that result from haploinsufficiency in three ASD risk genes-SUV420H1 (also known as KMT5B), ARID1B and CHD8-in multiple cell lines from different donors, using single-cell RNA-sequencing (scRNA-seq) analysis of more than 745,000 cells and proteomic analysis of individual organoids, to identify phenotypic convergence. Each of the three mutations confers asynchronous development of two main cortical neuronal lineages-gamma-aminobutyric-acid-releasing (GABAergic) neurons and deep-layer excitatory projection neurons-but acts through largely distinct molecular pathways. Although these phenotypes are consistent across cell lines, their expressivity is influenced by the individual genomic context, in a manner that is dependent on both the risk gene and the developmental defect. Calcium imaging in intact organoids shows that these early-stage developmental changes are followed by abnormal circuit activity. This research uncovers cell-type-specific neurodevelopmental abnormalities that are shared across ASD risk genes and are finely modulated by human genomic context, finding convergence in the neurobiological basis of how different risk genes contribute to ASD pathology.	[Paulsen, Bruna; Velasco, Silvia; Kedaigle, Amanda J.; Pigoni, Martina; Quadrato, Giorgia; Deo, Anthony J.; Uzquiano, Ana; Sartore, Rafaela; Yang, Sung Min; Kim, Kwanho; Abbate, Catherine; Tucewicz, Ashley; Smith, Samantha N.; Barrett, Lindy; Arlotta, Paola] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Paulsen, Bruna; Velasco, Silvia; Kedaigle, Amanda J.; Pigoni, Martina; Deo, Anthony J.; Adiconis, Xian; Uzquiano, Ana; Sartore, Rafaela; Yang, Sung Min; Simmons, Sean K.; Kim, Kwanho; Tsafou, Kalliopi; Abbate, Catherine; Tucewicz, Ashley; Smith, Samantha N.; Barrett, Lindy; Sanjana, Neville E.; Shi, Xi; Lage, Kasper; Levin, Joshua Z.; Arlotta, Paola] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Kedaigle, Amanda J.; Adiconis, Xian; Simmons, Sean K.; Kim, Kwanho; Regev, Aviv; Levin, Joshua Z.] Broad Inst MIT & Harvard, Krarman Cell Observ, Cambridge, MA USA; [Symvoulidis, Panagiotis; Podury, Archana; Boyden, Edward S.] MIT, MIT Ctr Neurobiorogicar Engn, Cambridge, MA USA; [Podury, Archana; Boyden, Edward S.] Harvard Med Sch, Harvard MIT Hearth Sci & Technol Program HST, Boston, MA USA; [Albanese, Alexandre; Chung, Kwanghun] MIT, Inst Med Engn & Sci, Cambridge, MA USA; [Chung, Kwanghun] MIT, Dept Chem Engn, Picower Inst Learning & Memory, Cambridge, MA USA; [Chung, Kwanghun] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA USA; [Lage, Kasper] Massachusetts Gen Hosp, Dept Surg, Boston, MA USA; [Lage, Kasper] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA USA; [Boyden, Edward S.] MIT, McGovern Inst Brain Res, Cambridge, MA USA; [Boyden, Edward S.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA USA; [Boyden, Edward S.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Boyden, Edward S.] MIT, Dept Brain Cognit Sci, Cambridge, MA USA; [Boyden, Edward S.] MIT, Dept Media Arts & Sci, Cambridge, MA USA; [Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Velasco, Silvia] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkvirre, Vic, Australia; [Quadrato, Giorgia] Univ Southern Calif, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA; [Deo, Anthony J.] Harvard Med Sch, Boston Childrens Hosp, Address Dept Psychiat, Boston, MA USA; [Deo, Anthony J.] Rutgers Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ USA; [Deo, Anthony J.] Rutgers Univ Behav Hearth Care, Piscataway, NJ USA; [Sanjana, Neville E.] New York Genome Ctr, New York, NY USA; [Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA; [Regev, Aviv] Genentech Inc, San Francisco, CA USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Southern California; Harvard University; Boston Children's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; Roche Holding; Genentech	Velasco, S; Arlotta, P (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Velasco, S; Arlotta, P (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Velasco, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkvirre, Vic, Australia.	sirvia.veLasco@mcri.edu.au; paora_arrotta@harvard.edu	Symvoulidis, Panagiotis/H-4219-2011; Sartore, Rafaela/AAV-5609-2021	Symvoulidis, Panagiotis/0000-0002-1396-3426; Sartore, Rafaela/0000-0002-1801-8650; Velasco, Silvia/0000-0003-0638-0932; da Silveira Paulsen, Bruna/0000-0001-5304-0610; Podury, Archana/0000-0001-5042-9196; Kedaigle, Amanda/0000-0001-6156-5046; Pigoni, Martina/0000-0002-7896-6978	Stanley Center for Psychiatric Research; Broad Institute of MIT and Harvard; National Institutes of Health [R01-MH112940, P50MH094271, U01MH115727, 1RF1MH123977, MH099448]; Klarman Cell Observatory; Howard Hughes Medical Institute; Simons Foundation [346073]	Stanley Center for Psychiatric Research; Broad Institute of MIT and Harvard; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation	We thank J. R. Brown (from the P.A. laboratory) for input and assistance in editing the manuscript and all of the members of the Arlotta laboratory for discussions; M. Daly, E. Robinson and B. Neale for discussions on autism genetics; T. Nguyen (from the G.Q. laboratory) for support with organoid generation; X. Jin (from the P.A. laboratory) for helping with designing and sequencing edited lines; A. Shetty (from the P.A. laboratory) for help with scRNA-seq cell type classification; N. Haywood for help with scRNA-seq experiments; D. Di Bella (from the P.A. laboratory) for help with final edits of the manuscript; S. Andreadis and S. Getz (from the P.A. laboratory) for help with editing images; F. Zhang and J. Pan for supporting the creation of the HUES66 CHD8-mutant line; members of the Talkowski laboratory for the GM08330 line; members of the Cohen laboratory for the Mito210 line; members of the Ricci laboratory for providing nanoblades for the generation of SUV420H1 edited cell lines; L. M. Daheron at the Harvard Stem Cell Facility for expanding edited lines; and B. Budnik at the Harvard Center for Mass Spectrometry for assisting with proteomics experiments. This work was supported by grants from the Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, the National Institutes of Health (R01-MH112940 to P.A. and J.Z.L.; P50MH094271, U01MH115727 and 1RF1MH123977 to P.A.), the Klarman Cell Observatory to J.Z.L. and A.R., and the Howard Hughes Medical Institute to A.R. A.R. was a Howard Hughes Medical Institute and a Koch Institute extramural member while conducting this study. The HUES66 CHD8-mutant line was created with support from the Simons Foundation (346073 to F. Zhang) and the National Institutes of Health (MH099448 to J. Pan).	Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Adhya D, 2021, BIOL PSYCHIAT, V89, P486, DOI 10.1016/j.biopsych.2020.06.014; Akhmedov M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005694; [Anonymous], 2019, NUCLEI ISOLATION MOU; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Faundes V, 2018, AM J HUM GENET, V102, P175, DOI 10.1016/j.ajhg.2017.11.013; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang YH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1865-2; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Lord C, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-019-0138-4; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lovell-Badge R, 2021, STEM CELL REP, V16, P1398, DOI 10.1016/j.stemcr.2021.05.012; Lun ATL, 2017, BIOSTATISTICS, V18, P451, DOI 10.1093/biostatistics/kxw055; Mangeot PE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07845-z; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; McCarthy DJ, 2020, NAT METHODS, V17, P414, DOI 10.1038/s41592-020-0766-3; MOFFAT JJ, MOL PSYCHIATR; Muller J, 2015, LAB CHIP, V15, P2767, DOI 10.1039/c5lc00133a; Ohgane K., 2019, QUANTIFICATION GEL B; Ostasiewicz P, 2010, J PROTEOME RES, V9, P3688, DOI 10.1021/pr100234w; Pachitariu M., 2017, BIORXIV, DOI DOI 10.1101/061507; Pardy C, 2020, MPMI MIXED PAIR MUTU; Park YG, 2019, NAT BIOTECHNOL, V37, P73, DOI 10.1038/nbt.4281; Quadrato G., 2017, PROTOC EXCHANGE, DOI 10.1038/protex.2017.049; Rainer J., 2017, HSAPIENS V86 ENSEM; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Ruzzo EK, 2019, CELL, V178, P850, DOI 10.1016/j.cell.2019.07.015; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tuncbag N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004879; Tuncbag N, 2013, J COMPUT BIOL, V20, P124, DOI 10.1089/cmb.2012.0092; Vals MA, 2014, EUR J HUM GENET, V22, P1327, DOI 10.1038/ejhg.2014.25; Velasco S., 2019, PROTOC EXCHANGE, DOI 10.21203/rs.2.9542/v1; Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Villa C. E., 2020, CHD8 HAPLOINSUFFIENC, DOI 10.1101/2020.11.26.399469; Wade AA, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00481; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Wang ZJ, 2021, NEUROPSYCHOPHARMACOL, V46, P1617, DOI 10.1038/s41386-021-01029-y; Wickramasekara RN, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010011; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wisniewski JR, 2016, ANAL CHEM, V88, P5438, DOI 10.1021/acs.analchem.6b00859; Yoon S, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5738-6; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147; ZHENG GX, 2017, NATURE, V0008; Zlotogora J, 2003, GENET MED, V5, P347, DOI 10.1097/01.GIM.0000086478.87623.69	80	28	28	44	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					268	+		10.1038/s41586-021-04358-6	http://dx.doi.org/10.1038/s41586-021-04358-6		FEB 2022	40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	35110736	Green Accepted			2022-12-28	WOS:000750001600001
J	Slomski, A				Slomski, Anita			Extending Rivaroxaban After COVID-19 Hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2022	327	8					710	710		10.1001/jama.2022.1533	http://dx.doi.org/10.1001/jama.2022.1533		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ2NN	35107564	Bronze			2022-12-28	WOS:000750997800001
J	Heier, JS; Khanani, AM; Ruiz, CQ; Basu, K; Ferrone, PJ; Brittain, C; Figueroa, MS; Lin, H; Holz, FG; Patel, V; Lai, TYY; Silverman, D; Regillo, C; Swaminathan, B; Viola, F; Cheung, CMG; Wong, TY				Heier, Jeffrey S.; Khanani, Arshad M.; Ruiz, Carlos Quezada; Basu, Karen; Ferrone, Philip J.; Brittain, Christopher; Figueroa, Marta S.; Lin, Hugh; Holz, Frank G.; Patel, Vaibhavi; Lai, Timothy Y. Y.; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Wong, Tien Y.		TENAYA Investigators; LUCERNE Investigators	Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials	LANCET			English	Article							TREAT-AND-EXTEND; RANIBIZUMAB; THERAPY; EYE	Background Faricimab is a bispecific antibody that acts through dual inhibition of both angiopoietin-2 and vascular endothelial growth factor A. We report primary results of two phase 3 trials evaluating intravitreal faricimab with extension up to every 16 weeks for neovascular age-related macular degeneration (nAMD). Methods TENAYA and LUCERNE were randomised, double-masked, non-inferiority trials across 271 sites worldwide. Treatment-naive patients with nAMD aged 50 years or older were randomly assigned (1:1) to intravitreal faricimab 6 center dot 0 mg up to every 16 weeks, based on protocol-defined disease activity assessments at weeks 20 and 24, or aflibercept 2 center dot 0 mg every 8 weeks. Randomisation was performed through an interactive voice or web-based response system using a stratified permuted block randomisation method. Patients, investigators, those assessing outcomes, and the funder were masked to group assignments. The primary endpoint was mean change in bestcorrected visual acuity (BCVA) from baseline averaged over weeks 40, 44, and 48 (prespecified non- inferiority margin of four letters), in the intention-to-treat population. Safety analyses included patients who received at least one dose of study treatment. These trials are registered with ClinicalTrials.gov (TENAYA NCT03823287 and LUCERNE NCT03823300). Findings Across the two trials, 1329 patients were randomly assigned between Feb 19 and Nov 19, 2019 (TENAYA n=334 faricimab and n=337 aflibercept), and between March 11 and Nov 1, 2019 (LUCERNE n=331 faricimab and n=327 aflibercept). BCVA change from baseline with faricimab was non-inferior to aflibercept in both TENAYA (adjusted mean change 5.8 letters [95% CI 4.6 to 7.1] and 5.1 letters [3.9 to 6.4]; treatment difference 0.7 letters [-1.1 to 2.5]) and LUCERNE (6.6 letters [5.3 to 7.8] and 6.6 letters [5.3 to 7.8]; treatment difference 0.0 letters [-1.7 to 1.8]). Rates of ocular adverse events were comparable between faricimab and aflibercept (TENAYA n=121 [36.3%] vs n=128 [38.1%], and LUCERNE n=133 [40.2%] vs n=118 [36.2%]). Interpretation Visual benefits with faricimab given at up to 16-week intervals demonstrates its potential to meaningfully extend the time between treatments with sustained efficacy, thereby reducing treatment burden in patients with nAMD. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Heier, Jeffrey S.] Ophthalm Consultants Boston, Boston, MA 02114 USA; [Khanani, Arshad M.] Sierra Eye Associates, Reno, NV USA; [Khanani, Arshad M.] Univ Nevada, Reno Sch Med, Reno, NV 89557 USA; [Ruiz, Carlos Quezada] San Pedro Garza Garcia, San Pedro Garza Garcia, Nuevo Leon, Mexico; [Ruiz, Carlos Quezada; Brittain, Christopher; Lin, Hugh] Genentech Inc, San Francisco, CA USA; [Basu, Karen] Roche Prod Ireland, Dublin, Ireland; [Ferrone, Philip J.] Vitreoretinal Consultants New York, Great Neck, NY USA; [Figueroa, Marta S.] Ramon y Cajal Univ Hosp, Clin Baviera, Madrid, Spain; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Holz, Frank G.] Univ Bonn, GRADE Reading Ctr, Bonn, Germany; [Patel, Vaibhavi; Silverman, David] Roche Prod, Welwyn Garden City, Herts, England; [Lai, Timothy Y. Y.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China; [Regillo, Carl] Thomas Jefferson Univ, Wills Eye Hosp, Mid Atlantic Retina, Philadelphia, PA 19107 USA; [Swaminathan, Balakumar] Hoffmann La Roche, Mississauga, ON, Canada; [Viola, Francesco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Viola, Francesco] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Cheung, Chui Ming Gemmy; Wong, Tien Y.] Natl Univ Singapore, Singapore Natl Eye Ctr, Duke NUS Med Sch, Singapore, Singapore	Ophthalmic Consultants of Boston; Nevada System of Higher Education (NSHE); University of Nevada Reno; Roche Holding; Genentech; Hospital Universitario Ramon y Cajal; University of Bonn; University of Bonn; Roche Holding; Chinese University of Hong Kong; Jefferson University; Roche Holding; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; National University of Singapore; Singapore National Eye Center	Heier, JS (corresponding author), Ophthalm Consultants Boston, Boston, MA 02114 USA.	jsheier@eyeboston.com	Cagini, Carlo/H-3431-2019; Sikorski, Bartosz L/AHD-2057-2022; Khoramnia, Ramin/AAR-8358-2020; Nowinska, Anna K/G-6165-2013; Virgili, Gianni/P-6607-2014	Cagini, Carlo/0000-0002-3812-9219; Sikorski, Bartosz L/0000-0001-5357-9560; Khoramnia, Ramin/0000-0002-6237-7773; Nowinska, Anna K/0000-0002-8418-3486; Talks, James/0000-0001-6126-6476; Silverman, David/0000-0003-1842-5739; Virgili, Gianni/0000-0002-9960-2989; Lai, Chi-Chun/0000-0001-9547-7212; Mones, Jordi/0000-0003-3685-2160	F Hoffmann-La Roche	F Hoffmann-La Roche(Hoffmann-La Roche)	F Hoffmann-La Roche.	American Academy of Ophthalmology Retina/Vitreous PPP Panel Hoskins Center for Quality Eye Care, 2019, PREF PRACT PATT AG R; American Society of Retina Specialists,, 2020, MEMB UPD NOV SAF REV; Augsburger M, 2019, GRAEF ARCH CLIN EXP, V257, P1889, DOI 10.1007/s00417-019-04404-0; Busbee BG, 2013, OPHTHALMOLOGY, V120, P1046, DOI 10.1016/j.ophtha.2012.10.014; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Ciulla TA, 2020, OPHTHALMOL RETINA, V4, P19, DOI 10.1016/j.oret.2019.05.017; Daien V, 2021, BRIT J OPHTHALMOL, V105, P1475, DOI 10.1136/bjophthalmol-2020-317434; Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017; Eylea, 2021, PRESCRIBING INFORM; Gillies MC, 2019, JAMA OPHTHALMOL, V137, P372, DOI 10.1001/jamaophthalmol.2018.6776; Heier JS, 2021, RETINA-J RET VIT DIS, V41, P1, DOI 10.1097/IAE.0000000000003003; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; Joussen AM, 2021, EYE, V35, P1305, DOI 10.1038/s41433-020-01377-x; Khanani Arshad M, 2021, Ophthalmol Sci, V1, P100076, DOI 10.1016/j.xops.2021.100076; Khanani AM, 2020, JAMA OPHTHALMOL, V138, P964, DOI 10.1001/jamaophthalmol.2020.2699; Khanani AM, 2020, OPHTHALMOL RETINA, V4, P122, DOI 10.1016/j.oret.2019.09.009; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Okada M, 2021, OPHTHALMOLOGY, V128, P234, DOI 10.1016/j.ophtha.2020.07.060; Prenner JL, 2015, AM J OPHTHALMOL, V160, P725, DOI 10.1016/j.ajo.2015.06.023; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Regula JT, 2016, EMBO MOL MED, V8, P1265, DOI 10.15252/emmm.201505889; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sahni J, 2020, JAMA OPHTHALMOL, V138, P955, DOI 10.1001/jamaophthalmol.2020.2685; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Silva R, 2018, OPHTHALMOLOGY, V125, P57, DOI 10.1016/j.ophtha.2017.07.014; Singer MA, 2012, OPHTHALMOLOGY, V119, P1175, DOI 10.1016/j.ophtha.2011.12.016; Wykoff CC, 2015, OPHTHALMOLOGY, V122, P2514, DOI 10.1016/j.ophtha.2015.08.009	29	24	24	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					729	740		10.1016/S0140-6736(22)00010-1	http://dx.doi.org/10.1016/S0140-6736(22)00010-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE3NS	35085502	Green Accepted			2022-12-28	WOS:000758794200020
J	McIntyre, A; Shepard, M				McIntyre, Adrianna; Shepard, Mark			Automatic Insurance Policies - Important Tools for Preventing Coverage Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McIntyre, Adrianna] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Shepard, Mark] Harvard Kennedy Sch, Cambridge, MA USA; [Shepard, Mark] Natl Bureau Econ Res, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; National Bureau of Economic Research	McIntyre, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Domurat R, 2021, AM ECON REV, V111, P1549, DOI 10.1257/aer.20190823; McIntyre A, 2021, AEA PAP P, V111, P560, DOI 10.1257/pandp.20211083; Rae M., 2021, AM RESCUE PLAN ACT A; Shepard M., 2021, REDUCING ORDEALS AUT; U.S. Department of Health and Human Services, 2021, FED REGISTER, V86, P35156	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					408	411		10.1056/NEJMp2114189	http://dx.doi.org/10.1056/NEJMp2114189		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YR1JU	35089664	Green Accepted			2022-12-28	WOS:000748300500001
J	Luks, AM; Hackett, PH				Luks, Andrew M.; Hackett, Peter H.			Medical Conditions and High-Altitude Travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MOUNTAIN-SICKNESS; PULMONARY-EDEMA; CARDIOVASCULAR-DISEASES; MODERATE ALTITUDE; AIR-TRAVEL; HYPOXIA; EXERCISE; RECOMMENDATIONS; PROPHYLAXIS; PREVALENCE	High-Altitude Travel with Medical Problems Travel to high altitude is increasing. The authors discuss physiological changes at high altitude, pretravel evaluation for common medical conditions, and the risks of high-altitude headache, acute mountain sickness, high-altitude pulmonary edema, and high-altitude cerebral edema.	[Luks, Andrew M.] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Hackett, Peter H.] Univ Colorado Anschutz Med Campus, Dept Med, Div Pulm Sci & Crit Care Med, Altitude Res Ctr, Aurora, CO USA	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Luks, AM (corresponding author), Harborview Med Ctr, Div Pulm Crit Care & Sleep Med, 325 Ninth Ave,Box 359762, Seattle, WA 98104 USA.	aluks@uw.edu		Hackett, Peter/0000-0002-6882-4853				Agostoni P, 2000, AM J MED, V109, P450, DOI 10.1016/S0002-9343(00)00532-5; Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Basnyat B, 1997, WILD ENVIRON MED, V8, P176, DOI 10.1580/1080-6032(1997)008[0176:LTTE]2.3.CO;2; Basnyat B, 2000, WILD ENVIRON MED, V11, P89, DOI 10.1580/1080-6032(2000)011[0089:DAAPAE]2.3.CO;2; Beidleman BA, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14263; Beidleman BA, 2009, HIGH ALT MED BIOL, V10, P253, DOI 10.1089/ham.2009.1004; Bloch KE, 2009, HIGH ALT MED BIOL, V10, P25, DOI 10.1089/ham.2008.1043; Christensen CC, 2000, EUR RESPIR J, V15, P635, DOI 10.1183/09031936.00.15463500; Christensen CC, 2002, EUR RESPIR J, V20, P300, DOI 10.1183/09031936.02.00222302; Cogo A, 2009, HIGH ALT MED BIOL, V10, P117, DOI 10.1089/ham.2009.1007; Cornwell WK, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.121.023225; Dehnert C, 2005, EUR RESPIR J, V25, P545, DOI 10.1183/09031936.05.00070404; Dehnert C, 2014, WILD ENVIRON MED, V25, P263, DOI 10.1016/j.wem.2014.04.004; DeLoughery TG, 2021, HIGH ALT MED BIOL, V22, P113, DOI 10.1089/ham.2021.0038; DILLARD TA, 1989, ANN INTERN MED, V111, P362, DOI 10.7326/0003-4819-111-5-362; Dine CJ, 2008, CHEST, V133, P1002, DOI 10.1378/chest.07-1354; Dunham-Snary KJ, 2017, CHEST, V151, P181, DOI 10.1016/j.chest.2016.09.001; Faulhaber M, 2007, HIGH ALT MED BIOL, V8, P245, DOI 10.1089/ham.2007.1005; Faulhaber M, 2011, J TRAVEL MED, V18, P355, DOI 10.1111/j.1708-8305.2011.00536.x; Fischer R, 2005, EUR RESPIR J, V25, P718, DOI 10.1183/09031936.05.10087304; Furian M, 2018, INT J CHRONIC OBSTR, V13, P3529, DOI 10.2147/COPD.S173039; GONG H, 1984, AM REV RESPIR DIS, V130, P980; Hackett PH, 2001, LUNG BIOL HEALTH DIS, V161, P839; HACKETT PH, 1980, NEW ENGL J MED, V302, P1070, DOI 10.1056/NEJM198005083021907; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2004, HIGH ALT MED BIOL, V5, P136, DOI 10.1089/1527029041352054; Hampson NB, 2013, AVIAT SPACE ENVIR MD, V84, P27, DOI 10.3357/ASEM.3438.2013; Harinck E, 1996, CIRCULATION, V93, P272, DOI 10.1161/01.CIR.93.2.272; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Hvidberg MF, 2020, PHARMACOECON-OPEN, V4, P361, DOI 10.1007/s41669-019-0167-7; Jean D, 2012, HIGH ALT MED BIOL, V13, P73, DOI 10.1089/ham.2012.1021; Karinen H, 2008, HIGH ALT MED BIOL, V9, P301, DOI 10.1089/ham.2008.1008; Keyes LE, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw052; Kim JH, 2021, JAMA CARDIOL, V6, P219, DOI 10.1001/jamacardio.2020.5890; King BR, 2011, DIABETES CARE, V34, P1932, DOI 10.2337/dc11-0139; Latshang TD, 2011, HIGH ALT MED BIOL, V12, P303, DOI 10.1089/ham.2011.1055; Lucas SJE, 2011, J PHYSIOL-LONDON, V589, P741, DOI 10.1113/jphysiol.2010.192534; Luks AM, 2007, EUR RESPIR J, V29, P770, DOI 10.1183/09031936.00052606; Luks AM., 2017, AUERBACHS WILDERNESS, V7th ed, P29; Luks AM., 2021, HIGH ALTITUDE MED PH, V6, P75; Luks AM., 2014, HIGH ALTITUDE HUMAN, P449; Luks AM, 2008, CHEST, V133, P744, DOI 10.1378/chest.07-1417; Luks AM, 2021, HIGH ALT MED BIOL, V22, P119, DOI 10.1089/ham.2021.0049; Luks AM, 2019, WILD ENVIRON MED, V30, pS3, DOI 10.1016/j.wem.2019.04.006; Luks AM, 2016, HIGH ALT MED BIOL, V17, P147, DOI 10.1089/ham.2016.0060; Luks AM, 2011, HIGH ALT MED BIOL, V12, P109, DOI 10.1089/ham.2011.0013; Luks AM, 2009, HIGH ALT MED BIOL, V10, P321, DOI 10.1089/ham.2009.1051; Luks AM, 2009, HIGH ALT MED BIOL, V10, P215, DOI 10.1089/ham.2009.10306; Maggiorini M, 2006, ANN INTERN MED, V145, P497, DOI 10.7326/0003-4819-145-7-200610030-00007; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; Parati G, 2018, EUR HEART J, V39, P1546, DOI 10.1093/eurheartj/ehx720; Pavan P, 2004, MED SCI SPORT EXER, V36, P1283, DOI 10.1249/01.MSS.0000135782.93008.6C; PUGH LGC, 1964, J APPL PHYSIOL, V19, P431, DOI 10.1152/jappl.1964.19.3.431; Richalet JP, 2012, AM J RESP CRIT CARE, V185, P192, DOI 10.1164/rccm.201108-1396OC; Richards P, 2013, HIGH ALT MED BIOL, V14, P197, DOI 10.1089/ham.2013.1020; ROEGGLA G, 1995, BRIT J SPORT MED, V29, P110, DOI 10.1136/bjsm.29.2.110; Roggla G, 2006, J TRAVEL MED, V13, P248, DOI 10.1111/j.1708-8305.2006.00052.x; Schneider M, 2018, HIGH ALT MED BIOL, V19, P321, DOI 10.1089/ham.2018.0025; Schodel J, 2019, NAT REV NEPHROL, V15, P641, DOI 10.1038/s41581-019-0182-z; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; SHLIM DR, 1989, JAMA-J AM MED ASSOC, V261, P1017, DOI 10.1001/jama.261.7.1017; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; SWENSON ER, 1995, J APPL PHYSIOL, V78, P377, DOI 10.1152/jappl.1995.78.2.377; Swenson ER, 2013, HIGH ALT MED BIOL, V14, P101, DOI 10.1089/ham.2013.1010; van Adrichem EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142641; Weil JV, 2004, HIGH ALT MED BIOL, V5, P180, DOI 10.1089/1527029041352162; WEIL JV, 1970, J CLIN INVEST, V49, P1061, DOI 10.1172/JCI106322	70	10	10	19	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					364	373		10.1056/NEJMra2104829	http://dx.doi.org/10.1056/NEJMra2104829			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081281				2022-12-28	WOS:000753548900013
J	Fouladpour, N				Fouladpour, Nickolas			Poppy's Final Lesson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fouladpour, Nickolas] Ohio State Univ, Dept Internal Med, Div Palliat Med, Columbus, OH 43210 USA	Ohio State University	Fouladpour, N (corresponding author), Ohio State Univ, McCampbell Hall,Fifth Floor,1581 Dodd Dr, Columbus, OH 43210 USA.	fouladpour@osumc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					325	326						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076662				2022-12-28	WOS:000753055700007
J	Slomski, A				Slomski, Anita			Teriflunomide Reduced Lesions in Pediatric Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					314	314						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076668				2022-12-28	WOS:000753055700032
J	Slavov, N				Slavov, Nikolai			Counting protein molecules for single-cell proteomics	CELL			English	Editorial Material								Technologies for counting protein molecules are enabling single-cell proteomics at increasing depth and scale. New advances in single-molecule methods by Brinkerhoff and colleagues promise to further increase the sensitivity of protein analysis and motivate questions about scaling up the counting of the human proteome.	[Slavov, Nikolai] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Slavov, Nikolai] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Slavov, N (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.; Slavov, N (corresponding author), Northeastern Univ, Barnett Inst, Boston, MA 02115 USA.	nslavov@northeastern.edu			The Paul G. Allen Frontiers Group; Seed Networks Award from CZI [CZF2019-002424]; NIH [1UG3CA268117]	The Paul G. Allen Frontiers Group; Seed Networks Award from CZI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author is funded by an Allen Distinguished Investigator award through The Paul G. Allen Frontiers Group, a Seed Networks Award from CZI (CZF2019-002424), and an NIH award 1UG3CA268117.	Alfaro JA, 2021, NAT METHODS, V18, P604, DOI 10.1038/s41592-021-01143-1; Bekker-Jensen DB, 2017, CELL SYST, V4, P587, DOI 10.1016/j.cels.2017.05.009; Brinkerhoff H, 2021, SCIENCE, V374, P1509, DOI 10.1126/science.abl4381; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Marx V, 2019, NAT METHODS, V16, P809, DOI 10.1038/s41592-019-0540-6; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Slavov N, 2021, J PROTEOME RES, V20, P4915, DOI 10.1021/acs.jproteome.1c00639; Slavov N, 2020, SCIENCE, V367, P512, DOI 10.1126/science.aaz6695; Vistain LF, 2021, TRENDS BIOCHEM SCI, V46, P661, DOI 10.1016/j.tibs.2021.01.013	9	1	1	13	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					232	234		10.1016/j.cell.2021.12.013	http://dx.doi.org/10.1016/j.cell.2021.12.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35063071	Green Accepted			2022-12-28	WOS:000746172100005
J	Higgins, RD; Das, A				Higgins, Rosemary D.; Das, Abhik			Progress in neonate safety	LANCET			English	Editorial Material							INTENSIVE-CARE-UNIT; QUALITY IMPROVEMENT		[Higgins, Rosemary D.] George Mason Univ, Dept Global & Community Hlth, Coll Hlth & Human Serv, Fairfax, VA 22030 USA; [Das, Abhik] RTI Int, Biostat & Epidemiol Div, Rockville, MD USA	George Mason University; Research Triangle Institute	Higgins, RD (corresponding author), George Mason Univ, Dept Global & Community Hlth, Coll Hlth & Human Serv, Fairfax, VA 22030 USA.	rhiggin@gmu.edu	Das, Abhik/AAF-1883-2020	Das, Abhik/0000-0003-2722-0479				Caeymaex L, 2021, LANCET, V399, P384; Edwards EM, 2019, TRANSL PEDIATR, V8, P182, DOI 10.21037/tp.2019.07.01; Ellsbury DL, 2017, CURR OPIN PEDIATR, V29, P129, DOI 10.1097/MOP.0000000000000457; Hemming K, BMJ; Hemming K, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k1614; Ho T, 2017, CLIN PERINATOL, V44, P617, DOI 10.1016/j.clp.2017.05.009; Panagos PG, 2017, CLIN PERINATOL, V44, P645, DOI 10.1016/j.clp.2017.05.006; Shah V, 2013, ACAD PEDIATR, V13, pS75, DOI 10.1016/j.acap.2013.04.014; Spitzer AR, 2017, CLIN PERINATOL, V44, P469, DOI 10.1016/j.clp.2017.04.005; Tawfik DS, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4592-1	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					340	341						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065772				2022-12-28	WOS:000746046100004
J	McCall, C				McCall, Chris			Tonga disaster health response accelerates	LANCET			English	Editorial Material								Communications with the island nation are being restored as the aid response begins to reach affected populations. Chris McCall reports.											0	0	0	6	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					423	423						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093216	Bronze			2022-12-28	WOS:000755141600009
J	van der Merwe, LLA; Cloete, A; Skinner, D				van der Merwe, L. Leigh-Ann; Cloete, Allanise; Skinner, Donald			How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa	LANCET			English	Editorial Material							WOMEN		[van der Merwe, L. Leigh-Ann] Social Hlth & Empowerment Feminist Collect Transg, East London, South Africa; [Cloete, Allanise; Skinner, Donald] Human Sci Res Council, Human & Social Capabil Div, Pretoria, South Africa	Human Sciences Research Council-South Africa	van der Merwe, LLA (corresponding author), Social Hlth & Empowerment Feminist Collect Transg, East London, South Africa.	transfeminists@gmail.com						Bockting W, 2020, AIDS PATIENT CARE ST, V34, P16, DOI 10.1089/apc.2019.0067; CloeteA, 2019, 9 S AFR AIDS C DURB; de Villiers L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09942-5; Luvuno ZP, 2017, GEND BEHAV, V15, P8703; Moran A, 2020, ANN EPIDEMIOL, V42, P25, DOI 10.1016/j.annepidem.2019.11.003; da Rocha ABM, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002374; Muller A, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0124-4; Phanuphuk N., 2021, J INT AIDS SOC, V24; Poteat TC, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25661; Price R., 2021, ACCESS CLIMATE FINAN; Rees K, 2017, SEX TRANSM DIS, V44, P768, DOI 10.1097/OLQ.0000000000000679; Scheibe A, 2018, S AFRICAN HEAL REV; Sevelius J, 2019, CULT HEALTH SEX, V21, P543, DOI 10.1080/13691058.2018.1496277; Shaikh S, 2016, J INT AIDS SOC, V19, P35, DOI 10.7448/IAS.19.3.20809; Tomson A, 2021, S AFR J HIV MED, V22, DOI 10.4102/sajhivmed.v22i1.1299; Van der Merwe LLA, 2020, AGENDA-EMPOWER WOMEN, V34, P41, DOI 10.1080/10130950.2019.1706985; Ziegler E, 2020, SAGE OPEN, V10, DOI 10.1177/2158244020962824	17	0	0	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1099	1101		10.1016/S0140-6736(22)00177-5	http://dx.doi.org/10.1016/S0140-6736(22)00177-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35131042				2022-12-28	WOS:000770814300006
J	Tokar, JL; Higa, JT				Tokar, Jeffrey L.; Higa, Jennifer T.			In the Clinic Acute Gastrointestinal Bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BOWEL CAPSULE ENDOSCOPY; HELICOBACTER-PYLORI; PEPTIC-ULCER; EUROPEAN-SOCIETY; COMPUTED-TOMOGRAPHY; PRACTICE UPDATE; RISK-FACTORS; MANAGEMENT; DIAGNOSIS; GUIDELINE	Acute gastrointestinal bleeding (GIB) is a common clinical entity. Expert management of acute GIB requires collaborative care between internists and other specialists. This article reviews the presentation, treatment, and prevention of acute GIB using recommendations from recent guidelines and expert panel reviews. The article acknowledges the pivotal role played by primary care providers in the inpatient and outpatient management of acute GIB.	[Tokar, Jeffrey L.; Higa, Jennifer T.] Temple Hlth, Fox Chase Canc Ctr, Gastroenterol Sect, Philadelphia, PA 19140 USA	Fox Chase Cancer Center	Tokar, JL (corresponding author), Temple Hlth, Fox Chase Canc Ctr, Gastroenterol Sect, Philadelphia, PA 19140 USA.							Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Anglin R, 2014, AM J GASTROENTEROL, V109, P810, DOI 10.1038/ajg.2014.82; Arisawa T, 2007, INT J MOL MED, V20, P373; Azam Z, 2012, J HEPATOL, V56, P819, DOI 10.1016/j.jhep.2011.11.019; Aziz M, 2020, ANN GASTROENTEROL, V33, P145, DOI 10.20524/aog.2020.0448; Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Barkun AN, 2019, ANN INTERN MED, V171, P805, DOI 10.7326/M19-1795; Barkun AN, 2012, AM J GASTROENTEROL, V107, P507, DOI 10.1038/ajg.2011.474; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Becq A, 2017, GASTROINTEST ENDOSC, V86, P792, DOI 10.1016/j.gie.2017.05.018; Cappell MS, 2008, MED CLIN N AM, V92, P491, DOI 10.1016/j.mcna.2008.01.005; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Cheng LF, 2010, CLIN GASTROENTEROL H, V8, P760, DOI 10.1016/j.cgh.2010.05.019; Chey WD, 2017, AM J GASTROENTEROL, V112, P212, DOI 10.1038/ajg.2016.563; Cook D, 2018, NEW ENGL J MED, V378, P2506, DOI 10.1056/NEJMra1605507; Crowe SE, 2019, NEW ENGL J MED, V380, P1158, DOI 10.1056/NEJMcp1710945; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Fallone CA, 2019, GASTROENTEROLOGY, V157, P44, DOI 10.1053/j.gastro.2019.04.011; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Gerson Lauren B, 2017, Gastrointest Endosc Clin N Am, V27, P171, DOI 10.1016/j.giec.2016.08.010; Gerson LB, 2015, AM J GASTROENTEROL, V110, P1265, DOI 10.1038/ajg.2015.246; Gralnek IM, 2021, ENDOSCOPY, V53, P300, DOI 10.1055/a-1369-5274; Gralnek IM, 2011, GASTROINTEST ENDOSC, V73, P909, DOI 10.1016/j.gie.2011.01.035; Henry Z, 2021, CLIN GASTROENTEROL H, V19, P1098, DOI 10.1016/j.cgh.2021.01.027; Holster IL, 2013, GASTROENTEROLOGY, V145, P105, DOI 10.1053/j.gastro.2013.02.041; Jensen DM, 2021, CLIN GASTROENTEROL H, V19, P2315, DOI 10.1016/j.cgh.2020.08.046; Karstensen JG, 2020, ENDOSC INT OPEN, V08, pE990, DOI 10.1055/a-1187-1154; Karuppasamy K, 2021, J AM COLL RADIOL, V18, pS139, DOI 10.1016/j.jacr.2021.02.018; Kim CY, 2020, J AM COLL RADIOL, V17, pS239, DOI 10.1016/j.jacr.2020.01.017; Kim JH, 2009, KOREAN J RADIOL, V10, P384, DOI 10.3348/kjr.2009.10.4.384; Kim T, 1997, HEPATOLOGY, V25, P307; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; Kyaw Moe H, 2018, Gastrointest Endosc Clin N Am, V28, P351, DOI 10.1016/j.giec.2018.02.007; LAINE L, 1995, ANN INTERN MED, V123, P280, DOI 10.7326/0003-4819-123-4-199508150-00007; Laine L, 2021, AM J GASTROENTEROL, V116, P899, DOI 10.14309/ajg.0000000000001245; Laursen SB, 2017, GASTROINTEST ENDOSC, V85, P936, DOI 10.1016/j.gie.2016.08.049; Laursen SB, 2015, CLIN GASTROENTEROL H, V13, P115, DOI 10.1016/j.cgh.2014.07.023; Laursen SB, 2021, GUT, V70, P707, DOI 10.1136/gutjnl-2019-320002; Liao ZA, 2010, GASTROINTEST ENDOSC, V71, P280, DOI 10.1016/j.gie.2009.09.031; Malaty HM, 2000, ARCH INTERN MED, V160, P105, DOI 10.1001/archinte.160.1.105; MCCOLL KEL, 1993, GUT, V34, P762, DOI 10.1136/gut.34.6.762; Mishra SR, 2011, J HEPATOL, V54, P1161, DOI 10.1016/j.jhep.2010.09.031; Mullady DK, 2020, GASTROENTEROLOGY, V159, P1120, DOI 10.1053/j.gastro.2020.05.095; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Myburgh JA, 2011, NEW ENGL J MED, V364, P2543, DOI 10.1056/NEJMe1105490; Nakatsu S, 2015, INTERNAL MED, V54, P553, DOI 10.2169/internalmedicine.54.2829; Ofosu A, 2021, J CLIN GASTROENTEROL, V55, pE37, DOI 10.1097/MCG.0000000000001379; Pennazio M, 2015, ENDOSCOPY, V47, P352, DOI 10.1055/s-0034-1391855; Pohl H, 2019, GASTROENTEROLOGY, V157, P977, DOI 10.1053/j.gastro.2019.03.019; Razzaghi A, 2012, J CLIN GASTROENTEROL, V46, P482, DOI 10.1097/MCG.0b013e31823d33e3; Rockall TA, 1996, LANCET, V347, P1138, DOI 10.1016/S0140-6736(96)90607-8; Rondonotti E, 2013, DIGEST LIVER DIS, V45, P179, DOI 10.1016/j.dld.2012.07.012; Schmidt A, 2018, GASTROENTEROLOGY, V155, P674, DOI 10.1053/j.gastro.2018.05.037; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Shah SC, 2021, GASTROENTEROLOGY, V160, P1831, DOI 10.1053/j.gastro.2020.11.059; Shingina A, 2011, ALIMENT PHARM THER, V33, P1010, DOI 10.1111/j.1365-2036.2011.04618.x; Sinagra E, 2014, ALIMENT PHARM THER, V39, P557, DOI 10.1111/apt.12634; Singh-Bhinder N, 2017, J AM COLL RADIOL, V14, pS177, DOI 10.1016/j.jacr.2017.02.038; Strate LL, 2016, AM J GASTROENTEROL, V111, P459, DOI 10.1038/ajg.2016.41; Sugiyama T, 2015, INTERNAL MED, V54, P2961, DOI 10.2169/internalmedicine.54.5097; Talamini G, 1997, DIGESTION, V58, P211, DOI 10.1159/000201446; Triantafyllou K, 2021, ENDOSCOPY, V53, P850, DOI 10.1055/a-1496-8969; Weinhouse GL, 2021, UPTODATE; Wolf AT, 2007, AM J GASTROENTEROL, V102, P290, DOI 10.1111/j.1572-0241.2006.00969.x; Zuccaro G, 1998, AM J GASTROENTEROL, V93, P1202	66	0	0	4	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					ITC17	ITC32		10.7326/AITC202202150	http://dx.doi.org/10.7326/AITC202202150		FEB 2022	16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35130044				2022-12-28	WOS:000758846300003
J	Torjesen, I				Torjesen, Ingrid			Should I send my colleague a Valentine's Day card?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								While almost a fifth of people meet their significant other at work, Ingrid Torjesen finds out if it's acceptable to send a Valentine's card to a colleague											0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o261	10.1136/bmj.o261	http://dx.doi.org/10.1136/bmj.o261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135835	Bronze			2022-12-28	WOS:000754132400001
J	Limb, M				Limb, Matthew			What's behind the government's plan for hospitals to employ more GPs?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		lacobucci G., 2022, BMJ, V376, DOI [10.1136/bmj.o267 pmid: 35105665, DOI 10.1136/BMJ.O267PMID:35105665]; lacobucci G., 2022, BMJ, V376, DOI [10.1136/bmj.o145 pmid: 35045972, DOI 10.1136/BMJ.O145PMID:35045972]; University of Birmingham, VERT INT PRIM PRACT; Yu V, 2020, BRIT J GEN PRACT, V70, pE705, DOI 10.3399/bjgp20X712613	4	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o315	10.1136/bmj.o315	http://dx.doi.org/10.1136/bmj.o315			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121612				2022-12-28	WOS:000753552800022
J	Mahase, E				Mahase, Elisabeth			Opioid related hospital admissions in England increased by nearly 50% in 10 years	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Friebel R, 2022, LANCET PUBLIC HEALTH, V7, pE195, DOI 10.1177/01410768221077360; Levy N, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4901	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o299	10.1136/bmj.o299	http://dx.doi.org/10.1136/bmj.o299			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35115335				2022-12-28	WOS:000753552800023
J	Polizzotto, MN; Nordwall, J; Babiker, AG; Phillips, A; Vock, DM; Eriobu, N; Kwaghe, V; Paredes, R; Mateu, L; Ramachandruni, S; Narang, R; Jain, MK; Lazarte, SM; Baker, JV; Frosch, AEP; Poulakou, G; Syrigos, KN; Amoczy, GS; McBride, NA; Robinson, PA; Sarafian, F; Bhagani, S; Taha, ILS; Benfield, T; Liu, STH; Antoniadou, A; Jensen, JUS; Kalomenidis, I; Susilo, A; Hariadi, P; Jensen, TO; Morales-Rull, JL; Helleberg, M; Meegada, S; Johansen, IS; Canario, D; Fernandez-Cruz, E; Metallidis, S; Shah, A; Sakurai, A; Koulouris, NG; Trounan, R; Weintrob, AC; Podlekareva, D; Hadi, U; Lloyd, KM; Roge, BT; Saito, S; Sweenis, K; Malin, JJ; Lubbert, C; Munoz, J; Cummings, MJ; Losso, MH; Turner, D; Shaw-Saliba, K; Dewar, R; Highbarger, H; Lallemand, P; Rehman, T; Gerry, N; Arlinda, D; Chang, CC; Grund, B; Holbrook, MR; Holley, HP; Hudson, F; McNay, LA; Murray, DD; Pett, SL; Shaughnessy, M; Smolslcis, MC; Touloumi, G; Wright, MF; Doyle, MK; Popik, S; Hall, C; Ramanathan, R; Cao, HY; Mondou, E; Willis, T; Thakuria, JV; Yel, L; Liggs, EI; Kan, VL; Lundgren, JD; Neaton, JD; Lane, HC				Polizzotto, Mark N.; Nordwall, Jacqueline; Babiker, Abdel G.; Phillips, Andrew; Vock, David M.; Eriobu, Nnakelu; Kwaghe, Vivian; Paredes, Roger; Mateu, Lourdes; Ramachandruni, Srikanth; Narang, Rajeev; Jain, Manua K.; Lazarte, Susana M.; Baker, Jason, V; Frosch, Anne E. P.; Poulakou, Garyfallia; Syrigos, Konstantinos N.; Amoczy, Gretchen S.; McBride, Natalie A.; Robinson, Philip A.; Sarafian, Farjad; Bhagani, Sanjay; Taha, I. Lassan S.; Benfield, Thomas; Liu, Sean T. H.; Antoniadou, Anastasia; Jensen, Jens Ulrik Staehr; Kalomenidis, Ioannis; Susilo, Adityo; Hariadi, Prasetyo; Jensen, Tomas O.; Morales-Rull, Jose Luis; Helleberg, Marie; Meegada, Sreenath; Johansen, Isik S.; Canario, Daniel; Fernandez-Cruz, Eduardo; Metallidis, Simeon; Shah, Amish; Sakurai, Aki; Koulouris, Nikolaus G.; Trounan, Robin; Weintrob, Amy C.; Podlekareva, Dania; Hadi, Usman; Lloyd, Kathryn M.; Roge, Birgit Thorup; Saito, Sho; Sweenis, Kelly; Malin, Jakob J.; Luebbert, Christoph; Munoz, Jose; Cummings, Matthew J.; Losso, Marcelo H.; Turner, Dan; Shaw-Saliba, Kathryn; Dewar, Robin; Highbarger, Helene; Lallemand, Pertine; Rehman, Tauseef; Gerry, Norman; Arlinda, Dona; Chang, Christina C.; Grund, Birgit; Holbrook, Michael R.; Holley, Horace P.; Hudson, Fleur; McNay, Laura A.; Murray, Daniel D.; Pett, Sarah L.; Shaughnessy, Megan; Smolslcis, Mary C.; Touloumi, Giota; Wright, Mary F.; Doyle, Mittie K.; Popik, Sharon; Hall, Christine; Ramanathan, Roshan; Cao, Huyen; Mondou, Elsa; Willis, Todd; Thakuria, Joseph, V; Yel, Leman; Liggs, Elizabeth, I; Kan, Virginia L.; Lundgren, Jens D.; Neaton, James D.; Lane, H. Clifford		ITAC INSIGHT 013 Study Grp	Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial	LANCET			English	Article								Background Passive immunotherapy using hyperimmune intravenous immunoglobulin (hIVIG) to SARS-CoV-2, derived from recovered donors, is a potential rapidly available, specific therapy for an outbreak infection such as SARS-CoV-2. Findings from randomised clinical trials of hIVIG for the treatment of COVID-19 are limited. Methods In this international randomised, double-blind, placebo-controlled trial, hospitalised patients with COVID-19 who had been symptomatic for up to 12 days and did not have acute end-organ failure were randomly assigned (1:1) to receive either hIVIG or an equivalent volume of saline as placebo, in addition to remdesivir, when not contraindicated, and other standard clinical care. Randomisation was stratified by site pharmacy; schedules were prepared using a mass-weighted urn design. Infusions were prepared and masked by trial pharmacists; all other investigators, research staff, and trial participants were masked to group allocation. Follow-up was for 28 days. The primary outcome was measured at day 7 by a seven-category ordinal endpoint that considered pulmonary status and extrapulmonary complications and ranged from no limiting symptoms to death. Deaths and adverse events, including organ failure and serious infections, were used to define composite safety outcomes at days 7 and 28. Prespecified subgroup analyses were carried out for efficacy and safety outcomes by duration of symptoms, the presence of antispike neutralising antibodies, and other baseline factors. Analyses were done on a modified intention-to-treat (mITT) population, which included all randomly assigned participants who met eligibility criteria and received all or part of the assigned study product infusion. This study is registered with ClinicalTrials.gov, NCT04546581. Findings From Oct 8, 2020, to Feb 10, 2021, 593 participants (n=301 hIVIG, n=292 placebo) were enrolled at 63 sites in 11 countries; 579 patients were included in the mITT analysis. Compared with placebo, the hIVIG group did not have significantly greater odds of a more favourable outcome at day 7; the adjusted OR was 1.06 (95% CI 0.77-1.45; p=0.72). Infusions were well tolerated, although infusion reactions were more common in the hIVIG group (18.6% vs 9.5% for placebo; p=0.002). The percentage with the composite safety outcome at day 7 was similar for the hIVIG (24%) and placebo groups (25%; OR 0.98, 95% CI 0.66-1.46; p=0.91). The ORs for the day 7 ordinal outcome did not vary for subgroups considered, but there was evidence of heterogeneity of the treatment effect for the day 7 composite safety outcome: risk was greater for hIVIG compared with placebo for patients who were antibody positive (OR 2.21, 95% CI 1.14-4.29); for patients who were antibody negative, the OR was 0.51 (0.29-0.90; p(interaction)=0.001). Interpretation When administered with standard of care including remdesivir, SARS-CoV-2 hIVIG did not demonstrate efficacy among patients hospitalised with COVID-19 without end-organ failure. The safety of hIVIG might vary by the presence of endogenous neutralising antibodies at entry. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Polizzotto, Mark N.] Australian Natl Univ, Clin Hub Intervent Res, Canberra, ACT 2600, Australia	Australian National University	Polizzotto, MN (corresponding author), Australian Natl Univ, Clin Hub Intervent Res, Canberra, ACT 2600, Australia.	mark.polizzotto@anu.edu.au	Jensen, Tomas/AFN-5759-2022; Hadi, Usman/ABE-9657-2020; Lundgren, Jens/AAE-6876-2019; Malin, Jakob J./L-7935-2019	Jensen, Tomas/0000-0003-0398-4431; Hadi, Usman/0000-0001-9348-7046; Malin, Jakob J./0000-0002-2989-0436; Vock, David M/0000-0002-5459-9579; Bhagani, Sanjay/0000-0003-2557-4337; Jain, Mamta/0000-0003-2292-6544; Mateu, Lourdes/0000-0001-7223-7611; Jensen, Jens Ulrik/0000-0003-4036-0521; Paredes, Roger/0000-0002-6553-691X; Benfield, Thomas/0000-0003-0698-9385; Podlekareva, Daria/0000-0003-3187-0597; ERIOBU, NNAKELU/0000-0003-2528-8082	US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US National Institutes of Health.	AALEN OO, 1978, SCAND J STAT, V5, P141; ACTIV-3 TICO LY-CoV555 Study Grp, 2021, NEW ENGL J MED, V384, P905, DOI 10.1056/NEJMoa2033130; Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Ali S, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100926; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Avendano-Sola C, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI152740; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Begin P, 2021, NAT MED, V27, P2012, DOI 10.1038/s41591-021-01488-2; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Davey RT, 2019, LANCET RESP MED, V7, P951, DOI 10.1016/S2213-2600(19)30253-X; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Gharbharan A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23469-2; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Griffin DO, 2021, AIDS REV, V23, P40, DOI 10.24875/AIDSRev.200001261; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Horby PW, 2021, LANCET, DOI [10.1101/2021.06.15.21258542, DOI 10.1101/2021.06.15.21258542V1]; Janiaud P, 2021, JAMA-J AM MED ASSOC, V325, P1185, DOI 10.1001/jama.2021.2747; Joyner MJ, 2021, NEW ENGL J MED, V384, P1015, DOI 10.1056/NEJMoa2031893; Korley FK, 2021, NEW ENGL J MED, V385, P1951, DOI 10.1056/NEJMoa2103784; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lopardo G, 2021, ECLINICALMEDICINE, V34, DOI 10.1016/j.eclinm.2021.100843; Lundgren JD, 2022, ANN INTERN MED, V175, P234, DOI 10.7326/M21-3507; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Vandeberg P, 2021, TRANSFUSION, V61, P1705, DOI 10.1111/trf.16378; Vanderen HA, 2018, J INFECT DIS, V218, P1383, DOI 10.1093/infdis/jiy328; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Zhao WL, 2015, CONTEMP CLIN TRIALS, V43, P209, DOI 10.1016/j.cct.2015.06.008; Zhou BQ, 2011, BIOMETRICS, V67, P661, DOI 10.1111/j.1541-0420.2010.01493.x	36	17	17	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					530	540		10.1016/S0140-6736(22)00101-5	http://dx.doi.org/10.1016/S0140-6736(22)00101-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9ZX	35093205	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000755144500026
J	Rodman, GK; DasGupta, S				Rodman, Glen Kalliope; DasGupta, Sayantani			Beyond Trans competency: imagining a Trans liberatory future	LANCET			English	Editorial Material									[Rodman, Glen Kalliope; DasGupta, Sayantani] Columbia Univ, Div Narrat Med, New York, NY 10027 USA	Columbia University	DasGupta, S (corresponding author), Columbia Univ, Div Narrat Med, New York, NY 10027 USA.	sd2030@columbia.edu							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					514	515						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123684				2022-12-28	WOS:000755144500015
J	Mahase, E				Mahase, Elisabeth			Hampshire maternity units have too few staff to keep women and babies safe, says regulator	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, BAS N HAMPSH HOSP, P2022; Care Quality Commission, ROYAL HAMPSHIRE COUN, P2022; Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2317	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o244	10.1136/bmj.o244	http://dx.doi.org/10.1136/bmj.o244			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091430				2022-12-28	WOS:000749313200008
J	Dhaliwal, M; Small, R; Webb, D; Cluver, L; Ibrahim, M; Bok, L; Nascimento, C; Wang, C; Garagic, A; Jensen, L				Dhaliwal, Mandeep; Small, Roy; Webb, Douglas; Cluver, Lucie; Ibrahim, Mona; Bok, Ludo; Nascimento, Collin; Wang, Cheng; Garagic, Aidan; Jensen, Lars			Covid-19 as a long multiwave event: implications for responses to safeguard younger generations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN; HIV		[Dhaliwal, Mandeep; Small, Roy; Webb, Douglas; Bok, Ludo; Jensen, Lars] United Nations Dev Programme, New York, NY 10017 USA; [Cluver, Lucie; Ibrahim, Mona] Univ Oxford, Oxford, England; [Cluver, Lucie] Univ Cape Town, Cape Town, South Africa; [Nascimento, Collin; Wang, Cheng; Garagic, Aidan] OXY Occidental Coll, Kahane United Nations Program, Los Angeles, CA USA	University of Oxford; University of Cape Town	Dhaliwal, M (corresponding author), United Nations Dev Programme, New York, NY 10017 USA.	mandeep.dhaliwal@undp.org						[Anonymous], 2021, STAT GLOB ED CRIS PA; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Baniya B., 2021, IMPACTS COVID 19 WOR; Bank T.W., 2021, REMOTE LEARNING COVI; Bhatia A, 2021, B WORLD HEALTH ORGAN, V99, P730, DOI 10.2471/BLT.20.283051; Bowe B, 2021, J AM SOC NEPHROL, V32, P2851, DOI 10.1681/ASN.2021060734; Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1; Cluver L., NEW YORK TIMES; Cluver LD, 2019, LANCET CHILD ADOLESC, V3, P245, DOI 10.1016/S2352-4642(19)30033-1; Dixit SM, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005031; Fajardo-Gonzalez J., 2021, MITIGATING POVERTY G; Hillis SD, 2021, LANCET, V398, P391, DOI 10.1016/S0140-6736(21)01253-8; Horobin W., 2021, BLOOMBERG EQUAL 1201; Hughes B. B., 2021, PURSUING SUSTAINABLE; ILO, 2020, WORLD SOC PROT REP 2; Imperial College London, ORPH MAR 6 2020 NOV; International Labour Organization, 2020, YOUTH COVID 19 IMP J; Ismayilova L, 2020, J CLIN CHILD ADOLESC, V49, P18, DOI 10.1080/15374416.2018.1485103; Jensen L., 2021, DEV FUTURES SERIES W; Jha A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i409; MontoyaAguirre M, 2021, UNDP DEV FUTURE SERI; Newsroom TBR, 2021, BRAZ POOR REG MOV HE; Nixon SA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-41; Ogbuoji O, 2021, LANCET, V398, P1280, DOI 10.1016/S0140-6736(21)01448-3; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Phillips David E, 2020, BMJ Glob Health, V5, DOI 10.1136/bmjgh-2020-003430; Rattiwan S, 2021, URG EFF ACT REQ QUEL; Rawlings L, 2021, WORLD BANK BLOG 0621; Santomauro DF, 2021, LANCET, V398, P1700, DOI 10.1016/S0140-6736(21)02143-7; Shah RJ, 2021, FOREIGN AFF, V100, P179; Sherr L, 2020, MASKS SOC IMPACTS CO; Sherr L, 2020, LANCET GLOB HEALTH, V8, pE637, DOI 10.1016/S2214-109X(20)30103-0; UNDP, 2021, PHIL CASE INV MENT H; UNDP data futures platform, GLOB DASHB VACC EQUI; United Nations, 2020, POL BRI ED DUR COVID; United Nations, 2021, REPORT SECRETARY GEN; United Nations, COVID 19 RESP; United Nations, 2020, POL BRI COVID 19 NEE; United Nations Children's Fund, 2021, COVID 19 THR PROGR A; United Nations Children's Fund data hub, COVID19 CHILDR; United Nations Development Programme, 2017, SDG ACC BOTTL ASS; United Nations Educational Scientific and Cultural Organization, ED DISR REC; United Nations Population Fund, 2021, IMP COVID 19 FAM PLA; Whitehead M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n376; Workicho A, 2021, CURR DEV NUTR, V5, DOI 10.1093/cdn/nzab024; World Bank, 2021, GHAN RIS ACC EC TRAN, DOI [10.1596/978-1-4648-1612-3, DOI 10.1596/36580]; World Health Organization, 2021, 2 ROUND NATL PULS SU; World Health Organization, 2022, WHO DIR GEN OPEN REM	48	6	6	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								e068123	10.1136/bmj-2021-068123	http://dx.doi.org/10.1136/bmj-2021-068123			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086910	hybrid, Green Published			2022-12-28	WOS:000748641100011
J	Chase, H; Hampshire, K; Tun, S				Chase, Hannah; Hampshire, Karly; Tun, SanYuMay			Improving the medical curriculum on planetary health and sustainable healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chase, Hannah] Univ Oxford, Oxford, England; [Hampshire, Karly] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Oxford; University of California System; University of California San Francisco	Chase, H (corresponding author), Univ Oxford, Oxford, England.			Chase, Hannah/0000-0002-9858-159X				El Omrani O, 2020, MED TEACH, V42, P1107, DOI 10.1080/0142159X.2020.1796949; GMC, 2018, OUTC GRAD 2018; Hampshire K, PLANETARY HLTH REPOR; Health Care Without Harm, 2019, HEAL CLIM FOOTPR REP; Shaw E, 2021, MED TEACH, V43, P272, DOI 10.1080/0142159X.2020.1860207; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; The Royal Society of Medicine, 2021, HLTH EMERG CLIM CHAN; Tun SanYuMay, 2019, Med Teach, V41, P1168, DOI 10.1080/0142159X.2019.1623870	8	4	4	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o209	10.1136/bmj.o209	http://dx.doi.org/10.1136/bmj.o209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078768	Bronze			2022-12-28	WOS:000759189200008
J	Morgan, M				Morgan, Matt			Matt Morgan: The trouble with "just asking questions"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o172	10.1136/bmj.o172	http://dx.doi.org/10.1136/bmj.o172			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078769	Bronze			2022-12-28	WOS:000759189200007
J	Slomski, A				Slomski, Anita			Apixaban vs Rivaroxaban for Preventing Recurrent VTE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					314	314						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076669				2022-12-28	WOS:000753055700031
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word ... New medical words 1422-1972	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				Aronson JK, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o39; Aronson JK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7586; Aronson JK., 2020, BMJ OPINION; Aronson JK., 2021, BMJ OPINION	4	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o187	10.1136/bmj.o187	http://dx.doi.org/10.1136/bmj.o187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063940	Bronze			2022-12-28	WOS:000838119600002
J	Chantler, C				Chantler, Cyril			Public repository of consultants' practice details should include competing interests	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chantler, Cyril] UCL Partners, London, England	University of London; University College London	Chantler, C (corresponding author), UCL Partners, London, England.							Cumberlege J., 2020, 1 NO HARM REPORT IND; Jones Graham, 2020, REPORT INDEPENDENT I; Lo B, 2009, CONFLICT INTEREST ME; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3115	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o188	10.1136/bmj.o188	http://dx.doi.org/10.1136/bmj.o188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063998	Bronze			2022-12-28	WOS:000838119600009
J	Cheng, S; Butrus, S; Tan, LM; Xu, RZ; Sagireddy, S; Trachtenberg, JT; Shekhar, K; Zipursky, SL				Cheng, Sarah; Butrus, Salwan; Tan, Liming; Xu, Runzhe; Sagireddy, Srikant; Trachtenberg, Joshua T.; Shekhar, Karthik; Zipursky, S. Lawrence			Vision-dependent specification of cell types and function in the developing cortex	CELL			English	Article							CRITICAL PERIOD PLASTICITY; GENE-EXPRESSION; VISUAL-CORTEX; EXPERIENCE; MICROCIRCUITS; CONNECTIVITY; EMERGENCE; RESPONSES; TAXONOMY	The role of postnatal experience in sculpting cortical circuitry, while long appreciated, is poorly understood at the level of cell types. We explore this in the mouse primary visual cortex (V1) using single-nucleus RNA sequencing, visual deprivation, genetics, and functional imaging. We find that vision selectively drives the specification of glutamatergic cell types in upper layers (L) (L2/3/4), while deeper-layer glutamatergic, GABAergic, and non-neuronal cell types are established prior to eye opening. L2/3 cell types form an experience-dependent spatial continuum defined by the graded expression of -200 genes, including regulators of cell adhesion and synapse formation. One of these genes, Igsf9b, a vision-dependent gene encoding an inhibitory synaptic cell adhesion molecule, is required for the normal development of binocular responses in L2/3. In summary, vision preferentially regulates the development of upper-layer glutamatergic cell types through the regulation of cell-type-specific gene expression programs.	[Cheng, Sarah; Tan, Liming; Xu, Runzhe; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cheng, Sarah] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Butrus, Salwan; Sagireddy, Srikant; Shekhar, Karthik] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Helen Wills Neurosci Inst, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Shekhar, Karthik] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.; Shekhar, K (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Helen Wills Neurosci Inst, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Shekhar, K (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	kshekhar@berkeley.edu; lzipursky@mednet.ucla.edu		Sagireddy, Srikant/0000-0002-0057-961X	Stein Eye Institute EyeSTAR program; NSF Graduate Research Fellowship [DGE1752814]; NIH [R00EY028625, EY023871]; W.M. Keck Foundation; University of California, Berkeley	Stein Eye Institute EyeSTAR program; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); University of California, Berkeley(University of California System)	The authors would like to thank Maria del Carmen Diaz de la Loza for illustra-tions. Select images were made using BioRender. The authors thank Xiang Li, Michael Mashock, and Xinmin Li from UCLA Technology Center for Genomics and Bioinformatics for assistance with scRNA-seq. They also thank Andrew El-kins, Damon Polioudakis, Jessica Rexach, and Dan Geschwind for advice and help at early stages in this project. The authors thank Joao Couto for advice on AAV injections and Dilja Krueger-Burg for Igsf9b mutant mice. The authors are grateful to Weizhe Hong, Jonathan Flint, Emilie Marcus, Dario Ringach, and Joshua Sanes and members of the Shekhar and Zipursky labs for critical feed-back. The authors thank Bosiljka Tasic, Hongkui Zeng, and others at the Allen Institute for helpful discussions. This work was supported by the Stein Eye Institute EyeSTAR program (S.C.) , NSF Graduate Research Fellowship (grant DGE1752814 to S.B.) , an NIH grant (R00EY028625 to K.S.) , a grant from the W.M. Keck Foundation to S.L.Z and J.T.T., an NIH grant (EY023871 to J.T.T.) , and startup funds from the University of California, Berkeley (K.S.) . S.L.Z. is an investigator of the Howard Hughes Medical Institute.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Babaev O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07762-1; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Berens P, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006157; Berg J, 2021, NATURE, V598, P151, DOI 10.1038/s41586-021-03813-8; Callaway EM, 2021, NATURE, V598, P86, DOI 10.1038/s41586-021-03950-0; Cembrowski MS, 2018, TRENDS NEUROSCI, V41, P337, DOI 10.1016/j.tins.2018.02.010; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gouwens NW, 2019, NAT NEUROSCI, V22, P1182, DOI 10.1038/s41593-019-0417-0; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hinojosa AJ, 2018, CELL REP, V24, P1231, DOI 10.1016/j.celrep.2018.06.115; Hooks BM, 2020, NEURON, V107, P986, DOI 10.1016/j.neuron.2020.08.004; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim EJ, 2020, NEURON, V107, P274, DOI 10.1016/j.neuron.2020.04.018; Kim MH, 2018, NEURON, V100, P1313, DOI 10.1016/j.neuron.2018.10.023; Kishi JY, 2019, NAT METHODS, V16, P533, DOI 10.1038/s41592-019-0404-0; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; La Chioma A, 2019, CURR BIOL, V29, P2954, DOI 10.1016/j.cub.2019.07.037; Li MS, 2010, BRAIN RES BULL, V81, P107, DOI 10.1016/j.brainresbull.2009.08.028; Lu W, 2017, BRAIN RES BULL, V129, P30, DOI 10.1016/j.brainresbull.2016.07.004; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mardinly AR, 2016, NATURE, V531, P371, DOI 10.1038/nature17187; Mastakov MY, 2001, MOL THER, V3, P225, DOI 10.1006/mthe.2001.0246; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Motta A, 2019, SCIENCE, V366, P1093, DOI 10.1126/science.aay3134; Munoz-Castaneda R, 2021, NATURE, V598, P159, DOI 10.1038/s41586-021-03970-w; Nakashima A, 2019, SCIENCE, V365, P46, DOI 10.1126/science.aaw5030; O'Leary TP, 2020, ELIFE, V9, DOI 10.7554/eLife.59003; Ortiz C, 2021, ANNU REV NEUROSCI, V44, P547, DOI 10.1146/annurev-neuro-100520-082639; Paxinos G, 2012, PAXINOS FRANKLINS MO; Peng YR, 2019, CELL, V176, P1222, DOI 10.1016/j.cell.2019.01.004; Reh RK, 2020, P NATL ACAD SCI USA, V117, P23242, DOI 10.1073/pnas.1820836117; Sanes JR, 2020, CELL, V181, P536, DOI 10.1016/j.cell.2020.04.008; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scala F, 2021, NATURE, V598, P144, DOI 10.1038/s41586-020-2907-3; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tan LM, 2021, CURR BIOL, V31, P4305, DOI 10.1016/j.cub.2021.07.053; Tan LM, 2020, NEURON, V108, P735, DOI 10.1016/j.neuron.2020.09.022; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wojtowicz WM, 2020, CELL, V182, P1027, DOI 10.1016/j.cell.2020.07.025; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yao Z., 2020, INTEGRATED TRANSCRIP, DOI [10.1101/2020.02.29.970558, DOI 10.1101/2020.02.29.970558]; Yao ZZ, 2021, NATURE, V598, P103, DOI 10.1038/s41586-021-03500-8; Yao ZZ, 2021, CELL, V184, P3222, DOI 10.1016/j.cell.2021.04.021; Yuste R, 2020, NAT NEUROSCI, V23, P1456, DOI 10.1038/s41593-020-0685-8; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhang M, 2021, NATURE, V598, P137, DOI 10.1038/s41586-021-03705-x; Zhu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7802	70	7	7	8	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					311	+		10.1016/j.cell.2021.12.022	http://dx.doi.org/10.1016/j.cell.2021.12.022			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8PF	35063073				2022-12-28	WOS:000746148700002
J	Daniels, JP				Daniels, Joe Parkin			Colombia euthanasia cases prompt regional debate	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					348	348						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065775				2022-12-28	WOS:000746046100009
J	Jin, WB; Li, TT; Huo, D; Qu, SP; Li, XV; Arifuzzaman, M; Lima, SF; Shi, HQ; Wang, AL; Putzel, GG; Longman, RS; Artis, D; Guo, CJ				Jin, Wen-Bing; Li, Ting-Ting; Huo, Da; Qu, Sophia; Li, Xin V.; Arifuzzaman, Mohammad; Lima, Svetlana F.; Shi, Hui-Qing; Wang, Aolin; Putzel, Gregory G.; Longman, Randy S.; Artis, Davi; Guo, Chun-Jun			Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome	CELL			English	Article							BILE-SALT BIOTRANSFORMATIONS; MULTI-OMICS; EXPRESSION; BACTERIA; GENOME; CANCER; METABOLITES; SYSTEM; CPF1	Hundreds of microbiota genes are associated with host biology/disease. Unraveling the causal contribution of a microbiota gene to host biology remains difficult because many are encoded by nonmodel gut commensals and not genetically targetable. A general approach to identify their gene transfer methodology and build their gene manipulation tools would enable mechanistic dissections of their impact on host physiology. We developed a pipeline that identifies the gene transfer methods for multiple nonmodel microbes spanning five phyla, and we demonstrated the utility of their genetic tools by modulating microbiome-derived short-chain fatty acids and bile acids in vitro and in the host. In a proof-of-principle study, by deleting a commensal gene for bile acid synthesis in a complex microbiome, we discovered an intriguing role of this gene in regulating colon inflammation. This technology will enable genetically engineering the nonmodel gut microbiome and facilitate mechanistic dissection of microbiota-host interactions.	[Jin, Wen-Bing; Li, Ting-Ting; Huo, Da; Qu, Sophia; Li, Xin V.; Arifuzzaman, Mohammad; Lima, Svetlana F.; Shi, Hui-Qing; Wang, Aolin; Putzel, Gregory G.; Longman, Randy S.; Artis, Davi; Guo, Chun-Jun] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA; [Jin, Wen-Bing; Li, Ting-Ting; Li, Xin V.; Arifuzzaman, Mohammad; Lima, Svetlana F.; Shi, Hui-Qing; Longman, Randy S.; Artis, Davi; Guo, Chun-Jun] Cornell Univ, Friedman Ctr Nutr & Inflammat, Weill Cornell Med, New York, NY 10021 USA; [Li, Xin V.; Arifuzzaman, Mohammad; Longman, Randy S.; Artis, Davi; Guo, Chun-Jun] Cornell Univ, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA; [Longman, Randy S.; Artis, Davi; Guo, Chun-Jun] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA; [Longman, Randy S.; Artis, Davi; Guo, Chun-Jun] Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, Weill Cornell Med, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Guo, CJ (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.; Guo, CJ (corresponding author), Cornell Univ, Friedman Ctr Nutr & Inflammat, Weill Cornell Med, New York, NY 10021 USA.; Guo, CJ (corresponding author), Cornell Univ, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, Weill Cornell Med, New York, NY 10021 USA.; Guo, CJ (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10065 USA.; Guo, CJ (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, Weill Cornell Med, New York, NY 10065 USA.	cj@guo-group.org		Huo, Da/0000-0002-1378-5033; Wang, Aolin/0000-0002-3490-648X; jin, wenbing/0000-0002-3528-7297; Li, Xin/0000-0002-9444-8214; Artis, David/0000-0002-1753-4100; Li, Tingting/0000-0002-2303-6394				Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Bencivenga-Barry NA, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00544-19; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Canadas IC, 2019, ACS SYNTH BIOL, V8, P1379, DOI 10.1021/acssynbio.9b00075; Cani PD, 2019, NAT METAB, V1, P34, DOI 10.1038/s42255-018-0017-4; Chen ML, 2019, MUCOSAL IMMUNOL, V12, P851, DOI 10.1038/s41385-019-0162-4; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Fiorucci S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01853; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Funabashi M, 2020, NATURE, V582, P566, DOI 10.1038/s41586-020-2396-4; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Garcia-Bayona L, 2019, MBIO, V10, DOI 10.1128/mBio.01762-19; Guo CJ, 2019, SCIENCE, V366, P1331, DOI 10.1126/science.aav1282; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Hong W, 2018, ACS SYNTH BIOL, V7, P1588, DOI 10.1021/acssynbio.8b00087; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Isenbarger TA, 2008, ORIGINS LIFE EVOL B, V38, P517, DOI 10.1007/s11084-008-9148-z; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Johnston CD, 2019, P NATL ACAD SCI USA, V116, P11454, DOI 10.1073/pnas.1820256116; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Keller KL, 2011, METHOD ENZYMOL, V497, P503, DOI 10.1016/B978-0-12-385075-1.00022-6; Kim SK, 2017, ACS SYNTH BIOL, V6, P1273, DOI 10.1021/acssynbio.6b00368; Klompe SE, 2019, NATURE, V571, P219, DOI 10.1038/s41586-019-1323-z; Kraal L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097279; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li J, 2021, EMBO J, V40, DOI 10.15252/embj.2021108287; Lim B, 2017, CELL, V169, P547, DOI 10.1016/j.cell.2017.03.045; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lu YW, 2013, METABOLITES, V3, P993, DOI 10.3390/metabo3040993; McAllister KN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15236-5; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Naito M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030551; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peluso EA, 2020, CURR PROTOC MICROBIO, V57, P104; Peters JM, 2019, NAT MICROBIOL, V4, P244, DOI 10.1038/s41564-018-0327-z; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Pyne ME, 2014, BIOTECHNOL ADV, V32, P623, DOI 10.1016/j.biotechadv.2014.04.003; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13; Salyers AA, 1999, METHOD MICROBIOL, V29, P229; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sheridan PO, 2019, ANAEROBE, V59, P131, DOI 10.1016/j.anaerobe.2019.06.008; Shiver AL, 2021, NAT PROTOC, V16, P3049, DOI 10.1038/s41596-021-00531-3; Sinha SR, 2020, CELL HOST MICROBE, V27, P659, DOI 10.1016/j.chom.2020.01.021; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Strecker J, 2019, SCIENCE, V365, P48, DOI 10.1126/science.aax9181; Taketani M, 2020, NAT BIOTECHNOL, V38, P962, DOI 10.1038/s41587-020-0468-5; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Vo PLH, 2021, NAT BIOTECHNOL, V39, P480, DOI 10.1038/s41587-020-00745-y; Waller MC, 2017, CURR OPIN MICROBIOL, V38, P156, DOI 10.1016/j.mib.2017.05.006; Whitaker WR, 2017, CELL, V169, P538, DOI 10.1016/j.cell.2017.03.041; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Woods C, 2019, ANAEROBE, V59, P184, DOI 10.1016/j.anaerobe.2019.06.020; Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7; Yang XR, 2016, APPL MICROBIOL BIOT, V100, P2289, DOI 10.1007/s00253-015-7141-9; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2018, METAB ENG, V47, P49, DOI 10.1016/j.ymben.2018.03.007; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18; Zhao SN, 2018, J IMMUNOL RES, V2018, DOI [10.1155/2018/2481118, 10.1155/2018/2481418]; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zhou WY, 2019, NATURE, V569, P663, DOI 10.1038/s41586-019-1236-x	82	17	17	27	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					547	+		10.1016/j.cell.2021.12.035	http://dx.doi.org/10.1016/j.cell.2021.12.035			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YV3VN	35051369				2022-12-28	WOS:000752659000001
J	Nguyen, B; Fong, C; Luthra, A; Smith, SA; DiNatale, RG; Nandakumar, S; Walch, H; Chatila, WK; Madupuri, R; Kundra, R; Bielski, CM; Mastrogiacomo, B; Donoghue, MTA; Boire, A; Chandarlapaty, S; Ganesh, K; Harding, JJ; Iacobuzio-Donahue, CA; Razavi, P; Reznik, E; Rudin, CM; Zamarin, D; Abida, W; Abou-Alfa, GK; Aghajanian, C; Cercek, A; Chi, P; Feldman, D; Ho, AL; Iyer, G; Janjigian, YY; Morris, M; Motzer, RJ; O'Reilly, EM; Postow, MA; Raj, NP; Riely, GJ; Robson, ME; Rosenberg, JE; Safonov, A; Shoushtari, AN; Tap, W; Teo, MY; Varghese, AM; Voss, M; Yaeger, R; Zauderer, MG; Abu-Rustum, N; Garcia-Aguilar, J; Bochner, B; Hakimi, A; Jarnagin, WR; Jones, DR; Molena, D; Morris, L; Rios-Doria, E; Russo, P; Singer, S; Strong, VE; Chakravarty, D; Ellenson, LH; Gopalan, A; Reis, JS; Weigelt, B; Ladanyi, M; Gonen, M; Shah, SHP; Massague, J; Gao, JJ; Zehir, A; Berger, MF; Solit, DB; Bakhoum, SF; Sanchez-Vega, F; Schultz, N				Nguyen, Bastien; Fong, Christopher; Luthra, Anisha; Smith, Shaleigh A.; DiNatale, Renzo G.; Nandakumar, Subhiksha; Walch, Henry; Chatila, Walid K.; Madupuri, Ramyasree; Kundra, Ritika; Bielski, Craig M.; Mastrogiacomo, Brooke; Donoghue, Mark T. A.; Boire, Adrienne; Chandarlapaty, Sarat; Ganesh, Karuna; Harding, James J.; Iacobuzio-Donahue, Christine A.; Razavi, Pedram; Reznik, Ed; Rudin, Charles M.; Zamarin, Dmitriy; Abida, Wassim; Abou-Alfa, Ghassan K.; Aghajanian, Carol; Cercek, Andrea; Chi, Ping; Feldman, Darren; Ho, Alan L.; Iyer, Gopakumar; Janjigian, Yelena Y.; Morris, Michael; Motzer, Robert J.; O'Reilly, Eileen M.; Postow, Michael A.; Raj, Nitya P.; Riely, Gregory J.; Robson, Mark E.; Rosenberg, Jonathan E.; Safonov, Anton; Shoushtari, Alexander N.; Tap, William; Teo, Min Yuen; Varghese, Anna M.; Voss, Martin; Yaeger, Rona; Zauderer, Marjorie G.; Abu-Rustum, Nadeem; Garcia-Aguilar, Julio; Bochner, Bernard; Hakimi, Abraham; Jarnagin, William R.; Jones, David R.; Molena, Daniela; Morris, Luc; Rios-Doria, Eric; Russo, Paul; Singer, Samuel; Strong, Vivian E.; Chakravarty, Debyani; Ellenson, Lora H.; Gopalan, Anuradha; Reis-Filho, Jorge S.; Weigelt, Britta; Ladanyi, Marc; Gonen, Mithat; Shah, Sohrab P.; Massague, Joan; Gao, Jianjiong; Zehir, Ahmet; Berger, Michael F.; Solit, David B.; Bakhoum, Samuel F.; Sanchez-Vega, Francisco; Schultz, Nikolaus			Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients	CELL			English	Article							BREAST-CANCER; LANDSCAPE; PROGRESSION; TRAJECTORIES; MUTATION; TUMORS	Metastatic progression is the main cause of death in cancer patients, whereas the underlying genomic mechanisms driving metastasis remain largely unknown. Here, we assembled MSK-MET, a pan-cancer cohort of over 25,000 patients with metastatic diseases. By analyzing genomic and clinical data from this cohort, we identified associations between genomic alterations and patterns of metastatic dissemination across 50 tumor types. We found that chromosomal instability is strongly correlated with metastatic burden in some tumor types, including prostate adenocarcinoma, lung adenocarcinoma, and HR+/HER2+ breast ductal carcinoma, but not in others, including colorectal cancer and high-grade serous ovarian cancer, where copy-number alteration patterns may be established early in tumor development. We also identified somatic alterations associated with metastatic burden and specific target organs. Our data offer a valuable resource for the investigation of the biological basis for metastatic spread and highlight the complex role of chromosomal instability in cancer progression.	[Nguyen, Bastien; Fong, Christopher; Luthra, Anisha; Smith, Shaleigh A.; Nandakumar, Subhiksha; Walch, Henry; Chatila, Walid K.; Madupuri, Ramyasree; Kundra, Ritika; Mastrogiacomo, Brooke; Donoghue, Mark T. A.; Reznik, Ed; Berger, Michael F.; Solit, David B.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Nguyen, Bastien; Fong, Christopher; Luthra, Anisha; Smith, Shaleigh A.; Nandakumar, Subhiksha; Walch, Henry; Chatila, Walid K.; Madupuri, Ramyasree; Kundra, Ritika; Bielski, Craig M.; Mastrogiacomo, Brooke; Boire, Adrienne; Chandarlapaty, Sarat; Reznik, Ed; Berger, Michael F.; Solit, David B.; Bakhoum, Samuel F.; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Nguyen, Bastien; Fong, Christopher; Luthra, Anisha; Smith, Shaleigh A.; Nandakumar, Subhiksha; Walch, Henry; Chatila, Walid K.; Madupuri, Ramyasree; Kundra, Ritika; Mastrogiacomo, Brooke; Reznik, Ed; Gonen, Mithat; Shah, Sohrab P.; Gao, Jianjiong; Sanchez-Vega, Francisco; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA; [DiNatale, Renzo G.; Ganesh, Karuna; Rudin, Charles M.] Sloan Kettering Inst, Mol Pharmacol Program, New York, NY USA; [DiNatale, Renzo G.] Virginia Mason Med Ctr, Urol & Renal Transplantat Serv, Seattle, WA 98101 USA; [Bielski, Craig M.; Harding, James J.; Razavi, Pedram; Zamarin, Dmitriy; Solit, David B.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Chandarlapaty, Sarat; Ganesh, Karuna; Harding, James J.; Rudin, Charles M.; Zamarin, Dmitriy; Abida, Wassim; Abou-Alfa, Ghassan K.; Aghajanian, Carol; Cercek, Andrea; Chi, Ping; Feldman, Darren; Ho, Alan L.; Iyer, Gopakumar; Janjigian, Yelena Y.; Morris, Michael; Motzer, Robert J.; O'Reilly, Eileen M.; Postow, Michael A.; Raj, Nitya P.; Riely, Gregory J.; Robson, Mark E.; Rosenberg, Jonathan E.; Safonov, Anton; Shoushtari, Alexander N.; Tap, William; Teo, Min Yuen; Varghese, Anna M.; Voss, Martin; Yaeger, Rona; Zauderer, Marjorie G.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Abu-Rustum, Nadeem; Garcia-Aguilar, Julio; Bochner, Bernard; Hakimi, Abraham; Jarnagin, William R.; Jones, David R.; Molena, Daniela; Morris, Luc; Rios-Doria, Eric; Russo, Paul; Singer, Samuel; Strong, Vivian E.; Sanchez-Vega, Francisco] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chakravarty, Debyani; Ellenson, Lora H.; Gopalan, Anuradha; Reis-Filho, Jorge S.; Weigelt, Britta; Ladanyi, Marc; Zehir, Ahmet; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Massague, Joan] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA; Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Boire, Adrienne] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Boire, Adrienne] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Virginia Mason Medical Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.; Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Sanchez-Vega, F; Schultz, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA.; Sanchez-Vega, F (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	sanchezf@mskcc.org; schultzn@mskcc.org	Boire, Adrienne/AAJ-9352-2021; Gao, JianJiong/B-5673-2016	Boire, Adrienne/0000-0002-9029-1248; Gao, JianJiong/0000-0002-5739-1781; Nandakumar, Subhiksha/0000-0003-0258-3484; Walch, Henry/0000-0003-1188-350X; Madupuri, Ramyasree/0000-0001-7771-7868; Harding, James/0000-0002-7029-4310; Smith, Shaleigh/0000-0003-4597-9876	MSK Cancer Center Support Grant [P30 CA008748]; MSK MIND initiative; Cycle for Survival; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Fund for Innovation in Cancer Informatics (ICI); Robertson Foundation; Prostate Cancer Foun-dation Challenge Award; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	MSK Cancer Center Support Grant; MSK MIND initiative; Cycle for Survival; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Fund for Innovation in Cancer Informatics (ICI); Robertson Foundation; Prostate Cancer Foun-dation Challenge Award; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	This study was supported by the MSK Cancer Center Support Grant (P30 CA008748) , the MSK MIND initiative, Cycle for Survival, the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center, the Fund for Innovation in Cancer Informatics (ICI) , the Robertson Foundation, a Prostate Cancer Foun-dation Challenge Award, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Ben-David U, 2020, NAT REV GENET, V21, P44, DOI 10.1038/s41576-019-0171-x; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bielski CM, 2018, NAT GENET, V50, P1189, DOI 10.1038/s41588-018-0165-1; Birkbak NJ, 2020, CANCER CELL, V37, P8, DOI 10.1016/j.ccell.2019.12.004; BORST MJ, 1993, SURGERY, V114, P637; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brown D, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15759, 10.1038/ncomms14944]; Bucheit AD, 2014, CLIN CANCER RES, V20, P5527, DOI 10.1158/1078-0432.CCR-14-1027; Budczies J, 2015, ONCOTARGET, V6, P570, DOI 10.18632/oncotarget.2677; Caso R, 2020, J THORAC ONCOL, V15, P1844, DOI 10.1016/j.jtho.2020.08.005; Cejas P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008199; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Eckert MA, 2016, CANCER DISCOV, V6, P1342, DOI 10.1158/2159-8290.CD-16-0607; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao Y, 2019, DEV CELL, V49, P375, DOI 10.1016/j.devcel.2019.04.012; Gerratana L, 2021, EUR J CANCER, V143, P147, DOI 10.1016/j.ejca.2020.11.005; Hieronymus H, 2018, ELIFE, V7, DOI 10.7554/eLife.37294; Hu Z, 2020, NAT GENET, V52, P701, DOI 10.1038/s41588-020-0628-z; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Jones GD, 2021, JAMA SURG, V156, DOI 10.1001/jamasurg.2020.5601; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kosmidis I, 2021, BIOMETRIKA, V108, P71, DOI 10.1093/biomet/asaa052; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leibold J, 2020, CANCER DISCOV, V10, P1038, DOI 10.1158/2159-8290.CD-19-1242; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Massague J, 2021, CANCER DISCOV, V11, P971, DOI 10.1158/2159-8290.CD-21-0010; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Natrajan R, 2009, GENE CHROMOSOME CANC, V48, P351, DOI 10.1002/gcc.20646; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Nixon MJ, 2019, NPJ BREAST CANCER, V5, DOI 10.1038/s41523-019-0126-6; Noorani A, 2020, NAT GENET, V52, P74, DOI 10.1038/s41588-019-0551-3; PAGET S, 1989, CANCER METAST REV, V8, P98; Pareja F, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-00195-4; Pereira AAL, 2015, BRIT J CANCER, V112, P424, DOI 10.1038/bjc.2014.619; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Ran R, 2020, ONCOGENE, V39, P2624, DOI 10.1038/s41388-020-1170-2; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Reiter JG, 2020, NAT GENET, V52, P692, DOI 10.1038/s41588-020-0633-2; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rueda OM, 2019, NATURE, V567, P399, DOI 10.1038/s41586-019-1007-8; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shih DJH, 2020, NAT GENET, V52, P371, DOI 10.1038/s41588-020-0592-7; Shoushtari AN, 2021, CLIN CANCER RES, V27, P2226, DOI 10.1158/1078-0432.CCR-20-4189; Shukla A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14286-0; Spurr LF, 2021, BIOINFORMATICS, V37, P2461, DOI 10.1093/bioinformatics/btaa980; Stopsack KH, 2019, P NATL ACAD SCI USA, V116, P11390, DOI 10.1073/pnas.1902645116; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tie J, 2011, CLIN CANCER RES, V17, P1122, DOI 10.1158/1078-0432.CCR-10-1720; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Vokes NI, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.19.00171; Watkins TBK, 2020, NATURE, V587, P126, DOI 10.1038/s41586-020-2698-6; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	65	37	37	28	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					563	+		10.1016/j.cell.2022.01.003	http://dx.doi.org/10.1016/j.cell.2022.01.003			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YV3VN	35120664	Green Published			2022-12-28	WOS:000752659000002
J	Sakers, A; De Siqueira, MK; Seale, P; Villanueva, CJ				Sakers, Alexander; De Siqueira, Mirian Krystel; Seale, Patrick; Villanueva, Claudio J.			Adipose-tissue plasticity in health and disease	CELL			English	Review							ADIPOCYTE PROGENITOR CELLS; COLD-INDUCED THERMOGENESIS; INNATE LYMPHOID TYPE-2; BEIGE FAT DEVELOPMENT; REGULATORY T-CELLS; BODY-MASS INDEX; INSULIN-RESISTANCE; BROWN FAT; ENERGY-EXPENDITURE; SUBCUTANEOUS FAT	Adipose tissue, colloquially known as "fat,"is an extraordinarily flexible and heterogeneous organ. While his-torically viewed as a passive site for energy storage, we now appreciate that adipose tissue regulates many aspects of whole-body physiology, including food intake, maintenance of energy levels, insulin sensitivity, body temperature, and immune responses. A crucial property of adipose tissue is its high degree of plasticity. Physiologic stimuli induce dramatic alterations in adipose-tissue metabolism, structure, and phenotype to meet the needs of the organism. Limitations to this plasticity cause diminished or aberrant responses to physiologic cues and drive the progression of cardiometabolic disease along with other pathological conse-quences of obesity.	[Sakers, Alexander; Seale, Patrick] Univ Penn, Inst Diabet Obes & Metab, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [De Siqueira, Mirian Krystel; Villanueva, Claudio J.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA; [De Siqueira, Mirian Krystel; Villanueva, Claudio J.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Seale, P (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Villanueva, CJ (corresponding author), Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA.; Villanueva, CJ (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	sealep@pennmedicine.upenn.edu; cvillanueva@g.ucla.edu		De Siqueira, Mirian Krystel/0000-0001-9455-7931; Sakers, Alexander/0000-0003-2010-7211	NIDDK at the National Institutes of Health [R01DK103930, DK123356, DK120982]; UCLA Life Sciences Fund; UCLA Graduate Council Diversity Fellowship	NIDDK at the National Institutes of Health; UCLA Life Sciences Fund; UCLA Graduate Council Diversity Fellowship	Research reported in this publication was supported by NIDDK at the National Institutes of Health under R01DK103930 (to C.J.V.) and DK123356 and DK120982 (to P.S.), UCLA Life Sciences Fund, and UCLA Graduate Council Diversity Fellowship for M.K.S.	Acosta JR, 2016, DIABETOLOGIA, V59, P560, DOI 10.1007/s00125-015-3810-6; Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Andersson DP, 2014, DIABETES CARE, V37, P1831, DOI 10.2337/dc13-2395; Angueira AR, 2020, CELL REP, V30, P2869, DOI 10.1016/j.celrep.2020.02.023; Aouadi M, 2014, AM J PHYSIOL-ENDOC M, V307, pE374, DOI 10.1152/ajpendo.00187.2014; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Arner P, 2019, NAT MED, V25, P1385, DOI 10.1038/s41591-019-0565-5; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Barreau C, 2016, OBESITY, V24, P1081, DOI 10.1002/oby.21455; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Becher T, 2021, NAT MED, V27, P58, DOI 10.1038/s41591-020-1126-7; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Berry R, 2014, CELL METAB, V19, P8, DOI 10.1016/j.cmet.2013.10.003; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bertholet AM, 2017, BIOCHIMIE, V134, P28, DOI 10.1016/j.biochi.2016.10.013; Bi PP, 2016, J EXP MED, V213, P2019, DOI 10.1084/jem.20160157; BJORNTOR.P, 1971, METABOLISM, V20, P703, DOI 10.1016/0026-0495(71)90084-9; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Burl RB, 2018, CELL METAB, V28, P300, DOI 10.1016/j.cmet.2018.05.025; Cancello R, 2013, OBESITY, V21, P2562, DOI 10.1002/oby.20417; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Q, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14031; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao Y, 2018, MOL METAB, V14, P71, DOI 10.1016/j.molmet.2018.06.004; Cao Y, 2018, PROTEIN CELL, V9, P527, DOI 10.1007/s13238-018-0528-5; Carpentier AC, 2021, AM J PHYSIOL-ENDOC M, V320, pE653, DOI 10.1152/ajpendo.00620.2020; Caso G, 2013, METABOLISM, V62, P337, DOI 10.1016/j.metabol.2012.08.007; Cattaneo P, 2020, CELL REP, V30, P571, DOI 10.1016/j.celrep.2019.12.046; Chait A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00022; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen Y, 2019, NATURE, V565, P180, DOI 10.1038/s41586-018-0801-z; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Chitraju C, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108348; Cho DS, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900561; Cho YK, 2021, NAT METAB, V3, P428, DOI 10.1038/s42255-021-00362-2; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chu AY, 2017, NAT GENET, V49, P125, DOI 10.1038/ng.3738; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010; Cinti S, 2002, J HISTOCHEM CYTOCHEM, V50, P21, DOI 10.1177/002215540205000103; Cohen P, 2021, NAT REV MOL CELL BIO, V22, P393, DOI 10.1038/s41580-021-00350-0; Cote JA, 2019, CELL TISSUE RES, V378, P385, DOI 10.1007/s00441-019-03061-3; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Czech MP, 2020, MOL METAB, V34, P27, DOI 10.1016/j.molmet.2019.12.014; Darcy J, 2019, GEROSCIENCE, V41, P285, DOI 10.1007/s11357-019-00076-0; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Dichamp J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43130-9; Ding HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11533; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Donohoe CL, 2017, TRENDS ENDOCRIN MET, V28, P46, DOI 10.1016/j.tem.2016.08.004; Dumesic DA, 2016, J CLIN ENDOCR METAB, V101, P4178, DOI 10.1210/jc.2016-2586; During MJ, 2015, ENDOCRINOLOGY, V156, P2059, DOI 10.1210/en.2014-1905; El Agha E, 2017, CELL STEM CELL, V20, P261, DOI 10.1016/j.stem.2016.10.004; Esteve D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09992-3; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Ferrero R, 2020, TRENDS CELL BIOL, V30, P937, DOI 10.1016/j.tcb.2020.09.007; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Flaherty SE, 2019, SCIENCE, V363, P989, DOI 10.1126/science.aaw2586; FODOR PB, 1993, AESTHET PLAST SURG, V17, P179; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Francisco V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00640; Frayn KN, 2014, INT J OBESITY, V38, P1019, DOI 10.1038/ijo.2013.200; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Funcke JB, 2019, J LIPID RES, V60, P1648, DOI 10.1194/jlr.R094060; Gao ZG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155861; Gastaldelli A, 2017, DIABETES, V66, P815, DOI 10.2337/db16-1167; Ghaben AL, 2019, NAT REV MOL CELL BIO, V20, P242, DOI 10.1038/s41580-018-0093-z; Goldberg EL, 2021, CELL METAB, V33, P2277, DOI 10.1016/j.cmet.2021.08.004; Gonzalez-Hurtado E, 2018, MOL METAB, V7, P45, DOI 10.1016/j.molmet.2017.11.004; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x; Ha CWY, 2020, CELL, V183, P666, DOI 10.1016/j.cell.2020.09.009; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Han XM, 2021, CELL STEM CELL, V28, P1160, DOI 10.1016/j.stem.2021.01.007; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Haslam D, 2010, LANCET, V376, P85, DOI 10.1016/S0140-6736(10)61065-3; Henninger AMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105262; Henriques F, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107998; Hepler C, 2018, ELIFE, V7, DOI 10.7554/eLife.39636; Hepler C, 2017, MOL CELL ENDOCRINOL, V445, P95, DOI 10.1016/j.mce.2016.10.011; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hildreth AD, 2021, NAT IMMUNOL, V22, P639, DOI 10.1038/s41590-021-00922-4; Hilgendorf KI, 2019, CELL, V179, P1289, DOI 10.1016/j.cell.2019.11.005; Hill DA, 2018, P NATL ACAD SCI USA, V115, pE5096, DOI 10.1073/pnas.1802611115; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hong KY, 2015, DEVELOPMENT, V142, P2623, DOI 10.1242/dev.125336; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Ikeda K, 2017, NAT MED, V23, P1454, DOI 10.1038/nm.4429; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x; Iwayama T, 2015, GENE DEV, V29, P1106, DOI 10.1101/gad.260554.115; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jeffery E, 2016, CELL METAB, V24, P142, DOI 10.1016/j.cmet.2016.05.012; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Jiang YW, 2014, CELL REP, V9, P1007, DOI 10.1016/j.celrep.2014.09.049; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Johansen OS, 2021, CELL, V184, P3502, DOI 10.1016/j.cell.2021.04.037; Jung SM, 2019, MOL CELL, V75, P807, DOI 10.1016/j.molcel.2019.07.023; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Karastergiou K, 2017, ADV EXP MED BIOL, V1043, P29, DOI 10.1007/978-3-319-70178-3_3; Kazak L, 2017, CELL METAB, V26, P693, DOI 10.1016/j.cmet.2017.09.007; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Khanh VC, 2018, BIOCHEM BIOPH RES CO, V500, P682, DOI 10.1016/j.bbrc.2018.04.136; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JI, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00210-19; Kim SH, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0127-7; Kim SM, 2014, CELL METAB, V20, P1049, DOI 10.1016/j.cmet.2014.10.010; Klaver M, 2018, EUR J ENDOCRINOL, V178, P163, DOI [10.1530/EJE-17-0496, 10.1530/eje-17-0496]; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Koethe JR, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0181-1; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Labbe SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37223; Lanktree MB, 2017, GENOMIC AND PRECISION MEDICINE: PRIMARY CARE, 3RD EDITION, P283, DOI 10.1016/B978-0-12-800685-6.00015-1; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lee MJ, 2014, BBA-MOL BASIS DIS, V1842, P473, DOI 10.1016/j.bbadis.2013.05.029; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lee YH, 2012, ADIPOCYTE, V1, P230, DOI 10.4161/adip.20804; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Li M, 2019, OBESITY, V27, P767, DOI 10.1002/oby.22434; Li X, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00564-19; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; LOCKWOOD TE, 1991, PLAST RECONSTR SURG, V87, P1009, DOI 10.1097/00006534-199106000-00001; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111; Marangoni RG, 2015, ARTHRITIS RHEUMATOL, V67, P1062, DOI 10.1002/art.38990; Marcelin G, 2019, J CLIN INVEST, V129, P4032, DOI 10.1172/JCI129192; Marcelin G, 2017, CELL METAB, V25, P673, DOI 10.1016/j.cmet.2017.01.010; MARKMAN B, 1987, PLAST RECONSTR SURG, V80, P248, DOI 10.1097/00006534-198708000-00015; McLaughlin T, 2016, DIABETES, V65, P1245, DOI 10.2337/db15-1213; Mehta NK, 2020, P NATL ACAD SCI USA, V117, P6998, DOI 10.1073/pnas.1920391117; Merlotti C, 2017, INT J OBESITY, V41, P672, DOI 10.1038/ijo.2017.31; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Meyer LK, 2013, ADIPOCYTE, V2, P217, DOI 10.4161/adip.24953; Meza-Perez S, 2017, TRENDS IMMUNOL, V38, P526, DOI 10.1016/j.it.2017.03.002; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024; Morley TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8906; Morrison SF, 2016, AUTON NEUROSCI-BASIC, V196, P14, DOI 10.1016/j.autneu.2016.02.010; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Ngo DTM, 2014, CIRCULATION, V130, P1072, DOI 10.1161/CIRCULATIONAHA.113.008171; Nguyen HP, 2021, DEV CELL, V56, P1437, DOI 10.1016/j.devcel.2021.03.026; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oguri Y, 2020, CELL, V182, P563, DOI 10.1016/j.cell.2020.06.021; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Pan WW, 2018, NAT REV NEUROSCI, V19, P95, DOI 10.1038/nrn.2017.168; Park J, 2021, DEV CELL, V56, P985, DOI 10.1016/j.devcel.2021.02.018; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pearson S, 2019, GENE DEV, V33, P747, DOI 10.1101/gad.321059.118; Pellegrinelli V, 2014, J PATHOL, V233, P183, DOI 10.1002/path.4347; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Peurichard D, 2017, J THEOR BIOL, V429, P61, DOI 10.1016/j.jtbi.2017.06.030; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Raajendiran A, 2019, CELL REP, V27, P1528, DOI 10.1016/j.celrep.2019.04.010; Rajbhandari P, 2019, ELIFE, V8, DOI 10.7554/eLife.49501; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; REUBINOFF BE, 1995, FERTIL STERIL, V64, P963, DOI 10.1016/S0015-0282(16)57910-2; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Roh HC, 2018, CELL METAB, V27, P1121, DOI 10.1016/j.cmet.2018.03.005; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rytka JM, 2011, DIABETES, V60, P56, DOI 10.2337/db10-0697; Sakaguchi M, 2017, CELL METAB, V25, P448, DOI 10.1016/j.cmet.2016.12.008; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; Sanchez-Gurmaches J, 2016, TRENDS CELL BIOL, V26, P313, DOI 10.1016/j.tcb.2016.01.004; Sanchez-Gurmaches J, 2015, STEM CELL REP, V4, P541, DOI 10.1016/j.stemcr.2015.02.008; Sarvari AK, 2021, CELL METAB, V33, DOI 10.1016/j.cmet.2020.12.004; Schreiber R, 2017, CELL METAB, V26, P753, DOI 10.1016/j.cmet.2017.09.004; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Sebo ZL, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172098; Shamsi F, 2021, NAT METAB, V3, P485, DOI 10.1038/s42255-021-00373-z; Shan B, 2021, GENE DEV, V35, P1333, DOI 10.1101/gad.348762.121; Shan B, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00301-7; Shao ML, 2021, GENE DEV, V35, P1461, DOI 10.1101/gad.348780.121; Shao ML, 2021, CELL STEM CELL, V28, P685, DOI 10.1016/j.stem.2020.12.008; Shao ML, 2019, DIABETES, V68, P1874, DOI 10.2337/db19-0308; Shao M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03196-x; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023; Shapira SN, 2019, OBESITY, V27, P13, DOI 10.1002/oby.22334; Shearin AL, 2016, MOL METAB, V5, P472, DOI 10.1016/j.molmet.2016.05.006; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Shin HS, 2017, CELL METAB, V26, P764, DOI 10.1016/j.cmet.2017.09.002; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Shook BA, 2020, CELL STEM CELL, V26, P880, DOI 10.1016/j.stem.2020.03.013; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Smith GI, 2019, J CLIN INVEST, V129, P3978, DOI 10.1172/JCI129186; Song AY, 2020, J CLIN INVEST, V130, P247, DOI 10.1172/JCI129167; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Stefkovich M, 2021, MOL METAB, V54, DOI 10.1016/j.molmet.2021.101357; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; Sun CY, 2020, CELL STEM CELL, V26, P707, DOI 10.1016/j.stem.2020.03.004; Sun CY, 2017, DEVELOPMENT, V144, P83, DOI 10.1242/dev.135962; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Sun WF, 2020, NATURE, V587, P98, DOI 10.1038/s41586-020-2856-x; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Tang HN, 2017, NUTR METAB, V14, DOI 10.1186/s12986-016-0159-x; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Tilg H, 2020, NAT REV IMMUNOL, V20, P40, DOI 10.1038/s41577-019-0198-4; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tran CM, 2016, DIABETES, V65, P927, DOI 10.2337/db15-0502; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; Vijay J, 2020, NAT METAB, V2, P97, DOI 10.1038/s42255-019-0152-6; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Vishvanath L, 2019, J CLIN INVEST, V129, P4022, DOI 10.1172/JCI129191; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Wang QA, 2018, CELL METAB, V28, P282, DOI 10.1016/j.cmet.2018.05.022; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; West-Eberhard MJ, 2019, P NATL ACAD SCI USA, V116, P723, DOI 10.1073/pnas.1809046116; Westcott GP, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109388; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiao L, 2016, INT J OBESITY, V40, P112, DOI 10.1038/ijo.2015.145; Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Ye YQ, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0404-1; Yilmaz M, 2016, DIABETES, V65, P1800, DOI 10.2337/db16-0251; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Yoshino J, 2019, OBESITY, V27, P957, DOI 10.1002/oby.22463; Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zatterale F, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01607; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zeng X, 2019, NATURE, V569, P229, DOI 10.1038/s41586-019-1156-9; Zhang F, 2018, CELL METAB, V27, P252, DOI 10.1016/j.cmet.2017.12.004; Zhang ZZ, 2019, J CLIN INVEST, V129, P5327, DOI 10.1172/JCI130239; Zhao SG, 2019, CELL METAB, V30, P706, DOI 10.1016/j.cmet.2019.08.005; Zhou P, 2019, J CLIN INVEST, V129, P4138, DOI 10.1172/JCI127092; Zwick RK, 2018, CELL METAB, V27, P68, DOI 10.1016/j.cmet.2017.12.002	296	45	45	51	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					419	446		10.1016/j.cell.2021.12.016	http://dx.doi.org/10.1016/j.cell.2021.12.016			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35120662				2022-12-28	WOS:000753615000006
J	Chaudhuri, D; Rochwerg, B				Chaudhuri, Dipayan; Rochwerg, Bram			In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chaudhuri, Dipayan; Rochwerg, Bram] McMaster Univ, Hamilton, ON, Canada	McMaster University	Chaudhuri, D (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC18	JC18		10.7326/J21-0021	http://dx.doi.org/10.7326/J21-0021		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099996				2022-12-28	WOS:000750885100001
J	Ovtcharenko, N; Oczkowski, S				Ovtcharenko, Natalia; Oczkowski, Simon			In critically ill adults, IV fluid bolus infused at slower vs. faster rates did not differ for 90-d mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT; SEPSIS		[Ovtcharenko, Natalia; Oczkowski, Simon] McMaster Univ, Hamilton, ON, Canada	McMaster University	Ovtcharenko, N (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Cecconi M, 2015, INTENS CARE MED, V41, P1529, DOI 10.1007/s00134-015-3850-x; Evans L, 2021, CRIT CARE MED, V49, pE1063, DOI 10.1097/CCM.0000000000005337; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Silversides JA, 2017, INTENS CARE MED, V43, P155, DOI 10.1007/s00134-016-4573-3	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC23	JC23		10.7326/J21-0015	http://dx.doi.org/10.7326/J21-0015		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099988				2022-12-28	WOS:000750883100001
J	Suzuki, R; Yamasoba, D; Kimura, I; Wang, L; Kishimoto, M; Ito, J; Morioka, Y; Nao, N; Nasser, H; Uriu, K; Kosugi, Y; Tsuda, M; Orba, Y; Sasaki, M; Shimizu, R; Kawabata, R; Yoshimatsu, K; Asakura, H; Nagashima, M; Sadamasu, K; Yoshimura, K; Sawa, H; Ikeda, T; Irie, T; Matsuno, K; Tanaka, S; Fukuhara, T; Sato, K				Suzuki, Rigel; Yamasoba, Daichi; Kimura, Izumi; Wang, Lei; Kishimoto, Mai; Ito, Jumpei; Morioka, Yuhei; Nao, Naganori; Nasser, Hesham; Uriu, Keiya; Kosugi, Yusuke; Tsuda, Masumi; Orba, Yasuko; Sasaki, Michihito; Shimizu, Ryo; Kawabata, Ryoko; Yoshimatsu, Kumiko; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Sawa, Hirofumi; Ikeda, Terumasa; Irie, Takashi; Matsuno, Keita; Tanaka, Shinya; Fukuhara, Takasuke; Sato, Kei		Genotype Phenotype Japan G2P-Japan	Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant	NATURE			English	Article							CELLS	The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern(1). In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2.Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell-cell fusion(2,3), the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity.	[Suzuki, Rigel; Morioka, Yuhei; Fukuhara, Takasuke] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Yamasoba, Daichi; Kimura, Izumi; Ito, Jumpei; Uriu, Keiya; Kosugi, Yusuke; Sato, Kei] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Infect Dis Control,Div Syst Virol, Tokyo, Japan; [Yamasoba, Daichi] Kobe Univ, Fac Med, Kobe, Hyogo, Japan; [Wang, Lei; Tsuda, Masumi; Tanaka, Shinya] Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Wang, Lei; Tsuda, Masumi; Tanaka, Shinya] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan; [Kishimoto, Mai; Orba, Yasuko; Sasaki, Michihito; Sawa, Hirofumi] Hokkaido Univ, Int Inst Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan; [Nao, Naganori; Sawa, Hirofumi] Hokkaido Univ, Int Inst Zoonosis Control, Div Int Res Promot, Sapporo, Hokkaido, Japan; [Nao, Naganori; Sawa, Hirofumi; Matsuno, Keita] Hokkaido Univ, Hlth Res Ctr 1, Sapporo, Hokkaido, Japan; [Nasser, Hesham; Shimizu, Ryo; Ikeda, Terumasa] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan; [Nasser, Hesham] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt; [Uriu, Keiya; Sato, Kei] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kosugi, Yusuke] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Syst Virol, Kyoto, Japan; [Kosugi, Yusuke] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Orba, Yasuko; Sasaki, Michihito; Sawa, Hirofumi; Matsuno, Keita] Hokkaido Univ, Int Inst Zoonosis Control, Int Collaborat Unit, Sapporo, Hokkaido, Japan; [Kawabata, Ryoko; Irie, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Yoshimatsu, Kumiko] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan; [Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa] Tokyo Metropolitan Inst Publ Hlth, Tokyo, Japan; [Matsuno, Keita] Hokkaido Univ, Int Inst Zoonosis Control, Div Risk Anal & Management, Sapporo, Hokkaido, Japan; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan	Hokkaido University; University of Tokyo; Kobe University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Kumamoto University; Egyptian Knowledge Bank (EKB); Suez Canal University; University of Tokyo; Kyoto University; Kyoto University; Hokkaido University; Hiroshima University; Hokkaido University; Tokyo Metropolitan Institute of Public Health; Hokkaido University; Japan Science & Technology Agency (JST)	Fukuhara, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.; Sato, K (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Infect Dis Control,Div Syst Virol, Tokyo, Japan.; Tanaka, S (corresponding author), Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan.; Tanaka, S (corresponding author), Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan.; Sato, K (corresponding author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.; Matsuno, K (corresponding author), Hokkaido Univ, Int Inst Zoonosis Control, Int Collaborat Unit, Sapporo, Hokkaido, Japan.; Matsuno, K (corresponding author), Hokkaido Univ, Int Inst Zoonosis Control, Div Risk Anal & Management, Sapporo, Hokkaido, Japan.; Sato, K (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.	matsuk@czc.hokudai.ac.jp; tanaka@med.hokudai.ac.jp; fukut@pop.med.hokudai.ac.jp; KeiSato@g.ecc.u-tokyo.ac.jp	Nakagawa, So/Q-2712-2015; Sawa, Hirofumi/F-6954-2012; Tokunaga, Kenzo/Q-9914-2018	Nakagawa, So/0000-0003-1760-3839; Sawa, Hirofumi/0000-0003-2569-2755; Tokunaga, Kenzo/0000-0002-2625-5322; Kishimoto, Mai/0000-0001-8039-4764; Ikeda, Terumasa/0000-0003-2869-9450; lei, wang/0000-0001-6145-395X; Ferdous, Zannatul/0000-0003-3973-6050; Morimatsu, Kumiko/0000-0002-0062-2753; Tanaka, Shinya/0000-0001-6470-3301; Ito, Jumpei/0000-0003-0440-8321; Nasser, Hesham/0000-0001-9163-1665	AMED Research Program on Emerging and Re-emerging Infectious Diseases [20fk0108401, 20fk010847, 21fk0108617, 20fk0108146, 20fk0108270, 20fk0108413, 20fk0108451]; AMED Research Program on HIV/AIDS [21fk0410039]; AMED Japan Program for Infectious Diseases Research and Infrastructure [21wm0125008, 21wm0225003]; JST A-STEP [JPMJTM20SL]; JST SICORP (e-ASIA) [JPMJSC20U1]; JST SICORP [JPMJSC21U5]; JST CREST [JPMJCR20H4]; JSPS KAKENHI [21H02736, 18H02662, 21H02737]; JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) [18KK0447]; JSPS Core-to-Core Program (A. Advanced Research Networks) [JPJSCCA20190008]; JSPS Research Fellow DC1 [19J20488]; JSPS Leading Initiative for Excellent Young Researchers (LEADER); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Tsuchiya Foundation; Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University	AMED Research Program on Emerging and Re-emerging Infectious Diseases; AMED Research Program on HIV/AIDS; AMED Japan Program for Infectious Diseases Research and Infrastructure; JST A-STEP; JST SICORP (e-ASIA); JST SICORP; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research); JSPS Core-to-Core Program (A. Advanced Research Networks)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Research Fellow DC1; JSPS Leading Initiative for Excellent Young Researchers (LEADER); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Tsuchiya Foundation(Tsuchiya Foundation); Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University	U We thank all members of The Genotype to Phenotype Japan (G2P-Japan) Consortium. We also thank the National Institute for Infectious Diseases, Japan, for providing an Omicron isolate; A. Sasaki for suggestions; and H. Arase, K. Tokunaga and J. Gohda for providing reagents. The super-computing resource was provided by the Human Genome Center at The University of Tokyo. This study was supported in part by the AMED Research Program on Emerging and Re-emerging Infectious Diseases (20fk0108401 to T.F.; 20fk010847 to T.F.; 21fk0108617 to T.F.; 20fk0108146 to K. Sato; 20fk0108270 to K. Sato; 20fk0108413 to T. Ikeda and K. Sato; and 20fk0108451 to G2P-Japan Consortium, T. Ikeda, T. Irie, K.M., T.F. and K. Sato); AMED Research Program on HIV/AIDS (21fk0410039 to K. Sato); AMED Japan Program for Infectious Diseases Research and Infrastructure (21wm0125008 to H.S. and 21wm0225003 to H.S.); JST A-STEP (JPMJTM20SL to T. Ikeda); JST SICORP (e-ASIA) (JPMJSC20U1 to K. Sato); JST SICORP (JPMJSC21U5 to K. Sato); JST CREST (JPMJCR20H4 to K. Sato); JSPS KAKENHI Grant-in-Aid for Scientific Research B (21H02736 to T.F.; 18H02662 to K. Sato; and 21H02737 to K. Sato); JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) (18KK0447 to K. Sato); JSPS Core-to-Core Program (A. Advanced Research Networks) (JPJSCCA20190008, to K. Sato); JSPS Research Fellow DC1 (19J20488, to I.K.); JSPS Leading Initiative for Excellent Young Researchers (LEADER) (to T. Ikeda); World-leading Innovative and Smart Education (WISE) Program 1801 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to N.N.); The Tokyo Biochemical Research Foundation (to K. Sato); Mitsubishi Foundation (to T. Ikeda); Shin-Nihon Foundation of Advanced Medical Research (to T. Ikeda); Tsuchiya Foundation (to T. Irie); an intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE) (to T. Ikeda); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS (to T. Ikeda); and Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University (to K. Sato).	Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; CDC, 2021, SCI BRIEF OM B 1 1 5; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Ikegame S, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026027118; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu Y, 2022, NATURE, V602, P294, DOI 10.1038/s41586-021-04245-0; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Mannar D, 2022, SCIENCE, V375, P760, DOI 10.1126/science.abn7760; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Meng B, 2022, NATURE, V603, P706, DOI 10.1038/s41586-022-04474-x; Miyamoto S., 2022, VACCINATION INFECT I, DOI [10.1101/2021.12.28.21268481, DOI 10.1101/2021.12.28.21268481]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Motozono C, 2021, CELL HOST MICROBE, V29, P1124, DOI 10.1016/j.chom.2021.06.006; National Institute for Communicatable Diseases South Africa, 2021, NEW COVID 19 VAR DET; Nishiura H, 2022, J CLIN MED, V11, DOI 10.3390/jcm11010030; Obermeyer F., 2021, ANAL 2 1 MILLION SAR, DOI [10.1101/2021.09.07.21263228, DOI 10.1101/2021.09.07.21263228, 10.1101/2021.09.07.21263228(2021]; Peacock T. B, 2021, B 1 1 DESC ASS SO AF; Planas D, 2021, NAT MED, V27, P917, DOI [DOI 10.1038/s41591-021-01318-5, 10.1038/s41591-021- 01318-5]; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Public Health England, 2021, 3 JUN 2021 RISK ASS; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rossi F, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-89; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Twohig KA, 2022, LANCET INFECT DIS, V22, P35, DOI 10.1016/S1473-3099(21)00475-8; Uriu K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMc2114706; Vohringer HS, 2021, NATURE, V600, P506, DOI 10.1038/s41586-021-04069-y; Wang PF, 2021, CELL HOST MICROBE, V29, P747, DOI 10.1016/j.chom.2021.04.007; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Watanabe S, 2013, J VIROL, V87, P2648, DOI 10.1128/JVI.02632-12; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4; World Health Organization, 2022, TRACK SARS COV 2 VAR; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yamamoto M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060629	47	105	108	60	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					700	+		10.1038/s41586-022-04462-1	http://dx.doi.org/10.1038/s41586-022-04462-1		FEB 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35104835	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000766518200001
J	Tatum, M				Tatum, Megan			China's population peak	LANCET			English	Editorial Material								Demographic changes in the world's most populous country is posing challenges for health and the health system. Megan Tatum reports.											0	2	2	5	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					509	509						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123681				2022-12-28	WOS:000755144500011
J	Berg, J				Berg, Janine			The Digital Factory: The Human Labor of Automation	SCIENCE			English	Book Review									[Berg, Janine] Int Labor Org, Res Dept, Geneva, Switzerland		Berg, J (corresponding author), Int Labor Org, Res Dept, Geneva, Switzerland.	berg@ilo.org						Altenried, 2022, DIGITAL FACTORY HUMA	1	0	0	4	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					389	389		10.1126/science.abn1041	http://dx.doi.org/10.1126/science.abn1041			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084974				2022-12-28	WOS:000750899500024
J	Wise, J				Wise, Jacqui			Covid-19: Antibody "signature" could predict risk of long covid	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cervia C, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27797-1; Office of National Statistics, 2022, SELF REP LONG COVID	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o245	10.1136/bmj.o245	http://dx.doi.org/10.1136/bmj.o245			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091474	Bronze			2022-12-28	WOS:000749313200005
J	Luo, Y; Wunderink, RG; Lloyd-Jones, D				Luo, Yuan; Wunderink, Richard G.; Lloyd-Jones, Donald			Proactive vs Reactive Machine Learning in Health Care Lessons From the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Luo, Yuan] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Div Hlth & Biomed Informat, 750 N Lake Shore Dr,11-189, Chicago, IL 60611 USA; [Wunderink, Richard G.] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Lloyd-Jones, Donald] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Lloyd-Jones, Donald] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Luo, Y (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Div Hlth & Biomed Informat, 750 N Lake Shore Dr,11-189, Chicago, IL 60611 USA.	yuan.luo@northwestern.edu						Bastani H, 2021, NATURE, V599, P108, DOI 10.1038/s41586-021-04014-z; Dreisbach C, 2019, INT J MED INFORM, V125, P37, DOI 10.1016/j.ijmedinf.2019.02.008; Estcourt LJ, 2021, JAMA-J AM MED ASSOC, V326, P1690, DOI 10.1001/jama.2021.18178; Finlayson SG, 2021, NEW ENGL J MED, V385, P283, DOI 10.1056/NEJMc2104626; Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433; Roberts M, 2021, NAT MACH INTELL, V3, P199, DOI 10.1038/s42256-021-00307-0; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7	7	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					623	624		10.1001/jama.2021.24935	http://dx.doi.org/10.1001/jama.2021.24935		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35085382				2022-12-28	WOS:000747991300003
J	Forrest, IS; Chaudhary, K; Vy, HT; Petrazzini, B; Bafna, S; Jordan, DM; Rocheleau, G; Loos, RJF; Nadkarni, GN; Cho, JH; Do, R				Forrest, Iain S.; Chaudhary, Kumardeep; Vy, Ha My T.; Petrazzini, Ben O.; Bafna, Shantanu; Jordan, Daniel M.; Rocheleau, Ghislain; Loos, Ruth J. F.; Nadkarni, Girish N.; Cho, Judy H.; Do, Ron			Population-Based Penetrance of Deleterious Clinical Variants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ASSOCIATION; BREAST-CANCER; GENOME; RECOMMENDATIONS; IDENTIFICATION; ALGORITHM; SOCIETY; RISKS; BRCA1	IMPORTANCE Population-based assessment of disease risk associated with gene variants informs clinical decisions and risk stratification approaches. OBJECTIVE To evaluate the population-based disease risk of clinical variants in known disease predisposition genes. DESIGN, SETTING, AND PARTICIPANTS This cohort study included 72 434 individuals with 37 780 clinical variants who were enrolled in the BioMe Biobank from 2007 onwards with follow-up until December 2020 and the UK Biobank from 2006 to 2010 with follow-up until June 2020. Participants had linked exome and electronic health record data, were older than 20 years, and were of diverse ancestral backgrounds. EXPOSURES Variants previously reported as pathogenic or predicted to cause a loss of protein function by bioinformatic algorithms (pathogenic/loss-of-function variants). MAIN OUTCOMES AND MEASURES The primary outcome was the disease risk associated with clinical variants. The risk difference (RD) between the prevalence of disease in individuals with a variant allele (penetrance) vs in individuals with a normal allele was measured. RESULTS Among 72 434 study participants, 43 395 were from the UK Biobank (mean [SD] age, 57 [8.0] years; 24 065 [55%] women; 2948 [7%] non-European) and 29 039 were from the BioMe Biobank (mean [SD] age, 56 [16] years; 17 355 [60%] women; 19 663 [68%] non-European). Of 5360 pathogenic/loss-of-function variants, 4795 (89%) were associated with an RD less than or equal to 0.05. Mean penetrance was 6.9% (95% CI, 6.0%-7.8%) for pathogenic variants and 0.85% (95% CI, 0.76%-0.95%) for benign variants reported in ClinVar (difference, 6.0 [95% CI, 5.6-6.4] percentage points), with a median of 0% for both groups due to large numbers of nonpenetrant variants. Penetrance of pathogenic/loss-offunction variants for late-onset diseases was modified by age: mean penetrance was 10.3% (95% CI, 9.0%-11.6%) in individuals 70 years or older and 8.5% (95% CI, 7.9%-9.1%) in individuals 20 years or older (difference, 1.8 [95% Cl. 0.40-3.3] percentage points). Penetrance of pathogenic/loss-of-function variants was heterogeneous even in known disease predisposition genes, including BRCAI (mean [range], 38% [0%-100%]). BRCA2 (mean [range], 38% [0%-100%]), and PAL82 (mean [range], 26% [0%-100%]). CONCLUSIONS AND RELEVANCE In 2 large biobank cohorts, the estimated penetrance of pathogenic/loss-of-function variants was variable but generally low. Further research of population-based penetrance is needed to refine variant interpretation and clinical evaluation of individuals with these variant alleles. JAMA.	[Forrest, Iain S.; Chaudhary, Kumardeep; Vy, Ha My T.; Petrazzini, Ben O.; Bafna, Shantanu; Jordan, Daniel M.; Rocheleau, Ghislain; Loos, Ruth J. F.; Nadkarni, Girish N.; Cho, Judy H.; Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Forrest, Iain S.] Icahn Sch Med Mt Sinai, Med Scientist Training Program, New York, NY 10029 USA; [Forrest, Iain S.; Chaudhary, Kumardeep; Nadkarni, Girish N.; Cho, Judy H.; Do, Ron] Icahn Sch Med Mt Sinai, BioMe Phen Ctr, New York, NY 10029 USA; [Forrest, Iain S.; Chaudhary, Kumardeep; Vy, Ha My T.; Petrazzini, Ben O.; Bafna, Shantanu; Jordan, Daniel M.; Rocheleau, Ghislain; Loos, Ruth J. F.; Cho, Judy H.; Do, Ron] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chaudhary, Kumardeep; Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Hasso Plattner Inst Digital Hlth Mt Sinai, New York, NY 10029 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Nadkarni, Girish N.; Cho, Judy H.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Do, R (corresponding author), 1468 Madison Ave,Annenberg Bldg Floor 18,Room 80B, New York, NY 10029 USA.	ron.do@mssm.edu	Loos, Ruth/GON-5877-2022; Chaudhary, Kumardeep/Q-9740-2018	Chaudhary, Kumardeep/0000-0002-4117-6403; Forrest, Iain/0000-0002-5642-422X	National Institute of General Medical Sciences of the National Institutes of Health (NIH) [T32-GM007280]; National Institute of General Medical Sciences of the NIH [R35-GM124836]; National Heart, Lung, and Blood Institute of the NIH [R01-HL139865, R01-HL155915]	National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mr Forrest is supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) (T32-GM007280). Dr Do is supported by the National Institute of General Medical Sciences of the NIH (R35-GM124836) and the National Heart, Lung, and Blood Institute of the NIH (R01-HL139865 and R01-HL155915).	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; [Anonymous], 2014, TIER 1 GEN APPL THEI; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cozzolino F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218919; DEBELLEROCHE J, 1995, J MED GENET, V32, P841, DOI 10.1136/jmg.32.11.841; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Goldberg DS, 2013, PHARMACOEPIDEM DR S, V22, P103, DOI 10.1002/pds.3367; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hu CL, 2021, NEW ENGL J MED, V384, P440, DOI 10.1056/NEJMoa2005936; Khera AV, 2020, CIRCULATION, V141, P1760, DOI 10.1161/CIRCULATIONAHA.120.046961; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Manrai AK, 2016, NEW ENGL J MED, V375, P655, DOI 10.1056/NEJMsa1507092; Manrai AK, 2016, JAMA-J AM MED ASSOC, V315, P1233, DOI 10.1001/jama.2016.1519; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller DT, 2021, GENET MED, V23, P1381, DOI 10.1038/s41436-021-01172-3; Murphy NA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02364-1; Papani R, 2018, PULM CIRC, V8, DOI 10.1177/2045894018759246; Park S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0198-6; PheKB, 2018, BREAST CANCER-TOKYO; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Safarova MS, 2016, J CLIN LIPIDOL, V10, P1230, DOI 10.1016/j.jacl.2016.08.001; Shah N, 2018, AM J HUM GENET, V102, P609, DOI 10.1016/j.ajhg.2018.02.019; Shendure J, 2019, CELL, V177, P45, DOI 10.1016/j.cell.2019.02.003; Simonett JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12875; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Sturm AC, 2018, J AM COLL CARDIOL, V72, P662, DOI 10.1016/j.jacc.2018.05.044; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Van Hout CV, 2020, NATURE, V586, P749, DOI 10.1038/s41586-020-2853-0; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wright CF, 2019, AM J HUM GENET, V104, P275, DOI 10.1016/j.ajhg.2018.12.015; Xiang JL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57335-5; Ye JZ, 2019, CLIN GENET, V96, P506, DOI 10.1111/cge.13621	40	8	8	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					350	359		10.1001/jama.2021.23686	http://dx.doi.org/10.1001/jama.2021.23686			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076666	Green Published			2022-12-28	WOS:000753055700012
J	Kuehn, BM				Kuehn, Bridget M.			CDC Establishes Global Networks to Combat Antimicrobial Resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					315	315						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076657				2022-12-28	WOS:000753055700035
J	Jaffe, S				Jaffe, Susan			The next steps for US vaccine mandates	LANCET			English	Editorial Material								As the Supreme Court blocks one of the Biden Administration's plans to raise COVID-19 vaccination rates but approves another, Susan Jaffe looks at the next steps.											0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					425	426						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093218	Bronze, Green Published			2022-12-28	WOS:000755141600011
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Medical regulators should ensure that health workers are vaccinated, says Javid	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o269; Smyth C., 2022, TIMES 0207	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o346	10.1136/bmj.o346	http://dx.doi.org/10.1136/bmj.o346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135821	Bronze			2022-12-28	WOS:000754132400011
J	John, RA				John, Rohit Abraham			An adaptive device for AI neural networks	SCIENCE			English	Editorial Material									[John, Rohit Abraham] Swiss Fed Inst Technol, Inst Inorgan Chem, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	John, RA (corresponding author), Swiss Fed Inst Technol, Inst Inorgan Chem, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.	rohjohn@ethz.ch			ETH Zurich Postdoctoral Fellowship scheme	ETH Zurich Postdoctoral Fellowship scheme	R.A.J. acknowledges the suport from the ETH Zurich Postdoctoral Fellowship scheme.	Davies M, 2018, IEEE MICRO, V38, P82, DOI 10.1109/MM.2018.112130359; Goswami S, 2021, NATURE, V597, P51, DOI 10.1038/s41586-021-03748-0; Janzakova K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27274-9; John RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16985-0; John RA, 2018, ADV MATER, V30, DOI 10.1002/adma.201800220; Kumar S, 2020, NATURE, V585, P518, DOI 10.1038/s41586-020-2735-5; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Milano G, 2022, NAT MATER, V21, P195, DOI 10.1038/s41563-021-01099-9; Torrejon J, 2017, NATURE, V547, P428, DOI 10.1038/nature23011; Wang Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04953-8; Yi W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07052-w; Zhang HT, 2022, SCIENCE, V375, P533, DOI 10.1126/science.abj7943	12	2	2	10	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					495	496		10.1126/science.abn6196	http://dx.doi.org/10.1126/science.abn6196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113694				2022-12-28	WOS:000753965100023
J	Valero, M; Zutshi, I; Yoon, E; Buzsaki, G				Valero, Manuel; Zutshi, Ipshita; Yoon, Euisik; Buzsaki, Gyorgy			Probing subthreshold dynamics of hippocampal neurons by pulsed optogenetics	SCIENCE			English	Article							SHARP-WAVE RIPPLES; PYRAMIDAL CELLS; PLACE FIELDS; INHIBITION; EXCITATION; REACTIVATION; INTERNEURONS; DETERMINANTS; INFORMATION; NETWORKS	Understanding how excitatory (E) and inhibitory (I) inputs are integrated by neurons requires monitoring their subthreshold behavior. We probed the subthreshold dynamics using optogenetic depolarizing pulses in hippocampal neuronal assemblies in freely moving mice. Excitability decreased during sharp-wave ripples coupled with increased I. In contrast to this "negative gain," optogenetic probing showed increased within-field excitability in place cells by weakening I and unmasked stable place fields in initially non-place cells. Neuronal assemblies active during sharp-wave ripples in the home cage predicted spatial overlap and sequences of place fields of both place cells and unmasked preexisting place fields of non-place cells during track running. Thus, indirect probing of subthreshold dynamics in neuronal populations permits the disclosing of preexisting assemblies and modes of neuronal operations.	[Valero, Manuel; Zutshi, Ipshita; Buzsaki, Gyorgy] NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA; [Yoon, Euisik] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Yoon, Euisik] Yonsei Univ, Ctr Nanomed, Inst Basic Sci IBS, Seoul 03722, South Korea; [Yoon, Euisik] Yonsei Univ, Grad Program Nano Biomed Engn Nano BME, Seoul 03722, South Korea; [Buzsaki, Gyorgy] Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA; [Buzsaki, Gyorgy] Langone Med Ctr, Dept Neurol, New York, NY 10016 USA; [Buzsaki, Gyorgy] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; NYU Langone Medical Center; University of Michigan System; University of Michigan; Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University; NYU Langone Medical Center; NYU Langone Medical Center; New York University	Valero, M; Buzsaki, G (corresponding author), NYU, Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA.; Buzsaki, G (corresponding author), Langone Med Ctr, Neurosci Inst, New York, NY 10016 USA.; Buzsaki, G (corresponding author), Langone Med Ctr, Dept Neurol, New York, NY 10016 USA.; Buzsaki, G (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	valegarman@gmail.com; gyorgy.buzsaki@nyumc.org	Valero, Manuel/J-2287-2018	Valero, Manuel/0000-0001-7860-577X; Yoon, Euisik/0000-0002-2127-1200; Zutshi, Ipshita/0000-0001-8180-0816; Buzsaki, Gyorgy/0000-0002-3100-4800	European Molecular Biology Organization (EMBO) postdoctoral fellowship [EMBO ALTF 1161-2017]; Human Frontiers Science Program (HFSP) postdoctoral fellowship [LT0000717/2018]; Leon Levy Neuroscience Fellowship; NIH [MH107396, NS 090583]; NSF PIRE grant [1545858, U19 NS107616, U19 NS104590]; NSF NeuroNex MINT grant [1707316]	European Molecular Biology Organization (EMBO) postdoctoral fellowship; Human Frontiers Science Program (HFSP) postdoctoral fellowship; Leon Levy Neuroscience Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF PIRE grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF NeuroNex MINT grant	This work was supported by the European Molecular Biology Organization (EMBO) postdoctoral fellowship (EMBO ALTF 1161-2017) and Human Frontiers Science Program (HFSP) postdoctoral fellowship (LT0000717/2018) to M.V.; a Leon Levy Neuroscience Fellowship to I.Z.; and NIH MH107396, NS 090583, NSF PIRE grant (1545858), U19 NS107616, U19 NS104590, and NSF NeuroNex MINT grant 1707316.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Barron HC, 2017, P NATL ACAD SCI USA, V114, P6666, DOI 10.1073/pnas.1701812114; Bhatia A, 2019, ELIFE, V8, DOI 10.7554/eLife.43415; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Cohen JD, 2017, ELIFE, V6, DOI 10.7554/eLife.23040; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; English DF, 2014, J NEUROSCI, V34, P16509, DOI 10.1523/JNEUROSCI.2600-14.2014; English DF, 2017, NEURON, V96, P505, DOI 10.1016/j.neuron.2017.09.033; Fernandez-Ruiz A, 2019, SCIENCE, V364, P1082, DOI 10.1126/science.aax0758; Foster DJ, 2017, ANNU REV NEUROSCI, V40, P581, DOI 10.1146/annurev-neuro-072116-031538; Grienberger C, 2017, NAT NEUROSCI, V20, P417, DOI 10.1038/nn.4486; Grosmark AD, 2016, SCIENCE, V351, P1440, DOI 10.1126/science.aad1935; Hulse BK, 2017, CELL REP, V18, P136, DOI 10.1016/j.celrep.2016.11.084; Joo HR, 2018, NAT REV NEUROSCI, V19, P744, DOI 10.1038/s41583-018-0077-1; Kamondi A, 1998, J NEUROSCI, V18, P3919; Karnani MM, 2014, CURR OPIN NEUROBIOL, V26, P96, DOI 10.1016/j.conb.2013.12.015; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Long MA, 2012, CURR OPIN NEUROBIOL, V22, P34, DOI 10.1016/j.conb.2011.10.013; Lopes-dos-Santos V, 2013, J NEUROSCI METH, V220, P149, DOI 10.1016/j.jneumeth.2013.04.010; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; MCKENZIE S, 2021, NEURON, V109, DOI DOI 10.1016/J.NEUR0N.2021.01.011; McKenzie S, 2021, NEURON, V109, DOI 10.1016/j.neuron.2021.01.011; Meyers EM, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00008; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; O'Keefe J, 2021, PHYSIOL REV, V101, P1427, DOI 10.1152/physrev.00014.2020; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKeefe John., 1978, HIPPOCAMPUS COGNITIV; Olypher AV, 2003, J NEUROSCI METH, V127, P123, DOI 10.1016/S0165-0270(03)00123-7; Pachitariu M., 2016, ADV NEURAL INFORM PR, P4455, DOI DOI 10.1101/061481; Petersen CCH, 2017, NEURON, V95, P1266, DOI 10.1016/j.neuron.2017.06.049; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Schomburg EW, 2014, NEURON, V84, P470, DOI 10.1016/j.neuron.2014.08.051; Sharif F, 2021, NEURON, V109, P363, DOI 10.1016/j.neuron.2020.10.034; Souza BC, 2018, NEUROSCIENCE, V375, P62, DOI 10.1016/j.neuroscience.2018.01.066; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Tingley D, 2018, NEURON, V98, P1229, DOI 10.1016/j.neuron.2018.04.028; Valero M, 2021, NAT NEUROSCI, V24, P401, DOI 10.1038/s41593-021-00797-6; Valero M, 2019, J NEUROSCI METH, V326, DOI 10.1016/j.jneumeth.2019.108397; Valero M, 2017, NEURON, V94, P1234, DOI 10.1016/j.neuron.2017.05.032; Valero M, 2015, NAT NEUROSCI, V18, P1281, DOI 10.1038/nn.4074; van de Ven GM, 2016, NEURON, V92, P968, DOI 10.1016/j.neuron.2016.10.020; Watson BO, 2016, NEURON, V90, P839, DOI 10.1016/j.neuron.2016.03.036; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wu F, 2015, NEURON, V88, P1136, DOI 10.1016/j.neuron.2015.10.032	55	6	6	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					570	+		10.1126/science.abm1891	http://dx.doi.org/10.1126/science.abm1891			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113721	Green Accepted			2022-12-28	WOS:000753965100045
J	Wise, J				Wise, Jacqui			Covid-19: UK approves Novavax's protein based vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Heath PT, NEW ENGL J MED; Mallory R, IMMUNOGENICITY SAFET, DOI [10.1101/2021.12.23.21267374, DOI 10.1101/2021.12.23.21267374]; Tinari S, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2965	3	2	2	4	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o309	10.1136/bmj.o309	http://dx.doi.org/10.1136/bmj.o309			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121593	Bronze			2022-12-28	WOS:000753552800014
J	Lau, CN; Bockrath, MW; Mak, KF; Zhang, F				Lau, Chun Ning; Bockrath, Marc W.; Mak, Kin Fai; Zhang, Fan			Reproducibility in the fabrication and physics of moire materials	NATURE			English	Review							MAGIC-ANGLE; CORRELATED STATES; INSULATING STATES; DIRAC FERMIONS; BILAYER; GRAPHENE; SUPERCONDUCTIVITY; TRANSITION; TRANSPORT; MOTT	Overlaying two atomic layers with a slight lattice mismatch or at a small rotation angle creates a moire superlattice, which has properties that are markedly modified from (and at times entirely absent in) the 'parent' materials. Such moire materials have progressed the study and engineering of strongly correlated phenomena and topological systems in reduced dimensions. The fundamental understanding of the electronic phases, such as superconductivity, requires a precise control of the challenging fabrication process, involving the rotational alignment of two atomically thin layers with an angular precision below 0.1 degrees. Here we review the essential properties of moire materials and discuss their fabrication and physics from a reproducibility perspective.	[Lau, Chun Ning; Bockrath, Marc W.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Mak, Kin Fai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Mak, Kin Fai] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Zhang, Fan] Univ Texas Dallas, Dept Phys, Dallas, TX USA	University System of Ohio; Ohio State University; Cornell University; Cornell University; University of Texas System; University of Texas Dallas	Lau, CN (corresponding author), Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.	lau.232@osu.edu		Lau, Chun Ning/0000-0003-2159-6723; Zhang, Fan/0000-0003-4623-4200	Department of Energy [DOE DE-SC0020187]; National Science Foundation [DMR-1945351, DMR-2105139, DMR-1921581]; Army Research Office [W911NF-18-1-0416]; Air Force Office of Scientific Research [FA9550-20-1-0219]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	C.N.L. acknowledges support from the Department of Energy under grant number DOE DE-SC0020187. M.W.B. acknowledges support from the National Science Foundation under grant numbers DMR 2004801 and DMR-2105028. F.Z. acknowledges support from the Army Research Office under grant number W911NF-18-1-0416 and the National Science Foundation under grant numbers DMR-1945351, DMR-2105139 and DMR-1921581. K.F.M. acknowledges support from the Air Force Office of Scientific Research under award number FA9550-20-1-0219.	Ahn J, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021013; Alden JS, 2013, P NATL ACAD SCI USA, V110, P11256, DOI 10.1073/pnas.1309394110; An LH, 2020, NANOSCALE HORIZ, V5, P1309, DOI 10.1039/d0nh00248h; Andrei EY, 2020, NAT MATER, V19, P1265, DOI 10.1038/s41563-020-00840-0; Angeli M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021826118; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Bao W, 2011, NAT PHYS, V7, P948, DOI [10.1038/NPHYS2103, 10.1038/nphys2103]; Beechem TE, 2014, ACS NANO, V8, P1655, DOI 10.1021/nn405999z; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Borodin BR, 2021, NANOTECHNOLOGY, V32, DOI 10.1088/1361-6528/abd817; Brown L, 2012, NANO LETT, V12, P1609, DOI 10.1021/nl204547v; Burg GW, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.197702; Cao Y, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.116804; Cao Y., 2020, NEMATICITY COMPETING, DOI [10.1126/science.aaw3780, DOI 10.1126/science.aaw3780]; Cao Y, 2020, NATURE, V583, P215, DOI 10.1038/s41586-020-2260-6; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2020, NATURE, V579, P56, DOI 10.1038/s41586-020-2049-7; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Chen SW, 2021, NAT PHYS, V17, P374, DOI 10.1038/s41567-020-01062-6; Chen XD, 2016, ADV MATER, V28, P2563, DOI 10.1002/adma.201505129; Choi Y, 2019, NAT PHYS, V15, P1174, DOI 10.1038/s41567-019-0606-5; Cui X, 2015, NAT NANOTECHNOL, V10, P534, DOI [10.1038/nnano.2015.70, 10.1038/NNANO.2015.70]; De Sanctis A, 2018, NANO LETT, V18, P7919, DOI 10.1021/acs.nanolett.8b03854; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Fallahazad B, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.086601; Feng XF, 2013, ACS NANO, V7, P1718, DOI 10.1021/nn305722d; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Geisenhof FR, 2021, NATURE, V598, P53, DOI 10.1038/s41586-021-03849-w; Ghiotto A, 2021, NATURE, V597, P345, DOI 10.1038/s41586-021-03815-6; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Gustafsson MV, 2018, NAT MATER, V17, P411, DOI 10.1038/s41563-018-0036-2; Hao ZY, 2021, SCIENCE, V371, P1133, DOI 10.1126/science.abg0399; He MH, 2021, NAT PHYS, V17, P26, DOI 10.1038/s41567-020-1030-6; Hejazi K, 2020, P NATL ACAD SCI USA, V117, P10721, DOI 10.1073/pnas.2000347117; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Huang X., 2020, CORRELATED INSULATIN; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jiang YH, 2019, NATURE, V573, P91, DOI 10.1038/s41586-019-1460-4; Jin C., 2020, STRIPE PHASES WSE 2; Jin CH, 2021, NAT MATER, V20, P940, DOI 10.1038/s41563-021-00959-8; Julku A, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.060505; Kariyado T, 2019, PHYS REV RES, V1, DOI 10.1103/PhysRevResearch.1.033076; Kazmierczak NP, 2021, NAT MATER, V20, P956, DOI 10.1038/s41563-021-00973-w; Kerelsky A, 2019, NATURE, V572, P95, DOI 10.1038/s41586-019-1431-9; Khalaf E, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.085109; Kim K, 2017, P NATL ACAD SCI USA, V114, P3364, DOI 10.1073/pnas.1620140114; Kim K, 2016, NANO LETT, V16, P1989, DOI 10.1021/acs.nanolett.5b05263; Larentis S, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.201407; Lee S, 2015, CARBON, V93, P286, DOI 10.1016/j.carbon.2015.05.038; Lee Y., 2019, GATE TUNABLE MAGNETI; Li HY, 2021, NAT MATER, V20, P945, DOI 10.1038/s41563-021-00923-6; Li T., CHARGE ORDER ENHANCE; Li Tingxin, 2021, Nature, V600, P641, DOI 10.1038/s41586-021-04171-1; Li TX, 2021, NATURE, V597, P350, DOI 10.1038/s41586-021-03853-0; Liang L, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.024515; Liu JP, 2021, NAT REV PHYS, V3, P367, DOI 10.1038/s42254-021-00297-3; Liu JP, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031021; Liu XM, 2020, NATURE, V583, P221, DOI 10.1038/s41586-020-2458-7; Liu Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205503; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Lui CH, 2011, NANO LETT, V11, P164, DOI 10.1021/nl1032827; Ma C, 2020, NANO LETT, V20, P6076, DOI 10.1021/acs.nanolett.0c02131; Masubuchi S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03723-w; McGilly LJ, 2020, NAT NANOTECHNOL, V15, P580, DOI 10.1038/s41565-020-0708-3; Nuckolls KP, 2020, NATURE, V588, P610, DOI 10.1038/s41586-020-3028-8; Park JM, 2021, NATURE, V590, DOI 10.1038/s41586-021-03192-0; Pierce A. T., UNCONVENTIONAL SEQUE; Pizzocchero F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11894; Po HC, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.195455; Polshyn H, 2020, NATURE, V588, P66, DOI 10.1038/s41586-020-2963-8; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Qiao JB, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.235402; Ramires A, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.146801; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Rodan-Legrain D., 2020, HIGHLY TUNABLE JUNCT; Rosenberger MR, 2018, ACS APPL MATER INTER, V10, P10379, DOI 10.1021/acsami.8b01224; Sainz-Cruz H., 2021, PHYS REV B, V104; Saito Y, 2020, NAT PHYS, V16, P926, DOI 10.1038/s41567-020-0928-3; San-Jose P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.216802; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Shen C, 2020, NAT PHYS, V16, P520, DOI 10.1038/s41567-020-0825-9; Shi HH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14207-w; Shi YM, 2020, NATURE, V584, P210, DOI 10.1038/s41586-020-2568-2; Shimazaki Y, 2020, NATURE, V580, P472, DOI 10.1038/s41586-020-2191-2; Song ZD, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.036401; Stepanov P., 2020, COMPETING ZERO FIELD; Stepanov P, 2020, NATURE, V583, P375, DOI 10.1038/s41586-020-2459-6; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Tarnopolsky G, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.106405; Tian H., 2021, EVIDENCE FLAT BAND D; Tschirhart C. L., 2020, IMAGING ORBITAL FERR; Uri A, 2020, NATURE, V581, P47, DOI 10.1038/s41586-020-2255-3; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; Vries F. K. D., 2020, GATE DEFINED JOSEPHS; Wang DM, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.126101; Wang L, 2020, NAT MATER, V19, P861, DOI 10.1038/s41563-020-0708-6; Wang P, 2015, NANO LETT, V15, P6395, DOI 10.1021/acs.nanolett.5b01568; Woods CR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10800; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Wu FC, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.086402; Wu FC, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.026402; Wu S, 2021, NAT MATER, V20, P488, DOI 10.1038/s41563-020-00911-2; Xian L., 2020, REALIZATION NEARLY D; Xie YL, 2019, NATURE, V572, P101, DOI 10.1038/s41586-019-1422-x; Xu SG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11971-7; Xu SG, 2021, NAT PHYS, V17, P619, DOI 10.1038/s41567-021-01172-9; Xu Y., EMERGENCE NONCOLLINE; Xu Y, 2020, NATURE, V587, P214, DOI 10.1038/s41586-020-2868-6; Yang JR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.255504; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Yoo H, 2019, NAT MATER, V18, P448, DOI 10.1038/s41563-019-0346-z; Zhang CD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601459; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zheng QS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067205; Zhou H., SUPERCONDUCTIVITY RH; Zhou H, 2022, RARE METALS, V41, P992, DOI 10.1007/s12598-021-01849-3; Zhu MJ, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa5176; Zondiner U, 2020, NATURE, V582, P203, DOI 10.1038/s41586-020-2373-y	133	23	23	66	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					41	50		10.1038/s41586-021-04173-z	http://dx.doi.org/10.1038/s41586-021-04173-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110759				2022-12-28	WOS:000750429600016
J	Liverman, D; vonHedemann, N; Nying'uro, P; Rummukainen, M; Stendahl, K; Gay-Antaki, M; Craig, M; Aguilar, L; Bynoe, P; Call, F; Connors, S; David, L; Ferrone, A; Hayward, B; Jayawardena, S; Touray, LM; Parikh, J; Pathak, M; Perez, R; Pirani, A; Prakash, A; Textor, C; Tibig, L; Tignor, M; Tugac, C; Vera, C; Wagle, R				Liverman, Diana; vonHedemann, Nicolena; Nying'uro, Patricia; Rummukainen, Markku; Stendahl, Kerstin; Gay-Antaki, Miriam; Craig, Marlies; Aguilar, Lorena; Bynoe, Paulette; Call, Friedemann; Connors, Sarah; David, Laura; Ferrone, Andrew; Hayward, Bronwyn; Jayawardena, Shiromani; Mai Touray, Lamin; Parikh, Jyoti; Pathak, Minal; Perez, Rosa; Pirani, Anna; Prakash, Anjal; Textor, Christiane; Tibig, Lourdes; Tignor, Melinda; Tugac, Cigdem; Vera, Carolina; Wagle, Radha			Survey of gender bias in the IPCC	NATURE			English	Editorial Material							INTERGOVERNMENTAL PANEL; CLIMATE-CHANGE		[Liverman, Diana] Univ Arizona, Tucson, AZ 85721 USA	University of Arizona	Liverman, D (corresponding author), Univ Arizona, Tucson, AZ 85721 USA.	liverman@u.arizona.edu	Bynoe, Paulette/HGU-6040-2022; TUĞAÇ, Çiğdem/ABB-8858-2020; Pirani, Anna/GSO-0172-2022	Bynoe, Paulette/0000-0002-9152-2693; TUĞAÇ, Çiğdem/0000-0002-2555-6641; Craig, Marlies/0000-0002-9181-2607; Gay-Antaki, Miriam/0000-0001-9368-8593; Nying'uro, Patricia/0000-0001-5896-9533; Pathak, Minal/0000-0002-9474-0485				Campbell LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079147; Corbera E, 2016, NAT CLIM CHANGE, V6, P94, DOI [10.1038/nclimate2782, 10.1038/NCLIMATE2782]; Ho-Lem C, 2011, GLOBAL ENVIRON CHANG, V21, P1308, DOI 10.1016/j.gloenvcha.2011.05.007; Marin-Spiotta E., 2020, ADV GEOSCIENCES, V53, P117, DOI [10.5194/adgeo-53-117-2020, DOI 10.5194/ADGEO-53-117-2020]; Nagel J, 2015, GENDER CLIMATE CHANG, DOI [10.4324/9781315675275, DOI 10.4324/9781315675275]; National Academies of Sciences Engineering and Medicine, 2020, ENG MED PROM PRACT A; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114; Pearse R, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.451; Popp AL, 2019, EARTH SPACE SCI, V6, P1460, DOI 10.1029/2019EA000706; Yamineva Y, 2017, ENVIRON SCI POLICY, V77, P244, DOI 10.1016/j.envsci.2017.04.005	10	3	3	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					30	32						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8PL	35105992				2022-12-28	WOS:000749566700014
J	Perkel, JM				Perkel, Jeffrey M.			HOW TO FIX YOUR SCIENTIFIC CODING ERRORS	NATURE			English	Editorial Material						Lab life; Authorship; Software												Clementi NC, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.063305; Curcic M, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087647; Donelan MA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019460; Neupane JB, 2019, ORG LETT, V21, P8449, DOI 10.1021/acs.orglett.9b03216; Strand J. F., 2021, PREPRINT PSYARXIV, DOI [10.31234/osf.io/rsn5y, DOI 10.31234/OSF.IO/RSN5Y]; Strand JF, 2019, PSYCHON B REV, V26, P291, DOI 10.3758/s13423-018-1489-7; Weisberg SM, 2014, J EXP PSYCHOL LEARN, V40, P669, DOI 10.1037/a0035261	7	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					172	173		10.1038/d41586-022-00217-0	http://dx.doi.org/10.1038/d41586-022-00217-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS2HG	35102330	Bronze			2022-12-28	WOS:000750503100002
J	Riechers, DA; Weiss, A; Walter, F; Carilli, CL; Cox, P; Decarli, R; Neri, R				Riechers, Dominik A.; Weiss, Axel; Walter, Fabian; Carilli, Christopher L.; Cox, Pierre; Decarli, Roberto; Neri, Roberto			Microwave background temperature at a redshift of 6.34 from H2O absorption	NATURE			English	Article							RADIATION TEMPERATURE; MOLECULAR-HYDROGEN; STARBURST GALAXY; CO; EXCITATION; LINES; DUST; GAS	Distortions of the observed cosmic microwave background provide a direct measurement of the microwave background temperature at redshifts from 0 to 1 (refs.(1,2)). Some additional background temperature estimates exist at redshifts from 1.8 to 3.3 based on molecular and atomic line-excitation temperatures in quasar absorption-line systems, but are model dependent(3). No deviations from the expected (1 + z) scaling behaviour of the microwave background temperature have been seen4, but the measurements have not extended deeply into the matter-dominated era of the Universe at redshifts z > 3.3. Here we report observations of submillimetre line absorption from the water molecule against the cosmic microwave background at z = 6.34 in a massive starburst galaxy, corresponding to a lookback time of 12.8 billion years (ref.(5)). Radiative pumping of the upper level of the ground-state ortho-H2O(1(10)-1(01)) line due to starburst activity in the dusty galaxy HFLS3 results in a cooling to below the redshifted microwave background temperature, after the transition is initially excited by the microwave background. This implies a microwave background temperature of 16.4-30.2 K (1 sigma range) at z = 6.34, which is consistent with a background temperature increase with redshift as expected from the standard Lambda CDM cosmology(4).	[Riechers, Dominik A.] Univ Cologne, Phys Inst, Cologne, Germany; [Weiss, Axel] Max Planck Inst Radioastron, Bonn, Germany; [Walter, Fabian] Max Planck Inst Astron, Heidelberg, Germany; [Walter, Fabian; Carilli, Christopher L.] Pete V Domenici Array Sci Ctr, Natl Radio Astron Observ, Socorro, NM USA; [Cox, Pierre] UPMC Univ Paris 6, Sorbonne Univ, Paris, France; [Cox, Pierre] Inst Astrophys Paris, CNRS, UMR 7095, Paris, France; [Decarli, Roberto] INAF, Osservatorio Astrofis & Sci Spazio, Bologna, Italy; [Neri, Roberto] Inst Radioastron Millimetr, St Martin Dheres, France	University of Cologne; Max Planck Society; Max Planck Society; National Radio Astronomy Observatory (NRAO); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Istituto Nazionale Astrofisica (INAF)	Riechers, DA (corresponding author), Univ Cologne, Phys Inst, Cologne, Germany.	riechers@ph1.uni-koeln.de			Universitat zu Koln	Universitat zu Koln	Open access funding provided by Universitat zu Koln.	Aghanim N, 2020, ASTRON ASTROPHYS, V641, DOI 10.1051/0004-6361/201833880; Balashev SA, 2017, MON NOT R ASTRON SOC, V470, P2890, DOI 10.1093/mnras/stx1339; Balashev SA, 2011, MON NOT R ASTRON SOC, V418, P357, DOI 10.1111/j.1365-2966.2011.19489.x; Balashev SA, 2010, ASTRON LETT+, V36, P761, DOI 10.1134/S1063773710110010; Burgh EB, 2007, ASTROPHYS J, V658, P446, DOI 10.1086/511259; Daniel F, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201118049; Darling J, 2012, ASTROPHYS J LETT, V749, DOI 10.1088/2041-8205/749/2/L33; Dubernet ML, 2009, ASTRON ASTROPHYS, V497, P911, DOI 10.1051/0004-6361/200810680; Ge J, 1997, ASTROPHYS J, V474, P67, DOI 10.1086/303426; Gonzalez-Alfonso E, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201423980; Gonzalez-Alfonso E, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118029; Guimaraes R, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/6/147; Hurier G, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322632; Jaeckel J, 2010, ANNU REV NUCL PART S, V60, P405, DOI 10.1146/annurev.nucl.012809.104433; Jorgenson RA, 2010, ASTROPHYS J, V722, P460, DOI 10.1088/0004-637X/722/1/460; Klimenko VV, 2020, ASTRON LETT+, V46, P715, DOI 10.1134/S1063773720110031; Ledoux C, 2003, MON NOT R ASTRON SOC, V346, P209, DOI 10.1046/j.1365-2966.2003.07082.x; Liu L, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa81b4; Maeder A, 2017, ASTROPHYS J, V847, DOI 10.3847/1538-4357/aa88cf; Muller HSP, 2001, ASTRON ASTROPHYS, V370, pL49, DOI 10.1051/0004-6361:20010367; Noterdaeme P, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201732266; Noterdaeme P, 2017, ASTRON ASTROPHYS, V597, DOI 10.1051/0004-6361/201629173; Noterdaeme P, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201016140; Pavesi R, 2018, ASTROPHYS J, V864, DOI 10.3847/1538-4357/aacb79; Ranjan A, 2018, ASTRON ASTROPHYS, V618, DOI 10.1051/0004-6361/201833446; REPHAELI Y, 1995, ANNU REV ASTRON ASTR, V33, P541; Riechers DA, 2021, ASTROPHYS J, V907, DOI 10.3847/1538-4357/abcf2e; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Saro A, 2014, MON NOT R ASTRON SOC, V440, P2610, DOI 10.1093/mnras/stu575; SONGAILA A, 1994, NATURE, V371, P43, DOI 10.1038/371043a0; SUNYAEV RA, 1980, ANNU REV ASTRON ASTR, V18, P537, DOI 10.1146/annurev.aa.18.090180.002541; Townes CH, 1997, QUANTUM ELECTRON+, V27, P1031, DOI 10.1070/QE1997v027n12ABEH001104; Uzan JP, 2011, LIVING REV RELATIV, V14, DOI 10.12942/lrr-2011-2; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; Weiss A, 2007, ASTRON ASTROPHYS, V467, P955, DOI 10.1051/0004-6361:20066117; Wess A, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015078	46	5	5	6	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					58	+		10.1038/s41586-021-04294-5	http://dx.doi.org/10.1038/s41586-021-04294-5			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110755	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000750429600018
J	Knox, HL; Sinner, EK; Townsend, CA; Boal, AK; Booker, SJ				Knox, Hayley L.; Sinner, Erica K.; Townsend, Craig A.; Boal, Amie K.; Booker, Squire J.			Structure of a B-12-dependent radical SAM enzyme in carbapenem biosynthesis	NATURE			English	Article							S-ADENOSYLMETHIONINE METHYLASE; ENZYMOLOGY WEB TOOLS; GENE-CLUSTER; TSRM; THIENAMYCIN; TRYPTOPHAN; CHEMISTRY; REQUIRES; PATHWAY; MODELS	Carbapenems are antibiotics of last resort in the clinic. Owing to their potency and broad-spectrum activity, they are an important part of the antibiotic arsenal. The vital role of carbapenems is exemplified by the approval acquired by Merck from the US Food and Drug Administration (FDA) for the use of an imipenem combination therapy to treat the increased levels of hospital-acquired and ventilator-associated bacterial pneumonia that have occurred during the COVID-19 pandemic(1). The C6 hydroxyethyl side chain distinguishes the clinically used carbapenems from the other classes of beta-lactam antibiotics and is responsible for their low susceptibility to inactivation by occluding water from the beta-lactamase active site(2). The construction of the C6 hydroxyethyl side chain is mediated by cobalamin- or B-12-dependent radical S-adenosylmethionine (SAM) enzymes(3). These radical SAM methylases (RSMTs) assemble the alkyl backbone by sequential methylation reactions, and thereby underlie the therapeutic usefulness of clinically used carbapenems. Here we present X-ray crystal structures of TokK, a B-12-dependent RSMT that catalyses three-sequential methylations during the biosynthesis of asparenomycin A. These structures, which contain the two metallocofactors of the enzyme and were determined in the presence and absence of a carbapenam substrate, provide a visualization of a B-12-dependent RSMT that uses the radical mechanism that is shared by most of these enzymes. The structures provide insight into the stereochemistry of initial C6 methylation and suggest that substrate positioning governs the rate of each methylation event.	[Knox, Hayley L.; Boal, Amie K.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Sinner, Erica K.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Boal, Amie K.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boal, AK; Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Townsend, CA (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.; Boal, AK; Booker, SJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.	ctownsend@jhu.edu; akb20@psu.edu; squire@psu.edu		Knox, Hayley L./0000-0003-1467-309X; Sinner, Erica/0000-0003-2417-9319	National Institutes of Health (NIH) [GM122595, GM119707, AI121072, GM080189]; Eberly Family Distinguished Chair in Science; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NIH [S10 OD012289]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Howard Hughes Medical Institute; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NIH, National Institute of General Medical Sciences [P30 GM124169]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eberly Family Distinguished Chair in Science; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) (GM122595 to S.J.B., GM119707 to A.K.B., AI121072 to C.A.T. and GM080189 to E.K.S.) and the Eberly Family Distinguished Chair in Science (S.J.B.). S.J.B. is an investigator of the Howard Hughes Medical Institute. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Use of GM/CA@APS has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The Eiger 16M detector at GM/CA-XSD was funded by NIH grant S10 OD012289. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). This research also used the resources of the Berkeley Center for Structural Biology supported in part by the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract no. DE-AC02-05CH11231. The ALS-ENABLE beamlines are supported in part by the NIH, National Institute of General Medical Sciences, grant P30 GM124169. E.K.S. and C.A.T. thank M. S. Lichstrahl for providing a synthetic intermediate, and I. P. Mortimer and J. Tang for their help with ESI-MS and NMR experiments, respectively. We thank D. Iwig for his help in the mass spectrometry analysis of the TokK crystals.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; ALBERSSCHONBERG G, 1978, J AM CHEM SOC, V100, P6491, DOI 10.1021/ja00488a038; Blaszczyk AJ, 2017, J BIOL CHEM, V292, P15456, DOI 10.1074/jbc.M117.778548; Blaszczyk AJ, 2017, METHOD ENZYMOL, V595, P303, DOI 10.1016/bs.mie.2017.07.007; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Bridwell-Rabb J, 2017, NATURE, V544, P322, DOI 10.1038/nature21689; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Chang WC, 2014, SCIENCE, V343, P1140, DOI 10.1126/science.1248000; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Gerlt JA, 2017, BIOCHEMISTRY-US, V56, P4293, DOI 10.1021/acs.biochem.7b00614; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Holliday GL, 2018, METHOD ENZYMOL, V606, P1, DOI 10.1016/bs.mie.2018.06.004; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang C, 2015, CHEM BIOL, V22, P251, DOI 10.1016/j.chembiol.2014.12.012; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Knox HL, 2021, NAT CHEM BIOL, V17, P485, DOI 10.1038/s41589-020-00717-y; KRAUTLER B, 1990, FEMS MICROBIOL LETT, V87, P349, DOI 10.1111/j.1574-6968.1990.tb04935.x; KRAUTLER B, 1987, HELV CHIM ACTA, V70, P1268, DOI 10.1002/hlca.19870700506; Lanz ND, 2018, BIOCHEMISTRY-US, V57, P1475, DOI 10.1021/acs.biochem.7b01205; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; Li RF, 2014, CHEMBIOCHEM, V15, P320, DOI 10.1002/cbic.201300319; Marous DR, 2015, P NATL ACAD SCI USA, V112, P10354, DOI 10.1073/pnas.1508615112; Miller D. V., 2020, COMPREHENSIVE NATURA, V5, P24, DOI [10.1016/B978-0-12-409547-2.14863-2, DOI 10.1016/B978-0-12-409547-2.14863-2]; MILTON PA, 1977, J AM CHEM SOC, V99, P1390, DOI 10.1021/ja00447a018; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mitchell AJ, 2017, J AM CHEM SOC, V139, P13830, DOI 10.1021/jacs.7b07374; Nunez LE, 2003, CHEM BIOL, V10, P301, DOI 10.1016/S1074-5521(03)00069-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Radler MI, 2019, J BIOL CHEM, V294, P11712, DOI 10.1074/jbc.RA119.007609; Schaff J, 1997, BIOPHYS J, V73, P1135, DOI 10.1016/S0006-3495(97)78146-3; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinner Erica K, 2022, ACS Bio Med Chem Au, V2, P4, DOI 10.1021/acsbiomedchemau.1c00032; Sinner EK, 2019, CHEM COMMUN, V55, P14934, DOI 10.1039/c9cc07197k; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; US Food and Drug Administration, 2020, NEW DRUG APPR RECA S; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang B, 2018, BIOCHEMISTRY-US, V57, P4972, DOI 10.1021/acs.biochem.8b00693; Wang SC, 2018, NAT PROD REP, V35, P707, DOI 10.1039/c7np00059f; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; Westrich L, 2003, CHEMBIOCHEM, V4, P768, DOI 10.1002/cbic.200300609; Zallot R, 2019, BIOCHEMISTRY-US, V58, P4169, DOI 10.1021/acs.biochem.9b00735; Zallot R, 2018, CURR OPIN CHEM BIOL, V47, P77, DOI 10.1016/j.cbpa.2018.09.009	56	15	15	19	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					343	+		10.1038/s41586-021-04392-4	http://dx.doi.org/10.1038/s41586-021-04392-4		FEB 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	35110734	Green Accepted, Bronze			2022-12-28	WOS:000750001600004
J	Mahase, E				Mahase, Elisabeth			Afghanistan: window to save lives is "closing fast" as families resort to selling children, charities warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, BMJ ANN APPEAL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o283	10.1136/bmj.o283	http://dx.doi.org/10.1136/bmj.o283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110295				2022-12-28	WOS:000758682200004
J	Kang, M; Yi, Y; Li, Y; Sun, LM; Deng, AP; Hu, T; Zhang, JY; Liu, J; Cheng, MJ; Xie, S; Luo, M; Jiang, J; Jiang, YW; Tang, SX; He, JF				Kang, Min; Yi, Yao; Li, Yan; Sun, Limei; Deng, Aiping; Hu, Ting; Zhang, Jiayi; Liu, Jun; Cheng, Mingji; Xie, Shen; Luo, Min; Jiang, Jing; Jiang, Yawen; Tang, Shixing; He, Jianfeng			Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SARS-COV-2 INFECTION; RISK; RATIOS	Background: Real-world evidence on inactivated COVID-19 vaccines against the highly transmissible B.1.617.2 (Delta) variant of SARS-CoV-2 is limited, leaving an important gap in the evidence base about inactivated COVID-19 vaccines for use by immunization programs. Objective: To estimate inactivated vaccine effectiveness (VE) against the B.1.617.2 variant. Design: Retrospective cohort study. Setting: The study was based on the first outbreak of the B.1.617.2 variant in mainland China that was discovered and traced in Guangdong in May and June 2021. Participants: 10 805 adult case patients with laboratory-confirmed infection and close contacts. Measurements: Participants were categorized as unvaccinated, partially vaccinated (1 dose), and fully vaccinated (2 doses). We estimated VE against the primary outcome of pneumonia and the secondary outcomes of infections, symptomatic infections, and severe or critical illness associated with the B.1.617.2 variant. Results: Results are reported in the order of outcome severity. Of 10 805 participants, 1.3% contracted infections, 1.2% developed symptomatic infections, 1.1% had pneumonia, and 0.2% had severe or critical illness. The adjusted VEs of full vaccination were 51.8% (95% CI, 20.3% to 83.2%) against infection, 60.4% (CI, 31.8% to 88.9%) against symptomatic infection, and 78.4% (CI, 56.9% to 99.9%) against pneumonia. Also, full vaccination was 100% (CI, 98.4% to 100.0%) effective against severe or critical illness. By contrast, the adjusted VEs of partial vaccination against infection, symptomatic infection, and pneumonia were 10.7% (CI, -41.2% to 62.6%), 6.8% (CI, -47.4% to 61.0%), and 11.6% (CI, -42.6% to 65.8%), respectively. Limitation: Observational study with possible unmeasured confounders; insufficient data to do reliable subgroup analyses by age and vaccine brand. Conclusion: Full vaccination with inactivated vaccines is effective against the B.1.617.2 variant. Effort should be made to ensure full vaccination of target populations.	[Kang, Min] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China; [Kang, Min; Yi, Yao; Li, Yan; Sun, Limei; Deng, Aiping; Hu, Ting; Zhang, Jiayi; Liu, Jun; Cheng, Mingji; Xie, Shen; Luo, Min; Jiang, Jing; He, Jianfeng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Peoples R China; [Jiang, Yawen] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Peoples R China; [Tang, Shixing] Southern Med Univ, Sch Publ Hlth, Guangzhou, Peoples R China	Southern Medical University - China; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University; Southern Medical University - China	Jiang, YW (corresponding author), Sun Yat Sen Univ, Room 215,Mingde Garden 6,132 East Outer Ring Rd, Guangzhou, Peoples R China.; Tang, SX (corresponding author), 1023-1063 Shatai South Rd, Guangzhou, Peoples R China.; He, JF (corresponding author), 160 Qunxian Rd, Guangzhou, Peoples R China.	jiangyw26@mail.sysu; tamgshixing@smu.edu.cn; 1460035443@qq.com		Yi, Yao/0000-0002-2116-4341	National Natural Science Foundation of China [82041030]; Key-Area Research and Development Programof Guangdong Province [2019B111103001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key-Area Research and Development Programof Guangdong Province	By grant 82041030 from the National Natural Science Foundation of China and grant 2019B111103001 from the Key-Area Research and Development Programof Guangdong Province.	Al Kaabi N, 2021, JAMA-J AM MED ASSOC, V326, P35, DOI 10.1001/jama.2021.8565; Altmann DM, 2021, LANCET RESP MED, V9, P1356, DOI 10.1016/S2213-2600(21)00458-6; Andersson O, 2021, J HEALTH ECON, V80, DOI 10.1016/j.jhealeco.2021.102530; Baraniuk C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n912; Baraniuk C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n743; Bartlett VL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12869; Berger ML, 2017, PHARMACOEPIDEM DR S, V26, P1033, DOI 10.1002/pds.4297; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Campbell F, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.24.2100509; Cox C., 2005, ENCY BIOSTATISTICS, V2nd, P1550; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Forni G, 2021, CELL DEATH DIFFER, V28, P626, DOI 10.1038/s41418-020-00720-9; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Griffin M, 2021, ANN MED SURG, V61, P88, DOI 10.1016/j.amsu.2020.12.012; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Li MC, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00767-1; Liu, 2021, REUTERS 0514; Mallapaty S, 2021, NATURE, V598, P398, DOI 10.1038/d41586-021-02796-w; Mallapaty Smriti, 2021, Nature, DOI 10.1038/d41586-021-00094-z; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; National Health Commission & National Administration of Traditional Chinese Medicine, 2021, INFECT DIS IMMUN, V1, P8, DOI [10.1097/01.ID9.0000733564.21786.b0, DOI 10.1097/01.ID9.0000733564.21786.B0]; National Health Commission of the People's Republic of China, 2021, PREV CONTR SCHEM COV, V8th; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Palacios R., 2021, SSRN ELECT J, DOI [10.2139/ssrn.3822780, DOI 10.2139/SSRN.3822780]; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI 10.15585/mmwr.mm7020e2externalicon; Poland GA, 2021, VACCINE, V39, P457, DOI 10.1016/j.vaccine.2020.12.017; Reis B, 2021, NEW ENGL J MED, V385, P2101, DOI 10.1056/NEJMc2114290; Rostad CA, 2021, LANCET INFECT DIS, V21, P581, DOI 10.1016/S1473-3099(20)30988-9; Swift MD, 2021, CLIN INFECT DIS, V73, pE1376, DOI 10.1093/cid/ciab361; Thiagarajan K, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n997; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Trogen B, 2021, ANN INTERN MED, V174, P858, DOI 10.7326/M20-8251; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wang YP, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101129; Zhang M, 2021, CHINA CDC WEEKLY, V3, P584, DOI 10.46234/ccdcw2021.148	39	19	20	3	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					533	+		10.7326/M21-3509	http://dx.doi.org/10.7326/M21-3509		FEB 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35099990	Green Published			2022-12-28	WOS:000750872600001
J	Persad, G; Pathak, PA; Sonmez, T; Unver, MU				Persad, Govind; Pathak, Parag A.; Sonmez, Tayfun; Unver, M. Utku			Fair access to scarce medical capacity for non-covid-19 patients: a role for reserves	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Persad, Govind] Univ Denver, Sturm Coll Law, Denver, CO 80208 USA; [Pathak, Parag A.] MIT, Boston, MA USA; [Sonmez, Tayfun; Unver, M. Utku] Boston Coll, Boston, MA USA	University of Denver; Massachusetts Institute of Technology (MIT); Boston College	Persad, G (corresponding author), Univ Denver, Sturm Coll Law, Denver, CO 80208 USA.							Brown TR, 2021, WASH POST; California Department of Public Health, 2021, CAL COMM HLTH EQ; Hsia RY, 2017, HEALTH AFFAIR, V36, P1070, DOI 10.1377/hlthaff.2016.0925; Pathak PA, P 22 ACM C EC COMP, P785; Rubin E, 2021, CHEST, V160, P2324, DOI 10.1016/j.chest.2021.08.003; Schmidt H, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3795; Sonmez T, 2021, CHEST, V159, P1294, DOI 10.1016/j.chest.2020.12.019; Sparks S., 2021, VACCINE DISCRIMINATI; Tennessee Department of Health, 2020, INT COVID 19 VACC PL; Vawter D, GOOD US ALL ETHICALL; Wikler D., 2021, WASH POST; Zucker HA., 2015, VENTILATOR ALLOCATIO	12	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o276	10.1136/bmj.o276	http://dx.doi.org/10.1136/bmj.o276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105540	Bronze			2022-12-28	WOS:000758676500013
J	Voelker, R				Voelker, Rebecca			A New Option Is Approved for Patients With Myasthenia Gravis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					417	417						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103783				2022-12-28	WOS:000753056200009
J	Mahmood, A; Dar, S; Dabhad, A; Aksi, B; Chowdhury, TA				Mahmood, Ammad; Dar, Sahira; Dabhad, Ammarah; Aksi, Bilal; Chowdhury, Tahseen A.			Advising patients with existing conditions about fasting during Ramadan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; RESTRICTION; DISEASE		[Mahmood, Ammad] Univ Glasgow, Queen Elizabeth Univ Hosp, Imaging Ctr Excellence, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Dar, Sahira] NHS Greater Glasgow & Clyde, Primary Care Div, Glasgow, Lanark, Scotland; [Dabhad, Ammarah] Royal Wolverhampton NHS Trust, Wolverhampton, England; [Chowdhury, Tahseen A.] Royal London Hosp, London, England	Queen Elizabeth University Hospital (QEUH); University of Glasgow; Barts Health NHS Trust; Royal London Hospital	Mahmood, A (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Imaging Ctr Excellence, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	ammad.mahmood@glasgow.ac.uk		Mahmood, Ammad/0000-0001-5138-6706				Aadil N, 2004, BMJ-BRIT MED J, V329, P778, DOI 10.1136/bmj.329.7469.778; Abu'l Ikhlas al- Shurunbulali FK, 2010, ASCENT FELICITY MARA; Ahmed SH, 2020, DIABETES THER, V11, P2477, DOI 10.1007/s13300-020-00886-y; Akhtar AM, 2022, HEART, V108, P258, DOI 10.1136/heartjnl-2021-319273; Al-Qahtani Awad Mohammed, 2020, Sudan J Paediatr, V20, P42, DOI 10.24911/SJP.106-1569847908; Allegaert K, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7060060; Almond D, 2015, ECON J, V125, P1501, DOI 10.1111/ecoj.12168; Assy MH, 2019, DIABETES RES CLIN PR, V151, P299, DOI 10.1016/j.diabres.2019.03.012; Barakat I, 2020, J NUTR METAB, V2020, DOI 10.1155/2020/8849832; Baynouna Al Ketbi Latifa Mohammad, 2014, BMC Res Notes, V7, P392, DOI 10.1186/1756-0500-7-392; Beshyah SA, 2020, ENDOCR CONNECT, V9, P804, DOI 10.1530/EC-20-0314; British Islamic Medical Association, 2020, RAM RAP REV; British Islamic Medical Association, 2021, RAM COMP; British Nutrition Foundation, 2021, HLTH RAM 2021; Chamsi-Pasha H, 2014, J SAUDI HEART ASSOC, V26, P212, DOI 10.1016/j.jsha.2014.04.002; Chowdhury TA, 2020, DIABETES THER, V11, P2447, DOI 10.1007/s13300-020-00887-x; Damier P, 2017, JAMA NEUROL, V74, P233, DOI 10.1001/jamaneurol.2016.4291; egality, 2021, COLLABORATION CHANGE; FROST G, 1987, HUM NUTR-APPL NUTR, V41A, P47; Furqan Z, 2019, LANCET PSYCHIAT, V6, P556, DOI 10.1016/S2215-0366(19)30161-0; Ghouri N, 2012, DIABETIC MED, V29, P696, DOI 10.1111/j.1464-5491.2011.03519.x; Ghouri N, 2021, DIABETES RES CLIN PR, V175, DOI 10.1016/j.diabres.2021.108835; Ghouri N, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2018-000520; Glazier JD, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2048-y; Hassanein M, 2017, DIABETES RES CLIN PR, V126, P303, DOI 10.1016/j.diabres.2017.03.003; Heun R., 2018, GLOBAL PSYCH, V1, P7, DOI [10.2478/gp-2018-0002, DOI 10.2478/GP-2018-0002]; Hussain S, 2020, CLIN ENDOCRINOL, V93, P87, DOI 10.1111/cen.14250; Ibrahim M, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001248; IDF-DAR, 2021, DIAB RAM PRACT GUID; Jahromi SR, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-56; Leiper JB, 2003, EUR J CLIN NUTR, V57, pS30, DOI 10.1038/sj.ejcn.1601899; Mahmood A, 2020, EPILEPSY BEHAV, V111, DOI 10.1016/j.yebeh.2020.107117; Majid F, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001185; Malik S, 2021, CLIN KIDNEY J, V14, P1524, DOI 10.1093/ckj/sfab032; Moothadeth A, 2020, OCCUP MED-OXFORD, V70, P306, DOI 10.1093/occmed/kqaa103; National Institute for Health and Care Excellence (NICE), 2021, SHARED DECISION MAKI; NHS, 2019, SHARED DECISION MAKI; Nugraha B, 2017, APPETITE, V111, P38, DOI 10.1016/j.appet.2016.12.030; Or Koca A, 2020, TURK J MED SCI, V50, P784, DOI 10.3906/sag-1911-28; Oxford Bibliographies, 2013, OXF BIBL; Pew Research Center, 2019, MOST MUSL SAY THEY F; Pickrell WO, 2015, EPILEPSY BEHAV, V47, P78, DOI 10.1016/j.yebeh.2015.01.033; PRENTICE AM, 1983, HUM NUTR-CLIN NUTR, V37, P283; Rashid, 2020, WHAT INVALIDATES FAS; Raza Syed A, 2012, Indian J Endocrinol Metab, V16, P522, DOI 10.4103/2230-8210.98001; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Savitri AI, 2020, J DEV ORIG HLTH DIS, V11, P664, DOI 10.1017/S2040174419000837; Schmahl F W, 1991, Pol J Occup Med Environ Health, V4, P219; Sheikh A, 2018, ENDOCR PRACT, V24, P882, DOI 10.4158/EP-2018-0038; Turin TC, 2016, J FAM COMMUNITY MED, V23, P73, DOI 10.4103/2230-8229.181006; Waqar Salman, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101097; Zeeneldin AA, 2012, ANN SAUDI MED, V32, P243, DOI 10.5144/0256-4947.2012.243; Zeeneldin AA, 2012, J EGYPT NATL CANCER, V24, P133, DOI 10.1016/j.jnci.2012.06.003	53	3	3	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2022	376								e063613	10.1136/bmj-2020-063613	http://dx.doi.org/10.1136/bmj-2020-063613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS2TM	35101897				2022-12-28	WOS:000750534900001
J	Klompas, M; Karan, A				Klompas, Michael; Karan, Abraar			Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Klompas, Michael] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Klompas, Michael] Harvard Pilgrim Hlth Care Inst, 401 Pk Dr, Boston, MA 02215 USA; [Klompas, Michael] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Karan, Abraar] Stanford Univ, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Stanford University	Klompas, M (corresponding author), Harvard Pilgrim Hlth Care Inst, 401 Pk Dr, Boston, MA 02215 USA.; Klompas, M (corresponding author), Harvard Med Sch, 401 Pk Dr, Boston, MA 02215 USA.	mklompas@bwh.harvard.edu						Adenaiye OO, 2022, CLIN INFECT DIS, V75, pE241, DOI 10.1093/cid/ciab797; Klompas M, 2021, CLIN INFECT DIS, V73, P1693, DOI 10.1093/cid/ciab218; Lawton T, 2022, J HOSP INFECT, V120, P81, DOI 10.1016/j.jhin.2021.11.018; Lindsley WG, 2021, AEROSOL SCI TECH, V55, P449, DOI 10.1080/02786826.2020.1862409; Lumley SF, 2021, J INFECTION, V83, P473, DOI 10.1016/j.jinf.2021.07.034; Lyngse FP., 2021, MEDRXIV, DOI [10.1101/2021.12.27.21268278, DOI 10.1101/2021.12.27.21268278], Patent No. 21268278; Shitrit P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.39.2100822; Sickbert-Bennett EE, 2020, JAMA INTERN MED, V180, P1607, DOI 10.1001/jamainternmed.2020.4221; UK Health Security Agency, 2021, ESTIMATING PREVALENC; UKHSA,, 2022, MONK CAS CONF ENGL L	10	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					619	620		10.1001/jama.2022.0262	http://dx.doi.org/10.1001/jama.2022.0262		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35072715				2022-12-28	WOS:000747991900004
J	Jakobsson, J; Vincendeau, M				Jakobsson, Johan; Vincendeau, Michelle			SnapShot: Human endogenous retroviruses	CELL			English	Editorial Material									[Jakobsson, Johan] Lund Univ, Lund Stem Cell Ctr, Dept Expt Med Sci, Lund, Sweden; [Vincendeau, Michelle] Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany	Lund University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jakobsson, J (corresponding author), Lund Univ, Lund Stem Cell Ctr, Dept Expt Med Sci, Lund, Sweden.		Vincendeau, Michelle/AAD-4320-2022; Jakobsson, Johan/E-7745-2014	Jakobsson, Johan/0000-0003-0669-7673				Chelmicki T, 2021, NATURE, V591, P312, DOI 10.1038/s41586-020-03135-1; Dembny P, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131093; Johansson EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0708; Jonsson ME, 2021, EMBO J, V40, DOI 10.15252/embj.2020106423; Jonsson ME, 2020, TRENDS GENET, V36, P610, DOI 10.1016/j.tig.2020.05.004; Kury P, 2018, TRENDS MOL MED, V24, P379, DOI 10.1016/j.molmed.2018.02.007; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Mager D.L., 2003, NATURE ENCY HUMAN GE; Nair VP, 2021, CELL STEM CELL, V28, P1566, DOI [10.1016/j.stem.2021.04.009, 10.1016/j.stem.2021.05.003]; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90	10	1	1	6	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					400	+		10.1016/j.cell.2021.12.028	http://dx.doi.org/10.1016/j.cell.2021.12.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8GV	35063077				2022-12-28	WOS:000746126900002
J	Jones, SM; Kim, EH; Nadeau, KC; Nowak-Wegrzyn, A; Wood, RA; Sampson, HA; Scurlock, AM; Chinthrajah, S; Wang, JL; Pesek, RD; Sindher, SB; Kulis, M; Johnson, J; Spain, K; Babineau, DC; Chin, H; Laurienzo-Panza, J; Yan, R; Larson, D; Qin, T; Whitehouse, D; Sever, ML; Sanda, S; Plaut, M; Wheatley, LM; Burks, AW				Jones, Stacie M.; Kim, Edwin H.; Nadeau, Kari C.; Nowak-Wegrzyn, Anna; Wood, Robert A.; Sampson, Hugh A.; Scurlock, Amy M.; Chinthrajah, Sharon; Wang, Julie; Pesek, Robert D.; Sindher, Sayantani B.; Kulis, Mike; Johnson, Jacqueline; Spain, Katharine; Babineau, Denise C.; Chin, Hyunsook; Laurienzo-Panza, Joy; Yan, Rachel; Larson, David; Qin, Tian; Whitehouse, Don; Sever, Michelle L.; Sanda, Srinath; Plaut, Marshall; Wheatley, Lisa M.; Burks, A. Wesley		Immune Tolerance Network	Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study	LANCET			English	Article							SUSTAINED UNRESPONSIVENESS; MECHANISMS	Background For young children with peanut allergy, dietary avoidance is the current standard of care. We aimed to assess whether peanut oral immunotherapy can induce desensitisation (an increased allergic reaction threshold while on therapy) or remission (a state of non-responsiveness after discontinuation of immunotherapy) in this population. Methods We did a randomised, double-blind, placebo-controlled study in five US academic medical centres. Eligible participants were children aged 12 to younger than 48 months who were reactive to 500 mg or less of peanut protein during a double-blind, placebo-controlled food challenge (DBPCFC). Participants were randomly assigned by use of a computer, in a 2:1 allocation ratio, to receive peanut oral immunotherapy or placebo for 134 weeks (2000 mg peanut protein per day) followed by 26 weeks of avoidance, with participants and study staff and investigators masked to group treatment assignment. The primary outcome was desensitisation at the end of treatment (week 134), and remission after avoidance (week 160), as the key secondary outcome, were assessed by DBPCFC to 5000 mg in the intention-to-treat population. Safety and immunological parameters were assessed in the same population. Findings Between Aug 13, 2013, and Oct 1, 2015, 146 children, with a median age of 39.3 months (IQR 30.8-44.7), were randomly assigned to receive peanut oral immunotherapy (96 participants) or placebo (50 participants). At week 134, 68 (71%, 95% CI 61-80) of 96 participants who received peanut oral immunotherapy compared with one (2%, 0.05-11) of 50 who received placebo met the primary outcome of desensitisation (risk difference [RD] 69%, 95% CI 59-79; p<0.0001). The median cumulative tolerated dose during the week 134 DBPCFC was 5005 mg (IQR 3755-5005) for peanut oral immunotherapy versus 5 mg (0-105) for placebo (p<0.0001). After avoidance, 20 (21%, 95% CI 13-30) of 96 participants receiving peanut oral immunotherapy compared with one (2%, 0.05-11) of 50 receiving placebo met remission criteria (RD 19%, 95% CI 10-28; p=0.0021). The median cumulative tolerated dose during the week 160 DBPCFC was 755 mg (IQR 0-2755) for peanut oral immunotherapy and 0 mg (0-55) for placebo (p< 0.0001). A significant proportion of participants receiving peanut oral immunotherapy who passed the 5000 mg DBPCFC at week 134 could no longer tolerate 5000 mg at week 160 (p<0.001). The participant receiving placebo who was desensitised at week 134 also achieved remission at week 160. Compared with placebo, peanut oral immunotherapy decreased peanut-specific and Ara h2-specific IgE, skin prick test, and basophil activation, and increased peanut-specific and Ara h2-specific IgG4 at weeks 134 and 160. By use of multivariable regression analysis of participants receiving peanut oral immunotherapy, younger age and lower baseline peanut-specific IgE was predictive of remission. Most participants (98% with peanut oral immunotherapy vs 80% with placebo) had at least one oral immunotherapy dosing reaction, predominantly mild to moderate and occurring more frequently in participants receiving peanut oral immunotherapy. 35 oral immunotherapy dosing events with moderate symptoms were treated with epinephrine in 21 participants receiving peanut oral immunotherapy. Interpretation In children with a peanut allergy, initiation of peanut oral immunotherapy before age 4 years was associated with an increase in both desensitisation and remission. Development of remission correlated with immunological biomarkers. The outcomes suggest a window of opportunity at a young age for intervention to induce remission of peanut allergy. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Jones, Stacie M.; Scurlock, Amy M.; Pesek, Robert D.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Jones, Stacie M.; Scurlock, Amy M.; Pesek, Robert D.] Arkansas Childrens Hosp, 800 Marshall St, Little Rock, AR 72202 USA; [Kim, Edwin H.; Kulis, Mike; Burks, A. Wesley] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Kim, Edwin H.; Kulis, Mike; Burks, A. Wesley] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27515 USA; [Nadeau, Kari C.; Chinthrajah, Sharon; Sindher, Sayantani B.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Nadeau, Kari C.; Chinthrajah, Sharon; Sindher, Sayantani B.] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Palo Alto, CA 94304 USA; [Nowak-Wegrzyn, Anna; Sampson, Hugh A.; Wang, Julie] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Nowak-Wegrzyn, Anna] NYU, Dept Pediat, Langone Hlth, New York, NY 10016 USA; [Johnson, Jacqueline; Spain, Katharine; Babineau, Denise C.; Chin, Hyunsook; Sever, Michelle L.] Rho Fed Syst Div, Durham, NC USA; [Laurienzo-Panza, Joy; Plaut, Marshall; Wheatley, Lisa M.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Yan, Rachel; Whitehouse, Don; Sanda, Srinath] Immune Tolerance Network, San Francisco, CA USA; [Larson, David; Qin, Tian] Immune Tolerance Network, Bethesda, MD USA	University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stanford University; Stanford University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Immune Tolerance Network; Immune Tolerance Network	Jones, SM (corresponding author), Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA.	jonesstaciem@uams.edu			National Institute of Allergy and Infectious Diseases, Immune Tolerance Network	National Institute of Allergy and Infectious Diseases, Immune Tolerance Network	National Institute of Allergy and Infectious Diseases, Immune Tolerance Network.	Aceves SS, 2009, ANN ALLERG ASTHMA IM, V103, P401, DOI 10.1016/S1081-1206(10)60359-6; Berglund JP, 2017, J ALLER CL IMM-PRACT, V5, P1098, DOI 10.1016/j.jaip.2016.11.034; Bilaver LA, 2019, ANN ALLERG ASTHMA IM, V122, P373, DOI 10.1016/j.anai.2019.01.014; Bird JA, 2018, J ALLER CL IMM-PRACT, V6, P476, DOI 10.1016/j.jaip.2017.09.016; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Burks AW, 2018, J ALLERGY CLIN IMMUN, V141, P1, DOI 10.1016/j.jaci.2017.11.004; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Fleischer DM, 2012, PEDIATRICS, V130, pE25, DOI 10.1542/peds.2011-1762; Fleischer DM, 2003, J ALLERGY CLIN IMMUN, V112, P183, DOI 10.1067/mai.2003.1517; Gupta RS, 2013, ANN ALLERG ASTHMA IM, V111, P194, DOI 10.1016/j.anai.2013.06.026; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Jones SM, 2016, J ALLERGY CLIN IMMUN, V137, P1117, DOI 10.1016/j.jaci.2015.12.1316; Kulis MD, 2018, J ALLERGY CLIN IMMUN, V141, P491, DOI 10.1016/j.jaci.2017.12.979; Nitsche C, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0298-z; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sampson HA, 2018, J ALLERGY CLIN IMMUN, V141, P11, DOI 10.1016/j.jaci.2017.11.005; Santos AF, 2020, J ALLERGY CLIN IMMUN, V146, P344, DOI 10.1016/j.jaci.2020.03.035; Scurlock AM, 2018, J ALLERGY CLIN IMMUN, V141, P2002, DOI 10.1016/j.jaci.2017.12.1008; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; Soller L, 2019, J ALLER CL IMM-PRACT, V7, P2759, DOI 10.1016/j.jaip.2019.04.010; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vickery BP, 2019, J ALLER CL IMM-PRACT, V7, P357, DOI 10.1016/j.jaip.2018.11.049; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; Wood RA, 2016, J ALLERGY CLIN IMMUN, V137, P973, DOI 10.1016/j.jaci.2016.01.001	29	28	28	6	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					359	371						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL7CQ	35065784				2022-12-28	WOS:000746046100019
J	Lane, R				Lane, Richard			Jamal Rifi: family doctor building bridges in the community	LANCET			English	Biographical-Item																		RIFI J, PUBLICATION LIST	1	0	0	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					353	353						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL7CQ	35065777	Green Published			2022-12-28	WOS:000746046100012
J	Han, PC; Li, LJ; Liu, S; Wang, QS; Zhang, D; Xu, ZP; Han, P; Li, XM; Peng, Q; Su, C; Huang, BH; Li, DD; Zhang, R; Tian, MX; Fu, LT; Gao, YZ; Zhao, X; Liu, KF; Qi, JX; Gao, GF; Wang, PY				Han, Pengcheng; Li, Linjie; Liu, Sheng; Wang, Qisheng; Zhang, Di; Xu, Zepeng; Han, Pu; Li, Xiaomei; Peng, Qi; Su, Chao; Huang, Baihan; Li, Dedong; Zhang, Rong; Tian, Mingxiong; Fu, Lutang; Gao, Yuanzhu; Zhao, Xin; Liu, Kefang; Qi, Jianxun; Gao, George F.; Wang, Peiyi			Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2	CELL			English	Article							VARIANT B.1.1.7; NEUTRALIZATION; EPIDEMIOLOGY; MOLPROBITY; FEATURES	The coronavirus disease 2019 (COVID-19) pandemic continues worldwide with many variants arising, some of which are variants of concern (VOCs). A recent VOC, omicron (B.1.1.529), which obtains a large number of mutations in the receptor-binding domain (RBD) of the spike protein, has risen to intense scientific and public attention. Here, we studied the binding properties between the human receptor ACE2 (hACE2) and the VOC RBDs and resolved the crystal and cryoelectron microscopy structures of the omicron RBD-hACE2 complex as well as the crystal structure of the delta RBD-hACE2 complex. We found that, unlike alpha, beta, and gamma, omicron RBD binds to hACE2 at a similar affinity to that of the prototype RBD, which might be due to compensation of multiple mutations for both immune escape and transmissibility. The complex structures of omicron RBD-hACE2 and delta RBD-hACE2 reveal the structural basis of how RBD-specific mutations bind to hACE2.	[Han, Pengcheng; Li, Linjie; Zhang, Di; Xu, Zepeng; Han, Pu; Peng, Qi; Huang, Baihan; Li, Dedong; Zhang, Rong; Zhao, Xin; Liu, Kefang; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Han, Pengcheng] Southeast Univ, Zhongda Hosp, Sch Med, Nanjing 210009, Peoples R China; [Li, Linjie; Qi, Jianxun; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Liu, Sheng; Fu, Lutang; Gao, Yuanzhu; Wang, Peiyi] Southern Univ Sci & Technol, Cryo EM Ctr, Dept Biol, Shenzhen 518055, Peoples R China; [Wang, Qisheng] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China; [Zhang, Di; Xu, Zepeng] Univ Macau, Fac Hlth Sci, Macau 999078, Peoples R China; [Li, Xiaomei] Shanxi Acad Adv Res & Innovat, Cryo EM Ctr, Taiyuan 030032, Peoples R China; [Su, Chao] City Univ Hong Kong, Dept Biomed Sci, Hong Kong 999077, Peoples R China; [Tian, Mingxiong] Shanxi Univ, Coll Life Sci, Taiyuan 03006, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Southeast University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southern University of Science & Technology; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of Macau; City University of Hong Kong; Shanxi University	Qi, JX; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Qi, JX; Gao, GF (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Wang, PY (corresponding author), Southern Univ Sci & Technol, Cryo EM Ctr, Dept Biol, Shenzhen 518055, Peoples R China.	jxqi@im.ac.cn; gaof@im.ac.cn; wangpy@sustech.edu.cn		Xu, Zepeng/0000-0003-1132-8805	National Key R&D Program of China [2021YFC2301401, 2020YFA0907102, 2020YFA0509202, 2021YFC0863300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29010202, XDB37030204]; Queensland-Chinese Academy of Sciences Collaborative Science Fund 2020 [153211KYSB20200001]; Chinese Academy of Sciences; Science and Technology Innovation Committee of Shenzhen Municipality [JSGG20200207155251653]; President's Excellent Postdoctoral Program of SUSTech	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Queensland-Chinese Academy of Sciences Collaborative Science Fund 2020; Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Innovation Committee of Shenzhen Municipality; President's Excellent Postdoctoral Program of SUSTech	We are grateful to Drs G. Wong and G. Shang for revising the manuscript. We are grateful to the PMI-IMCAS Public Technology Service Center for its support on FACS assay. We thank Tong Zhao from Institute of Microbiology, Chinese Academy of Sciences, for her technical support in FACS assay. We acknowledge the staff of beamline BL02U1 and BL10U2 at the Shanghai Synchrotron Radiation Facility for assistance during data collection. We thank all staff at the Cryo-EM Center of Southern University of Science and Technology for their assistances. We thank Y.Q. Mi, H. Feng, and X.X. Bai at the Cryo-EM Center, Shanxi Academy of Advanced Research and Innovation, for their technical support on the cryo-EM. We thank Shuimu BioSciences for cryo-EM facility access and technical support during image acquisition. This work was supported by the National Key R&D Program of China (2021YFC2301401, 2020YFA0907102, 2020YFA0509202, 2021YFC0863300), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29010202, XDB37030204), the Queensland-Chinese Academy of Sciences Collaborative Science Fund 2020 (153211KYSB20200001), the intramural special grant for SARS-CoV-2 research from the Chinese Academy of Sciences, and the Science and Technology Innovation Committee of Shenzhen Municipality (JSGG20200207155251653). S. Liu is funded by President's Excellent Postdoctoral Program of SUSTech.	Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baay M, 2020, BIOLOGICALS, V66, P35, DOI 10.1016/j.biologicals.2020.06.005; Cao Y., 2021, B 1 1 529 ESCAPES MA, DOI [10.1101/2021.12.07 .4703922021.12.07.470392, DOI 10.1101/2021.12.07.470392]; Cao YL, 2021, CELL RES, V31, P732, DOI 10.1038/s41422-021-00514-9; Cele Sandile, 2021, medRxiv, DOI 10.1101/2021.12.08.21267417; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira I., 2021, BIORXIV2021050844325, p2021.05.08.443253, DOI 10.1101/2021.05.08.443253; Focosi D, 2021, EMERG INFECT DIS, V27, P2728, DOI 10.3201/eid2710.211538; Gao GRF, 2021, CHINA CDC WEEKLY, V3, P855, DOI 10.46234/ccdcw2021.210; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1101/2021.02.14.21251704, 10.1016/j.cell.2021.04.006]; Genovese L., 2021, BIORXIV, V2021, DOI [10.1101/2021.12.01.470748, DOI 10.1101/2021.12.01.470748]; Graham MS, 2021, LANCET PUBLIC HEALTH, V6, pE335, DOI 10.1016/S2468-2667(21)00055-4; Guigon A, 2022, J INFECTION, V84, P273, DOI 10.1016/j.jinf.2021.08.033; Han PC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26401-w; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huang BY, 2021, LANCET MICROBE, V2, pE285, DOI 10.1016/S2666-5247(21)00082-3; Huang K, 2021, EBIOMEDICINE, V67, DOI 10.1016/j.ebiom.2021.103381; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Li J, 2021, NATURE, V600, P408, DOI 10.1038/s41586-021-04188-6; Li QQ, 2021, CELL, V184, P2362, DOI 10.1016/j.cell.2021.02.042; Liu KF, 2021, CELL, V184, P3438, DOI 10.1016/j.cell.2021.05.031; Liu KF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020216118; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu Y, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab124; Liu YH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025373118; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Nabel K.G., 2021, SCIENCE; Niu S, 2021, EMBO J, V40, DOI 10.15252/embj.2021107786; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Qin Si, 2021, Zoonoses, V1, DOI 10.15212/ZOONOSES-2021-0024; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Shen XY, 2021, CELL HOST MICROBE, V29, P529, DOI 10.1016/j.chom.2021.03.002; Singh A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83761-5; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; Thye AYK, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9101303; Tian DD, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.751778; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang YC, 2022, EMERG MICROBES INFEC, V11, P1, DOI 10.1080/22221751.2021.2017757; Wilhelm A., 2021, REDUCED NEUTRALIZATI, DOI [10.1101/2021.12.07.21267432, DOI 10.15585/MMWR.MM7011A1EXTERNALICON, DOI 10.1101/2021.12.07.21267432]; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu LL, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00210-9; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zhang ZY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24326-y; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhu X, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001237; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	58	118	120	35	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					630	+		10.1016/j.cell.2022.01.001	http://dx.doi.org/10.1016/j.cell.2022.01.001			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1XX	35093192	Bronze, Green Published			2022-12-28	WOS:000768265900006
J	Kishi, KE; Kim, YS; Fukuda, M; Inoue, M; Kusakizako, T; Wang, PY; Ramakrishnan, C; Byrne, EFX; Thadhani, E; Paggi, JM; Matsui, TE; Yamashita, K; Nagata, T; Konno, M; Quirin, S; Lo, M; Benster, T; Uemura, T; Liu, KH; Shibata, M; Nomura, N; Iwata, S; Nureki, O; Dror, RO; Inoue, K; Deisseroth, K; Kato, HE				Kishi, Koichiro E.; Kim, Yoon Seok; Fukuda, Masahiro; Inoue, Masatoshi; Kusakizako, Tsukasa; Wang, Peter Y.; Ramakrishnan, Charu; Byrne, Eamon F. X.; Thadhani, Elina; Paggi, Joseph M.; Matsui, Toshiki E.; Yamashita, Keitaro; Nagata, Takashi; Konno, Masae; Quirin, Sean; Lo, Maisie; Benster, Tyler; Uemura, Tomoko; Liu, Kehong; Shibata, Mikihiro; Nomura, Norimichi; Iwata, So; Nureki, Osamu; Dror, Ron O.; Inoue, Keiichi; Deisseroth, Karl; Kato, Hideaki E.			Structural basis for channel conduction in the pump-like channelrhodopsin ChRmine	CELL			English	Article							BEAM-INDUCED MOTION; DRIVEN PROTON PUMP; PROTEIN STRUCTURES; CRYSTAL-STRUCTURES; BACTERIORHODOPSIN; MECHANISM; ELECTROSTATICS; VISUALIZATION; EXCITATION; TRANSPORT	ChRmine, a recently discovered pump-like cation-conducting channelrhodopsin, exhibits puzzling properties (large photocurrents, red-shifted spectrum, and extreme light sensitivity) that have created new opportunities in optogenetics. ChRmine and its homologs function as ion channels but, by primary sequence, more closely resemble ion pump rhodopsins; mechanisms for passive channel conduction in this family have remained mysterious. Here, we present the 2.0 A resolution cryo-EM structure of ChRmine, revealing architectural features atypical for channelrhodopsins: trimeric assembly, a short transmembrane-helix 3, a twisting extracellular-loop 1, large vestibules within the monomer, and an opening at the trimer interface. We applied this structure to design three proteins (rsChRmine and hsChRmine, conferring further red-shifted and highspeed properties, respectively, and frChRmine, combining faster and more red-shifted performance) suitable for fundamental neuroscience opportunities. These results illuminate the conduction and gating of pump-like channelrhodopsins and point the way toward further structure-guided creation of channelrhodopsins for applications across biology.	[Kishi, Koichiro E.; Fukuda, Masahiro; Matsui, Toshiki E.; Kato, Hideaki E.] Univ Tokyo, Komaba Inst Sci, Meguro Ku, Tokyo, Japan; [Kim, Yoon Seok; Inoue, Masatoshi; Wang, Peter Y.; Byrne, Eamon F. X.; Thadhani, Elina; Quirin, Sean; Lo, Maisie; Benster, Tyler; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kusakizako, Tsukasa; Nureki, Osamu; Kato, Hideaki E.] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, CNC Program, Palo Alto, CA 94304 USA; [Thadhani, Elina; Paggi, Joseph M.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Yamashita, Keitaro] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Nagata, Takashi; Konno, Masae; Inoue, Keiichi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan; [Nagata, Takashi; Konno, Masae; Kato, Hideaki E.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Uemura, Tomoko; Liu, Kehong; Nomura, Norimichi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto, Japan; [Shibata, Mikihiro] Kanazawa Univ, WPI Nano Life Sci Inst WPI NanoLSI, Kanazawa, Ishikawa, Japan; [Shibata, Mikihiro] Kanazawa Univ, Inst Frontier Sci Initiat, High Speed AFM Biol Applicat Unit, Kanazawa, Ishikawa, Japan; [Iwata, So] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan; [Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kato, Hideaki E.] Japan Sci & Technol Agcy, FOREST, Saitama, Japan	University of Tokyo; Stanford University; University of Tokyo; Stanford University; Stanford University; MRC Laboratory Molecular Biology; University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Kanazawa University; Kanazawa University; RIKEN; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Japan Science & Technology Agency (JST)	Kato, HE (corresponding author), Univ Tokyo, Komaba Inst Sci, Meguro Ku, Tokyo, Japan.; Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Kato, HE (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.; Deisseroth, K (corresponding author), Stanford Univ, CNC Program, Palo Alto, CA 94304 USA.; Kato, HE (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Kato, HE (corresponding author), Japan Sci & Technol Agcy, FOREST, Saitama, Japan.	deissero@stanford.edu; hekato@bio.c.u-tokyo.ac.jp	Konno, Masae/C-1066-2009; Inoue, Keiichi/AEO-3337-2022; Kato, Hideaki/Q-5606-2017	Konno, Masae/0000-0002-0605-1816; Inoue, Keiichi/0000-0002-6898-4347; Fukuda, Masahiro/0000-0002-8824-846X; Nagata, Takashi/0000-0001-5379-2951; Dror, Ron/0000-0002-6418-2793; Byrne, Eamon/0000-0001-7513-5944; Kato, Hideaki/0000-0002-1941-5535; Inoue, Masatoshi/0000-0001-5077-0052; Wang, Yiliu/0000-0002-6654-9595; Yamashita, Keitaro/0000-0002-5442-7582	MRC, UKRI [MC_UP_A025_1012]; Osamu Hayaishi Memorial Scholarship for Study Abroad; Nakajima Foundation; Yamada Science Foundation; Nakatani Foundation; UTEC-UTokyo FSI Research Grant Program; AMED [JP21wm0525018]; JSPS KAKENHI [JP20K21383, JP21H01875, 21H05142]; JST PRESTO [JPMJPR1888, JPMJPR1782]; JST FOREST [JPMJFR204S]; JST CREST [JPMJCR21P3]; NSF NeuroNex program; NOMIS Foundation; Else Kroner-Fresenius Foundation; Gatsby Foundation; NIMH [R01MH075957]; AMED/BINDS [JP18am0101079, 2165, JP20am0101115, 2841]	MRC, UKRI(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Osamu Hayaishi Memorial Scholarship for Study Abroad; Nakajima Foundation; Yamada Science Foundation; Nakatani Foundation; UTEC-UTokyo FSI Research Grant Program; AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST PRESTO(Japan Science & Technology Agency (JST)); JST FOREST; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NSF NeuroNex program; NOMIS Foundation; Else Kroner-Fresenius Foundation; Gatsby Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AMED/BINDS	We thank R. Danev, M. Kikkawa, K. Hasegawa (Univ. of Tokyo), A. Kotecha (Thermo Fisher), A. Maturana (Nagoya Univ.), and C. Delacruz (Stanford Univ.) for technical and administrative support. This work was supported by the MRC, as part of UKRI (MC_UP_A025_1012 to K.Y.), Osamu Hayaishi Memorial Scholarship for Study Abroad (M.I.), the Nakajima Foundation (H.E.K.), the Yamada Science Foundation (H.E.K.), the Nakatani Foundation (H.E.K.), the UTEC-UTokyo FSI Research Grant Program (H.E.K.), AMED/BINDS (JP18am0101079 [support no. 2165] and JP20am0101115 [support no. 2841]), AMED (JP21wm0525018 to H.E.K.), JSPS KAKENHI (JP20K21383 and JP21H01875 to K.I. and 21H05142 to H.E.K.), JST PRESTO (JPMJPR1888 to T.N. and JPMJPR1782 to H.E.K.), JST FOREST (JPMJFR204S to H.E.K.), JST CREST (JPMJCR21P3 to H.E.K.), the NSF NeuroNex program (K.D.), the NOMIS Foundation (K.D.), the Else Kroner-Fresenius Foundation (K.D.), the Gatsby Foundation (K.D.), and a grant for ChR structure determination from NIMH (R01MH075957 to K.D.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bansal H, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/ac1175; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2015, SCIENCE, V349, P590, DOI 10.1126/science.aac7889; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Chan SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108362; Chen R, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0679-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deisseroth K, 2021, CELL, V184, P5279, DOI 10.1016/j.cell.2021.08.018; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fenno LE, 2020, NEURON, V107, P836, DOI 10.1016/j.neuron.2020.06.003; Fudim R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav4203; GERWERT K, 1990, P NATL ACAD SCI USA, V87, P9774, DOI 10.1073/pnas.87.24.9774; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Govorunova E.G., 2021, BIORXIV2021091746068; Govorunova EG, 2016, BIOPHYS J, V110, P2302, DOI 10.1016/j.bpj.2016.05.001; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hasegawa N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31370-0; Higuchi A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016328118; Inoue K, 2015, J AM CHEM SOC, V137, P3291, DOI 10.1021/ja511788f; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Inoue M, 2019, CELL, V177, P1346, DOI 10.1016/j.cell.2019.04.007; Jaenecke F, 2018, METHODS MOL BIOL, V1700, P97, DOI 10.1007/978-1-4939-7454-2_7; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kamiya M, 2013, CHEM PHYS LETT, V556, P266, DOI 10.1016/j.cplett.2012.11.066; Kandori Hideki, 2020, Biophys Rev, V12, P355, DOI 10.1007/s12551-020-00645-0; Kato HE, 2021, ADV EXP MED BIOL, V1293, P35, DOI 10.1007/978-981-15-8763-4_3; Kato HE, 2018, NATURE, V561, P349, DOI 10.1038/s41586-018-0504-5; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Kim YS, 2018, NATURE, V561, P343, DOI 10.1038/s41586-018-0511-6; Kishi K.E., 2021, BIORXIV2021081545639; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2015, BIOPHYS J, V108, P2680, DOI 10.1016/j.bpj.2015.04.027; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kovalev K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16032-y; Kuhlbrandt W, 2000, NATURE, V406, P569, DOI 10.1038/35020654; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurihara M, 2015, BIOPHYS PHYSICOBIOL, V12, P121, DOI 10.2142/biophysico.12.0_121; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Mager T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04146-3; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Marshel JH, 2019, SCIENCE, V365, P558, DOI 10.1126/science.aaw5202; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Morizumi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47445-5; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Oda K, 2021, ELIFE, V10, DOI 10.7554/eLife.62389; Oda K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06421-9; Oppermann J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11322-6; Pan ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098924; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rozenberg A, 2020, CURR BIOL, V30, P4910, DOI 10.1016/j.cub.2020.09.056; Sahel JA, 2021, NAT MED, V27, P1223, DOI 10.1038/s41591-021-01351-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Shibata M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01466-8; Shigemura S, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9173440; Shihoya W, 2019, NATURE, V574, P132, DOI 10.1038/s41586-019-1604-6; Sineshchekov OA, 2020, MBIO, V11, DOI 10.1128/mBio.00657-20; Sineshchekov OA, 2017, P NATL ACAD SCI USA, V114, pE9512, DOI 10.1073/pnas.1710702114; Sridharan S., 2021, BIORXIV2021040143813; Takemoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131094; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; TREHAN A, 1990, BIOORG CHEM, V18, P30, DOI 10.1016/0045-2068(90)90013-U; Tucker A., 2021, BIORXIV2021112146945; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; Vogt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16450; Volkov O, 2017, SCIENCE, V358, DOI 10.1126/science.aan8862; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152; Weinert T, 2019, SCIENCE, V365, P61, DOI 10.1126/science.aaw8634; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yamashita K, 2021, ACTA CRYSTALLOGR D, V77, P1282, DOI 10.1107/S2059798321009475; Yamauchi Y, 2017, BIOPHYS PHYSICOBIOL, V14, P57, DOI 10.2142/biophysico.14.0_57; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Yun JH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020486118; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang J, 2013, PROTEINS, V81, P1585, DOI 10.1002/prot.24316; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	108	12	12	11	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					672	+		10.1016/j.cell.2022.01.007	http://dx.doi.org/10.1016/j.cell.2022.01.007			42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7EU	35114111	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000759729300001
J	Fernandez, MA; Achten, J; Parsons, N; Griffin, XL; Png, ME; Gould, J; McGibbon, A; Costa, ML				Fernandez, Miguel A.; Achten, Juul; Parsons, Nicholas; Griffin, Xavier L.; Png, May-Ee; Gould, Jenny; McGibbon, Alwin; Costa, Matthew L.		WHiTE 5 Investigators	Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; FEMORAL-NECK; DISPLACED FRACTURE; EQ-5D	BACKGROUND Controversy exists over the use of bone cement in hip fractures treated with hemiarthroplasty. Only limited data on quality of life after cemented as compared with modern uncemented hemiarthroplasties are available. METHODS We conducted a multicenter, randomized, controlled trial comparing cemented with uncemented hemiarthroplasty in patients 60 years of age or older with an intracapsular hip fracture. The primary outcome was health-related quality of life measured with the use of utility scores on the EuroQol Group 5-Dimension (EQ-5D) questionnaire at 4 months after randomization (range of scores, -0.594 to 1, with higher scores indicating better quality of life; range for minimal clinically important difference, 0.050 to 0.075). RESULTS A total of 610 patients were assigned to undergo cemented hemiarthroplasty and 615 to undergo modern uncemented hemiarthroplasty; follow-up data were available for 71.6% of the patients at 4 months. The mean EQ-5D utility score was 0.371 in patients assigned to the cemented group and 0.315 in those assigned to the uncemented group (adjusted difference, 0.055; 95% confidence interval [CI], 0.009 to 0.101; P=0.02). The between-group difference at 1 month was similar to that at 4 months, but the difference at 12 months was smaller than that at 4 months. Mortality at 12 months was 23.9% in the cemented group and 27.8% in the uncemented group (odds ratio for death, 0.80; 95% CI, 0.62 to 1.05). Periprosthetic fractures occurred in 0.5% and 2.1% of the patients in the respective groups (odds ratio [uncemented vs. cemented], 4.37; 95% CI, 1.19 to 24.00). The incidences of other complications were similar in the two groups. CONCLUSIONS Among patients 60 years of age or older with an intracapsular hip fracture, cemented hemiarthroplasty resulted in a modestly but significantly better quality of life and a lower risk of periprosthetic fracture than uncemented hemiarthroplasty.	[Fernandez, Miguel A.; Achten, Juul; Costa, Matthew L.] Univ Oxford, Oxford Trauma & Emergency Care, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kadoorie Ctr, Oxford, England; [Png, May-Ee] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Gould, Jenny; McGibbon, Alwin] Patient & Publ Representat, Oxford, England; [Parsons, Nicholas] Univ Warwick, Warwick Med Sch, Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Parsons, Nicholas] Univ Warwick, Warwick Med Sch, Stat & Epidemiol Unit, Coventry, W Midlands, England; [Griffin, Xavier L.] Queen Mary Univ London, Blizard Inst, Dept Trauma & Orthopaed Surg, London, England; [Griffin, Xavier L.] Barts Hlth NHS Trust, Royal London Hosp, Dept Trauma & Orthopaed Surg, London, England	University of Oxford; University of Oxford; University of Warwick; University of Warwick; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Costa, ML (corresponding author), Univ Oxford, Kadoorie Ctr, NDORMS, Oxford Trauma & Emergency Care, Headley Way, Oxford OX3 9DU, England.	matthew.costa@ndorms.ox.ac.uk	Griffin, Xavier/ABD-2354-2020; Png, May Ee/AAG-4902-2019	Griffin, Xavier/0000-0003-2976-7523; Png, May Ee/0000-0001-5876-9363; Achten, Juul/0000-0002-8857-5743; Archer, James/0000-0001-7329-2401	National Institute for Health Research (NIHR); NIHR [PB-PG-0215-36043, PB-PG-1216-20021]; Oxford Biomedical Research Centre	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Oxford Biomedical Research Centre	Supported by the National Institute for Health Research (NIHR) under its Research for Patient Benefit. The NIHR funded both phases of the trial (PB-PG-0215-36043 and PB-PG-1216-20021). The Oxford Biomedical Research Centre supported the infrastructure that was used to run the trial but did not provide funding for the trial.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhandari M, 2019, NEW ENGL J MED, V381, P2199, DOI 10.1056/NEJMoa1906190; Bryan S, 2005, QUAL LIFE RES, V14, P107, DOI 10.1007/s11136-004-1920-6; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Costa ML, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011679; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; Fernandez MA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033957; Figved W, 2009, CLIN ORTHOP RELAT R, V467, P2426, DOI 10.1007/s11999-008-0672-y; Griffin XL, 2015, BONE JOINT J, V97B, P372, DOI 10.1302/0301-620X.97B3.35738; Griffiths F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005406; Haywood KL, 2014, BONE JOINT J, V96B, P1016, DOI 10.1302/0301-620X.96B8.33766; Hebert-Davies J, 2012, INJURY, V43, P1978, DOI 10.1016/j.injury.2012.08.061; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Inngul C, 2015, BONE JOINT J, V97B, P1475, DOI 10.1302/0301-620X.97B11.36248; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Kristensen TB, 2020, CLIN ORTHOP RELAT R, V478, P90, DOI 10.1097/CORR.0000000000000826; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Metcalfe D, 2019, BONE JOINT J, V101B, P708, DOI 10.1302/0301-620X.101B6.BJJ-2018-1623.R1; Moerman S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1526-0; Nantha Kumar Nakulan, 2020, Bone Joint J, V102-B, P1113, DOI 10.1302/0301-620X.102B9.BJJ-2020-0282.R1; Parker MJ, 2020, BONE JOINT J, V102B, P11, DOI 10.1302/0301-620X.102B1.BJJ-2019-1041.R1; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub4; Parsons N, 2018, BONE JOINT RES, V7, P1, DOI 10.1302/2046-3758.71; Parsons N, 2014, BONE JOINT RES, V3, P69, DOI 10.1302/2046-3758.33.2000250; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Taylor F, 2012, J BONE JOINT SURG AM, V94A, P577, DOI 10.2106/JBJS.K.00006; Tutton E, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042040; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Veldman HD, 2017, BONE JOINT J, V99B, P421, DOI 10.1302/0301-620X.99B4.BJJ-2016-0758.R1; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0	31	10	11	7	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					521	530		10.1056/NEJMoa2108337	http://dx.doi.org/10.1056/NEJMoa2108337			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW0GW	35139272	Green Published			2022-12-28	WOS:000753100900008
J	Dahl, D; Onishi, Y; Norwood, P; Huh, R; Bray, R; Patel, H; Rodriguez, A				Dahl, Dominik; Onishi, Yukiko; Norwood, Paul; Huh, Ruth; Bray, Ross; Patel, Hiren; Rodriguez, Angel			Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes The SURPASS-5 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PEPTIDE-1 RECEPTOR AGONIST; THERAPY; EFFICACY; SAFETY	IMPORTANCE The effects of tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, as an addition to insulin glargine for treatment of type 2 diabetes have not been described. OBJECTIVE To assess the efficacy and safety of tirzepatide added to insulin glargine in patients with type 2 diabetes with inadequate glycemic control. DESIGN, SETTING, AND PARTICIPANTS Randomized phase 3 clinical trial conducted at 45 medical research centers and hospitals in 8 countries (enrollment from August 30, 2019, to March 20, 2020; follow-up completed January 13, 2021) in 475 adults with type 2 diabetes and inadequate glycemic control while treated with once-daily insulin glargine with or without metformin. INTERVENTIONS Patients were randomized in a 1:1:1:1 ratio to receive once-weekly subcutaneous injections of 5-mg (n = 116), 10-mg (n = 119), or 15-mg (n = 120) tirzepatide or volume-matched placebo (n = 120) over 40 weeks. Tirzepatide was initiated at 2.5mg/week and escalated by 2.5mg every 4 weeks until the assigned dose was achieved. MAIN OUTCOMES AND MEASURES The primary end pointwas mean change from baseline in glycated hemoglobin A1c (HbA1c) at week 40. The 5 key secondary end points included mean change in body weight and percentage of patients achieving prespecified HbA1c levels. RESULTS Among 475 randomized participants (211 [44%] women; mean [SD] age, 60.6 [9.9] years; mean [SD] HbA1c, 8.31% [0.85%]), 451 (94.9%) completed the trial. Treatment was prematurely discontinued by 10% of participants in the 5-mg tirzepatide group, 12% in the 10-mg tirzepatide group, 18% in the 15-mg tirzepatide group, and 3% in the placebo group. At week 40, mean HbA1c change from baseline was -2.40% with 10-mg tirzepatide and -2.34% with 15-mg tirzepatide vs -0.86% with placebo (10mg: difference vs placebo, -1.53%[97.5% CI, -1.80% to -1.27%]; 15mg: difference vs placebo, -1.47%[97.5% CI, -1.75% to -1.20%]; P<.001 for both). Mean HbA1c change from baseline was -2.11% with 5-mg tirzepatide (difference vs placebo, -1.24%[95% CI, -1.48% to -1.01%]; P<.001]). Mean body weight change from baseline was -5.4 kg with 5-mg tirzepatide, -7.5 kg with 10-mg tirzepatide, -8.8 kg with 15-mg tirzepatide and 1.6 kg with placebo (5mg: difference, -7.1 kg [95% CI, -8.7 to -5.4]; 10mg: difference, -9.1 kg [95% CI, -10.7 to -7.5]; 15mg: difference, -10.5 kg [95% CI, -12.1 to -8.8]; P<.001 for all). Higher percentages of patients treated with tirzepatide vs those treated with placebo had HbA1c less than 7%(85%-90% vs 34%; P<.001 for all). The most common treatment-emergent adverse events in the tirzepatide groups vs placebo group were diarrhea (12%-21% vs 10%) and nausea (13%-18% vs 3%). CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes and inadequate glycemic control despite treatment with insulin glargine, the addition of subcutaneous tirzepatide, compared with placebo, to titrated insulin glargine resulted in statistically significant improvements in glycemic control after 40 weeks.	[Dahl, Dominik] Gemeinschaftspraxis Innere Med & Diabetol, Hamburg, Germany; [Onishi, Yukiko] Asahi Life Fdn, Inst Med Sci, Tokyo, Japan; [Norwood, Paul] Valley Endocrine & Res, Fresno, CA USA; [Huh, Ruth; Bray, Ross; Patel, Hiren] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Rodriguez, Angel] Lilly Spain, Ave Ind 30, Madrid 28108, Spain	Asahi Life Foundation; Eli Lilly	Rodriguez, A (corresponding author), Lilly Spain, Ave Ind 30, Madrid 28108, Spain.	rodriguez_angel@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This study was sponsored by Eli Lilly and Company.	Baggio LL, 2020, MOL METAB, V46, DOI 10.1016/j.molmet.2020.101090; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Del Prato S, 2021, LANCET, V398, P1811, DOI 10.1016/S0140-6736(21)02188-7; Frias JP, 2021, NEW ENGL J MED, V385, P503, DOI 10.1056/NEJMoa2107519; Frias JP, 2018, LANCET, V392, P2180, DOI 10.1016/S0140-6736(18)32260-8; Gasbjerg LS, 2019, DIABETES, V68, P906, DOI 10.2337/db18-1123; Huthmacher JA, 2020, DIABETES CARE, V43, P2303, DOI 10.2337/dc20-0498; Ludvik B, 2021, LANCET, V398, P583, DOI 10.1016/S0140-6736(21)01443-4; Nauck MA, 2018, DIABETES OBES METAB, V20, P5, DOI 10.1111/dom.13129; Pozzilli P, 2017, DIABETES OBES METAB, V19, P1024, DOI 10.1111/dom.12937; Rodbard HW, 2018, J CLIN ENDOCR METAB, V103, P2291, DOI 10.1210/jc.2018-00070; Rosenstock J, 2021, LANCET, V398, P143, DOI 10.1016/S0140-6736(21)01324-6; Rosenstock J, 2020, DIABETES CARE, V43, P2509, DOI 10.2337/dc19-2316; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; Yu M, 2017, CLIN THER, V39, P2399, DOI 10.1016/j.clinthera.2017.11.001; Zinman B, 2019, DIABETES CARE, V42, P2262, DOI 10.2337/dc19-0898	16	37	37	11	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					534	545		10.1001/jama.2022.0078	http://dx.doi.org/10.1001/jama.2022.0078			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35133415	Bronze, Green Published			2022-12-28	WOS:000758257900012
J	Bai, YC; Yang, CQ; Halitschke, R; Paetz, C; Kessler, D; Burkard, K; Gaquerel, E; Baldwin, IT; Li, DP				Bai, Yuechen; Yang, Caiqiong; Halitschke, Rayko; Paetz, Christian; Kessler, Danny; Burkard, Konrad; Gaquerel, Emmanuel; Baldwin, Ian T.; Li, Dapeng			Natural history-guided omics reveals plant defensive chemistry against leafhopper pests	SCIENCE			English	Article							NONHOST RESISTANCE; OXYLIPIN; DIVERSITY; HERBIVORY; RESPONSES; PATHWAY	Although much is known about plant traits that function in nonhost resistance against pathogens, little is known about nonhost resistance against herbivores, despite its agricultural importance. Empoasca leafhoppers, serious agricultural pests, identify host plants by eavesdropping on unknown outputs of jasmonate (JA)-mediated signaling. Forward- and reverse-genetics lines of a native tobacco plant were screened in native habitats with native herbivores using high-throughput genomic, transcriptomic, and metabolomic tools to reveal an Empoasca-elicited JA-JAZi module. This module induces an uncharacterized caffeoylputrescine-green leaf volatile compound, catalyzed by a polyphenol oxidase in a Michael addition reaction, which we reconstitute in vitro; engineer in crop plants, where it requires a berberine bridge enzyme-like 2 (BBL2) for its synthesis; and show that it confers resistance to leafhoppers. Natural history-guided forward genetics reveals a conserved nonhost resistance mechanism useful for crop protection.	[Bai, Yuechen; Yang, Caiqiong; Halitschke, Rayko; Kessler, Danny; Burkard, Konrad; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany; [Paetz, Christian] Max Planck Inst Chem Ecol, Dept Biosynth NMR, D-07745 Jena, Germany; [Gaquerel, Emmanuel] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, Strasbourg, France; [Li, Dapeng] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Li, Dapeng] Chinese Acad Sci, CAS JIC Ctr Excellence Plant & Microbial Sci CEPA, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Max Planck Society; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chinese Academy of Sciences; Chinese Academy of Sciences	Bai, YC; Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany.; Li, DP (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.; Li, DP (corresponding author), Chinese Acad Sci, CAS JIC Ctr Excellence Plant & Microbial Sci CEPA, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	ybai@ice.mpg.de; baldwin@ice.mpg.de; dpli@cemps.ac.cn	; Gaquerel, Emmanuel/I-2503-2014	caiqiong, Yang/0000-0003-3847-4167; Li, Dapeng/0000-0003-1737-7114; Baldwin, Ian/0000-0001-5371-2974; Halitschke, Rayko/0000-0002-1109-8782; Paetz, Christian/0000-0002-5776-7574; Bai, Yuechen/0000-0002-2314-8660; Gaquerel, Emmanuel/0000-0003-0796-6417	Max Planck Society [293926]; European Research Council; Deutsche Forschungsgemeinschaft [SFB 1127/2 ChemBioSys -239748522]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max Planck Society, advanced grant no. 293926 of the European Research Council to I.T.B., and the Deutsche Forschungsgemeinschaft -SFB 1127/2 ChemBioSys -239748522 to I.T.B.	Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Allmann S, 2010, PLANT CELL ENVIRON, V33, P2028, DOI 10.1111/j.1365-3040.2010.02203.x; Alseekh S, 2021, TRENDS PLANT SCI, V26, P650, DOI 10.1016/j.tplants.2021.02.005; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Boeckx T, 2015, J EXP BOT, V66, P3571, DOI 10.1093/jxb/erv141; Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Hayward A, 2019, NAT ECOL EVOL, V3, P1521, DOI 10.1038/s41559-019-1011-2; Joo Y, 2019, PLANT CELL ENVIRON, V42, P972, DOI 10.1111/pce.13474; Kallenbach M, 2012, P NATL ACAD SCI USA, V109, pE1548, DOI 10.1073/pnas.1200363109; Karban R., 2007, INDUCED RESPONSES HE; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kessler A, 2018, ANNU REV ECOL EVOL S, V49, P115, DOI 10.1146/annurev-ecolsys-110617-062406; Kim CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15777-w; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Lau W, 2015, SCIENCE, V349, P1224, DOI 10.1126/science.aac7202; Li DP, 2021, ANNU REV PLANT BIOL, V72, P867, DOI 10.1146/annurev-arplant-071720-114836; Li DP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0381; Li DP, 2016, P NATL ACAD SCI USA, V113, pE7610, DOI 10.1073/pnas.1610218113; Li DP, 2015, P NATL ACAD SCI USA, V112, pE4147, DOI 10.1073/pnas.1503106112; Li R, 2017, P NATL ACAD SCI USA, V114, pE7205, DOI 10.1073/pnas.1703463114; Major IT, 2017, NEW PHYTOL, V215, P1533, DOI 10.1111/nph.14638; Marchiosi R, 2020, PHYTOCHEM REV, V19, P865, DOI 10.1007/s11101-020-09689-2; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; McLarin MA, 2020, CRIT REV BIOCHEM MOL, V55, P274, DOI 10.1080/10409238.2020.1768209; Muller R, 2010, J CHEM ECOL, V36, P905, DOI 10.1007/s10886-010-9825-z; Oh Y, 2012, PLANT PHYSIOL, V159, P769, DOI 10.1104/pp.112.193771; Onkokesung N, 2012, PLANT PHYSIOL, V158, P389, DOI 10.1104/pp.111.187229; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Rajniak J, 2015, NATURE, V525, P376, DOI 10.1038/nature14907; Reed J, 2017, METAB ENG, V42, P185, DOI 10.1016/j.ymben.2017.06.012; Sanchez-Perez R, 2019, SCIENCE, V364, P1095, DOI 10.1126/science.aav8197; Savchenko T, 2014, PLANT PHYSIOL, V164, P1151, DOI 10.1104/pp.113.234310; Schafer M, 2017, J INTEGR PLANT BIOL, V59, P844, DOI 10.1111/jipb.12593; Sohn KH, 2012, NEW PHYTOL, V193, P58, DOI 10.1111/j.1469-8137.2011.03950.x; Sonawane PD, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.205; Szymanski J, 2020, NAT GENET, V52, P1111, DOI 10.1038/s41588-020-0690-6; Xu S.Y., 2020, ADV GENET, V1, P10022, DOI [10.1002/ggn2.10022, DOI 10.1002/GGN2.10022]; Zenkner FF., 2019, TOB SCI, V56, P1, DOI [10.3381/18-063, DOI 10.3381/18-063]; Zhu GT, 2018, CELL, V172, P249, DOI 10.1016/j.cell.2017.12.019	43	8	8	62	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					514	+	eabm2948	10.1126/science.abm2948	http://dx.doi.org/10.1126/science.abm2948			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113706				2022-12-28	WOS:000753965100034
J	Fink, G; Mrema, S; Abdulla, S; Kachur, SP; Khatib, R; Lengeler, C; Masanja, H; Okumu, F; Schellenberg, J				Fink, Gunther; Mrema, Sigilbert; Abdulla, Salim; Kachur, S. Patrick; Khatib, Rashid; Lengeler, Christian; Masanja, Honorati; Okumu, Fredros; Schellenberg, Joanna			Mosquito Net Use in Early Childhood and Survival to Adulthood in Tanzania	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALARIA TRANSMISSION; TREATED NETS; MORTALITY; CHILDREN; MORBIDITY; HEALTH; LEVEL	BACKGROUND It has been hypothesized that in high-transmission settings, malaria control in early childhood (<5 years of age) might delay the acquisition of functional immunity and shift child deaths from younger to older ages. METHODS We used data from a 22-year prospective cohort study in rural southern Tanzania to estimate the association between early-life use of treated nets and survival to adulthood. All the children born between January 1, 1998, and August 30, 2000, in the study area were invited to enroll in a longitudinal study from 1998 through 2003. Adult survival outcomes were verified in 2019 through community outreach and mobile telephones. We used Cox proportional-hazards models to estimate the association between the use of treated nets in early childhood and survival to adulthood, adjusting for potential confounders. RESULTS A total of 6706 children were enrolled. In 2019, we verified information on the vital status of 5983 participants (89%). According to reports of early-life community outreach visits, approximately one quarter of children never slept under a treated net, one half slept under a treated net some of the time, and the remaining quarter always slept under a treated net. Participants who were reported to have used treated nets at half the early-life visits or more had a hazard ratio for death of 0.57 (95% confidence interval [CI], 0.45 to 0.72) as compared with those who were reported to have used treated nets at less than half the visits. The corresponding hazard ratio between 5 years of age and adulthood was 0.93 (95% CI, 0.58 to 1.49). CONCLUSIONS In this long-term study of early-life malaria control in a high-transmission setting, the survival benefit from early-life use of treated nets persisted to adulthood.	[Fink, Gunther; Lengeler, Christian] Swiss Trop & Publ Hlth Inst, Kreuz Str 2, CH-4123 Allschwil, Switzerland; [Fink, Gunther; Lengeler, Christian] Univ Basel, Basel, Switzerland; [Mrema, Sigilbert; Abdulla, Salim; Khatib, Rashid; Masanja, Honorati; Okumu, Fredros] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Kachur, S. Patrick] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Schellenberg, Joanna] London Sch Hyg & Trop Med, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; Columbia University; University of London; London School of Hygiene & Tropical Medicine	Fink, G (corresponding author), Swiss Trop & Publ Hlth Inst, Kreuz Str 2, CH-4123 Allschwil, Switzerland.	guenther.fink@swisstph.ch		Schellenberg, Joanna/0000-0002-0708-3676	Swiss Agency for Development and Cooperation; Swiss National Science Foundation	Swiss Agency for Development and Cooperation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Supported by the Eckenstein-Geigy Professorship for data collection during the 2019 follow-up and by the Swiss Agency for Development and Cooperation and the Swiss National Science Foundation for the period of 1997 through 2003.	[Anonymous], 2019, STATA STAT SOFTWARE; Binka FN, 2002, T ROY SOC TROP MED H, V96, P597, DOI 10.1016/S0035-9203(02)90321-4; DAlessandro U, 1997, LANCET, V350, P362, DOI 10.1016/S0140-6736(97)26031-9; Diallo DA, 2004, B WORLD HEALTH ORGAN, V82, P85; Eisele TP, 2005, AM J TROP MED HYG, V73, P149; Geubbels E, 2015, INT J EPIDEMIOL, V44, P848, DOI 10.1093/ije/dyv068; Khatib RA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-140; Levitz L, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2183-y; Lines J, 1997, LANCET, V350, P813, DOI 10.1016/S0140-6736(05)62608-6; Louis VR, 2012, TROP MED INT HEALTH, V17, P733, DOI 10.1111/j.1365-3156.2012.02990.x; Molineaux L, 1997, LANCET, V349, P1636, DOI 10.1016/S0140-6736(97)22023-4; Pryce J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000363.pub3; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 1998, B I PASTEUR, V96, P15, DOI 10.1016/S0020-2452(98)80025-0; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2000, AB DECL PLAN ACT EXT	20	3	3	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					428	436		10.1056/NEJMoa2112524	http://dx.doi.org/10.1056/NEJMoa2112524			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR1JU	35108469	Bronze, Green Published			2022-12-28	WOS:000749755800008
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government writes off 10bn pound on unusable, overpriced, or undelivered PPE	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, TODAY; Department of Health and Social Care, ANN REP ACC 2020 21; Dyer C, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o96	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2022	376								o296	10.1136/bmj.o296	http://dx.doi.org/10.1136/bmj.o296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9HM	35115311	Bronze			2022-12-28	WOS:000759187700001
J	Zeng, YW; Gordiichuk, P; Ichihara, T; Zhang, G; Sandoz-Rosado, E; Wetzel, ED; Tresback, J; Yang, J; Kozawa, DC; Yang, ZY; Kuehne, M; Quien, M; Yuan, Z; Gong, X; He, GW; Lundberg, DJ; Liu, PW; Liu, AT; Yang, JF; Kulik, HJ; Strano, MS				Zeng, Yuwen; Gordiichuk, Pavlo; Ichihara, Takeo; Zhang, Ge; Sandoz-Rosado, Emil; Wetzel, Eric D.; Tresback, Jason; Yang, Jing; Kozawa, Daichi; Yang, Zhongyue; Kuehne, Matthias; Quien, Michelle; Yuan, Zhe; Gong, Xun; He, Guangwei; Lundberg, Daniel James; Liu, Pingwei; Liu, Albert Tianxiang; Yang, Jing Fan; Kulik, Heather J.; Strano, Michael S.			Irreversible synthesis of an ultrastrong two-dimensional polymeric material	NATURE			English	Article							MEMBRANES	Polymers that extend covalently in two dimensions have attracted recent attention(1,2) as a means of combining the mechanical strength and in-plane energy conduction of conventional two-dimensional (2D) materials(3,4) with the low densities, synthetic processability and organic composition of their one-dimensional counterparts. Efforts so far have proven successful in forms that do not allow full realization of these properties, such as polymerization at flat interfaces(5,6) or fixation of monomers in immobilized lattices(7-9). Another frequently employed synthetic approach is to introduce microscopic reversibility, at the cost of bond stability, to achieve 2D crystals after extensive error correction(10,11). Here we demonstrate a homogenous 2D irreversible polycondensation that results in a covalently bonded 2D polymeric material that is chemically stable and highly processable. Further processing yields highly oriented, free-standing films that have a 2D elastic modulus and yield strength of 12.7 +/- 3.8 gigapascals and 488 +/- 57 megapascals, respectively. This synthetic route provides opportunities for 2D materials in applications ranging from composite structures to barrier coating materials.	[Zeng, Yuwen; Gordiichuk, Pavlo; Ichihara, Takeo; Zhang, Ge; Sandoz-Rosado, Emil; Yang, Jing; Kozawa, Daichi; Yang, Zhongyue; Kuehne, Matthias; Quien, Michelle; Yuan, Zhe; Gong, Xun; He, Guangwei; Lundberg, Daniel James; Liu, Pingwei; Liu, Albert Tianxiang; Yang, Jing Fan; Kulik, Heather J.; Strano, Michael S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Wetzel, Eric D.] US Army Combat Capabil Dev Command, Army Res Lab, Aberdeen Proving Ground, MD USA; [Tresback, Jason] Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Harvard University	Strano, MS (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	strano@mit.edu	Yang, Jing Fan/GNP-7531-2022; Kuehne, Matthias/T-6863-2019; Kozawa, Daichi/C-3917-2012; Zhang, Ge/C-9750-2017	Yang, Jing Fan/0000-0001-8180-7452; Kuehne, Matthias/0000-0002-5096-7522; Kozawa, Daichi/0000-0002-0629-5589; Zhang, Ge/0000-0002-2631-8987; Zeng, Yuwen/0000-0003-2619-108X; Quien, Michelle/0000-0003-4990-2577	Center for Enhanced Nanofluidic Transport (CENT), an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-SC0019112]; Army Research Laboratory [W911NF-18-2-0055]; Burroughs Wellcome Fund; Center for Nanoscale Systems at Harvard; National Science Foundation under NSF [1541959]; DOE Office of Science by Brookhaven National Laboratory [DE-SC0012704]; Cypher VRS DURIP award [N000142012203]; German Research Foundation (DFG) [KU 3952/1-1]	Center for Enhanced Nanofluidic Transport (CENT), an Energy Frontier Research Center - US Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Center for Nanoscale Systems at Harvard; National Science Foundation under NSF(National Science Foundation (NSF)); DOE Office of Science by Brookhaven National Laboratory(United States Department of Energy (DOE)); Cypher VRS DURIP award; German Research Foundation (DFG)(German Research Foundation (DFG))	Membraackackackne fabrication, permeability testing and transport analysis of 2DPA-1 was supported by the Center for Enhanced Nanofluidic Transport (CENT), an Energy Frontier Research Center sponsored by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences under award #DE-SC0019112. The synthetic chemistry and mechanical testing aspects of this work were funded by the Army Research Laboratory under cooperative agreement W911NF-18-2-0055. H.J.K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, which supported the molecular modelling aspects of this work. We acknowledge fabrication support from the Center for Nanoscale Systems at Harvard, a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award no. 1541959. This research used beamline 11-BM Complex Materials Scattering (CMS) of the National Synchrotron Light Source II (NSLS-II) and the Center for Functional Nanomaterials (CFN), both of which are US DOE Office of Science User Facilities operated for the DOE Office of Science by Brookhaven National Laboratory under contract no. DE-SC0012704. We thank E. Tsai for her assistance in performing experiments at the beamline, R. Verduzco for beamline access, A. Penn and E.Brignole for MIT.Nano assistance for STEM and Cryo EM, and S. Xin Li for discussions on 2D membrane properties. We acknowledge MIT.Nano facilities and the Cypher VRS DURIP award (N000142012203) for the support on AFM characterizations. M.K. acknowledges support by the German Research Foundation (DFG) Research Fellowship KU 3952/1-1.	Baek K, 2013, J AM CHEM SOC, V135, P6523, DOI 10.1021/ja4002019; Berlanga I, 2011, SMALL, V7, P1207, DOI 10.1002/smll.201002264; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Cai ZY, 2018, CHEM REV, V118, P6091, DOI 10.1021/acs.chemrev.7b00536; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Diercks CS, 2017, SCIENCE, V355, DOI 10.1126/science.aal1585; Fang QY, 2021, MATTER-US, V4, P1017, DOI 10.1016/j.matt.2021.01.001; Gee G., 1935, P R SOC LONDON A, V153, P116; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Guan XY, 2019, NAT CHEM, V11, P587, DOI 10.1038/s41557-019-0238-5; Kandambeth S, 2019, J AM CHEM SOC, V141, P1807, DOI 10.1021/jacs.8b10334; Kissel P, 2014, NAT CHEM, V6, P774, DOI 10.1038/nchem.2008; Kissel P, 2012, NAT CHEM, V4, P287, DOI 10.1038/nchem.1265; Kory MJ, 2014, NAT CHEM, V6, P779, DOI [10.1038/nchem.2007, 10.1038/NCHEM.2007]; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Leterrier Y, 2003, PROG MATER SCI, V48, P1, DOI 10.1016/S0079-6425(02)00002-6; Li PF, 2017, NANOSCALE, V9, P9119, DOI 10.1039/c7nr02171b; Liu PW, 2016, SCIENCE, V353, P364, DOI 10.1126/science.aaf4362; OZAKI H, 1995, J CHEM PHYS, V103, P1226, DOI 10.1063/1.469832; Payamyar P, 2016, CHEM COMMUN, V52, P18, DOI 10.1039/c5cc07381b; Pop E, 2012, MRS BULL, V37, P1273, DOI 10.1557/mrs.2012.203; Sakamoto J, 2009, ANGEW CHEM INT EDIT, V48, P1030, DOI 10.1002/anie.200801863; Sandoz-Rosado E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22011-7; Schluter AD, 2016, MACROMOL RAPID COMM, V37, P1638, DOI 10.1002/marc.201600425; STUPP SI, 1993, SCIENCE, V259, P59, DOI 10.1126/science.259.5091.59; Sun PZ, 2020, NATURE, V579, P229, DOI 10.1038/s41586-020-2070-x; Varoon K, 2011, SCIENCE, V334, P72, DOI 10.1126/science.1208891; Yeh TM, 2013, J MATER CHEM A, V1, P12998, DOI 10.1039/c3ta12480k; Zhang B, 2018, J AM CHEM SOC, V140, P12715, DOI 10.1021/jacs.8b08374; Zhang G, 2021, J CHEM PHYS, V154, DOI 10.1063/5.0044050; Zhong Y, 2019, SCIENCE, V366, P1379, DOI 10.1126/science.aax9385	31	4	4	77	196	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					91	+		10.1038/s41586-021-04296-3	http://dx.doi.org/10.1038/s41586-021-04296-3			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110762				2022-12-28	WOS:000750429600024
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Lower vaccination rates partly explain higher death rates among minority ethnic groups	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Office for National Statistics, 2022, UPD ETHN CONTR DEATH	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o233	10.1136/bmj.o233	http://dx.doi.org/10.1136/bmj.o233			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086890	Bronze			2022-12-28	WOS:000748641100001
J	Khatri, UG; Winkelman, TNA				Khatri, Utsha G.; Winkelman, Tyler N. A.			Strengthening the Medicaid Reentry Act - Supporting the Health of People Who Are Incarcerated	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Strengthening the Medicaid Reentry Act Under the Reentry Act, Medicaid would be able to pay for health care for eligible people who are incarcerated starting up to 30 days before their release from jail or prison. Changes to this bill could bring care in these facilities in line with community standards.	[Khatri, Utsha G.] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA; [Khatri, Utsha G.] Icahn Sch Med Mt Sinai, Inst Hlth Equ Res, New York, NY 10029 USA; [Winkelman, Tyler N. A.] Hennepin Healthcare, Div Gen Internal Med, Dept Med, Minneapolis, MN USA; [Winkelman, Tyler N. A.] Hennepin Healthcare Res Inst, Hlth Homelessness & Criminal Justice Lab, Minneapolis, MN USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Khatri, UG (corresponding author), Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA.; Khatri, UG (corresponding author), Icahn Sch Med Mt Sinai, Inst Hlth Equ Res, New York, NY 10029 USA.							Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Olson Marin G, 2020, JAMA Health Forum, V1, pe200885, DOI 10.1001/jamahealthforum.2020.0885; Wiggins, 2021, U COLO LAW REV, V92, P256; Zeng Z, 2021, JAIL INMATES 2019	4	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2022	386	16					1488	1490		10.1056/NEJMp2119571	http://dx.doi.org/10.1056/NEJMp2119571		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1F4SD	35081297				2022-12-28	WOS:000747075900001
J	Dyer, O				Dyer, Owen			Covid-19: Europe could be headed for pandemic "endgame," says WHO region chief	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o205	10.1136/bmj.o205	http://dx.doi.org/10.1136/bmj.o205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078772	Bronze			2022-12-28	WOS:000759189200017
J	Wei, J; Choi, HK; Neogi, T; Dalbeth, N; Terkeltaub, R; Stamp, LK; Lyu, HC; McCormick, N; Niu, JB; Zeng, C; Lei, GH; Zhang, YQ				Wei, Jie; Choi, Hyon K.; Neogi, Tuhina; Dalbeth, Nicola; Terkeltaub, Robert; Stamp, Lisa K.; Lyu, Houchen; McCormick, Natalie; Niu, Jingbo; Zeng, Chao; Lei, Guanghua; Zhang, Yuqing			Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							EVIDENCE-BASED RECOMMENDATIONS; URIC-ACID; RENAL-DISEASE; SERUM URATE; RHEUMATOLOGY GUIDELINE; INCIDENT GOUT; RISK-FACTORS; MANAGEMENT; HYPERURICEMIA; PROGRESSION	Background: Two recent randomized clinical trials of escalat-ing doses of allopurinol for the progression of chronic kidney disease (CKD) reported no benefits but potentially increased risk for death. Whether the risk could occur in patients with gout and concurrent CKD remains unknown. Objective: To examine the relation of allopurinol initiation, allopurinol dose escalation, and achieving target serum urate (SU) level after allopurinol initiation to all-cause mortality in patients with both gout and CKD. Design: Cohort study. Setting: The Health Improvement Network U.K. primary care database (2000 to 2019). Participants: Patients aged 40 years or older who had gout and concurrent moderate-to-severe CKD. Measurements: The association between allopurinol initiation and all-cause mortality over 5-year follow-up in propensity score (PS)-matched cohorts was examined. Analysis of hypothetical trials were emulated: achieving target SU level (<0.36 mmol/L) versus not achieving target SU level and dose escalation versus no dose escalation for mortality over 5-year follow-up in allopurinol initiators. Results: Mortality was 4.9 and 5.8 per 100 person-years in 5277 allopurinol initiators and 5277 PS-matched noninitia-tors, respectively (hazard ratio [HR], 0.85 [95% CI, 0.77 to 0.93). In the target trial emulation analysis, the HR of mortal-ity for the achieving target SU level group compared with the not achieving target SU level group was 0.87 (CI, 0.75 to 1.01); the HR of mortality for allopurinol in the dose escalation group versus the no dose escalation group was 0.88 (CI, 0.73 to 1.07). Limitation: Residual confounding cannot be ruled out. Conclusion: In this population-based data, neither allo-purinol initiation, nor achieving target SU level with allo-purinol, nor allopurinol dose escalation was associated with increased mortality in patients with gout and concur-rent CKD. Primary Funding Source: Project Program of National Clinical Research Center for Geriatric Disorders.	[Wei, Jie] Cent South Univ, Xiangya Hosp, Hlth Management Ctr, Changsha, Peoples R China; [Choi, Hyon K.; McCormick, Natalie; Zhang, Yuqing] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA; [Choi, Hyon K.; McCormick, Natalie; Zhang, Yuqing] Harvard Med Sch, Mongan Inst, Massachusetts Gen Hosp, Boston, MA USA; [Neogi, Tuhina] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA USA; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland, New Zealand; [Terkeltaub, Robert] San Diego VA Med Ctr, Rheumatol Allergy Immunol Sect, San Diego, CA USA; [Stamp, Lisa K.] Univ Otago, Dept Med, Christchurch, New Zealand; [Lyu, Houchen] Gen Hosp Chinese PLA, Dept Orthoped, Beijing, Peoples R China; [Lyu, Houchen; Zeng, Chao; Lei, Guanghua] Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [McCormick, Natalie] Arthrit Res Canada, Richmond, BC, Canada; [Niu, Jingbo] Baylor Coll Med, Dept Med, Sect Nephrol, Selzman Inst Kidney Hlth, Houston, TX 77030 USA; [Zeng, Chao] Cent South Univ, Hunan Key Lab Joint Degenerat & Injury, Xiangya Hosp, Changsha, Peoples R China; [Zeng, Chao; Lei, Guanghua] Cent South Univ, Natl Clin Res Ctr Geriatr Disorders, Xiangya Hosp, Changsha, Peoples R China; [Lei, Guanghua] Hunan Key Lab Joint Degenerat & Injury, Changsha, Peoples R China	Central South University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Auckland; University of Otago; Central South University; Arthritis Research Canada; Baylor College of Medicine; Central South University; Central South University	Zhang, YQ (corresponding author), Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.; Lei, GH (corresponding author), Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	lei_guanghua@csu.edu.cn; yzhang108@mgh.harvard.edu	Wei, Jie/ACR-8087-2022	Wei, Jie/0000-0003-3510-8241; Neogi, Tuhina/0000-0002-9515-1711; Lyu, Houchen/0000-0002-0128-0062; Stamp, Lisa/0000-0003-0138-2912; McCormick, Natalie/0000-0002-4147-8348	Project Program of National Clinical Research Center for Geriatric Disorders	Project Program of National Clinical Research Center for Geriatric Disorders	Project Program of National Clinical Research Center for Geriatric Disorders.	Ahola AJ, 2017, KIDNEY INT, V91, P1178, DOI 10.1016/j.kint.2016.11.025; Badve SV, 2020, NEW ENGL J MED, V382, P2504, DOI 10.1056/NEJMoa1915833; Bevis M, 2018, RHEUMATOLOGY, V57, P1358, DOI 10.1093/rheumatology/key096; Chen JH, 2015, J RHEUMATOL, V42, P1694, DOI 10.3899/jrheum.141542; Coburn BW, 2018, ARTHRITIS RHEUMATOL, V70, P1298, DOI 10.1002/art.40486; Conway R, 2020, NEW ENGL J MED, V383, P1689, DOI 10.1056/NEJMc2026125; Dalbeth N, 2019, ARTHRITIS RHEUMATOL, V71, P1739, DOI 10.1002/art.40929; Danaei G, 2018, J CLIN EPIDEMIOL, V96, P12, DOI 10.1016/j.jclinepi.2017.11.021; Dehlin M, 2020, NAT REV RHEUMATOL, V16, P380, DOI 10.1038/s41584-020-0441-1; Dehlin M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1062-6; Doherty M, 2018, LANCET, V392, P1403, DOI 10.1016/S0140-6736(18)32158-5; Domrongkitchaiporn S, 2005, J AM SOC NEPHROL, V16, P791, DOI 10.1681/ASN.2004030208; Doria A, 2020, NEW ENGL J MED, V382, P2493, DOI 10.1056/NEJMoa1916624; Dubreuil M, 2015, ANN RHEUM DIS, V74, P1368, DOI 10.1136/annrheumdis-2014-205269; Dunkler D, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i02; Emilsson L, 2018, JAMA ONCOL, V4, P63, DOI 10.1001/jamaoncol.2017.2752; First Databank, FDB MULT; FitzGerald JD, 2020, ARTHRITIS RHEUMATOL, V72, P879, DOI [10.1002/art.41247, 10.1002/acr.24180]; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hay CA, 2021, ARTHRIT CARE RES, V73, P1049, DOI 10.1002/acr.24205; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k182; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hughes K, 2014, KIDNEY INT, V85, P344, DOI 10.1038/ki.2013.353; Hui M, 2017, RHEUMATOLOGY, V56, P1056, DOI 10.1093/rheumatology/kex150; Jordan DM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002725; Ju CS, 2020, RHEUMATOLOGY, V59, P2340, DOI 10.1093/rheumatology/kez576; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Kim JW, 2017, RHEUMATOL INT, V37, P1499, DOI 10.1007/s00296-017-3768-4; Kim SC, 2021, ARTHRITIS RHEUMATOL, V73, P542, DOI 10.1002/art.41550; Kim SC, 2018, J AM COLL CARDIOL, V71, P994, DOI 10.1016/j.jacc.2017.12.052; Krishnamurthy A, 2017, JCR-J CLIN RHEUMATOL, V23, P1, DOI 10.1097/RHU.0000000000000480; Kuo CF, 2011, SCAND J RHEUMATOL, V40, P116, DOI 10.3109/03009742.2010.507218; Kuo CF, 2015, RHEUMATOLOGY, V54, P2145, DOI 10.1093/rheumatology/kev246; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Langan SM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3532; Larsen KS, 2016, AM J MED, V129, P299, DOI 10.1016/j.amjmed.2015.11.003; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy GD, 2014, J RHEUMATOL, V41, P955, DOI 10.3899/jrheum.131159; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Liu P, 2015, CLIN ENDOCRINOL, V83, P475, DOI 10.1111/cen.12673; Luk AJ, 2009, RHEUMATOLOGY, V48, P804, DOI 10.1093/rheumatology/kep069; Lyu HC, 2020, ANN INTERN MED, V173, P516, DOI 10.7326/M20-0882; MacIsaac RL, 2016, HYPERTENSION, V67, P535, DOI 10.1161/HYPERTENSIONAHA.115.06344; McCormick N, 2020, NEW ENGL J MED, V383, P1689, DOI 10.1056/NEJMc2026125; Meier CR, 1997, BRIT J CLIN PHARMACO, V44, P175, DOI 10.1046/j.1365-2125.1997.00647.x; Mikuls TR, 2019, AM J MED, V132, P354, DOI 10.1016/j.amjmed.2018.11.011; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Pai B H Santhosh, 2013, Indian J Nephrol, V23, P280, DOI 10.4103/0971-4065.114499; Rai SK, 2017, SEMIN ARTHRITIS RHEU, V46, P451, DOI 10.1016/j.semarthrit.2016.08.006; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Rubin DB, 1987, MULTIPLE IMPUTATION; Safiri S, 2020, ARTHRITIS RHEUMATOL, V72, P1916, DOI 10.1002/art.41404; Schlesinger N, 2018, J RHEUMATOL, V45, P1192, DOI 10.3899/jrheum.170444; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Shoji A, 2004, ARTHRIT RHEUM-ARTHR, V51, P321, DOI 10.1002/art.20405; Singh JA, 2017, ANN RHEUM DIS, V76, P133, DOI 10.1136/annrheumdis-2015-209046; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; Stamp LK, 2017, ANN RHEUM DIS, V76, P1522, DOI 10.1136/annrheumdis-2016-210872; Suissa S, 2021, ARTHRITIS RHEUMATOL, V73, P1749, DOI 10.1002/art.41710; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Vargas-Santos AB, 2018, JAMA INTERN MED, V178, P1526, DOI 10.1001/jamainternmed.2018.4463; Webster-Clark M, 2021, STAT MED, V40, P1718, DOI 10.1002/sim.8866; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Xia Y, 2020, RHEUMATOLOGY, V59, P1529, DOI 10.1093/rheumatology/kez476; Zhang YQ, 2015, ARTHRITIS RHEUMATOL, V67, P3298, DOI 10.1002/art.39330; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zobbe K, 2019, RHEUMATOLOGY, V58, P836, DOI 10.1093/rheumatology/key390	74	3	3	17	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					461	+		10.7326/M21-2347	http://dx.doi.org/10.7326/M21-2347		JAN 2022	16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35073156				2022-12-28	WOS:000748963300001
J	Sittig, DF; Sengstack, P; Singh, H				Sittig, Dean F.; Sengstack, Patricia; Singh, Hardeep			Guidelines for US Hospitals and Clinicians on Assessment of Electronic Health Record Safety Using SAFER Guides	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sittig, Dean F.] Univ Texas Hlth Sci Ctr Houston, Univ Texas, Sch Biomed Informat, Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX 77030 USA; [Sengstack, Patricia] Vanderbilt Univ, Sch Nursing, Nursing Informat Ctr 1, Nashville, TN 37240 USA; [Singh, Hardeep] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Singh, Hardeep] Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Vanderbilt University; Baylor College of Medicine; Baylor College of Medicine	Sittig, DF (corresponding author), Univ Texas Houston, Univ Texas Hlth Sci Ctr Houston, Mem Hermann Ctr Healthcare Qual & Safety, 6410 Fannin St, Houston, TX 77030 USA.	dean.f.sittig@uth.tmc.edu	Sittig, Dean/D-2471-2009	Sittig, Dean/0000-0001-5811-8915	Veterans Affairs (VA) Health Services Research and Development Service (HSRD) [CIN 13-413]; Agency for Healthcare Research and Quality; Gordon and Betty Moore Foundation; Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety	Veterans Affairs (VA) Health Services Research and Development Service (HSRD); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety	Dr Sittig reported receipt of personal fees (electronic health records [EHR] safety consulting) from Informatics Review LLC and a contract from the Office of the National Coordinator for Health Information Technology (ONC) to develop and revise the SAFER Guides. Dr Singh reported receipt of personal fees (EHR safety consulting) from Informatics Review LLC and a contract from the ONC to develop and revise the SAFER Guides; and being partially supported by grants from the Veterans Affairs (VA) Health Services Research and Development Service (HSR&D) (CIN 13-413), the Agency for Healthcare Research and Quality, the Gordon and Betty Moore Foundation, and the Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety during the composition of this article. No other disclosures were reported.	[Anonymous], 2021, FED REGISTER, V86, P45479; Ash JS, 2020, HEALTH INFORM J, V26, P3140, DOI 10.1177/1460458219833109; Meditech Knowledge Base, MEDITECH EXP ASS ACC; program Medicare, 2021, FED REGISTER, V86, P65475; Sittig DF, 2021, JAMA-J AM MED ASSOC, V326, P1477, DOI 10.1001/jama.2021.13945; Sittig DF, 2018, J AM MED INFORM ASSN, V25, P913, DOI 10.1093/jamia/ocy033; Sittig DF, 2018, HEALTHCARE-J DEL SCI, V6, P7, DOI 10.1016/j.hjdsi.2017.06.004	7	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2022	327	8					719	720		10.1001/jama.2022.0085	http://dx.doi.org/10.1001/jama.2022.0085		FEB 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ2NN	35129591				2022-12-28	WOS:000754027100002
J	Sherman, SV				Sherman, Stephanie V.			Chronic Generalized Pruritus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Chronic Generalized Pruritus A 57-year-old man presented with itching of the whole body. Examination showed hyperpigmentation and excoriations, with sparing of a butterfly-shaped area on his back. Laboratory studies showed evidence of advanced kidney disease, and chronic generalized pruritus due to chronic kidney disease was diagnosed. Hemodialysis was initiated, and his symptoms abated.						Yokoyama, Tomoaki/0000-0002-1094-3569					0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					E12	E12		10.1056/NEJMicm2114503	http://dx.doi.org/10.1056/NEJMicm2114503		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YW0GW	35119805				2022-12-28	WOS:000751512700001
J	Wymant, C; Bezemer, D; Blanquart, F; Ferretti, L; Gall, A; Hall, M; Golubchik, T; Bakker, M; Ong, SH; Zhao, L; Bonsall, D; de Cesare, M; MacIntyre-Cockett, G; Abeler-Dorner, L; Albert, J; Bannert, N; Fellay, J; Grabowski, MK; Gunsenheimer-Bartmeyer, B; Gunthard, HF; Kivela, P; Kouyos, RD; Laeyendecker, O; Meyer, L; Porter, K; Ristola, M; van Sighem, A; Ben Berkhout; Kellam, P; Cornelissen, M; Reiss, P; Fraser, C				Wymant, Chris; Bezemer, Daniela; Blanquart, Francois; Ferretti, Luca; Gall, Astrid; Hall, Matthew; Golubchik, Tanya; Bakker, Margreet; Ong, Swee Hoe; Zhao, Lele; Bonsall, David; de Cesare, Mariateresa; MacIntyre-Cockett, George; Abeler-Doerner, Lucie; Albert, Jan; Bannert, Norbert; Fellay, Jacques; Grabowski, M. Kate; Gunsenheimer-Bartmeyer, Barbara; Gunthard, Huldrych F.; Kivela, Pia; Kouyos, Roger D.; Laeyendecker, Oliver; Meyer, Laurence; Porter, Kholoud; Ristola, Matti; van Sighem, Ard; Ben Berkhout; Kellam, Paul; Cornelissen, Marion; Reiss, Peter; Fraser, Christophe		Netherlands ATHENA HIV Observation; BEEHIVE Collaboration	A highly virulent variant of HIV-1 circulating in the Netherlands	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SETPOINT VIRAL LOAD; REVERSE-TRANSCRIPTASE; TRANSMISSION; MODEL; HERITABILITY; PROGRESSION; SELECTION; EPIDEMIC; DYNAMICS	We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log(10) increase (i.e., a similar to 3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV-CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences-is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination. with increased transmissibility and an unfamiliar molecular mechanism of virulence.	[Wymant, Chris; Ferretti, Luca; Hall, Matthew; Golubchik, Tanya; Zhao, Lele; Bonsall, David; MacIntyre-Cockett, George; Abeler-Doerner, Lucie; Fraser, Christophe] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Nuffield Dept Med, Oxford, England; [Bezemer, Daniela; van Sighem, Ard; Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Blanquart, Francois] PSL Res Univ, Coll France, Ctr Interdisciplinary Res Biol CIRB, INSERM, Paris, France; [Blanquart, Francois] Univ Paris, INSERM, IAME, UMR 1137, Paris, France; [Gall, Astrid] European Mol Biol Lab, European Bioinformat Inst, Wellcome Genome Campus, Cambridge, England; [Bakker, Margreet; Ben Berkhout; Cornelissen, Marion] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Microbiol & Infect Prevent, Lab Expt Virol, Amsterdam, Netherlands; [Ong, Swee Hoe] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge, England; [Bonsall, David; de Cesare, Mariateresa; MacIntyre-Cockett, George; Fraser, Christophe] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Bannert, Norbert] Robert Koch Inst, Dept Infect Dis, Div HIV & Other Retroviruses, Berlin, Germany; [Fellay, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Fellay, Jacques] Swiss Inst Bioinformat, Lausanne, Switzerland; [Fellay, Jacques] Lausanne Univ Hosp, Precis Med Unit, Lausanne, Switzerland; [Fellay, Jacques] Univ Lausanne, Lausanne, Switzerland; [Grabowski, M. Kate] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Gunsenheimer-Bartmeyer, Barbara] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Gunthard, Huldrych F.; Kouyos, Roger D.] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Gunthard, Huldrych F.; Kouyos, Roger D.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Kivela, Pia; Ristola, Matti] Helsinki Univ Hosp, Dept Infect Dis, Helsinki, Finland; [Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, Baltimore, MD USA; [Meyer, Laurence] Univ Paris Saclay, Hop Bicetre, AP HP, Serv Sante Publ,INSERM CESP U1018, Le Kremlin Bicetre, France; [Porter, Kholoud] UCL, Inst Global Hlth, London, England; [Kellam, Paul] Kymab Ltd, Cambridge, England; [Kellam, Paul] Imperial Coll London, Fac Med, Dept Infect Dis, London, England; [Cornelissen, Marion] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Microbiol & Infect Prevent, Mol Diagnost Unit, Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Reiss, Peter] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; European Molecular Biology Laboratory (EMBL); University of Amsterdam; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Robert Koch Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Johns Hopkins University; Robert Koch Institute; University of Zurich; University Zurich Hospital; University of Zurich; University of Helsinki; Helsinki University Central Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Imperial College London; University of Amsterdam; University of Amsterdam	Wymant, C; Fraser, C (corresponding author), Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Nuffield Dept Med, Oxford, England.; Fraser, C (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England.	chris.wymant@bdi.ox.ac.uk; christophe.fraser@bdi.ox.ac.uk	Fellay, Jacques/A-6681-2009; gunthard, huldrych f/F-1724-2011; Anderson, Josephine/AAW-9680-2020; Fraser, Christophe/A-8109-2008; Kouyos, Roger/G-6226-2014; Bourgeois, Christine/L-5944-2018; Golubchik, Tanya/B-4226-2018	Fellay, Jacques/0000-0002-8240-939X; gunthard, huldrych f/0000-0002-1142-6723; Anderson, Josephine/0000-0002-2802-6769; Fraser, Christophe/0000-0003-2399-9657; Kouyos, Roger/0000-0002-9220-8348; Laeyendecker, Oliver/0000-0002-6429-4760; Fidler, Sarah/0000-0003-1676-7583; Hirsch, Hans H./0000-0003-0883-0423; Vermont, Clementien/0000-0002-2219-856X; Gall, Astrid/0000-0001-6452-5816; Ristola, Matti/0000-0001-5115-2811; Bourgeois, Christine/0000-0003-1146-6087; Ong, Swee Hoe/0000-0002-3629-5387; Golubchik, Tanya/0000-0003-2765-9828; Zhao, Lele/0000-0002-2807-1914; Hall, Matthew/0000-0002-2671-3864; Ferretti, Luca/0000-0001-7578-7301; van Nieuwkoop, Cees/0000-0003-0734-0844	ERC [PBDR-339251]; Li Ka Shing Foundation; Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment	ERC(European Research Council (ERC)European Commission); Li Ka Shing Foundation; Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment	This study was funded by ERC Advanced Grant PBDR-339251 and a Li Ka Shing Foundation grant, both awarded to C.F. The ATHENA Cohort is managed by Stichting HIV Monitoring and supported by a grant from the Dutch Ministry of Health, Welfare and Sport through the Centre for Infectious Disease Control of the National Institute for Public Health and the Environment.	Alizon S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-49; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASJO B, 1986, LANCET, V2, P660; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertels F, 2018, MOL BIOL EVOL, V35, P27, DOI 10.1093/molbev/msx246; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Bezemer D, 2022, AIDS, V36, P83, DOI 10.1097/QAD.0000000000003074; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Blanquart F, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001855; Blanquart F, 2016, ELIFE, V5, DOI 10.7554/eLife.20492; Boender TS, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022516; Bonsall D, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00382-20; Bull JJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004387; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; Cornelissen M, 2017, VIRUS RES, V239, P10, DOI 10.1016/j.virusres.2016.08.004; Cressler CE, 2016, PARASITOLOGY, V143, P915, DOI 10.1017/S003118201500092X; Davies NG, 2021, NATURE, V593, P270, DOI [10.1038/s41586-021-03426-1, 10.1101/2021.02.01.21250959]; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; de Silva E, 2012, J R SOC INTERFACE, V9, P1797, DOI 10.1098/rsif.2011.0850; Dearlove BL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004312; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Fraser C, 2010, AIDS, V24, P2596, DOI 10.1097/QAD.0b013e32833e7a64; Gall A, 2012, J CLIN MICROBIOL, V50, P3838, DOI 10.1128/JCM.01516-12; Geoghegan JL, 2018, NAT REV GENET, V19, P756, DOI 10.1038/s41576-018-0055-5; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grint DJ, 2021, EUROSURVEILLANCE, V26, P10, DOI 10.2807/1560-7917.ES.2021.26.11.2100256; Harrison L, 2009, STAT MED, V28, P3260, DOI 10.1002/sim.3725; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Herbeck JT, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew028; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Hernan M., 2020, CAUSAL INFERENCE WHA; Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kusejko K, 2019, J INFECT DIS, V220, P244, DOI 10.1093/infdis/jiz093; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lipsitch, 2020, TWITTER; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mitov V, 2018, MOL BIOL EVOL, V35, P756, DOI 10.1093/molbev/msx328; Neher RA, 2014, ELIFE, V3, DOI 10.7554/eLife.03568; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pantazis N, 2014, LANCET HIV, V1, pE119, DOI 10.1016/S2352-3018(14)00002-2; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosperi MCF, 2009, AIDS RES HUM RETROV, V25, P305, DOI 10.1089/aid.2008.0039; Raberg L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001989; Raberg Lars, 2011, P548; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Renaud M., 2019, J OPEN SOURCE SOFTW, V4, P1186, DOI [10.21105/joss.01186, DOI 10.21105/JOSS.01186]; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Roberts HE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0888; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Scherrer AU, 2022, INT J EPIDEMIOL, V51, P33, DOI 10.1093/ije/dyab141; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song HS, 2019, P NATL ACAD SCI USA, V116, P239, DOI 10.1073/pnas.1814714116; Song HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04217-5; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; van Sighem A, 2015, EPIDEMIOLOGY, V26, P653, DOI 10.1097/EDE.0000000000000324; Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex025; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Wertheim JO, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13723-z; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Wymant C., 2021, ZENODO VERSION 1, DOI [10.5281/zenodo.5761935, DOI 10.5281/ZENODO.5761935]; Wymant C, 2018, MOL BIOL EVOL, V35, P719, DOI 10.1093/molbev/msx304; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	85	12	12	16	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					540	+		10.1126/science.abk1688	http://dx.doi.org/10.1126/science.abk1688			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113714	Green Submitted, Green Published			2022-12-28	WOS:000753965100039
J	Dyer, C				Dyer, Clare			Government considers capping lawyers' fees for small negligence claims against NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2022	376								o297	10.1136/bmj.o297	http://dx.doi.org/10.1136/bmj.o297			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9HM	35115312				2022-12-28	WOS:000759187700004
J	Deng, WY; Bai, Y; Deng, F; Pan, YD; Mei, SL; Zheng, ZZ; Min, R; Wu, ZY; Li, W; Miao, R; Zhang, ZB; Kupper, TS; Lieberman, J; Liu, X				Deng, Wanyan; Bai, Yang; Deng, Fan; Pan, Youdong; Mei, Shenglin; Zheng, Zengzhang; Min, Rui; Wu, Zeyu; Li, Wu; Miao, Rui; Zhang, Zhibin; Kupper, Thomas S.; Lieberman, Judy; Liu, Xing			Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis	NATURE			English	Article							GROUP-A STREPTOCOCCUS; MECHANISM; INFLAMMASOME; SPECIFICITY; INVASION; ZYMOGEN	Gasdermins, a family of five pore-forming proteins (GSDMA-GSDME) in humans expressed predominantly in the skin, mucosa and immune sentinel cells, are key executioners of inflammatory cell death (pyroptosis), which recruits immune cells to infection sites and promotes protective immunity(1,2). Pore formation is triggered by gasdermin cleavage(1,2). Although the proteases that activate GSDMB, C, D and E have been identified, how GSDMA-the dominant gasdermin in the skin-is activated, remains unknown. Streptococcus pyogenes, also known as group A Streptococcus (GAS), is a major skin pathogen that causes substantial morbidity and mortality worldwide(3). Here we show that the GAS cysteine protease SpeB virulence factor triggers keratinocyte pyroptosis by cleaving GSDMA after Gln246, unleashing an active N-terminal fragment that triggers pyroptosis. Gsdma1 genetic deficiency blunts mouse immune responses to GAS, resulting in uncontrolled bacterial dissemination and death. GSDMA acts as both a sensor and substrate of GAS SpeB and as an effector to trigger pyroptosis, adding a simple one-molecule mechanism for host recognition and control of virulence of a dangerous microbial pathogen.	[Deng, Wanyan; Bai, Yang; Deng, Fan; Zheng, Zengzhang; Min, Rui; Wu, Zeyu; Li, Wu; Liu, Xing] Chinese Acad Sci, Ctr Microbes, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Deng, Wanyan; Zheng, Zengzhang; Li, Wu; Liu, Xing] Guangzhou Women & Childrens Med Ctr, Joint Ctr Infect & Immun, Guangzhou Inst Pediat, Guangzhou, Peoples R China; [Deng, Wanyan; Zheng, Zengzhang; Li, Wu; Liu, Xing] Chinese Acad Sci, Joint Ctr Infect & Immun, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Bai, Yang; Deng, Fan; Min, Rui; Wu, Zeyu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Pan, Youdong; Kupper, Thomas S.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA; [Pan, Youdong; Kupper, Thomas S.] Harvard Med Sch, Harvard Skin Dis Res Ctr, Boston, MA USA; [Mei, Shenglin] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Miao, Rui; Zhang, Zhibin; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Miao, Rui; Zhang, Zhibin; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Liu, X (corresponding author), Chinese Acad Sci, Ctr Microbes, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Liu, X (corresponding author), Guangzhou Women & Childrens Med Ctr, Joint Ctr Infect & Immun, Guangzhou Inst Pediat, Guangzhou, Peoples R China.; Liu, X (corresponding author), Chinese Acad Sci, Joint Ctr Infect & Immun, Inst Pasteur Shanghai, Shanghai, Peoples R China.	xingliu@ips.ac.cn		Zhang, Zhibin/0000-0003-1349-2713	National Key R&D Program of China [2020YFA0509600]; National Natural Science Foundation of China [32122034, 31972897]; Key Research Program of the Chinese Academy of Sciences [ZDBS-LY-SM008]; Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences [JCYJ-SHFY-2021-009]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB29030300]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; NIH [R01CA240955, R01AI39914, R01AI127654]; China Postdoctoral Science Foundation [2019M650193]; Guangzhou Science and Technology Project [202102020093]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Science and Technology Major Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangzhou Science and Technology Project	We thank V. Nizet for sharing S. pyogenes isolate M1T1 strain 5448 and its isogenic mutant strains (.speB, covR/S-,.cepA and.mac variants) as well as SpeB constructs, Z. Zhang for providing S. pyogenes M9, M12 amd M73 strains, C. Wang for providing Phage-Flag vector, and Y. Chen for providing a modified pET vector with an N-terminal 6xHis-SUMO tag. This work was supported by National Key R&D Program of China (2020YFA0509600), National Natural Science Foundation of China (32122034, 31972897), Key Research Program of the Chinese Academy of Sciences (ZDBS-LY-SM008), Shanghai Pilot Program for Basic Research-Chinese Academy of Sciences, Shanghai Branch (JCYJ-SHFY-2021-009), Strategic Priority Research Program of Chinese Academy of Sciences (XDB29030300), Shanghai Municipal Science and Technology Major Project (2019SHZDZX02) (X.L.), NIH R01CA240955 and R01AI39914 (J.L.), NIH R01AI127654 (T.S.K.) and China Postdoctoral Science Foundation (2019M650193), Guangzhou Science and Technology Project (202102020093) (W.D.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Barnett TC, 2013, CELL HOST MICROBE, V14, P675, DOI 10.1016/j.chom.2013.11.003; Brouwer S, 2016, FEBS LETT, V590, P3739, DOI 10.1002/1873-3468.12254; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Carothers KE, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00008-20; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; GERWIN BI, 1966, J BIOL CHEM, V241, P3331; Hynes W, 2016, STREPTOCOCCUS PYOGEN; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; LaRock CN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3539; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Lichtenberger BM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005886; Liu X, 2021, NAT REV DRUG DISCOV, V20, P384, DOI 10.1038/s41573-021-00154-z; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Mitchell PS, 2019, CURR OPIN IMMUNOL, V60, P37, DOI 10.1016/j.coi.2019.04.015; Musser JM, 1996, INFECT IMMUN, V64, P1913, DOI 10.1128/IAI.64.6.1913-1917.1996; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Orzalli MH, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6184; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Richter J, 2021, IMMUNOL CELL BIOL, V99, P1040, DOI 10.1111/imcb.12499; Richter J, 2021, CELL MICROBIOL, V23, DOI 10.1111/cmi.13373; Rohde M, 2013, CURR TOP MICROBIOL, V368, P83, DOI 10.1007/82_2012_281; Saouda M, 2001, J INFECT DIS, V184, P723, DOI 10.1086/323083; Sawada Y, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe1935; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Sumitomo T, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00010; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; WHATMORE AM, 1994, MOL MICROBIOL, V11, P363, DOI 10.1111/j.1365-2958.1994.tb00316.x; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046390; Zheng ZZ, 2021, SCIENCE, V372, P1412, DOI 10.1126/science.abg0269; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026	40	34	34	16	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2022	602	7897					496	+		10.1038/s41586-021-04384-4	http://dx.doi.org/10.1038/s41586-021-04384-4		FEB 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZB5PA	35110732				2022-12-28	WOS:000750001600003
J	Wise, J				Wise, Jacqui			Racism in medicine: Employers and government must act now, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o289	10.1136/bmj.o289	http://dx.doi.org/10.1136/bmj.o289			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110296				2022-12-28	WOS:000758682200001
J	Al Abbasi, B; Borzak, S				Al Abbasi, Baher; Borzak, Steven			In patients with stable CVD receiving statins, evolocumab reduced acute arterial events across all vascular territories	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Al Abbasi, Baher; Borzak, Steven] Univ Miami, Miller Sch Med, Palm Beach Campus, Atlantis, FL 33462 USA		Al Abbasi, B (corresponding author), Univ Miami, Miller Sch Med, Palm Beach Campus, Atlantis, FL 33462 USA.							Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Dayoub EJ, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019331; Giugliano RP, 2020, STROKE, V51, P1546, DOI 10.1161/STROKEAHA.119.027759	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC14	JC14		10.7326/J21-0013	http://dx.doi.org/10.7326/J21-0013		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35100002				2022-12-28	WOS:000750873300001
J	Meng, B; Abdullahi, A; Ferreira, IATM; Goonawardane, N; Saito, A; Kimura, I; Yamasoba, D; Gerber, PP; Fatihi, S; Rathore, S; Zepeda, SK; Papa, G; Kemp, SA; Ikeda, T; Toyoda, M; Tan, TS; Kuramochi, J; Mitsunaga, S; Ueno, T; Shirakawa, K; Takaori-Kondo, A; Brevini, T; Mallery, DL; Charles, OJ; Bowen, JE; Joshi, A; Walls, AC; Jackson, L; Martin, D; Smith, KGC; Bradley, J; Briggs, JAG; Choi, J; Madissoon, E; Meyer, KB; Mlcochova, P; Ceron-Gutierrez, L; Doffinger, R; Teichmann, SA; Fisher, AJ; Pizzuto, MS; de Marco, A; Corti, D; Hosmillo, M; Lee, JH; James, LC; Thukral, L; Veesler, D; Sigal, A; Sampaziotis, F; Goodfellow, IG; Matheson, NJ; Sato, K; Gupta, RK				Meng, Bo; Abdullahi, Adam; Ferreira, Isabella A. T. M.; Goonawardane, Niluka; Saito, Akatsuki; Kimura, Izumi; Yamasoba, Daichi; Gerber, Pehuen Pereyra; Fatihi, Saman; Rathore, Surabhi; Zepeda, Samantha K.; Papa, Guido; Kemp, Steven A.; Ikeda, Terumasa; Toyoda, Mako; Tan, Toong Seng; Kuramochi, Jin; Mitsunaga, Shigeki; Ueno, Takamasa; Shirakawa, Kotaro; Takaori-Kondo, Akifumi; Brevini, Teresa; Mallery, Donna L.; Charles, Oscar J.; Bowen, John E.; Joshi, Anshu; Walls, Alexandra C.; Jackson, Laurelle; Martin, Darren; Smith, Kenneth G. C.; Bradley, John; Briggs, John A. G.; Choi, Jinwook; Madissoon, Elo; Meyer, Kerstin B.; Mlcochova, Petra; Ceron-Gutierrez, Lourdes; Doffinger, Rainer; Teichmann, Sarah A.; Fisher, Andrew J.; Pizzuto, Matteo S.; de Marco, Anna; Corti, Davide; Hosmillo, Myra; Lee, Joo Hyeon; James, Leo C.; Thukral, Lipi; Veesler, David; Sigal, Alex; Sampaziotis, Fotios; Goodfellow, Ian G.; Matheson, Nicholas J.; Sato, Kei; Gupta, Ravindra K.			Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity	NATURE			English	Article							ACE2; VISUALIZATION; PERFORMANCE; ALIGNMENT; RECEPTOR; L452R	The SARS-CoV-2 Omicron BA.1 variant emerged in 2021(1) and has multiple mutations in its spike protein(2). Here we show that the spike protein of Omicron has a higher affinity for ACE2 compared with Delta, and a marked change in its antigenicity increases Omicron's evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutralizing antibodies after two doses. mRNA vaccination as a third vaccine dose rescues and broadens neutralization. Importantly, the antiviral drugs remdesivir and molnupiravir retain efficacy against Omicron BA.1. Replication was similar for Omicron and Delta virus isolates in human nasal epithelial cultures. However, in lung cells and gut cells, Omicron demonstrated lower replication. Omicron spike protein was less efficiently cleaved compared with Delta. The differences in replication were mapped to the entry efficiency of the virus on the basis of spike-pseudotyped virus assays. The defect in entry of Omicron pseudotyped virus to specific cell types effectively correlated with higher cellular RNA expression of TMPRSS2, and deletion of TMPRSS2 affected Delta entry to a greater extent than Omicron. Furthermore, drug inhibitors targeting specific entry pathways(3) demonstrated that the Omicron spike inefficiently uses the cellular protease TMPRSS2, which promotes cell entry through plasma membrane fusion, with greater dependency on cell entry through the endocytic pathway. Consistent with suboptimal S1/S2 cleavage and inability to use TMPRSS2, syncytium formation by the Omicron spike was substantially impaired compared with the Delta spike. The less efficient spike cleavage of Omicron at S1/S2 is associated with a shift in cellular tropism away from TMPRSS2-expressing cells, with implications for altered pathogenesis.	[Meng, Bo; Abdullahi, Adam; Ferreira, Isabella A. T. M.; Goonawardane, Niluka; Gerber, Pehuen Pereyra; Kemp, Steven A.; Smith, Kenneth G. C.; Mlcochova, Petra; Sampaziotis, Fotios; Matheson, Nicholas J.; Gupta, Ravindra K.] Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England; [Meng, Bo; Abdullahi, Adam; Ferreira, Isabella A. T. M.; Goonawardane, Niluka; Gerber, Pehuen Pereyra; Kemp, Steven A.; Brevini, Teresa; Smith, Kenneth G. C.; Bradley, John; Mlcochova, Petra; Sampaziotis, Fotios; Matheson, Nicholas J.; Gupta, Ravindra K.] Univ Cambridge, Dept Med, Cambridge, England; [Saito, Akatsuki] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan; [Kimura, Izumi; Yamasoba, Daichi; Sato, Kei] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Infect Dis Control,Div Syst Virol, Tokyo, Japan; [Fatihi, Saman; Rathore, Surabhi; Thukral, Lipi] CSIR Inst Genom & Integrat Biol, Delhi, India; [Zepeda, Samantha K.; Bowen, John E.; Joshi, Anshu; Walls, Alexandra C.; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Papa, Guido; Mallery, Donna L.; James, Leo C.] MRC Lab Mol Biol, Cambridge, England; [Ikeda, Terumasa] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan; [Toyoda, Mako; Tan, Toong Seng; Ueno, Takamasa] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Infect & Immun, Kumamoto, Japan; [Kuramochi, Jin] Kuramochi Clin Interpk, Utsunomiya, Tochigi, Japan; [Mitsunaga, Shigeki] Natl Inst Genet, Human Genet Lab, Mishima, Shizuoka, Japan; [Shirakawa, Kotaro; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Charles, Oscar J.] UCL, Div Infect & Immun, London, England; [Walls, Alexandra C.; Hosmillo, Myra; Goodfellow, Ian G.] Univ Cambridge, Dept Virol, Cambridge, England; [Jackson, Laurelle; Sigal, Alex; Gupta, Ravindra K.] Africa Hlth Res Inst, Durban, South Africa; [Martin, Darren] Univ Cape Town, Cape Town, South Africa; [Briggs, John A. G.] Max Planck Inst Biochem, Martinsried, Germany; [Choi, Jinwook; Lee, Joo Hyeon; Sampaziotis, Fotios] Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England; [Madissoon, Elo; Meyer, Kerstin B.; Teichmann, Sarah A.] Welcome Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Madissoon, Elo] EMBL EBI, European Mol Biol Lab, European Bioinformat Inst, Wellcome Trust Genome Campus, Hinxton, England; [Ceron-Gutierrez, Lourdes; Doffinger, Rainer; Sampaziotis, Fotios; Matheson, Nicholas J.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Biomed Campus, Cambridge, England; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Fisher, Andrew J.] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Transplant & Regenerat Med Lab, Newcastle Upon Tyne, Tyne & Wear, England; [Pizzuto, Matteo S.; de Marco, Anna; Corti, Davide] Humabs Biomed SA, Bellinzona, Switzerland; [Lee, Joo Hyeon] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Veesler, David] Howard Hughes Med Inst, Seattle, WA USA; [Sigal, Alex] Max Planck Inst Infect Biol, Berlin, Germany; [Sigal, Alex] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Matheson, Nicholas J.] NHS Blood & Transplant, Cambridge, England; [Sato, Kei] Japan Sci & Technol Agcy, CREST, Saitama, Japan	University of Cambridge; University of Miyazaki; University of Tokyo; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Washington; University of Washington Seattle; MRC Laboratory Molecular Biology; Kumamoto University; Kumamoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; University of London; University College London; University of Cambridge; Africa Health Research Institute; University of Cape Town; Max Planck Society; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Newcastle University - UK; University of Cambridge; Howard Hughes Medical Institute; Max Planck Society; University of Kwazulu Natal; Japan Science & Technology Agency (JST)	Gupta, RK (corresponding author), Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England.; Gupta, RK (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Sato, K (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Infect Dis Control,Div Syst Virol, Tokyo, Japan.; Gupta, RK (corresponding author), Africa Hlth Res Inst, Durban, South Africa.; Sato, K (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.	keisato@g.ecc.u-tokyo.ac.jp; rkg20@cam.ac.uk	Maxwell, Patrick H/C-5557-2008; Nakagawa, So/Q-2712-2015; Goonawardane, Niluka/HHS-4988-2022; Tokunaga, Kenzo/Q-9914-2018; Ueno, Takamasa/AAW-9491-2020; Veesler, David/HCH-3986-2022; Trueba, Gabriel/F-9707-2015; Summers, Charlotte/A-6973-2012	Maxwell, Patrick H/0000-0002-0338-2679; Nakagawa, So/0000-0003-1760-3839; Goonawardane, Niluka/0000-0003-2906-5513; Tokunaga, Kenzo/0000-0002-2625-5322; Ueno, Takamasa/0000-0003-4852-4236; Krishna, Benjamin/0000-0003-0919-2961; Trueba, Gabriel/0000-0003-2617-9021; Ikeda, Terumasa/0000-0003-2869-9450; Rathore, Surabhi/0000-0002-3137-6006; Walker, Neil/0000-0001-9796-7688; Kuramochi, Jin/0000-0002-9078-0527; Kemp, Steven/0000-0001-7077-6793; Summers, Charlotte/0000-0002-7269-2873; Kingston, Nathalie/0000-0002-9190-2231; Jackson, Laurelle/0000-0003-3235-2468; Becerra Wong, Monica/0000-0002-0028-2832; Munoz, Erika/0000-0001-5737-4263; Abdullahi, Adam/0000-0001-9703-8264; ANDRADE MOLINA, DERLY MADELEINY/0000-0002-2651-5884; Cardenas, Paul/0000-0001-9626-4489; Charles, Oscar/0000-0003-2578-5193; Potts, Martin/0000-0002-6738-0066	Wellcome Trust Senior Fellowship in Clinical Science [WT108082AIA]; Cambridge NIHRB Biomedical Research Centre; SANTHE award [DEL-15-006]; Africa Research Excellence Fund Research Development Fellowship [AREF-318-ABDUL-F-C0882]; MRC (TSF) [MR/T032413/1]; NHSBT [WPA15-02]; Addenbrooke's Charitable Trust [900239]; G2P-UK National Virology consortium - MRC/UKRI [MR/W005611/1]; The Rosetrees Trust; Geno2pheno UK consortium; EPSRC [EP/V002910/1]; AMED Research Program on Emerging and Re-emerging Infectious Diseases [20fk0108270, 20fk0108413, 20fk0108163, 20fk0108146, 20fk0108451]; JST SICORP [JPMJSC20U1, JPMJSC21U5]; JST CREST [JPMJCR20H4]; AMED Research Program on HIV/AIDS [21fk0410033, 21fk0410039]; AMED Japan Program for Infectious Diseases Research and Infrastructure [20wm0325009, 21wm0325009]; JST A-STEP [JPMJTM20SL]; JST SICORP (e-ASIA) [JPMJSC20U1]; JSPS KAKENHI [19K06382, 18H02662, 21H02737]; JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) [18KK0447]; JSPS [JPJSCCA20190008, DC1 19J20488]; JSPS Leading Initiative for Excellent Young Researchers (LEADER); Takeda Science Foundation; Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Grant for Joint Research Projects of the Research Institute for Microbial Diseases, Osaka University; intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University; National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C]; Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Fast Grants; Bill and Melinda Gates Foundation [OPP1156262]; EASL Juan Rodes fellowship; UKRI Future Leaders fellowship; Bill and Melinda Gates award [INV-018944]; National Institutes of Health [R01 AI138546]	Wellcome Trust Senior Fellowship in Clinical Science(Wellcome Trust); Cambridge NIHRB Biomedical Research Centre; SANTHE award; Africa Research Excellence Fund Research Development Fellowship; MRC (TSF); NHSBT; Addenbrooke's Charitable Trust; G2P-UK National Virology consortium - MRC/UKRI; The Rosetrees Trust(Rosetrees Trust); Geno2pheno UK consortium; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AMED Research Program on Emerging and Re-emerging Infectious Diseases; JST SICORP; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED Research Program on HIV/AIDS; AMED Japan Program for Infectious Diseases Research and Infrastructure; JST A-STEP; JST SICORP (e-ASIA); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Leading Initiative for Excellent Young Researchers (LEADER); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation; Mitsubishi Foundation; Shin-Nihon Foundation of Advanced Medical Research; Grant for Joint Research Projects of the Research Institute for Microbial Diseases, Osaka University; intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE); Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS; Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Fast Grants; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EASL Juan Rodes fellowship; UKRI Future Leaders fellowship(UK Research & Innovation (UKRI)); Bill and Melinda Gates award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Lehner for Calu-3 cells; J. Voss for HeLa ACE2; S. Cook for H1299 and S. Rihn for the A549-ACE2/TMPRSS2 cells; G. Screaton for the Omicron isolate M21021166; C. Cormie for microscope training; A. Albecka for advice on SARS-CoV2 virion purification; K. Khan for work on foci; T. de Silva for the Delta variant isolate; all of the members belonging to The Genotype to Phenotype Japan (G2P-Japan) Consortium; the staff at the National Institute for Infectious Diseases, Japan and H. Arase (Osaka University, Japan) for providing virus isolates and reagents; and the staff at Ituro Inoue and Sachiko Sakamoto (National Institute of Genetics, Japan) for technical support. R.K.G. is supported by a Wellcome Trust Senior Fellowship in Clinical Science (WT108082AIA). I.G. is a Wellcome Senior Fellow (207498/Z/17/Z). This study was supported by the Cambridge NIHRB Biomedical Research Centre. I.A.T.M.F. is funded by a SANTHE award (DEL-15-006). A.A. is supported by a Africa Research Excellence Fund Research Development Fellowship (AREF-318-ABDUL-F-C0882). This work was supported by the MRC (TSF, MR/T032413/1 to N.J.M.), NHSBT (WPA15-02 to N.J.M.), Addenbrooke's Charitable Trust (900239 to N.J.M.). The authors acknowledge support from the G2P-UK National Virology consortium funded by MRC/UKRI (MR/W005611/1) and thank T. Peacock and W. Barclay. This study was also supported by The Rosetrees Trust and the Geno2pheno UK consortium. S.F. acknowledges the EPSRC (EP/V002910/1). K. Sato is supported by AMED Research Program on Emerging and Re-emerging Infectious Diseases (20fk0108270 and 20fk0108413), JST SICORP (JPMJSC20U1 and JPMJSC21U5) and JST CREST (JPMJCR20H4). This study was supported in part by AMED Research Program on Emerging and Re-emerging Infectious Diseases 20fk0108163 (to A. Saito), 20fk0108146 (to K. Sato), 20fk0108270 (to K. Sato), 20fk0108413 (to T. Ikeda and K. Sato) and 20fk0108451 (to A. Saito, T. Ikeda, T.U., A.T.-K., the G2P-Japan Consortium and K. Sato); the AMED Research Program on HIV/AIDS 21fk0410033 (to A. Saito) and 21fk0410039 (to K. Sato); the AMED Japan Program for Infectious Diseases Research and Infrastructure 20wm0325009 (to A. Saito) and 21wm0325009 (to A. Saito); JST A-STEP JPMJTM20SL (to T. Ikeda); JST SICORP (e-ASIA) JPMJSC20U1 (to K. Sato); JST SICORP JPMJSC21U5 (to K. Sato), JST CREST JPMJCR20H4 (to K. Sato); JSPS KAKENHI Grant-in-Aid for Scientific Research C 19K06382 (to A. Saito), Scientific Research B 18H02662 (to K. Sato) and 21H02737 (to K. Sato); JSPS Fund for the Promotion of Joint International Research (Fostering Joint International Research) 18KK0447 (to K. Sato); the JSPS Core-to-Core Program JPJSCCA20190008 (A. Advanced Research Networks) (to K. Sato); JSPS Research Fellow DC1 19J20488 (to I.K.); the JSPS Leading Initiative for Excellent Young Researchers (LEADER) (to T. Ikeda); the Takeda Science Foundation (to T. Ikeda); the Tokyo Biochemical Research Foundation (to K. Sato); the Mitsubishi Foundation (to T. Ikeda); the Shin-Nihon Foundation of Advanced Medical Research (to T. Ikeda); a Grant for Joint Research Projects of the Research Institute for Microbial Diseases, Osaka University (to A. Saito); an intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE) (to T. Ikeda); the Intercontinental Research and Educational Platform Aiming for Eradication of HIV/AIDS (toT. Ikeda); and the Joint Usage/Research Center program of Institute for Frontier Life and Medical Sciences, Kyoto University (to K. Sato).; This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.), a Pew Biomedical Scholars Award (to D.V.), an Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (to D.V.), Fast Grants (to D.V.) and the Bill and Melinda Gates Foundation (OPP1156262 to D.V.). D.V. is an Investigator of the Howard Hughes Medical Institute. T.B. is supported by an EASL Juan Rodes fellowship. F.S. was supported by a UKRI Future Leaders fellowship. A. Sigal. was supported by the Bill and Melinda Gates award INV-018944, National Institutes of Health award R01 AI138546 and a South African Medical Research Council award 6084-CO-AP-2020. S.K.Z. was supported by the National Institute of General Medical Sciences (5T32GM008268-32). Studies using human donor lung tissue were supported by the NIHR Blood and Transplant Research Unit (BTRU) in Organ Donation and Transplantation at Newcastle University and the University of Cambridge and in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the author(s) and not necessarily those of the NIHR, the Department of Health and Social Care or NHSBT. We thank NIHR BioResource volunteers for their participation, and gratefully acknowledge NIHR BioResource centres, NHS Trusts and staff for their contribution. We thank the National Institute for Health Research, NHS Blood and Transplant, and Health Data Research UK as part of the Digital Innovation Hub Programme. The work was partly funded by awards from NIHR to the NIHR BioResource (RG94028 & RG85445)	Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braga L, 2021, NATURE, V594, P88, DOI 10.1038/s41586-021-03491-6; Brevini T., 2021, FXR INHIBITION REDUC, DOI [10.1101/2021.06.06.446781, DOI 10.1101/2021.06.06.446781]; Buchrieser J, 2021, EMBO J, V40, DOI 10.15252/embj.2020107405; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cathcart AL, 2021, DUAL FUNCTION MONOCL, DOI [10.1101/2021.03.09.434607, DOI 10.1101/2021.03.09.434607, 10.1101/2021.03.09. 434607]; Cattin-Ortola JM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25589-1; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chen SF, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3280-9; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Ferreira IATM, 2021, J INFECT DIS, V224, P989, DOI 10.1093/infdis/jiab368; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gerber PP, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1010265; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Itokawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239403; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura I, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2021.110218; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MADISSOON E, 1800, SPATIAL MULTIOMICS A; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; McCallum M, 2022, SCIENCE, V375, P864, DOI 10.1126/science.abn8652; McCallum M, 2021, SCIENCE, V374, P1621, DOI [10.1126/science.abl8506, 10.1101/2021.08.11.455956]; Meng B, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109292; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Mlcochova P, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100099; Motozono C, 2021, CELL HOST MICROBE, V29, P1124, DOI 10.1016/j.chom.2021.06.006; Mousavizadeh L, 2021, J MICROBIOL IMMUNOL, V54, P159, DOI 10.1016/j.jmii.2020.03.022; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ou TL, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009212; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w; Pommerenke C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255622; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Salahudeen AA, 2020, NATURE, V588, P670, DOI 10.1038/s41586-020-3014-1; Shuai HP, 2022, NATURE, V603, P693, DOI 10.1038/s41586-022-04442-5; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Viana R., NATURE, DOI [10.1038/s41586-022-04411-y (2022, DOI 10.1038/S41586-022-04411-Y(2022]; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4; Youk J, 2020, CELL STEM CELL, V27, P905, DOI 10.1016/j.stem.2020.10.004	54	183	183	47	121	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					706	+		10.1038/s41586-022-04474-x	http://dx.doi.org/10.1038/s41586-022-04474-x		FEB 2022	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35104837	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000769826200002
J	Sallnow, L; Smith, R; Ahmedzai, SH; Bhadelia, A; Chamberlain, C; Cong, YL; Doble, B; Dullie, L; Durie, R; Finkelstein, EA; Guglani, S; Hodson, M; Husebo, BS; Kellehear, A; Kitzinger, C; Knaul, FM; Murray, SA; Neuberger, J; O'Mahony, S; Rajagopal, MR; Russell, S; Sase, E; Sleeman, KE; Solomon, S; Taylor, R; van Furth, MT; Wyatt, K; Blazeby, J; Bleakley, T; Gafer, N; Johnson, M; Kitzinger, J; Kraus, A				Sallnow, Libby; Smith, Richard; Ahmedzai, Sam H.; Bhadelia, Afsan; Chamberlain, Charlotte; Cong, Yali; Doble, Brett; Dullie, Luckson; Durie, Robin; Finkelstein, Eric A.; Guglani, Sam; Hodson, Melanie; Husebo, Bettina S.; Kellehear, Allan; Kitzinger, Celia; Knaul, Felicia Marie; Murray, Scott A.; Neuberger, Julia; O'Mahony, Seamus; Rajagopal, M. R.; Russell, Sarah; Sase, Eriko; Sleeman, Katherine E.; Solomon, Sheldon; Taylor, Ros; van Furth, Mpho Tutu; Wyatt, Katrina; Blazeby, Jane; Bleakley, Tracey; Gafer, Nahla; Johnson, Malcolm; Kitzinger, Jenny; Kraus, Arnoldo		Lancet Commission Value Death	Report of the Lancet Commission on the Value of Death: bringing death back into life	LANCET			English	Review							LIVERPOOL CARE PATHWAY; OF-LIFE; PALLIATIVE CARE; INTENSIVE-CARE; LAST YEAR; TERMINALLY-ILL; UNITED-STATES; MEDICARE PAYMENTS; HEALTH OUTCOMES; OLDER-PEOPLE		[Sallnow, Libby] St Christophers Hosp, London SE26 6DZ, England; [Smith, Richard] UK Hlth Alliance Climate Change, London, England; [Ahmedzai, Sam H.] Univ Sheffield, Sheffield, S Yorkshire, England; [Bhadelia, Afsan] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Chamberlain, Charlotte] Univ Bristol Sch Med, Bristol, Avon, England; [Cong, Yali] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China; [Doble, Brett; Finkelstein, Eric A.] Duke NUS Med Sch, Singapore, Singapore; [Dullie, Luckson] Univ Malawi, Blantyre, Malawi; [Durie, Robin; Wyatt, Katrina] Univ Exeter, Exeter, Devon, England; [Guglani, Sam] Gloucestershire Hosp, Cheltenham, Glos, England; [Hodson, Melanie] Hosp UK, London, England; [Husebo, Bettina S.] Univ Bergen, Bergen, Norway; [Kellehear, Allan] Univ Vermont, Burlington, VT USA; [Kitzinger, Celia] Cardiff Univ, Cardiff, Wales; [Knaul, Felicia Marie] Univ Miami, Miami, FL USA; [Murray, Scott A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Neuberger, Julia] Univ Coll London Hosp NHS Fdn Trust, London, England; [O'Mahony, Seamus; Sleeman, Katherine E.] Kings Coll London, London, England; [Rajagopal, M. R.] Pallium India, Thiruvananthapuram, Kerala, India; [Russell, Sarah] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England; [Sase, Eriko] Georgetown Univ, Washington, DC USA; [Solomon, Sheldon] Skidmore Coll, Saratoga Springs, NY 12866 USA; [Taylor, Ros] Harlington Hosp, London, England	University of Sheffield; Harvard University; Harvard T.H. Chan School of Public Health; University of Bristol; Peking University; National University of Singapore; University of Malawi; University of Exeter; University of Bergen; University of Vermont; Cardiff University; University of Miami; University of Edinburgh; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; King's College London; Georgetown University; Skidmore College	Sallnow, L (corresponding author), St Christophers Hosp, London SE26 6DZ, England.	libby.sallnow@nhs.net	Sase, Eriko/HCJ-0175-2022; Gafer, Nahla/GWR-2114-2022; Sallnow, Libby/ABF-2995-2021	Sallnow, Libby/0000-0001-7079-9637; Sleeman, Katherine/0000-0002-9777-4373; Knaul, Felicia/0000-0002-0512-4788; Wyatt, Katrina/0000-0001-7099-159X; Husebo, Bettina Sandgathe/0000-0002-6037-2864	West of England (Bath); West of England (Bristol); West of England (Cardiff); West of England (Exeter); Rockefeller Foundation; Abe Fellowship; Cicely Saunders International; Kirby Laing Foundation; GW4	West of England (Bath); West of England (Bristol); West of England (Cardiff); West of England (Exeter); Rockefeller Foundation; Abe Fellowship; Cicely Saunders International; Kirby Laing Foundation; GW4	The Commission received funding from GW4--the four universities of the West of England (Bath, Bristol, Cardiff, and Exeter)--to hold a meeting in Bristol, UK, and from the Rockefeller Foundation, which funded a meeting of the Commission at Bellagio, Italy. The National Institute for Health Research Bristol Biomedical Research Centre (Jane Blazeby) provided administrative support, and St Christopher's Hospice supported LS in writing up the manuscript. The Abe Fellowship supported ES's participatation in the Commission. KES is the Laing Galazka Chair in palliative care at King's College London, funded by an endowment from Cicely Saunders International and the Kirby Laing Foundation. We thank GW4, the Rockefeller Foundation, and Jane Blazeby for funding; Carol Davies for executive assistance; and the following for material that was used in preparing the report: T Baker, M J Bates, T Bleakley, L Hawryluck, J Hughes, Intensive Care National Audit and Research Centre, P W Keeley, R K Kayambankadzanja, A Kraus, D Miller, C Morris, E Namisango, L C Quigley, C O Schell, T Walter, I Williams, and N Yamaguchi.	Abarshi E, 2010, AGE AGEING, V39, P716, DOI 10.1093/ageing/afq097; Abbafati C, 2020, LANCET, V396, P1135, DOI 10.1016/S0140-6736(20)31404-5; Abbasi J, 2020, JAMA-J AM MED ASSOC, V324, P427, DOI 10.1001/jama.2020.11672; Abel Julian, 2020, Palliat Care Soc Pract, V14, p2632352420934491, DOI 10.1177/2632352420934491; Abercrombie R., 2015, SYSTEMS CHANGE GUIDE; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Alcor Life Extension Foundation, EXT YOUR LIF CRYON; Aldridge MD, 2015, AM J PUBLIC HEALTH, V105, P2411, DOI 10.2105/AJPH.2015.302889; All Party Parliamentary Group for Longevity, 2020, HLTH NAT STRAT HEALT; Angelis A, 2018, EUR J HEALTH ECON, V19, P123, DOI 10.1007/s10198-017-0871-0; [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30822-9; [Anonymous], 2020, PROG PALLIAT CARE, V28, P123; Aoun SM, 2019, DEATH STUD, V43, P619, DOI 10.1080/07481187.2018.1506835; Aragon MJ, 2016, FISC STUD, V37, P405, DOI 10.1111/j.1475-5890.2016.12102; Aries P, W ATTITUDES DEATH MI; Ashton J., 1986, Health Promotion, V1, P319, DOI 10.1093/heapro/1.3.319; Attridge C., 2018, BMJ SUPPORT PALLIAT, V8, P36; Badger F, 2012, INT J NURS STUD, V49, P586, DOI 10.1016/j.ijnurstu.2011.10.021; Baloyi L, 2014, SUSTAINABLE DEV NURT; Barilan YM, 2007, PERSPECT BIOL MED, V50, P557, DOI 10.1353/pbm.2007.0042; Becker Ernest, 1973, DENIAL DEATH; Becker G., 2007, 13333 NAT BUR EC RES; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bleakley T, 2019, LANCET, V393, P387, DOI 10.1016/S0140-6736(19)30201-6; Braganza MA, 2017, BJA EDUC, V17, P396, DOI 10.1093/bjaed/mkx031; Bristowe K, 2015, PALLIATIVE MED, V29, P797, DOI 10.1177/0269216315578990; Brodwin E., 2006, BUSINESS INSIDE 0406; Brown GK, 2005, AM J PSYCHIAT, V162, P1977, DOI 10.1176/appi.ajp.162.10.1977; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Burrell A, 2022, OMEGA-J DEATH DYING, V85, P345, DOI 10.1177/0030222820941296; Buyum AM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003394; Calfo S., 2015, LAST YEAR LIFE STUDY; Cardona-Morrell M, 2016, INT J QUAL HEALTH C, V28, P456, DOI 10.1093/intqhc/mzw060; Care Quality Commission, 2021, PROT RESP CONN DEC L; Cassell E.J., 2004, NATURE SUFFERING GOA; Cave S., 2013, IMMORTALITY QUEST LI; Chan CA, 2016, ASIA COMMUN PHOTON; Chen CH, 2017, PALLIATIVE MED, V31, P406, DOI 10.1177/0269216316663976; Chochinov HM, 2007, J PAIN SYMPTOM MANAG, V34, P463, DOI 10.1016/j.jpainsymman.2006.12.012; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chu C, 2019, CLIN MED, V19, P306, DOI 10.7861/clinmedicine.19-4-306; Clark AW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1375; Clark D, 2014, PROJECT DEATH AM 20; Cloyes KG, 2018, SEMIN ONCOL NURS, V34, P60, DOI 10.1016/j.soncn.2017.12.003; Cognitive Functioning and Aging Study, COGN FUNCT AG STUD; Collective for Radical Death Studies, 2021, CRDS; Conrad P, 2007, MED SOC; Cooke R, 2020, GUARDIAN 0705; Costantini M, 2014, LANCET, V383, P226, DOI 10.1016/S0140-6736(13)61725-0; Cottam H., 2018, RADICAL HELP WE CAN; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1, P139, DOI DOI 10.4324/9780429500480-5; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Croucher K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244058; Cutler DM, 2000, HANDB ECON, V17, P563; da Cruz VM, 2015, AM J HOSP PALLIAT ME, V32, P329, DOI 10.1177/1049909113518269; Dead Social, DEAD SOC SERV WE; Diagne Souleymane Bachir, 2004, COMPANION AFRICAN PH; Digital Legacy Association, DIG LEG ASS; Dignitas, DAT DEATHS DIGN; Divatia JV, 2020, INDIAN J CRIT CARE M, V24, P375, DOI 10.5005/jp-journals-10071-23496; Doka K.J., 1989, DISENFRANCHISED GRIE; Doughty C., 2017, HERE ETERNITY TRAVEL; Durie R, 2007, SOC SCI MED, V65, P1928, DOI 10.1016/j.socscimed.2007.05.039; Durie R, 2013, CRIT PUBLIC HEALTH, V23, P174, DOI 10.1080/09581596.2013.781266; Economist Intelligence Unit, 2015, QUAL DEATH RANK END; Ehrenreich B., 2010, GUARDIAN 0102; Eil D, 2011, AM ECON J-MICROECON, V3, P114, DOI 10.1257/mic.3.2.114; EMANUEL EJ, 1994, NEW ENGL J MED, V330, P540, DOI 10.1056/NEJM199402243300806; End of Life Doula UK, WHAT IS END LIF DOUL; Epicurus B., 1994, THE EPICURUS READER; Erlangsen A, 2017, JAMA PSYCHIAT, V74, P456, DOI 10.1001/jamapsychiatry.2017.0226; Evans CJ, 2019, MILBANK Q, V97, P113, DOI 10.1111/1468-0009.12373; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferrando-Vivas P, 2017, J CRIT CARE, V38, P335, DOI 10.1016/j.jcrc.2016.11.031; Finkelstein EA, 2021, PSYCHO-ONCOLOGY, V30, P780, DOI 10.1002/pon.5675; Fleming J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150686; Foster GL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14845; Foucault M, 1963, BIRTH CLIN ARCHAEOLO; Fowler PJ, 2019, ANNU REV PUBL HEALTH, V40, P465, DOI 10.1146/annurev-publhealth-040617-013553; French EB, 2017, HEALTH AFFAIR, V36, P1211, DOI 10.1377/hlthaff.2017.0174; Friedson E, 2006, PROFESSIONAL DOMINAN; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gafaar TO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233494; Gambles M, 2006, INT J PALLIAT NURS, V12, P414, DOI 10.12968/ijpn.2006.12.9.21869; Gandhi MK., 2009, MY EXPT TRUTH; Gawande Atul, 2015, BEING MORTAL ILLNESS; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Glaser BG, 1965, AWARENESS DYING; Goffman E., 1961, ASYLUMS; Goleman H, 2016, TRICYCLE; Government of Canada, 2019, 4 INT REP MED ASS DY; GREENWALD AG, 1980, AM PSYCHOL, V35, P603, DOI 10.1037//0003-066X.35.7.603; Guy Maytal, 2006, Prim Care Companion J Clin Psychiatry, V8, P299; Hakkinen U, 2008, HEALTH ECON POLICY L, V3, P165, DOI 10.1017/S174413310800443X; Harari YN., 2020, GUARDIAN 0420; Harding R, 2008, J PAIN SYMPTOM MANAG, V36, P304, DOI 10.1016/j.jpainsymman.2008.04.008; Harper S, 2021, ANNU REV PUBL HEALTH, V42, P381, DOI 10.1146/annurev-publhealth-082619-104231; Hasson F, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-0520-8; Hauskeller M., 2012, INT J MACHINE CONSCI, V4, P187; Hay K, 2019, LANCET, V393, P2535, DOI 10.1016/S0140-6736(19)30648-8; Healthcare Without Harm, 2019, HEALTHC CARB FOOTPR; Heidegger M., 1927, BEING TIME; Hendrich Ann, 2008, Perm J, V12, P25; Higginson IJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-111; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; HINTON JM, 1963, Q J MED, V32, P1; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Holt-Lunstad J, 2017, AM PSYCHOL, V72, P517, DOI 10.1037/amp0000103; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Horsfall D, 2013, PROG PALLIAT CARE, V21, P331, DOI 10.1179/1743291X12Y.0000000047; Horsfall D, 2012, HEALTH SOCIOL REV, V21, P373, DOI 10.5172/hesr.2012.21.4.373; Horton Helena, 2016, TELEGRAPH; House of Commons Public Accounts Committee, 2021, COVID 19 GOV PROC SU; Hsieh JG, 2012, TZU CHI MED J, V24, P12, DOI 10.1016/j.tcmj.2012.02.004; Huang CY, 2020, J PALLIAT MED, V23, P747, DOI 10.1089/jpm.2020.0026; Hungerford TL, 2001, GERONTOLOGIST, V41, P103, DOI 10.1093/geront/41.1.103; Illich I, 1975, LIMITS MED; Institute for Advanced Study of the Americas, 2015, BURD SER HLTH REL SU; Institute of Medicine Food and Nutrition Board, 2012, NUTR HLTH AG COMM WO; Institute of Palliative Medicine, KER CUR FEST; Intensive Care National Audit and Research Centre, INT CAR NAT AUD RES; International Labor Organisation, 2017, WORLD EMPL SOC OUTL; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Jagger C, 2016, LANCET, V387, P779, DOI 10.1016/S0140-6736(15)00947-2; Jain V., 2018, J MAHATMA GANDHI I M, V23, P55; Jimenez G, 2018, J PAIN SYMPTOM MANAG, V56, P436, DOI 10.1016/j.jpainsymman.2018.05.016; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Juthani-Mehta M, 2015, JAMA-J AM MED ASSOC, V314, P2017, DOI 10.1001/jama.2015.13080; Kahane A., 2012, TRANSFORMATIVE SCENA; Kapadia F, 2005, CRIT CARE MED, V33, P1272, DOI 10.1097/01.CCM.0000165557.02879.29; Karar ZA, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1904; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Kastenbaum R., 1977, DEATH SOC HUMAN EXPE; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kellehear A., 2014, INNER LIFE DYING PER; Kellehear A., IN PRESS; Kellehear A., 2005, COMPASSIONATE CITIES; Kellehear A, 2020, PROG PALLIAT CARE, V28, P115, DOI 10.1080/09699260.2019.1701835; Kellehear A, 2016, ROUT KEY THEME HEALT, P76; Kennedy C, 2014, BMJ SUPPORT PALLIAT, V4, P263, DOI 10.1136/bmjspcare-2013-000621; Khan H, 2018, CHANGE POWER HLTH; Khan Luluel, 2010, Cancer J, V16, P524, DOI 10.1097/PPO.0b013e3181f45b90; Kim Do Yeun, 2006, Cancer Res Treat, V38, P214, DOI 10.4143/crt.2006.38.4.214; King's Fund, 2021, WHAT IS HAPP LIF EXP; Kinley J, 2014, AGE AGEING, V43, P375, DOI 10.1093/ageing/aft158; Kitzinger J., 2017, INT J MENTAL HLTH CA, V129, P84; Klass D., 1996, CONTINUING BONDS NEW; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Kon AA, 2016, CRIT CARE MED, V44, P1769, DOI 10.1097/CCM.0000000000001965; Kremer W., 2017, DISSOLVING DEAD; Kroik L, 2020, MORTALITY-UK, V25, P470, DOI 10.1080/13576275.2020.1715359; Kubler-Ross E., 1969, DEATH DYING; Kumar S, 2020, PROG PALLIAT CARE, V28, P83, DOI 10.1080/09699260.2019.1706272; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Langton JM, 2014, PALLIATIVE MED, V28, P1167, DOI 10.1177/0269216314533813; Leadership Alliance of the Care of Dying People, 2014, PUBL GAT REF; Leng AL, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0426-5; Levinas E., 1995, ALTERITY TRANSCENDEN; Lien Foundation, LIF DEATH; Ling T., 1999, FORESIGHT, V1, P17; Liu YP, 2019, DEATH STUD, V43, P270, DOI 10.1080/07481187.2018.1458760; Lofland LH., 2019, CRAFT DYING; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Luta X., 2020, BMJ SUPPORT PALLIAT, V02; Lyu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181970; Mackinnon Christopher J, 2009, Palliat Support Care, V7, P501, DOI 10.1017/S1478951509990514; Mani RK., 2003, INDIAN J CRIT CARE M, V7, P112; MANNING WG, 1987, AM ECON REV, V77, P251; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Martindale DA, 2005, J CHILD CUSTODY, V2, P31, DOI 10.1300/J190v02n01_03; Matters D, AWARENESS WEEK; Mauss M., 2000, GIFT FORM REASON EXC; Mbiti JS, AFRICAN RELIG PHILOS; McDowell M, 2017, MED INDEPENDENT 0921; MEADOWS D H, 1972, P205; Melberg Hans Olav, 2013, Tidsskr Nor Laegeforen, V133, P841, DOI 10.4045/tidsskr.12.0802; Menkiti IA., 2004, COMPANION AFRICAN PH; Menzies RE, 2020, BEHAV CHANGE, V37, P111, DOI 10.1017/bec.2020.10; Mercadante S, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0574-9; Carrasco JM, 2015, J PAIN SYMPTOM MANAG, V50, P516, DOI 10.1016/j.jpainsymman.2015.04.019; Miles L, 2017, OMEGA-J DEATH DYING, V75, P151, DOI 10.1177/0030222815612602; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Miller-Lewis L, 2020, OMEGA-J DEATH DYING, V81, P242, DOI 10.1177/0030222818765813; Moeke-Maxwell T., 2019, TXB PALLIATIVE CARE; Montaigne Michel de, 2003, COMPLETE WORKS; Montez JK, 2014, AM J PUBLIC HEALTH, V104, pE5, DOI 10.2105/AJPH.2014.302146; Morrison I, 2015, HOSP HEALTH NETWORK; Mtango SE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224355; Mullick A, 2009, PALLIATIVE MED, V23, P571, DOI 10.1177/0269216309106459; Murray SA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j878; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Myburgh J, 2016, J CRIT CARE, V34, P125, DOI 10.1016/j.jcrc.2016.04.017; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2008, BETT WORS REV CAR PA; National Institute for Health and Care Excellence, 2015, CAR DYING AD LAST DA; National Institute for Health and Clinical Excellence, 2014, CONS PAP VAL BAS ASS; National Institute for Health and Clinical Excellence, 2004, GUID METH TECHN APPR; Neuberger J., 2013, MORE CARE LESS PATHW; New JP, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5554; Ngubane S., 2019, DEATH CULTURES DEATH; NHS England, 2020, DEL NET ZER NAT HLTH; Office for National Statistics, LEAD CAUS DEATH UK 2; Oregon Health Authority, DEATH DIGN ACT; Ozer O, 2021, OMEGA-J DEATH DYING, DOI 10.1177/00302228211026169; Paleri AK, 2008, INDIAN J PALLIAT CAR, V14, P51, DOI 10.4103/0973-1075.41936; Pastrana T, 2010, J PAIN SYMPTOM MANAG, V39, P54, DOI 10.1016/j.jpainsymman.2009.05.023; Payne G, 2009, HEALTH POLICY, V90, P270, DOI 10.1016/j.healthpol.2008.09.017; Petersen EE, 2019, MMWR-MORBID MORTAL W, V68, P762, DOI 10.15585/mmwr.mm6835a3; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Pickett J, 2019, LANCET, V394, P1888, DOI 10.1016/S0140-6736(19)32599-1; Pivodic L, 2016, J EPIDEMIOL COMMUN H, V70, P17, DOI 10.1136/jech-2014-205365; Planck M., 1950, SCI AUTOBIOGRAPHY OT; Plato R, 1955, PHAEDO; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; Pope Thaddeus Mason, 2013, J Clin Ethics, V24, P156; Public Health Division Center for Health Statistics, 2020, OR DEATH DIGN ACT 20; Public Health England, 2020, DISP RISK OUTC COVID; Public Health Palliative Care International, CREAT COMP COMM; Radbruch L, 2013, J PALLIAT MED, V16, P301, DOI 10.1089/jpm.2012.0394; Rajagopal MR, 1999, J PALLIATIVE CARE, V15, P44, DOI 10.1177/082585979901500107; Ranchod S, 2015, S AFR ACTUAR J, V15, P31, DOI 10.4314/saaj.v15i1.2; Raphael B., 1983, ANATOMY BEREAVEMENT; Rawlings D, 2019, HEALTH SOC CARE COMM, V27, pE82, DOI 10.1111/hsc.12660; Rawls John, 1993, LAW PEOPLES; Rhoods S, 2018, LEARN PUBL, V31, P254, DOI 10.1002/leap.1152; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Rodin G, 2007, J PAIN SYMPTOM MANAG, V33, P661, DOI 10.1016/j.jpainsymman.2006.09.034; Rodriguez-Prat A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016659; Royal College of Physicians, 2018, TALKING DYING BEGIN; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Russell S., 2019, ARE CARE HOMES HOSPI; Ryan S, 2020, CURR TREAT OPTION ON, V21, DOI 10.1007/s11864-020-0716-4; Sallnow ES., 2018, THESIS U EDINBURGH; Sallnow L, 2005, INDIAN J PALLIAT CAR, V11, P10, DOI 10.4103/0973-1075.16638; Sands MB, 2015, OXFORD TXB PALLIATIV, P1; Saunders C, 1996, BRIT MED J, V313, P1599, DOI 10.1136/bmj.313.7072.1599; Selvaraj S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018020; Sen A., 2005, J HUMAN DEV, V6, P151, DOI DOI 10.1080/14649880500120491; Seneca J W., 1932, MORAL ESSAYS, V254; Shah KK, 2018, SOC SCI MED, V204, P39, DOI 10.1016/j.socscimed.2018.03.010; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Shepherd A, 2019, BMJ, V365; Shimizu M, 2008, BASIC APPL SOC PSYCH, V30, P36, DOI 10.1080/01973530701866482; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Sibanda P, 2014, DIMENSIONS-NBS, V4, P26; Sikora K, 2017, BBC NEWSNIGHT 0222; Sleeman K, 2018, BMJ OPINION; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Sleeman KE, 2018, PALLIATIVE MED, V32, P1474, DOI 10.1177/0269216318786333; Sleeman KE, 2012, LANCET, V379, P519, DOI 10.1016/S0140-6736(12)60230-X; Smith R., 2020, BMJ OPINION; Smith R., 2012, BMJ OPINION; Smith S, 2014, PALLIATIVE MED, V28, P130, DOI 10.1177/0269216313493466; Solomon Sheldon, 2015, WORM CORE ROLE DEATH; Span P, 2016, NEW YORK TIMES; Springer, BIOGERONTOLOGY; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stooker T, 2001, INQUIRY-J HEALTH CAR, V38, P73, DOI 10.5034/inquiryjrnl_38.1.73; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; SunLife, COST DYING 2021 REP; SunLife, COST DYING WORLD; Sustainable Healthcare Coalition, SUSTAINABLE CARE PAT; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Tataryn D, 2002, PSYCHOSOMATICS, V43, P370, DOI 10.1176/appi.psy.43.5.370; The Loomba Foundation, 2016, WORLD WID REP, V1; Tomer A, 1996, DEATH STUD, V20, P343, DOI 10.1080/07481189608252787; Tonkin L, 1996, BEREAVE CARE, V15, P10, DOI DOI 10.1080/02682629608657376; Toolis K., 2018, MY FATHERS WAKE; Tutu D., 2000, NO FUTURE FORGIVENES; UCL Institute of Global Equity, 2021, BUILD BACK FAIR GREA; UK Clinical Research Collaboration, 2015, IGN OUR POT; UK Health Alliance for Climate Change, 2021, CALL ACT; Umberson D, 2017, P NATL ACAD SCI USA, V114, P915, DOI 10.1073/pnas.1605599114; UN, 2015, SUSTAINABLE DEV GOAL; United Nations, 2019, WORLD MORT REP; van der Heide A, 2010, J PAIN SYMPTOM MANAG, V39, P33, DOI 10.1016/j.jpainsymman.2009.05.018; van Wijngaarden E, 2015, SOC SCI MED, V138, P257, DOI 10.1016/j.socscimed.2015.05.015; Veerbeek L, 2008, PALLIATIVE MED, V22, P145, DOI 10.1177/0269216307087164; Vijay D, 2018, WELLCOME OPEN RES; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; WHO, 2018, ASTANA DECLARATION P; WHO, 2014, WHA 19 STRENGTH PALL; WHO, 2020, DEC HLTH AG; WHO. World Bank, 2019, GLOB MON REP FIN PRO; Wight R, 2004, SHORT HIST PROGR; Wilkinson D, 2019, AM J BIOETHICS, V19, P21, DOI 10.1080/15265161.2019.1574465; Williams H, LESBIAN GAY BISEXUAL; Williams R, 2020, LANCET, V395, P226, DOI 10.1016/S0140-6736(19)32908-3; Woolf SH, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1343; World Bank, CAUS DEATH COMM DIS; World Bank, 2019, MATERNAL MORTALITY R; World Health Organization, 2016, SUIC RAT EST AG STAN; World Health Organization, 2016, NCD MORT MORB; World Health Organization, 2017, CLIN CRIT DET DEATH; World Health Organization, PALL CAR; World Health Organization (WHO), SOCIAL DETERMINANTS; World Health Organization (WHO), DEF PALL CAR; World Population Review, GIN COEFF COUNTR 202; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yadav S, 2020, SUPPORT CARE CANCER, V28, P4561, DOI 10.1007/s00520-020-05512-y; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Zaman M, 2021, LANCET HEALTH LONGEV, V2, pE593, DOI 10.1016/S2666-7568(21)00097-0; Zeckhauser R, 2009, 200903 HARV ENV EC P, P116	310	47	48	13	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					837	884		10.1016/S0140-6736(21)02314-X	http://dx.doi.org/10.1016/S0140-6736(21)02314-X			48	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	35114146	Bronze, Green Published			2022-12-28	WOS:000762307100024
J	Silverman, RF; Hodgson, N				Silverman, Rebecca F.; Hodgson, Nickisa			Orbital Necrotizing Fasciitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Silverman, Rebecca F.; Hodgson, Nickisa] SUNY Downstate Med Ctr, New York, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Silverman, RF (corresponding author), SUNY Downstate Med Ctr, New York, NY 11203 USA.	rebeccafsilverman@gmail.com							0	0	0	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					E10	E10		10.1056/NEJMicm2113033	http://dx.doi.org/10.1056/NEJMicm2113033		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YR1JU	35089665				2022-12-28	WOS:000748300700001
J	Wise, J				Wise, Jacqui			Covid-19: One in 23 people in England had infection in early January	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Elliott P, 2022, POSTPEAK DYNAMICS NA	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o222	10.1136/bmj.o222	http://dx.doi.org/10.1136/bmj.o222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082130	Bronze			2022-12-28	WOS:000748440900017
J	Slomski, A				Slomski, Anita			Surgery Improves Relapsed Ovarian Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					314	314						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076667				2022-12-28	WOS:000753055700033
J	Suran, M				Suran, Melissa			Oncostatin M Cytokine Associated With Chronic Itch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					313	313						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076681				2022-12-28	WOS:000753055700029
J	Halfmann, PJ; Iida, S; Iwatsuki-Horimoto, K; Maemura, T; Kiso, M; Scheaffer, SM; Darling, TL; Joshi, A; Loeber, S; Singh, G; Foster, SL; Ying, BL; Case, JB; Chong, ZL; Whitener, B; Moliva, J; Floyd, K; Ujie, M; Nakajima, N; Ito, M; Wright, R; Uraki, R; Warang, P; Gagne, M; Li, R; Sakai-Tagawa, Y; Liu, YA; Larson, D; Osorio, JE; Hernandez-Ortiz, JP; Henry, AR; Ciuoderis, K; Florek, KR; Patel, M; Odle, A; Wong, LYR; Bateman, AC; Wang, ZD; Edara, VV; Chong, ZL; Franks, J; Jeevan, T; Fabrizio, T; DeBeauchamp, J; Kercher, L; Seiler, P; Gonzalez-Reiche, AS; Sordillo, EM; Chang, LA; van Baker, H; Simon, V; Douek, DC; Sullivan, NJ; Thackray, LB; Ueki, H; Yamayoshi, S; Imai, M; Perlman, S; Webby, RJ; Seder, RA; Suthar, MS; Garcia-Sastre, A; Schotsaert, M; Suzuki, T; Boon, ACM; Diamond, MS; Kawaoka, Y				Halfmann, Peter J.; Iida, Shun; Iwatsuki-Horimoto, Kiyoko; Maemura, Tadashi; Kiso, Maki; Scheaffer, Suzanne M.; Darling, Tamarand L.; Joshi, Astha; Loeber, Samantha; Singh, Gagandeep; Foster, Stephanie L.; Ying, Baoling; Case, James Brett; Chong, Zhenlu; Whitener, Bradley; Moliva, Juan; Floyd, Katharine; Ujie, Michiko; Nakajima, Noriko; Ito, Mutsumi; Wright, Ryan; Uraki, Ryuta; Warang, Prajakta; Gagne, Matthew; Li, Rong; Sakai-Tagawa, Yuko; Liu, Yanan; Larson, Deanna; Osorio, Jorge E.; Hernandez-Ortiz, Juan P.; Henry, Amy R.; Ciuoderis, Karl; Florek, Kelsey R.; Patel, Mit; Odle, Abby; Wong, Lok-Yin Roy; Bateman, Allen C.; Wang, Zhongde; Edara, Venkata-Viswanadh; Chong, Zhentu; Franks, John; Jeevan, Trushar; Fabrizio, Thomas; DeBeauchamp, Jennifer; Kercher, Lisa; Seiler, Patrick; Gonzalez-Reiche, Ana Silvia; Sordillo, Emilia Mia; Chang, Lauren A.; van Baker, Harm; Simon, Viviana; Douek, Daniel C.; Sullivan, Nancy J.; Thackray, Larissa B.; Ueki, Hiroshi; Yamayoshi, Seiya; Imai, Masaki; Perlman, Stanley; Webby, Richard J.; Seder, Robert A.; Suthar, Mehut S.; Garcia-Sastre, Adolfo; Schotsaert, Michael; Suzuki, Tadaki; Boon, Adrianus C. M.; Diamond, Michael S.; Kawaoka, Yoshihiro		Consortium Mt Sinai Pathogen Surve	SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters	NATURE			English	Article							NEUTRALIZING ANTIBODIES; INFECTION; BAD	The recent emergence of B.1.1.529, the Omicron variant(1,2), has raised concerns of escape from protection by vaccines and therapeutic antibodies. A key test for potential countermeasures against B.1.1.529 is their activity in preclinical rodent models of respiratory tract disease. Here, using the collaborative network of the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme of the National Institute of Allergy and Infectious Diseases (NIAID), we evaluated the ability of several B.1.1.529 isolates to cause infection and disease in immunocompetent and human ACE2 (hACE2)-expressing mice and hamsters. Despite modelling data indicating that B.1.1.529 spike can bind more avidly to mouse ACE2 (refs. (3,4)), we observed less infection by B.1.1.529 in 129, C57BL/6, BALB/c and K18-hACE2 transgenic mice than by previous SARS-CoV-2 variants, with limited weight loss and lower viral burden in the upper and lower respiratory tracts. In wild-type and hACE2 transgenic hamsters, lung infection, clinical disease and pathology with B.1.1.529 were also milder than with historical isolates or other SARS-CoV-2 variants of concern. Overall, experiments from the SAVE/NIAID network with several B.1.1.529 isolates demonstrate attenuated lung disease in rodents, which parallels preliminary human clinical data. [GRAPHICS] .	[Halfmann, Peter J.; Maemura, Tadashi; Wright, Ryan; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA; [Iida, Shun; Nakajima, Noriko; Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Iwatsuki-Horimoto, Kiyoko; Kiso, Maki; Ujie, Michiko; Ito, Mutsumi; Uraki, Ryuta; Sakai-Tagawa, Yuko; Ueki, Hiroshi; Yamayoshi, Seiya; Imai, Masaki; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan; [Scheaffer, Suzanne M.; Darling, Tamarand L.; Joshi, Astha; Ying, Baoling; Case, James Brett; Chong, Zhenlu; Whitener, Bradley; Thackray, Larissa B.; Boon, Adrianus C. M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Loeber, Samantha] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Singh, Gagandeep; Warang, Prajakta; Chang, Lauren A.; Simon, Viviana; Garcia-Sastre, Adolfo; Schotsaert, Michael] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Singh, Gagandeep; Warang, Prajakta; Chang, Lauren A.; Garcia-Sastre, Adolfo; Schotsaert, Michael] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Foster, Stephanie L.; Floyd, Katharine; Patel, Mit; Edara, Venkata-Viswanadh; Suthar, Mehut S.] Emory Univ, Ctr Childhood Infect & Vaccines Childrens Healthc, Emory Vaccine Ctr, Dept Pediat,Sch Med, Atlanta, GA USA; [Moliva, Juan; Gagne, Matthew; Henry, Amy R.; Douek, Daniel C.; Sullivan, Nancy J.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Uraki, Ryuta; Ueki, Hiroshi; Yamayoshi, Seiya; Imai, Masaki; Kawaoka, Yoshihiro] Natl Ctr Global Hlth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Japan; [Li, Rong; Liu, Yanan; Larson, Deanna; Wang, Zhongde; Chong, Zhentu; Franks, John] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, Logan, UT 84322 USA; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Osorio, Jorge E.; Hernandez-Ortiz, Juan P.; Ciuoderis, Karl] Univ Nacl Colombia, Colombia Wisconsin One Hlth Consortium & One Hlth, Medellin, Colombia; [Florek, Kelsey R.; Bateman, Allen C.] Wisconsin State Lab Hyg, Madison, WI USA; [Odle, Abby; Wong, Lok-Yin Roy; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Jeevan, Trushar; Fabrizio, Thomas; DeBeauchamp, Jennifer; Kercher, Lisa; Seiler, Patrick; Webby, Richard J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA; [Gonzalez-Reiche, Ana Silvia; van Baker, Harm; Simon, Viviana] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Sordillo, Emilia Mia; Simon, Viviana; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Chang, Lauren A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA; [Simon, Viviana; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY USA; [Suthar, Mehut S.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Boon, Adrianus C. M.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA; [Boon, Adrianus C. M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA	University of Wisconsin System; University of Wisconsin Madison; National Institute of Infectious Diseases (NIID); University of Tokyo; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utah System of Higher Education; Utah State University; University of Wisconsin System; University of Wisconsin Madison; Universidad Nacional de Colombia; University of Iowa; St Jude Children's Research Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Emory University; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Influenza Res Inst, Dept Pathobiol Sci, Madison, WI 53706 USA.; Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan.; Boon, ACM; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Kawaoka, Y (corresponding author), Natl Ctr Global Hlth & Med Res Inst, Res Ctr Global Viral Dis, Tokyo, Japan.; Boon, ACM; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.; Boon, ACM; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.	jboon@wustl.edu; mdiamond@wustl.edu; yoshihiro.kawaoka@wisc.edu	Joshi, Astha/U-9014-2019; Suzuki, Tadaki/ABH-2661-2020	Joshi, Astha/0000-0003-4914-8228; Odle, Abby/0000-0003-0526-9503; Loeber, Samantha/0000-0003-4921-2357; Floyd, Katharine/0000-0002-0866-6961; Foster, Stephanie/0000-0002-3097-1129; Yamayoshi, Seiya/0000-0001-7768-5157; Hernandez-Ortiz, Juan/0000-0003-0404-9947; Warang, Prajakta/0000-0002-5571-8277; Wong, Lok Yin Roy/0000-0002-0727-8289; Whitener, Bradley/0000-0001-6652-0701	NIH [R01 AI157155, U01 AI151810, 75N93021C00014, HHSN272201400008C, HHSN272201700041I, 75N93020F00001/A38, P51OD011132, R56AI147623, HHSN272201400004C, 75N93021C00017, P01 AI060699, R01 AI129269, R01DK130425, 5T32AI007647-22, 75N93019C00051, 75N93021C00016]; Defense Advanced Research Projects Agency [HR0011-19-2-319 0020]; Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP20fk0108412, JP21fk0108615, JP20fk0108472, JP21fk0108104, JP20nk0101632]; Japan Program for Infectious Diseases Research and Infrastructure from the Japan Agency for Medical Research and Development (AMED) [JP21wm0125002]; Woodruff Health Sciences Center; Emory School of Medicine, Woodruff Health Sciences Center 2020 COVID-19 CURE Award; NIAID, NIH; Project Promoting Support for Drug Discovery from the Japan Agency for Medical Research and Development (AMED) [JP20nk0101632]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Program for Infectious Diseases Research and Infrastructure from the Japan Agency for Medical Research and Development (AMED); Woodruff Health Sciences Center; Emory School of Medicine, Woodruff Health Sciences Center 2020 COVID-19 CURE Award; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Project Promoting Support for Drug Discovery from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	Y This study was supported by grants and contracts from the NIH (R01 AI157155 (M.S.D.), U01 AI151810 (M.S.D. and A.C.M.B.), 75N93021C00014 (Center for Research on Influenza Pathogenesis and Transmission; Y.K. and A.G.-S.), HHSN272201400008C (Y.K.), HHSN272201700041I (Z.W.), 75N93020F00001/A38 (Z.W.), P51OD011132 (M.S.S.), R56AI147623 (M.S.S.), HHSN272201400004C (M.S.S.), 75N93021C00017 (M.S.S.), P01 AI060699 (S.P.), R01 AI129269 (S.P.), R01DK130425 (M.S.), 5T32AI007647-22 (L.A.C.), 75N93019C00051 (M.S.D.) and 75N93021C00016 (St Jude Center of Excellence on Influenza Research and Response; R.J.W. and A.C.M.B.)), as well as grants from the Defense Advanced Research Projects Agency (HR0011-19-2-319 0020 (A.G.-S.)), and the Research Program on Emerging and Re-emerging Infectious Diseases (JP20fk0108412, JP21fk0108615, JP20fk0108472 and JP21fk0108104), a Project Promoting Support for Drug Discovery (JP20nk0101632) and the Japan Program for Infectious Diseases Research and Infrastructure (JP21wm0125002) from the Japan Agency for Medical Research and Development (AMED). The Woodruff Health Sciences Center and Emory School of Medicine, Woodruff Health Sciences Center 2020 COVID-19 CURE Award, and the Intramural programme of the NIAID, NIH (D.C.D., R.A.S. and N.J.S.) also supported this study. The piggyBac vector, pmhyGEMIE-3, was a gift from S. Moisyadi at the University of Hawaii. The Mount Sinai Pathogen Surveillance (E.M.S., H.v.B. and V.S.) is supported by institutional school and hospital funds as well as by an option to 75N93021C00014 (A.G.-S.). We thank R. Albrecht for support with the biosafety level 3 facility and procedures at the Icahn School of Medicine at Mount Sinai, New York.	Abdelnabi R., 2022, ANTIVIR RES, V198; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Callaway E, 2021, NATURE, V600, P197, DOI 10.1038/d41586-021-03614-z; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Case JB, 2020, VIROLOGY, V548, P39, DOI 10.1016/j.virol.2020.05.015; Chen RE, 2021, NATURE, V596, P103, DOI 10.1038/s41586-021-03720-y; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1007/s00330-019-06574-1, 10.1148/radiol.2020200230]; Corbett KS, 2021, NAT IMMUNOL, V22, P1306, DOI 10.1038/s41590-021-01021-0; Damas Joana, 2020, bioRxiv, DOI [10.1101/2020.04.16.045302, 10.1073/pnas.2010146117]; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Espenhain L, 2021, EUROSURVEILLANCE, V26, DOI [10.2807/1560-7917.ES.2021.26.50.21011462015, 10.2807/1560-7917.ES.2021.26.50.2101146]; Gagne M, 2022, CELL, V185, P113, DOI 10.1016/j.cell.2021.12.002; Gilliland Theron, 2021, bioRxiv, DOI 10.1101/2021.07.26.453840; Griffin BD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23848-9; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Halfmann PJ, 2022, J INFECT DIS, V225, P282, DOI 10.1093/infdis/jiab587; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Imai M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106535118; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jangra S, 2021, ANGEW CHEM INT EDIT, V60, P9467, DOI 10.1002/anie.202015362; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Kenrie P.Y., 2021, NATURE, DOI [10.1038/s41586-02200447906, DOI 10.1038/S41586-02200447906]; Kibler Karen V, 2021, bioRxiv, DOI 10.1101/2021.12.06.471483; Kuiper M. J., 2022, ILAR J, V12; Kupferschmidt K, 2021, SCIENCE, V374, P1304, DOI 10.1126/science.acx9782; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li Z, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116905; Mannar D., 2022, SCIENCE, V20; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; McCallum M., 2022, SCIENCE, V25; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Muruato A, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001284; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Rathe JA, 2021, J INFECT DIS, V223, P1120, DOI 10.1093/infdis/jiaa797; Rathnasinghe Raveen, 2021, medRxiv, DOI 10.1101/2021.01.19.21249592; Roy Wong Lok-Yin, 2021, bioRxiv, DOI 10.1101/2021.04.20.440676; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Sun J, 2020, CELL, V182, P734, DOI 10.1016/j.cell.2020.06.010; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Torjesen I, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2943; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Ulrich L, 2022, NATURE, V602, P307, DOI 10.1038/s41586-021-04342-0; Vanderheiden A, 2021, MBIO, V12, DOI 10.1128/mBio.02749-21; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wei CS, 2021, J GENET GENOMICS, V48, P1111, DOI 10.1016/j.jgg.2021.12.003; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Winkler ES., 2021, J VIROL, V96; Yadav P., 2021, J INFECT PUBLIC HEAL, V15, P164; Ying BL, 2022, SCI TRANSL MED, V14, DOI [10.1101/2021.08.25.457693, 10.1126/scitranslmed.abm3302]; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	61	154	154	30	47	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					687	+	s41586-022-04441-6	10.1038/s41586-022-04441-6	http://dx.doi.org/10.1038/s41586-022-04441-6		JAN 2022	12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35062015	Green Published, hybrid			2022-12-28	WOS:000763362000001
J	Mahase, E				Mahase, Elisabeth			Flu, covid, and bivalent vaccines: five minutes with ... Anthony Harnden	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2022	378								o2164	10.1136/bmj.o2164	http://dx.doi.org/10.1136/bmj.o2164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	5A6AF	35063934				2022-12-28	WOS:000862967400005
J	Dyer, C				Dyer, Clare			Covid-19: Vulnerable adult must be vaccinated against parents' wishes, judge rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o308	10.1136/bmj.o308	http://dx.doi.org/10.1136/bmj.o308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121573	Bronze			2022-12-28	WOS:000753552800020
J	Dejnirattisai, W; Huo, JD; Zhou, DM; Zahradnik, J; Supasa, P; Liu, C; Duyvesteyn, HME; Ginn, HM; Mentzer, AJ; Tuekprakhon, A; Nutalai, R; Wang, BB; Dijokaite, A; Khan, S; Avinoam, O; Bahar, M; Skelly, D; Adele, S; Johnson, SA; Amini, A; Ritter, TG; Mason, C; Dold, C; Pan, D; Assadi, S; Bellass, A; Omo-Dare, N; Koeckerling, D; Flaxman, A; Jenkin, D; Aley, PK; Voysey, M; Clemens, SAC; Naveca, FG; Nascimento, V; Nascimento, F; da Costa, CF; Resende, PC; Pauvolid-Correa, A; Siqueira, MM; Baillie, V; Serafin, N; Kwatra, G; Da Silva, K; Madhi, SA; Nunes, MC; Malik, T; Openshaw, PJM; Baillie, JK; Semple, MG; Townsend, AR; Huang, KYA; Tan, TK; Carroll, MW; Klenerman, P; Barnes, E; Dunachie, SJ; Constantinides, B; Webster, H; Crook, D; Pollard, AJ; Lambe, T; Paterson, NG; Williams, MA; Hall, DR; Fry, EE; Mongkolsapaya, J; Ren, JS; Schreiber, G; Stuart, DI; Screaton, GR				Dejnirattisai, Wanwisa; Huo, Jiandong; Zhou, Daming; Zahradnik, Jiri; Supasa, Piyada; Liu, Chang; Duyvesteyn, Helen M. E.; Ginn, Helen M.; Mentzer, Alexander J.; Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Wang, Beibei; Dijokaite, Aiste; Khan, Suman; Avinoam, Ori; Bahar, Mohammad; Skelly, Donal; Adele, Sandra; Johnson, Sile Ann; Amini, Ali; Ritter, Thomas G.; Mason, Chris; Dold, Christina; Pan, Daniel; Assadi, Sara; Bellass, Adam; Omo-Dare, Nicola; Koeckerling, David; Flaxman, Amy; Jenkin, Daniel; Aley, Parvinder K.; Voysey, Merryn; Clemens, Sue Ann Costa; Naveca, Felipe Gomes; Nascimento, Valdinete; Nascimento, Fernanda; da Costa, Cristiano Fernandes; Resende, Paola Cristina; Pauvolid-Correa, Alex; Siqueira, Marilda M.; Baillie, Vicky; Serafin, Natali; Kwatra, Gaurav; Da Silva, Kelly; Madhi, Shabir A.; Nunes, Marta C.; Malik, Tariq; Openshaw, Peter J. M.; Baillie, J. Kenneth; Semple, Malcolm G.; Townsend, Alain R.; Huang, Kuan-Ying A.; Tan, Tiong Kit; Carroll, Miles W.; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna J.; Constantinides, Bede; Webster, Hermione; Crook, Derrick; Pollard, Andrew J.; Lambe, Teresa; Paterson, Neil G.; Williams, Mark A.; Hall, David R.; Fry, Elizabeth E.; Mongkolsapaya, Juthathip; Ren, Jingshan; Schreiber, Gideon; Stuart, David, I; Screaton, Gavin R.		OPTIC Consortium; ISARIC4C Consortium	SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses	CELL			English	Article							SPIKE; EXPRESSION; FEATURES; DISEASE; CLONING; SYSTEM; VIRUS	On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announced, containing far more mutations in Spike (S) than previously reported variants. Neutralization titers of Omicron by sera from vaccinees and convalescent subjects infected with early pandemic Alpha, Beta, Gamma, or Delta are substantially reduced, or the sera failed to neutralize. Titers against Omicron are boosted by third vaccine doses and are high in both vaccinated individuals and those infected by Delta. Mutations in Omicron knock out or substantially reduce neutralization by most of the large panel of potent monoclonal antibodies and antibodies under commercial development. Omicron S has structural changes from earlier viruses and uses mutations that confer tight binding to ACE2 to unleash evolution driven by immune escape. This leads to a large number of mutations in the ACE2 binding site and rebalances receptor affinity to that of earlier pandemic viruses.	[Dejnirattisai, Wanwisa; Supasa, Piyada; Liu, Chang; Mentzer, Alexander J.; Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Wang, Beibei; Dijokaite, Aiste; Carroll, Miles W.; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Huo, Jiandong; Zhou, Daming; Duyvesteyn, Helen M. E.; Bahar, Mohammad; Fry, Elizabeth E.; Ren, Jingshan; Stuart, David, I] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Div Struct Biol, Oxford, England; [Zhou, Daming; Liu, Chang; Townsend, Alain R.; Lambe, Teresa; Mongkolsapaya, Juthathip; Stuart, David, I; Screaton, Gavin R.] Univ Oxford, Chinese Acad Med Sci CAMS, Oxford Inst COI, Oxford, England; [Zahradnik, Jiri; Khan, Suman; Avinoam, Ori; Schreiber, Gideon] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Ginn, Helen M.; Paterson, Neil G.; Williams, Mark A.; Hall, David R.; Stuart, David, I] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Mentzer, Alexander J.; Skelly, Donal; Amini, Ali; Ritter, Thomas G.; Mason, Chris; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna J.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Skelly, Donal; Adele, Sandra; Johnson, Sile Ann; Amini, Ali; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna J.] Peter Medawar Bldg Pathogen Res, Oxford, England; [Skelly, Donal] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Amini, Ali; Klenerman, Paul; Barnes, Eleanor] Univ Oxford, Translat Gastroenterol Unit, Oxford, England; [Dold, Christina; Klenerman, Paul; Barnes, Eleanor; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Dold, Christina; Aley, Parvinder K.; Voysey, Merryn; Pollard, Andrew J.; Lambe, Teresa] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pan, Daniel; Assadi, Sara; Bellass, Adam; Omo-Dare, Nicola] Univ Hosp Leicester NHS Trust, Dept Infect Dis & HIV Med, Leicester, Leics, England; [Pan, Daniel] Univ Leicester, Dept Resp Sci, Leicester, Leics, England; [Koeckerling, David] Univ Oxford, Med Sci Div, Oxford, England; [Flaxman, Amy; Jenkin, Daniel] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Clemens, Sue Ann Costa] Univ Siena, Inst Global Hlth, Siena, Brazil; [Naveca, Felipe Gomes; Nascimento, Valdinete; Nascimento, Fernanda] Fiocruz MS, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [da Costa, Cristiano Fernandes] Fundacao Vigilancia Saude Amazonas, Manaus, Amazonas, Brazil; [Resende, Paola Cristina; Pauvolid-Correa, Alex; Siqueira, Marilda M.] Lab Rus Resp IOC FIOCRUZ, Rio De Janeiro, Brazil; [Pauvolid-Correa, Alex] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Baillie, Vicky; Serafin, Natali; Kwatra, Gaurav; Da Silva, Kelly; Madhi, Shabir A.; Nunes, Marta C.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol,Vaccines & Infect Dis Analyt Res Unit, South African Med Res Council, Johannesburg, South Africa; [Baillie, Vicky; Serafin, Natali; Kwatra, Gaurav; Da Silva, Kelly; Madhi, Shabir A.; Nunes, Marta C.] Univ Witwatersrand, Natl Res Fdn, Fac Hlth Sci, Dept Sci & Technol,South African Res Chair Initia, Johannesburg, South Africa; [Malik, Tariq; Carroll, Miles W.] Publ Hlth England PHE, Natl Infect Serv, Salisbury, Wilts, England; [Openshaw, Peter J. M.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Genet & Genom, Edinburgh, Midlothian, Scotland; [Semple, Malcolm G.] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect Vet & Ecol Sci, NIHR Hlth Protect Res Unit, Liverpool, Merseyside, England; [Townsend, Alain R.; Tan, Tiong Kit] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Huang, Kuan-Ying A.] Chang Gung Univ, Div Pediat Infect Dis, Coll Med, Dept Pediat,Chang Gung Mem Hosp, Taoyuan, Taiwan; [Huang, Kuan-Ying A.] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Dunachie, Susanna J.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Dunachie, Susanna J.] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Dunachie, Susanna J.; Constantinides, Bede; Webster, Hermione; Crook, Derrick] Univ Oxford, Nuffield Dept Med, Oxford, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Siriraj Ctr Res Excellence Dengue & Emerging Path, Dean Off Res,Siriraj Hosp, Bangkok, Thailand; [Stuart, David, I] Instruct ERIC, Oxford House,Pkwy Court,John Smith Dr, Oxford, England; [Clemens, Sue Ann Costa] Univ Oxford, Dept Paediat, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Weizmann Institute of Science; Diamond Light Source; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University of Oxford; University of Oxford; Jenner Institute; Fundacao Oswaldo Cruz; Texas A&M University System; Texas A&M University College Station; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Liverpool; University of Oxford; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; Mahidol University; University of Oxford	Mongkolsapaya, J; Screaton, GR (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England.; Ren, JS; Stuart, DI (corresponding author), Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Div Struct Biol, Oxford, England.; Mongkolsapaya, J; Stuart, DI; Screaton, GR (corresponding author), Univ Oxford, Chinese Acad Med Sci CAMS, Oxford Inst COI, Oxford, England.; Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.; Stuart, DI (corresponding author), Instruct ERIC, Oxford House,Pkwy Court,John Smith Dr, Oxford, England.	jmongkol@well.ox.ac.uk; ren@strubi.ox.ac.uk; gideon.schreiber@weizmann.ac.il; dave@strubi.ox.ac.uk; gavin.screaton@medsci.ox.ac.uk	Baillie, Kenneth/AEK-6650-2022; Pan, Daniel/GYI-8783-2022; Pauvolid-Correa, Alex/AGF-6881-2022; Zhou, Daming/HHM-5776-2022; Naveca, Felipe/H-1130-2012; Huo, Jiandong/AAL-5945-2021; Resende, Paola Cristina/P-5002-2015; Baillie, John Kenneth/F-3124-2011; Tuekprakhon, Aekkachai/GLT-2776-2022; Dorival, Isabel Garcia/AAX-5807-2020; Dushianthan, Ahilanandan/T-8390-2019; Lambe, Teresa/E-5733-2016; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Pauvolid-Corrêa, Alex/D-3643-2017; Summers, Charlotte/A-6973-2012; moon, james/F-1031-2014; Semple, Malcolm Gracie/A-8790-2008; Dumas, Marc-Emmanuel/C-1736-2008	Baillie, Kenneth/0000-0001-5258-793X; Pauvolid-Correa, Alex/0000-0002-6924-157X; Zhou, Daming/0000-0002-7188-5243; Naveca, Felipe/0000-0002-2888-1060; Huo, Jiandong/0000-0002-7899-1815; Resende, Paola Cristina/0000-0002-2884-3662; Baillie, John Kenneth/0000-0001-5258-793X; Dorival, Isabel Garcia/0000-0002-5654-5662; Dushianthan, Ahilanandan/0000-0002-0165-3359; Lambe, Teresa/0000-0001-7711-897X; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Pauvolid-Corrêa, Alex/0000-0002-6924-157X; Dijokaite-Guraliuc, Aiste/0000-0002-4850-9709; Adele, Sandra/0000-0003-4458-1751; Avinoam, Ori/0000-0003-3543-168X; Zahradnik, Jiri/0000-0002-8698-4236; Koukorava, Chrysa/0000-0001-5723-0390; Skelly, Donal/0000-0002-2426-3097; de Silva, Thushan/0000-0002-6498-9212; Paterson, Neil/0000-0003-4292-6971; Stafford, Lizzie/0000-0002-1610-5136; Sharma, Anil/0000-0002-9768-1644; Costa Clemens, Sue Ann/0000-0001-9576-0878; Moore, Shona/0000-0001-8610-2806; Summers, Charlotte/0000-0002-7269-2873; Dunachie, Susanna/0000-0001-5665-6293; moon, james/0000-0001-8071-1491; Tuekprakhon, Aekkachai/0000-0003-1275-0581; McCafferty, Sarah/0000-0003-2641-970X; Lant, Suzannah/0000-0003-0852-7803; Ritter, Thomas/0000-0002-3153-342X; Mentzer, Alexander/0000-0002-4502-2209; Pan, Daniel/0000-0002-1268-2243; Dark, Paul/0000-0003-3309-0164; Hartshorn, Stuart/0000-0003-0419-1564; Planche, Timothy/0000-0002-0263-0888; Mason, Chris/0000-0002-4725-1320; Olanipekun, Michael/0000-0001-7844-0370; Ren, Jingshan/0000-0003-4015-1404; Andrikopoulos, Petros/0000-0002-1555-3498; Semple, Malcolm Gracie/0000-0001-9700-0418; Asiimwe, Innocent Gerald/0000-0002-1196-1822; Thwaites, Ryan/0000-0003-3052-2793; Hormis, Anil/0000-0001-5510-7639; Barclay, Wendy/0000-0002-3948-0895; Hall, David/0000-0002-5333-6136; Lillie, Patrick/0000-0002-4811-4774; Lyttle, Mark/0000-0002-8634-7210; Dumas, Marc-Emmanuel/0000-0001-9523-7024; Leeming, Gary/0000-0002-5554-5302; Tan, Tiong Kit/0000-0001-8746-8308; davis, chris/0000-0002-7317-3266; Lim, Wei Shen/0000-0002-7694-3051; Screaton, Gavin/0000-0002-3549-4309; Koeckerling, David/0000-0002-8475-2861	Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China [2018-I2M-2-002]; Schmidt Futures; Red Avenue Foundation; Oak Foundation; Wellcome Trust [101122/Z/13/Z, 090532/Z/09/Z, 203141/Z/16/Z]; Israel Science Foundation [3814/19]; KillCorona-Curbing Coronavirus Research Program; Ben B. and Joyce E. Eisenberg Foundation; NIHR [MC_PC_19059]; National Institutes for Health and Oxford Biomedical Research Centre; Oxfordshire Health Services Research Committee grant; National Institutes for Health and Oxford Biomedical Research Centre and an Oxfordshire Health Services Research Committee grant; NIHR Oxford BRC; UK Research and Innovation, Coalition for Epidemic Preparedness Innovations; National Institute for Health Research (NIHR); NIHR Oxford Biomedical Research Centre, Thames Valley; South Midland's NIHR Clinical Research Network; UK Department of Health and Social Care as part of the PITCH (Protective Immunity from T cells to COVID-19 in Health workers) consortium; UK Coronavirus Immunology Consortium (UK-CIC); Huo Family Foundation; NIH [U19 I082360]; NIHR Global Research Professorship [NIHR300791]; FAPEAM [005/2020]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [403276/20209]; Inova Fiocruz/Fundacao Oswaldo Cruz [VPPCB-007-FIO-18-2-30]; Bill & Melinda Gates Foundation [INV016202];  [WT109965MA]	Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China; Schmidt Futures; Red Avenue Foundation; Oak Foundation; Wellcome Trust(Wellcome Trust); Israel Science Foundation(Israel Science Foundation); KillCorona-Curbing Coronavirus Research Program; Ben B. and Joyce E. Eisenberg Foundation; NIHR(National Institute for Health Research (NIHR)); National Institutes for Health and Oxford Biomedical Research Centre; Oxfordshire Health Services Research Committee grant; National Institutes for Health and Oxford Biomedical Research Centre and an Oxfordshire Health Services Research Committee grant; NIHR Oxford BRC; UK Research and Innovation, Coalition for Epidemic Preparedness Innovations; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Oxford Biomedical Research Centre, Thames Valley; South Midland's NIHR Clinical Research Network; UK Department of Health and Social Care as part of the PITCH (Protective Immunity from T cells to COVID-19 in Health workers) consortium; UK Coronavirus Immunology Consortium (UK-CIC); Huo Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Global Research Professorship; FAPEAM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Inova Fiocruz/Fundacao Oswaldo Cruz; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); 	This work was supported by the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China (grant number: 2018-I2M-2-002) to D.I.S. and G.R.S. We are also grateful for support from Schmidt Futures, the Red Avenue Foundation, and the Oak Foundation. G.R.S. was supported by the Wellcome Trust. H.M.E.D. and J.R. are supported by the Wellcome Trust (101122/Z/13/Z), D.I.S. and E.E.F. by the UKRI MRC (MR/N00065X/1). G.S. and J.Z. were supported by the Israel Science Foundation (grant no. 3814/19) within the KillCorona-Curbing Coronavirus Research Program and by the Ben B. and Joyce E. Eisenberg Foundation. D.I.S. and G.R.S. are Jenner Investigators. This is a contribution from the UK Instruct-ERIC Centre. A.J.M. is an NIHR-supported academic Clinical Lecturer. The convalescent sampling was supported by the Medical Research Council (grant MC_PC_19059) (awarded to the ISARIC-4C Consortium) (with a full contributor list available at https://isaric4c.net/about/authors/) and the National Institutes for Health and Oxford Biomedical Research Centre and an Oxfordshire Health Services Research Committee grant to A.J.M. OPTIC Consortium: Christopher Conlon, Alexandra Deeks, John Frater, Lisa Frending, Siobhan Gardiner, Anni Jamsen, Katie Jeffery, Tom Malone, Eloise Phillips, Lucy Rothwell, and Lizzie Stafford. The Wellcome Centre for Human Genetics is supported by the Wellcome Trust (grant 090532/Z/09/Z). The computational aspects of this research were supported by the Wellcome Trust Core award grant number 203141/Z/16/Z and the NIHR Oxford BRC. We thank the staff of the MRC Human Immunology Unit for access to their Biacore Facility. Access to beamline I03 at Diamond Light Source was under application lb27009. The Oxford Vaccine work was supported by UK Research and Innovation, Coalition for Epidemic Preparedness Innovations, National Institute for Health Research (NIHR), NIHR Oxford Biomedical Research Centre, Thames Valley, and South Midland's NIHR Clinical Research Network. We thank the Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team for participant sample collection and the Oxford Immunology Network COVID19 Response T cell Consortium for laboratory support. We acknowledge the rapid sharing of Victoria, B.1.1.7 and B.1.351, which was isolated by scientists within the National Infection Service at PHE Porton Down, and the B.1.617.2 virus was kindly provided Wendy Barclay and Thushan De Silva. We thank The Secretariat of National Surveillance, Ministry of Health Brazil for assistance in obtaining P.1 samples. This work was supported by the UK Department of Health and Social Care as part of the PITCH (Protective Immunity from T cells to COVID-19 in Health workers) consortium, the UK Coronavirus Immunology Consortium (UK-CIC), and the Huo Family Foundation. E.B. and P.K. are NIHR Senior Investigators and P.K. is funded by WT109965MA and NIH (U19 I082360). S.J.D. is funded by an NIHR Global Research Professorship (NIHR300791). D.S. is an NIHR academic clinical fellow. F.G.N. is a CNPq fellow and is supported by FAPEAM (PCTI-EmergeSaude/AM call 005/2020 and Rede Geno<^> mica de Vigilancia em Sau ' de -REGESAM), Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (403276/20209), and Inova Fiocruz/Fundacao Oswaldo Cruz (VPPCB-007-FIO-18-2-30 Geracao de conhecimento). The team at the University of Witwatersrand were supported by The Bill & Melinda Gates Foundation (grant number INV016202).; The views expressed in this article are those of the authors and not necessarily those of the National Health Service (NHS), the Department of Health and Social Care (DHSC), the National Institutes for Health Research (NIHR), the Medical Research Council (MRC), or Public Healtc, England.	ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Cameroni E., 2021, BROADL NEUTR ANT OV, V2021; Carrique L., 2020, BOIRXIV, DOI 10.1101/; Cele S., 2021, SARS COV 2 EVOLVED A, V2021; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Cohen-Khait R, 2016, P NATL ACAD SCI USA, V113, P14982, DOI 10.1073/pnas.1613122113; Colmenares-Mejia CC, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084172; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flaxman A, 2021, LANCET, V398, P981, DOI 10.1016/S0140-6736(21)01699-8; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Huang KYA, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009352; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karim F., 2021, MEDRXIV2021060321258; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; LIBBY RT, 1988, BIOCHEMISTRY-US, V27, P6262, DOI 10.1021/bi00417a010; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu C, 2022, CELL HOST MICROBE, V30, P53, DOI 10.1016/j.chom.2021.11.013; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu YF, 2021, CELL, V184, P3452, DOI 10.1016/j.cell.2021.05.032; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mullen J.L., 2020, OUTBREAKINFO; Nettleship JE, 2008, PROTEIN EXPRES PURIF, V62, P83, DOI 10.1016/j.pep.2008.06.017; Peleg Y, 2014, METHODS MOL BIOL, V1116, P73, DOI 10.1007/978-1-62703-764-8_6; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Roy Wong Lok-Yin, 2021, bioRxiv, DOI 10.1101/2021.04.20.440676; Schrodinger L., 2020, PYMOL; Schubert M., 2021, MEDRXIV2021121021267; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun Y, 2021, CELL RES, V31, P597, DOI 10.1038/s41422-021-00497-7; Sun Yaping, 2020, Antib Ther, V3, P246, DOI 10.1093/abt/tbaa025; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Toelzer C, 2020, SCIENCE, V370, P725, DOI 10.1126/science.abd3255; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Walter TS, 2003, J APPL CRYSTALLOGR, V36, P308, DOI 10.1107/S0021889803001997; Weinreich DM, 2021, NEW ENGL J MED, V384, P238, DOI 10.1056/NEJMoa2035002; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zahradnik J., 2021, SARS COV 2 CONVERGEN, DOI [10.1101/2021.05.24.445534, DOI 10.1101/2021.05.24.445534]; Zahradnik J, 2021, ACS SYNTH BIOL, V10, P3445, DOI 10.1021/acssynbio.1c00395; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou DM, 2020, NAT STRUCT MOL BIOL, V27, P950, DOI 10.1038/s41594-020-0480-y	66	276	279	54	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					467	+		10.1016/j.cell.2021.12.046	http://dx.doi.org/10.1016/j.cell.2021.12.046			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35081335	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000753615000009
J	Fyfe, CD; Bernardo-Garcia, N; Fradale, L; Grimaldi, S; Guillot, A; Brewee, C; Chavas, LMG; Legrand, P; Benjdia, A; Berteau, O				Fyfe, Cameron D.; Bernardo-Garcia, Noelia; Fradale, Laura; Grimaldi, Stephane; Guillot, Alain; Brewee, Clemence; Chavas, Leonard M. G.; Legrand, Pierre; Benjdia, Alhosna; Berteau, Olivier			Crystallographic snapshots of a B-12-dependent radical SAM methyltransferase	NATURE			English	Article							DEPENDENT METHIONINE SYNTHASE; COENZYME-M REDUCTASE; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; ENZYME; COBALAMIN; BIOSYNTHESIS; MODEL; METHYLATION; IRON	By catalysing the microbial formation of methane, methyl-coenzyme M reductase has a central role in the global levels of this greenhouse gas(1,2). The activity of methyl-coenzyme M reductase is profoundly affected by several unique post-translational modifications(3-6), such as a unique C-methylation reaction catalysed by methanogenesis marker protein 10 (Mmp10), a radical S-adenosyl-l-methionine (SAM) enzyme(7,8). Here we report the spectroscopic investigation and atomic resolution structure of Mmp10 from Methanosarcina acetivorans, a unique B-12 (cobalamin)-dependent radical SAM enzyme(9). The structure of Mmp10 reveals a unique enzyme architecture with four metallic centres and critical structural features involved in the control of catalysis. In addition, the structure of the enzyme-substrate complex offers a glimpse into a B-12-dependent radical SAM enzyme in a precatalytic state. By combining electron paramagnetic resonance spectroscopy, structural biology and biochemistry, our study illuminates the mechanism by which the emerging superfamily of B-12-dependent radical SAM enzymes catalyse chemically challenging alkylation reactions and identifies distinctive active site rearrangements to provide a structural rationale for the dual use of the SAM cofactor for radical and nucleophilic chemistry.	[Fyfe, Cameron D.; Bernardo-Garcia, Noelia; Fradale, Laura; Guillot, Alain; Brewee, Clemence; Benjdia, Alhosna; Berteau, Olivier] Univ Paris Saclay, MicaLis Inst, ChemSyBio, AgroParisTech,INRAE, Jouy En Josas, France; [Grimaldi, Stephane] Aix Marseille Univ, BIP UMR7281, CNRS, Marseille, France; [Chavas, Leonard M. G.; Legrand, Pierre] FranceSynchrotron SOLEIL, HeLioBio Grp, Gif Sur Yvette, France; [Chavas, Leonard M. G.] Nagoya Univ, Nagoya, Aichi, Japan	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Nagoya University	Benjdia, A; Berteau, O (corresponding author), Univ Paris Saclay, MicaLis Inst, ChemSyBio, AgroParisTech,INRAE, Jouy En Josas, France.	Alhosna.Benjdia@inrae.fr; OLivier.Berteau@inrae.fr	Berteau, Olivier/AAF-9080-2019; LEGRAND, Pierre/G-7709-2011	Berteau, Olivier/0000-0002-3434-5168; LEGRAND, Pierre/0000-0003-2431-2255; Fyfe, Cameron/0000-0001-7604-8009; Grimaldi, Stephane/0000-0002-9559-6112; BENJDIA, ALHOSNA/0000-0002-3544-2541; Bernardo Garcia, Noelia/0000-0002-9156-2601	European Research Council [617053]; ANR [ANR-17-CE11-0014]; CHARMMMAT Laboratory of Excellence [ANR-11-LABX0039]	European Research Council(European Research Council (ERC)European Commission); ANR(French National Research Agency (ANR)); CHARMMMAT Laboratory of Excellence	This work was supported by the European Research Council (ERC consolidator grant 617053), ANR (ANR-17-CE11-0014) and the CHARMMMAT Laboratory of Excellence (ANR-11-LABX0039). We express appreciation for use of the EPR facilities available at the French EPR network (IR CNRS3443) and the Aix-Marseille University EPR centre. Use of the beamline PROXIMA-1 at the synchrotron SOLEIL (Saint-Aubin, France) is also acknowledged.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Balty C, 2020, J BIOL CHEM, V295, P16665, DOI 10.1074/jbc.RA120.015371; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; Benjdia A, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.678068; Benjdia A, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00087; Benjdia A, 2017, NAT CHEM, V9, P698, DOI [10.1038/NCHEM.2714, 10.1038/nchem.2714]; Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Berteau O, 2017, PHOTOCHEM PHOTOBIOL, V93, P67, DOI 10.1111/php.12702; Bricogne G, 2017, BUSTER VERSION 2116; Bridwell-Rabb J, 2017, NATURE, V544, P322, DOI 10.1038/nature21689; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Chavas LMG, 2021, J SYNCHROTRON RADIAT, V28, P970, DOI 10.1107/S1600577521002605; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Demmer JK, 2015, J BIOL CHEM, V290, P21985, DOI 10.1074/jbc.M115.656520; Deobald D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25716-x; Dowling DP, 2014, NAT CHEM BIOL, V10, P106, DOI 10.1038/nchembio.1426; DRENNAN CL, 1994, CURR OPIN STRUC BIOL, V4, P919, DOI 10.1016/0959-440X(94)90275-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Holliday GL, 2018, METHOD ENZYMOL, V606, P1, DOI 10.1016/bs.mie.2018.06.004; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kahnt J, 2007, FEBS J, V274, P4913, DOI 10.1111/j.1742-4658.2007.06016.x; Kim HJ, 2017, J AM CHEM SOC, V139, P16084, DOI 10.1021/jacs.7b09890; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Knox HL, 2021, NAT CHEM BIOL, V17, P485, DOI 10.1038/s41589-020-00717-y; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee M, 2010, J MOL BIOL, V404, P600, DOI 10.1016/j.jmb.2010.09.050; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Lyu Z, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00654-19; Mahanta N, 2017, BIOCHEMISTRY-US, V56, P5229, DOI 10.1021/acs.biochem.7b00771; Marous DR, 2015, P NATL ACAD SCI USA, V112, P10354, DOI 10.1073/pnas.1508615112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin MI, 2021, BIOCHEMISTRY-US, V60, P1587, DOI 10.1021/acs.biochem.1c00113; Nayak DD, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000507; Owens CP, 2016, J AM CHEM SOC, V138, P10124, DOI 10.1021/jacs.6b06783; Parent A, 2018, J AM CHEM SOC, V140, P2469, DOI 10.1021/jacs.7b08402; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Radler MI, 2019, J BIOL CHEM, V294, P11712, DOI 10.1074/jbc.RA119.007609; Rohac R, 2016, NAT CHEM, V8, P491, DOI [10.1038/NCHEM.2490, 10.1038/nchem.2490]; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher W, 1997, FEBS LETT, V409, P421, DOI 10.1016/S0014-5793(97)00520-6; Shisler KA, 2017, J AM CHEM SOC, V139, P11803, DOI 10.1021/jacs.7b04883; Tang WX, 2015, NAT CHEM, V7, P57, DOI [10.1038/NCHEM.2113, 10.1038/nchem.2113]; Tapio I, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0141-0; Tickle I.J., 2018, STARANISO; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wagner T, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00197-17; Wang B, 2018, BIOCHEMISTRY-US, V57, P4972, DOI 10.1021/acs.biochem.8b00693; Wang YY, 2020, J AM CHEM SOC, V142, P9944, DOI 10.1021/jacs.9b06454; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; Wongnate T, 2016, SCIENCE, V352, P953, DOI 10.1126/science.aaf0616; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; Zhong AS, 2021, BIOCHEMISTRY-US, V60, P537, DOI 10.1021/acs.biochem.0c00915	65	11	11	19	61	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					336	+		10.1038/s41586-021-04355-9	http://dx.doi.org/10.1038/s41586-021-04355-9		FEB 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	35110733	hybrid, Green Published			2022-12-28	WOS:000750001600002
J	Cowan, AJ; Green, DJ; Kwok, M; Lee, S; Coffey, DG; Holmberg, LA; Tuazon, S; Gopal, AK; Libby, EN				Cowan, Andrew J.; Green, Damian J.; Kwok, Mary; Lee, Sarah; Coffey, David G.; Holmberg, Leona A.; Tuazon, Sherilyn; Gopal, Ajay K.; Libby, Edward N.			Diagnosis and Management of Multiple Myeloma A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							STEM-CELL TRANSPLANTATION; LOW-DOSE DEXAMETHASONE; TERM-FOLLOW-UP; LENALIDOMIDE PLUS DEXAMETHASONE; OPEN-LABEL; DOUBLE-BLIND; INTERGROUPE FRANCOPHONE; MONOCLONAL GAMMOPATHIES; CONSENSUS STATEMENT; PROGNOSTIC-FACTOR	IMPORTANCE Multiple myeloma is a hematologic malignancy characterized by presence of abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth causing destructive bone lesions, kidney injury, anemia, and hypercalcemia. Multiple myeloma is diagnosed in an estimated 34 920 people in the US and in approximately 588 161 people worldwide each year. OBSERVATIONS Among patients with multiple myeloma, approximately 73% have anemia, 79% have osteolytic bone disease, and 19% have acute kidney injury at the time of presentation. Evaluation of patients with possible multiple myeloma includes measurement of hemoglobin, serum creatinine, serum calcium, and serum free light chain levels; serum protein electrophoresis with immunofixation; 24-hour urine protein electrophoresis; and full-body skeletal imaging with computed tomography, positron emission tomography, or magnetic resonance imaging. The Revised International Staging System combines data from the serum biomarkers beta(2) microglobulin, albumin, and lactate dehydrogenase in conjunction with malignant plasma cell genomic features found on fluorescence in situ hybridization-t(4;14), del(17p), and t(14;16)-to assess estimated progression-free survival and overall survival. At diagnosis, 28% of patients are classified as having Revised International Staging stage I multiple myeloma, and these patients have a median 5-year survival of 82%. Among all patients with multiple myeloma, standard first-line (induction) therapy consists of a combination of an injectable proteasome inhibitor (ie, bortezomib), an oral immunomodulatory agent (ie, lenalidomide), and dexamethasone and is associated with median progression-free survival of 41 months, compared with historical reports of 8.5 months without therapy. This induction therapy combined with autologous hematopoietic stem cell transplantation followed by maintenance lenalidomide is standard of care for eligible patients. CONCLUSIONS AND RELEVANCE Approximately 34 920 people in the US and 155 688 people worldwide are diagnosed with multiple myeloma each year. Induction therapy with an injectable proteasome inhibitor, an oral immunomodulatory agent and dexamethasone followed by treatment with autologous hematopoietic stem cell transplantation, and maintenance therapy with lenalidomide are among the treatments considered standard care for eligible patients.	[Cowan, Andrew J.; Green, Damian J.; Lee, Sarah; Holmberg, Leona A.; Gopal, Ajay K.; Libby, Edward N.] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98109 USA; [Cowan, Andrew J.; Green, Damian J.; Lee, Sarah; Holmberg, Leona A.; Tuazon, Sherilyn; Gopal, Ajay K.; Libby, Edward N.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Cowan, Andrew J.; Green, Damian J.; Kwok, Mary; Lee, Sarah; Holmberg, Leona A.; Gopal, Ajay K.; Libby, Edward N.] Seattle Canc Care Alliance, Seattle, WA USA; [Kwok, Mary] Univ Washington, Dept Med, Div Hematol, Seattle, WA USA; [Coffey, David G.] Univ Miami Hlth Syst, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Tuazon, Sherilyn] Bristol Myers Squibb, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Bristol-Myers Squibb	Libby, EN (corresponding author), Univ Washington, Div Med Oncol, Dept Internal Med, 1144 Eastlake Ave E,LG-650, Seattle, WA 98109 USA.	elibby@seattlecca.org		Coffey, David G./0000-0003-3544-8836				Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Attal M, 2019, LANCET, V394, P2096, DOI 10.1016/S0140-6736(19)32556-5; Attal M, 2017, NEW ENGL J MED, V376, P1311, DOI 10.1056/NEJMoa1611750; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Baffour FI, 2020, AM J HEMATOL, V95, P966, DOI 10.1002/ajh.25846; Bahlis NJ, 2006, BONE MARROW TRANSPL, V38, P7, DOI 10.1038/sj.bmt.1705395; Bahlis NJ, 2020, LEUKEMIA, V34, P1875, DOI 10.1038/s41375-020-0711-6; BERGSAGEL DE, 1989, EUR J CANCER CLIN ON, V25, P159, DOI 10.1016/0277-5379(89)90001-1; Bertazzi PA, 1997, EPIDEMIOLOGY, V8, P646, DOI 10.1097/00001648-199710000-00006; Birmann BM, 2017, CANCER EPIDEM BIOMAR, V26, P876, DOI 10.1158/1055-9965.EPI-16-0762-T; Bjorklund CC, 2020, LEUKEMIA, V34, P1197, DOI 10.1038/s41375-019-0620-8; Burwick N, 2019, ANN HEMATOL, V98, P19, DOI 10.1007/s00277-018-3465-8; Chan H, 2018, CL LYMPH MYELOM LEUK, V18, P225, DOI 10.1016/j.clml.2017.12.009; Chang H, 2005, BLOOD, V105, P358, DOI 10.1182/blood-2004-04-1363; Chari A, 2019, NEW ENGL J MED, V381, P727, DOI 10.1056/NEJMoa1903455; Cowan AJ, 2020, BIOL BLOOD MARROW TR, V26, P2372, DOI 10.1016/j.bbmt.2020.08.018; CRAWFORD J, 1987, AM J MED, V82, P39, DOI 10.1016/0002-9343(87)90375-5; Delforge M, 2017, BLOOD, V129; Dhakal B, 2020, LEUKEMIA, V34, P3338, DOI 10.1038/s41375-020-0830-0; Dimopoulos MA, 2016, NEW ENGL J MED, V375, P1319, DOI 10.1056/NEJMoa1607751; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Dimopoulos M, 2020, LANCET, V396, P186, DOI 10.1016/S0140-6736(20)30734-0; Dimopoulos MA, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.02060; Dimopoulos MA, 2018, NEW ENGL J MED, V379, P1811, DOI 10.1056/NEJMoa1805762; Dimopoulos MA, 2018, HAEMATOLOGICA, V103, P2088, DOI 10.3324/haematol.2018.194282; Dimopoulos MA, 2017, LANCET ONCOL, V18, P1327, DOI 10.1016/S1470-2045(17)30578-8; Dimopoulos MA, 2016, LANCET ONCOL, V17, P27, DOI 10.1016/S1470-2045(15)00464-7; Drayson MT, 2019, LANCET ONCOL, V20, P1760, DOI 10.1016/S1470-2045(19)30506-6; Dupuis MM, 2016, ONCOTARGETS THER, V9, P7583, DOI 10.2147/OTT.S122241; Durie BGM, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0311-8; Facon T, 2019, NEW ENGL J MED, V380, P2104, DOI 10.1056/NEJMoa1817249; de Larrea CF, 2013, LEUKEMIA, V27, P780, DOI 10.1038/leu.2012.336; Fonseca R, 2017, LEUKEMIA, V31, P1915, DOI 10.1038/leu.2016.380; Fonseca R, 2003, BLOOD, V101, P4569, DOI 10.1182/blood-2002-10-3017; Fonseca R, 2002, BLOOD, V99, P3735, DOI 10.1182/blood.V99.10.3735; Gagelmann N, 2019, BIOL BLOOD MARROW TR, V25, P2134, DOI 10.1016/j.bbmt.2019.07.004; Gay F, 2020, LANCET HAEMATOL, V7; Ghobrial IM, 2012, BLOOD, V120, P20, DOI 10.1182/blood-2012-01-379024; Goldman-Mazur S, 2020, AM J HEMATOL, V95, P503, DOI 10.1002/ajh.25758; Goldschmidt H, 2018, LEUKEMIA, V32, P383, DOI 10.1038/leu.2017.211; Grosicki S, 2020, LANCET, V396, P1563, DOI 10.1016/S0140-6736(20)32292-3; Hillengass J, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.78; Hillengass J, 2019, LANCET ONCOL, V20, pE302, DOI 10.1016/S1470-2045(19)30309-2; Hillengass J, 2010, J CLIN ONCOL, V28, P1606, DOI 10.1200/JCO.2009.25.5356; Holstein SA, 2017, LANCET HAEMATOL, V4, pE431, DOI 10.1016/S2352-3026(17)30140-0; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Joseph NS, 2020, J CLIN ONCOL, V38, P1928, DOI 10.1200/JCO.19.02515; Jurczyszyn A, 2016, AM J HEMATOL, V91, P575, DOI 10.1002/ajh.24351; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kumar SK, 2020, LANCET ONCOL, V21, P1317, DOI 10.1016/S1470-2045(20)30452-6; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2018, NEW ENGL J MED, V378, P241, DOI 10.1056/NEJMoa1709974; Lakshman A, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0191-y; Lakshman A, 2018, AM J HEMATOL, V93, P179, DOI 10.1002/ajh.24954; Landgren O, 2018, JAMA ONCOL, V4, P821, DOI 10.1001/jamaoncol.2018.0509; Larocca A, 2015, BLOOD, V126, P2179, DOI 10.1182/blood-2015-05-612960; Leleu X, 2013, BLOOD, V121, P1968, DOI 10.1182/blood-2012-09-452375; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; Lightman SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00965; Lonial S, 2014, LEUKEMIA, V28, P258, DOI 10.1038/leu.2013.220; Lonial S, 2020, LANCET ONCOL, V21, P207, DOI 10.1016/S1470-2045(19)30788-0; Lonial S, 2020, J CLIN ONCOL, V38, P1126, DOI 10.1200/JCO.19.01740; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Martinez-Lopez J, 2014, BLOOD, V123, P3073, DOI 10.1182/blood-2014-01-550020; Mateos MV, 2020, CL LYMPH MYELOM LEUK, V20, P509, DOI 10.1016/j.clml.2019.09.623; Mateos MV, 2013, NEW ENGL J MED, V369, P438, DOI 10.1056/NEJMoa1300439; McCarthy PL, 2017, J CLIN ONCOL, V35, P3279, DOI 10.1200/JCO.2017.72.6679; McDonald RJ, 2008, AM J NEURORADIOL, V29, P642, DOI 10.3174/ajnr.A0918; Mellors PW, 2020, BLOOD ADV, V4, P2236, DOI 10.1182/bloodadvances.2019001275; Mhaskar R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003188.pub3; Moreau P, 2016, NEW ENGL J MED, V374, P1621, DOI 10.1056/NEJMoa1516282; Moreau P, 2019, LANCET, V394, P29, DOI 10.1016/S0140-6736(19)31240-1; Moreau P, 2018, LANCET ONCOL, V19, P953, DOI 10.1016/S1470-2045(18)30354-1; Morgan GJ, 2011, LANCET ONCOL, V12, P743, DOI 10.1016/S1470-2045(11)70157-7; Munshi NC, 2021, NEW ENGL J MED, V384, P705, DOI 10.1056/NEJMoa2024850; Munshi PN, 2020, CANCER-AM CANCER SOC, V126, P5077, DOI 10.1002/cncr.33171; Musto P, 2017, ANN ONCOL, V28, P228, DOI 10.1093/annonc/mdw606; Nooka AK, 2014, LEUKEMIA, V28, P690, DOI 10.1038/leu.2013.335; Nucci M, 2009, CLIN INFECT DIS, V49, P1211, DOI 10.1086/605664; Palumbo A, 2016, NEW ENGL J MED, V375, P754, DOI 10.1056/NEJMoa1606038; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Palumbo A, 2014, J CLIN ONCOL, V32, P587, DOI 10.1200/JCO.2013.48.7934; Raje N, 2019, NEW ENGL J MED, V380, P1726, DOI 10.1056/NEJMoa1817226; Raje N, 2018, LANCET ONCOL, V19, P370, DOI 10.1016/S1470-2045(18)30072-X; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.1853; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Ravindran A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.100; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Ross FM, 2010, HAEMATOL-HEMATOL J, V95, P1221, DOI 10.3324/haematol.2009.016329; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Saxe D, 2019, INT J LAB HEMATOL, V41, P5, DOI 10.1111/ijlh.12882; Schey S, 2015, BRIT J HAEMATOL, V170, P336, DOI 10.1111/bjh.13435; Schmidt TM, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0254-0; Shah N, 2012, CANCER-AM CANCER SOC, V118, P3549, DOI 10.1002/cncr.26662; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stadtmauer EA, 2019, J CLIN ONCOL, V37, P589, DOI 10.1200/JCO.18.00685; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Topp MS, 2020, J CLIN ONCOL, V38, P775, DOI 10.1200/JCO.19.02657; Trudel S, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0196-6; Trudel S, 2018, LANCET ONCOL, V19, P1641, DOI 10.1016/S1470-2045(18)30576-X; Tsang RW, 2018, INT J RADIAT ONCOL, V101, P794, DOI 10.1016/j.ijrobp.2018.05.009; Usmani SZ, 2012, HAEMATOL-HEMATOL J, V97, P1761, DOI 10.3324/haematol.2012.065698; Voorhees PM, 2020, BLOOD, V136, P936, DOI 10.1182/blood.2020005288; Walker BA, 2019, LEUKEMIA, V33, P159, DOI 10.1038/s41375-018-0196-8; Weinhold N, 2016, BLOOD, V128, P1735, DOI 10.1182/blood-2016-06-723007; Zamagni E, 2007, HAEMATOL-HEMATOL J, V92, P50, DOI 10.3324/haematol.10554; Zhou LH, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08280-y	111	41	41	43	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					464	477		10.1001/jama.2022.0003	http://dx.doi.org/10.1001/jama.2022.0003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103762				2022-12-28	WOS:000753056200019
J	Tromp, TR; Hartgers, ML; Hovingh, GK; Vallejo-Vaz, AJ; Ray, KK; Soran, H; Freiberger, T; Bertolini, S; Harada-Shiba, M; Blom, DJ; Raal, FJ; Cuchel, M				Tromp, Tycho R.; Hartgers, Merel L.; Hovingh, G. Kees; Vallejo-Vaz, Antonio J.; Ray, Kausik K.; Soran, Handrean; Freiberger, Tomas; Bertolini, Stefano; Harada-Shiba, Mariko; Blom, Dirk J.; Raal, Frederick J.; Cuchel, Marina		Homozygous Familial Hypercholester	Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study	LANCET			English	Article							LIPOPROTEIN-APHERESIS; OPEN-LABEL; EVOLOCUMAB; EFFICACY; GUIDANCE; INSIGHTS; CHILDREN; CARE	Background Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited disorder resulting in extremely elevated low-density lipoprotein cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Current guidance about its management and prognosis stems from small studies, mostly from high-income countries. The objective of this study was to assess the clinical and genetic characteristics, as well as the impact, of current practice on health outcomes of HoFH patients globally. Methods The HoFH International Clinical Collaborators registry collected data on patients with a clinical, or genetic, or both, diagnosis of HoFH using a retrospective cohort study design. This trial is registered with ClinicalTrials.gov, NCT04815005. Findings Overall, 751 patients from 38 countries were included, with 565 (75%) reporting biallelic pathogenic variants. The median age of diagnosis was 12.0 years (IQR 5.5-27.0) years. Of the 751 patients, 389 (52%) were female and 362 (48%) were male. Race was reported for 527 patients; 338 ( 64%) patients were White, 121 (23%) were Asian, and 68 (13%) were Black or mixed race. The major manifestations of ASCVD or aortic stenosis were already present in 65 (9%) of patients at diagnosis of HoFH. Globally, pretreatment LDL cholesterol levels were 14.7 mmol/L (IQR 11.6-18.4). Among patients with detailed therapeutic information, 491 (92%) of 534 received statins, 342 (64%) of 534 received ezetimibe, and 243 (39%) of 621 received lipoprotein apheresis. On-treatment LDL cholesterol levels were lower in high-income countries (3.93 mmol/ L, IQR 2.6-5.8) versus non-highincome countries (9.3 mmol/ L, 6.7-12.7), with greater use of three or more lipid-lowering therapies (LLT; highincome 66% vs non-high-income 24%) and consequently more patients attaining guideline-recommended LDL cholesterol goals (high- income 21% vs non-high- income 3%). A first major adverse cardiovascular event occurred a decade earlier in non-high-income countries, at a median age of 24.5 years (IQR 17.0-34.5) versus 37.0 years (29.0-49.0) in high-income countries (adjusted hazard ratio 1.64, 95% CI 1.13-2.38). Interpretation Worldwide, patients with HoFH are diagnosed too late, undertreated, and at high premature ASCVD risk. Greater use of multi-LLT regimens is associated with lower LDL cholesterol levels and better outcomes. Significant global disparities exist in treatment regimens, control of LDL cholesterol levels, and cardiovascular event-free survival, which demands a critical re-evaluation of global health policy to reduce inequalities and improve outcomes for all patients with HoFH. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Tromp, Tycho R.; Hartgers, Merel L.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Med Ctr, Amsterdam, Netherlands; [Hartgers, Merel L.] Nanyang Technol Univ Singapore, Ctr Populat Hlth Sci, Lee Kong Chian Sch Med, Singapore, Singapore; [Vallejo-Vaz, Antonio J.; Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Vallejo-Vaz, Antonio J.] Univ Seville, Clin Epidemiol & Vasc Risk, Inst Biomed Seville, IBiS Hosp Univ Virgen del Rocio,CSIC, Seville, Spain; [Vallejo-Vaz, Antonio J.] Univ Seville, Fac Med, Dept Med, Seville, Spain; [Soran, Handrean] Manchester Univ NHS Fdn Trust, Dept Diabet Endocrinol & Metab, Manchester, Lancs, England; [Soran, Handrean] Natl Inst Hlth Res, Wellcome Trust Clin Res Facil, Manchester, Lancs, England; [Freiberger, Tomas] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Fac Med, Brno, Czech Republic; [Bertolini, Stefano] Univ Genoa, Dept Internal Med, Genoa, Italy; [Harada-Shiba, Mariko] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Res Inst, Osaka, Japan; [Blom, Dirk J.] Univ Cape Town, Dept Med, Div Lipidol, Cape Town, South Africa; [Blom, Dirk J.] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa; [Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Carbohydrate & Lipid Metab Res Unit, Johannesburg, South Africa; [Cuchel, Marina] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Amsterdam; Academic Medical Center Amsterdam; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Sevilla; University of Manchester; Masaryk University Brno; University of Genoa; National Cerebral & Cardiovascular Center - Japan; University of Cape Town; University of Cape Town; University of Witwatersrand; University of Pennsylvania; Pennsylvania Medicine	Cuchel, M (corresponding author), Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	mcuchel@pennmedicine.upenn.edu	Kaynar, Leylagul/F-6991-2013; Yenercag, Mustafa/AAL-3873-2020; Pasta, Andrea/AAX-3013-2021; Vallejo-Vaz, Antonio J./AAT-9301-2021; Santos, Raul/A-1170-2010; Bourbon, Mafalda/K-6866-2014; Nawawi, Hapizah/F-3617-2018	Kaynar, Leylagul/0000-0002-2035-9462; Yenercag, Mustafa/0000-0002-0933-7852; Pasta, Andrea/0000-0003-1791-4506; Vallejo-Vaz, Antonio J./0000-0001-7954-1253; Santos, Raul/0000-0002-9860-6582; Alareedh, Mohammed/0000-0001-9804-1799; D'Erasmo, Laura/0000-0002-9174-4667; Durst, Ronen/0000-0003-3559-1050; Cicero, Arrigo Francesco Giuseppe/0000-0002-4367-3884; Cupido, Arjen/0000-0003-3300-8124; STEVENS, CHRISTOPHE A.T./0000-0002-7129-8524; Bourbon, Mafalda/0000-0001-8843-3799; Nawawi, Hapizah/0000-0003-4462-8484; Abdalsahib, Ali/0000-0002-6792-5767; Sadiq, Fouzia/0000-0001-9399-6078	NIH/NHLBI [P01HL059407]; European Atherosclerosis Society; National Institute for Health Research Imperial Biomedical Research Centre, UK; Ministry of Universities, Government of Spain; University of Sevilla, Spain; Ministry of Health, Czech Republic [NU20-02-00261]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Atherosclerosis Society; National Institute for Health Research Imperial Biomedical Research Centre, UK; Ministry of Universities, Government of Spain; University of Sevilla, Spain; Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	In-house funding at each institution was used to cover effort of contributors for data collection and entry. The creation and the maintenance of the REDCap database and support of a study coordinator for bulk data entry was provided in house by MC at the University of Pennsylvania. MC acknowledges support from NIH/NHLBI grant P01HL059407. Support of the registry coordinators (TRT and MLH) was provided in house by GKH at Amsterdam UMC, supplemented by a grant from the European Atherosclerosis Society to MLH. KKR acknowledges support from the National Institute for Health Research Imperial Biomedical Research Centre, UK. AJV-V acknowledges support from the Programa de Ayudas Beatriz Galindo from the Ministry of Universities, Government of Spain, and University of Sevilla, Spain. TF was partly supported by the Ministry of Health, Czech Republic, grant number NU20-02-00261. The HICC is an investigator-initiated project supported by funding from the academic institutions of the collaborators. The European Atherosclerosis Society provided funding to support a registry coordinator. The writing committee takes final responsibility for the content of the Article and the decision to submit for publication.	Alonso R, 2016, J CLIN LIPIDOL, V10, P953, DOI 10.1016/j.jacl.2016.04.006; Alves AC, 2020, ARTERIOSCL THROM VAS, V40, P2508, DOI 10.1161/ATVBAHA.120.313722; Beheshti SO, 2020, J AM COLL CARDIOL, V75, P2553, DOI 10.1016/j.jacc.2020.03.057; Beliard S, 2018, ATHEROSCLEROSIS, V277, P66, DOI 10.1016/j.atherosclerosis.2018.08.007; Ben-Omran T, 2019, ADV THER, V36, P1786, DOI 10.1007/s12325-019-00985-8; Bertolini S, 2020, ATHEROSCLEROSIS, V312, P72, DOI 10.1016/j.atherosclerosis.2020.08.027; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; D'Erasmo L, 2018, J AM COLL CARDIOL, V71, P279, DOI 10.1016/j.jacc.2017.11.028; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Di Taranto MD, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010219; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; France M, 2016, ATHEROSCLEROSIS, V255, P128, DOI 10.1016/j.atherosclerosis.2016.10.017; Hegele RA, 2020, LANCET DIABETES ENDO, V8, P50, DOI 10.1016/S2213-8587(19)30264-5; Hu PW, 2020, CIRCULATION, V141, P1742, DOI 10.1161/CIRCULATIONAHA.119.044795; Kayikcioglu M, 2019, J CLIN LIPIDOL, V13, P455, DOI 10.1016/j.jacl.2019.02.001; Luirink IK, 2020, ATHEROSCLEROSIS, V299, P24, DOI 10.1016/j.atherosclerosis.2020.01.031; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Raal FJ, 2020, NEW ENGL J MED, V383, P711, DOI 10.1056/NEJMoa2004215; Raal FJ, 2017, LANCET DIABETES ENDO, V5, P280, DOI 10.1016/S2213-8587(17)30044-X; Santos RD, 2020, J AM COLL CARDIOL, V75, P565, DOI 10.1016/j.jacc.2019.12.020; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Stefanutti C, 2019, J CLIN LIPIDOL, V13, P608, DOI 10.1016/j.jacl.2019.05.002; Stefanutti C, 2017, J CLIN LIPIDOL, V11, P858, DOI 10.1016/j.jacl.2017.04.114; Sturm AC, 2018, J AM COLL CARDIOL, V72, P662, DOI 10.1016/j.jacc.2018.05.044; The World Bank, DATA WORLD BANK NAT; Thompson GR, 2018, EUR HEART J, V39, P1162, DOI 10.1093/eurheartj/ehx317; Vallejo-Vaz AJ, 2018, ATHEROSCLEROSIS, V277, P234, DOI 10.1016/j.atherosclerosis.2018.08.051; Watts GF, 2021, HEART LUNG CIRC, V30, P324, DOI 10.1016/j.hlc.2020.09.943; Widhalm K, 2017, ATHEROSCLEROSIS, V257, P86, DOI 10.1016/j.atherosclerosis.2017.01.002	30	17	17	14	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					719	728		10.1016/S0140-6736(21)02001-8	http://dx.doi.org/10.1016/S0140-6736(21)02001-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE3NS	35101175	Green Submitted			2022-12-28	WOS:000758794200019
J	Gregg, J				Gregg, Jessica			The Care I Needed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gregg, Jessica] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Gregg, J (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					411	413		10.1056/NEJMp2112526	http://dx.doi.org/10.1056/NEJMp2112526		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YR1JU	35089663				2022-12-28	WOS:000748300400001
J	Hartke, T; Oreg, B; Jia, NY; Zwierlein, M				Hartke, Thomas; Oreg, Botond; Jia, Ningyuan; Zwierlein, Martin			Quantum register of fermion pairs	NATURE			English	Article							NEUTRAL ATOMS; ENTANGLEMENT; POLAR	Quantum control of motion is central for modern atomic clocks(1) and interferometers(2). It enables protocols to process and distribute quantum information(3,4), and allows the probing of entanglement in correlated states of matter(5). However, the motional coherence of individual particles can be fragile to maintain, as external degrees of freedom couple strongly to the environment. Systems in nature with robust motional coherence instead often involve pairs of particles, from the electrons in helium, to atom pairs(6), molecules(7) and Cooper pairs. Here we demonstrate long-lived motional coherence and entanglement of pairs of fermionic atoms in an optical lattice array. The common and relative motion of each pair realize a robust qubit, protected by exchange symmetry. The energy difference between the two motional states is set by the atomic recoil energy, is dependent on only the mass and the lattice wavelength, and is insensitive to the noise of the confining potential. We observe quantum coherence beyond ten seconds. Modulation of the interactions between the atoms provides universal control of the motional qubit. The methods presented here will enable coherently programmable quantum simulators of many-fermion systems(8), precision metrology based on atom pairs and molecules(9,10) and, by implementing further advances(11-13), digital quantum computation using fermion pairs(14).	[Hartke, Thomas; Oreg, Botond; Jia, Ningyuan; Zwierlein, Martin] MIT, Dept Phys, Res Lab Elect, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hartke, T; Zwierlein, M (corresponding author), MIT, Dept Phys, Res Lab Elect, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA.	hartke@mit.edu; zwierlein@mit.edu		Hartke, Thomas/0000-0001-7978-0473; Oreg, Botond/0000-0002-0998-1824	NSF through the Center for Ultracold Atoms [PHY-2012110]; ONR [N00014-17-1-2257]; AFOSR [FA9550-16-1-0324]; AFOSR-MURI [FA9550-14-1-0035, FA9550-21-1-0069]; Gordon and Betty Moore Foundation [GBMF5279]; Vannevar Bush Faculty Fellowship; Alexander von Humboldt Foundation	NSF through the Center for Ultracold Atoms; ONR(Office of Naval Research); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR-MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Vannevar Bush Faculty Fellowship; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank C. Robens for discussions. This work was supported by the NSF through the Center for Ultracold Atoms and Grant PHY-2012110, ONR (grant number N00014-17-1-2257), AFOSR (grant number FA9550-16-1-0324), AFOSR-MURIs on Quantum Phases of Matter (grant number FA9550-14-1-0035) and on Full Quantum State Control at Single Molecule Levels (grant number FA9550-21-1-0069), the Gordon and Betty Moore Foundation through grant GBMF5279, and the Vannevar Bush Faculty Fellowship. M.Z. acknowledges support from the Alexander von Humboldt Foundation.	Anderlini M, 2007, NATURE, V448, P452, DOI 10.1038/nature06011; Bakr WS, 2011, NATURE, V480, P500, DOI 10.1038/nature10668; Bauer B, 2020, CHEM REV, V120, P12685, DOI 10.1021/acs.chemrev.9b00829; Bergschneider A, 2019, NAT PHYS, V15, P640, DOI 10.1038/s41567-019-0508-6; Bolda EL, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033404; Browaeys A, 2020, NAT PHYS, V16, P132, DOI 10.1038/s41567-019-0733-z; Busch T, 1998, FOUND PHYS, V28, P549, DOI 10.1023/A:1018705520999; Cairncross WB, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.153001; Chen Y, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.053624; Cheuk LW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.193001; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Chiu CS, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.243201; D'Errico C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/223; Daniel DJ, 2020, PROG THEOR EXP PHYS, V2020, DOI 10.1093/ptep/ptaa024; Diener RB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010402; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Forster L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.233001; Greene CH, 2000, PHYS REV LETT, V85, P2458, DOI 10.1103/PhysRevLett.85.2458; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Greiner M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110401; Gross C, 2021, NAT PHYS, V17, P1316, DOI 10.1038/s41567-021-01370-5; Guardado-Sanchez E, 2021, PHYS REV X, V11, DOI [10.1103/physrevx.11.021036, 10.1103/PhysRevX.11.021036]; Haller E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153203; Hartke T, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.113601; HARTMANN SR, 1962, PHYS REV, V128, P2042, DOI 10.1103/PhysRev.128.2042; Ho AF, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.061601; Hollerith S, 2019, SCIENCE, V364, P664, DOI 10.1126/science.aaw4150; Idziaszek Z, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.050701; Ishmukhamedov IS, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.062701; Islam R, 2015, NATURE, V528, P77, DOI 10.1038/nature15750; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Kaufman AM, 2015, NATURE, V527, P208, DOI 10.1038/nature16073; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Koga A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216402; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Kondov SS, 2019, NAT PHYS, V15, P1118, DOI 10.1038/s41567-019-0632-3; Kubo K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.224509; Kwiat PG, 2000, SCIENCE, V290, P498, DOI 10.1126/science.290.5491.498; Laucht A, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.161302; Levine H, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.170503; Liu LR, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021039; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Mamaev M, 2020, ADV QUANTUM TECHNOL, V3, DOI 10.1002/qute.201900132; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Mitra D, 2018, NAT PHYS, V14, P173, DOI 10.1038/NPHYS4297; Muller T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.200405; Murmann S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.080402; Myrskog SH, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013615; Rom T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.073002; Sala S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203202; Sala S, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.022713; Schiller S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023004; Serwane F, 2011, SCIENCE, V332, P336, DOI 10.1126/science.1201351; Syassen N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.033201; Thompson ST, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190404; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; van Frank S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5009; Viverit L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.110401; Wang GQ, 2021, PHYS REV A, V103, DOI 10.1103/PhysRevA.103.022415; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Xu V, 2019, SCIENCE, V366, P745, DOI 10.1126/science.aay6428; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Zurn G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.075303	66	7	7	8	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					537	+		10.1038/s41586-021-04205-8	http://dx.doi.org/10.1038/s41586-021-04205-8			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082420	Green Submitted			2022-12-28	WOS:000749546400020
J	Robinson, A				Robinson, Ann			Ann Robinson's research reviews-27 January 2022	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Accorsi EK, 2022, JAMA-J AM MED ASSOC, V327, P639, DOI 10.1001/jama.2022.0470; Gao W, 2022, JAMA INTERN MED, V182, P283, DOI 10.1001/jamainternmed.2021.7769; Jones SM, 2022, LANCET, V399, P359, DOI 10.1016/S0140-6736(21)02390-4; Schneider CV, 2022, JAMA INTERN MED, V182, P291, DOI 10.1001/jamainternmed.2021.7804; Ware J, 2022, NEW ENGL J MED, V386, P209, DOI 10.1056/NEJMoa2111673	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o193	10.1136/bmj.o193	http://dx.doi.org/10.1136/bmj.o193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086848	Bronze			2022-12-28	WOS:000748641100014
J	Atmar, RL; Lyke, KE; Deming, ME; Jackson, LA; Branche, AR; El Sahly, HM; Rostad, CA; Martin, JM; Johnston, C; Rupp, RE; Mulligan, MJ; Brady, RC; Frenck, RW; Backer, M; Kottkamp, AC; Babu, TM; Rajakumar, K; Edupuganti, S; Dobrzynski, D; Coler, RN; Posavad, CM; Archer, JI; Crandon, S; Nayak, SU; Szydlo, D; Zemanek, JA; Islas, CPD; Brown, ER; Suthar, MS; McElrath, MJ; McDermott, AB; Montefiori, DC; Eaton, A; Neuzil, KM; Stephens, DS; Roberts, PC; Beigel, JH				Atmar, R. L.; Lyke, K. E.; Deming, M. E.; Jackson, L. A.; Branche, A. R.; El Sahly, H. M.; Rostad, C. A.; Martin, J. M.; Johnston, C.; Rupp, R. E.; Mulligan, M. J.; Brady, R. C.; Frenck, R. W., Jr.; Backer, M.; Kottkamp, A. C.; Babu, T. M.; Rajakumar, K.; Edupuganti, S.; Dobrzynski, D.; Coler, R. N.; Posavad, C. M.; Archer, J., I; Crandon, S.; Nayak, S. U.; Szydlo, D.; Zemanek, J. A.; Islas, C. P. Dominguez; Brown, E. R.; Suthar, M. S.; McElrath, M. J.; McDermott, A. B.; Montefiori, D. C.; Eaton, A.; Neuzil, K. M.; Stephens, D. S.; Roberts, P. C.; Beigel, J. H.		DMID 21-0012 Study Grp	Homologous and Heterologous Covid-19 Booster Vaccinations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELTA VARIANT PREDOMINANCE; SARS-COV-2; ANTIBODIES; VACCINES	BACKGROUND Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring. Data are needed on the serial use of homologous boosters (same as the primary vaccine) and heterologous boosters (different from the primary vaccine) in fully vaccinated recipients. METHODS In this phase 1-2, open-label clinical trial conducted at 10 sites in the United States, adults who had completed a Covid-19 vaccine regimen at least 12 weeks earlier and had no reported history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection received a booster injection with one of three vaccines: mRNA-1273 (Moderna) at a dose of 100 mu g, Ad26.COV2.S (Johnson & Johnson-Janssen) at a dose of 5x10(10) virus particles, or BNT162b2 (Pfizer-BioNTech) at a dose of 30 mu g. The primary end points were safety, reactogenicity, and humoral immunogenicity on trial days 15 and 29. RESULTS Of the 458 participants who were enrolled in the trial, 154 received mRNA-1273, 150 received Ad26.COV2.S, and 153 received BNT162b2 as booster vaccines; 1 participant did not receive the assigned vaccine. Reactogenicity was similar to that reported for the primary series. More than half the recipients reported having injection-site pain, malaise, headache, or myalgia. For all combinations, antibody neutralizing titers against a SARS-CoV-2 D614G pseudovirus increased by a factor of 4 to 73, and binding titers increased by a factor of 5 to 55. Homologous boosters increased neutralizing antibody titers by a factor of 4 to 20, whereas heterologous boosters increased titers by a factor of 6 to 73. Spike-specific T-cell responses increased in all but the homologous Ad26.COV2.S-boosted subgroup. CD8+ T-cell levels were more durable in the Ad26.COV2.S-primed recipients, and heterologous boosting with the Ad26.COV2.S vaccine substantially increased spike-specific CD8+ T cells in the mRNA vaccine recipients. CONCLUSIONS Homologous and heterologous booster vaccines had an acceptable safety profile and were immunogenic in adults who had completed a primary Covid-19 vaccine regimen at least 12 weeks earlier.	[Atmar, R. L.; El Sahly, H. M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Atmar, R. L.; El Sahly, H. M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rupp, R. E.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA; [Lyke, K. E.; Deming, M. E.; Neuzil, K. M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Crandon, S.; Nayak, S. U.; Roberts, P. C.; Beigel, J. H.] NIAID, Div Microbiol & Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Jackson, L. A.] Kaiser Permanence Washington Hlth Res Inst, Seattle, WA USA; [Johnston, C.; Babu, T. M.; McElrath, M. J.] Univ Washington, Dept Med, Seattle, WA USA; [Johnston, C.; Posavad, C. M.] Univ Washington, Dept Lab Med & Pathol, c, Seattle, WA 98195 USA; [Johnston, C.; Posavad, C. M.; Islas, C. P. Dominguez; Brown, E. R.; McElrath, M. J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Szydlo, D.; Zemanek, J. A.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Coler, R. N.] Univ Washington, Sch Med, Seattle Childrens Res Inst, Seattle, WA USA; [Coler, R. N.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Branche, A. R.; Dobrzynski, D.] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY USA; [Mulligan, M. J.; Kottkamp, A. C.] NYU Grossman Sch Med, NYU Langone Vaccine Ctr, New York, NY USA; [Mulligan, M. J.; Kottkamp, A. C.] NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY USA; [Backer, M.] NYU Long Isl Sch Med, NYU Langone Hosp, Long Isl Vaccine Ctr Res Clin, Mineola, NY USA; [Backer, M.] NYU Long Isl Sch Med, Dept Med, Div Infect Dis, Mineola, NY USA; [Rostad, C. A.] Emory Univ, Dept Pediat, Sch Med, Atlanta, GA 30322 USA; [Suthar, M. S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Edupuganti, S.; Stephens, D. S.] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; [Rostad, C. A.] Emory Univ, Ctr Childhood Infect & Vaccines, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Edupuganti, S.] Emory Univ, Hope Clin Emory Vaccine Ctr, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Suthar, M. S.] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Rostad, C. A.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Martin, J. M.; Rajakumar, K.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Brady, R. C.; Frenck, R. W., Jr.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH USA; [Archer, J., I] FHI 360, Durham, NC USA; [Montefiori, D. C.] Duke Univ Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Montefiori, D. C.; Eaton, A.] Duke Univ Med Ctr, Dept Surg, Durham, NC USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; FHI 360; Duke University; Duke University	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA.; Atmar, RL (corresponding author), Baylor Coll Med, 1 Baylor Plaza,MS BCM280, Houston, TX 77030 USA.	ratmar@bcm.edu; klyke@som.umaryland.edu	Atmar, Robert/AFQ-5392-2022; MACDONALD, Clint/AAR-6962-2021; Deming, Meagan/AEX-6400-2022; Beigel, John H/GNP-2628-2022	Atmar, Robert/0000-0001-9989-6772; MACDONALD, Clint/0000-0003-0995-0072; Deming, Meagan/0000-0003-2574-0542; Rostad, Christina/0000-0001-8439-0592; Kottkamp, Angelica/0000-0003-4103-1666; , T MAHESH BABU/0000-0002-4440-8329; DOBRZYNSKI, DAVID/0000-0001-5652-7432	Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI48372, UM1AI148373, UM1AI148450, UM1AI148452, UM1AI148573, UM1AI148574, UM1AI148575, UM1AI148576, UM1AI148684, UM1 AI148689]; NIAID Collaborative Influenza Vaccine Innovation Centers [75N93019C00050]; NIH Vaccine Research Center	Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH); NIAID Collaborative Influenza Vaccine Innovation Centers; NIH Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), under award numbers UM1AI48372, UM1AI148373, UM1AI148450, UM1AI148452, UM1AI148573, UM1AI148574, UM1AI148575, UM1AI148576, UM1AI148684, and UM1 AI148689, and with support from the NIAID Collaborative Influenza Vaccine Innovation Centers contract 75N93019C00050 and the NIH Vaccine Research Center.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Barouch DH, 2021, NEW ENGL J MED, V385, P951, DOI 10.1056/NEJMc2108829; Barros-Martins J, 2021, NAT MED, V27, P1525, DOI 10.1038/s41591-021-01449-9; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Brown CM, 2021, MMWR-MORBID MORTAL W, V70, P1059, DOI 10.15585/mmwr.mm7031e2; Centers for Disease Control and Prevention, ACIP PRES SLID NOV 1; Centers for Disease Control and Prevention,, 2021, CDC EXP EL COVID 19; Centers for Disease Control and Prevention, COVID DAT TRACK COVI; Choi A, 2021, NAT MED, V27, P2025, DOI 10.1038/s41591-021-01527-y; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Cromer D, 2022, LANCET MICROBE, V3, pE52, DOI 10.1016/S2666-5247(21)00267-6; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Food and Drug Administration, 2007, GUID IND; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Gilbert PB, 2022, SCIENCE, V375, P43, DOI 10.1126/science.abm3425; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Grannis SJ, 2021, MMWR-MORBID MORTAL W, V70, P1291, DOI 10.15585/mmwr.mm7037e2; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Patalon T, 2022, JAMA INTERN MED, V182, P179, DOI 10.1001/jamainternmed.2021.7382; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Pilishvili T, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2106599; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pozzetto B, 2021, NATURE, V600, P701, DOI 10.1038/s41586-021-04120-y; Rosenberg ES, 2022, NEW ENGL J MED, V386, P116, DOI 10.1056/NEJMoa2116063; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Schmidt T, 2021, NAT MED, V27, P1530, DOI 10.1038/s41591-021-01464-w; Shen Xiaoying, 2021, Cell Host Microbe, V29, P529, DOI [10.1101/2021.01.27.428516, 10.1016/j.chom.2021.03.002]; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175	35	125	129	10	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2022	386	11					1046	1057		10.1056/NEJMoa2116414	http://dx.doi.org/10.1056/NEJMoa2116414		JAN 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2P8CD	35081293	Bronze, Green Published			2022-12-28	WOS:000747075300001
J	Kuehn, BM				Kuehn, Bridget M.			Increased Use of Medicare Telehealth During the Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	12	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					313	313						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076683	Bronze			2022-12-28	WOS:000753055700002
J	Tracy, TE; Madero-Perez, J; Swaney, DL; Chang, TS; Moritz, M; Konrad, C; Ward, ME; Stevenson, E; Huttenhain, R; Kauwe, G; Mercedes, M; Sweetland-Martin, L; Chen, X; Mok, SA; Wong, MY; Telpoukhovskaia, M; Min, SW; Wang, C; Sohn, PD; Martin, J; Zhou, YG; Luo, WJ; Trojanowski, JQ; Lee, VMY; Gong, SC; Manfredi, G; Coppola, G; Krogan, NJ; Geschwind, DH; Gan, L				Tracy, Tara E.; Madero-Perez, Jesus; Swaney, Danielle L.; Chang, Timothy S.; Moritz, Michelle; Konrad, Csaba; Ward, Michael E.; Stevenson, Erica; Huttenhain, Ruth; Kauwe, Grant; Mercedes, Maria; Sweetland-Martin, Lauren; Chen, Xu; Mok, Sue-Ann; Wong, Man Ying; Telpoukhovskaia, Maria; Min, Sang-Won; Wang, Chao; Sohn, Peter Dongmin; Martin, Jordie; Zhou, Yungui; Luo, Wenjie; Trojanowski, John Q.; Lee, Virginia M. Y.; Gong, Shiaoching; Manfredi, Giovanni; Coppola, Giovanni; Krogan, Nevan J.; Geschwind, Daniel H.; Gan, Li			Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration	CELL			English	Article							PROTEIN; PHOSPHORYLATION; DYSFUNCTION; TAUOPATHY; NEURONS; BINDING; CELLS; P301L; BETA; MISLOCALIZATION	Tau (MAPT) drives neuronal dysfunction in Alzheimer disease (AD) and other tauopathies. To dissect the underlying mechanisms, we combined an engineered ascorbic acid peroxidase (APEX) approach with quantitative affinity purification mass spectrometry (AP-MS) followed by proximity ligation assay (PLA) to characterize Tau interactomes modified by neuronal activity and mutations that cause frontotemporal dementia (FTD) in human induced pluripotent stem cell (iPSC)-derived neurons. We established interactions of Tau with presynaptic vesicle proteins during activity-dependent Tau secretion and mapped the Tau-binding sites to the cytosolic domains of integral synaptic vesicle proteins. We showed that FTD mutations impair bioenergetics and markedly diminished Tau's interaction with mitochondria proteins, which were downregulated in AD brains of multiple cohorts and correlated with disease severity. These multimodal and dynamic Tau interactomes with exquisite spatial resolution shed light on Tau's role in neuronal function and disease and highlight potential therapeutic targets to block Tau-mediated pathogenesis.	[Tracy, Tara E.; Swaney, Danielle L.; Ward, Michael E.; Stevenson, Erica; Huttenhain, Ruth; Chen, Xu; Telpoukhovskaia, Maria; Min, Sang-Won; Wang, Chao; Sohn, Peter Dongmin; Martin, Jordie; Zhou, Yungui; Krogan, Nevan J.] Gladstone Inst, San Francisco, CA 94158 USA; [Tracy, Tara E.; Kauwe, Grant] Buck Inst Res Aging, Novato, CA 94945 USA; [Madero-Perez, Jesus; Mercedes, Maria; Sweetland-Martin, Lauren; Wong, Man Ying; Luo, Wenjie; Gong, Shiaoching; Gan, Li] Weill Cornell Med, Feil Family Brain & Mind Res Inst, Helen & Robert Appel Alzheimer Dis Res Inst, New York, NY 10021 USA; [Swaney, Danielle L.; Moritz, Michelle; Stevenson, Erica; Huttenhain, Ruth; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Swaney, Danielle L.; Stevenson, Erica; Huttenhain, Ruth; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94158 USA; [Chang, Timothy S.; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Movement Disorders Program, Los Angeles, CA 90095 USA; [Chang, Timothy S.; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Los Angeles, CA 90095 USA; [Konrad, Csaba; Manfredi, Giovanni] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Mok, Sue-Ann] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada; [Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA; [Trojanowski, John Q.; Lee, Virginia M. Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Buck Institute for Research on Aging; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine	Tracy, TE; Swaney, DL (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Tracy, TE (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Madero-Perez, J; Gan, L (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, Helen & Robert Appel Alzheimer Dis Res Inst, New York, NY 10021 USA.; Swaney, DL (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Swaney, DL (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst QBI, San Francisco, CA 94158 USA.	ttracy@buckinstitute.org; jem4002@med.cornell.edu; danielle.swaney@gladstone.ucsf.edu; lig2033@med.cornell.edu	; Telpoukhovskaia, Maria/O-5070-2015	Moritz, Michelle/0000-0003-3811-5623; Tracy, Tara/0000-0003-3356-4091; Chang, Timothy/0000-0002-9225-9874; Mok, Sue-Ann/0000-0003-4593-3368; Telpoukhovskaia, Maria/0000-0002-5237-4042	NIH [U54NS100717, R01AG054214, K01 AG057862, R25NS065723]; Tau Consortium; JPB Foundation; Fundacion Ramon Areces; NINDS [U24 NS072026]; NIA [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; JPB Foundation; Fundacion Ramon Areces; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research	We thank Dr. Bruce Conklin (Gladstone Institutes) for the WTC11 iPSCs, pUCM vector, and TALENS; Connor Ludwig for technical support; Kathryn Claiborn for editorial support; and Nathan Basisty for analysis advice. This work was supported by the NIH (U54NS100717 to L.G. and N.J.K., R01AG054214 to L.G., K01 AG057862 to T.E.T., R25NS065723), Tau Consortium and JPB Foundation (to L.G.), and Fundacion Ramon Areces (to J.M.-P.). The results published here are based on data obtained from the AMP-AD Knowledge Portal (https://adknowledgeportal.synapse.org/).Dr.Levey (Emory University) provided BLSA data from brain tissue collected through the NIA's BLSA, UPenn data from brain tissue collected through the University of Pennsylvania, Emory data from brain tissue collected through Emory Alzheimer's Disease Research Center Brain Bank, and Banner data generated in part from samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona, supported by the NINDS (U24 NS072026), the NIA (P30 AG19610), the Arizona Department of Health Services (contract 211002), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research.	Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Amadoro G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.001; Bardai FH, 2018, J NEUROSCI, V38, P108, DOI 10.1523/JNEUROSCI.1550-17.2017; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Benussi L, 2005, EXP CELL RES, V308, P78, DOI 10.1016/j.yexcr.2005.04.021; Berk JM, 2013, NUCLEUS-PHILA, V4, P298, DOI 10.4161/nucl.25751; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chang CW, 2021, SCIENCE, V371, P904, DOI 10.1126/science.abb8255; Choi H, 2020, AGING CELL, V19, DOI 10.1111/acel.13081; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Eftekharzadeh B, 2018, NEURON, V99, P925, DOI 10.1016/j.neuron.2018.07.039; Ehrlich M, 2015, STEM CELL REP, V5, P83, DOI 10.1016/j.stemcr.2015.06.001; Evans HT, 2019, EMBO J, V38, DOI 10.15252/embj.2018101174; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Frandemiche ML, 2014, J NEUROSCI, V34, P6084, DOI 10.1523/JNEUROSCI.4261-13.2014; Gaiteri C., 2019, METAANALYSIS HUMAN B, DOI [10. 1101/510420v1. abstract, DOI 10.1101/510420V1.ABSTRACT]; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Guix FX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030663; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; Helm MS, 2021, NAT NEUROSCI, V24, P1151, DOI 10.1038/s41593-021-00874-w; Hodes RJ, 2016, EXPERT OPIN THER TAR, V20, P389, DOI 10.1517/14728222.2016.1135132; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Lobingier BT, 2017, CELL, V169, P350, DOI 10.1016/j.cell.2017.03.022; Loh KH, 2016, CELL, V166, P1295, DOI 10.1016/j.cell.2016.07.041; Matsui T, 2018, J CELL BIOL, V217, P2633, DOI 10.1083/jcb.201712058; Maziuk BF, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0574-5; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Meier S, 2016, J NEUROSCI, V36, P1001, DOI 10.1523/JNEUROSCI.3029-15.2016; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Pearson ES, 1931, J AM STAT ASSOC, V26, P128, DOI 10.2307/2277761; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Schulz KL, 2012, MOL NEUROBIOL, V46, P205, DOI 10.1007/s12035-012-8308-3; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Sohn PD, 2019, NEURON, V104, P458, DOI 10.1016/j.neuron.2019.08.008; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Sokolow S, 2015, J NEUROCHEM, V133, P368, DOI 10.1111/jnc.12991; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarup V, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107807; Taylor IR, 2018, J BIOL CHEM, V293, P10796, DOI 10.1074/jbc.RA118.002234; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Udeshi ND, 2017, NAT METHODS, V14, P1167, DOI 10.1038/nmeth.4465; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vogel JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15701-2; Wang C, 2017, STEM CELL REP, V9, P1221, DOI 10.1016/j.stemcr.2017.08.019; Wang P, 2017, ACTA NEUROPATHOL, V133, P731, DOI 10.1007/s00401-016-1663-9; Wang XZ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52543-5; Wang Y, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0143-y; Weickert S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6999; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	90	22	22	33	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					712	+		10.1016/j.cell.2021.12.041	http://dx.doi.org/10.1016/j.cell.2021.12.041			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7CM	35063084	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000759723100001
J	Borthwick, M; Bannaga, A; Ashmore, AA; Johnson, CHN; Arasaradnam, RP				Borthwick, Molly; Bannaga, Ayman; Ashmore, Ayisha A.; Johnson, Charles H. N.; Arasaradnam, Ramesh P.			Preliminary management of acute onset right sided abdominal pain in women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE APPENDICITIS		[Borthwick, Molly] Queensland Hlth, Brisbane, Qld, Australia; [Bannaga, Ayman; Arasaradnam, Ramesh P.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Bannaga, Ayman; Arasaradnam, Ramesh P.] Univ Warwick, Warwick Med Sch, Warwick, England; [Ashmore, Ayisha A.] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Johnson, Charles H. N.] Hlth Educ England North East, Newcastle Upon Tyne, Tyne & Wear, England	Queensland Health; University of Warwick; University of Warwick; University Hospitals of Leicester NHS Trust; University of Leicester	Arasaradnam, RP (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England.; Arasaradnam, RP (corresponding author), Univ Warwick, Warwick Med Sch, Warwick, England.	Ramesh.Arasaradnam@rcp.ac.uk		Ashmore, Ayisha/0000-0003-1011-6253; Arasaradnam, Ramesh/0000-0002-2231-3062; Bannaga, Ayman/0000-0003-4814-7864				Andersson M, 2008, WORLD J SURG, V32, P1843, DOI 10.1007/s00268-008-9649-y; [Anonymous], 2016, BJOG-INT J OBSTET GY, V123, pE16, DOI 10.1111/1471-0528.14189; Ashdown HF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8012; DAVEY WW, 1956, BRIT MED J, V2, P28, DOI 10.1136/bmj.2.4983.28; Fagerstrom A, 2017, SCAND J GASTROENTERO, V52, P1072, DOI 10.1080/00365521.2017.1342140; Griffey RT, 2013, J EMERG MED, V44, P155, DOI 10.1016/j.jemermed.2011.05.032; Kharbanda AB, 2005, PEDIATRICS, V116, P709, DOI 10.1542/peds.2005-0094; Kleinschmidt S, 2021, JACEP OPEN, V2, DOI 10.1002/emp2.12427; National Institute for Health and Care Excellence, 2019, NG126; Nepogodiev D, 2020, BRIT J SURG, V107, P73, DOI 10.1002/bjs.11440; Nguyen LK, 2012, ANZ J SURG, V82, P36, DOI 10.1111/j.1445-2197.2010.05632.x; Rud B, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009977.pub2; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Soda K, 2001, ARCH SURG-CHICAGO, V136, P1136, DOI 10.1001/archsurg.136.10.1136; To N, 2016, ALIMENT PHARM THER, V43, P549, DOI 10.1111/apt.13511; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156	16	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								e068020	10.1136/bmj-2021-068020	http://dx.doi.org/10.1136/bmj-2021-068020			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135819				2022-12-28	WOS:000754132400009
J	Kuehn, BM				Kuehn, Bridget M.			Health Care Professionals Advice Can Increase COVID-19 Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					518	518		10.1001/jama.2022.0338	http://dx.doi.org/10.1001/jama.2022.0338			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35133408	Bronze			2022-12-28	WOS:000758257900004
J	Zerilli, J				Zerilli, John			Reality plus : Virtual Worlds and the Problems of Philosophy	SCIENCE			English	Book Review									[Zerilli, John] Univ Oxford, Inst Eth AI, Oxford OX1 3UL, England; [Zerilli, John] Univ Oxford, Fac Law, Oxford OX1 3UL, England	University of Oxford; University of Oxford	Zerilli, J (corresponding author), Univ Oxford, Inst Eth AI, Oxford OX1 3UL, England.; Zerilli, J (corresponding author), Univ Oxford, Fac Law, Oxford OX1 3UL, England.							Chalmers D.J., 2022, REALITY VIRTUAL WORL	1	0	0	3	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					503	503						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113701				2022-12-28	WOS:000753965100027
J	Akashi, H; Shimada, S; Tamura, T; Chinda, E; Kokudo, N				Akashi, Hidechika; Shimada, Satoshi; Tamura, Toyomitsu; Chinda, Eiki; Kokudo, Norihiro			SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo Olympic and Paralympic Games	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study examines SARS-CoV-2 infections detected in close contacts of confirmed cases within the Olympic Village at the 2021 Tokyo Olympic and Paralympic Games.	[Akashi, Hidechika; Tamura, Toyomitsu; Chinda, Eiki] Natl Ctr Global Hlth & Med NCGM, Bur Int Hlth Cooperat BIHC, Tokyo, Japan; [Shimada, Satoshi] Tokyo Organising Comm Olymp & Paralymp Games, Infect Dis Control Ctr, Tokyo, Japan; [Kokudo, Norihiro] Natl Ctr Global Hlth & Med NCGM, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Akashi, H (corresponding author), Natl Ctr Global Hlth & Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	hakashi@it.ncgm.go.jp		Shimada, Satoshi/0000-0002-9551-181X				[Anonymous], 2021, REV TOK 2020; International Olympic Committee and International Paralympic Committee, 2021, PLAYB ATHL OFF; Shimizu K, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n962; Sparrow AK, 2021, NEW ENGL J MED, V385, pE2, DOI 10.1056/NEJMp2108567; World Health Organisation, 2020, GLOB SURV COVID 19 C	5	4	4	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2022	327	10					978	980		10.1001/jama.2022.0818	http://dx.doi.org/10.1001/jama.2022.0818		FEB 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZT9ON	35113161	Bronze, Green Published			2022-12-28	WOS:000750998000002
J	Creevy, KE; Akey, JM; Kaeberlein, M; Promislow, DEL				Creevy, Kate E.; Akey, Joshua M.; Kaeberlein, Matt; Promislow, Daniel E. L.		Dog Aging Project Consortium	An open science study of ageing in companion dogs	NATURE			English	Article							LONGEVITY; DRIVEN	The Dog Aging Project is a long-term longitudinal study of ageing in tens of thousands of companion dogs. The domestic dog is among the most variable mammal species in terms of morphology, behaviour, risk of age-related disease and life expectancy. Given that dogs share the human environment and have a sophisticated healthcare system but are much shorter-lived than people, they offer a unique opportunity to identify the genetic, environmental and lifestyle factors associated with healthy lifespan. To take advantage of this opportunity, the Dog Aging Project will collect extensive survey data, environmental information, electronic veterinary medical records, genome-wide sequence information, clinicopathology and molecular phenotypes derived from blood cells, plasma and faecal samples. Here, we describe the specific goals and design of the Dog Aging Project and discuss the potential for this open-data, community science study to greatly enhance understanding of ageing in a genetically variable, socially relevant species living in a complex environment.	[Creevy, Kate E.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX USA; [Akey, Joshua M.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kaeberlein, Matt; Promislow, Daniel E. L.] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Texas A&M University System; Texas A&M University College Station; Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Promislow, DEL (corresponding author), Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA 98195 USA.; Promislow, DEL (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	promislo@uw.edu		Morrill, Kathleen/0000-0002-9139-453X; Kaeberlein, Matt/0000-0002-1311-3421; Collins, Devin/0000-0002-5959-9455; Castelhano, Marta/0000-0003-2497-1939; Snyder-Mackler, Noah/0000-0003-3026-6160; Ma, Jing/0000-0001-6294-227X; Promislow, Daniel/0000-0001-7088-4495	National Institute on Aging, National Institutes of Health [U19AG057377]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All dog research described here, including informed owner consent, is approved by the Texas A&M University Institutional Animal Care and Use Committee, under AUPs 2018-0401 CAM and 2018-0368 CAM. The DAP is supported by grant U19AG057377 from the National Institute on Aging, a part of the National Institutes of Health, and by private donations. We thank S. Moon for help in preparing figures.	Bisong E., 2019, BUILDING MACHINE LEA, P7, DOI [10.1007/978-1-4842-4470-8_2, DOI 10.1007/978-1-4842-4470-8_2]; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haumann R, 2018, METHODS MOL BIOL, V1730, P361, DOI 10.1007/978-1-4939-7592-1_27; Kaeberlein M, 2016, MAMM GENOME, V27, P279, DOI 10.1007/s00335-016-9638-7; Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267; Kim SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228535; Li JH, 2021, GENOME RES, V31, P529, DOI 10.1101/gr.266486.120; Lippi G, 2019, CLIN CHEM LAB MED, V57, P974, DOI 10.1515/cclm-2018-1334; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Melzer D, 2007, J GERONTOL A-BIOL, V62, P301, DOI 10.1093/gerona/62.3.301; Minnema L, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00077; Mooney SJ, 2020, HEALTH PLACE, V63, DOI 10.1016/j.healthplace.2020.102332; Salvin HE, 2011, VET J, V188, P331, DOI 10.1016/j.tvjl.2010.05.014; Simeon-Dubach D, 2016, TRANSFUS MED HEMOTH, V43, P353, DOI 10.1159/000448254; Taylor HA, 2018, AM J BIOETHICS, V18, P58, DOI 10.1080/15265161.2018.1522166; US Department of the Census, 2013, American Community Survey (ACS): Public Use Microdata Sample (PUMS), DOI 10.3886/ICPSR33802.v1; Vose R.S., 2014, **DATA OBJECT**, DOI 10.7289/V5M32STR; Wilfond BS, 2018, AM J BIOETHICS, V18, P64, DOI 10.1080/15265161.2018.1513591	20	10	10	4	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					51	+		10.1038/s41586-021-04282-9	http://dx.doi.org/10.1038/s41586-021-04282-9			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110758	Green Accepted			2022-12-28	WOS:000750429600017
J	Marsh, JW; Ley, RE				Marsh, James W.; Ley, Ruth E.			Microbiome engineering: Taming the untractable	CELL			English	Editorial Material									[Marsh, James W.; Ley, Ruth E.] Max Planck Inst Biol, Dept Microbiome Sci, D-72076 Tubingen, Germany	Max Planck Society	Ley, RE (corresponding author), Max Planck Inst Biol, Dept Microbiome Sci, D-72076 Tubingen, Germany.	ruth.ley@tuebingen.mpg.de	Ley, Ruth E/M-8542-2014; Marsh, James/F-1037-2016	Ley, Ruth E/0000-0002-9087-1672; Marsh, James/0000-0003-4681-1012				Bernheim A, 2020, NAT REV MICROBIOL, V18, P113, DOI 10.1038/s41579-019-0278-2; Brophy JAN, 2018, NAT MICROBIOL, V3, P1043, DOI 10.1038/s41564-018-0216-5; Farzadfard F, 2021, CELL SYST, V12, P860, DOI 10.1016/j.cels.2021.07.001; Hsu BB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18614-2; Jin WB, 2022, CELL, V185, P547, DOI 10.1016/j.cell.2021.12.035; Johnston CD, 2019, P NATL ACAD SCI USA, V116, P11454, DOI 10.1073/pnas.1820256116; Redondo-Salvo S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17278-2; Rubin BE, 2022, NAT MICROBIOL, V7, P34, DOI 10.1038/s41564-021-01014-7; Waller MC, 2017, CURR OPIN MICROBIOL, V38, P156, DOI 10.1016/j.mib.2017.05.006	9	2	2	5	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					416	418		10.1016/j.cell.2021.12.034	http://dx.doi.org/10.1016/j.cell.2021.12.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35081334				2022-12-28	WOS:000753615000005
J	Wesemann, DR				Wesemann, Duane R.			Omicron's message on vaccines: Boosting begets breadth	CELL			English	Editorial Material								In this issue of Cell, three studies confirm that SARS-CoV-2 Omicron strongly evades a key immune de-fense-neutralizing antibodies. However, while one-or two-dose vaccine regimens fail to induce anti-Omi-cron neutralizing antibodies, a homologous third-dose booster rescues neutralization function in a way that highlights the adaptability of immune memory, where recalled immunity extends antibody reach across SARS-CoV-2 variants.	[Wesemann, Duane R.] Harvard Med Sch, Brigham & Womens Hosp, Div Allergy & Clin Immunol, Dept Med,Div Genet, Boston, MA 02115 USA; [Wesemann, Duane R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Wesemann, DR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Allergy & Clin Immunol, Dept Med,Div Genet, Boston, MA 02115 USA.; Wesemann, DR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dwesemann@bwh.harvard.edu		Wesemann, Duane/0000-0002-6690-944X	Massachusetts Consortium for Pathogen Readiness; NIH [AI165072, AI139538, AI158811, AI169619]; Bill and Melinda Gates Foundation; Food Allergy Science Initiative; China Ever-grande Group	Massachusetts Consortium for Pathogen Readiness; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Food Allergy Science Initiative; China Ever-grande Group	D.R.W. is supported by the Massachusetts Consortium for Pathogen Readiness; NIH grants AI165072, AI139538, AI158811, and AI169619; the Bill and Melinda Gates Foundation; the Food Allergy Science Initiative; and the China Ever-grande Group.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Bates JT, 2013, J IMMUNOL, V190, P3732, DOI 10.4049/jimmunol.1202964; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Dejnirattisai W., 2022, CELL, V185; Eguia RT, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009453; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran W.F., 2021, CELL, V185; Hoffmann M., 2021, CELL, V185; Kistler KE, 2021, ELIFE, V10, DOI 10.7554/eLife.64509; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]	12	7	6	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					411	413		10.1016/j.cell.2022.01.006	http://dx.doi.org/10.1016/j.cell.2022.01.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35065712	Bronze, Green Published			2022-12-28	WOS:000753615000003
J	Cerdeira, AS; Ismail, L; Moore, N; George, B; Majd, HS				Cerdeira, Ana Sofia; Ismail, Lamiese; Moore, Niall; George, Bruce; Majd, Hooman Soleymani			Retroperitoneal leiomyomatosis: a benign outcome of power morcellation with potentially serious consequences	LANCET			English	Editorial Material									[Cerdeira, Ana Sofia; Ismail, Lamiese] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Dept Obstet & Gynaecol, Oxford, England; [Moore, Niall] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Dept Radiol, Oxford, England; [George, Bruce] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Colorectal Surg, Churchill Canc Ctr, Oxford, England; [Majd, Hooman Soleymani] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Dept Gynaecol Oncol, Oxford OX3 7LE, England; [Cerdeira, Ana Sofia; Majd, Hooman Soleymani] Univ Oxford, Womens Ctr, John Radcliffe Hosp, Nuffield Dept Womens & Reprod Hlth, Oxford, England	Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Majd, HS (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Dept Gynaecol Oncol, Oxford OX3 7LE, England.	hooman.soleymani@ouh.nhs.uk	Soleymani majd, Hooman/ABI-5841-2020	Soleymani majd, Hooman/0000-0003-3293-5321					0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					554	554						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123695	Green Submitted			2022-12-28	WOS:000755144500028
J	Madaan, A; Gandhi, N; Madaan, S				Madaan, Anika; Gandhi, Naimish; Madaan, Sanjeev			Visible haematuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COHORT		[Madaan, Anika] Imperial Coll London, Fac Med, London, England; [Gandhi, Naimish] Jubilee Med Ctr, House Surg, Longfield, England; [Madaan, Sanjeev] Dartford & Gravesham NHS Trust, Dept Urol & Nephrol, Canterbury, Kent, England; [Madaan, Sanjeev] Canterbury Christchurch Univ, Inst Med Sci, Canterbury, Kent, England	Imperial College London; Canterbury Christ Church University	Madaan, S (corresponding author), Dartford & Gravesham NHS Trust, Dept Urol & Nephrol, Canterbury, Kent, England.; Madaan, S (corresponding author), Canterbury Christchurch Univ, Inst Med Sci, Canterbury, Kent, England.	Sanjeev.Madaan@nhs.net		Madaan, Sanjeev/0000-0003-4220-5613				Bataille Aurelien, 2016, BMC Res Notes, V9, P435, DOI 10.1186/s13104-016-2240-y; Cancer Research UK, 2018, SYMPTOMS BLADDER CAN; Edwards TJ, 2006, BJU INT, V97, P301, DOI 10.1111/j.1464-410X.2006.05976.x; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Kelly JD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3021; Khadra MH, 2000, J UROLOGY, V163, P524, DOI 10.1016/S0022-5347(05)67916-5; Mishriki SF, 2012, J UROLOGY, V187, P1561, DOI [10.1016/j.juro.2011.12.100, 10.1016/j.juro.2012.08.213]; National Institute for Health and Care Excellence, 2015, SUSPECTED CANC RECOG; National Institute for Health and Care Excellence, 2020, UROLOGICAL CANCERSRE; Public Health England, 2020, DIAGNOSIS URINARY TR; Reynolds BR, 2021, ANZ J SURG, V91, P565, DOI 10.1111/ans.16439; Shepherd EA, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654560; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Tan WS, 2018, EUR UROL, V74, P10, DOI 10.1016/j.eururo.2018.03.008; VANSAVAGE JG, 1995, J UROLOGY, V153, P1594, DOI 10.1016/S0022-5347(01)67469-X	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								e067395	10.1136/bmj-2021-067395	http://dx.doi.org/10.1136/bmj-2021-067395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105541				2022-12-28	WOS:000758676500001
J	Sanchez-Hernandez, RM; Civeira, F				Sanchez-Hernandez, Rosa M.; Civeira, Fernando			Homozygous familiar hypercholesterolemia: still a long way to go	LANCET			English	Editorial Material									[Sanchez-Hernandez, Rosa M.] Univ Los Palmas Gran Canaria, Secc Endocrinol & Nutr, Complejo Hosp Univ Insular Materno Infantil Las P, Inst Univ Invest Biomed & Sanitarias, Las Palmas Gran Canaria 35016, Spain; [Civeira, Fernando] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Invest Sanitaria Aragon, CIBERCV, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Miguel Servet University Hospital; University of Zaragoza	Sanchez-Hernandez, RM (corresponding author), Univ Los Palmas Gran Canaria, Secc Endocrinol & Nutr, Complejo Hosp Univ Insular Materno Infantil Las P, Inst Univ Invest Biomed & Sanitarias, Las Palmas Gran Canaria 35016, Spain.	rsanherj@gobiernodecanarias.org						Astaneh B, 2021, J CARDIOVASC DEV DIS, V8, DOI 10.3390/jcdd8070082; Ben-Omran T, 2019, ADV THER, V36, P1786, DOI 10.1007/s12325-019-00985-8; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Hegele RA, 2020, LANCET DIABETES ENDO, V8, P50, DOI 10.1016/S2213-8587(19)30264-5; Raal FJ, 2020, NEW ENGL J MED, V383, P711, DOI 10.1056/NEJMoa2004215; Raal FJ, 2017, LANCET DIABETES ENDO, V5, P280, DOI 10.1016/S2213-8587(17)30044-X; Sanchez-Hernandez RM, 2016, CIRC-CARDIOVASC GENE, V9, P504, DOI 10.1161/CIRCGENETICS.116.001545; Thompson GR, 2018, EUR HEART J, V39, P1162, DOI 10.1093/eurheartj/ehx317; Tromp TR, 2022, LANCET, V399, P719, DOI 10.1016/S0140-6736(21)02001-8	10	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					696	697		10.1016/S0140-6736(21)02223-6	http://dx.doi.org/10.1016/S0140-6736(21)02223-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE3NS	35101174				2022-12-28	WOS:000758794200003
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: unravelling the conundrum of omicron and deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, CORONAVIRUS COVID 19; Gov.uk, DEATHS UK; NHS England, 2022, COVID 19 HOSP ACT PR; Oliver D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n352; Rayner G, 2022, TELEGRAPH 0103; Reuters, 2022, REUTERS; Spiegelhalter D., 2021, POLITICO JAN	7	5	5	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o254	10.1136/bmj.o254	http://dx.doi.org/10.1136/bmj.o254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091392	Bronze			2022-12-28	WOS:000749313200009
J	Looi, MK				Looi, Mun-Keat			The BMJ Interview: Peter Piot	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mlooi@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o138	10.1136/bmj.o138	http://dx.doi.org/10.1136/bmj.o138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086820				2022-12-28	WOS:000748641100002
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Prolonging omicron	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						[Anonymous], 2022, BBC NEWS 0605; BMA, 2022, IMMED RESTR REL RISK; Office for National Statistics, 2022, COR COVID 19 LAT INS; Sharma R, INEWS 0619, V2022; Worldometers, WEEKL TRENDS	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o191	10.1136/bmj.o191	http://dx.doi.org/10.1136/bmj.o191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078775	Bronze			2022-12-28	WOS:000759189200016
J	Vigneshwaran, J; Kumar, MS; Raghavan, V; Sundari, S				Vigneshwaran, J.; Kumar, M. Senthil; Raghavan, Vijayashree; Sundari, Sivagama			Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis	LANCET			English	Editorial Material									[Vigneshwaran, J.; Kumar, M. Senthil] Chettinad Acad Res & Educ, Chettinad Hosp & Res Inst, Dept Gen Med, Chennai, Tamil Nadu, India; [Raghavan, Vijayashree; Sundari, Sivagama] Chettinad Acad Res & Educ, Chettinad Hosp & Res Inst, Dept Pathol, Chennai, Tamil Nadu, India		Kumar, MS (corresponding author), Chettinad Hosp & Res Inst, Dept Gen Med, Chennai 603103, Tamil Nadu, India.	senthil1992@gmail.com							0	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					393	393						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065787				2022-12-28	WOS:000746046100022
J	Cui, Z; Liu, P; Wang, N; Wang, L; Fan, KY; Zhu, QH; Wang, K; Chen, RH; Feng, R; Jia, ZJ; Yang, MN; Xu, G; Zhu, BL; Fu, WJ; Chu, TM; Feng, LL; Wang, YD; Pei, XR; Yang, P; Xie, XS; Cao, L; Cao, YL; Wang, XX				Cui, Zhen; Liu, Pan; Wang, Nan; Wang, Lei; Fan, Kaiyue; Zhu, Qianhui; Wang, Kang; Chen, Ruihong; Feng, Rui; Jia, Zijing; Yang, Minnan; Xu, Ge; Zhu, Boling; Fu, Wangjun; Chu, Tianming; Feng, Leilei; Wang, Yide; Pei, Xinran; Yang, Peng; Xie, Xiaoliang Sunney; Cao, Lei; Cao, Yunlong; Wang, Xiangxi			Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron	CELL			English	Article							ACE2; BINDING; SPIKE	The SARS-CoV-2 Omicron variant with increased fitness is spreading rapidly worldwide. Analysis of cryoEM structures of the spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. The relatively more compact domain organization confers improved stability and enhances attachment but compromises the efficiency of the viral fusion step. Alterations in local conformation, charge, and hydrophobic microenvironments underpin the modulation of the epitopes such that they are not recognized by most NTD-and RBD-antibodies, facilitating viral immune escape. Structure of the Omicron S bound with human ACE2, together with the analysis of sequence conservation in ACE2 binding region of 25 sarbecovirus members, as well as heatmaps of the immunogenic sites and their corresponding mutational frequencies, sheds light on conserved and structurally restrained regions that can be used for the development of broad-spectrum vaccines and therapeutics.	[Cui, Zhen; Liu, Pan; Wang, Nan; Wang, Lei; Fan, Kaiyue; Zhu, Qianhui; Wang, Kang; Feng, Rui; Jia, Zijing; Yang, Minnan; Xu, Ge; Zhu, Boling; Fu, Wangjun; Chu, Tianming; Feng, Leilei; Wang, Yide; Pei, Xinran; Yang, Peng; Cao, Lei; Wang, Xiangxi] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Natl Lab Macromol, Beijing 100101, Peoples R China; [Cui, Zhen; Liu, Pan; Wang, Lei; Fan, Kaiyue; Zhu, Qianhui; Jia, Zijing; Xu, Ge; Fu, Wangjun; Chu, Tianming; Feng, Leilei; Wang, Yide; Yang, Peng; Wang, Xiangxi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chen, Ruihong] Guangzhou Med Univ, Guangzhou 511495, Peoples R China; [Xie, Xiaoliang Sunney; Cao, Yunlong] Peking Univ, Biomed Pioneering Innovat Ctr Biop, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Medical University; Peking University	Cao, L; Wang, XX (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Natl Lab Macromol, Beijing 100101, Peoples R China.; Wang, XX (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Cao, YL (corresponding author), Peking Univ, Biomed Pioneering Innovat Ctr Biop, Beijing 100080, Peoples R China.	catcao1991@ibp.ac.cn; yunlongcao@pku.edu.cn; xiangxi@ibp.ac.cn	Cao, Yunlong/HCH-3492-2022	Wang, Kang/0000-0002-7467-1953	Strategic Priority Research Program [XDB29010000, XDB37030000]; CAS [YSBR-010]; National Key Research and Development Program [2020YFA0707500, 2018YFA0900801]; Beijing Municipal Science and Technology Project [Z201100005420017]; Ministry of Science and Technology of China [EKPG21-09, CPL-1233]; Thousand Talent Program; NSFS Innovative Research Group [81921005]; Special Research Assistant Project of the Chinese Academy of Medical Sciences	Strategic Priority Research Program(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); National Key Research and Development Program; Beijing Municipal Science and Technology Project; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Thousand Talent Program; NSFS Innovative Research Group; Special Research Assistant Project of the Chinese Academy of Medical Sciences	We thank Dr. Xiaojun Huang, Dr. Xujing Li, and Dr. Lihong Chen for cryo-EM data collection at the Center for Biological Imaging (CBI) in the Institution of Biophysics, CAS. We also thank Dr. Yuanyuan Chen, Zhenwei Yang, and Bingxue Zhou for technical support on Bio-layer interferometry (BLI) and surface plasmon resonance (SPR). Work was supported by the Strategic Priority Research Program (XDB29010000 and XDB37030000), CAS (YSBR-010), National Key Research and Development Program (2020YFA0707500 and 2018YFA0900801), Beijing Municipal Science and Technology Project (Z201100005420017), and Ministry of Science and Technology of China (EKPG21-09 and CPL-1233). X.W. was supported by Ten Thousand Talent Program and the NSFS Innovative Research Group (no. 81921005). K.W. and N.W. were supported by the Special Research Assistant Project of the Chinese Academy of Medical Sciences.	Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Cai YF, 2021, SCIENCE, V373, P642, DOI [10.1101/2021.04.13.439709, 10.1126/science.abi9745]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao Y., 2021, B 1 1 529 ESCAPES MA, DOI [10.1101/2021.12.07 .4703922021.12.07.470392, DOI 10.1101/2021.12.07.470392]; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Focosi D, 2021, EMERG INFECT DIS, V27, P2728, DOI 10.3201/eid2710.211538; Gobeil SMC, 2021, SCIENCE, V373, P641, DOI [10.1126/science.abi6226, 10.1101/2021.03.11.435037]; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kumar S, 2022, J MED VIROL, V94, P1641, DOI 10.1002/jmv.27526; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liu KF, 2021, CELL, V184, P3438, DOI 10.1016/j.cell.2021.05.031; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; Martinez DR, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj7125; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; Meng B., 2021, BIORXIV, V12, DOI [10.1101/2021.12.17.473248, DOI 10.1101/2021.12.17.473248]; Mibulo T., RESEARCHSQUARE, P2022, DOI [10.21203/rs.3.rs-1708394/v1, DOI 10.21203/RS.3.RS-1708394/V1, 11.17.516888, 10.1101/2021.05.19.21257469v2, DOI 10.1101/2021.05.19.21257469V2]; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; NABEL KG, 2021, SCIENCE; Nie JH, 2020, EMERG MICROBES INFEC, V9, P680, DOI 10.1080/22221751.2020.1743767; Park YJ, 2022, SCIENCE, V375, P449, DOI 10.1126/science.abm8143; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Su Y., 2020, CLIN INFECT DIS, V71, P2027, DOI [DOI 10.1093/cid/ciaa344, 10.1093/cid/ciaa344]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wang K., 2021, 3 DOSE INACTIVATED V, DOI [10.1101/2021.09.02.21261735, DOI 10.1101/2021.09.02.21261735]; Wang N, 2019, SCIENCE, V366, P640, DOI 10.1126/science.aaz1439; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wrobel AG, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21006-9; Yang YX, 2020, PROTEIN CELL, V11, P339, DOI 10.1007/s13238-020-00710-0; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1126/science.abl9463, 10.1101/2021.08.17.456689]; Zhang L, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwab053; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhu L, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa297; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	53	89	89	91	181	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2022	185	5					860	+		10.1016/j.cell.2022.01.019	http://dx.doi.org/10.1016/j.cell.2022.01.019			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1YW	35120603	hybrid, Green Published			2022-12-28	WOS:000768268500002
J	Qiu, XJ; Zhang, Y; Martin-Rufino, JD; Weng, C; Hosseinzadeh, S; Yang, DA; Pogson, AN; Hein, MY; Min, KH; Wang, L; Grody, EI; Shurtleff, MJ; Yuan, RS; Xu, S; Ma, YA; Replogle, JM; Lander, ES; Darmanis, S; Bahar, I; Sankaran, VG; Xing, JH; Weissman, JS				Qiu, Xiaojie; Zhang, Yan; Martin-Rufino, Jorge D.; Weng, Chen; Hosseinzadeh, Shayan; Yang, Dian; Pogson, Angela N.; Hein, Marco Y.; Min, Kyung Hoi (Joseph); Wang, Li; Grody, Emanuelle, I; Shurtleff, Matthew J.; Yuan, Ruoshi; Xu, Song; Ma, Yian; Replogle, Joseph M.; Lander, Eric S.; Darmanis, Spyros; Bahar, Ivet; Sankaran, Vijay G.; Xing, Jianhua; Weissman, Jonathan S.			Mapping transcriptomic vector fields of single cells	CELL			English	Article							RNA; EXPRESSION; DYNAMICS; GATA-1; PU.1; SEQ; DIFFERENTIATION; HEMATOPOIESIS; REGULATORS; LANDSCAPE	Single-cell (sc)RNA-seq, together with RNA velocity and metabolic labeling, reveals cellular states and transitions at unprecedented resolution. Fully exploiting these data, however, requires kinetic models capable of unveiling governing regulatory functions. Here, we introduce an analytical framework dynamo (https://github. com/aristoteleo/dynamo-release), which infers absolute RNA velocity, reconstructs continuous vector fields that predict cell fates, employs differential geometry to extract underlying regulations, and ultimately predicts optimal reprogramming paths and perturbation outcomes. We highlight dynamo's power to overcome fundamental limitations of conventional splicing-based RNA velocity analyses to enable accurate velocity estimations on a metabolically labeled human hematopoiesis scRNA-seq dataset. Furthermore, differential geometry analyses reveal mechanisms driving early megakaryocyte appearance and elucidate asymmetrical regulation within the PU.1-GATA1 circuit. Leveraging the least-action-path method, dynamo accurately predicts drivers of numerous hematopoietic transitions. Finally, in silico perturbations predict cell-fate diversions induced by gene perturbations. Dynamo, thus, represents an important step in advancing quantitative and predictive theories of cell-state transitions.	[Qiu, Xiaojie; Weng, Chen; Yang, Dian; Pogson, Angela N.; Min, Kyung Hoi (Joseph); Replogle, Joseph M.; Weissman, Jonathan S.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Qiu, Xiaojie; Weng, Chen; Yang, Dian; Pogson, Angela N.; Min, Kyung Hoi (Joseph); Replogle, Joseph M.; Weissman, Jonathan S.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Zhang, Yan; Bahar, Ivet; Xing, Jianhua] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Zhang, Yan; Bahar, Ivet; Xing, Jianhua] Univ Pittsburgh, Joint CMU Pitt PhD Program Computat Biol, Pittsburgh, PA 15260 USA; [Martin-Rufino, Jorge D.; Grody, Emanuelle, I; Lander, Eric S.; Sankaran, Vijay G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Martin-Rufino, Jorge D.; Weng, Chen; Sankaran, Vijay G.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Martin-Rufino, Jorge D.; Weng, Chen; Sankaran, Vijay G.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hosseinzadeh, Shayan] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Hein, Marco Y.] Chan Zuckerberg Biohub, 499 Illinois St, San Francisco, CA 94158 USA; [Min, Kyung Hoi (Joseph)] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Wang, Li] Univ Texas Arlington, Dept Math, Arlington, TX 76019 USA; [Shurtleff, Matthew J.] Lycia Therapeut, San Francisco, CA USA; [Yuan, Ruoshi] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Xu, Song] Microsoft, Redmond, WA USA; [Ma, Yian] Univ Calif San Diego, Halicioglu Data Sci Inst, San Diego, CA 92103 USA; [Replogle, Joseph M.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Darmanis, Spyros] Genentech Inc, San Francisco, CA 94080 USA; [Xing, Jianhua] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Xing, Jianhua] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Weissman, Jonathan S.] MIT, Koch Inst Integrat Canc Res MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Arlington; University of California System; University of California Berkeley; Microsoft; University of California System; University of California San Diego; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT)	Qiu, XJ; Weissman, JS (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Qiu, XJ; Weissman, JS (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Xing, JH (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.; Xing, JH (corresponding author), Univ Pittsburgh, Joint CMU Pitt PhD Program Computat Biol, Pittsburgh, PA 15260 USA.; Xing, JH (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15260 USA.; Xing, JH (corresponding author), Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.; Weissman, JS (corresponding author), MIT, Koch Inst Integrat Canc Res MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	xqiu@wi.mit.edu; xing1@pitt.edu; weissman@wi.mit.edu	Hein, Marco/C-2994-2014; Xing, Jianhua/A-8101-2012	Hein, Marco/0000-0002-9490-2261; Weissman, Jonathan/0000-0003-2445-670X; Qiu, Xiaojie/0000-0002-7881-5395; Min, Kyung Hoi/0000-0003-0894-4017; Xing, Jianhua/0000-0002-3700-8765; Hosseinzadeh, Shayan/0000-0002-8270-0582; Martin-Rufino, Jorge Diego/0000-0002-7631-5442; Pogson, Angela/0000-0002-6927-2456; Zhang, Yan/0000-0002-2267-8408	Jameel Clinic grant; La Caixa Foundation [100010434, LCF/BQ/AA20/11820031]; HHMI; NIH [1RM1 HG009490-01, P41 GM103712, R01 K103794, R37CA232209, R01DK119232]; New York Stem Cell Foundation; NSF [DMS-1462049]	Jameel Clinic grant; La Caixa Foundation(La Caixa Foundation); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NSF(National Science Foundation (NSF))	We thank Jiayi Ma, Tatsu Hashimoto, and Kazumitsu Maehara for technical discussions on recovering vector fields and potential functions; Alex Ge and Luke Gilbert for help with culture of HL60 cells and implementation of scSLAM-seq; Jay Shendure, Cole Trapnell, and Junyue Cao for sharing scifate datasets; and Hao Wu, Marco Jost, Sara Sunshine, Vedran Franke, Emanuel Wyler, Thomas Norman, Kara Mckinley, Richard She, Yuancheng Lu, Qi Qiu, Peng Hu, Laren Sanders, and other members of the Weissman lab for discussion and comments on this work. Special thanks to Chris Patil for editorial help, Shijie Hao, Longqi Liu, and Christina Usher for graphical abstract design. This work was supported by Jameel Clinic grant (X.Q.), La Caixa Foundation fellowship ID 100010434 (J.D.M.-R., fellowship code: LCF/BQ/AA20/11820031), HHMI (J.S.W.), and the NIH 1RM1 HG009490-01 (J.S.W.), NIH P41 GM103712 (I.B.), NIH R01 K103794 (V.G.S.), the New York Stem Cell Foundation (V.G.S.), NSF DMS-1462049 (J.X.), NIH R37CA232209 (J.X.), and R01DK119232 (J.X.). V.G.S. is a New York Stem Cell Foundation-Robertson Investigator.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1; Aurell E, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.048101; Baker M, 2010, NATURE, V466, P1137, DOI 10.1038/4661137a; Barile M, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02414-y; Battich N, 2020, SCIENCE, V367, P1151, DOI 10.1126/science.aax3072; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bergen V, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.202110282; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Brauer F., 2015, DYNAMICAL SYSTEMS BI; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cao JY, 2020, SCIENCE, V370, P924, DOI 10.1126/science.abf1686; Cao JY, 2020, SCIENCE, V370, P808, DOI 10.1126/science.aba7721; Cao JY, 2020, NAT BIOTECHNOL, V38, P980, DOI 10.1038/s41587-020-0480-9; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Chan MM, 2019, NATURE, V570, P77, DOI 10.1038/s41586-019-1184-5; Chen A., 2021, 427004 BIORXIV; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Drissen R, 2016, NAT IMMUNOL, V17, P666, DOI 10.1038/ni.3412; Erhard F, 2019, NATURE, V571, P419, DOI 10.1038/s41586-019-1369-y; Feynman R.P., 2010, QUANTUM MECH PATH IN; Freidlin M.I., 1998, RANDOM PERTURBATIONS; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gorin G, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1945-3; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo MH, 2017, P NATL ACAD SCI USA, V114, pE327, DOI 10.1073/pnas.1619052114; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; Hendriks GJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11028-9; Holler K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23834-1; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jurges C, 2018, BIOINFORMATICS, V34, P218, DOI 10.1093/bioinformatics/bty256; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kiefer L, 2018, J AM CHEM SOC, V140, P14567, DOI 10.1021/jacs.8b08554; Kim Y, 2000, J CHEM PHYS, V112, P2718, DOI 10.1063/1.480846; Kimmerling RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10220; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Larsson AJM, 2019, NATURE, V565, P251, DOI 10.1038/s41586-018-0836-1; Lehnertz B, 2021, BLOOD, V138, P2642, DOI 10.1182/blood.2021010745; Li T., 2021, 304584 BIORXIV, V2020; Liu Y, 2020, CELL, V183, P1665, DOI 10.1016/j.cell.2020.10.026; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma JY, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4492; Ma JY, 2013, PATTERN RECOGN, V46, P3519, DOI 10.1016/j.patcog.2013.05.017; Ma S, 2020, CELL, V183, P1103, DOI 10.1016/j.cell.2020.09.056; Macklin DN, 2020, SCIENCE, V369, P390, DOI 10.1126/science.aav3751; Maehara K., 2019, 592089 BIORXIV; Maier RS, 1997, SIAM J APPL MATH, V57, P752, DOI 10.1137/S0036139994271753; Marsden Jerrold E., 2003, VECTOR CALCULUS; Martin-Rufino JD, 2021, CURR OPIN HEMATOL, V28, P269, DOI 10.1097/MOH.0000000000000657; Matsuda M, 2020, SCIENCE, V369, P1450, DOI 10.1126/science.aba7668; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; ONSAGER L, 1953, PHYS REV, V91, P1505, DOI 10.1103/PhysRev.91.1505; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paul F, 2016, CELL, V164, P325, DOI 10.1016/j.cell.2015.12.046; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Perez-Carrasco R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005154; Qiu Q, 2020, NAT METHODS, V17, P991, DOI 10.1038/s41592-020-0935-4; Qiu XJ, 2020, CELL SYST, V10, P265, DOI 10.1016/j.cels.2020.02.003; Qiu XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049271; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Rayon T, 2020, SCIENCE, V369, P1449, DOI 10.1126/science.aba7667; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rodriques SG, 2021, NAT BIOTECHNOL, V39, P320, DOI 10.1038/s41587-020-0704-z; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Saelens W, 2019, NAT BIOTECHNOL, V37, P547, DOI 10.1038/s41587-019-0071-9; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schofield JA, 2018, NAT METHODS, V15, P221, DOI [10.1038/NMETH.4582, 10.1038/nmeth.4582]; Seydel R., 1988, EQUILIBRIUM CHAOS PR; Sheth RU, 2018, NAT REV GENET, V19, P718, DOI 10.1038/s41576-018-0052-8; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15889-2; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Truong AHL, 2000, ONCOGENE, V19, P6482, DOI 10.1038/sj.onc.1204042; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P193; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Waddington C H, 1957, STRATEGY GENES DISCU; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Wang P, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0068; Wang WY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0931; Weinreb C, 2020, SCIENCE, V367, DOI 10.1126/science.aaw3381; Weinreb C, 2018, P NATL ACAD SCI USA, V115, pE2467, DOI 10.1073/pnas.1714723115; Williams EA, 2005, J INTERDISCIPL HIST, V35, P631, DOI 10.1162/002219505323382681; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	106	19	19	29	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					690	+		10.1016/j.cell.2021.12.045	http://dx.doi.org/10.1016/j.cell.2021.12.045			68	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7EU	35108499	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000759729300002
J	Engelberg, AB; Avorn, J; Kesselheim, AS				Engelberg, Alfred B.; Avorn, Jerry; Kesselheim, Aaron S.			A New Way to Contain Unaffordable Medication Costs - Exercising the Government's Existing Rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material; Early Access								Existing laws could be used to help make many drugs more affordable. One gives the government a royalty-free license to use patented inventions that were discovered using federal funding; the other gives the government immunity from being sued for patent infringement.	[Engelberg, Alfred B.] Engelberg Fdn, Palm Beach, FL 33480 USA; [Avorn, Jerry; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Avorn, Jerry; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Engelberg, AB (corresponding author), Engelberg Fdn, Palm Beach, FL 33480 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Abinader LG., 2021, US GOVT RIGHTS PATEN; Department of Health and Human Services, 2016, COMMUNICATION 0620; Struver Z., 2016, BIOLYSE PHARMA OFFER; U.S. General Accounting Office, 2003, AG RIGHTS FED SPONS	4	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.												10.1056/NEJMp2117102	http://dx.doi.org/10.1056/NEJMp2117102		FEB 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW0NR	35139270				2022-12-28	WOS:000753118900001
J	Rigotti, NA; Kruse, GR; Livingstone-Banks, J; Hartmann-Boyce, J				Rigotti, Nancy A.; Kruse, Gina R.; Livingstone-Banks, Jonathan; Hartmann-Boyce, Jamie			Treatment of Tobacco Smoking A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NICOTINE REPLACEMENT THERAPY; UNITED-STATES; PRODUCT USE; CESSATION; VARENICLINE; ADULTS; CIGARETTE; CYTISINE; DEPENDENCE; BUPROPION	IMPORTANCE More deaths in the US are attributed to cigarette smoking each year than to any other preventable cause. Approximately 34 million people and an estimated 14% of adults in the US smoke cigarettes. If they stopped smoking, they could reduce their risk of tobacco-related morbidity and mortality and potentially gain up to 10 years of life. OBSERVATIONS Tobacco smoking is a chronic disorder maintained by physical nicotine dependence and learned behaviors. Approximately 70% of people who smoke cigarettes want to quit smoking. However, individuals who attempt to quit smoking make an average of approximately 6 quit attempts before achieving long-term abstinence. Both behavioral counseling and pharmacotherapy while using nicotine replacement therapy (NRT) products, varenicline, or bupropion are effective treatments when used individually, but they are most effective when combined. In ameta-analysis including 19 488 people who smoked cigarettes, the combination of medication and behavioral counseling was associated with a quit rate of 15.2% over 6 months compared with a quit rate of 8.6% with brief advice or usual care. The EAGLES trial, a randomized double-blind clinical trial of 8144 people who smoked, directly compared the efficacy and safety of varenicline, bupropion, nicotine patch, and placebo and found a significantly higher 6-month quit rate for varenicline (21.8%) than for bupropion (16.2%) and the nicotine patch (15.7%). Each therapy was more effective than placebo (9.4%). Combining a nicotine patch with other NRT products is more effective than use of a single NRT product. Combining drugs with different mechanisms of action, such as varenicline and NRT, has increased quit rates in some studies compared with use of a single product. Brief or intensive behavioral support can be delivered effectively in person or by telephone, textmessages, or the internet. The combination of a clinician's brief advice to quit and assistance to obtain tobacco cessation treatment is effective when routinely administered to tobacco users in virtually all health care settings. CONCLUSIONS AND RELEVANCE Approximately 34 million people in the US smoke cigarettes and could potentially gain up to a decade of life expectancy by stopping smoking. First-line therapy should include both pharmacotherapy and behavioral support, with varenicline or combination NRT as preferred initial interventions.	[Rigotti, Nancy A.; Kruse, Gina R.] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Mongan Inst, Dept Med,Div Gen Internal Med, Boston, MA 02114 USA; [Rigotti, Nancy A.; Kruse, Gina R.] Harvard Med Sch, Boston, MA 02115 USA; [Livingstone-Banks, Jonathan; Hartmann-Boyce, Jamie] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oxford	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, 100 Cambridge St,Ste 1600, Boston, MA 02114 USA.	rigotti.nancy@mgh.harvard.edu		Livingstone-Banks, Jonathan/0000-0002-3757-5591	NIHR via Cochrane Infrastructure	NIHR via Cochrane Infrastructure	Dr Livingstone-Banks is funded by the NIHR, via Cochrane Infrastructure funding to the Cochrane Tobacco Addiction Group.	[Anonymous], Cigarette labeling and health warning requirements; [Anonymous], FDA commits to evidence-based actions aimed at saving lives and preventing future generations of smokers; [Anonymous], 2014, HLTH CONS SMOK 50 YE; [Anonymous], Patients not ready to make a quit attempt now (the "5 R's; [Anonymous], 2020, SMOK CESS REP SURG G; Anthenelli RM, 2016, LANCET, V387, P2507, DOI 10.1016/S0140-6736(16)30272-0; Asfar T, 2021, NICOTINE TOB RES, V23, P1308, DOI 10.1093/ntr/ntaa277; Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Baker TB, 2021, ANNU REV CLIN PSYCHO, V17, P1, DOI 10.1146/annurev-clinpsy-081219-090343; Baker TB, 2016, JAMA-J AM MED ASSOC, V315, P371, DOI 10.1001/jama.2015.19284; Barnes J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001008.pub3; Barua RS, 2018, J AM COLL CARDIOL, V72, P3332, DOI 10.1016/j.jacc.2018.10.027; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Byaruhanga J, 2021, J SUBST ABUSE TREAT, V131, DOI 10.1016/j.jsat.2021.108448; Byaruhanga J, 2020, DRUG ALCOHOL DEPEN, V217, DOI 10.1016/j.drugalcdep.2020.108296; Cahill K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub7; Chaiton M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011045; Chang PH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2055-0; Clancy CM, 2021, ANN INTERN MED, V174, P116, DOI 10.7326/M20-5593; Cornelius ME, 2020, MMWR-MORBID MORTAL W, V69, P1736, DOI 10.15585/mmwr.mm6946a4; Courtney RJ, 2021, JAMA-J AM MED ASSOC, V326, P56, DOI 10.1001/jama.2021.7621; Creamer MR, 2019, MMWR-MORBID MORTAL W, V68, P1013, DOI 10.15585/mmwr.mm6845a2; Ebbert JO, 2015, JAMA-J AM MED ASSOC, V313, P687, DOI 10.1001/jama.2015.280; Ebbert JO, 2014, JAMA-J AM MED ASSOC, V311, P155, DOI 10.1001/jama.2013.283185; Evins AE, 2019, J CLIN PSYCHOPHARM, V39, P108, DOI 10.1097/JCP.0000000000001015; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Fiore MC, 2014, NEW ENGL J MED, V370, P297, DOI 10.1056/NEJMp1314942; Hajek P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-140; Hartmann-Boyce J, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013229.pub2; Hartmann-Boyce J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009670.pub4; Hartmann-Boyce J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub5; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010216.pub3, 10.1002/14651858.CD010216.pub4]; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; Howes S, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000031.pub5; Hughes JR, 2014, NICOTINE TOB RES, V16, P1190, DOI 10.1093/ntr/ntu052; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kalkhoran S, 2018, J AM COLL CARDIOL, V72, P1030, DOI 10.1016/j.jacc.2018.06.036; Koegelenberg CFN, 2014, JAMA-J AM MED ASSOC, V312, P155, DOI 10.1001/jama.2014.7195; Kotsen C, 2021, TELEMED E-HEALTH, V27, P20, DOI 10.1089/tmj.2020.0194; Krist AH, 2021, JAMA-J AM MED ASSOC, V325, P265, DOI 10.1001/jama.2020.25019; Lancaster T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001292.pub3; Leone FT, 2020, AM J RESP CRIT CARE, V202, pE5, DOI 10.1164/rccm.202005-1982ST; Lindson N, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013183.pub2; Lindson N, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006936.pub4; Lindson N, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013308; Lindson-Hawley N, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005231.pub3; Livingstone-Banks J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001118.pub4; Matkin W, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub4; McNeill A, 2021, VAPING ENGLAND EVIDE; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Nash SH, 2017, AM J PREV MED, V52, P276, DOI 10.1016/j.amepre.2016.09.036; National Academies of Sciences Engineering and Medicine, 2018, PUBLIC HLTH CONSEQUE; Notley C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004307.pub6; Patnode CD, 2021, JAMA-J AM MED ASSOC, V325, P280, DOI 10.1001/jama.2020.23541; Piper ME, 2015, NICOTINE TOB RES, V17, P1405, DOI 10.1093/ntr/ntv048; Ramon JM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0172-8; Rice VH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001188.pub5; Rigotti NA, 2019, J AM COLL CARDIOL, V74, P508, DOI 10.1016/j.jacc.2019.06.003; Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Sheffer CE, 2016, J SMOK CESS, V11, P229, DOI 10.1017/jsc.2014.30; Sherman SE, 2008, AM J MANAG CARE, V14, P141; Stead LF, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001007.pub3; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Taylor GMJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub5; Thomas KH, 2022, ADDICTION, V117, P861, DOI 10.1111/add.15675; Tindle HA, 2016, AM J PREV MED, V51, P522, DOI 10.1016/j.amepre.2016.05.024; Tzelepis F, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012659.pub2; US Food and Drug Administration, YOUTH TOB; VanFrank B, 2021, JAMA-J AM MED ASSOC, V325, P232, DOI 10.1001/jama.2020.23608; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; Walker N, 2021, ADDICTION, V116, P2847, DOI 10.1111/add.15489; Walker N, 2014, NEW ENGL J MED, V371, P2353, DOI 10.1056/NEJMoa1407764; West R, 2011, NEW ENGL J MED, V365, P1193, DOI 10.1056/NEJMoa1102035; White AR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000009.pub4; Whittaker R, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006611.pub5; World Health Organization, 2021, TOBACCO	78	14	14	5	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					566	577		10.1001/jama.2022.0395	http://dx.doi.org/10.1001/jama.2022.0395			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZD5RT	35133411				2022-12-28	WOS:000758257900015
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Levelling up-or punching down?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Blackall M., 2021, UNIVERSAL CREDIT UPL; BMA, 2022, BMA RESP LEV AG; Haynes L, 2022, GP ONLINE; Office for National Statistics, 2022, CONS PRIC INFL; Trussell Trust, FOOD BANK STAT PREV; World Health Organization (WHO), SOCIAL DETERMINANTS	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o324	10.1136/bmj.o324	http://dx.doi.org/10.1136/bmj.o324			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135813	Bronze			2022-12-28	WOS:000754132400012
J	Delgado, JL				Delgado, Jane L.			Beyond Diversity - Time for New Models of Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Delgado, Jane L.] Natl Alliance Hispan Hlth, Washington, DC 20036 USA		Delgado, JL (corresponding author), Natl Alliance Hispan Hlth, Washington, DC 20036 USA.			Delgado, Jane L./0000-0002-0154-0717				ABRAIDOLANZA AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI DOI 10.2105/AJPH.89.10.1543; [Anonymous], 2015, LANCET, V385, P1918, DOI 10.1016/S0140-6736(15)60944-8; [Anonymous], 2020, JAMA NETW OPEN, V3, DOI [DOI 10.1001/JAMANETWORKOPEN.2019.21085, 10.1001/jamanetworkopen.2020, DOI 10.1001/JAMANETWORKOPEN.2020]; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; Heron Melonie, 2021, Natl Vital Stat Rep, V70, P1	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					503	505		10.1056/NEJMp2115149	http://dx.doi.org/10.1056/NEJMp2115149		FEB 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YW0GW	35119804	Bronze			2022-12-28	WOS:000751512400001
J	Blease, C; Cohen, IG; Hoffman, S				Blease, Charlotte; Cohen, I. Glenn; Hoffman, Sharona			Sharing Clinical Notes Potential Medical-Legal Benefits and Risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSTIC ERRORS	This Viewpoint discusses a new federal rule (part of the 21st Century Cures Act) that mandates US clinicians and health organizations make electronic health records more accessible to patients, examines the potential legal benefits and risks of sharing clinical notes, and offers recommendations for ensuring that the new rule advances the interests of both patients and clinicians.	[Blease, Charlotte] Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave, Boston, MA 02215 USA; [Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Boston, MA 02115 USA; [Hoffman, Sharona] Case Western Reserve Univ, Sch Law, Cleveland, OH 44106 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Case Western Reserve University	Blease, C (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med, 330 Brookline Ave, Boston, MA 02215 USA.	cblease@bidmc.harvard.edu						Bell SK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5867; Bell SK, 2021, J PATIENT SAF, V17, pE791, DOI 10.1097/PTS.0000000000000494; Denneson LM, 2019, J AM MED INFORM ASSN, V26, P3, DOI 10.1093/jamia/ocy134; Gupta A, 2018, BMJ QUAL SAF, V27, P53, DOI 10.1136/bmjqs-2017-006774; Lagoo J, 2019, ANN SURG, V270, P84, DOI 10.1097/SLA.0000000000002742; Neves AL, 2020, BMJ QUAL SAF, V29, P1019, DOI 10.1136/bmjqs-2019-010581; ONC, 2021, ONCS CUR ACT FIN RUL; Ralston JD, 2021, J GEN INTERN MED, V36, P3330, DOI 10.1007/s11606-021-06729-1; Singh H, 2017, BMJ QUAL SAF, V26, P484, DOI 10.1136/bmjqs-2016-005401; U.S. Department of Health and Human Services, 2020, 21 CENT CUR ACT INT	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2022	327	8					717	718		10.1001/jama.2021.23179	http://dx.doi.org/10.1001/jama.2021.23179		FEB 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ2NN	35119468				2022-12-28	WOS:000750998100002
J	Lopez, G				Lopez, Gabriela			More than an exam	SCIENCE			English	Editorial Material								My Ph.D. adviser had encouraged me to take a vacation. So I was sitting at an airport restaurant, sipping a margarita, when I received the email. It informed me I had failed my qualifying exam on my third attempt, which meant dismissal from the program. I knew things hadn't gone perfectly. A day earlier my committee had told me it needed more time to decide whether I passed. But I was still dumbfounded. How was it possible that one exam-1 hour of my life-could erase all my other successes and define me as unfit to be a scientist?	[Lopez, Gabriela] Northwestern Univ, Evanston, IL 60208 USA	Northwestern University	Lopez, G (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					582	582						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113683				2022-12-28	WOS:000753965100047
J	ODowd, A				ODowd, Adrian			Government was negligent and naive over failed finance schemes, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Public Accounts Committee, 2022, PHARM EARL PAYM SAL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o307	10.1136/bmj.o307	http://dx.doi.org/10.1136/bmj.o307			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121615				2022-12-28	WOS:000753552800002
J	Appleby, J				Appleby, John			Planning the healthcare workforce: how many GPs do we need?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.			Nodarse Alvarez, Juan Carlos/0000-0003-3809-835X				Hunt J, 2015, NEW DEAL GEN PRACTIC; Iacobucci G, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6463; NHS Digital, 2021, GEN PRACT WORKF	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o123	10.1136/bmj.o123	http://dx.doi.org/10.1136/bmj.o123			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110293				2022-12-28	WOS:000758682200011
J	Bowman, K; Matney, C; Berwick, DM				Bowman, Katherine; Matney, Chanel; Berwick, Donald M.			Improving Traumatic Brain Injury Care and Research A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Bowman, Katherine; Matney, Chanel] Natl Acad Sci Engn & Med, 500 Fifth St,NW,Keck Bldg,Room 825, Washington, DC 20001 USA; [Berwick, Donald M.] Inst Healthcare Improvement, Boston, MA USA	National Academies of Sciences, Engineering & Medicine; Institute for Healthcare Improvement	Bowman, K (corresponding author), Natl Acad Sci Engn & Med, 500 Fifth St,NW,Keck Bldg,Room 825, Washington, DC 20001 USA.	KBowman@nas.edu						[Anonymous], 2021, BRAIN INJURY RELATED; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lawrence BA, 2018, NEUROTRAUMA CRITICAL, V2nd; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; National Academies of Sciences Engineering and Medicine, 2022, TRAUMATIC BRAIN INJU; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	10	6	6	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					419	420						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YV9QB	35103760				2022-12-28	WOS:000753056200010
J	Jain, M; Dechet, A				Jain, Meera; Dechet, Amy			In mild acute diverticulitis, outpatient therapy without antibiotics was noninferior to antibiotics	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jain, Meera; Dechet, Amy] Providence Portland Med Ctr, Portland, OR 97213 USA	Providence Portland Medical Center	Jain, M (corresponding author), Providence Portland Med Ctr, Portland, OR 97213 USA.							Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Isacson D, 2019, BRIT J SURG, V106, P1542, DOI 10.1002/bjs.11239; Schultz JK, 2020, COLORECTAL DIS, V22, P5, DOI 10.1111/codi.15140	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC15	JC15		10.7326/J21-0022	http://dx.doi.org/10.7326/J21-0022		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099998				2022-12-28	WOS:000750919900001
J	Kmietowicz, Z				Kmietowicz, Zosia			We need to talk about shielders: five minutes with...Lucy Watson	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1170; The Patients Association, 2020, PAND PAT EXP UK PAT; Wise J, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o163; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n467	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o268	10.1136/bmj.o268	http://dx.doi.org/10.1136/bmj.o268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105546	Bronze			2022-12-28	WOS:000758676500010
J	Bansal, M; Morley, RJ; Nagaraju, SK; Dutta, S; Mishra, AK; Selveraj, J; Kumar, S; Niyolia, D; Harish, SM; Abdelrahim, OB; Hasan, SE; Ramesh, BR; Dayanandan, S; Morley, HP; Ashton, PS; Prasad, V				Bansal, Mahi; Morley, Robert J.; Nagaraju, Shivaprakash K.; Dutta, Suryendu; Mishra, Ashish Kumar; Selveraj, Jeyakumar; Kumar, Sumit; Niyolia, Deepti; Harish, Sachin Medigeshi; Abdelrahim, Omer Babiker; Hasan, Shaa Eldin; Ramesh, Bramasamdura Rangana; Dayanandan, Selvadurai; Morley, Harsanti P.; Ashton, Peter S.; Prasad, Vandana			Southeast Asian Dipterocarp origin and diversification driven by Africa-India floristic interchange	SCIENCE			English	Article							EARLY EOCENE; LIGNITE MINE; FOSSIL WOODS; POLLEN TYPES; GONDWANA; PALEOENVIRONMENT; PALEOGEOGRAPHY; ASSEMBLAGE; MORPHOLOGY; PHYLOGENY	The evolution and diversification of ancient megathermal angiosperm lineages with Africa-India origins in Asian tropical forests is poorly understood because of the lack of reliable fossils. Our palaeobiogeographical analysis of pollen fossils from Africa and India combined with molecular data and fossil amber records suggest a tropical-African origin of Dipterocarpaceae during the mid-Cretaceous and its dispersal to India during the Late Maastrichtian and Paleocene, leading to range expansion of aseasonal dipterocarps on the Indian Plate. The India-Asia collision further facilitated the dispersal of dipterocarps from India to similar climatic zones in Southeast Asia, which supports their out-of-India migration. The dispersal pathway suggested for Dipterocarpaceae may provide a framework for an alternative biogeographic hypothesis for several megathermal angiosperm families that are presently widely distributed in Southeast Asia.	[Bansal, Mahi; Mishra, Ashish Kumar; Selveraj, Jeyakumar; Prasad, Vandana] Birbal Sahni Inst Palaeosci, Lucknow 226007, Uttar Pradesh, India; [Morley, Robert J.; Morley, Harsanti P.] Palynova Ltd, Littleport CB6 1PY, Cambs, England; [Morley, Robert J.] Royal Holloway Univ London, Earth Sci Dept, Egham TW20 0EX, Surrey, England; [Nagaraju, Shivaprakash K.] Nat Conservancy Ctr, New Delhi 110024, India; [Dutta, Suryendu; Kumar, Sumit; Niyolia, Deepti] Indian Inst Technol, Dept Earth Sci, Mumbai 400076, Maharashtra, India; [Harish, Sachin Medigeshi; Dayanandan, Selvadurai] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada; [Harish, Sachin Medigeshi; Dayanandan, Selvadurai] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; [Harish, Sachin Medigeshi; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ H3A 1B1, Canada; [Abdelrahim, Omer Babiker; Hasan, Shaa Eldin] Minist Petr & Gas, Petr Labs Res & Amp Studies PLRS, Khartoum, Sudan; [Ramesh, Bramasamdura Rangana] Inst Francais Pondichery, UMIFRE CNRS MAEE 21, Pondicherry 605001, India; [Ashton, Peter S.] Harvard Univ, Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); University of London; Royal Holloway University London; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Concordia University - Canada; Concordia University - Canada; Harvard University	Prasad, V (corresponding author), Birbal Sahni Inst Palaeosci, Lucknow 226007, Uttar Pradesh, India.	prasad.van@gmail.com	SELVARAJ, JEYAKUMAR/AGP-4079-2022; Kumar, Sumit/HHS-8959-2022	SELVARAJ, JEYAKUMAR/0000-0001-8031-7419; Bansal, Mahi/0000-0001-8068-2168; K N, Shivaprakash/0000-0002-4065-5453; Medigeshi Harish, Sachin/0000-0003-4975-5474; Kumar, Sumit/0000-0001-8668-4762	CSIR under MoES [09/0528(11219)/2021-EMR-I, MoES/P.O.(GeoSci.)/36/2014]; DST [DST/SJF/EASA-01/2016-17]; Birbal Sahni Institute of Paleosciences [3]; Palynova Ltd.	CSIR under MoES; DST(Department of Science & Technology (India)); Birbal Sahni Institute of Paleosciences(Department of Science & Technology (India)); Palynova Ltd.	This work is a contribution of CSIR grant no. 09/0528(11219)/2021-EMR-I, a sponsored project under MoES [MoES/P.O.(GeoSci.)/36/2014], and in-house project no. 3 at the Birbal Sahni Institute of Paleosciences and is part of a long-term evaluation of rainforest evolution supported by Palynova Ltd. A DST-sponsored project (DST/SJF/E&ASA-01/2016-17) at the Indian Institute of Technology, Bombay, has also financially supported this work.	Ashton PS, 2021, KEW BULL, V76, P87, DOI 10.1007/s12225-021-09934-7; Ashton P. S., 1982, Flora Malesiana, I, Spermatophyta, V9, P237; ASHTON PS, 1987, J BIOGEOGR, V14, P249, DOI 10.2307/2844895; AUBREVILLE A, 1976, Adansonia, V16, P205; Audley-Charles M. G., 1981, WALLACES LINE PLATE, P9; Bancroft H, 1935, AM J BOT, V22, P164, DOI 10.2307/2436007; Bansal M, 2021, BOT J LINN SOC, V197, P147, DOI 10.1093/botlinnean/boab025; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boucot A.J., 2013, PHANEROZOIC PALEOCLI, V11, P1, DOI 10.2110/sepmcsp.11; Chatterjee Sankar, 2016, Proceedings of the Indian National Science Academy, V82, P479, DOI 10.16943/ptinsa/2016/48462; Clementz M, 2011, GEOLOGY, V39, P15, DOI 10.1130/G31585.1; COETZEE JA, 1984, ANN MO BOT GARD, V71, P1088, DOI 10.2307/2399246; Cole JM, 2017, PALYNOLOGY, V41, P547, DOI 10.1080/01916122.2017.1303795; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Doyle JA, 2004, INT J PLANT SCI, V165, pS55, DOI 10.1086/421068; Dutta S, 2017, REV PALAEOBOT PALYNO, V237, P96, DOI 10.1016/j.revpalbo.2016.11.004; Dutta S, 2011, REV PALAEOBOT PALYNO, V166, P63, DOI 10.1016/j.revpalbo.2011.05.002; El-Taguri HMA, 2014, SAINS MALAYS, V43, P1283; Fresnillo B, 2008, PLANT SYST EVOL, V270, P243, DOI 10.1007/s00606-007-0615-1; Garg Rahul, 2008, Journal of the Palaeontological Society of India, V53, P99; Grudinski M, 2014, J BIOGEOGR, V41, P1149, DOI 10.1111/jbi.12280; Heckenhauer J, 2017, BOT J LINN SOC, V185, P1, DOI 10.1093/botlinnean/box044; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husson L, 2020, J BIOGEOGR, V47, P843, DOI 10.1111/jbi.13762; Khan MA, 2020, PLANT SYST EVOL, V306, DOI 10.1007/s00606-020-01718-z; Kudoh H, 2013, PAC SCI, V67, P591, DOI 10.2984/67.4.9; Licht A, 2014, REV PALAEOBOT PALYNO, V202, P29, DOI 10.1016/j.revpalbo.2013.12.002; Likkason OK, 2013, ENERG SOURCE PART A, V35, P706, DOI 10.1080/15567036.2010.514588; Matzke J., 2013, FRONT BIOGEOGR, V5, P242; Matzke NJ, 2013, FRONT BIOGEOGR, V5, P242, DOI DOI 10.21425/F5FBG19694; MAURY G, 1975, REV PALAEOBOT PALYNO, V19, P241, DOI 10.1016/0034-6667(75)90048-2; MEHER-HOMJI V M, 1979, Phytocoenologia, V6, P85; Merrill E. D., 1923, PHILIPP J SCI, V23, P1; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley RJ, 2018, J TROP ECOL, V34, P209, DOI 10.1017/S0266467418000202; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Nugraha AMS, 2018, PALAEOGEOGR PALAEOCL, V490, P191, DOI 10.1016/j.palaeo.2017.10.033; Parrish J. T., 1986, PALEOCLIMATES EC GEO; Petersen K, 2005, Transducers '05, Digest of Technical Papers, Vols 1 and 2, P1; Phipps D., 1984, PAPERS DEP GEOLOGY, V11, P1; Poole I, 1993, SPECIAL PAPERS PALEO, V49, P155; Prasad V, 2018, PALAEOGEOGR PALAEOCL, V497, P139, DOI 10.1016/j.palaeo.2018.02.013; Prasad V, 2009, J BIOSCIENCES, V34, P777, DOI 10.1007/s12038-009-0062-y; Prasad V, 2020, EPISODES, V43, P476, DOI 10.18814/epiiugs/2020/020030; Prasad V, 2018, CRETACEOUS RES, V86, P186, DOI 10.1016/j.cretres.2018.03.004; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Samant B, 2020, J GEOL SOC INDIA, V95, P475, DOI 10.1007/s12594-020-1464-6; Shukla A, 2012, J EARTH SYST SCI, V121, P195, DOI 10.1007/s12040-012-0142-5; Singh AK, 2017, ENERG SOURCE PART A, V39, P1686, DOI 10.1080/15567036.2017.1370514; Smith T, 2016, GEOSCI FRONT, V7, P969, DOI 10.1016/j.gsf.2016.05.001; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Talip N, 2008, SAINS MALAYS, V37, P169; Thomas DC, 2015, PERSPECT PLANT ECOL, V17, P1, DOI 10.1016/j.ppees.2014.11.001; Toussaint EFA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5001; Venkatachala B. S., 1988, PALEOBOTANIST, V37, P1; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Westerweel J, 2020, TECTONICS, V39, DOI 10.1029/2020TC006413; Woodcock DW, 2017, IAWA J, V38, P313, DOI 10.1163/22941932-20170175; Zwickl D, 2006, THESIS U TEXAS AUSTI	61	6	6	12	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					455	460		10.1126/science.abk2177	http://dx.doi.org/10.1126/science.abk2177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084986				2022-12-28	WOS:000750899500041
J	Pimm, S				Pimm, Stuart			Edward O. Wilson (1929-2021)	SCIENCE			English	Biographical-Item									[Pimm, Stuart] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Pimm, Stuart] Saving Nat, Durham, NC 27713 USA	Duke University	Pimm, S (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.; Pimm, S (corresponding author), Saving Nat, Durham, NC 27713 USA.	stuartpimm@me.com						WILSON EO, PUBLICATION LIST	1	0	0	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					385	385		10.1126/science.abn9848	http://dx.doi.org/10.1126/science.abn9848			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084972				2022-12-28	WOS:000750899500022
J	Hoglund, ER; Bao, DL; O'Hara, A; Makarem, S; Piontkowski, ZT; Matson, JR; Yadav, AK; Haislmaier, RC; Engel-Herbert, R; Ihlefeld, JF; Ravichandran, J; Ramesh, R; Caldwell, JD; Beechem, TE; Tomko, JA; Hachtel, JA; Pantelides, ST; Hopkins, PE; Howe, JM				Hoglund, Eric R.; Bao, De-Liang; O'Hara, Andrew; Makarem, Sara; Piontkowski, Zachary T.; Matson, Joseph R.; Yadav, Ajay K.; Haislmaier, Ryan C.; Engel-Herbert, Roman; Ihlefeld, Jon F.; Ravichandran, Jayakanth; Ramesh, Ramamoorthy; Caldwell, Joshua D.; Beechem, Thomas E.; Tomko, John A.; Hachtel, Jordan A.; Pantelides, Sokrates T.; Hopkins, Patrick E.; Howe, James M.			Emergent interface vibrational structure of oxide superlattices	NATURE			English	Article							RAMAN-SCATTERING; SPECTROSCOPY; FERROELECTRICITY; CATIO3	As the length scales of materials decrease, the heterogeneities associated with interfaces become almost as important as the surrounding materials. This has led to extensive studies of emergent electronic and magnetic interface properties in superlattices(1-9). However, the interfacial vibrations that affect the phonon-mediated properties, such as thermal conductivity(10,11), are measured using macroscopic techniques that lack spatial resolution. Although it is accepted that intrinsic phonons change near boundaries(12,13), the physical mechanisms and length scales through which interfacial effects influence materials remain unclear. Here we demonstrate the localized vibrational response of interfaces in strontium titanate-calcium titanate superlattices by combining advanced scanning transmission electron microscopy imaging and spectroscopy, density functional theory calculations and ultrafast optical spectroscopy. Structurally diffuse interfaces that bridge the bounding materials are observed and this local structure creates phonon modes that determine the global response of the superlattice once the spacing of the interfaces approaches the phonon spatial extent. Our results provide direct visualization of the progression of the local atomic structure and interface vibrations as they come to determine the vibrational response of an entire superlattice. Direct observation of such local atomic and vibrational phenomena demonstrates that their spatial extent needs to be quantified to understand macroscopic behaviour. Tailoring interfaces, and knowing their local vibrational response, provides a means of pursuing designer solids with emergent infrared and thermal responses.	[Hoglund, Eric R.; Makarem, Sara; Ihlefeld, Jon F.; Hopkins, Patrick E.; Howe, James M.] Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22903 USA; [Bao, De-Liang; O'Hara, Andrew; Pantelides, Sokrates T.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Piontkowski, Zachary T.; Beechem, Thomas E.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [Matson, Joseph R.; Caldwell, Joshua D.] Vanderbilt Univ, Dept Mech Engn & Elect Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yadav, Ajay K.; Ramesh, Ramamoorthy] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Haislmaier, Ryan C.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Engel-Herbert, Roman] Paul Drude Inst Festkorperelekt, Berlin, Germany; [Engel-Herbert, Roman] Humboldt Univ, Inst Phys, Berlin, Germany; [Ravichandran, Jayakanth] Univ Southern Calif, Dept Chem Engn & Mat Sci, Los Angeles, CA 90007 USA; [Beechem, Thomas E.] Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA; [Beechem, Thomas E.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Beechem, Thomas E.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Tomko, John A.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA; [Hachtel, Jordan A.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37830 USA; [Pantelides, Sokrates T.] Vanderbilt Univ, Dept Elect & Comp Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hopkins, Patrick E.] Univ Virginia, Dept Phys, Charlottesville, VA 22901 USA	University of Virginia; Vanderbilt University; United States Department of Energy (DOE); Sandia National Laboratories; Vanderbilt University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Paul Drude Institute for Solid State Electronics; Humboldt University of Berlin; University of Southern California; United States Department of Energy (DOE); Sandia National Laboratories; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Virginia; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Vanderbilt University; University of Virginia	Hoglund, ER; Hopkins, PE; Howe, JM (corresponding author), Univ Virginia, Dept Mat Sci & Engn, Charlottesville, VA 22903 USA.; Pantelides, ST (corresponding author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.; Hachtel, JA (corresponding author), Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37830 USA.; Pantelides, ST (corresponding author), Vanderbilt Univ, Dept Elect & Comp Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Hopkins, PE (corresponding author), Univ Virginia, Dept Phys, Charlottesville, VA 22901 USA.	erh3cq@virginia.edu; hachtelja@ornl.gov; pantelides@vanderbilt.edu; phopkins@virginia.edu; jh9s@virginia.edu	Ravichandran, Jayakanth/H-6329-2011; Matson, Joseph/GYU-4075-2022; O'Hara, Andrew/N-8010-2014	Ravichandran, Jayakanth/0000-0001-5030-9143; O'Hara, Andrew/0000-0002-0323-9039; Ihlefeld, Jon/0000-0003-0166-8136; Hoglund, Eric/0000-0002-3409-4960; Piontkowski, Zachary/0000-0002-6282-0106	Office of Naval Research through a MURI Program [N00014-18-1-2429]; Army Research Office [W911NF-21-1-0119, W911NF-19-1-0137, W911NF-21-1-0327]; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Directorate [DE-FG02-09ER46554]; McMinn Endowment; National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility located at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Quantum Materials program from the DOE Office of Science, Basic Energy Sciences [DE-AC02-05CH11231]; MRSEC for Nanoscale Science at Penn State [DMR1420620]; UT-Battelle, LLC [DE-AC05- 00OR22725]; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; ARO MURI [W911NF-21-2-0162]; NSF, Division of Materials Research [1904793]; NIH Biotechnology Training Program	Office of Naval Research through a MURI Program; Army Research Office; US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Directorate(United States Department of Energy (DOE)); McMinn Endowment; National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility located at Lawrence Berkeley National Laboratory; Quantum Materials program from the DOE Office of Science, Basic Energy Sciences; MRSEC for Nanoscale Science at Penn State; UT-Battelle, LLC; Laboratory Directed Research and Development Program of Oak Ridge National Laboratory; ARO MURI(MURI); NSF, Division of Materials Research(National Science Foundation (NSF)); NIH Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E.R.H., J.A.T., S.M. and P.E.H. appreciate support from the Office of Naval Research through a MURI Program, grant number N00014-18-1-2429. J.A.T., S.M. and P.E.H. acknowledge support from Army Research Office, grant number W911NF-21-1-0119. Use of the Thermo Fisher Scientific Z-STEM and Titan instruments within UVa's Nanoscale Materials Characterization Facility (NMCF) was fundamental to this work. Theory at Vanderbilt University was supported by the US Department of Energy, Office of Science, Basic Energy Sciences, Materials Science and Engineering Directorate grant number DE-FG02-09ER46554 and by the McMinn Endowment. Calculations were performed at the National Energy Research Scientific Computing Center (NERSC), a US Department of Energy Office of Science User Facility located at Lawrence Berkeley National Laboratory, operated under contract number DE-AC02-05CH11231. The oxide heteroepitaxy synthesis work at Berkeley and Penn State is supported by the Quantum Materials program from the DOE Office of Science, Basic Energy Sciences, under contract number DE-AC02-05CH11231, and by the MRSEC for Nanoscale Science at Penn State through grant DMR1420620. EELS experiments conducted as part of a user proposal at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility using instrumentation within ORNL's Materials Characterization Core provided by UT-Battelle, LLC, under contract number DE-AC05- 00OR22725 with the DOE and sponsored by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for the US Department of Energy. R.R. also acknowledges the ARO MURI under agreement W911NF-21-2-0162. J.R. acknowledges support from the Army Research Office with award numbers W911NF-19-1-0137 and W911NF-21-1-0327. J.D.C. and J.R.M. acknowledge funding under NSF, Division of Materials Research award number 1904793. S.M. acknowledges support from the NIH Biotechnology Training Program.	Aguado-Puente P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184105; Aso R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02214; Balachandran PV, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7191; BALACHANDRAN U, 1982, SOLID STATE COMMUN, V44, P815, DOI 10.1016/0038-1098(82)90280-0; Biegalski MD, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4918805; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chen BB, 2021, NANO LETT, V21, P1295, DOI 10.1021/acs.nanolett.0c03850; Chen YZ, 2015, NAT MATER, V14, P801, DOI [10.1038/NMAT4303, 10.1038/nmat4303]; de Graaf S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4312; Dominguez C, 2020, NAT MATER, V19, P1182, DOI 10.1038/s41563-020-0757-x; GHAHRAMANI E, 1990, PHYS REV B, V41, P5112, DOI 10.1103/PhysRevB.41.5112; GILLET P, 1993, PHYS CHEM MINER, V20, P159, DOI 10.1007/BF00200118; Giri A, 2018, J PHYS CHEM C, V122, P29577, DOI 10.1021/acs.jpcc.8b09249; Hage FS, 2020, SCIENCE, V367, P1124, DOI 10.1126/science.aba1136; Hage FS, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.016103; Haislmaier RC, 2018, APL MATER, V6, DOI 10.1063/1.5061778; He J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.227203; He Q, 2015, ACS NANO, V9, P8412, DOI 10.1021/acsnano.5b03232; Himmetoglu B, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.241204; Hirata T, 1996, J SOLID STATE CHEM, V124, P353, DOI 10.1006/jssc.1996.0249; Hwang J, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.060101; King G, 2010, J MATER CHEM, V20, P5785, DOI 10.1039/b926757c; Koh YK, 2009, ADV FUNCT MATER, V19, P610, DOI 10.1002/adfm.200800984; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lazic I, 2016, ULTRAMICROSCOPY, V160, P265, DOI 10.1016/j.ultramic.2015.10.011; Li YH, 2019, CHINESE PHYS LETT, V36, DOI 10.1088/0256-307X/36/2/026801; Luckyanova MN, 2012, SCIENCE, V338, P936, DOI 10.1126/science.1225549; MCMILLAN P, 1988, PHYS CHEM MINER, V16, P21, DOI 10.1007/BF00201326; Middey S, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.045115; Moon EJ, 2014, NANO LETT, V14, P2509, DOI 10.1021/nl500235f; Nataf GF, 2020, NAT REV PHYS, V2, P634, DOI 10.1038/s42254-020-0235-z; Paudel TR, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104202; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Petzelt J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184111; Petzelt J, 2006, J EUR CERAM SOC, V26, P2855, DOI 10.1016/j.jeurceramsoc.2006.02.001; Premper J, 2020, PHYS STATUS SOLIDI B, V257, DOI 10.1002/pssb.201900650; Ratchford DC, 2019, ACS NANO, V13, P6730, DOI 10.1021/acsnano.9b01275; Ravichandran J, 2014, NAT MATER, V13, P168, DOI [10.1038/NMAT3826, 10.1038/nmat3826]; Rondinelli JM, 2012, ADV MATER, V24, P1961, DOI 10.1002/adma.201104674; Rondinelli JM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113402; SCHAUFELE RF, 1967, J CHEM PHYS, V46, P2859, DOI 10.1063/1.1841140; Schober A, 2020, APL MATER, V8, DOI 10.1063/5.0010233; Shi F, 2020, J MATER SCI-MATER EL, V31, P18070, DOI 10.1007/s10854-020-04357-9; Simkin MV, 2000, PHYS REV LETT, V84, P927, DOI 10.1103/PhysRevLett.84.927; Tai KP, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788688; Tenne DA, 2006, SCIENCE, V313, P1614, DOI 10.1126/science.1130306; Tomko JA, 2018, NAT NANOTECHNOL, V13, P959, DOI 10.1038/s41565-018-0227-7; Vattuone L., 2016, OXIDE MAT 2 DIMENSIO, V234, P169; Venkatraman K, 2019, NAT PHYS, V15, P1237, DOI 10.1038/s41567-019-0675-5; Wang Y, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.165406; Yan XX, 2021, NATURE, V589, P65, DOI 10.1038/s41586-020-03049-y; Zelezny V, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224303; Zhai XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5283; Zhang YB, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.035143; Zhao WW, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao2682; Zheng H, 2004, J MATER RES, V19, P488, DOI 10.1557/jmr.2004.19.2.488; Zheng Q, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe6819	58	6	6	25	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					556	+		10.1038/s41586-021-04238-z	http://dx.doi.org/10.1038/s41586-021-04238-z			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082421	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000749546400023
J	Perkins, GD; Ji, C; Connolly, BA; Couper, K; Lall, R; Baillie, JK; Bradley, JM; Dark, P; Dave, C; De Soyza, A; Dennis, AV; Devrell, A; Fairbairn, S; Ghani, H; Gorman, EA; Green, CA; Hart, N; Hee, SW; Kimbley, Z; Madathil, S; McGowan, N; Messer, B; Naisbitt, J; Norman, C; Parekh, D; Parkin, EM; Patel, J; Regan, SE; Ross, C; Rostron, AJ; Saim, M; Simonds, AK; Skilton, E; Stallard, N; Steiner, M; Vancheeswaran, R; Yeung, J; McAuley, DF				Perkins, Gavin D.; Ji, Chen; Connolly, Bronwen A.; Couper, Keith; Lall, Ranjit; Baillie, J. Kenneth; Bradley, Judy M.; Dark, Paul; Dave, Chirag; De Soyza, Anthony; Dennis, Anna, V; Devrell, Anne; Fairbairn, Sara; Ghani, Hakim; Gorman, Ellen A.; Green, Christopher A.; Hart, Nicholas; Hee, Siew Wan; Kimbley, Zoe; Madathil, Shyam; McGowan, Nicola; Messer, Benjamin; Naisbitt, Jay; Norman, Chloe; Parekh, Dhruv; Parkin, Emma M.; Patel, Jaimin; Regan, Scott E.; Ross, Clare; Rostron, Anthony J.; Saim, Mohammad; Simonds, Anita K.; Skilton, Emma; Stallard, Nigel; Steiner, Michael; Vancheeswaran, Rama; Yeung, Joyce; McAuley, Daniel F.		RECOVERY-RS Collaborators	Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 The RECOVERY-RS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-FLOW OXYGEN; MECHANICAL VENTILATION; OBSERVATIONAL COHORT; THERAPY	IMPORTANCE Continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) have been recommended for acute hypoxemic respiratory failure in patients with COVID-19. Uncertainty exists regarding the effectiveness and safety of these noninvasive respiratory strategies. OBJECTIVE To determine whether either CPAP or HFNO, compared with conventional oxygen therapy, improves clinical outcomes in hospitalized patients with COVID-19-related acute hypoxemic respiratory failure. DESIGN, SETTING, AND PARTICIPANTS A parallel group, adaptive, randomized clinical trial of 1273 hospitalized adults with COVID-19-related acute hypoxemic respiratory failure. The trial was conducted between April 6, 2020, and May 3, 2021, across 48 acute care hospitals in the UK and Jersey. Final follow-up occurred on June 20, 2021. INTERVENTIONS Adult patients were randomized to receive CPAP (n = 380), HFNO (n = 418), or conventional oxygen therapy (n = 475). MAIN OUTCOMES AND MEASURES The primary outcomewas a composite of tracheal intubation or mortality within 30 days. RESULTS The trial was stopped prematurely due to declining COVID-19 case numbers in the UK and the end of the funded recruitment period. Of the 1273 randomized patients (mean age, 57.4 [95% CI, 56.7 to 58.1] years; 66% male; 65% White race), primary outcome data were available for 1260. Crossover between interventions occurred in 17.1% of participants (15.3% in the CPAP group, 11.5% in the HFNO group, and 23.6% in the conventional oxygen therapy group). The requirement for tracheal intubation or mortality within 30 days was significantly lower with CPAP (36.3%; 137 of 377 participants) vs conventional oxygen therapy (44.4%; 158 of 356 participants) (absolute difference, -8%[95% CI, -15% to -1%], P =.03), but was not significantly different with HFNO (44.3%; 184 of 415 participants) vs conventional oxygen therapy (45.1%; 166 of 368 participants) (absolute difference, -1% [95% CI, -8% to 6%], P=.83). Adverse events occurred in 34.2% (130/380) of participants in the CPAP group, 20.6%(86/418) in the HFNO group, and 13.9% (66/475) in the conventional oxygen therapy group. CONCLUSIONS AND RELEVANCE Among patients with acute hypoxemic respiratory failure due to COVID-19, an initial strategy of CPAP significantly reduced the risk of tracheal intubation or mortality compared with conventional oxygen therapy, but there was no significant difference between an initial strategy of HFNO compared with conventional oxygen therapy. The study may have been underpowered for the comparison of HFNO vs conventional oxygen therapy, and early study termination and crossover among the groups should be considered when interpreting the findings.	[Perkins, Gavin D.; Ji, Chen; Couper, Keith; Lall, Ranjit; Devrell, Anne; McGowan, Nicola; Norman, Chloe; Regan, Scott E.; Skilton, Emma; Yeung, Joyce] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Perkins, Gavin D.; Couper, Keith; Dave, Chirag; Dennis, Anna, V; Green, Christopher A.; Kimbley, Zoe; Madathil, Shyam; Parekh, Dhruv; Patel, Jaimin; Saim, Mohammad; Yeung, Joyce] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Connolly, Bronwen A.; Bradley, Judy M.; Gorman, Ellen A.; McAuley, Daniel F.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Connolly, Bronwen A.; Hart, Nicholas] Guys & St Thomas NHS Fdn Trust, Lane Fox Clin Resp Physiol Res Ctr, London, England; [Connolly, Bronwen A.; Hart, Nicholas] Kings Coll London, Ctr Human Arid Appl Physiol Sci, London, England; [Connolly, Bronwen A.] Univ Melbourne, Dept Physiotherapy, Melbourne, Vic, Australia; [Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Baillie, J. Kenneth] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh, Midlothian, Scotland; [Dark, Paul] Univ Manchester, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England; [Dark, Paul] Northern Care Alliance NHS Grp, Salford Royal Hosp, Manchester, Lancs, England; [De Soyza, Anthony] Newcastle Univ, NIHR Biomed Res Ctr, Populat & Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [De Soyza, Anthony; Messer, Benjamin] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Devrell, Anne] West Midlands Clin Res Network, Res Champ Team, Wolverhampton, England; [Fairbairn, Sara] Aneurin Bevan Univ Hlth Board, Grange Univ Hosp, Cwmbran, Wales; [Ghani, Hakim; Vancheeswaran, Rama] West Hertfordshire Hosp NHS Trust, Watford Gen Hosp, Watford, England; [Hee, Siew Wan; Stallard, Nigel] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry, W Midlands, England; [Naisbitt, Jay; Parkin, Emma M.] Pennine Acute Hosp NHS Trust, Fairfield Gen Hosp, Northern Care Alliance NHS Grp, Bury, England; [Parekh, Dhruv; Patel, Jaimin] Univ Birmingham, Sch Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Ross, Clare] Imperial Coll Healthcare NHS Trust, London, England; [Rostron, Anthony J.] South Tyneside & Sunderland NHS Fdn Trust, Sunderland Royal Hosp, Sunderland, England; [Rostron, Anthony J.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Simonds, Anita K.] Guys & St Thomas NHS Fdn Trust, Royal Brompton & Harefield Hosp, London, England; [Steiner, Michael] Univ Leicester, Inst Lung Hlth, Dept Resp Sci, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [McAuley, Daniel F.] Royal Victoria Hosp, Belfast, Antrim, North Ireland	University of Warwick; University of Birmingham; Queens University Belfast; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Manchester; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Watford General Hospital; University of Warwick; University of Birmingham; Imperial College London; Sunderland Royal Hospital; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of Leicester	McAuley, DF (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	d.f.mcauley@qub.ac.uk	MACDONALD, Clint/AAR-6962-2021; Dosanjh, Davinder/ABD-8895-2021; Baillie, Kenneth/AEK-6650-2022; Veenith, Tonny/A-9948-2010; Baillie, John Kenneth/F-3124-2011; Hart, Nicholas/O-7076-2015	MACDONALD, Clint/0000-0003-0995-0072; Dosanjh, Davinder/0000-0002-9169-5607; Baillie, Kenneth/0000-0001-5258-793X; Veenith, Tonny/0000-0002-4125-8804; Baillie, John Kenneth/0000-0001-5258-793X; Bentley, Andrew/0000-0002-6883-9246; Crooks, Michael/0000-0001-6876-0258; Naisbitt, Michael/0000-0003-1560-6235; Rostron, Anthony/0000-0002-9336-1723; Lowsby, Richard/0000-0001-9940-191X; Edwards, Julia/0000-0001-8337-8962; Waite, Alicia/0000-0001-8734-994X; Vidler, Jennifer/0000-0003-2996-3014; Perkins, Gavin/0000-0003-3027-7548; Mehta, Meera/0000-0002-6833-5574; Green, Christopher/0000-0002-1984-4014; Jhanji, Shaman/0000-0002-1116-628X; Yeung, Joyce/0000-0003-2950-4758; Lall, Ranjit/0000-0003-1737-2866; Parekh, Dhruv/0000-0002-1508-8362; Welch, Hugh/0000-0001-6906-2718; Couper, Keith/0000-0003-2123-2022; Dark, Paul/0000-0003-3309-0164; Hart, Nicholas/0000-0002-6863-585X; Patel, Manish/0000-0003-1134-1591; Patel, Manish/0000-0003-3012-7507; Hee, Siew Wan/0000-0002-0415-263X; McAuley, Daniel/0000-0002-3283-1947; Stallard, Nigel/0000-0001-7781-1512; Bibby, Anna/0000-0001-7386-7754; Steiner, Michael/0000-0002-0127-0614	National Institute for Health Research [COVID-19-RSC]	National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by grant COVID-19-RSC from the National Institute for Health Research.	Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; Azoulay E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03194-w; Azoulay E, 2018, JAMA-J AM MED ASSOC, V320, P2099, DOI 10.1001/jama.2018.14282; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Carteaux G, 2016, CRIT CARE MED, V44, P282, DOI 10.1097/CCM.0000000000001379; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Docherty AB, 2021, LANCET RESP MED, V9, P773, DOI 10.1016/S2213-2600(21)00175-2; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Esquinas AM, 2014, EUR RESPIR REV, V23, P427, DOI 10.1183/09059180.00009413; Ferreyro BL, 2020, JAMA-J AM MED ASSOC, V324, P57, DOI 10.1001/jama.2020.9524; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433; Gorman E, 2021, LANCET RESP MED, V9, P553, DOI 10.1016/S2213-2600(21)00168-5; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Grieco DL, 2021, JAMA-J AM MED ASSOC, V325, P1731, DOI 10.1001/jama.2021.4682; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Jennison C, 2000, GROUP SEQUENTIAL MET; Kow CS, 2021, AM J THER, V28, pE616, DOI 10.1097/MJT.0000000000001441; Lemiale V, 2015, JAMA-J AM MED ASSOC, V314, P1711, DOI 10.1001/jama.2015.12402; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marciniak SJ, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00929-2021; Mathur R, 2021, LANCET, V397, P1711, DOI 10.1016/S0140-6736(21)00634-6; Ospina-Tascon GA, 2021, JAMA-J AM MED ASSOC, V326, P2161, DOI 10.1001/jama.2021.20714; Osuchowski MF, 2021, LANCET RESP MED, V9, P622, DOI 10.1016/S2213-2600(21)00218-6; Papoutsi E, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03540-6; Perkins GD, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04617-3; Tong A, 2020, CRIT CARE MED, V48, P1622, DOI 10.1097/CCM.0000000000004585; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	30	68	68	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					546	558		10.1001/jama.2022.0028	http://dx.doi.org/10.1001/jama.2022.0028		JAN 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35072713	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000747991900002
J	Yong, GY; Lim, ALS				Yong, Geng-Yi; Lim, Amelia L. -S.			Eosinophilic Granulomatosis with Polyangiitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yong, Geng-Yi] Univ Malaya, Kuala Lumpur, Malaysia; [Lim, Amelia L. -S.] Hosp Selayang, Batu Caves, Malaysia	Universiti Malaya	Yong, GY (corresponding author), Univ Malaya, Kuala Lumpur, Malaysia.	yonggengyi_88@hotmail.com		YONG, GENG YI/0000-0002-3680-601X					0	1	1	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					374	374		10.1056/NEJMicm2112515	http://dx.doi.org/10.1056/NEJMicm2112515		JAN 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35061339				2022-12-28	WOS:000745541900001
J	Chalif, JI; Martinez-Silva, MD; Pagiazitis, JG; Murray, AJ; Mentis, GZ				Chalif, Joshua, I; Martinez-Silva, Maria de Lourdes; Pagiazitis, John G.; Murray, Andrew J.; Mentis, George Z.			Control of mammalian locomotion by ventral spinocerebellar tract neurons	CELL			English	Article							ACTIVATED CATION CURRENT; SPINAL-CORD; AXON COLLATERALS; MOTOR-NEURONS; IN-VITRO; CEREBELLAR LESIONS; RHYTHMIC ACTIVITY; MOUSE MODEL; BRAIN-STEM; INTERNEURONS	Locomotion is a complex behavior required for animal survival. Vertebrate locomotion depends on spinal interneurons termed the central pattern generator (CPG), which generates activity responsible for the alternation of flexor and extensor muscles and the left and right side of the body. It is unknown whether multiple or a single neuronal type is responsible for the control of mammalian locomotion. Here, we show that ventral spinocerebellar tract neurons (VSCTs) drive generation and maintenance of locomotor behavior in neonatal and adult mice. Using mouse genetics, physiological, anatomical, and behavioral assays, we demonstrate that VSCTs exhibit rhythmogenic properties and neuronal circuit connectivity consistent with their essential role in the locomotor CPG. Importantly, optogenetic activation and chemogenetic silencing reveals that VSCTs are necessary and sufficient for locomotion. These findings identify VSCTs as critical components for mammalian locomotion and provide a paradigm shift in our understanding of neural control of complex behaviors.	[Chalif, Joshua, I; Martinez-Silva, Maria de Lourdes; Pagiazitis, John G.; Mentis, George Z.] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Chalif, Joshua, I; Martinez-Silva, Maria de Lourdes; Pagiazitis, John G.; Mentis, George Z.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Mentis, George Z.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Murray, Andrew J.] UCL, Sainsbury Wellcome Ctr, 25 Howland St, London W1T 4JG, England; [Chalif, Joshua, I] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA	Columbia University; Columbia University; Columbia University; University of London; University College London; Harvard University; Brigham & Women's Hospital	Mentis, GZ (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA.; Mentis, GZ (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.; Mentis, GZ (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	gzmentis@columbia.edu			NINDS, NIH [R01-NS078375, R21-NS079981, F30NS098551]; NIH Blueprint for Neuroscience Research [R01-AA027079]; SMA Foundation; Project-ALS	NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Blueprint for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SMA Foundation; Project-ALS	We thank D. Ginty for the Cdx2FlpO mice and T. Jessell for the Chx10Cre mice. We are also grateful to L. Pellizzoni, S. Przedborski, F.J. Alvarez, J. Gogos, M.J. O'Donovan, and members of the Mentis lab for comments on the manu-script. G.Z.M. is supported by NINDS, NIH (R01-NS078375, R21-NS079981) , the NIH Blueprint for Neuroscience Research (R01-AA027079) , the SMA Foun-dation, and Project-ALS. J.I.C. was supported by NINDS, NIH (F30NS098551) .	Abraira VE, 2017, CELL, V168, P295, DOI 10.1016/j.cell.2016.12.010; Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; ARSHAVSKY YI, 1972, BRAIN RES, V43, P276, DOI 10.1016/0006-8993(72)90296-X; Atkinson L, 2004, NEUROSCIENCE, V123, P761, DOI 10.1016/j.neuroscience.2003.08.065; BALDISSERA F, 1975, ACTA PHYSIOL SCAND, V93, P228, DOI 10.1111/j.1748-1716.1975.tb05813.x; BENTIVOGLIO M, 1982, EXP BRAIN RES, V46, P339; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Bonnot A, 2002, BRAIN RES REV, V40, P141, DOI 10.1016/S0165-0173(02)00197-2; Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Bouvier J, 2015, CELL, V163, P1191, DOI 10.1016/j.cell.2015.10.074; BRAS H, 1988, J COMP NEUROL, V273, P584, DOI 10.1002/cne.902730412; Britz O, 2015, ELIFE, V4, DOI [10.7554/eLife.04718, 10.7554/eLife.13038]; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Chopek JW, 2018, CELL REP, V25, P146, DOI 10.1016/j.celrep.2018.08.095; Cooper S, 1940, BRAIN, V63, P123, DOI 10.1093/brain/63.2.123; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Earhart GM, 2001, J NEUROPHYSIOL, V85, P759, DOI 10.1152/jn.2001.85.2.759; ECCLES JC, 1954, J PHYSIOL-LONDON, V126, P524, DOI 10.1113/jphysiol.1954.sp005226; EDGLEY SA, 1988, J PHYSIOL-LONDON, V397, P99, DOI 10.1113/jphysiol.1988.sp016990; Enjin A, 2017, J NEUROSCI, V37, P5634, DOI 10.1523/JNEUROSCI.0949-16.2017; Falgairolle M, 2017, ELIFE, V6, DOI 10.7554/eLife.26622; Federico F, 2006, RESTOR NEUROL NEUROS, V24, P1; Fletcher EV, 2017, NAT NEUROSCI, V20, P905, DOI 10.1038/nn.4561; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gosgnach S, 2017, J NEUROSCI, V37, P10835, DOI 10.1523/JNEUROSCI.1829-17.2017; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Guertin PA, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00183; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Hammar I, 2011, J PHYSIOL-LONDON, V589, P653, DOI 10.1113/jphysiol.2010.201178; HOUCHIN J, 1983, Q J EXP PHYSIOL CMS, V68, P719, DOI 10.1113/expphysiol.1983.sp002761; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Jankowska E, 2011, J PHYSIOL-LONDON, V589, P5709, DOI 10.1113/jphysiol.2011.213678; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kase Daisuke, 2012, J Signal Transduct, V2012, P619747, DOI 10.1155/2012/619747; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Lev-Tov A, 2000, J NEUROPHYSIOL, V83, P888, DOI 10.1152/jn.2000.83.2.888; LUNDBERG A, 1971, EXP BRAIN RES, V12, P317; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Manvich DF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22116-z; Martinez-Silva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109936; MATSUSHITA M, 1978, BRAIN RES, V142, P237, DOI 10.1016/0006-8993(78)90633-9; Meehan CF, 2012, J PHYSIOL-LONDON, V590, P289, DOI 10.1113/jphysiol.2011.214643; Meehan CF, 2017, NAT PROTOC, V12, P732, DOI 10.1038/nprot.2017.001; Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Mentis GZ, 2006, J NEUROSCI, V26, P13297, DOI 10.1523/JNEUROSCI.2945-06.2006; Mentis GZ, 2002, J PHYSIOL-LONDON, V544, P757, DOI 10.1113/jphysiol.2002.028159; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; NOGA BR, 1987, EXP BRAIN RES, V66, P99; O'Donovan MJ, 2010, ANN NY ACAD SCI, V1198, P63, DOI 10.1111/j.1749-6632.2010.05535.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pastor AM, 2003, J NEUROPHYSIOL, V89, P793, DOI 10.1152/jn.00498.2002; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; Picton LD, 2018, CURR BIOL, V28, P3911, DOI 10.1016/j.cub.2018.10.048; Pisotta I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00475; Rand MK, 1998, EXP BRAIN RES, V122, P31, DOI 10.1007/s002210050488; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Richards DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097240; ROBERTS BL, 1992, J EXP BIOL, V167, P171; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Sathyamurthy A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107595; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shrestha SS, 2012, NEUROSCIENCE, V226, P253, DOI 10.1016/j.neuroscience.2012.09.015; Shrestha SS, 2012, J PHYSIOL-LONDON, V590, P1737, DOI 10.1113/jphysiol.2011.226852; Simon CM, 2017, CELL REP, V21, P3767, DOI 10.1016/j.celrep.2017.12.003; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Song JR, 2016, NATURE, V529, P399, DOI 10.1038/nature16497; Talpalar AE, 2013, NATURE, V500, P85, DOI 10.1038/nature12286; Thoby-Brisson M, 2000, J NEUROSCI, V20, P2994; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119; WALTON KD, 1991, J PHYSIOL-LONDON, V433, P283, DOI 10.1113/jphysiol.1991.sp018426; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; WIRTH FP, 1974, J COMP NEUROL, V157, P53, DOI 10.1002/cne.901570106; Yu F, 2015, BRAIN, V138, DOI 10.1093/brain/awu239; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zhang Y, 2003, J NEUROSCI, V23, P9059; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Ziskind-Conhaim L, 2017, J NEUROPHYSIOL, V118, P2956, DOI 10.1152/jn.00322.2017; Ziskind-Conhaim L, 2010, ANN NY ACAD SCI, V1198, P72, DOI 10.1111/j.1749-6632.2010.05533.x	95	3	3	12	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					328	+		10.1016/j.cell.2021.12.014	http://dx.doi.org/10.1016/j.cell.2021.12.014			44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8WY	35063074	hybrid, Green Published			2022-12-28	WOS:000746168800001
J	Beyrer, C; Allotey, P; Amon, JJ; Cepeda, J				Beyrer, Chris; Allotey, Pascale; Amon, Joseph J.; Cepeda, Javier			Archbishop Desmond Tutu and the universality of health and human rights Comment	LANCET			English	Editorial Material									[Beyrer, Chris; Allotey, Pascale; Amon, Joseph J.; Cepeda, Javier] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu		Jabbour, Samer/0000-0002-7150-6856	International AIDS Society; Desmond M Tutu Endowment at Johns Hopkins University	International AIDS Society; Desmond M Tutu Endowment at Johns Hopkins University	The International AIDS Society-Lancet Commission is supported by the International AIDS Society and the Desmond M Tutu Endowment at Johns Hopkins University. We declare no other competing interests.	[Anonymous], 2021, THEDESMONDTUTU; Beyrer C, 2021, LANCET, V397, P1524, DOI 10.1016/S0140-6736(21)00708-X; Beyrer C, 2016, LANCET, V388, P1033, DOI 10.1016/S0140-6736(16)30829-7; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; du Preez P, 1997, PEACE CONFL J PEACE, V3, P245; Healy C., 2022, US NEWS WORLD R 0104; Human Rights Watch, 2021, THRESH CROSS ISR AUT; International Campaign for Tibet, 2021, DESM TUT TIB SUPP RE; International Criminal Court, 1998, ROME STATUTE INT CRI; International Criminal Tribunal for the Former Yugoslavia, 2004, CASES; Jacobs K, 1986, UNITED PRESS IN 1010; Macharia J, 2007, REUTERS 0831; Magome M., 2021, ABC NEWS; McCarthy J., 2019, GLOBAL CITIZEN; Reuters, 2021, REUTERS 0517; Reuters, 2017, REUTERS 0907; Tutu D., 2014, GUARDIAN 0921; Tutu DM., 2010, WASH POST; UN, 1973, CONV SUPPR PUN CRIM; United Nations, 2015, UN STAND MIN RUL TRE	20	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					503	504		10.1016/S0140-6736(22)00121-0	http://dx.doi.org/10.1016/S0140-6736(22)00121-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35093208				2022-12-28	WOS:000755144500006
J	Chaireti, R				Chaireti, Roza			In patients hospitalized for COPD exacerbation, a PE diagnostic strategy plus usual care did not improve outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chaireti, Roza] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Chaireti, R (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.		Chaireti, Roza/G-7456-2014	Chaireti, Roza/0000-0002-9069-1903					0	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC19	JC19		10.7326/J21-0017	http://dx.doi.org/10.7326/J21-0017		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099991				2022-12-28	WOS:000750881500001
J	Lau, E; Wang, HH; Jiang, BG; Horton, R				Lau, Esther; Wang, Helena Hui; Jiang, Baoguo; Horton, Richard			Hidden heroes of health: winner of the 2021 Wakley-Wu Lien Teh Prize Comment	LANCET			English	Editorial Material									[Lau, Esther] Lancet Child & Adolescent Hlth, London, England; [Wang, Helena Hui] The Lancet, Beijing, Peoples R China; [Jiang, Baoguo] Peking Univ Peoples Hosp, Beijing, Peoples R China; [Horton, Richard] The Lancet, London, England	Peking University	Lau, E (corresponding author), Lancet Child & Adolescent Hlth, London, England.							Li X, 2020, LANCET, V395, P1802, DOI 10.1016/S0140-6736(20)30122-7; Wang HH, 2021, LANCET, V398, P104, DOI 10.1016/S0140-6736(21)01587-7; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0	3	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					505	505		10.1016/S0140-6736(22)00002-2	http://dx.doi.org/10.1016/S0140-6736(22)00002-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35065009				2022-12-28	WOS:000755144500007
J	Levy, B; Girerd, N; Amour, J; Besnier, E; Nesseler, N; Helms, J; Delmas, C; Sonneville, R; Guidon, C; Rozec, B; David, H; Bougon, D; Chaouch, O; Walid, O; Herve, D; Belin, N; Gaide-Chevronnay, L; Rossignol, P; Kimmoun, A; Duarte, K; Slutsky, AS; Brodie, D; Fellahi, JL; Ouattara, A; Combes, A				Levy, Bruno; Girerd, Nicolas; Amour, Julien; Besnier, Emmanuel; Nesseler, Nicolas; Helms, Julie; Delmas, Clement; Sonneville, Romain; Guidon, Catherine; Rozec, Bertrand; David, Helene; Bougon, David; Chaouch, Oussama; Walid, Oulehri; Herve, Dupont; Belin, Nicolas; Gaide-Chevronnay, Lucie; Rossignol, Patrick; Kimmoun, Antoine; Duarte, Kevin; Slutsky, Arthur S.; Brodie, Daniel; Fellahi, Jean-Luc; Ouattara, Alexandre; Combes, Alain		HYPO-ECMO Trial Grp; Int ECMO Network ECMONet	Effect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TARGETED TEMPERATURE MANAGEMENT; ACUTE MYOCARDIAL-INFARCTION; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; SUPPORT; LIFE	IMPORTANCE The optimal approach to the use of venoarterial extracorporeal membrane oxygenation (ECMO) during cardiogenic shock is uncertain. OBJECTIVE To determine whether early use of moderate hypothermia (33-34 degrees C) compared with strict normothermia (36-37 degrees C) improves mortality in patients with cardiogenic shock receiving venoarterial ECMO. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of patients (who were eligible if they had been endotracheally intubated and were receiving venoarterial ECMO for cardiogenic shock for <6 hours) conducted in the intensive care units at 20 French cardiac shock care centers between October 2016 and July 2019. Of 786 eligible patients, 374 were randomized. Final follow-up occurred in November 2019. INTERVENTIONS Early moderate hypothermia (33-34 degrees C; n = 168) for 24 hours or strict normothermia (36-37 degrees C; n =166). MAIN OUTCOMES AND MEASURES The primary outcome was mortality at 30 days. There were 31 secondary outcomes including mortality at days 7, 60, and 180; a composite outcome of death, heart transplant, escalation to left ventricular assist device implantation, or stroke at days 30, 60. and 180; and days without requiring a ventilator or kidney replacement therapy at days 30, 60, and 180. Adverse events included rates of severe bleeding, sepsis, and number of units of packed red blood cells transfused during venoarterial ECMO. RESULTS Among the 374 patients who were randomized, 334 completed the trial (mean age, 58 [SD, 12] years; 24% women) and were included in the primary analysis. At 30 days, 71 patients (42%) in the moderate hypothermia group had died vs 84 patients (51%) in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15; risk difference, -8.3% [95% CI, -16.3% to -0.3%]). For the composite outcome of death, heart transplant, escalation to left ventricular assist device implantation, or stroke at day 30, the adjusted odds ratio was 0.61(95% CI, 0.39 to 0.96; P = .03) for the moderate hypothermia group compared with the normothermia group and the risk difference was -11.5% (95% CI, -23.2% to 0.2%). Of the 31 secondary outcomes, 30 were inconclusive. The incidence of moderate or severe bleeding was 41% in the moderate hypothermia group vs 42% in the normothermia group. The incidence of infections was 52% in both groups. The incidence of bacteremia was 20% in the moderate hypothermia group vs 30% in the normothermia group. CONCLUSIONS AND RELEVANCE In this randomized clinical trial involving patients with refractory cardiogenic shock treated with venoarterial ECMO, early application of moderate hypothermia for 24 hours did not significantly increase survival compared with normothermia. However, because the 95% CI was wide and included a potentially important effect size, these findings should be considered inconclusive.	[Levy, Bruno; Kimmoun, Antoine] CHRU Nancy, Pole Cardiomedicochirurg, Med Intens & Reanimat, F-54511 Vandoeuvre Les Nancy, France; [Levy, Bruno] INSERM U1116, Fac Med, Vandoeuvre Les Nancy, France; [Levy, Bruno] Univ Lorraine, Nancy, France; [Girerd, Nicolas] Univ Lorraine, CHRU Nancy, Ctr Invest Clin Plurithemat, INSERM,Inst Lorrain Coeur & Vaisseaux,INSERM 1433, Nancy, France; [Girerd, Nicolas] INI CRCT Cardiovasc & Renal Clin Trialists CRIN N, Nancy, France; [Amour, Julien] Hop Prive Jacques Cartier, Inst Perfus Reanimat & Anesthesie Chirurg Cardiaq, Massy, France; [Besnier, Emmanuel] Rouen Univ Hosp, Dept Anaesthesiol & Crit Care, Rouen, France; [Besnier, Emmanuel] UNIROUEN, Normandie Univ, INSERM U1096, EnVi, Rouen, France; [Nesseler, Nicolas] Pontchaillou Univ Hosp Rennes, Dept Anesthesia & Crit Care, Rennes, France; [Nesseler, Nicolas] Univ Rennes, CHU Rennes, CIC Ctr Invest Clin Rennes 1414, INSERM,Inra,UMR S 1241,Inst NUMECAN UMR A 1341, Rennes, France; [Helms, Julie] Univ Strasbourg, Hop Univ Strasbourg, Nouvel Hop Civil, Fac Med,Serv Med Intens Reanimat, Strasbourg, France; [Delmas, Clement] Rangueil Univ Hosp, Intens Cardiac Care Unit, Toulouse, France; [Sonneville, Romain] Hop Xavier Bichat, AP HP, Med & Infect Dis ICU, Paris, France; [Guidon, Catherine] Pole Anesthesie Reanimat, Marseille, France; [Rozec, Bertrand] CHU Nantes, Hop G&R Laennec, Serv Anesthesie Reanimat, Nantes, France; [Rozec, Bertrand] UNIV Nantes, CHU Nantes, CNRS, Inst Thorax INSERM, Nantes, France; [David, Helene] CHU Montpellier, Arnaud de Villeneuve Hosp, Dept Anesthesiol & Crit Care Med, Montpellier, France; [David, Helene] Montpellier Univ, PhyMedExp, CNRS, INSERM, Montpellier, France; [Bougon, David; Rossignol, Patrick] Ctr Hosp Annecy, Serv Reanimat, Genevois, France; [Chaouch, Oussama] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Anesthesiol & Crit Care Med, Paris, France; [Walid, Oulehri] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Anesthesie Reanimat & Med Peri Operatoire, Strasbourg, France; [Herve, Dupont] CHU Amiens Picardie, Reanimat Medicochirurg Cardiothorac Vasc & Resp, Amiens, France; [Belin, Nicolas] CHU Besancon, Serv Reanimat Med, Besancon, France; [Gaide-Chevronnay, Lucie] CHU Grenoble Alpes, Unite Reanimat Cardiovasc & Thorac, Pole Anesthesie Reanimat, Grenoble, France; [Duarte, Kevin] Univ Lorraine, CHRU Nancy, Inst Lorrain Coeur & Vaisseaux, Ctr Invest Clin Plurithemat,INSERM 1433, Inserm, France; [Slutsky, Arthur S.] St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Med Surg & Biomed Engn, Toronto, ON, Canada; [Brodie, Daniel] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; [Brodie, Daniel] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Ctr Acute Resp Failure, New York, NY USA; [Fellahi, Jean-Luc] Hosp Civils Lyon, Hop Louis Pradel, Serv Anesthesie Reanimat, Lyon, France; [Fellahi, Jean-Luc] Univ Lyon 1 Claude Bernard, Lab CarMeN, INSERM 1060, Lyon, France; [Ouattara, Alexandre] CHU Bordeaux, Magellan Medicosurg Ctr, Dept Anaesthesia & Crit Care, Bordeaux, France; [Ouattara, Alexandre] Univ Bordeaux, Biol Cardiovasc Dis, INSERM, UMR 1034, Pessac, France; [Combes, Alain] Sorbonne Univ, Inst Cardiometab & Nutr, INSERM, UMRS 1166 ICAN, Paris, France; [Combes, Alain] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Inst Cardiol,Serv Med Intens Reanimat, Paris, France	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Jacques Cartier Private Hospital; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; CHU Rennes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Franche-Comte; CHU Besancon; CHU Grenoble Alpes; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Columbia University; Columbia University; NewYork-Presbyterian Hospital; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Levy, B (corresponding author), CHRU Nancy, Pole Cardiomedicochirurg, Med Intens & Reanimat, F-54511 Vandoeuvre Les Nancy, France.	blevy5463@gmail.com	CHOLLEY, Bernard/AAK-5354-2020; Carmen, Team3/Y-7384-2019; GIRERD, Nicolas/D-5493-2011; Kimmoun, Antoine/ADQ-2174-2022	CHOLLEY, Bernard/0000-0001-6388-6011; Carmen, Team3/0000-0002-3614-0924; TONON, David/0000-0002-8800-9856; patrick, nataf/0000-0002-8412-6182; Girerd, Nicolas/0000-0002-3278-2057; Lab, Carmen/0000-0002-5935-3236; dorez, didier/0000-0003-2590-4949	Direction de la Recherche Clinique, CHU Nancy; French Ministry of Health	Direction de la Recherche Clinique, CHU Nancy; French Ministry of Health	The trial was sponsored and conducted by the Direction de la Recherche Clinique, CHU Nancy, with a grant from the French Ministry of Health.	Alushi B, 2021, CLIN RES CARDIOL, V110, P84, DOI 10.1007/s00392-020-01652-7; Annoni F, 2021, RESUSCITATION, V162, P365, DOI 10.1016/j.resuscitation.2021.01.029; Chen X, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-019-0698-z; Chioncel O, 2020, EUR J HEART FAIL, V22, P1315, DOI 10.1002/ejhf.1922; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Combes A, 2020, LANCET, V396, P199, DOI 10.1016/S0140-6736(20)31047-3; Dankiewicz J, 2021, NEW ENGL J MED, V384, P2283, DOI 10.1056/NEJMoa2100591; Dmitrienko A, 2010, CH CRC BIOSTAT SER, V33, P1; Duan JW, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.703567; Fernando SM, 2021, INTENS CARE MED, DOI 10.1007/s00134-021-06505-z; Fuernau G, 2019, CIRCULATION, V139, P448, DOI 10.1161/CIRCULATIONAHA.117.032722; Goligher EC, 2018, JAMA-J AM MED ASSOC, V320, P2251, DOI 10.1001/jama.2018.14276; Gotberg M, 2010, RESUSCITATION, V81, P1190, DOI 10.1016/j.resuscitation.2010.04.033; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; Int Liaison Comm Resuscitation, 2005, RESUSCITATION, V67, P181, DOI 10.1016/j.resuscitation.2005.09.010; Jacquot A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031697; Kirkegaard H, 2017, JAMA-J AM MED ASSOC, V318, P341, DOI 10.1001/jama.2017.8978; Landoni G, 2015, CRIT CARE MED, V43, P1559, DOI 10.1097/CCM.0000000000000974; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Noyes AM, 2015, J INTENSIVE CARE MED, V30, P259, DOI 10.1177/0885066613516416; Pedroza C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0217-0; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Prondzinsky R, 2012, CLIN RES CARDIOL, V101, P375, DOI 10.1007/s00392-011-0403-3; Rab T, 2018, J AM COLL CARDIOL, V72, P1972, DOI 10.1016/j.jacc.2018.07.074; Rao P, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.118.004905; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Stegman B, 2015, EUR HEART J-ACUTE CA, V4, P263, DOI 10.1177/2048872614547688; Stegman BM, 2012, J AM COLL CARDIOL, V59, P644, DOI 10.1016/j.jacc.2011.11.010; Thiagarajan RR, 2017, ASAIO J, V63, P60, DOI 10.1097/MAT.0000000000000475; Thiele H, 2019, EUR HEART J, V40, P2671, DOI 10.1093/eurheartj/ehz363; Vanhuyse F, 2017, SHOCK, V47, P236, DOI 10.1097/SHK.0000000000000712; Villablanca PA, 2016, HEART, V102, P712, DOI 10.1136/heartjnl-2015-308559; Zobel C, 2012, CRIT CARE MED, V40, P1715, DOI 10.1097/CCM.0b013e318246b820	34	9	9	9	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					442	453		10.1001/jama.2021.24776	http://dx.doi.org/10.1001/jama.2021.24776			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103766	Green Submitted, Green Published			2022-12-28	WOS:000753056200017
J	Kurihara, C; Manerikar, A; Querrey, M; Felicelli, C; Yeldandi, A; Garza-Castillon, R; Lung, K; Kim, S; Ho, B; Tomic, R; Arunachalam, A; Budinger, GRS; Pesce, L; Bharat, A				Kurihara, Chitaru; Manerikar, Adwaiy; Querrey, Melissa; Felicelli, Christopher; Yeldandi, Anjana; Garza-Castillon, Rafael, Jr.; Lung, Kalvin; Kim, Samuel; Ho, Bing; Tomic, Rade; Arunachalam, Ambalavanan; Budinger, G. R. Scott; Pesce, Lorenzo; Bharat, Ankit			Clinical Characteristics and Outcomes of Patients With COVID-19-Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; COVID-19; DEFINITION; SUPPORT; SOCIETY	IMPORTANCE Lung transplantation is a potentially lifesaving treatment for patients who are critically ill due to COVID-19-associated acute respiratory distress syndrome (ARDS), but there is limited information about the long-term outcome. OBJECTIVE To report the clinical characteristics and outcomes of patients who had COVID-19-associated ARDS and underwent a lung transplant at a single US hospital. DESIGN, SETTING, AND PARTICIPANTS Retrospective case series of 102 consecutive patients who underwent a lung transplant at Northwestern University Medical Center in Chicago, Illinois, between January 21, 2020, and September 30, 2021, including 30 patients who had COVID-19-associated ARDS. The date of final follow-up was November 15, 2021. EXPOSURES Lung transplant. MAIN OUTCOMES AND MEASURES Demographic, clinical, laboratory, and treatment data were collected and analyzed. Outcomes of lung transplant, including postoperative complications, intensive care unit and hospital length of stay, and survival, were recorded. RESULTS Among the 102 lung transplant recipients, 30 patients (median age, 53 years [range, 27 to 62]; 13 women [43%]) had COVID-19-associated ARDS and 72 patients (median age, 62 years [range, 22 to 74]; 32 women [44%]) had chronic end-stage lung disease without COVID-19. For lung transplant recipients with COVID-19 compared with those without COVID-19, the median lung allocation scores were 85.8 vs 46.7, the median time on the lung transplant wait list was 11.5 vs 15 days, and preoperative venovenous extracorporeal membrane oxygenation (ECMO) was used in 56.7% vs 1.4%, respectively. During transplant, patients who had COVID-19-associated ARDS received transfusion of a median of 6.5 units of packed red blood cells vs 0 in those without COVID-19, 96.7% vs 62.5% underwent intraoperative venoarterial ECMO, and the median operative time was 8.5 vs 7.4 hours, respectively. Postoperatively, the rates of primary graft dysfunction (grades 1 to 3) within 72 hours were 70% in the COVID-19 cohort vs 20.8% in those without COVID-19, the median time receiving invasive mechanical ventilation was 6.5 vs 2.0 days, the median duration of intensive care unit stay was 18 vs 9 days, the median post-lung transplant hospitalization duration was 28.5 vs 16 days, and 13.3% vs 5.5% required permanent hemodialysis, respectively. None of the lung transplant recipients who had COVID-19-associated ARDS demonstrated antibody-mediated rejection compared with 12.5% in those without COVID-19. At follow-up, all 30 lung transplant recipients who had COVID-19-associated ARDSwere alive (median follow-up, 351 days [IQR, 176-555] after transplant) vs 60 patients (83%) who were alive in the non-COVID-19 cohort (median follow-up, 488 days [IQR, 368-570] after lung transplant). CONCLUSIONS AND RELEVANCE In this single-center case series of 102 consecutive patients who underwent a lung transplant between January 21, 2020, and September 30, 2021, survival was 100% in the 30 patients who had COVID-19-associated ARDS as of November 15, 2021.	[Kurihara, Chitaru; Manerikar, Adwaiy; Querrey, Melissa; Garza-Castillon, Rafael, Jr.; Lung, Kalvin; Kim, Samuel; Pesce, Lorenzo; Bharat, Ankit] Northwestern Univ, Div Thorac Surg, Chicago, IL 60611 USA; [Felicelli, Christopher; Yeldandi, Anjana] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Ho, Bing] Northwestern Univ, Div Nephrol, Chicago, IL 60611 USA; [Tomic, Rade; Arunachalam, Ambalavanan; Budinger, G. R. Scott] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Bharat, A (corresponding author), Northwestern Med, 676 N St Clair St,Ste 650, Chicago, IL 60611 USA.	ankit.bharat@nm.org			National Institutes of Health [NIH HL145478, HL147290, HL147575]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (NIH HL145478, HL147290, and HL147575 to Dr Bharat).	Attaway AH, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n436; Badulak J, 2021, ASAIO J, V67, P485, DOI 10.1097/MAT.0000000000001422; Barbaro RP, 2021, LANCET, V398, P1230, DOI 10.1016/S0140-6736(21)01960-7; Barbaro RP, 2020, LANCET, V396, P1071, DOI 10.1016/S0140-6736(20)32008-0; Beigel JH, 2020, NEW ENGL J MED, V383, P994, DOI 10.1056/NEJMc2022236; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bermudez CA, 2014, ANN THORAC SURG, V98, P1936, DOI 10.1016/j.athoracsur.2014.06.072; Bharat A, 2007, TRANSPLANTATION, V84, P1316, DOI 10.1097/01.tp.0000288192.11396.70; Bharat A, 2020, LANCET RESP MED, V9, pE90, DOI 10.1016/S2213-2600(21)00288-5; Bharat A, 2021, LANCET RESP MED, V9, P487, DOI 10.1016/S2213-2600(21)00077-1; Bharat A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe4282; Bowe B, 2021, J AM SOC NEPHROL, V32, P2851, DOI 10.1681/ASN.2021060734; Budinger GRS, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149412; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Cypel M, 2020, LANCET RESP MED, V8, P944, DOI 10.1016/S2213-2600(20)30393-3; Dmytriw AA, 2021, EXPERT REV RESP MED, V15, P1347, DOI 10.1080/17476348.2021.1920927; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Fernandez FG, 2005, J HEART LUNG TRANSPL, V24, pS255, DOI 10.1016/j.healun.2004.07.009; Garijo JM, 2019, J CARDIOTHOR VASC AN, V33, P1995, DOI 10.1053/j.jvca.2018.10.007; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Hashimoto K, 2018, J HEART LUNG TRANSPL, V37, P1418, DOI 10.1016/j.healun.2018.07.003; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kurihara C, 2022, ARTIF ORGANS, V46, P688, DOI 10.1111/aor.14090; Kurihara C, 2020, ANN THORAC SURG, V110, P1209, DOI 10.1016/j.athoracsur.2020.02.011; Machuca TN, 2021, ANN SURG, V274, pE870, DOI 10.1097/SLA.0000000000004623; Manerikar A, 2022, ASAIO J, V68, P859, DOI 10.1097/MAT.0000000000001575; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pickens CO, 2021, AM J RESP CRIT CARE, V204, P921, DOI 10.1164/rccm.202106-1354OC; Querrey M, 2021, AM J TRANSPLANT, V21, P4073, DOI 10.1111/ajt.16777; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Snell GI, 2017, J HEART LUNG TRANSPL, V36, P1097, DOI 10.1016/j.healun.2017.07.021; Todd JL, 2020, AM J RESP CRIT CARE, V202, P576, DOI 10.1164/rccm.201910-1915OC; van der Mark SC, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0132-2019; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Weingarten N, 2020, EXPERT REV MED DEVIC, V17, P1075, DOI 10.1080/17434440.2020.1841630	37	19	20	4	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					652	661		10.1001/jama.2022.0204	http://dx.doi.org/10.1001/jama.2022.0204		JAN 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35085383	Green Published, Bronze			2022-12-28	WOS:000747991300001
J	Majzner, RG; Ramakrishna, S; Yeom, KW; Patel, S; Chinnasamy, H; Schultz, LM; Richards, RM; Jiang, L; Barsan, V; Mancusi, R; Geraghty, AC; Good, Z; Mochizuki, AY; Gillespie, SM; Toland, AMS; Mahdi, J; Reschke, A; Nie, EH; Chau, IJ; Rotiroti, MC; Mount, CW; Baggott, C; Mavroukakis, S; Egeler, E; Moon, J; Erickson, C; Green, S; Kunicki, M; Fujimoto, M; Ehlinger, Z; Reynolds, W; Kurra, S; Warren, KE; Prabhu, S; Vogel, H; Rasmussen, L; Cornell, TT; Partap, S; Fisher, PG; Campen, CJ; Filbin, MG; Grant, G; Sahaf, B; Davis, KL; Feldman, SA; Mackall, CL; Monje, M				Majzner, Robbie G.; Ramakrishna, Sneha; Yeom, Kristen W.; Patel, Shabnum; Chinnasamy, Harshini; Schultz, Liora M.; Richards, Rebecca M.; Jiang, Li; Barsan, Valentin; Mancusi, Rebecca; Geraghty, Anna C.; Good, Zinaida; Mochizuki, Aaron Y.; Gillespie, Shawn M.; Toland, Angus Martin Shaw; Mahdi, Jasia; Reschke, Agnes; Nie, Esther H.; Chau, Isabelle J.; Rotiroti, Maria Caterina; Mount, Christopher W.; Baggott, Christina; Mavroukakis, Sharon; Egeler, Emily; Moon, Jennifer; Erickson, Courtney; Green, Sean; Kunicki, Michael; Fujimoto, Michelle; Ehlinger, Zach; Reynolds, Warren; Kurra, Sreevidya; Warren, Katherine E.; Prabhu, Snehit; Vogel, Hannes; Rasmussen, Lindsey; Cornell, Timothy T.; Partap, Sonia; Fisher, Paul G.; Campen, Cynthia J.; Filbin, Mariella G.; Grant, Gerald; Sahaf, Bita; Davis, Kara L.; Feldman, Steven A.; Mackall, Crystal L.; Monje, Michelle			GD2-CART cell therapy for H3K27M-mutated diffuse midline gliomas	NATURE			English	Article							INTRINSIC PONTINE GLIOMA; RECEPTOR T-CELLS; ANTITUMOR-ACTIVITY; ANTIGEN; GLIOBLASTOMA; MICROGLIA	Diffuse intrinsic pontineglioma (DIPG) and other H3K27M-mutated diffuse midline gliomas (DMGs) are universally lethal paediatrictumours ofthe central nervous system(1). We have previously shown that the disialoganglioside GD2 is highly expressed on H3K27M-mutated glioma cells and have demonstrated promising preclinical efficacy of GD2-directed chimeric antigen receptor (CAR) T cells(2), providing the rationale fora first-in-human phase I clinical trial (NCT04196413). Because CAR T cell-induced brainstem inflammation can result in obstructive hydrocephalus, increased intracranial pressure and dangeroustissue shifts, neurocritical care precautions were incorporated. Here we present the clinical experience from the first four patients with H3K27M-mutated DIPG or spinal cord DMG treated with GD2-CART cells at dose level 1(1 x 10(6) GD2-CAR T cells per kg administered intravenously). Patients who exhibited clinical benefit were eligible for subsequent GD2-CART cell infusions administered intracerebroventricularly(3). Toxicity was largely related to the location ofthe tumour and was reversible with intensive supportive care. On-target, off-tumour toxicity was not observed. Three of four patients exhibited clinical and radiographic improvement. Pro-inflammatory cytokine levels were increased in the plasma and cerebrospinal fluid. Transcriptomic analyses of 65,598 single cells from CART cell products and cerebrospinal fluid elucidate heterogeneity in response between participants and administration routes. These early results underscore the promise ofthis therapeutic approach for patients with H3K27M-mutated DIPG or spinal cord DMG.	[Majzner, Robbie G.; Ramakrishna, Sneha; Patel, Shabnum; Chinnasamy, Harshini; Schultz, Liora M.; Richards, Rebecca M.; Barsan, Valentin; Good, Zinaida; Reschke, Agnes; Baggott, Christina; Mavroukakis, Sharon; Egeler, Emily; Moon, Jennifer; Erickson, Courtney; Kunicki, Michael; Fujimoto, Michelle; Prabhu, Snehit; Sahaf, Bita; Davis, Kara L.; Feldman, Steven A.; Mackall, Crystal L.; Monje, Michelle] Stanford Univ, Stanford Ctr Canc Cell Therapy, Stanford Canc Inst, Stanford, CA 94305 USA; [Majzner, Robbie G.; Ramakrishna, Sneha; Schultz, Liora M.; Richards, Rebecca M.; Barsan, Valentin; Reschke, Agnes; Rotiroti, Maria Caterina; Green, Sean; Kunicki, Michael; Fujimoto, Michelle; Ehlinger, Zach; Reynolds, Warren; Kurra, Sreevidya; Sahaf, Bita; Davis, Kara L.; Mackall, Crystal L.; Monje, Michelle] Stanford Univ, Dept Pediat, Div Pediat Hematol Oncol Stem Cell Transplantat &, Stanford, CA 94305 USA; [Majzner, Robbie G.; Good, Zinaida; Mackall, Crystal L.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Yeom, Kristen W.] Stanford Univ, Dept Radiol, Div Neuroradiol, Stanford, CA USA; [Jiang, Li; Warren, Katherine E.; Filbin, Mariella G.] Dana Farber Canc Inst, Div Pediat Neuro Oncol, Boston, MA 02115 USA; [Mancusi, Rebecca; Geraghty, Anna C.; Mochizuki, Aaron Y.; Gillespie, Shawn M.; Mahdi, Jasia; Nie, Esther H.; Chau, Isabelle J.; Mount, Christopher W.; Partap, Sonia; Fisher, Paul G.; Campen, Cynthia J.; Monje, Michelle] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Good, Zinaida] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Toland, Angus Martin Shaw; Vogel, Hannes; Monje, Michelle] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Rasmussen, Lindsey; Cornell, Timothy T.] Stanford Univ, Dept Pediat, Div Crit Care Med, Stanford, CA 94305 USA; [Grant, Gerald; Monje, Michelle] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Mackall, Crystal L.] Stanford Univ, Dept Med, Div Stem Cell Transplantat & Cell Therapy, Stanford, CA 94305 USA; [Monje, Michelle] Stanford Univ, Howard Rd Hughes Med Inst, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Mackall, CL; Monje, M (corresponding author), Stanford Univ, Stanford Ctr Canc Cell Therapy, Stanford Canc Inst, Stanford, CA 94305 USA.; Mackall, CL; Monje, M (corresponding author), Stanford Univ, Dept Pediat, Div Pediat Hematol Oncol Stem Cell Transplantat &, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Monje, M (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Univ, Dept Med, Div Stem Cell Transplantat & Cell Therapy, Stanford, CA 94305 USA.; Monje, M (corresponding author), Stanford Univ, Howard Rd Hughes Med Inst, Stanford, CA 94305 USA.	cmackall@stanford.edu; mmonje@stanford.edu		Barsan, Valentin/0000-0001-5099-9009; Yeom, Kristen/0000-0001-9860-3368; Ramakrishna, Sneha/0000-0001-7445-3190; Mochizuki, Aaron/0000-0003-1073-916X; Partap, Sonia/0000-0001-5615-7689; Nie, Esther H./0000-0002-2280-5905; Ehlinger, Zachary/0000-0003-0849-1089; Mancusi, Rebecca/0000-0002-4809-5569; Rasmussen, Lindsey/0000-0002-9084-659X; Reynolds, Warren/0000-0002-1755-2835; Vogel, Otto Hannes/0000-0002-0960-3508; Good, Zinaida/0000-0003-2343-5771; Mahdi, Jasia/0000-0003-1316-4998	National Institutes of Health [R01 CA263500-01]; Parker Institute for Cancer Immunotherapy; CureSearch; St. Baldrick's Foundation -Stand Up 2 Cancer Pediatric Cancer Dream Team translational research grant [SU2CAACR-DT1113]; Stella S. Jones Foundation; V Foundation; NIH [DP1NS111132, DP2-CA272092]; ChadTough Defeat DIPG; Waxman Family Research Fund; Virginia and D.K. Ludwig Fund for Cancer Research; Stand Up 2 Cancer, a programme of the Entertainment Industry Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; CureSearch; St. Baldrick's Foundation -Stand Up 2 Cancer Pediatric Cancer Dream Team translational research grant; Stella S. Jones Foundation; V Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ChadTough Defeat DIPG; Waxman Family Research Fund; Virginia and D.K. Ludwig Fund for Cancer Research; Stand Up 2 Cancer, a programme of the Entertainment Industry Foundation	We are grateful to our courageous patients and their families; A. Quinones-Hinojosa, K. Jaeckle, H. Tran, D. Poon, M. Casazza, D. Brown, S. Herrera, R. Taiwo, R. Jamiolkowski, A. Wu, S. Vaca, D. Herrick, D. Purger, D. Hong, A. Cluster, D. Limbrick, E. Mayne, C. Tesi-Rocha, C. Wusthoff, S. Lee, F. Baumer, J. Klotz, T. Nguyen and many others on the clinical teams for collaboration in the care of these patients; J. Senesac and Bellicum for providing study-enabling materials in the form of the viral vector and the AP1903 supply; J. S. Tamaresis for statistical support in the trial design; Y. Pan for help with figure formatting; S. Marsh and B. Stevens for input on myeloid cell transcriptional signatures; N. Lepori-Bui, T. Tutt and A.-L. Gramstrup Petersen for their expertise in cell formulation; and the Stanford Human Immune Monitoring Core (HIMC) for performing cytokine assays. This work was supported by the National Institutes of Health R01 CA263500-01 (C.L.M. and M.M.), the Parker Institute for Cancer Immunotherapy (C.L.M. and R.G.M.), CureSearch (C.L.M., M.M. and R.G.M.), a St. Baldrick's Foundation -Stand Up 2 Cancer Pediatric Cancer Dream Team translational research grant (SU2CAACR-DT1113; C.L.M., R.G.M., S.R. and M.M.), the Stella S. Jones Foundation (M.M.), The V Foundation (R.G.M.), NIH Director's Pioneer Award (DP1NS111132; M.M.), NIH Director's New Innovator Award (DP2-CA272092; R.G.M.), ChadTough Defeat DIPG (J. Mahdi), Waxman Family Research Fund (A.C.G.) and the Virginia and D.K. Ludwig Fund for Cancer Research (C.L.M. and M.M.). The St. Baldrick's Foundation partners with Stand Up 2 Cancer, a programme of the Entertainment Industry Foundation administered by the American Association for Cancer Research.	Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Broniscer A, 2006, CANCER, V106, P1364, DOI 10.1002/cncr.21749; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Cooney T, 2017, NEURO-ONCOLOGY, V19, P1279, DOI 10.1093/neuonc/nox107; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gabrusiewicz K., 2017, TRANSLATIONAL IMMUNO, P63, DOI DOI 10.1016/B978-0-12-802420-1.00004-1; Gojo J, 2020, CANCER CELL, V38, P44, DOI 10.1016/j.ccell.2020.06.004; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Heczey A, 2020, NAT MED, V26, P1686, DOI 10.1038/s41591-020-1074-2; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kiselev VY, 2019, NAT REV GENET, V20, P273, DOI 10.1038/s41576-018-0088-9; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Lin GL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0553-x; Lin GL, 2017, JOVE-J VIS EXP, DOI 10.3791/55360; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Majzner RG, 2020, CANCER DISCOV, V10, P702, DOI 10.1158/2159-8290.CD-19-0945; Majzner RG, 2019, CLIN CANCER RES, V25, P2560, DOI 10.1158/1078-0432.CCR-18-0432; Marconi S, 2005, J NEUROIMMUNOL, V170, P115, DOI 10.1016/j.jneuroim.2005.03.025; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robison NJ, 2014, J NEURO-ONCOL, V119, P7, DOI 10.1007/s11060-014-1448-8; Shen KL, 2020, WORLD J PEDIATR, V16, P232, DOI 10.1007/s12519-020-00362-4; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Stallard S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0580-7; Straathof K, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd6169; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Theruvath J, 2020, NAT MED, V26, P712, DOI 10.1038/s41591-020-0821-8; Venkatesh HS, 2019, NATURE, V573, P539, DOI 10.1038/s41586-019-1563-y; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Weber EW, 2021, SCIENCE, V372, P49, DOI 10.1126/science.aba1786; Weber EW, 2019, BLOOD ADV, V3, P711, DOI 10.1182/bloodadvances.2018028720; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e	45	62	63	45	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					934	+		10.1038/s41586-022-04489-4	http://dx.doi.org/10.1038/s41586-022-04489-4		FEB 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35130560	hybrid, Green Published			2022-12-28	WOS:000772729200001
J	Batut, PJ; Bing, XY; Sisco, Z; Raimundo, J; Levo, M; Levine, MS				Batut, Philippe J.; Bing, Xin Yang; Sisco, Zachary; Raimundo, Joao; Levo, Michal; Levine, Michael S.			Genome organization controls transcriptional dynamics during development	SCIENCE			English	Article							CHROMATIN DOMAINS; ENHANCER FUNCTION; DROSOPHILA; GENE; ELEMENTS; BINDING; LOCUS; LOOPS; IDENTIFICATION; PROTEINS	Past studies offer contradictory claims for the role of genome organization in the regulation of gene activity. Here, we show through high-resolution chromosome conformation analysis that the Drosophila genome is organized by two independent classes of regulatory sequences, tethering elements and insulators. Quantitative live imaging and targeted genome editing demonstrate that this two-tiered organization is critical for the precise temporal dynamics of Hox gene transcription during development. Tethering elements mediate long-range enhancer-promoter interactions and foster fast activation kinetics. Conversely, the boundaries of topologically associating domains (TADs) prevent spurious interactions with enhancers and silencers located in neighboring TADs. These two levels of genome organization operate independently of one another to ensure precision of transcriptional dynamics and the reliability of complex patterning processes.	[Batut, Philippe J.; Bing, Xin Yang; Sisco, Zachary; Raimundo, Joao; Levo, Michal; Levine, Michael S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University	Batut, PJ; Levine, MS (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	pbatut@princeton.edu; msl2@princeton.edu		Bing, Xinyang/0000-0001-6789-1918; Batut, Philippe/0000-0003-4250-0663; Sisco, Zachary/0000-0002-8730-3228; Levine, Michael/0000-0001-7629-0081	National Institutes of Health [R35 GM118147]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health grant R35 GM118147.	Abdennur N, 2020, BIOINFORMATICS, V36, P311, DOI 10.1093/bioinformatics/btz540; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Batut P., 2021, phil-batut/transcription_imaging: transcription_imaging, DOI 10.5281/zenodo.5730297; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Chen HT, 2018, NAT GENET, V50, P1296, DOI 10.1038/s41588-018-0175-z; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Despang A, 2019, NAT GENET, V51, P1263, DOI 10.1038/s41588-019-0466-z; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eksi SE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007320; Espinas ML, 1999, J BIOL CHEM, V274, P16461, DOI 10.1074/jbc.274.23.16461; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Gaskill MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66668; Ghavi-Helm Y, 2019, NAT GENET, V51, P1272, DOI 10.1038/s41588-019-0462-3; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; GINDHART JG, 1995, GENETICS, V139, P797; GINDHART JG, 1995, GENETICS, V139, P781; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Harrison MM, 2010, DEV BIOL, V345, P248, DOI 10.1016/j.ydbio.2010.06.026; Hsieh THS, 2020, MOL CELL, V78, P539, DOI 10.1016/j.molcel.2020.03.002; Ing-Simmons E, 2021, NAT GENET, V53, P487, DOI 10.1038/s41588-021-00799-x; JACK J, 1995, GENETICS, V139, P1689; Kerpedjiev P, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1486-1; Koromila T, 2020, ELIFE, V9, DOI 10.7554/eLife.59610; Kragesteen BK, 2018, NAT GENET, V50, P1463, DOI 10.1038/s41588-018-0221-x; Kruse K, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02215-9; Kubo N, 2021, NAT STRUCT MOL BIOL, V28, P152, DOI 10.1038/s41594-020-00539-5; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2015, MOL CELL BIOL, V35, P4018, DOI 10.1128/MCB.00663-15; Lim B, 2018, MOL CELL, V70, P287, DOI 10.1016/j.molcel.2018.02.029; LIU S, 1991, GENETICS, V127, P151; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Loubiere V, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax4001; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mahmoudi T, 2002, EMBO J, V21, P1775, DOI 10.1093/emboj/21.7.1775; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nevil M, 2017, GENETICS, V205, P605, DOI 10.1534/genetics.116.195685; Pachano T, 2021, NAT GENET, V53, P1036, DOI 10.1038/s41588-021-00888-x; Paliou C, 2019, P NATL ACAD SCI USA, V116, P12390, DOI 10.1073/pnas.1900672116; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Robson MI, 2019, MOL CELL, V74, P1110, DOI 10.1016/j.molcel.2019.05.032; Rodriguez-Carballo E, 2020, P NATL ACAD SCI USA, V117, P31231, DOI 10.1073/pnas.2015083117; Rowley MJ, 2020, GENOME RES, V30, P447, DOI 10.1101/gr.257832.119; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; transcription_imaging, 2021, Zenodo, DOI 10.5281/zenodo.5730297; Zenk F, 2021, NATURE, V593, P289, DOI 10.1038/s41586-021-03460-z; Zhou QL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20282-1; Zolotarev N, 2016, NUCLEIC ACIDS RES, V44, P7228, DOI 10.1093/nar/gkw371	58	13	13	20	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					566	+		10.1126/science.abi7178	http://dx.doi.org/10.1126/science.abi7178			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113722				2022-12-28	WOS:000753965100044
J	Adam, D				Adam, David			WILL OMICRON END THE PANDEMIC? HERE'S WHAT EXPERTS SAY	NATURE			English	News Item																			0	13	13	5	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					20	21						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8PL	35102287				2022-12-28	WOS:000749566700013
J	Edgar, RC; Taylor, J; Lin, V; Altman, T; Barbera, P; Meleshko, D; Lohr, D; Novakovsky, G; Buchfink, B; Al-Shayeb, B; Banfield, JF; de la Pena, M; Korobeynikov, A; Chikhi, R; Babaian, A				Edgar, Robert C.; Taylor, Jeff; Lin, Victor; Altman, Tomer; Barbera, Pierre; Meleshko, Dmitry; Lohr, Dan; Novakovsky, Gherman; Buchfink, Benjamin; Al-Shayeb, Basem; Banfield, Jillian F.; de la Pena, Marcos; Korobeynikov, Anton; Chikhi, Rayan; Babaian, Artem			Petabase-scale sequence alignment catalyses viral discovery	NATURE			English	Article							STRUCTURAL BASIS; SEARCH; HEPATITIS; VIRUSES	Public databases contain a planetary collection of nucleic acid sequences, but their systematic exploration has been inhibited by a lack of efficient methods for searching this corpus, which (at the time of writing) exceeds 20 petabases and is growing exponentially(1). Here we developed a cloud computing infrastructure, Serratus, to enable ultra-high-throughput sequence alignment at the petabase scale. We searched 5.7 million biologically diverse samples (10.2 petabases) for the hallmark gene RNA-dependent RNA polymerase and identified well over 10(5) novel RNA viruses, thereby expanding the number of known species by roughly an order of magnitude. We characterized novel viruses related to coronaviruses, hepatitis delta virus and huge phages, respectively, and analysed their environmental reservoirs. To catalyse the ongoing revolution of viral discovery, we established a free and comprehensive database of these data and tools. Expanding the known sequence diversity of viruses can reveal the evolutionary origins of emerging pathogens and improve pathogen surveillance for the anticipation and mitigation of future pandemics.	[Altman, Tomer] Altman Analyt, San Francisco, CA USA; [Barbera, Pierre] Heidelberg Inst Theoret Studies, Computat Mol Evolut Grp, Heidelberg, Germany; [Meleshko, Dmitry; Korobeynikov, Anton] St Petersburg State Univ, Ctr Algorithm Biotechnol, St Petersburg, Russia; [Meleshko, Dmitry] Weill Cornell Med Coll, Triinst PhD Program Computat Biol & Med, New York, NY USA; [Novakovsky, Gherman] Univ British Columbia, Bioinformat Grad Program, Vancouver, BC, Canada; [Buchfink, Benjamin] Max Planck Inst Biol, Computat Biol Grp, Tubingen, Germany; [Al-Shayeb, Basem] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [de la Pena, Marcos] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Korobeynikov, Anton] St Petersburg State Univ, Dept Stat Modelling, St Petersburg, Russia; [Chikhi, Rayan] Inst Pasteur, Dept Computat Biol, G5 Sequence Bioinformat, Paris, France	Heidelberg Institute for Theoretical Studies; Saint Petersburg State University; Cornell University; University of British Columbia; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Saint Petersburg State University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris		ab2788@cam.ac.uk	de la Pena, Marcos/D-5001-2009	de la Pena, Marcos/0000-0002-7949-8459; Babaian, Artem/0000-0002-4315-6262; Barbera, Pierre/0000-0002-3437-150X	University of British Columbia; Max Plank Society; Klaus Tschira Foundation; ANR Transipedia, Inception and PRAIRIE grants [PIA/ANR16-CONV-0005, ANR-18CE45-0020, ANR-19-P3IA-0001]; Ministerio de Economia y Competitividad of Spain; FEDER [BFU2017-87370-P, PID2020-116008GB-I00]; Russian Science Foundation [19-14-00172]	University of British Columbia; Max Plank Society(Max Planck Society); Klaus Tschira Foundation; ANR Transipedia, Inception and PRAIRIE grants(French National Research Agency (ANR)); Ministerio de Economia y Competitividad of Spain(Spanish Government); FEDER(European Commission); Russian Science Foundation(Russian Science Foundation (RSF))	The Serratus project is an initiative of the hackseqRNA genomics hackathon (https://www.hackseq.com).We thank the many contributors for code snippets and bioinformatic discussion (E. Erhan, J. Chu, S. Jackman, I. Birol, K. Wellman, O. Fornes, C. Xu, M. Huss, K. Ha, M. Krzywinski, E. Nawrocki, R. McLaughlin, C. Morgan-Lang, C. Blumberg and the J. Brister laboratory); A. Rodrigues, S. McMillan, V. Wu, C. Kennett, K. Chao, and N. Pereyaslavsky for AWS support; the J. Joy laboratory, G. Mordecai, J. Taylor, S. Roux, N. Kyrpides, E. Jan, T. Reddy, L. Bergner, R. Orton and D. Streicker for virology discussions; and H.-G. Drost and D. Weigel for supporting the adoption of DIAMOND v2 for Serratus protein alignments as part of an extended feature request. We are grateful to the entire team managing the NCBI SRA and the biology community for data sharing, with particular thanks to the E. Brodie, E. Lilleskov and E. Young laboratories. T.A. thanks Advanced Research Computing resource at the University of British Columbia and B.B. thanks the Max Plank Society for financial support. P.B. was financially supported by the Klaus Tschira Foundation; R.C. by ANR Transipedia, Inception and PRAIRIE grants (PIA/ANR16-CONV-0005, ANR-18CE45-0020, ANR-19-P3IA-0001); and M.d.l.P. by the Ministerio de Economia y Competitividad of Spain and FEDER grants (BFU2017-87370-P and PID2020-116008GB-I00). A.K. and D.M. were supported by the Russian Science Foundation (grant 19-14-00172) and computation was carried out in part by Resource Centre `Computer Centre of SPbU'. A.K. and D.M. are grateful to Saint Petersburg State University for the overall support of this work. Project support and computing resources were provided by the University of British Columbia Community Health and Wellbeing Cloud Innovation Centre, powered by AWS.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Al-Shayeb B, 2020, NATURE, V578, P425, DOI 10.1038/s41586-020-2007-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Antipov D, 2020, BIOINFORMATICS, V36, P4126, DOI 10.1093/bioinformatics/btaa490; Babaian A., 2021, RIBOVIRUS CLASSIFICA, DOI [10.1101/2021.03.02.433648v1, DOI 10.1101/2021.03.02.433648V1]; Baker D, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008643; Bradley P, 2019, NAT BIOTECHNOL, V37, P152, DOI 10.1038/s41587-018-0010-1; Buchfink B, 2021, NAT METHODS, V18, P366, DOI 10.1038/s41592-021-01101-x; Bukhari K, 2018, VIROLOGY, V524, P160, DOI 10.1016/j.virol.2018.08.010; Bushmanova E, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz100; Camarillo-Guerrero LF, 2021, CELL, V184, P1098, DOI 10.1016/j.cell.2021.01.029; Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463; Chang WS, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez021; Chase JM, 2020, NATURE, V584, P238, DOI 10.1038/s41586-020-2531-2; Chen IMA, 2021, NUCLEIC ACIDS RES, V49, pD751, DOI 10.1093/nar/gkaa939; Courtot M, 2022, NUCLEIC ACIDS RES, V50, pD1500, DOI 10.1093/nar/gkab1046; Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189; de la Pena M, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab016; Devoto AE, 2019, NAT MICROBIOL, V4, P693, DOI 10.1038/s41564-018-0338-9; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flores R, 2014, ANNU REV MICROBIOL, V68, P395, DOI 10.1146/annurev-micro-091313-103416; Hunt M, 2015, BIOINFORMATICS, V31, P2374, DOI 10.1093/bioinformatics/btv120; Iwamoto M, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab003; Johnson CK, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2736; Karasikov M, 2020, METAGRAPH INDEXING A, DOI 10.1101/2020.10.01.322164; Katz KS, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02490-0; Koonin EV, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00061-19; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0; Letko M, 2020, NAT REV MICROBIOL, V18, P461, DOI 10.1038/s41579-020-0394-z; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Meleshko D, 2022, BIOINFORMATICS, V38, P1, DOI 10.1093/bioinformatics/btab597; Miller A. K, 2021, VIRUS EVOL, V7, pv; Mitchell AL, 2020, NUCLEIC ACIDS RES, V48, pD570, DOI 10.1093/nar/gkz1035; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Mordecai GJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47615; Morel B, 2019, BIOINFORMATICS, V35, P1771, DOI 10.1093/bioinformatics/bty839; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Mukherjee S, 2021, NUCLEIC ACIDS RES, V49, pD723, DOI 10.1093/nar/gkaa983; Nayfach S, 2021, NAT BIOTECHNOL, V39, P499, DOI 10.1038/s41587-020-0718-6; NIH, 2021, STRIDES IN DAT SCI N; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Obbard DJ, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/vez061; Paraskevopoulou S, 2020, P NATL ACAD SCI USA, V117, P17977, DOI 10.1073/pnas.2006750117; Rynge M., 2021, P PRACT EXP ADV RES, P1; Sabin KZ, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0335-4; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Szirovicza L, 2020, MBIO, V11, DOI 10.1128/mBio.03250-19; Tao Y., 2020, BROAD RANGE VIRUS DE, DOI [10.1101/2020.06.10.145052v1, DOI 10.1101/2020.06.10.145052V1]; Taylor JM, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060648; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Tsai SL, 2020, ELIFE, V9, DOI 10.7554/eLife.50765; Wahba L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00160-20; Wille M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120720; Wolf YI, 2020, NAT MICROBIOL, V5, P1262, DOI 10.1038/s41564-020-0755-4; Wolf YI, 2018, MBIO, V9, DOI 10.1128/mBio.02329-18; Zuccola HJ, 1998, STRUCTURE, V6, P821, DOI 10.1016/S0969-2126(98)00084-7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	41	41	33	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					142	+		10.1038/s41586-021-04332-2	http://dx.doi.org/10.1038/s41586-021-04332-2			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35082445	Green Submitted, hybrid			2022-12-28	WOS:000750429600033
J	Gowda, K; Ping, D; Mani, M; Kuehn, S				Gowda, Karna; Ping, Derek; Mani, Madhav; Kuehn, Seppe			Genomic structure predicts metabolite dynamics in microbial communities	CELL			English	Article							CONTAINING NITRITE REDUCTASE; ESCHERICHIA-COLI; SPECTROPHOTOMETRIC METHOD; PSEUDOMONAS-AERUGINOSA; DISSIMILATORY NITRATE; CELL-GROWTH; DENITRIFICATION; PURIFICATION; KINETICS; EVOLUTION	The metabolic activities of microbial communities play a defining role in the evolution and persistence of life on Earth, driving redox reactions that give rise to global biogeochemical cycles. Community metabolism emerges from a hierarchy of processes, including gene expression, ecological interactions, and environmental factors. In wild communities, gene content is correlated with environmental context, but predicting metabolite dynamics from genomes remains elusive. Here, we show, for the process of denitrification, that metabolite dynamics of a community are predictable from the genes each member of the community possesses. A simple linear regression reveals a sparse and generalizable mapping from gene content to metabolite dynamics for genomically diverse bacteria. A consumer-resource model correctly predicts community metabolite dynamics from single-strain phenotypes. Our results demonstrate that the conserved impacts of metabolic genes can predict community metabolite dynamics, enabling the prediction of metabolite dynamics from metagenomes, designing denitrifying communities, and discovering how genome evolution impacts metabolism.	[Gowda, Karna; Kuehn, Seppe] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gowda, Karna; Kuehn, Seppe] Univ Chicago, Ctr Phys Evolving Syst, Chicago, IL 60637 USA; [Ping, Derek] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Mani, Madhav] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Mani, Madhav] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Mani, Madhav] Northwestern Univ, NSF Simons Ctr Quantitat Biol, Evanston, IL 60208 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University	Kuehn, S (corresponding author), Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA.; Kuehn, S (corresponding author), Univ Chicago, Ctr Phys Evolving Syst, Chicago, IL 60637 USA.; Mani, M (corresponding author), Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA.; Mani, M (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Mani, M (corresponding author), Northwestern Univ, NSF Simons Ctr Quantitat Biol, Evanston, IL 60208 USA.	madhav.mani@gmail.com; seppe.kuehn@gmail.com		Gowda, Karna/0000-0001-6812-4745	National Science Foundation Division of Emerging Frontiers [EF 2025293, EF 2025521]; National Science Foundation Physics Frontiers Center Program [PHY 0822613, PHY 1430124]; James S. McDonnell Foundation [220020499]; Simons Foundation Investigator Award [597491]	National Science Foundation Division of Emerging Frontiers; National Science Foundation Physics Frontiers Center Program; James S. McDonnell Foundation; Simons Foundation Investigator Award	We thank Laura Troyer for assistance with isolating bacterial strains and Elizabeth Ujhelyi and Annette Wells for assistance with sequencing. We acknowledge Cameron Pittelkow for access to corn and soybean fields in Savoy, Illinois, and the laboratory of Julie Zilles for providing the bacterial strain Paracoccus denitrificans ATCC 19367. We also thank Rama Ranganathan, David Pincus, James Sethna, William Metcalf, Jun Song, Sara Clifton, and members of the Kuehn laboratory and Mani group for helpful discussions. This work was supported by the National Science Foundation Division of Emerging Frontiers EF 2025293 (S.K.) and EF 2025521 (M.M.), the National Science Foundation Physics Frontiers Center Program PHY 0822613 and PHY 1430124 (S.K.), James S. McDonnell Foundation Postdoctoral Fellowship Award 220020499 (K.G.), and the Simons Foundation Investigator Award 597491 (M.M.).	ABRAHAM ZHL, 1993, BIOCHEM J, V295, P587, DOI 10.1042/bj2950587; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BECCARI M, 1983, J WATER POLLUT CON F, V55, P58; BELL LC, 1990, FEBS LETT, V265, P85, DOI 10.1016/0014-5793(90)80889-Q; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; BESSON S, 1995, ANAEROBE, V1, P219, DOI 10.1006/anae.1995.1021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAUN C, 1991, J BIOL CHEM, V266, P22785; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cermak N, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100915; CLAUS G, 1985, APPL MICROBIOL BIOT, V22, P283; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; COULTATE TP, 1975, J BACTERIOL, V121, P55, DOI 10.1128/JB.121.1.55-64.1975; Datta MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11965; DENARIAZ G, 1991, BIOCHIM BIOPHYS ACTA, V1056, P225, DOI 10.1016/S0005-2728(05)80053-2; Dincer AR, 2000, ENZYME MICROB TECH, V27, P37, DOI 10.1016/S0141-0229(00)00145-9; Erbilgin O, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1478-2; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferguson Stuart J., 2004, V16, P169; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; Fraebel DT, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101678; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; GLOCKNER AB, 1993, ARCH MICROBIOL, V160, P18; Goddard AD, 2017, MOL MICROBIOL, V103, P117, DOI 10.1111/mmi.13546; Goddard AD, 2008, MOL MICROBIOL, V70, P667, DOI 10.1111/j.1365-2958.2008.06436.x; Goldford JE, 2018, SCIENCE, V361, P469, DOI 10.1126/science.aat1168; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Hassen A, 1998, BIORESOURCE TECHNOL, V65, P73, DOI 10.1016/S0960-8524(98)00011-X; Hastie T., 2016, MONOGRAPHS STAT APPL, V143; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Haywood-Farmer E, 2003, EVOLUTION, V57, P1783; HEMPFLING WP, 1975, J BACTERIOL, V123, P1076, DOI 10.1128/JB.123.3.1076-1087.1975; Hessen DO, 2010, TRENDS ECOL EVOL, V25, P75, DOI 10.1016/j.tree.2009.08.004; Heylen K, 2006, APPL ENVIRON MICROB, V72, P2637, DOI 10.1128/AEM.72.4.2637-2643.2006; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Ikeda E, 2009, BIOSCI BIOTECH BIOCH, V73, P896, DOI 10.1271/bbb.80833; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; IWASAKI H, 1972, J BIOCHEM, V71, P645; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; KAKUTANI T, 1981, J BIOCHEM, V89, P453, DOI 10.1093/oxfordjournals.jbchem.a133220; Keck F, 2016, ECOL EVOL, V6, P2774, DOI 10.1002/ece3.2051; Kehe J, 2019, P NATL ACAD SCI USA, V116, P12804, DOI 10.1073/pnas.1900102116; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kornaros M, 1996, WATER ENVIRON RES, V68, P934, DOI 10.2175/106143096X127947; KUKIMOTO M, 1994, BIOCHEMISTRY-US, V33, P5246, DOI 10.1021/bi00183a030; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; LENSI R, 1995, SOIL BIOL BIOCHEM, V27, P61, DOI 10.1016/0038-0717(94)00132-K; Li JH, 2019, ISME J, V13, P2162, DOI 10.1038/s41396-019-0422-z; Lilja EE, 2016, ISME J, V10, P1568, DOI 10.1038/ismej.2015.243; Liu BB, 2013, ENVIRON MICROBIOL, V15, P2816, DOI 10.1111/1462-2920.12142; LIU MY, 1986, J BACTERIOL, V166, P604, DOI 10.1128/jb.166.2.604-608.1986; Louca S, 2018, NAT ECOL EVOL, V2, P936, DOI 10.1038/s41559-018-0519-1; Louca S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0015; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Lu HJ, 2014, WATER RES, V64, P237, DOI 10.1016/j.watres.2014.06.042; Lycus P, 2017, ISME J, V11, P2219, DOI 10.1038/ismej.2017.82; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323; MASUKO M, 1984, J BIOCHEM, V96, P447, DOI 10.1093/oxfordjournals.jbchem.a134856; Mathupala SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148923; Medlock GL, 2018, CELL SYST, V7, P245, DOI 10.1016/j.cels.2018.08.003; MICHALSKI WP, 1985, BIOCHIM BIOPHYS ACTA, V828, P130; Mickalide H, 2019, CELL SYST, V9, P521, DOI 10.1016/j.cels.2019.11.004; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Molina N, 2009, TRENDS GENET, V25, P243, DOI 10.1016/j.tig.2009.04.004; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Mori M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004913; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nikel PI, 2021, ISME J, V15, P1751, DOI 10.1038/s41396-020-00884-9; Norsigian CJ, 2020, NAT PROTOC, V15, P1, DOI 10.1038/s41596-019-0254-3; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pequignot C, 1998, BIOTECHNOL TECH, V12, P899, DOI 10.1023/A:1008865512272; Perisin M, 2016, ISME J, V10, P1020, DOI 10.1038/ismej.2015.161; Phaiboun A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004198; Price MN, 2018, NATURE, V557, P503, DOI 10.1038/s41586-018-0124-0; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Roller BRK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.160, 10.1038/nmicrobiol.2016.160]; ROSENBERGER RF, 1960, J GEN MICROBIOL, V22, P726, DOI 10.1099/00221287-22-3-726; Sakoparnig T, 2021, ELIFE, V10, DOI 10.7554/eLife.65366; Sanchez-Gorostiaga A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000550; SAWADA E, 1978, PLANT CELL PHYSIOL, V19, P1339; SAWHNEY V, 1978, J GEN MICROBIOL, V106, P119, DOI 10.1099/00221287-106-1-119; Schober AF, 2019, CELL REP, V27, P3359, DOI 10.1016/j.celrep.2019.05.030; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sela I, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031018; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Si YY, 2019, CAN J MICROBIOL, V65, P486, DOI 10.1139/cjm-2019-0037; Sieber CMK, 2018, NAT MICROBIOL, V3, P836, DOI 10.1038/s41564-018-0171-1; Stein LY, 2016, CURR BIOL, V26, pR94, DOI 10.1016/j.cub.2015.12.021; Stewart V, 2002, J BACTERIOL, V184, P1314, DOI 10.1128/JB.184.5.1314-1323.2002; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Taylor J, 2015, P NATL ACAD SCI USA, V112, P7629, DOI 10.1073/pnas.1507583112; TIEDJE JM, 1982, A VAN LEEUW J MICROB, V48, P569, DOI 10.1007/BF00399542; TIMKOVICH R, 1982, ARCH BIOCHEM BIOPHYS, V215, P47, DOI 10.1016/0003-9861(82)90277-6; Vaccaro BJ, 2016, APPL ENVIRON MICROB, V82, P51, DOI 10.1128/AEM.02602-15; Van Alst NE, 2009, CAN J MICROBIOL, V55, P1133, DOI [10.1139/W09-065, 10.1139/w09-065]; Verbaendert I, 2011, BIOCHEM SOC T, V39, P254, DOI 10.1042/BST0390254; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919; WARNECKEEBERZ U, 1993, ARCH MICROBIOL, V159, P405, DOI 10.1007/BF00288585; White D., 2012, PHYSL BIOCH PROKARYO; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	117	10	9	36	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					530	+		10.1016/j.cell.2021.12.036	http://dx.doi.org/10.1016/j.cell.2021.12.036			43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1YD	35085485	Green Submitted			2022-12-28	WOS:000768266500003
J	Park, SY; Rao, CT; Coyte, KZ; Kuziel, GA; Zhang, YC; Huang, WT; Franzosa, EA; Weng, JK; Huttenhower, C; Rakoff-Nahoum, S				Park, Sun-Yang; Rao, Chitong; Coyte, Katharine Z.; Kuziel, Gavin A.; Zhang, Yancong; Huang, Wentao; Franzosa, Eric A.; Weng, Jing-Ke; Huttenhower, Curtis; Rakoff-Nahoum, Seth			Strain-level fitness in the gut microbiome is an emergent property of glycans and a single metabolite	CELL			English	Article							CHAIN FATTY-ACIDS; POLYSACCHARIDE UTILIZATION; GENE-EXPRESSION; HOST-MICROBIOME; REVEALS; HOMEOSTASIS; ECOSYSTEM; IMMUNITY; SYSTEM; UNIREF	The human gut microbiota resides within a diverse chemical environment challenging our ability to understand the forces shaping this ecosystem. Here, we reveal that fitness of the Bacteroidales, the dominant order of bacteria in the human gut, is an emergent property of glycans and one specific metabolite, butyrate. Distinct sugars serve as strain-variable fitness switches activating context-dependent inhibitory functions of butyrate. Differential fitness effects of butyrate within the Bacteroides are mediated by species-level variation in Acyl-CoA thioesterase activity and nucleotide polymorphisms regulating an Acyl-CoA transferase. Using in vivo multi-omic profiles, we demonstrate Bacteroides fitness in the human gut is associated together, but not independently, with Acyl-CoA transferase expression and butyrate. Our data reveal that each strain of the Bacteroides exists within a unique fitness landscape based on the interaction of chemical components unpredictable by the effect of each part alone mediated by flexibility in the core genome.	[Park, Sun-Yang; Rao, Chitong; Coyte, Katharine Z.; Kuziel, Gavin A.; Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Pediat, Div Infect Dis, Boston, MA 02115 USA; [Park, Sun-Yang; Rao, Chitong; Coyte, Katharine Z.; Kuziel, Gavin A.; Rakoff-Nahoum, Seth] Boston Childrens Hosp, Dept Pediat, Div Gastroenterol, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Zhang, Yancong; Franzosa, Eric A.; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Zhang, Yancong; Huttenhower, Curtis; Rakoff-Nahoum, Seth] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huang, Wentao; Weng, Jing-Ke] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Huang, Wentao; Weng, Jing-Ke] MIT, Dept Biol, Cambridge, MA USA; [Coyte, Katharine Z.] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Manchester	Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Dept Pediat, Div Infect Dis, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Dept Pediat, Div Gastroenterol, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	seth.rakoff-nahoum@childrens.harvard.edu	Zhang, Yancong/P-3679-2015	Zhang, Yancong/0000-0002-2768-2975; Huttenhower, Curtis/0000-0002-1110-0096; Coyte, Katharine/0000-0002-5231-9350; Huang, Wentao/0000-0003-2921-8524; Kuziel, Gavin/0000-0003-2338-0176	NIDDK [R24DK110499]; Keck Foundation; Mathers Foundation; NDSEG Fellowship; Sir Henry Wellcome Postdoctoral Research Fellowship; Harvard Digestive Disease Center [P30 DK034854]; Burroughs Wellcome Fund; Pew Biomedical Scholarship; Basil O'Connor Starter Scholar Award from the March of Dimes; NIH [1K08AI130392-01, DP2GM136652]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Keck Foundation(W.M. Keck Foundation); Mathers Foundation; NDSEG Fellowship; Sir Henry Wellcome Postdoctoral Research Fellowship; Harvard Digestive Disease Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Biomedical Scholarship; Basil O'Connor Starter Scholar Award from the March of Dimes; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the S. R.-N. lab for helpful comments on the manuscript, Beneo (Inulin) and Glycom (HMO) for reagents, and J. Livny and the Broad MOC (assistance for RNASeq). We thank M. and B. Rakoff-O'Neill for sugar preparation and tube labelling. This work is supported by NIDDK R24DK110499 (C.H.), Keck Foundation (J.-K.W.), Mathers Foundation (J.-K.W., S.R.-N.), a NDSEG Fellowship (G.A.K.), a Sir Henry Wellcome Postdoctoral Research Fellowship (K.Z. C.), the Harvard Digestive Disease Center (P30 DK034854 to S.R.-N.), a Career Award for Medical Scientists from the Burroughs Wellcome Fund (S.R.-N.), a Pew Biomedical Scholarship (S.R.-N.), a Basil O'Connor Starter Scholar Award from the March of Dimes (S.R.-N.), and the NIH (1K08AI130392-01 and DP2GM136652 to S.R.-N.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barcik W, 2020, IMMUNITY, V52, P241, DOI 10.1016/j.immuni.2020.01.007; Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1111/j.1574-6968.2000.tb09417.x; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Charbonneau MR, 2016, NATURE, V535, P48, DOI 10.1038/nature18845; Coyne MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2377-z; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; DeJesus MA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004401; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2019, NAT REV CANCER, V19, P371, DOI 10.1038/s41568-019-0155-3; Ferreiro A, 2018, CELL, V172, P1216, DOI 10.1016/j.cell.2018.02.015; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hecht AL, 2017, CELL HOST MICROBE, V22, P443, DOI 10.1016/j.chom.2017.08.007; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Jawed K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160035; Kaiser JC, 2018, MBIO, V9, DOI 10.1128/mBio.01188-18; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; Kino Y, 2016, ANAEROBE, V42, P81, DOI 10.1016/j.anaerobe.2016.09.004; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z; Leshem A, 2020, MOL CELL, V78, P597, DOI 10.1016/j.molcel.2020.03.001; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim B, 2017, CELL, V169, P547, DOI 10.1016/j.cell.2017.03.045; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mimee M, 2016, CELL SYST, V2, P214, DOI 10.1016/j.cels.2016.03.007; Pal D, 2005, J BACTERIOL, V187, P7167, DOI 10.1128/JB.187.21.7167-7175.2005; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; PANTOSTI A, 1991, INFECT IMMUN, V59, P2075, DOI 10.1128/IAI.59.6.2075-2082.1991; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Patnode ML, 2019, CELL, V179, P59, DOI 10.1016/j.cell.2019.08.011; Plichta DR, 2019, CELL, V178, P1041, DOI 10.1016/j.cell.2019.07.045; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sato M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01146; Sberro H, 2019, CELL, V178, P1245, DOI 10.1016/j.cell.2019.07.016; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schwaim ND, 2017, MOL MICROBIOL, V104, P32, DOI 10.1111/mmi.13609; Sherwin E, 2019, SCIENCE, V366, P587, DOI 10.1126/science.aar2016; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SMITH CJ, 1992, PLASMID, V27, P141, DOI 10.1016/0147-619X(92)90014-2; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Sorbara MT, 2019, J EXP MED, V216, P84, DOI 10.1084/jem.20181639; Stokes JM, 2019, CELL METAB, V30, P251, DOI 10.1016/j.cmet.2019.06.009; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; West-Eberhard MJ, 2019, J EXP ZOOL PART B, V332, P356, DOI 10.1002/jez.b.22913; Wexler AG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.26; Woltereck R, 1909, VER DTSCH ZOOL GESEL, P110; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992; Zeevi D, 2019, NATURE, V568, P43, DOI 10.1038/s41586-019-1065-y; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Ziels RM, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00159-19; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3; Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918	81	7	7	11	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					513	+		10.1016/j.cell.2022.01.002	http://dx.doi.org/10.1016/j.cell.2022.01.002			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1YD	35120663				2022-12-28	WOS:000768266500002
J	Starr, TN; Zepeda, SK; Walls, AC; Greaney, AJ; Alkhovsky, S; Veesler, D; Bloom, JD				Starr, Tyler N.; Zepeda, Samantha K.; Walls, Alexandra C.; Greaney, Allison J.; Alkhovsky, Sergey; Veesler, David; Bloom, Jesse D.			ACE2 binding is an ancestral and evolvable trait of sarbecoviruses	NATURE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-LIKE CORONAVIRUS; GENOMIC CHARACTERIZATION; BAT CORONAVIRUS; RECEPTOR; SARS-COV-2; RECONSTRUCTION; DETERMINANTS; ADAPTATION; VIRUS	Two different sarbecoviruses have caused major human outbreaks in the past two decades(1,2). Both of these sarbecoviruses, SARS-CoV-1 and SARS-CoV-2, engage ACE2 through the spike receptor-binding domain(2-6). However, binding to ACE2 orthologues of humans, bats and other species has been observed only sporadically among the broader diversity of bat sarbecoviruses(7-11). Here we use high-throughput assays(12) to trace the evolutionary history of ACE2 binding across a diverse range of sarbecoviruses and ACE2 orthologues. We find that ACE2 binding is an ancestral trait of sarbecovirus receptor-binding domains that has subsequently been lost in some clades. Furthermore, we reveal that bat sarbecoviruses from outside Asia can bind to ACE2. Moreover, ACE2 binding is highly evolvable-for many sarbecovirus receptor-binding domains, there are single amino-acid mutations that enable binding to new ACE2 orthologues. However, the effects of individual mutations can differ considerably between viruses, as shown by the N501Y mutation, which enhances the human ACE2-binding affinity of several SARS-CoV-2 variants of concern(12) but substantially decreases it for SARS-CoV-1. Our results point to the deep ancestral origin and evolutionary plasticity of ACE2 binding, broadening the range of sarbecoviruses that should be considered to have spillover potential.	[Starr, Tyler N.; Greaney, Allison J.; Bloom, Jesse D.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, 1124 Columbia St, Seattle, WA 98104 USA; [Starr, Tyler N.; Veesler, David; Bloom, Jesse D.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zepeda, Samantha K.; Walls, Alexandra C.; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Greaney, Allison J.; Bloom, Jesse D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Alkhovsky, Sergey] Minist Hearth Russian Federat, NF Gamreya Natl Ctr Epidemiol & Microbiol, Moscow, Russia	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Starr, TN; Bloom, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Basic Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.; Starr, TN; Veesler, D; Bloom, JD (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.; Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Bloom, JD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	tstarr@fredhutch.org; dveesler@uw.edu; jbloom@fredhutch.org	Greaney, Allison/HDM-8896-2022; Veesler, David/HCH-3986-2022; Alkhovsky, Sergey/A-9542-2014; Bloom, Jesse/C-6837-2013	Alkhovsky, Sergey/0000-0001-6913-5841; Walls, Alexandra/0000-0002-9636-8330; Zepeda, Samantha/0000-0003-0005-9793; Bloom, Jesse/0000-0003-1267-3408; Veesler, David/0000-0002-6019-8675	ORIP grant [S10OD028685]; National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C, R01AI141707]; National Institute of General Medical Sciences [R01GM120553, 5T32GM008268-32]; Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Bill & Melinda Gates Foundation [OPP1156262, INV-004949]; Russian Foundation for Basic Research [20-04-60154]; Fast Grants	ORIP grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Fast Grants	We thank the staff at the Fred Hutch Flow Cytometry and Genomics facilities and the Scientific Computing group supported by ORIP grant S10OD028685; Z. Shi for sharing R. sinicus and R. affinis ACE2 sequences from a preprint before formal publication; H. Tani for providing the reagents necessary for preparing VSV pseudotyped viruses; S. Goldstein and A. Chan for discussions; and all sequence contributors, including contributors to GISAID (https://github.com/jbloomlab/SARSr-CoV_homolog_ survey/tree/master/RBD_ ASR/gisaid). This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V., and R01AI141707 to J.D.B.), the National Institute of General Medical Sciences (R01GM120553 to D.V., and 5T32GM008268-32 to S.K.Z.), a Pew Biomedical Scholars Award (to D.V.), Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (to D.V. and J.D. B.), Fast Grants (to D.V.), the Bill & Melinda Gates Foundation (OPP1156262 to D.V., and INV-004949 to J.D.B.) and the Russian Foundation for Basic Research (20-04-60154 `An analysis of genetic diversity of zoonotic viruses in Russian populations of bats and rodents' to S. A.). T.N.S. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation. D.V. and J.D.B. are investigators of the Howard	Adams RM, 2016, ELIFE, V5, DOI 10.7554/eLife.23156; Alkhovsky S, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14010113; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Bergner LM, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020252; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Crawford KHD., 2019, J OPEN SOURCE SOFTW, V4, P1915, DOI DOI 10.1128/AEM.02927-16; Crook JM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94011-z; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Demogines A, 2012, J VIROL, V86, P6350, DOI 10.1128/JVI.00311-12; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Eick GN, 2017, MOL BIOL EVOL, V34, P247, DOI 10.1093/molbev/msw223; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Guo H, 2021, EMERG MICROBES INFEC, V10, P1507, DOI 10.1080/22221751.2021.1956373; Guo H, 2020, J VIROL, V94, DOI 10.1128/JVI.00902-20; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; He BA, 2014, J VIROL, V88, P7070, DOI 10.1128/JVI.00631-14; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Huang K, 2021, EBIOMEDICINE, V67, DOI 10.1016/j.ebiom.2021.103381; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Latinne A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17687-3; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Letko M., 2020, NAT MICROBIOL, V5, P562, DOI [DOI 10.1038/s41564-020-0688-y, 10.1038/s41564-020-0688-y]; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Liu KF, 2021, CELL, V184, P3438, DOI 10.1016/j.cell.2021.05.031; Menachery VD, 2017, CURR OPIN VIROL, V23, P1, DOI 10.1016/j.coviro.2017.01.002; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Montagutelli X., 2021, BIORXIV, DOI [10.1101/2021.03.18.436013, DOI 10.1101/2021.03.18.436013]; Mou HH, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009501; Murakami S, 2020, EMERG INFECT DIS, V26, P3025, DOI 10.3201/eid2612.203386; Nature, 2021, NATURE; Peterman N, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2533-5; Reguera J, 2014, VIRUS RES, V194, P3, DOI 10.1016/j.virusres.2014.10.005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Roelle S. M., 2021, EXPANDED ACE2 DEPEND, DOI [DOI 10.1101/2021.12.25.474149, 10.1101/2021.12.25.474149]; Seifert S. N., 2021, SARBECOVIRUS FOUND R, DOI [DOI 10.1101/2021.12.05.471310, 10.1101/2021.12.05.471310]; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tao KM, 2021, NAT REV GENET, V22, P757, DOI 10.1038/s41576-021-00408-x; Tao Y, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00548-19, 10.1128/mra.00548-19]; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tortorici MA, 2021, NATURE, V597, P103, DOI 10.1038/s41586-021-03817-4; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Tortorici MA, 2019, NAT STRUCT MOL BIOL, V26, P481, DOI 10.1038/s41594-019-0233-y; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wells HL, 2021, VIRUS EVOL, V7, DOI [10.1093/ve/veab007, 10.1101/2020.07.07.190546]; Wentz AE, 2007, APPL ENVIRON MICROB, V73, P1189, DOI 10.1128/AEM.02427-06; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15; Zhou H, 2021, CELL, V184, P4380, DOI 10.1016/j.cell.2021.06.008	71	20	20	3	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					913	+		10.1038/s41586-022-04464-z	http://dx.doi.org/10.1038/s41586-022-04464-z		FEB 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35114688	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000772459700001
J	Oliver, D				Oliver, David			David Oliver: Making GPs hospital employees won't solve pressure on hospitals or general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADMISSIONS											Bardsley M, 2013, THE NUFFIELD TRUST; Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; British Geriatrics Society, 2021, RIGHT TIM RIGHT PLAC; Cambridge English Dictionary, KITE FLYING; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Iacobucci Gareth, 2022, BMJ, V376, po145, DOI 10.1136/bmj.o145; Imison C, 2012, OLDER PEOPLE EMERGEN; Kavanagh P., 2021, THE NATIONAL; Lloyd T., 2021, HLTH FDN; NHS Benchmarking Network, 2021, INT CAR BENCHM 2020; NHS Digital, 2018, STAT SHOW CHANG NHS; Oliver D, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o107; Papanicolas I, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6326; Purdy S, 2013, J ROY COLL PHYS EDIN, V43, P340, DOI 10.4997/JRCPE.2013.415; Rolewicz L., 2021, THE NUFFIELD TRUST; Smyth C, 2022, TIMES 0129; Society for Acute Medicine, SAMBA 2021 REP	17	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o259	10.1136/bmj.o259	http://dx.doi.org/10.1136/bmj.o259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110327	Bronze			2022-12-28	WOS:000758682200009
J	Thornton, J				Thornton, Jacqui			Covid-19: Trust in government and other people linked with lower infection rate and higher vaccination uptake	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Covid-19 National Preparedness Collaborators, 2022, LANCET; Global Health Exchange Data, COVID 19 PAND PREP I; OECD, 2022, 1 LESS GOV EV COV 19; OECD (Organisation for Economic Co-operation and Development), TRUST GOV	4	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o292	10.1136/bmj.o292	http://dx.doi.org/10.1136/bmj.o292			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110301	Bronze			2022-12-28	WOS:000758682200013
J	Blagden, SP				Blagden, Sarah P.			Targeting MAPK in recurrent, low-grade serous ovarian cancer Comment	LANCET			English	Editorial Material									[Blagden, Sarah P.] Univ Oxford, Dept Oncol, Oxford OX3 7DG, England	University of Oxford	Blagden, SP (corresponding author), Univ Oxford, Dept Oncol, Oxford OX3 7DG, England.	sarah.blagden@oncology.ox.ac.uk						Amaria RN, 2018, LANCET ONCOL, V19, P181, DOI 10.1016/S1470-2045(18)30015-9; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Cobb LP, 2018, HEMATOL ONCOL CLIN N, V32, P1011, DOI 10.1016/j.hoc.2018.07.015; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Gershenson DM, 2021, LANCET, V399, P541; Kato S, 2021, ONCOLOGIST, V26, pE530, DOI 10.1002/onco.13702; Monk BJ, 2020, J CLIN ONCOL, V38, P3753, DOI 10.1200/JCO.20.01164; Slomovitz B, 2020, GYNECOL ONCOL, V156, P715, DOI 10.1016/j.ygyno.2019.12.033; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					499	501						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123677				2022-12-28	WOS:000755144500004
J	Gershenson, DM; Miller, A; Brady, WE; Paul, J; Carty, K; Rodgers, W; Millan, D; Coleman, RL; Moore, KN; Banerjee, S; Connolly, K; Secord, AA; O'Malley, DM; Dorigo, O; Gaillard, S; Gabra, H; Slomovitz, B; Hanjani, P; Farley, J; Churchman, M; Ewing, A; Hollis, RL; Herrington, CS; Huang, HQ; Wenzel, L; Gourley, C				Gershenson, David M.; Miller, Austin; Brady, William E.; Paul, James; Carty, Karen; Rodgers, William; Millan, David; Coleman, Robert L.; Moore, Kathleen N.; Banerjee, Susana; Connolly, Kate; Secord, Angeles Alvarez; O'Malley, David M.; Dorigo, Oliver; Gaillard, Stephanie; Gabra, Hani; Slomovitz, Brian; Hanjani, Parviz; Farley, John; Churchman, Michael; Ewing, Ailith; Hollis, Robert L.; Herrington, C. Simon; Huang, Helen Q.; Wenzel, Lari; Gourley, Charlie			Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial	LANCET			English	Article							MEK INHIBITOR; CARCINOMA; WOMEN; THERAPY; RARE; SELUMETINIB; PERITONEUM; IMPACT; TUMORS	Background Low-grade serous carcinoma of the ovary or peritoneum is characterised by MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high-grade serous carcinoma. We compared the MEK inhibitor trametinib to physician's choice standard of care in patients with recurrent low-grade serous carcinoma. Methods This international, randomised, open-label, multicentre, phase 2/3 trial was done at 84 hospitals in the USA and UK. Eligible patients were aged 18 years or older with recurrent low-grade serous carcinoma and measurable disease, as defined by Response Evaluation Criteria In Solid Tumors version 1.1, had received at least one platinum-based regimen, but not all five standard-of-care drugs, and had received an unlimited number of previous regimens. Patients with serous borderline tumours or tumours containing low-grade serous and high-grade serous carcinoma were excluded. Eligible patients were randomly assigned (1:1) to receive either oral trametinib 2 mg once daily (trametinib group) or one of five standard-of-care treatment options (standard-of-care group): intravenous paclitaxel 80 mg/m(2) by body surface area on days 1, 8, and 15 of every 28-day cycle; intravenous pegylated liposomal doxorubicin 40-50 mg/m(2) by body surface area once every 4 weeks; intravenous topotecan 4 mg/m(2) by body surface area on days 1, 8, and 15 of every 28-day cycle; oral letrozole 2.5 mg once daily; or oral tamoxifen 20 mg twice daily. Randomisation was stratified by geographical region (USA or UK), number of previous regimens (1, 2, or =3), performance status (0 or 1), and planned standard-of-care regimen. The primary endpoint was investigator-assessed progression-free survival while receiving randomised therapy, as assessed by imaging at baseline, once every 8 weeks for 15 months, and then once every 3 months thereafter, in the intention-to-treat population. Safety was assessed in patients who received at least one dose of study therapy. This trial is registered with ClinicalTrials.gov, NCT02101788, and is active but not recruiting. Findings Between Feb 27, 2014, and April 10, 2018, 260 patients were enrolled and randomly assigned to the trametinib group (n=130) or the standard-of-care group (n=130). At the primary analysis, there were 217 progression-free survival events (101 [78%] in the trametinib group and 116 [89%] in the standard-of-care group). Median progression-free survival in the trametinib group was 13.0 months (95% CI 9.9-15.0) compared with 7.2 months (5.6-9.9) in the standard-of-care group (hazard ratio 0.48 [95% CI 0.36-0.64]; p<0.0001). The most frequent grade 3 or 4 adverse events in the trametinib group were skin rash (17 [13%] of 128), anaemia (16 [13%]), hypertension (15 [12%]), diarrhoea (13 [10%]), nausea (12 [9%]), and fatigue (ten [8%]). The most frequent grade 3 or 4 adverse events in the standard-ofcare group were abdominal pain (22 [17%]), nausea (14 [11%]), anaemia (12 [10%]), and vomiting (ten [8%]). There were no treatment-related deaths. Interpretation Trametinib represents a new standard-of-care option for patients with recurrent low-grade serous carcinoma. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Gershenson, David M.; Coleman, Robert L.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Miller, Austin; Brady, William E.; Huang, Helen Q.] Roswell Pk Comprehens Canc Ctr, NRG Oncol Clin Trial Dev Div, Biostat & Bioinformat, Buffalo, NY USA; [Paul, James; Carty, Karen] Univ Glasgow, Inst Canc Sci, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; [Rodgers, William] Cornell Univ, Weill Med Coll, Dept Pathol, New York Presbyterian Queens, Flushing, NY USA; [Millan, David] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Moore, Kathleen N.] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma City, OK USA; [Banerjee, Susana] Royal Marsden Hosp NHS Fdn Trust, Inst Canc Res, London, England; [Connolly, Kate] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland; [Secord, Angeles Alvarez] Duke Canc Inst, Durham, NC USA; [O'Malley, David M.] Ohio State Univ, Columbus, OH 43210 USA; [O'Malley, David M.] James Canc Ctr, Columbus, OH 43210 USA; [Dorigo, Oliver] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Gaillard, Stephanie] Johns Hopkins Sidney Kimmel Canc Ctr, Baltimore, MD USA; [Gabra, Hani] Imperial Coll London, Surg & Canc, London, England; [Slomovitz, Brian] Mt Sinai Med Ctr, Div Gynecol Oncol, Miami Beach, FL 33140 USA; [Hanjani, Parviz] Abington Mem Hosp, Abington, PA 19001 USA; [Farley, John] St Josephs Hosp, Phoenix, AZ USA; [Churchman, Michael; Hollis, Robert L.; Herrington, C. Simon; Gourley, Charlie] Nicola Murray Ctr Ovarian Canc Res, Inst Genet & Canc, Edinburgh, Midlothian, Scotland; [Ewing, Ailith] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Ewing, Ailith] Univ Edinburgh, Western Gen Hosp, CRUK Edinburgh Ctr, MRC Inst Genet & Canc, Edinburgh, Midlothian, Scotland; [Wenzel, Lari] Univ Calif Irvine, Med & Publ Hlth, Irvine, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Glasgow; Cornell University; Queen Elizabeth University Hospital (QEUH); University of Oklahoma System; University of Oklahoma Health Sciences Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Edinburgh; Duke University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; Stanford Cancer Institute; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Imperial College London; Mount Sinai Medical Center; Abington Memorial Hospital; St. Joseph's Hospital and Medical Center; University of Edinburgh; University of Edinburgh; University of California System; University of California Irvine	Gershenson, DM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.	dgershen@mdanderson.org	Hollis, Robert/AAA-1188-2019; Herrington, C Simon/O-4688-2017	Hollis, Robert/0000-0002-1390-3298; Herrington, C Simon/0000-0001-9177-8165; Gabra, Hani/0000-0002-3322-4399; Banerjee, Susana/0000-0002-8840-7934	NRG Oncology; Cancer Research UK; Target Ovarian Cancer; Novartis	NRG Oncology; Cancer Research UK(Cancer Research UK); Target Ovarian Cancer; Novartis(Novartis)	NRG Oncology, Cancer Research UK, Target Ovarian Cancer, and Novartis.	Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; Bodurka DC, 2012, CANCER-AM CANCER SOC, V118, P3087, DOI 10.1002/cncr.26618; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cheasley D, 2021, J PATHOL, V253, P41, DOI 10.1002/path.5545; Dalton HJ, 2017, GYNECOL ONCOL, V145, P37, DOI 10.1016/j.ygyno.2017.01.027; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emmanuel C, 2014, CLIN CANCER RES, V20, P6618, DOI 10.1158/1078-0432.CCR-14-1292; Fader AN, 2017, GYNECOL ONCOL, V147, P85, DOI 10.1016/j.ygyno.2017.07.127; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Fernandez ML, 2016, AM J CANCER RES, V6, P2235; Gershenson DM, 2006, OBSTET GYNECOL, V108, P361, DOI 10.1097/01.AOG.0000227787.24587.d1; Gershenson DM, 2017, J CLIN ONCOL, V35, P1103, DOI 10.1200/JCO.2016.71.0632; Gershenson DM, 2015, BRIT J CANCER, V113, P1254, DOI 10.1038/bjc.2015.364; Gershenson DM, 2015, J CLIN ONCOL, V33, P2675, DOI 10.1200/JCO.2015.61.0873; Gershenson DM, 2012, GYNECOL ONCOL, V125, P661, DOI 10.1016/j.ygyno.2012.02.037; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Gore M, 2019, GYNECOL ONCOL, V153, P541, DOI 10.1016/j.ygyno.2019.03.256; Grabowski JP, 2016, GYNECOL ONCOL, V140, P457, DOI 10.1016/j.ygyno.2016.01.022; Hew KE, 2016, CLIN CANCER RES, V22, P935, DOI 10.1158/1078-0432.CCR-15-0534; Hollis RL, 2016, CANCER BIOL MED, V13, P236, DOI 10.20892/j.issn.2095-3941.2016.0024; Hou JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054103; Huang HQ, 2007, INT J GYNECOL CANCER, V17, P387, DOI 10.1111/j.1525-1438.2007.00794.x; Jones S, 2012, J PATHOL, V226, P413, DOI 10.1002/path.3967; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Monk BJ, 2020, J CLIN ONCOL, V38, P3753, DOI 10.1200/JCO.20.01164; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Prat J, 2018, HUM PATHOL, V80, P11, DOI 10.1016/j.humpath.2018.06.018; Tang M, 2019, GYNECOL ONCOL, V154, P531, DOI 10.1016/j.ygyno.2019.06.011; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wong KK, 2010, AM J PATHOL, V177, P1611, DOI 10.2353/ajpath.2010.100212; Young RH, 2014, WHO CLASS TUM SER, V6	31	13	13	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					541	553						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	2E0SF	35123694	Green Accepted, Green Published			2022-12-28	WOS:000811944600001
J	Cao, DM; Yu, J; Wang, H; Luo, ZP; Liu, XY; He, LC; Qi, JZ; Fan, LY; Tang, LJ; Chen, ZC; Li, JS; Cheng, JJ; Wang, S				Cao, Dongmei; Yu, Jing; Wang, Huan; Luo, Zhipu; Liu, Xinyu; He, Licong; Qi, Jianzhong; Fan, Luyu; Tang, Lingjie; Chen, Zhangcheng; Li, Jinsong; Cheng, Jianjun; Wang, Sheng			Structure-based discovery of nonhallucinogenic psychedelic analogs	SCIENCE			English	Article							LIFE-THREATENING CANCER; SEROTONIN 2A RECEPTOR; 5-HT2A RECEPTOR; PSILOCYBIN; HALLUCINOGENS; DEPRESSION; COMPLEX; ANXIETY	Drugs that target the human serotonin 2A receptor (5-HT2AR) are used to treat neuropsychiatric diseases; however, many have hallucinogenic effects, hampering their use. Here, we present structures of 5-HT2AR complexed with the psychedelic drugs psilocin (the active metabolite of psilocybin) and D-lysergic acid diethylamide (LSD), as well as the endogenous neurotransmitter serotonin and the nonhallucinogenic psychedelic analog lisuride. Serotonin and psilocin display a second binding mode in addition to the canonical mode, which enabled the design of the psychedelic IHCH-7113 (a substructure of antipsychotic lumateperone) and several 5-HT2AR beta-arrestin-biased agonists that displayed antidepressant-like activity in mice but without hallucinogenic effects. The 5-HT2AR complex structures presented herein and the resulting insights provide a solid foundation for the structure-based design of safe and effective nonhallucinogenic psychedelic analogs with therapeutic effects.	[Cao, Dongmei; Yu, Jing; He, Licong; Qi, Jianzhong; Fan, Luyu; Tang, Lingjie; Chen, Zhangcheng; Wang, Sheng] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Univ Chinese Acad Sci,Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Huan; Cheng, Jianjun] ShanghaiTech Univ, iHuman Inst, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Luo, Zhipu] Soochow Univ, Sch Biol & Basic Med Sci, Inst Mol Enzymol, Suzhou 215123, Jiangsu, Peoples R China; [Liu, Xinyu; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Univ Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Wang, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Univ Chinese Acad Sci,Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Cheng, JJ (corresponding author), ShanghaiTech Univ, iHuman Inst, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China.	chengji@shanghaitect.edu.cn; wangsheng@sibcb.ac.cn		Chen, Zhangcheng/0000-0001-5858-2769				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Boger DL, 1998, P NATL ACAD SCI USA, V95, P4102, DOI 10.1073/pnas.95.8.4102; Cameron LP, 2021, NATURE, V589, P474, DOI 10.1038/s41586-020-3008-z; Carhart-Harris RL, 2018, PSYCHOPHARMACOLOGY, V235, P399, DOI 10.1007/s00213-017-4771-x; Carhart-Harris R, 2021, NEW ENGL J MED, V384, P1402, DOI 10.1056/NEJMoa2032994; Diez-Alarcia R, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01430-7; Dong CY, 2021, CELL, V184, P2779, DOI 10.1016/j.cell.2021.03.043; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Garcia EE, 2007, NEUROPHARMACOLOGY, V52, P1671, DOI 10.1016/j.neuropharm.2007.03.013; GLENNON RA, 1984, LIFE SCI, V35, P2505, DOI 10.1016/0024-3205(84)90436-3; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gourley S. L, 2009, CURR PROTOC NEUROSCI, V49; Gourley Shannon L, 2009, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0932s49; Griffiths RR, 2016, J PSYCHOPHARMACOL, V30, P1181, DOI 10.1177/0269881116675513; Halberstadt AL, 2013, PSYCHOPHARMACOLOGY, V227, P727, DOI 10.1007/s00213-013-3006-z; HuidobroToro JP, 1996, P NATL ACAD SCI USA, V93, P8078, DOI 10.1073/pnas.93.15.8078; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim K, 2020, CELL, V182, P1574, DOI 10.1016/j.cell.2020.08.024; Kimura KT, 2019, NAT STRUCT MOL BIOL, V26, P121, DOI 10.1038/s41594-018-0180-z; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Madsen MK, 2019, NEUROPSYCHOPHARMACOL, V44, P1328, DOI 10.1038/s41386-019-0324-9; McCorvy JD, 2018, NAT STRUCT MOL BIOL, V25, P787, DOI 10.1038/s41594-018-0116-7; Mendelson WB, 2001, NEUROPSYCHOPHARMACOL, V25, pS36, DOI 10.1016/S0893-133X(01)00341-4; Nichols DE, 2016, PHARMACOL REV, V68, P264, DOI 10.1124/pr.115.011478; Nutt D, 2020, CELL, V181, P24, DOI 10.1016/j.cell.2020.03.020; Olsen RHJ, 2020, NAT CHEM BIOL, V16, P841, DOI 10.1038/s41589-020-0535-8; Peng Y, 2018, CELL, V172, P719, DOI 10.1016/j.cell.2018.01.001; Reiff CM, 2020, AM J PSYCHIAT, V177, P391, DOI 10.1176/appi.ajp.2019.19010035; Revenga MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49913-4; Rodriguiz R. M., 2021, BIORXIV2021020442977; Ross S, 2016, J PSYCHOPHARMACOL, V30, P1165, DOI 10.1177/0269881116675512; SADZOT B, 1989, PSYCHOPHARMACOLOGY, V98, P495, DOI 10.1007/BF00441948; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Shulgin A., 1997, TIHKAL CONTINUATION; Shulgin AT, 1991, PIHKAL CHEM LOVE STO; Thomas EA, 1997, P NATL ACAD SCI USA, V94, P14115, DOI 10.1073/pnas.94.25.14115; Vanover KE, 2019, NEUROPSYCHOPHARMACOL, V44, P598, DOI 10.1038/s41386-018-0251-1; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wang S, 2018, NATURE, V555, P269, DOI 10.1038/nature25758; Xu PY, 2021, NATURE, V592, P469, DOI 10.1038/s41586-021-03376-8; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576; Zhuang YW, 2021, CELL, V184, P931, DOI 10.1016/j.cell.2021.01.027	50	18	18	38	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					403	+		10.1126/science.abl8615	http://dx.doi.org/10.1126/science.abl8615			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084960				2022-12-28	WOS:000750899500031
J	Suran, M				Suran, Melissa			Coverage of COVID-19 Vaccine Counseling for Children and Youths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					313	313						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076682	Bronze			2022-12-28	WOS:000753055700028
J	Watt, JA; Thompson, W; Marple, R; Brown, D; Liu, B				Watt, Jennifer A.; Thompson, Wade; Marple, Roger; Brown, Deborah; Liu, Barbara			Managing neuropsychiatric symptoms in patients with dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LONG-TERM-CARE; OLDER-ADULTS; RISK; TRENDS; RECOMMENDATIONS; ANTIPSYCHOTICS; DIAGNOSIS; DRUGS; DEATH		[Watt, Jennifer A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada; [Watt, Jennifer A.; Liu, Barbara] Univ Toronto, Dept Med, Div Geriatr Med, Toronto, ON, Canada; [Thompson, Wade] Womens Coll, Res Inst, Toronto, ON, Canada; [Thompson, Wade] Univ Southern Denmark, Res Unit Gen Practice, Odense, Denmark; [Brown, Deborah] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Women's College Research Institute; University of Southern Denmark; University of Toronto	Watt, JA (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, Toronto, ON, Canada.; Watt, JA (corresponding author), Univ Toronto, Dept Med, Div Geriatr Med, Toronto, ON, Canada.	jennifer.watt@utoronto.ca						American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; Baharudin AD, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6868-0; Bickerdike L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013384; Bjerre LM, 2018, CAN FAM PHYSICIAN, V64, P17; Borsje P, 2015, INT PSYCHOGERIATR, V27, P385, DOI 10.1017/S1041610214002282; Bronskill SE, 2018, J AM GERIATR SOC, V66, P1963, DOI 10.1111/jgs.15519; Choosing Wisely Canada, 2019, WHEN PSYCH ISNT DIAG; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dennis M, 2017, NEUROL THER, V6, P57, DOI 10.1007/s40120-016-0060-6; Donegan K, 2017, LANCET PUBLIC HEALTH, V2, pE149, DOI 10.1016/S2468-2667(17)30031-2; Dua T., 2017, GLOB ACT PLAN PUBL H, DOI 10.1016/j.jalz.2017.07.758; Fauth EB, 2014, INT J GERIATR PSYCH, V29, P263, DOI 10.1002/gps.4002; Gauthier S, 2012, CAN GERIATR J, V15, P120, DOI 10.5770/cgj.15.49; Gerlach LB, 2020, J AM MED DIR ASSOC, V21, P1629, DOI 10.1016/j.jamda.2020.05.039; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Husk K, 2020, HEALTH SOC CARE COMM, V28, P309, DOI 10.1111/hsc.12839; Jennings LA, 2018, J AM GERIATR SOC, V66, P2120, DOI 10.1111/jgs.15541; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Kaup BA, 2007, AM J GERIAT PSYCHIAT, V15, P438, DOI 10.1097/JGP.0b013e31803c54f7; Kuntz Jennifer, 2018, Perm J, V22, P17, DOI 10.7812/TPP/17-157; Macri JC, 2017, AM J GERIAT PSYCHIAT, V25, P1326, DOI 10.1016/j.jagp.2017.08.014; Maust DT, 2015, JAMA PSYCHIAT, V72, P438, DOI 10.1001/jamapsychiatry.2014.3018; National Institute for Health and Care Excellence (UK), 2018, DEM ASS MAN SUPP PEO; Nikolakopoulou A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003082; Pond CD, 2016, CLIN PRACTICE GUIDEL; Rapaport P, 2021, AGING MENT HEALTH, V25, P1463, DOI 10.1080/13607863.2020.1845299; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Simmons SF, 2018, GERONTOLOGIST, V58, pE239, DOI 10.1093/geront/gnx083; Sterke CS, 2012, J CLIN PHARMACOL, V52, P947, DOI 10.1177/0091270011405665; Thompson W, 2019, J AM GERIATR SOC, V67, P172, DOI 10.1111/jgs.15616; Thompson W, 2019, RES SOC ADMIN PHARM, V15, P801, DOI 10.1016/j.sapharm.2018.08.013; Van Leeuwen E, 2018, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007726.pub3, 10.1002/14651858.C.D007726.pub3]; Vasudev A, 2015, AM J GERIAT PSYCHIAT, V23, P1259, DOI 10.1016/j.jagp.2015.07.001; Walsh KA, 2018, J AM MED DIR ASSOC, V19, P948, DOI 10.1016/j.jamda.2018.07.004; Watt JA, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n532; Watt JA, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01607-7; Watt JA, 2019, ANN INTERN MED, V171, P633, DOI 10.7326/M19-0993; Watt JA, 2018, CAN MED ASSOC J, V190, pE1376, DOI 10.1503/cmaj.180551	39	2	2	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								e069187	10.1136/bmj-2021-069187	http://dx.doi.org/10.1136/bmj-2021-069187			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE9IB	35078774				2022-12-28	WOS:000759189200010
J	Capurro, D; Coghlan, S; Pires, DEV				Capurro, Daniel; Coghlan, Simon; Pires, Douglas E., V			Preventing Digital Overdiagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Capurro, Daniel; Pires, Douglas E., V] Univ Melbourne, Ctr Digital Transformat Hlth, Sch Comp & Informat Syst, 700 Swanston St, Melbourne, Vic 3010, Australia; [Coghlan, Simon] Univ Melbourne, Sch Comp & Informat Syst, Ctr AI & Digital Eth, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Capurro, D (corresponding author), Univ Melbourne, Ctr Digital Transformat Hlth, Sch Comp & Informat Syst, 700 Swanston St, Melbourne, Vic 3010, Australia.	dcapurro@unimelb.edu.au	Capurro, Daniel/AAP-3643-2020; Capurro, Daniel/G-2200-2011	Capurro, Daniel/0000-0002-9256-1256				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Glasziou PP, 2020, MED J AUSTRALIA, V212, P163, DOI 10.5694/mja2.50455; Kazda L, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5335; Li MM, 2020, LANCET DIABETES ENDO, V8, P468, DOI 10.1016/S2213-8587(20)30115-7; Manley B. J., 2016, PROSTATE CANC DILEMM, P3, DOI DOI 10.1007/978-3-319-21485-6_1; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Peachap AB, 2020, SN APPL SCI, V2, DOI 10.1007/s42452-020-03473-9; Perez MV, 2019, NEW ENGL J MED, V381, P1909, DOI 10.1056/NEJMoa1901183; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Walter SD, 2021, CANCER CAUSE CONTROL, V32, P1299, DOI 10.1007/s10552-021-01480-8	10	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					525	526		10.1001/jama.2021.22969	http://dx.doi.org/10.1001/jama.2021.22969		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35061004				2022-12-28	WOS:000745105800002
J	Coombes, R				Coombes, Rebecca			Taking down online scientific misinformation isn't necessary, as most people don't believe it, says Royal Society	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, ONL INF ENV UND INT	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o182	10.1136/bmj.o182	http://dx.doi.org/10.1136/bmj.o182			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063967				2022-12-28	WOS:000838119600016
J	Limb, M				Limb, Matthew			Inspectors must take account of challenges faced by ethnic minority GPs, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ashmore AA., 2022, ETHN MIN LED GP PRAC, V57, pleader, DOI 10.1136/leader-2022-000606	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o171	10.1136/bmj.o171	http://dx.doi.org/10.1136/bmj.o171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058227				2022-12-28	WOS:000750649900006
J	Horton, R				Horton, Richard			Offline: Sex and power during a pandemic Comment	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					422	422						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093215	Bronze, Green Published			2022-12-28	WOS:000755141600008
J	Nealon, J; Cowling, BJ				Nealon, Joshua; Cowling, Benjamin J.			Omicron severity: milder but not mild Comment	LANCET			English	Editorial Material									[Nealon, Joshua; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China; [Cowling, Benjamin J.] Hong Kong Sci & Technol Pk, Lab Data Discovery Hlth Ltd, Hong Kong, Peoples R China	University of Hong Kong; World Health Organization	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China.; Cowling, BJ (corresponding author), Hong Kong Sci & Technol Pk, Lab Data Discovery Hlth Ltd, Hong Kong, Peoples R China.	bcowling@hku.hk						Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P2487, DOI 10.1056/NEJMc2108120; Cao Y, 2021, NUMER LINEAR ALGEBR, V28, DOI [10.1002/nla.2362, 10.1038/s41586-021-04385-3]; Chan MCW., 2021, NAT PORTF, DOI [10.21203/rs.3.rs-1189219/v1, DOI 10.21203/RS.3.RS-1189219/V1]; Diamond Michael, 2021, Res Sq, DOI 10.21203/rs.3.rs-1211792/v1; Madhi S., 2021, S AFRICAN POPULATION, DOI [10.1101/2021.12.20.21268096, DOI 10.1101/2021.12.20.21268096]; Sastry SR, 2020, INFECT CONT HOSP EP, V41, P1231, DOI 10.1017/ice.2020.358; UK Health Security Agency, 2021, TECHN BRIEF UPD HOSP; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4	8	35	35	14	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					412	413		10.1016/S0140-6736(22)00056-3	http://dx.doi.org/10.1016/S0140-6736(22)00056-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35065007	Green Published			2022-12-28	WOS:000755141600003
J	Dean, N				Dean, Natalie			Tracking COVID-19 infections: time for change	NATURE			English	Editorial Material						SARS-CoV-2; Epidemiology; Research management; Health care			[Dean, Natalie] Emory Univ, Atlanta, GA 30322 USA	Emory University	Dean, N (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	nataliedean@emory.edu							0	10	10	6	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					185	185		10.1038/d41586-022-00336-8	http://dx.doi.org/10.1038/d41586-022-00336-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YV8GO	35136224	Bronze			2022-12-28	WOS:000752963300002
J	Sadoff, J; Gray, G; Vandebosch, A; Cardenas, V; Shukarev, G; Grinsztejn, B; Goepfert, PA; Truyers, C; Van Dromme, I; Spiessens, B; Vingerhoets, J; Custers, J; Scheper, G; Robb, ML; Treanor, J; Ryser, MF; Barouch, DH; Swan, E; Marovic, MA; Neuzil, KM; Corey, L; Stoddar, J; Hard, K; Ruiz-Guinazu, J; Le Gars, M; Schuitemaker, H; Van Hoof, J; Stru, F; Douoguih, M				Sadoff, J.; Gray, G.; Vandebosch, A.; Cardenas, V; Shukarev, G.; Grinsztejn, B.; Goepfert, P. A.; Truyers, C.; Van Dromme, I; Spiessens, B.; Vingerhoets, J.; Custers, J.; Scheper, G.; Robb, M. L.; Treanor, J.; Ryser, M. F.; Barouch, D. H.; Swan, E.; Marovic, M. A.; Neuzil, K. M.; Corey, L.; Stoddar, J.; Hard, K.; Ruiz-Guinazu, J.; Le Gars, M.; Schuitemaker, H.; Van Hoof, J.; Stru, F.; Douoguih, M.		ENSEMBLE Study Grp	Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COVID-19 VACCINE; STATES	BACKGROUND The Ad26.COV2.S vaccine was highly effective against severe-critical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase 3 efficacy analysis. METHODS We conducted the final analysis in the double-blind phase of our multinational, randomized, placebo-controlled trial, in which adults were assigned in a 1:1 ratio to receive single-dose Ad26.COV2.S (5x10(10) viral particles) or placebo. The primary end points were vaccine efficacy against moderate to severe-critical Covid-19 with onset at least 14 days after administration and at least 28 days after administration in the per-protocol population. Safety and key secondary and exploratory end points were also assessed. RESULTS Median follow-up in this analysis was 4 months; 8940 participants had at least 6 months of follow-up. In the per-protocol population (39,185 participants), vaccine efficacy against moderate to severe-critical Covid-19 at least 14 days after administration was 56.3% (95% confidence interval [CI], 51.3 to 60.8; 484 cases in the vaccine group vs. 1067 in the placebo group); at least 28 days after administration, vaccine efficacy was 52.9% (95% CI, 47.1 to 58.1; 433 cases in the vaccine group vs. 883 in the placebo group). Efficacy in the United States, primarily against the reference strain (B.1.D614G) and the B.1.1.7 (alpha) variant, was 69.7% (95% CI, 60.7 to 76.9); efficacy was reduced elsewhere against the P.1 (gamma), C.37 (lambda), and B.1.621 (mu) variants. Efficacy was 74.6% (95% CI, 64.7 to 82.1) against severe-critical Covid-19 (with only 4 severe-critical cases caused by the B.1.617.2 [delta] variant), 75.6% (95% CI, 54.3 to 88.0) against Covid-19 leading to medical intervention (including hospitalization), and 82.8% (95% CI, 40.5 to 96.8) against Covid-19-related death, with protection lasting 6 months or longer. Efficacy against any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was 41.7% (95% CI, 36.3 to 46.7). Ad26.COV2.S was associated with mainly mild-to-moderate adverse events, and no new safety concerns were identified. CONCLUSIONS A single dose of Ad26.COV2.S provided 52.9% protection against moderate to severe-critical Covid-19. Protection varied according to variant; higher protection was observed against severe Covid-19, medical intervention, and death than against other end points and lasted for 6 months or longer.	[Sadoff, J.; Shukarev, G.; Custers, J.; Scheper, G.; Le Gars, M.; Schuitemaker, H.; Van Hoof, J.; Douoguih, M.] Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands; [Gray, G.] South African Res Council, Cape Town, South Africa; [Vandebosch, A.; Truyers, C.; Van Dromme, I; Spiessens, B.; Vingerhoets, J.; Ryser, M. F.; Hard, K.; Ruiz-Guinazu, J.; Stru, F.] Janssen Res & Dev, Beerse, Belgium; [Cardenas, V] Janssen Res & Dev, Spring House, PA USA; [Grinsztejn, B.] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [Goepfert, P. A.] Univ Alabama Birmingham, Birmingham, AL USA; [Robb, M. L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Swan, E.; Marovic, M. A.] NIAID, Rockville, MD USA; [Neuzil, K. M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Treanor, J.] Biomed Adv Res & Dev Author, Washington, DC USA; [Barouch, D. H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Corey, L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Stoddar, J.] Janssen Res & Dev, Raritan, NJ USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Fundacao Oswaldo Cruz; University of Alabama System; University of Alabama Birmingham; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Fred Hutchinson Cancer Center; Johnson & Johnson; Janssen Pharmaceuticals	Douoguih, M (corresponding author), Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands.	mdouogui@its.jnj.com	Kilgore, Paul E/L-1462-2013; Pilotto, Jose Henrique/AAD-9773-2019	Kilgore, Paul E/0000-0003-3214-4482; Pilotto, Jose Henrique/0000-0003-0521-8597; Struyf, Frank/0000-0001-9988-0260; Gottlieb, Robert/0000-0001-8376-8709; Brumskine, William/0000-0002-1092-9919; Shukarev, Georgi/0000-0001-5154-7047; Gray, Glenda E./0000-0003-4649-1477	Janssen Research and Development, an affiliate of Janssen Vaccines and Prevention; federal funds from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services [HHSO100201700018C]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NIAID [UM1 AI68614, UM1 AI68635, UM1 AI68618, UM1 AI68619, UM1 AI68636, UM1 AI148684, UM1 AI148576, UM1 AI148373, UM1 AI148685, UM1 AI148452]	Janssen Research and Development, an affiliate of Janssen Vaccines and Prevention; federal funds from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Janssen Research and Development, an affiliate of Janssen Vaccines and Prevention and part of the Janssen pharmaceutical companies of Johnson & Johnson, and in whole or in part by federal funds from the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services, under Other Transaction Agreement HHSO100201700018C, and from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. The NIAID provides grant funding to the HIV Vaccine Trials Network (HVTN) Leadership and Operations Center (UM1 AI68614), the HVTN Statistics and Data Management Center (UM1 AI68635), the HVTN Laboratory Center (UM1 AI68618), the HIV Prevention Trials Network (HPTN) Leadership and Operations Center (UM1 AI68619), the AIDS Clinical Trials Group (ACTG) Leadership and Operations Center (UM1 AI68636), the Infectious Diseases Clinical Research Consortium Leadership Group (UM1 AI148684) and Vaccine and Therapeutic Evaluation Units (UM1 AI148576, UM1 AI148373, UM1 AI148685, UM1 AI148452).	Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; [Anonymous], 2021, FACT SHEET RECIPIENT; Barouch DH, 2021, NEW ENGL J MED, V385, P951, DOI 10.1056/NEJMc2108829; Bekker L-G., 2021, SSRN, DOI DOI 10.2139/SSRN.3979291; Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x; Centers for Disease Control and Prevention, 2021, OM VAR WHAT YOU NEED; Cohn BA, 2022, SCIENCE, V375, P331, DOI 10.1126/science.abm0620; Corchado-Garcia J, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.32540; Crotty S, 2021, SCIENCE, V372, P1392, DOI 10.1126/science.abj2258; de Gier B., 2021, COVID 19 VACCINE EFF, DOI [10.1101/2021.09.15.21263613v1, DOI 10.1101/2021.09.15.21263613V1]; El Sahly HM, 2021, NEW ENGL J MED, V385, P1774, DOI 10.1056/NEJMoa2113017; Grannis SJ, 2021, MMWR-MORBID MORTAL W, V70, P1291, DOI 10.15585/mmwr.mm7037e2; Gray GE., 2021, VACCINE EFFECTIVENES, DOI [10.1101/2021.12.28.21268436v1, DOI 10.1101/2021.12.28.21268436V1]; Institute Infectious Disease Epidemiology and Surveillance AGES Austrian Agency for Health and Food Safety, 2021, EST COVID 19 VACC EF; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Kojima N, 2021, EVAL HEALTH PROF, V44, P327, DOI 10.1177/01632787211047932; Nauta J, 2010, STATISTICS IN CLINICAL VACCINE TRIALS, P1, DOI 10.1007/978-3-642-14691-6_1; Polinski JM., 2021, EFFECTIVENESS SINGLE, DOI [10.1101/2021.09.10.21263385v2, DOI 10.1101/2021.09.10.21263385V2]; Rizk JG, 2021, JAMA CARDIOL, V6, P1451, DOI 10.1001/jamacardio.2021.3444; Rosenberg ES, 2022, NEW ENGL J MED, V386, P116, DOI 10.1056/NEJMoa2116063; Rosenblum HG, 2021, MMWR-MORBID MORTAL W, V70, P1094, DOI 10.15585/mmwr.mm7032e4; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; See I, 2021, JAMA-J AM MED ASSOC, V325, P2448, DOI 10.1001/jama.2021.7517; Shay DK, 2021, MMWR-MORBID MORTAL W, V70, P680, DOI 10.15585/mmwr.mm7018e2; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345	26	36	36	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2022	386	9					847	860		10.1056/NEJMoa2117608	http://dx.doi.org/10.1056/NEJMoa2117608		FEB 2022	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZK5CH	35139271	Bronze, Green Published			2022-12-28	WOS:000753119300001
J	Schultz, DC; Johnson, RM; Ayyanathan, K; Miller, J; Whig, K; Kamalia, B; Dittmar, M; Weston, S; Hammond, HL; Dillen, C; Ardanuy, J; Taylor, L; Lee, JS; Li, MH; Lee, E; Shoffler, C; Petucci, C; Constant, S; Ferrer, M; Thaiss, CA; Frieman, MB; Cherry, S				Schultz, David C.; Johnson, Robert M.; Ayyanathan, Kasirajan; Miller, Jesse; Whig, Kanupriya; Kamalia, Brinda; Dittmar, Mark; Weston, Stuart; Hammond, Holly L.; Dillen, Carly; Ardanuy, Jeremy; Taylor, Louis; Lee, Jae Seung; Li, Minghua; Lee, Emily; Shoffler, Clarissa; Petucci, Christopher; Constant, Samuel; Ferrer, Marc; Thaiss, Christoph A.; Frieman, Matthew B.; Cherry, Sara			Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2	NATURE			English	Article								The SARS-CoV-2 virus has infected more than 261 million people and has led to more than 5 million deaths in the past year and a half(1) (https://www.who.org/). Individuals with SARS-CoV-2 infection typically develop mild-to-severe flu-like symptoms, whereas infection of a subset of individuals leads to severe-to-fatal clinical outcomes(2). Although vaccines have been rapidly developed to combat SARS-CoV-2, there has been a dearth of antiviral therapeutics. There is an urgent need for therapeutics, which has been amplified by the emerging threats of variants that may evade vaccines. Large-scale efforts are underway to identify antiviral drugs. Here we screened approximately 18,000 drugs for antiviral activity using live virus infection in human respiratory cells and validated 122 drugs with antiviral activity and selectivity against SARS-CoV-2. Among these candidates are 16 nucleoside analogues, the largest category of clinically used antivirals. This included the antivirals remdesivir and molnupiravir, which have been approved for use in COVID-19. RNA viruses rely on a high supply of nucleoside triphosphates from the host to efficiently replicate, and we identified a panel of host nucleoside biosynthesis inhibitors as antiviral. Moreover, we found that combining pyrimidine biosynthesis inhibitors with antiviral nucleoside analogues synergistically inhibits SARS-CoV-2 infection in vitro and in vivo against emerging strains of SARS-CoV-2, suggesting a clinical path forward.	[Schultz, David C.; Whig, Kanupriya; Kamalia, Brinda; Cherry, Sara] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Johnson, Robert M.; Weston, Stuart; Hammond, Holly L.; Dillen, Carly; Ardanuy, Jeremy; Taylor, Louis; Frieman, Matthew B.] Univ Maryland, Sch Med, Ctr Pathogen Res, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Ayyanathan, Kasirajan; Miller, Jesse; Dittmar, Mark; Lee, Jae Seung; Li, Minghua; Cherry, Sara] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lee, Emily; Ferrer, Marc] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Shoffler, Clarissa; Petucci, Christopher] Univ Penn, Penn Cardiovasc Inst, Metab Core, Philadelphia, PA 19104 USA; [Constant, Samuel] Epithelix, Geneva, Switzerland; [Thaiss, Christoph A.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Pennsylvania; University of Pennsylvania	Schultz, DC; Cherry, S (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Frieman, MB (corresponding author), Univ Maryland, Sch Med, Ctr Pathogen Res, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.; Cherry, S (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dschultz@pennmedicine.upenn.edu; mfrieman@som.umaryrand.edu; cherrys@pennmedicine.upenn.edu		Johnson, Robert/0000-0002-1976-7688; Li, Minghua/0000-0003-0409-5214; Dittmar, Mark/0000-0003-2884-5630; Shoffler, Clarissa/0000-0002-9064-2378; Schultz, David/0000-0002-7890-8815; Taylor, Louis/0000-0002-6993-5838; Miller, Jesse/0000-0002-7990-4912	National Institutes of Health [R01AI074951, R01AI122749, 1R21AI151882, R01AI140539]; Penn Center for Precision Medicine, Mercatus; Bill and Melinda Gates Foundation [INV-018479, INV-016638]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; Deans Innovation Fund; Linda and Laddy Montague; Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health [TR000414-01]; NIH [R21AI158134, R21AI153480]; HHS/BARDA [ASPR-20-01495]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Precision Medicine, Mercatus; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Deans Innovation Fund; Linda and Laddy Montague; Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS/BARDA	We thank members of the Cherry, Lynch, Frieman and Penn Center for Precision Medicine for advice and discussion; R. Perera for viral preparations; D. Nguyen for his data analysis and all members of the High-Throughput Screening Core at University of Pennsylvania for reagents and technical support; the Penn Metabolomics Core in the Cardiovascular Institute for liquid chromatography-mass spectrometry quantitation of nucleotides; S. Weiss and Y. Li for sharing SARS-related coronavirus 2, isolate USA-WA1/2020; A. Pekosz for SARS-CoV-2 variants (Alpha, Beta, Gamma and Delta); X. Hu, R. Eastman, M. Hall and members of NCATS Compound Management for assembly and preparation of the NCATS compound collections; and CALIBR for providing the ReFrame library and validation plates. This work was supported by grants from the National Institutes of Health to S. Cherry (R01AI074951, R01AI122749, 1R21AI151882 and R01AI140539), as well as funding from the Penn Center for Precision Medicine, Mercatus and the Bill and Melinda Gates Foundation (INV-018479). S. Cherry is a recipient of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award, the Deans Innovation Fund as well as Linda and Laddy Montague. Work at the NCATS was funded by the by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health (ZIA Project #TR000414-01). M.B.F., R.M.J., H.L.H. and S.W. are supported by funding from Bill and Melinda Gates Foundation (INV-016638), NIH R21AI158134, NIH R21AI153480 and HHS/BARDA ASPR-20-01495.	Agostini ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01348-19; Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Ariav Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg6165; Bakowski MA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23328-0; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Dittmar M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108959; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huchting Johanna, 2020, Antiviral Chemistry & Chemotherapy, V28, DOI 10.1177/2040206620976786; Janes J, 2018, P NATL ACAD SCI USA, V115, P10750, DOI 10.1073/pnas.1810137115; Jordan PC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006889; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Ma Jun, 2019, Proteom Bioinform, V1, P43; Pizzorno A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100059; Pruijssers AJ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107940; Riva L, 2020, NATURE, V586, P113, DOI 10.1038/s41586-020-2577-1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tyson John R, 2020, bioRxiv, DOI 10.1101/2020.09.04.283077; Urakova N, 2018, J VIROL, V92, DOI 10.1128/JVI.01965-17; Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w; Yates MK, 2019, ANTIVIR RES, V162, P5, DOI 10.1016/j.antiviral.2018.11.016	27	38	38	26	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					134	+		10.1038/s41586-022-04482-x	http://dx.doi.org/10.1038/s41586-022-04482-x		FEB 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35130559	Bronze			2022-12-28	WOS:000772362800001
J	Evich, MG; Davis, MJB; McCord, JP; Acrey, B; Awkerman, JA; Knappe, DRU; Lindstrom, AB; Speth, TF; Tebes-Stevens, C; Strynar, MJ; Wang, ZY; Weber, EJ; Henderson, WM; Washington, JW				Evich, Marina G.; Davis, Mary J. B.; McCord, James P.; Acrey, Brad; Awkerman, Jill A.; Knappe, Detlef R. U.; Lindstrom, Andrew B.; Speth, Thomas F.; Tebes-Stevens, Caroline; Strynar, Mark J.; Wang, Zhanyun; Weber, Eric J.; Henderson, W. Matthew; Washington, John W.			Per- and polyfluoroalkyl substances in the environment	SCIENCE			English	Review							8/2 FLUOROTELOMER ALCOHOL; PERFLUORINATED CARBOXYLIC-ACIDS; GLOBAL EMISSION INVENTORIES; FILM-FORMING FOAM; PERFLUOROALKYL SUBSTANCES; AEROBIC BIOTRANSFORMATION; POLYFLUORINATED COMPOUNDS; PERFLUOROOCTANE SULFONATE; TROPHIC MAGNIFICATION; PFCA HOMOLOGS	Over the past several years, the term PFAS (per- and polyfluoroalkyl substances) has grown to be emblematic of environmental contamination, garnering public, scientific, and regulatory concern. PFAS are synthesized by two processes, direct fluorination (e.g., electrochemical fluorination) and oligomerization (e.g., fluorotelomerization). More than a megatonne of PFAS is produced yearly, and thousands of PFAS wind up in end-use products. Atmospheric and aqueous fugitive releases during manufacturing, use, and disposal have resulted in the global distribution of these compounds. Volatile PFAS facilitate long-range transport, commonly followed by complex transformation schemes to recalcitrant terminal PFAS, which do not degrade under environmental conditions and thus migrate through the environment and accumulate in biota through multiple pathways. Efforts to remediate PFAS-contaminated matrices still are in their infancy, with much current research targeting drinking water.	[Evich, Marina G.; Davis, Mary J. B.; Acrey, Brad; Tebes-Stevens, Caroline; Weber, Eric J.; Henderson, W. Matthew; Washington, John W.] US EPA, Off Res & Dev ORD, Ctr Environm Measurement & Modeling, Athens, GA 30605 USA; [McCord, James P.; Strynar, Mark J.] US EPA, ORD, Ctr Environm Measurement & Modeling, Durham, NC 27711 USA; [Awkerman, Jill A.] US EPA, ORD, Ctr Environm Measurement & Modeling, Gulf Breeze, FL 32561 USA; [Knappe, Detlef R. U.] North Carolina State Univ, Dept Civil Construct & Environm Engneerirg, Raleigh, NC 27695 USA; [Knappe, Detlef R. U.] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Lindstrom, Andrew B.] US EPA, ORD, Ctr Publ Hlth & Environm Assessment, Durham, NC 27711 USA; [Speth, Thomas F.] US EPA, ORD, Ctr Environm Solut & Emergency Response, Cincinnati, OH 45268 USA; [Wang, Zhanyun] Swiss Fed Inst Technol, Inst Environm Engn, CH-8093 Zurich, Switzerland; [Washington, John W.] Univ Georgia, Dept Geol, Athens, GA 30602 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Environmental Protection Agency; United States Environmental Protection Agency; Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Georgia; University of Georgia	Henderson, WM; Washington, JW (corresponding author), US EPA, Off Res & Dev ORD, Ctr Environm Measurement & Modeling, Athens, GA 30605 USA.; Washington, JW (corresponding author), Univ Georgia, Dept Geol, Athens, GA 30602 USA.	henderson.matt@epa.gov; washington.john@epa.gov		Davis, Mary J. B./0000-0001-6674-1678; Speth, Thomas/0000-0002-6640-2737; Tebes-Stevens, Caroline/0000-0001-7780-2691; McCord, James/0000-0002-1780-4916; Knappe, Detlef/0000-0003-1315-1791; Strynar, Mark/0000-0003-3472-7921; Acrey, Brad/0000-0001-5969-2222; Evich, Marina/0000-0002-2386-0682	EPA Office of Research and Development; North Carolina State University (NCSU); National Institute of Environmental Health Sciences of the National Institutes of Health [P42ES031009]; ETH Zurich, Institute of Environmental Engineering	EPA Office of Research and Development; North Carolina State University (NCSU); National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ETH Zurich, Institute of Environmental Engineering	This research was supported by the EPA Office of Research and Development; North Carolina State University (NCSU), the National Institute of Environmental Health Sciences of the National Institutes of Health (P42ES031009); and ETH Zurich, Institute of Environmental Engineering. It has been subjected to the EPA's administrative review and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The views expressed in this article are those of the authors and do not necessarily represent the views or policies of the EPA.	Ahrens L, 2014, ENVIRON TOXICOL CHEM, V33, P1921, DOI 10.1002/etc.2663; Ahrens L, 2012, ENVIRON SCI TECHNOL, V46, P7199, DOI 10.1021/es300898s; Alesio JL, 2022, CHEMOSPHERE, V287, DOI 10.1016/j.chemosphere.2021.131979; Allred BM, 2015, ENVIRON SCI TECHNOL, V49, P7648, DOI 10.1021/acs.est.5b01040; Ankley GT, 2021, ENVIRON TOXICOL CHEM, V40, P564, DOI 10.1002/etc.4869; Avendano SM, 2015, CHEMOSPHERE, V119, P1084, DOI 10.1016/j.chemosphere.2014.09.059; Banks R.E., 1994, ORGANOFLUORINE CHEM; Bao YX, 2017, RSC ADV, V7, P46948, DOI 10.1039/c7ra09728j; Bartell SM, 2021, J AIR WASTE MANAGE, V71, P663, DOI 10.1080/10962247.2021.1909668; Barth E, 2021, J ENVIRON MANAGE, V296, DOI 10.1016/j.jenvman.2021.113069; Barzen-Hanson KA, 2017, ENVIRON SCI TECHNOL, V51, P2047, DOI 10.1021/acs.est.6b05843; Benotti MJ, 2020, ENVIRON FORENSICS, V21, P319, DOI 10.1080/15275922.2020.1771631; Benskin JP, 2013, ENVIRON SCI TECHNOL, V47, P1381, DOI 10.1021/es304336r; Bizkarguenaga E, 2016, SCI TOTAL ENVIRON, V571, P444, DOI 10.1016/j.scitotenv.2016.07.010; Blaine AC, 2014, ENVIRON SCI TECHNOL, V48, P14361, DOI 10.1021/es504150h; Blaine AC, 2014, ENVIRON SCI TECHNOL, V48, P7858, DOI 10.1021/es500016s; Blaine AC, 2013, ENVIRON SCI TECHNOL, V47, P14062, DOI 10.1021/es403094q; Bolan N, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123892; Bonato M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218020; Booten C, 2020, NRELTP550070207 CLEA; Borga K, 2012, INTEGR ENVIRON ASSES, V8, P64, DOI 10.1002/ieam.244; Borthakur A, 2021, ENVIRON POLLUT, V286, DOI 10.1016/j.envpol.2021.117297; Brusseau ML, 2019, WATER RES, V152, P148, DOI 10.1016/j.watres.2018.12.057; Bruton TK, 2017, ENVIRON SCI TECHNOL, V51, P13878, DOI 10.1021/acs.est.7b03969; Buck Robert C., 2011, Integrated Environmental Assessment and Management, V7, P513, DOI 10.1002/ieam.258; Burkhard LP, 2021, ENVIRON TOXICOL CHEM, V40, P1530, DOI 10.1002/etc.5010; Chen Y, 2021, J ENVIRON SCI, V109, P219, DOI 10.1016/j.jes.2021.03.036; Chowdhury MI, 2021, ENVIRON TOXICOL CHEM, V40, P1973, DOI 10.1002/etc.5055; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Crone BC, 2019, CRIT REV ENV SCI TEC, V49, P2359, DOI 10.1080/10643389.2019.1614848; Cui JK, 2020, ENVIRON SCI TECHNOL, V54, P3752, DOI 10.1021/acs.est.9b05565; D'Ambro EL, 2021, ENVIRON SCI TECHNOL, V55, P862, DOI 10.1021/acs.est.0c06580; Dassuncao C, 2018, ENVIRON SCI TECHNOL, V52, P3738, DOI 10.1021/acs.est.7b06044; Dassuncao C, 2017, ENVIRON SCI TECHNOL, V51, P4512, DOI 10.1021/acs.est.7b00293; Dasu K, 2016, CHEMOSPHERE, V144, P2482, DOI 10.1016/j.chemosphere.2015.11.021; De Silva AO, 2021, ENVIRON TOXICOL CHEM, V40, P631, DOI 10.1002/etc.4935; DeWitt JC, 2012, TOXICOL PATHOL, V40, P300, DOI 10.1177/0192623311428473; Dombrowski PM, 2018, REMEDIATION, V28, P135, DOI 10.1002/rem.21555; Dreyer A, 2015, CHEMOSPHERE, V129, P142, DOI 10.1016/j.chemosphere.2014.06.069; Dreyer A, 2009, ENVIRON SCI TECHNOL, V43, P6507, DOI 10.1021/es9010465; Ebnesajjad S, 2013, INTRODUCTION TO FLUOROPOLYMERS: MATERIALS, TECHNOLOGY, AND APPLICATIONS, pXIII; Ellis DA, 2003, ENVIRON SCI TECHNOL, V37, P3816, DOI 10.1021/es034136j; Eriksson U, 2017, J ENVIRON SCI-CHINA, V61, P80, DOI 10.1016/j.jes.2017.05.004; Eschauzier C, 2013, SCI TOTAL ENVIRON, V458, P477, DOI 10.1016/j.scitotenv.2013.04.066; Fenton SE, 2021, ENVIRON TOXICOL CHEM, V40, P606, DOI 10.1002/etc.4890; Fitzgerald NJM, 2019, ENVIRON SCI-PROC IMP, V21, P1915, DOI 10.1039/c9em00241c; Friedlander G., 1981, NUCL RADIOCHEMISTRY, V3; Galloway JE, 2020, ENVIRON SCI TECHNOL, V54, P7175, DOI 10.1021/acs.est.9b07384; Gawor A, 2014, ENVIRON SCI-PROC IMP, V16, P404, DOI 10.1039/c3em00499f; Glaser D, 2021, INTEGR ENVIRON ASSES, V17, P705, DOI 10.1002/ieam.4414; Gluge J, 2020, ENVIRON SCI-PROC IMP, V22, P2345, DOI 10.1039/d0em00291g; Gold SC, 2020, SCIENCE, V368, P1066, DOI 10.1126/science.abc1250; Gonzalez-Gaya B, 2019, ENVIRON SCI-PROC IMP, V21, P1957, DOI 10.1039/c9em00266a; Goodrum PE, 2021, TOXICOL SCI, V179, P262, DOI 10.1093/toxsci/kfaa123; GRAMSTAD T, 1957, J CHEM SOC, P2640, DOI 10.1039/jr9570002640; Hamid H, 2020, SCI TOTAL ENVIRON, V713, DOI 10.1016/j.scitotenv.2020.136547; Hamid H, 2018, ENVIRON POLLUT, V235, P74, DOI 10.1016/j.envpol.2017.12.030; Harding-Marjanovic KC, 2015, ENVIRON SCI TECHNOL, V49, P7666, DOI 10.1021/acs.est.5b01219; Hoover G, 2019, CHEMOSPHERE, V233, P25, DOI 10.1016/j.chemosphere.2019.05.065; Huang S, 2019, ENVIRON SCI TECHNOL, V53, P11410, DOI 10.1021/acs.est.9b04047; Inoue M, 2020, ACS OMEGA, V5, P10633, DOI 10.1021/acsomega.0c00830; Jackson DA, 2013, ENVIRON SCI TECHNOL, V47, P382, DOI 10.1021/es303152m; Janousek RM, 2019, TRAC-TREND ANAL CHEM, V120, DOI 10.1016/j.trac.2019.01.017; Ji K, 2008, ENVIRON TOXICOL CHEM, V27, P2159, DOI 10.1897/07-523.1; Jiao XC, 2021, CRIT REV ENV SCI TEC, V51, P2745, DOI 10.1080/10643389.2020.1809219; Johansson JH, 2019, ENVIRON SCI-PROC IMP, V21, P635, DOI 10.1039/c8em00525g; Khan MY, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124615; Kissa E., 2001, FLUORINATED SURFACTA, Vsecond; Knutsen HK, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5194; Koch A, 2021, CHEMOSPHERE, V276, DOI 10.1016/j.chemosphere.2021.130179; Kwiatkowski CF, 2020, ENVIRON SCI TECH LET, V7, P532, DOI 10.1021/acs.estlett.0c00255; Lang JR, 2017, ENVIRON SCI TECHNOL, V51, P2197, DOI 10.1021/acs.est.6b05005; Larson ES, 2018, CHEMOSPHERE, V201, P335, DOI 10.1016/j.chemosphere.2018.03.004; Lasier PJ, 2011, ENVIRON TOXICOL CHEM, V30, P2194, DOI 10.1002/etc.622; Lee H, 2010, ENVIRON SCI TECHNOL, V44, P3305, DOI 10.1021/es9028183; Lescord GL, 2015, ENVIRON SCI TECHNOL, V49, P2694, DOI 10.1021/es5048649; Lesmeister L, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.142640; Lewis M, 2016, SCI TOTAL ENVIRON, V572, P935, DOI 10.1016/j.scitotenv.2016.07.223; Li Z, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134762; Liu C, 2016, ENVIRON POLLUT, V212, P230, DOI 10.1016/j.envpol.2016.01.069; Liu JX, 2013, ENVIRON INT, V61, P98, DOI 10.1016/j.envint.2013.08.022; Liu YL, 2021, ENVIRON SCI TECH LET, V8, P66, DOI 10.1021/acs.estlett.0c00819; Loi EIH, 2011, ENVIRON SCI TECHNOL, V45, P5506, DOI 10.1021/es200432n; Maclnnis JJ, 2019, ENVIRON SCI TECHNOL, V53, P10753, DOI 10.1021/acs.est.9b03372; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P5379, DOI 10.1021/es049331s; McCarthy CJ, 2021, INTEGR ENVIRON ASSES, V17, P697, DOI 10.1002/ieam.4415; McGuire ME, 2014, ENVIRON SCI TECHNOL, V48, P6644, DOI 10.1021/es5006187; Mejia-Avendano S, 2016, ENVIRON SCI TECHNOL, V50, P9923, DOI 10.1021/acs.est.6b00140; MERESAAR U, 1974, ACTA CHEM SCAND A, VA 28, P715, DOI 10.3891/acta.chem.scand.28a-0715; Miranda DA, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142146; Muir Derek, 2019, Emerging Contaminants, V5, P240, DOI 10.1016/j.emcon.2019.06.002; Navarro I, 2016, ENVIRON RES, V149, P32, DOI 10.1016/j.envres.2016.05.004; Newton S, 2017, ENVIRON SCI TECHNOL, V51, P1544, DOI 10.1021/acs.est.6b05330; Ng CA, 2014, ENVIRON SCI TECHNOL, V48, P4637, DOI 10.1021/es404008g; Nzeribe N, 2019, CRIT REV ENV SCI TEC, V49, P866, DOI 10.1080/10643389.2018.1542916; Ogawa Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101467; Organisation for Economic Co-operation and Development, 2018, OECD SER RISK MAN, V39; Organisation for Economic Cooperation and Development, OECD SER RISK MAN, V61; PFAS destruction and disposal, 2020, 12866121720508 EO EP; Pi N, 2017, WATER RES, V117, P167, DOI 10.1016/j.watres.2017.04.003; Post GB, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002855; Rand AA, 2011, ENVIRON SCI TECHNOL, V45, P8053, DOI 10.1021/es1043968; Rankin K, 2016, CHEMOSPHERE, V161, P333, DOI 10.1016/j.chemosphere.2016.06.109; Rayne S, 2009, J ENVIRON SCI HEAL A, V44, P1145, DOI 10.1080/10934520903139811; Rhoads KR, 2008, ENVIRON SCI TECHNOL, V42, P2873, DOI 10.1021/es702866c; Riedel TP, 2021, CHEMOSPHERE, V272, DOI 10.1016/j.chemosphere.2021.129859; Rose A. W., 1979, GEOCHEMISTRY MINERAL, V2; Ross I, 2018, REMEDIATION, V28, P101, DOI 10.1002/rem.21553; Royer LA, 2015, CHEMOSPHERE, V129, P54, DOI 10.1016/j.chemosphere.2014.09.077; SGS, 2019, DENM BANS PFAS CHEM; Shaw DMJ, 2019, SCI TOTAL ENVIRON, V647, P690, DOI 10.1016/j.scitotenv.2018.08.012; Shoeib M, 2006, ENVIRON SCI TECHNOL, V40, P7577, DOI 10.1021/es0618999; Shoeib M, 2010, ATMOS ENVIRON, V44, P2887, DOI 10.1016/j.atmosenv.2010.04.056; Siegemund G. S., 2000, FLUORINE COMPOUNDS O, V33; Sima MW, 2021, SCI TOTAL ENVIRON, V757, DOI 10.1016/j.scitotenv.2020.143793; Simpson SL, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.146008; Sunderland EM, 2019, J EXPO SCI ENV EPID, V29, P131, DOI 10.1038/s41370-018-0094-1; Tebes-Stevens C, 2017, ENVIRON SCI TECHNOL, V51, P5008, DOI 10.1021/acs.est.6b05412; The Chemours Company Fayetteville Works Plant, 2020, P001393 CHEM COMP FA; Nguyen TMH, 2020, ENVIRON SCI TECHNOL, V54, P15883, DOI 10.1021/acs.est.0c05705; Tow Emily W, 2021, AWWA Water Sci, V3, P1, DOI 10.1002/aws2.1233; Tsai WT, 2017, MITIG ADAPT STRAT GL, V22, P225, DOI 10.1007/s11027-015-9684-6; United Nations, 2016, ENV 2 F AM MONTR PRO; US Environmental Protection Agency, 2021, ALL ALL TRAD PROGR A; US Environmental Protection Agency, 2021, DRINK WAT TREAT DAT; US Environmental Protection Agency, 2010, FACT SHEET 2010 2015; US Environmental Protection Agency, 2021, EPA ADM REG ANN COMP; US Environmental Protection Agency, 2020, PFAS STRUCT DSSTOX U; US Environmental Protection Agency, 2020, LONG CHAIN PERFL CAR; US Environmental Protection Agency, 2009, LONG CHAIN PERFL CHE; US Environmental Protection Agency, 2010, PREM NOT EXC POL AM; USDA (United States Department of Agriculture), 1975, AGR HDB, V436; USEPA, 2019, 0010 22021563521X; Wackett LP, 2020, BIOCHEM J, V477, P2875, DOI 10.1042/BCJ20190720; Wang N, 2005, ENVIRON SCI TECHNOL, V39, P7516, DOI 10.1021/es0506760; Wang N, 2011, CHEMOSPHERE, V82, P853, DOI 10.1016/j.chemosphere.2010.11.003; Wang N, 2009, CHEMOSPHERE, V75, P1089, DOI 10.1016/j.chemosphere.2009.01.033; Wang Z., 2020, NORDIC WORKING PAPER; Wang ZY, 2021, SCIENCE, V371, P774, DOI 10.1126/science.abe9090; Wang ZY, 2014, ENVIRON INT, V70, P62, DOI 10.1016/j.envint.2014.04.013; Wang Z, 2014, ENVIRON INT, V69, P166, DOI 10.1016/j.envint.2014.04.006; Wang ZY, 2013, ENVIRON INT, V60, P242, DOI 10.1016/j.envint.2013.08.021; Washington JW, 2020, SCIENCE, V368, P1103, DOI 10.1126/science.aba7127; Washington JW, 2019, SCI TOTAL ENVIRON, V651, P2444, DOI 10.1016/j.scitotenv.2018.10.071; Washington JW, 2015, ENVIRON SCI TECHNOL, V49, P14129, DOI 10.1021/acs.est.5b03686; Washington JW, 2015, ENVIRON SCI TECHNOL, V49, P13256, DOI 10.1021/acs.est.5b03379; Washington JW, 2015, ENVIRON SCI TECHNOL, V49, P915, DOI 10.1021/es504347u; Washington JW, 2014, ENVIRON SCI TECHNOL, V48, P5762, DOI 10.1021/es500373b; Washington JW, 2010, ENVIRON SCI TECHNOL, V44, P8390, DOI 10.1021/es1003846; Winchell LJ, 2021, WATER ENVIRON RES, V93, P826, DOI 10.1002/wer.1483; Xiao F, 2019, ENVIRON SCI TECHNOL, V53, P11818, DOI 10.1021/acs.est.9b05379; Xiao X, 2017, ENVIRON SCI TECHNOL, V51, P6342, DOI 10.1021/acs.est.7b00970; Xu C, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145731; Xu L, 2017, ENVIRON SCI TECHNOL, V51, P14173, DOI 10.1021/acs.est.7b04332; Yi S, 2018, ENVIRON SCI TECH LET, V5, P283, DOI 10.1021/acs.estlett.8b00148; Yoo H, 2011, ENVIRON SCI TECHNOL, V45, P7985, DOI 10.1021/es102972m; Yu XL, 2018, SCI TOTAL ENVIRON, V610, P776, DOI 10.1016/j.scitotenv.2017.08.075; Yu Xiaolong, 2016, Journal of Water and Environment Technology, V14, P177, DOI 10.2965/jwet.15-056; Zhai ZH, 2015, CHEMOSPHERE, V129, P110, DOI 10.1016/j.chemosphere.2014.09.033; Zhang HN, 2016, ENVIRON SCI TECHNOL, V50, P13309, DOI 10.1021/acs.est.6b03734; Zhang S, 2013, ENVIRON SCI TECHNOL, V47, P4227, DOI 10.1021/es4000824; [张伟 Zhang Wei], 2017, [中国科学. 化学, Scientia Sinica Chimica], V47, P1312; Zhu XJ, 2021, SCI TOTAL ENVIRON, V761, DOI 10.1016/j.scitotenv.2020.143230	163	44	47	299	455	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					512	+	eabg9065	10.1126/science.abg9065	http://dx.doi.org/10.1126/science.abg9065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113710				2022-12-28	WOS:000753965100032
J	Iacobucci, G				Iacobucci, Gareth			"Levelling up" plan needs more funding and a focus on health inequalities, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o303	10.1136/bmj.o303	http://dx.doi.org/10.1136/bmj.o303			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121610				2022-12-28	WOS:000753552800017
J	Mulgan, G				Mulgan, Geoff			Governments: learn to think better	NATURE			English	Editorial Material						Government; Policy; Politics		National leaders need better ways to weigh evidence and make complex decisions.	[Mulgan, Geoff] UCL, Collect Intelligence Publ Policy & Social Innovat, London, England	University of London; University College London	Mulgan, G (corresponding author), UCL, Collect Intelligence Publ Policy & Social Innovat, London, England.	g.mulgan@ucl.ac.uk		mulgan, geoff/0000-0003-0907-5132					0	3	3	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					9	9		10.1038/d41586-022-00212-5	http://dx.doi.org/10.1038/d41586-022-00212-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8PL	35105997	Green Submitted, Bronze			2022-12-28	WOS:000749566700001
J	Torjesen, I				Torjesen, Ingrid			Covid-19 patients discharged from hospital have "substantially higher risk" of adverse outcomes and need monitoring	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ayoubkhani D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n693; Bhaskaran Krishnan, 2022, PLoS Med, V19, pe1003871, DOI 10.1371/journal.pmed.1003871	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o265	10.1136/bmj.o265	http://dx.doi.org/10.1136/bmj.o265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105538	Bronze			2022-12-28	WOS:000758676500005
J	Jreidini, C				Jreidini, Carl			How can you help me integrate my long covid care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								n3102	10.1136/bmj.n3102	http://dx.doi.org/10.1136/bmj.n3102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086863	Bronze			2022-12-28	WOS:000748641100004
J	Shepherd, A				Shepherd, Alison			BMJ readers have so far helped raise more than 112 pound 000 for annual appeal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o202	10.1136/bmj.o202	http://dx.doi.org/10.1136/bmj.o202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082113				2022-12-28	WOS:000748440900019
J	Davidson, KW; Barry, MJ; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Epling, JW; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Davidson, Karina W.; Barry, Michael J.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Epling, John W.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.			Screening for Atrial Fibrillation US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ROUTINE PRACTICE; HEART-DISEASE; AGED 65; STROKE; RHYTHM; CARE; ACCURACY; MONITOR; UPDATE; ADULTS	IMPORTANCE Atrial fibrillation (AF) is the most common cardiac arrhythmia. The prevalence of AF increases with age, from less than 02% in adults younger than 55 years to about 10% in those 85 years or older, with a higher prevalence in men than in women. It is uncertain whether the prevalence of AF differs by race and ethnicity. Atrial fibrillation is a major risk factor for ischemic stroke and is associated with a substantial increase in the risk of stroke. Approximately 20% of patients who have a stroke associated with AF are first diagnosed with AF at the time of the stroke or shortly thereafter. OBJECTIVE To update its 2018 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the benefits and harms of screening for AF in older adults, the accuracy of screening tests, the effectiveness of screening tests to detect previously undiagnosed AF compared with usual care, and the benefits and harms of anticoagulant therapy for the treatment of screen-detected AF in older adults. POPULATION Adults 50 years or older without a diagnosis or symptoms of AF and without a history of transient ischemic attack or stroke. EVIDENCE ASSESSMENT The USPSTF concludes that evidence is lacking, and the balance of benefits and harms of screening for AF in asymptomatic adults cannot be determined. RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for AF.	[Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, New York, NY USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Epling, John W.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Silverstein, Michael] Brown Univ, Providence, RI 02912 USA; [Stevermer, James] Univ Missouri, Columbia, MO USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Northwell Health; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; Virginia Polytechnic Institute & State University; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; Brown University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Davidson, KW (corresponding author), Feinstein Inst Med Res, 130 E 59th St,Ste 14C, New York, NY 10032 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				American Academy of Family Physicians, ATRIAL FIBRILLATION; Benjamin EJ, 2021, CIRCULATION, V143; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P478, DOI 10.1001/jama.2018.10321; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Gladstone DJ, 2021, JAMA CARDIOL, V6, P558, DOI 10.1001/jamacardio.2021.0038; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Halcox JPJ, 2017, CIRCULATION, V136, P1784, DOI 10.1161/CIRCULATIONAHA.117.030583; Hannon N, 2010, CEREBROVASC DIS, V29, P43, DOI 10.1159/000255973; Himmelreich JCL, 2019, ANN FAM MED, V17, P403, DOI 10.1370/afm.2438; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kaasenbrood F, 2020, BRIT J GEN PRACT, V70, pE427, DOI 10.3399/bjgp20X708161; Kahwati L, EVIDENCE SYNTHESIS; Kahwati LC, JAMA-J AM MED ASSOC; Kearley K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004565; Krist AH, 2021, JAMA-J AM MED ASSOC, V325, P265, DOI 10.1001/jama.2020.25019; Krist AH, 2020, JAMA-J AM MED ASSOC, V324, P2069, DOI 10.1001/jama.2020.21749; LIN HJ, 1995, STROKE, V26, P1527, DOI 10.1161/01.STR.26.9.1527; Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040; Mant J, 2007, BMJ-BRIT MED J, V335, P380, DOI 10.1136/bmj.39227.551713.AE; Marazzi G, 2012, ADV THER, V29, P64, DOI 10.1007/s12325-011-0087-0; Menke J, 2010, AM J CARDIOL, V105, P502, DOI 10.1016/j.amjcard.2009.10.018; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Noseworthy PA, 2019, CIRCULATION, V140, pE944, DOI 10.1161/CIR.0000000000000740; Philippsen Tine J, 2017, JACC Clin Electrophysiol, V3, P1557, DOI 10.1016/j.jacep.2017.06.020; Sabar MI, 2019, PACE, V42, P1383, DOI 10.1111/pace.13800; Steinhubl SR, 2018, JAMA-J AM MED ASSOC, V320, P146, DOI 10.1001/jama.2018.8102; Svennberg E, 2021, LANCET, V398, P1498, DOI 10.1016/S0140-6736(21)01637-8; Swancutt Dawn, 2004, BMC Cardiovasc Disord, V4, P12, DOI 10.1186/1471-2261-4-12; Tereshchenko LG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003206; Uittenbogaart SB, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3208; US Preventive Services Task Force, PROC MAN; Wiesel J, 2014, AM J CARDIOL, V114, P1046, DOI 10.1016/j.amjcard.2014.07.016; WOLF PA, 1983, STROKE, V14, P664, DOI 10.1161/01.STR.14.5.664; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	43	29	29	9	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					360	367		10.1001/jama.2021.23732	http://dx.doi.org/10.1001/jama.2021.23732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076659	Bronze			2022-12-28	WOS:000753055700013
J	Kuehn, BM				Kuehn, Bridget M.			Fall Influenza A(H3N2) Outbreak at a Midwestern University	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					315	315						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076658				2022-12-28	WOS:000753055700034
J	Ray, JG; Abdulaziz, KE; Berger, H				Ray, Joel G.; Abdulaziz, Kasim E.; Berger, Howard		DOH-NET Diabet Obesity Hypertensi	Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ray, Joel G.] St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Abdulaziz, Kasim E.] Better Outcomes Registry & Network Ontario, Ottawa, ON, Canada; [Berger, Howard] St Michaels Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ray, JG (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca	Abdulaziz, Kasim E/GZA-8875-2022	Abdulaziz, Kasim E/0000-0002-6072-0822	Canadian Institutes for Health Research [146442]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant 146442 from the Canadian Institutes for Health Research.	Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Berger H, 2019, J OBSTET GYNAECOL CA, V41, P1579, DOI 10.1016/j.jogc.2019.01.020; Davidson KW, 2021, JAMA-J AM MED ASSOC, V326, P1186, DOI 10.1001/jama.2021.14781; Krishnamurti T, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.30804; LeFevre ML, 2014, ANN INTERN MED, V161, P819, DOI 10.7326/M14-1884; Viguiliouk E, 2017, J OBSTET GYNAECOL CA, V39, P722, DOI 10.1016/j.jogc.2017.04.040	6	1	1	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					388	390						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076678	Green Published			2022-12-28	WOS:000753055700017
J	Sokol, D				Sokol, Daniel			Why mandatory vaccination for healthcare workers should not be scrapped	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2021, ECONOMIST 0731; Dyer O, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2390; General Medical Council, GOOD MED PRACTICE; Le Figaro, OBL VACC 160 MED LIB; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3151; The Royal College of Nursing, RCN POS MAND VACC HL	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								o206	10.1136/bmj.o206	http://dx.doi.org/10.1136/bmj.o206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4MD	35074894	Bronze			2022-12-28	WOS:000750652200009
J	Williams, N; Lee, J; Mitchell, E; Moore, L; Baxter, EJ; Hewinson, J; Dawson, KJ; Menzies, A; Godfrey, AL; Green, AR; Campbell, PJ; Nangalia, J				Williams, Nicholas; Lee, Joe; Mitchell, Emily; Moore, Luiza; Baxter, E. Joanna; Hewinson, James; Dawson, Kevin J.; Menzies, Andrew; Godfrey, Anna L.; Green, Anthony R.; Campbell, Peter J.; Nangalia, Jyoti			Life histories of myeloproliferative neoplasms inferred from phylogenies	NATURE			English	Article							SOMATIC MUTATIONS; CLONAL HEMATOPOIESIS; EXPANSION; CANCER; CLASSIFICATION; LANDSCAPE; EVOLUTION; DYNAMICS; LEUKEMIA; COMMON	Mutations in cancer-associated genes drive tumour outgrowth, but our knowledge of the timing of driver mutations and subsequent clonal dynamics is limited(1-3). Here, using whole-genome sequencing of 1,013 clonal haematopoietic colonies from 12 patients with myeloproliferative neoplasms, we identified 580,133 somatic mutations to reconstruct haematopoietic phylogenies and determine clonal histories. Driver mutations were estimated to occur early in life, including the in utero period. JAK2(V617F) was estimated to have been acquired by 33 weeks of gestation to 10.8 years of age in 5 patients in whom JAK2(V617F) was the first event. DNMT3A mutations were acquired by 8 weeks of gestation to 7.6 years of age in 4 patients, and a PPM1D mutation was acquired by 5.8 years of age. Additional genomic events occurred before or following JAK2(V617F) acquisition and as independent clonal expansions. Sequential driver mutation acquisition was separated by decades across life, often outcompeting ancestral clones. The mean latency between JAK2(V617F) acquisition and diagnosis was 30 years (range 11-54 years). Estimated historical rates of clonal expansion varied substantially (3% to 190% per year), increased with additional driver mutations, and predicted latency to diagnosis. Our study suggests that early driver mutation acquisition and life-long growth and evolution underlie adult myeloproliferative neoplasms, raising opportunities for earlier intervention and a new model for cancer development.	[Williams, Nicholas; Lee, Joe; Mitchell, Emily; Moore, Luiza; Hewinson, James; Dawson, Kevin J.; Menzies, Andrew; Campbell, Peter J.; Nangalia, Jyoti] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Lee, Joe; Mitchell, Emily; Green, Anthony R.; Campbell, Peter J.; Nangalia, Jyoti] Jeffrey Cheah Biomed Ctr, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England; [Mitchell, Emily; Baxter, E. Joanna; Green, Anthony R.; Campbell, Peter J.; Nangalia, Jyoti] Univ Cambridge, Dept Haematol, Cambridge, England; [Mitchell, Emily; Godfrey, Anna L.; Green, Anthony R.; Nangalia, Jyoti] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge	Nangalia, J (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England.; Nangalia, J (corresponding author), Jeffrey Cheah Biomed Ctr, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England.; Nangalia, J (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.; Nangalia, J (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge, England.	jn5@sanger.ac.uk		Moore, Luiza/0000-0001-5315-516X; Williams, Nicholas/0000-0003-3989-9167	Cambridge Cancer Centre; Wellcome Trust Cambridge Stem Cell Institute; Wellcome Sanger CASM and DNA pipelines; Cancer Research UK; EHA Research Award; MPN Research Foundation; Wellcome Trust; Bloodwise; Kay Kendall Leukaemia Fund; Leukaemia and Lymphoma Society of America	Cambridge Cancer Centre; Wellcome Trust Cambridge Stem Cell Institute; Wellcome Sanger CASM and DNA pipelines; Cancer Research UK(Cancer Research UK); EHA Research Award; MPN Research Foundation; Wellcome Trust(Wellcome Trust); Bloodwise; Kay Kendall Leukaemia Fund; Leukaemia and Lymphoma Society of America	We thank Cambridge Blood and Stem Cell Biobank, funded by the Cambridge Cancer Centre and Wellcome Trust Cambridge Stem Cell Institute, Wellcome Sanger CASM and DNA pipelines for their assistance; and S. Behjati and C. Harrison for valuable discussion. The study was supported by Cancer Research UK (J.N.), EHA Research Award (J.N.), MPN Research Foundation (J.N.) and the Wellcome Trust (P.J.C., A.R.G. and J.L.). Work in the A.R.G. laboratory is supported by the Wellcome Trust, Bloodwise, Cancer Research UK, the Kay Kendall Leukaemia Fund and the Leukaemia and Lymphoma Society of America. J.N. is a CRUK Clinician Scientist fellow. We thank the patients for their participation in the study.	Abascal F, 2021, NATURE, V593, P405, DOI 10.1038/s41586-021-03477-4; Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Anand S, 2011, BLOOD, V118, P177, DOI 10.1182/blood-2010-12-327593; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bao EL, 2020, NATURE, V586, DOI 10.1038/s41586-020-2786-7; Bick AG, 2020, NATURE, V586, P763, DOI [10.1038/s41586-020-2819-2, 10.1038/s41586-021-03280-1, 10.1038/s41586-021-03280]; Brunner SF, 2019, NATURE, V574, P538, DOI 10.1038/s41586-019-1670-9; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; de Kanter JK, 2021, CELL STEM CELL, V28, P1726, DOI 10.1016/j.stem.2021.07.012; Hoang DT, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1131-3; Ellis P, 2021, NAT PROTOC, V16, P841, DOI 10.1038/s41596-020-00437-6; Fleischman AG, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/606819; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Godfrey AL, 2012, BLOOD, V120, P2704, DOI 10.1182/blood-2012-05-431791; Grinfeld J, 2018, NEW ENGL J MED, V379, P1416, DOI 10.1056/NEJMoa1716614; Hinds DA, 2016, BLOOD, V128, P1121, DOI 10.1182/blood-2015-06-652941; Hirsch P, 2016, LEUKEMIA, V30, P1756, DOI 10.1038/leu.2016.31; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones David, 2016, Curr Protoc Bioinformatics, V56, DOI 10.1002/cpbi.20; Kahn JD, 2018, BLOOD, V132, P1095, DOI 10.1182/blood-2018-05-850339; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McKerrell T, 2017, BLOOD ADV, V1, P968, DOI 10.1182/bloodadvances.2017007047; Mehta J, 2014, LEUKEMIA LYMPHOMA, V55, P595, DOI 10.3109/10428194.2013.813500; Mitchell E, CLONAL DYNAMICS HAEM, V2021, DOI [10.1101/2021.08.16.456475, DOI 10.1101/2021.08.16.456475]; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Moore L, 2020, NATURE, V580, P640, DOI 10.1038/s41586-020-2214-z; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Nangalia J, 2015, HAEMATOLOGICA, V100, pE438, DOI 10.3324/haematol.2015.129510; Nielsen C, 2013, BRIT J HAEMATOL, V160, P70, DOI 10.1111/bjh.12099; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Osorio FG, 2018, CELL REP, V25, P2308, DOI 10.1016/j.celrep.2018.11.014; Pan J, 2020, NATURE, V578, P559, DOI 10.1038/s41586-020-2016-3; Pieri L, 2015, BLOOD, V125, P3352, DOI 10.1182/blood-2015-01-624536; Radivoyevitch T, 2012, BLOOD, V119, P4363, DOI 10.1182/blood-2011-09-381855; Chapman MS, 2021, NATURE, V595, P85, DOI 10.1038/s41586-021-03548-6; Tavare S, 2018, ADV APPL PROBAB, V50, P253, DOI 10.1017/apr.2018.84; Titmarsh GJ, 2014, AM J HEMATOL, V89, P581, DOI 10.1002/ajh.23690; Vainchenker W, 2017, BLOOD, V129, P667, DOI 10.1182/blood-2016-10-695940; Van Egeren D, 2021, CELL STEM CELL, V28, P514, DOI 10.1016/j.stem.2021.02.001; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Watson CJ, 2020, SCIENCE, V367, P1449, DOI 10.1126/science.aay9333; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wong WH, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6249; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484	56	31	31	14	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					162	+		10.1038/s41586-021-04312-6	http://dx.doi.org/10.1038/s41586-021-04312-6		JAN 2022	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35058638	Green Submitted			2022-12-28	WOS:000744785400001
J	Salian, P				Salian, Priti			"I am disabled, it doesn't mean I have no dignity"	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					349	350						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065776				2022-12-28	WOS:000746046100010
J	He, W; Sparen, P; Fang, F; Sengpiel, V; Strander, B; Czene, K				He, Wei; Sparen, Par; Fang, Fang; Sengpiel, Verena; Strander, Bjoern; Czene, Kamila			Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis A Nationwide Population-Based Cohort Study With Sibling Comparison Design	ANNALS OF INTERNAL MEDICINE			English	Article							PRETERM BIRTH; CANCER; RISK; EXCISION; PREDICTOR; FAMILY	Background: Treatment of cervical intraepithelial neoplasia grade 3 (CIN 3) removes or destroys part of the cervix and might subsequently influence pregnancy outcomes. Objective: To investigate pregnancy outcomes in women diagnosed with CIN 3. Design: Population- and sibling-matched cohort study. Setting: Sweden, 1973 to 2018. Participants: The general population comparison included 78 450 singletons born to women diagnosed with CIN 3 and 784 500 matched singletons born to women in the general population who had no CIN 3 diagnosis; the sibling comparison included 23 199 singletons born to women diagnosed with CIN 3 and 28 135 singletons born to their sisters without a CIN 3 diagnosis. Measurements: Preterm birth, including spontaneous or iatrogenic preterm birth; infection-related outcomes, including chorioamnionitis and infant sepsis; and early neonatal death, defined as death during the first week after birth. Results: Compared with the matched general population, women previously diagnosed with CIN 3 were more likely to have a preterm birth, especially extremely preterm (22 to 28 weeks; odds ratio [OR], 3.00 [95% CI, 2.69 to 3.34]) or spontaneous preterm (OR, 2.12 [CI, 2.05 to 2.20]); infection-related outcomes, including chorioamnionitis (OR, 3.23 [CI, 2.89 to 3.62]) and infant sepsis (OR, 1.72 [CI, 1.60 to 1.86]); or early neonatal death (OR, 1.83 [CI, 1.61 to 2.09]). Sibling comparison analyses rendered largely similar results. Over time, the risk difference attenuated for all outcomes and disappeared for early neonatal death. Limitation: Lack of data on CIN 3 treatment and spontaneous abortion. Conclusion: History of CIN 3 is associated with adverse pregnancy outcomes even after accounting for familial factors. Decreasing risk estimates over time suggest that adverse pregnancy outcomes among women diagnosed with CIN 3 may be minimized by improving treatment methods. Primary funding source: The Swedish Research Council, the Swedish Cancer Society, and the Swedish Research Council for Health, Working Life and Welfare.	[He, Wei] Zhejiang Univ, Chron Dis Res Inst, Childrens Hosp, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [He, Wei] Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Sch Publ Hlth, Sch Med, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [He, Wei] Zhejiang Univ, Sch Publ Hlth, Sch Med, Dept Nutr & Food Hyg, Hangzhou, Zhejiang, Peoples R China; [He, Wei; Sparen, Par; Czene, Kamila] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Fang, Fang] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Sengpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Reg Vastra Gotaland, Gothenburg, Sweden; [Sengpiel, Verena; Strander, Bjoern] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Strander, Bjoern] Reg Canc Ctr West, Gothenburg, Sweden	Zhejiang University; Zhejiang University; Zhejiang University; Karolinska Institutet; Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg	He, W (corresponding author), Zhejiang Univ, Chron Dis Res Inst, Childrens Hosp, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; He, W (corresponding author), Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Sch Publ Hlth, Sch Med, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	wei.he@ki.se		Sengpiel, Verena/0000-0002-3608-7430; Fang, Fang/0000-0002-3310-6456; Strander, Bjorn/0000-0001-8369-7955; Sparen, Par/0000-0002-5184-8971	Swedish Research Council [2018-02547]; Swedish Cancer Society [19 0266]; Swedish Research Council for Health, Working Life and Welfare [2016-00081, 2018-00877]; Zhejiang University through the Hundred Talents Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Zhejiang University through the Hundred Talents Program	By grant 2018-02547 from the Swedish Research Council, grant 19 0266 from the Swedish Cancer Society, and grants 2016-00081 and 2018-00877 from the Swedish Research Council for Health, Working Life and Welfare. Dr. He was supported by Zhejiang University through the Hundred Talents Program.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; [Anonymous], 2013, WHO GUID SCREEN TREA; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2017, LANCET ONCOL, V18, P1665, DOI 10.1016/S1470-2045(17)30700-3; Barken SS, 2012, INT J CANCER, V130, P2438, DOI 10.1002/ijc.26248; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bjorge T, 2016, OBSTET GYNECOL, V128, P1265, DOI 10.1097/AOG.0000000000001777; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Castanon A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6223; Castanon A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5174; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez R, 2005, AM J OBSTET GYNECOL, V192, P678, DOI 10.1016/j.ajog.2004.10.624; Kallen ~, 2003, SWEDISH MED BIRT REG; KRISTENSEN J, 1993, OBSTET GYNECOL, V81, P1005; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Kyrgiou M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3633; Kyrgiou M, 2015, INT J GYNECOL OBSTET, V128, P141, DOI 10.1016/j.ijgo.2014.07.038; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McHale SM, 2009, J FAM PSYCHOL, V23, P562, DOI 10.1037/a0014982; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Shah PS, 2009, ACTA OBSTET GYN SCAN, V88, P1307, DOI 10.3109/00016340903358820; Strander B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6611; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; Wiik J, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003641	33	2	3	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					210	+		10.7326/M21-2793	http://dx.doi.org/10.7326/M21-2793		FEB 2022	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35130050				2022-12-28	WOS:000758846300028
J	Kuehn, BM				Kuehn, Bridget M.			Cluster of Mucormycosis Cases Linked With Delta Surge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					518	518						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O7FE	35133409				2022-12-28	WOS:000783688600002
J	Kostick-Quenet, K; Mandl, KD; Minssen, T; Cohen, IG; Gasser, U; Kohane, I; McGuire, AL				Kostick-Quenet, Kristin; Mandl, Kenneth D.; Minssen, Timo; Cohen, I. Glenn; Gasser, Urs; Kohane, Isaac; McGuire, Amy L.			How NFTs could transform health information exchange	SCIENCE			English	Editorial Material									[Kostick-Quenet, Kristin; McGuire, Amy L.] Baylor Coll Med, Houston, TX 77030 USA; [Mandl, Kenneth D.; Kohane, Isaac] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Mandl, Kenneth D.; Kohane, Isaac] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Minssen, Timo] Univ Copenhagen, Ctr Adv Studies Biomed Innovat Law CeBIL, Copenhagen, Denmark; [Cohen, I. Glenn] Harvard Law Sch, Boston, MA USA; [Gasser, Urs] Tech Univ Munich, Sch Social Sci & Technol, Munich, Germany	Baylor College of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Copenhagen; Harvard University; Technical University of Munich	Kostick-Quenet, K (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	kristin.kostick@bcm.edu		Gasser, Urs/0000-0001-6899-5647; Minssen, Timo/0000-0002-3286-4888	Novo Nordisk Foundation [NNF17SA0027784]; Info Commons [R01HG008918]; Sulston [R01CA237118]; BRAIN share [R01MH126937]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Info Commons; Sulston; BRAIN share	M.and I.G.C. were supported by the Novo Nordisk Foundation (NNF17SA0027784). A.L.M. has received funding from Info Commons, Sulston, and BRAIN share through grants R01HG008918, R01CA237118, and R01MH126937, respectively, and is on the board of the Greenwall Foundation and on the science advisory board for Danaher, the Morgridge Institute of Research, and Geisinger Research.	Briscoe F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229044; Council on Foreign Relations, 2018, REF US APPR DAT PROT; European Union, 2016, GEN DATA PROTECTION; Fazlioglu M, 2021, DATA PROTECTION WORL, P231; Mandl KD, 2021, NEW ENGL J MED, V385, DOI [10.1056/NEJMc2111490, 10.1056/NEJMp2102616]; Mandl KD, 2020, NEW ENGL J MED, V382, P1781, DOI 10.1056/NEJMp1917640; Mandl KD, 2016, NEW ENGL J MED, V374, P205, DOI 10.1056/NEJMp1512142; Mann SP, 2021, J MED ETHICS, V47, P244, DOI 10.1136/medethics-2019-105963; McGuire AL, 2019, J LAW MED ETHICS, V47, P12, DOI 10.1177/1073110519840480; Minssen T, 2020, EPLR, V4, P153; Minssen Timo, 2018, BIG DATA HLTH LAW BI, P311; Price WN, 2019, SCIENCE, V363, P448, DOI 10.1126/science.aav5133; Rieke N, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00323-1; Rocher L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10933-3	14	5	5	3	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					500	502		10.1126/science.abm2004	http://dx.doi.org/10.1126/science.abm2004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113709				2022-12-28	WOS:000753965100026
J	Makowski, C; van der Meer, D; Dong, WX; Wang, H; Wu, Y; Zou, JJ; Liu, C; Rosenthal, SB; Hagler, DJ; Fan, CC; Kremen, WS; Andreassen, OA; Jernigan, TL; Dale, AM; Zhang, K; Visscher, PM; Yang, J; Chen, CH				Makowski, Carolina; van der Meer, Dennis; Dong, Weixiu; Wang, Hao; Wu, Yan; Zou, Jingjing; Liu, Cin; Rosenthal, Sara B.; Hagler, Donald J., Jr.; Fan, Chun Chieh; Kremen, William S.; Andreassen, Ole A.; Jernigan, Terry L.; Dale, Anders M.; Zhang, Kun; Visscher, Peter M.; Yang, Jian; Chen, Chi-Hua			Discovery of genomic loci of the human cerebral cortex using genetically informed brain atlases	SCIENCE			English	Article							WIDE ASSOCIATION; SINGLE-CELL; POPULATION-STRUCTURE; FUNCTIONAL IMPACT; COMPLEX TRAITS; ANNOTATION; ELEMENTS; RISK; HERITABILITY; SEGMENTATION	To determine the impact of genetic variants on the brain, we used genetically informed brain atlases in genome-wide association studies of regional cortical surface area and thickness in 39,898 adults and 9136 children. We uncovered 440 genome-wide significant loci in the discovery cohort and 800 from a post hoc combined meta-analysis. Loci in adulthood were largely captured in childhood, showing signatures of negative selection, and were linked to early neurodevelopment and pathways associated with neuropsychiatric risk. Opposing gradations of decreased surface area and increased thickness were associated with common inversion polymorphisms. Inferior frontal regions, encompassing Broca's area, which is important for speech, were enriched for human-specific genomic elements. Thus, a mixed genetic landscape of conserved and human-specific features is concordant with brain hierarchy and morphogenetic gradients.	[Makowski, Carolina; Wang, Hao; Liu, Cin; Hagler, Donald J., Jr.; Fan, Chun Chieh; Dale, Anders M.; Chen, Chi-Hua] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, San Diego, CA 92103 USA; [van der Meer, Dennis; Andreassen, Ole A.; Dale, Anders M.] Univ Oslo, Oslo Univ Hosp, Norwegian Ctr Mental Disorders Res NORMENT, Div Mental Hlth & Addict, Oslo, Norway; [van der Meer, Dennis; Andreassen, Ole A.; Dale, Anders M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [van der Meer, Dennis] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Dong, Weixiu; Wu, Yan; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Zou, Jingjing] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, Div Biostat, San Diego, CA 92103 USA; [Rosenthal, Sara B.] Univ Calif San Diego, Ctr Computat Biol & Bioinformat, San Diego, CA 92103 USA; [Kremen, William S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Kremen, William S.] Univ Calif San Diego, Ctr Behav Genet Aging, San Diego, CA 92103 USA; [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, San Diego, CA 92103 USA; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Yang, Jian] Westlake Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wu, Yan] Cellarity, Somerville, MA USA	University of California System; University of California San Diego; University of Oslo; University of Oslo; Maastricht University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Queensland; Westlake University	Chen, CH (corresponding author), Univ Calif San Diego, Ctr Multimodal Imaging & Genet, San Diego, CA 92103 USA.	chc101@ucsd.edu	Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020; Wang, Hao/AAE-4647-2022; Zhang, Kun/ABE-6349-2020	Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Wang, Hao/0000-0002-1518-9702; Zhang, Kun/0000-0002-7596-5224; Rosenthal, Sara Brin/0000-0002-6548-9658; van der Meer, Dennis/0000-0002-0466-386X; Wu, Yan/0000-0002-9702-330X; Dong, Weixiu/0000-0003-1059-5653; Zou, Jingjing/0000-0002-4749-105X; Fan, Chun Chieh/0000-0001-9437-2128; Makowski, Carolina/0000-0002-8816-4549; Liu, Cin/0000-0002-9178-1433	NIH [R01MH118281, R56AG061163, R01MH122688, R01AG050595, R01AG022381]; Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQS); Kavli Institute for Brain and Mind (KIBM); National Health and Medical Research Council [1113400]; Australian Research Council [FT180100186, FL180100072]; Westlake Education Foundation; Research Council of Norway [276082, 283798, 273291, 248778, 223273]; KG Jebsen Stiftelsen	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); Kavli Institute for Brain and Mind (KIBM); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Westlake Education Foundation; Research Council of Norway(Research Council of Norway); KG Jebsen Stiftelsen	This research was supported by the NIH under grants R01MH118281, R56AG061163, R01MH122688, R01AG050595, and R01AG022381. C.M. is supported by the Canadian Institutes of Health Research (CIHR), Fonds de Recherche du Quebec-Sante (FRQS), and the Kavli Institute for Brain and Mind (KIBM). P.M.V. and J.Y. acknowledge funding from the National Health and Medical Research Council (1113400) and the Australian Research Council (FT180100186 and FL180100072). J.Y. is supported by the Westlake Education Foundation. D.v.d.M. is supported by the Research Council of Norway (project 276082). O.A.A. is funded by the Research Council of Norway (283798, 273291, 248778, and 223273) and KG Jebsen Stiftelsen.	Abou-Khalil B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07524-z; Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Adolescent Brain Cognitive Development Study (ABCD), 2021, 2 0 1 REL 721, DOI [10.15154/1504041, DOI 10.15154/1504041.10.15154/1504041]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Arnold PD, 2018, MOL PSYCHIATR, V23, P1181, DOI 10.1038/mp.2017.154; Bakken TE, 2021, NATURE, V598, P111, DOI 10.1038/s41586-021-03465-8; Baurley JW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2495-7; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CH, 2013, P NATL ACAD SCI USA, V110, P17089, DOI 10.1073/pnas.1308091110; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen CH, 2011, NEURON, V72, P537, DOI 10.1016/j.neuron.2011.08.021; CHEN JA, 2018, MOL NEURODEGENER, V13, DOI DOI 10.1186/S40035-018-0118-8MEDLINE; Chen S, 2019, NAT BIOTECHNOL, V37, P1452, DOI 10.1038/s41587-019-0290-0; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Couvy-Duchesne B, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0153-17.2017; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Jong S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-458; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Fan CC, 2018, HUM MOL GENET, V27, pR22, DOI 10.1093/hmg/ddy082; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Giusti-Rodriguez P., 2019, BIORXIV, V18, P406330, DOI 10.1101/406330; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gogarten SM, 2019, BIOINFORMATICS, V35, P5346, DOI 10.1093/bioinformatics/btz567; Gokhman D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15020-6; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Grasby KL, 2020, SCIENCE, V367, P1340, DOI 10.1126/science.aay6690; Grotzinger AD, 2019, NAT HUM BEHAV, V3, P513, DOI 10.1038/s41562-019-0566-x; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Hagler DJ, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116091; Harrison-Uy SJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008094; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hujoel MLA, 2019, AM J HUM GENET, V104, P611, DOI 10.1016/j.ajhg.2019.02.008; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jiang LD, 2019, NAT GENET, V51, P1749, DOI 10.1038/s41588-019-0530-8; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kremen WS, 2013, TWIN RES HUM GENET, V16, P399, DOI 10.1017/thg.2012.86; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwon TJ, 2014, HUM MOL GENET, V23, P1591, DOI 10.1093/hmg/ddt549; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Matoba N, 2022, HUM BRAIN MAPP, V43, P329, DOI 10.1002/hbm.25257; Michel M, 2012, DEV NEUROBIOL, V72, P1277, DOI 10.1002/dneu.22044; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Minniti AN, 2015, ANTIOXID REDOX SIGN, V22, P48, DOI 10.1089/ars.2013.5803; Molnar Z, 2019, J ANAT, V235, P432, DOI 10.1111/joa.13055; Mullins N, 2021, NAT GENET, V53, P817, DOI 10.1038/s41588-021-00857-4; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nievergelt CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12576-w; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Palamara PF, 2018, NAT GENET, V50, P1311, DOI 10.1038/s41588-018-0177-x; Peng Q, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006143; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04558-1; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rane P, 2015, HARVARD REV PSYCHIAT, V23, P223, DOI 10.1097/HRP.0000000000000072; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruiz-Arenas C, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008203; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Strang KH, 2019, LAB INVEST, V99, P912, DOI 10.1038/s41374-019-0197-x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; Uban KA, 2018, DEV COGN NEUROS-NETH, V32, P97, DOI 10.1016/j.dcn.2018.03.005; Ulirsch JC, 2019, NAT GENET, V51, P683, DOI 10.1038/s41588-019-0362-6; van der Meer D, 2020, CEREB CORTEX, V30, P5597, DOI 10.1093/cercor/bhaa146; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Volkow ND, 2018, DEV COGN NEUROS-NETH, V32, P4, DOI 10.1016/j.dcn.2017.10.002; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Watson HJ, 2019, NAT GENET, V51, P1207, DOI 10.1038/s41588-019-0439-2; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yu DM, 2019, AM J PSYCHIAT, V176, P217, DOI 10.1176/appi.ajp.2018.18070857; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zeng J, 2018, NAT GENET, V50, P746, DOI 10.1038/s41588-018-0101-4; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	117	3	3	5	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					522	+		10.1126/science.abe8457	http://dx.doi.org/10.1126/science.abe8457			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113692	Green Accepted			2022-12-28	WOS:000753965100036
J	Palmer, PI; Marvin, MR; Siddans, R; Kerridge, BJ; Moore, DP				Palmer, Paul, I; Marvin, Margaret R.; Siddans, Richard; Kerridge, Brian J.; Moore, David P.			Nocturnal survival of isoprene linked to formation of upper tropospheric organic aerosol	SCIENCE			English	Article							AIRCRAFT OBSERVATIONS; PARTICLE FORMATION; REACTIVE UPTAKE; IEPOX-SOA; EMISSIONS; MODEL; EPOXYDIOL; FORMALDEHYDE; CHEMISTRY; MECHANISM	Isoprene is emitted mainly by terrestrial vegetation and is the dominant volatile organic compound (VOC) in Earth's atmosphere. It plays key roles in determining the oxidizing capacity of the troposphere and the formation of organic aerosol. Daytime infrared satellite observations of isoprene reported here broadly agree with emission inventories, but we found substantial differences in the locations and magnitudes of isoprene hotspots, consistent with a recent study. The corresponding nighttime infrared observations reveal unexpected hotspots over tropical South America, the Congo basin, and Southeast Asia. We used an atmospheric chemistry model to link these nighttime isoprene measurements to low-NOx regions with high biogenic VOC emissions: at sunrise the remaining isoprene can lead to the production of epoxydiols and subsequently to the widespread seasonal production of organic aerosol in the tropical upper troposphere.	[Palmer, Paul, I; Marvin, Margaret R.] Univ Edinburgh, Natl Ctr Earth Observat, Edinburgh, Midlothian, Scotland; [Palmer, Paul, I; Marvin, Margaret R.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Siddans, Richard; Kerridge, Brian J.] STFC Rutherford Appleton Lab, Natl Ctr Earth Observat, Chilton, England; [Siddans, Richard; Kerridge, Brian J.] STFC Rutherford Appleton Lab, Remote Sensing Grp, Chilton, England; [Moore, David P.] Univ Leicester, Natl Ctr Earth Observat, Leicester, Leics, England; [Moore, David P.] Univ Leicester, Sch Phys & Astron, Leicester, Leics, England	University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Leicester; University of Leicester	Palmer, PI (corresponding author), Univ Edinburgh, Natl Ctr Earth Observat, Edinburgh, Midlothian, Scotland.; Palmer, PI (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland.	paul.plamer@ed.ac.uk		Marvin, Margaret/0000-0001-8799-3532	UK National Centre for Earth Observation - National Environment Research Council [NE/R016518/1, NE/R000115/1]	UK National Centre for Earth Observation - National Environment Research Council	All authors acknowledge support from the UK National Centre for Earth Observation funded by the National Environment Research Council (NE/R016518/1 and NE/R000115/1).	Allan JD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002358; Andreae MO, 2018, ATMOS CHEM PHYS, V18, P921, DOI 10.5194/acp-18-921-2018; Apel E., 2019, ATOM L2 VOLATILE ORG; Arneth A, 2011, ATMOS CHEM PHYS, V11, P8037, DOI 10.5194/acp-11-8037-2011; Barkley MP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015893; Barkley MP, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2008JD009863, 10.1029/2008JD01576]; Barkley MP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036843; Bates KH, 2019, ATMOS CHEM PHYS, V19, P9613, DOI 10.5194/acp-19-9613-2019; Bates KH, 2014, J PHYS CHEM A, V118, P1237, DOI 10.1021/jp4107958; Brauer CS, 2014, ATMOS MEAS TECH, V7, P3839, DOI 10.5194/amt-7-3839-2014; Canagaratna MR, 2015, ATMOS CHEM PHYS, V15, P253, DOI 10.5194/acp-15-253-2015; Cecil J, 2006, LIS OTD 0 5 DEGREE H; Cuisset A, 2016, J QUANT SPECTROSC RA, V179, P51, DOI 10.1016/j.jqsrt.2016.03.020; Curci G, 2010, ATMOS CHEM PHYS, V10, P11501, DOI 10.5194/acp-10-11501-2010; D'Ambro EL, 2019, ATMOS CHEM PHYS, V19, P11253, DOI 10.5194/acp-19-11253-2019; Dreyfus GB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001490; Dudhia A, 2017, J QUANT SPECTROSC RA, V186, P243, DOI 10.1016/j.jqsrt.2016.06.018; Eastham SD, 2014, ATMOS ENVIRON, V89, P52, DOI 10.1016/j.atmosenv.2014.02.001; Fisher JA, 2016, ATMOS CHEM PHYS, V16, P5969, DOI 10.5194/acp-16-5969-2016; Fu DJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11835-0; Fu TM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007853; Gaston CJ, 2014, ENVIRON SCI TECHNOL, V48, P11178, DOI 10.1021/es5034266; Gordon IE, 2017, J QUANT SPECTROSC RA, V203, P3, DOI 10.1016/j.jqsrt.2017.06.038; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; Heald CL, 2011, ATMOS CHEM PHYS, V11, P12673, DOI 10.5194/acp-11-12673-2011; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Jacob DJ, 2000, ATMOS ENVIRON, V34, P2131, DOI 10.1016/S1352-2310(99)00462-8; Jimenez J.L, 2020, ATMOS MEAS TECH, V2020, P1; Jo DS, 2021, ATMOS CHEM PHYS, V21, P3395, DOI 10.5194/acp-21-3395-2021; Kupc A, 2020, ATMOS CHEM PHYS, V20, P15037, DOI 10.5194/acp-20-15037-2020; Lee L, 2014, J PHYS CHEM A, V118, P1622, DOI 10.1021/jp4107603; Liu YJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2547; Machado LAT, 2018, ATMOS CHEM PHYS, V18, P6461, DOI 10.5194/acp-18-6461-2018; Marais EA, 2016, ATMOS CHEM PHYS, V16, P1603, DOI 10.5194/acp-16-1603-2016; Martin ST, 2016, ATMOS CHEM PHYS, V16, P4785, DOI 10.5194/acp-16-4785-2016; Miller CC, 2017, ATMOS CHEM PHYS, V17, P8725, DOI 10.5194/acp-17-8725-2017; Millet DB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008950; Muller JF, 2014, ATMOS CHEM PHYS, V14, P2497, DOI 10.5194/acp-14-2497-2014; Murray LT, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017934; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Ott LE, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD011880; Otter LB, 2002, ATMOS ENVIRON, V36, P4265, DOI 10.1016/S1352-2310(02)00333-3; Pai SJ, 2020, ATMOS CHEM PHYS, V20, P2637, DOI 10.5194/acp-20-2637-2020; Palmer PI, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006689; Palmer PI, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002153; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Pegoraro E, 2006, GLOBAL CHANGE BIOL, V12, P456, DOI 10.1111/j.1365-2486.2006.01112.x; Pye HOT, 2010, ATMOS CHEM PHYS, V10, P11261, DOI 10.5194/acp-10-11261-2010; Pye HOT, 2020, ATMOS CHEM PHYS, V20, P4809, DOI 10.5194/acp-20-4809-2020; Remedios JJ, 2007, ATMOS CHEM PHYS, V7, P1599, DOI 10.5194/acp-7-1599-2007; Rodgers C.D., 2000, INVERSE METHODS ATMO, VVolume 2, DOI DOI 10.1142/3171; Saunders R., 2017, RTTOV 12 SCI VALIDAT; Schulz C, 2018, ATMOS CHEM PHYS, V18, P14979, DOI 10.5194/acp-18-14979-2018; Seemann SW, 2008, J APPL METEOROL CLIM, V47, P108, DOI 10.1175/2007JAMC1590.1; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Shilling JE, 2018, ATMOS CHEM PHYS, V18, P10773, DOI 10.5194/acp-18-10773-2018; Siddans R., 2015, OPTIMAL ESTIMATION M; Siddans R., 2021, RAL EXTENDED INFRARE; Siddans R, 2018, RAL INFRARED MICROWA; Simpson CD, 2005, ENVIRON SCI TECHNOL, V39, P631, DOI 10.1021/es0486871; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P12109, DOI 10.5194/acp-11-12109-2011; Stavrakou T, 2014, ATMOS CHEM PHYS, V14, P4587, DOI 10.5194/acp-14-4587-2014; Surl L, 2018, ATMOS CHEM PHYS, V18, P4549, DOI 10.5194/acp-18-4549-2018; Surratt JD, 2010, P NATL ACAD SCI USA, V107, P6640, DOI 10.1073/pnas.0911114107; Travis KR, 2016, ATMOS CHEM PHYS, V16, P13561, DOI 10.5194/acp-16-13561-2016; Wells KC, 2020, NATURE, V585, P225, DOI 10.1038/s41586-020-2664-3; Wendisch M, 2016, B AM METEOROL SOC, V97, P1885, DOI 10.1175/BAMS-D-14-00255.1; Wiedinmyer C, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005800; Williamson CJ, 2019, NATURE, V574, P399, DOI 10.1038/s41586-019-1638-9; Wofsy S. C., 2018, ORNL DAAC, DOI 10.3334/ornldaac/1581; Xie Y, 2013, ATMOS CHEM PHYS, V13, P8439, DOI 10.5194/acp-13-8439-2013; Yee LD, 2013, ATMOS CHEM PHYS, V13, P8019, DOI 10.5194/acp-13-8019-2013; Zarzana KJ, 2012, ENVIRON SCI TECHNOL, V46, P4845, DOI 10.1021/es2040152; Zhang Y, 2018, ENVIRON SCI TECH LET, V5, P167, DOI 10.1021/acs.estlett.8b00044	75	7	7	20	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					562	+		10.1126/science.abg4506	http://dx.doi.org/10.1126/science.abg4506			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113698	Green Accepted			2022-12-28	WOS:000753965100043
J	Dance, A				Dance, Amber			CONSTRUCTIVE CRITICISM	NATURE			English	Editorial Material						Careers; Peer review; Authorship	REVIEWERS; QUALITY											Black N, 1998, JAMA-J AM MED ASSOC, V280, P231, DOI 10.1001/jama.280.3.231; EVANS AT, 1993, J GEN INTERN MED, V8, P422, DOI 10.1007/BF02599618; Helmer M, 2017, ELIFE, V6, DOI 10.7554/eLife.21718; Kliewer MA, 2005, AM J ROENTGENOL, V184, P1731, DOI 10.2214/ajr.184.6.01841731; Kovanis M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166387; McDowell GS, 2019, ELIFE, V8, DOI 10.7554/eLife.48425; Murray D., 2018, BIORXIV, DOI [10.1101/400515, DOI 10.1101/400515]; Publons  Scholarone  Clarivate Analytics, 2018, 2018 GLOB STAT PEER, DOI [10.14322/publons.GSPR2018, DOI 10.14322/PUBLONS.GSPR2018]; Silbiger NJ, 2019, PEERJ, V7, DOI 10.7717/peerj.8247; Squazzoni F, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd0299; Wolfram D, 2020, SCIENTOMETRICS, V125, P1033, DOI 10.1007/s11192-020-03488-4	11	1	1	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					169	171						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS2HG	35102332				2022-12-28	WOS:000750503100001
J	Hochheiser, IV; Pilsl, M; Hagelueken, G; Moecking, J; Marleaux, M; Brinkschulte, R; Latz, E; Engel, C; Geyer, M				Hochheiser, Inga, V; Pilsl, Michael; Hagelueken, Gregor; Moecking, Jonas; Marleaux, Michael; Brinkschulte, Rebecca; Latz, Eicke; Engel, Christoph; Geyer, Matthias			Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3	NATURE			English	Article							CRYSTAL-STRUCTURE; INFLAMMASOME; ACTIVATION; NEK7; REVEALS	NLRP3 is an intracellular sensor protein that when activated by a broad spectrum of exogenous and endogenous stimuli leads to inflammasome formation and pyroptosis(1,2). The conformational states of NLRP3 and the way antagonistic small molecules act at the molecular level remain poorly understood(2,3). Here we report the cryo-electron microscopy structures of full-length human NLRP3 in its native form and complexed with the inhibitor CRID3 (also named MCC950)(4). Inactive, ADP-bound NLRP3 is a decamer composed of homodimers of intertwined leucine-rich repeat (LRR) domains that assemble back-to-back as pentamers. The NACHT domain is located at the apical axis of this spherical structure. One pyrin domain dimer is in addition formed inside the LRR cage. Molecular contacts between the concave sites of two opposing LRR domains are mediated by an acidic loop that extends from an LRR transition segment. Binding of CRID3 considerably stabilizes the NACHT and LRR domains relative to each other. CRID3 binds into a cleft, connecting four subdomains of the NACHT with the transition LRR. Its central sulfonylurea group interacts with the Walker A motif of the NLRP3 nucleotide-binding domain and is sandwiched between two arginine residues, which explains the specificity of NLRP3 for this chemical entity. With the determination of the binding site of this key therapeutic agent, specific targeting of NLRP3 for the treatment of autoinflammatory and autoimmune diseases and rational drug optimization is within reach.	[Hochheiser, Inga, V; Hagelueken, Gregor; Moecking, Jonas; Marleaux, Michael; Brinkschulte, Rebecca; Geyer, Matthias] Univ Bonn, Inst Struct Biol, Bonn, Germany; [Pilsl, Michael; Engel, Christoph] Univ Regensburg, Regensburg Ctr Biochem, Struct Biochem Grp, Regensburg, Germany; [Latz, Eicke] Univ Bonn, Inst Innate Immun, Bonn, Germany	University of Bonn; University of Regensburg; University of Bonn	Geyer, M (corresponding author), Univ Bonn, Inst Struct Biol, Bonn, Germany.	matthias.geyer@uni-bonn.de		Pilsl, Michael/0000-0002-5993-4735; Engel, Christoph/0000-0001-8451-3599; Geyer, Matthias/0000-0002-7718-5002; Moecking, Jonas/0000-0001-5914-1359	iNEXT [PID 11967]; INSTRUCT [PID 11340]; Emmy Noether Programme (DFG) [EN 1204/1-1, SFB 960 (TP-A8)]; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [EXC2151-390873048]	iNEXT; INSTRUCT; Emmy Noether Programme (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG))	Access to cryo-EM time was supported by iNEXT-Discovery grant PID 11967 for the NLRP3-CRID3 sample and INSTRUCT grant PID 11340 for the NLRP3 apo sample. We thank W. Hagen, F. Weis and A. Durand for cryo-EM data recordings; H. Stark for initial advice on electron microscopy sample preparation; and A. Steiner for instructions on cell assays. C.E. thanks B. Bottcher for facility access, R. Witzgall for JEM2100F access, G. Meister for shared infrastructure, G. Lehmann and N. Eichner for IT support and all members of the Structural Biochemistry Group of the Regensburg Center for Biochemistry for help and support. C.E. and M.P. acknowledge funding by the Emmy Noether Programme (DFG grant EN 1204/1-1 to C.E.) and SFB 960 (TP-A8 to C.E.). M.G. and E.L. are funded by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy-EXC2151-390873048.	Andersson A, 2019, ENVIRON SCI-WAT RES, V5, P861, DOI 10.1039/c9ew00034h; Andreeva L, 2012, BIORXIV2021459968200, V2021; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Corcoran SE, 2021, PHARMACOL REV, V73, P968, DOI 10.1124/pharmrev.120.000171; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Dekker C, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167309; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Green JP, 2018, P NATL ACAD SCI USA, V115, pE9371, DOI 10.1073/pnas.1812744115; Hafner-Bratkovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07573-4; Harrison D, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127560; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hochheiser, 2021, STRUCTURE NLRP3 DECA, DOI [DOI 10.1016/j.jmb.2007.05.022, 10.1101/2021.07.22.453353, DOI 10.1101/2021.07.22.453353]; Hochheiser IV., 2022, SCI ADV, V8, peabn7583, DOI DOI 10.1101/2021.11.25.470035; Hoss F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11076-1; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Keuler T, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.642273; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kofoed Eric M, 2013, Methods Mol Biol, V1040, P169, DOI 10.1007/978-1-62703-523-1_13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Park K, 2015, NAT STRUCT MOL BIOL, V22, P167, DOI 10.1038/nsmb.2938; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Primiano MJ, 2016, J IMMUNOL, V197, P2421, DOI 10.4049/jimmunol.1600035; Prisant MG, 2020, PROTEIN SCI, V29, P315, DOI 10.1002/pro.3786; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwaid AG, 2021, J MED CHEM, V64, P101, DOI 10.1021/acs.jmedchem.0c01307; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Sharif H, 2019, NATURE, V570, P338, DOI 10.1038/s41586-019-1295-z; Shi H., 2015, NUTR CANC, V1, P10, DOI DOI 10.1038/NI.3333; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Vande Walle L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000354; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	50	24	24	25	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					184	+		10.1038/s41586-022-04467-w	http://dx.doi.org/10.1038/s41586-022-04467-w		FEB 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35114687	Green Submitted			2022-12-28	WOS:000772363000001
J	Mallapaty, S				Mallapaty, Smriti			THE HUNT FOR THE ORIGINS OF OMICRON	NATURE			English	Editorial Material						SARS-CoV-2; Evolution; Genetics; Virology												Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Wei CS, 2021, J GENET GENOMICS, V48, P1111, DOI 10.1016/j.jgg.2021.12.003	3	27	29	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					26	28						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YO9LH	35091701				2022-12-28	WOS:000748252800001
J	Colivicchi, F				Colivicchi, Furio			In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Colivicchi, Furio] San Filippo Neri Hosp, Rome, Italy	San Filippo Neri Hospital	Colivicchi, F (corresponding author), San Filippo Neri Hosp, Rome, Italy.							Aisenberg J, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003998; Capodanno D, 2021, JACC-CARDIOVASC INTE, V14, P1688, DOI 10.1016/j.jcin.2021.06.020; Collet JP, 2021, AM COLL CARD VIRT AN; Dangas GD, 2020, NEW ENGL J MED, V382, P120, DOI 10.1056/NEJMoa1911425; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; ten Berg J, 2021, EUR HEART J, V42, P2265, DOI 10.1093/eurheartj/ehab196	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC22	JC22		10.7326/J21-0014	http://dx.doi.org/10.7326/J21-0014		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099999				2022-12-28	WOS:000750879200001
J	Huggins, GS; Kinnamon, DD; Haas, GJ; Jordan, E; Hofmeyer, M; Kransdorf, E; Ewald, GA; Morris, AA; Owens, A; Lowes, B; Stoller, D; Tang, WHW; Garg, S; Trachtenberg, BH; Shah, P; Pamboukian, SV; Sweitzer, NK; Wheeler, MT; Wilcox, JE; Katz, S; Pan, S; Jimenez, J; Aaronson, KD; Fishbein, DP; Smart, F; Wang, J; Gottlieb, SS; Judge, DP; Moore, CK; Mead, JO; Ni, HY; Burke, W; Hershberger, RE				Huggins, Gordon S.; Kinnamon, Daniel D.; Haas, Garrie J.; Jordan, Elizabeth; Hofmeyer, Mark; Kransdorf, Evan; Ewald, Gregory A.; Morris, Alanna A.; Owens, Anjali; Lowes, Brian; Stoller, Douglas; Tang, W. H. Wilson; Garg, Sonia; Trachtenberg, Barry H.; Shah, Palak; Pamboukian, Salpy, V; Sweitzer, Nancy K.; Wheeler, Matthew T.; Wilcox, Jane E.; Katz, Stuart; Pan, Stephen; Jimenez, Javier; Aaronson, Keith D.; Fishbein, Daniel P.; Smart, Frank; Wang, Jessica; Gottlieb, Stephen S.; Judge, Daniel P.; Moore, Charles K.; Mead, Jonathan O.; Ni, Hanyu; Burke, Wylie; Hershberger, Ray E.		DCM Consortium	Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; SCIENTIFIC STATEMENT; RACIAL-DIFFERENCES; SURVIVAL	IMPORTANCE Idiopathic dilated cardiomyopathy (DCM) aggregates in families, and early detection in at-risk family members can provide opportunity to initiate treatment prior to late-phase disease. Most studies have included only White patients, yet Black patients with DCM have higher risk of heart failure-related hospitalization and death. OBJECTIVE To estimate the prevalence of familial DCM among DCM probands and the age-specific cumulative risk of DCM in first-degree relatives across race and ethnicity groups. DESIGN, SETTING, AND PARTICIPANTS A family-based, cross-sectional study conducted by a multisite consortium of 25 US heart failure programs. Participants included patients with DCM (probands), defined as left ventricular systolic dysfunction and left ventricular enlargement after excluding usual clinical causes, and their first-degree relatives. Enrollment commenced June 7, 2016; proband and family member enrollment concluded March 15, 2020, and April 1, 2021, respectively. EXPOSURES The presence of DCM in a proband. MAIN OUTCOMES AND MEASURES Familial DCM defined by DCM in at least 1 first-degree relative; expanded familial DCM defined by the presence of DCM or either left ventricular enlargement or left ventricular systolic dysfunction without known cause in at least 1 first-degree relative. RESULTS The study enrolled 1220 probands (median age, 52.8 years [IQR, 42.4-61.8]; 43.8% female; 43.1% Black and 8.3% Hispanic) and screened 1693 first-degree relatives for DCM. A median of 28% (IQR, 0%-60%) of living first-degree relatives were screened per family. The crude prevalence of familial DCM among probands was 11.6% overall. The model-based estimate of the prevalence of familial DCM among probands at a typical US advanced heart failure program if all living first-degree relatives were screened was 29.7% (95% CI, 23.5% to 36.0%) overall. The estimated prevalence of familial DCM was higher in Black probands than in White probands (difference, 11.3% [95% CI, 1.9% to 20.8%]) but did not differ significantly between Hispanic probands and non-Hispanic probands (difference. -1.4% [95% Cl. -15.9% to 13.1%]). The estimated prevalence of expanded familial DCM was 56.9% (95% CI, 50.8% to 63.0%) overall. Based on age-specific disease status at enrollment, estimated cumulative risks in first-degree relatives at a typical US advanced heart failure program reached 19% (95% Cl, 13% to 24%) by age 80 years for DCM and 33% (95% CI, 27% to 40%) for expanded DCM inclusive of partial phenotypes. The DCM hazard was higher in first-degree relatives of non-Hispanic Black probands than non-Hispanic White probands (hazard ratio, 1.89 [95% CI, 1.26 to 2.83]). CONCLUSIONS AND RELEVANCE In a US cross-sectional study, there was substantial estimated prevalence of familial DCM among probands and modeled cumulative risk of DCM among their first-degree relatives.	[Huggins, Gordon S.] Tufts Med Ctr, Cardiol Div, Boston, MA USA; [Huggins, Gordon S.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Kinnamon, Daniel D.; Jordan, Elizabeth; Mead, Jonathan O.; Ni, Hanyu; Hershberger, Ray E.] Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH USA; [Kinnamon, Daniel D.; Haas, Garrie J.; Jordan, Elizabeth; Mead, Jonathan O.; Ni, Hanyu; Hershberger, Ray E.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH USA; [Haas, Garrie J.; Hershberger, Ray E.] Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Columbus, OH USA; [Hofmeyer, Mark] Washington Hosp Ctr, Medstar Res Inst, Washington, DC USA; [Kransdorf, Evan] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA USA; [Ewald, Gregory A.] Washington Univ, St Louis, MO 63110 USA; [Morris, Alanna A.] Emory Univ, Sch Med, Atlanta, GA USA; [Owens, Anjali] Univ Penn, Ctr Inherited Cardiovasc Dis, Perelman Sch Med, Div Cardiol, Philadelphia, PA USA; [Lowes, Brian; Stoller, Douglas] Univ Nebraska Med Ctr, Omaha, NE USA; [Tang, W. H. Wilson] Cleveland Clin, Cleveland, OH 44106 USA; [Garg, Sonia] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Trachtenberg, Barry H.] Houston Methodist DeBakey Heart & Vasc Ctr, JC Walter Jr Transplant Ctr, Houston, TX USA; [Shah, Palak] Inova Heart & Vasc Inst, Falls Church, VA USA; [Pamboukian, Salpy, V] Univ Alabama Birmingham, Birmingham, AL USA; [Sweitzer, Nancy K.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Wheeler, Matthew T.] Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA USA; [Wilcox, Jane E.] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA; [Katz, Stuart] NYU Langone Med Ctr, New York, NY USA; [Pan, Stephen] Westchester Med Ctr, Dept Cardiol, Valhalla, NY USA; [Pan, Stephen] New York Med Coll, Valhalla, NY 10595 USA; [Jimenez, Javier] Miami Cardiac & Vasc Inst, Baptist Hlth South, Miami, FL USA; [Aaronson, Keith D.] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Fishbein, Daniel P.] Univ Washington, Seattle, WA 98195 USA; [Smart, Frank] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Wang, Jessica] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; [Gottlieb, Stephen S.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Judge, Daniel P.] Med Univ South Carolina, Charleston, SC 29425 USA; [Moore, Charles K.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA USA	Tufts Medical Center; Tufts University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; MedStar Washington Hospital Center; Cedars Sinai Medical Center; Washington University (WUSTL); Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Nebraska System; University of Nebraska Medical Center; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Inova Fairfax Hospital; University of Alabama System; University of Alabama Birmingham; University of Arizona; Stanford University; Northwestern University; Feinberg School of Medicine; NYU Langone Medical Center; Westchester Medical Center; New York Medical College; Baptist Cardiac & Vascular Institute; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University System of Maryland; University of Maryland Baltimore; Medical University of South Carolina; University of Mississippi; University of Mississippi Medical Center; University of Washington; University of Washington Seattle	Hershberger, RE (corresponding author), Ohio State Univ, Wexner Med Ctr, 460 12th Ave,Biomed Res Tower Room 304, Columbus, OH 43210 USA.	Ray.Hershberger@osumc.edu	Kinnamon, Daniel D./J-4207-2013; Lowes, Brian/M-9020-2017	Kinnamon, Daniel D./0000-0002-0867-5227; Shah, Palak/0000-0001-8175-168X; Lowes, Brian/0000-0002-5919-2540; Hofmeyer, Mark/0000-0001-9339-5889	NHLBI of the NIH [R01HL128857]; National Human Genome Research Institute	NHLBI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research reported in this publication was supported by a parent award from the NHLBI of the NIH under award No. R01HL128857 to Dr Hershberger, which included a supplement from the National Human Genome Research Institute.	Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Bozkurt B, 2016, CIRCULATION, V134, pE579, DOI 10.1161/CIR.0000000000000455; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Devereux RB, 2001, HYPERTENSION, V38, P417, DOI 10.1161/01.HYP.38.3.417; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Falconieri N, 2020, BIOMETRICAL J, V62, P932, DOI 10.1002/bimj.201900075; Hershberger RE, 2021, CIRC RES, V128, P1514, DOI 10.1161/CIRCRESAHA.121.318157; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Husaini BA, 2011, CIRC-HEART FAIL, V4, P161, DOI 10.1161/CIRCHEARTFAILURE.110.958306; Jewell NP., 2002, UC BERKELEY DIVISION; Kinnamon DD, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001826; Lawless J., 2011, STAT MODELS METHODS, V2nd; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Molenberghs G., 2005, MODELS DISCRETE LONG; Musunuru K, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/HCG.0000000000000067; Nayak A, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.120.007264; Petretta M, 2011, AM J CARDIOL, V108, P1171, DOI 10.1016/j.amjcard.2011.06.022; Smirnoff M, 2018, AJOB Empir Bioeth, V9, P39, DOI 10.1080/23294515.2018.1432718; Stroup W.W., 2012, GEN LINEAR MIXED MOD; US Census Bureau, 2020, ANN EST RES POP SEX; van der Vaart A.W., 1998, ASYMPTOTIC STAT, pxvi+443; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 1997, CIRCULATION, V96, P1863, DOI 10.1161/01.CIR.96.6.1863; Vonesh EF, 2012, GEN LINEAR NONLINEAR; Wynants L, 2018, STAT METHODS MED RES, V27, P1723, DOI 10.1177/0962280216668555; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	32	11	11	3	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					454	463		10.1001/jama.2021.24674	http://dx.doi.org/10.1001/jama.2021.24674			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103767	Green Published			2022-12-28	WOS:000753056200018
J	Wykoff, CC; Abreu, F; Adamis, AP; Basu, K; Eichenbaum, DA; Haskova, Z; Lin, H; Loewenstein, A; Mohan, S; Pearce, IA; Sakamoto, T; Schlottmann, PG; Silverman, D; Sun, JK; Wells, JA; Willis, JR; Tadayoni, R				Wykoff, Charles C.; Abreu, Francis; Adamis, Anthony P.; Basu, Karen; Eichenbaum, David A.; Haskova, Zdenka; Lin, Hugh; Loewenstein, Anat; Mohan, Shaun; Pearce, Ian A.; Sakamoto, Taiji; Schlottmann, Patricio G.; Silverman, David; Sun, Jennifer K.; Wells, John A.; Willis, Jeffrey R.; Tadayoni, Ramin		YOSEMITE Investigators; RHINE Investigators	Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials	LANCET			English	Article							RANIBIZUMAB; AFLIBERCEPT; OUTCOMES; BEVACIZUMAB; DISEASES	Background To reduce treatment burden and optimise patient outcomes in diabetic macular oedema, we present 1-year results from two phase 3 trials of faricimab, a novel angiopoietin-2 and vascular endothelial growth factor-A bispecific antibody. Methods YOSEMITE and RHINE were randomised, double-masked, non-inferiority trials across 353 sites worldwide. Adults with vision loss due to centre-involving diabetic macular oedema were randomly assigned (1:1:1) to intravitreal faricimab 6.0 mg every 8 weeks, faricimab 6.0 mg per personalised treatment interval (PTI), or aflibercept 2.0 mg every 8 weeks up to week 100. PTI dosing intervals were extended, maintained, or reduced (every 4 weeks up to every 16 weeks) based on disease activity at active dosing visits. The primary endpoint was mean change in best-corrected visual acuity at 1 year, averaged over weeks 48, 52, and 56. Efficacy analyses included the intention-to-treat population (non-inferiority margin 4 Early Treatment Diabetic Retinopathy Study [ETDRS] letters); safety analyses included patients with at least one dose of study treatment. These trials are registered with ClinicalTrials.gov (YOSEMITE NCT03622580 and RHINE NCT03622593). Findings 3247 patients were screened for eligibility in YOSEMITE (n=1532) and RHINE (n=1715). After exclusions, 940 patients were enrolled into YOSEMITE between Sept 5, 2018, and Sept 19, 2019, and 951 patients were enrolled into RHINE between Oct 9, 2018, and Sept 20, 2019. These 1891 patients were randomly assigned to faricimab every 8 weeks (YOSEMITE n=315, RHINE n=317), faricimab PTI (n=313, n=319), or aflibercept every 8 weeks (n=312, n=315). Non-inferiority for the primary endpoint was achieved with faricimab every 8 weeks (adjusted mean vs aflibercept every 8 weeks in YOSEMITE 10.7 ETDRS letters [97.52% CI 9.4 to 12.0] vs 10.9 ETDRS letters [9.6 to 12.2], difference 0.2 ETDRS letters [-2.0 to 1.6]; RHINE 11.8 ETDRS letters [10.6 to 13.0] vs 10.3 ET DRS letters [9.1 to 11.4] letters, difference 1.5 ETDRS letters [-0.1 to 3.2]) and faricimab PTI (YOSEMITE 11.6 ETDRS letters [10.3 to 12.9], difference 0.7 IETDRS letters [-1.1 to 2.5]; RHINE 10.8 ETDRS letters [9.6 to 11.9], difference 0.5 ETDRS letters [-1.1 to 2.1]). Incidence of ocular adverse events was comparable between faricimab every 8 weeks (YOSEMITE n=98 [31%], RHINE n=137 [43%]), faricimab PTI (n=106 [34%], n=119 [37%]), and aflibercept every 8 weeks (n=102 [33%], n=113 [36%]). Interpretation Robust vision gains and anatomical improvements with faricimab were achieved with adjustable dosing up to every 16 weeks, demonstrating the potential for faricimab to extend the durability of treatment for patients with diabetic macular oedema. Copyright 2022 Published by Elsevier Ltd. All rights reserved.	[Wykoff, Charles C.] Houston Methodist Hosp, Retina Consultants Texas, Retina Consultants Amer, Blanton Eye Inst, Houston, TX 77401 USA; [Abreu, Francis; Adamis, Anthony P.; Haskova, Zdenka; Lin, Hugh; Mohan, Shaun; Willis, Jeffrey R.] Genentech Inc, San Francisco, CA USA; [Basu, Karen] Roche Prod Ireland, Dublin, Ireland; [Eichenbaum, David A.] Retina Vitreous Associates Florida, St Petersburg, FL USA; [Eichenbaum, David A.] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA; [Loewenstein, Anat] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel; [Loewenstein, Anat] Tel Aviv Univ, Tel Aviv, Israel; [Pearce, Ian A.] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Sakamoto, Taiji] Kagoshima Univ, Dept Ophthalmol, Kagoshima, Japan; [Schlottmann, Patricio G.] Org Mad Invest, Buenos Aires, DF, Argentina; [Silverman, David] Roche Prod, Welwyn Garden City, Herts, England; [Sun, Jennifer K.] Harvard Dept Ophthalmol, Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA USA; [Wells, John A.] Retina Consultants Amer, Palmetto Retina Ctr, Columbia, SC USA; [Tadayoni, Ramin] Univ Paris, Lariboisiere, AP HP, Paris, France; [Tadayoni, Ramin] Fdn Adolphe Rothschild Hosp, Paris, France	The Methodist Hospital System; The Methodist Hospital - Houston; Roche Holding; Genentech; State University System of Florida; University of South Florida; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Kagoshima University; Roche Holding; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Fondation Adolphe de Rothschild	Wykoff, CC (corresponding author), Houston Methodist Hosp, Retina Consultants Texas, Retina Consultants Amer, Blanton Eye Inst, Houston, TX 77401 USA.	charleswykoff@gmail.com	Sun, Jennifer K/AAP-2734-2020; Sikorski, Bartosz L/AHD-2057-2022; Cagini, Carlo/H-3431-2019; Virgili, Gianni/P-6607-2014	Sun, Jennifer K/0000-0003-0915-6303; Sikorski, Bartosz L/0000-0001-5357-9560; Cagini, Carlo/0000-0002-3812-9219; Figueira, Joao P/0000-0002-3511-1515; Chang, Jonathan/0000-0001-5693-5065; Silverman, David/0000-0003-1842-5739; Virgili, Gianni/0000-0002-9960-2989; Lai, Chi-Chun/0000-0001-9547-7212; Talks, James/0000-0001-6126-6476; Burton, Ben/0000-0001-9579-9078; Adrean, Sean/0000-0001-6004-0643	F Hoffmann-La Roche (Basel, Switzerland); F Hoffmann-La Roche	F Hoffmann-La Roche (Basel, Switzerland)(Hoffmann-La Roche); F Hoffmann-La Roche(Hoffmann-La Roche)	We sincerely thank the trial participants and their families, investigators, and staff at all YOSEMITE and RHINE clinical sites, and members of the independent data monitoring committee. We also thank Aaron Osborne for his contributions to the design of the YOSEMITE and RHINE trials. F Hoffmann-La Roche (Basel, Switzerland) provided support for the study and participated in the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication. Funding was provided by F Hoffmann-La Roche for third-party writing assistance, which was provided by Karina D Hamilton-Peel of Envision Pharma Group.	[Anonymous], 2018, LUC PACK INS; [Anonymous], 2021, EYL PACK INS; Ashraf M, 2016, BRIT J OPHTHALMOL, V100, P1596, DOI 10.1136/bjophthalmol-2016-308388; Bretz F, 2011, BIOMETRICAL J, V53, P894, DOI 10.1002/bimj.201000239; Brown DM, 2015, OPHTHALMOLOGY, V122, P2044, DOI 10.1016/j.ophtha.2015.06.017; Ciulla TA, 2021, BRIT J OPHTHALMOL, V105, P216, DOI 10.1136/bjophthalmol-2020-315933; Daruich A, 2018, PROG RETIN EYE RES, V63, P20, DOI 10.1016/j.preteyeres.2017.10.006; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Eter Nicole, 2022, Ophthalmol Sci, V2, P100111, DOI 10.1016/j.xops.2021.100111; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Freund KB, 2015, RETINA-J RET VIT DIS, V35, P1489, DOI 10.1097/IAE.0000000000000627; Funatsu H, 2003, OPHTHALMOLOGY, V110, P1690, DOI 10.1016/S0161-6420(03)00568-2; Funatsu H, 2009, OPHTHALMOLOGY, V116, P73, DOI 10.1016/j.ophtha.2008.09.037; Glassman AR, 2020, OPHTHALMOLOGY, V127, P1201, DOI 10.1016/j.ophtha.2020.03.021; Hahn P., 2020, ASRS 2020 PREFERENCE; Heier JS, 2021, RETINA-J RET VIT DIS, V41, P1, DOI 10.1097/IAE.0000000000003003; Joussen AM, 2021, EYE, V35, P1305, DOI 10.1038/s41433-020-01377-x; Kiss S, 2020, J MANAG CARE SPEC PH, V26, P253, DOI 10.18553/jmcp.2020.19245; Olsen TW, 2020, OPHTHALMOLOGY, V127, pP66, DOI 10.1016/j.ophtha.2019.09.025; Patel S.S., 2020, INVESTIG OPHTHALMOL, V61, P4286; Payne JF, 2019, AM J OPHTHALMOL, V202, P91, DOI 10.1016/j.ajo.2019.02.005; Prunte C, 2016, BRIT J OPHTHALMOL, V100, P787, DOI 10.1136/bjophthalmol-2015-307249; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Regula JT, 2016, EMBO MOL MED, V8, P1265, DOI 10.15252/emmm.201505889; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Sahni J, 2019, OPHTHALMOLOGY, V126, P1155, DOI 10.1016/j.ophtha.2019.03.023; Van Aken E, 2020, CLIN OPHTHALMOL, V14, P4173, DOI 10.2147/OPTH.S281501; Volkmann I, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01397-x; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264	29	22	22	12	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					741	755		10.1016/S0140-6736(22)00018-6	http://dx.doi.org/10.1016/S0140-6736(22)00018-6			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE3NS	35085503	Green Accepted			2022-12-28	WOS:000758794200021
J	Liu, JY; Chandrashekar, A; Sellers, D; Barrett, J; Jacob-Dolan, C; Lifton, M; McMahan, K; Sciacca, M; VanWyk, H; Wu, C; Yu, JY; Collier, ARY; Barouch, DH				Liu, Jinyan; Chandrashekar, Abishek; Sellers, Daniel; Barrett, Julia; Jacob-Dolan, Catherine; Lifton, Michelle; McMahan, Katherine; Sciacca, Michaela; VanWyk, Haley; Wu, Cindy; Yu, Jingyou; Collier, Ai-ris Y.; Barouch, Dan H.			Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron	NATURE			English	Article								The highly mutated SARS-CoV-2 Omicron (B.1.1.529) variant has been shown to evade a substantial fraction of neutralizing antibody responses elicited by current vaccines that encode the WA1/2020 spike protein(1). Cellular immune responses, particularly CD8(+)T cell responses, probably contribute to protection against severe SARS-CoV-2 infection(2-6). Here we showthat cellular immunity induced by current vaccines against SARS-CoV-2 is highly conserved to the SARS-CoV-2 Omicron spike protein. Individuals who received the Ad26.COV2.S or BNT162b2 vaccines demonstrated durable spike-specific CD8(+) and CD4(+)T cell responses, which showed extensive cross-reactivity against both the Delta and the Omicron variants, including in central and effector memory cellular subpopulations. Median Omicron spike-specific CD8(+)T cell responses were 82-84% of the WA1/2020 spike-specific CD8(+)T cell responses. These data provide immunological context for the observation that current vaccines still show robust protection against severe disease with the SARS-CoV-2 Omicron variant despite the substantially reduced neutralizing antibody responses(7,8).	[Liu, Jinyan; Chandrashekar, Abishek; Sellers, Daniel; Barrett, Julia; Jacob-Dolan, Catherine; Lifton, Michelle; McMahan, Katherine; Sciacca, Michaela; VanWyk, Haley; Wu, Cindy; Yu, Jingyou; Collier, Ai-ris Y.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jacob-Dolan, Catherine; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu		Lifton, Michelle/0000-0003-0279-2198; Jacob-Dolan, Catherine/0000-0001-6641-0342; Chandrashekar, Abishek/0000-0001-7821-5552	NIH [CA260476]; Massachusetts Consortium for Pathogen Readiness; Ragon Institute; Musk Foundation; Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Burroughs Wellcome Fund [HD000849]; Biomedical Advanced Research and Development Authority [HHSO100201700018C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Consortium for Pathogen Readiness; Ragon Institute; Musk Foundation; Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biomedical Advanced Research and Development Authority	We acknowledge NIH grant CA260476, the Massachusetts Consortium for Pathogen Readiness, the Ragon Institute and the Musk Foundation (D.H.B.), as well as the Reproductive Scientist Development Program from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and Burroughs Wellcome Fund HD000849 (A.Y.C.). The COV1001 study was funded in part by Biomedical Advanced Research and Development Authority HHSO100201700018C. We thank MesoScale Discovery for providing the ECLA kits.	Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; Barouch DH, 2021, NEW ENGL J MED, V385, P951, DOI 10.1056/NEJMc2108829; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Collie S, 2022, NEW ENGL J MED, V386, P494, DOI 10.1056/NEJMc2119270; Collier AY, 2021, NEW ENGL J MED, V385, P2010, DOI 10.1056/NEJMc2115596; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Falsey AR, 2021, NEW ENGL J MED, V385, P1627, DOI 10.1056/NEJMc2113468; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Gray MBBCH G.E., 2021, MEDRXIV, DOI [10.1101/2021.12.28.21268436, DOI 10.1101/2021.12.28.21268436]; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poon MML, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl9105; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Vidal SJ, 2021, J VIROL, V95, DOI 10.1128/JVI.00404-21	16	111	112	22	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 17	2022	603	7901					493	+		10.1038/s41586-022-04465-y	http://dx.doi.org/10.1038/s41586-022-04465-y		JAN 2022	16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZV2TI	35102312	Green Published, hybrid			2022-12-28	WOS:000766518300001
J	Thornton, J				Thornton, Jacqui			Man whose genetic condition went undiagnosed for 36 years is awarded 2.5m pound	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m820	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o238	10.1136/bmj.o238	http://dx.doi.org/10.1136/bmj.o238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086909				2022-12-28	WOS:000748641100009
J	Soljak, M; Majeed, A				Soljak, Michael; Majeed, Azeem			Reducing the covid-19 isolation period in England: a policy change that needs careful evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Soljak, Michael; Majeed, Azeem] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Soljak, M (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.			Soljak, Michael/0000-0002-0303-1617; Majeed, Azeem/0000-0002-2357-9858				Birrell P, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0279; Byrne AW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039856; D. Bays, 2021, medRxiv, DOI 10.1101/2021.12.23.21268326; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; National Institute of Infectious Diseases; Disease Control and Prevention Center National Center for Global Health and Medicine, 2022, ACTIVE EPIDEMIOLOGIC; Torjesen I, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o89; UK Health Security Agency, 2022, US LAT FLOW TESTS RE; US Centers for Disease Control, 2022, WHAT WE KNOW QUAR IS; Vink MA, 2014, AM J EPIDEMIOL, V180, P865, DOI 10.1093/aje/kwu209	9	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o184	10.1136/bmj.o184	http://dx.doi.org/10.1136/bmj.o184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063939	Bronze			2022-12-28	WOS:000838119600005
J	Taconet, A				Taconet, Aurore			Caring for patients with covid-19 in Afghanistan-another hard winter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Taconet, Aurore] MSF, Taimanai, Kabul, Afghanistan	Doctors Without Borders	Taconet, A (corresponding author), MSF, Taimanai, Kabul, Afghanistan.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o175	10.1136/bmj.o175	http://dx.doi.org/10.1136/bmj.o175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063937	Bronze			2022-12-28	WOS:000838119600007
J	Bravo, L; Smolenov, I; Han, HH; Li, P; Hosain, R; Rockhold, F; Clemens, SAC; Roa, C; Borja-Tabora, C; Quinsaat, A; Lopez, P; Lopez-Medina, E; Brochado, L; Hernandez, EA; Reynales, H; Medina, T; Velasquez, H; Toloza, LB; Rodriguez, EJ; de Salazar, DIM; Rodriguez, CA; Sprinz, E; Cerbino-Neto, J; Luz, KG; Schwarzbold, AV; Paiva, MS; Carlos, J; Montellano, MEB; de Los Reyes, MRA; Yu, CY; Alberto, ER; Panaligan, MM; Saivani-Bautista, M; Buntinx, E; Hites, M; Martinot, JB; Bhorat, QE; Badat, A; Baccarini, C; Hu, B; Jurgens, J; Engelbrecht, J; Ambrosino, D; Richmond, P; Siber, G; Liang, JH; Clemens, R				Bravo, Lulu; Smolenov, Igor; Han, Htay Htay; Li, Ping; Hosain, Ramona; Rockhold, Frank; Clemens, Sue Ann Costa; Roa, Camilo, Jr.; Borja-Tabora, Charissa; Quinsaat, Antoinette; Lopez, Pio; Lopez-Medina, Eduardo; Brochado, Leonardo; Hernandez, Eder A.; Reynales, Humberto; Medina, Tatiana; Velasquez, Hector; Bautista Toloza, Leonardo; Johana Rodriguez, Edith; Molina de Salazar, Dora Ines; Rodriguez, Camilo A.; Sprinz, Eduardo; Cerbino-Neto, Jose; Luz, Kleber Giovanni; Schwarzbold, Alexandre Vargas; Paiva, Maria Sanali; Carlos, Josefina; Montellano, May Emmeline B.; de Los Reyes, Mari Rose A.; Yu, Charles Y.; Alberto, Edison R.; Panaligan, Mario M.; Saivani-Bautista, Milagros; Buntinx, Erik; Hites, Maya; Martinot, Jean-Benoit; Bhorat, Qasim E.; Badat, Aysha; Baccarini, Carmen; Hu, Branda; Jurgens, Jaco; Engelbrecht, Jan; Ambrosino, Donna; Richmond, Peter; Siber, George; Liang, Joshua; Clemens, Ralf			Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial	LANCET			English	Article								Background A range of safe and effective vaccines against SARS CoV 2 are needed to address the COVID 19 pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccine SCB-2019. Methods This ongoing phase 2 and 3 double-blind, placebo-controlled trial was done in adults aged 18 years and older who were in good health or with a stable chronic health condition, at 31 sites in five countries (Belgium, Brazil, Colombia, Philippines, and South Africa). The participants were randomly assigned 1:1 using a centralised internet randomisation system to receive two 0.5 mL intramuscular doses of SCB-2019 (30 mu g, adjuvanted with 1.50 mg CpG-1018 and 0.75 mg alum) or placebo (0.9% sodium chloride for injection supplied in 10 mL ampoules) 21 days apart. All study staff and participants were masked, but vaccine administrators were not. Primary endpoints were vaccine efficacy, measured by RT-PCR-confirmed COVID-19 of any severity with onset from 14 days after the second dose in baseline SARS-CoV-2 seronegative participants (the per-protocol population), and the safety and solicited local and systemic adverse events in the phase 2 subset. This study is registered on EudraCT (2020-004272-17) and ClinicalTrials.gov (NCT04672395). Findings 30 174 participants were enrolled from March 24, 2021, until the cutoff date of Aug 10, 2021, of whom 30 128 received their first assigned vaccine (n=15 064) or a placebo injection (n=15 064). The per-protocol population consisted of 12 355 baseline SARS-CoV-2-naive participants (6251 vaccinees and 6104 placebo recipients). Most exclusions (13 389 [44.4%]) were because of seropositivity at baseline. There were 207 confirmed per-protocol cases of COVID-19 at 14 days after the second dose, 52 vaccinees versus 155 placebo recipients, and an overall vaccine efficacy against any severity COVID-19 of 67.2% (95.72% CI 54.3-76.8), 83.7% (97.86% CI 55.9-95.4) against moderateto-severe COVID-19, and 100% (97.86% CI 25.3-100.0) against severe COVID-19. All COVID-19 cases were due to virus variants; vaccine efficacy against any severity COVID-19 due to the three predominant variants was 78.7% (95% CI 57.3-90.4) for delta, 91.8% (44.9-99.8) for gamma, and 58.6% (13.3-81.5) for mu. No safety issues emerged in the follow-up period for the efficacy analysis (median of 82 days [IQR 63-103]). The vaccine elicited higher rates of mainly mild-to-moderate injection site pain than the placebo after the first (35.7% [287 of 803] vs 10.3% [81 of 786]) and second (26.9% [189 of 702] vs 7.4% [52 of 699]) doses, but the rates of other solicited local and systemic adverse events were similar between the groups. Interpretation Two doses of SCB-2019 vaccine plus CpG and alum provides notable protection against the entire severity spectrum of COVID-19 caused by circulating SAR-CoV-2 viruses, including the predominating delta variant.	[Bravo, Lulu] Univ Philippines Manila, Manila, Philippines; [Smolenov, Igor; Han, Htay Htay; Li, Ping; Hosain, Ramona; Baccarini, Carmen; Hu, Branda] Clover Biopharmaceut, Cambridge, MA USA; [Rockhold, Frank] Duke Univ, Duke Univ Clin Res Inst, Med Ctr, Durham, NC USA; [Clemens, Sue Ann Costa] Univ Oxford, Oxford Vaccine Grp, Oxford, England; [Roa, Camilo, Jr.] Manila Doctors Hosp, Manila, Philippines; [Borja-Tabora, Charissa] Asian Hosp & Med Ctr, Alabang, Muntinlupa, Philippines; [Quinsaat, Antoinette] Global Res Infect Dis, Singapore, Singapore; [Lopez, Pio; Lopez-Medina, Eduardo] Univ Valle Clin Imbanaco, Ctr Estudios Infectol Pediat, Cali, Colombia; [Brochado, Leonardo] Clin Costa, Barranquilla, Atlantico, Colombia; [Hernandez, Eder A.] Hosp Univ Norte, Barranquilla, Colombia; [Reynales, Humberto; Medina, Tatiana; Velasquez, Hector; Bautista Toloza, Leonardo; Johana Rodriguez, Edith] Ctr Attent Med Res, Bogota, Colombia; [Molina de Salazar, Dora Ines] Univ Caldas, Fac Hlth Sci, Manizales, Colombia; [Rodriguez, Camilo A.] Policlin Social Norte, Bogota, Colombia; [Sprinz, Eduardo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Cerbino-Neto, Jose] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Natal, RN, Brazil; [Schwarzbold, Alexandre Vargas] Univ Fed Santa Maria, Infect Dis Div, Santa Maria, RS, Brazil; [Paiva, Maria Sanali] Atena Inst Clin Res, Natal, RN, Brazil; [Carlos, Josefina; Saivani-Bautista, Milagros] Univ East Ramon Magsaysay Mem Med Ctr, Quezon City, Philippines; [Montellano, May Emmeline B.] Far Eastern Univ Hosp, Nicanor Reyes Med Fdn, Quezon City, Philippines; [de Los Reyes, Mari Rose A.] Las Pinas Doctors Hosp, Las Pinas City, Philippines; [Yu, Charles Y.] De La Salle Med & Hlth Sci Inst, Cavite City, Philippines; [Alberto, Edison R.] Trop Dis Fdn, Cavite City, Philippines; [Panaligan, Mario M.] St Lukes Med Ctr, Infect Control Serv, Taguig, Philippines; [Buntinx, Erik] Anima Res Ctr, Alken, Belgium; [Hites, Maya] CUB Hop Erasme, Clin Infect Dis, Brussels, Belgium; [Martinot, Jean-Benoit] CHU Univ Catholique Louvain, Pulmonol Dept, Namur Site St Elisabeth, Namur, Belgium; [Bhorat, Qasim E.] Soweto Clin Trials Ctr, Johannesburg, South Africa; [Badat, Aysha] Wits Clin Res, Johannesburg, South Africa; [Jurgens, Jaco] DJW Res, Krugersdorp, Gauteng, South Africa; [Engelbrecht, Jan] Vergelegen Mediclin, Dr JM Engelbrecht Trial Site, Western Cape, South Africa; [Richmond, Peter] Univ Western Australia, Wesfarmers Ctr Vaccines & Infect Dis, Telethon Kids Inst, Div Paediat, Perth, WA, Australia; [Richmond, Peter] Perth Childrens Hosp, Perth, WA, Australia; [Siber, George] Independent Advisor, New York, NY USA; [Liang, Joshua] Clover Biopharmaceut, Chengdu, Peoples R China; [Clemens, Ralf] Global Res Infect Dis, BR-22261070 Rio De Janeiro, RJ, Brazil	University of the Philippines System; University of the Philippines Manila; Duke University; University of Oxford; Universidad del Norte; Universidad de Caldas; Universidade Federal do Rio Grande do Sul; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio Grande do Norte; Universidade Federal de Santa Maria (UFSM); UERM Memorial Medical Center; Far Eastern University; De La Salle Medical & Health Sciences Institute (DLSMHSI); Universite Libre de Bruxelles; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited	Clemens, R (corresponding author), Global Res Infect Dis, BR-22261070 Rio De Janeiro, RJ, Brazil.	clemens.ralf@outlook.com	Smolenov, Igor/N-8950-2015; Neto, José Cerbino/P-3713-2018	Smolenov, Igor/0000-0002-7075-9827; Neto, José Cerbino/0000-0001-9254-917X; Richmond, Peter/0000-0001-7562-7228; Clemens, Ralf/0000-0003-4685-4207; Lopez Lopez, Pio/0000-0001-5230-6595; Costa Clemens, Sue Ann/0000-0001-9576-0878; Bhorat, Qasim Ebrahim/0000-0002-4102-8750	Clover Biopharmaceuticals; Coalition for Epidemic Preparedness Innovations	Clover Biopharmaceuticals; Coalition for Epidemic Preparedness Innovations	Clover Biopharmaceuticals and the Coalition for Epidemic Preparedness Innovations.	Ambrosino D, 2022, J INFECT DIS, V225, P327, DOI 10.1093/infdis/jiab574; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Falsey AR, 2021, NEW ENGL J MED, V385, P2348, DOI 10.1056/NEJMoa2105290; Food and Drug Administration, 2020, DEV LIC VACC PREV CO; Heath PT, 2021, NEW ENGL J MED, V385, P1172, DOI 10.1056/NEJMoa2107659; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Johns Hopkins University and Medicine, COVID 19 DASHB; Liang JG, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21634-1; Ma JH, 2021, J VIROL, V95, DOI 10.1128/JVI.00194-21; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nextstrain, GEN EP SARS COV 2 GL; Olliaro P, 2021, LANCET MICROBE, V2, pE279, DOI 10.1016/S2666-5247(21)00069-0; Ong SWX, 2022, CLIN INFECT DIS, V75, pE1128, DOI 10.1093/cid/ciab721; Our World in Data, STAT RES COR COVID 1; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Richmond P, 2021, LANCET, V397, P682, DOI 10.1016/S0140-6736(21)00241-5; Richmond PC, 2021, J INFECT DIS, V224, P1699, DOI 10.1093/infdis/jiab447; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Tanriover MD, 2021, LANCET, V398, P213, DOI 10.1016/S0140-6736(21)01429-X; Uriu K, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMc2114706; WHO, 2021, CLASSIFICATION OMICR; WHO, 2021, NATURE, DOI DOI 10.1101/2020.06.17.156455; WHO, 2021, VACC EFF COV 19 VACC; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3	25	20	23	9	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					461	472		10.1016/S0140-6736(22)00055-1	http://dx.doi.org/10.1016/S0140-6736(22)00055-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9YU	35065705	Green Published			2022-12-28	WOS:000755141600026
J	Mahase, E				Mahase, Elisabeth			Covid-19: Past infection may not protect against future variants, researcher warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o263	1	2	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								o334	10.1136/bmj.o334	http://dx.doi.org/10.1136/bmj.o334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9JI	35131806	Bronze			2022-12-28	WOS:000759192600009
J	Fazekas, TJ; Alty, JW; Neidhart, EK; Miller, AS; Leibfarth, FA; Alexanian, EJ				Fazekas, Timothy J.; Alty, Jill W.; Neidhart, Eliza K.; Miller, Austin S.; Leibfarth, Frank A.; Alexanian, Erik J.			Diversification of aliphatic C-H bonds in small molecules and polyolefins through radical chain transfer	SCIENCE			English	Article							ELEMENTAL FLUORINE; ALKYL-HALIDES; AMINO-ACIDS; FUNCTIONALIZATION; ENABLES; ACCESS	The ability to selectively introduce diverse functionality onto hydrocarbons is of substantial value in the synthesis of both small molecules and polymers. Herein, we report an approach to aliphatic carbon-hydrogen bond diversification using radical chain transfer featuring an easily prepared O-alkenylhydroxamate reagent, which upon mild heating facilitates a range of challenging or previously undeveloped aliphatic carbon-hydrogen bond functionalizations of small molecules and polyolefins. This broad reaction platform enabled the functionalization of postconsumer polyolefins in infrastructure used to process plastic waste. Furthermore, the chemoselective placement of ionic functionality onto a branched polyolefin using carbon-hydrogen bond functionalization upcycled the material from a thermoplastic into a tough elastomer with the tensile properties of high-value polyolefin ionomers.	[Fazekas, Timothy J.; Alty, Jill W.; Neidhart, Eliza K.; Miller, Austin S.; Leibfarth, Frank A.; Alexanian, Erik J.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Leibfarth, FA; Alexanian, EJ (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	frankl@email.unc.edu; eja@email.unc.edu	Ehrmann, Mass Spectrometry Core/GLQ-5891-2022; , UNC Chemistry NMR/AGR-7635-2022	Ehrmann, Mass Spectrometry Core/0000-0002-6741-7914; Neidhart, Eliza/0000-0001-7663-7268; Alty, Jill/0000-0002-9780-1343	National Institute of General Medical Sciences [R35 GM131708]; Air Force Office of Scientific Research [17RT0487]; Henry G. Luce Foundation; University of North Carolina-Chapel Hill (UNC); UNC Chemistry Department; National Science Foundation [CHE-1726291, CHE-1828183, CHE-0922858]; National Institute of General Medical Sciences of the National Institutes of Health [R35GM118055]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Henry G. Luce Foundation; University of North Carolina-Chapel Hill (UNC); UNC Chemistry Department; National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (award no. R35 GM131708 to E.J.A.) and the Air Force Office of Scientific Research (award no. 17RT0487 under the Young Investigator Program to F.A.L). J.W. A. thanks the Henry G. Luce Foundation and the University of North Carolina-Chapel Hill (UNC) for a Clare Boothe Luce Graduate Student Fellowship and the UNC Chemistry Department for the Venable Award. The UNC Department of Chemistry's Mass Spectrometry Core Laboratory provided expertise and instrumentation that enabled this study with support from the National Science Foundation (grant no. CHE-1726291) and the National Institute of General Medical Sciences of the National Institutes of Health (grant no. R35GM118055). The UNC Department of Chemistry's NMR Core Laboratory provided expertise and instrumentation that enabled this study with support from National Science Foundation (grant nos. CHE-1828183 and CHE-0922858). We thank the Dow Chemical Company for supplying samples of SURLYN ionomers and HighCube or providing samples of postindustrial and postconsumer plastic waste.	ALEWOOD PF, 1981, SYNTHESIS-STUTTGART, P121; An Q, 2020, J AM CHEM SOC, V142, P6216, DOI 10.1021/jacs.0c00212; Anthore L, 2015, ORG LETT, V17, P3058, DOI 10.1021/acs.orglett.5b01344; Artaryan A, 2017, J ORG CHEM, V82, P7093, DOI 10.1021/acs.joc.7b00557; Berube M, 2006, SYNTHESIS-STUTTGART, P3085, DOI 10.1055/s-2006-950204; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Boaen NK, 2005, CHEM SOC REV, V34, P267, DOI 10.1039/b311405h; Britt F. P., 2019, REPORT BASIC ENERGY; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chambers RD, 2002, J CHEM SOC PERK T 1, P2190, DOI 10.1039/b204776b; Chambers RD, 2008, J FLUORINE CHEM, V129, P811, DOI 10.1016/j.jfluchem.2008.04.010; Chavez-Flores D, 2012, TETRAHEDRON-ASYMMETR, V23, P237, DOI 10.1016/j.tetasy.2012.02.014; Cheng Y, 2018, ANGEW CHEM INT EDIT, V57, P16832, DOI 10.1002/anie.201810782; Czaplyski WL, 2016, J AM CHEM SOC, V138, P13854, DOI 10.1021/jacs.6b09414; Davies HML, 2019, J ORG CHEM, V84, P12722, DOI 10.1021/acs.joc.9b02428; Feng KB, 2020, NATURE, V580, P621, DOI 10.1038/s41586-020-2137-8; Ge SS, 2018, RSC ADV, V8, P29428, DOI 10.1039/c8ra03538e; Grady BP, 2008, POLYM ENG SCI, V48, P1029, DOI 10.1002/pen.21024; Haussler M, 2021, NATURE, V590, DOI 10.1038/s41586-020-03149-9; Halperin SD, 2014, ANGEW CHEM INT EDIT, V53, P4690, DOI 10.1002/anie.201400420; HAMIELEC AE, 1991, CAN J CHEM ENG, V69, P611, DOI 10.1002/cjce.5450690302; Hartwig JF, 2016, J AM CHEM SOC, V138, P2, DOI 10.1021/jacs.5b08707; Hong BK, 2020, ACS CENTRAL SCI, V6, P622, DOI 10.1021/acscentsci.9b00916; Hua AM, 2017, ORG LETT, V19, P2949, DOI 10.1021/acs.orglett.7b01188; Huang XY, 2015, J AM CHEM SOC, V137, P5300, DOI 10.1021/jacs.5b01983; Kamijo S, 2016, SYNTHESIS-STUTTGART, V48, P115, DOI 10.1055/s-0035-1560705; Kamijo S, 2011, ORG LETT, V13, P5928, DOI 10.1021/ol202659e; Kennedy N, 2016, ANGEW CHEM INT EDIT, V55, P383, DOI 10.1002/anie.201508971; Koch V, 2017, ORG BIOMOL CHEM, V15, P92, DOI 10.1039/c6ob02496c; Kohler F, 2007, ORG LETT, V9, P1231, DOI 10.1021/ol063082q; Kondo Y, 2002, J AM CHEM SOC, V124, P1164, DOI 10.1021/ja016763j; Korley LTJ, 2021, SCIENCE, V373, P66, DOI 10.1126/science.abg4503; KROPP PJ, 1991, J AM CHEM SOC, V113, P2709, DOI 10.1021/ja00007a053; Larkina MS, 2020, EUR J ORG CHEM, V2020, P6375, DOI 10.1002/ejoc.202000934; Lepage ML, 2019, SCIENCE, V366, P875, DOI 10.1126/science.aay6230; Levy LM, 2004, TETRAHEDRON-ASYMMETR, V15, P2051, DOI 10.1016/j.tetasy.2004.05.035; Li HY, 2017, CHEM SCI, V8, P2610, DOI 10.1039/c6sc05093j; Li X, 2013, ADV FUNCT MATER, V23, P3344, DOI 10.1002/adfm.201203374; Liao KB, 2018, NAT CHEM, V10, P1048, DOI 10.1038/s41557-018-0087-7; Liu D, 2017, POLYM INT, V66, P70, DOI 10.1002/pi.5180; Liu W, 2012, SCIENCE, V337, P1322, DOI 10.1126/science.1222327; MacArthur Ellen, 2016, WORLD EC FORUM; Margrey KA, 2018, J AM CHEM SOC, V140, P4213, DOI 10.1021/jacs.8b00592; Matier CD, 2017, J AM CHEM SOC, V139, P17707, DOI 10.1021/jacs.7b09582; Merchant RR, 2018, SCIENCE, V360, P75, DOI 10.1126/science.aar7335; Meyer D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07196-9; Meyer D, 2017, ANGEW CHEM INT EDIT, V56, P10858, DOI 10.1002/anie.201703340; Naciuk FF, 2020, ACS MED CHEM LETT, V11, P1250, DOI 10.1021/acsmedchemlett.0c00106; Nakamura M, 2004, J AM CHEM SOC, V126, P3686, DOI 10.1021/ja049744t; Nielsen MK, 2018, J AM CHEM SOC, V140, P5004, DOI 10.1021/jacs.8b01523; Oeschger R, 2020, SCIENCE, V368, P736, DOI 10.1126/science.aba6146; Perry IB, 2018, NATURE, V560, P70, DOI 10.1038/s41586-018-0366-x; Piou T, 2014, J AM CHEM SOC, V136, P11292, DOI 10.1021/ja506579t; Pitts CR, 2014, J AM CHEM SOC, V136, P9780, DOI 10.1021/ja505136j; Plummer CM, 2020, POLYM CHEM-UK, V11, P6862, DOI 10.1039/d0py01279c; Plummer CM, 2018, POLYM CHEM-UK, V9, P1309, DOI 10.1039/c8py00013a; Quinn RK, 2016, J AM CHEM SOC, V138, P696, DOI 10.1021/jacs.5b12308; Rahimi A, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0046; Ravelli D, 2018, ACS CATAL, V8, P701, DOI 10.1021/acscatal.7b03354; Reiss T, 2009, ORG LETT, V11, P3286, DOI 10.1021/ol9011635; Schmidt VA, 2014, J AM CHEM SOC, V136, P14389, DOI 10.1021/ja508469u; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Shu C, 2020, NATURE, V586, P714, DOI 10.1038/s41586-020-2831-6; Tierney MM, 2019, J ORG CHEM, V84, P12983, DOI 10.1021/acs.joc.9b01774; Toda N, 2013, ANGEW CHEM INT EDIT, V52, P12592, DOI 10.1002/anie.201306241; Vadenbo C, 2017, J IND ECOL, V21, P1078, DOI 10.1111/jiec.12519; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; Wang YC, 2014, RSC ADV, V4, P30850, DOI 10.1039/c4ra03075c; White MC, 2018, J AM CHEM SOC, V140, P13988, DOI 10.1021/jacs.8b05195; White MC, 2012, SCIENCE, V335, P807, DOI 10.1126/science.1207661; Williamson JB, 2019, J AM CHEM SOC, V141, P12815, DOI 10.1021/jacs.9b05799; Williamson JB, 2019, ANGEW CHEM INT EDIT, V58, P8654, DOI 10.1002/anie.201810970; Williamson JB, 2018, ANGEW CHEM INT EDIT, V57, P6261, DOI 10.1002/anie.201803020; Wu H, 2015, ANGEW CHEM INT EDIT, V54, P4070, DOI 10.1002/anie.201411953; Xu WT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12844-9; Yadav AK, 2013, CHEM COMMUN, V49, P2154, DOI 10.1039/c3cc00122a; Zeng CY, 2018, ORG LETT, V20, P6859, DOI 10.1021/acs.orglett.8b02980	77	19	19	69	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					545	+		10.1126/science.abh4308	http://dx.doi.org/10.1126/science.abh4308			170	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113718	Green Accepted			2022-12-28	WOS:000753965100040
J	Sanford, M				Sanford, Melanie			Robert H. Grubbs (1942-2021) Brilliant organic chemist and inspiring mentor	SCIENCE			English	Biographical-Item									[Sanford, Melanie] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, M (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.							GRUBBS RH, PUBLICATION LIST	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					499	499						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113715				2022-12-28	WOS:000753965100025
J	Schmidt, R; Steinhart, Z; Layeghi, M; Freimer, JW; Bueno, R; Nguyen, VQ; Blaeschke, F; Ye, CJ; Marson, A				Schmidt, Ralf; Steinhart, Zachary; Layeghi, Madeline; Freimer, Jacob W.; Bueno, Raymund; Nguyen, Vinh Q.; Blaeschke, Franziska; Ye, Chun Jimmie; Marson, Alexander			CRISPR activation and interference screens decode stimulation responses in primary human T cells	SCIENCE			English	Article							RESISTANCE; DISCOVERY; EFFECTOR	Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.	[Schmidt, Ralf; Steinhart, Zachary; Layeghi, Madeline; Freimer, Jacob W.; Blaeschke, Franziska; Ye, Chun Jimmie; Marson, Alexander] Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94158 USA; [Schmidt, Ralf; Steinhart, Zachary; Freimer, Jacob W.; Bueno, Raymund; Blaeschke, Franziska; Ye, Chun Jimmie; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Freimer, Jacob W.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Nguyen, Vinh Q.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Ye, Chun Jimmie; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Ye, Chun Jimmie; Marson, Alexander] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Ye, Chun Jimmie; Marson, Alexander] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marson, A (corresponding author), Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Marson, A (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	alexander.marson@ucsf.edu		Freimer, Jacob/0000-0001-9239-2272; Bueno, Raymund/0000-0001-8534-9399; Marson, Alexander/0000-0002-2734-5776	National Institute of Diabetes and Digestive and Kidney Diseases [DP3DK111914-01]; Simons Foundation; Burroughs Wellcome Fund, Career Award for Medical Scientists; Cancer Research Institute Lloyd J. Old STAR grant; Parker Institute for Cancer Immunotherapy; Innovative Genomics Institute; National Institutes of Health [R01HG008140, S10 RR028962, P30 DK063720, S10 1S10OD021822-01]; Parker Institute for Cancer Immunology scholarship; Austrian Exchange Service Fellowship; Austrian Society of Laboratory Medicine Fellowship; James B. Pendleton Charitable Trust; Max Kade Foundation; Care-for-Rare Foundation; German Research Foundation	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Simons Foundation; Burroughs Wellcome Fund, Career Award for Medical Scientists(Burroughs Wellcome Fund); Cancer Research Institute Lloyd J. Old STAR grant; Parker Institute for Cancer Immunotherapy; Innovative Genomics Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunology scholarship; Austrian Exchange Service Fellowship; Austrian Society of Laboratory Medicine Fellowship; James B. Pendleton Charitable Trust; Max Kade Foundation; Care-for-Rare Foundation; German Research Foundation(German Research Foundation (DFG))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant DP3DK111914-01 to A. M.); Simons Foundation (A.M.); Burroughs Wellcome Fund, Career Award for Medical Scientists (A.M.); The Cancer Research Institute Lloyd J. Old STAR grant (A.M.); Parker Institute for Cancer Immunotherapy (A.M.); Innovative Genomics Institute (A.M.); National Institutes of Health grant P30 DK063720 to the Parnassus Flow Cytometry Core and A.M.; National Institutes of Health grant S10 1S10OD021822-01 to the PFCC and A.M.; gifts from B. Byers, B. Bakar, K. Jordan, and E. Radutzky (A.M.); Parker Institute for Cancer Immunology scholarship (Z.S.); Austrian Exchange Service and Austrian Society of Laboratory Medicine Fellowships (R.S.); Max Kade Foundation (R.S.); Care-for-Rare Foundation and German Research Foundation Fellowships (F.B.); National Institutes of Health grant R01HG008140 (J.W.F.); and National Institutes of Health grant S10 RR028962 and James B. Pendleton Charitable Trust to the Gladstone Institutes Flow Cytometry Core Facility. A.M. and C.J.Y. are Chan Zuckerberg Biohub investigators.	Abbas AK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1482; Aguilar SV, 2020, NAT IMMUNOL, V21, P700, DOI 10.1038/s41590-020-0687-4; Alda-Catalinas C, 2020, CELL SYST, V11, P25, DOI 10.1016/j.cels.2020.06.004; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bartelt RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005430; Boardman DA, 2019, NAT BIOMED ENG, V3, P259, DOI 10.1038/s41551-019-0359-6; Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847; Chen X, 2018, J IMMUNOL, V201, P1586, DOI 10.4049/jimmunol.1701616; Chun I, 2020, BLOOD, V136, DOI 10.1182/blood-2020-136860; Colin-York H, 2020, J CELL SCI, V133, DOI 10.1242/jcs.232322; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Evans CM, 2013, BRIEF FUNCT GENOMICS, V12, P499, DOI 10.1093/bfgp/elt025; Ferdosi SR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09693-x; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Freimer J. W, SYSTEMATIC DISCOVERY, V2021; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Heaton H, 2020, NAT METHODS, V17, P615, DOI 10.1038/s41592-020-0820-1; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Holland SJ, 2001, J EXP MED, V194, P1263, DOI 10.1084/jem.194.9.1263; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hu HB, 2016, J EXP MED, V213, P399, DOI 10.1084/jem.20151426; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Korotkevich G., 2016, BIORXIV060012; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu YX, 2018, CELL STEM CELL, V23, P758, DOI 10.1016/j.stem.2018.09.003; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Nasrallah R, 2020, NATURE, V583, P447, DOI 10.1038/s41586-020-2296-7; Ni L, 2018, CANCER MED-US, V7, P4509, DOI 10.1002/cam4.1700; Nicolet BP, 2020, P NATL ACAD SCI USA, V117, P6686, DOI 10.1073/pnas.1913940117; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Replogle JM, 2020, NAT BIOTECHNOL, V38, P954, DOI 10.1038/s41587-020-0470-y; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Ting PY, 2018, NAT METHODS, V15, P941, DOI 10.1038/s41592-018-0149-1; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu XS, 2019, J MOL BIOL, V431, P34, DOI 10.1016/j.jmb.2018.06.037; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	60	31	31	35	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					513	+	eabj4008	10.1126/science.abj4008	http://dx.doi.org/10.1126/science.abj4008			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113687	Green Accepted			2022-12-28	WOS:000753965100033
J	Tangcharoensathien, V; Carroll, D; Lekagul, A				Tangcharoensathien, Viroj; Carroll, Dennis; Lekagul, Angkana			Resilient and equitable recovery from the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COUNTRY		[Tangcharoensathien, Viroj; Lekagul, Angkana] Minist Publ Hlth, Int Hlth Policy Programme, Nonthaburi, Thailand; [Carroll, Dennis] Univ Res Co, Chevy Chase, MD USA	Ministry of Public Health - Thailand	Tangcharoensathien, V (corresponding author), Minist Publ Hlth, Int Hlth Policy Programme, Nonthaburi, Thailand.							Agyemang C, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-007433; [Anonymous], 2021, NATURE, DOI [10.1038/d41586-021-01762-w, DOI 10.1038/D41586-021-01762-W]; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Cronin CJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101386118; Furuse Y, 2021, INT J INFECT DIS, V103, P305, DOI 10.1016/j.ijid.2020.12.034; Gover AR, 2020, AM J CRIM JUSTICE, V45, P647, DOI 10.1007/s12103-020-09545-1; Hahm HC, 2021, PSYCHIAT RES, V303, DOI 10.1016/j.psychres.2021.114084; Haldane V, 2021, NAT MED, V27, P964, DOI 10.1038/s41591-021-01381-y; Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137; Kapitsinis N, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-07169-7; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4921; Stroebe W., 2021, PLOS ONE, V16, DOI [10.1371/journal.pone.0256740, DOI 10.1371/journal.pone.0256740]; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; Thacker PD, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3430; The World Bank, 2022, GLOBAL EC PROSPECTS	15	3	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o311	10.1136/bmj.o311	http://dx.doi.org/10.1136/bmj.o311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121579	Bronze			2022-12-28	WOS:000753552800001
J	Wertheim, JO				Wertheim, Joel O.			When viruses become more virulent	SCIENCE			English	Editorial Material									[Wertheim, Joel O.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wertheim, JO (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jwertheim@health.ucsd.edu			National Institutes of Health; US Centers for Disease Control and Prevention	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	J.O.W. is funded by the National Institutes of Health and US Centers for Disease Control and Prevention.	Blanquart F, 2016, ELIFE, V5, DOI 10.7554/eLife.20492; Crawley L. M, 2005, VIRTUAL MENTOR, V7, P790; Diamond Michael, 2021, Res Sq, DOI 10.21203/rs.3.rs-228079/v1; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Geoghegan JL, 2018, NAT REV GENET, V19, P756, DOI 10.1038/s41576-018-0055-5; Grubaugh ND, 2020, NAT MICROBIOL, V5, P529, DOI 10.1038/s41564-020-0690-4; Herbeck JT, 2012, AIDS, V26, P193, DOI 10.1097/QAD.0b013e32834db418; Kerr PJ, 2015, VIRUSES-BASEL, V7, P1020, DOI 10.3390/v7031020; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522; Oster AM, 2018, JAMA-J AM MED ASSOC, V319, P1657, DOI 10.1001/jama.2018.1513; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Wertheim JO, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13723-z; Wymant C, 2022, SCIENCE, V375, P540, DOI 10.1126/science.abk1688	14	0	0	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					493	494		10.1126/science.abn4887	http://dx.doi.org/10.1126/science.abn4887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113688				2022-12-28	WOS:000753965100021
J	Jan, YN				Jan, Yuh Nung			Underrepresentation of Asian awardees of United States biomedical research prizes	CELL			English	Editorial Material								The lack of racial diversity among the winners of United States biomedical research prizes reflects a chronic problem of the underappreciation of certain groups of biomedical scientists. Asians continue to be severely underrepresented as awardees of United States biomedical research prizes, a trend that shows no obvious recent improvement.	[Jan, Yuh Nung] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Jan, Yuh Nung] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu						Chen B.X., 2021, NEW YORK TIMES; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Lawrence P.A., 2012, CURR BIOL, V22, pR214; Meho LI, 2021, QUANT SCI STUD, V2, P976, DOI 10.1162/qss_a_00148; Meixiong J, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI151581; Sullivan B., 2021, SCIENTIST; Women in Engineering Society, 2019, WOM MIN PERS DIS SCI	7	2	2	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					407	410		10.1016/j.cell.2022.01.004	http://dx.doi.org/10.1016/j.cell.2022.01.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35120660	Green Published			2022-12-28	WOS:000753615000002
J	Ben Hassen, C; Fayosse, A; Landre, B; Raggi, M; Bloomberg, M; Sabia, S; Singh-Manoux, A				Ben Hassen, Celine; Fayosse, Aurore; Landre, Benjamin; Raggi, Martina; Bloomberg, Mikaela; Sabia, Severine; Singh-Manoux, Archana			Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; HEALTH-CARE; RISK; DISORDERS	OBJECTIVE To examine the association of midlife and late life multimorbidity, including severity of multimorbidity, with incident dementia. DESIGN Prospective cohort study. SETTING Civil service departments in London (Whitehall II study, study inception in 1985-88). PARTICIPANTS 10 095 participants, aged 35 to 55 at baseline. MAIN OUTCOME MEASURE Incident dementia at follow-up between 1985 and 2019. Cause specific Cox proportional hazards regression was used to examine the association of multimorbidity overall and at age 55, 60, 65, and 70 with subsequent dementia, taking into account the competing risk of death. RESULTS The prevalence of multimorbidity (>= 2 chronic diseases) was 6.6% (655/9937) at age 55 and 31.7% (2464/7783) at age 70; 639 cases of incident dementia occurred over a median follow-up of 31.7 years. After adjustment for sociodemographic factors and health behaviours, multimorbidity at age 55 was associated with subsequent risk of dementia (difference in incidence rate per 1000 person years 1.56, 95% confidence interval 0.62 to 2.77; hazard ratio 2.44, 95% confidence interval 1.82 to 3.26). The association weakened progressively with older age at onset of multimorbidity. At age 65, onset of multimorbidity before age 55 was associated with 3.86 (1.80 to 6.52) per 1000 person years higher incidence of dementia (hazard ratio 2.46, 1.80 to 2.26) and onset between 60 and 65 was associated with 1.85 (0.64 to 3.39) per 1000 person years higher incidence (1.51, 1.16 to 1.97). Severity of multimorbidity (>= 3 chronic diseases) at age 55 was associated with a 5.22 (1.14 to 11.95) per 1000 person years higher incidence of dementia (hazard ratio 4.96, 2.54 to 9.67); the same analyses at age 70 showed 4.49 (2.33 to 7.19) per 1000 person years higher incidence (1.65, 1.25 to 2.18). CONCLUSION Multimorbidity, particularly when onset is in midlife rather than late life, has a robust association with subsequent dementia. The increasingly younger age at onset of multimorbidity makes prevention of multimorbidity in people with a first chronic disease important.	[Ben Hassen, Celine; Fayosse, Aurore; Landre, Benjamin; Raggi, Martina; Bloomberg, Mikaela; Sabia, Severine; Singh-Manoux, Archana] Univ Paris, INSERM, Epidemiol Ageing & Neurodegenerat Dis, U1153, Paris, France; [Bloomberg, Mikaela; Sabia, Severine; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Ben Hassen, C (corresponding author), Univ Paris, INSERM, Epidemiol Ageing & Neurodegenerat Dis, U1153, Paris, France.	celine.ben-hassen@inserm.fr	Sabia, Séverine/G-2966-2017; Singh-Manoux, Archana/F-6804-2013	Sabia, Séverine/0000-0003-3109-9720; Singh-Manoux, Archana/0000-0002-1244-5037; Raggi, Martina/0000-0002-3309-9006; Ben Hassen, Celine/0000-0001-7884-2986	National Institute on Aging, NIH [R01AG056477, R01AG062553]; UK Medical Research Council [R024227, S011676]	National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the National Institute on Aging, NIH (R01AG056477, R01AG062553), and UK Medical Research Council (R024227, S011676). The funding source played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Aarsland D, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00280-3; Abell JG, 2018, EUR HEART J, V39, P3119, DOI 10.1093/eurheartj/ehy288; Amidei CB, 2021, JAMA-J AM MED ASSOC, V325, P1640, DOI 10.1001/jama.2021.4001; [Anonymous], 2019, LANCET NEUROL; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Baker E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178562; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Batty GD, 2014, EPIDEMIOLOGY, V25, P932, DOI 10.1097/EDE.0000000000000184; Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4; Bendayan R, 2021, J GERONTOL A-BIOL, V76, P867, DOI 10.1093/gerona/glab009; Biundo R, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.18; Bunn F, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0192-4; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Fabbri E, 2015, J GERONTOL A-BIOL, V70, P63, DOI 10.1093/gerona/glu127; Gerber Y, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01681-0; Gimson A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019399; Grande G, 2021, ALZHEIMERS DEMENT, V17, P768, DOI 10.1002/alz.12237; Hayes-Larson E, 2020, ALZHEIMERS DEMENT, V16, P1696, DOI 10.1002/alz.12168; Hobson P, 2015, INT J GERIATR PSYCH, V30, P1048, DOI 10.1002/gps.4261; Holmquist S, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003016; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kjaergaard K, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040673; Koyanagi A, 2018, J AM GERIATR SOC, V66, P721, DOI 10.1111/jgs.15288; Lee YR, 2021, ARCH GERONTOL GERIAT, V95, DOI 10.1016/j.archger.2021.104424; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McKee M, 2021, LANCET, V397, P1979, DOI 10.1016/S0140-6736(21)00229-4; Nicholson K, 2019, HEALTH PSYCHOL, V38, P783, DOI 10.1037/hea0000739; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Ribe AR, 2015, JAMA PSYCHIAT, V72, P1095, DOI 10.1001/jamapsychiatry.2015.1546; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sabia S, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.14414; Sanderson Maureen, 2002, Am J Alzheimers Dis Other Demen, V17, P73, DOI 10.1177/153331750201700210; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Shang Y, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2020.100218; Singh-Manoux A, 2017, JAMA PSYCHIAT, V74, P712, DOI 10.1001/jamapsychiatry.2017.0660; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Sommerlad A, 2018, ALZHEIMERS DEMENT, V14, P933, DOI 10.1016/j.jalz.2018.02.012; Song XW, 2011, NEUROLOGY, V77, P227, DOI 10.1212/WNL.0b013e318225c6bc; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Vassilaki M, 2019, J GERONTOL A-BIOL, V74, P877, DOI 10.1093/gerona/gly149; Vassilaki M, 2015, J AM GERIATR SOC, V63, P1783, DOI 10.1111/jgs.13612; Wei MY, 2020, J GERONTOL A-BIOL, V75, P1206, DOI 10.1093/gerona/glz147; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Wilkinson T, 2018, ALZHEIMERS DEMENT, V14, P1038, DOI 10.1016/j.jalz.2018.02.016; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Zilkens RR, 2014, CURR ALZHEIMER RES, V11, P681, DOI 10.2174/1567205011666140812115004	47	9	9	7	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								e068005	10.1136/bmj-2021-068005	http://dx.doi.org/10.1136/bmj-2021-068005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE1XC	35110302	Green Published, hybrid			2022-12-28	WOS:000758682200008
J	Bikdeli, B; Garcia, DA				Bikdeli, Behnood; Garcia, David A.			In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bikdeli, Behnood] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Garcia, David A.] Univ Washington, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Bikdeli, B (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.			Giannis, Dimitrios/0000-0001-9246-976X					0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC17	JC17		10.7326/J21-0019	http://dx.doi.org/10.7326/J21-0019		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099994				2022-12-28	WOS:000750886100003
J	Mahase, E				Mahase, Elisabeth			Government announces cancer hotline staffed by specialist nurses	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2295	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o186	10.1136/bmj.o186	http://dx.doi.org/10.1136/bmj.o186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063947				2022-12-28	WOS:000838119600003
J	Lane, R				Lane, Richard			Ali Zumla: respiratory medicine and global health supremo	LANCET			English	Biographical-Item																			0	0	0	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					427	427						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9YU	35093219	Green Published, Bronze			2022-12-28	WOS:000755141600012
J	Murray, CJL				Murray, Christopher J. L.			COVID-19 will continue but the end of the pandemic is near Comment	LANCET			English	Editorial Material																		ANA Enterprise,, 2022, COR COVID 19 INF SUR; Davidson H, 2022, THE GUARDIAN 0110; Garrett Nigel, 2022, medRxiv, DOI 10.1101/2021.12.20.21268130; Greek Government, 2022, COVID 19 DAIL OV; Institute for Health Metrics and Evaluation, 2022, COVID 19 PROJ; Johns Hopkins Coronavirus Resource Center, 2022, COVID 19 DASHB; Ma QY, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.37257; Maslo C, 2022, JAMA-J AM MED ASSOC, V327, P583, DOI 10.1001/jama.2021.24868; Qin A, 2022, NEW YORK TIMES 0115; Ulloa AC., 2021, MEDRXIV, DOI [10.1101/2021.12.24.21268382, DOI 10.1101/2021.12.24.21268382]; US Centers for Disease Control and Prevention, 2022, DIS BURD FLU	11	57	62	16	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					417	419		10.1016/S0140-6736(22)00100-3	http://dx.doi.org/10.1016/S0140-6736(22)00100-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35065006	Green Published			2022-12-28	WOS:000755141600006
J	McGarrity, TJ				McGarrity, Thomas J.			Roulette	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Roulette While facing an ophthalmic cancer diagnosis and treatment of his own, a gastroenterologist refocuses his good eye on his patients, helping them play whatever cards they have been dealt, as his scar is etched in survivor's guilt.	[McGarrity, Thomas J.] Penn State Hlth Milton S Hershey Med Ctr, Dept Gastroenterol & Hepatol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	McGarrity, TJ (corresponding author), Penn State Hlth Milton S Hershey Med Ctr, Dept Gastroenterol & Hepatol, Hershey, PA 17033 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					505	507		10.1056/NEJMp2112743	http://dx.doi.org/10.1056/NEJMp2112743		FEB 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YW0GW	35119806				2022-12-28	WOS:000751512500001
J	Hota, SK; Rao, KS; Blair, AP; Khalilimeybodi, A; Hu, KM; Thomas, R; So, K; Kameswaran, V; Xu, JW; Polacco, BJ; Desai, RV; Chatterjee, N; Hsu, A; Muncie, JM; Blotnick, AM; Winchester, SAB; Weinberger, LS; Huttenhain, R; Kathiriya, IS; Krogan, NJ; Saucerman, JJ; Bruneau, BG				Hota, Swetansu K.; Rao, Kavitha S.; Blair, Andrew P.; Khalilimeybodi, Ali; Hu, Kevin M.; Thomas, Reuben; So, Kevin; Kameswaran, Vasumathi; Xu, Jiewei; Polacco, Benjamin J.; Desai, Ravi, V; Chatterjee, Nilanjana; Hsu, Austin; Muncie, Jonathon M.; Blotnick, Aaron M.; Winchester, Sarah A. B.; Weinberger, Leor S.; Huttenhain, Ruth; Kathiriya, Irfan S.; Krogan, Nevan J.; Saucerman, Jeffrey J.; Bruneau, Benoit G.			Brahma safeguards canalization of cardiac mesoderm differentiation	NATURE			English	Article							CHROMATIN REMODELING COMPLEX; EXPRESSION ANALYSIS; COMPONENTS; REPRESSION; MUTATIONS; PACKAGE; GENES; RANGE; BRG1; BRM	Differentiation proceeds along a continuum of increasingly fate-restricted intermediates, referred to as canalization(1,2). Canalization is essential for stabilizing cell fate, but the mechanisms that underlie robust canalization are unclear. Here we show that the BRG1/BRM-associated factor (BAF) chromatin-remodelling complex ATPase gene Brm safeguards cell identity during directed cardiogenesis of mouse embryonic stem cells. Despite the establishment of a well-differentiated precardiac mesoderm, Brm(-/-) cells predominantly became neural precursors, violating germ layer assignment. Trajectory inference showed a sudden acquisition of a non-mesodermal identity in Brm(-/-) cells. Mechanistically, the loss of Brm prevented de novo accessibility of primed cardiac enhancers while increasing the expression of neurogenic factor POU3F1, preventing the binding of the neural suppressor REST and shifting the composition of BRG1 complexes. The identity switch caused by the Brm mutation was overcome by increasing BMP4 levels during mesoderm induction. Mathematical modelling supports these observations and demonstrates that Brm deletion affects cell fate trajectory by modifying saddle-node bifurcations(2). In the mouse embryo, Brm deletion exacerbated mesoderm-deleted Brg1-mutant phenotypes, severely compromising cardiogenesis, and reveals an in vivo role for Brm. Our results show that Brm is a compensable safeguard of the fidelity of mesoderm chromatin states, and support a model in which developmental canalization is not a rigid irreversible path, but a highly plastic trajectory.	[Hota, Swetansu K.; Rao, Kavitha S.; Blair, Andrew P.; Hu, Kevin M.; Thomas, Reuben; So, Kevin; Kameswaran, Vasumathi; Xu, Jiewei; Polacco, Benjamin J.; Desai, Ravi, V; Hsu, Austin; Muncie, Jonathon M.; Blotnick, Aaron M.; Winchester, Sarah A. B.; Weinberger, Leor S.; Huttenhain, Ruth; Kathiriya, Irfan S.; Krogan, Nevan J.; Bruneau, Benoit G.] Gladstone Inst, San Francisco, CA 94158 USA; [Hota, Swetansu K.; Rao, Kavitha S.; Hu, Kevin M.; So, Kevin; Kameswaran, Vasumathi; Hsu, Austin; Blotnick, Aaron M.; Winchester, Sarah A. B.; Kathiriya, Irfan S.; Bruneau, Benoit G.] Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA; [Hota, Swetansu K.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Khalilimeybodi, Ali; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Xu, Jiewei; Polacco, Benjamin J.; Huttenhain, Ruth; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Xu, Jiewei; Polacco, Benjamin J.; Huttenhain, Ruth; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Chatterjee, Nilanjana] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kathiriya, Irfan S.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Virginia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hota, SK; Bruneau, BG (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.; Hota, SK; Bruneau, BG (corresponding author), Roddenberry Ctr Stem Cell Biol & Med Gladstone, San Francisco, CA 94158 USA.; Hota, SK; Bruneau, BG (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Bruneau, BG (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	swetansu.hota@gladstone.ucsf.edu; benoit.bruneau@gladstone.ucsf.edu	Rao, Kavitha S/ABG-4636-2021; Hota, Swetansu/GRR-2697-2022; Hsu, Austin/GZK-8164-2022; Kameswaran, Vasumathi/AAJ-8771-2020	Rao, Kavitha S/0000-0001-5401-6989; Hota, Swetansu/0000-0003-3105-9729; Kameswaran, Vasumathi/0000-0003-2552-6183; Khalilimeybodi, Ali/0000-0001-9318-8433; So, Kevin/0000-0002-5193-7384; Polacco, Benjamin/0000-0003-1570-9234; Hu, Kevin/0000-0001-5513-7854	NIH/NHLBI [P01HL089707, P01HL146366, UM1HL098179, R01HL114948, R01HL137755]; American Heart Association [13POST17290043, 861914]; Tobacco Related Disease Research Program [22FT-0079]; NIH [2T32-HL007731-26]; Society for Pediatric Anesthesia, Hellman Family Fund; UCSF REAC Award; UCSF Department of Anesthesia and Perioperative Care; NIH/NCRR [C06 RR018928]; Roddenberry Foundation; Younger Family Fund	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Tobacco Related Disease Research Program(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society for Pediatric Anesthesia, Hellman Family Fund; UCSF REAC Award; UCSF Department of Anesthesia and Perioperative Care; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Roddenberry Foundation; Younger Family Fund	We thank N. Carli, Y. Hao, M. Bernardi and J. McGuire (Gladstone Genomics Core) for RNA-seq and 10x Genomics library preparation; staff at the UCSF Center for Applied Technologies for sequencing; E. Nora for help with Brm-AID strain construction; J. Zhang (Gladstone Transgenic Core) for mouse knockout generation; staff at the Gladstone Stem Cell Core for cell culture; R. Wang for ChIP-seq; K. Choudhary for ATAC-seq analysis; K. Claiborn for editorial assistance; and G. Maki for graphics. This work was supported by grants from the NIH/NHLBI (P01HL089707 and P01HL146366 to B.G.B. and N.J.K.; Bench to Bassinet Program UM1HL098179; and R01HL114948 to B.G.B. and R01HL137755 to J.J.S.); and postdoctoral fellowships from the American Heart Association (13POST17290043), Tobacco Related Disease Research Program (22FT-0079), NIH training grant (2T32-HL007731-26) and career development award (861914) from the American Heart Association to S.K.H. I.S.K. was supported by funds from the Society for Pediatric Anesthesia, Hellman Family Fund, UCSF REAC Award and the UCSF Department of Anesthesia and Perioperative Care. This work was also supported by an NIH/NCRR grant (C06 RR018928) to the J. David Gladstone Institutes, The Roddenberry Foundation and The Younger Family Fund (to B.G.B.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Bier E, 2015, SCIENCE, V348, DOI 10.1126/science.aaa5838; Bultman SJ, 2016, CARDIOVASC PATHOL, V25, P258, DOI 10.1016/j.carpath.2016.02.004; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eling N, 2018, CELL SYST, V7, P284, DOI 10.1016/j.cels.2018.06.011; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Gouti M, 2017, DEV CELL, V41, P243, DOI 10.1016/j.devcel.2017.04.002; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hota SK, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174086; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Jiang ZL, 2015, STEM CELLS DEV, V24, P2328, DOI 10.1089/scd.2015.0069; Kadoch C, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay1018; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Lambiotte R, 2014, IEEE T NETW SCI ENG, V1, P76, DOI 10.1109/TNSE.2015.2391998; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rhee HS, 2016, NEURON, V92, P1252, DOI 10.1016/j.neuron.2016.11.037; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Smith-Roe SL, 2013, MAMM GENOME, V24, P21, DOI 10.1007/s00335-012-9433-z; Takeuchi JK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1187; Teschendorff AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15599; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Treutlein B, 2016, NATURE, V534, P391, DOI 10.1038/nature18323; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Waddington C. H., 1957, STRATEGY GENES DISCU, P20; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Weber CM, 2021, NAT STRUCT MOL BIOL, V28, P501, DOI 10.1038/s41594-021-00604-7; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Xing HP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002613; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu QQ, 2014, ELIFE, V3, DOI 10.7554/eLife.02224; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	65	4	4	5	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					129	+		10.1038/s41586-021-04336-y	http://dx.doi.org/10.1038/s41586-021-04336-y			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35082446	Green Accepted			2022-12-28	WOS:000750429600031
J	Tauchert, SR; Volkov, M; Ehberger, D; Kazenwadel, D; Evers, M; Lange, H; Donges, A; Book, A; Kreuzpaintner, W; Nowak, U; Baum, P				Tauchert, S. R.; Volkov, M.; Ehberger, D.; Kazenwadel, D.; Evers, M.; Lange, H.; Donges, A.; Book, A.; Kreuzpaintner, W.; Nowak, U.; Baum, P.			Polarized phonons carry angular momentum in ultrafast demagnetization	NATURE			English	Article							MAGNETIC-ANISOTROPY; GYROMAGNETIC RATIO; REVERSAL; NI; CU	Magnetic phenomena are ubiquitous in nature and indispensable for modern science and technology, but it is notoriously difficult to change the magnetic order of a material in a rapid way. However, if a thin nickel film is subjected to ultrashort laser pulses, it loses its magnetic order almost completely within femtosecond timescales(1). This phenomenon is widespread(2-7) and offers opportunities for rapid information processing(8-11) or ultrafast spintronics at frequencies approaching those of light(8,9,12). Consequently, the physics of ultrafast demagnetization is central to modern materials research(1-7,13-28), but a crucial question has remained elusive: if a material loses its magnetization within mere femtoseconds, where is the missing angular momentum in such a short time? Here we use ultrafast electron diffraction to reveal in nickel an almost instantaneous, long-lasting, non-equilibrium population of anisotropic high-frequency phonons that appear within 150-750 fs. The anisotropy plane is perpendicular to the direction of the initial magnetization and the atomic oscillation amplitude is 2 pm. We explain these observations by means of circularly polarized phonons that quickly absorb the angular momentum of the spin system before macroscopic sample rotation. The time that is needed for demagnetization is related to the time it takes to accelerate the atoms. These results provide an atomistic picture of the Einstein-de Haas effect and signify the general importance of polarized phonons for non-equilibrium dynamics and phase transitions.	[Tauchert, S. R.; Volkov, M.; Kazenwadel, D.; Evers, M.; Lange, H.; Donges, A.; Nowak, U.; Baum, P.] Univ Konstanz, Fachbereich Phys, Constance, Germany; [Tauchert, S. R.; Volkov, M.; Ehberger, D.; Baum, P.] Ludwig Maximilians Univ Munchen, Garching, Germany; [Book, A.; Kreuzpaintner, W.] Tech Univ Munich, Phys Dept E21, Garching, Germany; [Kreuzpaintner, W.] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Kreuzpaintner, W.] Spallat Neutron Source Sci Ctr, Dongguan, Peoples R China	University of Konstanz; University of Munich; Technical University of Munich; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Baum, P (corresponding author), Univ Konstanz, Fachbereich Phys, Constance, Germany.; Baum, P (corresponding author), Ludwig Maximilians Univ Munchen, Garching, Germany.	peter.baum@uni-konstanz.de	Volkov, Mikhail/ABD-4080-2021; Nowak, Ulrich/P-9548-2018; Baum, Peter/B-7637-2008	Volkov, Mikhail/0000-0003-1594-8542; Nowak, Ulrich/0000-0003-2925-6774; Kreuzpaintner, Wolfgang/0000-0001-6107-0836; Kazenwadel, Daniel/0000-0003-0225-5317; Lange, Hannah/0000-0002-0051-2087; Book, Alexander/0000-0003-0127-6052; Baum, Peter/0000-0002-1521-8729	European Union [647771]; German Research Foundation (DFG) [SFB 1432]	European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	We thank I. Wimmer for magnetic hysteresis data, B.-H. Chen for help with the optics, S. Geprags for access to his X-ray diffractometer and F. Krausz for laboratory infrastructure. This research was supported by the European Union's Horizon 2020 research and innovation program via CoG 647771 and by the German Research Foundation (DFG) via SFB 1432.	Battiato M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.027203; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; BIRGENEAU RJ, 1964, PHYS REV A-GEN PHYS, V136, P1359, DOI 10.1103/PhysRev.136.A1359; Bjorck M, 2007, J APPL CRYSTALLOGR, V40, P1174, DOI 10.1107/S0021889807045086; Carva K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207201; Cemin F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01755-8; CHANG CA, 1990, J APPL PHYS, V68, P4873, DOI 10.1063/1.346127; CHANG CA, 1991, J MAGN MAGN MATER, V97, P102, DOI 10.1016/0304-8853(91)90166-8; Chen L, 2013, CRYST GROWTH DES, V13, P2075, DOI 10.1021/cg400142g; Chen ZH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8000; Coleman SP, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/5/055020; DANAN H, 1968, J APPL PHYS, V39, P669, DOI 10.1063/1.2163571; Disa AS, 2020, NAT PHYS, V16, P937, DOI 10.1038/s41567-020-0936-3; Dornes C, 2019, NATURE, V565, P209, DOI 10.1038/s41586-018-0822-7; Ehberger D, 2019, PHYS REV APPL, V11, DOI 10.1103/PhysRevApplied.11.024034; Eschenlohr A, 2013, NAT MATER, V12, P332, DOI [10.1038/NMAT3546, 10.1038/nmat3546]; Farle M, 1997, PHYS REV B, V55, P3708, DOI 10.1103/PhysRevB.55.3708; Fechner M, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.064401; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Frietsch B, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb1601; Frietsch B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9262; Gao MN, 2018, NANO LETT, V18, P4424, DOI 10.1021/acs.nanolett.8b01487; Garanin DA, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.024421; Graves CE, 2013, NAT MATER, V12, P293, DOI [10.1038/NMAT3597, 10.1038/nmat3597]; Grissonnanche G, 2020, NAT PHYS, V16, P1108, DOI 10.1038/s41567-020-0965-y; Grossinger R, 2014, IOP CONF SER-MAT SCI, V60, DOI 10.1088/1757-899X/60/1/012002; Guo GY, 2000, J MAGN MAGN MATER, V209, P33, DOI 10.1016/S0304-8853(99)00639-3; Hinzke D, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.054412; HIRASHITA N, 1990, APPL PHYS LETT, V56, P451, DOI 10.1063/1.102762; Hofherr M, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.174419; Hull CM, 2018, ACS APPL MATER INTER, V10, P38596, DOI 10.1021/acsami.8b13188; Ji JY, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.115309; Jiang H, 1998, J VAC SCI TECHNOL A, V16, P3376, DOI 10.1116/1.581489; Kasmi L, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/033008; Kealhofer C, 2016, SCIENCE, V352, P429, DOI 10.1126/science.aae0003; KITTEL C, 1949, PHYS REV, V76, P743, DOI 10.1103/PhysRev.76.743; Koopmans B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267207; Koopmans B, 2010, NAT MATER, V9, P259, DOI [10.1038/NMAT2593, 10.1038/nmat2593]; Kreuzpaintner W, 2008, J APPL PHYS, V104, DOI 10.1063/1.3032383; La-O-Vorakiat C, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.011005; LEE EW, 1955, REP PROG PHYS, V18, P184, DOI 10.1088/0034-4885/18/1/305; Maldonado P, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.100302; Malinowski G, 2008, NAT PHYS, V4, P855, DOI 10.1038/nphys1092; Mazzara C, 1999, SURF SCI, V427-28, P208, DOI 10.1016/S0039-6028(99)00266-6; Melnikov A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076601; Miller RJD, 2014, SCIENCE, V343, P1108, DOI 10.1126/science.1248488; Ostler TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1666; Pateras A, 2019, NPG ASIA MATER, V11, DOI 10.1038/s41427-019-0160-8; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Radu I, 2011, NATURE, V472, P205, DOI 10.1038/nature09901; Roth T, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.021006; Rudolf D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2029; Sandia National Laboratories LAMMPS, 2019, LAMMPS LARG SCAL ATO; Schellekens AJ, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4812658; Schmehl A, 2018, NUCL INSTRUM METH A, V883, P170, DOI 10.1016/j.nima.2017.11.086; Schmising CV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.217203; SCOTT GG, 1962, REV MOD PHYS, V34, P102, DOI 10.1103/RevModPhys.34.102; SCOTT GG, 1952, PHYS REV, V87, P697, DOI 10.1103/PhysRev.87.697; Seidel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01504-x; Siegrist F, 2019, NATURE, V571, P240, DOI 10.1038/s41586-019-1333-x; SIMERSKA M, 1962, CZECH J PHYS, V12, P54, DOI 10.1007/BF01688397; Srinivasan R, 2003, HELV CHIM ACTA, V86, P1763; Stamm C, 2007, NAT MATER, V6, P740, DOI 10.1038/nmat1985; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.047601; TENGDIN P, 2018, SCI ADV, DOI DOI 10.1126/SCIENCE.AAW9486; VANVLECK JH, 1950, PHYS REV, V78, P266, DOI 10.1103/PhysRev.78.266; Volkov M, 2019, NAT PHYS, V15, P1145, DOI 10.1038/s41567-019-0602-9; Wang X, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220301; Warren B, 1990, XRAY DIFFRACTION, P253; Wienholdt S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020406; Wietstruk M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.127401; Ye JF, 2020, NUCL INSTRUM METH A, V964, DOI 10.1016/j.nima.2020.163710; You WJ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.077204; Zahn D, 2021, PHYS REV RES, V3, DOI 10.1103/PhysRevResearch.3.023032; Zhang LF, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.085503; Zhu HY, 2018, SCIENCE, V359, P579, DOI 10.1126/science.aar2711	76	16	16	37	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					73	77		10.1038/s41586-021-04306-4	http://dx.doi.org/10.1038/s41586-021-04306-4			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110761	Green Submitted			2022-12-28	WOS:000750429600021
J	Kumar, A; Preston, N; Phillips, R				Kumar, Alexander; Preston, Nicholas; Phillips, Richard			Picturing health: Buruli ulcer in Ghana	LANCET			English	Editorial Material									[Kumar, Alexander] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Kumar, Alexander] Global Hlth Creat, London, England; [Preston, Nicholas] NavigAID Inc, Mayne Isl, BC, Canada; [Phillips, Richard] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Phillips, Richard] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med & Dent, Kumasi, Ghana	University of London; King's College London; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Kumar, A (corresponding author), Kings Coll London, Sch Populat Hlth & Environm Sci, London, England.; Kumar, A (corresponding author), Global Hlth Creat, London, England.								0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					786	797		10.1016/S0140-6736(22)00157-X	http://dx.doi.org/10.1016/S0140-6736(22)00157-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	35093204				2022-12-28	WOS:000762307100013
J	Eichmuller, OL; Corsini, NS; Vertesy, A; Morassut, I; Scholl, T; Gruber, VE; Peer, AM; Chu, JL; Novatchkova, M; Hainfellner, JA; Paredes, MF; Feucht, M; Knoblich, JA				Eichmueller, Oliver L.; Corsini, Nina S.; Vertesy, Abel; Morassut, Ilaria; Scholl, Theresa; Gruber, Victoria-Elisabeth; Peer, Angela M.; Chu, Julia; Novatchkova, Maria; Hainfellner, Johannes A.; Paredes, Mercedes F.; Feucht, Martha; Knoblich, Juergen A.			Amplification of human interneuron progenitors promotes brain tumors and neurological defects	SCIENCE			English	Article							GIANT-CELL ASTROCYTOMA; TUBEROUS SCLEROSIS COMPLEX; CORTICAL TUBERS; STEM-CELLS; TSC1; CANCER; LESIONS; MODEL; ABNORMALITIES; EXPRESSION	Evolutionary development of the human brain is characterized by the expansion of various brain regions. Here, we show that developmental processes specific to humans are responsible for malformations of cortical development (MCDs), which result in developmental delay and epilepsy in children. We generated a human cerebral organoid model for tuberous sclerosis complex (TSC) and identified a specific neural stem cell type, caudal late interneuron progenitor (CLIP) cells. In TSC, CLIP cells overproliferate, generating excessive interneurons, brain tumors, and cortical malformations. Epidermal growth factor receptor inhibition reduces tumor burden, identifying potential treatment options for TSC and related disorders. The identification of CLIP cells reveals the extended interneuron generation in the human brain as a vulnerability for disease. In addition, this work demonstrates that analyzing MCDs can reveal fundamental insights into human-specific aspects of brain development.	[Eichmueller, Oliver L.; Corsini, Nina S.; Vertesy, Abel; Morassut, Ilaria; Peer, Angela M.; Novatchkova, Maria; Knoblich, Juergen A.] Austrian Acad Sci, Vienna Bioctr VBC, Inst Mol Biotechnol IMBA, Vienna, Austria; [Eichmueller, Oliver L.] Heidelberg Univ, Heidelberg, Germany; [Scholl, Theresa; Gruber, Victoria-Elisabeth; Feucht, Martha] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Chu, Julia; Paredes, Mercedes F.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Hainfellner, Johannes A.; Knoblich, Juergen A.] Med Univ Vienna, Dept Neurol, Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Ruprecht Karls University Heidelberg; Medical University of Vienna; University of California System; University of California San Francisco; Medical University of Vienna	Corsini, NS; Knoblich, JA (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, Inst Mol Biotechnol IMBA, Vienna, Austria.; Knoblich, JA (corresponding author), Med Univ Vienna, Dept Neurol, Vienna, Austria.	nina.corsini@imba.oeaw.ac.at; juergen.knoblich@imba.oeaw.ac.at		Morassut, Ilaria/0000-0001-9735-9308; Feucht, Martha/0000-0001-7691-8158; Scholl, Theresa/0000-0002-9835-7328; Gruber, Victoria-Elisabeth/0000-0002-6153-9291; Corsini, Nina/0000-0001-6731-3544; Eichmuller, Oliver L/0000-0002-1077-403X				Agu CA, 2015, STEM CELL REP, V5, P660, DOI 10.1016/j.stemcr.2015.08.012; Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bhaduri A, 2020, NATURE, V578, P142, DOI 10.1038/s41586-020-1962-0; Bhaduri A, 2020, CELL STEM CELL, V26, P48, DOI 10.1016/j.stem.2019.11.015; Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y; Buccoliero AM, 2009, NEUROPATHOLOGY, V29, P25, DOI 10.1111/j.1440-1789.2008.00934.x; Buccoliero AM, 2016, CLIN NEUROPATHOL, V35, P295, DOI 10.5414/NP300936; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Cotter JA, 2020, ACTA NEUROPATHOL, V139, P613, DOI 10.1007/s00401-019-02003-1; Crino PB, 2013, ACTA NEUROPATHOL, V125, P317, DOI 10.1007/s00401-013-1085-x; Danecek P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155014; Eichmuller O., 2021, Zenodo, DOI 10.5281/zenodo.5741170; Eichmuller O., 2021, OliverEichmueller/TSC_Science2021: Reference scripts, DOI 10.5281/zenodo.5741170; Feliciano DM, 2012, HUM MOL GENET, V21, P799, DOI 10.1093/hmg/ddr511; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Franz DN, 2014, LANCET ONCOL, V15, P1513, DOI 10.1016/S1470-2045(14)70489-9; Garcia Maxime, 2020, F1000Res, V9, P63, DOI 10.12688/f1000research.16665.2; Gelot AB, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00899; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hang JF, 2017, MODERN PATHOL, V30, P318, DOI 10.1038/modpathol.2016.205; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Henske EP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.35; Henske EP, 1996, AM J HUM GENET, V59, P400; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Huang W, 2020, CELL, V182, P594, DOI 10.1016/j.cell.2020.06.027; Hui KK, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8237; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson MW, 1999, BRAIN PATHOL, V9, P45; Kerfoot C, 1996, BRAIN PATHOL, V6, P367, DOI 10.1111/j.1750-3639.1996.tb00866.x; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Krueger DA, 2016, NEUROLOGY, V87, P2408, DOI 10.1212/WNL.0000000000003400; KUZNIECKY RI, 1995, MAGN RESON IMAGING, V13, P1137, DOI 10.1016/0730-725X(95)02024-N; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lim JS, 2017, AM J HUM GENET, V100, P454, DOI 10.1016/j.ajhg.2017.01.030; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816; Martins F, 2013, ORAL ONCOL, V49, P293, DOI 10.1016/j.oraloncology.2012.11.008; McGinnis CS, 2019, NAT METHODS, V16, P619, DOI 10.1038/s41592-019-0433-8; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [10.21105/joss.00861, DOI 10.21105/JOSS.00861]; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Mizuguchi M, 2001, BRAIN DEV-JPN, V23, P508, DOI 10.1016/S0387-7604(01)00304-7; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Park SH, 1997, ACTA NEUROPATHOL, V94, P180, DOI 10.1007/s004010050691; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Raju CS, 2018, CEREB CORTEX, V28, P1946, DOI 10.1093/cercor/bhx101; Ruppe V, 2014, EPILEPSIA, V55, P539, DOI 10.1111/epi.12545; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x; Vinters HV, 1998, EPILEPSY RES, V32, P12, DOI 10.1016/S0920-1211(98)00036-9; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211	60	17	17	15	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					401	+	eabf5546	10.1126/science.abf5546	http://dx.doi.org/10.1126/science.abf5546			74	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084981	Green Accepted			2022-12-28	WOS:000750899500029
J	Kessaris, N				Kessaris, Nicoletta			Human cortical interneuron development unraveled	SCIENCE			English	Editorial Material									[Kessaris, Nicoletta] UCL, Wolfson Inst Biomed Res, Gower St, London, England; [Kessaris, Nicoletta] UCL, Dept Cell & Dev Biol, Gower St, London, England	University of London; University College London; University of London; University College London	Kessaris, N (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London, England.; Kessaris, N (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London, England.	n.kessaris@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019	Kessaris, Nicoletta/0000-0003-1191-6009	UK Biotechnology and Biological Sciences Research Council [BB/N009061/1]; UK Wellcome Trust [108726/Z/15/Z]	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Wellcome Trust(Wellcome Trust)	I thank W. Richardson, D. Kullmann, and H. Kessaris for comments and discussion. Funding is provided by the UK Biotechnology and Biological Sciences Research Council (BB/N009061/1) and the UK Wellcome Trust (108726/Z/15/Z).	Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hu JS, 2017, DEVELOPMENT, V144, P3867, DOI 10.1242/dev.132852; Hunt RF, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022376; Kessaris N, 2014, CURR OPIN NEUROBIOL, V26, P79, DOI 10.1016/j.conb.2013.12.012; Krienen FM, 2020, NATURE, V586, P262, DOI 10.1038/s41586-020-2781-z; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Mayer C, 2018, NATURE, V555, P457, DOI 10.1038/nature25999; Mi D, 2018, SCIENCE, V360, P81, DOI 10.1126/science.aar6821; Paredes M. F., 2022, SCIENCE, V375; Shi P, 2021, SCIENCE, V374, DOI 10.1126/science.abm7979; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yu Y, 2021, NAT NEUROSCI, V24, P1745, DOI 10.1038/s41593-021-00940-3	15	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					383	384		10.1126/science.abn6333	http://dx.doi.org/10.1126/science.abn6333			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084977	Green Submitted			2022-12-28	WOS:000750899500021
J	Chen, SD; Hashimoto, M; He, Y; Song, D; He, JF; Li, YF; Ishida, S; Eisaki, H; Zaanen, J; Devereaux, TP; Lee, DH; Lu, DH; Shen, ZX				Chen, Su-Di; Hashimoto, Makoto; He, Yu; Song, Dongjoon; He, Jun-Feng; Li, Ying-Fei; Ishida, Shigeyuki; Eisaki, Hiroshi; Zaanen, Jan; Devereaux, Thomas P.; Lee, Dung-Hai; Lu, Dong-Hui; Shen, Zhi-Xun			Unconventional spectral signature of T-c in a pure d-wave superconductor	NATURE			English	Article							PHASE FLUCTUATIONS; PAIR FORMATION; TEMPERATURE; PSEUDOGAP	In conventional superconductors, the phase transition into a zero-resistance and perfectly diamagnetic state is accompanied by a jump in the specific heat and the opening of a spectral gap(1). In the high-transition-temperature (high-T-c) cuprates, although the transport, magnetic and thermodynamic signatures of T-c have been known since the 1980s(2), the spectroscopic singularity associated with the transition remains unknown. Here we resolve this long-standing puzzle with a high-precision angle-resolved photoemission spectroscopy (ARPES) study on overdoped (Bi,Pb)(2)Sr2CaCu2O8+delta (Bi2212). We first probe the momentum-resolved electronic specific heat via spectroscopy and reproduce the specific heat peak at T-c, completing the missing link for a holistic description of superconductivity. Then, by studying the full momentum, energy and temperature evolution of the spectra, we reveal that this thermodynamic anomaly arises from the singular growth of in-gap spectral intensity across T-c. Furthermore, we observe that the temperature evolution of in-gap intensity is highly anisotropic in the momentum space, and the gap itself obeys both the d-wave functional form and particle-hole symmetry. These findings support the scenario that the superconducting transition is driven by phase fluctuations. They also serve as an anchor point for understanding the Fermi arc and pseudogap phenomena in underdoped cuprates.	[Chen, Su-Di; He, Yu; He, Jun-Feng; Li, Ying-Fei; Shen, Zhi-Xun] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Su-Di; He, Yu; He, Jun-Feng; Li, Ying-Fei; Shen, Zhi-Xun] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Chen, Su-Di; He, Yu; He, Jun-Feng; Li, Ying-Fei; Devereaux, Thomas P.; Shen, Zhi-Xun] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Chen, Su-Di; He, Yu; He, Jun-Feng; Li, Ying-Fei; Devereaux, Thomas P.; Shen, Zhi-Xun] Stanford Univ, Menlo Pk, CA USA; [Hashimoto, Makoto; Lu, Dong-Hui] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Song, Dongjoon; Ishida, Shigeyuki; Eisaki, Hiroshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Zaanen, Jan] Leiden Univ, Inst Lorentz Theoret Phys, Leiden, Netherlands; [Devereaux, Thomas P.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Lee, Dung-Hai] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lee, Dung-Hai] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA USA; [Chen, Su-Di] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [He, Yu] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Song, Dongjoon] Inst for Basic Sci Korea, Ctr Correlated Electron Syst, Seoul, South Korea; [He, Jun-Feng] Univ Sci & Technol China, Dept Phys, Hefei, Peoples R China	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Institute of Advanced Industrial Science & Technology (AIST); Leiden University; Leiden University - Excl LUMC; Stanford University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yale University; Institute for Basic Science - Korea (IBS); Chinese Academy of Sciences; University of Science & Technology of China, CAS	Shen, ZX (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.; Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Shen, ZX (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.; Shen, ZX (corresponding author), Stanford Univ, Menlo Pk, CA USA.	zxshen@stanford.edu	; Ishida, Shigeyuki/L-6231-2018	Song, Dongjoon/0000-0003-3759-9646; He, Junfeng/0000-0001-5584-9827; He, YU/0000-0003-0425-4529; Ishida, Shigeyuki/0000-0001-9445-8079; Hashimoto, Makoto/0000-0003-1689-8997; devereaux, thomas/0000-0001-8072-9237	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05-CH11231, KC2202]	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	We thank S.A. Kivelson, M.Sulangi, J.L. Tallon, and F.Wang for discussions, and J.L. Tallon for sharing the specific heat data. We thank J.-J.Wen, W.He, and Y.S. Lee for help with magnetic susceptibility measurements. Synchrotron ARPES measurements were performed at Beamline 5-4, Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory. The works at Stanford University and SLAC are supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, under contract no. DE-AC02-76SF00515. The works at UC Berkeley and LBNL are supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division under contract no. DE-AC02-05-CH11231 within the Quantum Materials Program (KC2202).	BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.247001; Bozovic I, 2016, NATURE, V536, P309, DOI 10.1038/nature19061; Chen S.-D., 2021, THESIS STANFORD U; Chen SD, 2019, SCIENCE, V366, P1099, DOI 10.1126/science.aaw8850; Cuk T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.117003; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Eckl T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.140510; Franz M, 1998, PHYS REV B, V58, P14572, DOI 10.1103/PhysRevB.58.14572; Gomes KK, 2007, NATURE, V447, P569, DOI 10.1038/nature05881; Hashimoto M, 2015, NAT MATER, V14, P37, DOI [10.1038/nmat4116, 10.1038/NMAT4116]; He Y, 2021, PHYS REV X, V11, DOI 10.1103/PhysRevX.11.031068; JANKE W, 1990, PHYS REV B, V42, P10673, DOI 10.1103/PhysRevB.42.10673; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Kondo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8699; Kondo T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.157003; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Lee-Hone NR, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.024501; Li L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054510; Li ZX, 2021, NPJ QUANTUM MATER, V6, DOI 10.1038/s41535-021-00335-4; Loram JW, 2001, J PHYS CHEM SOLIDS, V62, P59, DOI 10.1016/S0022-3697(00)00101-3; Mannella N, 2004, J ELECTRON SPECTROSC, V141, P45, DOI 10.1016/j.elspec.2004.03.009; Norman MR, 2000, PHYS REV B, V61, P14742, DOI 10.1103/PhysRevB.61.14742; PRESLAND MR, 1991, PHYSICA C, V176, P95, DOI 10.1016/0921-4534(91)90700-9; Reber TJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4870283; Reber TJ, 2012, NAT PHYS, V8, P606, DOI [10.1038/NPHYS2352, 10.1038/nphys2352]; Reber T. J., 2015, PAIRING PAIR BREAKIN; Sobota JA, 2021, REV MOD PHYS, V93, DOI 10.1103/RevModPhys.93.025006; Tallon JL, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.174512; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; UEMURA YJ, 1993, NATURE, V364, P605, DOI 10.1038/364605a0; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; Zaki N, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.195163	36	1	1	15	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					562	+		10.1038/s41586-021-04251-2	http://dx.doi.org/10.1038/s41586-021-04251-2			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082417				2022-12-28	WOS:000749546400024
J	Kahwati, LC; Asher, GN; Kadro, ZO; Keen, S; Ali, R; Coker-Schwimmer, E; Jonas, DE				Kahwati, Leila C.; Asher, Gary N.; Kadro, Zachary O.; Keen, Susan; Ali, Rania; Coker-Schwimmer, Emmanuel; Jonas, Daniel E.			Screening for Atrial Fibrillation Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COMPOSITE END-POINTS; STROKE PREVENTION; RANDOMIZED-TRIAL; ROUTINE PRACTICE; AGED 65; POPULATION; RISK; METAANALYSIS; ACCURACY; WARFARIN	IMPORTANCE Atrial fibrillation (AF), the most common arrhythmia, increases the risk of stroke. OBJECTIVE To review the evidence on screening for AF in adults without prior stroke to inform the US Preventive Services Task Force. DATA SOURCES PubMed, Cochrane Library, and trial registries through October 5, 2020; references, experts, and literature surveillance through October 31, 2021. STUDY SELECTION Randomized clinical trials (RCTs) of screening among asymptomatic persons without known AF or prior stroke; test accuracy studies; RCTs of anticoagulation among persons with AF; systematic reviews; and observational studies reporting harms. DATA EXTRACTION AND SYNTHESIS Two reviewers assessed titles/abstracts, full-text articles, and study quality and extracted data; when at least 3 similar studies were available, meta-analyses were conducted. MAIN OUTCOMES AND MEASURES Detection of undiagnosed AF, test accuracy, mortality, stroke, stroke-related morbidity, and harms. RESULTS Twenty-six studies (N = 113 784) were included. In 1 RCT (n = 28 768) of twice-daily electrocardiography (ECG) screening for 2 weeks, the likelihood of a composite end point (ischemic stroke, hemorrhagic stroke, systemic embolism, all-cause mortality, and hospitalization for bleeding) was lower in the screened group over 6.9 years (hazard ratio, 0.96 [95% CI, 0.92-1.00]; P = .045), but that study had numerous limitations. In 4 RCTs (n = 32 491), significantly more AF was detected with intermittent and continuous ECG screening compared with no screening (risk difference range, 1.0%-4.8%). Treatment with warfarin over a mean of 1.5 years in populations with clinical, mostly persistent AF was associated with fewer ischemic strokes (pooled risk ratio [RR], 0.32 [95% CI, 0.20-0.51]; 5 RCTs; n = 2415) and lower all-cause mortality (pooled RR, 0.68 [95% CI, 0.50-0.93]) compared with placebo. Treatment with direct oral anticoagulants was also associated with lower incidence of stroke (adjusted odds ratios range, 0.32-0.44) in indirect comparisons with placebo. The pooled RR for major bleeding for warfarin compared with placebo was 1.8 (95% CI. 0.85-3.7; 5 RCTs; n = 2415), and the adjusted odds ratio for major bleeding for direct oral anticoagulants compared with placebo or no treatment ranged from 1.38 to 2.21, but CIs did not exclude a null effect. CONCLUSIONS AND RELEVANCE Although screening can detect more cases of unknown AF, evidence regarding effects on health outcomes is limited. Anticoagulation was associated with lower risk of first stroke and mortality but with increased risk of major bleeding, although estimates for this harm are imprecise; no trials assessed benefits and harms of anticoagulation among screen-detected populations.	[Kahwati, Leila C.; Asher, Gary N.; Kadro, Zachary O.; Keen, Susan; Ali, Rania; Coker-Schwimmer, Emmanuel; Jonas, Daniel E.] Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC 27515 USA; [Kahwati, Leila C.; Ali, Rania] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Asher, Gary N.; Keen, Susan] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA; [Kadro, Zachary O.] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Coker-Schwimmer, Emmanuel; Jonas, Daniel E.] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University	Kahwati, LC (corresponding author), Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC 27515 USA.; Kahwati, LC (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	lkahwati@rti.org		Keen, Susan/0000-0003-1238-7006; Kahwati, Leila/0000-0001-6963-2848; Kadro, Zachary/0000-0003-3894-9804	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2015-00011-I]; National Center for Complementary and Integrative Health National Research Service Award (NRSA) Institutional Research Training Program (T32) at University of North Carolina [5T32AT003378-13, 5T32AT003378-14]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; National Center for Complementary and Integrative Health National Research Service Award (NRSA) Institutional Research Training Program (T32) at University of North Carolina	This project was funded under contract HHSA-290-2015-00011-I, Task Order 15, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, to support the US Preventive Services Task Force (USPSTF). Dr Kadro was supported by the National Center for Complementary and Integrative Health National Research Service Award (NRSA) Institutional Research Training Program (T32) at University of North Carolina, grants 5T32AT003378-13 and 5T32AT003378-14.	Aguilar MI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001927.pub2; [Anonymous], 2021, PROC MAN APP 13 SUMM; Armstrong PW, 2017, CIRCULATION, V135, P2299, DOI 10.1161/CIRCULATIONAHA.117.026229; Bassand JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191592; Bogun F, 2004, AM J MED, V117, P636, DOI 10.1016/j.amjmed.2004.06.024; Choi SW, 2016, ANAESTHESIA, V71, P1101, DOI 10.1111/anae.13590; Coleman CI, 2012, INT J CLIN PRACT, V66, P53, DOI 10.1111/j.1742-1241.2011.02809.x; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P478, DOI 10.1001/jama.2018.10321; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donal E, 2015, EUR J HEART FAIL, V17, P680, DOI 10.1002/ejhf.291; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fitzmaurice DA, 2014, FAM PRACT, V31, P298, DOI 10.1093/fampra/cmu011; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Friberg L, 2013, EUROPACE, V15, P135, DOI 10.1093/europace/eus217; Gladstone DJ, 2021, JAMA CARDIOL, V6, P558, DOI 10.1001/jamacardio.2021.0038; Gomez G, 2014, CIRC-CARDIOVASC QUAL, V7, P170, DOI 10.1161/CIRCOUTCOMES.113.000149; Halcox JPJ, 2017, CIRCULATION, V136, P1784, DOI 10.1161/CIRCULATIONAHA.117.030583; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Himmelreich JCL, 2019, ANN FAM MED, V17, P403, DOI 10.1370/afm.2438; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kaasenbrood F, 2020, BRIT J GEN PRACT, V70, pE427, DOI 10.3399/bjgp20X708161; Kahwati L, AHRQ PUBLICATION, V21; Kearley K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004565; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Lahtela H, 2012, CIRC J, V76, P1363, DOI 10.1253/circj.CJ-11-1206; Mant J, 2007, BMJ-BRIT MED J, V335, P380, DOI 10.1136/bmj.39227.551713.AE; Marazzi G, 2012, ADV THER, V29, P64, DOI 10.1007/s12325-011-0087-0; MCBRIDE R, 1990, NEW ENGL J MED, V322, P863; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Okunrintemi V, 2020, CIRCULATION, V142; PETERSEN P, 1989, LANCET, V1, P175; Philippsen Tine J, 2017, JACC Clin Electrophysiol, V3, P1557, DOI 10.1016/j.jacep.2017.06.020; Sabar MI, 2019, PACE, V42, P1383, DOI 10.1111/pace.13800; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Staerk L, 2017, CIRC RES, V120, P1501, DOI 10.1161/CIRCRESAHA.117.309732; Steinhubl SR, 2018, JAMA-J AM MED ASSOC, V320, P146, DOI 10.1001/jama.2018.8102; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Svennberg E, 2021, LANCET, V398, P1498, DOI 10.1016/S0140-6736(21)01637-8; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Swancutt Dawn, 2004, BMC Cardiovasc Disord, V4, P12, DOI 10.1186/1471-2261-4-12; Tereshchenko LG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003206; Uittenbogaart SB, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3208; van Walraven C, 2009, STROKE, V40, P1410, DOI 10.1161/STROKEAHA.108.526988; Wiesel J, 2014, AM J CARDIOL, V114, P1046, DOI 10.1016/j.amjcard.2014.07.016	49	8	8	11	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					368	383		10.1001/jama.2021.21811	http://dx.doi.org/10.1001/jama.2021.21811			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076660	Bronze			2022-12-28	WOS:000753055700014
J	Lai, FTT; Li, X; Peng, K; Huang, L; Ip, P; Tong, XN; Chui, CSL; Wan, EYF; Wong, CKH; Chan, EWY; Siu, DCW; Wong, ICK				Lai, Francisco Tsz Tsun; Li, Xue; Peng, Kuan; Huang, Lei; Ip, Patrick; Tong, Xinning; Chui, Celine Sze Ling; Wan, Eric Yuk Fai; Wong, Carlos King Ho; Chan, Esther Wai Yin; Siu, David Chung Wah; Wong, Ian Chi Kei			Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine A Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDITIS; ASSOCIATION	Background: Case reports of carditis after BNT162b2 vaccination are accruing worldwide. Objective: To examine the association of BNT162b2 and CoronaVac (Sinovac) vaccination with carditis. Design: Case-control study with hospital control participants. Setting: Territory-wide, public health care database with linkage to population-based vaccination records in Hong Kong. Patients: Inpatients aged 12 years or older first diagnosed with carditis were selected as case patients. All other hospitalized patients without carditis were treated as control participants. Ten control participants were randomly matched with each case patient by age, sex, and admission date. Intervention: Vaccination with BNT162b2 or CoronaVac. Measurements: Incident diagnosis of carditis based on the International Classification of Diseases, elevated troponin levels. Results: A total of 160 case patients and 1533 control participants were included. Incidence of carditis per 100 000 doses of CoronaVac and BNT162b2 administered was estimated to be 0.31 (95% CI, 0.13 to 0.66) and 0.57 (CI, 0.36 to 0.90), respectively. Multivariable analyses showed that recipients of the BNT162b2 vaccine had higher odds of carditis (adjusted odds ratio [OR], 3.57 [CI, 1.93 to 6.60]) than unvaccinated persons. Stratified by sex, the OR was 4.68 (CI, 2.25 to 9.71) for males and 2.22 (CI, 0.57 to 8.69) for females receiving the BNT162b2 vaccine. The ORs for adults and adolescents receiving the BNT162b2 vaccine were 2.41 (CI, 1.18 to 4.90) and 13.79 (CI, 2.86 to 110.38), respectively. Subanalysis showed an OR of 9.29 (CI, 3.94 to 21.91) for myocarditis and 1.06 (CI, 0.35 to 3.22) for pericarditis associated with BNT162b2. The risk was mainly seen after the second dose of BNT162b2 rather than the first. No association between CoronaVac and carditis with a magnitude similar to that for BNT162b2 was seen. Limitation: Limited sample size, absence of electrocardiography and other clinical investigative data, and unrecorded overseas vaccination exposure. Conclusion: Despite a low absolute risk, there is an increased risk for carditis associated with BNT162b2 vaccination. This elevated risk should be weighed against the benefits of vaccination.	[Lai, Francisco Tsz Tsun; Li, Xue; Peng, Kuan; Huang, Lei; Wan, Eric Yuk Fai; Wong, Carlos King Ho; Chan, Esther Wai Yin; Wong, Ian Chi Kei] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Lai, Francisco Tsz Tsun; Chui, Celine Sze Ling; Wan, Eric Yuk Fai; Wong, Carlos King Ho; Chan, Esther Wai Yin; Wong, Ian Chi Kei] Lab Data Discovery Hlth D24H, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Li, Xue] Univ Hong Kong, Dept Med, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Ip, Patrick] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China; [Tong, Xinning; Siu, David Chung Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Peoples R China; [Chui, Celine Sze Ling] Univ Hong Kong, Sch Nursing, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Chui, Celine Sze Ling] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Wan, Eric Yuk Fai; Wong, Carlos King Ho] Univ Hong Kong, Dept Family Med & Primary Care, Li Ka Shing Fac Med, Hong Kong Sci Pk,Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Wong, Ian Chi Kei] UCL, Sch Pharm, Res Dept Practice & Policy, London, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of London; University College London; University of London School of Pharmacy	Wong, ICK (corresponding author), 2-F Lab Block,21 Sassoon Rd, Hong Kong, Peoples R China.	wongick@hku.hk	Lai, Francisco TT/F-3842-2019; WAN, Eric Yuk Fai/A-1681-2015; Chan, Esther Wai Yin/B-3522-2012; Wong, Carlos King-ho/B-4322-2011	Lai, Francisco TT/0000-0002-9121-1959; Li, Xue/0000-0003-4836-7808; Tong, Xinning/0000-0003-2310-0365; Chui, Sze Ling Celine/0000-0003-1513-8726; WAN, Eric Yuk Fai/0000-0002-6275-1147; Chan, Esther Wai Yin/0000-0002-7602-9470; Wong, Carlos King-ho/0000-0002-6895-6071	Food and Health Bureau, The Government of the Hong Kong Special Administrative Region [COVID19F01]	Food and Health Bureau, The Government of the Hong Kong Special Administrative Region	By a research grant from the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (reference COVID19F01).	Abu Mouch S, 2021, VACCINE, V39, P3790, DOI 10.1016/j.vaccine.2021.05.087; Barda N, 2021, NEW ENGL J MED, V385, P1078, DOI 10.1056/NEJMoa2110475; Boehmer TK, 2021, MMWR-MORBID MORTAL W, V70, P1228, DOI 10.15585/mmwr.mm7035e5; Borobia AM, 2021, LANCET, V398, P121, DOI 10.1016/S0140-6736(21)01420-3; Bozkurt B, 2021, CIRCULATION, V144, P471, DOI 10.1161/CIRCULATIONAHA.121.056135; Brighton Collaboration, MYOC PER CAS FIN; Dionne A, 2021, JAMA CARDIOL, V6, P1446, DOI 10.1001/jamacardio.2021.3471; Doctor NS, 2017, PROG CARDIOVASC DIS, V59, P349, DOI 10.1016/j.pcad.2016.12.001; European Medicines Agency, EMA COMM IND RES PRE; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Frenck RW, 2021, NEW ENGL J MED, V385, P239, DOI 10.1056/NEJMoa2107456; King William W, 2021, Am Heart J Plus, V8, P100042, DOI 10.1016/j.ahjo.2021.100042; Klein NP, 2021, JAMA-J AM MED ASSOC, V326, P1390, DOI 10.1001/jama.2021.15072; Kuo CL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00057; Kyto V, 2013, EUR HEART J, V34, P644; Lau WCY, 2020, ANN INTERN MED, V173, P1, DOI 10.7326/M19-3671; Lau WCY, 2017, JAMA-J AM MED ASSOC, V317, P1151, DOI 10.1001/jama.2017.1363; Lee K, 2009, GLOB INST, P1; Li C, 2022, CLIN INFECT DIS, V74, P1933, DOI [10.1093/cid/ciab941, 10.1093/cid/ciab707]; Li XT, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1435; Man KKC, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2350; Marshall M, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-052478; Mevorach D, 2021, NEW ENGL J MED, V385, P2140, DOI 10.1056/NEJMoa2109730; Montgomery J, 2021, JAMA CARDIOL, V6, P1202, DOI 10.1001/jamacardio.2021.2833; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Salah HM, 2021, AM J CARDIOL, V157, P146, DOI 10.1016/j.amjcard.2021.07.009; Shay DK, 2021, JAMA CARDIOL, V6, P1115, DOI 10.1001/jamacardio.2021.2821; Simpson CR, 2021, NAT MED, V27, P1290, DOI 10.1038/s41591-021-01408-4; Tanriover MD, 2021, LANCET, V398, P213, DOI 10.1016/S0140-6736(21)01429-X; The Government of the Hong Kong Special Administrative Region, VACCINES-BASEL; The Government of the Hong Kong Special Administrative Region, HONG KONG VACC DASHB; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1; Tschope C, 2021, NAT REV CARDIOL, V18, P169, DOI 10.1038/s41569-020-00435-x; U.S. Food and Drug Administration, APPR LETT COM; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wan EYF, 2022, LANCET INFECT DIS, V22, P64, DOI 10.1016/S1473-3099(21)00451-5; Wong AYS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6926	40	37	37	5	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2022	175	3					362	+		10.7326/M21-3700	http://dx.doi.org/10.7326/M21-3700		JAN 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	0O5UF	35073155	Green Published			2022-12-28	WOS:000748953800001
J	Heesakkers, H; van der Hoeven, JG; Corsten, S; Janssen, I; Ewalds, E; Simons, KS; Westerhof, B; Rettig, TCD; Jacobs, C; van Santen, S; Slooter, AJC; van der Woude, MCE; van den Boogaard, M; Zegers, M				Heesakkers, Hidde; van der Hoeven, Johannes G.; Corsten, Stijn; Janssen, Inge; Ewalds, Esther; Simons, Koen S.; Westerhof, Brigitte; Rettig, Thijs C. D.; Jacobs, Cretien; van Santen, Susanne; Slooter, Arjen J. C.; van der Woude, Margaretha C. E.; van den Boogaard, Mark; Zegers, Marieke			Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; FRAILTY	IMPORTANCE One-year outcomes in patients who have had COVID-19 and who received treatment in the intensive care unit (ICU) are unknown. OBJECTIVE To assess the occurrence of physical, mental, and cognitive symptoms among patients with COVID-19 at 1 year after ICU treatment. DESIGN, SETTING, AND PARTICIPANTS An exploratory prospective multicenter cohort study conducted in ICUs of 11 Dutch hospitals. Patients (N = 452) with COVID-19, aged 16 years and older, and alive after hospital discharge following admission to 1 of the 11 ICUs during the first COVID-19 surge (March 1, 2020, until July 1, 2020) were eligible for inclusion. Patients were followed up for 1 year, and the date of final follow-up was June 16, 2021. EXPOSURES Patients with COVID-19 who received ICU treatment and survived 1 year after ICU admission. MAIN OUTCOMES AND MEASURES The main outcomeswere self-reported occurrence of physical symptoms (frailty [Clinical Frailty Scale score >= 5], fatigue [Checklist Individual Strength-fatigue subscale score >= 27], physical problems), mental symptoms (anxiety [Hospital Anxiety and Depression {HADS} subscale score >= 8], depression [HADS subscale score >= 8], posttraumatic stress disorder [mean Impact of Event Scale score >= 1.75]), and cognitive symptoms (Cognitive Failure Questionnaire-14 score >= 43) 1 year after ICU treatment and measured with validated questionnaires. CONCLUSIONS AND RELEVANCE In this exploratory study of patients in 11 Dutch hospitals who survived 1 year following ICU treatment for COVID-19, physical, mental, or cognitive symptoms were frequently reported.	[Heesakkers, Hidde; van der Hoeven, Johannes G.; van den Boogaard, Mark; Zegers, Marieke] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Intens Care, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Corsten, Stijn] Canisius Wilhelmina Hosp, Dept Intens Care Med, Nijmegen, Netherlands; [Janssen, Inge] Maasziekenhuis Pantein, Dept Intens Care Med, Beugen, Netherlands; [Ewalds, Esther] Bernhoven Hosp, Dept Intens Care Med, Uden, Netherlands; [Simons, Koen S.] Jeroen Bosch Hosp, Dept Intens Care Med, Shertogenbosch, Netherlands; [Westerhof, Brigitte] Rijnstate Hosp, Dept Intens Care Med, Arnhem, Netherlands; [Rettig, Thijs C. D.] Amphia Hosp, Dept Anesthesiol Intens Care & Pain Med, Breda, Netherlands; [Jacobs, Cretien] Elkerliek Hosp, Dept Intens Care Med, Helmond, Netherlands; [van Santen, Susanne] Maastricht Univ, Dept Intens Care Med, Med Ctr, Maastricht, Netherlands; [Slooter, Arjen J. C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Slooter, Arjen J. C.] Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Utrecht, Netherlands; [Slooter, Arjen J. C.] UZ Brussel, Dept Neurol, Brussels, Belgium; [Slooter, Arjen J. C.] Vrije Univ Brussel, Brussels, Belgium; [van der Woude, Margaretha C. E.] Heerlen Med Ctr, Dept Intens Care, Heerlen, Netherlands; [van der Woude, Margaretha C. E.] Heerlen Med Ctr, Dept Qual & Safety, Heerlen, Netherlands	Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Jeroen Bosch Ziekenhuis; Rijnstate Hospital; Amphia Hospital; Maastricht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University Hospital Brussels; Vrije Universiteit Brussel	Heesakkers, H (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Intens Care, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	hidde.heesakkers@radboudumc.nl; marieke.zeger@radboudumc.nl	van den Boogaard, M./N-5857-2014	van den Boogaard, M./0000-0003-4233-2903; Zegers, Marieke/0000-0002-7472-6184				Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Bell Melanie L, 2016, BMC Res Notes, V9, P479; Berlin DA, 2020, NEW ENGL J MED, V383, P2451, DOI 10.1056/NEJMcp2009575; Biehl Michelle, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc055; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Carenzo L, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00881-x; De Biase S, 2020, AGE AGEING, V49, P696, DOI 10.1093/ageing/afaa118; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Geense W, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018006; Geense WW, 2021, AM J RESP CRIT CARE, V203, P1512, DOI 10.1164/rccm.202009-3381OC; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hodgson CL, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03794-0; Hosey MM, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2553-z; Iwashyna TJ, 2021, J HOSP MED, V16, P531, DOI 10.12788/jhm.3660; Knoop H, 2007, PSYCHOTHER PSYCHOSOM, V76, P171, DOI 10.1159/000099844; Medrinal C, 2021, BMC ANESTHESIOL, V21, DOI 10.1186/s12871-021-01274-0; Miskowiak KW, 2021, EUR NEUROPSYCHOPHARM, V46, P39, DOI 10.1016/j.euroneuro.2021.03.019; Morin L, 2021, JAMA-J AM MED ASSOC, V325, P1525, DOI 10.1001/jama.2021.3331; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; Nelliot A, 2019, ANN AM THORAC SOC, V16, P731, DOI 10.1513/AnnalsATS.201812-851OC; Peach BC, 2021, WORLD MED HEALTH POL, V13, P373, DOI 10.1002/wmh3.401; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Schandl A, 2021, ACTA ANAESTH SCAND, V65, P1285, DOI 10.1111/aas.13939; Tan E, 2021, CHEST, V159, P524, DOI 10.1016/j.chest.2020.10.014; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wassenaar A, 2018, CRIT CARE MED, V46, P79, DOI 10.1097/CCM.0000000000002806; Wynne SC, 2020, CHRON RESP DIS, V17, DOI 10.1177/1479973120933292; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	46	46	10	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					559	565		10.1001/jama.2022.0040	http://dx.doi.org/10.1001/jama.2022.0040		JAN 2022	7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZD5RT	35072716	Green Published, Bronze			2022-12-28	WOS:000747991900001
J	Adashi, EY; Cohen, IG; Elberg, JT				Adashi, Eli Y.; Cohen, I. Glenn; Elberg, Jacob T.			Transparency and the Doctor-Patient Relationship - Rethinking Conflict-of-Interest Disclosures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Dept Med Sci, Warren Alpert Med Sch, Providence, RI 02912 USA; [Cohen, I. Glenn] Harvard Univ, Harvard Law Sch, Cambridge, MA 02138 USA; [Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Elberg, Jacob T.] Seton Hall Univ, Sch Law, Ctr Hlth & Pharmaceut Law, Newark, NJ USA	Brown University; Harvard University; Harvard University; Seton Hall University	Adashi, EY (corresponding author), Brown Univ, Dept Med Sci, Warren Alpert Med Sch, Providence, RI 02912 USA.			Adashi, Eli/0000-0001-7730-1192				Adashi EY, 2021, JAMA-J AM MED ASSOC, V326, P807, DOI 10.1001/jama.2021.13156; Sah S, 2019, PERS SOC PSYCHOL B, V45, P1099, DOI 10.1177/0146167218805991; Sah S, 2014, PSYCHOL SCI, V25, P575, DOI 10.1177/0956797613511824; Schulte F., 2021, KAISER HLTH NEWS; United States Department of Justice, 2020, DOJ FIL SUIT SPIN DE	5	0	0	3	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					300	302		10.1056/NEJMp2114495	http://dx.doi.org/10.1056/NEJMp2114495		JAN 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35061340				2022-12-28	WOS:000745541800001
J	Dzau, VJ; Mate, K; O'Kane, M				Dzau, Victor J.; Mate, Kedar; O'Kane, Margaret			Equity and Quality-Improving Health Care Delivery Requires Both	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dzau, Victor J.] Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA; [Mate, Kedar] Inst Healthcare Improvement, Boston, MA USA; [O'Kane, Margaret] Natl Comm Qual Assurance, Washington, DC USA	National Academies of Sciences, Engineering & Medicine; Institute for Healthcare Improvement	Dzau, VJ (corresponding author), Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu						Christopher GC, CHARTING COURSE EQUI; Hostetter M, FOCUS REDUCING RACIA; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; O'Kane M, 2021, EQUITY AGENDA FIELD	5	2	2	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					519	520		10.1001/jama.2022.0283	http://dx.doi.org/10.1001/jama.2022.0283		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35060998				2022-12-28	WOS:000745105800007
J	Richards, T				Richards, Tessa			False dawns: implications for patients of the Theranos debacle	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], US NEWS TODAY; businessinsider, BUSINESS INSIDER; Diamandis EP, 2022, CLIN CHEM LAB MED, V60, P4, DOI 10.1515/cclm-2021-0994; Dyer O, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o11; Flier J., 2019, BMJ OPINION; Mazer B., 2021, ATLANTIC SEP; Mazer B, 2019, BMJ OPINION; pewtrusts, WHAT ARE IN VITRO DI; Spotify, BAD BLOOD FIN CHAPT	9	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o178	10.1136/bmj.o178	http://dx.doi.org/10.1136/bmj.o178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063997	Bronze			2022-12-28	WOS:000838119600015
J	Knoedler, JR; Inoue, S; Bayless, DW; Yang, T; Tantry, A; Davis, CH; Leung, NY; Parthasarathy, S; Wang, G; Alvarado, M; Rizvi, AH; Fenno, LE; Ramakrishnan, C; Deisseroth, K; Shah, NM				Knoedler, Joseph R.; Inoue, Sayaka; Bayless, Daniel W.; Yang, Taehong; Tantry, Adarsh; Davis, Chung-ha; Leung, Nicole Y.; Parthasarathy, Srinivas; Wang, Grace; Alvarado, Maricruz; Rizvi, Abbas H.; Fenno, Lief E.; Ramakrishnan, Charu; Deisseroth, Karl; Shah, Nirao M.			A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior	CELL			English	Article							MICE LACKING; PROGESTERONE INDUCTION; R/BIOCONDUCTOR PACKAGE; RECEPTOR-ALPHA; MESSENGER-RNA; AGGRESSION; NEURONS; DIFFERENTIATION; BRAIN; RECEPTIVITY	Sex hormones exert a profound influence on gendered behaviors. How individual sex hormone-responsive neuronal populations regulate diverse sex-typical behaviors is unclear. We performed orthogonal, genetically targeted sequencing of four estrogen receptor 1-expressing (Esr1(+)) populations and identified 1,415 genes expressed differentially between sexes or estrous states. Unique subsets of these genes were distributed across all 137 transcriptomically defined Esr1(+) cell types, including estrous stage-specific ones, that comprise the four populations. We used differentially expressed genes labeling single Esr1(+) cell types as entry points to functionally characterize two such cell types, BNSTpr(Tac1/Esr1) and VMHvl(Cckar/Esr1). We observed that these two cell types, but not the other Esr1(+) cell types in these populations, are essential for sex recognition in males and mating in females, respectively. Furthermore, VMHvl(Cckar/Esr1) cell type projections are distinct from those of other VMHvl(Esr1) cell types. Together, projection and functional specialization of dimorphic cell types enables sex hormone-responsive populations to regulate diverse social behaviors.	[Knoedler, Joseph R.; Inoue, Sayaka; Bayless, Daniel W.; Yang, Taehong; Tantry, Adarsh; Leung, Nicole Y.; Wang, Grace; Alvarado, Maricruz; Fenno, Lief E.; Deisseroth, Karl; Shah, Nirao M.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Shah, Nirao M.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Davis, Chung-ha] Stanford Univ, Neurosci Grad Program, Stanford, CA 94305 USA; [Ramakrishnan, Charu] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Parthasarathy, Srinivas] Accent Therapeut, 65 Hayden Ave, Lexington, MA 02421 USA; [Rizvi, Abbas H.] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Columbia University	Shah, NM (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Shah, NM (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	nirao@stanford.edu	Core, Vector/CAF-4832-2022	Tantry, Adarsh/0000-0002-4211-5549; Wang, Grace/0000-0003-1044-9381	NSF GRFP [2018265046]; PD Soros Fellowship for New Americans; NSF NeuroNex Program; AE Foundation; NIH [F32MH125593, U01DA052783, R01MH124047, S10RR025518-01]; Walter V. and Idun Berry Postdoctoral Fellowship, Stanford; HFSP; CZI [CZF2019-002460]; Bio-X Undergraduate Summer Research Program; VPUE major grant;  [R01NS049488];  [R01HD104565]	NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); PD Soros Fellowship for New Americans; NSF NeuroNex Program; AE Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walter V. and Idun Berry Postdoctoral Fellowship, Stanford; HFSP(Human Frontier Science Program); CZI; Bio-X Undergraduate Summer Research Program; VPUE major grant; ; 	We thank Liqun Luo for comments on the manuscript, Fabian Muller for help with data analysis, Shah lab members for discussions, and Lily Duong for administrative support. This work was supported by grants to C.D. (NSF GRFP 2018265046 and PD Soros Fellowship for New Americans), K.D. (NSF NeuroNex Program and AE Foundation), N.Y.L. (NIH F32MH125593 and Walter V. and Idun Berry Postdoctoral Fellowship, Stanford), S.P. (HFSP), A.H.R. (CZI, CZF2019-002460 and NIH U01DA052783 and R01MH124047), N.M.S. (R01NS049488 and R01HD104565), and G.W. (Bio-X Undergraduate Summer Research Program, VPUE major grant). Nuclear sorting was done in the Stanford Shared FACS Facility (NIH S10RR025518-01).	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Alexa A, 2021, TOPGO ENRICHMENT ANA; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Bayless DW, 2019, CELL, V176, P1190, DOI 10.1016/j.cell.2018.12.041; BEEMAN EA, 1947, PHYSIOL ZOOL, V20, P373, DOI 10.1086/physzool.20.4.30151969; Berger A, 2012, GENES BRAIN BEHAV, V11, P568, DOI 10.1111/j.1601-183X.2012.00787.x; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brock O, 2011, J NEUROSCI, V31, P5574, DOI 10.1523/JNEUROSCI.0209-11.2011; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carbon S, 2021, NUCLEIC ACIDS RES, V49, pD325, DOI 10.1093/nar/gkaa1113; Chen PB, 2019, CELL, V176, P1206, DOI 10.1016/j.cell.2019.01.024; Choi HMT, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165753; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Correa SM, 2015, CELL REP, V10, P62, DOI 10.1016/j.celrep.2014.12.011; De Vries GJ, 1998, BEHAV BRAIN RES, V92, P205, DOI 10.1016/S0166-4328(97)00192-7; DEDEREN PJWC, 1994, HISTOCHEM J, V26, P856, DOI 10.1007/BF00162931; Dey S, 2015, CELL, V161, P1334, DOI 10.1016/j.cell.2015.04.052; Dias IC, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0049-21.2021; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ellmann S, 2009, CELL MOL LIFE SCI, V66, P2405, DOI 10.1007/s00018-009-0017-3; Falkner AL, 2016, NAT NEUROSCI, V19, P596, DOI 10.1038/nn.4264; Fenno LE, 2020, NEURON, V107, P836, DOI 10.1016/j.neuron.2020.06.003; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferreira-Pinto MJ, 2021, CELL, V184, P4564, DOI 10.1016/j.cell.2021.07.002; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fletcher RB, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800056; Forsell C, 2010, NEUROBIOL AGING, V31, P409, DOI 10.1016/j.neurobiolaging.2008.04.009; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hashikawa K, 2017, NAT NEUROSCI, V20, P1580, DOI 10.1038/nn.4644; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hellier V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02797-2; Hoffman EJ, 2016, NEURON, V89, P725, DOI 10.1016/j.neuron.2015.12.039; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Inoue S, 2019, CELL, V179, P1393, DOI 10.1016/j.cell.2019.10.025; Ishii KK, 2017, NEURON, V95, P123, DOI 10.1016/j.neuron.2017.05.038; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Karigo T, 2021, NATURE, V589, P258, DOI 10.1038/s41586-020-2995-0; Katsouni E, 2009, PEPTIDES, V30, P1586, DOI 10.1016/j.peptides.2009.05.001; Kim DW, 2019, CELL, V179, P713, DOI 10.1016/j.cell.2019.09.020; Kohl J, 2018, NATURE, V556, P326, DOI 10.1038/s41586-018-0027-0; Kow LM, 1998, BEHAV BRAIN RES, V92, P169, DOI 10.1016/S0166-4328(97)00189-7; Krause WC, 2021, NATURE, V599, P131, DOI 10.1038/s41586-021-04010-3; Krause WC, 2017, ADV EXP MED BIOL, V1043, P199, DOI 10.1007/978-3-319-70178-3_10; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1662-y; Maynard KR, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa312; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McHenry JA, 2017, NAT NEUROSCI, V20, P449, DOI 10.1038/nn.4487; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Melsted P, 2021, NAT BIOTECHNOL, V39, P813, DOI 10.1038/s41587-021-00870-2; Micevych P, 2001, PEPTIDES, V22, P1235, DOI 10.1016/S0196-9781(01)00447-8; Miller JA, 2020, ELIFE, V9, DOI 10.7554/eLife.59928; Miura H, 2018, NAT PROTOC, V13, P195, DOI 10.1038/nprot.2017.153; Mo A, 2015, NEURON, V86, P1369, DOI 10.1016/j.neuron.2015.05.018; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Osakada T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07003-5; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Remedios R, 2017, NATURE, V550, P388, DOI 10.1038/nature23885; Ring JR, 1944, ENDOCRINOLOGY, V34, P269, DOI 10.1210/endo-34-4-269; Rissman EF, 1997, ENDOCRINOLOGY, V138, P507, DOI 10.1210/en.138.1.507; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; Schriml LM, 2019, NUCLEIC ACIDS RES, V47, pD955, DOI 10.1093/nar/gky1032; Scordalakes EM, 2003, BEHAV NEUROSCI, V117, P38, DOI 10.1037/0735-7044.117.1.38; SHAPIRO H. A., 1937, Nature, V139, P588, DOI 10.1038/139588b0; Siegel A, 1997, NEUROSCI BIOBEHAV R, V21, P733, DOI 10.1016/S0149-7634(96)00056-5; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Tang M, 2021, BIOINFORMATICS, V37, P2212, DOI 10.1093/bioinformatics/btaa956; THOMPSON ML, 1971, HORM BEHAV, V2, P299, DOI 10.1016/0018-506X(71)90004-3; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; Todd WD, 2018, NAT NEUROSCI, V21, P717, DOI 10.1038/s41593-018-0126-0; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Unger EK, 2015, CELL REP, V10, P453, DOI 10.1016/j.celrep.2014.12.040; van Veen JE, 2020, NAT METAB, V2, P351, DOI 10.1038/s42255-020-0189-6; Wei YC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02648-0; Welch JD, 2019, CELL, V177, P1873, DOI 10.1016/j.cell.2019.05.006; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Willsey HR, 2021, NEURON, V109, P1409, DOI 10.1016/j.neuron.2021.03.030; Wu MV, 2017, HORM BEHAV, V95, P3, DOI 10.1016/j.yhbeh.2017.07.001; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang CF, 2014, NEURON, V82, P261, DOI 10.1016/j.neuron.2014.03.029; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yang T, 2017, NEURON, V95, P955, DOI 10.1016/j.neuron.2017.06.046; Yao SQ, 2017, ELIFE, V6, DOI 10.7554/eLife.31373; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Zhang Z, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20050-1; Zhou QM, 2003, P NATL ACAD SCI USA, V100, P15041, DOI 10.1073/pnas.2533866100	110	6	6	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					654	+		10.1016/j.cell.2021.12.031	http://dx.doi.org/10.1016/j.cell.2021.12.031			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7YE	35065713				2022-12-28	WOS:000759786000002
J	Castelvecchi, D				Castelvecchi, Davide			THE RACE TO SAVE THE INTERNET FROM QUANTUM HACKERS	NATURE			English	News Item						Quantum physics; Information technology; Mathematics and computing													0	4	4	3	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					198	201		10.1038/d41586-022-00339-5	http://dx.doi.org/10.1038/d41586-022-00339-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YV8GO	35136223	Bronze			2022-12-28	WOS:000752963300015
J	Li, HY				Li, Huiying			Beyond gut instincts: Microbe survival depends on sugars and butyrate	CELL			English	Editorial Material							FIBER	The factors and mechanisms that shape the composition and function of closely related members in a com-plex microbial community are largely unknown. The study by Park and colleagues reveals that the fitness of various Bacteroidales species and strains in the gut microbiome is regulated by butyrate in a glycan-depen-dent manner.	[Li, Huiying] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Li, HY (corresponding author), Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	huiying@mednet.ucla.edu		Li, Huiying/0000-0001-5633-5270				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Park SY, 2022, CELL, V185, P513, DOI 10.1016/j.cell.2022.01.002; Patnode ML, 2019, CELL, V179, P59, DOI 10.1016/j.cell.2019.08.011; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Wexler AG, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.26	9	1	1	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					414	416		10.1016/j.cell.2021.12.037	http://dx.doi.org/10.1016/j.cell.2021.12.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YW7SP	35120661				2022-12-28	WOS:000753615000004
J	Hui, KPY; Ho, JCW; Cheung, MC; Ng, KC; Ching, RHH; Lai, KL; Kam, TT; Gu, HG; Sit, KY; Hsin, MKY; Au, TWK; Poon, LLM; Peiris, M; Nicholls, JM; Chan, MCW				Hui, Kenrie P. Y.; Ho, John C. W.; Cheung, Man-chun; Ng, Ka-chun; Ching, Rachel H. H.; Lai, Ka-ling; Kam, Tonia Tong; Gu, Haogao; Sit, Ko-Yung; Hsin, Michael K. Y.; Au, Timmy W. K.; Poon, Leo L. M.; Peiris, Malik; Nicholls, John M.; Chan, Michael C. W.			SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo	NATURE			English	Article							INFLUENZA-VIRUS; IN-VITRO; TROPISM; H5N1; AFRICA; CAMELS	The emergence of SARS-CoV-2 variants of concern with progressively increased transmissibility between humans is a threat to global public health. The Omicron variant of SARS-CoV-2 also evades immunity from natural infection or vaccines(1), but it is unclear whether its exceptional transmissibility is due to immune evasion or intrinsic virological properties. Here we compared the replication competence and cellular tropism of the wild-type virus and the D614G, Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2) and Omicron (B.1.1.529) variants in ex vivo explant cultures of human bronchi and lungs. We also evaluated the dependence on TMPRSS2 and cathepsins for infection. We show that Omicron replicates faster than all other SARS-CoV-2 variants studied in the bronchi but less efficiently in the lung parenchyma. All variants of concern have similar cellular tropism compared to the wild type. Omicron is more dependent on cathepsins than the other variants of concern tested, suggesting that the Omicron variant enters cells through a different route compared with the other variants. The lower replication competence of Omicron in the human lungs may explain the reduced severity of Omicron that is now being reported in epidemiological studies, although determinants of severity are multifactorial. These findings provide important biological correlates to previous epidemiological observations.	[Hui, Kenrie P. Y.; Ho, John C. W.; Cheung, Man-chun; Ng, Ka-chun; Ching, Rachel H. H.; Lai, Ka-ling; Kam, Tonia Tong; Gu, Haogao; Poon, Leo L. M.; Peiris, Malik; Chan, Michael C. W.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hearth, Hong Kong, Peoples R China; [Hui, Kenrie P. Y.; Poon, Leo L. M.; Peiris, Malik; Chan, Michael C. W.] Hong Kong Sci Pk, Ctr Immunol & Infect C21, Hong Kong, Peoples R China; [Sit, Ko-Yung; Hsin, Michael K. Y.; Au, Timmy W. K.] Queen Mary Hosp, Dept Surg, Div Cardiothorac Surg, Hong Kong, Peoples R China; [Nicholls, John M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, MCW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hearth, Hong Kong, Peoples R China.; Chan, MCW (corresponding author), Hong Kong Sci Pk, Ctr Immunol & Infect C21, Hong Kong, Peoples R China.	mchan@hku.hk	Poon, Leo/AAP-6887-2020	Hui, Kenrie Pui Yan/0000-0003-1506-0535; Sit, Ko Yung/0000-0001-6289-663X; Cheung, Man Chun/0000-0001-5717-3322; Gu, Haogao/0000-0002-7541-4262	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [75N93021C00016, T11-705/21N, T11-712/19-N]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T. Shack, H.-W. Yeung, C. Lin and Kevin Fung provided technical support. We acknowledge research funding from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services (contract no. 75N93021C00016) and the Theme-Based Research Scheme (T11-705/21N and T11-712/19-N) under University Grants Committee of Hong Kong Special Administrative Region. The funding providers had no role in study design, data collection, analysis or interpretation of the data, or in the writing of the report or in the decision to submit it for publication. The authors have not been paid to write this Article by a pharmaceutical company or other agency. The authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. The corresponding author had full access to all of the data and the final responsibility to submit for publication.	Adenaiye OO, 2022, CLIN INFECT DIS, V75, pE241, DOI 10.1093/cid/ciab797; Allen H, 2022, LANCET REG HEALTH-EU, V12, DOI 10.1016/j.lanepe.2021.100252; [Anonymous], 2021, WEEKLY EPIDEMIOLOGIC; [Anonymous], 2021, TRACK SARS COV 2 VAR; [Anonymous], 2021, SARS COV 2 VAR VAR I; Augusto G, 2022, ALLERGY, V77, P111, DOI 10.1111/all.15065; Baric RS, 2020, NEW ENGL J MED, V383, P2684, DOI 10.1056/NEJMcibr2032888; Berglin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105375; Blume C, 2021, NAT GENET, V53, P205, DOI 10.1038/s41588-020-00759-x; Bui CHT, 2021, J INFECT DIS, V224, P821, DOI 10.1093/infdis/jiab002; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chan MCW, 2013, LANCET RESP MED, V1, P534, DOI 10.1016/S2213-2600(13)70138-3; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan RWY, 2014, LANCET RESP MED, V2, P813, DOI 10.1016/S2213-2600(14)70158-4; Chan RWY, 2009, ANTIMICROB AGENTS CH, V53, P3935, DOI 10.1128/AAC.00389-09; Chu DKW, 2018, P NATL ACAD SCI USA, V115, P3144, DOI 10.1073/pnas.1718769115; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Gu HG, 2022, EMERG INFECT DIS, V28, P460, DOI 10.3201/eid2802.212422; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Hui KPY, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01710-2016; Hui KPY, 2011, J INFECT DIS, V204, P1866, DOI 10.1093/infdis/jir665; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Khan A, 2021, J CELL PHYSIOL, V236, P7045, DOI 10.1002/jcp.30367; Li HM, 2022, J MED VIROL, V94, P821, DOI 10.1002/jmv.27372; Liu Yang, 2021, bioRxiv, DOI 10.1101/2021.08.12.456173; Lubinski B., 2022, ISCIENCE, V25; Lubinski Bailey, 2022, bioRxiv, DOI 10.1101/2021.06.30.450632; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Peacock TP, 2022, SARS COV 2 VARIANT O, DOI [10.1101/2021.12. 31. 474653, 10.1101/2021.12.31.474653, DOI 10.1101/2021.12.31.474653]; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Srivastava S, 2021, J BIOSCIENCES, V46, DOI 10.1007/s12038-021-00145-7; Thomson EC., 2022, HYPERTRANSMISSIBLE S, DOI [10.1101/2022.01.03.21268111, DOI 10.1101/2022.01.03.21268111]; Twohig KA, 2022, LANCET INFECT DIS, V22, P35, DOI 10.1016/S1473-3099(21)00475-8; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4; Wu HB, 2021, CELL HOST MICROBE, V29, P1788, DOI 10.1016/j.chom.2021.11.005; Yen HL, 2022, VET PATHOL, V59, P639, DOI 10.1177/03009858211043084; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou ZQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103984118	45	169	172	40	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					715	+		10.1038/s41586-022-04479-6	http://dx.doi.org/10.1038/s41586-022-04479-6		FEB 2022	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35104836	Green Submitted, Bronze			2022-12-28	WOS:000769826200001
J	Karafillakis, E; Van Damme, P; Hendrickx, G; Larson, HJ				Karafillakis, Emilie; Van Damme, Pierre; Hendrickx, Greet; Larson, Heidi J.			COVID-19 in Europe: new challenges for addressing vaccine hesitancy	LANCET			English	Editorial Material									[Karafillakis, Emilie; Larson, Heidi J.] London Sch Hyg & Trop Med, Vaccine Confidence Project, London WC1E 7HT, England; [Van Damme, Pierre; Hendrickx, Greet; Larson, Heidi J.] Univ Antwerp, Vaccine Confidence Project, European Reg Off, Antwerp, Belgium	University of London; London School of Hygiene & Tropical Medicine; University of Antwerp	Larson, HJ (corresponding author), London Sch Hyg & Trop Med, Vaccine Confidence Project, London WC1E 7HT, England.; Larson, HJ (corresponding author), Univ Antwerp, Vaccine Confidence Project, European Reg Off, Antwerp, Belgium.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				Carmody ER, 2021, J COMMUN HEALTH, V46, P1161, DOI 10.1007/s10900-021-00995-0; Crawshaw AF, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab048; de Figueiredo Alexandre, 2021, Commun Med (Lond), V1, P30, DOI 10.1038/s43856-021-00027-x; de Figueiredo A, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101109; Deal Anna, 2021, J Migr Health, V4, P100050, DOI 10.1016/j.jmh.2021.100050; European Union, 2020, STAT VACC CONF EU UK; Fridman A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250123; Glampson B, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/30010; Holt E, 2021, LANCET MICROBE, V2, pE289, DOI 10.1016/S2666-5247(21)00155-5; Imohi O, 2021, COVID 19 VACCINE HES; Larson HJ, 2021, SCIENCE, V371, P1289, DOI 10.1126/science.abi6488; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Pennycook G, 2022, PERS SOC PSYCHOL B, V48, P750, DOI 10.1177/01461672211023652; Petousis-Harris H, 2021, COUNTERING VACCINE M; Sante publique France, 2019, SEM EUR VACC 24 30 A; Sharfstein JM, 2021, LANCET, V398, P1211, DOI 10.1016/S0140-6736(21)02099-7; Sowa P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080876; Su Zhaohui, 2021, Brain Behav Immun Health, V12, P100204, DOI 10.1016/j.bbih.2021.100204; Valckx S, 2022, VACCINE, V40, P151, DOI 10.1016/j.vaccine.2021.10.073; Walkowiak MP, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101153; Ward JK, 2022, NAT MED, V28, P232, DOI 10.1038/s41591-021-01661-7; Warren GW, 2021, J RISK RES, V24, P369, DOI 10.1080/13669877.2020.1870533; Weil -Olivier C., 2021, HPV PREV BOARD DEC	23	15	15	7	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					699	701		10.1016/S0140-6736(22)00150-7	http://dx.doi.org/10.1016/S0140-6736(22)00150-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE3NS	35123665	Green Submitted, Green Published			2022-12-28	WOS:000758794200005
J	Voelker, R				Voelker, Rebecca			Drug Approved to Prevent Graft-vs-Host Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					417	417						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103785				2022-12-28	WOS:000753056200008
J	Hawksbee, L; McKee, M; King, L				Hawksbee, Luke; McKee, Martin; King, Lawrence			Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VACCINES		[Hawksbee, Luke] Univ Cambridge, Dept Sociol, Cambridge, England; [McKee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, ON, Canada; [King, Lawrence] Univ Massachusetts, Dept Econ, Amherst, MA 01003 USA	University of Cambridge; University of Massachusetts System; University of Massachusetts Amherst	Hawksbee, L (corresponding author), Univ Cambridge, Dept Sociol, Cambridge, England.	lh372@cam.ac.uk						Abraham J, 1996, SCI POLITICS PHARM I; Baker D., 2017, INNOVATION INTELLECT; Cao M, 2021, STEM CELL REP, V16, P398, DOI 10.1016/j.stemcr.2020.12.010; Coalition for Epidemic Preparedness Innovations, 2021, CEPI LAUNCH FUND CAL; Cohen J, 2021, SCIENCE, V372, P227, DOI 10.1126/science.372.6539.227; Dickson S, 2019, MUCH CAN PHARM LOSE; Drugs for Neglected Diseases Initiative, 2021, STRAT PLAN 2021 2028; European Commission, PHARM STRAT EUR 2020; Fang Lee, 2021, THE INTERCEPT; Frank RG, HLTH AFF, V2021, DOI [10.1377/hblog20210512.191448, DOI 10.1377/HBLOG20210512.191448]; Gilbert S, 2021, GUARDIAN 0627; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Hopkins JS, 2021, WALL STR J; Jackson NAC, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0159-8; Kapczynski A, 2017, CORNELL LAW REV, V102, P1539; Lawder D, 2021, US WANTS COVID VACCI; Ledley FD, 2020, JAMA-J AM MED ASSOC, V323, P834, DOI 10.1001/jama.2020.0442; Mazzucato M., 2021, MISSION EC MOONSHOT; Neville S., 2021, FINANC TIMES; Nitzan J, 2021, PHARM BEATING HELL O; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Plackett B, 2020, NATURE, V586, pS50, DOI 10.1038/d41586-020-02884-3; Pluss JD, 2020, NO PROSPECTS PROFITS; Ravelo JL., 2021, DEVEX; Robbins, 2021, NEW YORK TIMES; Sidley P, 2001, BRIT MED J, V322, P447, DOI 10.1136/bmj.322.7284.447; Silverman E., 2021, STAT-US; The European Federation of Pharmaceutical Industries and Associations, 2020, PHARM IND FIG; The WHO Council on the Economics of Health for All, 2021, GOV HLTH INN COMM GO; UNAIDS, UNAIDS ANN NEARL 21; Wouters OJ, 2020, JAMA-J AM MED ASSOC, V323, P844, DOI 10.1001/jama.2020.1166; Ziegler T, 2018, INFLUENZA OTHER RESP, V12, P558, DOI 10.1111/irv.12570	33	3	3	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2022	376								e067367	10.1136/bmj-2021-067367	http://dx.doi.org/10.1136/bmj-2021-067367			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS2TM	35101900	Bronze			2022-12-28	WOS:000750534900003
J	Cohen, IG; Reingold, RB; Gostin, LO				Cohen, I. Glenn; Reingold, Rebecca B.; Gostin, Lawrence O.			Supreme Court Ruling on the Texas Abortion Law Beginning to Unravel Roe v Wade	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Reingold, Rebecca B.; Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Law Ctr,500 First St NW,Off 810, Washington, DC 20001 USA	Harvard University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Law Ctr,500 First St NW,Off 810, Washington, DC 20001 USA.	gostin@georgetown.edu						Abrams Abigail, 2021, TIME; [Anonymous], 2021, SB8 TEX 2021; Cohen IG, 2021, JAMA-J AM MED ASSOC, V326, P1473, DOI 10.1001/jama.2021.17639; Guttmacher Institute, US AB STAT POL AB; Hubler S., 2021, NEW YORK TIMES; Nash E., 2021, 1 TIME EVER US STATE; Sobel L., 2021, ABORTION SCOTUS DOBB	7	3	3	4	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					621	622		10.1001/jama.2022.0050	http://dx.doi.org/10.1001/jama.2022.0050		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35089318				2022-12-28	WOS:000747991100001
J	Mondaini, R; Tarat, S; Scalettar, RT				Mondaini, R.; Tarat, S.; Scalettar, R. T.			Quantum critical points and the sign problem	SCIENCE			English	Article							MONTE-CARLO SIMULATIONS; HIGH-TEMPERATURE SUPERCONDUCTIVITY; MOTT INSULATOR; HUBBARD-MODEL; PHYSICS	The "sign problem" (SP) is a fundamental limitation to simulations of strongly correlated matter. It is often argued that the SP is not intrinsic to the physics of particular Hamiltonians because its behavior can be influenced by the choice of algorithm. By contrast, we show that the SP in determinant quantum Monte Carlo (QMC) is quantitatively linked to quantum critical behavior. We demonstrate this through simulations of several models with critical properties that are relatively well understood. We propose a reinterpretation of the low average sign for the Hubbard model on the square lattice away from half filling in terms of the onset of pseudogap behavior and exotic superconductivity. Our study charts a path for exploiting the average sign in QMC simulations to understand quantum critical behavior.	[Mondaini, R.; Tarat, S.] Beijing Computat Sci Res Ctr, Beijing 100193, Peoples R China; [Scalettar, R. T.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA	Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); University of California System; University of California Davis	Mondaini, R; Tarat, S (corresponding author), Beijing Computat Sci Res Ctr, Beijing 100193, Peoples R China.; Scalettar, RT (corresponding author), Univ Calif Davis, Dept Phys, Davis, CA 95616 USA.	rmondaini@csrc.ac.cn; tarats@csrc.ac.cn; scalettar@physics.ucdavis.edu	Mondaini, Rubem/A-9433-2013	Mondaini, Rubem/0000-0001-8005-2297; Scalettar, RIchard/0000-0002-0521-3692				[Anonymous], 2009, QUEST QUANTUM ELECT; BLANKENBECLER R, 1981, PHYS REV D, V24, P2278, DOI 10.1103/PhysRevD.24.2278; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; BROGLIA RA, 1994, PERSPECTIVES MANY PA, P95; Carlson J, 2015, REV MOD PHYS, V87, P1067, DOI 10.1103/RevModPhys.87.1067; CEPERLEY DM, 1984, J CHEM PHYS, V81, P5833, DOI 10.1063/1.447637; CEPERLEY DM, 1995, REV MOD PHYS, V67, P279, DOI 10.1103/RevModPhys.67.279; Chandrasekharan S, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.025007; Chattopadhyay A, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.155127; Craco L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075121; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Degrand T., 2006, LATTICE METHODS QUAN; Esslinger T, 2010, ANNU REV CONDEN MA P, V1, P129, DOI 10.1146/annurev-conmatphys-070909-104059; Fabrizio M, 1999, PHYS REV LETT, V83, P2014, DOI 10.1103/PhysRevLett.83.2014; Foulkes WMC, 2001, REV MOD PHYS, V73, P33, DOI 10.1103/RevModPhys.73.33; Garg A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.046403; Garg A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.106406; Goetz A., 2021, ARXIV210208899CONDMA; Hammond B. L., 1994, LECT COURSE NOTES CH, V1; Hangleiter D, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb8341; Henelius P, 2000, PHYS REV B, V62, P1102, DOI 10.1103/PhysRevB.62.1102; Hesselmann S, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155157; HIRSCH JE, 1982, PHYS REV B, V26, P5033, DOI 10.1103/PhysRevB.26.5033; HIRSCH JE, 1983, PHYS REV B, V28, P4059, DOI 10.1103/PhysRevB.28.4059; Huang EW, 2019, SCIENCE, V366, P987, DOI 10.1126/science.aau7063; Huffman EF, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.111101; Iazzi M, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.115102; Iglovikov VI, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.045110; Jiang HC, 2019, SCIENCE, V365, P1424, DOI 10.1126/science.aal5304; Kampf AP, 2003, J PHYS-CONDENS MAT, V15, P5895, DOI 10.1088/0953-8984/15/34/319; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Lee M. A., 1992, COMPUT PHYS, V6, P192; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li ZX, 2019, ANNU REV CONDEN MA P, V10, P337, DOI 10.1146/annurev-conmatphys-033117-054307; Li ZX, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.267002; Li ZX, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.241117; LOH EY, 1990, PHYS REV B, V41, P9301, DOI 10.1103/PhysRevB.41.9301; Maier TA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11875; Maier TA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237001; Meng ZY, 2010, NATURE, V464, P847, DOI 10.1038/nature08942; Mondaini R., Zenodo (2021), DOI 10.5281/zenodo.5575501; Needs RJ, 2020, J CHEM PHYS, V152, DOI 10.1063/1.5144288; Paiva T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085123; Paris N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046403; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; RANDERIA M, 1992, PHYS REV LETT, V69, P2001, DOI 10.1103/PhysRevLett.69.2001; RIEGER H, 1994, PHYS REV LETT, V72, P4141, DOI 10.1103/PhysRevLett.72.4141; SCALAPINO DJ, 1994, P INT SCH PHYS, V121, P95; Schafer F, 2020, NAT REV PHYS, V2, P411, DOI 10.1038/s42254-020-0195-3; Sorella S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00992; Tremblay AMS, 2006, LOW TEMP PHYS+, V32, P424, DOI 10.1063/1.2199446; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Wan Z.-Q., 2020, ARXIV201001141CONDMA; Wang L, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.250601; Wang L, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103008; Wessel S, 2017, SCIPOST PHYS, V3, DOI 10.21468/SciPostPhys.3.1.005; WHITE SR, 1989, PHYS REV B, V40, P506, DOI 10.1103/PhysRevB.40.506; WHITE SR, 1989, PHYS REV B, V39, P839, DOI 10.1103/PhysRevB.39.839; Wu CJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155115; Zhang SW, 1997, PHYS REV B, V55, P7464, DOI 10.1103/PhysRevB.55.7464	62	10	10	10	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					418	+		10.1126/science.abg9299	http://dx.doi.org/10.1126/science.abg9299			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084971	Green Submitted			2022-12-28	WOS:000750899500033
J	Taylor, L				Taylor, Luke			Covid-19: Cuba will request WHO approval for homegrown vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cuban Ministry of Foreign Affairs, 2021, ABD VACC 100 EFF SEV; Holder J, 2022, NEW YORK TIMES; Our World In Data, 2022, GLOB COV 19 INF DAT; Progressive International, 2022, CUB PLEDG LIF PACK C; Taylor L., NEW SCI, V2021; Toledo-Romani ME, MEDRXIV2021103121265, DOI [10.1101/2021.10.31.21265703, DOI 10.1101/2021.10.31.21265703]; World Health Organization, 2021, STATUS COVID 19 VACC	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o230	10.1136/bmj.o230	http://dx.doi.org/10.1136/bmj.o230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082133				2022-12-28	WOS:000748440900007
J	Mahase, E				Mahase, Elisabeth			Covid-19: Advice on wider use of FFP3 masks should extend to GPs, BMA says	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gov.uk, 2022, INFECT PREVENTION CO; Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o38; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n30	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o176	10.1136/bmj.o176	http://dx.doi.org/10.1136/bmj.o176			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063970	Bronze			2022-12-28	WOS:000838119600008
J	Greenhawt, M; Shaker, M; Abrams, EM				Greenhawt, Matthew; Shaker, Marcus; Abrams, Elissa M.			Peanut oral immunotherapy in very young children	LANCET			English	Editorial Material									[Greenhawt, Matthew] Univ Colorado, Childrens Hosp Colorado, Sect Allergy & Clin Immunol, Sch Med, Aurora, CO 80045 USA; [Shaker, Marcus] Dartmouth Hitchcock Med Ctr, Sect Allergy & Immunol, Lebanon, NH 03766 USA; [Abrams, Elissa M.] Dartmouth Geisel Sch Med, Hanover, NH USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Dartmouth College; Dartmouth College	Greenhawt, M (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sect Allergy & Clin Immunol, Sch Med, Aurora, CO 80045 USA.	matthew.greenhawt@childrenscolorado.org						Begin P, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-0413-7; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Greenhawt M, 2020, ANN ALLERG ASTHMA IM, V125, P262, DOI 10.1016/j.anai.2020.05.031; Greenhawt M, 2018, ANN ALLERG ASTHMA IM, V121, P575, DOI 10.1016/j.anai.2018.06.018; Jones SM, 2022, LANCET, V399, P359, DOI 10.1016/S0140-6736(21)02390-4; Peters R, 2019, J ALLERGY CLIN IMMUN, V143, pAB421, DOI 10.1016/j.jaci.2018.12.946; Shaker Marcus, 2021, J Allergy Clin Immunol Pract, V9, P2876, DOI 10.1016/j.jaip.2021.02.058; Shaker M, 2020, ANN ALLERG ASTHMA IM, V124, P357, DOI 10.1016/j.anai.2020.01.004; Shaker M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3242; Soller L, 2021, J ALLER CL IMM-PRACT, V9, P1349, DOI 10.1016/j.jaip.2020.10.045; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Wasserman RL, 2021, J ALLER CL IMM-PRACT, V9, P1826, DOI 10.1016/j.jaip.2021.02.046	12	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					336	337						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065770				2022-12-28	WOS:000746046100002
J	Elliott, P; Bodinier, B; Eales, O; Wang, HW; Haw, D; Elliott, J; Whitaker, M; Jonnerby, J; Tang, D; Walters, CE; Atchison, C; Diggle, PJ; Page, AJ; Trotter, AJ; Ashby, D; Barclay, W; Taylor, G; Ward, H; Darzi, A; Cooke, GS; Chadeau-Hyam, M; Donnelly, CA				Elliott, Paul; Bodinier, Barbara; Eales, Oliver; Wang, Haowei; Haw, David; Elliott, Joshua; Whitaker, Matthew; Jonnerby, Jakob; Tang, David; Walters, Caroline E.; Atchison, Christina; Diggle, Peter J.; Page, Andrew J.; Trotter, Alexander J.; Ashby, Deborah; Barclay, Wendy; Taylor, Graham; Ward, Helen; Darzi, Ara; Cooke, Graham S.; Chadeau-Hyam, Marc; Donnelly, Christl A.			Rapid increase in Omicron infections in England during December 2021: REACT-1 study	SCIENCE			English	Article								The unprecedented rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during December 2021 was concurrent with rapid spread of the Omicron variant in England and globally. We analyzed the prevalence of SARS-CoV-2 and its dynamics in England from the end of November to mid-December 2021 among almost 100,000 participants in the REACT-1 study. Prevalence was high with rapid growth nationally and particularly in London during December 2021, with an increasing proportion of infections due to Omicron. We observed large decreases in swab positivity among mostly vaccinated older children (12 to 17 years) relative to unvaccinated younger children (5 to 11 years), and in adults who received a third (booster) vaccine dose versus two doses. Our results reinforce the importance of vaccination and booster campaigns, although additional measures have been needed to control the rapid growth of the Omicron variant.	[Elliott, Paul; Bodinier, Barbara; Eales, Oliver; Wang, Haowei; Haw, David; Whitaker, Matthew; Jonnerby, Jakob; Tang, David; Walters, Caroline E.; Atchison, Christina; Ashby, Deborah; Ward, Helen; Chadeau-Hyam, Marc; Donnelly, Christl A.] Imperial Coll London, Sch Publ Hlth, London, England; [Elliott, Paul; Bodinier, Barbara; Whitaker, Matthew; Tang, David; Chadeau-Hyam, Marc] Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, London, England; [Elliott, Paul; Elliott, Joshua; Atchison, Christina; Ward, Helen; Darzi, Ara; Cooke, Graham S.] Imperial Coll Healthcare NHS Trust, London, England; [Elliott, Paul; Ward, Helen; Darzi, Ara; Cooke, Graham S.] Natl Inst Hlth Res Imperial Biomed Res Ctr, London, England; [Elliott, Paul; Diggle, Peter J.] Imperial Coll London, Hlth Data Res HDR UK, London, England; [Elliott, Paul] Imperial Coll London, UK Dementia Res Inst, London, England; [Eales, Oliver; Wang, Haowei; Haw, David; Walters, Caroline E.; Ward, Helen; Donnelly, Christl A.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Eales, Oliver; Wang, Haowei; Haw, David; Walters, Caroline E.; Ward, Helen; Donnelly, Christl A.] Imperial Coll London, Jameel Inst, London, England; [Elliott, Joshua; Barclay, Wendy; Taylor, Graham; Cooke, Graham S.] Imperial Coll London, Dept Infect Dis, London, England; [Jonnerby, Jakob] Imperial Coll Healthcare NHS Trust, Natl Heart & Lung Inst, London, England; [Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster, England; [Page, Andrew J.; Trotter, Alexander J.] Quadram Inst, Norwich, Norfolk, England; [Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, London, England; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Lancaster University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; Imperial College London; University of Oxford	Elliott, P; Donnelly, CA (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.; Elliott, P (corresponding author), Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, London, England.; Elliott, P (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.; Elliott, P (corresponding author), Natl Inst Hlth Res Imperial Biomed Res Ctr, London, England.; Elliott, P (corresponding author), Imperial Coll London, Hlth Data Res HDR UK, London, England.; Elliott, P (corresponding author), Imperial Coll London, UK Dementia Res Inst, London, England.; Donnelly, CA (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England.; Donnelly, CA (corresponding author), Univ Oxford, Dept Stat, Oxford, England.	p.elliott@imperial.ac.uk; c.donnelly@imperial.ac.uk		Barclay, Wendy/0000-0002-3948-0895; Diggle, Peter/0000-0003-3521-5020; WANG, HAOWEI/0000-0003-4753-8783; Elliott, Paul/0000-0002-7511-5684; Elliott, Joshua/0000-0002-9005-623X; Bodinier, Barbara/0000-0002-0781-3624; Haw, David/0000-0002-9228-0542; Tang, David/0000-0002-6974-5663; Chadeau-Hyam, Marc/0000-0001-8341-5436	Department of Health and Social Care in England; Medical Research Council (MRC) Centre for Environment and Health [MR/L01341X/1, MR/S019669/1]; Health Data Research UK (HDR UK); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; NIHR Health Protection Research Units in Chemical and Radiation Threats and Hazards, and Environmental Exposures and Health; British Heart Foundation Centre for Research Excellence at Imperial College London [RE/18/4/34215]; UK Dementia Research Institute at Imperial College London [MC_PC_17114]; Biotechnology and Biological Sciences Research Council [BB/R012504/1]; MRC Centre for Environment and Health; NIHR Senior Investigator Award; Wellcome Trust [205456/Z/16/Z]; NIHR Applied Research Collaboration (ARC) North West London; NIHR Professorship; Cancer Research UK, Population Research Committee Project grant "Mechanomics" [22184]; H2020-EXPANSE project [874627]; MRC Centre for Global Infectious Disease Analysis; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections; NIHR [PR-OD-1017-20007]	Department of Health and Social Care in England; Medical Research Council (MRC) Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Data Research UK (HDR UK); National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; NIHR Health Protection Research Units in Chemical and Radiation Threats and Hazards, and Environmental Exposures and Health; British Heart Foundation Centre for Research Excellence at Imperial College London; UK Dementia Research Institute at Imperial College London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Senior Investigator Award; Wellcome Trust(Wellcome Trust); NIHR Applied Research Collaboration (ARC) North West London; NIHR Professorship; Cancer Research UK, Population Research Committee Project grant "Mechanomics"; H2020-EXPANSE project; MRC Centre for Global Infectious Disease Analysis(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit in Emerging and Zoonotic Infections; NIHR(National Institute for Health Research (NIHR))	The study was funded by the Department of Health and Social Care in England. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript. P.E. is Director of the Medical Research Council (MRC) Centre for Environment and Health (MR/L01341X/1, MR/S019669/1). P.E. acknowledges support from Health Data Research UK (HDR UK); the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; NIHR Health Protection Research Units in Chemical and Radiation Threats and Hazards, and Environmental Exposures and Health; the British Heart Foundation Centre for Research Excellence at Imperial College London (RE/18/4/34215); and the UK Dementia Research Institute at Imperial College London (MC_PC_17114). A.J.P. acknowledges the support of the Biotechnology and Biological Sciences Research Council (BB/R012504/1). B.B. is supported by an MRC PhD Studentship from the MRC Centre for Environment and Health. H.Ward acknowledges support from an NIHR Senior Investigator Award, the Wellcome Trust (205456/Z/16/Z), and the NIHR Applied Research Collaboration (ARC) North West London. J.E. is an NIHR academic clinical fellow in infectious diseases. G.C. is supported by an NIHR Professorship. M.C.-H. and B.B. acknowledge support from Cancer Research UK, Population Research Committee Project grant "Mechanomics" (grant 22184 to M.C.-H.). M.C.-H. and M.W. acknowledge support from the H2020-EXPANSE project (Horizon 2020 grant 874627). C.A.D. acknowledges support from the MRC Centre for Global Infectious Disease Analysis, the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections and the NIHR-funded Vaccine Efficacy Evaluation for Priority Emerging Diseases (PR-OD-1017-20007).	Abbott S., 2022, 22268920 BIORXIV; Andrews N., 2021, 21266341 BIORXIV; [Anonymous], 2021, NHS OPENS BOOKINGS 1; [Anonymous], [No title captured], DOI 10.5281/zenodo.5574472; [Anonymous], OMICRON DAILY OVERVI; [Anonymous], SARS COV 2 VARIANTS; [Anonymous], 2021, CORONAVIRUS COVID 19; Department of Health and Social Care, 2021, 1 UK CAS OM VAR ID; Doria-Rose N. A., 2021, 21267805 BIORXIV; Ferguson N., 2021, 50 IMP COLL LOND; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Prime Minister's Office 10 Downing Street, 2021, PRIM MIN CONF MOV PL; Riley S, 2021, SCIENCE, V372, P990, DOI 10.1126/science.abf0874; Riley Steven, 2020, Wellcome Open Res, V5, P200, DOI 10.12688/wellcomeopenres.16228.1; Schmidt F., 2021, 21267646 BIORXIV; SHAROT T, 1986, J MARKET RES SOC, V28, P269; UK Health Security Agency, OM DAIL OV 21 DEC 20; van Algemene Zaken M, 2021, SLOWING SPREAD OMICR	20	33	34	9	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2022	375	6587			SI		1406	+		10.1126/science.abn8347	http://dx.doi.org/10.1126/science.abn8347			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0H7EO	35133177	Green Published, Green Submitted			2022-12-28	WOS:000778894800043
J	Leung, KK; Hirschfield, GM				Leung, Kristel K.; Hirschfield, Gideon M.			Elevated Serum Aminotransferases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Leung, Kristel K.; Hirschfield, Gideon M.] Univ Toronto, Toronto Gen Hosp, Toronto Ctr Liver Dis, Div Gastroenterol & Hepatol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Hirschfield, GM (corresponding author), Univ Toronto, Toronto Ctr Liver Dis, Lily & Terry Horner Chair Autoimmune Liver Dis Re, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	gideon.hirschfield@uhn.ca		Leung, Kristel/0000-0002-1161-4118				Bussler S, 2018, HEPATOLOGY, V68, P1319, DOI 10.1002/hep.29542; Galvin Z, 2015, CLIN MED, V15, P244, DOI 10.7861/clinmedicine.15-3-244; Kasarala George, 2016, Clin Liver Dis (Hoboken), V8, P13, DOI 10.1002/cld.562; Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Marchesini G, 2005, J ENDOCRINOL INVEST, V28, P333, DOI 10.1007/BF03347199; Newsome PN, 2018, GUT, V67, P6, DOI 10.1136/gutjnl-2017-314924; Tran AN, 2021, ANN INTERN MED, V174, pITC129, DOI 10.7326/AITC202109210; Valenti L, 2021, HEPATOL COMMUN, V5, P1824, DOI 10.1002/hep4.1794	9	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					580	581						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35133427				2022-12-28	WOS:000758257900017
J	Wallace, DD; Urquiza, K; Raifman, J; Ko, M				Wallace, Deshira D.; Urquiza, Kristin; Raifman, Julia; Ko, Michelle			Putting equity at the heart of the US government's rollout of covid tests and masks	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wallace, Deshira D.] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Raifman, Julia] Boston Univ, Boston, MA 02215 USA; [Ko, Michelle] Univ Calif Davis, Dept Publ Hlth Sci, Div Hlth Policy & Management, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; University of California System; University of California Davis	Wallace, DD (corresponding author), UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.				COVID community	COVID community	We want to acknowledge Marked By COVID co-founder Christine Keeves, MPH, and the Marked By COVID community for their support and perspectives.	[Anonymous], PLACE YOUR ORDER FRE; Biden Joseph, 2021, NAT STRAT COVID 19 R; Bogage J., 2022, WASH POST; Dawson L, 2022, ARE PRIVATE INSURERS; Fox J., 2021, CURRENT COVID 19 SUR; Green T, 2022, NEW ENGL J MED, V386, P405, DOI 10.1056/NEJMp2104360; Guadamuz JS, 2021, HEALTH AFFAIR, V40, P802, DOI 10.1377/hlthaff.2020.01699; NACHC, 2021, HLTH CTR FIND COVID; Raifman J, 2021, THE CONVERSATION; Rudowitz R., 2022, MEDICAID AT HOME COV; Treisman R, 2022, NPR; Wolfe R., 2021, HLTH AFFAIRS HLTH PO, V4	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o344	10.1136/bmj.o344	http://dx.doi.org/10.1136/bmj.o344			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF8EL	35135808	Bronze			2022-12-28	WOS:000759803000002
J	Hodes, S; Stanley, S; Majeed, A				Hodes, Simon; Stanley, Sian; Majeed, Azeem			A national vaccination service for the NHS in England: a proposal to be considered with caution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stanley, Sian] Stort Valley & Villages Primary Care Network, Bishops Stortford, England; [Majeed, Azeem] Imperial Coll London, London, England	Imperial College London	Stanley, S (corresponding author), Stort Valley & Villages Primary Care Network, Bishops Stortford, England.			Majeed, Azeem/0000-0002-2357-9858	NIHR Applied Research Collaboration NW London	NIHR Applied Research Collaboration NW London	AM is supported by the NIHR Applied Research Collaboration NW London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Majeed A, 2020, J ROY SOC MED, V113, P208, DOI 10.1177/0141076820931452; Oliver David, 2022, BMJ, V376, pn3139, DOI 10.1136/bmj.n3139	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								o338	10.1136/bmj.o338	http://dx.doi.org/10.1136/bmj.o338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9JI	35131747	Bronze			2022-12-28	WOS:000759192600004
J	Boulias, K; Greer, EL				Boulias, Konstantinos; Greer, Eric Lieberman			The adenine methylation debate	SCIENCE			English	Editorial Material							DNA METHYLATION; N-6-ADENINE; N-6-METHYLADENINE		[Boulias, Konstantinos; Greer, Eric Lieberman] Harvard Med Sch, Dept Pediat, HMS Initiat RNA Med, Boston, MA 02115 USA; [Boulias, Konstantinos; Greer, Eric Lieberman] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Greer, EL (corresponding author), Harvard Med Sch, Dept Pediat, HMS Initiat RNA Med, Boston, MA 02115 USA.; Greer, EL (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.	eric.greer@childrens.harvard.edu			National Institutes of Health; US Centers for Disease Control and Prevention	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	J.O.W. is funded by the National Institutes of Health and US Centers for Disease Control and Prevention.	Douvlataniotis K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3335; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Hao ZY, 2020, MOL CELL, V78, P382, DOI 10.1016/j.molcel.2020.02.018; Huang W, 2015, RSC ADV, V5, P64046, DOI 10.1039/c5ra05307b; Kong YM, 2022, SCIENCE, V375, P515, DOI 10.1126/science.abe7489; Liang Z, 2018, DEV CELL, V45, P406, DOI [10.1016/j.devicel.2018.03.012, 10.1016/j.devcel.2018.03.012]; Liu BD, 2017, ANAL CHEM, V89, P6203, DOI 10.1021/acs.analchem.7b01152; O'Brown ZK, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5754-6; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Wang YY, 2017, NUCLEIC ACIDS RES, V45, P11594, DOI 10.1093/nar/gkx883; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	15	2	2	4	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					494	495		10.1126/science.abn6514	http://dx.doi.org/10.1126/science.abn6514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113697				2022-12-28	WOS:000753965100022
J	Neto, MBB; Badley, AD; Parikh, SA; Graham, RP; Kamath, PS				Braga Neto, Manuel B.; Badley, Andrew D.; Parikh, Sameer A.; Graham, Rondell P.; Kamath, Patrick S.			Calm before the Storm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SECONDARY; COVID-19	Calm before the Storm A 61-year-old man was evaluated after having jaundice, light-colored stools, dark urine, pruritus, fatigue, and a temperature of up to 39 degrees C (without chills) for 1 week. He had dull pain in the right upper quadrant of the abdomen and had nausea but no vomiting. Six weeks before jaundice developed, he had been hospitalized with Covid-19.	[Braga Neto, Manuel B.; Kamath, Patrick S.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN USA; [Parikh, Sameer A.] Mayo Clin, Div Hematol, Rochester, MN USA; [Graham, Rondell P.] Mayo Clin, Dept Med, Rochester, MN USA; [Graham, Rondell P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kamath, PS (corresponding author), Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	kamath.patrick@mayo.edu		Badley, Andrew/0000-0001-7796-7680				[Anonymous], 2021, MULTISYSTEM INFLAMMA; Davogustto GE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.10323; De Gottardi J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226899; Eloseily EM, 2020, ARTHRITIS RHEUMATOL, V72, P326, DOI 10.1002/art.41103; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690; Flower L, 2021, LANCET RHEUMATOL, V3, pE744, DOI 10.1016/S2665-9913(21)00248-4; Hakim NN, 2021, EXP BIOL MED, V246, P5, DOI 10.1177/1535370220962043; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; McArdle AJ, 2021, NEW ENGL J MED, V385, P11, DOI 10.1056/NEJMoa2102968; Morris SB, 2020, MMWR-MORBID MORTAL W, V69, P1450, DOI 10.15585/mmwr.mm6940e1; Prieto-Perez L, 2020, MODERN PATHOL, V33, P2139, DOI 10.1038/s41379-020-0613-1; Ramos-Casals M, 2021, NAT REV RHEUMATOL, V17, P315, DOI 10.1038/s41584-021-00608-z; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	15	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					479	485		10.1056/NEJMcps2111163	http://dx.doi.org/10.1056/NEJMcps2111163			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR1JU	35108473	Green Published, Bronze			2022-12-28	WOS:000749755800013
J	Chia, MA; Keane, PA				Chia, Mark A.; Keane, Pearse A.			Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?	LANCET			English	Editorial Material							MACULAR DEGENERATION		[Keane, Pearse A.] UCL, Inst Ophthalmol, London, England; Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London EC1V 2PD, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Keane, PA (corresponding author), UCL, Inst Ophthalmol, London, England.	pearse.keane1@nhs.net		Keane, Pearse/0000-0002-9239-745X; Chia, Mark/0000-0003-0339-5186				Adamis AP, 2020, EYE, V34, P1966, DOI 10.1038/s41433-020-0895-z; Arpa C, 2021, BRIT J OPHTHALMOL, V105, P1688, DOI 10.1136/bjophthalmol-2020-317161; Dugel PU, 2020, OPHTHALMOLOGY, V127, P72, DOI 10.1016/j.ophtha.2019.04.017; Heier JS, 2022, LANCET, V399, P729, DOI 10.1016/S0140-6736(22)00010-1; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Mones J, 2021, OPHTHALMOLOGY, V128, P1050, DOI 10.1016/j.ophtha.2020.11.011; Rezaei KA, 2015, GLOBAL TRENDS RETINA; Stitt AW, 2016, PROG RETIN EYE RES, V51, P156, DOI 10.1016/j.preteyeres.2015.08.001; Talks SJ, 2022, EYE, V36, P72, DOI 10.1038/s41433-021-01625-8; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wykoff CC, 2022, LANCET, V399, P741, DOI 10.1016/S0140-6736(22)00018-6	12	2	2	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					697	699		10.1016/S0140-6736(22)00105-2	http://dx.doi.org/10.1016/S0140-6736(22)00105-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE3NS	35085501	Green Submitted			2022-12-28	WOS:000758794200004
J	Hviid, A; Hansen, JV; Thiesson, EM; Wohlfahrt, J				Hviid, Anders; Hansen, Jorgen Vinslov; Thiesson, Emilia Myrup; Wohlfahrt, Jan			Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article								Background: In March 2021, several European countries suspended the use of the AZD1222 (Oxford-AstraZeneca) COVID-19 vaccine because of thromboembolic safety concerns. Reports from Norway and Germany subsequently described patients with venous thrombosis and thrombocytopenia within 5 to 16 days of vaccination. Objective: To evaluate the risk for outcomes related to thrombosis and thrombocytopenia after AZD1222 or BNT162b2 (Pfizer- BioNTech) COVID-19 vaccination. Design: Nationwide exploratory retrospective cohort study. Setting: Danish linkable registers on vaccinations, hospitalizations, occupation, and other covariates. Participants: 355 209 Danish frontline personnel designated for priority COVID-19 vaccination followed from 27 December 2020 (the day of the first COVID-19 vaccination in Denmark) to 13 April 2021. Measurements: Study outcomes were cerebral venous sinus thrombosis, splanchnic vein thrombosis, pulmonary embolism, deep venous thrombosis, arterial thrombosis, thrombocytopenia, and death. Cumulative incidences of study outcomes within 28 days of vaccination and unvaccinated risk time were compared using adjusted survival curves resulting in risk differences (RDs) at day 28 after vaccination. Adjustment for birth cohort, sex, calendar period, occupation, comorbid conditions, and prescription drug use was included. Results: Vaccination with AZD1222 versus no vaccination was associated with a significant RD at day 28 for deep venous thrombosis (RD, 8.35 [95% CI, 0.21 to 16.49] per 100000 vaccinations). The RDs for cerebral venous sinus thrombosis (RD, 1.68 [CI,-0.64 to 4.00] per 100000 vaccinations) and thrombocytopenia (RD, 2.39 [CI,-1.09 to 5.87] per 100000 vaccinations) were not significant. No adverse associations were seen for BNT162b2 vaccination. Limitation: No medical record review; surveillance bias. Conclusion: In this exploratory retrospective cohort study among frontline personnel in Denmark, receipt of the AZD1222 vaccine was associated with a small excess risk for deep venous thrombosis. Although the corresponding risks for the more rare and severe thrombotic outcomes (such as cerebral venous sinus thrombosis) were not statistically significantly increased, statistical precision was low, and clinically relevant risks could not be excluded with certainty. There was no statistically significant association of BNT162b2 vaccination with thrombotic or thrombocytopenic events.	[Hviid, Anders] Univ Copenhagen, Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Hviid, Anders] Univ Copenhagen, Pharmacovigilance Res Ctr, Dept Drug Dev & Clin Pharmacol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hansen, Jorgen Vinslov; Thiesson, Emilia Myrup; Wohlfahrt, Jan] Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen; Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark.	aii@ssi.dk		Hviid, Anders/0000-0002-7509-9127; Thiesson, Emilia/0000-0001-6258-4177	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	Primary Funding Source: Lundbeck Foundation.	Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; European Medicines Agency (EMA), 2021, COVID 19 VACC ASTRAZ; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1931; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klok FA, 2022, LANCET HAEMATOL, V9, pE73, DOI 10.1016/S2352-3026(21)00306-9; Krause TG, 2012, EUROSURVEILLANCE, V17, P5; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n774; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pottegard A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1114; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; See I, 2021, JAMA-J AM MED ASSOC, V325, P2448, DOI 10.1001/jama.2021.7517; Simpson CR, 2021, NAT MED, V27, P1290, DOI 10.1038/s41591-021-01408-4; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	16	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					541	+		10.7326/M21-2452	http://dx.doi.org/10.7326/M21-2452		FEB 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35103482	Green Published			2022-12-28	WOS:000793579300010
J	Lardaro, T; Hunter, BR				Lardaro, Thomas; Hunter, Benton R.			In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lardaro, Thomas; Hunter, Benton R.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Lardaro, T (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC20	JC20		10.7326/J21-0018	http://dx.doi.org/10.7326/J21-0018		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099989				2022-12-28	WOS:000750879500001
J	Laxminarayan, R				Laxminarayan, Ramanan			The overlooked pandemic of antimicrobial resistance Comment	LANCET			English	Editorial Material							ANTIBIOTIC-RESISTANCE; BURDEN		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Laxminarayan, Ramanan] Global Antibiot Res & Dev Partnership, Geneva, Switzerland		Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.; Laxminarayan, R (corresponding author), Global Antibiot Res & Dev Partnership, Geneva, Switzerland.	ramanan@cddep.org						Andrejko K, 2021, LANCET MICROBE, V2, pE450, DOI 10.1016/S2666-5247(21)00064-1; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; KPMG, 2014, GLOB EC IMP ANT RES; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lewnard JA, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008520; Lewnard JA, 2020, NATURE, V581, P94, DOI 10.1038/s41586-020-2238-4; Murray CJL, 2022, LANCET, V399, P629, DOI [10.1016/S0140-6736(21)02724-0, 10.1016/j.eururo.2022.08.023]; ONeill J., 2014, REV ANTIMICROB RESIS; Teillant A, 2015, LANCET INFECT DIS, V15, P1429, DOI 10.1016/S1473-3099(15)00270-4; University of California-Berkeley, 2020, SCIENCEDAILY; WHO, 2021, GLOB ANT RES US SURV; World Health Organization, 2021, MALARIA; World Health Organization, 2021, HIV AIDS	16	11	11	13	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					606	607		10.1016/S0140-6736(22)00087-3	http://dx.doi.org/10.1016/S0140-6736(22)00087-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY1RO	35065701	Green Published, Bronze			2022-12-28	WOS:000754571600002
J	Keeton, R; Tincho, MB; Ngomti, A; Baguma, R; Benede, N; Suzuki, A; Khan, K; Cele, S; Bernstein, M; Karim, F; Madzorera, SV; Moyo-Gwete, T; Mennen, M; Skelem, S; Adriaanse, M; Mutithu, D; Aremu, O; Stek, C; du Bruyn, E; Van der Mescht, MA; de Beer, Z; de Villiers, TR; Bodenstein, A; van den Berg, G; Mendes, A; Strydom, A; Venter, M; Giandhari, J; Naidoo, Y; Pillay, S; Tegally, H; Grifoni, A; Weiskopf, D; Sette, A; Wilkinson, RJ; de Oliveira, T; Bekker, LG; Gray, G; Ueckermann, V; Rossouw, T; Boswell, MT; Bihman, J; Moore, PL; Sigal, A; Ntusi, NAB; Burgers, WA; Riou, C				Keeton, Roanne; Tincho, Marius B.; Ngomti, Amkele; Baguma, Richard; Benede, Ntombi; Suzuki, Akiko; Khan, Khadija; Cele, Sandile; Bernstein, Mallory; Karim, Farina; Madzorera, Sharon, V; Moyo-Gwete, Thandeka; Mennen, Mathilda; Skelem, Sango; Adriaanse, Marguerite; Mutithu, Daniel; Aremu, Olukayode; Stek, Cari; du Bruyn, Elsa; Van der Mescht, Mieke A.; de Beer, Zelda; de Villiers, Talita R.; Bodenstein, Annie; van den Berg, Gretha; Mendes, Adriano; Strydom, Amy; Venter, Marietjie; Giandhari, Jennifer; Naidoo, Yeshnee; Pillay, Sureshnee; Tegally, Houriiyah; Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro; Wilkinson, Robert J.; de Oliveira, Tulio; Bekker, Linda-Gail; Gray, Glenda; Ueckermann, Veronica; Rossouw, Theresa; Boswell, Michael T.; Bihman, Jinal; Moore, Penny L.; Sigal, Alex; Ntusi, Ntobeko A. B.; Burgers, Wendy A.; Riou, Catherine			T cell responses to SARS-CoV-2 spike cross-recognize Omicron	NATURE			English	Article								The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations(1,)(2) that contribute to viral escape from antibody neutralization' and reduce vaccine protection from infection(7,8). The extent to which other components of the adaptive response such as T cells may still target Omicron and contribute to protection from severe outcomes is unknown. Here we assessed the ability of T cells to react to Omicron spike protein in participants who were vaccinated with Ad26.CoV2.S or BNT162b2, or unvaccinated convalescent COVID-19 patients (n = 70). Between 70% and 80% of the CD4(+) and CD8(+) T cell response to spike was maintained across study groups. Moreover, the magnitude of Omicron cross-reactive T cells was similar for Beta (B.1.351) and Delta (B.1.617.2) variants, despite Omicron harbouring considerably more mutations. In patients who were hospitalized with Omicron infections (n = 19), there were comparable T cell responsesto ancestral spike, nucleocapsid and membrane proteinsto those in patients hospitalized in previous waves dominated by the ancestral, Beta or Delta variants (n = 49) . Thus, despite extensive mutations and reduced susceptibility to neutralizing antibodies of Omicron, the majority of T cell responses induced by vaccination or infection cross-recognize the variant. It remains to be determined whether well-preserved T cell immunity to Omicron contributes to protection from severe COVID-19 and is linked to early clinical observations from South Africa and elsewhere(9-12).	[Keeton, Roanne; Tincho, Marius B.; Ngomti, Amkele; Baguma, Richard; Benede, Ntombi; Suzuki, Akiko; Stek, Cari; du Bruyn, Elsa; Wilkinson, Robert J.; Bekker, Linda-Gail; Moore, Penny L.; Ntusi, Ntobeko A. B.; Burgers, Wendy A.; Riou, Catherine] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Keeton, Roanne; Tincho, Marius B.; Ngomti, Amkele; Baguma, Richard; Benede, Ntombi; Suzuki, Akiko; Burgers, Wendy A.; Riou, Catherine] Univ Cape Town, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Khan, Khadija; Cele, Sandile; Bernstein, Mallory; Karim, Farina; Sigal, Alex] Africa Hlth Res Inst, Durban, South Africa; [Khan, Khadija; Cele, Sandile; Bernstein, Mallory; Karim, Farina; Sigal, Alex] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Madzorera, Sharon, V; Moyo-Gwete, Thandeka; Bihman, Jinal; Moore, Penny L.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Madzorera, Sharon, V; Moyo-Gwete, Thandeka; Bihman, Jinal; Moore, Penny L.] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, SA MRC Antibody Immun Res Unit, Johannesburg, South Africa; [Mennen, Mathilda; Skelem, Sango; Adriaanse, Marguerite; Mutithu, Daniel; Aremu, Olukayode; Stek, Cari; du Bruyn, Elsa; Wilkinson, Robert J.; Bekker, Linda-Gail; Ntusi, Ntobeko A. B.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Mennen, Mathilda; Skelem, Sango; Adriaanse, Marguerite; Mutithu, Daniel; Aremu, Olukayode; Stek, Cari; du Bruyn, Elsa; Wilkinson, Robert J.; Bekker, Linda-Gail; Ntusi, Ntobeko A. B.] Groote Schuur Hosp, Cape Town, South Africa; [Van der Mescht, Mieke A.; Rossouw, Theresa] Univ Pretoria, Dept Immunol, Pretoria, South Africa; [de Beer, Zelda; de Villiers, Talita R.; Bodenstein, Annie; van den Berg, Gretha] Tshwane Dist Hosp, Tshwane, South Africa; [Mendes, Adriano; Strydom, Amy; Venter, Marietjie] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Pretoria, South Africa; [Giandhari, Jennifer; Naidoo, Yeshnee; Pillay, Sureshnee; Tegally, Houriiyah; de Oliveira, Tulio] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform, Durban, South Africa; [Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA; [Sette, Alessandro] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Wilkinson, Robert J.; Ntusi, Ntobeko A. B.; Burgers, Wendy A.; Riou, Catherine] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Wilkinson, Robert J.] Imperial Coll London, Dept Infect Dis, London, England; [Wilkinson, Robert J.] Francis Crick Inst, London, England; [de Oliveira, Tulio] Stellenbosch Univ, Ctr Epidem Response & Innovat, Stellenbosch, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Gray, Glenda] South African Med Res Council, Cape Town, South Africa; [Ueckermann, Veronica; Boswell, Michael T.] Univ Pretoria, Dept Internal Med, Pretoria, South Africa; [Ueckermann, Veronica; Boswell, Michael T.] Steve Biko Acad Hosp, Pretoria, South Africa; [Moore, Penny L.] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Sigal, Alex] Max Planck Inst Infect Biol, Berlin, Germany; [Ntusi, Ntobeko A. B.] Univ Cape Town, Fac Hlth Sci, Cape Heart Inst, Cape Town, South Africa	University of Cape Town; University of Cape Town; Africa Health Research Institute; University of Kwazulu Natal; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Cape Town; University of Cape Town; University of Pretoria; Tshwane University of Technology; University of Pretoria; University of Kwazulu Natal; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of Cape Town; Imperial College London; Francis Crick Institute; Stellenbosch University; University of Cape Town; South African Medical Research Council; University of Pretoria; University of Pretoria; Max Planck Society; University of Cape Town	Burgers, WA; Riou, C (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Burgers, WA; Riou, C (corresponding author), Univ Cape Town, Dept Pathol, Div Med Virol, Cape Town, South Africa.; Burgers, WA; Riou, C (corresponding author), Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa.	wendy.burgers@uct.ac.za; cr.riou@uct.ac.za	Keeton, Roanne/AAS-2728-2021; Ueckermann, Veronica/GXV-4532-2022; Tincho, Marius Belmondo/S-2173-2019; Sette, Alessandro/AFO-8916-2022; Venter, Marietjie/P-9604-2016	Tincho, Marius Belmondo/0000-0002-1293-5933; Wilkinson, Robert/0000-0002-2753-1800; de Beer, Zelda/0000-0002-2385-889X; Burgers, Wendy/0000-0003-3396-9398; Boswell, Michael/0000-0003-2152-1617; Venter, Marietjie/0000-0003-2696-824X; Benede, Ntombi/0000-0002-3319-8215; Riou, Catherine/0000-0001-9679-0745; Baguma, Richard/0000-0002-5106-021X; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Ntusi, Ntobeko A. B./0000-0003-2347-7883; Suzuki, Akiko/0000-0001-8885-0189; de Oliveira, Tulio/0000-0002-3027-5254	South African Medical Research Council (SA-MRC); South African Department of Science and Innovation (DSI) [96825, SHIPNCD 76756, DST/CON 0250/2012]; Poliomyelitis Research Foundation [21/65]; Wellcome CIDRI-Africa - Wellcome Trust [203135/Z/16/Z, 222574]; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [75N93021C00016, 75N9301900065]; SA Research Chairs Initiative of the DSI; National Research Foundation (NRF) [9834]; EDCTP2 programme of the European Union's Horizon 2020 programme [TMA2017SF-1951-TB-SPEC, TMA2016SF-1535-CaTCH-22]; SA-MRC; MRC UK; NRF; Bill and Melinda Gates award [INV-018944]; NIH [AI138546]; Francis Crick Institute from Wellcome [FC0010218]; UKRI [FC0010218]; CRUK [FC0010218]; Rosetrees Trust [M926]	South African Medical Research Council (SA-MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)South African Medical Research Council); South African Department of Science and Innovation (DSI); Poliomyelitis Research Foundation; Wellcome CIDRI-Africa - Wellcome Trust; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services; SA Research Chairs Initiative of the DSI; National Research Foundation (NRF); EDCTP2 programme of the European Union's Horizon 2020 programme; SA-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF; Bill and Melinda Gates award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Francis Crick Institute from Wellcome; UKRI(UK Research & Innovation (UKRI)); CRUK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust)	We thank the participants who volunteered for this study. We thank W. van Hougenhouck-Tulleken for assistance with database management; R. Ramlall and J. Semugga for assistance with participant recruitment at Tshwane District Hospital; C. Scheepers and J. Everatt for generous assistance with plotting lineage prevalence; L. Singh and the NHLS Greenpoint Laboratory for PCR testing; and Biocair for assistance with shipping delays of critical reagents. Research reported in this publication was supported by the South African Medical Research Council (SA-MRC) with funds received from the South African Department of Science and Innovation (DSI), including grants 96825, SHIPNCD 76756 and DST/CON 0250/2012. This work was also supported by the Poliomyelitis Research Foundation (21/65) and Wellcome CIDRI-Africa, which is supported by core funding from Wellcome Trust (203135/Z/16/Z and 222574). This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract no. 75N93021C00016 to A. Sette and contract no. 75N9301900065 to A. Sette and D.W. P.L.M. is supported by the SA Research Chairs Initiative of the DSI and the National Research Foundation (NRF; 9834). W.A.B. and C.R. are supported by the EDCTP2 programme of the European Union's Horizon 2020 programme (TMA2017SF-1951-TB-SPEC to C.R. and TMA2016SF-1535-CaTCH-22 to W.A.B.). N.A.B.N. acknowledges funding from the SA-MRC, MRC UK and NRF. A. Sette acknowledges funding from the Bill and Melinda Gates award INV-018944, the NIH (AI138546) and the SA-MRC. R.J.W. acknowledges funding from the Francis Crick Institute, which receives funding from Wellcome FC0010218, UKRI FC0010218, CRUK FC0010218 and Rosetrees Trust (M926).	Adamo S, 2022, NATURE, V602, P148, DOI 10.1038/s41586-021-04280-x; Ahmed SF, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14010079; Andrews N., EFFECTIVENESS COVID, DOI [10.1101/2021.12.14.21267615 (2021, DOI 10.1101/2021.12.14.21267615(2021]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; De Marco L., PRESERVED T CELL REA, DOI [10.1101/2021.12.30.474453 (2021, DOI 10.1101/2021.12.30.474453(2021]; Doria-Rose N. A., BOOSTER MRNA 1273 ST, DOI [10.1101/2021.12.15.21267805 (2021, DOI 10.1101/2021.12.15.21267805(2021]; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Dupont L, 2021, NAT MICROBIOL, V6, P1433, DOI 10.1038/s41564-021-00974-0; Gao Y., NAT MED, DOI [10.1038/s41591-022-01700-x(2022), DOI 10.1038/S41591-022-01700-X(2022)]; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033]; GeurtsvanKessel CH, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abo2202; Goga A., 2021, MEDRXIV, DOI [10.1101/2021.12.21.21268171, DOI 10.1101/2021.12.21.21268171, 10.1101/ 2021.12.21.21268171]; Grifoni A, 2021, CELL HOST MICROBE, V29, P1076, DOI 10.1016/j.chom.2021.05.010; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holm Hansen C., VACCINE EFFECTIVENES, DOI [10.1101/2021.12.20.21267966 (2021), DOI 10.1101/2021.12.20.21267966(2021)]; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Liu J., NATURE, DOI [10.1038/s41586-022-04465-y (2022, DOI 10.1038/S41586-022-04465-Y(2022]; Madhi S. A., S AFRICAN POPULATION, DOI [10.1101/2021.12.20.21268096 (2021, DOI 10.1101/2021.12.20.21268096(2021]; Mahase E, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3151; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Meng B, SARS COV 2 OMICRON S, DOI [10.1101/2021.12.17.473248(2021, DOI 10.1101/2021.12.17.473248(2021]; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Naranbhai Vivek, 2022, medRxiv, DOI 10.1101/2022.01.04.21268586; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Planas D., NATURE, DOI [10.1038/s41586-021-04389-z (2021), DOI 10.1038/S41586-021-04389-Z(2021)]; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Riou C, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj6824; Scott L, 2021, SCIENCE, V374, P1454, DOI 10.1126/science.abn4543; Sheikh A, SEVERITY OMICRON VAR; Tarke A, CELL, DOI [10.1016/j.cell.2022.01.015 (2022, DOI 10.1016/J.CELL.2022.01.015(2022]; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100204; Viana R., NATURE, DOI [10.1038/s41586-022-04411-y (2022, DOI 10.1038/S41586-022-04411-Y(2022]; Wolter N., EARLY ASSESSMENT CLI, DOI [10.1101/2021.12.21.21268116 (2021, DOI 10.1101/2021.12.21.21268116(2021]; World Health Organization, CLASS OM B 1 1 529 S; Zhao HJ, 2022, EMERG MICROBES INFEC, V11, P277, DOI 10.1080/22221751.2021.2023329	45	163	162	33	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 17	2022	603	7901					488	+		10.1038/s41586-022-04460-3	http://dx.doi.org/10.1038/s41586-022-04460-3		JAN 2022	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZV2TI	35102311	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000766518300002
J	Melani, RD; Gerbasi, VR; Anderson, LC; Sikora, JW; Toby, TK; Hutton, JE; Butcher, DS; Negrao, F; Seckler, HS; Srzentic, K; Fornelli, L; Camarillo, JM; LeDuc, RD; Cesnik, AJ; Lundberg, E; Greer, JB; Fellers, RT; Robey, MT; DeHart, CJ; Forte, E; Hendrickson, CL; Abbatiello, SE; Thomas, PM; Kokaji, AI; Levitsky, J; Kelleher, NL				Melani, Rafael D.; Gerbasi, Vincent R.; Anderson, Lissa C.; Sikora, Jacek W.; Toby, Timothy K.; Hutton, Josiah E.; Butcher, David S.; Negrao, Fernanda; Seckler, Henrique S.; Srzentic, Kristina; Fornelli, Luca; Camarillo, Jeannie M.; LeDuc, Richard D.; Cesnik, Anthony J.; Lundberg, Emma; Greer, Joseph B.; Fellers, Ryan T.; Robey, Matthew T.; DeHart, Caroline J.; Forte, Eleonora; Hendrickson, Christopher L.; Abbatiello, Susan E.; Thomas, Paul M.; Kokaji, Andy, I; Levitsky, Josh; Kelleher, Neil L.			The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells	SCIENCE			English	Article							LATE ACUTE REJECTION; TOP-DOWN PROTEOMICS; LIVER-TRANSPLANTATION; COMBINATORIAL MODIFICATION; MASS-SPECTROMETRY; PERIPHERAL-BLOOD; ION COALESCENCE; HISTONE H3; PROTEIN; RNA	Human biology is tightly linked to proteins, yet most measurements do not precisely determine alternatively spliced sequences or posttranslational modifications. Here, we present the primary structures of similar to 30,000 unique proteoforms, nearly 10 times more than in previous studies, expressed from 1690 human genes across 21 cell types and plasma from human blood and bone marrow. The results, compiled in the Blood Proteoform Atlas (BPA), indicate that proteoforms better describe protein-level biology and are more specific indicators of differentiation than their corresponding proteins, which are more broadly expressed across cell types. We demonstrate the potential for clinical application, by interrogating the BPA in the context of liver transplantation and identifying cell and proteoform signatures that distinguish normal graft function from acute rejection and other causes of graft dysfunction.	[Melani, Rafael D.; Gerbasi, Vincent R.; Sikora, Jacek W.; Toby, Timothy K.; Hutton, Josiah E.; Negrao, Fernanda; Seckler, Henrique S.; Srzentic, Kristina; Fornelli, Luca; Camarillo, Jeannie M.; LeDuc, Richard D.; Greer, Joseph B.; Fellers, Ryan T.; Robey, Matthew T.; DeHart, Caroline J.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Dept Chem, Evanston, IL 60208 USA; [Melani, Rafael D.; Gerbasi, Vincent R.; Sikora, Jacek W.; Toby, Timothy K.; Hutton, Josiah E.; Negrao, Fernanda; Seckler, Henrique S.; Srzentic, Kristina; Fornelli, Luca; Camarillo, Jeannie M.; LeDuc, Richard D.; Greer, Joseph B.; Fellers, Ryan T.; Robey, Matthew T.; DeHart, Caroline J.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Anderson, Lissa C.; Butcher, David S.; Hendrickson, Christopher L.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL USA; [Cesnik, Anthony J.; Lundberg, Emma] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cesnik, Anthony J.; Lundberg, Emma] KTH Royal Inst Technol, Sci Life Lab, Sch Engn Sci Chem Biotechnol & Hlth, Stockholm, Sweden; [Forte, Eleonora] Northwestern Univ, Prote Ctr Excellence, Evanston, IL USA; [Forte, Eleonora] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL USA; [Abbatiello, Susan E.] Thermo Fisher Sci, Cambridge, MA USA; [Kokaji, Andy, I] STEMCELL Technol Inc, Vancouver, BC, Canada; [Levitsky, Josh] Northwestern Univ, Comprehens Transplant Ctr, Feinberg Sch Med, Chicago, IL 60208 USA; [Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60208 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; State University System of Florida; Florida State University; Stanford University; Royal Institute of Technology; Northwestern University; Northwestern University; Feinberg School of Medicine; Thermo Fisher Scientific; STEMCELL Technologies Canada Inc.; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kelleher, NL (corresponding author), Northwestern Univ, Dept Mol Biosci, Dept Chem, Evanston, IL 60208 USA.; Kelleher, NL (corresponding author), Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA.; Levitsky, J (corresponding author), Northwestern Univ, Comprehens Transplant Ctr, Feinberg Sch Med, Chicago, IL 60208 USA.; Kelleher, NL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60208 USA.	j-levitsky@northwestern.edu; n-kelleher@northwestern.edu	Levitsky, Josh/AAF-8662-2019; Melani, Rafael/H-8792-2018; Cesnik, Anthony/J-9238-2014	Levitsky, Josh/0000-0001-7527-6093; Butcher, David/0000-0002-1268-4150; Melani, Rafael/0000-0002-0349-235X; Sikora, Jacek/0000-0003-0240-567X; Cesnik, Anthony/0000-0002-5326-7134; Gerbasi, Robert/0000-0001-5573-0578; Kaller Lundberg, Emma/0000-0001-7034-0850				Aebersold R, 2018, NAT CHEM BIOL, V14, P206, DOI [10.1038/NCHEMBIO.2576, 10.1038/nchembio.2576]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Belov ME, 2013, ANAL CHEM, V85, P11163, DOI 10.1021/ac4029328; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Brown KA, 2020, EXPERT REV PROTEOMIC, V17, P719, DOI 10.1080/14789450.2020.1855982; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Cesnik AJ, 2021, J PROTEOME RES, V20, P1826, DOI 10.1021/acs.jproteome.0c00407; Dang XB, 2016, J PROTEOME RES, V15, P3196, DOI 10.1021/acs.jproteome.6b00414; Davis RG, 2018, ANAL CHEM, V90, P3802, DOI 10.1021/acs.analchem.7b04108; Di Palma S, 2011, J PROTEOME RES, V10, P3814, DOI 10.1021/pr200367p; Doerr A, 2019, NAT METHODS, V16, P20, DOI 10.1038/s41592-018-0273-y; Doll S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01747-2; Drescher HK, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00326; El Masri R, 2021, NAT REV IMMUNOL, V21, P499, DOI 10.1038/s41577-021-00500-7; Fornelli L, 2017, J PROTEOME RES, V16, P609, DOI 10.1021/acs.jproteome.6b00698; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Ghadie MA, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005717; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gorshkov MV, 2012, RAPID COMMUN MASS SP, V26, P1711, DOI 10.1002/rcm.6289; Gruning B, 2018, NAT METHODS, V15, P475, DOI 10.1038/s41592-018-0046-7; Guo H, 2015, SCAND J IMMUNOL, V81, P129, DOI 10.1111/sji.12257; GUPTA SK, 1995, P NATL ACAD SCI USA, V92, P7799, DOI 10.1073/pnas.92.17.7799; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hendrickson CL, 2015, J AM SOC MASS SPECTR, V26, P1626, DOI 10.1007/s13361-015-1182-2; Holt MV, 2019, J AM SOC MASS SPECTR, V30, P2548, DOI 10.1007/s13361-019-02350-z; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kleiveland C.R., 2015, IMPACT FOOD BIOACTIV, P161, DOI [10.1007/978-3-319-16104-4_15, DOI 10.1007/978-3-319-16104-4_15]; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; LeDuc RD, 2019, MOL CELL PROTEOMICS, V18, P796, DOI 10.1074/mcp.RA118.000993; Levitsky J, 2022, AM J TRANSPLANT, V22, P532, DOI 10.1111/ajt.16835; Levitsky J, 2022, TRANSPLANTATION, V106, P1004, DOI 10.1097/TP.0000000000003895; Levitsky J, 2020, AM J TRANSPLANT, V20, P2173, DOI 10.1111/ajt.15953; Levitsky J, 2017, CLIN GASTROENTEROL H, V15, P584, DOI 10.1016/j.cgh.2016.07.035; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Marx V, 2019, NAT METHODS, V16, P809, DOI 10.1038/s41592-019-0540-6; Moreau A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015461; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Ntai I, 2016, MOL CELL PROTEOMICS, V15, P45, DOI 10.1074/mcp.M114.047480; Ntai I, 2014, ANAL CHEM, V86, P4961, DOI 10.1021/ac500395k; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Pons JA, 2008, TRANSPLANTATION, V86, P1370, DOI 10.1097/TP.0b013e318188d3e6; Ramji A, 2002, LIVER TRANSPLANT, V8, P945, DOI 10.1053/jlts.2002.34969; Romano M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00043; Ronca V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02155; Schoppmeyer R, 2017, EUR J IMMUNOL, V47, P1562, DOI 10.1002/eji.201747124; Siuti N, 2006, J PROTEOME RES, V5, P233, DOI 10.1021/pr050268v; Smith L., 2020, HUMAN PROTEOFORM PRO; Smith LM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abk0734; Smith LM, 2019, NAT METHODS, V16, P939, DOI 10.1038/s41592-019-0573-x; Smith LM, 2018, SCIENCE, V359, P1106, DOI 10.1126/science.aat1884; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Snyder MP, 2019, NATURE, V574, P187, DOI 10.1038/s41586-019-1629-x; Stovsky M, 2019, J UROLOGY, V201, P1115, DOI 10.1097/JU.0000000000000185; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tarasova IA, 2015, EUR J MASS SPECTROM, V21, P459, DOI 10.1255/ejms.1356; Thomas CE, 2006, J PROTEOME RES, V5, P240, DOI 10.1021/pr050266a; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Thurairajah PH, 2013, TRANSPLANTATION, V95, P955, DOI 10.1097/TP.0b013e3182845f6c; Toby TK, 2017, AM J TRANSPLANT, V17, P2458, DOI 10.1111/ajt.14359; Toby TK, 2019, NAT PROTOC, V14, P119, DOI 10.1038/s41596-018-0085-7; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Uemura T, 2008, CLIN TRANSPLANT, V22, P316, DOI 10.1111/j.1399-0012.2007.00788.x; Uhlen M, 2019, SCIENCE, V366, P1471, DOI 10.1126/science.aax9198; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uversky VN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111874; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	76	13	13	9	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					411	+		10.1126/science.aaz5284	http://dx.doi.org/10.1126/science.aaz5284			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084980				2022-12-28	WOS:000750899500032
J	Lee, CD; Nelin, L; Foglia, EE				Lee, Clement D.; Nelin, Leif; Foglia, Elizabeth E.			Neonatal Resuscitation in 22-Week Pregnancies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE	Neonatal Resuscitation This interactive feature about infants born very prematurely offers a case vignette accompanied by two essays supporting resuscitation in all neonates born at 22 weeks' gestation or selective resuscitation. Vote and comment at NEJM.org.	[Nelin, Leif] Ohio State Univ, Columbus, OH 43210 USA; [Nelin, Leif] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Foglia, Elizabeth E.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Nelin, L (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.; Nelin, L (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.			Lee, Clement/0000-0002-2963-4731				Backes CH, 2021, AM J OBSTET GYNECOL, V224, P158, DOI 10.1016/j.ajog.2020.07.051; Backes CH, 2019, J PERINATOL, V39, P39, DOI 10.1038/s41372-018-0248-y; Carbajal R, 2008, JAMA-J AM MED ASSOC, V300, P60, DOI 10.1001/jama.300.1.60; Cummings J, 2015, PEDIATRICS, V136, P588, DOI 10.1542/peds.2015-2336; Di Nardo M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00109; Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046; Rysavy M, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2019.6294; Soderstrom F, 2021, ARCH DIS CHILD-FETAL, V106, P413, DOI 10.1136/archdischild-2020-320486; Watkins PL, 2020, J PEDIATR-US, V217, P52, DOI 10.1016/j.jpeds.2019.08.028; Wyckoff MH, 2014, SEMIN PERINATOL, V38, P12, DOI 10.1053/j.semperi.2013.07.003; Younge N, 2017, NEW ENGL J MED, V376, P617, DOI 10.1056/NEJMoa1605566	11	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					391	393		10.1056/NEJMclde2114954	http://dx.doi.org/10.1056/NEJMclde2114954			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081286				2022-12-28	WOS:000753548900019
J	McCarthy, MR; Lusk, CP				McCarthy, Megan R.; Lusk, C. Patrick			One ring doesn't rule them all: Distinct nuclear pore complexes in a single cell	CELL			English	Editorial Material								Determining the structural plasticity and dynamics of nuclear pore complexes (NPCs) are major challenges. In this issue of Cell, Akey et al. present comprehensive NPC structures from in vitro and in vivo preparations, demonstrating multiple NPC forms in single cells while providing insight into the evolutionary origin of NPC architecture.	[McCarthy, Megan R.; Lusk, C. Patrick] Yale Sch Med, Dept Cell Biol, 295 Congress Ave, New Haven, CT 06519 USA	Yale University	Lusk, CP (corresponding author), Yale Sch Med, Dept Cell Biol, 295 Congress Ave, New Haven, CT 06519 USA.	patrick.lusk@yale.edu						Akey CW, 2022, CELL, V185, P361, DOI 10.1016/j.cell.2021.12.015; Allegretti M, 2020, NATURE, V586, P796, DOI 10.1038/s41586-020-2670-5; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Huang GXY, 2020, CELL RES, V30, P520, DOI 10.1038/s41422-020-0319-4; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; Mosalaganti S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04739-y; Schuller AP, 2021, NATURE, V598, P667, DOI 10.1038/s41586-021-03985-3; Zimmerli CE, 2021, SCIENCE, V374, P1341, DOI 10.1126/science.abd9776	10	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					230	231		10.1016/j.cell.2021.12.042	http://dx.doi.org/10.1016/j.cell.2021.12.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35063070				2022-12-28	WOS:000746172100004
J	Fumagalli, F; Calbi, V; Sora, MGN; Sessa, M; Baldoli, C; Rancoita, PMV; Ciotti, F; Sarzana, M; Fraschini, M; Zambon, AA; Acquati, S; Redaelli, D; Attanasio, V; Miglietta, S; De Mattia, F; Barzaghi, F; Ferrua, F; Migliavacca, M; Tucci, F; Gallo, V; Del Carro, U; Canale, S; Spiga, I; Lorioli, L; Recupero, S; Fratini, ES; Morena, F; Silvani, P; Calvi, MR; Facchini, M; Locatelli, S; Corti, A; Zancan, S; Antonioli, G; Farinelli, G; Gabaldo, M; Garcia-Segovia, J; Schwab, LC; Downey, GF; Filippi, M; Cicalese, MP; Martino, S; Di Serio, C; Ciceri, F; Bernardo, ME; Naldini, L; Biffi, A; Aiuti, A				Fumagalli, Francesca; Calbi, Valeria; Sora, Maria Grazia Natali; Sessa, Maria; Baldoli, Cristina; Rancoita, Paola Maria, V; Ciotti, Francesca; Sarzana, Marina; Fraschini, Maddalena; Zambon, Alberto Andrea; Acquati, Serena; Redaelli, Daniela; Attanasio, Vanessa; Miglietta, Simona; De Mattia, Fabiola; Barzaghi, Federica; Ferrua, Francesca; Migliavacca, Maddalena; Tucci, Francesca; Gallo, Vera; Del Carro, Ubaldo; Canale, Sabrina; Spiga, Ivana; Lorioli, Laura; Recupero, Salvatore; Fratini, Elena Sophia; Morena, Francesco; Silvani, Paolo; Calvi, Maria Rosa; Facchini, Marcella; Locatelli, Sara; Corti, Ambra; Zancan, Stefano; Antonioli, Gigliola; Farinelli, Giada; Gabaldo, Michela; Garcia-Segovia, Jesus; Schwab, Laetitia C.; Downey, Gerald F.; Filippi, Massimo; Cicalese, Maria Pia; Martino, Sabata; Di Serio, Clelia; Ciceri, Fabio; Bernardo, Maria Ester; Naldini, Luigi; Biffi, Alessandra; Aiuti, Alessandro			Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access	LANCET			English	Article							CORD BLOOD TRANSPLANTATION; RECONSTITUTION; ABNORMALITIES; OUTCOMES; CHILDREN	Background Effective treatment for metachromatic leukodystrophy (MLD) remains a substantial unmet medical need. In this study we investigated the safety and efficacy of atidarsagene autotemcel (arsa-cel) in patients with MLD. Methods This study is an integrated analysis of results from a prospective, non-randomised, phase 1/2 clinical study and expanded-access frameworks. 29 paediatric patients with pre-symptomatic or early-symptomatic early-onset MLD with biochemical and molecular confirmation of diagnosis were treated with arsa-cel, a gene therapy containing an autologous haematopoietic stem and progenitor cell ( HSPC) population transduced ex vivo with a lentiviral vector encoding human arylsulfatase A (ARSA) cDNA, and compared with an untreated natural history (NHx) cohort of 31 patients with early-onset MLD, matched by age and disease subtype. Patients were treated and followed up at Ospedale San Raffaele, Milan, Italy. The coprimary efficacy endpoints were an improvement of more than 10% in total gross motor function measure score at 2 years after treatment in treated patients compared with controls, and change from baseline of total peripheral blood mononuclear cell (PBMC) ARSA activity at 2 years after treatment compared with values before treatment. This phase 1/2 study is registered with ClinicalTrials.gov, NCT01560182. Findings At the time of analyses, 26 patients treated with arsa-cel were alive with median follow-up of 3.16 years (range 0.64-7.51). Two patients died due to disease progression and one due to a sudden event deemed unlikely to be related to treatment. After busulfan conditioning, all arsa-cel treated patients showed sustained multilineage engraftment of genetically modified HSPCs. ARSA activity in PBMCs was significantly increased above baseline 2 years after treatment by a mean 18.7-fold (95% CI 8.3-42.2; p<0.0001) in patients with the late-infantile variant and 5.7-fold (2.6-12.4; p<0.0001) in patients with the early-juvenile variant. Mean differences in total scores for gross motor function measure between treated patients and age-matched and disease subtype-matched NHx patients 2 years after treatment were significant for both patients with late-infantile MLD (66% [95% CI 48.9-82.3]) and early-juvenile MLD (42% [12.3-71.8]). Most treated patients progressively acquired motor skills within the predicted range of healthy children or had stabilised motor performance (maintaining the ability to walk). Further, most displayed normal cognitive development and prevention or delay of central and peripheral demyelination and brain atrophy throughout follow-up; treatment benefits were particularly apparent in patients treated before symptom onset. The infusion was well tolerated and there was no evidence of abnormal clonal proliferation or replication-competent lentivirus. All patients had at least one grade 3 or higher adverse event; most were related to conditioning or to background disease. The only adverse event related to arsa-cel was the transient development of anti-ARSA antibodies in four patients, which did not affect clinical outcomes. Interpretation Treatment with arsa-cel resulted in sustained, clinically relevant benefits in children with early-onset MLD by preserving cognitive function and motor development in most patients, and slowing demyelination and brain atrophy. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Fumagalli, Francesca; Calbi, Valeria; Sessa, Maria; Acquati, Serena; Redaelli, Daniela; Attanasio, Vanessa; Miglietta, Simona; De Mattia, Fabiola; Barzaghi, Federica; Ferrua, Francesca; Migliavacca, Maddalena; Tucci, Francesca; Canale, Sabrina; Morena, Francesco; Facchini, Marcella; Locatelli, Sara; Corti, Ambra; Zancan, Stefano; Antonioli, Gigliola; Farinelli, Giada; Gabaldo, Michela; Cicalese, Maria Pia; Bernardo, Maria Ester; Naldini, Luigi; Biffi, Alessandra; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Fumagalli, Francesca; Calbi, Valeria; Ciotti, Francesca; Sarzana, Marina; Fraschini, Maddalena; Barzaghi, Federica; Ferrua, Francesca; Migliavacca, Maddalena; Tucci, Francesca; Gallo, Vera; Lorioli, Laura; Recupero, Salvatore; Fratini, Elena Sophia; Antonioli, Gigliola; Cicalese, Maria Pia; Bernardo, Maria Ester; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, Pediat Immunohematol Unit, Milan, Italy; [Fumagalli, Francesca; Calbi, Valeria; Ciotti, Francesca; Sarzana, Marina; Fraschini, Maddalena; Barzaghi, Federica; Ferrua, Francesca; Migliavacca, Maddalena; Tucci, Francesca; Gallo, Vera; Lorioli, Laura; Recupero, Salvatore; Fratini, Elena Sophia; Antonioli, Gigliola; Cicalese, Maria Pia; Bernardo, Maria Ester; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, BMT Program, Milan, Italy; [Fumagalli, Francesca; Sora, Maria Grazia Natali; Zambon, Alberto Andrea; Del Carro, Ubaldo; Filippi, Massimo] IRCCS San Raffaele Sci Inst, Unit Neurol, Milan, Italy; [Fumagalli, Francesca; Sora, Maria Grazia Natali; Zambon, Alberto Andrea; Del Carro, Ubaldo; Filippi, Massimo] IRCCS San Raffaele Sci Inst, Unit Neurophysiol, Milan, Italy; [Filippi, Massimo] IRCCS San Raffaele Sci Inst, Unit Neurorehabil, Milan, Italy; [Baldoli, Cristina] IRCCS San Raffaele Sci Inst, Neuroradiol Unit, Milan, Italy; [Spiga, Ivana] IRCCS San Raffaele Sci Inst, Clin Mol Biol Lab, Milan, Italy; [Silvani, Paolo; Calvi, Maria Rosa] IRCCS San Raffaele Sci Inst, Dept Anesthesia & Crit Care, Milan, Italy; [Ciceri, Fabio] IRCCS San Raffaele Sci Inst, Unit Hematol & Bone Marrow Transplantat, Milan, Italy; [Filippi, Massimo] IRCCS San Raffaele Sci Inst, Neuroimaging Res Unit, Div Neurosci, Milan, Italy; [Rancoita, Paola Maria, V; Di Serio, Clelia] Univ Ctr Stat Biomed Sci CUSSB, Milan, Italy; [Rancoita, Paola Maria, V; Recupero, Salvatore; Fratini, Elena Sophia; Filippi, Massimo; Di Serio, Clelia; Ciceri, Fabio; Bernardo, Maria Ester; Naldini, Luigi; Aiuti, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Di Serio, Clelia] Univ Svizzera Habana, Biomed Fac, Lugano, Switzerland; [Morena, Francesco; Martino, Sabata] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy; [Garcia-Segovia, Jesus; Schwab, Laetitia C.; Downey, Gerald F.] OrchardTherapeut Europe, London, England; [Canale, Sabrina] IRCCS Multimed, Dept Specialist Neurol Rehabil, Sesto San Giovanni, Italy; [Sessa, Maria] ASST Papa Giovanni XXIII Bergamo, Dept Neurol, Bergamo, Italy; [Biffi, Alessandra] Univ Padua, Div Pediat Hematol Oncol & Stem Cell Transplant, Padua, Italy; [Biffi, Alessandra] Padua Univ Hosp, Padua, Italy; [Biffi, Alessandra] Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Perugia; IRCCS Multimedica; ASST Papa Giovanni XXIII; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Aiuti, A (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Milan, Italy.	aiuti.alessandro@hsr.it	Zambon, Alberto A./AAD-2473-2022; Ferrua, Francesca/K-4340-2016	Zambon, Alberto A./0000-0002-6539-5360; Ferrua, Francesca/0000-0002-5695-4490	Orchard Therapeutics; Fondazione Telethon; GlaxoSmithKline	Orchard Therapeutics; Fondazione Telethon(Fondazione TelethonEuropean Commission); GlaxoSmithKline(GlaxoSmithKline)	Orchard Therapeutics, Fondazione Telethon, and GlaxoSmithKline.	Audouard E, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.677895; Biffi A, 2008, CLIN GENET, V74, P349, DOI 10.1111/j.1399-0004.2008.01058.x; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Bredius RGM, 2007, BONE MARROW TRANSPL, V39, P309, DOI 10.1038/sj.bmt.1705581; Calabria A, 2020, MOL THER, V28, P234; Calbi V, 2018, BONE MARROW TRANSPL, V53, P913, DOI 10.1038/s41409-017-0085-1; Capotondo A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701211; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; Dali CI, 2020, MOL GENET METAB, V131, P235, DOI 10.1016/j.ymgme.2020.07.002; Eichler FS, 2016, J CHILD NEUROL, V31, P1457, DOI 10.1177/0883073816656401; Elgun S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1113-6; Fumagalli F, 2021, J INHERIT METAB DIS, V44, P1151, DOI 10.1002/jimd.12388; Gieselmann V, 2010, NEUROPEDIATRICS, V41, P1, DOI 10.1055/s-0030-1253412; Groeschel S, 2016, JAMA NEUROL, V73, P1133, DOI 10.1001/jamaneurol.2016.2067; Hong XY, 2021, GENET MED, V23, P555, DOI 10.1038/s41436-020-01017-5; Hong XY, 2020, ANAL CHEM, V92, P6341, DOI 10.1021/acs.analchem.9b05274; Kehrer C, NATURAL COURSE GROSS; Kehrer C, 2021, NEUROLOGY, V96, pE255, DOI 10.1212/WNL.0000000000011047; Kim J, 2017, J SURG RES, V208, P187, DOI 10.1016/j.jss.2016.08.081; Lorioli L, 2015, MOL GENET METAB, V115, P48, DOI 10.1016/j.ymgme.2015.02.009; Martin HR, 2013, BIOL BLOOD MARROW TR, V19, P616, DOI 10.1016/j.bbmt.2013.01.010; Meneghini V, 2016, EMBO MOL MED, V8, P489, DOI 10.15252/emmm.201505850; Morena F, 2021, J APPL LAB MED, V6, P354, DOI 10.1093/jalm/jfaa108; Russell Debra, 2002, CLIN DEV MED; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Sevin C, 2018, MOL GENET METAB, V123, pS129, DOI 10.1016/j.ymgme.2017.12.352; Staal FJT, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00443; Tan EY, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00433; van den Broek BTA, 2018, BLOOD ADV, V2, P49, DOI 10.1182/bloodadvances.2017010645; van Rappard DF, 2015, BEST PRACT RES CL EN, V29, P261, DOI 10.1016/j.beem.2014.10.001; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695	34	15	15	4	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					372	383						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL7CQ	35065785	Green Published			2022-12-28	WOS:000746046100020
J	Jauhar, S; Johnstone, M; McKenna, PJ				Jauhar, Sameer; Johnstone, Mandy; McKenna, Peter J.			Schizophrenia	LANCET			English	Review							DEFAULT MODE NETWORK; DORSOLATERAL PREFRONTAL CORTEX; REPORTED PSYCHOTIC SYMPTOMS; TASK-INDUCED DEACTIVATION; POSITIVE SYMPTOMS; NEGATIVE SYMPTOMS; BRAIN VOLUMES; DOUBLE-BLIND; HIGH-RISK; QUANTITATIVE METAANALYSIS	Schizophrenia, characterised by psychotic symptoms and in many cases social and occupational decline, remains an aetiological and therapeutic challenge. Contrary to popular belief, the disorder is modestly more common in men than in women. Nor is the outcome uniformly poor. A division of symptoms into positive, negative, and disorganisation syndromes is supported by factor analysis. Catatonic symptoms are not specific to schizophrenia and so-called first rank symptoms are no longer considered diagnostically important. Cognitive impairment is now recognised as a further clinical feature of the disorder. Lateral ventricular enlargement and brain volume reductions of around 2% are established findings. Brain functional changes occur in different subregions of the frontal cortex and might ultimately be understandable in terms of disturbed interaction among large-scale brain networks. Neurochemical disturbance, involving dopamine function and glutamatergic N-methyl-D-aspartate receptor function, is supported by indirect and direct evidence. The genetic contribution to schizophrenia is now recognised to be largely polygenic. Birth and early life factors also have an important aetiological role. The mainstay of treatment remains dopamine receptor-blocking drugs; a psychological intervention, cognitive behavioural therapy, has relatively small effects on symptoms. The idea that schizophrenia is better regarded as the extreme end of a continuum of psychotic symptoms is currently influential. Other areas of debate include cannabis and childhood adversity as causative factors, whether there is progressive brain change after onset, and the long-term success of early intervention initiatives.	[Jauhar, Sameer; Johnstone, Mandy] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England; [Johnstone, Mandy] South London & Maudsley NHS Fdn Trust, Natl Psychosis Serv, London, England; [McKenna, Peter J.] FIDMAG Hermanas Hospitalarias Res Fdn, Barcelona 08830, Spain; [McKenna, Peter J.] Ctr Invest Biomed Red Salud Mental, Madrid, Spain	University of London; King's College London; South London & Maudsley NHS Trust; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	McKenna, PJ (corresponding author), FIDMAG Hermanas Hospitalarias Res Fdn, Barcelona 08830, Spain.	mckennapeter1@gmail.com		Jauhar, Sameer/0000-0002-3878-3659	FIDMAG Hermanas Hospitalarias; Spanish CIBERSAM research network	FIDMAG Hermanas Hospitalarias; Spanish CIBERSAM research network	SJ is funded by the National Institute for Health Research Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. He has received honoraria for lectures from Sunovion; King's College London has received honoraria from Lundbeck for lectures he has given. All funding is outside of the submitted work. MJ has recruited for clinical trials sponsored by Boehringer Ingelheim, from Biogen, from Astra-Zeneca, outside of the submitted work. PM is supported by FIDMAG Hermanas Hospitalarias and the Spanish CIBERSAM research network, both non-commercial enterprises. We thank William Honer for his comments and suggestions on successive drafts of the paper. We are grateful to Raymond Salvador and James Kirkbride for helpful discussions about topics in the paper, and to Mary Cannon for pointing us to the quote from Norman Sartorius. We also thank Silvia Alonso-Lana for drawing and redrawing the figures, and Tarjinder Singh for approving figure	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Baldwin JR, 2019, JAMA PSYCHIAT, V76, P584, DOI 10.1001/jamapsychiatry.2019.0097; Barchas JD, 2020, EXOME SEQUENCING IDE, DOI [10.1101/2020.09.18.20192815, DOI 10.1101/2020.09.18.20192815]; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beck K, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4693; Beck K, 2016, PSYCHOPHARMACOLOGY, V233, P2425, DOI 10.1007/s00213-016-4318-6; Bighelli I, 2018, WORLD PSYCHIATRY, V17, P316, DOI 10.1002/wps.20577; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Blumenfeld H., 2015, NEUROLOGY CONSCIOUSN, V2nd, P3; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Bouwkamp CG, 2017, AM J PSYCHIAT, V174, P1036, DOI 10.1176/appi.ajp.2017.16080946; BRADBURY TN, 1985, PSYCHOL BULL, V98, P569, DOI 10.1037/0033-2909.98.3.569; Brandl F, 2019, BIOL PSYCHIAT, V85, P573, DOI 10.1016/j.biopsych.2018.12.003; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Buchanan RW, 2007, AM J PSYCHIAT, V164, P1593, DOI 10.1176/appi.ajp.2007.06081358; BUCHSBAUM MS, 1982, ARCH GEN PSYCHIAT, V39, P251; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Bugarski-Kirola D, 2016, LANCET PSYCHIAT, V3, P1115, DOI 10.1016/S2215-0366(16)30344-3; BUKA SL, 1993, ARCH GEN PSYCHIAT, V50, P151; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P379, DOI 10.1093/oxfordjournals.schbul.a033460; Carbon M, 2018, WORLD PSYCHIATRY, V17, P330, DOI 10.1002/wps.20579; Catts VS, 2016, BIOL PSYCHOL, V116, P57, DOI 10.1016/j.biopsycho.2015.10.013; Chan SKW, 2019, INT REV PSYCHIATR, V31, P425, DOI 10.1080/09540261.2019.1643704; Connell PH, 1958, MAUDSLEY MONOGRAPH, V5; Corlett PR, 2010, PROG NEUROBIOL, V92, P345, DOI 10.1016/j.pneurobio.2010.06.007; Correll CU, 2018, JAMA PSYCHIAT, V75, P555, DOI 10.1001/jamapsychiatry.2018.0623; Craig TKJ, 2018, LANCET PSYCHIAT, V5, P31, DOI 10.1016/S2215-0366(17)30427-3; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CUNNINGHAMOWENS DG, 1980, BRIT J PSYCHIAT, V136, P384, DOI 10.1192/bjp.136.4.384; Cuthbert BN, 2010, SCHIZOPHRENIA BULL, V36, P1061, DOI 10.1093/schbul/sbq108; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; DONE DJ, 1991, BRIT MED J, V302, P1576, DOI 10.1136/bmj.302.6792.1576; Dreher JC, 2012, BIOL PSYCHIAT, V71, P890, DOI 10.1016/j.biopsych.2012.01.002; Driver DI, 2013, CHILD ADOL PSYCH CL, V22, P539, DOI 10.1016/j.chc.2013.04.001; Egerton A, 2013, BIOL PSYCHIAT, V74, P106, DOI 10.1016/j.biopsych.2012.11.017; Elkis H, 2007, PSYCHIAT CLIN N AM, V30, P511, DOI 10.1016/j.psc.2007.04.001; Fearon P, 2006, PSYCHOL MED, V36, P1541, DOI 10.1017/S0033291706008774; Feeney EJ, 2017, SCHIZOPHRENIA BULL, V43, P263, DOI 10.1093/schbul/sbw194; Fett AKJ, 2019, CURR OPIN PSYCHIATR, V32, P232, DOI 10.1097/YCO.0000000000000486; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Foussias G, 2014, EUR NEUROPSYCHOPHARM, V24, P693, DOI 10.1016/j.euroneuro.2013.10.017; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frankle WG, 2018, BIOL PSYCHIAT, V83, P707, DOI 10.1016/j.biopsych.2017.11.032; Fusar-Poli P, 2017, SCHIZOPHRENIA BULL, V43, P48, DOI 10.1093/schbul/sbw151; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Garrison JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9956; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; Goghari VM, 2010, NEUROSCI BIOBEHAV R, V34, P468, DOI 10.1016/j.neubiorev.2009.09.004; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grube BS, 1998, SCHIZOPHR RES, V31, P113, DOI 10.1016/S0920-9964(98)00011-5; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Haatveit B, 2016, NEUROIMAGE-CLIN, V12, P389, DOI 10.1016/j.nicl.2016.08.012; Haddad PM, 2018, THER ADV PSYCHOPHARM, V8, P303, DOI 10.1177/2045125318781475; Hafner H, 1998, SOC PSYCH PSYCH EPID, V33, P380, DOI 10.1007/s001270050069; Hahn B, 2017, SCHIZOPHR RES, V185, P190, DOI 10.1016/j.schres.2017.01.001; Hahn B, 2016, SCHIZOPHRENIA BULL, V42, P1158, DOI 10.1093/schbul/sbw019; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Harrison BJ, 2007, SCHIZOPHR RES, V91, P82, DOI 10.1016/j.schres.2006.12.027; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hart CL, 2021, DRUG USE GROWN UPS C; Harvey PD, 2014, J CLIN PSYCHIAT, V75, P34, DOI 10.4088/JCP.13065su1.08; HEATON RK, 1978, PSYCHOL BULL, V85, P141, DOI 10.1037/0033-2909.85.1.141; HEGARTY JD, 1994, AM J PSYCHIAT, V151, P1409; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Heinz A, 2016, EUR PSYCHIAT, V37, P8, DOI 10.1016/j.eurpsy.2016.04.010; Hietala J, 1999, SCHIZOPHR RES, V35, P41, DOI 10.1016/S0920-9964(98)00113-3; Hill K, 2004, ACTA PSYCHIAT SCAND, V110, P243, DOI 10.1111/j.1600-0447.2004.00376.x; Hill M, 2015, NATURE, V525, pS14, DOI 10.1038/525S14a; Hjorthoj C, 2017, LANCET PSYCHIAT, V4, P295, DOI 10.1016/S2215-0366(17)30078-0; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hor K, 2010, J PSYCHOPHARMACOL, V24, P81, DOI 10.1177/1359786810385490; Howes OD, 2020, NEUROPSYCHOPHARMACOL, V45, P641, DOI 10.1038/s41386-019-0541-2; Howes OD, 2009, ARCH GEN PSYCHIAT, V66, P13, DOI 10.1001/archgenpsychiatry.2008.514; Hu ML, 2017, NEUROSCI BULL, V33, P73, DOI 10.1007/s12264-016-0090-1; Hu W, 2015, ANN NY ACAD SCI, V1338, P38, DOI 10.1111/nyas.12547; INGVAR DH, 1974, ACTA PSYCHIAT SCAND, V50, P425, DOI 10.1111/j.1600-0447.1974.tb09707.x; Jaaskelainen E, 2013, SCHIZOPHRENIA BULL, V39, P1296, DOI 10.1093/schbul/sbs130; JABLENSKY A, 1992, PSYCHOL MED, P1; Jablensky A, 1997, SCHIZOPHR RES, V28, P111, DOI 10.1016/S0920-9964(97)85354-6; Jauhar S, 2014, BRIT J PSYCHIAT, V204, P20, DOI 10.1192/bjp.bp.112.116285; Jauhar S, 2018, LANCET PSYCHIAT, V5, P816, DOI 10.1016/S2215-0366(18)30268-2; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; JOHNSTONE EC, 1978, LANCET, V1, P848; JOHNSTONE EC, 1976, LANCET, V2, P924; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Jongsma HE, 2019, LANCET PUBLIC HEALTH, V4, pE229, DOI 10.1016/S2468-2667(19)30056-8; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Katthagen T, 2020, SCHIZOPHRENIA BULL, V46, P1535, DOI 10.1093/schbul/sbaa055; Kendall KM, 2019, BRIT J PSYCHIAT, V214, P297, DOI 10.1192/bjp.2018.301; Kendler KS, 2016, JAMA PSYCHIAT, V73, P1082, DOI 10.1001/jamapsychiatry.2016.1976; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Khandaker GM, 2011, SCHIZOPHR RES, V132, P220, DOI 10.1016/j.schres.2011.06.017; Kinon BJ, 2011, J CLIN PSYCHOPHARM, V31, P349, DOI 10.1097/JCP.0b013e318218dcd5; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; Knowles EEM, 2010, AM J PSYCHIAT, V167, P828, DOI 10.1176/appi.ajp.2010.09070937; Koblan KS, 2020, NEW ENGL J MED, V382, P1497, DOI 10.1056/NEJMoa1911772; Kraepelin E., 1919, CUTTING SHEPHERD; Kremen WS, 2000, J ABNORM PSYCHOL, V109, P743, DOI 10.1037/0021-843X.109.4.743; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Landin-Romero R, 2016, SCHIZOPHR RES, V178, P6, DOI 10.1016/j.schres.2016.07.015; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lawrie SM, 2001, BIOL PSYCHIAT, V49, P811, DOI 10.1016/S0006-3223(00)01117-3; Lawrie SM, 2010, BRIT J PSYCHIAT, V197, P423, DOI 10.1192/bjp.bp.109.072827; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewandowski KE, 2011, PSYCHOL MED, V41, P225, DOI 10.1017/S0033291710001042; Li CR, 2009, WORLD J BIOL PSYCHIA, V10, P919, DOI 10.1080/15622970802481895; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; Lieberman JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1322, DOI 10.1038/npp.2008.200; Lindstrom LH, 1999, BIOL PSYCHIAT, V46, P681, DOI 10.1016/S0006-3223(99)00109-2; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; MacCabe JH, 2012, NEUROPSYCHOLOGY, V26, P181, DOI 10.1037/a0026376; Maksymetz J, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0293-z; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003; Marwaha S, 2004, SOC PSYCH PSYCH EPID, V39, P337, DOI 10.1007/s00127-004-0762-4; Marwaha S, 2007, BRIT J PSYCHIAT, V191, P30, DOI 10.1192/bjp.bp.105.020982; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; McAllister-Williams RH, 2017, J PSYCHOPHARMACOL, V31, P519, DOI 10.1177/0269881117699361; McCutcheon R, 2018, SCHIZOPHRENIA BULL, V44, P1301, DOI 10.1093/schbul/sbx180; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath JJ, 2015, JAMA PSYCHIAT, V72, P697, DOI 10.1001/jamapsychiatry.2015.0575; Meacher M, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4468; Mehta TM, 2017, ARCH WOMEN MENT HLTH, V20, P1, DOI 10.1007/s00737-016-0670-0; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Moller P, 2000, SCHIZOPHRENIA BULL, V26, P217, DOI 10.1093/oxfordjournals.schbul.a033442; Murray GK, 2021, JAMA PSYCHIAT, V78, P210, DOI 10.1001/jamapsychiatry.2020.3042; Myles N, 2018, ACTA PSYCHIAT SCAND, V138, P101, DOI 10.1111/acps.12898; National Institute for Health and Care Excellence (NICE), 2014, PSYCH SCHIZ AD; Nozaki S, 2009, SCHIZOPHR RES, V108, P78, DOI 10.1016/j.schres.2008.11.006; Nutt D., 2009, CTR CRIME JUSTICE ST, P10; Ochoa S, 2008, SCHIZOPHR RES, V102, P261, DOI 10.1016/j.schres.2008.04.010; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Oloyede E, 2021, SCHIZOPHRENIA BULL, V47, P1088, DOI 10.1093/schbul/sbab006; Ordonez AE, 2016, J AM ACAD CHILD PSY, V55, P792, DOI 10.1016/j.jaac.2016.05.022; Owens DGC., 2014, GUIDE EXTRAPYRAMIDAL, V2nd; Palmer BW, 2009, NEUROPSYCHOL REV, V19, P365, DOI 10.1007/s11065-009-9109-y; Parnas J, 2015, PSYCHOPATHOLOGY, V48, P332, DOI 10.1159/000437232; PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518; Pillinger T, 2020, LANCET PSYCHIAT, V7, P64, DOI 10.1016/S2215-0366(19)30416-X; Pocklington AJ, 2015, NEURON, V86, P1203, DOI 10.1016/j.neuron.2015.04.022; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Pomarol-Clotet E, 2006, BRIT J PSYCHIAT, V189, P173, DOI 10.1192/bjp.bp.105.015263; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Powers AR, 2015, PSYCHOPATHOLOGY, V48, P376, DOI 10.1159/000438675; Radua J, 2018, WORLD PSYCHIATRY, V17, P49, DOI 10.1002/wps.20490; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees E, 2020, NAT NEUROSCI, V23, P179, DOI 10.1038/s41593-019-0565-2; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Reichenberg A, 2010, AM J PSYCHIAT, V167, P160, DOI 10.1176/appi.ajp.2009.09040574; Ripke S., 2020, MAPPING GENOMIC LOCI, DOI [10.1101/2020.09.12.20192922, DOI 10.1101/2020.09.12.20192922]; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rosanoff AJ, 1934, AM J PSYCHIAT, V91, P247, DOI 10.1176/ajp.91.2.247; Rosen GM, 2005, RES CHILDRENS EXPERI, pxi, DOI DOI 10.3138/9781442674707-003; Rosso IM, 2000, SCHIZOPHRENIA BULL, V26, P367, DOI 10.1093/oxfordjournals.schbul.a033459; Salgado-Pineda P, 2011, SCHIZOPHR RES, V125, P101, DOI 10.1016/j.schres.2010.10.027; Samara MT, 2016, JAMA PSYCHIAT, V73, P199, DOI 10.1001/jamapsychiatry.2015.2955; Sariaslan A, 2015, SCHIZOPHRENIA BULL, V41, P494, DOI 10.1093/schbul/sbu105; Schneider FC, 2011, SCHIZOPHR RES, V125, P110, DOI 10.1016/j.schres.2010.11.013; Schneider K., 1959, CLIN PSYCHOPATHOLOGY; Schultz W, 2016, DIALOGUES CLIN NEURO, V18, P23; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Shafer A, 2019, J PSYCHIATR RES, V115, P113, DOI 10.1016/j.jpsychires.2019.05.008; Singh T, 2017, NAT GENET, V49, P1167, DOI 10.1038/ng.3903; Siskind D, 2016, BRIT J PSYCHIAT, V209, P387, DOI 10.1192/bjp.bp.115.177261; Soares-Weiser K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010653.pub2; Solmi M, 2018, SCHIZOPHRENIA BULL, V44, P1133, DOI 10.1093/schbul/sbx157; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stroup TS, 2021, JAMA PSYCHIAT, V78, P632, DOI 10.1001/jamapsychiatry.2021.0042; Stuart GW, 1999, SCHIZOPHR RES, V39, P233, DOI 10.1016/S0920-9964(99)00019-5; Sullivan PF, 2020, AM J PSYCHIAT, V177, P204, DOI 10.1176/appi.ajp.2019.19040335; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan HY, 2006, AM J PSYCHIAT, V163, P1969, DOI 10.1176/appi.ajp.163.11.1969; Tandon R, 2013, SCHIZOPHR RES, V150, P26, DOI 10.1016/j.schres.2013.04.034; Turner DT, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00402; Turner DT, 2020, SCHIZOPHRENIA BULL, V46, P1072, DOI 10.1093/schbul/sbaa045; Ungvari GS, 2018, SCHIZOPHR RES, V200, P77, DOI 10.1016/j.schres.2017.08.008; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; van Erp TGM, 2018, BIOL PSYCHIAT, V84, P644, DOI 10.1016/j.biopsych.2018.04.023; van Haren NEM, 2008, BIOL PSYCHIAT, V63, P106, DOI 10.1016/j.biopsych.2007.01.004; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Ventriglio A, 2020, INT J SOC PSYCHIATR, V66, P735, DOI 10.1177/0020764020934827; Wadsworth MEJ, 2005, ENCY BIOSTATISTICS, V2nd; Walton E, 2018, PSYCHOL MED, V48, P82, DOI 10.1017/S0033291717001283; Walton E, 2017, ACTA PSYCHIAT SCAND, V135, P439, DOI 10.1111/acps.12718; Weber MM, 1997, J PSYCHIATR RES, V31, P635, DOI 10.1016/S0022-3956(97)00035-6; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weidenauer A, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-019-0681-5; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Weinberger DR, 2001, NEUROPSYCHOPHARMACOL; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; WHO, 1973, WHO OFFSET PUBLICATI, V2; WILSON M, 1993, AM J PSYCHIAT, V150, P399; Wing L, 2006, INT REV NEUROBIOL, V72, P21, DOI 10.1016/S0074-7742(05)72002-X; Yung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654; Zanelli J, 2019, AM J PSYCHIAT, V176, P811, DOI 10.1176/appi.ajp.2019.18091088; Zheutlin AB, 2019, AM J PSYCHIAT, V176, P846, DOI 10.1176/appi.ajp.2019.18091085; Zmigrod L, 2016, NEUROSCI BIOBEHAV R, V69, P113, DOI 10.1016/j.neubiorev.2016.05.037	221	45	45	62	82	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					473	486						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093231	Green Published			2022-12-28	WOS:000755141600027
J	Mous, S; Gotthard, G; Ehrenberg, D; Sen, S; Weinert, T; Johnson, PJM; James, D; Nass, K; Furrer, A; Kekilli, D; Ma, P; Brunle, S; Casadei, CM; Martiel, I; Dworkowski, F; Gashi, D; Skopintsev, P; Wranik, M; Knopp, G; Panepucci, E; Panneels, V; Cirelli, C; Ozerov, D; Schertler, GFX; Wang, MT; Milne, C; Standfuss, J; Schapiro, I; Heberle, J; Nogly, P				Mous, Sandra; Gotthard, Guillaume; Ehrenberg, David; Sen, Saumik; Weinert, Tobias; Johnson, Philip J. M.; James, Daniel; Nass, Karol; Furrer, Antonia; Kekilli, Demet; Ma, Pikyee; Bruenle, Steffen; Casadei, Cecilia Maria; Martiel, Isabelle; Dworkowski, Florian; Gashi, Dardan; Skopintsev, Petr; Wranik, Maximilian; Knopp, Gregor; Panepucci, Ezequiel; Panneels, Valerie; Cirelli, Claudio; Ozerov, Dmitry; Schertler, Gebhard F. X.; Wang, Meitian; Milne, Chris; Standfuss, Joerg; Schapiro, Igor; Heberle, Joachim; Nogly, Przemyslaw			Dynamics and mechanism of a light-driven chloride pump	SCIENCE			English	Article							CRYSTAL-STRUCTURE; FUNCTIONAL-CHARACTERIZATION; TRANSPORT MECHANISM; BASIS-SETS; ION PUMP; HALORHODOPSIN; BACTERIORHODOPSIN; CRYSTALLOGRAPHY; PHARAONIS; DENSITY	Chloride transport by microbial rhodopsins is an essential process for which molecular details such as the mechanisms that convert light energy to drive ion pumping and ensure the unidirectionality of the transport have remained elusive. We combined time-resolved serial crystallography with time-resolved spectroscopy and multiscale simulations to elucidate the molecular mechanism of a chloride-pumping rhodopsin and the structural dynamics throughout the transport cycle. We traced transient anion-binding sites, obtained evidence for how light energy is used in the pumping mechanism, and identified steric and electrostatic molecular gates ensuring unidirectional transport. An interaction with the pi-electron system of the retinal supports transient chloride ion binding across a major bottleneck in the transport pathway. These results allow us to propose key mechanistic features enabling finely controlled chloride transport across the cell membrane in this light-powered chloride ion pump.	[Mous, Sandra; Gotthard, Guillaume; Casadei, Cecilia Maria; Schertler, Gebhard F. X.; Nogly, Przemyslaw] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland; [Gotthard, Guillaume; Weinert, Tobias; James, Daniel; Furrer, Antonia; Kekilli, Demet; Ma, Pikyee; Bruenle, Steffen; Casadei, Cecilia Maria; Gashi, Dardan; Skopintsev, Petr; Wranik, Maximilian; Panneels, Valerie; Schertler, Gebhard F. X.; Standfuss, Joerg] Paul Scherrer Inst, Biol & Chem Div, Lab Biomol Res, Villigen, Switzerland; [Ehrenberg, David; Heberle, Joachim] Free Univ Berlin, Dept Phys, Expt Mol Biophys, Berlin, Germany; [Sen, Saumik; Schapiro, Igor] Hebrew Univ Jerusalem, Fritz Haber Ctr Mol Dynam, Inst Chem, Jerusalem, Israel; [Johnson, Philip J. M.] Paul Scherrer Inst, Photon Sci Div, Lab Nonlinear Opt, Villigen, Switzerland; [Nass, Karol; Gashi, Dardan; Knopp, Gregor; Cirelli, Claudio; Milne, Chris] Paul Scherrer Inst, Photon Sci Div, Lab Femtochem, Villigen, Switzerland; [Martiel, Isabelle; Dworkowski, Florian; Panepucci, Ezequiel; Wang, Meitian] Paul Scherrer Inst, Photon Sci Div, Lab Macromol & Bioimaging, Villigen, Switzerland; [Ozerov, Dmitry] Paul Scherrer Inst, Sci IT, Villigen, Switzerland; [Sen, Saumik] Paul Scherrer Inst, Condensed Matter Theory Grp, Lab Theoret & Computat Phys, CH-5232 Villigen, Switzerland; [James, Daniel] Utah Valley Univ, Dept Phys, Orem, UT 84058 USA; [Kekilli, Demet] Celerion Switzerland AG, CH-8320 Fehraltort, Switzerland; [Ma, Pikyee] Virometix AG, CH-8952 Schlieren, Switzerland; [Bruenle, Steffen] Leiden Univ, Leiden Inst Chem, NL-2333 CC Leiden, Netherlands; [Skopintsev, Petr] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA USA; [Milne, Chris] European XFEL GmbH, D-22869 Schenefeld, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Free University of Berlin; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utah System of Higher Education; Utah Valley University; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Berkeley; European XFEL	Nogly, P (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland.	przemyslaw.nogly@mol.biol.ethz.ch	Ozerov, Dmitry/E-9139-2016; Nogly, Przemyslaw/GQZ-7032-2022; Heberle, Joachim/D-8605-2016; Weinert, Tobias/I-4813-2013	Nogly, Przemyslaw/0000-0002-8040-7753; Heberle, Joachim/0000-0001-6321-2615; Ehrenberg, David/0000-0002-7582-1511; Brunle, Steffen/0000-0002-8057-245X; Sen, Saumik/0000-0002-7490-0517; Weinert, Tobias/0000-0002-0339-3722; James, Daniel/0000-0002-8348-6661; Kekilli, Demet/0000-0003-4422-923X; Nass, Karol/0000-0001-8843-1566; Dworkowski, Florian/0000-0001-5004-8684; Mous, Sandra/0000-0002-3532-5978	Swiss National Science Foundation [PZ00P3_174169, 31003A_179351, 310030B_173335]; National Centre of Competence in Research: Molecular Ultrafast Science and Technology; German Research Foundation [SFB 1078, EXC 2008/1 UniSysCat 390540038]; Holcim Stiftung; European Union [701646, 701647]; European Research Council (ERC) European Union [678169]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research: Molecular Ultrafast Science and Technology; German Research Foundation(German Research Foundation (DFG)); Holcim Stiftung; European Union(European Commission); European Research Council (ERC) European Union(European Research Council (ERC))	This work was supported by the Swiss National Science Foundation (Ambizione grant PZ00P3_174169 to P.N.; project grant 31003A_179351 to J.S.; and project grant 310030B_173335 to G.F.X.S.); the National Centre of Competence in Research: Molecular Ultrafast Science and Technology (C.M. and J.S.); the German Research Foundation via SFB 1078, projects B3 (J.H.), C6 (I.S.) and via EXC 2008/1 UniSysCat 390540038 (J.H.); Holcim Stiftung (P.M.); European Union's Horizon 2020 research and innovation program (Marie-Sklodowska-Curie grant agreements 701646 and 701647 to G.G., D.K., and S.B.); and the European Research Council (ERC) European Union's Horizon 2020 research and innovation program (grant 678169 `PhotoMutant' to I.S.).	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Borozan SZ, 2016, J BIOL INORG CHEM, V21, P357, DOI 10.1007/s00775-016-1346-y; Breberina LM, 2015, J BIOL INORG CHEM, V20, P475, DOI 10.1007/s00775-014-1227-1; Case D. A., 2017, AMBER 2017, DOI [10.13140/RG.2.2.36172.41606, DOI 10.13140/RG.2.2.36172.41606]; Chizhov I, 2001, BIOPHYS J, V81, P1600, DOI 10.1016/S0006-3495(01)75814-6; Claesson E, 2020, ELIFE, V9, DOI 10.7554/eLife.53514; Coquelle N, 2018, NAT CHEM, V10, P31, DOI [10.1038/NCHEM.2853, 10.1038/nchem.2853]; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Efremov R, 2006, BIOPHYS J, V91, P1441, DOI 10.1529/biophysj.106.083345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelhard C, 2018, CHEM REV, V118, P10629, DOI 10.1021/acs.chemrev.7b00715; Estarellas C, 2011, ANGEW CHEM INT EDIT, V50, P415, DOI 10.1002/anie.201005635; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Frisch M.J., 2016, GAUSSIAN 16; Furche F, 2014, WIRES COMPUT MOL SCI, V4, P91, DOI 10.1002/wcms.1162; Gmelin W, 2007, PHOTOCHEM PHOTOBIOL, V83, P369, DOI 10.1562/2006-06-23-RA-947; Gorel A, 2021, IUCRJ, V8, P532, DOI 10.1107/S205225252100467X; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hackmann C, 2001, BIOPHYS J, V81, P394, DOI 10.1016/S0006-3495(01)75708-6; Hattig C, 2005, ADV QUANTUM CHEM, V50, P37, DOI 10.1016/S0065-3276(05)50003-0; Haupts U, 1997, BIOCHEMISTRY-US, V36, P2, DOI 10.1021/bi962014g; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Horn PR, 2016, PHYS CHEM CHEM PHYS, V18, P23067, DOI 10.1039/c6cp03784d; Hosaka T, 2016, J BIOL CHEM, V291, P17488, DOI 10.1074/jbc.M116.728220; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Jaeger K, 2016, ADV EXP MED BIOL, V922, P137, DOI 10.1007/978-3-319-35072-1_10; James D, 2019, JOVE-J VIS EXP, DOI 10.3791/59087; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanada S, 2011, J MOL BIOL, V413, P162, DOI 10.1016/j.jmb.2011.08.021; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kim K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12677; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kouyama T, 2015, BIOPHYS J, V108, P2680, DOI 10.1016/j.bpj.2015.04.027; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Kovacs GN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10758-0; Lanyi JK, 1999, FEBS LETT, V464, P103, DOI 10.1016/S0014-5793(99)01685-3; LANYI JK, 1984, FEBS LETT, V175, P337, DOI 10.1016/0014-5793(84)80764-4; Law EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157553; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Lucas X, 2016, CHEM SCI, V7, P1038, DOI 10.1039/c5sc01386k; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Amezaga NJM, 2010, J PHYS CHEM A, V114, P552, DOI 10.1021/jp907550k; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Metz S, 2014, WIRES COMPUT MOL SCI, V4, P101, DOI 10.1002/wcms.1163; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Mous S., 2022, PSI PUBLIC DATA REPO, DOI [10.16907/14c30658-cc0b-41fe-b25b-240a9790d5ec, DOI 10.16907/14C30658-CC0B-41FE-B25B-240A9790D5EC]; Mous S., 2022, PSI PUBLIC DATA REPO, DOI [10.16907/8ecae5fe-4c00-4d59-be3d-5274f06188c2, DOI 10.16907/8ECAE5FE-4C00-4D59-BE3D-5274F06188C2]; Mous S., 2022, PSI PUBLIC DATA REPO, DOI [10.16907/12079b73-6563-467a-890a-2ab43e678343, DOI 10.16907/12079B73-6563-467A-890A-2AB43E678343]; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Niepotter B, 2014, ANGEW CHEM INT EDIT, V53, P2766, DOI 10.1002/anie.201308609; Nogly P, 2018, SCIENCE, V361, DOI 10.1126/science.aat0094; Nogly P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12314; Pande K, 2016, SCIENCE, V352, P725, DOI 10.1126/science.aad5081; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Prat E, 2020, NAT PHOTONICS, V14, P748, DOI 10.1038/s41566-020-00712-8; Robertazzi A, 2011, CRYSTENGCOMM, V13, P3293, DOI 10.1039/c0ce00819b; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schreiner M, 2015, J STRUCT BIOL, V190, P373, DOI 10.1016/j.jsb.2015.04.010; Schultz BJ, 2018, SPECTROCHIM ACTA A, V188, P666, DOI 10.1016/j.saa.2017.01.010; Shao YH, 2015, MOL PHYS, V113, P184, DOI 10.1080/00268976.2014.952696; Skopintsev P, 2020, NATURE, V583, P314, DOI 10.1038/s41586-020-2307-8; Smith MS, 2017, ACS CHEM BIOL, V12, P2535, DOI 10.1021/acschembio.7b00768; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Tsukamoto T, 2017, J PHYS CHEM B, V121, P2027, DOI 10.1021/acs.jpcb.6b11101; Weigend F, 2008, J COMPUT CHEM, V29, P167, DOI 10.1002/jcc.20702; Weinert T, 2019, SCIENCE, V365, P61, DOI 10.1126/science.aaw8634; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111; Yun JH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020486118; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zscherp C, 1997, J PHYS CHEM B, V101, P10542, DOI 10.1021/jp971047i	81	11	11	15	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2022	375	6583					845	+		10.1126/science.abj6663	http://dx.doi.org/10.1126/science.abj6663			71	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM2ZV	35113649				2022-12-28	WOS:000764232800039
J	Kar, P				Kar, Partha			Partha Kar: We need leaders who represent the NHS workforce	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com						NHS England, BOARD MEMB; NHS England and NHS Improvement, 2022, CHRIST NHS FDN TRUST; Wise J, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o289	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o293	10.1136/bmj.o293	http://dx.doi.org/10.1136/bmj.o293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135822	Bronze			2022-12-28	WOS:000754132400007
J	Aronson, JK				Aronson, Jeffrey K.			When I use a word.... Vaccination-rights and duties	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aronson, Jeffrey K.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England.			Aronson, Jeffrey/0000-0003-1139-655X				Aaronovitch D., 2021, THE TIMES 1209; Andrade BS, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040700; Aronson JK, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3111; Aronson JK, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2934; Baum M, 2022, THE TIMES 0202; Ferner RE, 2022, DRUG SAFETY, V45, P137, DOI 10.1007/s40264-021-01138-z; Freiberger M, 2019, NEW SCI, V17; Graves L., 2020, OXFORD RES ENCY COMM, V1, P505, DOI DOI 10.1093/ACREFORE/9780190228613.013.808; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o192; Oster ME, 2022, JAMA-J AM MED ASSOC, V327, P331, DOI 10.1001/jama.2021.24110; Wenar L., 2020, STANFORD ENCY PHILOS	11	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o317	10.1136/bmj.o317	http://dx.doi.org/10.1136/bmj.o317			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121618	Bronze			2022-12-28	WOS:000753552800005
J	Haidar, G; Singh, N				Haidar, Ghady; Singh, Nina			Fever of Unknown Origin	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROSPECTIVE MULTICENTER; HYPERTHERMIA; METAANALYSIS; INFECTIONS; TRAVELERS; DISEASES; YIELD	Fever of unknown origin (FUO) often is defined as a fever greater than 38.3 degrees C on several occasions during at least 3 weeks with uncertain diagnosis after a number of obligatory tests. In general, infection accounts for approximately one-fourth of cases of FUO, followed by neoplasm and noninfectious inflammatory diseases. No diagnosis is reached in up to 50% of cases. Scintigraphic methods, such as (67)Ga-citrate, labeled leukocytes, and (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET), are often used in the diagnosis of FUO. In FUO, FDG-PET appears to be of great advantage because malignancy, inflammation, and infection can be detected. FDG-PET does not seem to contribute to a final diagnosis in patients with normal erythrocyte sedimentation rate and C-reactive protein. Image fusion combining PET and computed tomography facilitates anatomical localization of increased FDG uptake and better guiding for further diagnostic tests to achieve a final diagnosis. In conclusion, the body of evidence on the utility of FDG-PET in patients with FUO is growing and FDG-PET will probably become the preferred diagnostic procedure, especially when a definite diagnosis cannot easily be achieved. Because of favorable characteristics of FDG-PET, conventional scintigraphic techniques may be replaced by FDG-PET in institutions in which PET is available.	[Haidar, Ghady] Univ Pittsburgh, Div Infect Dis, Dept Med, Sch Med, Pittsburgh, PA USA; [Singh, Nina] VA Healthcare Syst, Infect Dis Sect, Univ Dr C, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, N (corresponding author), VA Healthcare Syst, Infect Dis Sect, Univ Dr C, Pittsburgh, PA 15240 USA.	nis5@pitt.edu						Abellan-Martinez J, 2009, EUR J INTERN MED, V20, P474, DOI 10.1016/j.ejim.2009.01.004; BARBADO FJ, 1984, J MED, V15, P185; Bharucha T, 2017, CLIN RADIOL, V72, P764, DOI 10.1016/j.crad.2017.04.014; BISSUEL F, 1994, J INTERN MED, V236, P529, DOI 10.1111/j.1365-2796.1994.tb00840.x; Bleeker-Rovers CP, 2007, EUR J NUCL MED MOL I, V34, P694, DOI 10.1007/s00259-006-0295-z; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Bohaty BR, 2015, NEW ENGL J MED, V372, pE14, DOI 10.1056/NEJMicm1312910; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Bozo N, 2021, BMJ CASE REP, V14, DOI 10.1136/bcr-2020-237798; Cabot RC, 1907, BOSTON MED SURG J, V157, P281, DOI 10.1056/NEJM190708291570902; Chang FY, 1998, CLIN INFECT DIS, V26, P59, DOI 10.1086/516265; Cleri DJ, 2007, INFECT DIS CLIN N AM, V21, P963, DOI 10.1016/j.idc.2007.08.009; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; de Kleijn EMH, 1997, MEDICINE, V76, P392, DOI 10.1097/00005792-199711000-00002; Dong MJ, 2011, EUR J RADIOL, V80, P834, DOI 10.1016/j.ejrad.2010.11.018; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; El-Radhi A Sahib Mehdi, 2012, World J Clin Pediatr, V1, P29, DOI 10.5409/wjcp.v1.i4.29; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Fautrel B, 2001, J RHEUMATOL, V28, P322; Fink D, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5773; Francescangeli J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092288; Fusco FM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4285-8; Gaeta GB, 2006, NUCL MED COMMUN, V27, P205, DOI 10.1097/00006231-200603000-00002; Giacobbe DR, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1763-5; Gurven M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc6599; Haidar G., 2020, EMERGING TRANSPLANT, P683; Haidar G, 2020, CURR OPIN INFECT DIS, V33, P449, DOI 10.1097/QCO.0000000000000679; HALEVY J, 1988, AM J MED SCI, V295, P122, DOI 10.1097/00000441-198802000-00006; Hayakawa K, 2012, AM J MED SCI, V344, P307, DOI 10.1097/MAJ.0b013e31824ae504; Horowitz HW, 2013, NEW ENGL J MED, V368, P197, DOI 10.1056/NEJMp1212725; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Jhaveri VV, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz399; Kim Yi-Seul, 2017, Korean J Pediatr, V60, P77, DOI 10.3345/kjp.2017.60.3.77; KLUGER MJ, 1979, SCIENCE, V203, P374, DOI 10.1126/science.760197; Knockaert DC, 1996, ARCH INTERN MED, V156, P618, DOI 10.1001/archinte.156.6.618; Kozak W, 2000, ANN NY ACAD SCI, V917, P121; Kubota K, 2021, ANN NUCL MED, V35, P31, DOI 10.1007/s12149-020-01533-z; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Lee BH, 2012, CRIT CARE, V16, DOI 10.1186/cc11211; Loizidou A, 2016, CRIT REV ONCOL HEMAT, V101, P125, DOI 10.1016/j.critrevonc.2016.02.015; Lortholary O, 1999, J ANTIMICROB CHEMOTH, V43, P321, DOI 10.1093/jac/43.3.321; MACKOWIAK PA, 1981, REV INFECT DIS, V3, P508; Mavros MN, 2011, CHEST, V140, P418, DOI 10.1378/chest.11-0127; McAllen KJ, 2010, CRIT CARE MED, V38, pS244, DOI 10.1097/CCM.0b013e3181dda0d4; McKinsey DS, 2020, CLIN INFECT DIS, V70, P1011, DOI 10.1093/cid/ciz327; Mittal G, 2015, J CLIN DIAGN RES, V9, pDC22, DOI 10.7860/JCDR/2015/11168.6990; Moossa A R, 1972, Ann R Coll Surg Engl, V51, P396; Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036; Pannu AK, 2021, TROP DOCT, V51, P34, DOI 10.1177/0049475520947907; Patel RA, 2010, PHARMACOTHERAPY, V30, P57, DOI 10.1592/phco.30.1.57; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Rahman MT, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8091405; ROLAND WE, 1995, CLIN INFECT DIS, V20, P821, DOI 10.1093/clinids/20.4.821; Rytter H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.616971; Seguin P, 2012, CRIT CARE, V16, DOI 10.1186/cc11465; Sepkowitz KA., 1997, INT J INFECT DIS, V2, P47; Spernovasilis N, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2019.05.011; Spiers L, 2019, RHEUMATOLOGY, V58, P7, DOI 10.1093/rheumatology/kez418; Sun HY, 2009, CURR OPIN INFECT DIS, V22, P394, DOI 10.1097/QCO.0b013e32832d7aff; Takagi M, 2016, NEW ENGL J MED, V374, pE26, DOI 10.1056/NEJMicm1508258; Takeuchi M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012909; Takeuchi M, 2016, J NUCL MED, V57, P1913, DOI 10.2967/jnumed.116.174391; Taplitz RA, 2018, J CLIN ONCOL, V36, P1443, DOI 10.1200/JCO.2017.77.6211; Trese M, 2010, INFECT DIS SOC AM 48; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Wallace BI, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4920; WORMSER GP, 1985, JAMA-J AM MED ASSOC, V253, P3441, DOI 10.1001/jama.253.23.3441; Wright WF, 2021, AM J MED; Wright WF, 2022, CLIN INFECT DIS, V74, P924, DOI 10.1093/cid/ciab155; Wright WF, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa132; Wunderlich C.A., 1869, AM J MED SCI, V57, P425, DOI DOI 10.1097/00000441-186904000-00021; Yango A, 2021, CLIN NEPHROL, V96, P47, DOI 10.5414/CN110449; Yenilmez E, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.14138; Zhang HL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015840; Zhou WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101619	75	15	17	11	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					463	477		10.1056/NEJMra2111003	http://dx.doi.org/10.1056/NEJMra2111003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR1JU	35108471				2022-12-28	WOS:000749755800011
J	Jain, A				Jain, Ankur			A teenage girl with knuckle hyperpigmentation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-B12		[Jain, Ankur] Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Haematol, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital	Jain, A (corresponding author), Vardhman Mahavir Med Coll & Safdarjung Hosp, Dept Haematol, New Delhi, India.	drankur589@yahoo.in						Aaron S, 2005, NEUROL INDIA, V53, P55; Andres E, 2013, QJM-INT J MED, V106, P505, DOI 10.1093/qjmed/hct051; Betterle C, 2019, J ENDOCRINOL INVEST, V42, P1407, DOI 10.1007/s40618-019-01079-6; Bhalla M, 2018, PIGMENT INT, V5, P14; Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; Hunt A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5226; PRUTHI RK, 1994, MAYO CLIN PROC, V69, P144, DOI 10.1016/S0025-6196(12)61041-6; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]	10	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								e068243	10.1136/bmj-2021-068243	http://dx.doi.org/10.1136/bmj-2021-068243			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110299				2022-12-28	WOS:000758682200012
J	Hubschen, JM; Gouandjika-Vasilache, I; Dina, J				Hubschen, Judith M.; Gouandjika-Vasilache, Ionela; Dina, Julia			Measles	LANCET			English	Review							GLOBULIN POSTEXPOSURE PROPHYLAXIS; GLOBAL MEASLES; IMMUNIZATION COVERAGE; ELIMINATION; VIRUS; VACCINATION; CHALLENGES; SURVEILLANCE; ERADICATION; ANTIBODIES	Measles is a highly contagious, potentially fatal, but vaccine-preventable disease caused by measles virus. Symptoms include fever, maculopapular rash, and at least one of cough, coryza, or conjunctivitis, although vaccinated individuals can have milder or even no symptoms. Laboratory diagnosis relies largely on the detection of specific IgM antibodies in serum, dried blood spots, or oral fluid, or the detection of viral RNA in throat or nasopharyngeal swabs, urine, or oral fluid. Complications can affect many organs and often include otitis media, laryngotracheobronchitis, pneumonia, stomatitis, and diarrhoea. Neurological complications are uncommon but serious, and can occur during or soon after the acute disease (eg, acute disseminated encephalomyelitis) or months or even years later (eg, measles inclusion body encephalitis and subacute sclerosing panencephalitis). Patient management mainly involves supportive therapy, such as vitamin A supplementation, monitoring for and treatment of secondary bacterial infections with antibiotics, and rehydration in the case of severe diarrhoea. There is no specific antiviral therapy for the treatment of measles, and disease control largely depends on prevention. However, despite the availability of a safe and effective vaccine, measles is still endemic in many countries and causes considerable morbidity and mortality, especially among children in resource-poor settings. The low case numbers reported in 2020, after a worldwide resurgence of measles between 2017 and 2019, have to be interpreted cautiously, owing to the effect of the COVID-19 pandemic on disease surveillance. Disrupted vaccination activities during the pandemic increase the potential for another resurgence of measles in the near future, and effective, timely catch-up vaccination campaigns, strong commitment and leadership, and sufficient resources will be required to mitigate this threat.	[Hubschen, Judith M.] Luxembourg Inst Hlth, Dept Infect & Immun, L-4354 Esch Sur Alzette, Luxembourg; [Gouandjika-Vasilache, Ionela] Inst Pasteur, Lab Virus Enter & Rougeole, Bangui, Cent Afr Republ; [Dina, Julia] Normandie Univ, Caen Univ Hosp, Virol Dept, UNICAEN,INSERM U1311 DynaMicURe, Caen, France	Luxembourg Institute of Health; CHU de Caen NORMANDIE; Universite de Caen Normandie	Hubschen, JM (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun, L-4354 Esch Sur Alzette, Luxembourg.	judith.huebschen@lih.lu	Gouandjika, Ionela/AGR-0778-2022	Gouandjika, Ionela/0000-0002-2498-8725				Ali D, 2020, EUR J CASE REP INTER, V7; Allen IV, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00570-17; Alvarado-Facundo E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220780; [Anonymous], 2018, Wkly Epidemiol Rec, V93, P55; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P97; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P205; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; Arciuolo RJ, 2017, CLIN INFECT DIS, V65, P1843, DOI 10.1093/cid/cix639; Awotiwon AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011177.pub3; Bankamp B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095470; Bansal J, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2018-228781; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Bernadou A, 2018, EUROSURVEILLANCE, V23, DOI 10.2807/1560-7917.ES.2018.23.30.1800373; Bigham M, 2017, VACCINE, V35, P2723, DOI 10.1016/j.vaccine.2017.03.069; Bolotin S, 2020, J INFECT DIS, V221, P1576, DOI 10.1093/infdis/jiz380; Bosetti P, 2020, P NATL ACAD SCI USA, V117, P30118, DOI 10.1073/pnas.1920986117; Bozzola E, 2020, RISK MANAG HEALTHC P, V13, P2819, DOI 10.2147/RMHP.S201279; Brown DW, 2020, CURR OPIN VIROL, V41, P77, DOI 10.1016/j.coviro.2020.05.007; Carcelen AC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240734; Cattaneo R, 2019, VIRUS RES, V265, P74, DOI 10.1016/j.virusres.2019.03.007; CHARLIER C, 2021, CLIN INFECT DIS, V72, P1631; Chin T, 2020, EPIDEMICS-NETH, V30, DOI 10.1016/j.epidem.2020.100385; Cochi SL, 2011, J INFECT DIS, V204, pS4, DOI 10.1093/infdis/jir100; Conis E, 2019, PUBLIC HEALTH REP, V134, P118, DOI 10.1177/0033354919826558; Coughlin MM, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02716-20; Cox RM, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009371; Cutts FT, 2021, BMC MED, V19, DOI 10.1186/s12916-020-01843-z; Cutts FT, 2020, VACCINE, V38, P979, DOI 10.1016/j.vaccine.2019.11.020; Cutts FT, 2021, VACCINE, V39, P1359, DOI 10.1016/j.vaccine.2020.11.050; de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490; de Swart RL, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0022-8; de Vries RD, 2012, EXPERT REV VACCINES, V11, P779, DOI [10.1586/erv.12.45, 10.1586/ERV.12.45]; Di Pietrantonj C, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub4; Dimech W, 2016, VACCINE, V34, P4110, DOI 10.1016/j.vaccine.2016.06.002; Dina J, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00341-19; Donohue RC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007605; Durrheim DN, 2018, VACCINE, V36, P4001, DOI 10.1016/j.vaccine.2018.04.036; Durrheim DN, 2021, NAT MED, V27, P360, DOI 10.1038/s41591-021-01237-5; Durrheim DN, 2020, LANCET INFECT DIS, V20, pE138, DOI 10.1016/S1473-3099(20)30052-9; Durrheim DN, 2016, NEW ENGL J MED, V375, P1392, DOI 10.1056/NEJMe1610620; Farra A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213735; Feldman AG, 2021, CLIN INFECT DIS, V73, P1920, DOI 10.1093/cid/ciab127; Fitzgerald TL, 2012, COMMUN DIS INTELL, V36, pE277; Fletcher NF, 2020, J GEN VIROL, V101, P1090, DOI 10.1099/jgv.0.001472; Fu JY, 2019, INT J INFECT DIS, V78, P85, DOI 10.1016/j.ijid.2018.10.023; Gastanaduy PA, 2018, HUM VACC IMMUNOTHER, V14, P2222, DOI 10.1080/21645515.2018.1474310; Gavi The Vaccine Alliance, 2020, VACC INN PRIOR STRAT; Gibson DG, 2017, LANCET GLOB HEALTH, V5, pE428, DOI [10.1016/S2214-109X(17)30072-4, 10.1016/s2214-109x(17)30072-4]; Gignoux E, 2021, LANCET GLOB HEALTH, V9, pE223, DOI 10.1016/S2214-109X(21)00020-6; Gil H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199975; Grafen A, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00218; Graham M, 2019, SCIENCE, V364, P584, DOI 10.1126/science.aau6299; Griffin DE, 2013, FIELDS VIROLOGY, V1, P1042; Griffin DE, 2018, VIRAL IMMUNOL, V31, P86, DOI 10.1089/vim.2017.0143; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Haralambieva IH, 2019, EXPERT REV VACCINES, V18, P75, DOI 10.1080/14760584.2019.1559063; Hardie DR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-283; Herren M, 2018, J VIROL, V92, DOI 10.1128/JVI.00679-18; Hiebert J, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03161-20; Holzmann H, 2016, MED MICROBIOL IMMUN, V205, P201, DOI 10.1007/s00430-016-0451-4; Hotez PJ, 2020, CURR OPIN VIROL, V41, P1, DOI 10.1016/j.coviro.2020.01.001; Hubschen JM, 2017, CLIN MICROBIOL INFEC, V23, P511, DOI 10.1016/j.cmi.2017.04.009; Hubschen JM, 2018, VACCINE, V36, P899, DOI 10.1016/j.vaccine.2017.12.041; Jacobson Robert M, 2012, Hum Immunol, V73, P474, DOI 10.1016/j.humimm.2012.02.016; Joyce JC, 2018, J INFECT DIS, V218, P124, DOI 10.1093/infdis/jiy139; Khetsuriani N, 2020, EMERG INFECT DIS, V26, P2565, DOI 10.3201/eid2611.200259; Kimura H, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00269; Klingele M, 2000, J MED VIROL, V62, P91, DOI 10.1002/1096-9071(200009)62:1&lt;91::AID-JMV14&gt;3.0.CO;2-B; Koga R, 2018, J VIROL, V92, DOI 10.1128/JVI.00181-18; Kohnen M, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.22.2000012; Kreidl P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080765; Kurata T, 2021, J MED VIROL, V93, P3446, DOI 10.1002/jmv.26733; Laksono BM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008253; Laksono BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07515-0; Laksono BM, 2018, J VIROL, V92, DOI 10.1128/JVI.00131-18; Lee YC, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101804; Leong WY, 2019, J EPIDEMIOL GLOB HEA, V9, P294, DOI 10.2991/jegh.k.191007.001; Liersch J, 2019, AM J DERMATOPATH, V41, P914, DOI 10.1097/DAD.0000000000001431; Lin LT, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090250; Magdaleno-Tapial J, 2019, AM J DERMATOPATH, V41, P289, DOI 10.1097/DAD.0000000000001278; Magurano F, 2017, ANN I SUPER SANITA, V53, P167, DOI 10.4415/ANN_17_02_15; Masresha BG, 2020, PAN AFR MED J, V35, P31, DOI 10.11604/pamj.supp.2020.35.1.19059; Matysiak-Klose D, 2018, VACCINE, V36, P7916, DOI 10.1016/j.vaccine.2018.10.070; McKee A, 2017, EPIDEMIOL INFECT, V145, P227, DOI 10.1017/S0950268816002296; Mekki M, 2019, DEV MED CHILD NEUROL, V61, P1139, DOI 10.1111/dmcn.14166; Metcalf CJE, 2020, TRENDS MICROBIOL, V28, P597, DOI 10.1016/j.tim.2020.04.009; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Mina MJ, 2017, J INFECTION, V74, pS10, DOI 10.1016/S0163-4453(17)30185-8; Moss WJ, 2017, LANCET, V390, P2490, DOI 10.1016/S0140-6736(17)31463-0; Mulders MN, 2017, J INFECT DIS, V216, pS324, DOI 10.1093/infdis/jix077; Nicolay N, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.31.2001390; Nogareda F, 2020, VACCINE, V38, P4200, DOI 10.1016/j.vaccine.2020.04.024; O'Connor P, 2017, CLIN MICROBIOL INFEC, V23, P504, DOI 10.1016/j.cmi.2017.01.003; OBrien, 2020, M STRAT ADV GROUP EX; Okada H, 2001, ARCH VIROL, V146, P859, DOI 10.1007/s007050170121; Orenstein WA, 2018, VACCINE, V36, pA1, DOI 10.1016/j.vaccine.2017.09.026; Pabbaraju K, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01828-18; Pan American Health Organization, 2018, MEASL RUB WEEKL B ME, P24; Patel MK, 2020, MMWR-MORBID MORTAL W, V69, P1700, DOI 10.15585/mmwr.mm6945a6; Patel MK, 2019, LANCET GLOB HEALTH, V7, pE313, DOI 10.1016/S2214-109X(18)30492-3; Pfaller CK, 2020, J VIROL, V94, DOI 10.1128/JVI.01733-19; Plemper RK, 2020, CURR OPIN VIROL, V41, P8, DOI 10.1016/j.coviro.2020.02.007; Portnoy A, 2019, LANCET GLOB HEALTH, V7, pE472, DOI 10.1016/S2214-109X(18)30537-0; Prausnitz MR, 2020, CURR OPIN VIROL, V41, P68, DOI 10.1016/j.coviro.2020.05.005; Probert WS, 2021, J INFECT DIS, V224, P1015, DOI 10.1093/infdis/jiab059; Ragusa R, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/6532868; Richardson LC, 2020, PAN AFR MED J, V35, P7, DOI 10.11604/pamj.supp.2020.35.1.19753; Rima B, 2019, J GEN VIROL, V100, P1593, DOI 10.1099/jgv.0.001328; Rodriguez C, 2020, EMERG INFECT DIS, V26, P2231, DOI 10.3201/eid2609.200366; Rota PA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.49; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Roy F, 2017, J CLIN MICROBIOL, V55, P735, DOI 10.1128/JCM.01879-16; Salimovic-Besic I, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.02.005; Santana MF, 2020, AN BRAS DERMATOL, V95, P238, DOI 10.1016/j.abd.2019.02.015; Sbarra AN, 2021, NATURE, V589, P415, DOI 10.1038/s41586-020-03043-4; Schenk J, 2021, LANCET INFECT DIS, V21, P286, DOI 10.1016/S1473-3099(20)30442-4; Semmler G, 2021, J CLIN MICROBIOL, V59; Singh BK, 2019, MBIO, V10, DOI 10.1128/mBio.02434-19; Sowers SB, 2016, CLIN VACCINE IMMUNOL, V23, P707, DOI 10.1128/CVI.00268-16; Stein RA, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13456; Strebel PM, 2019, NEW ENGL J MED, V381, P349, DOI 10.1056/NEJMcp1905181; Tabak F, 2012, ANN DERMATOL, V24, P420, DOI 10.5021/ad.2012.24.4.420; Terletskaia-Ladwig E, 2011, J VIROL METHODS, V178, P124, DOI 10.1016/j.jviromet.2011.08.026; Tiwarekar V, 2018, J VIROL, V92, DOI 10.1128/JVI.00835-18; Utazi CE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09611-1; Uzicanin A, 2011, J INFECT DIS, V204, pS133, DOI 10.1093/infdis/jir102; Vaidya SR, 2020, J INFECTION, V80, P301, DOI 10.1016/j.jinf.2019.11.025; Wangchuk S, 2019, VACCINE, V37, P6463, DOI 10.1016/j.vaccine.2019.08.085; Wariri O, 2021, LANCET GLOB HEALTH, V9, pE280, DOI 10.1016/S2214-109X(20)30481-2; WHO, 2020, WHO IMM BAS IMM SER; WHO, 2018, SURV STAN VACC PREV; WHO, 2019, NONSP EFF VACC QUEST; Winer H, 2020, MOLECULES, V25, DOI 10.3390/molecules25071657; Winter AK, 2018, AM J EPIDEMIOL, V187, P2219, DOI 10.1093/aje/kwy114; Winter AK, 2018, J INFECT DIS, V218, P355, DOI 10.1093/infdis/jiy137; World Health Organization, 2020, GUID CLIN CAS MAN IN; Woudenberg T, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040158; Yermalovich MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111541; Young MK, 2018, EXPERT OPIN DRUG MET, V14, P663, DOI 10.1080/17425255.2018.1484449; Zhang ZJZ, 2020, HUM VACC IMMUNOTHER, V16, P358, DOI 10.1080/21645515.2019.1653742; Zuo SY, 2020, VACCINE, V38, P7379, DOI 10.1016/j.vaccine.2020.08.055	142	16	16	7	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					678	690		10.1016/S0140-6736(21)02004-3	http://dx.doi.org/10.1016/S0140-6736(21)02004-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY1RO	35093206				2022-12-28	WOS:000754571600026
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Sajid Javid's plan for a salaried GP service	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Fisher R, 2022, TACKLING INVERSE CAR; Kollewe J., 2021, GUARDIAN 0226; Smyth C, 2022, TIMES 0129	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o260	10.1136/bmj.o260	http://dx.doi.org/10.1136/bmj.o260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105544	Bronze			2022-12-28	WOS:000758676500008
J	Ytterberg, SR; Bhatt, DL; Mikuls, TR; Koch, GG; Fleischmann, R; Rivas, JL; Germino, R; Menon, S; Sun, YH; Wang, CS; Shapiro, AB; Kanik, KS; Connell, CA				Ytterberg, Steven R.; Bhatt, Deepak L.; Mikuls, Ted R.; Koch, Gary G.; Fleischmann, Roy; Rivas, Jose L.; Germino, Rebecca; Menon, Sujatha; Sun, Yanhui; Wang, Cunshan; Shapiro, Andrea B.; Kanik, Keith S.; Connell, Carol A.		ORAL Surveillance Investigators	Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE-ACTIVITY INDEX; METAANALYSIS; THERAPY; SAFETY; EVENTS; DMARDS; SDAI; LIFE	BACKGROUND Increases in lipid levels and cancers with tofacitinib prompted a trial of major adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis receiving tofacitinib as compared with a tumor necrosis factor (TNF) inhibitor. METHODS We conducted a randomized, open-label, noninferiority, postauthorization, safety end-point trial involving patients with active rheumatoid arthritis despite methotrexate treatment who were 50 years of age or older and had at least one additional cardiovascular risk factor. Patients were randomly assigned in a 1:1:1 ratio to receive tofacitinib at a dose of 5 mg or 10 mg twice daily or a TNF inhibitor. The coprimary end points were adjudicated MACE and cancers, excluding nonmelanoma skin cancer. The noninferiority of tofacitinib would be shown if the upper boundary of the two-sided 95% confidence interval for the hazard ratio was less than 1.8 for the combined tofacitinib doses as compared with a TNF inhibitor. RESULTS A total of 1455 patients received tofacitinib at a dose of 5 mg twice daily, 1456 received tofacitinib at a dose of 10 mg twice daily, and 1451 received a TNF inhibitor. During a median follow-up of 4.0 years, the incidences of MACE and cancer were higher with the combined tofacitinib doses (3.4% [98 patients] and 4.2% [122 patients], respectively) than with a TNF inhibitor (2.5% [37 patients] and 2.9% [42 patients]). The hazard ratios were 1.33 (95% confidence interval [CI], 0.91 to 1.94) for MACE and 1.48 (95% CI, 1.04 to 2.09) for cancers; the noninferiority of tofacitinib was not shown. The incidences of adjudicated opportunistic infections (including herpes zoster and tuberculosis), all herpes zoster (nonserious and serious), and adjudicated nonmelanoma skin cancer were higher with tofacitinib than with a TNF inhibitor. Efficacy was similar in all three groups, with improvements from month 2 that were sustained through trial completion. CONCLUSIONS In this trial comparing the combined tofacitinib doses with a TNF inhibitor in a cardiovascular risk-enriched population, risks of MACE and cancers were higher with tofacitinib and did not meet noninferiority criteria. Several adverse events were more common with tofacitinib.	[Ytterberg, Steven R.] Mayo Clin, Div Rheumatol, Rochester, MN USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA 02115 USA; [Mikuls, Ted R.] Univ Nebraska, Med Ctr, Div Rheumatol, Omaha, NE 68182 USA; [Koch, Gary G.] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Fleischmann, Roy] Metroplex Clin Res Ctr, Dallas, TX USA; [Fleischmann, Roy] Univ Texas Southwestern Med Ctr, Dallas, TX USA; [Rivas, Jose L.] Pfizer, Madrid, Spain; [Germino, Rebecca] Pfizer, New York, NY USA; [Menon, Sujatha; Wang, Cunshan; Kanik, Keith S.; Connell, Carol A.] Pfizer, Groton, CT USA; [Sun, Yanhui] Pfizer, Shanghai, Peoples R China; [Shapiro, Andrea B.] Pfizer, Peapack, NJ USA	Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Metroplex Clinical Research Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer	Ytterberg, SR (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	ytterberg.steven@mayo.edu	Bhatt, Deepak L./Y-3070-2019; KOBAK, SENOL/AAO-2482-2020	Bhatt, Deepak L./0000-0002-1278-6245; KOBAK, SENOL/0000-0001-8270-640X; Perez Venegas, Jose Javier/0000-0001-8737-7123; Arteaga Unigarro, Carlos Ernesto/0000-0002-7178-790X; Pacheco-Tena, Cesar/0000-0002-0793-8988	Pfizer	Pfizer(Pfizer)	In this trial comparing the combined tofacitinib doses with a TNF inhibitor in a cardiovascular risk-enriched population, risks of MACE and cancers were higher with tofacitinib and did not meet noninferiority criteria. Several adverse events were more common with tofacitinib. (Funded by Pfizer; ORAL Surveillance ClinicalTrials.gov number, NCT02092467.)	Aletaha D, 2005, ARTHRITIS RHEUM-US, V52, P2625, DOI 10.1002/art.21235; Anderson JK, 2011, ARTHRIT CARE RES, V63, pS14, DOI 10.1002/acr.20621; [Anonymous], 2020, XELJANZ TOFACITINIB; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Bechman K, 2019, RHEUMATOLOGY, V58, P1755, DOI 10.1093/rheumatology/kez087; Charles-Schoeman C, 2019, ARTHRITIS RHEUMATOL, V71, P1450, DOI 10.1002/art.40911; Charles-Schoeman C, 2016, SEMIN ARTHRITIS RHEU, V46, P71, DOI 10.1016/j.semarthrit.2016.03.004; Charles-Schoeman C, 2015, ARTHRITIS RHEUMATOL, V67, P616, DOI 10.1002/art.38974; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Divonne MD, 2017, JOINT BONE SPINE, V84, P133, DOI 10.1016/j.jbspin.2016.02.028; Food and Drug Administration, 2008, DIAB MELL EV CARD RI; Fraenkel L, 2021, ARTHRITIS RHEUMATOL, V73, P1108, DOI [10.1002/acr.24596, 10.1002/art.41752]; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Guo JJ, 2010, VALUE HEALTH, V13, P657, DOI 10.1111/j.1524-4733.2010.00725.x; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kremer JM, 2021, ACR OPEN RHEUMATOL, V3, P173, DOI 10.1002/acr2.11232; Maska L, 2011, ARTHRIT CARE RES, V63, pS4, DOI 10.1002/acr.20620; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Simms RW, 1996, ARTHRITIS RHEUM-US, V39, P723; Simon TA, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0728-9; Singh JA, 2015, LANCET, V386, P258, DOI 10.1016/S0140-6736(14)61704-9; Singh S, 2020, ARTHRIT CARE RES, V72, P561, DOI 10.1002/acr.23875; Smolen JS, 2014, CLIN EXP RHEUMATOL, V32, pS75; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Solomon DH, 2020, ANN INTERN MED, V172, P369, DOI 10.7326/M19-3369; Strait A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14745; Szekanecz Z, 2011, GERONTOLOGY, V57, P3, DOI 10.1159/000314634; Xie WH, 2020, SEMIN ARTHRITIS RHEU, V50, P930, DOI 10.1016/j.semarthrit.2020.08.007	32	140	139	20	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					316	326		10.1056/NEJMoa2109927	http://dx.doi.org/10.1056/NEJMoa2109927			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081280				2022-12-28	WOS:000753548900009
J	Dyer, C				Dyer, Clare			Former pupils of school for haemophiliac children seek legal redress for treatment with contaminated plasma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o217	10.1136/bmj.o217	http://dx.doi.org/10.1136/bmj.o217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082138				2022-12-28	WOS:000748440900003
J	Qaseem, A; Yost, J; Etxeandia-Ikobaltzeta, I; Forciea, MA; Abraham, GM; Miller, MC; Obley, AJ; Humphrey, LL				Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar; Forciea, Mary Ann; Abraham, George M.; Miller, Matthew C.; Obley, Adam J.; Humphrey, Linda L.		Amer Coll Phys	What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2)	ANNALS OF INTERNAL MEDICINE			English	Article							REINFECTION; KINETICS; COHORT; RATES; IGG	Description: The Scientific Medical Policy Committee (SMPC) of the American College of Physicians (ACP) developed these living, rapid practice points to summarize the current best available evidence on the antibody response to SARS-CoV-2 infection and protection against reinfection with SARS-CoV-2. This is version 2 of the ACP practice points, which serves to update version 1, published on 16 March 2021. These practice points do not evaluate vaccine-acquired immunity or cellular immunity. Methods: The SMPC developed this version of the living, rapid practice points based on an updated living, rapid, systematic review conducted by the Portland VA Research Foundation and funded by the Agency for Healthcare Research and Quality. Practice Point 1: Do not use SARS-CoV-2 antibody tests for the diagnosis of SARS-CoV-2 infection. Practice Point 2: Do not use SARS-CoV-2 antibody tests to predict the degree or duration of natural immunity conferred by antibodies against reinfection, including natural immunity against different variants. Retirement From Living Status: Although natural immunity remains a topic of scientific interest, this topic is being retired from living status given the availability of effective vaccines for SARS-CoV-2 and widespread recommendations for and prevalence of their use. Currently, vaccination is the best clinical recommendation for preventing infection, reinfection, and serious illness from SARS-CoV-2 and its variants. Ann Intern Med.	[Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Yost, Jennifer] Villanova Univ, Villanova, PA 19085 USA; [Forciea, Mary Ann] Penn Med, Philadelphia, PA USA; [Abraham, George M.] Univ Massachusetts, Med Sch, St Vincent Hosp, Worcester, MA USA; [Miller, Matthew C.] Penn Med Radnor, Radnor, PA USA; [Obley, Adam J.; Humphrey, Linda L.] Portland VA Med Ctr, Portland, OR USA; [Obley, Adam J.; Humphrey, Linda L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	American College of Physicians; Villanova University; University of Pennsylvania; Pennsylvania Medicine; University of Massachusetts System; University of Massachusetts Worcester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Forciea, Mary Ann/0000-0002-1999-1145; Etxeandia Ikobaltzeta, Itziar/0000-0001-6606-649X; Abraham, George/0000-0003-4296-8362; Qaseem, Amir/0000-0001-6866-7985; Yost, Jennifer/0000-0002-3170-1956; Miller, Matthew/0000-0001-7267-4897	ACP operating budget	ACP operating budget	Financial Support: Financial support for the development of the practice points comes exclusively from the ACP operating budget.	ABOLEYAH H, 2021, ECLINICALMEDICINE, V7, DOI DOI 10.1183/23120541.00080-2021; Advisory Committee on Immunization Practices, 2021, COVID 19 ACIP VACC R; Andrey DO, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082369; Andrey DO, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13357; Arkhipova-Jenkins I, 2021, ANN INTERN MED, V174, P811, DOI 10.7326/M20-7547; Bao YJ, 2021, INT J INFECT DIS, V103, P540, DOI 10.1016/j.ijid.2020.12.014; Blain H, 2020, J AM MED DIR ASSOC, V21, P933, DOI 10.1016/j.jamda.2020.06.013; Bruni M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103188; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P1081, DOI [10.15585/mmwr.mm7032e1, 10.15585/mmwr.mm7032e1externalicon]; Centers for Disease Control and Prevention, US ANT TESTS COVID 1; Centers for Disease Control and Prevention, PROT YOURS OTH; Centers for Disease Control and Prevention, INT PUBL HLTH REC FU; Chen Y, 2021, J MED VIROL, V93, P2782, DOI 10.1002/jmv.26617; Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Chirathaworn C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236905; Choe JY, 2020, J MED VIROL, V92, P2567, DOI 10.1002/jmv.26060; Crawford Katharine H D, 2020, J Infect Dis, DOI 10.1093/infdis/jiaa618; da Cunha TS, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072264; Dave M, 2020, J INDIAN ACAD CLIN M, V21, P7; de la Iglesia J, 2020, MED FAM-SEMERGEN, V46, P28, DOI 10.1016/j.semerg.2020.06.009; Delliere S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01233-20; Fafi-Kremer S, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102915; Finch E, 2021, SARS COV 2 INFECT RE, DOI [10.1101/ 2021.05.04.21256609, DOI 10.1101/2021.05.04.21256609]; Flannery DD, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd5709; Gallais F., 2021, MEDRXIV, DOI [10.1101/2021.05.07.21256823(2021, DOI 10.1101/2021.05.07.21256823(2021, 10.1101/2021.05.07.21256823]; Gazit S, COMP SARS COV 2 NATU, V2021, DOI [10.1101/2021.08.24.21262415, DOI 10.1101/2021.08.24.21262415, DOI 10.1101/2021.08.24.21262415V1]; Goldberg Y., 2021, PROTECTION PREVIOUS, DOI [10.1101/2021.04.20.21255670, DOI 10.1101/2021.04.20.21255670]; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Hagan LM, 2021, MMWR-MORBID MORTAL W, V70, P1349, DOI 10.15585/mmwr.mm7038e3; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Hanrath AT, 2021, J INFECTION, V82, pE29, DOI 10.1016/j.jinf.2020.12.023; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Harvey RA, 2021, JAMA INTERN MED, V181, P672, DOI 10.1001/jamainternmed.2021.0366; Helfand M, 2022, RISK REINFECTION SAR, V21-EHC034, DOI [10.23970/AHRQEPCCOVIDIMMUNITY2, DOI 10.23970/AHRQEPCC0VIDIMMUNITY2]; Helfand M, 2022, ANN INTERN MED, V175, P547, DOI 10.7326/M21-4245; Hou HY, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1136; Huang M, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00209-2; Imai K, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104393; Infantino M, 2020, J MED VIROL, V92, P1671, DOI 10.1002/jmv.25932; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Iversen K, 2020, LANCET INFECT DIS, V20, P1401, DOI 10.1016/S1473-3099(20)30589-2; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Jaaskelainen AJ, 2020, EUROSURVEILLANCE, V25, P11, DOI 10.2807/1560-7917.ES.2020.25.18.2000603; Jeffery-Smith A, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.5.2100092; Ko JH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072268; Koblischke M, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.592629; Krutikov M, 2021, INCIDENCE SARS COV 2, DOI [10.1101/2021.03.08.21253110, DOI 10.1101/2021.03.08.21253110]; Kwon JS, 2020, AM J TROP MED HYG, V103, P2412, DOI 10.4269/ajtmh.20-1110; Leidi A, 2022, CLIN INFECT DIS, V74, P622, DOI 10.1093/cid/ciab495; Li KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14362-5; Liu J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03138-4; Liu JL, 2021, ANN MED, V53, P34, DOI 10.1080/07853890.2020.1811887; Liu L, 2020, MICROBES INFECT, V22, P206, DOI 10.1016/j.micinf.2020.05.008; Liu R, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106746; Liu XM, 2020, EMERG MICROBES INFEC, V9, P1269, DOI 10.1080/22221751.2020.1773324; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Lynch Kara L, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa979; Manica M, 2021, RISK SYMPTOMATIC REI, DOI [10.1101/2021.04.14.21255502, DOI 10.1101/2021.04.14.21255502]; Pancrazzi A, 2020, CLIN BIOCHEM, V84, P87, DOI 10.1016/j.clinbiochem.2020.07.002; Payne DC, 2020, MMWR-MORBID MORTAL W, V69, P714, DOI [10.15585/mmwr.mm6923e4, 10.15585/mmwr.mm6923e4externalicon]; Petersen LR, 2021, CLIN INFECT DIS, V73, pE3066, DOI 10.1093/cid/ciaa1685; Pilz S, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13520; Qaseem A, 2021, ANN INTERN MED, V174, P828, DOI 10.7326/M20-7569; Qaseem A, 2021, ANN INTERN MED, V174, P1126, DOI 10.7326/M20-7641; Qu JX, 2020, CLIN INFECT DIS, V71, P2255, DOI 10.1093/cid/ciaa489; Rennert L, 2022, CLIN INFECT DIS, V74, P719, DOI 10.1093/cid/ciab454; Robbins T, 2021, J HOSP INFECT, V111, P102, DOI 10.1016/j.jhin.2020.11.019; Schaffner A, 2021, CLIN CHEM LAB MED, V59, pE49, DOI 10.1515/cclm-2020-1347; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shang YF, 2021, J MED VIROL, V93, P612, DOI 10.1002/jmv.26379; Sheehan MM, 2021, CLIN INFECT DIS, V73, P1882, DOI 10.1093/cid/ciab234; Shen B, 2020, AM J TRANSL RES, V12, P1348; Shu HQ, 2020, VIROL SIN, V35, P744, DOI 10.1007/s12250-020-00268-5; Staines HM, 2021, EMERG INFECT DIS, V27, P85, DOI 10.3201/eid2701.203074; Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; Terpos E, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8121885; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01243-20; Traugott M, 2020, J INFECT DIS, V222, P362, DOI 10.1093/infdis/jiaa305; Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.07.038; Vitale J, 2021, JAMA INTERN MED, V181, P1407, DOI 10.1001/jamainternmed.2021.2959; Wang Bo, 2020, medRxiv, DOI 10.1101/2020.06.04.20122846; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; Wang P, 2020, J VIROL METHODS, V283, DOI 10.1016/j.jviromet.2020.113919; Watson J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3325; Wendel S, 2020, TRANSFUSION, V60, p296A; WHO, 2020, ADV US MASKS CONT CO; Wolff F, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115140; World Health Organization (WHO), COVID 19 ADV PUBL GE; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Xie L, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620942129; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6; Young BE, 2021, CLIN INFECT DIS, V73, pE2932, DOI 10.1093/cid/ciaa1280; Zhang BC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00157; Zhao GL, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23483; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zheng YT, 2021, J MED VIROL, V93, P899, DOI 10.1002/jmv.26330	98	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					556	+		10.7326/M21-3272	http://dx.doi.org/10.7326/M21-3272		JAN 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35073153	Green Published			2022-12-28	WOS:000748965700001
J	Iacobucci, G				Iacobucci, Gareth			NEWS ANALYSIS Covid-19: How prepared is England's NHS for mandatory vaccination?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bannerman L, 2022, TIMES JAN; BMA, 2022, BMA REJ GOV UNF REF; Care Quality Commission,, 2021, VACC COND DEPL HLTH; Department of Health and Social Care,, 2021, CONS MAND VACC FRONT; Institute for Government, 2022, VACC MAND; Jena AB, 2021, NEW YORK TIMES; Moncrieff J, 2021, BMJ; NHS England,, 2021, GUID SUPP COV 19 VAC; NHS England, 2022, VACC COND DEP HEALTH; Office for National Statistics, COR VACC RAT PEOPL A; Royal College of General Practitioners,, 2021, COLL RESP MAND VACC; Waters A, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o139	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								o192	10.1136/bmj.o192	http://dx.doi.org/10.1136/bmj.o192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4MD	35074805	Bronze			2022-12-28	WOS:000750652200005
J	Wise, J				Wise, Jacqui			Covid-19: England prepares to ease plan B restrictions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ANA Enterprise,, 2022, COR COVID 19 INF SUR	1	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o163	10.1136/bmj.o163	http://dx.doi.org/10.1136/bmj.o163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058234	Bronze			2022-12-28	WOS:000750649900001
J	Lotscher, J; Lindez, AAMI; Kirchhammer, N; Cribioli, E; Attianese, GMPG; Trefny, MP; Lenz, M; Rothschild, SI; Strati, P; Kunzli, M; Lotter, C; Schenk, SH; Dehio, P; Loliger, J; Litzler, L; Schreiner, D; Koch, V; Page, N; Lee, D; Grahlert, J; Kuzmin, D; Burgener, AV; Merkler, D; Pless, M; Balmer, ML; Reith, W; Huwyler, J; Irving, M; King, CG; Zippelius, A; Hess, C				Loetscher, Jonas; Lindez, Adria-Arnau Marti, I; Kirchhammer, Nicole; Cribioli, Elisabetta; Attianese, Greta Maria Paola Giordano; Trefny, Marcel P.; Lenz, Markus; Rothschild, Sacha, I; Strati, Paolo; Kuenzli, Marco; Lotter, Claudia; Schenk, Susanne H.; Dehio, Philippe; Loeliger, Jordan; Litzler, Ludivine; Schreiner, David; Koch, Victoria; Page, Nicolas; Lee, Dahye; Graehlert, Jasmin; Kuzmin, Dmitry; Burgener, Anne-Valerie; Merkler, Doron; Pless, Miklos; Balmer, Maria L.; Reith, Walter; Huwyler, Joerg; Irving, Melita; King, Carolyn G.; Zippelius, Alfred; Hess, Christoph			Magnesium sensing via LFA-1 regulates CD8(+) T cell effector function	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; I-LIKE DOMAIN; SERUM MAGNESIUM; AFFINITY REGULATION; LIGAND RECOGNITION; BINDING SITE; ADHESION; RECEPTOR; BLINATUMOMAB; MULTICENTER	The relevance of extracellular magnesium in cellular immunity remains largely unknown. Here, we show that the co-stimulatory cell-surface molecule LFA-1 requires magnesium to adopt its active conformation on CD8(+) T cells, thereby augmenting calcium flux, signal transduction, metabolic reprogramming, immune synapse formation, and, as a consequence, specific cytotoxicity. Accordingly, magnesium-sufficiency sensed via LFA-1 translated to the superior performance of pathogen- and tumor-specific T cells, enhanced effectiveness of bi-specific T cell engaging antibodies, and improved CAR T cell function. Clinically, low serum magnesium levels were associated with more rapid disease progression and shorter overall survival in CAR T cell and immune checkpoint antibody-treated patients. LFA-1 thus directly incorporates information on the composition of the microenvironment as a determinant of outside-in signaling activity. These findings conceptually link co-stimulation and nutrient sensing and point to the magnesium-LFA-1 axis as a therapeutically amenable biologic system.	[Loetscher, Jonas; Lindez, Adria-Arnau Marti, I; Dehio, Philippe; Loeliger, Jordan; Lee, Dahye; Graehlert, Jasmin; Burgener, Anne-Valerie; Balmer, Maria L.; Hess, Christoph] Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland; [Loetscher, Jonas; Lindez, Adria-Arnau Marti, I; Kirchhammer, Nicole; Trefny, Marcel P.; Dehio, Philippe; Loeliger, Jordan; Koch, Victoria; Lee, Dahye; Graehlert, Jasmin; Burgener, Anne-Valerie; Balmer, Maria L.; Zippelius, Alfred; Hess, Christoph] Univ Hosp Basel, CH-4031 Basel, Switzerland; [Lindez, Adria-Arnau Marti, I; Reith, Walter] Univ Geneva, Fac Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Lindez, Adria-Arnau Marti, I; Hess, Christoph] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Dept Med, CITIID, Cambridge CB2 0AW, England; [Kirchhammer, Nicole; Trefny, Marcel P.; Koch, Victoria; Zippelius, Alfred] Univ Basel, Dept Biomed, Canc Immunol, CH-4031 Basel, Switzerland; [Cribioli, Elisabetta; Attianese, Greta Maria Paola Giordano; Irving, Melita] Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; [Cribioli, Elisabetta; Attianese, Greta Maria Paola Giordano; Irving, Melita] Univ Hosp Lausanne, Dept Oncol, CH-1011 Lausanne, Switzerland; [Lenz, Markus] Univ Appl Sci Northwestern Switzerland, Inst Ecopreneurship, CH-4132 Muttenz, Switzerland; [Rothschild, Sacha, I; Zippelius, Alfred] Univ Hosp Basel, Div Med Oncol, CH-4031 Basel, Switzerland; [Rothschild, Sacha, I; Zippelius, Alfred] Univ Hosp Basel, Comprehens Canc Ctr, CH-4031 Basel, Switzerland; [Rothschild, Sacha, I; Pless, Miklos] Swiss Grp Clin Canc Res, CH-3008 Bern, Switzerland; [Strati, Paolo] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Kuenzli, Marco; Litzler, Ludivine; Schreiner, David; King, Carolyn G.] Univ & Univ Hosp Basel, Dept Biomed, Immune Cell Biol, CH-4031 Basel, Switzerland; [Lotter, Claudia; Schenk, Susanne H.; Huwyler, Joerg] Univ Basel, Dept Pharmaceut Sci, Pharmaceut Technol, CH-4056 Basel, Switzerland; [Page, Nicolas; Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Kuzmin, Dmitry] Hornet Therapeut Ltd, London SW1Y 5ES, England; [Kuzmin, Dmitry] Yale Sch Med, Dept Med Oncol, New Haven, CT 06510 USA; [Pless, Miklos] Cantonal Hosp Winterthur, Dept Oncol, CH-8400 Winterthur, Switzerland; [Balmer, Maria L.] Univ Bern, Univ Clin Diabet Endocrinol Clin Nutr & Metab, Dept Biomed Res DBMR, Inselspital, CH-3008 Bern, Switzerland; [Balmer, Maria L.] Diabet Ctr Berne DCB, CH-3010 Bern, Switzerland	University of Basel; University of Basel; University of Geneva; University of Cambridge; University of Basel; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Basel; University of Basel; Swiss Group for Clinical Cancer Research (SAKK); University of Texas System; UTMD Anderson Cancer Center; University of Basel; University of Geneva; Yale University; University of Bern	Hess, C (corresponding author), Univ Basel, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland.; Hess, C (corresponding author), Univ Hosp Basel, CH-4031 Basel, Switzerland.; Hess, C (corresponding author), Univ Cambridge, Jeffrey Cheah Biomed Ctr, Dept Med, CITIID, Cambridge CB2 0AW, England.	chess@uhbs.ch	; Merkler, Doron/N-9157-2016	Cribioli, Elisabetta/0000-0001-9727-4443; Trefny, Marcel Philipp/0000-0001-6755-7899; Lenz, Markus/0000-0001-6832-3218; Schreiner, David/0000-0003-0324-2526; Kuzmin, Dmitry/0000-0002-4380-6018; Merkler, Doron/0000-0002-0247-2007; Kirchhammer, Nicole/0000-0001-6043-5143; Marti i Lindez, Adria-Arnau/0000-0003-1377-5430; King, Carolyn G./0000-0001-6059-323X; Litzler, Ludivine/0000-0002-3317-2648	SNSF [323530_171148, 183980, PMPDP3_171261/1, PCEFP3_194618/1, 320030_188576, 310030_204326, 31003A_172848, FZEB-0180487, 310030_192677]; Freiwillige Akademische Gesellschaft Basel; Nikolaus und Bertha Burckhardt-Burgin-Stiftung; Novartis Foundation [17C141]	SNSF(Swiss National Science Foundation (SNSF)); Freiwillige Akademische Gesellschaft Basel(General Electric); Nikolaus und Bertha Burckhardt-Burgin-Stiftung; Novartis Foundation(Novartis)	J. Loet. was supported by SNSF grant 323530_171148 as well grants from the Freiwillige Akademische Gesellschaft Basel and Nikolaus und Bertha Burckhardt-Burgin-Stiftung; P.D. by SNSF grant 183980; M.L.B. by SNSF grant PMPDP3_171261/1, PCEFP3_194618/1, and a Novartis Foundation grant 17C141; A.Z. by SNSF grant 320030_188576; M.I. by SNSF grant 310030_204326; and C.H. by SNSF grants 31003A_172848, FZEB-0180487, and 310030_192677. We thank Ricardo Mancuso for helpful discussion and scientific input; Klaus Ley and Markus Sperandio for providing reagents; Veronica Richina for help with the hematology analyzer; and Priska Grunig, Tobias Ottl, and Michael Mayr for organizational help during the revision.	Abramson JS, 2020, LANCET, V396, P839, DOI 10.1016/S0140-6736(20)31366-0; Akizawa Y, 2008, J EPIDEMIOL, V18, P151, DOI 10.2188/jea.JE2007381; Angenendt L, 2021, ANN HEMATOL, V100, P1871, DOI 10.1007/s00277-020-04382-y; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Costello RB, 2017, CURR OPIN CLIN NUTR, V20, P504, DOI [10.1097/MCO.0000000000000410, 10.1097/mco.0000000000000410]; Costello RB, 2016, ADV NUTR, V7, P977, DOI 10.3945/an.116.012765; Coyle L, 2020, LEUKEMIA LYMPHOMA, V61, P2103, DOI 10.1080/10428194.2020.1759055; DRANSFIELD I, 1992, J CELL BIOL, V116, P1527, DOI 10.1083/jcb.116.6.1527; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; FAN ST, 1993, CELL IMMUNOL, V148, P48, DOI 10.1006/cimm.1993.1090; Fan ZC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12658; Franco MS, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.623760; Franquiz MJ, 2020, BIOL-TARGETS THER, V14, P23, DOI 10.2147/BTT.S202746; Gerard A, 2021, TRENDS IMMUNOL, V42, P706, DOI 10.1016/j.it.2021.06.004; Giannoni E, 2003, J BIOL CHEM, V278, P36763, DOI 10.1074/jbc.M302686200; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Han JC, 2020, SEMIN IMMUNOL, V49, DOI 10.1016/j.smim.2020.101435; Hebeisen M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00154; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Huwyler J, 1997, J PHARMACOL EXP THER, V282, P1541; Juan R, 2018, CANCER EPIDEMIOL, V52, P70, DOI 10.1016/j.canep.2017.12.004; Kanarek N, 2020, NATURE, V579, P507, DOI 10.1038/s41586-020-2124-0; Kanellopoulou C, 2019, J EXP MED, V216, P1828, DOI 10.1084/jem.20181970; Kiyoi H, 2020, CANCER SCI, V111, P1314, DOI 10.1111/cas.14322; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Labadia ME, 1998, J IMMUNOL, V161, P836; Lajer H, 1999, CANCER TREAT REV, V25, P47, DOI 10.1053/ctrv.1999.0097; Larsson SC, 2012, AM J CLIN NUTR, V95, P362, DOI 10.3945/ajcn.111.022376; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Liu WL, 2019, ONCOLOGIST, V24, pE312, DOI 10.1634/theoncologist.2018-0465; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Lotscher J, 2019, CLIN EXP IMMUNOL, V197, P161, DOI 10.1111/cei.13291; LOWENSTEIN FW, 1986, J AM COLL NUTR, V5, P399; Moore TI, 2018, CELL REP, V22, P1903, DOI 10.1016/j.celrep.2018.01.062; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Nakamura Y, 2016, BIOCONJUGATE CHEM, V27, P2225, DOI 10.1021/acs.bioconjchem.6b00437; Nasulewicz A, 2004, BBA-MOL BASIS DIS, V1739, P26, DOI 10.1016/j.bbadis.2004.08.003; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; Oronsky B, 2017, CANCER CHEMOTH PHARM, V80, P895, DOI 10.1007/s00280-017-3392-8; Qu XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057720; Rothschild SI, 2021, J CLIN ONCOL, V39, P2872, DOI 10.1200/JCO.21.00276; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; San Sebastian E, 2006, J AM CHEM SOC, V128, P3554, DOI 10.1021/ja054142a; Santoro SP, 2015, CANCER IMMUNOL RES, V3, P68, DOI 10.1158/2326-6066.CIR-14-0192; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schmid DA, 2010, J IMMUNOL, V184, P4936, DOI 10.4049/jimmunol.1000173; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Sen M, 2018, J BIOL CHEM, V293, P6565, DOI 10.1074/jbc.RA117.000710; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Siddiqi T, 2019, BLOOD, V134, DOI 10.1182/blood-2019-127603; SOJKA JE, 1995, NUTR REV, V53, P71, DOI 10.1111/j.1753-4887.1995.tb01505.x; Thomas R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00947; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; van Aalderen MC, 2017, CELL REP, V19, P1068, DOI 10.1016/j.celrep.2017.04.014; Vorup-Jensen T, 2007, BBA-PROTEINS PROTEOM, V1774, P1148, DOI 10.1016/j.bbapap.2007.06.014; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Zhan YQ, 2014, BIOL TRACE ELEM RES, V159, P39, DOI 10.1007/s12011-014-9967-x; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	71	22	24	31	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					585	+		10.1016/j.cell.2021.12.039	http://dx.doi.org/10.1016/j.cell.2021.12.039			48	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1XX	35051368				2022-12-28	WOS:000768265900003
J	Ohinata, Y; Endo, TA; Sugishita, H; Watanabe, T; Iizuka, Y; Kawamoto, Y; Saraya, A; Kumon, M; Koseki, Y; Kondo, T; Ohara, O; Koseki, H				Ohinata, Yasuhide; Endo, Takaho A.; Sugishita, Hiroki; Watanabe, Takashi; Iizuka, Yusuke; Kawamoto, Yurie; Saraya, Atsunori; Kumon, Mami; Koseki, Yoko; Kondo, Takashi; Ohara, Osamu; Koseki, Haruhiko			Establishment of mouse stem cells that can recapitulate the developmental potential of primitive endoderm	SCIENCE			English	Article							FATE; LINEAGE	The mammalian blastocyst consists of three distinct cell types: epiblast, trophoblast (TB), and primitive endoderm (PrE). Although embryonic stem cells (ESCs) and trophoblast stem cells (TSCs) retain the functional properties of epiblast and TB, respectively, stem cells that fully recapitulate the developmental potential of PrE have not been established. Here, we report derivation of primitive endoderm stem cells (PrESCs) in mice. PrESCs recapitulate properties of embryonic day 4.5 founder PrE, are efficiently incorporated into PrE upon blastocyst injection, generate functionally competent PrE-derived tissues, and support fetal development of PrE-depleted blastocysts in chimeras. Furthermore, PrESCs can establish interactions with ESCs and TSCs and generate descendants with yolk sac-like structures in utero. Establishment of PrESCs will enable the elucidation of the mechanisms for PrE specification and subsequent pre- and postimplantation development.	[Ohinata, Yasuhide; Saraya, Atsunori; Koseki, Haruhiko] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ward, 1-8-1 Inohana, Chiba 2608670, Japan; [Ohinata, Yasuhide; Sugishita, Hiroki; Iizuka, Yusuke; Kawamoto, Yurie; Kumon, Mami; Koseki, Yoko; Kondo, Takashi; Koseki, Haruhiko] RIKEN Ctr Med Sci IMS, Lab Dev Genet, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Endo, Takaho A.; Watanabe, Takashi; Ohara, Osamu] RIKEN Ctr Med Sci IMS, Lab Integrat Genom, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Facil Clin Omics Anal, 2-6-7 Kazusakamatori, Kisarazu, Chiba 2920818, Japan	Chiba University; Kazusa DNA Research Institute	Ohinata, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chuo Ward, 1-8-1 Inohana, Chiba 2608670, Japan.; Ohinata, Y (corresponding author), RIKEN Ctr Med Sci IMS, Lab Dev Genet, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yasuhideohinata@chiba-u.jp		Sugishita, Hiroki/0000-0002-6561-8261; Ohinata, Yasuhide/0000-0002-1833-0636; Saraya, Atsunori/0000-0002-5867-7861	JSPS KAKENHI [18H05366, 19H05757]; AMED [19bk0104093h0001]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	This work was supported by JSPS KAKENHI under grants 18H05366 and 19H05757 and by AMED under grant 19bk0104093h0001 to Y.O.	Artus J, 2010, DEVELOPMENT, V137, P3361, DOI 10.1242/dev.050864; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Igarashi H, 2018, BIOL REPROD, V99, P578, DOI 10.1093/biolre/ioy079; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Mohammed H, 2017, CELL REP, V20, P1215, DOI 10.1016/j.celrep.2017.07.009; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Schrode N, 2014, DEV CELL, V29, P454, DOI 10.1016/j.devcel.2014.04.011; Sozen B, 2019, DEV CELL, V51, P698, DOI 10.1016/j.devcel.2019.11.014; TAM PPL, 1994, DEV GENET, V15, P491, DOI 10.1002/dvg.1020150608; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Ueno H, 2010, INT J DEV BIOL, V54, P1019, DOI 10.1387/ijdb.093039hu	14	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					574	+		10.1126/science.aay3325	http://dx.doi.org/10.1126/science.aay3325			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113719				2022-12-28	WOS:000753965100046
J	Swanstrom, R; Schinazi, RF				Swanstrom, Ronald; Schinazi, Raymond F.			Lethal mutagenesis as an antiviral strategy	SCIENCE			English	Editorial Material									[Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol, Atlanta, GA USA; [Schinazi, Raymond F.] Childrens Healthcare Atlanta, Atlanta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; Emory University; Children's Healthcare of Atlanta (CHOA)	Swanstrom, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	risunc@med.unc.edu						Bernal AJ, 2022, NEW ENGL J MED, V386, P509, DOI 10.1056/NEJMoa2116044; BROWN DM, 1968, J CHEM SOC C, P1925, DOI 10.1039/j39680001925; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Driouich JS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21992-w; FDA, 2021, FACT SHEET HEALTHC P; Fischer II W.A, 2021, SCI TRANSL MED, V14; Gordon CJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100770; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Holmes EC, 2011, J VIROL, V85, P5247, DOI 10.1128/JVI.02203-10; Kaptein SJF, 2020, P NATL ACAD SCI USA, V117, P26955, DOI 10.1073/pnas.2014441117; Morse S.S., 1994, EVOLUTIONARY BIOL VI; Schulte MB, 2015, ELIFE, V4, DOI 10.7554/eLife.03753; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003; Zhou ST, 2021, J INFECT DIS, V224, P415, DOI 10.1093/infdis/jiab247	15	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					497	498		10.1126/science.abn0048	http://dx.doi.org/10.1126/science.abn0048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113690	Green Submitted			2022-12-28	WOS:000753965100024
J	Grant, L; Khan, F				Grant, Liz; Khan, Farzana			The precariousness of balancing life and death	LANCET			English	Editorial Material									[Grant, Liz] Univ Edinburgh, Global Hlth Acad, Edinburgh EH8 9AG, Midlothian, Scotland; [Khan, Farzana] Fasiuddin Khan Res Fdn, Dhaka, Bangladesh	University of Edinburgh	Grant, L (corresponding author), Univ Edinburgh, Global Hlth Acad, Edinburgh EH8 9AG, Midlothian, Scotland.	liz.grant@ed.ac.uk						Anderson RE, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000139; Bhadelia A, 2019, AM J PUBLIC HEALTH, V109, P58, DOI 10.2105/AJPH.2018.304769; Blanchet K, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0079-4; Doherty M, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003011; Dyer O, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1076; Khan F, 2014, Bangladesh Med Res Counc Bull, V40, P18; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; LAST T., 2014, FATAL JOURNEYS TRACK, P85; Looi MK, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2997; Sallnow L, 2022, LANCET, V399, P837, DOI 10.1016/S0140-6736(21)02314-X; Soe ZW, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00457-8; UNHCR,, 2022, UN PARTN LAUNCH PLAN; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; World Economic Forum, WORLD EC FOR GLOB RI	14	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					775	777		10.1016/S0140-6736(22)00162-3	http://dx.doi.org/10.1016/S0140-6736(22)00162-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	35114145	Green Accepted, Green Published			2022-12-28	WOS:000762307100008
J	Voelker, R				Voelker, Rebecca			First Modified-Risk Combusted Cigarettes Are Authorized	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					417	417						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103784				2022-12-28	WOS:000753056200007
J	Regan, MD; Chiang, E; Liu, YX; Tonelli, M; Verdoorn, KM; Gugel, SR; Suen, G; Carey, HV; Assadi-Porter, FM				Regan, Matthew D.; Chiang, Edna; Liu, Yunxi; Tonelli, Marco; Verdoorn, Kristen M.; Gugel, Sadie R.; Suen, Garret; Carey, Hannah, V; Assadi-Porter, Fariba M.			Nitrogen recycling via gut symbionts increases in ground squirrels over the hibernation season	SCIENCE			English	Article							WATER SUPPRESSION; UREA TRANSPORTER; SKELETAL-MUSCLE; READ ALIGNMENT; UT-B; METABOLISM; NMR; MICROBIOTA; PROTEIN	Hibernation is a mammalian strategy that uses metabolic plasticity to reduce energy demands and enable long-term fasting. Fasting mitigates winter food scarcity but eliminates dietary nitrogen, jeopardizing body protein balance. Here, we reveal gut microbiome-mediated urea nitrogen recycling in hibernating thirteen-lined ground squirrels (Ictidomys tridecemlineatus). Ureolytic gut microbes incorporate urea nitrogen into metabolites that are absorbed by the host, with the nitrogen reincorporated into the squirrel's protein pool. Urea nitrogen recycling is greatest after prolonged fasting in late winter, when urea transporter abundance in gut tissue and urease gene abundance in the microbiome are highest. These results reveal a functional role for the gut microbiome during hibernation and suggest mechanisms by which urea nitrogen recycling may contribute to protein balance in other monogastric animals.	[Regan, Matthew D.; Verdoorn, Kristen M.; Gugel, Sadie R.; Carey, Hannah, V; Assadi-Porter, Fariba M.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Chiang, Edna; Suen, Garret] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Chiang, Edna] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI 53706 USA; [Liu, Yunxi; Assadi-Porter, Fariba M.] Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA; [Tonelli, Marco] Univ Wisconsin, Natl Magnet Resonance Facil Madison NMRFAM, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carey, HV; Assadi-Porter, FM (corresponding author), Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.; Assadi-Porter, FM (corresponding author), Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA.	hannah.carey@wisc.edu; fariba@nmrfam.wisc.edu		Suen, Garret/0000-0002-6170-711X; Tonelli, Marco/0000-0002-7700-5745; Carey, Hannah/0000-0002-8173-0421; Assadi-Porter, Fariba/0000-0002-1761-6608	NSF [IOS-1558044, DGE-1747503]; NIH [P41GM136463, P41GM103399, P41RR002301]; National Institute of General Medical Sciences of the NIH [T32GM008349]; NSERC Canada Postdoctoral Fellowship	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSERC Canada Postdoctoral Fellowship	Work was supported by NSF Grant IOS-1558044 to H.V. C., F. M.A.-P., and G. S.; NIH Grants P41GM136463, P41GM103399 (NIGMS), and P41RR002301 to the National Magnetic Resonance Facility at Madison; National Institute of General Medical Sciences of the NIH traineeship T32GM008349 and NSF Graduate Research Fellowship DGE-1747503 to E.C.; NSERC Canada Postdoctoral Fellowship to M. D.R.	Adams RW, 2013, CHEM COMMUN, V49, P358, DOI 10.1039/c2cc37579f; Andrews S., 2010, FASTQC QUALITY CONTR; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carey HV, 2013, AM J PHYSIOL-REG I, V304, pR33, DOI 10.1152/ajpregu.00387.2012; Chen YX, 2020, AM J PHYSIOL-GASTR L, V318, pG189, DOI 10.1152/ajpgi.00277.2019; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Epperson LE, 2011, PHYSIOL GENOMICS, V43, P799, DOI 10.1152/physiolgenomics.00028.2011; Epperson LE, 2010, AM J PHYSIOL-REG I, V298, pR329, DOI 10.1152/ajpregu.00416.2009; FAO-Food and Agriculture Organization of the United Nations, 2014, STATE FOOD INSECURIT; FU RQ, 1995, CHEM PHYS LETT, V245, P415, DOI 10.1016/0009-2614(95)01037-A; Gao YF, 2012, COMP BIOCHEM PHYS A, V161, P296, DOI 10.1016/j.cbpa.2011.11.009; Harlow Hank, 2012, P277; Haviland JA, 2012, METABOLISM, V61, P1162, DOI 10.1016/j.metabol.2011.12.010; Hindle AG, 2015, J EXP BIOL, V218, P276, DOI 10.1242/jeb.109512; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inoue H, 2005, AM J PHYSIOL-RENAL, V289, pF451, DOI 10.1152/ajprenal.00376.2004; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kupce E, 1996, J MAGN RESON SER A, V122, P81, DOI 10.1006/jmra.1996.0180; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LANGRAN M, 1992, CLIN SCI, V82, P191, DOI 10.1042/cs0820191; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu ZY, 2015, AM J PHYSIOL-REG I, V308, pR283, DOI 10.1152/ajpregu.00323.2014; Marty E, 2017, BONE, V105, P276, DOI 10.1016/j.bone.2017.09.008; Mikheenko A, 2016, BIOINFORMATICS, V32, P1088, DOI 10.1093/bioinformatics/btv697; MOUSA HM, 1983, COMP BIOCHEM PHYS A, V74, P715, DOI 10.1016/0300-9629(83)90574-1; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Patra AK, 2018, J ADV RES, V13, P39, DOI 10.1016/j.jare.2018.02.005; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Regan MI, 2019, AM J PHYSIOL-REG I, V316, pR764, DOI 10.1152/ajpregu.00379.2018; Remesy C, 1997, AM J PHYSIOL-GASTR L, V272, pG257, DOI 10.1152/ajpgi.1997.272.2.G257; Rice SA, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00312-4; RIEDESEL ML, 1980, FED PROC, V39, P2959; Rodrigues RR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02306; Rongstad O. J., 1965, Journal of Mammalogy, V46, P76, DOI 10.2307/1377818; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; SILVER MS, 1984, J MAGN RESON, V59, P347, DOI 10.1016/0022-2364(84)90181-1; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Smith MA, 2001, J MAGN RESON, V151, P269, DOI 10.1006/jmre.2001.2364; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Stevenson TJ, 2014, APPL ENVIRON MICROB, V80, P5611, DOI 10.1128/AEM.01537-14; Walpole ME, 2015, J DAIRY SCI, V98, P1204, DOI 10.3168/jds.2014-8757; Wiebler JM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0241	49	7	8	12	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					460	+		10.1126/science.abh2950	http://dx.doi.org/10.1126/science.abh2950			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084962	Green Accepted			2022-12-28	WOS:000750899500042
J	Lieu, TA; Wojtowicz, A; Stratton, K				Lieu, Tracy A.; Wojtowicz, Alexis; Stratton, Kathleen			Closing Evidence Gaps in Clinical Prevention A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lieu, Tracy A.] Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA; [Wojtowicz, Alexis; Stratton, Kathleen] Natl Acad Sci Engn & Med, Board Populat Hlth, Hlth & Med Div, Washington, DC USA	Kaiser Permanente; National Academies of Sciences, Engineering & Medicine	Lieu, TA (corresponding author), Kaiser Permanente Northern Calif, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	tracy.lieu@kp.org			AHRQand NIH [HHSN263201800029I/75N98020F00005]	AHRQand NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was sponsored by AHRQand NIH (contract/task order HHSN263201800029I/75N98020F00005).	[Anonymous], 2021, CLOSING EVIDENCE GAP; Bierman A, CLOSING EVIDENCE GAP; Klabunde CN, 2022, AM J PREV MED, V62, pE77, DOI 10.1016/j.amepre.2021.07.014; Murray, CLOSING EVIDENCE GAP; Murray DM, 2021, AM J PREV MED, V60, pE260, DOI 10.1016/j.amepre.2021.01.006; USPSTF, 2018, GRAD DEF; Villani J, 2018, JAMA-J AM MED ASSOC, V319, P2132, DOI 10.1001/jama.2018.5404	7	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2022	327	9					815	816		10.1001/jama.2022.0849	http://dx.doi.org/10.1001/jama.2022.0849		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZO9OI	35085389				2022-12-28	WOS:000747991300002
J	Ichiki, T; Wang, TT; Kennedy, A; Pool, AH; Ebisu, H; Anderson, DJ; Oka, Y				Ichiki, Takako; Wang, Tongtong; Kennedy, Ann; Pool, Allan-Hermann; Ebisu, Haruka; Anderson, David J.; Oka, Yuki			Sensory representation and detection mechanisms of gut osmolality change	NATURE			English	Article							SUBDIAPHRAGMATIC VAGOTOMY; UNDERLYING THIRST; VAGUS NERVE; NEURONS; WATER; APPETITE; BRAIN; RECEPTOR; RELEASE; FOOD	Ingested food and water stimulate sensory systems in the oropharyngeal and gastrointestinal areas before absorption(1,2). These sensory signals modulate brain appetite circuits in a feed-forward manner(3-5). Emerging evidence suggests that osmolality sensing in the gut rapidly inhibits thirst neurons upon water intake. Nevertheless, it remains unclear how peripheral sensory neurons detect visceral osmolality changes, and how they modulate thirst. Here we use optical and electrical recording combined with genetic approaches to visualize osmolality responses from sensory ganglion neurons. Gut hypotonic stimuli activate a dedicated vagal population distinct from mechanical-, hypertonic- or nutrient-sensitive neurons. We demonstrate that hypotonic responses are mediated by vagal afferents innervating the hepatic portal area (HPA), through which most water and nutrients are absorbed. Eliminating sensory inputs from this area selectively abolished hypotonic but not mechanical responses in vagal neurons. Recording from fore brain thirst neurons and behavioural analyses show that HPA-derived osmolality signals are required for feed-forward thirst satiation and drinking termination. Notably, HPA-innervating vagal afferents do not sense osmolality itself. Instead, these responses are mediated partly by vasoactive intestinal peptide secreted after water ingestion. Together, our results reveal visceral hypoosmolality as an important vagal sensory modality, and that intestinal osmolality change is translated into hormonal signals to regulate thirst circuit activity through the HPA pathway.	[Ichiki, Takako; Wang, Tongtong; Kennedy, Ann; Pool, Allan-Hermann; Ebisu, Haruka; Anderson, David J.; Oka, Yuki] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kennedy, Ann] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Northwestern University; California Institute of Technology; Howard Hughes Medical Institute	Oka, Y (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	yoka@caltech.edu		Wang, Tongtong/0000-0002-0408-2571; Anderson, David J./0000-0001-6175-3872	Startup funds from the President and Provost of California Institute of Technology; New York Stem Cell Foundation; NIH [R01NS109997, R01NS123918]; Alfred P. Sloan Foundation; Heritage Medical Research Institute; Japan Society for the Promotion of Science	Startup funds from the President and Provost of California Institute of Technology; New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Heritage Medical Research Institute; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the members of the Oka laboratory, S. D. Liberles and C. S. Zuker for helpful discussion and comments; B. Ho and A. Koranne for maintaining and genotyping mouse lines; T. Zhang, W. Han and I. E. Araujo for technical advice on surgical techniques; L. Luebbert for initial imaging analysis; T. Karigo for technical help; X. Chen and V. Gradinaru for advice on virus development and tissue clearing; and J. Parker for sharing the qPCR machine. This work was supported by Startup funds from the President and Provost of California Institute of Technology and the Biology and Biological Engineering Division of California Institute of Technology. Y.O. is also supported by New York Stem Cell Foundation, NIH (R01NS109997, R01NS123918), Alfred P. Sloan Foundation, and Heritage Medical Research Institute. T.I. is supported by the Japan Society for the Promotion of Science.	ADACHI A, 1976, AM J PHYSIOL, V231, P1043, DOI 10.1152/ajplegacy.1976.231.4.1043; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Augustine V, 2020, CELL, V180, P25, DOI 10.1016/j.cell.2019.11.040; Augustine V, 2019, NEURON, V103, P242, DOI 10.1016/j.neuron.2019.04.039; Augustine V, 2018, TRENDS NEUROSCI, V41, P526, DOI 10.1016/j.tins.2018.05.003; Augustine V, 2018, NATURE, V555, P204, DOI 10.1038/nature25488; BAERTSCHI AJ, 1981, J PHYSIOL-LONDON, V315, P217, DOI 10.1113/jphysiol.1981.sp013743; Bai L, 2019, CELL, V179, P1129, DOI 10.1016/j.cell.2019.10.031; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Browning KN, 2017, GASTROENTEROLOGY, V152, P730, DOI 10.1053/j.gastro.2016.10.046; CHRISTOFIDES ND, 1979, EXPERIENTIA, V35, P1521, DOI 10.1007/BF01962823; COSTA M, 1983, NEUROSCIENCE, V8, P665, DOI 10.1016/0306-4522(83)90002-7; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Giovannucci A, 2019, ELIFE, V8, DOI 10.7554/eLife.38173; Gribble FM, 2019, NAT REV ENDOCRINOL, V15, P226, DOI 10.1038/s41574-019-0168-8; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Han WF, 2018, CELL, V175, P665, DOI [10.1016/j.cell.2018.08.049, 10.1016/j.cell.2018.10.018]; Ichiki T, 2019, CURR OPIN NEUROBIOL, V57, P134, DOI 10.1016/j.conb.2019.01.014; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Kennedy A, 2020, NATURE, V586, P730, DOI 10.1038/s41586-020-2728-4; Kim DY, 2020, NATURE, V580, P376, DOI 10.1038/s41586-020-2167-2; Kim KS, 2018, NAT REV NEUROSCI, V19, P185, DOI 10.1038/nrn.2018.8; Kupari J, 2019, CELL REP, V27, P2508, DOI 10.1016/j.celrep.2019.04.096; L'Heureux-Bouron D, 2003, J NUTR, V133, P2639, DOI 10.1093/jn/133.8.2639; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Lee S, 2019, NATURE, V568, P93, DOI 10.1038/s41586-019-1053-2; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Lowell BB, 2019, NEW ENGL J MED, V380, P459, DOI 10.1056/NEJMra1812053; McHugh J, 2010, HYPERTENSION, V55, P1438, DOI 10.1161/HYPERTENSIONAHA.110.151860; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Morita H, 1999, NEUROSCI LETT, V264, P65, DOI 10.1016/S0304-3940(99)00157-3; NIIJIMA A, 1982, J PHYSIOL-LONDON, V332, P315, DOI 10.1113/jphysiol.1982.sp014415; Prescott SL, 2020, CELL, V181, P574, DOI 10.1016/j.cell.2020.03.004; SMITH GP, 1983, J AUTONOM NERV SYST, V9, P259, DOI 10.1016/0165-1838(83)90146-7; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Tan HE, 2020, NATURE, V580, P511, DOI 10.1038/s41586-020-2199-7; THRASHER TN, 1981, AM J PHYSIOL, V240, pE394, DOI 10.1152/ajpendo.1981.240.4.E394; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Xie CC, 2014, JOVE-J VIS EXP, DOI 10.3791/51955; ZIMMER LJ, 1976, PHYSIOL BEHAV, V16, P665, DOI 10.1016/0031-9384(76)90233-X; Zimmerman CA, 2020, CURR OPIN NEUROBIOL, V64, P79, DOI 10.1016/j.conb.2020.03.007; Zimmerman CA, 2019, NATURE, V568, P98, DOI 10.1038/s41586-019-1066-x; Zimmerman CA, 2017, NAT REV NEUROSCI, V18, P459, DOI 10.1038/nrn.2017.71; Zocchi D, 2017, NAT NEUROSCI, V20, P927, DOI 10.1038/nn.4575	44	7	7	8	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2022	602	7897					468	+		10.1038/s41586-021-04359-5	http://dx.doi.org/10.1038/s41586-021-04359-5		JAN 2022	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZB5PA	35082448				2022-12-28	WOS:000750881700002
J	Hicks, SR; O'Dempsey, T; Khoyratty, F; Gupta, A; Stockdale, A; Beadsworth, M; Jones, J; Slack, I				Hicks, Scott Rory; O'Dempsey, Tim; Khoyratty, Fadil; Gupta, Abha; Stockdale, Alexander; Beadsworth, Michael; Jones, Jayne; Slack, Iain			Cause of hypereosinophilia shows itself after 6 years: Loa loa	LANCET			English	Editorial Material									[Hicks, Scott Rory; Beadsworth, Michael] Royal Liverpool Hosp, Trop & Infect Dis Unit, Liverpool, Merseyside, England; [Hicks, Scott Rory; Beadsworth, Michael] Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England; [O'Dempsey, Tim] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Khoyratty, Fadil; Gupta, Abha] Manchester Royal Eye Hosp, Dept Ophthalmol, Manchester, Lancs, England; [Stockdale, Alexander] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England; [Jones, Jayne; Slack, Iain] Univ Liverpool Liverpool Sch Trop Med, Clin Diagnost Parasitol Lab, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Liverpool School of Tropical Medicine; Manchester Royal Eye Hospital; University of Liverpool; Liverpool School of Tropical Medicine	Hicks, SR (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Trust, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England.	scott.hicks@uhnm.nhs.uk	Stockdale, Alexander/ADU-6666-2022						0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					E2	E2						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093232				2022-12-28	WOS:000755141600001
J	Wolter, N; Jassat, W; Walaza, S; Welch, R; Moultrie, H; Groome, M; Amoako, DG; Everatt, J; Bhiman, JN; Scheepers, C; Tebeila, N; Chiwandire, N; du Plessis, M; Govender, N; Ismail, A; Glass, A; Mlisana, K; Stevens, W; Treurnicht, FK; Makatini, Z; Hsiao, NY; Parboosing, R; Wadula, J; Hussey, H; Davies, MA; Boulle, A; von Gottberg, A; Cohen, C				Wolter, Nicole; Jassat, Waasila; Walaza, Sibongile; Welch, Richard; Moultrie, Harry; Groome, Michelle; Amoako, Daniel Gyamfi; Everatt, Josie; Bhiman, Jinal N.; Scheepers, Cathrine; Tebeila, Naume; Chiwandire, Nicola; du Plessis, Mignon; Govender, Nevashan; Ismail, Arshad; Glass, Allison; Mlisana, Koleka; Stevens, Wendy; Treurnicht, Florette K.; Makatini, Zinhle; Hsiao, Nei-Yuan; Parboosing, Raveen; Wadula, Jeannette; Hussey, Hannah; Davies, Mary-Ann; Boulle, Andrew; von Gottberg, Anne; Cohen, Cheryl			Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study	LANCET			English	Article								Background The SARS-CoV-2 omicron variant of concern was identified in South Africa in November, 2021, and was associated with an increase in COVID-19 cases. We aimed to assess the clinical severity of infections with the omicron variant using S gene target failure (SGTF) on the Thermo Fisher Scientific TaqPath COVID-19 PCR test as a proxy. Methods We did data linkages for national, South African COVID-19 case data, SARS-CoV-2 laboratory test data, SARS-CoV-2 genome data, and COVID-19 hospital admissions data. For individuals diagnosed with COVID-19 via TaqPath PCR tests, infections were designated as either SGTF or non-SGTF. The delta variant was identified by genome sequencing. Using multivariable logistic regression models, we assessed disease severity and hospitalisations by comparing individuals with SGTF versus non-SGTF infections diagnosed between Oct 1 and Nov 30, 2021, and we further assessed disease severity by comparing SGTF-infected individuals diagnosed between Oct 1 and Nov 30, 2021, with delta variant-infected individuals diagnosed between April 1 and Nov 9, 2021. Findings From Oct 1 (week 39), 2021, to Dec 6 (week 49), 2021, 161 328 cases of COVID-19 were reported in South Africa. 38 282 people were diagnosed via TaqPath PCR tests and 29 721 SGTF infections and 1412 non-SGTF infections were identified. The proportion of SGTF infections increased from two (3.2%) of 63 in week 39 to 21 978 (97.9%) of 22 455 in week 48. After controlling for factors associated with hospitalisation, individuals with SGTF infections had significantly lower odds of admission than did those with non-SGTF infections (256 [2.4%] of 10 547 vs 121 [ 12. 8%] of 948; adjusted odds ratio [aOR] 0.2, 95% CI 0.1-0.3). After controlling for factors associated with disease severity, the odds of severe disease were similar between hospitalised individuals with SGTF versus non-SGTF infections (42 [21%] of 204 vs 45 [40%] of 113; aOR 0.7, 95% CI 0.3-1.4). Compared with individuals with earlier delta variant infections, SGTF-infected individuals had a significantly lower odds of severe disease (496 [62.5%] of 793 vs 57 [23.4%] of 244; aOR 0.3, 95% CI 0.2-0.5), after controlling for factors associated with disease severity. Interpretation Our early analyses suggest a significantly reduced odds of hospitalisation among individuals with SGTF versus non-SGTF infections diagnosed during the same time period. SGTF-infected individuals had a significantly reduced odds of severe disease compared with individuals infected earlier with the delta variant. Some of this reduced severity is probably a result of previous immunity.	[Wolter, Nicole; Walaza, Sibongile; Amoako, Daniel Gyamfi; Everatt, Josie; Tebeila, Naume; Chiwandire, Nicola; du Plessis, Mignon; von Gottberg, Anne; Cohen, Cheryl] Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Jassat, Waasila; Welch, Richard; Groome, Michelle; Govender, Nevashan] Natl Inst Communicable Dis Natl Hlth Lab Serv, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Moultrie, Harry] Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr TB, Johannesburg, South Africa; [Bhiman, Jinal N.; Scheepers, Cathrine] Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr HIV & STIs, Johannesburg, South Africa; [Ismail, Arshad] Natl Inst Communicable Dis Natl Hlth Lab Serv, Sequencing Core Facil, Johannesburg, South Africa; [Wolter, Nicole; Moultrie, Harry; du Plessis, Mignon; Stevens, Wendy; Treurnicht, Florette K.; Makatini, Zinhle; Parboosing, Raveen; von Gottberg, Anne] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Walaza, Sibongile; Cohen, Cheryl] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Bhiman, Jinal N.; Scheepers, Cathrine] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, SA MRC Antibody Immun Res Unit, Johannesburg, South Africa; [Amoako, Daniel Gyamfi] Univ KwaZulu Natal, Coll Hlth Sci, Sch Hlth Sci, Durban, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Parboosing, Raveen] Univ KwaZulu Natal, Dept Virol, Durban, South Africa; [Glass, Allison] Lancet Labs, Johannesburg, South Africa; [Mlisana, Koleka; Stevens, Wendy; Treurnicht, Florette K.; Makatini, Zinhle; Hsiao, Nei-Yuan; Parboosing, Raveen; Wadula, Jeannette] Natl Hlth Lab Serv, Johannesburg, South Africa; [Hsiao, Nei-Yuan] Univ Cape Town, Div Med Virol, Cape Town, South Africa; [Hussey, Hannah; Davies, Mary-Ann; Boulle, Andrew] Univ Cape Town, Western Cape Govt Hlth, Cape Town, South Africa; [Wadula, Jeannette] CH Baragwanath Acad Hosp, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; National Health Laboratory Service; University of Cape Town; University of Cape Town	Wolter, N; Cohen, C (corresponding author), Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa.	nicolew@nicd.ac.za; cherylc@nicd.ac.za	Groome, Michelle Jennifer/AAI-9967-2021; Scheepers, Cathrine/ABC-9229-2021; Ismail, Arshad/B-8552-2019; Moultrie, Harry/AFV-0903-2022; Jassat, Waasila/GZM-9860-2022	Groome, Michelle Jennifer/0000-0001-5893-3725; Ismail, Arshad/0000-0003-4672-5915; Moultrie, Harry/0000-0001-9722-0699; Parboosing, Raveen/0000-0002-5476-1011; Jassat, Waasila/0000-0003-4279-3056; von Gottberg, Anne/0000-0002-0243-7455; Welch, Richard/0000-0001-8298-8697	South African Medical Research Council; South African National Department of Health; US Centers for Disease Control and Prevention; African Society of Laboratory Medicine; Africa Centers for Disease Control and Prevention; Bill & Melinda Gates Foundation; Wellcome Trust; Fleming Fund	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Department of Health; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); African Society of Laboratory Medicine; Africa Centers for Disease Control and Prevention; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Fleming Fund	The South African Medical Research Council, the South African National Department of Health, US Centers for Disease Control and Prevention, the African Society of Laboratory Medicine, Africa Centers for Disease Control and Prevention, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the Fleming Fund.	Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P2487, DOI 10.1056/NEJMc2108120; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; HKUMed, 2021, HKUMED FINDS OM SARS; Jassat W, 2021, LANCET HIV, V8, pE554, DOI 10.1016/S2352-3018(21)00151-X; Kleynhans J, 2021, EMERG INFECT DIS, V27, P3020, DOI 10.3201/eid2712.211465; Madhi S., 2021, S AFRICAN POPULATION, DOI [10.1101/2021.12.20.21268096, DOI 10.1101/2021.12.20.21268096]; Meng B., 2021, BIORXIV, V12, DOI [10.1101/2021.12.17.473248, DOI 10.1101/2021.12.17.473248]; National Department of Health, LAT VACC STAT; National Institute for Communicable Diseases, 2021, COVID 19 WORKF SURV; National Institute for Communicable Diseases, 2021, NETW GEN SURV S AFR; National Institute for Communicable Diseases, 2021, COMMUN DIS COMMUN, V20, P11; National Institute for Communicable Diseases, 2021, EST SURV PLATF ASS C; National Institute for Communicable Diseases, 2021, WEEKL HOSP SURV DATC; Public Health England, INV NOV SARS COV 2 V; Pulliam JRC., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068:2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068:2021.11.11.21266068]; Scheepers C., 2021, CONTINUOUS EVOLUTION, DOI [10.1101/2021.08.20.21262342, DOI 10.1101/2021.08.20.21262342]; Scott L, 2021, SCIENCE, V374, P1454, DOI 10.1126/science.abn4543; South African COVID-19 Modelling Consortium, 2021, COVID 19 MOD UPD CON; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; WHO, 2021, CLASSIFICATION OMICR	20	292	300	45	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					437	446		10.1016/S0140-6736(22)00017-4	http://dx.doi.org/10.1016/S0140-6736(22)00017-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9YU	35065011	Green Published			2022-12-28	WOS:000755141600024
J	Shah, SJ; Borlaug, BA; Chung, ES; Cutlip, DE; Debonnaire, P; Fail, PS; Gao, Q; Hasenfuss, G; Kahwash, R; Kaye, DM; Litwin, SE; Lurz, P; Massaro, JM; Mohan, RC; Ricciardi, MJ; Solomon, SD; Sverdlov, AL; Swarup, V; van Veldhuisen, DJ; Winkler, S; Leon, MB				Shah, Sanjiv J.; Borlaug, Barry A.; Chung, Eugene S.; Cutlip, Donald E.; Debonnaire, Philippe; Fail, Peter S.; Gao, Qi; Hasenfuss, Gerd; Kahwash, Rami; Kaye, David M.; Litwin, Sheldon E.; Lurz, Philipp; Massaro, Joseph M.; Mohan, Rajeev C.; Ricciardi, Mark J.; Solomon, Scott D.; Sverdlov, Aaron L.; Swarup, Vijendra; van Veldhuisen, Dirk J.; Winkler, Sebastian; Leon, Martin B.		REDUCE LAP-HF II Investigators	Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial	LANCET			English	Article							CITY CARDIOMYOPATHY QUESTIONNAIRE; PRECISION MEDICINE; CLINICAL-TRIALS; ASSOCIATION; PRESSURE	Background Placement of an interatrial shunt device reduces pulmonary capillary wedge pressure during exercise in patients with heart failure and preserved or mildly reduced ejection fraction. We aimed to investigate whether an interatrial shunt can reduce heart failure events or improve health status in these patients. Methods In this randomised, international, blinded, sham-controlled trial performed at 89 health-care centres, we included patients (aged >= 40 years) with symptomatic heart failure, an ejection fraction of at least 40%, and pulmonary capillary wedge pressure during exercise of at least 25 mm Hg while exceeding right atrial pressure by at least 5 mm Hg. Patients were randomly assigned (1:1) to receive either a shunt device or sham procedure. Patients and outcome assessors were masked to randomisation. The primary endpoint was a hierarchical composite of cardiovascular death or non-fatal ischemic stroke at 12 months, rate of total heart failure events up to 24 months, and change in Kansas City Cardiomyopathy Questionnaire overall summary score at 12 months. Pre-specified subgroup analyses were conducted for the heart failure event endpoint. Analysis of the primary endpoint, all other efficacy endpoints, and safety endpoints was conducted in the modified intention-to-treat population, defined as all patients randomly allocated to receive treatment, excluding those found to be ineligible after randomisation and therefore not treated. This study is registered with ClinicalTrials.gov, NCT03088033. Findings Between May 25, 2017, and July 24, 2020, 1072 participants were enrolled, of whom 626 were randomly assigned to either the atrial shunt device (n=314) or sham procedure (n=312). There were no differences between groups in the primary composite endpoint (win ratio 1.0 [95% CI 0.8-1.2]; p=0.85) or in the individual components of the primary endpoint. The prespecified subgroups demonstrating a differential effect of atrial shunt device treatment on heart failure events were pulmonary artery systolic pressure at 20W of exercise (p(interaction)=0.002 [>70 mm Hg associated with worse outcomes]), right atrial volume index (p(interaction)=0.012 [>= 29.7 mL/m(2), worse outcomes]), and sex (p(interaction=)0.02 [men, worse outcomes]). There were no differences in the composite safety endpoint between the two groups (n=116 [38%] for shunt device vs n=97 [31%] for sham procedure; p=0.11). Interpretation Placement of an atrial shunt device did not reduce the total rate of heart failure events or improve health status in the overall population of patients with heart failure and ejection fraction of greater than or equal to 40%. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Shah, Sanjiv J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Borlaug, Barry A.] Mayo Clin, Rochester, MN USA; [Chung, Eugene S.] Christ Hosp, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Cutlip, Donald E.; Gao, Qi] Baim Clin Res Inst, Boston, MA USA; [Debonnaire, Philippe] AZ Sint Jan Brugge Oostende, Brugge, Belgium; [Fail, Peter S.] Cardiovasc Inst South, Houma, LA USA; [Hasenfuss, Gerd] Univ Med Ctr, Ctr Heart, Gottingen, Germany; [Kahwash, Rami] Ohio State Univ, Columbus, OH 43210 USA; [Kaye, David M.] Alfred Hosp, Melbourne, Vic, Australia; [Litwin, Sheldon E.] Med Univ South Carolina, Charleston, SC 29425 USA; [Litwin, Sheldon E.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA; [Lurz, Philipp] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany; [Massaro, Joseph M.] Boston Univ, Boston, MA 02215 USA; [Mohan, Rajeev C.] Scripps Hlth, La Jolla, CA USA; [Ricciardi, Mark J.] Northshore Univ Hlth Syst, Evanston, IL USA; [Solomon, Scott D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Sverdlov, Aaron L.] Univ Newcastle, John Hunter Hosp, New Lambton Hts, NSW, Australia; [Swarup, Vijendra] Arizona Heart & Rhythm Ctr, Phoenix, AZ USA; [van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Winkler, Sebastian] BG Klinikum Unfallkrankenhaus, Berlin, Germany; [Leon, Martin B.] Cardiovasc Res Fdn, New York, NY USA	Northwestern University; Feinberg School of Medicine; Mayo Clinic; Christ Hospital - Ohio; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University System of Ohio; Ohio State University; Florey Institute of Neuroscience & Mental Health; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Heart Center Leipzig GMBH; Leipzig University; Boston University; NorthShore University Health System; Harvard University; Brigham & Women's Hospital; John Hunter Hospital; University of Newcastle; University of Groningen; Cardiovascular Research Foundation (CRF)	Shah, SJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA.	sanjiv.shah@northwestern.edu	Zirlik, Andreas/A-6400-2011	Zirlik, Andreas/0000-0001-6290-3297; Nair, Ajith/0000-0002-3755-4985; Sakata, Yasushi/0000-0002-5618-4721; Winkler, Sebastian/0000-0002-0926-311X; Petrie, Mark/0000-0002-6333-9496	Corvia Medical	Corvia Medical	The study was funded by Corvia Medical. We thank the study participants; the study coordinators at each of the sites (listed in the appendix pp 19-21); Laura Mauri, former chair of the steering committee for the trial; Ted Feldman, former co-principal investigator for the trial; members of the Clinical Events Committee (Akshay Desai, David Gossman, Pablo Quintero, and David Thaler); and members of the Data Safety Monitoring Board (Paul Hauptman [chair], Jeffrey Feinstein, John Orav, Margaret Redfield, and Michael Rinaldi).	Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038; Anker SD, 2020, EUR HEART J, V41, P2109, DOI 10.1093/eurheartj/ehaa461; Berry N, 2020, AM HEART J, V226, P222, DOI 10.1016/j.ahj.2019.10.015; Borlaug BA, 2016, EUR HEART J, V37, P3294, DOI 10.1093/eurheartj/ehw241; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Cox ZL, 2020, EUR J HEART FAIL, V22, P1045, DOI 10.1002/ejhf.1921; Del Trigo M, 2016, LANCET, V387, P1290, DOI 10.1016/S0140-6736(16)00585-7; Emani S, 2021, TRENDS CARDIOVAS MED, V31, P427, DOI 10.1016/j.tcm.2020.09.004; Feldman T, 2018, CIRCULATION, V137, P364, DOI 10.1161/CIRCULATIONAHA.117.032094; Feldman T, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003025; Finkelstein DM, 1999, STAT MED, V18, P1341, DOI 10.1002/(SICI)1097-0258(19990615)18:11&lt;1341::AID-SIM129&gt;3.0.CO;2-7; Fudim M, 2021, J AM COLL CARDIOL, V78, P931, DOI 10.1016/j.jacc.2021.06.040; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hasenfuss G, 2016, LANCET, V387, P1298, DOI 10.1016/S0140-6736(16)00704-2; Hasenfuss G, 2015, J CARD FAIL, V21, P594, DOI 10.1016/j.cardfail.2015.05.008; Kaye DM, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003662; Lutembacher R., 1916, ARCH MAL COEUR VAISS, V9, P237; Nassif ME, 2021, NAT MED, V27, P1954, DOI 10.1038/s41591-021-01536-x; Obokata M, 2019, EUR HEART J, V40, P689, DOI 10.1093/eurheartj/ehy809; Pocock SJ, 2013, EUR HEART J, V34, P1404, DOI 10.1093/eurheartj/ehs337; Pocock SJ, 2012, EUR HEART J, V33, P176, DOI 10.1093/eurheartj/ehr352; Pokharel Y, 2017, JAMA CARDIOL, V2, P1315, DOI 10.1001/jamacardio.2017.3983; Savarese G, 2022, NAT REV CARDIOL, V19, P100, DOI 10.1038/s41569-021-00605-5; Shah SJ, 2020, CIRCULATION, V141, P1001, DOI 10.1161/CIRCULATIONAHA.119.041886; Shah SJ, 2018, JAMA CARDIOL, V3, P968, DOI 10.1001/jamacardio.2018.2936; Shah SJ, 2017, J CARDIOVASC TRANSL, V10, P322, DOI 10.1007/s12265-017-9759-8; Shah SJ, 2017, J CARDIOVASC TRANSL, V10, P233, DOI 10.1007/s12265-017-9756-y; Shah SJ, 2016, CIRCULATION, V134, P73, DOI 10.1161/CIRCULATIONAHA.116.021884; Singh I, 2019, PULM CIRC, V9, DOI 10.1177/2045894019862435; Solomon SD, 2019, NEW ENGL J MED, V381, P1609, DOI 10.1056/NEJMoa1908655	30	30	28	7	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1130	1140		10.1016/S0140-6736(22)00016-2	http://dx.doi.org/10.1016/S0140-6736(22)00016-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZV8ZO	35120593	Green Published			2022-12-28	WOS:000770814300021
J	Yoshimura, S; Sakai, N; Yamagami, H; Uchida, K; Beppu, M; Toyoda, K; Matsumaru, Y; Matsumoto, Y; Kimura, K; Takeuchi, M; Yazawa, Y; Kimura, N; Shigeta, K; Imamura, H; Suzuki, I; Enomoto, Y; Tokunaga, S; Morita, K; Sakakibara, F; Kinjo, N; Saito, T; Ishikura, R; Inoue, M; Morimoto, T				Yoshimura, S.; Sakai, N.; Yamagami, H.; Uchida, K.; Beppu, M.; Toyoda, K.; Matsumaru, Y.; Matsumoto, Y.; Kimura, K.; Takeuchi, M.; Yazawa, Y.; Kimura, N.; Shigeta, K.; Imamura, H.; Suzuki, I; Enomoto, Y.; Tokunaga, S.; Morita, K.; Sakakibara, F.; Kinjo, N.; Saito, T.; Ishikura, R.; Inoue, M.; Morimoto, T.			Endovascular Therapy for Acute Stroke with a Large Ischemic Region	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MECHANICAL THROMBECTOMY; PLASMINOGEN-ACTIVATOR; INTRAVENOUS ALTEPLASE; JAPAN; GUIDELINES; THROMBOLYSIS; METAANALYSIS; RELIABILITY; MANAGEMENT; EDITION	BACKGROUND Endovascular therapy for acute ischemic stroke is generally avoided when the infarction is large, but the effect of endovascular therapy with medical care as compared with medical care alone for large strokes has not been well studied. METHODS We conducted a multicenter, open-label, randomized clinical trial in Japan involving patients with occlusion of large cerebral vessels and sizable strokes on imaging, as indicated by an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) value of 3 to 5 (on a scale from 0 to 10, with lower values indicating larger infarction). Patients were randomly assigned in a 1:1 ratio to receive endovascular therapy with medical care or medical care alone within 6 hours after they were last known to be well or within 24 hours if there was no early change on fluid-attenuated inversion recovery images. Alteplase (0.6 mg per kilogram of body weight) was used when appropriate in both groups. The primary outcome was a modified Rankin scale score of 0 to 3 (on a scale from 0 to 6, with higher scores indicating greater disability) at 90 days. Secondary outcomes included a shift across the range of modified Rankin scale scores toward a better outcome at 90 days and an improvement of at least 8 points in the National Institutes of Health Stroke Scale (NIHSS) score (range, 0 to 42, with higher scores indicating greater deficit) at 48 hours. RESULTS A total of 203 patients underwent randomization; 101 patients were assigned to the endovascular-therapy group and 102 to the medical-care group. Approximately 27% of patients in each group received alteplase. The percentage of patients with a modified Rankin scale score of 0 to 3 at 90 days was 31.0% in the endovascular-therapy group and 12.7% in the medical-care group (relative risk, 2.43; 95% confidence interval [CI], 1.35 to 4.37; P=0.002). The ordinal shift across the range of modified Rankin scale scores generally favored endovascular therapy. An improvement of at least 8 points on the NIHSS score at 48 hours was observed in 31.0% of the patients in the endovascular-therapy group and 8.8% of those in the medical-care group (relative risk, 3.51; 95% CI, 1.76 to 7.00), and any intracranial hemorrhage occurred in 58.0% and 31.4%, respectively (P<0.001). CONCLUSIONS In a trial conducted in Japan, patients with large cerebral infarctions had better functional outcomes with endovascular therapy than with medical care alone but had more intracranial hemorrhages.	[Uchida, K.; Sakakibara, F.; Kinjo, N.; Saito, T.; Morimoto, T.] Hyogo Coll Med, Dept Clin Epidemiol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan; [Yoshimura, S.; Uchida, K.; Beppu, M.; Sakakibara, F.; Kinjo, N.] Hyogo Coll Med, Dept Neurosurg, Nishinomiya, Hyogo, Japan; [Sakai, N.; Imamura, H.] Kobe City Med Ctr, Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Ishikura, R.] Kobe City Med Ctr, Gen Hosp, Dept Diagnost Radiol, Kobe, Hyogo, Japan; [Yamagami, H.] Natl Hosp Org, Dept Stroke Neurol, Osaka Natl Hosp, Osaka, Japan; [Toyoda, K.; Inoue, M.] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Matsumaru, Y.] Univ Tsukuba, Fac Med, Dept Neurosurg, Div Stroke Prevent & Treatment, Ibaraki, Japan; [Matsumoto, Y.] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi, Japan; [Yazawa, Y.; Saito, T.] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi, Japan; [Kimura, K.] Nippon Med Sch, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Takeuchi, M.] Seisho Hosp, Dept Neurosurg, Odawara, Japan; [Kimura, N.] Iwate Prefectural Cent Hosp, Dept Neurosurg, Morioka, Iwate, Japan; [Shigeta, K.] Natl Hosp Org, Dept Neurosurg, Disaster Med Ctr, Tachikawa, Tokyo, Japan; [Suzuki, I] Hachinohe Municipal Hosp, Dept Neuroendovasc Therapy, Hachinohe, Aomori, Japan; [Enomoto, Y.] Gifu Univ Hosp, Dept Neurosurg, Gifu, Japan; [Tokunaga, S.] Natl Hosp Org, Dept Neuroendovasc Therapy, Kyusyu Med Ctr, Fukuoka, Japan; [Morita, K.] Niigata City Gen Hosp, Dept Cerebrovasc Med, Niigata, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Osaka National Hospital; National Cerebral & Cardiovascular Center - Japan; University of Tsukuba; Nippon Medical School; Iwate Prefectural Central Hospital; Gifu University	Morimoto, T (corresponding author), Hyogo Coll Med, Dept Clin Epidemiol, 1-1 Mukogawa, Nishinomiya, Hyogo 6638501, Japan.	t-morimoto@umin.net		Yazawa, Yukako/0000-0003-3891-0221	Mihara Cerebrovascular Disorder Research Promotion Fund; Japanese Society for Neuroendovascular Therapy	Mihara Cerebrovascular Disorder Research Promotion Fund; Japanese Society for Neuroendovascular Therapy	Supported in part by the Mihara Cerebrovascular Disorder Research Promotion Fund and the Japanese Society for Neuroendovascular Therapy.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Albers GW, 2019, STROKE, V50, P3277, DOI 10.1161/STROKEAHA.119.026430; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Cucchiara B, 2009, STROKE, V40, P3067, DOI 10.1161/STROKEAHA.109.554386; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Grotta JC, 2021, NEW ENGL J MED, V385, P971, DOI 10.1056/NEJMoa2103879; Kakita H, 2019, STROKE, V50, P901, DOI 10.1161/STROKEAHA.118.024646; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Mori E, 2010, STROKE, V41, P461, DOI 10.1161/STROKEAHA.109.573477; Nezu T, 2011, STROKE, V42, P2196, DOI 10.1161/STROKEAHA.111.614404; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Rebchuk AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3767; Roman LS, 2018, LANCET NEUROL, V17, P895, DOI 10.1016/S1474-4422(18)30242-4; Sakakibara F, 2020, CEREBROVASC DIS, V49, P292, DOI 10.1159/000508369; Sarraj A, 2020, J NEUROINTERV SURG, V12, P1172, DOI 10.1136/neurintsurg-2019-015509; Toyoda K, 2019, NEUROL MED-CHIR, V59, P449, DOI 10.2176/nmc.st.2019-0177; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Yamagami H, 2021, NEUROL MED-CHIR, V61, P163, DOI [10.2176/nmc.nmc.st.2020-0357, 10.2176/nmc.st.2020-0357]; Yoshimura S., 2021, NEUROL MED CHIR TOKY; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	25	36	37	24	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2022	386	14					1303	1313		10.1056/NEJMoa2118191	http://dx.doi.org/10.1056/NEJMoa2118191		FEB 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1T9JP	35138767	Bronze			2022-12-28	WOS:000753119000001
J	Blair, DJ; Chitti, S; Trobe, M; Kostyra, DM; Haley, HMS; Hansen, RL; Ballmer, SG; Woods, TJ; Wang, W; Mubayi, V; Schmidt, MJ; Pipal, RW; Morehouse, GF; Ray, AMEP; Gray, DL; Gill, AL; Burke, MD				Blair, Daniel J.; Chitti, Sriyankari; Trobe, Melanie; Kostyra, David M.; Haley, Hannah M. S.; Hansen, Richard L.; Ballmer, Steve G.; Woods, Toby J.; Wang, Wesley; Mubayi, Vikram; Schmidt, Michael J.; Pipal, Robert W.; Morehouse, Greg F.; Ray, Andrea M. E. Palazzolo; Gray, Danielle L.; Gill, Adrian L.; Burke, Martin D.			Automated iterative Csp(3)-C bond formation	NATURE			English	Article							CROSS-COUPLING REACTIONS; HYPERCONJUGATION; ESTERS; HOMOLOGATION; COMPLEXES; BENZOATES; REAGENTS; CARBON	Fully automated synthetic chemistry would substantially change the field by providing broad on-demand access to small molecules. However, the reactions that can be run autonomously are still limited. Automating the stereospecific assembly of Csp(3)-C bonds would expand access to many important types of functional organic molecules(1). Previously, methyliminodiacetic acid (MIDA) boronates were used to orchestrate the formation of Csp(2)-Csp(2) bonds and were effective building blocks for automating the synthesis of many small molecules(2), but they are incompatible with stereospecific Csp(3)-Csp(2) and Csp(3)-Csp(3) bond-forming reactions(3-10). Here we report that hyperconjugative and steric tuning provide a new class of tetramethyl N-methyliminodiacetic acid (TIDA) boronates that are stable to these conditions. Charge density analysis(11-13) revealed that redistribution of electron density increases covalency of the N-B bond and thereby attenuates its hydrolysis. Complementary steric shielding of carbonyl pi-faces decreases reactivity towards nucleophilic reagents. The unique features of the iminodiacetic acid cage(2), which are essential for generalized automated synthesis, are retained by TIDA boronates. This enabled Csp(3) boronate building blocks to be assembled using automated synthesis, including the preparation of natural products through automated stereospecific Csp(3)-Csp(2) and Csp(3)-Csp(3) bond formation. These findings will enable increasingly complex Csp(3)-rich small molecules to be accessed via automated assembly.	[Blair, Daniel J.; Chitti, Sriyankari; Trobe, Melanie; Kostyra, David M.; Haley, Hannah M. S.; Wang, Wesley; Mubayi, Vikram; Schmidt, Michael J.; Pipal, Robert W.; Morehouse, Greg F.; Ray, Andrea M. E. Palazzolo; Burke, Martin D.] Univ Illinois, Sch Chem Sci, Roger Adams Lab, Urbana, IL 61801 USA; [Hansen, Richard L.; Ballmer, Steve G.; Gill, Adrian L.] Revolut Med Inc, Dept Chem, Redwood City, CA USA; [Woods, Toby J.; Gray, Danielle L.] Univ Illinois, George L Clark Xray Facil, Urbana, IL USA; [Woods, Toby J.; Gray, Danielle L.] Univ Illinois, 3M Mat Lab, Urbana, IL USA; [Burke, Martin D.] Carle Illinois Coll Med, Urbana, IL 61801 USA; [Burke, Martin D.] Univ Illinois, Arnold & Mabel Beckman Inst, Urbana, IL 61801 USA; [Burke, Martin D.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; 3M; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Blair, DJ; Burke, MD (corresponding author), Univ Illinois, Sch Chem Sci, Roger Adams Lab, Urbana, IL 61801 USA.; Burke, MD (corresponding author), Carle Illinois Coll Med, Urbana, IL 61801 USA.; Burke, MD (corresponding author), Univ Illinois, Arnold & Mabel Beckman Inst, Urbana, IL 61801 USA.; Burke, MD (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	danielb@illinois.edu; mdburke@illinois.edu	Morehouse, Gregory/AGE-5989-2022	Morehouse, Gregory/0000-0001-9614-8808; Blair, Daniel/0000-0002-2279-7538; Mubayi, Vikram/0000-0002-6784-5177; Palazzolo Ray, Andrea/0000-0002-2359-6690; Wang, Wesley/0000-0002-1420-3031	Roy J. Carver Charitable Trust, Muscatine, Iowa, USA; Damon-Runyon Cancer Research Foundation; NIH [GM118185]; NSF [CHE-1955838]; Illini 4000 Fellow of the Damon-Runyon Cancer Research Foundation [DRG-2290-17]; ACS Division of Organic Chemistry Summer Undergraduate Research Fellowship; Henry Luce Foundation; Illinois Scholars Undergraduate Research Program; Erwin Schrodinger Post-Doctoral Fellow, Austrian Science Fund (FWF) [J3960-N34]	Roy J. Carver Charitable Trust, Muscatine, Iowa, USA; Damon-Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Illini 4000 Fellow of the Damon-Runyon Cancer Research Foundation; ACS Division of Organic Chemistry Summer Undergraduate Research Fellowship; Henry Luce Foundation; Illinois Scholars Undergraduate Research Program; Erwin Schrodinger Post-Doctoral Fellow, Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	thank F. Sun and H. Yao at the UIUC Mass Spectrometry Facility, D. Olson, L. Zhu and N. Duay at the School of Chemical Sciences NMR Laboratory at UIUC for NMR services, and members of the Burke laboratory for discussions related to this project. The Bruker 500 MHz NMR spectrometer was obtained with the financial support of the Roy J. Carver Charitable Trust, Muscatine, Iowa, USA. D.J.B. thanks the Damon-Runyon Cancer Research Foundation for additional support during the COVID-19 pandemic. S. Denmark is acknowledged for manuscript review. We thank P.-J. Chen, Y. Tong, A. Blake, H. Auby and D. Szczepankiewicz for technical assistance. Support was provided by the following sources: M.D.B.: NIH (GM118185), NSF (CHE-1955838); D.J.B.: Illini 4000 Fellow of the Damon-Runyon Cancer Research Foundation DRG-2290-17; S.C.: ACS Division of Organic Chemistry Summer Undergraduate Research Fellowship, Henry Luce Foundation and the Illinois Scholars Undergraduate Research Program; M.B.T.: Erwin Schrodinger Post-Doctoral Fellow, Austrian Science Fund (FWF) (J3960-N34).	Angelone D, 2021, NAT CHEM, V13, P63, DOI 10.1038/s41557-020-00596-9; Aspin S, 2012, ANGEW CHEM INT EDIT, V51, P10808, DOI 10.1002/anie.201206237; BADER RFW, 1983, J AM CHEM SOC, V105, P5061, DOI 10.1021/ja00353a035; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; BEAK P, 1981, J ORG CHEM, V46, P2363, DOI 10.1021/jo00324a030; Blakemore PR, 2006, ORG LETT, V8, P773, DOI 10.1021/ol053055k; Casoni G, 2017, J AM CHEM SOC, V139, P11877, DOI 10.1021/jacs.7b05457; Cherney AH, 2015, CHEM REV, V115, P9587, DOI 10.1021/acs.chemrev.5b00162; Falivene L, 2019, NAT CHEM, V11, P872, DOI 10.1038/s41557-019-0319-5; Fawcett A, 2016, ANGEW CHEM INT EDIT, V55, P14663, DOI 10.1002/anie.201608406; Fujita K, 2012, ANGEW CHEM INT EDIT, V51, P7271, DOI 10.1002/anie.201203093; Gonzalez JA, 2016, NAT CHEM, V8, P1067, DOI [10.1038/nchem.2571, 10.1038/NCHEM.2571]; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Imao D, 2009, J AM CHEM SOC, V131, P5024, DOI 10.1021/ja8094075; JONAS V, 1994, J AM CHEM SOC, V116, P8741, DOI 10.1021/ja00098a037; Koritsanszky TS, 2001, CHEM REV, V101, P1583, DOI 10.1021/cr990112c; Landry ML, 2016, J AM CHEM SOC, V138, P5150, DOI 10.1021/jacs.6b01643; Lehmann JW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09249-z; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Leonori D, 2014, ACCOUNTS CHEM RES, V47, P3174, DOI 10.1021/ar5002473; Li GC, 2019, J AM CHEM SOC, V141, P11161, DOI 10.1021/jacs.9b04136; Li JQ, 2015, SCIENCE, V347, P1221, DOI 10.1126/science.aaa5414; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Ma XH, 2020, NAT REV CHEM, V4, P584, DOI 10.1038/s41570-020-00222-9; Ma YH, 2020, CHEM-EUR J, V26, P3738, DOI 10.1002/chem.202000412; MANCILLA T, 1986, J ORGANOMET CHEM, V307, P1, DOI 10.1016/0022-328X(86)80169-3; Mancilla T, 2007, POLYHEDRON, V26, P1023, DOI 10.1016/j.poly.2006.09.067; Mlynarski SN, 2014, NATURE, V505, P386, DOI 10.1038/nature12781; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Mondol MAM, 2011, J NAT PROD, V74, P1606, DOI 10.1021/np200223r; Neuvonen H, 2002, J ORG CHEM, V67, P6995, DOI 10.1021/jo020121c; O'Brien NJ, 2020, EUR J INORG CHEM, V2020, P1995, DOI 10.1002/ejic.202000229; Pophristic V, 2001, NATURE, V411, P565, DOI 10.1038/35079036; Rablen PR, 1999, J CHEM SOC PERK T 2, P1719, DOI 10.1039/a901974j; Roesner S, 2015, CHEM SCI, V6, P3718, DOI 10.1039/c4sc03901g; Scherer W, 2002, CHEM-EUR J, V8, P2324, DOI 10.1002/1521-3765(20020517)8:10<2324::AID-CHEM2324>3.0.CO;2-X; Schurmann CJ, 2018, Z KRIST-CRYST MATER, V233, P723, DOI 10.1515/zkri-2018-2061; SENDEROWITZ H, 1994, TETRAHEDRON, V50, P9707, DOI 10.1016/S0040-4020(01)85538-1; Seo KB, 2018, J AM CHEM SOC, V140, P4335, DOI 10.1021/jacs.7b13701; Sharma HA, 2021, SCIENCE, V374, P752, DOI 10.1126/science.abm0386; Skara G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16244-1; Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708; Trobe M, 2018, ANGEW CHEM INT EDIT, V57, P4192, DOI 10.1002/anie.201710482; Ueki Y, 2011, CHEM-EUR J, V17, P8555, DOI 10.1002/chem.201101186; Ullrich M, 2010, ORGANOMETALLICS, V29, P3647, DOI 10.1021/om100563m; Uno BE, 2009, TETRAHEDRON, V65, P3130, DOI 10.1016/j.tet.2008.11.010; Worch JC, 2019, NAT REV CHEM, V3, P514, DOI 10.1038/s41570-019-0117-z; Wu JIC, 2013, PURE APPL CHEM, V85, P921, DOI 10.1351/PAC-CON-13-01-03; Xie XM, 2015, J AM CHEM SOC, V137, P3767, DOI 10.1021/jacs.5b01036; YAMAMOTO Y, 1990, J AM CHEM SOC, V112, P8598, DOI 10.1021/ja00179a063; Yang SW, 2005, J ANTIBIOT, V58, P535, DOI 10.1038/ja.2005.74	51	18	16	16	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 7	2022	604	7904					92	+		10.1038/s41586-022-04491-w	http://dx.doi.org/10.1038/s41586-022-04491-w		FEB 2022	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0I0EB	35134814	Bronze			2022-12-28	WOS:000776019900001
J	Langin, K				Langin, Katie			Her Hidden Genius: A Novel	SCIENCE			English	Book Review																		BENEDICT M, 2022, HER HIDDEN GENIUS NO	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					504	504		10.1126/science.abn2940	http://dx.doi.org/10.1126/science.abn2940			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113689				2022-12-28	WOS:000753965100028
J	Acharya, B; Alexandre, J; Benes, P; Bergmann, B; Bertolucci, S; Bevan, A; Branzas, H; Burian, P; Campbell, M; Cho, YM; de Montigny, M; De Roeck, A; Ellis, JR; El Sawy, M; Fairbairn, M; Felea, D; Frank, M; Gould, O; Hays, J; Hirt, AM; Ho, DLJ; Hung, PQ; Janecek, J; Kalliokoski, M; Korzenev, A; Lacarrere, DH; Leroy, C; Levi, G; Lionti, A; Maulik, A; Margiotta, A; Mauri, N; Mavromatos, NE; Mermod, P; Millward, L; Mitsou, VA; Ostrovskiy, I; Ouimet, PP; Papavassiliou, J; Parker, B; Patrizii, L; Pavalas, GE; Pinfold, JL; Popa, LA; Popa, V; Pozzato, M; Pospisil, S; Rajantie, A; de Austri, RR; Sahnoun, Z; Sakellariadou, M; Santra, A; Sarkar, S; Semenoff, G; Shaa, A; Sirri, G; Sliwa, K; Soluk, R; Spurio, M; Staelens, M; Suk, M; Tenti, M; Togo, V; Tuszyn'ski, JA; Upreti, A; Vento, V; Vives, O				Acharya, B.; Alexandre, J.; Benes, P.; Bergmann, B.; Bertolucci, S.; Bevan, A.; Branzas, H.; Burian, P.; Campbell, M.; Cho, Y. M.; de Montigny, M.; De Roeck, A.; Ellis, J. R.; El Sawy, M.; Fairbairn, M.; Felea, D.; Frank, M.; Gould, O.; Hays, J.; Hirt, A. M.; Ho, D. L-J; Hung, P. Q.; Janecek, J.; Kalliokoski, M.; Korzenev, A.; Lacarrere, D. H.; Leroy, C.; Levi, G.; Lionti, A.; Maulik, A.; Margiotta, A.; Mauri, N.; Mavromatos, N. E.; Mermod, P.; Millward, L.; Mitsou, V. A.; Ostrovskiy, I; Ouimet, P-P; Papavassiliou, J.; Parker, B.; Patrizii, L.; Pavalas, G. E.; Pinfold, J. L.; Popa, L. A.; Popa, V; Pozzato, M.; Pospisil, S.; Rajantie, A.; de Austri, R. Ruiz; Sahnoun, Z.; Sakellariadou, M.; Santra, A.; Sarkar, S.; Semenoff, G.; Shaa, A.; Sirri, G.; Sliwa, K.; Soluk, R.; Spurio, M.; Staelens, M.; Suk, M.; Tenti, M.; Togo, V; Tuszyn'ski, J. A.; Upreti, A.; Vento, V.; Vives, O.			Search for magnetic monopoles produced via the Schwinger mechanism	NATURE			English	Article							PAIR PRODUCTION; FIELD	Electrically charged particles can be created by the decay of strong enough electric fields, a phenomenon known as the Schwinger mechanism(1). By electromagnetic duality, a sufficiently strong magnetic field would similarly produce magnetic monopoles, if they exist(2). Magnetic monopoles are hypothetical fundamental particles that are predicted by several theories beyond the standard model(3-7) but have never been experimentally detected. Searching for the existence of magnetic monopoles via the Schwinger mechanism has not yet been attempted, but it is advantageous, owing to the possibility of calculating its rate through semi-classical techniques without perturbation theory, as well as that the production of the magnetic monopoles should be enhanced by their finite size(8,9) and strong coupling to photons(2,10). Here we present a search for magnetic monopole production by the Schwinger mechanism in Pb-Pb heavy ion collisions at the Large Hadron Collider, producing the strongest known magnetic fields in the current Universe(11). It was conducted by the MoEDAL experiment, whose trapping detectors were exposed to 0.235 per nanobarn, or approximately 1.8 x 10(9), of Pb-Pb collisions with 5.02-teraelectronvolt center-of-mass energy per collision in November 2018. A superconducting quantum interference device (SQUID) magnetometer scanned the trapping detectors of MoEDAL for the presence of magnetic charge, which would induce a persistent current in the SQUID. Magnetic monopoles with integer Dirac charges of 1, 2 and 3 and masses up to 75 gigaelectronvolts per speed of light squared were excluded by the analysis at the 95% confidence level. This provides a lower mass limit for finite-size magnetic monopoles from a collider search and greatly extends previous mass bounds.	[Acharya, B.; Alexandre, J.; Ellis, J. R.; Fairbairn, M.; Mavromatos, N. E.; Sakellariadou, M.; Sarkar, S.] Kings Coll London, Phys Dept, Theoret Particle Phys & Cosmol Grp, London, England; [Benes, P.; Bergmann, B.; Burian, P.; Janecek, J.; Pospisil, S.; Suk, M.] Czech Tech Univ, IEAP, Prague, Czech Republic; [Bertolucci, S.; Levi, G.; Maulik, A.; Mauri, N.; Patrizii, L.; Pozzato, M.; Sahnoun, Z.; Sirri, G.; Togo, V] Ist Nazl Fis Nucl, Sect Bologna, Bologna, Italy; [Bevan, A.; Hays, J.; Millward, L.] Queen Mary Univ London, Sch Phys & Astron, London, England; [Branzas, H.; Felea, D.; Pavalas, G. E.; Popa, L. A.; Popa, V] Inst Space Sci, Magurele, Romania; [Campbell, M.; De Roeck, A.; El Sawy, M.; Lacarrere, D. H.] CERN, Expt Phys Dept, Geneva, Switzerland; [Cho, Y. M.] Sogang Univ, Ctr Quantum Spacetime, Seoul, South Korea; [de Montigny, M.; Maulik, A.; Ouimet, P-P; Pinfold, J. L.; Shaa, A.; Soluk, R.; Staelens, M.; Tuszyn'ski, J. A.] Univ Alberta, Phys Dept, Edmonton, AB, Canada; [Ellis, J. R.] CERN, Theoret & Phys Dept, Geneva, Switzerland; [Frank, M.] Concordia Univ, Dept Phys, Montreal, PQ, Canada; [Gould, O.] Univ Nottingham, Nottingham, England; [Gould, O.; Kalliokoski, M.] Univ Helsinki, Helsinki Inst Phys, Helsinki, Finland; [Hirt, A. M.] Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Ho, D. L-J; Rajantie, A.] Imperial Coll London, Dept Phys, London, England; [Hung, P. Q.] Univ Virginia, Dept Phys, Charlottesville, VA 22901 USA; [Korzenev, A.; Lionti, A.; Mermod, P.] Univ Geneva, Dept Phys Nucl & Corpusculaire, Geneva, Switzerland; [Leroy, C.] Univ Montreal, Dept Phys, Montreal, PQ, Canada; [Levi, G.; Margiotta, A.; Spurio, M.] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Mitsou, V. A.; Papavassiliou, J.; de Austri, R. Ruiz; Santra, A.; Vento, V.; Vives, O.] Univ Valencia, CSIC, IFIC, Valencia, Spain; [Ostrovskiy, I; Upreti, A.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Parker, B.] Inst Res Sch, Canterbury, Kent, England; [Semenoff, G.] Univ British Columbia, Dept Phys, Vancouver, BC, Canada; [Sliwa, K.] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA; [Tenti, M.] Ist Nazl Fis Nucl, CNAF, Bologna, Italy	University of London; King's College London; Czech Technical University Prague; Istituto Nazionale di Fisica Nucleare (INFN); University of London; Queen Mary University London; University College London; Institute of Space Science; European Organization for Nuclear Research (CERN); Sogang University; University of Alberta; European Organization for Nuclear Research (CERN); Concordia University - Canada; University of Nottingham; Helsinki Institute of Physics; University of Helsinki; Swiss Federal Institutes of Technology Domain; ETH Zurich; Imperial College London; University of Virginia; University of Geneva; Universite de Montreal; University of Bologna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; University of Alabama System; University of Alabama Tuscaloosa; University of British Columbia; Tufts University; Istituto Nazionale di Fisica Nucleare (INFN)	Ostrovskiy, I (corresponding author), Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA.		Bergmann, Benedikt/L-8368-2019; Santra, Arka/AEE-4946-2022; Gould, Oliver/AAE-6913-2022; Tuszynski, Jack/AAA-2073-2020; Burian, Petr/HHR-9651-2022; Frank, Mariana/GWV-6012-2022; Mitsou, Vasiliki/D-1967-2009	Bergmann, Benedikt/0000-0002-8076-5614; Santra, Arka/0000-0003-4644-2579; Gould, Oliver/0000-0002-7815-3379; Tuszynski, Jack/0000-0001-9976-0429; Burian, Petr/0000-0001-6907-7901; Frank, Mariana/0000-0003-2268-4821; Staelens, Michael/0000-0002-6401-0043; Ostrovskiy, Igor/0000-0003-4939-0225; Alexandre, Jean Francois/0000-0003-3499-7534; Mitsou, Vasiliki/0000-0002-1533-8886; Kalliokoski, Matti/0000-0002-4963-0121; Sakellariadou, Mairi/0000-0002-2715-1517	Swiss NSF [PP00P2 150583]; UK Science and Technology Facilities Council [ST/L000326/1, ST/L00044X/1, ST/N00101X/1, ST/P000258/1, ST/P000762/1, ST/T000732/1, ST/T000759/1, ST/T000791/1]; Generalitat Valenciana [PROMETEO-II/2017/033, PROMETEO/2019/087]; MCIU/AEI/FEDER, UE [FPA2016-77177-C2-1-P, FPA2017-85985-P, FPA2017-84543-P, PGC2018-094856-B-I00]; Physics Department of King's College London; NSERC; V-P Research of the University of Alberta (UofA); UofA; UEFISCDI (Romania); INFN (Italy); Estonian Research Council [MOBTT5]; Research Funds of the University of Helsinki; NSF [2011214]; Institute for Particle Physics Phenomenology Associateship	Swiss NSF(Swiss National Science Foundation (SNSF)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MCIU/AEI/FEDER, UE; Physics Department of King's College London; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); V-P Research of the University of Alberta (UofA); UofA; UEFISCDI (Romania)(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); Estonian Research Council(Estonian Research Council); Research Funds of the University of Helsinki; NSF(National Science Foundation (NSF)); Institute for Particle Physics Phenomenology Associateship	We thank CERN for the LHC's successful Run-2 operation, as well as the support staff from our institutions without whom MoEDAL could not be operated. We acknowledge the invaluable assistance of particular members of the LHCb Collaboration: G. Wilkinson, R.Lindner, E.Thomas and G.Corti. Computing support was provided by the GridPP Collaboration, in particular by the Queen Mary University of London and Liverpool grid sites. This work was supported by grant PP00P2 150583 of the Swiss NSF; by the UK Science and Technology Facilities Council via the grants ST/L000326/1, ST/L00044X/1, ST/N00101X/1, ST/P000258/1, ST/P000762/1, ST/T000732/1, ST/T000759/1 and ST/T000791/1; by the Generalitat Valenciana via a special grant for MoEDAL and via the projects PROMETEO-II/2017/033 and PROMETEO/2019/087; by MCIU/AEI/FEDER, UE via the grants FPA2016-77177-C2-1-P, FPA2017-85985-P, FPA2017-84543-P and PGC2018-094856-B-I00; by the Physics Department of King's College London; by NSERC via a project grant; by the V-P Research of the University of Alberta (UofA); by the Provost of the UofA; by UEFISCDI (Romania); by the INFN (Italy); by the Estonian Research Council via a Mobilitas Pluss grant MOBTT5; by the Research Funds of the University of Helsinki; and by the NSF grant 2011214 to the University of Alabama MoEDAL group. A.R. was also supported by Institute for Particle Physics Phenomenology Associateship.	Aad G, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.052009; Aad G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.261803; Acharya B, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.021802; Acharya B, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X14300506; AFFLECK IK, 1982, NUCL PHYS B, V194, P38, DOI 10.1016/0550-3213(82)90511-9; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Alemanno F., 2021, PHYS REV LETT, V126; Arunasalam S, 2017, EUR PHYS J C, V77, DOI 10.1140/epjc/s10052-017-4999-y; ATLAS Collaboration, 2020, PHYS REV LETT, V124; BLAGOJEVIC M, 1988, PHYS REP, V157, P233, DOI 10.1016/0370-1573(88)90098-1; Cho YM, 1997, PHYS LETT B, V391, P360, DOI 10.1016/S0370-2693(96)01492-X; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; DRUKIER AK, 1982, PHYS REV LETT, V49, P102, DOI 10.1103/PhysRevLett.49.102; Ellis J, 2016, PHYS LETT B, V756, P29, DOI 10.1016/j.physletb.2016.02.048; Gamberg L, 2000, FOUND PHYS, V30, P543, DOI 10.1023/A:1003668812097; Gould O, 2021, PHYS REV D, V104, DOI 10.1103/PhysRevD.104.015033; Gould O, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.015041; Gould O, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.241601; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; He YD, 1997, PHYS REV LETT, V79, P3134, DOI 10.1103/PhysRevLett.79.3134; Heisenberg W, 1936, Z PHYS, V98, P714, DOI 10.1007/BF01343663; Ho DLJ, 2021, PHYS REV D, V103, DOI 10.1103/PhysRevD.103.115033; Ho DLJ, 2020, PHYS REV D, V101, DOI 10.1103/PhysRevD.101.055003; Huang XG, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/7/076302; Hung PQ, 2021, NUCL PHYS B, V962, DOI 10.1016/j.nuclphysb.2020.115278; Kaspi VM, 2017, ANNU REV ASTRON ASTR, V55, P261, DOI 10.1146/annurev-astro-081915-023329; Kimm K, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3290-3; Kobayashi T, 2021, PHYS REV D, V104, DOI 10.1103/PhysRevD.104.043501; Mavromatos NE, 2020, INT J MOD PHYS A, V35, DOI 10.1142/S0217751X20300124; Mavromatos NE, 2018, PHYS REV D, V97, DOI 10.1103/PhysRevD.97.125010; Mavromatos NE, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.104025; Milton KA, 2006, REP PROG PHYS, V69, P1637, DOI 10.1088/0034-4885/69/6/R02; POLYAKOV AM, 1974, JETP LETT+, V20, P194; Sauter F, 1931, Z PHYS, V69, P742, DOI 10.1007/BF01339461; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; The MoEDAL Collaboration, 2016, J HIGH ENERGY PHYS, V67; THOOFT G, 1974, NUCL PHYS B, VB 79, P276; WEN XG, 1985, NUCL PHYS B, V261, P651, DOI 10.1016/0550-3213(85)90592-9; WITTEN E, 1979, NUCL PHYS B, V160, P57, DOI 10.1016/0550-3213(79)90232-3	39	8	8	11	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					63	+		10.1038/s41586-021-04298-1	http://dx.doi.org/10.1038/s41586-021-04298-1			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110756	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000750429600019
J	Doki, Y; Ajani, JA; Kato, K; Xu, J; Wyrwicz, L; Motoyama, S; Ogata, T; Kawakami, H; Hsu, CH; Adenis, A; El Hajbi, F; Di Bartolomeo, M; Braghiroli, MI; Holtved, E; Ostoich, SA; Kim, HR; Ueno, M; Mansoor, W; Yang, WC; Liu, T; Bridgewater, J; Makino, T; Xynos, I; Liu, X; Lei, M; Kondo, K; Patel, A; Gricar, J; Chau, I; Kitagawa, Y				Doki, Y.; Ajani, J. A.; Kato, K.; Xu, J.; Wyrwicz, L.; Motoyama, S.; Ogata, T.; Kawakami, H.; Hsu, C. -H.; Adenis, A.; El Hajbi, F.; Di Bartolomeo, M.; Braghiroli, M. I.; Holtved, E.; Ostoich, S. A.; Kim, H. R.; Ueno, M.; Mansoor, W.; Yang, W. -C.; Liu, T.; Bridgewater, J.; Makino, T.; Xynos, I.; Liu, X.; Lei, M.; Kondo, K.; Patel, A.; Gricar, J.; Chau, I.; Kitagawa, Y.		CheckMate 648 Trial Investigators	Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPEN-LABEL; PLUS CHEMOTHERAPY; PHASE-II; MULTICENTER; IPILIMUMAB; 5-FLUOROURACIL; CISPLATIN; JUNCTION	BACKGROUND First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced esophageal squamous-cell carcinoma. METHODS In this open-label, phase 3 trial, we randomly assigned adults with previously untreated, unresectable advanced, recurrent, or metastatic esophageal squamous-cell carcinoma in a 1:1:1 ratio to receive nivolumab plus chemotherapy, nivolumab plus the monoclonal antibody ipilimumab, or chemotherapy. The primary end points were overall survival and progression-free survival, as determined by blinded independent central review. Hierarchical testing was performed first in patients with tumor-cell programmed death ligand 1 (PD-L1) expression of 1% or greater and then in the overall population (all randomly assigned patients). RESULTS A total of 970 patients underwent randomization. At a 13-month minimum follow-up, overall survival was significantly longer with nivolumab plus chemotherapy than with chemotherapy alone, both among patients with tumor-cell PD-L1 expression of 1% or greater (median, 15.4 vs. 9.1 months; hazard ratio, 0.54; 99.5% confidence interval [CI], 0.37 to 0.80; P<0.001) and in the overall population (median, 13.2 vs. 10.7 months; hazard ratio, 0.74; 99.1% CI, 0.58 to 0.96; P=0.002). Overall survival was also significantly longer with nivolumab plus ipilimumab than with chemotherapy among patients with tumor-cell PD-L1 expression of 1% or greater (median, 13.7 vs. 9.1 months; hazard ratio, 0.64; 98.6% CI, 0.46 to 0.90; P=0.001) and in the overall population (median, 12.7 vs. 10.7 months; hazard ratio, 0.78; 98.2% CI, 0.62 to 0.98; P=0.01). Among patients with tumor-cell PD-L1 expression of 1% or greater, a significant progression-free survival benefit was also seen with nivolumab plus chemotherapy over chemotherapy alone (hazard ratio for disease progression or death, 0.65; 98.5% CI, 0.46 to 0.92; P=0.002) but not with nivolumab plus ipilimumab as compared with chemotherapy. The incidence of treatment-related adverse events of grade 3 or 4 was 47% with nivolumab plus chemotherapy, 32% with nivolumab plus ipilimumab, and 36% with chemotherapy alone. CONCLUSIONS Both first-line treatment with nivolumab plus chemotherapy and first-line treatment with nivolumab plus ipilimumab resulted in significantly longer overall survival than chemotherapy alone in patients with advanced esophageal squamous-cell carcinoma, with no new safety signals identified.	[Doki, Y.; Makino, T.] Osaka Univ, Grad Sch Med, Osaka, Japan; [Kato, K.] Natl Canc Ctr, Tokyo, Japan; [Ueno, M.] Toranomon Gen Hosp, Tokyo, Japan; [Kitagawa, Y.] Keio Univ, Sch Med, Tokyo, Japan; [Motoyama, S.] Akita Univ Hosp, Akita, Japan; [Ogata, T.] Kanagawa Canc Ctr, Kanagawa, Japan; [Kawakami, H.] Kindai Univ, Fac Med, Osakasayama, Japan; [Ajani, J. A.] Univ Texas MD Anderson Canc Ctr, Houston, TX USA; [Xu, J.] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China; [Liu, T.] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China; [Wyrwicz, L.] Narodowy Inst Onkol, Klin Onkol & Radioterapii, Warsaw, Poland; [Hsu, C. -H.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, W. -C.] E Da Hosp, Kaohsiung, Taiwan; [Yang, W. -C.] I Shou Univ, Kaohsiung, Taiwan; [Adenis, A.] Univ Montpellier, Inst Canc Montpellier, Inst Rech Cancerol Montpellier, INSERM, Montpellier, France; [El Hajbi, F.] Ctr Oscar Lambret, Lille, France; [Di Bartolomeo, M.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Braghiroli, M. I.] Univ Sao Paulo, Inst Canc Sao Paulo, Sao Paulo, Brazil; [Holtved, E.] Odense Univ Hosp, Odense, Denmark; [Ostoich, S. A.] Hosp Prov Centenario, Rosario, Argentina; Yonsei Univ, Div Med Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea; [Mansoor, W.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Bridgewater, J.] UCL, UCL Canc Inst, London, England; [Chau, I.] Royal Marsden Hosp, Surrey, England; [Xynos, I.; Liu, X.; Lei, M.; Kondo, K.; Patel, A.; Gricar, J.] Bristol Myers Squibb, Princeton, NJ USA	Osaka University; National Cancer Center - Japan; Toranomon Hospital; Keio University; Akita University; Kanagawa Prefectural Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fudan University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Centre Oscar Lambret; Fondazione IRCCS Istituto Nazionale Tumori Milan; Universidade de Sao Paulo; University of Southern Denmark; Odense University Hospital; Yonsei University; Yonsei University Health System; Christie NHS Foundation Trust; University of London; University College London; Royal Marsden NHS Foundation Trust; Bristol-Myers Squibb	Kato, K (corresponding author), Natl Canc Ctr Hosp, Dept Head & Neck, Esophageal Med Oncol, Chuo, Tokyo 1040045, Japan.	kenkato@ncc.go.jp	ADENIS, ANTOINE/AAH-2034-2022; ADENIS, ANTOINE/AFL-9835-2022; Chau, Ian/ABC-2023-2020	Chau, Ian/0000-0003-0286-8703; Gu, Kangsheng/0000-0002-5800-5256	Bristol Myers Squibb; Ono Pharmaceutical	Bristol Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical	Supported by Bristol Myers Squibb and Ono Pharmaceutical. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2019, CHINESE J CANCER RES, V31, P223, DOI 10.21147/j.issn.1000-9604.2019.02.01; [Anonymous], PLYMOUTH M, P2022; [Anonymous], OESOPHAGEAL CANC INC; Arnold M, 2020, GUT, V69, P1564, DOI 10.1136/gutjnl-2020-321600; Baas P, 2021, LANCET, V397, P375, DOI 10.1016/S0140-6736(20)32714-8; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COX DR, 1972, J R STAT SOC B, V34, P187; Darling G, 2006, CANCER, V107, P854, DOI 10.1002/cncr.22055; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Hellmann MD, 2019, NEW ENGL J MED, V381, P2020, DOI 10.1056/NEJMoa1910231; Huang J, 2020, LANCET ONCOL, V21, P832, DOI 10.1016/S1470-2045(20)30110-8; IIZUKA T, 1992, JPN J CLIN ONCOL, V22, P172; Janjigian YY, 2021, LANCET, V398, P27, DOI 10.1016/S0140-6736(21)00797-2; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kato K, 2020, CANCER SCI, V111, P1676, DOI 10.1111/cas.14380; Kato K, 2019, LANCET ONCOL, V20, P1506, DOI 10.1016/S1470-2045(19)30626-6; Kitagawa Y, 2019, ESOPHAGUS-TOKYO, V16, P1, DOI 10.1007/s10388-018-0641-9; Koch GG., 1989, STAT METHODOLOGY PHA, P389; Kojima T, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.01888; Kudo T, 2017, LANCET ONCOL, V18, P631, DOI 10.1016/S1470-2045(17)30181-X; Kulangara K, 2019, ARCH PATHOL LAB MED, V143, P330, DOI 10.5858/arpa.2018-0043-OA; Lee SJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1716-9; Lei M, 2021, CLIN CANCER RES, V27, P3926, DOI 10.1158/1078-0432.CCR-20-2790; Lordick F, 2016, ANN ONCOL, V27, pv50, DOI 10.1093/annonc/mdw329; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Moehler M, 2020, ANN ONCOL, V31, P228, DOI 10.1016/j.annonc.2019.10.018; Patel N, 2018, CUREUS J MED SCIENCE, V10, DOI 10.7759/cureus.3709; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Ringash J, 2007, CANCER-AM CANCER SOC, V110, P196, DOI 10.1002/cncr.22799; Salem ME, 2018, ONCOLOGIST, V23, P1319, DOI 10.1634/theoncologist.2018-0143; Smyth EC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.48; Sun JM, 2021, LANCET, V398, P759, DOI 10.1016/S0140-6736(21)01234-4; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Tachimori Y, 2019, ESOPHAGUS-TOKYO, V16, P221, DOI 10.1007/s10388-019-00674-z; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Xu RH, 2021, J CLIN ONCOL, V39, DOI 10.1200/JCO.2021.39.15_suppl.4000	38	93	93	24	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					449	462		10.1056/NEJMoa2111380	http://dx.doi.org/10.1056/NEJMoa2111380			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR1JU	35108470	Green Published			2022-12-28	WOS:000749755800010
J	Kavokine, N; Bocquet, ML; Bocquet, L				Kavokine, Nikita; Bocquet, Marie-Laure; Bocquet, Lyderic			Fluctuation-induced quantum friction in nanoscale water flows	NATURE			English	Article							DIELECTRIC-RELAXATION; METAL-SURFACES; MASS-TRANSPORT; CARBON; GRAPHENE; SLIPPAGE	The flow of water in carbon nanochannels has defied understanding thus far(1), with accumulating experimental evidence for ultra-low friction, exceptionally high water flow rates and curvature-dependent hydrodynamic slippage(2-5). In particular, the mechanism of water-carbon friction remains unknown(6), with neither current theories(7) nor classical(8,9) or ab initio molecular dynamics simulations(10) providing satisfactory rationalization for its singular behaviour. Here we develop a quantum theory of the solid-liquid interface, which reveals a new contribution to friction, due to the coupling of charge fluctuations in the liquid to electronic excitations in the solid. We expect that this quantum friction, which is absent in Born-Oppenheimer molecular dynamics, is the dominant friction mechanism for water on carbon-based materials. As a key result, we demonstrate a marked difference in quantum friction between the water-graphene and water-graphite interface, due to the coupling of water Debye collective modes with a thermally excited plasmon specific to graphite. This suggests an explanation for the radius-dependent slippage of water in carbon nanotubes(4), in terms of the electronic excitations of the nanotubes. Our findings open the way for quantum engineering of hydrodynamic flows through the electronic properties of the confining wall.	[Kavokine, Nikita; Bocquet, Lyderic] Sorbonne Univ, Univ Paris Diderot, Sorbonne Paris Cite, Lab Phys,Ecole Normale Super,Univ PSL,CNRS, Paris, France; [Kavokine, Nikita] Flatiron Inst, Ctr Computat Quantum Phys, New York, NY 10010 USA; [Bocquet, Marie-Laure] PSL Univ, Sorbonne Univ, CNRS, PASTEUR,Dept Chim,Ecole Normale Super, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Kavokine, N; Bocquet, L (corresponding author), Sorbonne Univ, Univ Paris Diderot, Sorbonne Paris Cite, Lab Phys,Ecole Normale Super,Univ PSL,CNRS, Paris, France.; Kavokine, N (corresponding author), Flatiron Inst, Ctr Computat Quantum Phys, New York, NY 10010 USA.	nikita.kavokine@ens.fr; lyderic.bocquet@ens.fr		bocquet, lyderic/0000-0003-3577-5335; Bocquet, Marie-Laure/0000-0001-7122-4907				Bocquet L, 2007, SOFT MATTER, V3, P685, DOI 10.1039/b616490k; Bocquet L, 2020, NAT MATER, V19, P254, DOI 10.1038/s41563-020-0625-8; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Carlson S, 2020, J PHYS CHEM A, V124, P5599, DOI 10.1021/acs.jpca.0c04063; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Dou W., 2018, J CHEM PHYS, V148; Endo M, 1997, J PHYS CHEM SOLIDS, V58, P1707, DOI 10.1016/S0022-3697(97)00055-3; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Faucher S, 2019, J PHYS CHEM C, V123, P21309, DOI 10.1021/acs.jpcc.9b02178; FRANKLIN RE, 1951, ACTA CRYSTALLOGR, V4, P253, DOI 10.1107/S0365110X51000842; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Kavokine N, 2021, ANNU REV FLUID MECH, V53, P377, DOI 10.1146/annurev-fluid-071320-095958; Koeberg M, 2007, CHEM PHYS LETT, V439, P60, DOI 10.1016/j.cplett.2007.03.075; Laitenberger P, 1996, PHYS REV LETT, V76, P1952, DOI 10.1103/PhysRevLett.76.1952; LANG ND, 1970, PHYS REV B, V1, P4555, DOI 10.1103/PhysRevB.1.4555; Lavor IR, 2021, 2D MATER, V8, DOI 10.1088/2053-1583/abbecc; Maali A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2840717; Misra RP, 2017, J PHYS CHEM C, V121, P28166, DOI 10.1021/acs.jpcc.7b08891; Paniagua-Guerra LE, 2020, LANGMUIR, V36, P14772, DOI 10.1021/acs.langmuir.0c02718; Pendry JB, 1997, J PHYS-CONDENS MAT, V9, P10301, DOI 10.1088/0953-8984/9/47/001; Pitarke JM, 2007, REP PROG PHYS, V70, P1, DOI 10.1088/0034-4885/70/1/R01; Portail M, 1999, SURF SCI, V433, P863, DOI 10.1016/S0039-6028(99)00091-6; Radha B, 2016, NATURE, V538, P222, DOI 10.1038/nature19363; RAMMER J, 1986, REV MOD PHYS, V58, P323, DOI 10.1103/RevModPhys.58.323; Sam A, 2021, MOL SIMULAT, V47, P905, DOI 10.1080/08927022.2020.1782401; Sato T, 2004, J PHYS CHEM A, V108, P5007, DOI 10.1021/jp035255o; Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315; Sokoloff JB, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.033107; Song XY, 1996, J PHYS CHEM-US, V100, P11954, DOI 10.1021/jp960887e; SPECK JS, 1989, J CRYST GROWTH, V94, P834, DOI 10.1016/0022-0248(89)90116-4; Thomas JA, 2008, NANO LETT, V8, P2788, DOI 10.1021/nl8013617; Tocci G, 2014, NANO LETT, V14, P6872, DOI 10.1021/nl502837d; TOMANEK D, 1987, PHYS REV B, V35, P7790, DOI 10.1103/PhysRevB.35.7790; Pham TA, 2017, NAT MATER, V16, P401, DOI [10.1038/nmat4803, 10.1038/NMAT4803]; Volokitin AI, 2007, REV MOD PHYS, V79, P1291, DOI 10.1103/RevModPhys.79.1291; Whitby M, 2008, NANO LETT, V8, P2632, DOI 10.1021/nl080705f; Wodtke AM, 2004, INT REV PHYS CHEM, V23, P513, DOI 10.1080/01442350500037521; Xie Q, 2018, NAT NANOTECHNOL, V13, P238, DOI 10.1038/s41565-017-0031-9; Xie YB, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.014501	39	21	21	87	152	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					84	+		10.1038/s41586-021-04284-7	http://dx.doi.org/10.1038/s41586-021-04284-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110760	Green Submitted			2022-12-28	WOS:000750429600023
J	Green, T; Venkataramani, AS				Green, Tiffany; Venkataramani, Atheendar S.			Trade-offs and Policy Options - Using Insights from Economics to Inform Public Health Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Green, Tiffany] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Green, Tiffany] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Venkataramani, Atheendar S.] Univ Penn, Dept Med Eth & Hlth Policy, Policy Perelman Sch Med, Philadelphia, PA USA; [Venkataramani, Atheendar S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; University of Pennsylvania	Green, T (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA.; Green, T (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.							Alfonso YN, 2021, HEALTH AFFAIR, V40, P664, DOI 10.1377/hlthaff.2020.01084; Cawley J, 2004, AM J PREV MED, V27, P117, DOI 10.1016/j.amepre.2004.06.012; Gondi S, 2020, JAMA INTERN MED, V180, P1143, DOI 10.1001/jamainternmed.2020.2348; Mullainathan Sendhil., 2013, SCARCITY NEW SCI HAV; Yearby R., 2020, HLTH AFFAIRS BLOG 20	5	3	3	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					405	408		10.1056/NEJMp2104360	http://dx.doi.org/10.1056/NEJMp2104360		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YR1JU	35089666	Bronze			2022-12-28	WOS:000748300600001
J	Govindarajan, N; Xu, AN; Chan, K				Govindarajan, Nitish; Xu, Aoni; Chan, Karen			How pH affects electrochemical processes Three mechanisms underlie the impact of pH on the activity of electrochemical reactions	SCIENCE			English	Editorial Material							CARBON-MONOXIDE; REDUCTION; OXIDATION; ELECTROOXIDATION; GOLD		[Govindarajan, Nitish; Xu, Aoni; Chan, Karen] Tech Univ Denmark, Dept Phys, Catalysis Theory Ctr, DK-2800 Lyngby, Denmark	Technical University of Denmark	Chan, K (corresponding author), Tech Univ Denmark, Dept Phys, Catalysis Theory Ctr, DK-2800 Lyngby, Denmark.	kchan@fysik.dtu.dk		Xu, Aoni/0000-0001-5114-8740	Villum Fonden [9455, 29450]	Villum Fonden(Villum Fonden)	This work was supported by research grants (9455 and 29450) fromVillum Fonden.	Blizanac BB, 2004, J PHYS CHEM B, V108, P625, DOI 10.1021/jp036483l; Edens GJ, 1996, J PHYS CHEM-US, V100, P2322, DOI 10.1021/jp9525604; Heenen H. H., 2021, CHEMRXIV; Kelly SR, 2020, J PHYS CHEM C, V124, P14581, DOI 10.1021/acs.jpcc.0c02127; Kwon Y, 2011, J AM CHEM SOC, V133, P6914, DOI 10.1021/ja200976j; Lai SCS, 2010, CATAL TODAY, V154, P92, DOI 10.1016/j.cattod.2010.01.060; Lamoureux PS, 2019, ACS CATAL, V9, P6194, DOI 10.1021/acscatal.9b00268; Liu XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07970-9; Luc W, 2019, NAT CATAL, V2, P423, DOI 10.1038/s41929-019-0269-8; Rebollar L, 2020, ACS CATAL, V10, P14747, DOI 10.1021/acscatal.0c03801; Resasco J, 2018, CHEMELECTROCHEM, V5, P1064, DOI 10.1002/celc.201701316; Resasco J, 2017, J AM CHEM SOC, V139, P11277, DOI 10.1021/jacs.7b06765; Rodriguez P, 2010, PHYS CHEM CHEM PHYS, V12, P9373, DOI 10.1039/b926365a; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; Strmcniket al D., 2013, NAT CHEM, V5, P300	15	10	9	21	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					379	380		10.1126/science.abj2421	http://dx.doi.org/10.1126/science.abj2421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084961				2022-12-28	WOS:000750899500018
J	Sommer, F; Backhed, F				Sommer, Felix; Baeckhed, Fredrik			Staying strong during hibernation The microbiota of hibernating squirrels salvages urea to replenish amino acids	SCIENCE			English	Editorial Material							GROWTH		[Sommer, Felix] Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany; [Baeckhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Bruna Straket 16, S-41345 Gothenburg, Sweden; [Baeckhed, Fredrik] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden; [Baeckhed, Fredrik] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	University of Kiel; University of Gothenburg; Sahlgrenska University Hospital; Novo Nordisk Foundation; University of Copenhagen	Sommer, F (corresponding author), Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.	f.sommer@ikmb.uni-kiel.de						Carey HV, 2017, ANNU REV NUTR, V37, P477, DOI 10.1146/annurev-nutr-071816-064740; Chen RY, 2021, NEW ENGL J MED, V384, P1517, DOI 10.1056/NEJMoa2023294; Grond K, 2021, ANIM MICROBIOME, V3, DOI 10.1186/s42523-021-00117-0; Hindle AG, 2015, J EXP BIOL, V218, P276, DOI 10.1242/jeb.109512; LANGRAN M, 1992, CLIN SCI, V82, P191, DOI 10.1042/cs0820191; Puurunen MK, 2021, NAT METAB, V3, P1125, DOI 10.1038/s42255-021-00430-7; Raman AS, 2019, SCIENCE, V365, P140, DOI 10.1126/science.aau4735; Regan M. D, SCIENCE, V375, P460; Schroder L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103032; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Sommer F, 2017, NAT REV MICROBIOL, V15, P630, DOI 10.1038/nrmicro.2017.58; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Wiebler JM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0241	15	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					376	377		10.1126/science.abn6187	http://dx.doi.org/10.1126/science.abn6187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084958				2022-12-28	WOS:000750899500016
J	Hurley-Walker, N; Zhang, X; Bahramian, A; McSweeney, SJ; O'Doherty, TN; Hancock, PJ; Morgan, JS; Anderson, GE; Heald, GH; Galvin, TJ				Hurley-Walker, N.; Zhang, X.; Bahramian, A.; McSweeney, S. J.; O'Doherty, T. N.; Hancock, P. J.; Morgan, J. S.; Anderson, G. E.; Heald, G. H.; Galvin, T. J.			A radio transient with unusually slow periodic emission	NATURE			English	Article							PULSAR; SEARCH; I.	The high-frequency radio sky is bursting with synchrotron transients from massive stellar explosions and accretion events, but the low-frequency radio sky has, so far, been quiet beyond the Galactic pulsar population and the long-term scintillation of active galactic nuclei. The low-frequency band, however, is sensitive to exotic coherent and polarized radio-emission processes, such as electron-cyclotron maser emission from flaring M dwarfs(1), stellar magnetospheric plasma interactions with exoplanets(2) and a population of steep-spectrum pulsars(3), making Galactic-plane searches a prospect for blind-transient discovery. Here we report an analysis of archival low-frequency radio data that reveals a periodic, low-frequency radio transient. We find that the source pulses every 18.18 min, an unusual periodicity that has, to our knowledge, not been observed previously. The emission is highly linearly polarized, bright, persists for 30-60 s on each occurrence and is visible across a broad frequency range. At times, the pulses comprise short-duration (<0.5 s) bursts; at others, a smoother profile is observed. These profiles evolve on timescales of hours. By measuring the dispersion of the radio pulses with respect to frequency, we have localized the source to within our own Galaxy and suggest that it could be an ultra-long-period magnetar.	[Hurley-Walker, N.; Bahramian, A.; McSweeney, S. J.; O'Doherty, T. N.; Hancock, P. J.; Morgan, J. S.; Anderson, G. E.; Galvin, T. J.] Curtin Univ, Int Ctr Radio Astron Res ICRAR, Bentley, WA, Australia; [Zhang, X.; Heald, G. H.] CSIRO, Space & Astron, Bentley, WA, Australia; [Zhang, X.] Chinese Acad Sci, Shanghai Astron Observ, Shanghai, Peoples R China	Curtin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS	Hurley-Walker, N (corresponding author), Curtin Univ, Int Ctr Radio Astron Res ICRAR, Bentley, WA, Australia.	nhw@icrar.org	Galvin, Timothy/GOP-1751-2022; Anderson, Gemma/HGE-5759-2022; Hurley-Walker, Natasha/B-9520-2013; Hancock, Paul/G-8756-2014	Galvin, Timothy/0000-0002-2801-766X; Hurley-Walker, Natasha/0000-0002-5119-4808; McSweeney, Samuel/0000-0001-6114-7469; O'Doherty, Tyrone/0000-0001-9258-1508; Morgan, John/0000-0001-9224-5483; Hancock, Paul/0000-0002-4203-2946; Anderson, Gemma/0000-0001-6544-8007; Heald, George/0000-0002-2155-6054; Zhang, Xiang/0000-0002-2218-5638	Australian Research Council Future Fellowship [FT190100231]; Australian Research Council Discovery Early Career Researcher Award - Australian Government [DE180100346]; Australian Government (NCRIS); Western Australian Government; National Key R&D Programme of China [2018YFA0404603]; Chinese Academy of Sciences [114231KYSB20170003]; Australian Government	Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council Discovery Early Career Researcher Award - Australian Government(Australian Research Council); Australian Government (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); Western Australian Government; National Key R&D Programme of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Australian Government(Australian GovernmentCGIAR)	N.H.-W. is the recipient of an Australian Research Council Future Fellowship (project number FT190100231) and G.E.A. is the recipient of an Australian Research Council Discovery Early Career Researcher Award (project number DE180100346) funded by the Australian Government. This scientific work makes use of the Murchison Radio-astronomy Observatory, operated by CSIRO. We acknowledge the Wajarri Yamatji people as the traditional owners of the observatory site. Support for the operation of the Murchison Widefield Array is provided by the Australian Government (NCRIS), under a contract to Curtin University administered by Astronomy Australia Limited. We acknowledge the Pawsey Supercomputing Centre, which is supported by the Western Australian Government and the Australian Government. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. This project was supported by resources and expertise provided by CSIRO IMT Scientific Computing. This work used resources of China SKA Regional Centre prototype funded by the National Key R&D Programme of China (2018YFA0404603) and Chinese Academy of Sciences (114231KYSB20170003).	Bannister KW, 2016, SCIENCE, V351, P354, DOI 10.1126/science.aac7673; Bell ME, 2019, MON NOT R ASTRON SOC, V482, P2484, DOI 10.1093/mnras/sty2801; Benz AO, 2010, ANNU REV ASTRON ASTR, V48, P241, DOI 10.1146/annurev-astro-082708-101757; Brentjens MA, 2005, ASTRON ASTROPHYS, V441, P1217, DOI 10.1051/0004-6361:20052990; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Cameron AD, 2017, MON NOT R ASTRON SOC, V468, P1994, DOI 10.1093/mnras/stx589; Carbone D, 2016, MON NOT R ASTRON SOC, V459, P3161, DOI 10.1093/mnras/stw539; Champion D., 2020, MNRAS, V498, P6044; Clarke D, 2002, ASTRON ASTROPHYS, V386, P763, DOI 10.1051/0004-6361:20020258; Hajela A, 2019, MON NOT R ASTRON SOC, V490, P4898, DOI 10.1093/mnras/stz2918; Hurley-Walker N, 2018, ASTRON COMPUT, V25, P94, DOI 10.1016/j.ascom.2018.08.006; Hurley-Walker N, 2017, MON NOT R ASTRON SOC, V464, P1146, DOI 10.1093/mnras/stw2337; Hurley-Walker N., 2019, PASA, V36, pe047, DOI [10.1017/pasa.2019.37, DOI 10.1017/PASA.2019.37]; Hutschenreuter S, 2020, ASTRON ASTROPHYS, V633, DOI 10.1051/0004-6361/201935479; Hyman SD, 2005, NATURE, V434, P50, DOI 10.1038/nature03400; Keith MJ, 2010, MON NOT R ASTRON SOC, V409, P619, DOI 10.1111/j.1365-2966.2010.17325.x; Lafler J., 1965, ASTROPHYS J SUPPL, V11, P216; Levin L, 2012, MON NOT R ASTRON SOC, V422, P2489, DOI 10.1111/j.1365-2966.2012.20807.x; Lorimer DR., 2012, HDB PULSAR ASTRONOMY; Lynch CR, 2017, ASTROPHYS J LETT, V836, DOI 10.3847/2041-8213/aa5ffd; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Marsh TR, 2016, NATURE, V537, P374, DOI 10.1038/nature18620; Nasa High Energy Astrophysics Science Archive Research Center (Heasarc), 2014, ASCL1408004; Offringa AR, 2016, MON NOT R ASTRON SOC, V458, P1057, DOI 10.1093/mnras/stw310; Offringa AR, 2014, MON NOT R ASTRON SOC, V444, P606, DOI 10.1093/mnras/stu1368; Olausen SA, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/6; Pietka M, 2015, MON NOT R ASTRON SOC, V446, P3687, DOI 10.1093/mnras/stu2335; Polisensky E, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/1/60; Rea N, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/1/L12; Riseley CJ, 2020, PUBL ASTRON SOC AUST, V37, DOI 10.1017/pasa.2020.20; Riseley CJ, 2018, PUBL ASTRON SOC AUST, V35, DOI 10.1017/pasa.2018.39; SchwarzenbergCzerny A, 1996, ASTROPHYS J, V460, pL107, DOI 10.1086/309985; STELLINGWERF RF, 1978, ASTROPHYS J, V224, P953, DOI 10.1086/156444; Stewart AJ, 2016, MON NOT R ASTRON SOC, V456, P2321, DOI 10.1093/mnras/stv2797; Sutinjo A, 2015, RADIO SCI, V50, P52, DOI 10.1002/2014RS005517; Swainston NA, 2021, ASTROPHYS J LETT, V911, DOI 10.3847/2041-8213/abec7b; Szary A, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/59; Tingay SJ, 2013, PUBL ASTRON SOC AUST, V30, DOI 10.1017/pasa.2012.007; Vedantham HK, 2020, NAT ASTRON, V4, P577, DOI 10.1038/s41550-020-1011-9; Vedantham HK, 2017, ASTROPHYS J, V845, DOI 10.3847/1538-4357/aa745c; Wayth RB, 2015, PUBL ASTRON SOC AUST, V32, DOI 10.1017/pasa.2015.26; Wayth RB, 2018, PUBL ASTRON SOC AUST, V35, DOI 10.1017/pasa.2018.37; Yao JM, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/1/29; Zarka P, 2001, ASTROPHYS SPACE SCI, V277, P293, DOI 10.1023/A:1012221527425; Zhang B, 2000, ASTROPHYS J, V531, pL135, DOI 10.1086/312542	47	11	11	4	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					526	+		10.1038/s41586-021-04272-x	http://dx.doi.org/10.1038/s41586-021-04272-x			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082416				2022-12-28	WOS:000749546400018
J	Helfand, M; Fiordalisi, C; Wiedrick, J; Ramsey, KL; Armstrong, C; Gean, E; Winchell, K; Arkhipova-Jenkins, I				Helfand, Mark; Fiordalisi, Celia; Wiedrick, Jack; Ramsey, Katrina L.; Armstrong, Charlotte; Gean, Emily; Winchell, Kara; Arkhipova-Jenkins, Irina			Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection	ANNALS OF INTERNAL MEDICINE			English	Review							RATES	Background: The strength and duration of immunity from infection with SARS-CoV-2 are important for public health plan-ning and clinical practice. Purpose: To synthesize evidence on protection against rein-fection after SARS-CoV-2 infection. Data Sources: MEDLINE (Ovid), the World Health Organization global literature database, ClinicalTrials.gov, COVID19reviews.org, and reference lists. Study Selection: Longitudinal studies that compared the risk for reinfection after SARS-CoV-2 infection versus infec-tion risk in individuals with no prior infection. Data Extraction: Two investigators sequentially extracted study data and rated quality. Data Synthesis: Across 18 eligible studies, reinfection risk ranged from 0% to 2.2%. In persons with recent SARS-CoV-2 infection compared with unvaccinated, previously uninfected individuals, 80% to 98% of symptomatic infections with wild-type or Alpha variants were prevented (high strength of evi-dence). In the meta-analysis, previous infection reduced risk for reinfection by 87% (95% CI, 84% to 90%), equaling 4.3 fewer infections per 100 persons in both the general population (risk difference,-0.043 [CI,-0.071 to-0.015]) and health care workers (risk difference,-0.043 [CI,-0.069 to-0.016]), and 26.6 fewer infections per 100 persons in care facilities (risk dif-ference,-0.266 [CI,-0.449 to-0.083]). Protection remained above 80% for at least 7 months, but no study followed patients after the emergence of the Delta or Omicron variant. Results for the elderly were conflicting. Limitation: Methods to ascertain and diagnose infections varied. Conclusion: Before the emergence of the Delta and Omicron variants, persons with recent infection had strong protection against symptomatic reinfections for 7 months compared with unvacci-nated, previously uninfected individuals. Protection in immunocom-promised persons, racial and ethnic subgroups, and asymptomatic index case patients is unclear. The durability of protection in the setting of the Delta and Omicron variants is unknown.	[Helfand, Mark; Fiordalisi, Celia; Armstrong, Charlotte; Gean, Emily; Winchell, Kara; Arkhipova-Jenkins, Irina] Portland VA Res Fdn, Sci Resource Ctr AHRQ Evidence Based Practice Ctr, VA Portland Healthcare Syst, Portland, OR USA; [Wiedrick, Jack; Ramsey, Katrina L.] Oregon Hlth & Sci Univ, Biostat & Design Program, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Helfand, M (corresponding author), 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Mark.Helfand@va.gov		Helfand, Mark/0000-0003-4846-9900; Fiordalisi, Celia/0000-0001-5610-1925; Armstrong, Charlotte/0000-0001-7918-5228	Agency for Healthcare Research and Quality [PROSPERO: CRD42020207098]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality. (PROSPERO: CRD42020207098)	Abo-Leyah H, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00080-2021; Abu-Raddad LJ, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100861; Agency for Healthcare Research and Quality, 2020, IMM COVID 19; Arkhipova-Jenkins I, 2021, ANN INTERN MED, V174, P811, DOI 10.7326/M20-7547; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Berkman ND, 2013, METHODS GUIDE EFFECT; Borenstein M., 2009, INTRO METAANALYSIS; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Cavanaugh AM, 2021, MMWR-MORBID MORTAL W, V70, P1081, DOI [10.15585/mmwr.mm7032e1, 10.15585/mmwr.mm7032e1externalicon]; Dong X, 2021, COMPREHENSIVE CHARAC, DOI [10.1101/2021.06.10.21256915, DOI 10.1101/2021.06.10.21256915]; Finch E, 2021, SARS COV 2 INFECT RE, DOI [10.1101/ 2021.05.04.21256609, DOI 10.1101/2021.05.04.21256609]; Gallais F., 2021, MEDRXIV, DOI [10.1101/2021.05.07.21256823(2021, DOI 10.1101/2021.05.07.21256823(2021, 10.1101/2021.05.07.21256823]; Gazit S, COMP SARS COV 2 NATU, V2021, DOI [10.1101/2021.08.24.21262415, DOI 10.1101/2021.08.24.21262415, DOI 10.1101/2021.08.24.21262415V1]; Goldberg Y., 2021, PROTECTION PREVIOUS, DOI [10.1101/2021.04.20.21255670, DOI 10.1101/2021.04.20.21255670]; Graham MS, 2021, LANCET PUBLIC HEALTH, V6, pE335, DOI 10.1016/S2468-2667(21)00055-4; Hagan LM, 2021, MMWR-MORBID MORTAL W, V70, P1349, DOI 10.15585/mmwr.mm7038e3; Hall VJ, 2021, LANCET, V397, P1459, DOI 10.1016/S0140-6736(21)00675-9; Hanrath AT, 2021, J INFECTION, V82, pE29, DOI 10.1016/j.jinf.2020.12.023; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harvey RA, 2021, JAMA INTERN MED, V181, P672, DOI 10.1001/jamainternmed.2021.0366; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodgson SH, 2021, LANCET INFECT DIS, V21, pE26, DOI 10.1016/S1473-3099(20)30773-8; Jeffery-Smith A, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.5.2100092; Johanna Briggs Institute, 2017, CRIT APPR CHECKL COH; Krammer F, 2021, NAT MED, V27, P1147, DOI 10.1038/s41591-021-01432-4; Krutikov M, 2021, LANCET HEALTH LONGEV, V2, pE362, DOI 10.1016/S2666-7568(21)00093-3; Leidi A, 2022, CLIN INFECT DIS, V74, P622, DOI 10.1093/cid/ciab495; Letizia AG, 2021, LANCET RESP MED, V9, P712, DOI 10.1016/S2213-2600(21)00158-2; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Manica M, 2022, CLIN INFECT DIS, V74, P893, DOI 10.1093/cid/ciab556; Pilz S, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13520; Prete CA, 2021, MEDRXIV, DOI [10.1101/2021.05.10.21256644, DOI 10.1101/2021.05.10.21256644]; Pulliam J.R.C., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068.]; Qureshi AI, 2022, CLIN INFECT DIS, V74, P294, DOI 10.1093/cid/ciab345; Rennert L, 2022, CLIN INFECT DIS, V74, P719, DOI 10.1093/cid/ciab454; Schuler CF, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00087-21; Sheehan MM, 2021, CLIN INFECT DIS, V73, P1882, DOI 10.1093/cid/ciab234; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Vitale J, 2021, JAMA INTERN MED, V181, P1407, DOI 10.1001/jamainternmed.2021.2959	40	12	12	7	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					547	+		10.7326/M21-4245	http://dx.doi.org/10.7326/M21-4245		JAN 2022	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35073157	Green Published			2022-12-28	WOS:000748956600001
J	Slomski, A				Slomski, Anita			Financial Incentives Help People Quit Smoking During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					314	314						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076670				2022-12-28	WOS:000753055700030
J	Aybek, S; Perez, DL				Aybek, Selma; Perez, David L.			Diagnosis and management of functional neurological disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PSYCHOGENIC NONEPILEPTIC SEIZURES; QUALITY-OF-LIFE; TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE-BEHAVIORAL THERAPY; LABORATORY-SUPPORTED CRITERIA; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CLINICAL-TRIAL; MOVEMENT-DISORDERS; CONVERSION DISORDER; MOTOR SYMPTOMS	Functional neurological disorder (FND), previously regarded as a diagnosis of exclusion, is now a rule-in diagnosis with available treatments. This represents a major step toward destigmatizing the disorder, which was often doubted and deemed untreatable. FND is prevalent, generally affecting young and middle aged adults, and can cause severe disability in some individuals. An early diagnosis, with subsequent access to evidence based rehabilitative and/or psychological treatments, can promote recovery-albeit not all patients respond to currently available treatments. This review presents the latest advances in the use of validated rule-in examination signs to guide diagnosis, and the range of therapeutic approaches available to care for patients with FND. The article focuses on the two most frequently identified subtypes of FND: motor (weakness and/or movement disorders) and seizure type symptoms. Twenty two studies on motor and 27 studies on seizure type symptoms report high specificities of clinical signs (64-100%), and individual signs are reviewed. Rehabilitative interventions (physical and occupational therapy) are treatments of choice for functional motor symptoms, while psychotherapy is an emerging evidence based treatment across FND subtypes. The literature to date highlights heterogeneity in responses to treatment, underscoring that more research is needed to individualize treatments and develop novel interventions.	[Aybek, Selma] Univ Alberta Hosp, Edmonton, AB, Canada; [Perez, David L.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Perez, David L.] VA Pittsburgh Geriatr Res Educ & Clin Ctr GRECC, Pittsburgh, PA USA	University of Alberta; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aybek, S (corresponding author), Univ Alberta Hosp, Edmonton, AB, Canada.	selma.aybek@med.unibe.ch		Perez, David/0000-0003-2721-583X	Swiss National Science Foundation [PP00P3_176985]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	SA was supported by the Swiss National Science Foundation grant PP00P3_176985.	Aboud O, 2019, J CLIN NEUROSCI, V59, P141, DOI 10.1016/j.jocn.2018.10.113; Altalib HH, 2016, EPILEPSY BEHAV, V64, P4, DOI 10.1016/j.yebeh.2016.08.032; Anderson JR, 2019, SEMIN NEUROL, V39, P102, DOI 10.1055/s-0038-1676844; Anderson KE, 2007, MOVEMENT DISORD, V22, P2204, DOI 10.1002/mds.21687; Arain AM, 2007, EPILEPSY BEHAV, V11, P409, DOI 10.1016/j.yebeh.2007.07.017; Asadi-Pooya AA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106895; Asadi-Pooya AA, 2016, EPILEPSY BEHAV, V59, P1, DOI 10.1016/j.yebeh.2016.03.012; Aybek S, 2020, J NEUROPSYCH CLIN N, V32, P79, DOI 10.1176/appi.neuropsych.19040083; Aybek S, 2019, J NEUROL NEUROSUR PS, V90, P845, DOI 10.1136/jnnp-2019-320597; Azar NJ, 2008, EPILEPSIA, V49, P132, DOI 10.1111/j.1528-1167.2007.01215.x; Babinski, 1900, GAZETTE HOPITAUX, V73, P533; Baizabal-Carvallo JF, 2017, J NEUROL, V264, P1482, DOI 10.1007/s00415-017-8551-7; Baizabal-Carvallo JF, 2017, J NEUROL, V264, P359, DOI 10.1007/s00415-016-8356-0; Baker J, 2021, J NEUROL NEUROSUR PS, V92, P1112, DOI 10.1136/jnnp-2021-326767; BAKER JHE, 1987, J NEUROL NEUROSUR PS, V50, P375, DOI 10.1136/jnnp.50.4.375; Ball HA, 2020, BRAIN, V143, P2895, DOI 10.1093/brain/awaa224; Barry JJ, 2008, EPILEPSY BEHAV, V13, P624, DOI 10.1016/j.yebeh.2008.06.013; Baslet G, 2021, J NEUROPSYCH CLIN N, V33, P27, DOI 10.1176/appi.neuropsych.19120354; Baslet G, 2020, EPILEPSY BEHAV, V103, DOI 10.1016/j.yebeh.2019.106534; Battle DE, 2013, CODAS, V25, P191; Bazil CW, 1997, EPILEPSIA, V38, P56, DOI 10.1111/j.1528-1157.1997.tb01077.x; Begue I, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101798; Bell WL, 1998, ARCH NEUROL-CHICAGO, V55, P1456, DOI 10.1001/archneur.55.11.1456; Benbadis SR, 2010, NEUROLOGY, V75, P84, DOI 10.1212/WNL.0b013e3181e6216f; Benbadis SR, 1996, NEUROLOGY, V47, P63, DOI 10.1212/WNL.47.1.63; Binzer M, 1997, J NEUROL NEUROSUR PS, V63, P83, DOI 10.1136/jnnp.63.1.83; Bravo TP, 2013, NEUROLOGIST, V19, P30, DOI 10.1097/NRL.0b013e31827c6bfd; Brigo F, 2013, SEIZURE-EUR J EPILEP, V22, P85, DOI 10.1016/j.seizure.2012.10.011; Brough JL, 2015, J PSYCHOSOM RES, V79, P420, DOI 10.1016/j.jpsychores.2015.09.009; Bullock K, 2020, J NEUROPSYCH CLIN N, V32, P90, DOI 10.1176/appi.neuropsych.19030071; Bullock KD, 2015, J NEUROPSYCH CLIN N, V27, P240, DOI 10.1176/appi.neuropsych.13120359; Burke MJ, 2020, J NEUROPSYCH CLIN N, V32, P101, DOI 10.1176/appi.neuropsych.19030077; Burke MJ, 2019, JAMA NEUROL, V76, P1417, DOI 10.1001/jamaneurol.2019.3043; Carlson P, 2017, SEIZURE-EUR J EPILEP, V45, P142, DOI 10.1016/j.seizure.2016.12.007; Carson A, 2016, HAND CLINIC, V139, P47, DOI 10.1016/B978-0-12-801772-2.00005-9; Carson A, 2011, J NEUROL NEUROSUR PS, V82, P810, DOI 10.1136/jnnp.2010.220640; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P207, DOI 10.1136/jnnp.68.2.207; Carson Alan, 2016, Pract Neurol, V16, P56, DOI 10.1136/practneurol-2015-001242; Cervenka MC, 2013, EPILEPSY BEHAV, V28, P217, DOI 10.1016/j.yebeh.2013.05.016; CHABROL H, 1995, EUR PSYCHIAT, V10, P317, DOI 10.1016/0924-9338(96)80314-2; Charcot J.-M., 1889, CLIN LECT DIS NERVOU; Chen DK, 2008, EPILEPSY BEHAV, V13, P115, DOI 10.1016/j.yebeh.2008.02.018; Chen DK, 2014, EPILEPSIA, V55, P156, DOI 10.1111/epi.12481; Chung SS, 2006, NEUROLOGY, V66, P1730, DOI 10.1212/01.wnl.0000218160.31537.87; Conwill M, 2014, EPILEPSY BEHAV, V34, P68, DOI 10.1016/j.yebeh.2014.03.012; Cope SR, 2021, EUR J NEUROL, V28, P40, DOI 10.1111/ene.14525; Criswell S, 2010, PARKINSONISM RELAT D, V16, P197, DOI 10.1016/j.parkreldis.2009.11.007; Cronje G, 2013, EPILEPSY BEHAV, V29, P581, DOI 10.1016/j.yebeh.2013.09.045; Dallocchio C, 2016, PSYCHOTHER PSYCHOSOM, V85, P381, DOI 10.1159/000446660; Daum C, 2015, J NEUROL NEUROSUR PS, V86, P425, DOI 10.1136/jnnp-2013-307381; Daum C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-31; De Paola L, 2016, EPILEPSY BEHAV, V54, P40, DOI 10.1016/j.yebeh.2015.10.025; Deeley Q, 2016, HAND CLINIC, V139, P585, DOI 10.1016/B978-0-12-801772-2.00047-3; Demartini B, 2015, EUR J NEUROL, V22, P527, DOI 10.1111/ene.12609; Demartini B, 2020, PARKINSONISM RELAT D, V76, P108, DOI 10.1016/j.parkreldis.2019.05.004; DeToledo JC, 1996, NEUROLOGY, V47, P621, DOI 10.1212/WNL.47.3.621; Devinsky O, 1996, NEUROLOGY, V46, P1530, DOI 10.1212/WNL.46.6.1530; Ding JM, 2017, GEN HOSP PSYCHIAT, V45, P51, DOI 10.1016/j.genhosppsych.2016.12.009; Ding JM, 2016, J PSYCHOSOM RES, V91, P55, DOI 10.1016/j.jpsychores.2016.10.012; Drane DL, 2021, CNS SPECTRUMS, V26, P555, DOI 10.1017/S1092852920001789; Drane DL, 2016, EPILEPSY BEHAV, V54, P34, DOI 10.1016/j.yebeh.2015.10.026; Dreissen YEM, 2019, J NEUROL NEUROSUR PS, V90, P1244, DOI 10.1136/jnnp-2018-320071; Dufresne D, 2019, SEIZURE-EUR J EPILEP, V66, P39, DOI 10.1016/j.seizure.2019.02.005; Duncan R, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106667; Duncan R, 2011, EPILEPSY BEHAV, V20, P308, DOI 10.1016/j.yebeh.2010.10.022; Edwards MJ, 2019, BRAIN, V142, P1855, DOI 10.1093/brain/awz194; Edwards MJ, 2014, MOVEMENT DISORD, V29, P849, DOI 10.1002/mds.25562; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Edwards MJ, 2011, MOVEMENT DISORD, V26, P917, DOI 10.1002/mds.23562; Espay AJ, 2009, MOVEMENT DISORD, V24, P1366, DOI 10.1002/mds.22618; Fahn S, 2014, MOVEMENT DISORD, V29, P853, DOI 10.1002/mds.25899; Farias ST, 2003, EPILEPSY BEHAV, V4, P424, DOI 10.1016/S1525-5050(03)00143-4; Fasano A, 2012, MOVEMENT DISORD, V27, P1544, DOI 10.1002/mds.25190; Fekete R, 2012, J NEUROL NEUROSUR PS, V83, P202, DOI 10.1136/jnnp-2011-300733; Baizabal-Carvallo JF, 2020, NEUROL SCI, V41, P911, DOI 10.1007/s10072-019-04185-8; Frucht L, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.605262; Gambini O, 2014, EPILEPSY BEHAV, V41, P140, DOI 10.1016/j.yebeh.2014.09.076; Ganos C, 2019, NEUROLOGY, V93, P750, DOI 10.1212/WNL.0000000000008372; Garcin B, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00338; Garcin B, 2013, J NEUROL NEUROSUR PS, V84, P1043, DOI 10.1136/jnnp-2012-304062; GATES JR, 1985, ARCH NEUROL-CHICAGO, V42, P1183, DOI 10.1001/archneur.1985.04060110065017; Gelauff EM, 2019, BRAIN, V142, P2137, DOI 10.1093/brain/awz138; Gelauff JM, 2018, J NEUROL, V265, P1803, DOI 10.1007/s00415-018-8915-7; Gelauff J, 2014, J NEUROL NEUROSUR PS, V85, P220, DOI 10.1136/jnnp-2013-305321; Gelauff JM, 2020, NEUROLOGY, V95, pE1883, DOI 10.1212/WNL.0000000000010381; Gendre T, 2019, J PSYCHOSOM RES, V116, P10, DOI 10.1016/j.jpsychores.2018.11.006; Geyer JD, 2000, NEUROLOGY, V54, P227, DOI 10.1212/WNL.54.1.227; Goldstein LH, 2010, NEUROLOGY, V74, P1986, DOI 10.1212/WNL.0b013e3181e39658; Goldstein LH, 2020, LANCET PSYCHIAT, V7, P491, DOI 10.1016/S2215-0366(20)30128-0; Goleva SB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.27920; Gutkin M, 2020, J NEUROL NEUROSUR PS, V5; Hall-Patch L, 2010, EPILEPSIA, V51, P70, DOI 10.1111/j.1528-1167.2009.02099.x; Hallett M, 2006, CURR NEUROL NEUROSCI, V6, P269, DOI 10.1007/s11910-006-0015-x; Horn D, 2017, MOV DISORD CLIN PRAC, V4, P597, DOI 10.1002/mdc3.12492; Izadyar S, 2018, EPILEPSY BEHAV, V88, P123, DOI 10.1016/j.yebeh.2018.08.020; Jacob AE, 2018, J NEUROL NEUROSUR PS, V89, P1011, DOI 10.1136/jnnp-2017-316523; Jacob AE, 2018, PM&R, V10, P1164, DOI 10.1016/j.pmrj.2018.05.011; Jankovic J, 2014, MOVEMENT DISORD, V29, P1697, DOI 10.1002/mds.26040; Jedrzejczak J, 1999, EUR J NEUROL, V6, P473, DOI 10.1046/j.1468-1331.1999.640473.x; Jones B, 2016, EPILEPSIA, V57, P171, DOI 10.1111/epi.13268; Jordbru AA, 2014, J REHABIL MED, V46, P181, DOI 10.2340/16501977-1246; Kanaan R, 2009, PATIENT EDUC COUNS, V77, P296, DOI 10.1016/j.pec.2009.05.021; Kanaan R, 2009, BRAIN, V132, P2889, DOI 10.1093/brain/awp060; Kanaan RA, 2011, J NEUROL NEUROSUR PS, V82, P961, DOI 10.1136/jnnp.2010.233114; Karakis I, 2020, EPILEPSY BEHAV, V111, DOI 10.1016/j.yebeh.2020.107269; Kaski D, 2015, LANCET NEUROL, V14, P1196, DOI 10.1016/S1474-4422(15)00226-4; Kerr WT, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.107002; Keynejad RC, 2017, LANCET PSYCHIAT, V4, pE2, DOI 10.1016/S2215-0366(17)30036-6; Koehler PJ, 2004, NEUROLOGY, V63, P1693, DOI 10.1212/01.WNL.0000142977.21104.94; Kompoliti K, 2014, PARKINSONISM RELAT D, V20, P60, DOI 10.1016/j.parkreldis.2013.09.018; Kutlubaev MA, 2018, EPILEPSY BEHAV, V89, P70, DOI 10.1016/j.yebeh.2018.10.010; Kuyk J, 1999, EPILEPSIA, V40, P485, DOI 10.1111/j.1528-1157.1999.tb00745.x; LaFaver K, 2020, EUR J NEUROL, V27, P975, DOI 10.1111/ene.14200; LaFaver K, 2014, MOVEMENT DISORD, V29, P1698, DOI 10.1002/mds.26035; LaFrance WC, 2010, NEUROLOGY, V75, P1166, DOI 10.1212/WNL.0b013e3181f4d5a9; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2011, EPILEPSIA, V52, P292, DOI 10.1111/j.1528-1167.2010.02765.x; LaFrance WC, 2010, NEUROLOGY, V75, P87, DOI 10.1212/WNL.0b013e3181e62181; LaFrance WC, 2009, NEUROLOGY, V73, P366, DOI 10.1212/WNL.0b013e3181b04c83; LaFrance WC, 2020, EPILEPSIA, V61, P2572, DOI 10.1111/epi.16689; Lagrand T, 2021, EUR J NEUROL, V28, P33, DOI 10.1111/ene.14488; LANG AE, 1995, CAN J NEUROL SCI, V22, P136, DOI 10.1017/S031716710004021X; Laub HN, 2015, MOV DISORD CLIN PRAC, V2, P29, DOI 10.1002/mdc3.12102; Lenio S, 2021, EPILEPSY BEHAV, V116, DOI 10.1016/j.yebeh.2021.107767; Lombardi TL, 2014, J NEUROL NEUROSUR PS, V85, P165, DOI 10.1136/jnnp-2012-304314; Ludwig L, 2018, LANCET PSYCHIAT, V5, P307, DOI 10.1016/S2215-0366(18)30051-8; MACE CJ, 1991, J ROY SOC MED, V84, P471, DOI 10.1177/014107689108400808; Maggio J, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa156; Maggio JB, 2020, J NEUROPSYCH CLIN N, V32, P85, DOI 10.1176/appi.neuropsych.19030068; Mayor R, 2012, EPILEPSY BEHAV, V25, P676, DOI 10.1016/j.yebeh.2012.09.033; Mayor R, 2013, SEIZURE-EUR J EPILEP, V22, P760, DOI 10.1016/j.seizure.2013.06.008; McCormack R, 2014, J NEUROL NEUROSUR PS, V85, P893, DOI 10.1136/jnnp-2013-305716; McKee K, 2018, PSYCHOSOMATICS, V59, P358, DOI 10.1016/j.psym.2017.12.006; McWhirter L, 2016, J PSYCHOSOM RES, V89, P102, DOI 10.1016/j.jpsychores.2016.08.010; McWhirter L, 2011, J PSYCHOSOM RES, V71, P384, DOI 10.1016/j.jpsychores.2011.09.003; Medina M, 2021, ACAD PSYCHIATR, V45, P185, DOI 10.1007/s40596-020-01324-8; Mitchell JW, 2012, EPILEPSY BEHAV, V25, P307, DOI 10.1016/j.yebeh.2012.08.022; Moene FC, 2003, INT J CLIN EXP HYP, V51, P29, DOI 10.1076/iceh.51.1.29.14067; Moene FC, 2002, PSYCHOTHER PSYCHOSOM, V71, P66, DOI 10.1159/000049348; Myers L, 2017, EPILEPSY BEHAV, V66, P86, DOI 10.1016/j.yebeh.2016.10.019; Nicholson C, 2020, J NEUROL NEUROSUR PS, V91, P1037, DOI 10.1136/jnnp-2019-322281; Nicholson TRJ, 2016, HAND CLINIC, V139, P619, DOI 10.1016/B978-0-12-801772-2.00050-3; Nicholson TR, 2020, J NEUROPSYCH CLIN N, V32, P33, DOI 10.1176/appi.neuropsych.19060128; Nielsen G, 2017, J NEUROL NEUROSUR PS, V88, P484, DOI 10.1136/jnnp-2016-314408; Nielsen G, 2015, J NEUROL, V262, P674, DOI 10.1007/s00415-014-7631-1; Nielsen G, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1461-9; Nielsen G, 2015, J NEUROL NEUROSUR PS, V86, P1113, DOI 10.1136/jnnp-2014-309255; Nielsen G, 2013, J PSYCHOSOM RES, V75, P93, DOI 10.1016/j.jpsychores.2013.05.006; Nightscales R, 2020, NEUROLOGY, V95, pE643, DOI 10.1212/WNL.0000000000009855; Nonnekes J, 2020, NEUROLOGY, V94, P1093, DOI 10.1212/WNL.0000000000009649; Nunez-Wallace KR, 2015, EPILEPSY RES, V114, P114, DOI 10.1016/j.eplepsyres.2015.05.002; Okun MS, 2007, NEUROLOGIST, V13, P87, DOI 10.1097/01.nrl.0000256358.52613.cc; Oliva M, 2008, EPILEPSIA, V49, P962, DOI 10.1111/j.1528-1167.2008.01554.x; Park JE, 2015, MOV DISORD CLIN PRAC, V2, P286, DOI 10.1002/mdc3.12177; PEGUERO E, 1995, EPILEPSIA, V36, P586, DOI 10.1111/j.1528-1157.1995.tb02572.x; Perez DL, 2020, NEUROL-CLIN PRACT, V10, P484, DOI 10.1212/CPJ.0000000000000779; Perez DL, 2021, J NEUROPSYCH CLIN N, V33, P14, DOI 10.1176/appi.neuropsych.19120357; Perez DL, 2020, LANCET PSYCHIAT, V7, P464, DOI 10.1016/S2215-0366(20)30143-7; Perez DL, 2019, NEUROL-CLIN PRACT, V9, P165, DOI 10.1212/CPJ.0000000000000573; Perez DL, 2016, COGN BEHAV NEUROL, V29, P197, DOI 10.1097/WNN.0000000000000106; Perez DL, 2015, CLIN EEG NEUROSCI, V46, P4, DOI 10.1177/1550059414555905; Peterson KT, 2018, PSYCHOSOMATICS, V59, P601, DOI 10.1016/j.psym.2018.03.001; Pick S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037198; Pick S, 2020, J NEUROL NEUROSUR PS, V91, P638, DOI 10.1136/jnnp-2019-322180; Pintor L, 2010, J NEUROPSYCH CLIN N, V22, P401, DOI 10.1176/appi.neuropsych.22.4.401; Pizza F, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy026; Polara GF, 2018, J NEUROL SCI, V387, P37, DOI 10.1016/j.jns.2018.01.022; Popkirov Stoyan, 2018, Pract Neurol, V18, P5, DOI 10.1136/practneurol-2017-001809; Popkirov S, 2015, EPILEPSY BEHAV, V46, P88, DOI 10.1016/j.yebeh.2015.04.020; Quigg M, 2002, EPILEPSY BEHAV, V3, P455, DOI 10.1016/S1525-5050(02)00524-3; Rawlings GH, 2017, EPILEPSY BEHAV, V68, P153, DOI 10.1016/j.yebeh.2016.10.035; Razvi S, 2012, EPILEPSY BEHAV, V23, P7, DOI 10.1016/j.yebeh.2011.10.009; Reiter J, 2015, TAKING CONTROL YOUR, DOI [10.1093/me d:psych/9780199335015.001.0001, DOI 10.1093/MED:PSYCH/9780199335015.001.0001]; Reuber M, 2019, PRACT NEUROL, V19, P332, DOI 10.1136/practneurol-2018-002177; Reuber M, 2016, NEUROLOGY, V87, P625, DOI 10.1212/WNL.0000000000002948; Robson C, 2018, SEIZURE-EUR J EPILEP, V55, P93, DOI 10.1016/j.seizure.2018.01.001; Rockliffe-Fidler Claire, 2019, Pract Neurol, V19, P259, DOI 10.1136/practneurol-2018-002100; Roper Louise S, 2013, Pract Neurol, V13, P396, DOI 10.1136/practneurol-2013-000549; Salinsky M, 2016, EPILEPSY BEHAV, V60, P107, DOI 10.1016/j.yebeh.2016.04.007; SAYGI S, 1992, NEUROLOGY, V42, P1274, DOI 10.1212/WNL.42.7.1274; Schrag A, 2004, BRAIN, V127, P2360, DOI 10.1093/brain/awh262; Schwingenschuh P, 2016, MOVEMENT DISORD, V31, P555, DOI 10.1002/mds.26525; Schwingenschuh P, 2011, MOVEMENT DISORD, V26, P2509, DOI 10.1002/mds.23922; Selkirk M, 2008, EPILEPSIA, V49, P1446, DOI 10.1111/j.1528-1167.2008.01611.x; Sen A, 2007, EPILEPSY RES, V77, P62, DOI 10.1016/j.eplepsyres.2007.07.009; Seneviratne U, 2017, EPILEPSY BEHAV, V66, P127, DOI 10.1016/j.yebeh.2016.10.024; Sharpe M, 2011, NEUROLOGY, V77, P564, DOI 10.1212/WNL.0b013e318228c0c7; SHEN W, 1990, NEUROLOGY, V40, P756, DOI 10.1212/WNL.40.5.756; Sigurdardottir KR, 1998, EPILEPSIA, V39, P749, DOI 10.1111/j.1528-1157.1998.tb01161.x; SLATER JD, 1995, EPILEPSIA, V36, P580, DOI 10.1111/j.1528-1157.1995.tb02571.x; Sonoo M, 2004, J NEUROL NEUROSUR PS, V75, P121; Spina JP, 2019, J AFFECT DISORDERS, V258, P50, DOI 10.1016/j.jad.2019.07.061; STEFANSSON JG, 1976, ACTA PSYCHIAT SCAND, V53, P119, DOI 10.1111/j.1600-0447.1976.tb00066.x; Stephen CD, 2021, JAMA NEUROL, V78, P88, DOI 10.1001/jamaneurol.2020.3753; STEVENS DL, 1989, J NEUROL NEUROSUR PS, V52, P439, DOI 10.1136/jnnp.52.4.439; Stone J, 2005, BRIT MED J, V331, P989, DOI 10.1136/bmj.38628.466898.55; Stone J, 2016, HAND CLINIC, V139, P543, DOI 10.1016/B978-0-12-801772-2.00044-8; Stone J, 2014, NEUROPHYSIOL CLIN, V44, P363, DOI 10.1016/j.neucli.2014.01.002; Stone J, 2003, J NEUROL NEUROSUR PS, V74, P591, DOI 10.1136/jnnp.74.5.591; Stone J, 2002, BRIT MED J, V325, P1449, DOI 10.1136/bmj.325.7378.1449; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Stone J, 2006, PRACT NEUROL, V6, P64, DOI [10.1136/jnnp.2005.012345, DOI 10.1136/JNNP.2005.012345]; Stone JC, 2012, I COULDNT VIEW THIS; Stone J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3745; Stone Jon, 2017, Pract Neurol, V17, P417, DOI 10.1136/practneurol-2017-001660; Stone Jon, 2015, Continuum (Minneap Minn), V21, P818, DOI 10.1212/01.CON.0000466669.02477.45; Stone J, 2014, J PSYCHOSOM RES, V76, P165, DOI 10.1016/j.jpsychores.2013.10.003; Stone J, 2012, NEUROLOGY, V79, P282, DOI 10.1212/WNL.0b013e31825fdf63; Stone J, 2010, BRAIN, V133, P1537, DOI 10.1093/brain/awq068; Sundararajan T, 2016, SEIZURE-EUR J EPILEP, V35, P11, DOI 10.1016/j.seizure.2015.12.011; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345; Szaflarski JP, 2003, EPILEPSIA, V44, P236, DOI 10.1046/j.1528-1157.2003.35302.x; Taib S, 2019, MOVEMENT DISORD, V34, P1210, DOI 10.1002/mds.27727; Tatum WO, 2020, JAMA NEUROL, V77, P593, DOI 10.1001/jamaneurol.2019.4785; Teodoro T, 2019, NEURO-OPHTHALMOLOGY, V43, P240, DOI 10.1080/01658107.2018.1536998; Testa SM, 2007, EPILEPSIA, V48, P973, DOI 10.1111/j.1528-1167.2006.00965.x; Thenganatt MA, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8FJ2F0Q; Thomsen BLC, 2020, J NEUROL NEUROSUR PS, V91, P1261, DOI 10.1136/jnnp-2020-323141; Tinazzi M, 2008, MOVEMENT DISORD, V23, P2415, DOI 10.1002/mds.22268; Tolchin B, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107364; Tolchin B, 2019, EPILEPSIA, V60, P986, DOI 10.1111/epi.14728; Trimble M, 2016, HAND CLINIC, V139, P3, DOI 10.1016/B978-0-12-801772-2.00001-1; van der Stouwe AMM, 2016, PARKINSONISM RELAT D, V30, P23, DOI 10.1016/j.parkreldis.2016.06.008; Vanek J, 2021, NAT SCI SLEEP, V13, P209, DOI 10.2147/NSS.S289190; Vechetova G, 2018, J PSYCHOSOM RES, V115, P32, DOI 10.1016/j.jpsychores.2018.10.001; Villagran A, 2021, EPILEPSIA, V62, P1528, DOI 10.1111/epi.16949; Vizcarra JA, 2019, PARKINSONISM RELAT D, V63, P174, DOI 10.1016/j.parkreldis.2019.02.009; Vogrig A, 2019, EPILEPSY BEHAV, V90, P172, DOI 10.1016/j.yebeh.2018.11.030; Voon V, 2005, J CLIN PSYCHIAT, V66, P1529, DOI 10.4088/JCP.v66n1206; Vossler DG, 2004, NEUROLOGY, V63, P516, DOI 10.1212/01.WNL.0000133208.57562.CB; Walczak TS, 1996, EPILEPSIA, V37, P208, DOI 10.1111/j.1528-1157.1996.tb00013.x; WALCZAK TS, 1994, NEUROLOGY, V44, P2191, DOI 10.1212/WNL.44.11.2191; Walther K, 2019, EPILEPSIA, V60, P669, DOI 10.1111/epi.14682; Walzl D, 2022, J NEUROL, V269, P654, DOI 10.1007/s00415-021-10436-6; Wasserman D, 2017, EPILEPSY BEHAV, V73, P42, DOI 10.1016/j.yebeh.2017.04.020; Williams C, 2017, OVERCOMING FUNCTIONA, DOI [10.1201/b13567, DOI 10.1201/B13567]; Wissel BD, 2018, J NEUROL NEUROSUR PS, V89, P566, DOI 10.1136/jnnp-2017-317378; Wolf LD, 2015, EPILEPSY BEHAV, V43, P81, DOI 10.1016/j.yebeh.2014.12.010; Yugue I, 2004, SPINE, V29, P1910, DOI 10.1097/01.brs.0000137055.55350.37; Zeuner KE, 2003, NEUROLOGY, V61, P548, DOI 10.1212/01.WNL.0000076183.34915.CD	241	13	13	4	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								064	10.1136/bmj.064	http://dx.doi.org/10.1136/bmj.064			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YS4MD	35074803				2022-12-28	WOS:000750652200007
J	Yin, WC; Xu, YW; Xu, PY; Cao, XD; Wu, CR; Gu, CY; He, XH; Wang, XX; Huang, SJ; Yuan, QN; Wu, K; Hu, W; Huang, ZF; Liu, J; Wang, ZD; Jia, FF; Xia, KW; Liu, PP; Wang, XP; Song, B; Zheng, J; Jiang, HL; Cheng, X; Jiang, Y; Deng, SJ; Xu, HE				Yin, Wanchao; Xu, Youwei; Xu, Peiyu; Cao, Xiaodan; Wu, Canrong; Gu, Chunyin; He, Xinheng; Wang, Xiaoxi; Huang, Sijie; Yuan, Qingning; Wu, Kai; Hu, Wen; Huang, Zifu; Liu, Jia; Wang, Zongda; Jia, Fangfang; Xia, Kaiwen; Liu, Peipei; Wang, Xueping; Song, Bin; Zheng, Jie; Jiang, Hualiang; Cheng, Xi; Jiang, Yi; Deng, Su-Jun; Xu, H. Eric			Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody	SCIENCE			English	Article							CRYO-EM STRUCTURE; SARS-COV-2 SPIKE; MODEL	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant has become the dominant infective strain. We report the structures of the Omicron spike trimer on its own and in complex with angiotensin-converting enzyme 2 (ACE2) or an anti-Omicron antibody. Most Omicron mutations are located on the surface of the spike protein and change binding epitopes to many current antibodies. In the ACE2-binding site, compensating mutations strengthen receptor binding domain (RBD) binding to ACE2. Both the RBD and the apo form of the Omicron spike trimer are thermodynamically unstable. An unusual RBD-RBD interaction in the ACE2-spike complex supports the open conformation and further reinforces ACE2 binding to the spike trimer. A broad-spectrum therapeutic antibody, JMB2002, which has completed a phase 1 clinical trial, maintains neutralizing activity against Omicron. JMB2002 binds to RBD differently from other characterized antibodies and inhibits ACE2 binding.	[Yin, Wanchao; Xu, Youwei; Xu, Peiyu; Wu, Canrong; He, Xinheng; Wang, Xiaoxi; Huang, Sijie; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Cao, Xiaodan; Gu, Chunyin; Liu, Jia; Wang, Zongda; Jia, Fangfang; Xia, Kaiwen; Liu, Peipei; Wang, Xueping; Deng, Su-Jun] Shanghai Jemincare Pharmaceut Co Ltd, Shanghai 201203, Peoples R China; [He, Xinheng; Jiang, Hualiang; Cheng, Xi; Jiang, Yi; Xu, H. Eric] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yuan, Qingning; Wu, Kai; Hu, Wen] Chinese Acad Sci, Shanghai Adv Electron Microscope Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Huang, Zifu; Jiang, Hualiang; Cheng, Xi; Jiang, Yi] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Song, Bin; Zheng, Jie] Chinese Acad Sci, Immunol Dis Res Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Jiang, Hualiang; Xu, H. Eric] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; ShanghaiTech University	Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Deng, SJ (corresponding author), Shanghai Jemincare Pharmaceut Co Ltd, Shanghai 201203, Peoples R China.; Xu, HE (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Xu, HE (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	wcyin@simm.ac.cn; dengsujun@jemincare.com; eric.xu@simm.ac.cn	xia, kaiwen/HHN-8283-2022	yin, wanchao/0000-0002-6889-4907; He, Xinheng/0000-0001-7813-5480; Xu, H. Eric/0000-0002-6829-8144; Xu, Peiyu/0000-0003-3590-4037; Song, Bin/0000-0002-5327-5839	Ministry of Science and Technology of China [2018YFA0507002]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; CAS Strategic Priority Research Program [XDB37030103]; National Natural Science Foundation of China [32171189, 32130022, 31770796, 81902085]; Youth Innovation Promotion Association of CAS [2021278]; National Science Fund for Excellent Young Scholars [82122067]; Fund of Youth Innovation Promotion Association [2018319 Y8G7011009]; Science and Technology Commission of Shanghai Municipal [20431900100]; Jack Ma Foundation [2020-CMKYGG-05]; National Science and Technology Major Project [2018ZX09711002]; China Postdoctoral Science Foundation [E11289R078]; Key Tasks of LG Laboratory [LG202103-03-05, LG202101-01-03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Major Project; CAS Strategic Priority Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS; National Science Fund for Excellent Young Scholars; Fund of Youth Innovation Promotion Association; Science and Technology Commission of Shanghai Municipal(Science & Technology Commission of Shanghai Municipality (STCSM)); Jack Ma Foundation; National Science and Technology Major Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Tasks of LG Laboratory	This work was partially supported by the Ministry of Science and Technology of China (grant 2018YFA0507002 to H.E.X.); the Shanghai Municipal Science and Technology Major Project (grant 2019SHZDZX02 to H.E.X.); the CAS Strategic Priority Research Program (grant XDB37030103 to H.E.X.); the National Natural Science Foundation of China (grant 32171189 to W.Y., grant 32130022 to H.E.X., grant 31770796 to Y.J., and grant 81902085 to Y.X.); the Youth Innovation Promotion Association of CAS (grant 2021278 to W.Y.); the National Science Fund for Excellent Young Scholars (grant 82122067 to W.Y.); the Key Tasks of LG Laboratory (grant LG202103-03-05 to W.Y. and grant LG202101-01-03 to Y.X.); the Fund of Youth Innovation Promotion Association (grant 2018319 Y8G7011009 to X.C.); the Science and Technology Commission of Shanghai Municipal (grant 20431900100 to H.J.); the Jack Ma Foundation (grant 2020-CMKYGG-05 to H.J.); the National Science and Technology Major Project (grant 2018ZX09711002 to Y.J.); and the China Postdoctoral Science Foundation (Funded Project E11289R078 to C.W.).	Ai JW, 2022, EMERG MICROBES INFEC, V11, P337, DOI 10.1080/22221751.2021.2022440; Cai YF, 2021, SCIENCE, V373, P642, DOI [10.1101/2021.04.13.439709, 10.1126/science.abi9745]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Earnest Rebecca, 2021, medRxiv, DOI 10.1101/2021.10.06.21264641; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gu CY, 2021, MABS-AUSTIN, V13, DOI 10.1080/19420862.2021.1930636; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Juraszek J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20321-x; Kumar S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009885; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu LJ, 2022, NUTR NEUROSCI, V25, P2302, DOI 10.1080/1028415X.2021.1959099; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Pouwels KB, 2021, NAT MED, V27, P2127, DOI 10.1038/s41591-021-01548-7; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sanchez-Garcia R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02399-1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Toelzer C, 2020, SCIENCE, V370, P725, DOI 10.1126/science.abd3255; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yan Y, 2021, SCIENCE, V373, P413, DOI 10.1126/science.abe7565; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	38	74	73	43	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2022	375	6584			SI		1048	+		10.1126/science.abn8863	http://dx.doi.org/10.1126/science.abn8863			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM3BK	35133176	Green Published			2022-12-28	WOS:000764236900050
J	Lowery, FJ; Krishna, S; Yossef, R; Parikh, NB; Chatani, PD; Zacharakis, N; Parkhurst, MR; Levin, N; Sindiri, S; Sachs, A; Hitscherich, KJ; Yu, ZY; Vale, NR; Lu, YC; Zheng, ZL; Jia, L; Gartner, JJ; Hill, VK; Copeland, AR; Nah, SK; Masi, RV; Gasmi, B; Kivitz, S; Paria, BC; Florentin, M; Kim, SP; Hanada, K; Li, YF; Ngo, LT; Ray, S; Shindorf, ML; Levi, ST; Shepherd, R; Toy, C; Parikh, AY; Prickett, TD; Kelly, MC; Beyer, R; Goff, SL; Yang, JC; Robbins, PF; Rosenberg, SA				Lowery, Frank J.; Krishna, Sri; Yossef, Rami; Parikh, Neilesh B.; Chatani, Praveen D.; Zacharakis, Nikolaos; Parkhurst, Maria R.; Levin, Noam; Sindiri, Sivasish; Sachs, Abraham; Hitscherich, Kyle J.; Yu, Zhiya; Vale, Nolan R.; Lu, Yong-Chen; Zheng, Zhili; Jia, Li; Gartner, Jared J.; Hill, Victoria K.; Copeland, Amy R.; Nah, Shirley K.; Masi, Robert, V; Gasmi, Billel; Kivitz, Scott; Paria, Biman C.; Florentin, Maria; Kim, Sanghyun P.; Hanada, Ken-ichi; Li, Yong F.; Ngo, Lien T.; Ray, Satyajit; Shindorf, Mackenzie L.; Levi, Shoshana T.; Shepherd, Ryan; Toy, Chris; Parikh, Anup Y.; Prickett, Todd D.; Kelly, Michael C.; Beyer, Rachel; Goff, Stephanie L.; Yang, James C.; Robbins, Paul F.; Rosenberg, Steven A.			Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers	SCIENCE			English	Article							CHIMERIC ANTIGEN RECEPTOR; TUMOR; IMMUNOTHERAPY; MUTATIONS; IDENTIFICATION; REPERTOIRE; LANDSCAPE	The accurate identification of antitumor T cell receptors (TCRs) represents a major challenge for the engineering of cell-based cancer immunotherapies. By mapping 55 neoantigen-specific TCR clonotypes (NeoTCRs) from 10 metastatic human tumors to their single-cell transcriptomes, we identified signatures of CD8(+) and CD4(+) neoantigen-reactive tumor-infiltrating lymphocytes (TILs). Neoantigen-specific TILs exhibited tumor-specific expansion with dysfunctional phenotypes, distinct from blood-emigrant bystanders and regulatory TILs. Prospective prediction and testing of 73 NeoTCR signature-derived clonotypes demonstrated that half of the tested TCRs recognized tumor antigens or autologous tumors. NeoTCR signatures identified TCRs that target driver neoantigens and nonmutated viral or tumor-associated antigens, suggesting a common metastatic TIL exhaustion program. NeoTCR signatures delineate the landscape of TILs across metastatic tumors, enabling successful TCR prediction based purely on TIL transcriptomic states for use in cancer immunotherapy.	[Lowery, Frank J.; Krishna, Sri; Yossef, Rami; Parikh, Neilesh B.; Chatani, Praveen D.; Zacharakis, Nikolaos; Parkhurst, Maria R.; Levin, Noam; Sindiri, Sivasish; Sachs, Abraham; Hitscherich, Kyle J.; Yu, Zhiya; Vale, Nolan R.; Lu, Yong-Chen; Zheng, Zhili; Gartner, Jared J.; Hill, Victoria K.; Copeland, Amy R.; Nah, Shirley K.; Masi, Robert, V; Gasmi, Billel; Kivitz, Scott; Paria, Biman C.; Florentin, Maria; Kim, Sanghyun P.; Hanada, Ken-ichi; Li, Yong F.; Ngo, Lien T.; Ray, Satyajit; Shindorf, Mackenzie L.; Levi, Shoshana T.; Toy, Chris; Parikh, Anup Y.; Prickett, Todd D.; Beyer, Rachel; Goff, Stephanie L.; Yang, James C.; Robbins, Paul F.; Rosenberg, Steven A.] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Jia, Li] NIHL, NIH, Bethesda, MD 20892 USA; [Shepherd, Ryan] Frederick Natl Lab Canc Res, Clin Res Directorate, Vector Prod Facil, Bethesda, MD 20892 USA; [Kelly, Michael C.] Frederick Natl Lab, Canc Res Technol Program, Single Cell Anal Facil, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lowery, FJ; Krishna, S; Rosenberg, SA (corresponding author), NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	frank.lowery@nih.gov; sri.krishna@nih.gov; sar@nih.gov	Lu, Yong-Chen/G-4520-2014	Lu, Yong-Chen/0000-0002-0275-9825; Florentin, Maria/0000-0002-7784-3458; Vale, Nolan/0000-0002-7422-4918; Krishna, Sri/0000-0003-4994-3758; Masi, Robert/0000-0001-6641-7819; Parikh, Neilesh/0000-0001-5674-121X; Lowery, Frank/0000-0002-4620-5293; sindiri, sivasish/0000-0003-2516-969X	Center for Cancer Research intramural research program of the National Cancer Institute; CCR Single Cell Analysis Facility - FNLCR [HHSN261200800001E]; National Cancer Institute, National Institutes of Health [75N91019D00024]	Center for Cancer Research intramural research program of the National Cancer Institute; CCR Single Cell Analysis Facility - FNLCR; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Center for Cancer Research intramural research program of the National Cancer Institute. Support from the CCR Single Cell Analysis Facility was funded by FNLCR contract no. HHSN261200800001E. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. 75N91019D00024. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.	Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bagaev DV, 2020, NUCLEIC ACIDS RES, V48, pD1057, DOI 10.1093/nar/gkz874; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Caushi JX, 2021, NATURE, V596, P126, DOI 10.1038/s41586-021-03752-4; Cui C, 2021, CELL, V184, P6101, DOI 10.1016/j.cell.2021.11.007; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Ghorani E, 2020, NAT CANCER, V1, DOI 10.1038/s43018-020-0066-y; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Levin N, 2021, CLIN CANCER RES, V27, P5084, DOI 10.1158/1078-0432.CCR-21-0849; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Litchfield K, 2021, CELL, V184, P596, DOI 10.1016/j.cell.2021.01.002; Lu YC, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002595; Lu YC, 2018, MOL THER, V26, P379, DOI 10.1016/j.ymthe.2017.10.018; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Paria BC, 2021, J IMMUNOTHER, V44, P1, DOI 10.1097/CJI.0000000000000342; Parkhurst M, 2017, CLIN CANCER RES, V23, P2491, DOI 10.1158/1078-0432.CCR-16-2680; Parkhurst MR, 2019, CANCER DISCOV, V9, P1022, DOI 10.1158/2159-8290.CD-18-1494; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Roudko V, 2020, CELL, V183, P1634, DOI 10.1016/j.cell.2020.11.004; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Valpione S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24343-x; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yang W, 2019, NAT MED, V25, P767, DOI 10.1038/s41591-019-0434-2; Yossef R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122467; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3	56	29	29	29	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2022	375	6583					877	+		10.1126/science.abl5447	http://dx.doi.org/10.1126/science.abl5447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZM2ZV	35113651	Green Accepted			2022-12-28	WOS:000764232800045
J	Gopinathan, U; Buse, K				Gopinathan, Unni; Buse, Kent			How can WHO transform its approach to social determinants of health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POLICY-MAKING; EQUITY; INEQUALITIES; GUIDELINES	WHO has a pivotal role in reducing health inequities but faces five fundamental constraints to progress, argue Unni Gopinathan and Kent Buse	[Gopinathan, Unni] Norwegian Inst Publ Hlth, Div Hlth Serv, Cluster Global Hlth, Oslo, Norway; [Buse, Kent] Imperial Coll London, George Inst Global Hlth, Healthier Soc Programme, London, England	Norwegian Institute of Public Health (NIPH); Imperial College London	Gopinathan, U (corresponding author), Norwegian Inst Publ Hlth, Div Hlth Serv, Cluster Global Hlth, Oslo, Norway.	unni.gnathan@gmail.com		Buse, Kent/0000-0002-5485-0110				Alfven T, 2018, BMJ OPINION; Anaf J, 2018, AUST NZ J PUBL HEAL, V42, P133, DOI 10.1111/1753-6405.12769; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2016, CAMB WHO COUNTR COOP; Baker P, 2018, INT J HEALTH POLICY, V7, P101, DOI 10.15171/ijhpm.2017.130; Bambra C, 2005, HEALTH PROMOT INT, V20, P187, DOI 10.1093/heapro/dah608; Baum FE, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0164-x; Baum FE, 2013, SOC SCI MED, V87, P138, DOI 10.1016/j.socscimed.2013.03.033; Bonnefoy J., 2007, CONSTRUCTING EVIDENC; Boon MH, 2021, J CLIN EPIDEMIOL, V135, P42, DOI 10.1016/j.jclinepi.2021.01.001; Carter DJ, 2018, LANCET GLOB HEALTH, V6, pE514, DOI 10.1016/S2214-109X(18)30195-5; Cassels A, 2017, GLOB HEALT DIPL, V5, P39; Crammond BR, 2017, EVID POLICY, V13, P365, DOI 10.1332/174426416X14538920677201; de Leeuw E, 2017, ANNU REV PUBL HEALTH, V38, P329, DOI 10.1146/annurev-publhealth-031816-044309; Dhaliwal M, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2021-068123; Exworthy M, 2008, HEALTH POLICY PLANN, V23, P318, DOI 10.1093/heapol/czn022; Farrer L, 2015, MILBANK Q, V93, P392, DOI 10.1111/1468-0009.12112; Ghebreyesus TA, FOREIGN POLICY, V2021; Gomes Temporao Jose, 2009, Glob Health Promot, VSuppl 1, P45, DOI 10.1177/1757975909103750; Gopinathan U, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0128-6; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1407, DOI 10.1001/jama.2015.2334; International Health Conference, 2002, Bull World Health Organ, V80, P983; Langlois EV, 2018, B WORLD HEALTH ORGAN, V96, P79, DOI 10.2471/BLT.17.206540; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Loewenson R, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005257; Maani N, 2020, EUR J PUBLIC HEALTH, V30, P660, DOI 10.1093/eurpub/ckz197; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2021, LANCET, V397, P1527, DOI 10.1016/S0140-6736(21)00710-8; Navarro V, 2001, SOC SCI MED, V52, P481, DOI 10.1016/S0277-9536(00)00197-0; Norris SL, 2017, LANCET GLOB HEALTH, V5, pE855, DOI 10.1016/S2214-109X(17)30253-X; O'Grady C., 2020, SCIENCE; ODonnell M, 2021, GENDER SOCIAL PROTEC; Orton LC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-821; Oxfam, 2021, IN VIR BRING TOG WOR; Pan American Health Organization, 2019, JUST SOC HLTH EQ DIG; Paremoer L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n129; Parkhurst JO, 2016, SOC EPISTEMOL, V30, P665, DOI 10.1080/02691728.2016.1172365; Rasanathan K, 2018, LANCET, V392, P1176, DOI 10.1016/S0140-6736(18)32069-5; Reddy SK, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0436-8; Rehfuess EA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-000844; Rushton S, 2012, GLOB SOC, V26, P147, DOI 10.1080/13600826.2012.656266; Smith KE, 2021, SOC SCI MED, V291, DOI 10.1016/j.socscimed.2021.114458; Smith K, 2013, POLICY POLIT, V41, P81, DOI 10.1332/030557312X655413; Sutter R., 2021, CALL EXPR INT TEAM R, P1; Third World Network, 2021, COV 19 GLOB MOR FAIL; U.S. Department of Education, 2021, WHITE HOUSE INITIATI; UNEP, 2021, REG AIR QUAL 1 GLOB; WHO, 2021, COMP WHO OTH UN GUID; WHO, 2019, WHO EST COMM SOC DET; WHO, WHO COUNC EC HLTH AL; WHO, 2019, MULT ACC FRAM ACC PR; WHO EMRO, 2021, REP COMM SOC DET HLT; WHO UNDP, 2018, WHAT LEG NEED KNOW; World Health Organization, 2019, GLOB ACT PLAN HLTH L; World Health Organization, 2021, COMM DET HLTH FACT S	55	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								e066172	10.1136/bmj-2021-066172	http://dx.doi.org/10.1136/bmj-2021-066172			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YX5GV	35135754	Green Published			2022-12-28	WOS:000754132400005
J	Willyard, C				Willyard, Cassandra			THE OMICRON WAVE'S SURPRISING LESSONS FOR LONG-TERM IMMUNITY	NATURE			English	Editorial Material																		Andrews N., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.12.14.21267615, DOI 10.1101/2021.12.14.21267615]; Chen JS, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abl5652; Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]; Gao Y, 2022, NAT MED, V28, P472, DOI 10.1038/s41591-022-01700-x; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033]; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Keeton R., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.12.26.21268380, DOI 10.1101/2021.12.26.21268380]; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Slifka MK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00956; Stuart ASV, 2022, LANCET, V399, P36, DOI 10.1016/S0140-6736(21)02718-5; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tseng H. F, PREPRINT MEDRXIV, DOI [10.1101/2022.01.07.22268919(2021), DOI 10.1101/2022.01.07.22268919(2021)]; UK Health Security Agency, 2021, SARS COV 2 VAR VAR I, V33	15	13	16	5	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					22	25						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS1FH	35110764				2022-12-28	WOS:000750429600011
J	Melenhorst, JJ; Chen, GM; Wang, M; Porter, DL; Chen, CY; Collins, MA; Gao, P; Bandyopadhyay, S; Sun, HX; Zhao, ZR; Lundh, S; Pruteanu-Malinici, I; Nobles, CL; Maji, S; Frey, NV; Gill, SI; Tian, LF; Kulikovskaya, I; Gupta, M; Ambrose, DE; Davis, MM; Fraietta, JA; Brogdon, JL; Young, RM; Chew, A; Levine, BL; Siegel, DL; Alanio, C; Wherry, EJ; Bushman, FD; Lacey, SF; Tan, K; June, CH				Melenhorst, J. Joseph; Chen, Gregory M.; Wang, Meng; Porter, David L.; Chen, Changya; Collins, McKensie A.; Gao, Peng; Bandyopadhyay, Shovik; Sun, Hongxing; Zhao, Ziran; Lundh, Stefan; Pruteanu-Malinici, Iulian; Nobles, Christopher L.; Maji, Sayantan; Frey, Noelle, V; Gill, Saar, I; Tian, Lifeng; Kulikovskaya, Irina; Gupta, Minnal; Ambrose, David E.; Davis, Megan M.; Fraietta, Joseph A.; Brogdon, Jennifer L.; Young, Regina M.; Chew, Anne; Levine, Bruce L.; Siegel, Donald L.; Alanio, Cecile; Wherry, E. John; Bushman, Frederic D.; Lacey, Simon F.; Tan, Kai; June, Carl H.			Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells	NATURE			English	Article							B-CELL	The adoptive transfer of T lymphocytes reprogrammed to target tumour cells has demonstrated potential for treatment of various cancers(1-7). However, little is known about the long-term potential and clonal stability of the infused cells. Here we studied long-lasting CD19-redirected chimeric antigen receptor (CAR) T cells in two patients with chronic lymphocytic leukaemia(1-4) who achieved a complete remission in 2010. CAR T cells remained detectable more than ten years after infusion, with sustained remission in both patients. Notably, a highly activated CD4(+) population emerged in both patients, dominating the CAR T cell population at the later time points. This transition was reflected in the stabilization of the clonal make-up of CAR T cells with a repertoire dominated by a small number of clones. Single-cell profiling demonstrated that these long-persisting CD4(+) CAR T cells exhibited cytotoxic characteristics along with ongoing functional activation and proliferation. In addition, longitudinal profiling revealed a population of gamma delta CAR T cells that prominently expanded in one patient concomitant with CD8(+) CAR T cells during the initial response phase. Our identification and characterization of these unexpected CAR T cell populations provide novel insight into the CAR T cell characteristics associated with anti-cancer response and long-term remission in leukaemia.	[Melenhorst, J. Joseph; Wang, Meng; Collins, McKensie A.; Sun, Hongxing; Zhao, Ziran; Lundh, Stefan; Maji, Sayantan; Tian, Lifeng; Kulikovskaya, Irina; Gupta, Minnal; Ambrose, David E.; Davis, Megan M.; Fraietta, Joseph A.; Young, Regina M.; Chew, Anne; Levine, Bruce L.; Siegel, Donald L.; Lacey, Simon F.; June, Carl H.] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA; [Melenhorst, J. Joseph; Wang, Meng; Collins, McKensie A.; Sun, Hongxing; Zhao, Ziran; Lundh, Stefan; Maji, Sayantan; Kulikovskaya, Irina; Gupta, Minnal; Ambrose, David E.; Davis, Megan M.; Fraietta, Joseph A.; Young, Regina M.; Chew, Anne; Levine, Bruce L.; Siegel, Donald L.; Lacey, Simon F.; Tan, Kai; June, Carl H.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Melenhorst, J. Joseph; Wang, Meng; Porter, David L.; Collins, McKensie A.; Sun, Hongxing; Zhao, Ziran; Lundh, Stefan; Maji, Sayantan; Frey, Noelle, V; Gill, Saar, I; Tian, Lifeng; Kulikovskaya, Irina; Gupta, Minnal; Ambrose, David E.; Davis, Megan M.; Fraietta, Joseph A.; Young, Regina M.; Chew, Anne; Levine, Bruce L.; Lacey, Simon F.; June, Carl H.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Melenhorst, J. Joseph; Alanio, Cecile; Wherry, E. John; Tan, Kai; June, Carl H.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Melenhorst, J. Joseph; Alanio, Cecile; Wherry, E. John; June, Carl H.] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Chen, Gregory M.; Tan, Kai] Univ Penn, Grad Grp Genom & Computat Biol, Philadelphia, PA 19104 USA; [Porter, David L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Chen, Changya; Gao, Peng] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA USA; [Chen, Changya; Gao, Peng; Tan, Kai] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Collins, McKensie A.; Bandyopadhyay, Shovik; Tan, Kai] Univ Penn, Grad Grp Cell & Mol Biol, Philadelphia, PA 19104 USA; [Pruteanu-Malinici, Iulian; Brogdon, Jennifer L.] Novartis Inst Biomed Res, Cambridge, MA USA; [Nobles, Christopher L.; Fraietta, Joseph A.; Bushman, Frederic D.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA USA; [Siegel, Donald L.] Univ Penn, Perelman Sch Med, Dept Transfus Med, Philadelphia, PA USA; [Wang, Meng; Alanio, Cecile; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Novartis; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Melenhorst, JJ; June, CH (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA 19104 USA.; Melenhorst, JJ; Tan, K; June, CH (corresponding author), Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.; Melenhorst, JJ; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Melenhorst, JJ; Tan, K; June, CH (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Melenhorst, JJ; June, CH (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Tan, K (corresponding author), Univ Penn, Grad Grp Genom & Computat Biol, Philadelphia, PA 19104 USA.; Tan, K (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.; Tan, K (corresponding author), Univ Penn, Grad Grp Cell & Mol Biol, Philadelphia, PA 19104 USA.	mej@pennmedicine.upenn.edu; tank1@chop.edu; cjune@upenn.edu	Zhao, Ziran/GXF-1187-2022	Zhao, Ziran/0000-0002-8349-5322; Wang, Meng/0000-0002-3453-7805; Bandyopadhyay, Shovik/0000-0003-3919-3914; Melenhorst, Jan Joseph/0000-0001-7677-537X; Tan, Kai/0000-0002-9104-5567	Novartis Institute for Biomedical Research; NIH [R01-CA-241762-01, CA233285]; CIHR Doctoral Foreign Study Award [433117]; NIH Medical Scientist Training Program [T32 GM07170]	Novartis Institute for Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Doctoral Foreign Study Award(Canadian Institutes of Health Research (CIHR)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the contributions of the following research cores at the University of Pennsylvania and Children's Hospital of Philadelphia: the Translational and Correlative Studies Laboratory for providing standardized flow cytometric, quantitative PCR and cytokine multiplexing analyses, and biobanking of patient specimens on CAR T cell trials; the Clinical Cell and Vaccine Production Facility for cell processing and biobanking; the Human Immunology Core for providing healthy donor cells and analytical support; the Flow Cytometry Core for flow cytometry equipment maintenance and access to electronic sorters; the Stem Cell and Xenograft Core for providing de-identified patient specimens; and the High-Performance Computing Facility. This work was supported by Novartis Institute for Biomedical Research (to J.J.M. and C.H.J.), NIH grant R01-CA-241762-01 (to J.J.M. and F.D.B.); NIH grant CA233285 (to K.T.); CIHR Doctoral Foreign Study Award no. 433117 (to G.M.C.); and NIH Medical Scientist Training Program T32 GM07170 (to S.B.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Bandyopadhyay S, 2017, METHODS MOL BIOL, V1636, P371, DOI 10.1007/978-1-4939-7154-1_24; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; ElTanbouly MA, 2021, NAT REV IMMUNOL, V21, P257, DOI 10.1038/s41577-020-00454-2; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Frey NV, 2020, J CLIN ONCOL, V38, P2862, DOI 10.1200/JCO.19.03237; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Geyer MB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122627; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Nobles CL, 2020, J CLIN INVEST, V130, P673, DOI 10.1172/JCI130144; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Turtle CJ, 2017, J CLIN ONCOL, V35, P3010, DOI 10.1200/JCO.2017.72.8519; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309	27	91	92	71	108	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2022	602	7897					503	+		10.1038/s41586-021-04390-6	http://dx.doi.org/10.1038/s41586-021-04390-6		FEB 2022	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZB5PA	35110735	Green Accepted			2022-12-28	WOS:000750001600005
J	Mathew, R				Mathew, Rammya			Rammya Mathew: The difference between a doctor and a family doctor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net							0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o240	10.1136/bmj.o240	http://dx.doi.org/10.1136/bmj.o240			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105555	Bronze			2022-12-28	WOS:000758676500011
J	Wise, J				Wise, Jacqui			Covid-19: Pandemic waste threatens human and environmental health, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2022, GLOB AN HLTH CAR WAS	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o266	10.1136/bmj.o266	http://dx.doi.org/10.1136/bmj.o266			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105547	Bronze			2022-12-28	WOS:000758676500003
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: Halt mandatory vaccination to keep England's maternity services safe, pleads royal college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o192; O'Dowd A, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1712	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o249	10.1136/bmj.o249	http://dx.doi.org/10.1136/bmj.o249			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091447	Bronze			2022-12-28	WOS:000749313200001
J	Torjesen, I				Torjesen, Ingrid			More consultants are to receive excellence awards, but value is to be slashed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2021, CONS AW SCHEM CLIN E; Department of Health and Social Care, 2020, MEND GAP IND REV GEN; Rimmer A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4904	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o252	10.1136/bmj.o252	http://dx.doi.org/10.1136/bmj.o252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091424				2022-12-28	WOS:000749313200017
J	Greenland, P				Greenland, Philip			Screening for Atrial Fibrillation-More Data Still Needed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LUNG		[Greenland, Philip] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 North Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA; [Greenland, Philip] Northwestern Univ, Dept Med, Feinberg Sch Med, 680 North Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Greenland, P (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 North Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.; Greenland, P (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, 680 North Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.							Benjamin EJ, 2021, CIRCULATION, V143, P372, DOI 10.1161/CIRCULATIONAHA.120.047633; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; Jonas DE, 2018, JAMA-J AM MED ASSOC, V320, P485, DOI 10.1001/jama.2018.4190; Kahwati LC, 2022, JAMA-J AM MED ASSOC, V327, P368, DOI 10.1001/jama.2021.21811; Kaplan RM, 2019, CIRCULATION, V140, P1639, DOI 10.1161/CIRCULATIONAHA.119.041303; Mahajan R, 2018, EUR HEART J, V39, P1407, DOI 10.1093/eurheartj/ehx731; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Svendsen JH, 2021, LANCET, V398, P1507, DOI 10.1016/S0140-6736(21)01698-6; Svennberg E, 2021, LANCET, V398, P1498, DOI 10.1016/S0140-6736(21)01637-8	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					329	330						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076684	Bronze			2022-12-28	WOS:000753055700009
J	Wenham, C; McKee, M; Burgess, RA; Yamey, G				Wenham, Clare; McKee, Martin; Burgess, Rochelle A.; Yamey, Gavin			Parties may lead to his downfall, but is this the worst of what Johnson has done?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wenham, Clare] London Sch Econ, Dept Hlth Policy, London, England; [McKee, Martin] London Sch Hyg & Trop Med, London, England; [Burgess, Rochelle A.] UCL Inst Global Hlth, London, England; [Yamey, Gavin] Duke Univ, Duke Global Hlth Inst, Ctr Policy Impact Global Hlth, Durham, NC 27706 USA	University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Duke University	Wenham, C (corresponding author), London Sch Econ, Dept Hlth Policy, London, England.			Burgess, Rochelle/0000-0001-9749-7065				[Anonymous], 2021, TELEGRAPH; [Anonymous], 2021, NATURE; [Anonymous], VICE; [Anonymous], INDEPENDENT; Dayan M, 2021, WHAT HAPPENED THOSE, DOI [10.1136/bmj.n3119, DOI 10.1136/BMJ.N3119]; Dayan M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3119; Dyer C, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o96; Gove Michael, THE GUARDIAN; John Hopkins University, COR RES CTR; National Audit Office, TEST TRAC ENGL; Office for Budget Responsibility, BREX AN; Office for National Statistics, INT COMP GDP COR COV; Oliver D, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4937; Siddique H., USE VIP LANE AWARD C; Stuckler D, 2017, EUR J PUBLIC HEALTH, V27, P18, DOI 10.1093/eurpub/ckx167; The BMA, 2022, IMM RESTR REL IS RIS; The BMA, 2020, AUST COVIDS LITTL HE; The Health Foundation, LARG DROP NUMB NEW N; Yamey G., 2020, TIME	19	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								o196	10.1136/bmj.o196	http://dx.doi.org/10.1136/bmj.o196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4MD	35074783	Bronze			2022-12-28	WOS:000750652200002
J	Collora, JA; Ho, YC				Collora, Jack A.; Ho, Ya-Chi			The loud minority: Transcriptionally active HIV-1-infected cells survive, proliferate, and persist	CELL			English	Editorial Material								The shock-and-kill strategy reactivates HIV-1 latent reservoir for immune clearance. Einkauf et al. found that some HIV-1-infected cells that persist and proliferate have transcriptionally active HIV-1 in permissive chromatin. Silent proviruses in repressive chromatin resist reactivation. Understanding HIV-1-chromatin interactions and how transcriptionally active HIV-1-infected cells survive is a pressing need.	[Collora, Jack A.; Ho, Ya-Chi] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06519 USA	Yale University	Ho, YC (corresponding author), Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06519 USA.	ya-chi.ho@yale.edu			NIH [R01 AI141009, R61/R33 DA047037, R37 AI147868, R01 DA051906, R01AI145164, UM1 DA051410, U01 DA053628, CHEETAH P50 AI150464]; REACH Martin Delaney Collaboratory [UM1 AI164565]; BEAT-HIV Martin Delaney Collaboratory [UM1 AI126620, T32 AI055403]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); REACH Martin Delaney Collaboratory; BEAT-HIV Martin Delaney Collaboratory	This work is supported by NIH R01 AI141009, R61/R33 DA047037, R37 AI147868, R01 DA051906, R01AI145164, UM1 DA051410, U01 DA053628, CHEETAH P50 AI150464, REACH Martin Delaney Collaboratory UM1 AI164565, BEAT-HIV Martin Delaney Collaboratory UM1 AI126620, and T32 AI055403.	Chen HC, 2017, NAT STRUCT MOL BIOL, V24, P47, DOI 10.1038/nsmb.3328; Einkauf KB, 2022, CELL, V185, P266, DOI 10.1016/j.cell.2021.12.011; Einkauf KB, 2019, J CLIN INVEST, V129, P988, DOI 10.1172/JCI124291; Jiang CY, 2020, NATURE, V585, P261, DOI 10.1038/s41586-020-2651-8; Liu RX, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz0802; Lucic B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12046-3; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Patro SC, 2019, P NATL ACAD SCI USA, V116, P25891, DOI 10.1073/pnas.1910334116; Pollack RA, 2017, CELL HOST MICROBE, V21, P494, DOI 10.1016/j.chom.2017.03.008; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304	10	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					227	229		10.1016/j.cell.2021.12.038	http://dx.doi.org/10.1016/j.cell.2021.12.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35063069				2022-12-28	WOS:000746172100003
J	Prunas, O; Warren, JL; Crawford, FW; Gazit, S; Patalon, T; Weinberger, DM; Pitzer, VE				Prunas, Ottavia; Warren, Joshua L.; Crawford, Forrest W.; Gazit, Sivan; Patalon, Tal; Weinberger, Daniel M.; Pitzer, Virginia E.			Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel	SCIENCE			English	Article							INTERVENTIONS; DEATHS; IMPACT	The effectiveness of vaccines against COVID-19 on the individual level is well established. However, few studies have examined vaccine effectiveness against transmission. We used a chain binomial model to estimate the effectiveness of vaccination with BNT162b2 [Pfizer-BioNTech messenger RNA (mRNA)-based vaccine] against household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Israel before and after emergence of the B.1.617.2 (Delta) variant. Vaccination reduced susceptibility to infection by 89.4% [95% confidence interval (CI): 88.7 to 90.0%], whereas vaccine effectiveness against infectiousness given infection was 23.0% (95% CI: -11.3 to 46.7%) during days 10 to 90 after the second dose, before 1 June 2021. Total vaccine effectiveness was 91.8% (95% CI: 88.1 to 94.3%). However, vaccine effectiveness is reduced over time as a result of the combined effect of waning of immunity and emergence of the Delta variant.	[Prunas, Ottavia; Weinberger, Daniel M.; Pitzer, Virginia E.] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Prunas, Ottavia; Warren, Joshua L.; Crawford, Forrest W.; Weinberger, Daniel M.; Pitzer, Virginia E.] Yale Univ, Publ Hlth Modeling Unit, Yale Sch Publ Hlth, New Haven, CT 06520 USA; [Warren, Joshua L.; Crawford, Forrest W.] Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT USA; [Crawford, Forrest W.] Yale Univ, Yale Sch Publ Hlth, Dept Stat & Data Sci, New Haven, CT USA; [Crawford, Forrest W.] Yale Univ, Yale Sch Publ Hlth, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Crawford, Forrest W.] Yale Univ, Yale Sch Management, New Haven, CT USA; [Gazit, Sivan; Patalon, Tal] Maccabi Inst Res & Innovat, Maccabi Healthcare Serv, Tel Aviv, Israel	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Prunas, O (corresponding author), Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Prunas, O (corresponding author), Yale Univ, Publ Hlth Modeling Unit, Yale Sch Publ Hlth, New Haven, CT 06520 USA.	ottavia.prunas@yale.edu		Weinberger, Daniel/0000-0003-1178-8086; Crawford, Forrest/0000-0002-0046-0547; Prunas, Ottavia/0000-0003-4264-3090	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI137093]; National Institutes of Health [R01AI137093, R01AI112970, 1DP2HD091799, NICHD 1DP2HD091799-01]; Centers for Disease Control and Prevention [6NU50CK000524-01]; COVID-19 Paycheck Protection Program and Health Care Enhancement Act funding; Perishing Square Foundation	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); COVID-19 Paycheck Protection Program and Health Care Enhancement Act funding; Perishing Square Foundation	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI137093. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. National Institutes of Health grant R01AI137093 (to J.L.W., D. M.W., and V.E.P.); National Institutes of Health grant 1DP2HD091799 (to F.W.C.); National Institutes of Health grant R01AI112970 (to V.E.P.); National Institutes of Health grant NICHD 1DP2HD091799-01 (to F. W.C.); Centers for Disease Control and Prevention agreement 6NU50CK000524-01 (to F.W.C.); COVID-19 Paycheck Protection Program and Health Care Enhancement Act funding (to F.W.C.); Perishing Square Foundation funding (to F.W. C.). Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI137093. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. National Institutes of Health grant R01AI137093 (to J.L.W., D. M.W., and V.E.P.); National Institutes of Health grant 1DP2HD091799 (to F.W.C.); National Institutes of Health grant R01AI112970 (to V.E.P.); National Institutes of Health grant NICHD 1DP2HD091799-01 (to F. W.C.); Centers for Disease Control and Prevention agreement 6NU50CK000524-01 (to F.W.C.); COVID-19 Paycheck Protection Program and Health Care Enhancement Act funding (to F.W.C.); Perishing Square Foundation funding (to F.W. C.).	Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Dennis J.E., 1996, NUMERICAL METHODS UN, DOI DOI 10.1137/1.9781611971200; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; Eyre DW, 2022, NEW ENGL J MED, V386, P744, DOI 10.1056/NEJMoa2116597; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; Layan M, 2021, COLD SPRING HARB SYM, DOI [10.1101/2021.07.12.21260377, DOI 10.1101/2021.07.12.21260377]; Layan M., MEDRXIV 2021 07 12 2, DOI [10.1101/2021.07.12.21260377, DOI 10.1101/2021.07.12.21260377]; Leshem E, 2021, LANCET, V397, P1783, DOI 10.1016/S0140-6736(21)01018-7; Levine-Tiefenbrun M, 2021, NAT MED, V27, P790, DOI 10.1038/s41591-021-01316-7; Lyngse F. P., 2022, MEDRXIV 2022 01 06 2, DOI [10.1111/j.1467-9876.2006.00539.x, DOI 10.1111/J.1467-9876.2006.00539.X]; Lyngse F. P., 2021, MEDRXIV 2021 02 28 2, DOI [10.1101/2021.02.28.21252608, DOI 10.1101/2021.02.28.21252608]; Lyngse F. P., VACCINATION HOUSEHOL, V2022, DOI [10.1111/j.1467- 9876.2006.00539, DOI 10.1111/J.1467-9876.2006.00539]; Lyngse F. P., MEDRXIV 12 27 212682, V2021, DOI [10.1101/2021.12.27.21268278v1, DOI 10.1101/2021.12.27.21268278V1]; Lyngse FP., 2021, ASS SARS COV 2 TRANS, DOI [10.1101/2021.02.28.21252608, DOI 10.1101/2021.02.28.21252608]; Lyngse FP., 2021, SARS COV 2 OMICRON V, DOI 10.1101/2021.12.27.21268278v1; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Mizrahi B., 2021, CORRELATION SARS COV, DOI [10.1101/2021.07.29.21261317, DOI 10.1101/2021.07.29.21261317V1, DOI 10.1101/2021.07.29.21261317]; Mizrahi B., 2021, MEDRXIV 2021 07 29 2, DOI [10.1101/2021.07.29.21261317, DOI 10.1101/2021.07.29.21261317]; Patalon T, 2022, JAMA INTERN MED, V182, P179, DOI 10.1001/jamainternmed.2021.7382; Petter E., INITIAL REAL WORLD E, DOI [10.1101/2021.02.08.21251329v1, DOI 10.1101/2021.02.08.21251329V1, 10.1101/2021.02.08.21251329]; Pitzer VE, 2020, LANCET INFECT DIS, V20, P1103, DOI 10.1016/S1473-3099(20)30514-4; Prunas O. W., 2021, Zenodo, DOI 10.5281/ zenodo.5670699; Qiu XT, 2021, CLIN MICROBIOL INFEC, V27, P511, DOI 10.1016/j.cmi.2021.01.011; RAMPEY AH, 1992, BIOMETRICS, V48, P117, DOI 10.2307/2532743; Richterman A, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab101; Richterman A, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofab259; Salo J., 2021, MEDRXIV 05 27 212578, DOI [10.1101/2021.05.27.21257896, DOI 10.1101/2021.05.27.21257896]; Salo J., 2021, INDIRECT EFFECT MRNA, DOI 10.1101/2021.05.27.21257896; Shah ASV, 2021, NEW ENGL J MED, V385, P1718, DOI 10.1056/NEJMc2106757; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x	36	35	34	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2022	375	6585			SI		1151	+		10.1126/science.abl4292	http://dx.doi.org/10.1126/science.abl4292			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZV2SO	35084937	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000770385500058
J	Woolston, C				Woolston, Chris			START-UPS CREATE CAREER OPPORTUNITIES FOR SCIENTISTS	NATURE			English	Editorial Material						Careers; Business; Industry; Biotechnology												Godfrey PC, 2020, NAT BIOTECHNOL, V38, P132, DOI 10.1038/s41587-019-0399-1; Sorenson O, 2021, ORGAN SCI, V32, P587, DOI 10.1287/orsc.2020.1371	2	0	0	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					349	351		10.1038/d41586-022-00343-9	http://dx.doi.org/10.1038/d41586-022-00343-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YU9AS	35132258	Bronze			2022-12-28	WOS:000752328400003
J	Saul, H; Gursul, D; Wilson, J				Saul, Helen; Gursul, Deniz; Wilson, Janet			Self-testing kit for sexually transmitted infections increases diagnoses while reducing costs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz] NIHR Ctr Engagement & Disseminat, Twickenham, England; [Wilson, Janet] Leeds Hosp NHS Trust, Leeds, W Yorkshire, England		Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						Alberta Health Services, 2022, CURR OV; Lorenc A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050109; Wallace H, 2016, SEX TRANSM INFECT, V92, pA61, DOI 10.1136/sextrans-2016-052718.174; Wilson Janet D., 2021, Clinical Infectious Diseases, V73, pE3172, DOI 10.1093/cid/ciaa1266	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o242	10.1136/bmj.o242	http://dx.doi.org/10.1136/bmj.o242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135782				2022-12-28	WOS:000754132400008
J	Bhattacharyya, RP; Hanage, WP				Bhattacharyya, Roby P.; Hanage, William P.			Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Challenges in Inferring Omicron's Severity Omicron's spread in South Africa has led to fewer hospitalizations and deaths per documented case than were seen during previous waves. But caution is warranted when it comes to making inferences about omicron's intrinsic severity using population-level observations.	[Bhattacharyya, Roby P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Hanage, William P.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Bhattacharyya, RP (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.		Hanage, Bill/CAF-1813-2022					Davies M-A., 2022, OUTCOMES LAB CONFIRM, DOI [10.1101/2022.01.12.22269148v1, DOI 10.1101/2022.01.12.22269148V1]; Davies NG, 2021, NATURE, V593, P270, DOI [10.1038/s41586-021-03426-1, 10.1101/2021.02.01.21250959]; Ferguson N., 2021, REPORT 50 HOSPITALIS, DOI [10.25561/93035, DOI 10.25561/93035]; Twohig KA, 2022, LANCET INFECT DIS, V22, P35, DOI 10.1016/S1473-3099(21)00475-8; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y	5	47	48	8	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2022	386	7								10.1056/NEJMp2119682	http://dx.doi.org/10.1056/NEJMp2119682		FEB 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZA1QN	35108465	Bronze			2022-12-28	WOS:000749766600001
J	Iacobucci, G				Iacobucci, Gareth			Government wants more GPs to be employed by hospital trusts, says news report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci Gareth, 2022, BMJ, V376, po145, DOI 10.1136/bmj.o145; Royal Wolverhampton NHS Trust, 2019, LAT GP PRACT JOIN RO; Smyth C, 2022, TIMES 0129	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o267	10.1136/bmj.o267	http://dx.doi.org/10.1136/bmj.o267			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105665				2022-12-28	WOS:000758676500006
J	Berdyugin, AI; Xin, N; Gao, HY; Slizovskiy, S; Dong, ZY; Bhattacharjee, S; Kumaravadivel, P; Xu, SG; Ponomarenko, LA; Holwill, M; Bandurin, DA; Kim, M; Cao, Y; Greenaway, MT; Novoselov, KS; Grigorieva, IV; Watanabe, K; Taniguchi, T; Fal'ko, VI; Levitov, LS; Kumar, RK; Geim, AK				Berdyugin, Alexey, I; Xin, Na; Gao, Haoyang; Slizovskiy, Sergey; Dong, Zhiyu; Bhattacharjee, Shubhadeep; Kumaravadivel, P.; Xu, Shuigang; Ponomarenko, L. A.; Holwill, Matthew; Bandurin, D. A.; Kim, Minsoo; Cao, Yang; Greenaway, M. T.; Novoselov, K. S.; Grigorieva, I., V; Watanabe, K.; Taniguchi, T.; Fal'ko, V., I; Levitov, L. S.; Kumar, R. Krishna; Geim, A. K.			Out-of-equilibrium criticalities in graphene superlattices	SCIENCE			English	Article							ELECTRONIC-PROPERTIES; DIRAC FERMIONS; MOIRE BANDS; SATURATION; STATES	In thermodynamic equilibrium, current in metallic systems is carried by electronic states near the Fermi energy, whereas the filled bands underneath contribute little to conduction. Here, we describe a very different regime in which carrier distribution in graphene and its superlattices is shifted so far from equilibrium that the filled bands start playing an essential role, leading to a critical-current behavior. The criticalities develop upon the velocity of electron flow reaching the Fermi velocity. Key signatures of the out-of-equilibrium state are current-voltage characteristics that resemble those of superconductors, sharp peaks in differential resistance, sign reversal of the Hall effect, and a marked anomaly caused by the Schwinger-like production of hot electron-hole plasma. The observed behavior is expected to be common to all graphene-based superlattices.	[Berdyugin, Alexey, I; Xin, Na; Slizovskiy, Sergey; Bhattacharjee, Shubhadeep; Kumaravadivel, P.; Xu, Shuigang; Ponomarenko, L. A.; Holwill, Matthew; Bandurin, D. A.; Kim, Minsoo; Cao, Yang; Grigorieva, I., V; Fal'ko, V., I; Kumar, R. Krishna; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Berdyugin, Alexey, I; Xin, Na; Slizovskiy, Sergey; Bhattacharjee, Shubhadeep; Kumaravadivel, P.; Xu, Shuigang; Holwill, Matthew; Bandurin, D. A.; Kim, Minsoo; Cao, Yang; Novoselov, K. S.; Fal'ko, V., I; Kumar, R. Krishna; Geim, A. K.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Gao, Haoyang; Dong, Zhiyu; Levitov, L. S.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ponomarenko, L. A.] Univ Lancaster, Dept Phys, Lancaster LA1 4YW, England; [Greenaway, M. T.] Loughborough Univ, Dept Phys, Loughborough LE11 3TU, Leics, England; [Greenaway, M. T.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Watanabe, K.] Natl Inst Mat Sci, Res Ctr Funct Mat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Taniguchi, T.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Fal'ko, V., I] Henry Royce Inst Adv Mat, Manchester M13 9PL, Lancs, England; [Kumar, R. Krishna] Barcelona Inst Sci & Technol, Inst Ciencies Foton ICF0, Barcelona 08860, Spain	University of Manchester; University of Manchester; Massachusetts Institute of Technology (MIT); Lancaster University; Loughborough University; University of Nottingham; National Institute for Materials Science; National Institute for Materials Science; Barcelona Institute of Science & Technology	Berdyugin, AI; Kumar, RK; Geim, AK (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.; Berdyugin, AI; Kumar, RK; Geim, AK (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England.; Kumar, RK (corresponding author), Barcelona Inst Sci & Technol, Inst Ciencies Foton ICF0, Barcelona 08860, Spain.	alexey.berdyugin@manchester.ac.uk; roshankrishnakumar90@gmail.com; geim@manchester.ac.uk	Ponomarenko, Leonid/AAF-1731-2021	Xu, Shuigang/0000-0002-0589-5291; Gao, Haoyang/0000-0003-0591-4031; Kumaravadivel, Piranavan/0000-0002-9817-1697; Fal'ko, Vladimir/0000-0003-0828-0310; Kim, Minsoo/0000-0001-6304-6901; Bhattacharjee, Shubhadeep/0000-0002-5813-033X; Slizovskiy, Sergey/0000-0003-0131-0775	European Research Agency; Lloyd's Register Foundation; Graphene Flagship Core3 Project; Royal Society; EPSRC [EP/V008110/1, EP/V007033, EP/S030719]; NOWNANO Doctoral Training Centre; ESPRC doctoral-prize fellowship award; EU [754510, 893030]; EU Quantum Flagship Project [2D-SIPC]; Science and Technology Center for Integrated Quantum Materials, NSF [DMR-1231319]; Army Research Office [W911NF-18-1-0116]; Elemental Strategy Initiative of Japan [JPMXP0112101001]; JSPS KAKENHI [19H05790, 20H00354, 21H05233]	European Research Agency; Lloyd's Register Foundation; Graphene Flagship Core3 Project; Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NOWNANO Doctoral Training Centre; ESPRC doctoral-prize fellowship award; EU(European Commission); EU Quantum Flagship Project; Science and Technology Center for Integrated Quantum Materials, NSF; Army Research Office; Elemental Strategy Initiative of Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge financial support from the European Research Agency (grants ARTIMATTER and VANDER), Lloyd's Register Foundation, Graphene Flagship Core3 Project, and the Royal Society. M.T.G acknowledges the support from EPSRC grant EP/V008110/1, and A.I.B. acknowledges the support from NOWNANO Doctoral Training Centre. R.K.K. acknowledges a ESPRC doctoral-prize fellowship award and the EU Horizon 2020 program under the Marie Sklodowska-Curie grants 754510 and 893030. V.I.F. was also supported by EU Quantum Flagship Project 2D-SIPC and EPSRC grants EP/V007033 and EP/S030719. L.L. acknowledges support from the Science and Technology Center for Integrated Quantum Materials, NSF grant DMR-1231319, and Army Research Office grant W911NF-18-1-0116. K.W. and T.T. acknowledge support from Elemental Strategy Initiative of Japan (grant JPMXP0112101001) and JSPS KAKENHI (19H05790, 20H00354, and 21H05233). L.S.L. acknowledges support by the Science and Technology Center for Integrated Quantum Materials, NSF grant DMR-1231319, and Army Research Office grant W911NF-18-1-0116.	Allor D, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.096009; Andrei EY, 2020, NAT MATER, V19, P1265, DOI 10.1038/s41563-020-00840-0; Balents L, 2020, NAT PHYS, V16, P725, DOI 10.1038/s41567-020-0906-9; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Barrier J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19604-0; Berdyugin A. I., 2021, Out-of-equilibrium criticalities in graphene superlattices, DOI 10.5281/zenodo.5639021; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Cao Y, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.116804; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; Das Sarma S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035415; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Eckmann A, 2013, NANO LETT, V13, P5242, DOI 10.1021/nl402679b; Freitag M, 2009, NANO LETT, V9, P1883, DOI 10.1021/nl803883h; Fritz L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085416; Gallagher P, 2019, SCIENCE, V364, P158, DOI 10.1126/science.aat8687; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Kashuba AB, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085415; Kim K, 2017, P NATL ACAD SCI USA, V114, P3364, DOI 10.1073/pnas.1620140114; Kittel C, 2005, INTRO SOLID STATE PH, V8; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Ku MJH, 2020, NATURE, V583, P537, DOI 10.1038/s41586-020-2507-2; Kumar RK, 2017, SCIENCE, V357, P181, DOI 10.1126/science.aal3357; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; RYDER EJ, 1953, PHYS REV, V90, P766, DOI 10.1103/PhysRev.90.766; Saito Y, 2020, NAT PHYS, V16, P926, DOI 10.1038/s41567-020-0928-3; SCHWINGER J, 1951, PHYS REV, V82, P664, DOI 10.1103/PhysRev.82.664; SHOCKLEY W, 1951, AT&T TECH J, V30, P990, DOI 10.1002/j.1538-7305.1951.tb03692.x; Slizovskiy S., 2021, SLIZOVSKIY GRAPHENMO; Sze S. M., 2021, PHYS SEMICONDUCTOR D, DOI DOI 10.1002/0470068329; Tikhonov ES, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161405; Vandecasteele N, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045416; Wallbank JR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245408; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Wu YQ, 2012, ACS NANO, V6, P2610, DOI 10.1021/nn205106z; Xu SG, 2021, NAT PHYS, V17, P619, DOI 10.1038/s41567-021-01172-9; Yamoah MK, 2017, ACS NANO, V11, P9914, DOI 10.1021/acsnano.7b03878; Yang W, 2018, NAT NANOTECHNOL, V13, P47, DOI 10.1038/s41565-017-0007-9; Yankowitz M, 2019, NAT REV PHYS, V1, P112, DOI 10.1038/s42254-018-0016-0; Yu GL, 2014, NAT PHYS, V10, P525, DOI [10.1038/NPHYS2979, 10.1038/nphys2979]; Zener C., 1934, P R SOC LOND A, V145, P523	45	6	6	20	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					430	+		10.1126/science.abi8627	http://dx.doi.org/10.1126/science.abi8627			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084955	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000750899500035
J	Sarzynski, SH; Mancera, A; Mann, C; Dai, MT; Sun, JF; Warner, S; Kadri, SS				Sarzynski, Sadia H.; Mancera, Alex; Mann, Clay; Dai, Mengtao; Sun, Junfeng; Warner, Sarah; Kadri, Sameer S.			Frequency and Risk of Emergency Medical Service Interhospital Transportation of Patients With Acute Lower Respiratory Tract Illness During the COVID-19 Pandemic in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sarzynski, Sadia H.; Mancera, Alex; Sun, Junfeng; Warner, Sarah; Kadri, Sameer S.] NIH, Crit Care Med Dept, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA; [Mann, Clay; Dai, Mengtao] Univ Utah, Sch Med, Natl Emergency Med Serv Informat Syst, Tech Assistance Ctr, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Utah System of Higher Education; University of Utah	Kadri, SS (corresponding author), NIH, Clin Epidemiol Sect, Crit Care Med Dept, 10 Ctr Dr,Bldg 10-2C145, Bethesda, MD 20892 USA.	Sameer.Kadri@nih.gov			Intramural Research Program of the National Institutes of Health (NIH) Clinical Center	Intramural Research Program of the National Institutes of Health (NIH) Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH) Clinical Center.	Allen Rebecca, 2020, Air Med J, V39, P498, DOI 10.1016/j.amj.2020.07.007; Kadri SS, 2021, ANN INTERN MED, V174, P1240, DOI 10.7326/M21-1213; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Painvin B, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00841-5; Payet C, 2022, CRIT CARE MED, V50, P138, DOI 10.1097/CCM.0000000000005215; Troncoso Ruben D Jr, 2021, Air Med J, V40, P220, DOI 10.1016/j.amj.2021.04.001	6	1	1	3	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 1	2022	327	9					874	877		10.1001/jama.2022.0812	http://dx.doi.org/10.1001/jama.2022.0812		JAN 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZO9OI	35089309	Green Published, Bronze			2022-12-28	WOS:000747991100002
J	Wynn, J; Padget, O; Mouritsen, H; Morford, J; Jaggers, P; Guilford, T				Wynn, Joe; Padget, Oliver; Mouritsen, Henrik; Morford, Joe; Jaggers, Paris; Guilford, Tim			Magnetic stop signs signal a European songbird's arrival at the breeding site after migration	SCIENCE			English	Article							NAVIGATION; DIRECTION	Although it is known that birds can return to their breeding grounds with exceptional precision, it has remained a mystery how they know when and where to stop migrating. Using nearly a century's worth of Eurasian reed warbler (Acrocephalus scirpaceus) ringing recoveries, we investigated whether fluctuations in Earth's magnetic field predict variation in the sites to which birds return. Ringing recoveries suggest that magnetic inclination is learned before departure and is subsequently used as a uni-coordinate "stop sign" when relocating the natal or breeding site. However, many locations have the same inclination angle. Data from populations with different migratory directions indicate that birds solve this ambiguity by stopping at the first place where the right inclination is encountered on an inherited return vector.	[Wynn, Joe; Padget, Oliver; Morford, Joe; Jaggers, Paris; Guilford, Tim] Dept Zool, Oxford Nav Grp, Oxford OX1 3SZ, England; [Mouritsen, Henrik] Carl Von Ossietzky Univ Oldenburg, AG Neurosensor Anim Nav, D-26111 Oldenburg, Germany; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Wynn, J; Guilford, T (corresponding author), Dept Zool, Oxford Nav Grp, Oxford OX1 3SZ, England.	joseph.wynn@zoo.ox.ac.uk; tim.guilford@zoo.ox.ac.uk	Morford, Joe/GXH-2403-2022; Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839; Wynn, Joe/0000-0002-5552-6435; Jaggers, Paris/0000-0002-3859-6909; Padget, Oliver/0000-0001-5412-4306; Morford, Joe/0000-0003-3687-1783	UKRI BBSRC scholarship [BB/M011224/1]; UKRI NERC scholarship [NE/S007474/1]; Junior Research Fellowship at St John's College, University of Oxford; European Research Council [European Union] [810002]; Deutsche Forschungsgemeinschaft [SFB 1372, GRK 1885]; Merton College, Oxford; Mary Griffiths award	UKRI BBSRC scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UKRI NERC scholarship; Junior Research Fellowship at St John's College, University of Oxford; European Research Council [European Union](European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Merton College, Oxford; Mary Griffiths award	J.W. and J.M. were funded by a UKRI BBSRC scholarship (grant no. BB/M011224/1); P.J. was funded by a UKRI NERC scholarship (grant no. NE/S007474/1); O.P. was funded by a Junior Research Fellowship at St John's College, University of Oxford; H.M. received funding from the European Research Council [under the European Union's Horizon 2020 research and innovation program, grant agreement no. 810002 (synergy grant: "QuantumBirds")] and the Deutsche Forschungsgemeinschaft (SFB 1372, "Magnetoreception and navigation in vertebrates," and GRK 1885, "Molecular basis of sensory biology"); and T.G.'s research was supported by Merton College, Oxford, and by the Mary Griffiths award.	Baker R.R., 1978, EVOL ECOL; Brothers JR, 2018, CURR BIOL, V28, P1325, DOI 10.1016/j.cub.2018.03.022; Brothers JR, 2015, CURR BIOL, V25, P392, DOI 10.1016/j.cub.2014.12.035; Chernetsov N, 2008, ANIM BEHAV, V75, P539, DOI 10.1016/j.anbehav.2007.05.019; Chernetsov N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232136; Chernetsov N, 2017, CURR BIOL, V27, P2647, DOI 10.1016/j.cub.2017.07.024; Chernetsov Nikita, 1999, Avian Ecology and Behaviour, V2, P75; GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Holland RA, 2014, J ZOOL, V293, P1, DOI 10.1111/jzo.12107; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2018, NATURE, V558, P50, DOI 10.1038/s41586-018-0176-1; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; PERDECK A. C., 1958, ARDEA, V46, P1; Prochazka P, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01769; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; R Core Team, 2021, R LANG ENV STAT COMP; Schulze-Hagen K., 2011, **DROPPED REF**; Svensson L., 1970, IDENTIFICATION GUIDE; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Thorup K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64230-x; Thorup K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601360; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; Wynn J, 2020, CURR BIOL, V30, P2869, DOI 10.1016/j.cub.2020.05.039; Zwarts L., 2012, LIVING EDGE WETLANDS, DOI 10.1163/9789004278134	27	5	5	6	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					446	+		10.1126/science.abj4210	http://dx.doi.org/10.1126/science.abj4210			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084979				2022-12-28	WOS:000750899500039
J	Zanger, K; Nimkin, K; Israel, EJ; Shih, AR				Zanger, Kerstin; Nimkin, Katherine; Israel, Esther J.; Shih, Angela R.			Case 3-2022: A 14-Year-Old Boy with Fever, Joint Pain, and Abdominal Cramping	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; CHILDREN; THERAPY	A Boy with Fever, Joint Pain, and Abdominal Cramping A 14-year-old boy was admitted with fatigue, fever, joint pain, abdominal cramping, and diarrhea. He had been well until 2 weeks earlier, when fatigue and fever developed on his final day of summer camp. On the day of admission, he had pain in his shoulders and knees and a temperature of 39.2 degrees C. A diagnostic test was performed.	[Zanger, Kerstin; Israel, Esther J.; Shih, Angela R.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Nimkin, Katherine] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zanger, Kerstin; Israel, Esther J.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Nimkin, Katherine] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Shih, Angela R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zanger, K (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.		Shih, Angela R/AAQ-7578-2020	Shih, Angela R/0000-0002-8945-5997				Ansell BM, 2000, CURR OPIN RHEUMATOL, V12, P445, DOI 10.1097/00002281-200009000-00017; Boneh RS, 2017, J CROHNS COLITIS, V11, P1205, DOI 10.1093/ecco-jcc/jjx071; Borrelli O, 2006, CLIN GASTROENTEROL H, V4, P744, DOI 10.1016/j.cgh.2006.03.010; Borren NZ, 2019, NAT REV GASTRO HEPAT, V16, P247, DOI 10.1038/s41575-018-0091-9; Bruining DH, 2018, GASTROENTEROLOGY, V154, P1172, DOI 10.1053/j.gastro.2017.11.274; Dilauro Steven, 2010, Curr Gastroenterol Rep, V12, P249, DOI 10.1007/s11894-010-0112-5; Gunther U, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000714; Jose FA, 2009, INFLAMM BOWEL DIS, V15, P63, DOI 10.1002/ibd.20604; Kugathasan S, 2017, LANCET, V389, P1710, DOI 10.1016/S0140-6736(17)30317-3; Kullberg BJ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1041; Ledder O, 2017, J CROHNS COLITIS, V11, P1230, DOI 10.1093/ecco-jcc/jjx082; Lee D, 2015, INFLAMM BOWEL DIS, V21, P1786, DOI 10.1097/MIB.0000000000000426; Lee JJY, 2018, PEDIATR CLIN N AM, V65, P691, DOI 10.1016/j.pcl.2018.04.005; Levine A, 2019, GASTROENTEROLOGY, V157, P440, DOI 10.1053/j.gastro.2019.04.021; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Raoult D, 2010, EMERG INFECT DIS, V16, P776, DOI 10.3201/eid1605.091801; Rosh JR, 2021, J CROHNS COLITIS, V15, P1931, DOI 10.1093/ecco-jcc/jjab089; Rufo PA, 2012, J PEDIATR GASTR NUTR, V55, P93, DOI 10.1097/MPG.0b013e31825959b8; Saavedra-Lozano J, 2017, PEDIATR INFECT DIS J, V36, P788, DOI 10.1097/INF.0000000000001635; Suskind DL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123749; Suskind DL, 2014, J PEDIATR GASTR NUTR, V58, P87, DOI 10.1097/MPG.0000000000000103; Thavamani A, 2019, PEDIATR GASTROENTERO, V22, P527, DOI 10.5223/pghn.2019.22.6.527; van Rheenen PF, 2021, J CROHNS COLITIS, V15, P171, DOI 10.1093/ecco-jcc/jjaa161	25	0	0	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4					375	383		10.1056/NEJMcpc2115850	http://dx.doi.org/10.1056/NEJMcpc2115850			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081284				2022-12-28	WOS:000753548900015
J	Iacobucci, G				Iacobucci, Gareth			Long covid: "Holistic" approach is best, given range of symptoms, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Munblit D, 2022, LANCET; Stephenson T, LONG COVID POSTCOVID; Stephenson T, 2022, LANCET CHILD ADOLESC, V6, P230, DOI 10.1016/S2352-4642(22)00022-0	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o336	10.1136/bmj.o336	http://dx.doi.org/10.1136/bmj.o336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135781	Bronze			2022-12-28	WOS:000754132400004
J	Cooney, K				Cooney, Kieron			Has covid-19 precipitated the end of the family doctor?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o320	10.1136/bmj.o320	http://dx.doi.org/10.1136/bmj.o320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121614	Bronze			2022-12-28	WOS:000753552800007
J	Gaskill, M; Harrison, M				Gaskill, Marissa; Harrison, Melissa			Tethering gene regulation to chromatin organization	SCIENCE			English	Editorial Material							ZYGOTIC GENOME; DOMAINS; ACTIVATION		[Gaskill, Marissa; Harrison, Melissa] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Harrison, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA.	mharrison3@wisc.edu						Batut PJ, 2022, SCIENCE, V375, P566, DOI 10.1126/science.abi7178; Despang A, 2019, NAT GENET, V51, P1263, DOI 10.1038/s41588-019-0466-z; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Espinola SM, 2021, NAT GENET, V53, P477, DOI 10.1038/s41588-021-00816-z; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Gaskill MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66668; Ghavi-Helm Y, 2019, NAT GENET, V51, P1272, DOI 10.1038/s41588-019-0462-3; Hsieh THS, 2020, MOL CELL, V78, P539, DOI 10.1016/j.molcel.2020.03.002; Hug CB, 2017, CELL, V169, P216, DOI 10.1016/j.cell.2017.03.024; Ing-Simmons E, 2021, NAT GENET, V53, P487, DOI 10.1038/s41588-021-00799-x; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mir M, 2018, ELIFE, V7, DOI 10.7554/eLife.40497; Ogiyama Y, 2018, MOL CELL, V71, P73, DOI 10.1016/j.molcel.2018.05.032; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281	15	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					491	492		10.1126/science.abn6380	http://dx.doi.org/10.1126/science.abn6380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113712				2022-12-28	WOS:000753965100020
J	Tal, N; Sorek, R				Tal, Nitzan; Sorek, Rotem			SnapShot: Bacterial immunity	CELL			English	Editorial Material									[Tal, Nitzan; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Tal, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.				ERC-AdG grant [101018520]; ISF [296/21]	ERC-AdG grant; ISF(Israel Science Foundation)	Research in the Sorek lab is supported by ERC-AdG grant 101018520 and ISF grant 296/21.	Bernheim A, 2021, NATURE, V589, P120, DOI 10.1038/s41586-020-2762-2; Bernheim A, 2020, NAT REV MICROBIOL, V18, P113, DOI 10.1038/s41579-019-0278-2; Doron S, 2018, SCIENCE, V359, DOI 10.1126/science.aar4120; Gao LY, 2020, SCIENCE, V369, P1077, DOI 10.1126/science.aba0372; Hampton HG, 2020, NATURE, V577, P327, DOI 10.1038/s41586-019-1894-8; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lisitskaya L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07449-7; Lopatina A, 2020, ANNU REV VIROL, V7, P371, DOI 10.1146/annurev-virology-011620-040628; Rousset F., 2021, BIORXIV, DOI [10.1101/2021.01.21.427644, DOI 10.1101/2021.01.21.427644]; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	10	4	4	10	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 3	2022	185	3					578	579		10.1016/j.cell.2021.12.029	http://dx.doi.org/10.1016/j.cell.2021.12.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YV3VN	35120666				2022-12-28	WOS:000752659000004
J	Mahase, E				Mahase, Elisabeth			Women's rights groups call on Sierra Leone to criminalise FGM after recent death and complications	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o284	10.1136/bmj.o284	http://dx.doi.org/10.1136/bmj.o284			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110297				2022-12-28	WOS:000758682200002
J	Laxminarayan, R				Laxminarayan, Ramanan			Supporting bereaved family members: three steps in the right direction	LANCET			English	Editorial Material							CARE		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Laxminarayan, Ramanan] Global Antibiot Res & Dev Partnership, Geneva, Switzerland		Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.; Laxminarayan, R (corresponding author), Global Antibiot Res & Dev Partnership, Geneva, Switzerland.	ramanan@cddep.org						Barnato AE, 2017, CRIT CARE MED, V45, P35, DOI 10.1097/CCM.0000000000002009; Crowe S, 2021, INTENS CRIT CARE NUR, V63, DOI 10.1016/j.iccn.2020.102999; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; Downar J, 2018, INTENS CARE MED, V44, P521, DOI 10.1007/s00134-017-5027-2; Downar J, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.11.024; Efstathiou N, 2019, J CRIT CARE, V50, P177, DOI 10.1016/j.jcrc.2018.11.026; Kentish-Barnes N, 2022, LANCET, V399, P656, DOI 10.1016/S0140-6736(21)02176-0; Shear MK, 2015, NEW ENGL J MED, V372, P153, DOI 10.1056/NEJMcp1315618; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Vanderspank-Wright B, 2018, INT J NURS STUD, V77, P15, DOI 10.1016/j.ijnurstu.2017.09.012	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					607	609		10.1016/S0140-6736(21)02446-6	http://dx.doi.org/10.1016/S0140-6736(21)02446-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY1RO	35065010				2022-12-28	WOS:000754571600003
J	Li, XD; Zhang, WX; Guo, XM; Lu, CY; Wei, JY; Fang, JF				Li, Xiaodong; Zhang, Wenxiao; Guo, Xuemin; Lu, Chunyan; Wei, Jiyao; Fang, Junfeng			Constructing heterojunctions by surface sulfidation for efficient inverted perovskite solar cells	SCIENCE			English	Article							DEGRADATION; STABILITY; CATION	A stable perovskite heterojunction was constructed for inverted solar cells through surface sulfidation of lead (Pb)-rich perovskite films. The formed lead-sulfur (Pb-S) bonds upshifted the Fermi level at the perovskite interface and induced an extra back-surface field for electron extraction. The resulting inverted devices exhibited a power conversion efficiency (PCE) >24% with a high open-circuit voltage of 1.19 volts, corresponding to a low voltage loss of 0.36 volts. The strong Pb-S bonds could stabilize perovskite heterojunctions and strengthen underlying perovskite structures that have a similar crystal lattice. Devices with surface sulfidation retained more than 90% of the initial PCE after aging at 85 degrees C for 2200 hours or operating at the maximum power point under continuous illumination for 1000 hours at 55 degrees +/- 5 degrees C.	[Li, Xiaodong; Zhang, Wenxiao; Guo, Xuemin; Lu, Chunyan; Wei, Jiyao; Fang, Junfeng] East China Normal Univ, Engn Res Ctr Nanophoton & Adv Instrument, Sch Phys & Elect Sci, Minist Educ, Shanghai 200062, Peoples R China; [Fang, Junfeng] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Peoples R China	East China Normal University; Chinese Academy of Sciences; Ningbo Institute of Materials Technology and Engineering, CAS	Fang, JF (corresponding author), East China Normal Univ, Engn Res Ctr Nanophoton & Adv Instrument, Sch Phys & Elect Sci, Minist Educ, Shanghai 200062, Peoples R China.; Fang, JF (corresponding author), Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Peoples R China.	jffang@phy.ecnu.edu.cn		Li, Xiaodong/0000-0003-0184-008X	National Natural Science Foundation of China [51903242, 52173161, 61974150, 62104070]; Key Research Program of Frontier Sciences; Chinese Academy of Sciences (CAS) [QYZDB-SSW-JSC047]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (51903242, 52173161, 61974150, and 62104070), the Key Research Program of Frontier Sciences, the Chinese Academy of Sciences (CAS) (QYZDB-SSW-JSC047), and the Fundamental Research Funds for the Central Universities.	Almora O, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4966127; Amat A, 2014, NANO LETT, V14, P3608, DOI 10.1021/nl5012992; Bai S, 2019, NATURE, V571, P245, DOI 10.1038/s41586-019-1357-2; Carrillo J, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502246; Deschler F, 2014, J PHYS CHEM LETT, V5, P1421, DOI 10.1021/jz5005285; El-Mellouhi F, 2016, CHEMSUSCHEM, V9, P2648, DOI 10.1002/cssc.201600864; Eperon GE, 2016, ACS NANO, V10, P10258, DOI 10.1021/acsnano.6b05825; Fu S, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201901852; Guerrero A, 2016, ACS NANO, V10, P218, DOI 10.1021/acsnano.5b03687; Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Hui W, 2021, SCIENCE, V371, P1359, DOI 10.1126/science.abf7652; Jang YW, 2021, NAT ENERGY, V6, P63, DOI 10.1038/s41560-020-00749-7; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Leijtens T, 2014, ACS NANO, V8, P7147, DOI 10.1021/nn502115k; Li NX, 2019, NAT ENERGY, V4, P408, DOI 10.1038/s41560-019-0382-6; Li XD, 2021, J MATER CHEM A, V9, P12684, DOI 10.1039/d1ta01572a; Li XD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd1580; Li XD, 2019, NANO ENERGY, V64, DOI 10.1016/j.nanoen.2019.103962; Li XD, 2019, NANO ENERGY, V58, P825, DOI 10.1016/j.nanoen.2019.02.009; Li XD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06204-2; Li XD, 2017, ACS APPL MATER INTER, V9, P31357, DOI 10.1021/acsami.7b11977; Li XD, 2015, J MATER CHEM A, V3, P15024, DOI 10.1039/c5ta04712a; Liu MX, 2019, NATURE, V570, P96, DOI 10.1038/s41586-019-1239-7; Lu HZ, 2020, SCIENCE, V370, P74, DOI 10.1126/science.abb8985; Luo DY, 2018, SCIENCE, V360, P1442, DOI 10.1126/science.aap9282; Motta C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8026; National Renewable Energy Laboratory, BEST RES CELL EFF CH; Ning ZJ, 2015, NATURE, V523, P324, DOI 10.1038/nature14563; Qing J, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201800185; Shao YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6784; Tress W, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201602358; Wang F, 2018, NPJ FLEX ELECTRON, V2, DOI 10.1038/s41528-018-0035-z; Wang YB, 2019, SCIENCE, V365, P687, DOI 10.1126/science.aax8018; Xiong SB, 2021, JOULE, V5, P467, DOI 10.1016/j.joule.2020.12.009; Yang S, 2019, SCIENCE, V365, P473, DOI 10.1126/science.aax3294; Yoo JJ, 2021, NATURE, V590, DOI 10.1038/s41586-021-03285-w; Zhao YC, 2017, J PHYS CHEM C, V121, P14517, DOI 10.1021/acs.jpcc.7b04684; Zheng XP, 2020, NAT ENERGY, V5, P131, DOI 10.1038/s41560-019-0538-4	38	114	114	287	530	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					434	+		10.1126/science.abl5676	http://dx.doi.org/10.1126/science.abl5676			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084976				2022-12-28	WOS:000750899500036
J	Marklund, E; Mao, GZ; Yuan, JW; Zikrin, S; Abdurakhmanov, E; Deindl, S; Elf, J				Marklund, Emil; Mao, Guanzhong; Yuan, Jinwen; Zikrin, Spartak; Abdurakhmanov, Eldar; Deindl, Sebastian; Elf, Johan			Sequence specificity in DNA binding is mainly governed by association	SCIENCE			English	Article							DIFFUSION-DRIVEN MECHANISMS; PROTEIN TRANSLOCATION; NUCLEIC-ACIDS; REPRESSOR; KINETICS; EQUILIBRIUM; DYNAMICS; LEVEL; CAS9	Sequence-specific binding of proteins to DNA is essential for accessing genetic information. We derive a model that predicts an anticorrelation between the macroscopic association and dissociation rates of DNA binding proteins. We tested the model for thousands of different lac operator sequences with a protein binding microarray and by observing kinetics for individual lac repressor molecules in single-molecule experiments. We found that sequence specificity is mainly governed by the efficiency with which the protein recognizes different targets. The variation in probability of recognizing different targets is at least 1.7 times as large as the variation in microscopic dissociation rates. Modulating the rate of binding instead of the rate of dissociation effectively reduces the risk of the protein being retained on nontarget sequences while searching.	[Marklund, Emil; Mao, Guanzhong; Yuan, Jinwen; Zikrin, Spartak; Deindl, Sebastian; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Box 596, S-75124 Uppsala, Sweden; [Abdurakhmanov, Eldar] Uppsala Univ, Drug Discovery & Dev Platform, Sci Life Lab, BMC,Dept Chem, Box 576, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University	Deindl, S; Elf, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Box 596, S-75124 Uppsala, Sweden.	sebastian.deindl@icm.uu.se; johan.elf@icm.uu.se	Zikrin, Spartak/AAM-8833-2020	Zikrin, Spartak/0000-0002-7802-8869; elf, johan/0000-0001-5522-1810; Deindl, Sebastian/0000-0001-6807-8654	Knut and Alice Wallenberg Foundation [2016.0077, 2019.0439, 2019.0306]; Swedish Research Council [2016-06213, 2020-06459]; European Research Council [714068, 885360]; eSSENCE e-science initiative; Swedish National Infrastructure for Computing (SNIC) at UPPMAX	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); eSSENCE e-science initiative; Swedish National Infrastructure for Computing (SNIC) at UPPMAX	This research was supported by the Knut and Alice Wallenberg Foundation (2016.0077 and 2019.0439 to J.E.; 2019.0306 to S.D.), the Swedish Research Council (2016-06213 to J.E.; 2020-06459 to E.M.), the European Research Council (Starting Grant, 714068 to S.D.; Advanced Grant, 885360 to J.E.), the eSSENCE e-science initiative and the Swedish National Infrastructure for Computing (SNIC) at UPPMAX.	Ali MZ, 2020, ELIFE, V9, DOI 10.7554/eLife.56517; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonilla S, 2017, J AM CHEM SOC, V139, P18576, DOI 10.1021/jacs.7b08870; Boyle EA, 2017, P NATL ACAD SCI USA, V114, P5461, DOI 10.1073/pnas.1700557114; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; CHEN J, 1994, J BIOL CHEM, V269, P12482; Deindl S, 2012, METHOD ENZYMOL, V513, P59, DOI 10.1016/B978-0-12-391938-0.00003-3; Dupuis NF, 2013, BIOPHYS J, V105, P756, DOI 10.1016/j.bpj.2013.05.061; Edelstein Arthur D, 2014, J Biol Methods, V1; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Gronlund A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2867; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Kipper K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198416; Klein M, 2018, CELL REP, V22, P1413, DOI 10.1016/j.celrep.2018.01.045; LAIKEN SL, 1972, J MOL BIOL, V66, P143, DOI 10.1016/S0022-2836(72)80012-3; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Linden M, 2016, BIOINFORMATICS, V32, P2394, DOI 10.1093/bioinformatics/btw109; Marklund E, 2020, NATURE, V583, P858, DOI 10.1038/s41586-020-2413-7; Milo R., 2015, CELL BIOL NUMBERS; Morrison M, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008572; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Poddar A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21144-0; Sabantsev A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09657-1; Sadler BM, 1999, IEEE T INFORM THEORY, V45, P1043, DOI 10.1109/18.761341; Siggers T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.89; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yang DL, 2016, ANAL BIOCHEM, V508, P78, DOI 10.1016/j.ab.2016.06.024; Yuan J., 2021, SCILIFELAB, DOI [10.17044/scilifelab.17099687, DOI 10.17044/SCILIFELAB.17099687]	38	2	2	5	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					442	+		10.1126/science.abg7427	http://dx.doi.org/10.1126/science.abg7427			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084952	Green Submitted			2022-12-28	WOS:000750899500038
J	Viswanathan, V; Epstein, AH; Chiang, YM; Takeuchi, E; Bradley, M; Langford, J; Winter, M				Viswanathan, Venkatasubramanian; Epstein, Alan H.; Chiang, Yet-Ming; Takeuchi, Esther; Bradley, Marty; Langford, John; Winter, Michael			The challenges and opportunities of battery-powered flight	NATURE			English	Article							ENERGY; PRINCIPLES; CFX	Aircraft, and the aviation ecosystem in which they operate, are shaped by complex trades among technical requirements, economics and environmental concerns, all built on a foundation of safety. This Perspective explores the requirements of battery-powered aircraft and the chemistries that hold promise to enable them. The difference between flight and terrestrial needs and chemistries are highlighted. Safe, usable specific energy rather than cost is the major constraint for aviation. We conclude that battery packs suitable for flight with specific energy approaching 600 kilowatt hours per kilogram may be achievable in the next decade given sufficient investment targeted at aeronautical applications.	[Viswanathan, Venkatasubramanian] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Epstein, Alan H.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Chiang, Yet-Ming] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Takeuchi, Esther] SUNY Stony Brook, Dept Mat Sci & Chem Engn, Stony Brook, NY 11794 USA; [Takeuchi, Esther] Brookhaven Natl Lab, Interdisciplinary Sci Dept, Upton, NY 11973 USA; [Bradley, Marty] Univ Southern Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90007 USA; [Langford, John] Electra Aero, Falls Church, VA USA; [Winter, Michael] Pratt & Whitney, Hartford, CT USA	Carnegie Mellon University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Southern California; Raytheon Technologies; Pratt & Whitney	Viswanathan, V (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.; Epstein, AH (corresponding author), MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA.	venkvis@cmu.edu; epstein@mit.edu		Viswanathan, Venkatasubramanian/0000-0003-1060-5495; Chiang, Yet-Ming/0000-0002-0833-7674; /0000-0002-2850-5831				Albertus P, 2018, NAT ENERGY, V3, P16, DOI 10.1038/s41560-017-0047-2; [Anonymous], SOLID POWER BATTERY; [Anonymous], 2010, AIRCRAFT COMMERCE, V70, P12; [Anonymous], 2020, PR NEWSWIRE; Crittenden M, 2020, IEEE SPECTRUM, V57, P44, DOI 10.1109/mspec.2020.9173903; Dave A, 2020, CELL REP PHYS SCI, V1, DOI 10.1016/j.xcrp.2020.100264; Davis SJ, 2018, SCIENCE, V360, P1419, DOI 10.1126/science.aas9793; Duffy MJ, 2017, 17 AIAA AV TECHN INT, DOI [10.2514/6.2017-3442, DOI 10.2514/6.2017-3442]; Epstein AH, 2019, J PROPUL POWER, V35, P572, DOI 10.2514/1.B37015; European Aviation Safety Agency, 2017, DOC NO SC LSA F2480; Famprikis T, 2019, NAT MATER, V18, P1278, DOI 10.1038/s41563-019-0431-3; Fang CC, 2019, TRENDS CHEM, V1, P152, DOI 10.1016/j.trechm.2019.02.015; Gallagher KG, 2014, ENERG ENVIRON SCI, V7, P1555, DOI 10.1039/c3ee43870h; Grey CP, 2017, NAT MATER, V16, P45, DOI [10.1038/NMAT4777, 10.1038/nmat4777]; Hatzell KB, 2020, ACS ENERGY LETT, V5, P922, DOI 10.1021/acsenergylett.9b02668; Hepperle M., 2012, ENERGY EFFICIENT TEC; Hua X, 2021, NAT MATER, V20, P841, DOI 10.1038/s41563-020-00893-1; ICAO, 2019, 2019 ENV REP, V24, P17; Kadhiresan A. R., 2019, AIAA AVIATION 2019 F; Kondo T, 2005, PROC 2005 BOEING PER, P3; Krause FC, 2018, J ELECTROCHEM SOC, V165, pA2312, DOI 10.1149/2.1061810jes; Krishnamurthy V, 2020, ACS ENERGY LETT, V5, P3330, DOI 10.1021/acsenergylett.0c01815; Lain MJ, 2019, BATTERIES-BASEL, V5, DOI 10.3390/batteries5040064; Langford J. S., 2020, BRIDGE, V50, P21; Lents C.E., 2019, P AIAA PROP EN 2019, P4396; Li YD, 2018, J PHYS CHEM C, V122, P7128, DOI 10.1021/acs.jpcc.8b00569; Liu DQ, 2019, ADV MATER, V31, DOI 10.1002/adma.201806620; Liu W, 2014, ACS APPL MATER INTER, V6, P2209, DOI 10.1021/am4051348; Marien TV, 2016, P 54 AIAA AER SCI M, P1; Meng YS, 2013, ACCOUNTS CHEM RES, V46, P1171, DOI 10.1021/ar2002396; National Academies of Sciences Engineering and Medicine., 2020, REV OPPORTUNITIES EN, DOI [10.17226/25760, DOI 10.17226/25760]; National Academies of Sciences Engineering and Medicine., 2016, REV STATE ART PROSPE, DOI [10.17226/23490, DOI 10.17226/23490]; Neubauer J, 2014, J POWER SOURCES, V271, P614, DOI 10.1016/j.jpowsour.2014.06.043; Office of Energy Efficiency & Renewable Energy, BATTERY500 PROGR UPD; Pratt & Whitney Canada, PT6 FLAT RATE OVERHA; Reddy MA, 2013, ACS APPL MATER INTER, V5, P11207, DOI 10.1021/am403438m; Schneider D. C, 2009, THESIS G WASHINGTON; Severson KA, 2019, NAT ENERGY, V4, P383, DOI 10.1038/s41560-019-0356-8; Silva C., 2018 AVIATION TECHNO, DOI [10.2514/6.2018-3847, DOI 10.2514/6.2018-3847]; Sindreu J, 2021, WALL STR J; Singh J., 2020, ZENODO, DOI [10.5281/zenodo.4609278, DOI 10.5281/ZENODO.4609278]; Smith PF, 2017, ACCOUNTS CHEM RES, V50, P544, DOI 10.1021/acs.accounts.6b00540; Society of Automotive Engineers, 2020, STANDARD AIR6343; Soloveichik G., 2020, 2020 IONICS ANN REV; Soreau R, 1894, PRACTICAL ENG, V9, P266; Sripad S, 2017, ACS ENERGY LETT, V2, P1669, DOI 10.1021/acsenergylett.7b00432; Technologies, 2020, 2020 IONICS ANN REV; US Federal Aviation Authority, EVENTS SMOKE FIRE EX; Voskuijl M., 2018, CEAS AERONAUTICAL J, V9, P15, DOI [10.1007/s13272-017-0272-1, DOI 10.1007/S13272-017-0272-1]; Yang YYC, 2020, ENERG ENVIRON SCI, V13, P2209, DOI 10.1039/d0ee01446j; Zhang H., 2017, 51 S 51 O2 BATTERIES; Zhu YY, 2020, P NATL ACAD SCI USA, V117, P27195, DOI 10.1073/pnas.2001923117; Zu CX, 2011, ENERG ENVIRON SCI, V4, P2614, DOI 10.1039/c0ee00777c	53	31	31	56	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					519	525		10.1038/s41586-021-04139-1	http://dx.doi.org/10.1038/s41586-021-04139-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082419				2022-12-28	WOS:000749546400017
J	Abramowicz, M				Abramowicz, Mark			Tixagevimab and Cilgavimab (Evusheld) for Pre-Exposure Prophylaxis of COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review																		[Anonymous], 2021, MED LETT DRUGS THER, V63, P186; [Anonymous], 2021, MED LETT DRUGS THER, V63, P163; [Anonymous], 2021, Med Lett Drugs Ther, V63, P145; [Anonymous], 2021, Med Lett Drugs Ther, V63, P130; AstraZeneca, 2021, EV LONG ACT ANT COMB; Fabian, 2021, PHL17; U.S. Food and Drug Administration, FACT SHEET HLTH CAR; United States Centers for Disease Control and Prevention, 2021, INT CLIN CONS US COV	8	48	48	11	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					384	385						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076671	Bronze			2022-12-28	WOS:000753055700015
J	Iacobucci, G				Iacobucci, Gareth			NHS Race and Health Observatory to stage first international conference in July	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kmietowicz Z, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2191; Racism in medicine, BMJ	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o201	10.1136/bmj.o201	http://dx.doi.org/10.1136/bmj.o201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35074844	Bronze			2022-12-28	WOS:000759189200013
J	Mahase, E				Mahase, Elisabeth			Recovery trial lead launches organisation to cut costs of clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1201	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								o203	10.1136/bmj.o203	http://dx.doi.org/10.1136/bmj.o203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4MD	35074791				2022-12-28	WOS:000750652200003
J	Torjesen, I				Torjesen, Ingrid			Campaign aims to increase hospital staff's access to hot meals at night and at weekends	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2018, BMA FAT FAC CHART; Department of Health, 2014, HOSP FOOD STAND PAN; Department of Health and Social Care, 2020, REPORT INDEPENDENT R; Hawkes N, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l4262; UK Parliament, 2022, 24 HOUR HOT FOOD SER	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o167	10.1136/bmj.o167	http://dx.doi.org/10.1136/bmj.o167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058242				2022-12-28	WOS:000750649900005
J	Welch, E; Vaughan, J; Cranfield, KR; Mehdian, R				Welch, Ellen; Vaughan, Jenny; Cranfield, Kristina Rebecca; Mehdian, Roshana			What implications does the Toombes vs Mitchell case have for other healthcare professionals?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Welch, Ellen; Vaughan, Jenny] Doctors Assoc, Barracks, Lancs, England		Welch, E (corresponding author), Doctors Assoc, Barracks, Lancs, England.							Dyer C, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2999; Dyer C, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2919; Papanikitas A, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o79; Wallis KA, 2017, BRIT J GEN PRACT, V67, P38, DOI 10.3399/bjgp17X688777	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o162	10.1136/bmj.o162	http://dx.doi.org/10.1136/bmj.o162			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058233	Bronze			2022-12-28	WOS:000750649900003
J	Kapur, NK; Upshaw, JN; Wessler, BS				Kapur, Navin K.; Upshaw, Jenica N.; Wessler, Benjamin S.			REDUCE LAP-HF II interatrial shunt trial: neutral, but necessary	LANCET			English	Editorial Material							HEART-FAILURE; DEVICE		[Kapur, Navin K.; Upshaw, Jenica N.; Wessler, Benjamin S.] Tufts Med Ctr, CardioVasc Ctr, Boston, MA 02111 USA	Tufts Medical Center	Kapur, NK (corresponding author), Tufts Med Ctr, CardioVasc Ctr, Boston, MA 02111 USA.	nkapur@tuftsmedicalcenter.org						Anker SD, 2021, NEW ENGL J MED, V385, P1451, DOI 10.1056/NEJMoa2107038; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Butler J, 2021, EUR HEART J, V42, P1203, DOI 10.1093/eurheartj/ehaa1007; Fallick C, 2011, CIRC-HEART FAIL, V4, P669, DOI 10.1161/CIRCHEARTFAILURE.111.961789; Feldman T, 2018, CIRCULATION, V137, P364, DOI 10.1161/CIRCULATIONAHA.117.032094; Hasenfuss G, 2016, LANCET, V387, P1298, DOI 10.1016/S0140-6736(16)00704-2; Shah SJ, LANCET, V2022; Solomon SD, 2020, CIRCULATION, V141, P352, DOI 10.1161/CIRCULATIONAHA.119.044586	8	0	0	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10330					1094	1095		10.1016/S0140-6736(22)00108-8	http://dx.doi.org/10.1016/S0140-6736(22)00108-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZV8ZO	35120591				2022-12-28	WOS:000770814300003
J	Kmietowicz, Z				Kmietowicz, Zosia			Sixty seconds on ... food on prescription	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o303; Monroe J., 2022, TWITTER; Salisbury H., 2022, TWITTER	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								o318	10.1136/bmj.o318	http://dx.doi.org/10.1136/bmj.o318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9JI	35131765	Bronze			2022-12-28	WOS:000759192600008
J	Dyer, O				Dyer, Owen			Doctors back out of participating in Nevada fentanyl execution after court asks for their qualifications	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4861; Dyer O, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3064	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o319	10.1136/bmj.o319	http://dx.doi.org/10.1136/bmj.o319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121616				2022-12-28	WOS:000753552800013
J	Vogel, F				Vogel, Felix			Chasing after methane's ultra-emitters	SCIENCE			English	Editorial Material									[Vogel, Felix] Environm & Climate Change Canada, Climate Res Div, Toronto, ON, Canada	Environment & Climate Change Canada	Vogel, F (corresponding author), Environm & Climate Change Canada, Climate Res Div, Toronto, ON, Canada.	felix.vogel@ec.gc.ca						Cusworth D. H., GEOPHYS RES LETT, V48, P1; Duren RM, 2019, NATURE, V575, P180, DOI 10.1038/s41586-019-1720-3; Etminan M, 2016, GEOPHYS RES LETT, V43, P12614, DOI 10.1002/2016GL071930; Ganesan AL, 2019, GLOBAL BIOGEOCHEM CY, V33, P1475, DOI 10.1029/2018GB006065; Lauvaux T, 2022, SCIENCE, V375, P557, DOI 10.1126/science.abj4351; MacKay K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87610-3; Nassar R, 2017, GEOPHYS RES LETT, V44, P10045, DOI 10.1002/2017GL074702; Nisbet EG, 2020, REV GEOPHYS, V58, DOI 10.1029/2019RG000675; Saunois M, 2020, EARTH SYST SCI DATA, V12, P1561, DOI 10.5194/essd-12-1561-2020; UN Environment Programme, INT METH EM OBS; UN Environment Programme, EM GAP REP 201; Veefkind JP, 2012, REMOTE SENS ENVIRON, V120, P70, DOI 10.1016/j.rse.2011.09.027; Weller ZD, 2020, ENVIRON SCI TECHNOL, V54, P8958, DOI 10.1021/acs.est.0c00437	13	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					490	491		10.1126/science.abm1676	http://dx.doi.org/10.1126/science.abm1676			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113711				2022-12-28	WOS:000753965100019
J	Lawler, M; Crul, M				Lawler, Mark; Crul, Mirjam			Data must underpin our response to the covid-19 pandemic's disastrous impact on cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lawler, Mark] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Lawler, Mark] DATA CAN, London, England; [Lawler, Mark; Crul, Mirjam] European Canc Org, Brussels, Belgium; [Crul, Mirjam] Amsterdam UMC, Amsterdam, Netherlands	Queens University Belfast; University of Amsterdam	Lawler, M (corresponding author), Queens Univ Belfast, Belfast, Antrim, North Ireland.; Lawler, M (corresponding author), DATA CAN, London, England.; Lawler, M (corresponding author), European Canc Org, Brussels, Belgium.							[Anonymous], 2021, CANC RES UK; [Anonymous], 2020, CONQ CANC MISS POSS; [Anonymous], 2021, TIM ACT DAT NAV BUIL; Dinmohamed AG, 2020, LANCET ONCOL, V21, P750, DOI 10.1016/S1470-2045(20)30265-5; Europe's Beating Cancer Plan, 2021, NEW EU APPR PREV TRE; Ho KMA, 2021, LANCET GASTROENTEROL, V6, P381, DOI 10.1016/S2468-1253(21)00058-3; Lai AG, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043828; Lawler M, 2021, BMJ OPINION; Lim KHJ, 2021, ESMO OPEN, V6, DOI 10.1016/j.esmoop.2021.100199; Loveday C, 2021, GUT, V70, P1053, DOI 10.1136/gutjnl-2020-321650; Sud A, 2020, LANCET ONCOL, V21, P1035, DOI 10.1016/S1470-2045(20)30392-2; Voisin Mathew R, 2020, Neurooncol Adv, V2, pvdaa104, DOI 10.1093/noajnl/vdaa104	12	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2022	376								o282	10.1136/bmj.o282	http://dx.doi.org/10.1136/bmj.o282			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9HM	35115384	Bronze			2022-12-28	WOS:000759187700006
J	Devi, S				Devi, Sharmila			Aid agencies warn of health consequences of Mali sanctions	LANCET			English	Editorial Material								Delayed elections in Mali have prompted sanctions, but humanitarian groups warn that health care is being adversely affected. Sharmila Devi reports.											0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					510	510						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123682				2022-12-28	WOS:000755144500012
J	Hakim, FE; Farooq, AV				Hakim, Farida E.; Farooq, Asim, V			Dry Eye Disease An Update in 2022	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hakim, Farida E.; Farooq, Asim, V] Univ Chicago, Dept Ophthalmol & Visual Sci, Med Ctr, 5841S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Farooq, AV (corresponding author), Univ Chicago, Dept Ophthalmol & Visual Sci, Med Ctr, 5841S Maryland Ave, Chicago, IL 60637 USA.	afarooq@bsd.uchicago.edu						Craig JP, 2017, OCUL SURF, V15, P802, DOI 10.1016/j.jtos.2017.08.003; Dana R, 2019, AM J OPHTHALMOL, V202, P47, DOI 10.1016/j.ajo.2019.01.026; Kawashima M, 2018, J OCCUP HEALTH, V60, P281, DOI 10.1539/joh.2017-0191-OA; Kojima T, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100842; Park JY, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.5.31; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shtein RM, 2020, OPHTHALMOLOGY, V127, P128, DOI 10.1016/j.ophtha.2019.08.018; Thode AR, 2015, DRUGS, V75, P1177, DOI 10.1007/s40265-015-0432-8; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001; Xiao JX, 2020, AM J OPHTHALMOL, V209, P160, DOI 10.1016/j.ajo.2019.09.005	10	7	7	6	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					478	479						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103781				2022-12-28	WOS:000753056200020
J	Li, JG; Somers, VK; Xu, H; Lopez-Jimenez, F; Covassin, N				Li, Jingen; Somers, Virend K.; Xu, Hao; Lopez-Jimenez, Francisco; Covassin, Naima			Trends in Use of Melatonin Supplements Among US Adults, 1999-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CLINICAL-PRACTICE GUIDELINE		[Li, Jingen] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China; [Somers, Virend K.; Lopez-Jimenez, Francisco; Covassin, Naima] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA; [Xu, Hao] Xiyuan Hosp, Natl Clin Res Ctr Chinese Med Cardiol, Beijing, Peoples R China	Beijing University of Chinese Medicine; Mayo Clinic; Xiyuan Hospital, CACMS	Covassin, N (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA.	covassin.naima@mayo.edu	Li, Jingen/AAP-2670-2021; Li, Jingen/GRY-1585-2022	Li, Jingen/0000-0002-4233-950X				Auger RR, 2015, J CLIN SLEEP MED, V11, P1199, DOI 10.5664/jcsm.5100; Besag FMC, 2019, CNS DRUGS, V33, P1167, DOI 10.1007/s40263-019-00680-w; Erland LAE, 2017, J CLIN SLEEP MED, V13, P275, DOI 10.5664/jcsm.6462; Morvaridzadeh M, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105210; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115	6	8	8	7	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					483	485						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103775	Green Published			2022-12-28	WOS:000753056200022
J	Zhang, Q; Bastard, P; Cobat, A; Casanova, JL				Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent		COVID Human Genetic Effort	Human genetic and immunological determinants of critical COVID-19 pneumonia	NATURE			English	Review							PLASMACYTOID DENDRITIC CELLS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; MYASTHENIA-GRAVIS PATIENTS; SINGLE-STRANDED RNA; SARS-COV-2 INFECTION; PROTECTIVE IMMUNITY; DISTINCT FUNCTIONS; INBORN-ERRORS; HIGH BURDEN; INTERFERON	SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases. The ensuing risk of death (approximately 1% across age and gender) doubles every five years from childhood onwards and is around 1.5 times greater in men than in women. Here we review the molecular and cellular determinants of critical COVID-19 pneumonia. Inborn errors of type I interferons (IFNs), including autosomal TLR3 and X-chromosome-linked TLR7 deficiencies, are found in around 1-5% of patients with critical pneumonia under 60 years old, and a lower proportion in older patients. Pre-existing auto-antibodies neutralizing IFN alpha, IFN beta and/or IFN omega, which are more common in men than in women, are found in approximately 15-20% of patients with critical pneumonia over 70 years old, and a lower proportion in younger patients. Thus, at least 15% of cases of critical COVID-19 pneumonia can be explained. The TLR3- and TLR7-dependent production of type I IFNs by respiratory epithelial cells and plasmacytoid dendritic cells, respectively, is essential for host defence against SARS-CoV-2. In ways that can depend on age and sex, insufficient type I IFN immunity in the respiratory tract during the first few days of infection may account for the spread of the virus, leading to pulmonary and systemic inflammation.	[Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA; [Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Necker Hosp Sick Children, Lab Human Genet Infect Dis, Necker Branch, INSERM,U1163, Paris, France; [Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Univ Paris, Imagine Inst, Paris, France; [Bastard, Paul; Casanova, Jean-Laurent] Necker Hosp Sick Children, Dept Pediat, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, Paris, France	Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhang, Q; Casanova, JL (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.; Zhang, Q; Casanova, JL (corresponding author), Necker Hosp Sick Children, Lab Human Genet Infect Dis, Necker Branch, INSERM,U1163, Paris, France.; Zhang, Q; Casanova, JL (corresponding author), Univ Paris, Imagine Inst, Paris, France.; Casanova, JL (corresponding author), Necker Hosp Sick Children, Dept Pediat, Paris, France.; Casanova, JL (corresponding author), Howard Hughes Med Inst, Paris, France.	qzhang02@rockefeller.edu; casanova@rockefeller.edu	Liu, Zhiyong/CAF-2366-2022; Béziat, Vivien/AAT-4097-2021; Cobat, Aurélie/H-4722-2017; şenoğlu, sevtap/AEM-3761-2022; Okada, Satoshi/B-8901-2011; Yahşi, Aysun/CED-6079-2022; Emiroğlu, Melike/AAH-3566-2019; Boyarchuk, Oksana/GSD-2473-2022; Morange, Pierre/T-9070-2019; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; Pujol, Aurora/N-4990-2014; Akçay, Nihal/ACQ-1470-2022; Haerynck, Filomeen/AAD-6761-2020; Bondarenko, Anastasiia/AAL-5037-2020; Tancevski, Ivan/AID-5169-2022; Levy, Romain/AAM-6426-2020; Puel, Anne/H-7305-2017; Lau, Yu Lung/C-4322-2009	Liu, Zhiyong/0000-0001-6473-348X; Béziat, Vivien/0000-0002-4020-824X; Cobat, Aurélie/0000-0001-7209-6257; Okada, Satoshi/0000-0002-4622-5657; Yahşi, Aysun/0000-0002-7245-2028; Boyarchuk, Oksana/0000-0002-1234-0040; Morange, Pierre/0000-0002-9065-722X; Pujol, Aurora/0000-0002-9606-0600; Akçay, Nihal/0000-0002-8273-2226; Bondarenko, Anastasiia/0000-0002-9737-2868; Tancevski, Ivan/0000-0001-5116-8960; Levy, Romain/0000-0002-6393-0198; Turvey, Stuart/0000-0003-1599-1065; Uddin, K M Furkan/0000-0001-7322-1988; Marr, Nico/0000-0002-1927-7072; van de Beek, Diederik/0000-0002-4571-044X; ARANGO FRANCO, CARLOS ANDRES/0000-0002-7404-0860; Puel, Anne/0000-0003-2603-0323; Rodriguez-Gallego, Carlos/0000-0002-4344-8644; Lau, Yu Lung/0000-0002-4780-0289; alkan, gulsum/0000-0003-3384-769X; Biggs, Catherine/0000-0002-4363-2660; Haerynck, Filomeen/0000-0001-9161-7361; Emiroglu, Melike/0000-0003-1307-0246; Imberti, Luisa/0000-0002-2075-8391; Zhang, Qian/0000-0002-9040-3289; Ogishi, Masato/0000-0003-2421-7389	Howard Hughes Medical Institute; Rockefeller University; St Giles Foundation; National Institutes of Health (NIH) [R01AI088364, R01AI163029]; National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]; Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]; Yale High Performance Computing Center [S10OD018521]; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; JPB Foundation; French National Research Agency (ANR) under the 'Investments for the Future' program [ANR-10-IAHU-01]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French Foundation for Medical Research (FRM) [EQU201903007798]; FRM [ANR-20-COVI-0003, EA20170638020]; ANR GENCOVID project [ANR-20-COVI-0003]; ANRS Nord-Sud [ANRS-COV05]; ANR grant GENVIR [ANR-20-CE93-003]; ANR AABIFNCOV [ANR-20-CO11-0001]; ANR MIS-C project [ANR 21-COVR-0039]; European Union's Horizon 2020 research and innovation program [824110]; Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Fondation du Souffle; French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19); Institut National de la Sante et de la Recherche Medicale (INSERM); REACTing-INSERM; University of Paris; MD-PhD programme of the Imagine Institute (Fondation Bettencourt Schueller); Regione Lazio (Research Group Projects 2020), GecoBiomark [A0375-2020-36663]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; St Giles Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - National Human Genome Research Institute (NHGRI); Yale High Performance Computing Center; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; JPB Foundation; French National Research Agency (ANR) under the 'Investments for the Future' program(French National Research Agency (ANR)); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); FRM(Fondation pour la Recherche Medicale); ANR GENCOVID project(French National Research Agency (ANR)); ANRS Nord-Sud(ANRS); ANR grant GENVIR(French National Research Agency (ANR)); ANR AABIFNCOV(French National Research Agency (ANR)); ANR MIS-C project(French National Research Agency (ANR)); European Union's Horizon 2020 research and innovation program; Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science; Fondation du Souffle; French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); REACTing-INSERM; University of Paris; MD-PhD programme of the Imagine Institute (Fondation Bettencourt Schueller); Regione Lazio (Research Group Projects 2020), GecoBiomark; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute, the Rockefeller University, the St Giles Foundation, the National Institutes of Health (NIH) (R01AI088364 and R01AI163029), the National Center for Advancing Translational Sciences (NCATS), the NIH Clinical and Translational Science Award (CTSA) program (UL1 TR001866), a Fast Grant from Emergent Ventures, the Mercatus Center at George Mason University, the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956), the Yale High Performance Computing Center (S10OD018521), the Fisher Center for Alzheimer's Research Foundation, the Meyer Foundation, the JPB Foundation, the French National Research Agency (ANR) under the 'Investments for the Future' program (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the French Foundation for Medical Research (FRM) (EQU201903007798), the FRM and ANR GENCOVID project (ANR-20-COVI-0003), ANRS Nord-Sud (ANRS-COV05), ANR grant GENVIR (ANR-20-CE93-003), ANR AABIFNCOV (ANR-20-CO11-0001) and ANR MIS-C (ANR 21-COVR-0039, GenMIS-C) projects, the European Union's Horizon 2020 research and innovation program under grant agreement no. 824110 (EASI-Genomics), the Square Foundation, Grandir-Fonds de solidarite pour l'enfance, the SCOR Corporate Foundation for Science, Fondation du Souffle, The French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19), Institut National de la Sante et de la Recherche Medicale (INSERM), REACTing-INSERM, and the University of Paris. P.B. was supported by the FRM (EA20170638020) and the MD-PhD programme of the Imagine Institute (with the support of the Fondation Bettencourt Schueller). G.N. is supported by Regione Lazio (Research Group Projects 2020) no. A0375-2020-36663, GecoBiomark. H.C.S. and L.D.N. are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Abers MS, 2021, IMMUNOL CELL BIOL, V99, P917, DOI 10.1111/imcb.12495; Abolhassani H, 2022, J CLIN IMMUNOL, V42, P1, DOI 10.1007/s10875-021-01151-y; Abraham RS, 2021, J ALLERGY CLIN IMMUN, V147, P532, DOI 10.1016/j.jaci.2020.09.020; Acosta-Ampudia Y, 2021, J AUTOIMMUN, V118, DOI 10.1016/j.jaut.2021.102598; Ambrosioni J, 2021, LANCET HIV, V8, pe294, DOI 10.1016/S2352-3018(21)00070-9; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Andreakos E, 2022, NAT IMMUNOL, V23, P159, DOI 10.1038/s41590-021-01030-z; Arkin LM, 2021, J INVEST DERMATOL, V141, P2791, DOI 10.1016/j.jid.2021.05.024; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Aydiner EK, 2022, ALLERGY, V77, P282, DOI 10.1111/all.15025; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Banerjee A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010041; Bartleson Juliet M, 2021, Nat Aging, V1, P769, DOI 10.1038/s43587-021-00114-7; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2021, J CLIN IMMUNOL, V41, P931, DOI 10.1007/s10875-021-01023-5; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20202486; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Beccuti G, 2020, J ENDOCRINOL INVEST, V43, P1175, DOI 10.1007/s40618-020-01323-4; Bello-Rivero I, 2004, J AUTOIMMUN, V23, P63, DOI 10.1016/j.jaut.2004.03.013; Bennett TD, 2021, JAMA NETW OPEN, V4, DOI [10.1001/jamanetworkopen.2021.16901, 10.1001/jamanetworkopen.2021.16915]; Bessiere P, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009427; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Brodin P, 2021, NAT MED, V27, P28, DOI 10.1038/s41591-020-01202-8; Carapito R, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj7521; Carvalho T, 2021, NAT REV IMMUNOL, V21, P245, DOI 10.1038/s41577-021-00522-1; Casanova JL, 2021, SCIENCE, V374, P1080, DOI 10.1126/science.abj7965; Casanova JL, 2020, CELL, V181, P1194, DOI 10.1016/j.cell.2020.05.016; Casanova JL, 2020, HUM GENET, V139, P681, DOI 10.1007/s00439-020-02184-w; Casanova JL, 2021, ANNU REV PATHOL-MECH, V16, P23, DOI 10.1146/annurev-pathol-031920-101429; Castano-Jaramillo LM, 2021, J CLIN IMMUNOL, V41, P1463, DOI 10.1007/s10875-021-01077-5; Chang SE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25509-3; Chauvineau-Grenier A., RES SQ, DOI 10.21203/rs.3.rs-915062/v1 (2021); Cheng Mickie H, 2010, N Engl J Med, V362, P764, DOI 10.1056/NEJMc0909510; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Colona VL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI155011; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Corey L, 2021, NEW ENGL J MED, V385, P562, DOI 10.1056/NEJMsb2104756; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; de Prost N, 2021, J CLIN IMMUNOL, V41, P536, DOI 10.1007/s10875-021-00994-9; Delavari S, 2021, J CLIN IMMUNOL, V41, P345, DOI 10.1007/s10875-020-00928-x; Deya-Martinez A, 2021, CLIN IMMUNOL, V230, DOI 10.1016/j.clim.2021.108821; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Drabe CH, 2021, INFECT DIS-NOR, V53, P953, DOI 10.1080/23744235.2021.1957144; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Eriksson D, 2019, J ALLERGY CLIN IMMUN, V144, P327, DOI 10.1016/j.jaci.2019.02.031; Esenboga S, 2021, J CLIN IMMUNOL, V41, P1515, DOI 10.1007/s10875-021-01065-9; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Gao DX, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134529; Giardino G, 2021, J ALLER CL IMM-PRACT, V9, P3237, DOI 10.1016/j.jaip.2021.06.045; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Goncalves D, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1327; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Goudouris ES, 2021, J CLIN IMMUNOL, V41, P1479, DOI 10.1007/s10875-021-01066-8; Gupta S, 2016, ARTHRITIS RHEUMATOL, V68, P1677, DOI 10.1002/art.39607; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMc2107808, 10.1056/NEJMoa2105000]; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hariharan SV, 2022, INDIAN J PEDIATR, V89, P94, DOI 10.1007/s12098-021-03935-x; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hassan A. N., J CLIN IMMUNOL, DOI 10.1007/s10875-022-01215-7 (2022); Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hatton CF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27318-0; Hayn M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109126; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hernandez N, 2019, J EXP MED, V216, P2057, DOI 10.1084/jem.20182295; Hernandez N, 2018, J EXP MED, V215, P2567, DOI 10.1084/jem.20180628; Hetemaki I, 2021, CLIN IMMUNOL, V231, DOI 10.1016/j.clim.2021.108851; Ho HE, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.09.052; Hoagland DA, 2021, IMMUNITY, V54, P557, DOI 10.1016/j.immuni.2021.01.017; Hoffmann HH, 2021, CELL, V184, P133, DOI 10.1016/j.cell.2020.12.005; Hoffmann H-Heinrich, 2021, Cell Host Microbe, V29, P267, DOI [10.1101/2020.09.11.291716, 10.1016/j.chom.2020.12.009]; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang LX, 2021, LANCET, V398, P747, DOI 10.1016/S0140-6736(21)01755-4; Israelow B, 2020, J EXP MED, V217, DOI [10.1101/2020.05.27.118893, 10.1084/jem.20201241]; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Katsura H, 2020, CELL STEM CELL, V27, P890, DOI 10.1016/j.stem.2020.10.005; Kemp S A, 2020, medRxiv, DOI 10.1101/2020.12.05.20241927; Kerner G, 2021, CURR OPIN IMMUNOL, V72, P148, DOI 10.1016/j.coi.2021.04.006; Kerner G, 2021, AM J HUM GENET, V108, P517, DOI 10.1016/j.ajhg.2021.02.009; Kerner G, 2019, P NATL ACAD SCI USA, V116, P10430, DOI 10.1073/pnas.1903561116; Khanmohammadi S, 2022, J CLIN IMMUNOL, V42, P19, DOI 10.1007/s10875-021-01166-5; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4; Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185; Kosmicki JA, 2021, AM J HUM GENET, V108, P1350, DOI [10.1016/j.ajhg.2021.05.017, 10.1016/j.ajhg.2021.017]; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Ku CL, 2020, HUM GENET, V139, P783, DOI 10.1007/s00439-020-02180-0; Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Lemarquis A, 2021, J ALLERGY CLIN IMMUN, V148, P96, DOI 10.1016/j.jaci.2021.03.034; Levin M, 2006, PLOS MED, V3, P972, DOI 10.1371/journal.pmed.0030292; Levy R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2114390118; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; Lin JW, 2021, CELL HOST MICROBE, V29, P489, DOI 10.1016/j.chom.2021.01.015; Liu C, 2021, CELL, V184, P1836, DOI 10.1016/j.cell.2021.02.018; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.2021121108132021c; Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9; Lowery SA, 2021, CELL HOST MICROBE, V29, P1052, DOI 10.1016/j.chom.2021.05.004; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marcus N, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.614086; Mariano G, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.605236; Marks ZRC, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.101328; Martin-Sancho L, 2021, MOL CELL, V81, P2656, DOI 10.1016/j.molcel.2021.04.008; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Meisel C, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150867; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Meyts I, 2021, EUR J IMMUNOL, V51, P1039, DOI 10.1002/eji.202048793; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Milito C, 2021, J ALLER CL IMM-PRACT, V9, P2904, DOI 10.1016/j.jaip.2021.04.017; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Mohanty MC, 2021, J CLIN IMMUNOL, V41, P1748, DOI 10.1007/s10875-021-01132-1; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Nakanishi T, 2021, J CLIN INVEST, V131, DOI [10.1172/JCI152386, 10.1101/2021.03.07.21252875]; Navaratnam AV, 2021, LANCET RESP MED, V9, P397, DOI 10.1016/S2213-2600(20)30579-8; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Onodi F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201387; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Palermo E, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090829; PANEM S, 1982, J IMMUNOL, V129, P1; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Peixoto VR, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.33.2001059; Pessoa NL, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01656-3; Pierce CA, 2021, JCI INSIGHT, V6, DOI [10.1172/jci.insight.148694, 10.1101/2021.02.12.21251310]; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Povysil G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147834; POZZETTO B, 1984, J INFECT DIS, V150, P707, DOI 10.1093/infdis/150.5.707; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Raadsen MP, 2022, J CLIN IMMUNOL, V42, P232, DOI 10.1007/s10875-021-01168-3; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Romi F, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/474512; Rosenberg JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00544; Sah P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109229118; Sancho-Shimizu V, 2021, J EXP MED, V218, DOI 10.1084/jem.20210446; Schmidt A, 2021, NPJ GENOM MED, V6, DOI 10.1038/s41525-021-00220-w; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Schultze JL, 2021, CELL, V184, P1671, DOI 10.1016/j.cell.2021.02.029; Sen P, 2021, NATURE, V598, P338, DOI 10.1038/s41586-021-03914-4; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Severa M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009878; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw E. R., CLIN INFECT DIS, DOI 10.1093/cid/ciab1002 (2021; Shields AM, 2021, J ALLERGY CLIN IMMUN, V147, P870, DOI 10.1016/j.jaci.2020.12.620; Shiono H, 2003, INT IMMUNOL, V15, P903, DOI 10.1093/intimm/dxg088; Solanich X, 2021, J CLIN IMMUNOL, V41, P1733, DOI 10.1007/s10875-021-01136-x; Solanich X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.719115; Sposito B, 2021, CELL, V184, P4953, DOI 10.1016/j.cell.2021.08.016; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stertz S, 2021, TRENDS MICROBIOL, V29, P973, DOI 10.1016/j.tim.2021.03.001; Sui LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662989; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3; Telenti A, 2021, NATURE, V596, P495, DOI 10.1038/s41586-021-03792-w; Trouillet-Assant S, 2020, J ALLERGY CLIN IMMUN, V146, P206, DOI 10.1016/j.jaci.2020.04.029; Troya J, 2021, J CLIN IMMUNOL, V41, P914, DOI 10.1007/s10875-021-01036-0; VALLBRACHT A, 1981, NATURE, V289, P496, DOI 10.1038/289496a0; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; van der Wijst MGP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh2624; van Splunter M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225825; Vazquez SE, 2021, J CLIN IMMUNOL, V41, P1169, DOI 10.1007/s10875-021-01060-0; Vinh DC, 2021, J CLIN IMMUNOL, V41, P1425, DOI 10.1007/s10875-021-01068-6; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477; Wang EY, 2021, NATURE, V595, P283, DOI [10.1101/2020.12.10.20247205, 10.1038/s41586-021-03631-y]; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; Zeberg H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026309118; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3; Zhang Q, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI152474; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Q, 2020, MED-CAMBRIDGE, V1, P14, DOI 10.1016/j.medj.2020.12.001; Zhang Q, 2020, HUM GENET, V139, P941, DOI 10.1007/s00439-019-02108-3; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x; Zhang SY, 2020, NAT REV IMMUNOL, V20, P455, DOI 10.1038/s41577-020-0373-7; Ziegler Carly G K, 2021, bioRxiv, DOI [10.1016/j.cell.2021.07.023, 10.1101/2021.02.20.431155]	199	55	55	62	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					587	598		10.1038/s41586-022-04447-0	http://dx.doi.org/10.1038/s41586-022-04447-0		JAN 2022	12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35090163	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000769826700001
J	Larsen, RT; Wagner, V; Korfitsen, CB; Keller, C; Juhl, CB; Langberg, H; Christensen, J				Larsen, Rasmus Tolstrup; Wagner, Vibeke; Korfitsen, Christoffer Bruun; Keller, Camilla; Juhl, Carsten Bogh; Langberg, Henning; Christensen, Jan			Effectiveness of physical activity monitors in adults: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; BEHAVIOR-CHANGE INTERVENTION; BREAST-CANCER PATIENTS; WEIGHT-LOSS; RECEIVING CHEMOTHERAPY; WALKING INTERVENTION; WEARABLE DEVICES; PUBLICATION BIAS; GOALS SET; PEDOMETER	OBJECTIVE To estimate the effectiveness of physical activity monitor (PAM) based interventions among adults and explore reasons for the heterogeneity. DESIGN Systematic review and meta-analysis. STUDY SELECTION The electronic databases MEDLINE, Embase, SPORTDiscus, CINAHL, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched on 4 June 2021. Eligible randomised controlled trials compared interventions in which adults received feedback from PAMs with control interventions in which no feedback was provided. No restrictions on type of outcome measurement, publication date, or language were applied. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted data and assessed risk of bias. Random effects meta-analyses were used to synthesise the results. The certainty of evidence was rated by the Grading of Recommendations Assessment and Evaluation (GRADE) approach. MAIN OUTCOME MEASURES The three primary outcomes of interest were physical activity, moderate to vigorous physical activity, and sedentary time. RESULTS 121 randomised controlled trials with 141 study comparisons, including 16743 participants, were included. The PAM based interventions showed a moderate effect (standardised mean difference 0.42, 95% confidence interval 0.28 to 0.55) on physical activity, equivalent to 1235 daily steps; a small effect (0.23, 0.16 to 0.30) on moderate to vigorous physical activity, equivalent to 48.5 weekly minutes; and a small insignificant effect (-0.12, -0.25 to 0.01) on sedentary time, equal to 9.9 daily minutes. All outcomes favoured the PAM interventions. CONCLUSIONS The certainty of evidence was low for the effect of PAM based interventions on physical activity and moderate for moderate to vigorous physical activity and sedentary time. PAM based interventions are safe and effectively increase physical activity and moderate to vigorous physical activity. The effect on physical activity and moderate to vigorous physical activity is well established but might be overestimated owing to publication bias.	[Larsen, Rasmus Tolstrup] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Larsen, Rasmus Tolstrup; Keller, Camilla; Christensen, Jan] Copenhagen Univ Hosp, Rigshosp Copenhagen, Dept Occupat Therapy & Physiotherapy, Copenhagen, Denmark; [Wagner, Vibeke] Copenhagen Univ Hosp, Rigshosp, Dept Brain Injury Rehabil, Copenhagen, Denmark; [Korfitsen, Christoffer Bruun] Bispebjerg & Frederiksberg Hosp, Parker Inst, Capital Reg, Frederiksberg, Denmark; [Korfitsen, Christoffer Bruun] Danish Hlth Author, Copenhagen, Denmark; [Keller, Camilla] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Juhl, Carsten Bogh] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Res Unit Musculoskeletal Funct & Physiotherapy, Odense, Denmark; [Juhl, Carsten Bogh] Copenhagen Univ Hosp, Dept Physiotherapy & Occupat Therapy, Herlev, Denmark; [Juhl, Carsten Bogh] Copenhagen Univ Hosp, Dept Physiotherapy & Occupat Therapy, Gentofte, Denmark; [Langberg, Henning] Univ Copenhagen, Dept Publ Hlth, Sect Hlth Serv Res, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Danish Cancer Society; University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Copenhagen	Larsen, RT (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark.; Larsen, RT (corresponding author), Copenhagen Univ Hosp, Rigshosp Copenhagen, Dept Occupat Therapy & Physiotherapy, Copenhagen, Denmark.	rala@sund.ku.dk	Wagner, Vibeke/GPX-1938-2022	Wagner, Vibeke/0000-0002-1712-1648; Keller, Camilla/0000-0001-5550-4482; Christensen, Jan/0000-0003-1114-7465; Tolstrup Larsen, Rasmus/0000-0002-8860-4233; Bruun Korfitsen, Christoffer/0000-0003-2159-7662	European Union [690425]	European Union(European Commission)	The content presented in this paper was produced as part of the project REACH, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 690425 (reach2020.eu). The funders had no role in considering the study design, in the collection, analysis, or interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	Aittasalo M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-403; Al-Anqodi N, 2018, P NUTR SOC, V77, pE149, DOI 10.1017/S0029665118001556; Alshahrani A, 2021, E MEDITERR HEALTH J, V27, P782, DOI 10.26719/emhj.21.012; Anderson AS, 2021, INT J BEHAV NUTR PHY, V18, DOI 10.1186/s12966-021-01099-7; Armit CM, 2009, PREV MED, V48, P156, DOI 10.1016/j.ypmed.2008.11.009; Armstrong M, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0039-2019; Arrogi A, 2019, HEALTH PROMOT INT, V34, P16, DOI 10.1093/heapro/dax046; Ashton LM, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0227-8; Backman M, 2014, ACTA ONCOL, V53, P510, DOI 10.3109/0284186X.2013.873820; Baker G, 2011, INT J HEALTH PROMOT, V49, P60, DOI 10.1080/14635240.2011.10708210; Baker G, 2008, INT J HEALTH PROMOT, V46, P21, DOI 10.1080/14635240.2008.10708123; Baker G, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-51; Barwais FA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-183; Basen-Engquist K, 2006, PATIENT EDUC COUNS, V64, P225, DOI 10.1016/j.pec.2006.02.006; Baskerville R, 2017, DIABETIC MED, V34, P612, DOI 10.1111/dme.13331; Berglind D, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/14615; Biddle SJH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143398; Bond DS, 2015, SURG OBES RELAT DIS, V11, P169, DOI 10.1016/j.soard.2014.07.010; Braakhuis HEM, 2019, J REHABIL MED, V51, P151, DOI 10.2340/16501977-2522; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Brickwood KJ, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11819; Butler L, 2004, HLTH PROMOT J AUSTR, V2004, P134, DOI DOI 10.1071/HE04134; Cadmus-Bertram L, 2019, J CANCER SURVIV, V13, P593, DOI 10.1007/s11764-019-00778-6; Carr LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003261; Chaudhry UAR, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-01020-8; Cheung NW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030590; Cheung P, 2012, ASIAN J EXERC SPORTS, V9, P76; Coelho CM, 2018, J SPORT SCI, V36, P1186, DOI 10.1080/02640414.2017.1364402; Cooper AJM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1654-0; Copas J, 1999, J R STAT SOC A STAT, V162, P95, DOI 10.1111/1467-985X.00123; Copas JB, 2001, STAT METHODS MED RES, V10, P251, DOI 10.1191/096228001678227776; Creel DB, 2016, OBESITY, V24, P1660, DOI 10.1002/oby.21548; Dadaczynski K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4697-6; Davergne T, 2019, ARTHRIT CARE RES, V71, P758, DOI 10.1002/acr.23752; de Vries HJ, 2016, OBESITY, V24, P2078, DOI 10.1002/oby.21619; Dicken-Kano R, 2006, J AM BOARD FAM MED, V19, P524, DOI 10.3122/jabfm.19.5.524; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; DuVall C, 2004, AM J HEALTH BEHAV, V28, P280, DOI 10.5993/AJHB.28.3.9; Eastep E, 2004, PERCEPT MOTOR SKILL, V99, P392, DOI 10.2466/pms.99.2.392-402; Eisenberg MH, 2017, PSYCHOL SPORT EXERC, V30, P55, DOI 10.1016/j.psychsport.2017.01.008; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Farnell G, 2017, J HUM SPORT EXERC, V12, P1230, DOI 10.14198/jhse.2017.124.09; Finkelstein EA, 2016, LANCET DIABETES ENDO, V4, P983, DOI 10.1016/S2213-8587(16)30284-4; Freitas PD, 2021, CHEST, V159, P46, DOI 10.1016/j.chest.2020.08.2113; Freitas PD, 2018, MED SCI SPORT EXER, V50, P1367, DOI 10.1249/MSS.0000000000001574; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Funk M, 2013, CURR DIABETES REV, V9, P462, DOI 10.2174/15733998113096660084; Glynn LG, 2014, BRIT J GEN PRACT, V64, pE384, DOI 10.3399/bjgp14X680461; Gokal K, 2016, SUPPORT CARE CANCER, V24, P1139, DOI 10.1007/s00520-015-2884-5; Goode AD, 2012, AM J PREV MED, V42, P81, DOI 10.1016/j.amepre.2011.08.025; Goto M, 2014, HAEMOPHILIA, V20, pE121, DOI 10.1111/hae.12355; Greene J, 2013, J PRIM CARE COMMUNIT, V4, P189, DOI 10.1177/2150131912469546; Grey EB, 2019, INT J BEHAV MED, V26, P645, DOI 10.1007/s12529-019-09821-3; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hajna S, 2021, AM J PREV MED, V60, pE111, DOI 10.1016/j.amepre.2020.10.010; Hakala S, 2017, EUR J PHYS REHAB MED, V53, P953, DOI 10.23736/S1973-9087.17.04585-3; Hall KS, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00978-9; Hall M, 2015, ARTHRIT CARE RES, V67, P1289, DOI 10.1002/acr.22581; Hannan AL, 2019, BMC SPORTS SCI MED R, V11, DOI 10.1186/s13102-019-0126-8; Hansen BH, 2020, SCAND J MED SCI SPOR, V30, P1705, DOI 10.1111/sms.13726; Hardeman W, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003046; Harrington DM, 2014, OBESITY, V22, pE21, DOI 10.1002/oby.20684; Hartman SJ, 2016, AM J PREV MED, V51, P714, DOI 10.1016/j.amepre.2016.06.024; Haufe S, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00562; Herman HG, 2020, AM J OBSTET GYNECOL, V222, pS397, DOI 10.1016/j.ajog.2019.11.639; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hodkinson A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12895; Holmes VA, 2018, J CLIN ENDOCR METAB, V103, P2478, DOI 10.1210/jc.2017-02654; Hultquist CN, 2005, MED SCI SPORT EXER, V37, P676, DOI 10.1249/01.MSS.0000158993.39760.1B; Hurling R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e7; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jakicic JM, 2016, JAMA-J AM MED ASSOC, V316, P1161, DOI 10.1001/jama.2016.12858; Kanejima Y, 2019, AGING CLIN EXP RES, V31, P163, DOI 10.1007/s40520-018-0960-7; Kanstrup AM, 2018, DIGIT HEALTH, V4, P1, DOI 10.1177/2055207618775192; Katzmarzyk PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026667; Kendzor DE, 2017, J PHYS ACT HEALTH, V14, P88, DOI 10.1123/jpah.2016-0343; Kim C, 2012, DIABETIC MED, V29, P278, DOI 10.1111/j.1464-5491.2011.03415.x; Kim H, 2021, MEAS PHYS EDUC EXERC, V25, P171, DOI 10.1080/1091367X.2020.1862123; Kim JY, 2019, SUPPORT CARE CANCER, V27, P2933, DOI 10.1007/s00520-018-4588-0; Kim KA, 2019, J KOREAN ACAD NURS, V49, P113, DOI 10.4040/jkan.2019.49.2.113; Kirk MA, 2019, AM J HEALTH PROMOT, V33, P778, DOI 10.1177/0890117118816278; Kitagawa T, 2020, WOMEN HEALTH, V60, P212, DOI 10.1080/03630242.2019.1616043; Kong S, 2021, CANCERS, V13, DOI 10.3390/cancers13112692; Kovelis D, 2012, RESP CARE, V57, P1089, DOI 10.4187/respcare.01458; Lang AE, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04060-8; Larsen RT, 2019, EUR REV AGING PHYS A, V16, DOI 10.1186/s11556-019-0213-6; Larsen RT, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0970-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Levin ME, 2022, BEHAV MODIF, V46, P63, DOI 10.1177/0145445520913987; Lewis ZH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1947-3; Li LDC, 2020, ARTHRIT CARE RES, V72, P1755, DOI 10.1002/acr.24199; Li Linda C, 2017, JMIR Mhealth Uhealth, V5, pe86, DOI 10.2196/mhealth.7863; Ligibel JA, 2012, BREAST CANCER RES TR, V132, P205, DOI 10.1007/s10549-011-1882-7; Lin LF, 2021, STAT MED, V40, P403, DOI 10.1002/sim.8781; Long JE, 2013, PSYCHOSOM MED, V75, P774, DOI 10.1097/PSY.0b013e3182a0b664; Lynch C, 2020, AM J HEALTH PROMOT, V34, P418, DOI 10.1177/0890117119895204; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mansi S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1736-z; Mansi S, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-231; Mansoubi M, 2014, PREV MED, V69, P28, DOI 10.1016/j.ypmed.2014.08.028; Martin SS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002239; Maselli M, 2019, J SPORT MED PHYS FIT, V59, P132, DOI 10.23736/S0022-4707.17.07981-6; Matevey C, 2006, MEAS PHYS EDUC EXERC, V10, P1, DOI 10.1207/s15327841mpee1001_1; Melton BF, 2016, J BLACK STUD, V47, P610, DOI 10.1177/0021934716653349; Merom D, 2007, AM J PREV MED, V32, P290, DOI 10.1016/j.amepre.2006.12.007; Miragall M, 2018, PSYCHOL HEALTH, V33, P465, DOI 10.1080/08870446.2017.1368511; Morgan PJ, 2013, ANN BEHAV MED, V45, P139, DOI 10.1007/s12160-012-9424-z; Motl Robert W, 2015, Int J MS Care, V17, P65, DOI 10.7224/1537-2073.2014-016; Murawski B, 2019, AM J PREV MED, V57, P503, DOI 10.1016/j.amepre.2019.05.009; Nakata Y, 2019, PREV MED REP, V14, DOI 10.1016/j.pmedr.2019.100839; Nasseri NN, 2020, PEERJ, V8, DOI 10.7717/peerj.9303; Obling KH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6556-0; Omar N O, 2021, Med J Malaysia, V76, P375; Ormel HL, 2018, SUPPORT CARE CANCER, V26, P3915, DOI 10.1007/s00520-018-4263-5; Oxman A, 2013, GRADE HDB; Paschali AA, 2005, PERCEPT MOTOR SKILL, V100, P61; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Peacock AS, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/423717; Peacock OJ, 2020, INT J BEHAV NUTR PHY, V17, DOI 10.1186/s12966-020-00998-5; Pears S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3684-7; Pellegrini CA, 2012, OBESITY, V20, P356, DOI 10.1038/oby.2011.13; Petersen CB, 2012, PREV MED, V54, P125, DOI 10.1016/j.ypmed.2011.12.012; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Pillay J D, 2014, SA J. Sports Med., V26, P15, DOI [10.7196/sajsm.500, 10.7196/SAJSM.500]; Plow M, 2019, ARCH PHYS MED REHAB, V100, P2006, DOI 10.1016/j.apmr.2019.04.022; Poirier J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5295; Polzien KM, 2007, OBESITY, V15, P825, DOI 10.1038/oby.2007.584; Pope ZC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193579; Pope ZC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060140; Poston L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-148; Qiu SH, 2018, THER ADV RESPIR DIS, V12, DOI 10.1177/1753466618787386; Qiu SH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001412; Rayward AT, 2020, ANN BEHAV MED, V54, P470, DOI 10.1093/abm/kaz064; Recio-Rodriguez JI, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6814; Rees-Punia E, 2019, AM J PREV MED, V56, P736, DOI 10.1016/j.amepre.2018.12.006; Reijonsaari K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-344; Ribeiro MA, 2014, MED SCI SPORT EXER, V46, P1008, DOI 10.1249/MSS.0000000000000190; Rintala A, 2018, DISABIL REHABIL, V40, P373, DOI 10.1080/09638288.2016.1260649; Roos R, 2014, JAIDS-J ACQ IMM DEF, V67, P268, DOI 10.1097/QAI.0000000000000299; Rosenbaum S, 2015, ACTA PSYCHIAT SCAND, V131, P350, DOI 10.1111/acps.12371; Ryan JM, 2020, MULT SCLER J, V26, P1907, DOI 10.1177/1352458519886231; Ryan JM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018875; Saint-Maurice PF, 2020, JAMA-J AM MED ASSOC, V323, P1151, DOI 10.1001/jama.2020.1382; Sandborg J, 2021, JMIR MHEALTH UHEALTH, V9, DOI 10.2196/26091; Schwarzer G, 2010, J CLIN EPIDEMIOL, V63, P282, DOI 10.1016/j.jclinepi.2009.05.008; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Sharp P, 2016, J AM COLL HEALTH, V64, P630, DOI 10.1080/07448481.2016.1217538; Sheshadri A, 2020, AM J KIDNEY DIS, V75, P488, DOI 10.1053/j.ajkd.2019.07.026; Singh B, 2020, J SCI MED SPORT, V23, P283, DOI 10.1016/j.jsams.2019.09.019; Slootmaker SM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1139; Sniehotta FF, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002793; Spence JC, 2009, PSYCHOL HEALTH, V24, P777, DOI 10.1080/08870440801989938; Staudter Mary, 2011, US Army Med Dep J, P108; Stephenson A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0561-4; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; STUNKARD A, 1960, AM J CLIN NUTR, V8, P595, DOI 10.1093/ajcn/8.5.595; Taylor A, 2021, BRIT J SPORT MED, V55, P444, DOI 10.1136/bjsports-2020-103121; Teychenne M, 2021, MIDWIFERY, V93, DOI 10.1016/j.midw.2020.102898; The World Bank Group, 2016, WORLD BANK COUNTR LE; Thomas JG, 2017, OBESITY, V25, P1014, DOI 10.1002/oby.21846; Thompson Warren G, 2014, Work, V48, P47, DOI 10.3233/WOR-131708; Thorndike AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100251; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; Uhm KE, 2017, BREAST CANCER RES TR, V161, P443, DOI 10.1007/s10549-016-4065-8; Unick Jessica L, 2012, ISRN Obes, V2012, DOI 10.5402/2012/465158; Vaes AW, 2013, ANN MED, V45, P397, DOI 10.3109/07853890.2013.810891; Vallance JK, 2016, CANCER EPIDEM BIOMAR, V25, P391, DOI 10.1158/1055-9965.EPI-15-0812; Vallance JKH, 2007, J CLIN ONCOL, V25, P2352, DOI 10.1200/JCO.2006.07.9988; Van Blarigan EL, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5427-5; Van Hoye K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5402-0; Vandelanotte C, 2018, J MED INTERNET RES, V20, DOI 10.2196/11321; Wallbank G, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7514-6; Walsh JC, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5227; Whelan ME, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14195; Williams J, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2274-5; World Health O, 2020, WHO GUID PHYS ACT SE, DOI DOI 10.4324/9780203795002; Yang YP, 2017, OBES RES CLIN PRACT, V11, P718, DOI [10.1016/j.orcp.2017.06.007, 10.1016/j.orcp.2017.06.002]	179	7	7	6	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								e068047	10.1136/bmj.2021.068047	http://dx.doi.org/10.1136/bmj.2021.068047			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YP2FD	35082116				2022-12-28	WOS:000748440900004
J	Choo, E				Choo, Esther			Working in healthcare right now means being asked to do the impossible-then being abandoned to our inevitable failure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Choo, Esther] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Choo, E (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							[Anonymous], 2022, 2 100 ARM FORC PERS; [Anonymous], National guard covid-19 response; [Anonymous], 2021, DEM MENT HLTH TREATM; Eldridge E., 2022, GPB NEWS 0113; Fu SJ, 2020, ANN SURG, V272, pE79, DOI 10.1097/SLA.0000000000003998; Inskeep S, 2022, OMICRON SURGE OVERWH; Jacobs Andrew., 2021, NEW YORK TIMES, P1; KHN's, 2022, KAISER HLTH NEWS; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Parker-Pope T., 2021, NEW YORK TIMES; Segraves M., DC HOSPITALS ASK STA; Suarez C., 2021, RICHMOND TIMES DISPA	12	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2022	376								o197	10.1136/bmj.o197	http://dx.doi.org/10.1136/bmj.o197			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4MD	35074929	Bronze			2022-12-28	WOS:000750652200010
J	Accorsi, EK; Britton, A; Fleming-Dutra, KE; Smith, ZR; Shang, N; Derado, G; Miller, J; Schrag, SJ; Verani, JR				Accorsi, Emma K.; Britton, Amadea; Fleming-Dutra, Katherine E.; Smith, Zachary R.; Shang, Nong; Derado, Gordana; Miller, Joseph; Schrag, Stephanie J.; Verani, Jennifer R.			Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STATES	IMPORTANCE Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance. OBJECTIVE To estimate the association between receipt of 3 doses of Pfizer-BioNTech BNT162b2 or Moderna mRNA-1273 vaccine and symptomatic SARS-CoV-2 infection, stratified by variant (Omicron and Delta). DESIGN, SETTING, AND PARTICIPANTS A test-negative case-control analysis among adults 18 years or older with COVID-like illness tested December 10, 2021, through January 1, 2022, by a national pharmacy-based testing program (4666 COVID-19 testing sites across 49 US states). EXPOSURES Three doses of mRNA COVID-19 vaccine (third dose >= 14 days before test and >= 6 months after second dose) vs unvaccinated and vs 2 doses 6 months or more before test (ie, eligible for a booster dose). MAIN OUTCOMES AND MEASURES Association between symptomatic SARS-CoV-2 infection (stratified by Omicron or Delta variants defined using S-gene target failure) and vaccination (3 doses vs unvaccinated and 3 doses vs 2 doses). Associations were measured with multivariable multinomial regression. Among cases, a secondary outcome was median cycle threshold values (inversely proportional to the amount of target nucleic acid present) for 3 viral genes, stratified by variant and vaccination status. RESULTS Overall, 23 391 cases (13 098 Omicron; 10 293 Delta) and 46 764 controls were included (mean age, 40.3 [SD, 15.6] years; 42 050 [60.1%] women). Prior receipt of 3 mRNA vaccine doses was reported for 18.6%(n = 2441) of Omicron cases, 6.6%(n = 679) of Delta cases, and 39.7%(n = 18 587) of controls; prior receipt of 2 mRNA vaccine doses was reported for 55.3%(n = 7245), 44.4%(n = 4570), and 41.6%(n = 19 456), respectively; and being unvaccinated was reported for 26.0% (n = 3412), 49.0%(n = 5044), and 18.6% (n = 8721), respectively. The adjusted odds ratio for 3 doses vs unvaccinated was 0.33 (95% CI, 0.31-0.35) for Omicron and 0.065 (95% CI, 0.059-0.071) for Delta; for 3 vaccine doses vs 2 doses the adjusted odds ratio was 0.34 (95% CI, 0.32-0.36) for Omicron and 0.16 (95% CI, 0.14-0.17) for Delta. Median cycle threshold values were significantly higher in cases with 3 doses vs 2 doses for both Omicron and Delta (Omicron N gene: 19.35 vs 18.52; Omicron ORF1ab gene: 19.25 vs 18.40; Delta N gene: 19.07 vs 17.52; Delta ORF1ab gene: 18.70 vs 17.28; Delta S gene: 23.62 vs 20.24). CONCLUSIONS AND RELEVANCE Among individuals seeking testing for COVID-like illness in the US in December 2021, receipt of 3 doses of mRNA COVID-19 vaccine (compared with unvaccinated and with receipt of 2 doses) was less likely among cases with symptomatic SARS-CoV-2 infection compared with test-negative controls. These findings suggest that receipt of 3 doses of mRNA vaccine, relative to being unvaccinated and to receipt of 2 doses, was associated with protection against both the Omicron and Delta variants, although the higher odds ratios for Omicron suggest less protection for Omicron than for Delta.	[Accorsi, Emma K.; Britton, Amadea; Fleming-Dutra, Katherine E.; Smith, Zachary R.; Shang, Nong; Derado, Gordana; Miller, Joseph; Schrag, Stephanie J.; Verani, Jennifer R.] Ctr Dis Control & Prevent, COVID19 Response, Atlanta, GA USA; [Accorsi, Emma K.; Britton, Amadea] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Accorsi, EK (corresponding author), US Ctr Dis Control & Prevent, COVID19 Response, 1600 Clifton Rd,Mailstop H24-6, Atlanta, GA 30329 USA.	vgi0@cdc.gov	Accorsi, Emma/GMX-1462-2022	Accorsi, Emma/0000-0002-7443-7921	US Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)	US Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the Increasing Community Access to Testing platform was provided by the US Department of Health and Human Services. Funding for this analysis was provided by the Centers for Disease Control and Prevention (CDC).	Al Bayat S, 2021, J INFECT PUBLIC HEAL, V14, P1201, DOI 10.1016/j.jiph.2021.08.013; Bruxvoort KJ, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-068848; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Center for Disease Control and Prevention, POT RAP INCR OM VAR; Centers for Disease Control and Prevention, COVID DAT TRACK; Centers for Disease Control and Prevention, CDC ATSDR SVI FACT S; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Chua HY, 2020, EPIDEMIOLOGY, V31, P43, DOI 10.1097/EDE.0000000000001116; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Embi PJ, 2021, MMWR-MORBID MORTAL W, V70, P1553, DOI 10.15585/mmwr.mm7044e3; European Centre for Disease Prevention and Control, IMPL FURTH EM SPREAD; GISAID, TRACK VAR; Infectious Diseases Society of America and Association for Molecular Pathology, IDSA AMP JOINT STAT; Jackson ML, 2018, VACCINE, V36, P751, DOI 10.1016/j.vaccine.2017.12.022; Kissler SM, 2021, NEW ENGL J MED, V385, P2489, DOI 10.1056/NEJMc2102507; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Marcus JE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0202; Mbaeyi S, 2021, MMWR-MORBID MORTAL W, V70, P1545, DOI 10.15585/mmwr.mm7044e2; Miller MF, 2021, MMWR-MORBID MORTAL W, V70, P1706, DOI 10.15585/mmwr.mm7049a3; National Institute for Communicable Diseases, 2021, COVID 19 WORKF SURV; Perrine CG, 2021, MMWR-MORBID MORTAL W, V70, P1731, DOI 10.15585/mmwr.mm7050e1; Regev-Yochay G, 2021, LANCET REG HEALTH-EU, V7, DOI 10.1016/j.lanepe.2021.100150; Salvatore PP, 2021, CLIN INFECT DIS, V72, pE761, DOI 10.1093/cid/ciaa1469; Scott L, 2021, SCIENCE, V374, P1454, DOI 10.1126/science.abn4543; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064; Tabak YP, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.43346; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; UK Health Security Agency, 2021, TECHN BRIEF 33; US Department of Health and Human Services, COVID 19 PAND RESP L; Vandenbroucke JP, 2019, EPIDEMIOLOGY, V30, P838, DOI 10.1097/EDE.0000000000001088; Wang LY, 2021, J ADV CERAM, V10, P852, DOI 10.1007/s40145-021-0479-9; World Health Organization, CLASS OM B 1 1 529 S; World Health Organization [internet], 2022, ENH RESP OMICRON COV	36	190	191	23	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 15	2022	327	7					639	651		10.1001/jama.2022.0470	http://dx.doi.org/10.1001/jama.2022.0470		JAN 2022	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5SM	35060999	Green Published, Bronze			2022-12-28	WOS:000745105800004
J	Nundy, S; Cooper, LA; Mate, KS				Nundy, Shantanu; Cooper, Lisa A.; Mate, Kedar S.			The Quintuple Aim for Health Care Improvement A New Imperative to Advance Health Equity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISPARITIES; TRIPLE		[Nundy, Shantanu] George Washington Univ, Milken Inst, Sch Publ Hlth, 950 New Hampshire Ave NW,2, Washington, DC 20052 USA; [Nundy, Shantanu] Accolade Inc, Plymouth Meeting, PA USA; [Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Cooper, Lisa A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Mate, Kedar S.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Mate, Kedar S.] Inst Healthcare Improvement, Boston, MA USA	George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; Institute for Healthcare Improvement	Nundy, S (corresponding author), George Washington Univ, Milken Inst, Sch Publ Hlth, 950 New Hampshire Ave NW,2, Washington, DC 20052 USA.	shantanu.nundy@gmail.com						Anderson AC, 2018, HEALTH AFFAIR, V37, P371, DOI 10.1377/hlthaff.2017.1301; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Butler SM, 2021, JAMA-HEALTH FORUM, V2, DOI 10.1001/jamahealthforum.2021.3639; Centers for Disease Control and Prevention, RISK COVID 19 INF HO; Lyles CR, 2021, JAMA-J AM MED ASSOC, V326, P1795, DOI 10.1001/jama.2021.18459; Mueller M, 2015, AM J HYPERTENS, V28, P699, DOI 10.1093/ajh/hpu233; National Academies of Sciences Engineering and Medicine, 2014, COMM ACT PATHW HLTH; Pollack CE, 2011, JAMA-J AM MED ASSOC, V305, P1706, DOI 10.1001/jama.2011.533; Purnell TS, 2016, HEALTH AFFAIR, V35, P1410, DOI 10.1377/hlthaff.2016.0158	10	20	20	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					521	522		10.1001/jama.2021.25181	http://dx.doi.org/10.1001/jama.2021.25181		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZD5RT	35061006				2022-12-28	WOS:000745105800006
J	Kurtzberg, J				Kurtzberg, Joanne			Gene therapy offers new hope for children with metachromatic leukodystrophy	LANCET			English	Editorial Material									[Kurtzberg, Joanne] Duke Univ, Marcus Ctr Cellular Cures, Sch Med, Durham, NC 27705 USA	Duke University	Kurtzberg, J (corresponding author), Duke Univ, Marcus Ctr Cellular Cures, Sch Med, Durham, NC 27705 USA.	joanne.kurtzberg@dm.duke.edu						Beschle Judith, 2020, Mol Cell Pediatr, V7, P12, DOI 10.1186/s40348-020-00103-7; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Fumagalli F, 2022, LANCET, V399, P372, DOI 10.1016/S0140-6736(21)02017-1; Miyake N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99979-2; Penati R, 2017, J INHERIT METAB DIS, V40, P543, DOI 10.1007/s10545-017-0052-4; Rosenberg JB, 2016, J NEUROSCI RES, V94, P1169, DOI 10.1002/jnr.23792; Vander Lugt MT, 2020, BLOOD ADV, V4, P3041, DOI 10.1182/bloodadvances.2020001940; Wolf NI, 2020, ANN CLIN TRANSL NEUR, V7, P169, DOI 10.1002/acn3.50975	8	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					338	339						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065771				2022-12-28	WOS:000746046100003
J	Hayek, S; Shaham, G; Ben-Shlomo, Y; Kepten, E; Dagan, N; Nevo, D; Lipsitch, M; Reis, B; Balicer, RD; Barda, N				Hayek, Samah; Shaham, Galit; Ben-Shlomo, Yatir; Kepten, Eldad; Dagan, Noa; Nevo, Daniel; Lipsitch, Marc; Reis, Ben Y.; Balicer, Ran D.; Barda, Noam			Indirect protection of children from SARS-CoV-2 infection through parental vaccination	SCIENCE			English	Article							POISSON REGRESSION APPROACH; IMPACT	Children not vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may still benefit from vaccines through protection from vaccinated contacts. We estimated the protection provided to children through parental vaccination with the BNT162b2 vaccine. We studied households without prior infection consisting of two parents and unvaccinated children, estimating the effect of parental vaccination on the risk of infection for unvaccinated children. We studied two periods separately-an early period (17 January 2021 to 28 March 2021; Alpha variant, two doses versus no vaccination) and a late period (11 July 2021 to 30 September 2021; Delta variant, booster dose versus two vaccine doses). We found that having a single vaccinated parent was associated with a 26.0 and a 20.8% decreased risk in the early and late periods, respectively, and having two vaccinated parents was associated with a 71.7 and a 58.1% decreased risk, respectively. Thus, parental vaccination confers substantial protection on unvaccinated children in the household.	[Hayek, Samah; Shaham, Galit; Ben-Shlomo, Yatir; Kepten, Eldad; Dagan, Noa; Balicer, Ran D.; Barda, Noam] Clalit Res Inst, Clalit Hlth Serv, Ramat Gan, Israel; [Dagan, Noa; Barda, Noam] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel; [Dagan, Noa; Reis, Ben Y.; Barda, Noam] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Dagan, Noa; Reis, Ben Y.; Barda, Noam] Harvard Med Sch, Ivan & Francesca Berkowitz Family Living Lab Coll, Boston, MA 02115 USA; [Dagan, Noa; Reis, Ben Y.; Barda, Noam] Clalit Res Inst, Boston, MA 02135 USA; [Nevo, Daniel] Tel Aviv Univ, Dept Stat & Operat Res, Tel Aviv, Israel; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Reis, Ben Y.] Boston Childrens Hosp, Computat Hlth Informat Program, Predict Med Grp, Boston, MA USA; [Balicer, Ran D.] Ben Gurion Univ Negev, Fac Hlth Sci, Sch Publ Hlth, Beer Sheva, Israel	Clalit Health Services; Ben Gurion University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tel Aviv University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Ben Gurion University	Barda, N (corresponding author), Clalit Res Inst, Clalit Hlth Serv, Ramat Gan, Israel.; Barda, N (corresponding author), Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel.; Barda, N (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Barda, N (corresponding author), Harvard Med Sch, Ivan & Francesca Berkowitz Family Living Lab Coll, Boston, MA 02115 USA.; Barda, N (corresponding author), Clalit Res Inst, Boston, MA 02135 USA.	noambard@bgu.ac.il	Hayek, Samah/GRR-3582-2022; Barda, Noam/AAC-9434-2020	Barda, Noam/0000-0002-3400-235X; Dagan, Noa/0000-0001-8811-7825; Nevo, Daniel/0000-0002-9770-827X; Lipsitch, Marc/0000-0003-1504-9213; Balicer, Ran/0000-0002-7783-6362	Ivan and Francesca Berkowitz family living laboratory collaboration at the Harvard Medical School; Clalit Research Institute; Morris-Singer Fund	Ivan and Francesca Berkowitz family living laboratory collaboration at the Harvard Medical School; Clalit Research Institute; Morris-Singer Fund	This study was supported by the Ivan and Francesca Berkowitz family living laboratory collaboration at the Harvard Medical School and Clalit Research Institute. M.L. was supported by the Morris-Singer Fund.	Accorsi EK, 2021, EUR J EPIDEMIOL, V36, P179, DOI 10.1007/s10654-021-00727-7; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU), 2022, COVID 19 DASHB; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Danis K, 2020, CLIN INFECT DIS, V71, P825, DOI 10.1093/cid/ciaa424; Dattner I, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008559; European Centre for Disease Prevention and Control, 2022, COVID 19 VACC TRACK; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Halloran M Elizabeth, 2012, Epidemiol Methods, V1, P83; HALLORAN ME, 1991, EPIDEMIOLOGY, V2, P331, DOI 10.1097/00001648-199109000-00004; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Hayek S., ZENODO, V2022, DOI [10.5281/zenodo.5883892, DOI 10.5281/ZENODO.5883892]; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Israel Ministry of Health, 2022, IS COVID 19 DAT TRAC; Layan M., 2021, PREPRINT, DOI [10.1101/2021.07.12.21260377, DOI 10.1101/2021.07.12.21260377]; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Ludvigsson JF, 2021, ACTA PAEDIATR, V110, P914, DOI 10.1111/apa.15673; Madewell ZJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.22240; Mastrangelo A, 2021, CLIN J AM SOC NEPHRO, V16, P449, DOI 10.2215/CJN.13120820; Mayo Clinic, 2022, US COVID 19 VACC TRA; Miglioretti DL, 2007, AM J EPIDEMIOL, V165, P453, DOI 10.1093/aje/kwk020; Milman O, 2021, NAT MED, V27, P1367, DOI 10.1038/s41591-021-01407-5; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Richterman A, 2022, OPEN FORUM INFECT DI, V9, DOI 10.1093/ofid/ofab259; Salo J., 2021, PREPRINT, DOI [10.1101/2021.05.27.21257896, DOI 10.1101/2021.05.27.21257896]; Seaman S, 2014, STAT MED, V33, P5371, DOI 10.1002/sim.6277; Shekerdemian LS, 2020, JAMA PEDIATR, V174, P868, DOI 10.1001/jamapediatrics.2020.1948; Shi X, 2020, CURR EPIDEMIOL REP, V7, P190, DOI 10.1007/s40471-020-00243-4; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; VanderWeele TJ, 2012, EPIDEMIOLOGY, V23, P751, DOI 10.1097/EDE.0b013e31825fb7a0; Wang ZL, 2020, J INFECTION, V81, P179, DOI 10.1016/j.jinf.2020.03.040; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	10	11	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2022	375	6585			SI		1155	+		10.1126/science.abm3087	http://dx.doi.org/10.1126/science.abm3087			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZV2SO	35084938				2022-12-28	WOS:000770385500059
J	Reynolds, EE; Weinstein, A; Farid, H; Libman, H				Reynolds, Eileen E.; Weinstein, Amy; Farid, Huma; Libman, Howard			When and How Would You Screen This Patient for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; HPV; WOMEN; RISK; MANAGEMENT; CYTOLOGY; VACCINATION; CARE; CIN	Successful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytology remain incorporated into screening. Here, 2 experts debate how to apply these guidelines to Ms. L, a 22-year-old woman who has never undergone cervical cancer screening.	[Reynolds, Eileen E.; Farid, Huma; Libman, Howard] Beth Israel Deaconess Med Ctr, Yamins 100,330 Brookline Ave, Boston, MA 02215 USA; [Weinstein, Amy; Farid, Huma] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Reynolds, EE (corresponding author), Beth Israel Deaconess Med Ctr, Yamins 100,330 Brookline Ave, Boston, MA 02215 USA.	ereynold@bidmc.harvard.edu						American Cancer Society, AM CANC SOC GUID PRE; American Cancer Society, 2021, COMM IS BREAST CANC; American Cancer Society, 2021, KEY STAT CERV CANC; American College of Obstetricians and Gynecologists, 2021, UPD CERV CANC SCREEN; [Anonymous], 2019, AM FAMPHYSICIAN, P99; Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Barroeta JE, 2017, DIAGN CYTOPATHOL, V45, P903, DOI 10.1002/dc.23737; Bekos C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24882-2; Boersma Peter, 2020, NCHS Data Brief, P1; Castle PE, 2019, PREV MED, V118, P44, DOI 10.1016/j.ypmed.2018.10.001; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; El-Zein M, 2016, J CLIN VIROL, V76, pS62, DOI 10.1016/j.jcv.2015.11.020; Elam-Evans LD, 2020, MMWR-MORBID MORTAL W, V69, P1109, DOI 10.15585/mmwr.mm6933a1; Fontham ETH, 2020, CA-CANCER J CLIN, V70, P321, DOI 10.3322/caac.21628; Huh WK, 2015, GYNECOL ONCOL, V136, P178, DOI [10.1016/j.ygyno.2014.12.022, 10.1097/AOG.0000000000000669]; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; Jentschke M, 2012, GEBURTSH FRAUENHEILK, V72, P507, DOI 10.1055/s-0032-1314959; Jin XW, 2016, J GEN INTERN MED, V31, P1338, DOI 10.1007/s11606-016-3772-5; Johnson NL, 2020, PUBLIC HEALTH REP, V135, P483, DOI 10.1177/0033354920925094; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS64, DOI 10.1097/LGT.0b013e3182854399; Kim JJ, 2018, JAMA-J AM MED ASSOC, V320, P706, DOI 10.1001/jama.2017.19872; Lei JY, 2020, BRIT J CANCER, V123, P155, DOI 10.1038/s41416-020-0850-6; Loopik DL, 2021, J LOW GENIT TRACT DI, V25, P221, DOI 10.1097/LGT.0000000000000604; MacLaughlin KL, 2019, J WOMENS HEALTH, V28, P244, DOI 10.1089/jwh.2018.7380; Madzima TR, 2017, CAN FAM PHYSICIAN, V63, P597; Marcus JZ, 2021, J LOW GENIT TRACT DI, V25, P187, DOI 10.1097/LGT.0000000000000614; Maver PJ, 2020, CLIN MICROBIOL INFEC, V26, P579, DOI 10.1016/j.cmi.2019.09.006; Melnikow J, 2018, JAMA-J AM MED ASSOC, V320, P687, DOI 10.1001/jama.2018.10400; Mix JM, 2021, CANCER EPIDEM BIOMAR, V30, P30, DOI 10.1158/1055-9965.EPI-20-0846; National Center for Health Statistics, 2016, HLTH US 2015 SPEC FE; NIH National Cancer Institute, SEER CANC STAT FACTS; North American Association of Central Cancer Registries (NAACCR), 2019, NAACCR INC DAT CANC; Ogilvie GS, 2018, JAMA-J AM MED ASSOC, V320, P43, DOI 10.1001/jama.2018.7464; Perkins RB, 2020, J LOW GENIT TRACT DI, V24, P102, DOI 10.1097/LGT.0000000000000525; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Runowicz CD, 2007, NEW ENGL J MED, V357, P1650, DOI 10.1056/NEJMe078155; Sabatino SA, 2021, MMWR-MORBID MORTAL W, V70, P29, DOI 10.15585/mmwr.mm7002a1; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sawaya GF, 2018, JAMA INTERN MED, V178, P1293, DOI 10.1001/jamainternmed.2018.4282; Schiffman M, 2018, JNCI-J NATL CANCER I, V110, P501, DOI 10.1093/jnci/djx225; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Sharp L, 2014, J LOW GENIT TRACT DI, V18, P142, DOI 10.1097/LGT.0b013e31829c97d8; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; Surveillance Epidemiology and End Results (SEER) Program, 2017, SEER STAT DAT INC SE; Tainio K, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k499; Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1; World Health Organization, 2020, HUMAN PAPILLOMAVIRUS; Wright TC, 2015, GYNECOL ONCOL, V136, P189, DOI 10.1016/j.ygyno.2014.11.076	49	0	0	2	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					267	+		10.7326/M21-4372	http://dx.doi.org/10.7326/M21-4372		FEB 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35130045				2022-12-28	WOS:000758846300034
J	Deyrup, A; Graves, JL				Deyrup, Andrea; Graves, Joseph L., Jr.			Racial Biology and Medical Misconceptions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Deyrup, Andrea] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Graves, Joseph L., Jr.] North Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC USA	Duke University; University of North Carolina; North Carolina A&T State University	Deyrup, A (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA.							Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Goldstein B.G., 2021, TOPICAL CORTICOSTERO; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Ripp K, 2017, TEACH LEARN MED, V29, P115, DOI 10.1080/10401334.2016.1268056; Sheets L, 2011, ACAD MED, V86, P1300, DOI 10.1097/ACM.0b013e31822bbdb5	5	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					501	503		10.1056/NEJMp2116224	http://dx.doi.org/10.1056/NEJMp2116224		FEB 2022	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YW0GW	35119803	Bronze			2022-12-28	WOS:000751512600001
J	Zhao, HW; Liu, SJ; Wei, Y; Yue, YH; Gao, MR; Li, YB; Zeng, XL; Deng, XL; Kotov, NA; Guo, L; Jiang, L				Zhao, Hewei; Liu, Shaojia; Wei, Yan; Yue, Yonghai; Gao, Mingrui; Li, Yangbei; Zeng, Xiaolong; Deng, Xuliang; Kotov, Nicholas A.; Guo, Lin; Jiang, Lei			Multiscale engineered artificial tooth enamel	SCIENCE			English	Article							DYNAMIC-MECHANICAL PROPERTIES; VISCOELASTIC PROPERTIES; FRACTURE-TOUGHNESS; MICROMECHANICAL PROPERTIES; HIGH-STRENGTH; HYDROXYAPATITE; COMPOSITES; NANOCOMPOSITE; ENHANCEMENT; FABRICATION	Tooth enamel, renowned for its high stiffness, hardness, and viscoelasticity, is an ideal model for designing biomimetic materials, but accurate replication of complex hierarchical organization of high-performance biomaterials in scalable abiological composites is challenging. We engineered an enamel analog with the essential hierarchical structure at multiple scales through assembly of amorphous intergranular phase (AIP)-coated hydroxyapatite nanowires intertwined with polyvinyl alcohol. The nanocomposite simultaneously exhibited high stiffness, hardness, strength, viscoelasticity, and toughness, exceeding the properties of enamel and previously manufactured bulk enamel-inspired materials. The presence of AIP, polymer confinement, and strong interfacial adhesion are all needed for high mechanical performance. This multiscale design is suitable for scalable production of high-performance materials.	[Zhao, Hewei; Liu, Shaojia; Yue, Yonghai; Gao, Mingrui; Li, Yangbei; Zeng, Xiaolong; Guo, Lin; Jiang, Lei] Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Sch Chem, Beijing 100191, Peoples R China; [Wei, Yan; Deng, Xuliang] Peking Univ, Sch & Hosp Stomatol, NMPA Key Lab Dent Mat,Dept Geriatr Dent, Natl Engn Lab Digital & Mat Technol Stomatol,Beij, Beijing 100081, Peoples R China; [Kotov, Nicholas A.] Univ Michigan, Biointerface Inst, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Michigan Inst Translat Nanotechnol MITRAN, Ypsilanti, MI 48198 USA; [Jiang, Lei] Chinese Acad Sci, CAS Ctr Excellence Nanosci, Tech Inst Phys & Chem, CAS Key Lab Bioinspired Mat & Interfacial Sci, Beijing 100190, Peoples R China	Beihang University; Peking University; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Guo, L (corresponding author), Beihang Univ, Beijing Adv Innovat Ctr Biomed Engn, Sch Chem, Beijing 100191, Peoples R China.; Deng, XL (corresponding author), Peking Univ, Sch & Hosp Stomatol, NMPA Key Lab Dent Mat,Dept Geriatr Dent, Natl Engn Lab Digital & Mat Technol Stomatol,Beij, Beijing 100081, Peoples R China.; Kotov, NA (corresponding author), Univ Michigan, Biointerface Inst, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Michigan Inst Translat Nanotechnol MITRAN, Ypsilanti, MI 48198 USA.	kqdengxuliang@bjmu.edu.cn; kotov@umich.edu; guolin@buaa.edu.cn		Deng, Xuliang/0000-0003-1838-6274; shaojia, Liu/0000-0002-7072-9986; Kotov, Nicholas A./0000-0002-6864-5804	National Key R&D Program of China [2020YFA0710403, 2020YFA0710401]; National Natural Science Foundation of China [51532001, 51772011, 51802010, 52073008, 51922017, 51972009]; AFOSR [FA9550-20-1-0265]; Graph Theory Description of Network Material; NSF [1463474]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Graph Theory Description of Network Material; NSF(National Science Foundation (NSF))	This work was supported by the National Key R&D Program of China (2020YFA0710403 to L.G., 2020YFA0710401 to Y.W.), the National Natural Science Foundation of China (51532001 and 51772011 to L.G.; 51802010 and 52073008 to H.Z.; 51922017 and 51972009 to Y.Y.), AFOSR FA9550-20-1-0265 and Graph Theory Description of Network Material and NSF 1463474 to N.K.	Aguirre TG, 2019, J MECH BEHAV BIOMED, V93, P105, DOI 10.1016/j.jmbbm.2019.01.021; Alzarrug FA, 2015, MATER DESIGN, V86, P575, DOI 10.1016/j.matdes.2015.07.069; An NL, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41577; Barthelat F, 2006, J MATER RES, V21, P1977, DOI 10.1557/JMR.2006.0239; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/nmat3915, 10.1038/NMAT3915]; Chaudhry B, 2009, J MATER SCI-MATER M, V20, P257, DOI 10.1007/s10856-008-3574-3; Chen BQ, 2005, POLYM TEST, V24, P978, DOI 10.1016/j.polymertesting.2005.07.013; Chen ZX, 2019, J MATER CHEM B, V7, P5237, DOI 10.1039/c9tb00676a; Clifton KB, 2008, J ZOOL, V274, P150, DOI 10.1111/j.1469-7998.2007.00366.x; Das M, 2006, IND ENG CHEM RES, V45, P6489, DOI 10.1021/ie0603971; Deng YQ, 2019, ADV MATER, V31, DOI 10.1002/adma.201902432; DeRocher KA, 2020, NATURE, V583, P66, DOI 10.1038/s41586-020-2433-3; Dirks JH, 2012, J EXP BIOL, V215, P1502, DOI 10.1242/jeb.068221; Enax J, 2012, J STRUCT BIOL, V178, P290, DOI 10.1016/j.jsb.2012.03.012; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Goertzen WK, 2007, COMPOS PART B-ENG, V38, P1, DOI 10.1016/j.compositesb.2006.06.002; Sanchez AG, 2018, MATER CHEM PHYS, V217, P151, DOI 10.1016/j.matchemphys.2018.06.062; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Guo WW, 2018, COMPOS SCI TECHNOL, V158, P128, DOI 10.1016/j.compscitech.2018.01.020; He LH, 2008, J MECH BEHAV BIOMED, V1, P18, DOI 10.1016/j.jmbbm.2007.05.001; Hu HW, 2013, CARBOHYD POLYM, V91, P305, DOI 10.1016/j.carbpol.2012.08.038; Huang Y, 2015, J CHEM TECHNOL BIOT, V90, P1677, DOI 10.1002/jctb.4476; Kalita H, 2017, MAT SCI ENG C-MATER, V71, P363, DOI 10.1016/j.msec.2016.09.063; Kim S, 2002, J MATER SCI-MATER M, V13, P307, DOI 10.1023/A:1014019103240; Krishnamoorthy K, 2011, MATER EXPRESS, V1, P329, DOI 10.1166/mex.2011.1036; Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013; La Fontaine A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601145; Lewis G, 2008, J BIOMED MATER RES B, V87B, P286, DOI 10.1002/jbm.b.31092; Li AM, 2007, MATER LETT, V61, P1839, DOI 10.1016/j.matlet.2006.07.159; Liao X, 2019, SCIENCE, V366, P1376, DOI 10.1126/science.aay9033; Lin Y, 2015, COMPOS PART A-APPL S, V70, P35, DOI 10.1016/j.compositesa.2014.12.008; Liu L, 2020, SCIENCE, V368, P1347, DOI 10.1126/science.aba9413; Low IM, 2006, KEY ENG MATER, V312, P15, DOI 10.4028/www.scientific.net/KEM.312.15; Ma Y, 2008, ADV MATER, V20, P1555, DOI 10.1002/adma.200702842; Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036; Marcus MA, 2017, ACS NANO, V11, P11856, DOI 10.1021/acsnano.7b05044; Meaud J, 2014, ACS NANO, V8, P3468, DOI 10.1021/nn500284m; Melnick CA, 1996, J MATER RES, V11, P2903, DOI 10.1557/JMR.1996.0367; Mesquita RV, 2006, DENT MATER, V22, P258, DOI 10.1016/j.dental.2005.04.019; Mohanty B, 2006, J MATER RES, V21, P2045, DOI 10.1557/JMR.2006.0247; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026; Nie JF, 2019, CERAM INT, V45, P13647, DOI 10.1016/j.ceramint.2019.04.007; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Olsson A-M, 1997, NORD PULP PAP RES J, V3, P140, DOI DOI 10.3183/NPPRJ-1997-12-03-P140-144; Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422; Pelisser F, 2014, CEMENT CONCRETE COMP, V48, P1, DOI 10.1016/j.cemconcomp.2014.01.004; Podsiadlo P, 2007, NANO LETT, V7, P1224, DOI [10.1021/nl0700649, 10.1021/nI0700649]; Priya L, 2002, J POLYM SCI POL PHYS, V40, P1682, DOI 10.1002/polb.10223; PROKOPSKI G, 1993, J MATER SCI, V28, P5995, DOI 10.1007/BF00365010; Ravikumar K, 2016, J EUR CERAM SOC, V36, P805, DOI 10.1016/j.jeurceramsoc.2015.10.044; Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6; Ruan QC, 2016, ACS BIOMATER SCI ENG, V2, P1049, DOI 10.1021/acsbiomaterials.6b00164; Saba N, 2016, CONSTR BUILD MATER, V124, P133, DOI 10.1016/j.conbuildmat.2016.07.059; Saber-Samandari S, 2009, ACTA BIOMATER, V5, P2206, DOI 10.1016/j.actbio.2009.02.009; Saha AK, 1999, J APPL POLYM SCI, V71, P1505, DOI 10.1002/(SICI)1097-4628(19990228)71:9<1505::AID-APP15>3.0.CO;2-1; Sender C, 2007, J BIOMED MATER RES B, V83B, P628, DOI 10.1002/jbm.b.30930; SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G; Shen ZJ, 2001, ADV MATER, V13, P214, DOI 10.1002/1521-4095(200102)13:3<214::AID-ADMA214>3.0.CO;2-5; Shu YQ, 2012, J MATER CHEM, V22, P21667, DOI 10.1039/c2jm34728h; Singh MK, 2008, ADV FUNCT MATER, V18, P694, DOI 10.1002/adfm.200700888; Stanishevsky A, 2008, J BIOMED MATER RES A, V86A, P873, DOI 10.1002/jbm.a.31657; Takeoka Y, 2015, POLYM J, V47, P164, DOI 10.1038/pj.2014.121; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Uskokovic PS, 2007, J EUR CERAM SOC, V27, P1559, DOI 10.1016/j.jeurceramsoc.2006.04.122; Velayudhan S, 2005, MATER CHEM PHYS, V89, P454, DOI 10.1016/j.matchemphys.2004.10.004; Verma D, 2008, MAT SCI ENG C-BIO S, V28, P399, DOI 10.1016/j.msec.2007.04.026; Wang YY, 2015, J MATER CHEM B, V3, P65, DOI 10.1039/c4tb01476f; Wei JJ, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201904880; Wei Y, 2020, ADV MATER, V32, DOI 10.1002/adma.201907067; Wu JW, 2017, T INDIAN CERAM SOC, V76, P252, DOI 10.1080/0371750X.2017.1412838; Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U; Yang RL, 2018, ACS NANO, V12, P12284, DOI 10.1021/acsnano.8b06096; Yang Z, 2005, J MATER SCI, V40, P1121, DOI 10.1007/s10853-005-6927-z; Yeom B, 2017, NATURE, V543, P95, DOI 10.1038/nature21410; Yoshimura K, 2000, J AGR FOOD CHEM, V48, P685, DOI 10.1021/jf990389d; Yu HP, 2020, CHEM ENG J, V399, DOI 10.1016/j.cej.2020.125666; Yu Y, 2013, FERROELECTRICS, V451, P96, DOI 10.1080/00150193.2013.839249; Yue YH, 2020, NATURE, V582, P370, DOI 10.1038/s41586-020-2361-2; Yun F, 2020, BIOMATERIALS, V235, DOI 10.1016/j.biomaterials.2019.119748; Zhang HQ, 2012, DENT MATER, V28, P824, DOI 10.1016/j.dental.2012.04.030; Zhang Y, 2008, J BIOMED MATER RES A, V86A, P607, DOI 10.1002/jbm.a.31622; Zhang YR, 2014, INT J ORAL SCI, V6, P61, DOI 10.1038/ijos.2014.21; Zhao CQ, 2020, NATURE, V580, P210, DOI 10.1038/s41586-020-2161-8; Zhao HW, 2017, ANGEW CHEM INT EDIT, V56, P8766, DOI 10.1002/anie.201703871; Zhao ZT, 2012, J APPL POLYM SCI, V125, P2502, DOI 10.1002/app.36355; Zheng XC, 2013, CERAM INT, V39, P1233, DOI 10.1016/j.ceramint.2012.07.052	88	34	34	208	481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					551	+		10.1126/science.abj3343	http://dx.doi.org/10.1126/science.abj3343			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113708				2022-12-28	WOS:000753965100041
J	Bikdeli, B; Garcia, DA				Bikdeli, Behnood; Garcia, David A.			In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bikdeli, Behnood] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Garcia, David A.] Univ Washington, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Bikdeli, B (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.							Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005; Lawler PR, 2021, NEW ENGL J MED, V385, P790, DOI 10.1056/NEJMoa2105911; Lopes RD, 2021, LANCET, V397, P2253, DOI 10.1016/S0140-6736(21)01203-4; Sadeghipour P, 2021, JAMA-J AM MED ASSOC, V325, P1620, DOI 10.1001/jama.2021.4152; Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC16	JC17		10.7326/J21-0020	http://dx.doi.org/10.7326/J21-0020		FEB 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099997				2022-12-28	WOS:000750886100002
J	Humphreys, K; Shover, CL; Andrews, CM; Bohnert, ASB; Brandeau, ML; Caulkins, JP; Chen, JH; Cuellar, MF; Hurd, YL; Juurlink, DN; Koh, HK; Krebs, EE; Lembke, A; Mackey, SC; Ouellette, LL; Suffoletto, B; Timko, C				Humphreys, Keith; Shover, Chelsea L.; Andrews, Christina M.; Bohnert, Amy S. B.; Brandeau, Margaret L.; Caulkins, Jonathan P.; Chen, Jonathan H.; Cuellar, Mariano-Florentino; Hurd, Yasmin L.; Juurlink, David N.; Koh, Howard K.; Krebs, Erin E.; Lembke, Anna; Mackey, Sean C.; Ouellette, Lisa Larrimore; Suffoletto, Brian; Timko, Christine			Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission	LANCET			English	Review							SUBSTANCE-ABUSE TREATMENT; DRUG-MONITORING PROGRAMS; LOW-BACK-PAIN; USE DISORDER; UNITED-STATES; MAINTENANCE TREATMENT; TREATMENT SERVICES; POLICY RESPONSES; OVERDOSE DEATHS; RISK-EVALUATION		[Humphreys, Keith; Lembke, Anna; Timko, Christine] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Sch Med, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Sch Med, Div Hosp Med, Stanford, CA 94305 USA; [Suffoletto, Brian] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA; [Humphreys, Keith; Timko, Christine] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Shover, Chelsea L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA; [Andrews, Christina M.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA; [Bohnert, Amy S. B.] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Bohnert, Amy S. B.] Univ Michigan Hlth Syst, Dept Anesthesiol, Ann Arbor, MI USA; [Bohnert, Amy S. B.] Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Brandeau, Margaret L.] Stanford Univ, Huang Engn Ctr, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Caulkins, Jonathan P.] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Cuellar, Mariano-Florentino; Ouellette, Lisa Larrimore] Stanford Law Sch, Stanford, CA USA; [Hurd, Yasmin L.] Icahn Sch Med, Addict Inst, New York, NY USA; [Juurlink, David N.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Krebs, Erin E.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Krebs, Erin E.] Vet Affairs Minneapolis Hlth Care Syst, Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA; [Mackey, Sean C.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Stanford University; Carnegie Mellon University; Stanford University; Icahn School of Medicine at Mount Sinai; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Humphreys, K (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	knh@stanford.edu		Shover, Chelsea/0000-0002-0728-4101; Mackey, Sean/0000-0001-7744-5348; Krebs, Erin/0000-0003-0843-7410; Ouellette, Lisa/0000-0003-4363-7530; Suffoletto, Brian/0000-0002-9628-5260	Stanford University School of Medicine (Stanford, CA, USA)	Stanford University School of Medicine (Stanford, CA, USA)	The work of the Commission was funded by Stanford University School of Medicine (Stanford, CA, USA). The views expressed in this report are those of the authors and do not necessarily reflect the official position of Stanford University or of any governmental or non-governmental entity for which they work or that they advise.	Abraham AJ, 2017, AM J PUBLIC HEALTH, V107, P31, DOI 10.2105/AJPH.2016.303558; Accreditation Council for Continuing Medical Education, STAND COMM SUPP STAN, P2021; Action on Smoking and Health, 2019, ASH FACT SHEET TOB D; Agarwal SD, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7399; Ahmad FB, PROVISIONAL DRUG OVE, V2021; Al Achkar M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015083; Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Alberta Health, 2017, OP SUBST MIS 1 NAT P; Alexander GC, 2020, ANN INTERN MED, V173, P57, DOI 10.7326/M20-1141; Alpert A. E., 2019, ORIGINS OPIOID CRISI; American Bar Association Criminal Justice Section, 2018, COLLATERAL CONSEQUEN; American Medical Association, 2021, ISS BRIEF DRUG OV EP; American Medical Association,, 2020, ISS BRIEF REP INCR O; American Pain Foundation, 2010, 2010 ANN REP INSP HO; American Society of Addiction Medicine, 2015, WHAT AR ASAM LEV CAR; Andrews CM, 2019, PSYCHIAT SERV, V70, P537, DOI 10.1176/appi.ps.70705; Andrews CM, 2018, HEALTH AFFAIR, V37, P1216, DOI 10.1377/hlthaff.2018.0272; Andrews CM, 2013, AM J DRUG ALCOHOL AB, V39, P61, DOI 10.3109/00952990.2012.694515; Angell M., 2010, THIS AGENCY CAN BE D; Anglin MD, 2013, AM J PUBLIC HEALTH, V103, P1096, DOI 10.2105/AJPH.2012.301168; [Anonymous], 2020, B WORLD HEALTH ORGAN, V98, P3, DOI 10.2471/BLT.19.249417; [Anonymous], 2010, CIT UN FED EL COMM 0; [Anonymous], 2019, US DEP HLTH HUM SERV; [Anonymous], 2020, U FLORIDA NAMED COOR; [Anonymous], 2011, BROWN GOV CAL PLAT N; [Anonymous], 2020, POSTM REQ COMM REP; Arnarsson A, 2018, DRUG ALCOHOL REV, V37, pS49, DOI 10.1111/dar.12587; Artiga S., 2021, HLTH COVERAGE RACE E; Ayu AP, 2015, EUR ADDICT RES, V21, P223, DOI 10.1159/000381671; Babor T, 2018, DRUG POLICY PUBLIC G, V2nd; Babor TF, 2003, ALCOHOL NO ORDINARY; Babor TF, 2019, ADDICTION, V114, P1941, DOI 10.1111/add.14734; Babor TF, 2010, ADDICTION, V105, P769, DOI 10.1111/j.1360-0443.2010.02945.x; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Baker DW, 2017, JAMA-J AM MED ASSOC, V317, P1117, DOI 10.1001/jama.2017.0935; Baldwin TS., 2017, PHARM REGULATION CON; Balko R, 2012, WAR PRESCRIPTION PAI; Bandara S, 2020, J ADDICT MED, V14, pE257, DOI 10.1097/ADM.0000000000000718; Barnett S., 2005, LIFETIME EFFECTS HIG; Barr A., 2019, BREAKING CYCLE INTER; Becker WC, 2017, NEW ENGL J MED, V376, P2103, DOI 10.1056/NEJMp1701553; Beetham T, 2020, JAMA-J AM MED ASSOC, V324, P804, DOI 10.1001/jama.2020.8969; Belzak L, 2018, HEALTH PROMOT CHRON, V38, P224, DOI 10.24095/hpcdp.38.6.02; Bernard CL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003239; Best D, 2000, DRUG ALCOHOL REV, V19, P9; Best D, 2009, ADDICT RES THEORY, V17, P678, DOI 10.3109/16066350802447090; Biden Harris Presidential Campaign Platform, 2020, HEALTHC; Bien J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5055; Bird Mia, 2018, IMPACT PROPOSITION 4; Bird SM, 2016, ADDICTION, V111, P883, DOI 10.1111/add.13265; Blanch B, 2014, BRIT J CLIN PHARMACO, V78, P1159, DOI 10.1111/bcp.12446; Bockerman P, 2021, ADDICTION, V116, P170, DOI 10.1111/add.15071; Botticelli MP, 2016, JAMA-J AM MED ASSOC, V316, P1361, DOI 10.1001/jama.2016.11874; Bramham D, 2020, DONT WANT NICK BE ON; Brandt AM, 2008, NEW ENGL J MED, V359, P445, DOI 10.1056/NEJMp0803729; Brinkley-Rubinstein L, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.06.016; British Columbia Coroners Service,, ILL DRUG TOX DEATHS, P2021; Brooklyn JR, 2017, J ADDICT MED, V11, P286, DOI 10.1097/ADM.0000000000000310; Brooks L., 2019, SCOTTISH GOVT URGED; Buchbinder R, 2020, PAIN, V161, pS57, DOI 10.1097/j.pain.0000000000001869; Buchmueller TC, 2018, AM ECON J-ECON POLIC, V10, P77, DOI 10.1257/pol.20160094; California Product Stewardship Council, 2020, PROD; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Canadian Deprescribing Network, 2020, CAN DEPR NETW DED RA; Canadian Institute for Health Information, 2019, OP PRESCR CAN CAR PR; Canadian Institute for Health Information,, PAN CAN TRENDS PRESC; Cance JD, 2020, JAMA-J AM MED ASSOC, V324, P2442, DOI 10.1001/jama.2020.22154; Carroll KM, 2017, AM J PSYCHIAT, V174, P738, DOI 10.1176/appi.ajp.2016.16070792; Case A, 2020, DEATHS OF DESPAIR AND THE FUTURE OF CAPITALISM, P1; Charity Commission for England and Wales, 2019, PAIN UK REG COMPL CA; Charuvastra A, 2001, PUBLIC HEALTH REP, V116, P203, DOI 10.1093/phr/116.3.203; Chiu AS, 2018, JAMA SURG, V153, P1012, DOI 10.1001/jamasurg.2018.2083; Choose PT., 2016 PRESCRIBED OPIO; Clark SA, 2021, J SUBST ABUSE TREAT, V124, DOI 10.1016/j.jsat.2021.108283; Clarke H, 2020, CAN J PAIN, V4, P224, DOI 10.1080/24740527.2020.1795634; Collins FS, 2021, SCIENCE, V373, P165, DOI 10.1126/science.abj8547; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Compton WM, 2010, AM J PSYCHIAT, V167, P473, DOI 10.1176/appi.ajp.2009.09081087; Connecticut Office of the Chief Medical Examiner, STATISTICS-ABINGDON; Cook County Government, MED EX CAS ARCH; Cornelius K, 2018, SEWAGE IS HELPING CI; Council of Medical Specialty Societies, 2015, COD INT CO; Courtwright DavidT., 2019, AGE ADDICTION BAD HA; Crowe K, 2018, FOLLOWING MONEY PATI; Cuellar M -F, 2020, YALE LAW POLICY REV, V38, P1; Curtis HJ, 2019, LANCET PSYCHIAT, V6, P140, DOI 10.1016/S2215-0366(18)30471-1; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Daly R, 2010, MORE STATES EXPLORE, DOI [10.1176/pn.45.6.psychnews_45_6_014, DOI 10.1176/PN.45.6.PSYCHNEWS_45_6_014]; Darfler K, 2020, J SUBST ABUSE TREAT, V108, P26, DOI 10.1016/j.jsat.2019.07.014; DAunno T, 2021, ANAL DATA 346 CLIN N, P2021; Davis CS, 2020, PAIN MED, V21, P532, DOI 10.1093/pm/pnz159; Davis CS, 2019, DRUG ALCOHOL DEPEN, V194, P166, DOI 10.1016/j.drugalcdep.2018.09.022; Day E, 2017, ADDICTION, V112, P1329, DOI 10.1111/add.13644; Delgado MK, 2018, ANN EMERG MED, V72, P389, DOI 10.1016/j.annemergmed.2018.06.003; Delgado MK, 2018, J GEN INTERN MED, V33, P409, DOI 10.1007/s11606-017-4286-5; Deshazo RD, 2018, AM J MED, V131, P595, DOI 10.1016/j.amjmed.2017.12.045; DeVries A, 2014, J ADOLESCENT HEALTH, V55, P128, DOI 10.1016/j.jadohealth.2013.12.014; Dieleman JL, 2020, JAMA-J AM MED ASSOC, V323, P863, DOI 10.1001/jama.2020.0734; Dieners P., GERMANY PHARM ADVERT, P2021; Donelan CJ, 2021, J SUBST ABUSE TREAT, V124, DOI 10.1016/j.jsat.2020.108216; Dorsey T, 2017, ROOMS PROJECT TARAH; Douglas KR, 2010, ADDICT BEHAV, V35, P7, DOI 10.1016/j.addbeh.2009.07.004; Duncan A, 2021, J SUBST ABUSE TREAT, V121, DOI 10.1016/j.jsat.2020.108161; DuPont RL, 2019, PRINCIPLES ADDICTION, P1768; Eisenberg MD, 2020, HEALTH AFFAIR, V39, P1002, DOI 10.1377/hlthaff.2019.01289; Esposito CL, 2002, J TRAUMA STRESS, V15, P137, DOI 10.1023/A:1014860024980; European Monitoring Centre on Drugs and Drug Addiction, 2020, WAST AN DRUGS EUR MU; Eyre E., 2020, DEATH MUD LICK COAL; Fain KM, 2014, MED CARE, V52, P291, DOI 10.1097/MLR.0000000000000126; Fairley M, 2021, JAMA PSYCHIAT, V78, P767, DOI 10.1001/jamapsychiatry.2021.0247; Farrington DP., 2019, COMMUNITIES CARE BUI; Fentanyl Westhoff B., 2019, ROGUE CHEMISTS CREAT; Feucht TE., 1999, REDUCING DRUG USE PR; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Frank JW, 2019, PAIN MED, V20, P869, DOI 10.1093/pm/pny149; Frank JW, 2016, PAIN MED, V17, P1838, DOI 10.1093/pm/pnw078; Frank RG, 2017, NEW ENGL J MED, V376, P605, DOI 10.1056/NEJMp1615145; Friedman J, 2021, JAMA PSYCHIAT, V78, P886, DOI 10.1001/jamapsychiatry.2021.0967; Funk Cary, 2020, TRUST MED SCI HAS GR; Funk Cary, 2020, PUBLIC CONFIDENCE SC; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Furlan AD, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010324; Furlan AD, 2014, PAIN RES MANAG, V19, P102, DOI 10.1155/2014/634171; Galofaro C., 2019, PURDUE FOREIGN ARM C; Garcia A., 2016, SUPER BOWL DRUG AD S; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Gillis A, 2020, TRENDS PHARMACOL SCI, V41, P947, DOI 10.1016/j.tips.2020.09.009; Gladstone E, 2016, CAN MED ASSOC J, V188, pE67, DOI 10.1503/cmaj.150349; Goldman H.H., 2020, PALGRAVE HDB AM MENT, P259, DOI 10.1007/978-3-030-11908-9_10; Gomes T, 2014, CAN FAM PHYSICIAN, V60, P826; Goodman-Meza D, 2021, LANCET PUBLIC HEALTH, V6, pe88, DOI 10.1016/S2468-2667(20)30260-7; Goodman-Meza D, 2019, AM J PUBLIC HEALTH, V109, P73, DOI 10.2105/AJPH.2018.304767; Gossett TD, 2019, FOOT ANKLE INT, V40, P1043, DOI 10.1177/1071100719851117; Government of Canada, 2019, RESTR MARK ADV OP; Green CA, 2014, J SUBST ABUSE TREAT, V46, P390, DOI 10.1016/j.jsat.2013.09.002; Green TC, 2018, JAMA PSYCHIAT, V75, P405, DOI 10.1001/jamapsychiatry.2017.4614; Gregory A, 2020, SCI QUIT BACK PAIN C; Grogan CM, 2016, HEALTH AFFAIR, V35, P2289, DOI 10.1377/hlthaff.2016.0623; Guadamuz JS, 2020, JAMA-J AM MED ASSOC, V324, P299, DOI 10.1001/jama.2020.6611; Hadland SE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.6007; Hadland SE, 2018, JAMA INTERN MED, V178, P861, DOI 10.1001/jamainternmed.2018.1999; Hadlandsmyth K, 2018, J GEN INTERN MED, V33, P818, DOI 10.1007/s11606-017-4283-8; Haffajee RL, 2021, NEW ENGL J MED, V384, P2364, DOI 10.1056/NEJMp2101051; Hall WD, 2017, LANCET PSYCHIAT, V4, P265, DOI 10.1016/S2215-0366(17)30073-1; Hampton R., 2018, AM FIX INSIDE OPIOID; Han BC, 2017, AGONY OF EROS, P1; Harris AHS, 2016, J ADDICT MED, V10, P148, DOI 10.1097/ADM.0000000000000203; Harvey LM, 2020, J SUBST ABUSE TREAT, V112, P68, DOI 10.1016/j.jsat.2020.01.016; Hedegaard Holly, 2019, Natl Vital Stat Rep, V68, P1; Hemel DJ., 2020, J LAW BIOSCI, V7; Henderson S., 2017, OPIOID CRISIS VS WAR; Herper M, 2016, OPIOID SPRAY SHOWERE; Heyward J, 2020, JAMA INTERN MED, V180, P301, DOI 10.1001/jamainternmed.2019.5459; Higham S., 2017, DRUG INDUSTRYS TRIUM; Higham S., 2019, 76 BILLION OPIOID PI; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Hoffman KA, 2012, J BEHAV HEALTH SER R, V39, P234, DOI 10.1007/s11414-011-9270-y; Hoffman KA, 2011, ADDICT BEHAV, V36, P643, DOI 10.1016/j.addbeh.2011.01.031; Horwitz S., 2019, INSIDE OPIOID IND MA; Horwitz S, 2020, OPIOIDS FLOODED TRIB; Howard R, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2018.4234; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Humphreys K, 2004, J SUBST ABUSE TREAT, V26, P151, DOI 10.1016/S0740-5472(03)00212-5; Humphreys K, 2000, AM J PSYCHIAT, V157, P588, DOI 10.1176/appi.ajp.157.4.588; Humphreys K., 2020, WHAT US CANADA CAN L; Humphreys K, 2018, ASAM PRINCIPLES ADDI, P423; Humphreys K, 2006, RETHINKING SUBSTANCE, P257; Humphreys K, 2019, WE CANT FIGHT OPIOID; Humphreys K, 2018, LEGAL DRUG CO HELPED; Humphreys K, 2019, JAMA-J AM MED ASSOC, V321, P639, DOI 10.1001/jama.2019.0077; Humphreys K, 2018, PAIN MED, V19, P1514, DOI 10.1093/pm/pny120; Humphreys K, 2018, FOREIGN AFF, V97, P118; Humphreys K, 2018, AM J PUBLIC HEALTH, V108, P589, DOI 10.2105/AJPH.2018.304393; Humphreys K, 2017, LANCET, V390, P437, DOI 10.1016/S0140-6736(17)31918-9; Humphreys K, 2017, SCIENCE, V356, P1237, DOI 10.1126/science.aan0655; Humphreys K, 2014, ADDICTION, V109, P1957, DOI 10.1111/add.12606; Humphreys K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1316; Hunter SB, 2021, J SUBST ABUSE TREAT, V124, DOI 10.1016/j.jsat.2021.108288; Huskamp HA, 2020, JAMA-J AM MED ASSOC, V324, P2440, DOI 10.1001/jama.2020.21512; Institute for Safe Medication Practices Canada, 2021, OP STEW; Institute of Medicine Committee on Advancing Pain Research Care and Education, 2011, REL PAIN AM BLUEPR T; Interagency Pain Research Coordinating Committee, NAT PAIN STRAT OV, P2021; International Narcotics Control Board, 2020, NARC DRUGS TECHN REP; International Narcotics Control Board,, 2013, NARC DRUGS 2013; Ivsins A, 2020, INT J DRUG POLICY, V80, DOI 10.1016/j.drugpo.2020.102769; Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; JOHNS MW, 1977, BRIT MED J, V1, P1128, DOI 10.1136/bmj.1.6069.1128; Johnson K, 2020, INT J DRUG POLICY, V75, DOI 10.1016/j.drugpo.2019.10.009; Jonah L, 2017, Can Commun Dis Rep, V43, P257, DOI 10.14745/ccdr.v43i12a02; Jones DJ, 2013, J ABNORM CHILD PSYCH, V41, P139, DOI 10.1007/s10802-012-9656-1; Jonsson G, 2019, FUTURE GOVT, P315; Joseph G, 2021, J SUBST ABUSE TREAT, V122, DOI 10.1016/j.jsat.2020.108219; Kaafarani HMA, 2020, ANN SURG, V272, P879, DOI 10.1097/SLA.0000000000004225; Kahneman D, 2015, FORTUNE, V172, P20; Kalkman GA, 2019, LANCET PUBLIC HEALTH, V4, pE498, DOI 10.1016/S2468-2667(19)30128-8; Keefe PR., 2021, EMPIRE PAIN SECRET H, P2021; Keefe PR., 2020, SACKLER FAMILYS PLAN; Keefe PR., 2017, FAMILY BUILT EMPIRE; Kelly JF, 2011, CURR CLIN PSYCHIAT, P1, DOI 10.1007/978-1-60327-960-4; Kelly JF, 2021, ADDICTION, V116, P1757, DOI 10.1111/add.15333; Kennedy D.M., 2011, DONT SHOOT ONE MAN S; Kilmer B, 2014, HARD DRUGS DEMAND SO; Kilpatrick DG, 2000, J CONSULT CLIN PSYCH, V68, P19, DOI 10.1037/0022-006X.68.1.19; Kinetz E, 2019, FAKE DOCTORS MISLEAD; King County, 2020, OV DEATHS; Kleiman MAR, 2009, WHEN BRUTE FORCE FAILS: HOW TO HAVE LESS CRIME AND LESS PUNISHMENT, P1; Knaul FM, 2018, LANCET GLOB HEALTH, V6, P5; Koh HK, 2018, JAMA-J AM MED ASSOC, V320, P2301, DOI 10.1001/jama.2018.18397; Kravitz-Wirtz N, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19066; Krawczyk N, 2018, AM J PUBLIC HEALTH, V108, P666, DOI 10.2105/AJPH.2018.304341; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Krebs EE, 2014, J PAIN, V15, P1148, DOI 10.1016/j.jpain.2014.08.006; Kristjansson AL, 2020, HEALTH PROMOT PRACT, V21, P62, DOI 10.1177/1524839919849032; Larance B, 2018, LANCET PSYCHIAT, V5, P155, DOI 10.1016/S2215-0366(18)30003-8; Larkin I, 2017, JAMA-J AM MED ASSOC, V317, P1785, DOI 10.1001/jama.2017.4039; Lehman WEK, 2011, PSYCHOL ADDICT BEHAV, V25, P252, DOI 10.1037/a0022682; Lembke A., 2016, DRUG DEALER MD DOCTO, DOI [10.1086/705334, DOI 10.1086/705334]; Lembke A, 2020, J STUD ALCOHOL DRUGS, V81, P564; Lembke A, 2018, NEW ENGL J MED, V378, P693, DOI 10.1056/NEJMp1715050; Levin D, 2019, CLASS 2000 COULD HAV; Levy N, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4901; Logan MW, 2019, VICTIMS OFFENDERS, V14, P283, DOI 10.1080/15564886.2019.1595249; Luo FJ, 2021, MMWR-MORBID MORTAL W, V70, P541, DOI 10.15585/mmwr.mm7015a1; Lurie P, 2021, JAMA-J AM MED ASSOC, V326, P2469, DOI 10.1001/jama.2021.22354; Lynch B., 2017, WHAT DIFFERENCE YEAR; Mackey S, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l917; Mann B., 2020, FEDERAL JUDGE APPROV; Martin RA, 2019, PREV MED, V128, DOI 10.1016/j.ypmed.2019.105766; Martins SS, 2015, AM J PUBLIC HEALTH, V105, pE29, DOI 10.2105/AJPH.2015.302843; Maskell J, 2014, POSTEMPLOYMENT REVOL; McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625; McDonald DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069241; McGranahan D, OPIOID EPIDEMIC GEOG, P2021; McKenzie Michelle, 2009, J Opioid Manag, V5, P219; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McLellan AT, 2003, J SUBST ABUSE TREAT, V25, P117, DOI 10.1016/S0740-5472(03)00156-9; Meara E, 2005, ADDICTION, V100, P1240, DOI 10.1111/j.1360-0443.2005.01227.x; Medicaid Innovation Accelerator Program, 2019, COLL MOD MED ASS TRE; Meier B., 2018, PAIN KILLER EMPIRE D; Meier B., 2007, GUILTY PLEA OXYCONTI; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Messina N, 2010, J SUBST ABUSE TREAT, V38, P97, DOI 10.1016/j.jsat.2009.09.004; Mitchell TH., 2016, BIG FIX HOPE HEROIN; Monico LB, 2015, J SUBST ABUSE TREAT, V57, P89, DOI 10.1016/j.jsat.2015.05.005; Morden NE, 2021, NEW ENGL J MED, V385, P342, DOI 10.1056/NEJMsa2034159; Muhuri PK., 2013, CBHSQ DATA REV, P1; Mulvihill G, 2016, DRUGMAKERS FOUGHT ST; Nader MA, 2012, PSYCHOPHARMACOLOGY, V224, P57, DOI 10.1007/s00213-012-2843-5; National Academies of Sciences Engineering and Medicine, 2017, PAIN MAN OP EP BAL S; National Academies of Sciences Engineering and Medicine, 2019, MED OP US DIS SAV LI; National Academies of Sciences Engineering and Medicine, 2018, ADV THER DEV PAIN OP; National Center for Injury Prevention and Control, 2017, INT EXP PRESCR DRUG; National Conference of State Legislatures, 2020, REV DOOR PROH; Nechuta SJ, 2018, DRUG ALCOHOL DEPEN, V190, P62, DOI 10.1016/j.drugalcdep.2018.05.004; New York State Office of the Attorney General,, 2014, AG SCHNEID ANN SETTL; Nguyen TD, 2019, ADDICTION, V114, P1051, DOI 10.1111/add.14509; Office of Budget, 2015, HHS FY2016 BUDG BRIE; Oquendo MA, 2018, NEW ENGL J MED, V378, P1567, DOI 10.1056/NEJMp1801417; Ornstein C, 2012, AM PAIN FDN SHUTS SE; Ornstein C., 2011, CHAMPION PAINKILLERS; Ozieranski P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037351; Palamar JJ, 2021, DRUG ALCOHOL DEPEN, V221, DOI 10.1016/j.drugalcdep.2021.108580; Pardo B, 2018, ASSESSING EVIDENCE S; Pardo B., 2019, FUTURE FENTANYL ATHE; Pardo B, 2021, INT J DRUG POLICY, V93, DOI 10.1016/j.drugpo.2020.102833; Pardo B, 2017, ADDICTION, V112, P1773, DOI 10.1111/add.13741; Parmar MKB, 2017, ADDICTION, V112, P502, DOI 10.1111/add.13668; Pellowski JA, 2014, J ASSOC NURSE AIDS C, V25, P646, DOI 10.1016/j.jana.2014.06.002; Persaud N, 2014, J MED ETHICS, V40, P414, DOI 10.1136/medethics-2013-101343; Pfaff John F., 2017, LOCKED TRUE CAUSES M; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Piller C, 2018, SCIENCE, V361, P21, DOI 10.1126/science.361.6397.21; Pitt AL, 2018, AM J PUBLIC HEALTH, V108, P1394, DOI 10.2105/AJPH.2018.304590; Planet Ark Recycling Near You, 2020, UNW OUT OF DAT MED; Planet Youth, 2020, COMM COUNTR INTR IC; Polydorou Soteri, 2008, Curr Psychiatry Rep, V10, P399, DOI 10.1007/s11920-008-0064-8; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; Quinones S., 2015, DREAMLAND TRUE TALE; Raitasalo K, 2021, ADDICTION, V116, P62, DOI 10.1111/add.15089; Rao IJ., 2021, LANCET REG HLTH AM, V3, DOI DOI 10.1016/J.LANA.2021.100031/ATTACHMENT/DEB72DDB-08A9-4EE2-9F0A-E0BB28261842; Rawson RA, 2017, VERMONT HUB AND SPOK; Rennie D., 2008, J LAW POLICY, V15, P2; Reuter P, 2021, ADDICTION, V116, P2600, DOI 10.1111/add.15458; Rockett IRH, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2021.100741; Rollman JE, 2019, JAMA-J AM MED ASSOC, V321, P676, DOI 10.1001/jama.2019.0235; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443; Rosenstein RJ., 2018, FIGHT DRUG ABUSE DON; Ruhm C. J., 2018, Working Paper Series - National Bureau of Economic Research (Massachusetts); Ryan H, 2016, WERE ONLY JUST GETTI; Saloner B, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1588; Santo T, 2021, DRUG ALCOHOL REV, V40, pS131; Sarasohn J, 2004, TAUZIN HEAD DRUG TRA; Schmid CL, 2017, CELL, V171, P1165, DOI 10.1016/j.cell.2017.10.035; Schwartz LM, 2019, JAMA-J AM MED ASSOC, V321, P80, DOI 10.1001/jama.2018.19320; Schweinhart LJ., 2003, BENEFITS COSTS EXPLA; Scott MJ, 2019, IOWA LAW REV, V105, P431; Shaheen J, 2021, SHAHEEN RE INTRO BIL; Shapiro BT, 2018, J POLIT ECON, V126, P381, DOI 10.1086/695475; Sharp A, 2018, AM J PUBLIC HEALTH, V108, P642, DOI 10.2105/AJPH.2018.304338; Shover CL, 2021, J ADDICT MED, V15, P429, DOI 10.1097/ADM.0000000000000775; Shover CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10001; Shover CL, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.107586; Shover CL, 2019, P NATL ACAD SCI USA, V116, P12624, DOI 10.1073/pnas.1903434116; Sinha CB, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4410; Sixx N, 2017, TAKE IT RECOVERING A; Smith BT, 2018, AM J DRUG ALCOHOL AB, V44, P426, DOI 10.1080/00952990.2017.1411934; Social Programs that Work, 2020, EV SUMM NURS FAM PAR; Special Advisory Committee on the Epidemic of Opioid Overdoses, OP STIM REL HARMS CA, P2021; Spelsberg A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j337; Spencer Merianne R, 2019, Natl Vital Stat Rep, V68, P1; Stanczyk MA, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000650; Stevens MP, 2014, INT J INFECT DIS, V21, P37, DOI 10.1016/j.ijid.2014.03.492; Stewart H, 2015, AM J PUBLIC HEALTH, V105, pE65, DOI 10.2105/AJPH.2014.302207; STOFFELMAYR BE, 1989, J PSYCHOACTIVE DRUGS, V21, P145, DOI 10.1080/02791072.1989.10472154; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Strang J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4851; Suda KJ, 2020, AM J PREV MED, V58, P473, DOI 10.1016/j.amepre.2019.11.006; Sullivan T., 2018, MASSACHUSETTS PHARM; Sun EC, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j760; Taitsman JK, 2020, JAMA INTERN MED, V180, P925, DOI 10.1001/jamainternmed.2020.1318; Tarrant County TX, MED EX CAS REC; Teesson M, 2020, LANCET DIGIT HEALTH, V2, pE74, DOI 10.1016/S2589-7500(19)30213-4; The US Attorneys Office Southern District of California, 2020, PILL MILL DOCT PLEAD; The US District Attorney's Office District of Connecticut,, 2019, APRN WHO REC KICKB I; Tjagvad C, 2016, EUR ADDICT RES, V22, P249, DOI 10.1159/000446429; Tonko PD., 2019, TONKO TURNER REINTRO; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Traynor K, 2016, AM J HEALTH-SYST PH, V73, P940, DOI 10.2146/news160040; Tsang A, 2008, J PAIN, V9, P883, DOI 10.1016/j.jpain.2008.05.005; Tufts University Office of the President, 2019, IMP ANN; U.S. Department of Health and Human Services (HHS) Office of the Surgeon General, 2018, FAC ADD AM SURG GEN; UK Medicines and Healthcare products Regulatory Agency, 2020, DRUG SAFETY UPDATE, V14, P2; UN Office on Drugs and Crime, 2020, Q PERF REP JAN 2020; US Census Bureau, 2021, US WORLD POP CLOCK; US Centers for Disease Control and Prevention, MULT CAUS DEATH 1999, P2021; US Centers for Disease Control and Prevention, 2021, US OP DISP RAT MAPS; US Centers for Disease Control and Prevention, 2011, PRESCR PAINK OV US; US Centers for Disease Control and Prevention, 2020, PRESCRIPTION DRUG MO; US Centers for Medicare and Medicaid Services, 2016, MED COV SUBST AB SER; US Department of Health and Human Services, 2018, PATIENT PROTECTION A; US Department of Health and Human Services, PRACTICE GUIDELINES, P2021; US Department of Homeland Security, 2019, PRIZ WINN ANN 1 55M; US Department of Justice Office of Public Affairs, 2020, EL HLTH REC VEND PAY; US Federal Trade Commission, 2019, FTC BRINGS 1 CAS CHA; US. Financial Crimes Enforcement Network, 2019, ADV FIN I ILL FIN SC; US Food and Drug Administration,, TIM SEL FDA ACT SIGN; US Food and Drug Administration, 2018, COMMUNICATION; US Food and Drug Administration, 2016, DRAFT GUIDANCE DOCUM; US Food and Drug Administration, 2016, PRESCRIPTION DRUG US; US General Accounting Office, 2003, OXYCONTIN AB DIV EFF; US Government Accountability Office, 2017, PREV DRUG AB; US National Academy of Medicine, 2017, 1 DO NO HARM MARSH C; US National Institute on Drug Abuse, 2015, PRESCRIPTION OPIOID; US National Institutes of Health, 2020, EST FUND VAR RES CON; US Substance Abuse and Mental Health Services Administration, 2019, TI 18 009 IND GRANT; US Substance Abuse and Mental Health Services Administration, 2018, CLIN GUID TREATM PRE; Varney S, 2019, BIG PHARM IS TARGETI; Varney S, 2019, OPIOID ADDICTION RIS; Ventola C Lee, 2011, P T, V36, P669; Victor RG, 2019, CIRCULATION, V139, P10, DOI 10.1161/CIRCULATIONAHA.118.038165; Victor RG, 2018, NEW ENGL J MED, V378, P1291, DOI 10.1056/NEJMoa1717250; Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212; Vos T, 2020, LANCET, V396, P1562; Watson GL, 2015, ETHICAL HUM PSYCHOL, V17, P5; Watson ST., 2019, NAME CONVICTED DONOR; Webster F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215148; Webster PC, 2013, LANCET, V381, P1447, DOI 10.1016/S0140-6736(13)60913-7; WEICK KE, 1984, AM PSYCHOL, V39, P40, DOI 10.1037/0003-066X.39.1.40; Weiss RD, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.18m12292; Wertli MM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2086-6; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR; Williams AR, 2019, AM J DRUG ALCOHOL AB, V45, P1, DOI 10.1080/00952990.2018.1546862; Witkiewitz K, 2018, PSYCHOL ADDICT BEHAV, V32, P639, DOI 10.1037/adb0000381; Woods JS, 2012, J ADDICT DIS, V31, P226, DOI 10.1080/10550887.2012.694599; World Health Organization, 2018, TOP 10 CAUS DEATH; Yamamoto A, 2019, SOC SCI MED, V242, DOI 10.1016/j.socscimed.2019.112585; Yang LH, 2017, CURR OPIN PSYCHIATR, V30, P378, DOI 10.1097/YCO.0000000000000351; Yedinak JL, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002963, 10.1371/journal.pmed.1002963.r001, 10.1371/journal.pmed.1002963.r002, 10.1371/journal.pmed.1002963.r003, 10.1371/journal.pmed.1002963.r004, 10.1371/journal.pmed.1002963.r005]; Young E, 2017, ICELAND GOT TEENS SA; Yurko RJ., 2019, REPORT RECOMMENDATIO; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Zaring D, 2013, U ILLINOIS LAW REV, P507; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954; Zisblatt L, 2017, SUBST ABUS, V38, P168, DOI 10.1080/08897077.2016.1275927	388	27	27	7	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					555	604		10.1016/S0140-6736(21)02252-2	http://dx.doi.org/10.1016/S0140-6736(21)02252-2			50	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35122753				2022-12-28	WOS:000755144500029
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government abandons mandatory vaccination of NHS staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o192; Kmietowicz Z, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o249; TheyWorkForYou, VACC COND DEPL HOUS	3	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2022	376								o269	10.1136/bmj.o269	http://dx.doi.org/10.1136/bmj.o269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1UX	35105551	Bronze			2022-12-28	WOS:000758676500012
J	MacIntyre, N; Balasubramanian, A; Kaminsky, D				MacIntyre, Neil; Balasubramanian, Aparna; Kaminsky, David			Diffusing Capacity of the Lungs for Carbon Monoxide Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PULMONARY-HYPERTENSION; PREDICTOR		[MacIntyre, Neil] Duke Univ, Med Ctr, Durham, NC USA; [Balasubramanian, Aparna] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Kaminsky, David] Univ Vermont, Med Ctr, Burlington, VT USA	Duke University; Johns Hopkins University; Johns Hopkins Medicine; University of Vermont; University of Vermont Medical Center	MacIntyre, N (corresponding author), Duke Univ Hosp, Box 3911,Room 1120, Durham, NC 27710 USA.	neil.macintyre@duke.edu						Balasubramanian A, 2020, CHEST, V158, P722, DOI 10.1016/j.chest.2020.02.047; Bui A, 2020, INTERN MED J, V50, P1311, DOI 10.1111/imj.14647; COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; Graham BL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00016-2016; Hughes JMB, 2012, AM J RESP CRIT CARE, V186, P132, DOI 10.1164/rccm.201112-2160CI; Nakahara Y, 2017, RESPIROLOGY, V22, P120, DOI 10.1111/resp.12863; Saydain G, 2004, CHEST, V125, P446, DOI 10.1378/chest.125.2.446; Stanojevic S, 2021, EUR RESPIR J, DOI 10.183/13993003.01499-2021; Stanojevic S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00010-2017; Zou RH, 2020, PULM CIRC, V10, DOI 10.1177/2045894019891912	10	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 1	2022	327	5					480	481						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9QB	35103787				2022-12-28	WOS:000753056200021
J	Neilan, AM; Landovitz, RJ; Le, MH; Grinsztejn, B; Freedberg, KA; McCauley, M; Wattananimitgul, N; Cohen, MS; Ciaranello, AL; Clement, ME; Reddy, KP; Hyle, EP; Paltiel, AD; Walensky, RP				Neilan, Anne M.; Landovitz, Raphael J.; Le, Mylinh H.; Grinsztejn, Beatriz; Freedberg, Kenneth A.; McCauley, Marybeth; Wattananimitgul, Nattanicha; Cohen, Myron S.; Ciaranello, Andrea L.; Clement, Meredith E.; Reddy, Krishna P.; Hyle, Emily P.; Paltiel, A. David; Walensky, Rochelle P.			Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article						PrEP program costs; PrEP drug costs; HIV care costs; ART drug costs	QUALITY-OF-LIFE; DOUBLE-BLIND; EMTRICITABINE; DOLUTEGRAVIR; PREVENTION; LAMIVUDINE; RETENTION; DISEASE; ADULTS; CARE	Background: The HIV Prevention Trials Network (HPTN) 083 trial demonstrated the superiority of long-acting injectable cabotegravir (CAB-LA) compared with oral emtricitabine-tenofovir disoproxil fumarate (F/TDF) for HIV preexposure prophylaxis (PrEP). Objective: To identify the maximum price premium (that is, greatest possible price differential) that society should be willing to accept for the additional benefits of CAB-LA over tenofovirbased PrEP among men who have sex with men and transgender women (MSM/TGW) in the United States. Design: Simulation, cost-effectiveness analysis. Data Sources: Trial and published data, including estimated HIV incidence (5.32, 1.33, and 0.26 per 100 person-years for off PrEP, generic F/TDF and branded emtricitabine-tenofovir alafenamide (F/TAF), and CAB-LA, respectively); 28% 6-year PrEP retention. Annual base-case drug costs: $360 and $16800 for generic F/TDF and branded F/TAF. Fewer side effects with branded F/TAF versus generic F/TDF were assumed. Target Population: 476 700 MSM/TGW at very high risk for HIV (VHR). Time Horizon: 10 years. Perspective: Health care system. Intervention: CAB-LA versus generic F/TDF or branded F/TAF for HIV PrEP. Outcome Measures: Primary transmissions, quality-adjusted life-years (QALYs), costs (2020 U.S. dollars), incremental cost-effectiveness ratios (ICERs; U.S. dollars per QALY), maximum price premium for CAB-LA versus tenofovir-based PrEP. Results of Base-Case Analysis: Compared with generic F/ TDF (or branded F/TAF), CAB-LA increased life expectancy by 28000 QALYs (26 000 QALYs) among those at VHR. Branded F/ TAF cost more per QALY gained than generic F/TDF compared with no PrEP. At 10 years, CAB-LA could achieve an ICER of at most $100000 per QALY compared with generic F/TDF at a maximum price premium of $3700 per year over generic F/TDF (CAB-LA price <$4100 per year). Results of Sensitivity Analysis: In a PrEP-eligible population at high risk for HIV, rather than at VHR (n = 1 906 800; off PrEP incidence: 1.54 per 100 person-years), CAB-LA could achieve an ICER of at most $100000 per QALY versus generic F/TDF at a maximum price premium of $1100 per year over generic F/TDF (CAB-LA price <$1500 per year). Limitation: Uncertain clinical and economic benefits of averting future transmissions. Conclusion: Effective oral PrEP limits the additional price society should be willing to pay for CAB-LA.	[Neilan, Anne M.] Massachusetts Gen Hosp, Div Gen Acad Pediat, Div Infect Dis, Boston, MA 02114 USA; [Neilan, Anne M.; Le, Mylinh H.; Wattananimitgul, Nattanicha; Ciaranello, Andrea L.; Reddy, Krishna P.; Hyle, Emily P.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA; [Neilan, Anne M.; Freedberg, Kenneth A.; Ciaranello, Andrea L.; Reddy, Krishna P.; Hyle, Emily P.; Walensky, Rochelle P.] Harvard Med Sch, Boston, MA 02115 USA; [Landovitz, Raphael J.] Univ Calif Los Angeles, Ctr Clin AIDS Res & Educ, Los Angeles, CA USA; [Landovitz, Raphael J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Grinsztejn, Beatriz] Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Freedberg, Kenneth A.; Ciaranello, Andrea L.; Hyle, Emily P.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [McCauley, Marybeth] FHI 360, Sci Facilitat, Washington, DC USA; [Cohen, Myron S.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA; [Ciaranello, Andrea L.; Hyle, Emily P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Clement, Meredith E.] Louisiana State Univ, Div Infect Dis, Hlth Sci Ctr, New Orleans, LA USA; [Reddy, Krishna P.] Massachusetts Gen Hosp, Div Pulm & Crit Care Med, Boston, MA 02114 USA; [Paltiel, A. David] Yale Sch Publ Hlth, New Haven, CT USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Med Practice Evaluat Ctr, Boston, MA 02115 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Walensky, Rochelle P.] Ctr Dis Control & Prevent, Atlanta, GA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Massachusetts General Hospital; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA	Neilan, AM (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 100 Cambridge St,Suite 1600, Boston, MA 02114 USA.	aneilan@mgh.harvard.edu	, Andrea/ABB-3330-2021	, Andrea/0000-0002-4268-3263; Le, Mylinh/0000-0001-6980-3328; Neilan, Anne/0000-0001-7915-4974; Clement, Meredith/0000-0002-0283-6368; Landovitz, Raphael/0000-0002-1442-714X	FHI 360 [UM1AI068619]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08 HD094638]; National Institute of Allergy and Infectious Diseases [R01 AI093269, K23 AI137121]; National Heart, Lung, and Blood Institute [K01 HL123349]; National Institute on Drug Abuse [R37 DA015612]; Jerome and Celia Reich HIV Scholar Award; Steve and Deborah Gorlin MGH Research Scholars Award	FHI 360; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Jerome and Celia Reich HIV Scholar Award; Steve and Deborah Gorlin MGH Research Scholars Award	By grant UM1AI068619 from FHI 360 (Drs. Freedberg and Walensky) and additional support by grant K08 HD094638 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Dr. Neilan) , grants R01 AI093269 (Drs. Walensky and Reddy) and K23 AI137121 (Dr. Clement) from the National Institute of Allergy and Infectious Diseases, grant K01 HL123349 (Dr. Hyle) from the National Heart, Lung, and Blood Institute, grant R37 DA015612 (Dr. Paltiel) from the National Institute on Drug Abuse, the Jerome and Celia Reich HIV Scholar Award (Dr. Hyle) , and the Steve and Deborah Gorlin MGH Research Scholars Award (Dr. Walensky) .	Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Bernstein L, 2021, WASHINGTON POST; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P1781, DOI 10.1007/s00198-006-0193-z; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Cahn P, 2011, AIDS, V25, P929, DOI 10.1097/QAD.0b013e328345ee95; Canadian Agency for Drugs and Technologies in Health (CADTH), 2020, VIIV HEALTHC ULC C; Centers for Disease Control and Prevention, 2019, CHRON KIDN DIS SURV; Centers for Medicare & Medicaid Services, 2021, 2020 PHYS FEE SCHED; Centers for Medicare & Medicaid Services, 2020, CLIN LAB FEE SCHED; Conti Rena M, 2020, F1000Res, V9, P707, DOI 10.12688/f1000research.24934.1; Crepaz N, 2020, AIDS 2020 23 INT AID; Eggman AA, 2014, SEX TRANSM DIS, V41, P545, DOI 10.1097/OLQ.0000000000000168; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Furukawa NW, 2020, ANN INTERN MED, V173, P799, DOI 10.7326/M20-0786; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gilead, 2021, GIL ANN DEC NOT PURS; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Harris NS, 2019, MMWR-MORBID MORTAL W, V68, P1117, DOI 10.15585/mmwr.mm6848e1; Helleberg M, 2012, AIDS, V26, P741, DOI 10.1097/QAD.0b013e32834fa15e; Hoover KW, 2021, C RETR OPP INF CROI; Horn T., 2019, AM C TREATM HIV ACTH; Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439; Keen P, 2020, JAIDS-J ACQ IMM DEF, V83, P119, DOI 10.1097/QAI.0000000000002232; Komatsu A, 2018, DRUG SAFETY, V41, P843, DOI 10.1007/s40264-018-0665-z; Landovitz RJ, 2021, NEW ENGL J MED, V385, P595, DOI 10.1056/NEJMoa2101016; Landovitz RJ, 2016, CURR OPIN HIV AIDS, V11, P122, DOI 10.1097/COH.0000000000000219; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Levinson DR, 2021, MED DRUG PRICE COMP; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marzinke M, 2021, C RETR OPP INF CROI; Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5; McManus KA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.7445; Nayak RK, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5766; Neilan AM, 2021, CLIN INFECT DIS, V73, pE1927, DOI 10.1093/cid/ciaa1061; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2016, PUBLIC HEALTH REP, V131, P71, DOI 10.1177/00333549161310S109; Singh S, 2018, ANN INTERN MED, V168, P685, DOI 10.7326/M17-2082; Truven Health Analytics, 2021, IBM MICR RED BOOK; U.S. Department of Veterans Affairs, 2020, NAT ACQ CTR CCST PHA; U.S. House of Representatives Committee Repository, 2019, HEAR HIV PREV DRUG B; Walensky RP, 2020, ANN INTERN MED, V172, P583, DOI [10.7326/M19-3478, 10.7326/L20-0693]; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Williams R, 2020, OPEN FORUM INFECT DI, V7, pS180, DOI [10.1093/ofid/ofaa439.411, DOI 10.1093/0FID/OFAA439.411]; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210	49	12	12	3	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					479	+		10.7326/M21-1548	http://dx.doi.org/10.7326/M21-1548		FEB 2022	27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35099992				2022-12-28	WOS:000750887600001
J	Samarasekera, U				Samarasekera, Udani			Ros Taylor: seeing palliative care as relational	LANCET			English	Editorial Material																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					783	783		10.1016/S0140-6736(22)00146-5	http://dx.doi.org/10.1016/S0140-6736(22)00146-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZJ4WT	35114147	Green Published			2022-12-28	WOS:000762307100011
J	Paredes, MF; Mora, C; Flores-Ramirez, Q; Cebrian-Silla, A; Del Dosso, A; Larimer, P; Chen, JP; Kang, G; Granero, SG; Garcia, E; Chu, JL; Delgado, R; Cotter, JA; Tang, V; Spatazza, J; Obernier, K; Lozano, JF; Vento, M; Scott, J; Studholme, C; Nowakowski, TJ; Kriegstein, AR; Oldham, MC; Hasenstaub, A; Garcia-Verdugo, JM; Alvarez-Buylla, A; Huang, EJ				Paredes, Mercedes F.; Mora, Cristina; Flores-Ramirez, Quetzal; Cebrian-Silla, Arantxa; Del Dosso, Ashley; Larimer, Phil; Chen, Jiapei; Kang, Gugene; Gonzalez Granero, Susana; Garcia, Eric; Chu, Julia; Delgado, Ryan; Cotter, Jennifer A.; Tang, Vivian; Spatazza, Julien; Obernier, Kirsten; Ferrer Lozano, Jaime; Vento, Maximo; Scott, Julia; Studholme, Colin; Nowakowski, Tomasz J.; Kriegstein, Arnold R.; Oldham, Michael C.; Hasenstaub, Andrea; Manuel Garcia-Verdugo, Jose; Alvarez-Buylla, Arturo; Huang, Eric J.			Nests of dividing neuroblasts sustain interneuron production for the developing human brain	SCIENCE			English	Article							GANGLIONIC EMINENCE; NEURAL STEM; RADIAL GLIA; MIGRATION; EXPRESSION; GENES; CELLS; SPECIFICATION; ORGANIZATION; PROGENITORS	The human cortex contains inhibitory interneurons derived from the medial ganglionic eminence (MGE), a germinal zone in the embryonic ventral forebrain. How this germinal zone generates sufficient interneurons for the human brain remains unclear. We found that the human MGE (hMGE) contains nests of proliferative neuroblasts with ultrastructural and transcriptomic features that distinguish them from other progenitors in the hMGE. When dissociated hMGE cells are transplanted into the neonatal mouse brain, they reform into nests containing proliferating neuroblasts that generate young neurons that migrate extensively into the mouse forebrain and mature into different subtypes of functional interneurons. Together, these results indicate that the nest organization and sustained proliferation of neuroblasts in the hMGE provide a mechanism for the extended production of interneurons for the human forebrain.	[Paredes, Mercedes F.; Flores-Ramirez, Quetzal; Larimer, Phil; Garcia, Eric; Chu, Julia; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Paredes, Mercedes F.; Cebrian-Silla, Arantxa; Delgado, Ryan; Nowakowski, Tomasz J.; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo; Huang, Eric J.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA 94143 USA; [Paredes, Mercedes F.; Chen, Jiapei; Kriegstein, Arnold R.; Alvarez-Buylla, Arturo; Huang, Eric J.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Paredes, Mercedes F.; Kang, Gugene; Kriegstein, Arnold R.; Oldham, Michael C.; Alvarez-Buylla, Arturo; Huang, Eric J.] Univ Calif San Francisco, Dev & Stem Cell Grad Program, San Francisco, CA 94143 USA; [Mora, Cristina; Del Dosso, Ashley; Chen, Jiapei; Tang, Vivian; Oldham, Michael C.; Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Cebrian-Silla, Arantxa; Kang, Gugene; Spatazza, Julien; Obernier, Kirsten; Oldham, Michael C.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Gonzalez Granero, Susana; Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Lab Neurobiol Comparada, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Valencia, Spain; [Cotter, Jennifer A.] Univ Southern Calif, Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA; [Cotter, Jennifer A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90027 USA; [Ferrer Lozano, Jaime] Hosp Univ & Politecn La Fe, Dept Pathol, Valencia, Spain; [Vento, Maximo] Hlth Res Inst La Fe, Neonatal Res Grp, Valencia, Spain; [Vento, Maximo] Univ & Polytech Hosp La Fe, Div Neonatol, Valencia, Spain; [Scott, Julia] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA; [Studholme, Colin] Univ Washington, Dept Pediat, Biomed Image Comp Grp, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Bioengn, Biomed Image Comp Grp, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Radiol, Biomed Image Comp Grp, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Studholme, Colin] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Nowakowski, Tomasz J.] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Hasenstaub, Andrea] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; University of Valencia; Children's Hospital Los Angeles; University of Southern California; University of Southern California; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); Santa Clara University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Paredes, MF (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Paredes, MF; Alvarez-Buylla, A; Huang, EJ (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, San Francisco, CA 94143 USA.; Paredes, MF; Alvarez-Buylla, A; Huang, EJ (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.; Paredes, MF; Alvarez-Buylla, A; Huang, EJ (corresponding author), Univ Calif San Francisco, Dev & Stem Cell Grad Program, San Francisco, CA 94143 USA.; Huang, EJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	mercedes.paredes@ucsf.edu; alvarezbuyllaa@ucsf.edu; eric.huang2@ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Flores-Ramirez, Quetzal/0000-0003-0309-3428; Scott, Julia/0000-0002-8361-5259; Chen, Jiapei/0000-0002-8205-8593; Cebrian Silla, Arantxa/0000-0003-4623-7655				Anderson SA, 2001, DEVELOPMENT, V128, P353; Boldog E, 2018, NAT NEUROSCI, V21, P1185, DOI 10.1038/s41593-018-0205-2; Canitano R, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00069; Cebrian-Silla A, 2017, STEM CELL REP, V9, P203, DOI 10.1016/j.stemcr.2017.05.024; Chattopadhyaya Bidisha, 2012, Front Psychiatry, V3, P51, DOI 10.3389/fpsyt.2012.00051; Denechaud PD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00311; Ferguson BR, 2018, BIOL PSYCHIAT, V83, P657, DOI 10.1016/j.biopsych.2017.11.033; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogtmann M, 2014, IEEE T MED IMAGING, V33, P272, DOI 10.1109/TMI.2013.2284014; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Hagey DW, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007224; Hansen DV, 2013, NAT NEUROSCI, V16, P1576, DOI 10.1038/nn.3541; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hardin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-220; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hu JS, 2017, DEVELOPMENT, V144, P3867, DOI 10.1242/dev.132852; Huang W, 2020, CELL, V182, P594, DOI 10.1016/j.cell.2020.06.027; Kelley KW, 2018, NAT NEUROSCI, V21, P1171, DOI 10.1038/s41593-018-0216-z; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Krienen FM, 2020, NATURE, V586, P262, DOI 10.1038/s41586-020-2781-z; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lim L, 2018, NEURON, V100, P294, DOI 10.1016/j.neuron.2018.10.009; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Loug JE, 2009, CEREB CORTEX, V19, pI96, DOI 10.1093/cercor/bhp045; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Ma T, 2013, NAT NEUROSCI, V16, P1588, DOI 10.1038/nn.3536; Magri L, 2014, J NEUROSCI, V34, P1481, DOI 10.1523/JNEUROSCI.2840-13.2014; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2013, EUR J NEUROSCI, V38, P2019, DOI 10.1111/ejn.12225; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Paxinos G, 2020, ATLAS DEVELOPING MOU, V2; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Scott JA, 2011, INT J DEV NEUROSCI, V29, P529, DOI 10.1016/j.ijdevneu.2011.04.001; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Stenman J, 2003, J NEUROSCI, V23, P167; Studholme C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16763-y; Studholme C, 2015, SEMIN PERINATOL, V39, P105, DOI 10.1053/j.semperi.2015.01.003; Vogt D, 2015, JOVE-J VIS EXP, DOI 10.3791/52740; Vogt D, 2014, NEURON, V82, P350, DOI 10.1016/j.neuron.2014.02.030; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	57	3	3	5	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					402	+	eabk2346	10.1126/science.abk2346	http://dx.doi.org/10.1126/science.abk2346			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084970	Green Accepted			2022-12-28	WOS:000750899500030
J	Peng, J; Kremer, F; Walter, D; Wu, YL; Ji, Y; Xiang, J; Liu, WZ; Duong, T; Shen, HP; Lu, T; Brink, F; Zhong, DY; Li, L; Lem, OLC; Liu, Y; Weber, KJ; White, TP; Catchpole, KR				Peng, Jun; Kremer, Felipe; Walter, Daniel; Wu, Yiliang; Ji, Yi; Xiang, Jin; Liu, Wenzhu; Duong, The; Shen, Heping; Lu, Teng; Brink, Frank; Zhong, Dingyong; Li, Li; Lee Cheong Lem, Olivier; Liu, Yun; Weber, Klaus J.; White, Thomas P.; Catchpole, Kylie R.			Centimetre-scale perovskite solar cells with fill factors of more than 86 per cent	NATURE			English	Article							TITANIUM-DIOXIDE; EFFICIENT; CONTACTS; RUTILE	Owing to rapid development in their efficiency(1) and stability(2), perovskite solar cells are at the forefront of emerging photovoltaic technologies. State-of-the-art cells exhibit voltage losses(3-8) approaching the theoretical minimum and near-unity internal quantum efficiency(9-13), but conversion efficiencies are limited by the fill factor (<83%, below the Shockley-Queisser limit of approximately 90%). This limitation results from non-ideal charge transport between the perovskite absorber and the cell's electrodes(5,8,13-16). Reducing the electrical series resistance of charge transport layers is therefore crucial for improving efficiency. Here we introduce a reverse-doping process to fabricate nitrogen-doped titanium oxide electron transport layers with outstanding charge transport performance. By incorporating this charge transport material into perovskite solar cells, we demonstrate 1-cm(2) cells with fill factors of >86%, and an average fill factor of 85.3%. We also report a certified steady-state efficiency of 22.6% for a 1-cm(2) cell (23.33% +/- 0.58% from a reverse current-voltage scan).	[Peng, Jun; Walter, Daniel; Wu, Yiliang; Duong, The; Shen, Heping; Weber, Klaus J.; White, Thomas P.; Catchpole, Kylie R.] Australian Natl Univ, Sch Engn, Canberra, ACT, Australia; [Kremer, Felipe; Brink, Frank] Australian Natl Univ, Ctr Adv Microscopy, Canberra, ACT, Australia; [Ji, Yi; Xiang, Jin; Zhong, Dingyong] Sun Yat Sen Univ, Sch Phys, Guangzhou, Peoples R China; [Ji, Yi; Xiang, Jin; Zhong, Dingyong] Sun Yat Sen Univ, State Key Lab Optoelect Mat & Technol, Guangzhou, Peoples R China; [Liu, Wenzhu] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, Res Ctr New Energy Technol, Shanghai, Peoples R China; [Lu, Teng; Liu, Yun] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Li, Li; Lee Cheong Lem, Olivier] Australian Natl Univ, Res Sch Phys, Australian Natl Fabricat Facil, Canberra, ACT, Australia	Australian National University; Australian National University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Shanghai Institute of Microsystem & Information Technology, CAS; Australian National University; Australian National University	Peng, J; White, TP; Catchpole, KR (corresponding author), Australian Natl Univ, Sch Engn, Canberra, ACT, Australia.	jun.peng@anu.edu.au; thomas.white@anu.edu.au; kylie.catchpole@anu.edu.au	Zhong, Dingyong/D-5617-2017; Liu, Yun/O-6153-2015; Duong, The/R-4797-2017	Zhong, Dingyong/0000-0001-5650-4767; Liu, Yun/0000-0002-5404-3909; Duong, The/0000-0002-1298-4743; Liu, Wenzhu/0000-0003-0239-9089; Weber, Klaus/0000-0002-2421-6178	Australian Government through the Australian Renewable Energy Agency; Australian Research Council; Australian Centre for Advanced Photovoltaics; Australian Research Council Future Fellowship by the Australian Government [FT180100302]; Open Fund of the State Key Laboratory of Optoelectronic Materials and Technologies (Sun Yat-sen University); National Natural Science Foundation of China [11574403, 11974431]	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Australian Research Council(Australian Research Council); Australian Centre for Advanced Photovoltaics; Australian Research Council Future Fellowship by the Australian Government(Australian Research Council); Open Fund of the State Key Laboratory of Optoelectronic Materials and Technologies (Sun Yat-sen University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Australian Government through the Australian Renewable Energy Agency and the Australian Research Council. Responsibility for the views, information or advice expressed herein is not accepted by the Australian Government. J.P. acknowledges the financial support of a Postdoc Fellowship from the Australian Centre for Advanced Photovoltaics. T.P.W. is the recipient of an Australian Research Council Future Fellowship (project number FT180100302) funded by the Australian Government. T.P.W. also acknowledges the support of the Open Fund of the State Key Laboratory of Optoelectronic Materials and Technologies (Sun Yat-sen University). D.Z. acknowledges funding from the National Natural Science Foundation of China (grant numbers 11574403 and 11974431). The work was partly conducted at the ACT node of the Australian National Fabrication Facility, and the ANU node of the Australian Microscopy and Microanalysis Facility. We thank S. Surve and S. Zhao for experimental assistance.	Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Asahi R, 2014, CHEM REV, V114, P9824, DOI 10.1021/cr5000738; Bai S, 2019, NATURE, V571, P245, DOI 10.1038/s41586-019-1357-2; Batzill M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026103; Brudnik A, 2008, VACUUM, V82, P936, DOI 10.1016/j.vacuum.2008.01.020; Correa-Baena JP, 2017, ENERG ENVIRON SCI, V10, P1207, DOI 10.1039/c7ee00421d; Ding B, 2016, ACS APPL MATER INTER, V8, P20067, DOI 10.1021/acsami.6b05862; Giordano F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10379; Green M, 2021, PROG PHOTOVOLTAICS, V29, P3, DOI 10.1002/pip.3371; Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0; HOWARD CJ, 1991, ACTA CRYSTALLOGR B, V47, P462, DOI 10.1107/S010876819100335X; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jung EH, 2019, NATURE, V567, P511, DOI 10.1038/s41586-019-1036-3; Khenkin MV, 2020, NAT ENERGY, V5, P35, DOI 10.1038/s41560-019-0529-5; Kim M, 2019, JOULE, V3, P2179, DOI 10.1016/j.joule.2019.06.014; Lin YH, 2020, SCIENCE, V369, P96, DOI 10.1126/science.aba1628; Luo DY, 2018, SCIENCE, V360, P1442, DOI 10.1126/science.aap9282; MILOSEV I, 1995, SURF INTERFACE ANAL, V23, P529, DOI 10.1002/sia.740230713; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; Morikawa T, 2001, JPN J APPL PHYS 2, V40, pL561, DOI 10.1143/JJAP.40.L561; Napoli F, 2009, CHEM PHYS LETT, V477, P135, DOI 10.1016/j.cplett.2009.06.050; Naumkin A.V., 2000, NIST XRAY PHOTOELECT, DOI [10.18434/T4T88K, DOI 10.18434/T4T88K]; Peelaers H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.235201; Peng J, 2021, SCIENCE, V371, P390, DOI 10.1126/science.abb8687; Peng J, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201801208; Peng J, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201601768; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Shahiduzzaman M, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10091676; Shasti M, 2019, SOLID STATE SCI, V92, P68, DOI 10.1016/j.solidstatesciences.2019.03.024; Shi L, 2017, ACS APPL MATER INTER, V9, P25073, DOI 10.1021/acsami.7b07625; STADELMANN PA, 1987, ULTRAMICROSCOPY, V21, P131, DOI 10.1016/0304-3991(87)90080-5; WYCKOFF RWG, 1963, CRYSTAL STRUCTURES, V0001; Yang S, 2019, J AM CHEM SOC, V141, P5781, DOI 10.1021/jacs.8b13091; Yang XB, 2019, JOULE, V3, P1314, DOI 10.1016/j.joule.2019.03.008; Zhang L, 2016, J ENVIRON CHEM ENG, V4, P357, DOI 10.1016/j.jece.2015.11.027; Zhang ZL, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-016-1811-0; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Zhu HW, 2020, ADV MATER, V32, DOI 10.1002/adma.201907757	38	25	25	110	238	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					573	+		10.1038/s41586-021-04216-5	http://dx.doi.org/10.1038/s41586-021-04216-5			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082415	Green Submitted			2022-12-28	WOS:000749546400025
J	Waters, A				Waters, Adele			Covid-19: Long term plan on living with pandemic to come in spring, says Javid	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2733; Waters A, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o139	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o235	10.1136/bmj.o235	http://dx.doi.org/10.1136/bmj.o235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086809	Bronze			2022-12-28	WOS:000748641100012
J	Wright, LG; Onodera, T; Stein, MM; Wang, TY; Schachter, DT; Hu, Z; McMahon, PL				Wright, Logan G.; Onodera, Tatsuhiro; Stein, Martin M.; Wang, Tianyu; Schachter, Darren T.; Hu, Zoey; McMahon, Peter L.			Deep physical neural networks trained with backpropagation	NATURE			English	Article								Deep-learning models have become pervasive tools in science and engineering. However, their energy requirements now increasingly limit their scalability(1). Deep-learning accelerators(2-9) aim to perform deep learning energy-efficiently, usually targeting the inference phase and often by exploiting physical substrates beyond conventional electronics. Approaches so far(10-22) have been unable to apply the backpropagation algorithm to train unconventional novel hardware in situ. The advantages of backpropagation have made it the de facto training method for large-scale neural networks, so this deficiency constitutes a major impediment. Here we introduce a hybrid in situ-in silico algorithm, called physics-aware training, that applies backpropagation to train controllable physical systems. Just as deep learning realizes computations with deep neural networks made from layers of mathematical functions, our approach allows us to train deep physical neural networks made from layers of controllable physical systems, even when the physical layers lack any mathematical isomorphism to conventional artificial neural network layers. To demonstrate the universality of our approach, we train diverse physical neural networks based on optics, mechanics and electronics to experimentally perform audio and image classification tasks. Physics-aware training combines the scalability of backpropagation with the automatic mitigation of imperfections and noise achievable with in situ algorithms. Physical neural networks have the potential to perform machine learning faster and more energy-efficiently than conventional electronic processors and, more broadly, can endow physical systems with automatically designed physical functionalities, for example, for robotics(23-26), materials(27-29) and smart sensors(30-32).	[Wright, Logan G.; Onodera, Tatsuhiro; Stein, Martin M.; Wang, Tianyu; Hu, Zoey; McMahon, Peter L.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Wright, Logan G.; Onodera, Tatsuhiro] NTT Res Inc, NTT Phys & Informat Labs, Sunnyvale, CA 94085 USA; [Schachter, Darren T.] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY USA	Cornell University; Cornell University	Wright, LG; Onodera, T; McMahon, PL (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.; Wright, LG; Onodera, T (corresponding author), NTT Res Inc, NTT Phys & Informat Labs, Sunnyvale, CA 94085 USA.	lgw32@cornell.edu; to232@cornell.edu; pmcmahon@cornell.edu	Wright, Logan/ABA-8529-2020; Onodera, Tatsuhiro/AGD-4763-2022	Onodera, Tatsuhiro/0000-0002-6912-6504; Wang, Tianyu/0000-0002-6087-6376; McMahon, Peter/0000-0002-1177-9887; Wright, Logan/0000-0001-7696-1260	NTT Research; National Science Foundation [CCF-1918549]; Mong Fellowships from Cornell Neurotech	NTT Research; National Science Foundation(National Science Foundation (NSF)); Mong Fellowships from Cornell Neurotech	We thank NTT Research for their financial and technical support. Portions of this work were supported by the National Science Foundation (award CCF-1918549). L.G.W. and T.W. acknowledge support from Mong Fellowships from Cornell Neurotech during early parts of this work. P.L.M. acknowledges membership of the CIFAR Quantum Information Science Program as an Azrieli Global Scholar. We acknowledge discussions with D. Ahsanullah, M. Anderson, V. Kremenetski, E. Ng, S. Popoff, S. Prabhu, M. Saebo, H. Tanaka, R. Yanagimoto, H. Zhen and members of the NTT PHI Lab/NSF Expeditions research collaboration, and thank P. Jordan for discussions and illustrations.	Adhikari SP, 2012, IEEE T NEUR NET LEAR, V23, P1426, DOI 10.1109/TNNLS.2012.2204770; Akiba T, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2623, DOI 10.1145/3292500.3330701; Appeltant L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1476; Biewald Lukas, 2020, EXPT TRACKING WEIGHT; Bueno J, 2018, OPTICA, V5, P756, DOI 10.1364/OPTICA.5.000756; Burr GW, 2017, ADV PHYS-X, V2, P89, DOI 10.1080/23746149.2016.1259585; Chen T, 2020, NATURE, V577, P341, DOI 10.1038/s41586-019-1901-0; Cramer B, 2020, SURROGATE GRADIENTS; Degrave J, 2019, FRONT NEUROROBOTICS, V13, DOI 10.3389/fnbot.2019.00006; Dillavou S., 2021, DEMONSTRATION DECENT; Falcon William, 2019, PYTORCH LIGHTNING, V3, P7; FRYE RC, 1991, IEEE T NEURAL NETWOR, V2, P110, DOI 10.1109/72.80296; Furuhata G, 2021, PHYS REV APPL, V15, DOI 10.1103/PhysRevApplied.15.034092; Gokmen T, 2019, INT EL DEVICES MEET; Grollier J, 2020, NAT ELECTRON, V3, P360, DOI 10.1038/s41928-019-0360-9; Hermans M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7729; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hooker S., 2020, HARDWARE LOTTERY; Howison T, 2021, ARTIF LIFE, V26, P484, DOI 10.1162/artl_a_00330; Hughes TW, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay6946; Hughes TW, 2018, OPTICA, V5, P864, DOI 10.1364/OPTICA.5.000864; Kariyappa S, 2021, IEEE T ELECTRON DEV, V68, P4356, DOI 10.1109/TED.2021.3089987; Karniadakis GE, 2021, NAT REV PHYS, V3, P422, DOI 10.1038/s42254-021-00314-5; Kasim M.F., 2020, BUILDING HIGH ACCURA; Khaddam-Aljameh R., 2021, PROC S VLSI CIRCUITS, P1; Kohda Y, 2020, INT EL DEVICES MEET, DOI 10.1109/IEDM13553.2020.9371973; Krizhevsky A., P 25 INT C NEUR INF, P1097; Laborieux A, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.633674; Launay J., 2020, DIRECT FEEDBACK ALIG; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Lin HW, 2017, J STAT PHYS, V168, P1223, DOI 10.1007/s10955-017-1836-5; Lin X, 2018, SCIENCE, V361, P1004, DOI 10.1126/science.aat8084; Liu W, 2017, OPT LETT, V42, P1923, DOI 10.1364/OL.42.001923; Lopez-Pastor V., 2021, SELF LEARNING MACHIN; Markovic D, 2020, NAT REV PHYS, V2, P499, DOI 10.1038/s42254-020-0208-2; Martel JNP, 2020, IEEE T PATTERN ANAL, V42, P1642, DOI 10.1109/TPAMI.2020.2986944; Martin E, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102222; Matthes MEW, 2019, OPTICA, V6, P465, DOI 10.1364/OPTICA.6.000465; Mennel L, 2020, NATURE, V579, P62, DOI 10.1038/s41586-020-2038-x; Miller JF, 2014, EVOL INTELL, V7, P49, DOI 10.1007/s12065-014-0106-6; Mitarai K, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.032309; Molesky S, 2018, NAT PHOTONICS, V12, P659, DOI 10.1038/s41566-018-0246-9; Mouret JB, 2017, PROCEEDINGS OF THE 2017 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE COMPANION (GECCO'17 COMPANION), P1121, DOI 10.1145/3067695.3082052; Myopoulos Ray, 1991, INPROCEEDINGS, P569, DOI DOI 10.1007/BF01538672; Narayanan P., IEEE S VLSI TECHN; Paszke A, 2019, ADV NEUR IN, V32; PATTERSON D., 2021, CARBON EMISSIONS LAR; Peurifoy J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4206; Poggio T, 2020, P NATL ACAD SCI USA, V117, P30039, DOI 10.1073/pnas.1907369117; Popoff S. M., 2020, Zenodo, DOI 10.5281/zenodo.4076193; Prezioso M, 2015, NATURE, V521, P61, DOI 10.1038/nature14441; Rahmani B, 2020, NAT MACH INTELL, V2, P403, DOI 10.1038/s42256-020-0199-9; Rasch MJ, 2021, 2021 IEEE 3RD INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE CIRCUITS AND SYSTEMS (AICAS), DOI 10.1109/AICAS51828.2021.9458494; Reuther A, 2020, IEEE HIGH PERF EXTR; Romera M, 2018, NATURE, V563, P230, DOI 10.1038/s41586-018-0632-y; Euler HCR, 2020, NAT NANOTECHNOL, V15, P992, DOI 10.1038/s41565-020-00779-y; Scellier B., 2020, EQUILIBRIUM PROPAGAT; Scellier B, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00024; Shen YC, 2017, NAT PHOTONICS, V11, P441, DOI [10.1038/NPHOTON.2017.93, 10.1038/nphoton.2017.93]; Spoon K, 2021, FRONT COMPUT NEUROSC, V15, DOI 10.3389/fncom.2021.675741; Stern M, 2020, P NATL ACAD SCI USA, V117, P14843, DOI 10.1073/pnas.2000807117; Tanaka G, 2019, NEURAL NETWORKS, V115, P100, DOI 10.1016/j.neunet.2019.03.005; Veit A., 2016, ADV NEURAL INFORM PR, P550; Wetzstein G, 2021, NATURE, V588, P39, DOI 10.1038/s41586-020-2973-6; Wu ZC, 2020, PHOTONICS RES, V8, P46, DOI 10.1364/PRJ.8.000046; Xia QF, 2019, NAT MATER, V18, P309, DOI 10.1038/s41563-019-0291-x; Xiao H., 2017, ARXIV170807747; Zhou FC, 2020, NAT ELECTRON, V3, P664, DOI 10.1038/s41928-020-00501-9	71	27	27	88	185	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					549	+		10.1038/s41586-021-04223-6	http://dx.doi.org/10.1038/s41586-021-04223-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082422	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000749546400022
J	Eseonu, KC; Oduoza, U; Lucas, JD				Eseonu, Kelechi C.; Oduoza, Uche; Lucas, J. D.			Teenage girl with asymmetrical shoulder height	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENT IDIOPATHIC SCOLIOSIS; CURVE PROGRESSION		[Eseonu, Kelechi C.] Guys & St Thomas NHS Trust, London, England; [Oduoza, Uche] Royal Natl Orthopaed Hosp Rotat, Trauma & Orthopaed, Stanmore, Middx, England; [Lucas, J. D.] Guys & St Thomas NHS Trust, Evelina Childrens Hosp, Paediat Spinal Surg, London, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Eseonu, KC (corresponding author), Guys & St Thomas NHS Trust, London, England.	Kelechi.eseonu@doctors.org.uk						Altaf F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2508; Clark EM, 2016, SPINE, V41, pE611, DOI 10.1097/BRS.0000000000001330; Horne JP, 2014, AM FAM PHYSICIAN, V89, P193; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Negrini S, 2018, SCOLIOSIS SPINAL DIS, V13, DOI 10.1186/s13013-017-0145-8; PEHRSSON K, 1992, SPINE, V17, P1091, DOI 10.1097/00007632-199209000-00014; Ramirez N, 1997, J BONE JOINT SURG AM, V79A, P364, DOI 10.2106/00004623-199703000-00007; *TERM COMM SCOL RE, 1976, SPINE, V1, P57; Wan L., 2005, ZHONGGUO LINCHUANG K, V9, P82; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; Weinstein SL, 2019, J PEDIATR ORTHOPED, V39, pS44, DOI 10.1097/BPO.0000000000001350	13	0	0	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								e067392	10.1136/bmj-2019-067392	http://dx.doi.org/10.1136/bmj-2019-067392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082123				2022-12-28	WOS:000748440900006
J	Dyer, C				Dyer, Clare			BMA representative wins legal dispute over attempts to silence him about conditions in armed forces	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o207	10.1136/bmj.o207	http://dx.doi.org/10.1136/bmj.o207			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078825				2022-12-28	WOS:000759189200001
J	Labonte, R				Labonte, Ronald			A post-covid economy for health: from the great reset to build back differently	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Labonte, Ronald] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	University of Ottawa	Labonte, R (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					Akenji L., 2021, 15 DEGREE LIFESTYLES; Alam R, 2021, THERE IS WAY INVEST; Baumann-Pauly D, 2020, WHY COBALT MINING DR; Bosio E, 2020, LARGE IS PUBLIC PROC; Cairns S., 2020, INNOVATION CIRCULAR; Castelvecchi D, 2021, NATURE, V596, P336, DOI 10.1038/d41586-021-02222-1; Castronuovo C., 2021, HILL; Civicus, 2021, STAT CIV SOC 2021; D'Souza D, 2021, GREEN NEW DEAL EXPLA; Farrington D., 2021, NPR; Greer SL, 2021, CORONAVIRUS POLITICS, P615, DOI 10.3998/mpub.11927713; Harvey D., 2005, BRIEF HIST NEOLIBERA; Harvey F, 2020, GUARDIAN 1109; Hassan F, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2027; Hickel J., 2019, REAL WORLD EC REV, V87, P54; Hickel J, 2021, GLOBALIZATIONS, V18, P1105, DOI 10.1080/14747731.2020.1812222; InfluenceMap, 2021, CLIMATE FUNDS ARE TH; Labonte R, 2022, PMAC 0124; Labonte R., GLOBAL HLTH WATCH 6; Manahan M, 2021, GREAT TAK MULT SECT; Marmot M., 2020, PANDEMIC SOCIOECONOM; Matthews D, 2019, VOX 0416; Mazzucato M, 2019, MISSION EC MOONSHOT; MEADOWS D H, 1972, P205; Mitchell W.F., 2019, MACROECONOMICS; Raworth K., 2017, DOUGHNUT EC 7 WAYS T; Rogoff K, 2021, BACK SEVENTIES; Schwab K., 2019, WORLD EC FORUM, V2; Sekulova F, 2013, J CLEAN PROD, V38, P1, DOI 10.1016/j.jclepro.2012.06.022; Soderstrom J., 2021, EUROPES GREEN MOMENT; The WHO Council on the Economics of Health for All, 2021, GOV HLTH INN COMM GO; Wilkinson R., 2010, SPIRIT LEVEL NEW EDI	32	2	2	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								e068126	10.1136/bmj-2021-068126	http://dx.doi.org/10.1136/bmj-2021-068126			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078773	Green Published, hybrid			2022-12-28	WOS:000759189200006
J	Lett, E				Lett, Elle			Science as a tool for justice	CELL			English	Editorial Material								Elle Lett is the winner of the 2021 Rising Black Scientists Award for a post-graduate scholar. For this award, we asked emerging Black scientists to tell us about the experiences that sparked their interest in the life sciences, their vision and goals, and how they want to contribute to a more inclusive scientific community. This is her story.	[Lett, Elle] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Lett, E (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	ellel@upenn.edu	Lett, Elle/AAQ-2459-2021	Lett, Elle/0000-0002-6590-7821				Draney C, 2018, BIOCHEM J, V475, P3997, DOI 10.1042/BCJ20180465; Lett E, 2021, TRANSGENDER HEALTH, V6, P275, DOI 10.1089/trgh.2020.0095; Lett E, 2021, J EPIDEMIOL COMMUN H, V75, P394, DOI 10.1136/jech-2020-215097; Lett E, 2020, AM J PREV MED, V59, P639, DOI 10.1016/j.amepre.2020.04.013; Lett E, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10490; Lett LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207274	6	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					224	226		10.1016/j.cell.2021.12.020	http://dx.doi.org/10.1016/j.cell.2021.12.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35063068	Bronze			2022-12-28	WOS:000746172100002
J	Risom, T; Glass, DR; Averbukh, I; Liu, CC; Baranski, A; Kagel, A; McCaffrey, EF; Greenwald, NF; Rivero-Gutierrez, B; Strand, SH; Varma, S; Kong, A; Keren, L; Srivastava, S; Zhu, CF; Khair, Z; Veis, DJ; Deschryver, K; Vennam, S; Maley, C; Hwang, ES; Marks, JR; Bendall, SC; Colditz, GA; West, RB; Angelo, M				Risom, Tyler; Glass, David R.; Averbukh, Inna; Liu, Candace C.; Baranski, Alex; Kagel, Adam; McCaffrey, Erin F.; Greenwald, Noah F.; Rivero-Gutierrez, Belen; Strand, Siri H.; Varma, Sushama; Kong, Alex; Keren, Leeat; Srivastava, Sucheta; Zhu, Chunfang; Khair, Zumana; Veis, Deborah J.; Deschryver, Katherine; Vennam, Sujay; Maley, Carlo; Hwang, E. Shelley; Marks, Jeffrey R.; Bendall, Sean C.; Colditz, Graham A.; West, Robert B.; Angelo, Michael			Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma	CELL			English	Article							CARCINOMA IN-SITU; TERM FOLLOW-UP; IMMUNE MICROENVIRONMENT; INTRADUCTAL CARCINOMA; MACROPHAGES; EXPRESSION; INFILTRATION; FIBROBLASTS; METASTASIS; COLLAGEN	Ductal carcinoma in situ (DCIS) is a pre-invasive lesion that is thought to be a precursor to invasive breast cancer (IBC). To understand the changes in the tumor microenvironment (TME) accompanying transition to IBC, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) and a 37-plex antibody staining panel to interrogate 79 clinically annotated surgical resections using machine learning tools for cell segmentation, pixel-based clustering, and object morphometrics. Comparison of normal breast with patient matched DCIS and IBC revealed coordinated transitions between four TME states that were delineated based on the location and function of myoepithelium, fibroblasts, and immune cells. Surprisingly, myoepithelial disruption was more advanced in DCIS patients that did not develop IBC, suggesting this process could be protective against recurrence. Taken together, this HTAN Breast PreCancer Atlas study offers insight into drivers of IBC relapse and emphasizes the importance of the TME in regulating these processes.	[Risom, Tyler; Glass, David R.; Averbukh, Inna; Liu, Candace C.; Baranski, Alex; Kagel, Adam; McCaffrey, Erin F.; Greenwald, Noah F.; Rivero-Gutierrez, Belen; Strand, Siri H.; Varma, Sushama; Kong, Alex; Keren, Leeat; Srivastava, Sucheta; Zhu, Chunfang; Khair, Zumana; Vennam, Sujay; Bendall, Sean C.; West, Robert B.; Angelo, Michael] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Risom, Tyler] Genentech Inc, Dept Res Pathol, San Francisco, CA USA; [Deschryver, Katherine; Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Hwang, E. Shelley; Marks, Jeffrey R.] Duke Univ, Dept Surg, Durham, NC USA; [Maley, Carlo] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Veis, Deborah J.; Angelo, Michael] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Veis, Deborah J.; Angelo, Michael] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA	Stanford University; Roche Holding; Genentech; Washington University (WUSTL); Duke University; Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); Washington University (WUSTL)	West, RB; Angelo, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Angelo, M (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.; Angelo, M (corresponding author), Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA.	rbwest@stanford.edu; mangelo0@stanford.edu	Colditz, Graham/A-3963-2009; Greenwald, Noah/GNH-3982-2022; Rivero-Gutiérrez, Belen/K-8784-2019; Bendall, Sean/AGG-0126-2022	Colditz, Graham/0000-0002-7307-0291; Greenwald, Noah/0000-0002-7836-4379; Rivero-Gutiérrez, Belen/0000-0002-1263-0873; Strand, Siri/0000-0001-6596-9945; Bendall, Sean/0000-0003-1341-2453; Angelo, Michael/0000-0003-1531-5067; Glass, David/0000-0001-9924-167X; Khair, Zumana/0000-0003-3617-2472; McCaffrey, Erin/0000-0001-7241-1798	American Cancer Society Postdoctoral Fellowship [133099-PF-19-002-01-CCE]; Stanford Immunology Training Grant [5 T32 AI07290-33]; Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Graduate Fellowship; NIH [RFA-CA-17-035]; PCORI [1505-30497]; BCRF [BCRF 19-074]; DOD [BC132057, R01 CA185138-01]; Bill and Melinda Gates Foundation; Stanford Cancer Institute;  [R01CA193694];  [U2C CA233254];  [1-DP5-OD019822];  [1R01AG056287];  [1R01AG057915];  [1U24CA224309]	American Cancer Society Postdoctoral Fellowship(American Cancer Society); Stanford Immunology Training Grant; Bio-X Stanford Interdisciplinary Graduate Fellowship; Stanford Graduate Fellowship(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCORI(Patient-Centered Outcomes Research Institute - PCORI); BCRF; DOD(United States Department of Defense); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Stanford Cancer Institute; ; ; ; ; ; 	This publication is part of the HTAN (Human Tumor Atlas Network) Consortium paper package. A list of HTAN members is available at humantumoratlas.org/htan-authors/. The authors thank the HTAN Consortium for intellectual and collaborative support of this work. We thank Pauline Chu and the Stanford Hu-man Histology Core for providing technical assistance. T.R. was supported by American Cancer Society Postdoctoral Fellowship 133099-PF-19-002-01-CCE and Stanford Immunology Training Grant 5 T32 AI07290-33. D.R.G. was supported by the Bio-X Stanford Interdisciplinary Graduate Fellowship. C.C.L. was supported by the Stanford Graduate Fellowship. E.S.H. is funded by RFA-CA-17-035 (NIH) , 1505-30497 (PCORI) , and BCRF 19-074 (BCRF) ; E.S.H. and C.M. are funded by DOD BC132057 and R01 CA185138-01. R.B.W. was supported by R01CA193694 and U2C CA233254. M.A. was sup-ported by 1-DP5-OD019822. S.C.B. and M.A. were jointly supported by 1R01AG056287, 1R01AG057915, 1U24CA224309, the Bill and Melinda Gates Foundation, and a Translational Research Award from the Stanford Cancer Institute. Graphical abstract was created with Biorender.com .	Afghahi A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0623-y; Aguiar Fernando N, 2015, Breast Dis, V35, P249, DOI 10.3233/BD-150416; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aponte-Lopez A, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2584243; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Barth PJ, 2005, VIRCHOWS ARCH, V446, P532, DOI 10.1007/s00428-005-1256-9; Bartova M, 2014, BRATISL MED J, V115, P445, DOI 10.4149/BLL_2014_088; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; Casasent AK, 2018, CELL, V172, P205, DOI 10.1016/j.cell.2017.12.007; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Del Alcazar CRG, 2017, CANCER DISCOV, V7, P1098, DOI 10.1158/2159-8290.CD-17-0222; Ding LN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12125-5; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Esbona K, 2018, AM J PATHOL, V188, P559, DOI 10.1016/j.ajpath.2017.10.025; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Foley JW, 2019, GENOME RES, V29, P1816, DOI 10.1101/gr.234807.118; Friedman G., 2020, CANC ASS FIBROBLAST, DOI [10.1101/2020.01.12.903039, DOI 10.1101/2020.01.12.903039]; Fujii H, 1996, CANCER RES, V56, P5260; Greenwald N.F., WHOLE CELL SEGMENTAT, DOI [10.1101/2021.03.01.431313, DOI 10.1101/2021.03.01.431313]; Ibrahim AM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.569985; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Keren L, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5851; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kim SY, 2015, ONCOTARGET, V6, P7597, DOI 10.18632/oncotarget.3162; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; McCaffrey E.F., 2020, MULTIPLEXED IMAGING, DOI [10.1101/2020.06.08.140426, DOI 10.1101/2020.06.08.140426]; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Pelon F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14134-w; Perez AA, 2015, J HISTOCHEM CYTOCHEM, V63, P408, DOI 10.1369/0022155415576540; Rakovitch E, 2012, BRIT J CANCER, V106, P1160, DOI 10.1038/bjc.2012.41; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shani O, 2020, CANCER RES, V80, P5317, DOI 10.1158/0008-5472.CAN-20-2116; Sirka OK, 2018, J CELL BIOL, V217, P3368, DOI 10.1083/jcb.201802144; Sprague BL, 2021, CANCER EPIDEM BIOMAR, V30, P80, DOI 10.1158/1055-9965.EPI-20-0889; Strand S.H., 2021, DCIS GENOMIC SIGNATU, DOI [10.1101/2021.06.16.448585, DOI 10.1101/2021.06.16.448585]; Tsai ABG, 2020, NAT MED, V26, P408, DOI 10.1038/s41591-020-0783-x; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Yang M, 2018, J CANCER, V9, P2308, DOI 10.7150/jca.25155; Zhou J, 2018, J CANCER, V9, P4635, DOI 10.7150/jca.28583	48	31	31	21	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					299	+		10.1016/j.cell.2021.12.023	http://dx.doi.org/10.1016/j.cell.2021.12.023			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8PF	35063072	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000746148700001
J	Zhang, Q; Bastard, P; Cobat, A; Casanova, JL				Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent		COVID Human Genetic Effort	Human genetic and immunological determinants of critical COVID-19 pneumonia	NATURE			English	Review							PLASMACYTOID DENDRITIC CELLS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; MYASTHENIA-GRAVIS PATIENTS; SINGLE-STRANDED RNA; SARS-COV-2 INFECTION; PROTECTIVE IMMUNITY; DISTINCT FUNCTIONS; INTERFERON; AUTOANTIBODIES; ANTIBODIES	SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases. The ensuing risk of death (approximately 1% across age and gender) doubles every five years from childhood onwards and is around 1.5 times greater in men than in women. Here we review the molecular and cellular determinants of critical COVID-19 pneumonia. Inborn errors of type I interferons (IFNs), including autosomal TLR3 and X-chromosome-linked TLR7 deficiencies, are found in around 1-5% of patients with critical pneumonia under 60 years old, and a lower proportion in older patients. Pre-existing auto-antibodies neutralizing IFN alpha, IFN beta and/or IFN omega, which are more common in men than in women, are found in approximately 15-20% of patients with critical pneumonia over 70 years old, and a lower proportion in younger patients. Thus, at least 15% of cases of critical COVID-19 pneumonia can be explained. The TLR3- and TLR7-dependent production of type I IFNs by respiratory epithelial cells and plasmacytoid dendritic cells, respectively, is essential for host defence against SARS-CoV-2. In ways that can depend on age and sex, insufficient type I IFN immunity in the respiratory tract during the first few days of infection may account for the spread of the virus, leading to pulmonary and systemic inflammation.	[Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Necker Hosp Sick Children, INSERM, Lab Human Genet Infect Dis, Necker Branch,U1163, Paris, France; [Zhang, Qian; Bastard, Paul; Cobat, Aurelie; Casanova, Jean-Laurent] Univ Paris, Imagine Inst, Paris, France; [Bastard, Paul; Casanova, Jean-Laurent] Necker Hosp Sick Children, Dept Pediat, Paris, France; [Casanova, Jean-Laurent] Howard Hughes Med Inst, Paris, France	Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhang, Q; Casanova, JL (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.; Zhang, Q; Casanova, JL (corresponding author), Necker Hosp Sick Children, INSERM, Lab Human Genet Infect Dis, Necker Branch,U1163, Paris, France.; Zhang, Q; Casanova, JL (corresponding author), Univ Paris, Imagine Inst, Paris, France.; Casanova, JL (corresponding author), Necker Hosp Sick Children, Dept Pediat, Paris, France.; Casanova, JL (corresponding author), Howard Hughes Med Inst, Paris, France.	qzhang02@rockefeller.edu; casanova@rockefeller.edu	Liu, Zhiyong/CAF-2366-2022; Béziat, Vivien/AAT-4097-2021; Cobat, Aurélie/H-4722-2017; şenoğlu, sevtap/AEM-3761-2022; Okada, Satoshi/B-8901-2011; Yahşi, Aysun/CED-6079-2022; Emiroğlu, Melike/AAH-3566-2019; Boyarchuk, Oksana/GSD-2473-2022; Morange, Pierre/T-9070-2019; RODRIGUEZ-GALLEGO, CARLOS/AAB-7516-2022; Pujol, Aurora/N-4990-2014; Akçay, Nihal/ACQ-1470-2022; Haerynck, Filomeen/AAD-6761-2020; Bondarenko, Anastasiia/AAL-5037-2020; Tancevski, Ivan/AID-5169-2022; Levy, Romain/AAM-6426-2020; Puel, Anne/H-7305-2017; Lau, Yu Lung/C-4322-2009	Liu, Zhiyong/0000-0001-6473-348X; Béziat, Vivien/0000-0002-4020-824X; Cobat, Aurélie/0000-0001-7209-6257; Okada, Satoshi/0000-0002-4622-5657; Yahşi, Aysun/0000-0002-7245-2028; Boyarchuk, Oksana/0000-0002-1234-0040; Morange, Pierre/0000-0002-9065-722X; Pujol, Aurora/0000-0002-9606-0600; Akçay, Nihal/0000-0002-8273-2226; Bondarenko, Anastasiia/0000-0002-9737-2868; Tancevski, Ivan/0000-0001-5116-8960; Levy, Romain/0000-0002-6393-0198; Turvey, Stuart/0000-0003-1599-1065; Uddin, K M Furkan/0000-0001-7322-1988; Marr, Nico/0000-0002-1927-7072; van de Beek, Diederik/0000-0002-4571-044X; ARANGO FRANCO, CARLOS ANDRES/0000-0002-7404-0860; Puel, Anne/0000-0003-2603-0323; Rodriguez-Gallego, Carlos/0000-0002-4344-8644; Lau, Yu Lung/0000-0002-4780-0289; alkan, gulsum/0000-0003-3384-769X; Biggs, Catherine/0000-0002-4363-2660; Haerynck, Filomeen/0000-0001-9161-7361; Emiroglu, Melike/0000-0003-1307-0246; Imberti, Luisa/0000-0002-2075-8391; Zhang, Qian/0000-0002-9040-3289; Ogishi, Masato/0000-0003-2421-7389	Howard Hughes Medical Institute; Rockefeller University; St Giles Foundation; National Institutes of Health (NIH) [R01AI088364, R01AI163029]; National Center for Advancing Translational Sciences (NCATS); NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]; Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]; Yale High Performance Computing Center [S10OD018521]; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; JPB Foundation; French National Research Agency (ANR) under the 'Investments for the Future' program [ANR-10-IAHU-01]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR-10-LABX-62-IBEID]; French Foundation for Medical Research (FRM) [EQU201903007798]; FRM and ANR GENCOVID project [ANR-20-COVI-0003]; ANRS Nord-Sud [ANRS-COV05]; ANR grant GENVIR [ANR-20-CE93-003]; ANR AABIFNCOV [ANR-20-CO11-0001]; ANR MIS-C [ANR 21-COVR-0039]; European Union [824110]; Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science, Fondation du Souffle; French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19); Institut National de la Sante et de la Recherche Medicale (INSERM); REACTing-INSERM; University of Paris; FRM [EA20170638020]; MD-PhD programme of the Imagine Institute; Fondation Bettencourt Schueller; Regione Lazio (Research Group Projects) [A0375-2020-36663]; GecoBiomark; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; St Giles Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emergent Ventures; Mercatus Center at George Mason University; Yale Center for Mendelian Genomics; GSP Coordinating Center - National Human Genome Research Institute (NHGRI); Yale High Performance Computing Center; Fisher Center for Alzheimer's Research Foundation; Meyer Foundation; JPB Foundation; French National Research Agency (ANR) under the 'Investments for the Future' program(French National Research Agency (ANR)); Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; French Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); FRM and ANR GENCOVID project; ANRS Nord-Sud(ANRS); ANR grant GENVIR(French National Research Agency (ANR)); ANR AABIFNCOV(French National Research Agency (ANR)); ANR MIS-C(French National Research Agency (ANR)); European Union(European Commission); Square Foundation; Grandir-Fonds de solidarite pour l'enfance; SCOR Corporate Foundation for Science, Fondation du Souffle; French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); REACTing-INSERM; University of Paris; FRM(Fondation pour la Recherche Medicale); MD-PhD programme of the Imagine Institute; Fondation Bettencourt Schueller; Regione Lazio (Research Group Projects); GecoBiomark; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Laboratory of Human Genetics of Infectious Diseases is supported by the Howard Hughes Medical Institute, the Rockefeller University, the St Giles Foundation, the National Institutes of Health (NIH) (R01AI088364 and R01AI163029), the National Center for Advancing Translational Sciences (NCATS), the NIH Clinical and Translational Science Award (CTSA) program (UL1 TR001866), a Fast Grant from Emergent Ventures, the Mercatus Center at George Mason University, the Yale Center for Mendelian Genomics and the GSP Coordinating Center funded by the National Human Genome Research Institute (NHGRI) (UM1HG006504 and U24HG008956), the Yale High Performance Computing Center (S10OD018521), the Fisher Center for Alzheimer's Research Foundation, the Meyer Foundation, the JPB Foundation, the French National Research Agency (ANR) under the `Investments for the Future' program (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the French Foundation for Medical Research (FRM) (EQU201903007798), the FRM and ANR GENCOVID project (ANR-20-COVI-0003), ANRS Nord-Sud (ANRS-COV05), ANR grant GENVIR (ANR-20-CE93-003), ANR AABIFNCOV (ANR-20-CO11-0001) and ANR MIS-C (ANR 21-COVR-0039, GenMIS-C) projects, the European Union's Horizon 2020 research and innovation program under grant agreement no. 824110 (EASI-Genomics), the Square Foundation, Grandir-Fonds de solidarite pour l'enfance, the SCOR Corporate Foundation for Science, Fondation du Souffle, The French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19), Institut National de la Sante et de la Recherche Medicale (INSERM), REACTing-INSERM, and the University of Paris. P.B. was supported by the FRM (EA20170638020) and the MD-PhD programme of the Imagine Institute (with the support of the Fondation Bettencourt Schueller). G.N. is supported by Regione Lazio (Research Group Projects 2020) no. A0375-2020-36663, GecoBiomark. H.C.S. and L.D.N. are supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Abers MS, 2021, IMMUNOL CELL BIOL, V99, P917, DOI 10.1111/imcb.12495; Abolhassani H, 2022, J CLIN IMMUNOL, V42, P471, DOI 10.1007/s10875-022-01215-7; Abolhassani H, 2022, J CLIN IMMUNOL, V42, P1, DOI 10.1007/s10875-021-01151-y; Abraham RS, 2021, J ALLERGY CLIN IMMUN, V147, P532, DOI 10.1016/j.jaci.2020.09.020; Acosta-Ampudia Y, 2021, J AUTOIMMUN, V118, DOI 10.1016/j.jaut.2021.102598; Ambrosioni J, 2021, LANCET HIV, V8, pe294, DOI 10.1016/S2352-3018(21)00070-9; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Andreakos E, 2022, NAT IMMUNOL, V23, P159, DOI 10.1038/s41590-021-01030-z; Arkin LM, 2021, J INVEST DERMATOL, V141, P2791, DOI 10.1016/j.jid.2021.05.024; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Aydiner EK, 2022, ALLERGY, V77, P282, DOI 10.1111/all.15025; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bartleson Juliet M, 2021, Nat Aging, V1, P769, DOI 10.1038/s43587-021-00114-7; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2021, J CLIN IMMUNOL, V41, P931, DOI 10.1007/s10875-021-01023-5; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20202486; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Beccuti G, 2020, J ENDOCRINOL INVEST, V43, P1175, DOI 10.1007/s40618-020-01323-4; Bello-Rivero I, 2004, J AUTOIMMUN, V23, P63, DOI 10.1016/j.jaut.2004.03.013; Bennett TD, 2021, JAMA NETW OPEN, V4, DOI [10.1001/jamanetworkopen.2021.16901, 10.1001/jamanetworkopen.2021.16915]; Bessiere P, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009427; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Brodin P, 2021, NAT MED, V27, P28, DOI 10.1038/s41591-020-01202-8; Carapito R, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abj7521; Carvalho T, 2021, NAT REV IMMUNOL, V21, P245, DOI 10.1038/s41577-021-00522-1; Casanova JL, 2021, SCIENCE, V374, P1080, DOI 10.1126/science.abj7965; Casanova JL, 2020, CELL, V181, P1194, DOI 10.1016/j.cell.2020.05.016; Casanova JL, 2020, HUM GENET, V139, P681, DOI 10.1007/s00439-020-02184-w; Casanova JL, 2021, ANNU REV PATHOL-MECH, V16, P23, DOI 10.1146/annurev-pathol-031920-101429; Castano-Jaramillo LM, 2021, J CLIN IMMUNOL, V41, P1463, DOI 10.1007/s10875-021-01077-5; Chang SE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25509-3; Chauvineau-Grenier Angelique, 2021, Res Sq, DOI 10.21203/rs.3.rs-915062/v1; Cheng MH, 2010, NEW ENGL J MED, V362, P764, DOI 10.1056/NEJMc0909510; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Colona VL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI155011; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Corey L, 2021, NEW ENGL J MED, V385, P562, DOI 10.1056/NEJMsb2104756; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; de Prost N, 2021, J CLIN IMMUNOL, V41, P536, DOI 10.1007/s10875-021-00994-9; Delavari S, 2021, J CLIN IMMUNOL, V41, P345, DOI 10.1007/s10875-020-00928-x; Deya-Martinez A, 2021, CLIN IMMUNOL, V230, DOI 10.1016/j.clim.2021.108821; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Drabe CH, 2021, INFECT DIS-NOR, V53, P953, DOI 10.1080/23744235.2021.1957144; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Eriksson D, 2019, J ALLERGY CLIN IMMUN, V144, P327, DOI 10.1016/j.jaci.2019.02.031; Esenboga S, 2021, J CLIN IMMUNOL, V41, P1515, DOI 10.1007/s10875-021-01065-9; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Gao DX, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134529; Giardino G, 2021, J ALLER CL IMM-PRACT, V9, P3237, DOI 10.1016/j.jaip.2021.06.045; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Goncalves D, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1327; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Goudouris ES, 2021, J CLIN IMMUNOL, V41, P1479, DOI 10.1007/s10875-021-01066-8; Gupta S, 2016, ARTHRITIS RHEUMATOL, V68, P1677, DOI 10.1002/art.39607; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMc2107808, 10.1056/NEJMoa2105000]; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hariharan SV, 2022, INDIAN J PEDIATR, V89, P94, DOI 10.1007/s12098-021-03935-x; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hatton CF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27318-0; Hayn M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109126; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hernandez N, 2019, J EXP MED, V216, P2057, DOI 10.1084/jem.20182295; Hernandez N, 2018, J EXP MED, V215, P2567, DOI 10.1084/jem.20180628; Hetemaki I, 2021, CLIN IMMUNOL, V231, DOI 10.1016/j.clim.2021.108851; Ho HE, 2021, J ALLER CL IMM-PRACT, V9, DOI 10.1016/j.jaip.2020.09.052; Hoagland DA, 2021, IMMUNITY, V54, P557, DOI 10.1016/j.immuni.2021.01.017; Hoffmann HH, 2021, CELL, V184, P133, DOI 10.1016/j.cell.2020.12.005; Hoffmann HH, 2021, CELL HOST MICROBE, V29, P267, DOI 10.1016/j.chom.2020.12.009; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huang LX, 2021, LANCET, V398, P747, DOI 10.1016/S0140-6736(21)01755-4; Israelow B, 2020, J EXP MED, V217, DOI [10.1101/2020.05.27.118893, 10.1084/jem.20201241]; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Katsura H, 2020, CELL STEM CELL, V27, P890, DOI 10.1016/j.stem.2020.10.005; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Kerner G, 2021, CURR OPIN IMMUNOL, V72, P148, DOI 10.1016/j.coi.2021.04.006; Kerner G, 2021, AM J HUM GENET, V108, P517, DOI 10.1016/j.ajhg.2021.02.009; Kerner G, 2019, P NATL ACAD SCI USA, V116, P10430, DOI 10.1073/pnas.1903561116; Khanmohammadi S, 2022, J CLIN IMMUNOL, V42, P19, DOI 10.1007/s10875-021-01166-5; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Koning R, 2021, INTENS CARE MED, V47, P704, DOI 10.1007/s00134-021-06392-4; Konno Y, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108185; Kosmicki JA, 2021, AM J HUM GENET, V108, P1350, DOI [10.1016/j.ajhg.2021.05.017, 10.1016/j.ajhg.2021.017]; Krause PR, 2021, NEW ENGL J MED, V385, P179, DOI 10.1056/NEJMsr2105280; Ku CL, 2020, HUM GENET, V139, P783, DOI 10.1007/s00439-020-02180-0; Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Lemarquis A, 2021, J ALLERGY CLIN IMMUN, V148, P96, DOI 10.1016/j.jaci.2021.03.034; Levin M, 2006, PLOS MED, V3, P972, DOI 10.1371/journal.pmed.0030292; Levy R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2114390118; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; Lin JW, 2021, CELL HOST MICROBE, V29, P489, DOI 10.1016/j.chom.2021.01.015; Liu C, 2021, CELL, V184, P1836, DOI 10.1016/j.cell.2021.02.018; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lokugamage KG, 2020, J VIROL, V94, DOI 10.1128/JVI.01410-20; Lopez J, 2021, J EXP MED, V218, DOI 10.1084/jem.20211211; Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9; Lowery SA, 2021, CELL HOST MICROBE, V29, P1052, DOI 10.1016/j.chom.2021.05.004; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marcus N, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.614086; Mariano G, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.605236; Marks ZRC, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.101328; Martin-Sancho L, 2021, MOL CELL, V81, P2656, DOI 10.1016/j.molcel.2021.04.008; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Meisel C, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI150867; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Meyts I, 2021, EUR J IMMUNOL, V51, P1039, DOI 10.1002/eji.202048793; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Milito C, 2021, J ALLER CL IMM-PRACT, V9, P2904, DOI 10.1016/j.jaip.2021.04.017; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Mohanty MC, 2021, J CLIN IMMUNOL, V41, P1748, DOI 10.1007/s10875-021-01132-1; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Nakanishi T, 2021, J CLIN INVEST, V131, DOI [10.1172/JCI152386, 10.1101/2021.03.07.21252875]; Navaratnam AV, 2021, LANCET RESP MED, V9, P397, DOI 10.1016/S2213-2600(20)30579-8; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Onodi F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201387; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Palermo E, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090829; PANEM S, 1982, J IMMUNOL, V129, P1; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Pegu A, 2021, SCIENCE, V373, P1372, DOI 10.1126/science.abj4176; Peixoto VR, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.33.2001059; Pessoa NL, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01656-3; Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]; Pierce CA, 2021, JCI INSIGHT, V6, DOI [10.1172/jci.insight.148694, 10.1101/2021.02.12.21251310]; Pierce CA, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd5487; Povysil G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147834; POZZETTO B, 1984, J INFECT DIS, V150, P707, DOI 10.1093/infdis/150.5.707; Puel A, 2008, J IMMUNOL, V180, P647, DOI 10.4049/jimmunol.180.1.647; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Raadsen MP, 2022, J CLIN IMMUNOL, V42, P232, DOI 10.1007/s10875-021-01168-3; Reizis B, 2019, IMMUNITY, V50, P37, DOI 10.1016/j.immuni.2018.12.027; Romi F, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/474512; Rosenberg JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00544; Sah P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109229118; Sancho-Shimizu V, 2021, J EXP MED, V218, DOI 10.1084/jem.20210446; Schmidt A, 2021, NPJ GENOM MED, V6, DOI 10.1038/s41525-021-00220-w; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Schultze JL, 2021, CELL, V184, P1671, DOI 10.1016/j.cell.2021.02.029; Sen P, 2021, NATURE, V598, P338, DOI 10.1038/s41586-021-03914-4; Sette A, 2021, CELL, V184, P861, DOI 10.1016/j.cell.2021.01.007; Severa M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009878; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw ER, 2022, CLIN INFECT DIS, V75, pE1192, DOI 10.1093/cid/ciab1002; Shields AM, 2021, J ALLERGY CLIN IMMUN, V147, P870, DOI 10.1016/j.jaci.2020.12.620; Shiono H, 2003, INT IMMUNOL, V15, P903, DOI 10.1093/intimm/dxg088; Solanich X, 2021, J CLIN IMMUNOL, V41, P1733, DOI 10.1007/s10875-021-01136-x; Solanich X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.719115; Sposito B, 2021, CELL, V184, P4953, DOI 10.1016/j.cell.2021.08.016; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stertz S, 2021, TRENDS MICROBIOL, V29, P973, DOI 10.1016/j.tim.2021.03.001; Sui LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.662989; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3; Telenti A, 2021, NATURE, V596, P495, DOI 10.1038/s41586-021-03792-w; Trouillet-Assant S, 2020, J ALLERGY CLIN IMMUN, V146, P206, DOI 10.1016/j.jaci.2020.04.029; Troya J, 2021, J CLIN IMMUNOL, V41, P914, DOI 10.1007/s10875-021-01036-0; VALLBRACHT A, 1981, NATURE, V289, P496, DOI 10.1038/289496a0; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; van der Wijst MGP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh2624; van Splunter M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225825; Vazquez SE, 2021, J CLIN IMMUNOL, V41, P1169, DOI 10.1007/s10875-021-01060-0; Vinh DC, 2021, J CLIN IMMUNOL, V41, P1425, DOI 10.1007/s10875-021-01068-6; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477; Wang EY, 2021, NATURE, V595, P283, DOI [10.1101/2020.12.10.20247205, 10.1038/s41586-021-03631-y]; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Yuen CK, 2020, EMERG MICROBES INFEC, V9, P1418, DOI 10.1080/22221751.2020.1780953; Zeberg H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026309118; Zeberg H, 2020, NATURE, V587, P610, DOI 10.1038/s41586-020-2818-3; Zhang Q, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI152474; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Q, 2020, MED-CAMBRIDGE, V1, P14, DOI 10.1016/j.medj.2020.12.001; Zhang Q, 2020, HUM GENET, V139, P941, DOI 10.1007/s00439-019-02108-3; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x; Zhang SY, 2020, NAT REV IMMUNOL, V20, P455, DOI 10.1038/s41577-020-0373-7; Ziegler CGK, 2021, CELL, V184, P4713, DOI 10.1016/j.cell.2021.07.023	199	55	55	62	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					587	598		10.1038/s41586-022-04447-0	http://dx.doi.org/10.1038/s41586-022-04447-0			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9QZ	35090163	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000892634100001
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Only a third of children in need accessed mental health support in the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Children's Commissioner, 2022, CHILDRENS MENTAL HLT	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								o335	10.1136/bmj.o335	http://dx.doi.org/10.1136/bmj.o335			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE9JI	35131842	Bronze			2022-12-28	WOS:000759192600007
J	Zhang, HT; Park, TJ; Islam, ANMN; Tran, DSJ; Manna, S; Wang, Q; Mondal, S; Yu, HM; Banik, S; Cheng, SB; Zhou, H; Gamage, S; Mahapatra, S; Zhu, YM; Abate, Y; Jiang, N; Sankaranarayanan, SKRS; Sengupta, A; Teuscher, C; Ramanathan, S				Zhang, Hai-Tian; Park, Tae Joon; Islam, A. N. M. Nafiul; Tran, Dat S. J.; Manna, Sukriti; Wang, Qi; Mondal, Sandip; Yu, Haoming; Banik, Suvo; Cheng, Shaobo; Zhou, Hua; Gamage, Sampath; Mahapatra, Sayantan; Zhu, Yimei; Abate, Yohannes; Jiang, Nan; Sankaranarayanan, Subramanian K. R. S.; Sengupta, Abhronil; Teuscher, Christof; Ramanathan, Shriram			Reconfigurable perovskite nickelate electronics for artificial intelligence	SCIENCE			English	Article							ELASTIC BAND METHOD; NEURAL-NETWORKS; MEMRISTOR; DEVICES; SYNAPSE	Reconfigurable devices offer the ability to program electronic circuits on demand. In this work, we demonstrated on-demand creation of artificial neurons, synapses, and memory capacitors in post-fabricated perovskite NdNiO3 devices that can be simply reconfigured for a specific purpose by single-shot electric pulses. The sensitivity of electronic properties of perovskite nickelates to the local distribution of hydrogen ions enabled these results. With experimental data from our memory capacitors, simulation results of a reservoir computing framework showed excellent performance for tasks such as digit recognition and classification of electrocardiogram heartbeat activity. Using our reconfigurable artificial neurons and synapses, simulated dynamic networks outperformed static networks for incremental learning scenarios. The ability to fashion the building blocks of brain-inspired computers on demand opens up new directions in adaptive networks.	[Zhang, Hai-Tian; Park, Tae Joon; Wang, Qi; Mondal, Sandip; Yu, Haoming; Ramanathan, Shriram] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Islam, A. N. M. Nafiul; Sengupta, Abhronil] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA; [Tran, Dat S. J.] Santa Clara Univ, Dept Elect & Comp Engn, Santa Clara, CA 95053 USA; [Manna, Sukriti; Banik, Suvo; Sankaranarayanan, Subramanian K. R. S.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Manna, Sukriti; Banik, Suvo; Sankaranarayanan, Subramanian K. R. S.] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA; [Cheng, Shaobo; Zhu, Yimei] Brookhaven Natl Lab, Dept Condensed Matter Phys & Mat Sci, Upton, NY 11973 USA; [Zhou, Hua] Argonne Natl Lab, Xray Sci Div, Adv Photon Source, Lemont, IL 60439 USA; [Gamage, Sampath; Abate, Yohannes] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Mahapatra, Sayantan; Jiang, Nan] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Teuscher, Christof] Portland State Univ, Dept Elect & Comp Engn, Portland, OR 97201 USA; [Zhang, Hai-Tian] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China; [Mondal, Sandip] Indian Inst Technol, Dept Elect Engn, Mumbai 400076, Maharashtra, India; [Cheng, Shaobo] Zhengzhou Univ, Sch Phys & Microelect, Key Lab Mat Phys, Zhengzhou 450052, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Santa Clara University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Portland State University; Beihang University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Zhengzhou University	Zhang, HT; Park, TJ; Ramanathan, S (corresponding author), Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.; Zhang, HT (corresponding author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.	htzhang@buaa.edu.cn; park1080@purdue.edu; shriram@purdue.edu	Zhou, Hua/V-1827-2017; Manna, Sukriti/I-8410-2019	Zhou, Hua/0000-0001-9642-8674; Manna, Sukriti/0000-0002-3193-7803; Mahapatra, Sayantan/0000-0002-7332-196X; Banik, Suvo/0000-0001-7239-8853; Wang, Qi/0000-0002-6314-7021; Jiang, Nan/0000-0002-4570-180X; Cheng, Shaobo/0000-0001-8791-5315; Islam, A N M Nafiul/0000-0002-1964-862X; abate, yohannes/0000-0002-9299-8693	Quantum Materials for Energy Efficient Neuromorphic Computing (Q-MEEN-C), an Energy Frontier Research Center (EFRC) - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0019273]; Air Force Office of Scientific Research (AFOSR) [FA9550-19-1-0351]; ARO [W911NF-19-20237]; National Science Foundation (NSF) [BCS-2031632, CCF-1955815]; DOE, Office of Science, BES [DE-AC02-06CH11357]; National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory [DE-AC0205CH11231]; DOE, Office of Science, BES Data, Artificial Intelligence and Machine Learning at DOE Scientific User Facilities program; DOE-BES, Materials Sciences and Engineering Division [DE-SC0012704]; DOE Office of Science [DE-AC02-06CH11357]; DOE Office of Science through the National Virtual Biotechnology Laboratory; Coronavirus CARES Act; AFOSR [FA9559-16-1-0172]; NSF [DMR1904097, CHE-1944796]	Quantum Materials for Energy Efficient Neuromorphic Computing (Q-MEEN-C), an Energy Frontier Research Center (EFRC) - US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); DOE, Office of Science, BES(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory; DOE, Office of Science, BES Data, Artificial Intelligence and Machine Learning at DOE Scientific User Facilities program(United States Department of Energy (DOE)); DOE-BES, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); DOE Office of Science through the National Virtual Biotechnology Laboratory(United States Department of Energy (DOE)); Coronavirus CARES Act; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF))	The analysis of the synaptic properties and related measurements were supported by Quantum Materials for Energy Efficient Neuromorphic Computing (Q-MEEN-C), an Energy Frontier Research Center (EFRC) funded by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award DE-SC0019273. The fabrication and pulsed field measurements were supported by the Air Force Office of Scientific Research (AFOSR) FA9550-19-1-0351 and ARO W911NF-19-20237, respectively. A.N.M.N.I. and A.S.'s research was funded in part by the National Science Foundation (NSF) under grants BCS-2031632 and CCF-1955815. Use of the Center for Nanoscale Materials and Advanced Photon Source, both Office of Science user facilities, was supported by the DOE, Office of Science, BES, under contract DE-AC02-06CH11357. This research used resources of the National Energy Research Scientific Computing Center (NERSC), a DOE Office of Science User Facility located at Lawrence Berkeley National Laboratory, operated under contract DE-AC0205CH11231. This material is based on work supported by the DOE, Office of Science, BES Data, Artificial Intelligence and Machine Learning at DOE Scientific User Facilities program. This work at BNL was supported by DOE-BES, Materials Sciences and Engineering Division under contract DE-SC0012704. This research used resources of the Advanced Photon Source, a DOE Office of Science User Facility, operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Extraordinary facility operations were supported in part by the DOE Office of Science through the National Virtual Biotechnology Laboratory, a consortium of DOE national laboratories focused on the response to COVID-19, with funding provided by the Coronavirus CARES Act. S.G. and Y.A. acknowledge support from the AFOSR, grant FA9559-16-1-0172, and NSF under grant DMR1904097. S.M. and N.J. acknowledge support from NSF grant CHE-1944796.	Agarwal S, 2016, IEEE IJCNN, P929, DOI 10.1109/IJCNN.2016.7727298; [Anonymous], 2010, 2010 INT JOINT C NEU, DOI DOI 10.1109/IJCNN.2010.5596775; Appeltant L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1476; Arlington V., 2008, EC571998 ANSIAAMI; Baek K, 2017, NANOSCALE, V9, P582, DOI 10.1039/c6nr06293h; Bashivan P., 2018, NIPS18 WORK CONT LEA; Biolek D, 2013, RADIOENGINEERING, V22, P945; Browne CB, 2012, IEEE T COMP INTEL AI, V4, P1, DOI 10.1109/TCIAIG.2012.2186810; Clarkson P, 1999, INT CONF ACOUST SPEE, P585, DOI 10.1109/ICASSP.1999.759734; De S, 2016, PHYS CHEM CHEM PHYS, V18, P13754, DOI 10.1039/c6cp00415f; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Du C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02337-y; Girardot C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104101; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goswami S, 2020, NAT NANOTECHNOL, V15, P380, DOI 10.1038/s41565-020-0653-1; Goswami S, 2017, NAT MATER, V16, P1216, DOI [10.1038/NMAT5009, 10.1038/nmat5009]; Greenwald S. D., 1990, COMPUT CARDIOL, P461; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Himanen L, 2020, COMPUT PHYS COMMUN, V247, DOI 10.1016/j.cpc.2019.106949; Jackson Z., 2018, FREE SPOKEN DIGIT DA; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Jedvik E, 2015, SOLID STATE IONICS, V275, P2, DOI 10.1016/j.ssi.2015.02.017; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; John RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16985-0; John RA, 2018, ADV MATER, V30, DOI 10.1002/adma.201800220; Kirkpatricka J, 2017, P NATL ACAD SCI USA, V114, P3521, DOI 10.1073/pnas.1611835114; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee J, 2020, AAAI CONF ARTIF INTE, V34, P4561; Marsland S, 2002, NEURAL NETWORKS, V15, P1041, DOI 10.1016/S0893-6080(02)00078-3; Melianas A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2958; Mohamed M. G. A., 2015, THESCIENTIFICWORLDJO, V2015; Moon J, 2019, NAT ELECTRON, V2, P480, DOI 10.1038/s41928-019-0313-3; Nandakumar SR, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00406; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Parisi G. I., 2018, NIPS18 WORKSH CONT L; Parisi GI, 2019, NEURAL NETWORKS, V113, P54, DOI 10.1016/j.neunet.2019.01.012; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Shi J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5860; Sim H, 2005, INT EL DEVICES MEET, P777; Stanley KO, 2019, NAT MACH INTELL, V1, P24, DOI 10.1038/s42256-018-0006-z; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tran SJD, 2017, IEEE INT SYMP NANO, P115, DOI 10.1109/NANOARCH.2017.8053719; Tran SJD, 2017, INT J UNCONV COMPUT, V13, P35; Upadhyay NK, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800589; van de Burgt Y, 2017, NAT MATER, V16, P414, DOI [10.1038/NMAT4856, 10.1038/nmat4856]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varignon J, 2017, NPJ QUANTUM MATER, V2, DOI 10.1038/s41535-017-0024-9; Wah C., 2011, CALTECH UCSD BIRDS 2; Xiong W, 2019, NATURE, V575, P147, DOI 10.1038/s41586-019-1721-2; Yi W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07052-w; Yoo P, 2020, PHYS CHEM CHEM PHYS, V22, P6888, DOI 10.1039/c9cp06522a; Yoon JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02572-3; Zhang H.-T., 2021, ZENODO; Zhang H.-T., 2021, ZENODO, DOI [10.5281/zenodo.5768666, DOI 10.5281/ZENODO.5768666]	59	22	22	118	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					533	+		10.1126/science.abj7943	http://dx.doi.org/10.1126/science.abj7943			91	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113713				2022-12-28	WOS:000753965100038
J	Tanne, JH				Tanne, Janice Hopkins			Diabetes kills 100 000 Americans for second year in a row	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Centers for Disease Control and Prevention, 2022, NAT DIAB STAT REP; National Care Commission, 2021, REP C LEV FED PROGR; Terhune C, 2022, REUTERS 0131; Terhune C, 2021, REUTERS 0812	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2022	376								o300	10.1136/bmj.o300	http://dx.doi.org/10.1136/bmj.o300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9HM	35115317				2022-12-28	WOS:000759187700002
J	Yao, KX; Zhang, ZD; Chin, C				Yao, Kai-Xuan; Zhang, Zhendong; Chin, Cheng			Domain-wall dynamics in Bose-Einstein condensates with synthetic gauge fields	NATURE			English	Article							REALIZATION; INVARIANCE	Interactions in many-body physical systems, from condensed matter to high-energy physics,lead to the emergence of exotic particles. Examples are mesons in quantum chromodynamics and composite fermions in fractional quantum Hall systems, which arise from the dynamical coupling between matter and gauge fields(1,2). The challenge of understanding the complexity of matter-gauge interaction can be aided by quantum simulations, for which ultracold atoms offer a versatile platform via the creation of artificial gauge fields. An important step towards simulating the physics of exotic emergent particles is the synthesis of artificial gauge fields whose state depends dynamically on the presence of matter. Here we demonstrate deterministic formation of domain walls in a stable Bose-Einstein condensate with a gauge field that is determined by the atomic density. The density-dependent gauge field is created by simultaneous modulations of an optical lattice potential and interatomic interactions, and results in domains of atoms condensed into two different momenta. Modelling the domain walls as elementary excitations, we find that the domain walls respond to synthetic electric field with a charge-to-mass ratio larger than and opposite to that of the bare atoms. Our workoffers promising prospects to simulate the dynamics and interactions of previously undescribed excitations in quantum systems with dynamical gauge fields.	[Yao, Kai-Xuan; Zhang, Zhendong; Chin, Cheng] Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Yao, Kai-Xuan; Zhang, Zhendong; Chin, Cheng] Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Yao, Kai-Xuan; Zhang, Zhendong; Chin, Cheng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Chin, C (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.; Chin, C (corresponding author), Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.; Chin, C (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	cchin@uchicago.edu		Zhang, Zhendong/0000-0001-7221-1729; Yao, Kai-Xuan/0000-0002-4071-7060	National Science Foundation (NSF) [PHY-2103542]; NSF QLCI-HQAN [2016136]; Army Research Office STIR grant [W911NF2110108]; Grainger Graduate Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF QLCI-HQAN; Army Research Office STIR grant; Grainger Graduate Fellowship	We thank E. Mueller for helpful discussions and K. Patel for carefully reading the manuscript. This work is supported by the National Science Foundation (NSF) grant no. PHY-2103542, NSF QLCI-HQAN no. 2016136, and the Army Research Office STIR grant W911NF2110108. Z.Z. is supported by the Grainger Graduate Fellowship.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Alford MG, 2008, REV MOD PHYS, V80, P1455, DOI 10.1103/RevModPhys.80.1455; BASKARAN G, 1988, PHYS REV B, V37, P580, DOI 10.1103/PhysRevB.37.580; Cheng T., 1994, GAUGE THEORY ELEMENT; Clark LW, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030402; Clark LW, 2016, SCIENCE, V354, P606, DOI 10.1126/science.aaf9657; Cooper NR, 2019, REV MOD PHYS, V91, DOI [10.1103/RevModPhys.91.015005, 10.1103/revmodphys.91.015005]; Eckardt A, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.011004; Edmonds MJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.085301; Gani VA, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.125009; Gorg F, 2019, NAT PHYS, V15, P1161, DOI 10.1038/s41567-019-0615-4; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Griffiths D., 2020, INTRO ELEMENTARY PAR; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; KOGUT JB, 1979, REV MOD PHYS, V51, P659, DOI 10.1103/RevModPhys.51.659; Levin M, 2005, REV MOD PHYS, V77, P871, DOI 10.1103/RevModPhys.77.871; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Liu TT, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.063646; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Mil A, 2020, SCIENCE, V367, P1128, DOI 10.1126/science.aaz5312; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Savary L, 2017, REP PROG PHYS, V80, DOI 10.1088/0034-4885/80/1/016502; Shvarchuck I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270404; Stormer HL, 1999, REV MOD PHYS, V71, pS298, DOI 10.1103/RevModPhys.71.S298; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; VILENKIN A, 1985, PHYS REP, V121, P263, DOI 10.1016/0370-1573(85)90033-X; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445	35	5	5	5	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 3	2022	602	7895					68	+		10.1038/s41586-021-04250-3	http://dx.doi.org/10.1038/s41586-021-04250-3			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS1FH	35110757	Green Submitted			2022-12-28	WOS:000750429600020
J	Horton, R				Horton, Richard			Offline: Where is America? Comment	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					506	506						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123678				2022-12-28	WOS:000755144500008
J	Staub, K; Panczak, R; Matthes, KL; Floris, J; Berlin, C; Junker, C; Weitkunat, R; Mamelund, SE; Zwahlen, M; Riou, J				Staub, Kaspar; Panczak, Radoslaw; Matthes, Katarina L.; Floris, Joel; Berlin, Claudia; Junker, Christoph; Weitkunat, Rolf; Mamelund, Svenn-Erik; Zwahlen, Marcel; Riou, Julien			Historically High Excess Mortality During the COVID-19 Pandemic in Switzerland, Sweden, and Spain	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; INFLUENZA; PATTERNS; TRANSMISSIBILITY; EPIDEMICS; IMPACT; AGE	Background: Excess mortality quantifies the overall mortality impact of a pandemic. Mortality data have been accessible for many countries in recent decades, but few continuous data have been available for longer periods. Objective: To assess the historical dimension of the COVID-19 pandemic in 2020 for 3 countries with reliable death count data over an uninterrupted span of more than 100 years. Design: Observational study. Setting: Switzerland, Sweden, and Spain, which were milita-rily neutral and not involved in combat during either world war and have not been affected by significant changes in their territory since the end of the 19th century. Participants: Complete populations of these 3 countries. Measurements: Continuous series of recorded deaths (from all causes) by month from the earliest available year (1877 for Switzerland, 1851 for Sweden, and 1908 for Spain) were jointly modeled with annual age group-specific death and total population counts using negative binomial and multino-mial models, which accounted for temporal trends and seasonal variability of prepandemic years. The aim was to estimate the expected number of deaths in a pandemic year for a nonpan-demic scenario and the difference in observed and expected deaths aggregated over the year. Results: In 2020, the number of excess deaths recorded per 100000 persons was 100 (95% credible interval [CrI], 60 to 135) for Switzerland, 75 (CrI, 40 to 105) for Sweden, and 155 (CrI, 110 to 195) for Spain. In 1918, excess mortality was 6 to 7 times higher. In all 3 countries, the peaks of monthly excess mortality in 2020 were greater than most monthly excess mortality since 1918, including many peaks due to seasonal influenza and heat waves during that period. Limitation: Historical vital statistics might be affected by minor completeness issues before the beginning of the 20th century. Conclusion: In 2020, the COVID-19 pandemic led to the second-largest infection-related mortality disaster in Switzerland, Sweden, and Spain since the beginning of the 20th century. Primary Funding Source: Foundation for Research in Science and the Humanities at the University of Zurich, Swiss National Science Foundation, and National Institute of Allergy and Infectious Diseases.	[Staub, Kaspar; Matthes, Katarina L.; Floris, Joel] Univ Zurich, Inst Evolutionary Med, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Panczak, Radoslaw; Berlin, Claudia; Zwahlen, Marcel; Riou, Julien] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Floris, Joel] Univ Zurich, Dept Hist, Zurich, Switzerland; [Junker, Christoph; Weitkunat, Rolf] Fed Stat Off, Neuchatel, Switzerland; [Mamelund, Svenn-Erik] Oslo Metropolitan Univ, Ctr Res Pandem & Soc, Oslo, Norway	University of Zurich; University of Bern; University of Zurich; Oslo Metropolitan University (OsloMet)	Staub, K (corresponding author), Univ Zurich, Inst Evolutionary Med, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	kaspar.staub@iem.uzh.ch	Zwahlen, Marcel/AFF-8559-2022; Panczak, Radoslaw/E-7384-2018	Zwahlen, Marcel/0000-0002-6772-6346; Panczak, Radoslaw/0000-0001-5141-683X; Matthes, Katarina/0000-0002-5263-3542; Riou, Julien/0000-0002-3808-2852; Berlin, Claudia/0000-0003-3505-348X; Mamelund, Svenn-Erik/0000-0002-3980-3818; Junker, Christoph/0000-0002-9604-503X; Floris, Joel/0000-0002-8480-6495; Staub, Kaspar/0000-0002-3951-1807	Foundation for Research in Science and the Humanities at the University of Zurich [STWF-21-011]; National Institute of Allergy and Infectious Diseases [5U01-AI069924-05]; Swiss National Science Foundation [189498]	Foundation for Research in Science and the Humanities at the University of Zurich; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Grant Support: By the Foundation for Research in Science and the Humanities at the University of Zurich (grant STWF-21-011 to Drs. Staub and Floris) . Dr. Panczak was supported by the National Institute of Allergy and Infectious Diseases (grant 5U01-AI069924-05) . Dr. Riou was supported by the Swiss National Science Foundation (grant 189498) .	Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; Appleby J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n896; Bengtsson T, 1994, Ann Demogr Hist (Paris), P23; Briggs A, 2021, NATURE, V593, P502, DOI 10.1038/d41586-021-01392-2; Brinkhof MWG, 2006, SWISS MED WKLY, V136, P302; Brussow H, 2021, MICROB BIOTECHNOL, V14, P1860, DOI 10.1111/1751-7915.13889; Buchholz U, 2016, BUNDESGESUNDHEITSBLA, V59, P523, DOI 10.1007/s00103-016-2324-9; Calot G, 1998, DEUX SIECLES HIST SU; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Centers for Disease Control and Prevention, EXC DEATHS ASS COVID; Chandra S, 2021, AM J PUBLIC HEALTH, V111, P430, DOI 10.2105/AJPH.2020.305969; Chowell G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-371; Cilek L, 2018, AM J EPIDEMIOL, V187, P2511, DOI 10.1093/aje/kwy171; Crook H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1648; Dahal S, 2018, ANN EPIDEMIOL, V28, P273, DOI 10.1016/j.annepidem.2017.12.005; Ewing ET, 2019, INFLUENZA OTHER RESP, V13, P279, DOI 10.1111/irv.12632; Faust JS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17527; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; G. Konstantinoudis, 2021, medRxiv, DOI 10.1101/2021.10.18.21264686; Gelman A, 2020, REGRESSION OTHER STO, P263; Gonzalez-Val R, 2020, ANN REGIONAL SCI, V65, P491, DOI 10.1007/s00168-020-00992-6; GOURBIN C, 1995, B WORLD HEALTH ORGAN, V73, P449; Hernan MA, 2020, CAUSAL INFERENCE WHA; Hernan MA, 2021, AM J PUBLIC HEALTH, V111, P414, DOI 10.2105/AJPH.2020.306105; Honigsbaum M, 2020, LANCET, V395, P1824, DOI 10.1016/S0140-6736(20)31201-0; Instituto Nacional de Estadistica, STAT YB; Islam N, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1137; Johns Hopkins University, J HOPK COR RES CTR; Karlinsky Ariel, 2021, medRxiv, DOI 10.1101/2021.01.27.21250604; Kirkwood B. R., 2003, ESSENTIAL MED STAT, V2nd; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Ledberg A, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.579948; Locatelli I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253505; Mallet E, 1837, RECHERCHES HIST STAT; McMurtry A., 2021, SPAINS FICIAL 2020 C; Mesle MMI, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.47.2101021; Mooney G, 1997, SOC HIST MED, V10, P53, DOI 10.1093/shm/10.1.53; Morens DM, 2021, AM J PUBLIC HEALTH, V111, P1086, DOI 10.2105/AJPH.2021.306310; Morens DM, 2018, AM J PUBLIC HEALTH, V108, P1449, DOI 10.2105/AJPH.2018.304631; Nepomuceno MR, PREPRINT, DOI [10.1101/2021.07.20.21260869, DOI 10.1101/2021.07.20.21260869]; Norgaard SK, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.1.2002023; Ortega JA, 2006, EC GUERRA CIVIL MARC, P53; Pastor-Barriuso R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4509; Preston SH, 1972, CAUSES DEATH LIFE TA; Quetelet A., 1838, INFLUENCE SAISONS MO; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Ramiro D, 2018, ANN EPIDEMIOL, V28, P267, DOI 10.1016/j.annepidem.2017.12.009; Reher D.S., 1995, FUENTES INFORM DEMOG; Ritzmann-Blickenstorfer H., 1996, HIST STAT SWITZERLAN; Sanmarchi F, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.17359; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Schmid F, 1895, FLUENZA SCHWEIZ JAHR; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shiels MS, 2021, ANN INTERN MED, V174, P437, DOI 10.7326/M20-7385; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Stan Development Team, CMDSTANR R INT CMDST; Statistics Sweden, BIRTHS DEATHS MONTH; Staub K, 2021, ANN INTERN MED, V174, P533, DOI 10.7326/M20-6231; Staub K, 2021, INFLUENZA OTHER RESP, V15, P318, DOI 10.1111/irv.12806; Swiss Federal Statistical Office, MONTHL DEATHS MORT 1; Trias-Llimos S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241952; University of California Berkeley (USA) and Max Planck Institute for Demographic Research (Germany), HUM MORT DAT; Valleron AJ, 2010, P NATL ACAD SCI USA, V107, P8778, DOI 10.1073/pnas.1000886107; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Viboud C, 2016, J INFECT DIS, V213, P738, DOI 10.1093/infdis/jiv534; Wanner P, 2021, SWISS MED WKLY; Weinberger DM, 2012, AM J EPIDEMIOL, V176, P649, DOI 10.1093/aje/kws140; World Health Organization, TRUE DEATH TOLL COVI; Zurcher K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162575	69	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2022	175	4					523	+		10.7326/M21-3824	http://dx.doi.org/10.7326/M21-3824		FEB 2022	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	1D1PG	35099995	Green Published			2022-12-28	WOS:000750886400001
J	Tonelli, M; Thadhani, R				Tonelli, Marcello; Thadhani, Ravi			Anaemia in chronic kidney disease: what do new generation agents offer?	LANCET			English	Editorial Material							VADADUSTAT		[Tonelli, Marcello] Univ Calgary, Dept Med, Calgary, AB T2N 4Z6, Canada; [Thadhani, Ravi] Mass Gen Brigham, Boston, MA USA	University of Calgary	Tonelli, M (corresponding author), Univ Calgary, Dept Med, Calgary, AB T2N 4Z6, Canada.	tonelli.admin@ucalgary.ca	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				[Anonymous], 2012, Kidney Int Suppl (2011), V2, P299; Chen N, 2019, NEW ENGL J MED, V381, P1001, DOI 10.1056/NEJMoa1813599; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; Chertow GM, 2021, NEW ENGL J MED, V384, P1589, DOI 10.1056/NEJMoa2035938; Eckardt KU, 2021, NEW ENGL J MED, V384, P1601, DOI 10.1056/NEJMoa2025956; Haase VH, 2021, KIDNEY INT SUPPL, V11, P8, DOI 10.1016/j.kisu.2020.12.002; Hirota K, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050468; Kemp A, 2021, UPDATE US REGULATORY; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; McCarty N., 2021, CLIN TRIAL PAPER MAD; Singh AK, 2021, NEW ENGL J MED, V385, P2325, DOI 10.1056/NEJMoa2113379; Singh AK, 2021, NEW ENGL J MED, V385, P2313, DOI 10.1056/NEJMoa2113380; US Food & Drug Administration, 2021, CARDIOVASCULAR RENAL; US Renal Data System, 2011, 2011 USRDS ANN DAT R; Wish JB, 2021, AM J KIDNEY DIS, V78, P709, DOI 10.1053/j.ajkd.2021.06.019	15	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10326					702	703		10.1016/S0140-6736(22)00120-9	http://dx.doi.org/10.1016/S0140-6736(22)00120-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE3NS	35090603				2022-12-28	WOS:000758794200006
J	Zarocostas, J				Zarocostas, John			WHO concerned over COVID-19 health-care waste	LANCET			English	Editorial Material								In a new report, the agency calls for global action to deal with huge amounts of waste produced by personal protective equipment and other material. John Zarocostas reports from Geneva.											0	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					507	507						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123679	Green Published			2022-12-28	WOS:000755144500009
J	Winkler, MKH; van Loosdrecht, MCM				Winkler, M-K H.; van Loosdrecht, M. C. M.			Intensifying existing urban wastewater Aerobic granular sludge offers improvements to treatment processes	SCIENCE			English	Editorial Material									[Winkler, M-K H.] Univ Washington, Civil & Environm Engn, Seattle, WA 98165 USA; [van Loosdrecht, M. C. M.] Delft Univ Technol, Dept Biotechnol, NL-2629 HZ Delft, Netherlands	University of Washington; University of Washington Seattle; Delft University of Technology	Winkler, MKH (corresponding author), Univ Washington, Civil & Environm Engn, Seattle, WA 98165 USA.	mwinkler@uw.edu	van Loosdrecht, Mark C.M./B-2738-2009	van Loosdrecht, Mark C.M./0000-0003-0658-4775	National Science Foundation [1510665, 1603707]; Water Research Foundation [TIRR3C15]	National Science Foundation(National Science Foundation (NSF)); Water Research Foundation	The authors acknowledge support from the National Science Foundation (project nos. 1510665 and 1603707) and the Water Research Foundation (project no. TIRR3C15).	An ZH, 2021, ENVIRON SCI-WAT RES, V7, P1622, DOI [10.1039/D1EW00314C, 10.1039/d1ew00314c]; [Anonymous], 2018, 68 WORLD POP PROJ LI; Avila I, 2021, WATER SCI TECHNOL, V84, P302, DOI 10.2166/wst.2021.006; Quoc BN, 2021, WATER RES, V198, DOI 10.1016/j.watres.2021.117119; Beun JJ, 1999, WATER RES, V33, P2283, DOI 10.1016/S0043-1354(98)00463-1; de Kreuk MK, 2004, WATER SCI TECHNOL, V49, P9, DOI 10.2166/wst.2004.0792; Felz S, 2020, WATER RES, V169, DOI 10.1016/j.watres.2019.115291; Layer M, 2020, WATER RES X, V9, DOI 10.1016/j.wroa.2020.100075; Pronk M, 2015, WATER RES, V84, P207, DOI 10.1016/j.watres.2015.07.011; Roche C, 2022, WATER ENVIRON RES, V94, DOI 10.1002/wer.1664; The White House, 2021, FACT SHEET BIP INFR; Wei SP, 2021, WATER RES, V203, DOI 10.1016/j.watres.2021.117514; Wei SP, 2020, WATER RES, V179, DOI 10.1016/j.watres.2020.115865; White House, 2021, FACT SHEET AM FAM PL; Winkler MKH, 2013, APPL MICROBIOL BIOT, V97, P7459, DOI 10.1007/s00253-012-4459-4	15	8	8	50	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					377	378		10.1126/science.abm3900	http://dx.doi.org/10.1126/science.abm3900			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084964				2022-12-28	WOS:000750899500017
J	Oster, ME; Shay, DK; Su, JR; Gee, J; Creech, CB; Broder, KR; Edwards, K; Soslow, JH; Dendy, JM; Schlaudecker, E; Lang, SM; Barnett, ED; Ruberg, FL; Smith, MJ; Campbell, MJ; Lopes, RD; Sperling, LS; Baumblatt, JA; Thompson, DL; Marquez, PL; Strid, P; Woo, J; Pugsley, R; Reagan-Steiner, S; DeStefano, F; Shimabukuro, TT				Oster, Matthew E.; Shay, David K.; Su, John R.; Gee, Julianne; Creech, C. Buddy; Broder, Karen R.; Edwards, Kathryn; Soslow, Jonathan H.; Dendy, Jeffrey M.; Schlaudecker, Elizabeth; Lang, Sean M.; Barnett, Elizabeth D.; Ruberg, Frederick L.; Smith, Michael J.; Campbell, M. Jay; Lopes, Renato D.; Sperling, Laurence S.; Baumblatt, Jane A.; Thompson, Deborah L.; Marquez, Paige L.; Strid, Penelope; Woo, Jared; Pugsley, River; Reagan-Steiner, Sarah; DeStefano, Frank; Shimabukuro, Tom T.			Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC MAGNETIC-RESONANCE; UNITED-STATES; SCIENTIFIC STATEMENT; HEART-ASSOCIATION; TASK-FORCE; MANAGEMENT; DIAGNOSIS; THERAPY; TRENDS	IMPORTANCE Vaccination against COVID-19 provides clear public health benefits, but vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID-19 vaccination are unclear. OBJECTIVE To describe reports of myocarditis and the reporting rates after mRNA-based COVID-19 vaccination in the US. DESIGN, SETTING, AND PARTICIPANTS Descriptive study of reports of myocarditis to the Vaccine Adverse Event Reporting System (VAERS) that occurred after mRNA-based COVID-19 vaccine administration between December 2020 and August 2021 in 192 405 448 individuals older than 12 years of age in the US; data were processed by VAERS as of September 30, 2021. EXPOSURES Vaccination with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna). MAIN OUTCOMES AND MEASURES Reports of myocarditis to VAERS were adjudicated and summarized for all age groups. Crude reporting rates were calculated across age and sex strata. Expected rates of myocarditis by age and sex were calculated using 2017-2019 claims data. For persons younger than 30 years of age, medical record reviews and clinician interviews were conducted to describe dinical presentation, diagnostic test results, treatment, and early outcomes. RESULTS Among 192405 448 persons receiving a total of 354 100 845 mRNA-based COVID-19 vaccines during the study period, there were 1991 reports of myocarditis to VAERS and 1626 of these reports met the case definition of myocarditis. Of those with myocarditis, the median age was 21 years (IQR, 16-31 years) and the median time to symptom onset was 2 days (IQR, 1-3 days). Males comprised 82% of the myocarditis cases for whom sex was reported. The crude reporting rates for cases of myocarditis within 7 days after COVID-19 vaccination exceeded the expected rates of myocarditis across multiple age and sex strata. The rates of myocarditis were highest after the second vaccination dose in adolescent males aged 12 to 15 years (70.7 per million doses of the BNT162b2 vaccine), in adolescent males aged 16 to 17 years (105.9 per million doses of the BNT162b2 vaccine), and in young men aged 18 to 24 years (52.4 and 56.3 per million doses of the BNT162b2 vaccine and the mRNA-1273 vaccine, respectively). There were 826 cases of myocarditis among those younger than 30 years of age who had detailed clinical information available; of these cases, 792 of 809 (98%) had elevated troponin levels, 569 of 794 (72%) had abnormal electrocardiogram results, and 223 of 312 (72%) had abnormal cardiac magnetic resonance imaging results. Approximately 96% of persons (784/813) were hospitalized and 87% (577/661) of these had resolution of presenting symptoms by hospital discharge. The most common treatment was nonsteroidal anti-inflammatory drugs (589/676; 87%). CONCLUSIONS AND RELEVANCE Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of COVID-19 vaccination.	[Oster, Matthew E.; Shay, David K.; Su, John R.; Gee, Julianne; Broder, Karen R.; Sperling, Laurence S.; Marquez, Paige L.; Strid, Penelope; Woo, Jared; Pugsley, River; Reagan-Steiner, Sarah; DeStefano, Frank; Shimabukuro, Tom T.] US Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA; [Oster, Matthew E.; Sperling, Laurence S.] Emory Univ, Sch Med, Atlanta, GA USA; [Oster, Matthew E.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Creech, C. Buddy; Edwards, Kathryn; Soslow, Jonathan H.; Dendy, Jeffrey M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Schlaudecker, Elizabeth; Lang, Sean M.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Barnett, Elizabeth D.; Ruberg, Frederick L.] Boston Med Ctr, Boston, MA USA; [Smith, Michael J.; Campbell, M. Jay; Lopes, Renato D.] Duke Univ, Durham, NC USA; [Baumblatt, Jane A.; Thompson, Deborah L.] US FDA, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Children's Healthcare of Atlanta (CHOA); Vanderbilt University; Cincinnati Children's Hospital Medical Center; Boston Medical Center; Duke University; US Food & Drug Administration (FDA)	Oster, ME (corresponding author), US Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	eocevent416@cdc.gov		Campbell, Michael/0000-0002-5210-9038; Strid, Penelope/0000-0003-4730-6501	US Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment Project [200-2012-53709, 200-2012-53661, 200-2012-53663, 200-2012-50430]	US Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment Project(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by contracts 200-2012-53709 (Boston Medical Center), 200-2012-53661 (Cincinnati Children's Hospital Medical Center), 200-2012-53663 (Duke University), and 200-2012-50430 (Vanderbilt University Medical Center) with the US Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment Project.	Abu Mouch S, 2021, VACCINE, V39, P3790, DOI 10.1016/j.vaccine.2021.05.087; Aquaro GD, 2019, J AM COLL CARDIOL, V74, P2439, DOI 10.1016/j.jacc.2019.08.1061; Arola A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005306; Boehmer TK, 2021, MMWR-MORBID MORTAL W, V70, P1228, DOI 10.15585/mmwr.mm7035e5; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dasgupta S, 2019, CONGENIT HEART DIS, V14, P868, DOI 10.1111/chd.12835; Diaz GA, 2021, JAMA-J AM MED ASSOC, V326, P1210, DOI 10.1001/jama.2021.13443; Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072; Gargano JW, 2021, MMWR-MORBID MORTAL W, V70, P977, DOI 10.15585/mmwr.mm7027e2; Ghelani SJ, 2012, CIRC-CARDIOVASC QUAL, V5, P622, DOI 10.1161/CIRCOUTCOMES.112.965749; Gubernot D, 2021, VACCINE, V39, P3666, DOI 10.1016/j.vaccine.2021.05.016; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kim HW, 2021, JAMA CARDIOL, V6, P1196, DOI 10.1001/jamacardio.2021.2828; Kyto V, 2013, HEART, V99, P1681, DOI 10.1136/heartjnl-2013-304449; Larson KF, 2021, CIRCULATION, V144, P506, DOI 10.1161/CIRCULATIONAHA.121.055913; Law YM, 2021, CIRCULATION, V144, pE123, DOI 10.1161/CIR.0000000000001001; Mahrholdt H, 2006, CIRCULATION, V114, P1581, DOI 10.1161/CIRCULATIONAHA.105.606509; Maron BJ, 2015, J AM COLL CARDIOL, V66, P2362, DOI 10.1016/j.jacc.2015.09.035; Marshall M, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-052478; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; MedDRA, MED DICT REG ACT; Mevorach D, 2021, NEW ENGL J MED, V385, P2140, DOI 10.1056/NEJMoa2109730; Montgomery J, 2021, JAMA CARDIOL, V6, P1202, DOI 10.1001/jamacardio.2021.2833; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; Rosner CM, 2021, CIRCULATION, V144, P502, DOI 10.1161/CIRCULATIONAHA.121.055891; Sachdeva S, 2015, AM J CARDIOL, V115, P499, DOI 10.1016/j.amjcard.2014.11.029; Saji T, 2012, CIRC J, V76, P1222, DOI 10.1253/circj.CJ-11-1032; Shimabukuro TT, 2015, VACCINE, V33, P4398, DOI 10.1016/j.vaccine.2015.07.035; US Centers for Disease Control and Prevention, INT CLIN CONS US COV; US Centers for Disease Control and Prevention, 2003, MMWR S, V52, P19; US Centers for Disease Control and Prevention, CDC COVID 19 DAT TRA; US Centers for Disease Control and Prevention, INV LONG TERM EFF MY; US Centers for Disease Control and Prevention, CLIN CONS MYOC PER R; US Centers for Disease Control and Prevention, CLIN IMM SAF ASS PRO; Vasudeva R, 2021, AM J CARDIOL, V149, P95, DOI 10.1016/j.amjcard.2021.03.019; Witberg G, 2021, NEW ENGL J MED, V385, P2132, DOI 10.1056/NEJMoa2110737; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	39	134	136	8	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 25	2022	327	4					331	340		10.1001/jama.2021.24110	http://dx.doi.org/10.1001/jama.2021.24110			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YV9PW	35076665	Bronze, Green Published			2022-12-28	WOS:000753055700010
J	Wise, J				Wise, Jacqui			Covid-19: Be realistic about elective recovery plan, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Campbell D., 2022, GUARDIAN JAN; Iacobucci G, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2977; Mahase E, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o13; National Audit Office Department of Health and Social Care, 2021, NHS ENGL NHS IMPR NH; NHS England, STAT WORK AR	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o208	10.1136/bmj.o208	http://dx.doi.org/10.1136/bmj.o208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078761	Bronze			2022-12-28	WOS:000759189200012
J	Karunanithi, S				Karunanithi, Sakthi			Omicron and the NHS: we need to look beyond hospital care to solve the pressures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Karunanithi, Sakthi] Lancashire Cty Council, Preston, Lancs, England		Karunanithi, S (corresponding author), Lancashire Cty Council, Preston, Lancs, England.							[Anonymous], 2021, NHS PLANS NEW NIGHTI; Iacobucci G, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o3; Parliament UK, WORKF PLANN; Parliament UK, 2022, OM EM CAR CRIS COULD	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o185	10.1136/bmj.o185	http://dx.doi.org/10.1136/bmj.o185			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063935	Bronze			2022-12-28	WOS:000838119600004
J	Baraniuk, C				Baraniuk, Chris			Covid-19: How Europe is approaching long covid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						[Anonymous], 2021, GAZZETTA UFFICI 0525; Caspersen IH, EXCESS RISK CLUSTERS, V2021, P2021, DOI [10.1101/2021.10.15.21265038, DOI 10.1101/2021.10.15.21265038]; Department of Health and Social Care, 2021, 7000000000 NHS SOC C; European Commission, 2021, EU STRAT COV 19 THER; Onder G, 2021, ISS 0701; Paccalin C., 2021, FRANCE24 0626; WHO, 2021, CLIN CAS DEF POSTC C; WHO, EM US ICD COD COV 19; WHO Europe, 2021, WAK PAND PREP LONG C	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o158	10.1136/bmj.o158	http://dx.doi.org/10.1136/bmj.o158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058230	Bronze			2022-12-28	WOS:000750649900004
J	Bollyky, TJ; Hulland, EN; Barber, RM; Collins, JK; Kiernan, S; Moses, M; Pigott, DM; Reiner, RC; Sorensen, RJD; Abbafati, C; Adolph, C; Allorant, A; Amlag, JO; Aravkin, AY; Bang-Jensen, B; Carter, A; Castellano, R; Castro, E; Chakrabarti, S; Combs, E; Dai, XC; Dangel, WJ; Dapper, C; Deen, A; Duncan, BB; Earl, L; Erickson, M; Ewald, SB; Fedosseeva, T; Ferrari, AJ; Flaxman, AD; Fullman, N; Gakidou, E; Galal, B; Gallagher, J; Giles, JR; Guo, GR; He, JW; Helak, M; Huntley, BM; Idrisov, B; Johanns, C; LeGrand, KE; Letourneau, ID; Lindstrom, A; Linebarger, E; Lotufo, PA; Lozano, R; Magistro, B; Malta, DC; Mansson, J; Herrera, AMM; Marinho, F; Mirkuzie, AH; Mokdad, AH; Monasta, L; Naik, P; Nomura, S; O'Halloran, JK; Odell, CM; Olana, LT; Ostroff, SM; Pasovic, M; Passos, VMD; Penberthy, L; Reinke, G; Santomauro, DF; Schmidt, MI; Sholokhov, A; Spurlock, E; Troeger, CE; Varavikova, E; Vo, AT; Vos, T; Walcott, R; Walker, A; Wigley, SD; Wiysonge, CS; Worku, NA; Wu, YF; Hanson, SW; Zheng, P; Hay, SI; Murray, CJL; Dieleman, JL				Bollyky, Thomas J.; Hulland, Erin N.; Barber, Ryan M.; Collins, James K.; Kiernan, Samantha; Moses, Mark; Pigott, David M.; Reiner Jr, Robert C.; Sorensen, Reed J. D.; Abbafati, Cristiana; Adolph, Christopher; Allorant, Adrien; Amlag, Joanne O.; Aravkin, Aleksandr Y.; Bang-Jensen, Bree; Carter, Austin; Castellano, Rachel; Castro, Emma; Chakrabarti, Suman; Combs, Emily; Dai, Xiaochen; Dangel, William James; Dapper, Carolyn; Deen, Amanda; Duncan, Bruce B.; Earl, Lucas; Erickson, Megan; Ewald, Samuel B.; Fedosseeva, Tatiana; Ferrari, Alize J.; Flaxman, Abraham D.; Fullman, Nancy; Gakidou, Emmanuela; Galal, Bayan; Gallagher, John; Giles, John R.; Guo, Gaorui; He, Jiawei; Helak, Monika; Huntley, Bethany M.; Idrisov, Bulat; Johanns, Casey; LeGrand, Kate E.; Letourneau, Ian D.; Lindstrom, Akiaja; Linebarger, Emily; Lotufo, Paulo A.; Lozano, Rafael; Magistro, Beatrice; Malta, Deborah Carvalho; Mansson, Johan; Herrera, Ana M. Mantilla; Marinho, Fatima; Mirkuzie, Alemnesh H.; Mokdad, Ali H.; Monasta, Lorenzo; Naik, Paulami; Nomura, Shuhei; O'Halloran, James Kevin; Odell, Christopher M.; Olana, Latera Tesfaye; Ostroff, Samuel M.; Pasovic, Maja; de Azeredo Passos, Valeria Maria; Penberthy, Louise; Reinke, Grace; Santomauro, Damian Francesco; Schmidt, Maria Ines; Sholokhov, Aleksei; Spurlock, Emma; Troeger, Christopher E.; Varavikova, Elena; Vo, Anh T.; Vos, Theo; Walcott, Rebecca; Walker, Ally; Wigley, Simon D.; Wiysonge, Charles Shey; Worku, Nahom Alemseged; Wu, Yifan; Hanson, Sarah Wulf; Zheng, Peng; Hay, Simon, I; Murray, Christopher J. L.; Dieleman, Joseph L.		COVID-19 Natl Preparedness Collabo	Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021	LANCET			English	Article							PUBLIC-HEALTH; TRUST; IMPACT; GOVERNMENT; PNEUMONIA; MORTALITY; ALTITUDE	Background National rates of COVID-19 infection and fatality have varied dramatically since the onset of the pandemic. Understanding the conditions associated with this cross-country variation is essential to guiding investment in more effective preparedness and response for future pandemics. Methods Daily SARS-CoV-2 infections and COVID-19 deaths for 177 countries and territories and 181 subnational locations were extracted from the Institute for Health Metrics and Evaluation's modelling database. Cumulative infection rate and infection-fatality ratio (IFR) were estimated and standardised for environmental, demographic, biological, and economic factors. For infections, we included factors associated with environmental seasonality (measured as the relative risk of pneumonia), population density, gross domestic product (GDP) per capita, proportion of the population living below 100 m, and a proxy for previous exposure to other betacoronaviruses. For IFR, factors were age distribution of the population, mean body-mass index (BMI), exposure to air pollution, smoking rates, the proxy for previous exposure to other betacoronaviruses, population density, age-standardised prevalence of chronic obstructive pulmonary disease and cancer, and GDP per capita. These were standardised using indirect age standardisation and multivariate linear models. Standardised national cumulative infection rates and IFRs were tested for associations with 12 pandemic preparedness indices, seven health-care capacity indicators, and ten other demographic, social, and political conditions using linear regression. To investigate pathways by which important factors might affect infections with SARS-CoV-2, we also assessed the relationship between interpersonal and governmental trust and corruption and changes in mobility patterns and COVID-19 vaccination rates. Findings The factors that explained the most variation in cumulative rates of SARS-CoV-2 infection between Jan 1, 2020, and Sept 30, 2021, included the proportion of the population living below 100 m (5-4% [4-0-7-9] of variation), GDP per capita (4-2% [1-8-6-6] of variation), and the proportion of infections attributable to seasonality (2-1% [95% uncertainty interval 1-7-2-7] of variation). Most cross-country variation in cumulative infection rates could not be explained. The factors that explained the most variation in COVID-19 IFR over the same period were the age profile of the country (46-7% [18-4-67-6] of variation), GDP percapita (3-1%[0-3-8-6] ofvariation), and national mean BMI (1-1%[0-2-2-6] ofvariation). 44-4% (29-2-61-7) of cross-national variation in IFR could not be explained. Pandemic-preparedness indices, which aim to measure health security capacity, were not meaningfully associated with standardised infection rates or IFRs. Measures of trust in the government and interpersonal trust, as well as less government corruption, had larger, statistically significant associations with lower standardised infection rates. High levels of government and interpersonal trust, as well as less government corruption, were also associated with higher COVID-19 vaccine coverage among middle-income and high-income countries where vaccine availability was more widespread, and lower corruption was associated with greater reductions in mobility. If these modelled associations were to be causal, an increase in trust of governments such that all countries had societies that attained at least the amount of trust in government or interpersonal trust measured in Denmark, which is in the 75th percentile across these spectrums, might have reduced global infections by 12-9% (5-7-17-8) for government trust and 40-3% (24-3-51-4) for interpersonal trust. Similarly, if all countries had a national BMI equal to or less than that of the 25th percentile, our analysis suggests global standardised IFR would be reduced by 11-1%. Interpretation Efforts to improve pandemic preparedness and response for the next pandemic might benefit from greater investment in risk communication and community engagement strategies to boost the confidence that individuals have in public health guidance. Our results suggest that increasing health promotion for key modifiable risks is associated with a reduction of fatalities in such a scenario. Funding Bill & Melinda Gates Foundation, J Stanton, T Gillespie, J and E Nordstrom, and Bloomberg Philanthropies. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Bollyky, Thomas J.; Kiernan, Samantha] Council Foreign Relat, Washington, DC USA; [Hulland, Erin N.; Barber, Ryan M.; Collins, James K.; Moses, Mark; Pigott, David M.; Reiner Jr, Robert C.; Sorensen, Reed J. D.; Allorant, Adrien; Amlag, Joanne O.; Aravkin, Aleksandr Y.; Bang-Jensen, Bree; Carter, Austin; Castellano, Rachel; Castro, Emma; Chakrabarti, Suman; Combs, Emily; Dai, Xiaochen; Dangel, William James; Dapper, Carolyn; Deen, Amanda; Earl, Lucas; Erickson, Megan; Ewald, Samuel B.; Fedosseeva, Tatiana; Ferrari, Alize J.; Flaxman, Abraham D.; Fullman, Nancy; Gakidou, Emmanuela; Gallagher, John; Giles, John R.; Guo, Gaorui; He, Jiawei; Helak, Monika; Huntley, Bethany M.; Johanns, Casey; LeGrand, Kate E.; Letourneau, Ian D.; Linebarger, Emily; Lozano, Rafael; Mansson, Johan; Mokdad, Ali H.; Naik, Paulami; O'Halloran, James Kevin; Odell, Christopher M.; Ostroff, Samuel M.; Pasovic, Maja; Penberthy, Louise; Reinke, Grace; Santomauro, Damian Francesco; Sholokhov, Aleksei; Spurlock, Emma; Troeger, Christopher E.; Vo, Anh T.; Vos, Theo; Walker, Ally; Wu, Yifan; Hanson, Sarah Wulf; Zheng, Peng; Hay, Simon, I; Murray, Christopher J. L.; Dieleman, Joseph L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Hulland, Erin N.; Sorensen, Reed J. D.; Chakrabarti, Suman] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Pigott, David M.; Reiner Jr, Robert C.; Aravkin, Aleksandr Y.; Dai, Xiaochen; Flaxman, Abraham D.; Gakidou, Emmanuela; Lozano, Rafael; Mokdad, Ali H.; Vos, Theo; Zheng, Peng; Hay, Simon, I; Murray, Christopher J. L.; Dieleman, Joseph L.] Univ Washington, Dept Hlth Metr Sci, Sch Med, Seattle, WA 98195 USA; [Adolph, Christopher] Univ Washington, Dept Polit Sci, Seattle, WA 98195 USA; [Adolph, Christopher] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA; [Aravkin, Aleksandr Y.] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Ostroff, Samuel M.] Univ Washington, Henry M Jackson Sch Int Studies, Seattle, WA 98195 USA; [Walcott, Rebecca] Univ Washington, Evans Sch Publ Policy & Governance, Seattle, WA 98195 USA; [Abbafati, Cristiana] Univ Roma La Sapienza, Dept Jurid & Econ Studies, Rome, Italy; [Duncan, Bruce B.; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil; [Ferrari, Alize J.; Lindstrom, Akiaja; Herrera, Ana M. Mantilla; Santomauro, Damian Francesco] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Spurlock, Emma] Yale Univ, Dept Social & Behav Sci, New Haven, CT USA; [Galal, Bayan] Yale Univ, New Haven, CT USA; [Idrisov, Bulat] Bashkir State Med Univ, Infect Dis Dept, Ufa, Russia; [Idrisov, Bulat] Moscow Inst Phys & Technol, Lab Publ Hlth Indicators Anal & Hlth Digitalizat, Moscow, Russia; [Lindstrom, Akiaja] Queensland Ctr Mental Hlth Res, Sch Publ Hlth, Wacol, Qld, Australia; [Herrera, Ana M. Mantilla] Queensland Ctr Mental Hlth Res, West Moreton Hosp Hlth Serv, Wacol, Qld, Australia; [Santomauro, Damian Francesco] Queensland Ctr Mental Hlth Res, Policy & Epidemiol Grp, Wacol, Qld, Australia; [Lotufo, Paulo A.] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; [Magistro, Beatrice] Univ Toronto, Munk Sch Global Affairs & Publ Policy, Toronto, ON, Canada; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Belo Horizonte, MG, Brazil; [Marinho, Fatima] Univ Fed Minas Gerais, Dept Publ Hlth, Belo Horizonte, MG, Brazil; [de Azeredo Passos, Valeria Maria] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Marinho, Fatima] Vital Strategies, Dept Publ Hlth, Sao Paulo, Brazil; [Mirkuzie, Alemnesh H.; Worku, Nahom Alemseged] Ethiopian Publ Hlth Inst, Natl Data Management Ctr Hlth NDMC, Addis Ababa, Ethiopia; [Mirkuzie, Alemnesh H.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Monasta, Lorenzo] Burlo Garofolo Inst Maternal & Child Hlth, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Nomura, Shuhei] Keio Univ, Dept Hlth Policy & Management, Tokyo, Japan; [Nomura, Shuhei] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Olana, Latera Tesfaye] Addis Ababa Univ, Sch Elect & Comp Engn, Addis Ababa, Ethiopia; [Varavikova, Elena] Minist Hlth FRIHOI, Fed Res Inst Hlth Org & Informat, Cent Res Inst Cytol & Genet, Moscow, Russia; [Wigley, Simon D.] Bilkent Univ, Dept Philosophy, Ankara, Turkey; [Wiysonge, Charles Shey] South African Med Res Council, Cochrane South Africa, Cape Town, South Africa; [Wiysonge, Charles Shey] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Sapienza University Rome; Universidade Federal do Rio Grande do Sul; University of Queensland; Yale University; Yale University; Bashkir State Medical University; Moscow Institute of Physics & Technology; Queensland Centre for Mental Health Research; Queensland Centre for Mental Health Research; Queensland Centre for Mental Health Research; Universidade de Sao Paulo; University of Toronto; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Bergen; IRCCS Burlo Garofolo; Keio University; University of Tokyo; Addis Ababa University; Ihsan Dogramaci Bilkent University; South African Medical Research Council; University of Cape Town	Dieleman, JL (corresponding author), Inst Hlth Metr & Evaluat, Seattle, WA 98105 USA.	dieleman@uw.edu	Hay, Simon Iain/F-8967-2015; Monasta, Lorenzo/B-1388-2012; Wigley, Simon D/A-6664-2013; Lozano, Rafael/T-5352-2018; Ferrari, Alize J/G-1746-2011; Nomura, Shuhei/HCH-5356-2022; Duncan, Bruce/L-4140-2016	Hay, Simon Iain/0000-0002-0611-7272; Monasta, Lorenzo/0000-0001-7774-548X; Wigley, Simon D/0000-0001-9181-0129; Lozano, Rafael/0000-0002-7356-8823; Ferrari, Alize J/0000-0002-7863-9117; Adolph, Christopher/0000-0001-8550-6438; Hulland, Erin/0000-0003-0525-1856; Nomura, Shuhei/0000-0002-2963-7297; Duncan, Bruce/0000-0002-7491-2630	Bloomberg Philanthropies; National Health and Medical Research Council Early Career Fellowship [APP1121516]; Queensland Department of Health; National Science Foundation [FAIN: 2031096]; Department of Health, Queensland Government; South African Medical Research Council	Bloomberg Philanthropies; National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Queensland Department of Health; National Science Foundation(National Science Foundation (NSF)); Department of Health, Queensland Government; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T J Bolyky acknowledges support from Bloomberg Philanthropies. A J Ferrari acknowledges support from a National Health and Medical Research Council Early Career Fellowship Grant APP1121516 and is employed by the Queensland Centre for Mental Health Research, which receives core funding from the Queensland Department of Health. S Nomura acknowledges the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). R C Reiner Jr acknowledges partial support by the National Science Foundation (FAIN: 2031096). D F Santomauro is employed by the Queensland Centre for Mental Health Research, which receives core funding from the Department of Health, Queensland Government. C S Wiysonge is supported by the South African Medical Research Council.	Abascal M, 2015, AM J SOCIOL, V121, P722, DOI 10.1086/683144; Abbey EJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239398; Adamecz-Volgyi A, 2021, SSRN, DOI [10.2139/ssrn.3867690, DOI 10.2139/SSRN.3867690]; Afshin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172277; Aldrich DP, 2015, AM BEHAV SCI, V59, P254, DOI 10.1177/0002764214550299; Anderson CJ, 2003, AM J POLIT SCI, V47, P91, DOI 10.1111/1540-5907.00007; Barber RM, LANCET; Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Blecher E, 2008, J HEALTH ECON, V27, P930, DOI 10.1016/j.jhealeco.2008.02.010; Bollyky T.J., 2021, FOREIGN AFF; Bollyky TJ., 2021, COUNCIL FOREIGN RELA; Bollyky TJ., 2020, IMPROVING PANDEMIC P; Bosancianu C., 2020, SOCARXIV, DOI [10.31235/osf.io/ub3zd, DOI 10.31235/OSF.IO/UB3ZD]; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Lee CT, 2021, medRxiv, DOI 10.1101/2021.02.02.21251013; Chernozhukov V, 2021, J ECONOMETRICS, V220, P23, DOI 10.1016/j.jeconom.2020.09.003; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; COVID-19 Forecasting Team, 2022, LANCET; Crosby S, 2020, THINK GLOBAL HLTH; Daniels ME, 2014, 72 IND TASK FORC; Devine D, 2021, POLIT STUD REV, V19, P274, DOI 10.1177/1478929920948684; Farzanegan MR, EFFECT PUBLIC CORRUP, DOI [10.2139/ssrn.3805464, DOI 10.2139/SSRN.3805464]; Fukuyama F, 2020, FOREIGN AFF, V99, P26; Gachter S, 2004, J ECON BEHAV ORGAN, V55, P505, DOI 10.1016/j.jebo.2003.11.006; GHS Index, 2020, US COVID 19 LEAD WOR; GHS Index, 2020, COVID 19 ID MOST VUL; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Haider N, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820002046; Han Q., 2020, PSYARXIV, DOI [10.31234/osf.io/p5gns, DOI 10.31234/OSF.IO/P5GNS]; IHME, 2021, COVID 19 EST HIST TI; Independent Panel for Pandemic Preparedness and Response (Independent Panel), 2021, COVID 19 MAKE IT LAS; Institute for Health Metrics and Evaluation, 2021, EST TOTAL MORT DUE; Josse J, 2016, J STAT SOFTW, V70; Kaiser K, 2016, SIN TAX REFORM PHILI; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Khan AJ, 2009, B WORLD HEALTH ORGAN, V87, P193, DOI 10.2471/BLT.07.048264; Khosravi M, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7856; Kock RA, 2020, LANCET PLANET HEALTH, V4, pE87, DOI 10.1016/S2542-5196(20)30035-8; Kwon S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24115-7; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Mallapaty S, 2020, NATURE, V585, P16, DOI 10.1038/d41586-020-02483-2; Morse B, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000007; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mueller AL, 2020, AGING-US, V12, P9959, DOI 10.18632/aging.103344; Mukherjee S., 2021, NEW YORKER; Nuzzo JB, 2020, JAMA-J AM MED ASSOC, V324, P1391, DOI 10.1001/jama.2020.17395; Olsen A.L., 2020, WILLINGNESS DISTANCE; Parks CD, 1996, J CONFLICT RESOLUT, V40, P134, DOI 10.1177/0022002796040001007; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Perez-Padilla R, 2004, INT J TUBERC LUNG D, V8, P1315; Perez-Padilla R, 2013, SALUD PUBLICA MEXICO, V55, P92, DOI 10.1590/S0036-36342013000100013; Popkin BM, 2020, OBES REV, V21, DOI 10.1111/obr.13128; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; PUTNAM RD, 1995, J DEMOCRACY, V0006; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravi SJ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003648; Razavi A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002477; Reiner RC, 2021, NAT MED, V27, P94, DOI 10.1038/s41591-020-1132-9; Sorensen RJD, LANCET; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Stolberg SG., 2021, NEW YORK TIMES; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Taillie LS, 2017, PREV MED, V105, pS37, DOI 10.1016/j.ypmed.2017.07.009; US Centers for Disease Control and Prevention, 2020, SCI BRIEF EV US UPD; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Wang H, LANCET; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987	73	44	44	26	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2022	399	10334					1489	1512		10.1016/S0140-6736(22)00172-6	http://dx.doi.org/10.1016/S0140-6736(22)00172-6			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JN	35120592	Green Published, hybrid			2022-12-28	WOS:000795611300023
J	Castelvecchi, D				Castelvecchi, Davide			ASTRONOMERS CLOSE IN ON NEW WAY TO DETECT GRAVITATIONAL WAVES	NATURE			English	News Item						Astronomy and astrophysics	SEARCH											Antoniadis J, 2022, MON NOT R ASTRON SOC, V510, P4873, DOI 10.1093/mnras/stab3418; Arzoumanian Z, 2020, ASTROPHYS J LETT, V905, DOI 10.3847/2041-8213/abd401; Chen S, 2021, MON NOT R ASTRON SOC, V508, P4970, DOI 10.1093/mnras/stab2833; Goncharov B, 2021, ASTROPHYS J LETT, V917, DOI 10.3847/2041-8213/ac17f4	4	1	1	6	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					194	195		10.1038/d41586-022-00170-y	http://dx.doi.org/10.1038/d41586-022-00170-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YV8GO	35087253				2022-12-28	WOS:000752963300012
J	Jacobson, A				Jacobson, Anne			The Path of Courage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jacobson, Anne] 1042 Wenonah Ave, Oak Pk, IL 60304 USA		Jacobson, A (corresponding author), 1042 Wenonah Ave, Oak Pk, IL 60304 USA.	jacann611@yahoo.com						TOLKIEN JR, 1965, FELLOWSHIP RING; Whyte D., 2015, CONSOLATIONS SOLACE	2	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 8	2022	327	6					527	528						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZD5RT	35133412				2022-12-28	WOS:000758257900009
J	Mahase, E				Mahase, Elisabeth			Health leaders question absence of workforce strategy in NHS elective care recovery plan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, 2022, DEL PLAN TACKL COVID	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o343	10.1136/bmj.o343	http://dx.doi.org/10.1136/bmj.o343			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YX5GV	35135812				2022-12-28	WOS:000754132400002
J	Li, X; Luo, X; Wang, S; Xie, K; Liu, XP; Hu, H; Chen, YA; Yao, XC; Pan, JW				Li, Xi; Luo, Xiang; Wang, Shuai; Xie, Ke; Liu, Xiang-Pei; Hu, Hui; Chen, Yu-Ao; Yao, Xing-Can; Pan, Jian-Wei			Second sound attenuation near quantum criticality	SCIENCE			English	Article							UNIVERSAL THERMODYNAMICS; SUPERFLUID TRANSITION; LIQUID-HELIUM; LAMBDA-POINT; FERMI; TEMPERATURE; EXCITATIONS	Second sound attenuation, a distinctive dissipative hydrodynamic phenomenon in a superfluid, is crucial for understanding superfluidity and elucidating critical phenomena. Here, we report the observation of second sound attenuation in a homogeneous Fermi gas of lithium-6 atoms at unitarity by performing Bragg spectroscopy with high energy resolution in the long-wavelength limit. We successfully obtained the temperature dependence of second sound diffusivity D-2 and thermal conductivity kappa. Furthermore, we observed a sudden rise-a precursor of critical divergence-in both D-2 and kappa at a temperature of about 0.95 superfluid transition temperature T-c. This suggests that the unitary Fermi gas has a much larger critical region than does liquid helium. Our results pave the way for determining the universal critical scaling functions near quantum criticality.	[Li, Xi; Luo, Xiang; Wang, Shuai; Xie, Ke; Liu, Xiang-Pei; Hu, Hui; Chen, Yu-Ao; Yao, Xing-Can; Pan, Jian-Wei] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Li, Xi; Luo, Xiang; Wang, Shuai; Xie, Ke; Liu, Xiang-Pei; Hu, Hui; Chen, Yu-Ao; Yao, Xing-Can; Pan, Jian-Wei] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Li, Xi; Luo, Xiang; Wang, Shuai; Xie, Ke; Liu, Xiang-Pei; Chen, Yu-Ao; Yao, Xing-Can; Pan, Jian-Wei] Univ Sci & Technol China, CAS Ctr Excellence Quantum Informat & Quantum Phy, Shanghai Branch, Shanghai 201315, Peoples R China; [Li, Xi; Luo, Xiang; Wang, Shuai; Xie, Ke; Liu, Xiang-Pei; Chen, Yu-Ao; Yao, Xing-Can; Pan, Jian-Wei] Shanghai Res Ctr Quantum Sci, Shanghai 201315, Peoples R China; [Hu, Hui] Swinburne Univ Technol, Ctr Quantum Technol Theory, Melbourne, Vic 3122, Australia	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Swinburne University of Technology	Chen, YA; Yao, XC; Pan, JW (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.; Chen, YA; Yao, XC; Pan, JW (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China.; Chen, YA; Yao, XC; Pan, JW (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Quantum Informat & Quantum Phy, Shanghai Branch, Shanghai 201315, Peoples R China.; Chen, YA; Yao, XC; Pan, JW (corresponding author), Shanghai Res Ctr Quantum Sci, Shanghai 201315, Peoples R China.	yuaochen@ustc.edu.cn; yaoxing@ustc.edu.cn; pan@ustc.edu.cn	Liu, Xiangpei/ABE-2885-2021; HU, Hui/C-6878-2009; Yao, Xingcan/A-2457-2013; Pan, Jian-Wei/A-2332-2010	Yao, Xingcan/0000-0003-2331-7687; Hu, Hui/0000-0002-1541-1756; Pan, Jian-Wei/0000-0002-6100-5142; Luo, Xiang/0000-0001-7234-9760	National Key R&D Program of China [2018YFA0306501]; National Natural Science Foundation of China [11874340]; Chinese Academy of Sciences (CAS); Anhui Initiative in Quantum Information Technologies; Shanghai Municipal Science and Technology Major Project [2019SHZDZX01]; Fundamental Research Funds for the Central Universities [WK2340000081]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Anhui Initiative in Quantum Information Technologies; Shanghai Municipal Science and Technology Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Key R&D Program of China (grant no. 2018YFA0306501), National Natural Science Foundation of China (grant no. 11874340), the Chinese Academy of Sciences (CAS), the Anhui Initiative in Quantum Information Technologies, the Shanghai Municipal Science and Technology Major Project (grant no. 2019SHZDZX01), and the Fundamental Research Funds for the Central Universities (under grant no. WK2340000081).	AHLERS G, 1979, PHYS REV LETT, V43, P1417, DOI 10.1103/PhysRevLett.43.1417; Blake M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.091601; Blakie PB, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033602; Brunello A, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.063614; Burchianti A, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043408; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Donnelly RJ, 1998, J PHYS CHEM REF DATA, V27, P1217, DOI 10.1063/1.556028; Drut JE, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.051601; Ernst PT, 2010, NAT PHYS, V6, P56, DOI 10.1038/NPHYS1476; FERRELL RA, 1983, PHYS REV LETT, V51, P487, DOI 10.1103/PhysRevLett.51.487; FERRELL RA, 1967, PHYS REV LETT, V18, P891, DOI 10.1103/PhysRevLett.18.891; Frank B, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.023301; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Gaunt AL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00721; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Grier AT, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063411; Gustavson TL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.020401; Hartnoll SA, 2015, NAT PHYS, V11, P54, DOI [10.1038/NPHYS3174, 10.1038/nphys3174]; Ho TL, 2010, NAT PHYS, V6, P131, DOI 10.1038/NPHYS1477; HOHENBERG PC, 1976, PHYS REV B, V14, P2865, DOI 10.1103/PhysRevB.14.2865; HOHENBERG PC, 1976, PHYS REV B, V13, P2986, DOI 10.1103/PhysRevB.13.2986; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; HOHENBERG PC, 1965, ANN PHYS-NEW YORK, V34, P291, DOI 10.1016/0003-4916(65)90280-0; Hoinka S, 2017, NAT PHYS, V13, P943, DOI 10.1038/NPHYS4187; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Hou YH, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.043630; Hu H, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043040; Hu H, 2007, NAT PHYS, V3, P469, DOI 10.1038/nphys598; Hu H, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.023615; Hueck K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.060402; Jensen S, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.043402; Joseph JA, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.020401; Khalatnikov I.M., 2000, INTRO THEORY SUPERFL; Kovtun PK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111601; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Landau L, 1941, PHYS REV, V60, P356, DOI 10.1103/PhysRev.60.356; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li X., ZENODO, DOI [10.5281/zenodo.5767197(2021, DOI 10.5281/ZENODO.5767197(2021]; Mukherjee B, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.203402; Mukherjee B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.123401; Murthy PA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.043611; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Papp SB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135301; Pasienski M, 2008, OPT EXPRESS, V16, P2176, DOI 10.1364/OE.16.002176; Pines D., 1989, THEORY QUANTUM LIQUI; Rangamani M, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/01/075; Ries MG, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.230401; Sidorenkov LA, 2013, NATURE, V498, P78, DOI 10.1038/nature12136; SINGSAAS A, 1984, PHYS REV B, V30, P5103, DOI 10.1103/PhysRevB.30.5103; Sobirey L, 2021, SCIENCE, V372, P844, DOI 10.1126/science.abc8793; Son DT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.020604; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; TARVIN JA, 1977, PHYS REV B, V15, P4193, DOI 10.1103/PhysRevB.15.4193; Tisza L, 1938, NATURE, V141, P913, DOI 10.1038/141913a0; Wlazlowski G, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013639; WOODS ADB, 1973, REP PROG PHYS, V36, P1135, DOI 10.1088/0034-4885/36/9/002; Yang TL, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.103001; Zhang PF, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.041601; Zurn G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.135301	61	4	4	16	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					529	+		10.1126/science.abi4480	http://dx.doi.org/10.1126/science.abi4480			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113717				2022-12-28	WOS:000753965100037
J	Saul, H; Gursul, D; Piernas, C				Saul, Helen; Gursul, Deniz; Piernas, Carmen			People carrying excess weight have an increased risk of severe covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Piernas, Carmen] NIHR Ctr Engagement & Disseminat, Twickenham, England		Saul, H (corresponding author), NIHR Ctr Engagement & Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk	Piernas, Carmen/AAT-8276-2020	Piernas, Carmen/0000-0002-7536-922X				Department of Health and Social Care, 2020, POL PAP TACKL OB EMP	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								o141	10.1136/bmj.o141	http://dx.doi.org/10.1136/bmj.o141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE1XC	35110298				2022-12-28	WOS:000758682200010
J	Clemens, SAC; Weckx, L; Clemens, R; Mendes, AVA; Souza, AR; Silveira, MBV; da Guarda, SNF; de Nobrega, MM; Pinto, MID; Gonzalez, IGS; Salvador, N; Franco, MM; Mendonca, RND; Oliveira, ISQ; Souza, BSD; Fraga, M; Aley, P; Bibi, S; Cantrell, L; Dejnirattisai, W; Liu, XX; Mongkolsapaya, J; Supasa, P; Screaton, GR; Lambe, T; Voysey, M; Pollard, AJ				Costa Clemens, Sue Ann; Weckx, Lily; Clemens, Ralf; Almeida Mendes, Ana Verena; Souza, Alessandra Ramos; Silveira, Mariana B., V; Farias da Guarda, Suzete Nascimento; de Nobrega, Maristela Miyamoto; de Moraes Pinto, Maria Isabel; Gonzalez, Isabela G. S.; Salvador, Natalia; Franco, Marilia Miranda; de Avila Mendonca, Renata Navis; Queiroz Oliveira, Isabelle Silva; de Freitas Souza, Bruno Solano; Fraga, Mayara; Aley, Parvinder; Bibi, Sagida; Cantrell, Liberty; Dejnirattisai, Wanwisa; Liu, Xinxue; Mongkolsapaya, Juthathip; Supasa, Piyada; Screaton, Gavin R.; Lambe, Teresa; Voysey, Merryn; Pollard, Andrew J.		RHH-001 Study Team	Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study	LANCET			English	Article								Introduction The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a twodose schedule. We assessed whether a third dose of the homologous or a different vaccine could boost immune responses. Methods RHH-001 is a phase 4, participant masked, two centre, safety and immunogenicity study of Brazilian adults (18 years and older) in Sao Paulo or Salvador who had received two doses of CoronaVac 6 months previously. The third heterologous dose was of either a recombinant adenoviral vectored vaccine (Ad26.COV2-S, Janssen), an mRNA vaccine (BNT162b2, Pfizer-BioNTech), or a recombinant adenoviral-vectored ChAdOx1 nCoV-19 vaccine (AZD1222, AstraZeneca), compared with a third homologous dose of CoronaVac. Participants were randomly assigned (5:6:5:5) by a RedCAP computer randomisation system stratified by site, age group (18-60 years or 61 years and over), and day of randomisation, with a block size of 42. The primary outcome was non-inferiority of anti-spike IgG antibodies 28 days after the booster dose in the heterologous boost groups compared with homologous regimen, using a non-inferiority margin for the geometric mean ratio (heterologous vs homologous) of 0.67. Secondary outcomes included neutralising antibody titres at day 28, local and systemic reactogenicity profiles, adverse events, and serious adverse events. This study was registered with Registro Brasileiro de Ensaios Clinicos, number RBR-9nn3scw. Findings Between Aug 16, and Sept 1, 2021, 1240 participants were randomly assigned to one of the four groups, of whom 1239 were vaccinated and 1205 were eligible for inclusion in the primary analysis. Antibody concentrations were low before administration of a booster dose with detectable neutralising antibodies of 20.4% (95% CI 12.8-30.1) in adults aged 18-60 years and 8.9% (4.2-16.2) in adults 61 years or older. From baseline to day 28 after the booster vaccine, all groups had a substantial rise in IgG antibody concentrations: the geometric fold-rise was 77 (95% CI 67-88) for Ad26.COV2-S, 152 (134-173) for BNT162b2, 90 (77-104) for ChAdOx1 nCoV-19, and 12 (11-14) for CoronaVac. All heterologous regimens had anti-spike IgG responses at day 28 that were superior to homologous booster responses: geometric mean ratios (heterologous vs homologous) were 6.7 (95% CI 5.8-7.7) for Ad26. COV2-S, 13.4 (11.6-15.3) for BNT162b2, and 7.0 (6.1-8.1) for ChAdOx1 nCoV-19. All heterologous boost regimens induced high concentrations of pseudovirus neutralising antibodies. At day 28, all groups except for the homologous boost in the older adults reached 100% seropositivity: geometric mean ratios (heterologous vs homologous) were 8.7 (95% CI 5.9-12.9) for Ad26.COV2-S vaccine, 21.5 (14.5-31.9) for BNT162b2, and 10.6 (7.2-15.6) for ChAdOx1 nCoV-19. Live virus neutralising antibodies were also boosted against delta (B.1.617.2) and omicron variants (B.1.1.529). There were five serious adverse events. Three of which were considered possibly related to the vaccine received: one in the BNT162b2 group and two in the Ad26.COV2-S group. All participants recovered and were discharged home. Interpretation Antibody concentrations were low at 6 months after previous immunisation with two doses of CoronaVac. However, all four vaccines administered as a third dose induced a significant increase in binding and neutralising antibodies, which could improve protection against infection. Heterologous boosting resulted in more robust immune responses than homologous boosting and might enhance protection. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Costa Clemens, Sue Ann; Aley, Parvinder; Bibi, Sagida; Cantrell, Liberty; Liu, Xinxue; Lambe, Teresa; Voysey, Merryn] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England; [Costa Clemens, Sue Ann] Univ Sierra, Inst Global Hlth, Siena, Italy; [Weckx, Lily] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Clemens, Ralf] Int Vaccine Inst, Seoul, South Korea; [Almeida Mendes, Ana Verena] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Almeida Mendes, Ana Verena; Farias da Guarda, Suzete Nascimento; Franco, Marilia Miranda; de Avila Mendonca, Renata Navis; Queiroz Oliveira, Isabelle Silva] Hosp Sao Rafael, Gen Med, Salvador, BA, Brazil; [Almeida Mendes, Ana Verena; Farias da Guarda, Suzete Nascimento; Salvador, Natalia; Franco, Marilia Miranda; de Avila Mendonca, Renata Navis; Queiroz Oliveira, Isabelle Silva; de Freitas Souza, Bruno Solano; Fraga, Mayara] Inst DOr Pesquisa & Ensino, Salvador, BA, Brazil; [Souza, Alessandra Ramos; Silveira, Mariana B., V; de Nobrega, Maristela Miyamoto; de Moraes Pinto, Maria Isabel; Gonzalez, Isabela G. S.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Farias da Guarda, Suzete Nascimento] Univ Fed Bahia, Dept Pediat, Salvador, BA, Brazil; [de Freitas Souza, Bruno Solano] Fiocruz MS, Goncalo Moniz Inst, Salvador, BA, Brazil; [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip; Supasa, Piyada; Screaton, Gavin R.] Univ Oxford, Wellcome Ctr Human Genet, Nuffield Dept Med, Oxford, England; [Screaton, Gavin R.; Lambe, Teresa] Univ Oxford, Acad Med Sci Oxford Inst, Oxford, England; [Voysey, Merryn; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England	University of Oxford; Universidade Federal de Sao Paulo (UNIFESP); International Vaccine Institute; Escola Bahiana de Medicina e Saude Publica; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal da Bahia; Fundacao Oswaldo Cruz; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Pollard, AJ (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England.	andrew.pollard@paediatrics.ox.ac.uk	Cardoso Mourão, João Renato/HHN-7944-2022; Lambe, Teresa/E-5733-2016	Lambe, Teresa/0000-0001-7711-897X; Costa Clemens, Sue Ann/0000-0001-9576-0878; Clemens, Ralf/0000-0003-4685-4207; Felle, Sally/0000-0001-7855-4482; Screaton, Gavin/0000-0002-3549-4309; WECKX, LILY/0000-0003-4949-3582; Solano de Freitas Souza, Bruno/0000-0003-3771-0439	Ministry of Health, Brazil	Ministry of Health, Brazil	Ministry of Health, Brazil.	Feng S, 2021, NAT MED, V27, P2032, DOI 10.1038/s41591-021-01540-1; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Kanokudom S, 2021, SAFETY IMMUNOGENICIT, DOI [10.1101/2021.12.03.21267281, DOI 10.1101/2021.12.03.21267281]; Li J, 2021, HETEROLOGOUS PRIME B, DOI [10.1101/2021.09.03.21263062, DOI 10.1101/2021.09.03.21263062]; Li M., BOOSTER DOSE IS IMMU, DOI [DOI 10.1101/2021.08.03.21261544, 10.1101/2021.08.03.21261544]; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Palacios R., 2021, PROFISCOV STUDY, DOI [10.2139/ssrn.3822780, DOI 10.2139/SSRN.3822780]; Pan H, MEDRXIV, V2021, DOI [10.1101/2021.07.23.21261026, DOI 10.1101/2021.07.23.21261026]; PUrez-Then E., 2021, IMMUNOGENICITY HETER, DOI [10.1101/2021.12.27.21268459, DOI 10.1101/2021.12.27.21268459]; Ranzani O, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2015; Shaw RH, 2021, LANCET, V397, P2043, DOI [10.1016/S0140-6736(21)01158-2, 10.1016/S0140-6736(21)01115-6]; Spencer AJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23173-1; Tanriover MD, 2021, LANCET, V398, P213, DOI 10.1016/S0140-6736(21)01429-X; World Health Organisation, INT STAT BOOST DOS C; World Health Organization, 2021, INT REC HET COVID 19; Zhang JL, 2021, EMERG MICROBES INFEC, V10, P1598, DOI 10.1080/22221751.2021.1957401	17	93	94	16	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					521	529		10.1016/S0140-6736(22)00094-0	http://dx.doi.org/10.1016/S0140-6736(22)00094-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9ZX	35074136	Green Published, hybrid			2022-12-28	WOS:000755144500025
J	Nordstrom, P; Ballin, M; Nordstrom, A				Nordstrom, Peter; Ballin, Marcel; Nordstrom, Anna			Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden	LANCET			English	Article							BNT162B2	Background Vaccine effectiveness against COVID-19 beyond 6 months remains incompletely understood. We aimed to investigate the effectiveness of COVID-19 vaccination against the risk of infection, hospitalisation, and death during the first 9 months after vaccination for the total population of Sweden. Methods This retrospective, total population cohort study was done using data from Swedish nationwide registers. The cohort comprised all individuals vaccinated with two doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2, and matched unvaccinated individuals, with data on vaccinations and infections updated until Oct 4, 2021. Two outcomes were evaluated. The first was SARS-CoV-2 infection of any severity from Jan 12 to Oct 4, 2021. The second was severe COVID-19, defined as hospitalisation for COVID-19 or all-cause 30-day mortality after confirmed infection, from March 15 to Sept 28, 2021. Findings Between Dec 28, 2020, and Oct 4, 2021, 842 974 individuals were fully vaccinated (two doses), and were matched (1:1) to an equal number of unvaccinated individuals (total study cohort n=1 685 948). For the outcome SARS-CoV-2 infection of any severity, the vaccine effectiveness of BNT162b2 waned progressively over time, from 92% (95% CI 92 to 93; p<0.001) at 15-30 days, to 47% (39 to 55; p<0.001) at 121-180 days, and to 23% (-2 to 41; p=0.07) from day 211 onwards. Waning was slightly slower for mRNA-1273, with a vaccine effectiveness of 96% (94 to 97; p<0.001) at 15-30 days and 59% (18 to 79; p=0.012) from day 181 onwards. Waning was also slightly slower for heterologous ChAdOx1 nCoV-19 plus an mRNA vaccine, for which vaccine effectiveness was 89% (79 to 94; p<0.001) at 15-30 days and 66% (41 to 80; p<0.001) from day 121 onwards. By contrast, vaccine effectiveness for homologous ChAdOx1 nCoV-19 vaccine was 68% (52 to 79; p<0.001) at 15-30 days, with no detectable effectiveness from day 121 onwards (-19% [-98 to 28]; p=0.49). For the outcome of severe COVID-19, vaccine effectiveness waned from 89% (82 to 93; p<0.001) at 15-30 days to 64% (44 to 77; p<0.001) from day 121 onwards. Overall, there was some evidence for lower vaccine effectiveness in men than in women and in older individuals than in younger individuals. Interpretation We found progressively waning vaccine effectiveness against SARS-CoV-2 infection of any severity across all subgroups, but the rate of waning differed according to vaccine type. With respect to severe COVID-19, vaccine effectiveness seemed to be better maintained, although some waning became evident after 4 months. The results strengthen the evidence-based rationale for administration of a third vaccine dose as a booster. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Nordstrom, Peter; Ballin, Marcel; Nordstrom, Anna] Umea Univ, Dept Community Med & Rehabil, Unit Geriatr Med, S-90187 Umea, Sweden; [Nordstrom, Peter; Ballin, Marcel] Umea Univ, Sect Sustainable Hlth, Dept Publ Hlth & Clin Med, Umea, Sweden; [Nordstrom, Anna] UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway	Umea University; Umea University; UiT The Arctic University of Tromso	Nordstrom, P (corresponding author), Umea Univ, Dept Community Med & Rehabil, Unit Geriatr Med, S-90187 Umea, Sweden.	peter.nordstrom@umu.se						Andrews A, VACCINE EFFECTIVENES; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Bergman J, 2021, EUR J EPIDEMIOL, V36, P287, DOI 10.1007/s10654-021-00732-w; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; BioNTech, 2021, PFIZ BIONTECH ANN PH; Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Chemaitelly H, 2021, NAT MED, V27, P1614, DOI 10.1038/s41591-021-01446-y; Chung H, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1943; El Sahly HM, 2021, NEW ENGL J MED, V385, P1774, DOI 10.1056/NEJMoa2113017; Falsey AR, 2021, NEW ENGL J MED, V385, P2348, DOI 10.1056/NEJMoa2105290; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Gram MA, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003874; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Iacobucci G, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2113; Katikireddi SV, 2022, LANCET, V399, P25, DOI 10.1016/S0140-6736(21)02754-9; Keehner J, 2021, NEW ENGL J MED, V385, P1330, DOI 10.1056/NEJMc2112981; Levin EG, 2021, NEW ENGL J MED, V385, pE84, DOI 10.1056/NEJMoa2114583; Liu XX, 2021, LANCET, V398, P856, DOI 10.1016/S0140-6736(21)01694-9; Lustig Y, 2021, LANCET RESP MED, V9, P999, DOI 10.1016/S2213-2600(21)00220-4; Naaber P, 2021, LANCET REG HEALTH-EU, V10, DOI 10.1016/j.lanepe.2021.100208; Nordstrom P, 2021, LANCET REG HEALTH-EU, V11, DOI 10.1016/j.lanepe.2021.100249; Normark J, 2021, NEW ENGL J MED, V385, P1049, DOI 10.1056/NEJMc2110716; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Pollard AJ, 2021, NAT REV IMMUNOL, V21, P83, DOI 10.1038/s41577-020-00479-7; Public Health Agency of Sweden, SMINET; Public Health Agency of Sweden, NAT VACC REG; Self WH, 2021, MMWR-MORBID MORTAL W, V70, P1337, DOI 10.15585/mmwr.mm7038e1; Shrotri M, 2021, LANCET, V398, P385, DOI 10.1016/S0140-6736(21)01642-1; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	33	56	57	20	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2022	399	10327					814	823		10.1016/S0140-6736(22)00089-7	http://dx.doi.org/10.1016/S0140-6736(22)00089-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ4WT	35131043	Green Published			2022-12-28	WOS:000762307100022
J	Fuentes, A				Fuentes, Agustin			Racism, Not Race: Answers to Frequently Asked Questions	SCIENCE			English	Book Review									[Fuentes, Agustin] Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA	Princeton University	Fuentes, A (corresponding author), Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA.	afuentes2@princeton.edu						GRAVES JL, 2021, RACISM RACE ANSWERS	1	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					390	390		10.1126/science.abn7276	http://dx.doi.org/10.1126/science.abn7276			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084957				2022-12-28	WOS:000750899500025
J	Ihrie, RA; Henske, EP				Ihrie, Rebecca A.; Henske, Elizabeth P.			Modeling tuberous sclerosis with organoids	SCIENCE			English	Editorial Material									[Ihrie, Rebecca A.] Vanderbilt Univ, Sch Med, Cell & Dev Biol & Neurol Surg, Nashville, TN 37212 USA; [Henske, Elizabeth P.] Harvard Med Sch, Brigham & Womens Hosp, Pulm & Crit Care Med, Boston, MA 02115 USA	Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Henske, EP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Pulm & Crit Care Med, Boston, MA 02115 USA.	ehenske@bwh.harvard.edu						Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y; Bongaarts A, 2017, ONCOTARGET, V8, P95516, DOI 10.18632/oncotarget.20764; Delgado RN, 2022, NATURE, V601, P397, DOI 10.1038/s41586-021-04230-7; Eichmuller O.L., 2022, SCIENCE, V375; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Henske EP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.35; Hernandez JOR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26596-y; Huang W, 2020, CELL, V182, P594, DOI 10.1016/j.cell.2020.06.027; Liu HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98674; Martin P, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-019-0311-3; Rushing GV, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800218; Winden KD, 2019, J NEUROSCI, V39, P9294, DOI 10.1523/JNEUROSCI.0642-19.2019; Zhou J, 2011, GENE DEV, V25, P1595, DOI 10.1101/gad.16750211; Zordan P, 2018, J CLIN INVEST, V128, P1688, DOI 10.1172/JCI96342; Zou J, 2017, EPILEPSIA, V58, P2053, DOI 10.1111/epi.13923	15	2	2	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					382	383		10.1126/science.abn6158	http://dx.doi.org/10.1126/science.abn6158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084978				2022-12-28	WOS:000750899500020
J	Wang, K; Jia, ZJ; Bao, LL; Wang, L; Cao, L; Chi, H; Hu, YL; Li, QQ; Zhou, YJ; Jiang, YA; Zhu, QH; Deng, YQ; Liu, P; Wang, N; Wang, L; Liu, M; Li, YR; Zhu, BL; Fan, KY; Fu, WJ; Yang, P; Pei, XR; Cui, Z; Qin, LL; Ge, PJ; Wu, JJ; Liu, S; Chen, YD; Huang, WJ; Wang, Q; Qin, CF; Wang, YC; Qin, C; Wang, XX				Wang, Kang; Jia, Zijing; Bao, Linilin; Wang, Lei; Cao, Lei; Chi, Hang; Hu, Yaling; Li, Qianqian; Zhou, Yunjiao; Jiang, Yinan; Zhu, Qianhui; Deng, Yongqiang; Liu, Pan; Wang, Nan; Wang, Lin; Liu, Min; Li, Yurong; Zhu, Boling; Fan, Kaiyue; Fu, Wangjun; Yang, Peng; Pei, Xinran; Cui, Zhen; Qin, Lili; Ge, Pingju; Wu, Jiajing; Liu, Shuo; Chen, Yiding; Huang, Weijin; Wang, Qiao; Qin, Cheng-Feng; Wang, Youchun; Qin, Chuan; Wang, Xiangxi			Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants	NATURE			English	Article								Omicron (B.1.1.529), the most heavily mutated SARS-CoV-2 variant so far, is highly resistant to neutralizing antibodies, raising concerns about the effectiveness of antibody therapies and vaccines(1,2). Here we examined whether sera from individuals who received two or three doses of inactivated SARS-CoV-2 vaccine could neutralize authentic Omicron. The seroconversion rates of neutralizing antibodies were 3.3% (2 out of 60) and 95% (57 out of 60) for individuals who had received 2 and 3 doses of vaccine, respectively. For recipients of three vaccine doses, the geometric mean neutralization antibody titre for Omicron was 16.5-fold lower than for the ancestral virus (254). We isolated 323 human monoclonal antibodies derived from memory B cells in triple vaccinees, half of which recognized the receptor-binding domain, and showed that a subset (24 out of 163) potently neutralized all SARS-CoV-2 variants of concern, including Omicron. Therapeutic treatments with representative broadly neutralizing monoclonal antibodies were highly protective against infection of mice with SARS-CoV-2 Beta (B.1.351) and Omicron. Atomic structures of the Omicron spike protein in complex with three classes of antibodies that were active against all five variants of concern defined the binding and neutralizing determinants and revealed a key antibody escape site, G446S, that confers greater resistance to a class of antibodies that bind on the right shoulder of the receptor-binding domain by altering local conformation at the binding interface. Our results rationalize the use of three-dose immunization regimens and suggest that the fundamental epitopes revealed by these broadly ultrapotent antibodies are rational targets for a universal sarbecovirus vaccine.	[Wang, Kang; Jia, Zijing; Wang, Lei; Cao, Lei; Zhu, Qianhui; Liu, Pan; Wang, Nan; Zhu, Boling; Fan, Kaiyue; Fu, Wangjun; Yang, Peng; Pei, Xinran; Cui, Zhen; Wang, Xiangxi] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Natl Lab Macromol, Beijing, Peoples R China; [Jia, Zijing; Wang, Lei; Zhu, Qianhui; Liu, Pan; Fan, Kaiyue; Fu, Wangjun; Yang, Peng; Cui, Zhen; Wang, Xiangxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Bao, Linilin; Qin, Chuan] Chinese Acad Med Sci, Chinese Minist Hlth, Key Lab Human Dis Comparat Med,Inst Lab Anim Sci, Beijing Key Lab Anim Models Emerging & Remerging, Beijing, Peoples R China; [Bao, Linilin; Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China; [Chi, Hang; Deng, Yongqiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol AMMS, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Hu, Yaling; Wang, Lin; Liu, Min; Li, Yurong] Sinovac Biotech, Beijing, Peoples R China; [Li, Qianqian; Wu, Jiajing; Liu, Shuo; Huang, Weijin; Wang, Youchun] Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, Beijing, Peoples R China; [Zhou, Yunjiao; Wang, Qiao] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci,Shanghai Frontiers Sci Ctr Path, Key Lab Med Mol Virol MOE NHC CAMS,Shanghai Inst, Shanghai, Peoples R China; [Jiang, Yinan; Qin, Lili; Ge, Pingju; Chen, Yiding] Acrobiosystems, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Microbiology & Epidemiology; National Institute of Food & Drug Control - China; Fudan University	Wang, XX (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Natl Lab Macromol, Beijing, Peoples R China.; Wang, XX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Qin, C (corresponding author), Chinese Acad Med Sci, Chinese Minist Hlth, Key Lab Human Dis Comparat Med,Inst Lab Anim Sci, Beijing Key Lab Anim Models Emerging & Remerging, Beijing, Peoples R China.; Qin, C (corresponding author), Peking Union Med Coll, Comparat Med Ctr, Beijing, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol AMMS, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Wang, YC (corresponding author), Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, Beijing, Peoples R China.; Wang, Q (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci,Shanghai Frontiers Sci Ctr Path, Key Lab Med Mol Virol MOE NHC CAMS,Shanghai Inst, Shanghai, Peoples R China.	wangqiao@fudan.edu.cn; qincf@bmi.ac.cn; qinchuan@pumc.edu.cn; xiangxi@ibp.ac.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Kang/0000-0002-7467-1953	Strategic Priority Research Program [XDB29010000, XDB37030000]; CAS [YSBR-010]; National Key Research and Development Program [2020YFA0707500, 2018YFA0900801, 2021YFA1301400]; Beijing Municipal Science and Technology Project [Z201100005420017]; National Natural Science Foundation of China [31872730, 32070947]; Ministry of Science and Technology of China [EKPG21-09, CPL-1233]; Ten Thousand Talent Program; NSFS Innovative Research Group [81921005]; Special Research Assistant Project of the Chinese Academy of Sciences	Strategic Priority Research Program(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); National Key Research and Development Program; Beijing Municipal Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ten Thousand Talent Program; NSFS Innovative Research Group; Special Research Assistant Project of the Chinese Academy of Sciences	We thank X. Li, X. Huang and L. Chen for cryo-EM data collection at the Center for Biological imaging (CBI) at the Institute of Biophysics for EM work; Y. Chen, Z. Yang and B. Zhou for technical support on surface plasmon resonance. This work was supported by the Strategic Priority Research Program (XDB29010000, XDB37030000), CAS (YSBR-010), National Key Research and Development Program (2020YFA0707500, 2018YFA0900801, 2021YFA1301400), Beijing Municipal Science and Technology Project (Z201100005420017), National Natural Science Foundation of China (31872730 and 32070947) and Ministry of Science and Technology of China (EKPG21-09 and CPL-1233). X.W. was supported by Ten Thousand Talent Program and the NSFS Innovative Research Group (no. 81921005). K.W. was supported by the Special Research Assistant Project of the Chinese Academy of Sciences.	Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Biswas A, 2020, INT REV IMMUNOL, V39, P21, DOI 10.1080/08830185.2019.1685990; CAMERONI E, NATURE; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; CARRENO JM, NATURE; Chen Q, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwab167; Cui Z., 2021, STRUCTURAL FUNCTIONA, DOI 10.1101/2021.12.29.474402; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Gao Q, 2020, SCIENCE, V369, P77, DOI 10.1126/science.abc1932; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033]; Gardner B. J., 2021, OMICRON B 1 1 529 US, DOI 10.1101/2021.12.10.21267594; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Kathryn W., 2022, LY COV1404 BEBTELOVI, DOI 10.1101/2021.04.30.442182; Lv Z, 2020, SCIENCE, V369, P1505, DOI 10.1126/science.abc5881; Mbaeyi S, 2021, MMWR-MORBID MORTAL W, V70, P1545, DOI 10.15585/mmwr.mm7044e2; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Park YJ, 2022, SCIENCE, V375, P449, DOI 10.1126/science.abm8143; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; SAGE, 2021, INT STAT BOOST DOS C; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Sun Y, 2021, CELL RES, V31, P597, DOI 10.1038/s41422-021-00497-7; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Wang GL, 2021, NEW ENGL J MED, V384, P2354, DOI 10.1056/NEJMc2103022; Wang K., 2021, 3 DOSE INACTIVATED V, DOI 10.1101/2021.09.02.21261735; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wang N, 2021, CELL RES, V31, P101, DOI 10.1038/s41422-020-00446-w; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wilhelm A., 2021, REDUCED NEUTRALIZATI, DOI [10.1101/2021.12.07.21267432, DOI 10.15585/MMWR.MM7011A1EXTERNALICON, DOI 10.1101/2021.12.07.21267432]; Yao HP, 2021, CELL RES, V31, P25, DOI 10.1038/s41422-020-00444-y; Yuan Meng, 2021, Science, V373, P818, DOI [10.1101/2021.02.16.430500, 10.1126/science.abh1139]; Zhang J, 2021, SCIENCE, V374, P1353, DOI [10.1126/science.abl9463, 10.1101/2021.08.17.456689]; Zhou YJ, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108699; Zhu L, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa297; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	39	49	51	26	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2022	603	7903					919	+		10.1038/s41586-022-04466-x	http://dx.doi.org/10.1038/s41586-022-04466-x		JAN 2022	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0E0FI	35090164	hybrid, Green Published			2022-12-28	WOS:000770228700001
J	Jiang, MN; Wang, Y; Liu, FY; Du, HH; Li, YC; Zhang, HH; To, SE; Wang, S; Pan, C; Yu, JH; Quere, D; Wang, ZK				Jiang, Mengnan; Wang, Yang; Liu, Fayu; Du, Hanheng; Li, Yuchao; Zhang, Huanhuan; To, Suet; Wang, Steven; Pan, Chin; Yu, Jihong; Quere, David; Wang, Zuankai			Inhibiting the Leidenfrost effect above 1,000 degrees C for sustained thermal cooling	NATURE			English	Article							DROPLET IMPACT; TEMPERATURE; SURFACE; WATER	The Leidenfrost effect, namely the levitation of drops on hot solids', is known to deteriorate heat transfer at high temperature(2). The Leidenfrost point can be elevated by texturing materials to favour the solid-liquid contact(2-10) and by arranging channels at the surface to decouple the wetting phenomena from the vapour dynamics'. However, maximizing both the Leidenfrost point and thermal cooling across a wide range of temperatures can be mutually exclusive(3,7,8). Here we report a rational design of structured thermal armours that inhibit the Leidenfrost effect up to1,150 degrees C, that is, 600 degrees C more than previously attained, yet preserving heat transfer. Our design consists of steel pillars serving as thermal bridges, an embedded insulating membrane that wicks and spreads the liquid and U-shaped channels for vapour evacuation. The coexistence of materials with contrasting thermal and geometrical properties cooperatively transforms normally uniform temperatures into non-uniform ones, generates lateral wicking at all temperatures and enhances thermal cooling. Structured thermal armours are limited only by their melting point, rather than by a failure in the design. The material can be made flexible, and thus attached to substrates otherwise challenging to structure. Our strategy holds the potential to enable the implementation of efficient water cooling at ultra-high solid temperatures, which is, to date, an uncharted property.	[Jiang, Mengnan; Wang, Yang; Liu, Fayu; Li, Yuchao; Zhang, Huanhuan; Wang, Steven; Pan, Chin; Wang, Zuankai] City Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China; [Jiang, Mengnan; Wang, Yang; Wang, Zuankai] City Univ Hong Kong, Res Ctr Nat Inspired Engn, Hong Kong, Peoples R China; [Wang, Yang; Yu, Jihong] Jilin Univ, Coll Chem, Int Ctr Future Sci, State Key Lab Inorgan Synth & Preparat Chem, Changchun, Peoples R China; [Du, Hanheng; To, Suet] Hong Kong Polytech Univ, Dept Ind & Syst Engn, State Key Lab Ultraprecis Machining Technol, Hong Kong, Peoples R China; [Quere, David] PSL Res Univ, Phys & Mecan Milieux Heterogenes, UMR 7636 CNRS, ESPCI, Paris, France; [Wang, Zuankai] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	City University of Hong Kong; City University of Hong Kong; Jilin University; Hong Kong Polytechnic University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; City University of Hong Kong	Wang, ZK (corresponding author), City Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China.; Wang, ZK (corresponding author), City Univ Hong Kong, Res Ctr Nat Inspired Engn, Hong Kong, Peoples R China.; Yu, JH (corresponding author), Jilin Univ, Coll Chem, Int Ctr Future Sci, State Key Lab Inorgan Synth & Preparat Chem, Changchun, Peoples R China.; Quere, D (corresponding author), PSL Res Univ, Phys & Mecan Milieux Heterogenes, UMR 7636 CNRS, ESPCI, Paris, France.; Wang, ZK (corresponding author), City Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.	jihong@jlu.edu.cn; david.quere@espci.fr; zuanwang@cityu.edu.hk		Jiang, Mengnan/0000-0001-9658-0107; Wang, Yang/0000-0002-7464-9916; LI, Yuchao/0000-0001-9442-8339; Du, Hanheng/0000-0001-7426-3709; Pan, Chin/0000-0002-9000-5678; LIU, Fayu/0000-0002-4062-9896	Research Grants Council of Hong Kong [11218321, C1006-20WF, 11213320]; Tencent Foundation; Innovation and Technology Council [9440248]; National Natural Science Foundation of China [51975502, 21621001]; 111 Project [B17020]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Tencent Foundation; Innovation and Technology Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	We acknowledge financial support from the Research Grants Council of Hong Kong (no. 11218321, no. C1006-20WF and no. 11213320), the Tencent Foundation through the XPLORER PRIZE, the Innovation and Technology Council (no. 9440248), the National Natural Science Foundation of China (grant nos. 51975502 and 21621001) and the 111 Project (no. B17020).	Adera S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3518; Bernardin JD, 1997, INT J HEAT MASS TRAN, V40, P73, DOI 10.1016/S0017-9310(96)00067-1; Burton JC, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.074301; Deng T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3110054; Dhillon NS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9247; Farokhnia N, 2017, LANGMUIR, V33, P2541, DOI 10.1021/acs.langmuir.7b00163; Geraldi NR, 2016, MATER LETT, V176, P205, DOI 10.1016/j.matlet.2016.04.124; HASIMOTO H, 1959, J FLUID MECH, V5, P317, DOI 10.1017/S0022112059000222; Hsu SH, 2015, INT J HEAT MASS TRAN, V86, P65, DOI 10.1016/j.ijheatmasstransfer.2015.02.049; Kim H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560060; Kim SH, 2019, INT J HEAT MASS TRAN, V139, P1, DOI 10.1016/j.ijheatmasstransfer.2019.04.093; Kim SH, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809944; Kruse C, 2013, LANGMUIR, V29, P9798, DOI 10.1021/la401936w; Kwon HM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4828673; Lee GC, 2017, EXP THERM FLUID SCI, V84, P156, DOI 10.1016/j.expthermflusci.2017.01.022; Leidenfrost J. G., 1756, AQUAE COMMUNIS NONNU; Li J, 2016, NAT PHYS, V12, P606, DOI [10.1038/nphys3643, 10.1038/NPHYS3643]; Mao X, 2012, RSC ADV, V2, P12216, DOI 10.1039/c2ra22086e; Nair H, 2014, SOFT MATTER, V10, P2102, DOI 10.1039/c3sm52326h; Rahman MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13145; Sajadi SM, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.4993775; Saranadhi D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600686; Talari V, 2018, FRONT ENERGY, V12, P22, DOI 10.1007/s11708-018-0541-7; Tiwei T, 2017, INT EL DEVICES MEET; Tran T, 2013, SOFT MATTER, V9, P3272, DOI 10.1039/c3sm27643k; Vakarelski IU, 2012, NATURE, V489, P274, DOI 10.1038/nature11418; van Erp R, 2020, NATURE, V585, P211, DOI [10.1038/s41586-020-2666-1, 10.1038/s41586-020-2666]; Wei MY, 2020, APPL PHYS LETT, V116, DOI 10.1063/5.0010510; Weickgenannt CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036310; Yousaf K, 2020, DRY TECHNOL, V38, P2217, DOI 10.1080/07373937.2019.1691011	30	30	30	86	217	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894								10.1038/s41586-021-04307-3	http://dx.doi.org/10.1038/s41586-021-04307-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ3HM	35082423				2022-12-28	WOS:000749203400001
J	Megget, K				Megget, Katrina			How New Zealand's covid-19 strategy failed Maori people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												katrina.megget@googlemail.com						Steyn N, 2021, NEW ZEAL MED J, V134, P28	1	2	2	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o180	10.1136/bmj.o180	http://dx.doi.org/10.1136/bmj.o180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078767	Bronze			2022-12-28	WOS:000759189200009
J	Gostin, LO; Parmet, WE; Rosenbaum, S				Gostin, Lawrence O.; Parmet, Wendy E.; Rosenbaum, Sara			The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Parmet, Wendy E.] Northeastern Univ, Sch Law, Boston, MA 02115 USA; [Rosenbaum, Sara] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA	Georgetown University; Northeastern University; George Washington University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 500 First St NW,Off 810, Washington, DC 20001 USA.	gostin@georgetown.edu						[Anonymous], 2021, FED REGISTER, V86, P61402; Association of State and Territorial Health Officers, 2021, SHIFT LEG LANDSC COV; CMS, 2021, FED REGISTER, V86, P61555; Gostin LO, 2021, JAMA-J AM MED ASSOC, V325, P532, DOI 10.1001/jama.2020.26553; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Our world in data, COR COVID 19 VACC	6	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2022	327	8					713	714		10.1001/jama.2022.0852	http://dx.doi.org/10.1001/jama.2022.0852		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ2NN	35061000	Bronze			2022-12-28	WOS:000745105800005
J	Hammond, P				Hammond, Phil			Honours shouldn't be handed out until after the public covid-19 inquiry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Greenhalgh T, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o1; Gurdasani D, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2530; McKee M, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3015; Wenham C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1295	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2022	376								o181	10.1136/bmj.o181	http://dx.doi.org/10.1136/bmj.o181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	3Q3FW	35063933	Bronze			2022-12-28	WOS:000838119600010
J	Walls, AC; Sprouse, KR; Bowen, JE; Joshi, A; Franko, N; Navarro, MJ; Stewart, C; Cameroni, E; McCallum, M; Goecker, EA; Degli-Angeli, EJ; Logue, J; Greninger, A; Corti, D; Chu, HY; Veesler, D				Walls, Alexandra C.; Sprouse, Kaitlin R.; Bowen, John E.; Joshi, Anshu; Franko, Nicholas; Navarro, Mary Jane; Stewart, Cameron; Cameroni, Elisabetta; McCallum, Matthew; Goecker, Erin A.; Degli-Angeli, Emily J.; Logue, Jenni; Greninger, Alex; Corti, Davide; Chu, Helen Y.; Veesler, David			SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses	CELL			English	Article							SPIKE	Although infections among vaccinated individuals lead to milder COVID-19 symptoms relative to those in unvaccinated subjects, the specificity and durability of antibody responses elicited by breakthrough cases remain unknown. Here, we demonstrate that breakthrough infections induce serum-binding and-neutralizing antibody responses that are markedly more potent, durable, and resilient to spike mutations observed in variants than those in subjects who received only 2 doses of vaccine. However, we show that breakthrough cases, subjects who were vaccinated after infection, and individuals vaccinated three times have serum neutralizing activity of comparable magnitude and breadth, indicating that an increased number of exposures to SARS-CoV-2 antigen(s) enhance the quality of antibody responses. Neutralization of SARS-CoV was moderate, however, underscoring the importance of developing vaccines eliciting broad sarbecovirus immunity for pandemic preparedness.	[Walls, Alexandra C.; Sprouse, Kaitlin R.; Bowen, John E.; Joshi, Anshu; Navarro, Mary Jane; Stewart, Cameron; McCallum, Matthew; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Walls, Alexandra C.; Veesler, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Franko, Nicholas; Logue, Jenni; Chu, Helen Y.] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Cameroni, Elisabetta; Corti, Davide] Humabs Biomed SA, CH-6500 Bellinzona, Switzerland; [Goecker, Erin A.; Degli-Angeli, Emily J.; Greninger, Alex] Univ Washington, Sch Med, Dept Lab Med & Pathol, Seattle, WA USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Walls, AC; Veesler, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Walls, AC; Veesler, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	acwalls@uw.edu; dveesler@uw.edu	Logue, Jennifer K/GLS-7202-2022; Franko, Nicholas Macklin/GNP-3646-2022; Veesler, David/HCH-3986-2022	Logue, Jennifer K/0000-0002-7889-8960; Franko, Nicholas Macklin/0000-0001-8165-6332; 	National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C]; Pew Biomedical Scholars award; Burroughs Wellcome Fund; Bill and Melinda Gates Foundation [OPP1156262]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Biomedical Scholars award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank Hideki Tani (University of Toyama) for providing the reagents neces-sary for preparing VSV pseudotyped viruses. We thank Antonio Lanzavecchia for coordinating SARS-CoV-2 naive blood donors. We thank Christina Lock-wood and Lea Starita for their assistance in providing the sequencing data for participant identification. This study was supported by the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.) , a Pew Biomedical Scholars award (D.V.) , Investigators in the Patho-genesis of Infectious Disease Awards from the Burroughs Wellcome Fund (D.V.) , Fast Grants (D.V.) , and the Bill and Melinda Gates Foundation (OPP1156262 to D.V.) . D.V. is an Investigator of the Howard Hughes Medical Institute.	Arunachalam PS, 2021, NATURE, V594, P253, DOI 10.1038/s41586-021-03530-2; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bedford T., 2020, SCIENCE, V370, P571, DOI [10.1093/cid/ciaa1198, DOI 10.1093/CID/CIAA1198, DOI 10.1126/science.abc0523]; Bowen John E, 2021, bioRxiv, DOI 10.1101/2021.12.19.473391; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Case JB, 2020, CELL HOST MICROBE, V28, P475, DOI 10.1016/j.chom.2020.06.021; Case JB, 2020, CELL HOST MICROBE, V28, P465, DOI 10.1016/j.chom.2020.07.018; Cele S, 2021, NATURE, V593, P142, DOI 10.1038/s41586-021-03471-w; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Cohen AA, 2021, SCIENCE, V371, P735, DOI 10.1126/science.abf6840; Collier A.-R.Y., 2021, MEDRXIV2021101821265; Corbett KS, 2021, SCIENCE, V373, P1325, DOI 10.1126/science.abj0299; Corti D, 2021, CELL, V184, P3086, DOI [10.1016/j.cell.2021.05.005, 10.1016/j.cell.2021.07.027]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1101/2021.12.14.21267755, 10.1016/j.cell.2021.12.033]; Hassan AO, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100230; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; Levine-Tiefenbrun M, 2021, NAT MED, V27, P2108, DOI 10.1038/s41591-021-01575-4; Li B., 2021, EPIDEMIOLOGY, DOI [10.1101/2021.07.07.21260122v2, DOI 10.1101/2021.07.07.21260122, 10.1101/2021.07.07.21260122]; Liu L., 2021, NATURE; Liu Yang, 2021, bioRxiv, DOI 10.1101/2021.08.12.456173; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]; McCallum M, 2021, SCIENCE, V374, P1621, DOI [10.1126/science.abl8506, 10.1101/2021.08.11.455956]; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Paredes M.I., 2021, MEDRXIV2021092921264; Parry H, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-021-00246-9; Planas D., NATURE; Planas D, 2021, NAT MED, V27, P917, DOI [DOI 10.1038/s41591-021-01318-5, 10.1038/s41591-021- 01318-5]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Suryadevara N, 2021, CELL, V184, P2316, DOI 10.1016/j.cell.2021.03.029; Syed AM, 2021, SCIENCE, V374, P1626, DOI 10.1126/science.abl6184; Tan C.S., 2021, AD26 COV2 S BNT162B2; Tan CW, 2021, NEW ENGL J MED, V385, P1401, DOI 10.1056/NEJMoa2108453; Theel ES, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01231-21; Tortorici MA, 2019, NAT STRUCT MOL BIOL, V26, P481, DOI 10.1038/s41594-019-0233-y; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; Walls Alexandra C, 2021, bioRxiv, DOI [10.1016/j.cell.2021.09.015, 10.1101/2021.03.15.435528]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Winkler E.S., 2020, BIORXIV2020122842455; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Ying B., 2021, BIORXIV2021082545769	60	44	45	4	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2022	185	5					872	+		10.1016/j.cell.2022.01.011	http://dx.doi.org/10.1016/j.cell.2022.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZS1YW	35123650	Green Published, hybrid			2022-12-28	WOS:000768268500003
J	Prasad, VM; Leaman, DP; Lovendahl, KN; Croft, JT; Benhaim, MA; Hodge, EA; Zwick, MB; Lee, KK				Prasad, Vidya Mangala; Leaman, Daniel P.; Lovendahl, Klaus N.; Croft, Jacob T.; Benhaim, Mark A.; Hodge, Edgar A.; Zwick, Michael B.; Lee, Kelly K.			Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; EM STRUCTURE; MOLECULAR ARCHITECTURE; CYTOPLASMIC DOMAIN; BINDING-SITE; ENVELOPE; MEMBRANE; PROTEIN	HIV-1 Env mediates viral entry into host cells and is the sole target for neutralizing antibodies. However, Env structure and organization in its native virion context has eluded detailed characterization. Here, we used cryo-electron tomography to analyze Env in mature and immature HIV-1 particles. Immature particles showed distinct Env positioning relative to the underlying Gag lattice, providing insights into long-standing questions about Env incorporation. A 9.1-A sub-tomogram-averaged reconstruction of virion-bound Env in conjunction with structural mass spectrometry revealed unexpected features, including a variable central core of the gp41 subunit, heterogeneous glycosylation between protomers, and a flexible stalk that allows Env tilting and variable exposure of neutralizing epitopes. Together, our results provide an integrative understanding of HIV assembly and structural variation in Env antigen presentation.	[Prasad, Vidya Mangala; Lovendahl, Klaus N.; Croft, Jacob T.; Benhaim, Mark A.; Hodge, Edgar A.; Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Lee, Kelly K.] Univ Washington, Biol Phys Struct & Design Grad Program, Seattle, WA 98195 USA; [Lee, Kelly K.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Leaman, Daniel P.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Prasad, Vidya Mangala] Indian Inst Sci, Mol Biophys Unit, Bengaluru 560012, Karnataka, India; [Benhaim, Mark A.] Alkermes Inc, 900 Winter St, Waltham, MA 02451 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Scripps Research Institute; Indian Institute of Science (IISC) - Bangalore; Alkermes	Lee, KK (corresponding author), Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.; Lee, KK (corresponding author), Univ Washington, Biol Phys Struct & Design Grad Program, Seattle, WA 98195 USA.; Lee, KK (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Zwick, MB (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	zwick@scripps.edu; kklee@uw.edu		Croft, Jacob Tyler/0000-0002-8964-3699; Mangala Prasad, Vidya/0000-0002-4215-5700	National Institutes of Health [S10OD032290]; NIH NIGMS; NIH NIAID [R01GM099989, R01AI140868, T32GM008268, R01AI143563]; James B. Pendleton Charitable Trust; University of Washington's Proteomics Resource [UWPR95794]; Bill & Melinda Gates Foundation [OPP1126258]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); James B. Pendleton Charitable Trust; University of Washington's Proteomics Resource; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank the University of Washington Arnold and Mabel Beckman Cryo-EM Center and the School of Pharmacy Mass Spectrometry Center for data collection time and support. This work was supported by National Institutesof Health grants S10OD032290 and NIH NIGMS and NIAID grants R01GM099989 and R01AI140868 to K.K.L., T32GM008268 to M.A.B., R01AI143563 and the James B. Pendleton Charitable Trust to M.B.Z., and the University of Washington's Proteomics Resource (UWPR95794) . A grant from the Bill & Melinda Gates Foundation (OPP1126258) also supported por-tions of this work.	Adhikary S, 2017, P NATL ACAD SCI USA, V114, pE1786, DOI 10.1073/pnas.1613293114; Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Alfadhli A, 2019, J VIROL, V93, DOI 10.1128/JVI.01079-19; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Berndsen ZT, 2020, P NATL ACAD SCI USA, V117, P28014, DOI 10.1073/pnas.2000260117; Bharat TAM, 2016, NAT PROTOC, V11, P9, DOI 10.1038/nprot.2016.124; Buttler CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04220-w; Cao LW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06121-4; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Cavacini LA, 1998, AIDS RES HUM RETROV, V14, P545, DOI 10.1089/aid.1998.14.545; Celma CCP, 2004, AIDS RES HUM RETROV, V20, P733, DOI 10.1089/0889222041524580; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chen M, 2019, NAT METHODS, V16, P1161, DOI 10.1038/s41592-019-0591-8; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Cottrell CA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008753; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Fang J, 2011, INT J MASS SPECTROM, V302, P19, DOI 10.1016/j.ijms.2010.06.039; Frank GA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6854; Fu QS, 2018, P NATL ACAD SCI USA, V115, pE8892, DOI 10.1073/pnas.1807259115; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Gui L, 2016, J VIROL, V90, P6948, DOI 10.1128/JVI.00240-16; Guttman M, 2016, J AM SOC MASS SPECTR, V27, P662, DOI 10.1007/s13361-015-1330-8; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Guttman M, 2013, J VIROL, V87, P11462, DOI 10.1128/JVI.01681-13; Hamuro Y, 2018, J AM SOC MASS SPECTR, V29, P623, DOI 10.1007/s13361-017-1860-3; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Kim AS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004271; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lee JH, 2015, STRUCTURE, V23, P1943, DOI 10.1016/j.str.2015.07.020; Lee JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9167; Li Z, 2020, NAT STRUCT MOL BIOL, V27, P726, DOI 10.1038/s41594-020-0452-2; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Majumdar R, 2012, J AM SOC MASS SPECTR, V23, P2140, DOI 10.1007/s13361-012-0485-9; Manrique JM, 2001, AIDS RES HUM RETROV, V17, P1615, DOI 10.1089/088922201753342022; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattei S, 2018, P NATL ACAD SCI USA, V115, pE9401, DOI 10.1073/pnas.1811237115; McDonnell NB, 1997, J MED CHEM, V40, P1969, DOI 10.1021/jm970147+; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Moyo T, 2020, EXPERT OPIN THER TAR, V24, P499, DOI 10.1080/14728222.2020.1752183; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pan JH, 2020, J MOL BIOL, V432, P1158, DOI 10.1016/j.jmb.2019.11.028; Pandey A, 2019, LANCET HIV, V6, pE809, DOI 10.1016/S2352-3018(19)30230-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Piai A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16165-0; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; Qu K, 2021, SCIENCE, V373, P700, DOI 10.1126/science.abe6821; Rantalainen K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107583; Rawi R, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108432; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rutebemberwa A, 2007, AIDS RES HUM RETROV, V23, P532, DOI 10.1089/aid.2006.0136; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stadtmueller BM, 2018, IMMUNITY, V49, P235, DOI 10.1016/j.immuni.2018.06.017; Stano A, 2017, J VIROL, V91, DOI 10.1128/JVI.00415-17; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Taniguchi Y, 2000, VIROLOGY, V273, P333, DOI 10.1006/viro.2000.0436; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2014, TRENDS MICROBIOL, V22, P372, DOI 10.1016/j.tim.2014.04.012; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Verkerke HP, 2016, J VIROL, V90, P9471, DOI 10.1128/JVI.01351-16; Wang HQ, 2017, ELIFE, V6, DOI 10.7554/eLife.27389; Wang Y, 2019, P NATL ACAD SCI USA, V116, P22556, DOI 10.1073/pnas.1912427116; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016; Zhang ZQ, 2012, ANAL CHEM, V84, P4942, DOI 10.1021/ac300535r; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	97	7	7	9	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					641	+		10.1016/j.cell.2022.01.013	http://dx.doi.org/10.1016/j.cell.2022.01.013			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7YE	35123651	Green Published, hybrid			2022-12-28	WOS:000759786000001
J	Homer, V; Yap, C; Bond, S; Holmes, J; Stocken, D; Walker, K; Robinson, EJ; Wheeler, G; Brown, S; Hinsley, S; Schipper, M; Weir, CJ; Rantell, K; Prior, T; Yu, LM; Kirkpatrick, J; Bedding, A; Gamble, C; Gaunt, P				Homer, Victoria; Yap, Christina; Bond, Simon; Holmes, Jane; Stocken, Deborah; Walker, Katrina; Robinson, Emily J.; Wheeler, Graham; Brown, Sarah; Hinsley, Samantha; Schipper, Matthew; Weir, Christopher J.; Rantell, Khadija; Prior, Thomas; Yu, Ly-Mee; Kirkpatrick, John; Bedding, Alun; Gamble, Carrol; Gaunt, Piers			Early phase clinical trials extension to guidelines for the content of statistical analysis plans	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTINUAL REASSESSMENT METHOD; DOSE-ESCALATION; DESIGNS	This paper reports guidelines for the content of statistical analysis plans for early phase clinical trials, ensuring specification of the minimum reporting analysis requirements, by detailing extensions (11 new items) and modifications (25 items) to existing guidance after a review by various stakeholders.	[Homer, Victoria; Gaunt, Piers] Univ Birmingham, Canc Res Clin Trials Unit, Birmingham, W Midlands, England; [Yap, Christina] Inst Canc Res, Clin Trials & Stat Unit, London, England; [Bond, Simon] Cambridge Clin Trials Unit, Cambridge, England; [Holmes, Jane] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford Clin Trials Res Unit, Oxford, England; [Stocken, Deborah; Walker, Katrina; Brown, Sarah] Univ Leeds, Leeds Inst Clin Trials Res, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Robinson, Emily J.] Royal Marsden NHS Fdn Trust, Royal Marsden Clin Trials Unit, London, England; [Wheeler, Graham] Imperial Coll London, Imperial Clin Trials Unit, London, England; [Hinsley, Samantha] Univ Glasgow, Canc Res UK Glasgow Clin Trials Unit, Glasgow, Lanark, Scotland; [Schipper, Matthew] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Schipper, Matthew] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Weir, Christopher J.] Univ Edinburgh, Usher Inst, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Rantell, Khadija] Med & Healthcare Prod Regulatory Agcy, London, England; [Prior, Thomas] Janssen Res & Dev, Early Dev Oncol Stat Dept, Spring House, PA USA; [Yu, Ly-Mee] Univ Oxford, Primary Care Clin Trials Unit, Oxford, England; [Kirkpatrick, John; Bedding, Alun] Roche Prod, Welwyn Garden City, Herts, England; [Gamble, Carrol] Univ Liverpool, Liverpool Clin Trials Ctr, Liverpool, Merseyside, England	University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; University of Leeds; Royal Marsden NHS Foundation Trust; Imperial College London; University of Glasgow; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Edinburgh; The Medicines & Healthcare Products Regulatory Agency; Johnson & Johnson; Janssen Pharmaceuticals; University of Oxford; Roche Holding; University of Liverpool	Gaunt, P (corresponding author), Univ Birmingham, Canc Res Clin Trials Unit, Birmingham, W Midlands, England.	p.gaunt@bham.ac.uk	Yap, Christina/B-1418-2017	Yap, Christina/0000-0002-6715-2514; Weir, Christopher/0000-0002-6494-4903; Bond, Simon/0000-0003-2528-1040; Homer, Victoria/0000-0003-3639-7874; Stocken, Deborah/0000-0001-8031-1738; Yu, Ly-Mee/0000-0003-0331-7364	National Institute for Health Research (NIHR) Clinical Trials Unit Support Funding scheme; Cancer Research UK [C22436/A25354, C22436/A28028]; Birmingham Biomedical Research Centre (NIHR); Advanced Therapy Treatment Centre (Innovate UK); UK Clinical Research Collaboration Registered Clinical Trials Unit Network	National Institute for Health Research (NIHR) Clinical Trials Unit Support Funding scheme; Cancer Research UK(Cancer Research UK); Birmingham Biomedical Research Centre (NIHR); Advanced Therapy Treatment Centre (Innovate UK); UK Clinical Research Collaboration Registered Clinical Trials Unit Network	This project is funded by the National Institute for Health Research (NIHR) Clinical Trials Unit Support Funding scheme. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social CaDre. This project was supported and endorsed by the UK Clinical Research Collaboration Registered Clinical Trials Unit Network. Staff at the Cancer Research Clinical Trials Unit are supported by a core funding grant from Cancer Research UK (C22436/A25354 and C22436/A28028), and further grants from Birmingham Biomedical Research Centre (funded by the NIHR) and Advanced Therapy Treatment Centre (funded by Innovate UK).	Babb J, 1998, STAT MED, V17, P1103, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0.CO;2-9; Blair GW, 2018, INT J STROKE, V13, P530, DOI 10.1177/1747493017731947; Brown SR, 2014, STAT PRACT, P1, DOI 10.1002/9781118763612; Cheung YK, 2000, BIOMETRICS, V56, P1177, DOI 10.1111/j.0006-341X.2000.01177.x; Chiodini P, 2020, CONT CLIN TRIAL COMM, V20, DOI 10.1016/j.conctc.2020.100665; Cole M, 2021, TRIALS, V22, DOI 10.1186/s13063-021-05384-5; EFSPI/EFPIA Estimands Implementation Working Group, 2021, EST IMPL WORK GROUP; Eldridge SM, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5239; European Medicines Agency, 2006, ICH E9 STAT PRINC CL; European Medicines Agency, 1994, ICH E4 DOS RESP INF; Eurpoean Medicines Agency, 1996, ICH E3 STRUCT CONT C; Gamble C, 2017, JAMA-J AM MED ASSOC, V318, P2337, DOI 10.1001/jama.2017.18556; Gresham G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14682; Hemming K, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04828-8; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Iasonos A, 2021, BRIT J CANCER, V125, P920, DOI 10.1038/s41416-021-01412-y; ICH E9(R1) Expert Working Group, 2020, EMACHMPICH4362212017; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Ji Y, 2013, J CLIN ONCOL, V31, P1785, DOI 10.1200/JCO.2012.45.7903; Love SB, 2017, BRIT J CANCER, V117, P332, DOI 10.1038/bjc.2017.186; Morris TP, 2019, STAT MED, V38, P2074, DOI 10.1002/sim.8086; Neuenschwander B, 2008, STAT MED, V27, P2420, DOI 10.1002/sim.3230; Oncology Estimand Working Group. Oncology Estimand Working Group, 2021, CROSS IND INT WORK G; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Oron A., 2011, INT J BIOSTAT, V7, DOI [10.2202/1557-4679.1298, DOI 10.2202/1557-4679.1298]; Ramanan AV, 2018, BMC RHEUMATOL, V2, DOI 10.1186/s41927-018-0010-2; Rantell K, 2019, REGULATORY PERSPECTI; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; Royal Statistical Society, 2007, REP WORK PART STAT I; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; UK Clinical Research Collaborative Registered Clinical Trials Units, 2019, 2019 20 UKCRC REG ID; van der Westhuizen A, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020705; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Wheeler GM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-018-0638-z; Yap C, 2017, CLIN CANCER RES, V23, P7440, DOI 10.1158/1078-0432.CCR-17-0582; Yuan I, 2019, PEDIATR ANESTH, V29, P237, DOI 10.1111/pan.13576	37	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								e068177	10.1136/bmj-2021-068177	http://dx.doi.org/10.1136/bmj-2021-068177			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9JI	35131744	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000759192600001
J	Behr, CL; Maddox, KJE; Meara, E; Epstein, AM; Orav, EJ; Barnett, ML				Behr, Caroline L.; Joynt Maddox, Karen E.; Meara, Ellen; Epstein, Arnold M.; Orav, E. John; Barnett, Michael L.			Anti-SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.	[Behr, Caroline L.] Harvard Med Sch, Boston, MA 02115 USA; [Joynt Maddox, Karen E.] Washington Univ, Sch Med St Louis, Dept Internal Med, St Louis, MO 63110 USA; [Meara, Ellen] Dartmouth Coll, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Epstein, Arnold M.; Orav, E. John; Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 411, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Saint Louis University; Washington University (WUSTL); Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge 411, Boston, MA 02115 USA.	mbarnett@hsph.harvard.edu		Meara, Ellen/0000-0003-0211-1970	NIA [K23 AG058806]; Agency for Healthcare Research and Quality [U19 HS024075]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by grant K23 AG058806 from the NIA to Dr Barnett and award U19 HS024075 from the Agency for Healthcare Research and Quality to Drs Meara and Barnett.	Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; National Institutes of Health, UPD COVID 19 TREATM; National Institutes of Health, COR DIS 2019 COVID 1; Office of the Assistant Secretary for Preparedness and Response, UPD DISTR ADM COVID; US Department of Health and Human Services, HHS ANN STAT TERR CO	5	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2022	327	10					980	983		10.1001/jama.2022.1243	http://dx.doi.org/10.1001/jama.2022.1243		FEB 2022	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZT9ON	35119452	Bronze, Green Published			2022-12-28	WOS:000750998100001
J	Stokel-Walker, C				Stokel-Walker, Chris			What do we know about covid vaccines and preventing transmission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Eurostat, 2022, EN STAT OV, P1; Eyre D.W., 2021, IMPACT SARS COV 2 VA, DOI [10.1101/2021.09.28.21264260, DOI 10.1101/2021.09.28.21264260]; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; Lyngse FP., 2021, MEDRXIV, DOI [10.1101/2021.12.27.21268278, DOI 10.1101/2021.12.27.21268278], Patent No. 21268278; Mayor S, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o111; Riemersma KK, 2021073121261387 MED, DOI [10.1101/2021.07.31.21261387, DOI 10.1101/2021.07.31.21261387]; Shah ASV, 2021, NEW ENGL J MED, V385, P1718, DOI 10.1056/NEJMc2106757; Torjesen I, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o89; UK Health Security Agency, 2022, COVID 19 VACC SURV R	9	11	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o298	10.1136/bmj.o298	http://dx.doi.org/10.1136/bmj.o298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121611	Bronze			2022-12-28	WOS:000753552800019
J	Burki, T				Burki, Talha			Fresh questions over Gates Foundation governance	LANCET			English	Editorial Material								The Bill & Melinda Gates Foundation has appointed new trustees, which it says will provide additional oversight. But experts question how effective the changes will be. Talha Burki reports.											0	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					508	508						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35123680				2022-12-28	WOS:000755144500010
J	Santulli, G; Mone, P				Santulli, Gaetano; Mone, Pasquale			In permanent AF with narrow QRS, AV junction ablation plus CRT vs. rate-control drug therapy reduced mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Santulli, Gaetano; Mone, Pasquale] Montefiore Univ Hosp, Albert Einstein Coll Med, New York, NY 10467 USA	Yeshiva University	Santulli, G (corresponding author), Montefiore Univ Hosp, Albert Einstein Coll Med, New York, NY 10467 USA.							Bradley DJ, 2007, HEART RHYTHM, V4, P224, DOI 10.1016/j.hrthm.2006.10.016; Glikson M, 2022, EUROPACE, V24, P71, DOI [10.1093/europace/euab232, 10.1093/eurheartj/ehab364]; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB	2022	175	2					JC21	JC21		10.7326/J21-0016	http://dx.doi.org/10.7326/J21-0016		FEB 2022	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE4HR	35099986				2022-12-28	WOS:000750884600001
J	Kizer, KW; Nadeau, KC				Kizer, Kenneth W.; Nadeau, Kari Christine			Confronting Health Care's Climate Crisis Conundrum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the role that health care plays in climate change, both as a contributor to harm and as a leader in solutions, via approaches that can be implemented by US federal agencies.	[Kizer, Kenneth W.] Atlas Res LLC, 805 15th St NW,Ste 910, Washington, DC 20005 USA; [Nadeau, Kari Christine] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Nadeau, Kari Christine] Sean Parker Ctr Allergy Res, Palo Alto, CA USA	Stanford University	Kizer, KW (corresponding author), Atlas Res LLC, 805 15th St NW,Ste 910, Washington, DC 20005 USA.	kwkizer@atlasresearch.us						[Anonymous], 2021, AR6 CLIM CHANG 2021; [Anonymous], 2019, HLTH CARE HARM; DeAlwis D., COSTS INACTION EC BU; Dzau VJ, 2021, NEW ENGL J MED, V385, P2117, DOI 10.1056/NEJMp2115675; Eckelman MJ, 2020, HEALTH AFFAIR, V39, P2071, DOI 10.1377/hlthaff.2020.01247; GRI, GLOB STAND SUST REP; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; KIZER KW, 1988, JAMA-J AM MED ASSOC, V260, P951, DOI 10.1001/jama.260.7.951; World Health Organization, 2021, COP26 HLTH PROGR OV; Zhao Q, 2021, LANCET PLANET HEALTH, V5, pE415, DOI 10.1016/S2542-5196(21)00081-4	10	2	2	5	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 22	2022	327	8					715	716		10.1001/jama.2022.0259	http://dx.doi.org/10.1001/jama.2022.0259		JAN 2022	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZJ2NN	35099513				2022-12-28	WOS:000750997900001
J	Asche, F; Yang, BX; Gephart, JA; Smith, MD; Anderson, JL; Camp, EV; Garlock, TM; Love, DC; Oglend, A; Straume, HM				Asche, Frank; Yang, Bixuan; Gephart, Jessica A.; Smith, Martin D.; Anderson, James L.; Camp, Edward, V; Garlock, Taryn M.; Love, David C.; Oglend, Atle; Straume, Hans-Martin			China's seafood imports-Not for domestic consumption?	SCIENCE			English	Editorial Material									[Asche, Frank; Camp, Edward, V; Garlock, Taryn M.] Univ Florida, Sch Forest, Fisheries & Geomat Sci & Food Syst Inst, Gainesville, FL 32611 USA; [Asche, Frank; Oglend, Atle] Univ Stavanger, Dept Safety Econ & Planning, Stavanger, Norway; [Yang, Bixuan; Anderson, James L.] Univ Florida, Food & Resource Econ Dept, Gainesville, FL USA; [Yang, Bixuan; Anderson, James L.] Univ Florida, Food Syst Inst, Gainesville, FL USA; [Gephart, Jessica A.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA; [Smith, Martin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Love, David C.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Love, David C.] Johns Hopkins Univ, Dept Environm Hlth & Engn, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Straume, Hans-Martin] BI Norwegian Business Sch, Dept Econ, Bergen, Norway	State University System of Florida; University of Florida; Universitetet i Stavanger; State University System of Florida; University of Florida; State University System of Florida; University of Florida; American University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; BI Norwegian Business School	Asche, F (corresponding author), Univ Florida, Sch Forest, Fisheries & Geomat Sci & Food Syst Inst, Gainesville, FL 32611 USA.; Asche, F (corresponding author), Univ Stavanger, Dept Safety Econ & Planning, Stavanger, Norway.	frank.asche@ufl.edu	Gephart, Jessica/HCH-3165-2022	Garlock, Taryn/0000-0003-3534-7816; Anderson, James L./0000-0003-2942-8345	US Department of Agriculture INFEWS [2018-67003-27408]; Norwegian Research Council [324685, 295114]; Florida Sea Grant	US Department of Agriculture INFEWS; Norwegian Research Council(Research Council of NorwayEuropean Commission); Florida Sea Grant	Funding was provided by the US Department of Agriculture INFEWS grant 2018-67003-27408 (F.A., B.Y.,J.L.A., D.C.L.), Norwegian Research Council grants 324685 and 295114 (F.A., B.Y.,A.O., H.-M.S), and Florida Sea Grant (F.A., J.L.A.). The conclusions are those of the researchers and do not necessarily reflect the views of the funding organizations.	Abbott JK, 2021, MAR POLICY, V133, DOI 10.1016/j.marpol.2021.104733; Adams FG, 2006, WORLD ECON, V29, P95, DOI 10.1111/j.1467-9701.2006.00773.x; Anderson JL, 2018, J COMMOD MARK, V12, P2, DOI 10.1016/j.jcomm.2017.12.004; Asche F, 2018, P NATL ACAD SCI USA, V115, P11221, DOI 10.1073/pnas.1807677115; Asche F, 2015, WORLD DEV, V67, P151, DOI 10.1016/j.worlddev.2014.10.013; Birkenbach AM, 2017, NATURE, V544, P223, DOI 10.1038/nature21728; Crona B, 2020, ONE EARTH, V3, P32, DOI 10.1016/j.oneear.2020.06.013; Gephart JA, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125014; Homans FR, 2005, J ENVIRON ECON MANAG, V49, P381, DOI 10.1016/j.jeem.2003.12.008; Kittinger JN, 2017, SCIENCE, V356, P912, DOI 10.1126/science.aam9969; Kroetz K, 2020, P NATL ACAD SCI USA, V117, P30318, DOI 10.1073/pnas.2003741117; Ng J.S, 2007, GLOB TRAD C AQ FAO U, P221; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Sumaila UR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3801	14	7	7	4	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					386	+		10.1126/science.abl4756	http://dx.doi.org/10.1126/science.abl4756			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084951				2022-12-28	WOS:000750899500023
J	Hoorn, C; Lim, JY				Hoorn, Carina; Lim, Jun Ying			The African trees that conquered Asia	SCIENCE			English	Editorial Material									[Hoorn, Carina] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Lim, Jun Ying] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of Amsterdam; National University of Singapore	Hoorn, C (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	m.c.hoorn@uva.nl; junyinglim@gmail.com	Lim, Jun Ying/AFO-5605-2022	Lim, Jun Ying/0000-0001-7493-2159				Ashton P. S., 1982, Flora Malesiana, I, Spermatophyta, V9, P237; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; Bansal M, 2022, SCIENCE, V375, P455, DOI 10.1126/science.abk2177; Benton MJ, 2022, NEW PHYTOL, V233, P2017, DOI 10.1111/nph.17822; Carrillo JD, 2020, P NATL ACAD SCI USA, V117, P26281, DOI 10.1073/pnas.2009397117; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; Couvreur TLP, 2021, BIOL REV, V96, P16, DOI 10.1111/brv.12644; Heckenhauer J, 2017, BOT J LINN SOC, V185, P1, DOI 10.1093/botlinnean/box044; Khan MA, 2020, PLANT SYST EVOL, V306, DOI 10.1007/s00606-020-01718-z; Klaus S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12132; Kooyman RM, 2019, ANNU REV ECOL EVOL S, V50, P119, DOI 10.1146/annurev-ecolsys-110218-024737; Lim JY, 2022, GLOBAL ECOL BIOGEOGR, V31, P425, DOI 10.1111/geb.13436; Morley RJ, 2018, J TROP ECOL, V34, P209, DOI 10.1017/S0266467418000202; Romero IC, 2020, P NATL ACAD SCI USA, V117, P28496, DOI 10.1073/pnas.2007324117; Shenkin A, 2019, FRONT FOR GLOB CHANG, V2, DOI 10.3389/ffgc.2019.00032	15	0	0	3	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					380	381		10.1126/science.abn6191	http://dx.doi.org/10.1126/science.abn6191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084963				2022-12-28	WOS:000750899500019
J	Fialek, B				Fialek, Bartosz			On the verge of Poland's fifth wave of covid-19, healthcare staff are overworked and disenchanted	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2022, REUTERS 0126; [Anonymous], 2020, PULS MEDYCYNY; [Anonymous], 2022, EURONEWS; Chao-Fong L, 2022, GUARDIAN 0123; Dyer Owen, 2022, BMJ, V376, po137, DOI 10.1136/bmj.o137; Kosc W., 2022, POLITICO; Koschalka B., 2022, NOTES POLAND 0121; OECD/European Observatory on Health Systems and Policies, 2017, POL COUNTR HLTH PROF, DOI [10.1787/9789264283510-en, DOI 10.1787/9789264283510-EN]	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2022	376								o234	10.1136/bmj.o234	http://dx.doi.org/10.1136/bmj.o234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5CT	35086818	Bronze			2022-12-28	WOS:000748641100015
J	Zylstra, AB; Hurricane, OA; Callahan, DA; Kritcher, AL; Ralph, JE; Robey, HF; Ross, JS; Young, CV; Baker, KL; Casey, DT; Doppner, T; Divol, L; Hohenberger, M; Le Pape, S; Pak, A; Patel, PK; Tommasini, R; Ali, SJ; Amendt, PA; Atherton, LJ; Bachmann, B; Bailey, D; Benedetti, LR; Hopkins, LB; Betti, R; Bhandarkar, SD; Biener, J; Bionta, RM; Birge, NW; Bond, EJ; Bradley, DK; Braun, T; Briggs, TM; Bruhn, MW; Celliers, PM; Chang, B; Chapman, T; Chen, H; Choate, C; Christopherson, AR; Clark, DS; Crippen, JW; Dewald, EL; Dittrich, TR; Edwards, MJ; Farmer, WA; Field, JE; Fittinghoff, D; Frenje, J; Gaffney, J; Johnson, MG; Glenzer, SH; Grim, GP; Haan, S; Hahn, KD; Hall, GN; Hammel, BA; Harte, J; Hartouni, E; Heebner, JE; Hernandez, VJ; Herrmann, H; Herrmann, MC; Hinkel, DE; Ho, DD; Holder, JP; Hsing, WW; Huang, H; Humbird, KD; Izumi, N; Jarrott, LC; Jeet, J; Jones, O; Kerbel, GD; Kerr, SM; Khan, SF; Kilkenny, J; Kim, Y; Kleinrath, HG; Kleinrath, VG; Kong, C; Koning, JM; Kroll, JJ; Kruse, MKG; Kustowski, B; Landen, OL; Langer, S; Larson, D; Lemos, NC; Lindl, JD; Ma, T; MacDonald, MJ; MacGowan, BJ; Mackinnon, AJ; MacLaren, SA; MacPhee, AG; Marinak, MM; Mariscal, DA; Marley, EV; Masse, L; Meaney, K; Meezan, NB; Michel, PA; Millot, M; Milovich, JL; Moody, JD; Moore, AS; Morton, JW; Murphy, T; Newman, K; Di Nicola, JMG; Nikroo, A; Nora, R; Patel, MV; Pelz, LJ; Peterson, JL; Ping, Y; Pollock, BB; Ratledge, M; Rice, NG; Rinderknecht, H; Rosen, M; Rubery, MS; Salmonson, JD; Sater, J; Schiaffino, S; Schlossberg, DJ; Schneider, MB; Schroeder, CR; Scott, HA; Sepke, SM; Sequoia, K; Sherlock, MW; Shin, S; Smalyuk, VA; Spears, BK; Springer, PT; Stadermann, M; Stoupin, S; Strozzi, DJ; Suter, LJ; Thomas, CA; Town, RPJ; Tubman, ER; Volegov, PL; Weber, CR; Widmann, K; Wild, C; Wilde, CH; Van Wonterghem, BM; Woods, DT; Woodworth, BN; Yamaguchi, M; Yang, ST; Zimmerman, GB				Zylstra, A. B.; Hurricane, O. A.; Callahan, D. A.; Kritcher, A. L.; Ralph, J. E.; Robey, H. F.; Ross, J. S.; Young, C. V.; Baker, K. L.; Casey, D. T.; Doppner, T.; Divol, L.; Hohenberger, M.; Le Pape, S.; Pak, A.; Patel, P. K.; Tommasini, R.; Ali, S. J.; Amendt, P. A.; Atherton, L. J.; Bachmann, B.; Bailey, D.; Benedetti, L. R.; Berzak Hopkins, L.; Betti, R.; Bhandarkar, S. D.; Biener, J.; Bionta, R. M.; Birge, N. W.; Bond, E. J.; Bradley, D. K.; Braun, T.; Briggs, T. M.; Bruhn, M. W.; Celliers, P. M.; Chang, B.; Chapman, T.; Chen, H.; Choate, C.; Christopherson, A. R.; Clark, D. S.; Crippen, J. W.; Dewald, E. L.; Dittrich, T. R.; Edwards, M. J.; Farmer, W. A.; Field, J. E.; Fittinghoff, D.; Frenje, J.; Gaffney, J.; Gatu Johnson, M.; Glenzer, S. H.; Grim, G. P.; Haan, S.; Hahn, K. D.; Hall, G. N.; Hammel, B. A.; Harte, J.; Hartouni, E.; Heebner, J. E.; Hernandez, V. J.; Herrmann, H.; Herrmann, M. C.; Hinkel, D. E.; Ho, D. D.; Holder, J. P.; Hsing, W. W.; Huang, H.; Humbird, K. D.; Izumi, N.; Jarrott, L. C.; Jeet, J.; Jones, O.; Kerbel, G. D.; Kerr, S. M.; Khan, S. F.; Kilkenny, J.; Kim, Y.; Geppert Kleinrath, H.; Geppert Kleinrath, V.; Kong, C.; Koning, J. M.; Kroll, J. J.; Kruse, M. K. G.; Kustowski, B.; Landen, O. L.; Langer, S.; Larson, D.; Lemos, N. C.; Lindl, J. D.; Ma, T.; MacDonald, M. J.; MacGowan, B. J.; Mackinnon, A. J.; MacLaren, S. A.; MacPhee, A. G.; Marinak, M. M.; Mariscal, D. A.; Marley, E. V.; Masse, L.; Meaney, K.; Meezan, N. B.; Michel, P. A.; Millot, M.; Milovich, J. L.; Moody, J. D.; Moore, A. S.; Morton, J. W.; Murphy, T.; Newman, K.; Di Nicola, J. -M. G.; Nikroo, A.; Nora, R.; Patel, M. V.; Pelz, L. J.; Peterson, J. L.; Ping, Y.; Pollock, B. B.; Ratledge, M.; Rice, N. G.; Rinderknecht, H.; Rosen, M.; Rubery, M. S.; Salmonson, J. D.; Sater, J.; Schiaffino, S.; Schlossberg, D. J.; Schneider, M. B.; Schroeder, C. R.; Scott, H. A.; Sepke, S. M.; Sequoia, K.; Sherlock, M. W.; Shin, S.; Smalyuk, V. A.; Spears, B. K.; Springer, P. T.; Stadermann, M.; Stoupin, S.; Strozzi, D. J.; Suter, L. J.; Thomas, C. A.; Town, R. P. J.; Tubman, E. R.; Volegov, P. L.; Weber, C. R.; Widmann, K.; Wild, C.; Wilde, C. H.; Van Wonterghem, B. M.; Woods, D. T.; Woodworth, B. N.; Yamaguchi, M.; Yang, S. T.; Zimmerman, G. B.			Burning plasma achieved in inertial fusion	NATURE			English	Article							CONFINEMENT FUSION; IGNITION	Obtaining a burning plasma is a critical step towards self-sustaining fusion energy(1). A burning plasma is one in which the fusion reactions themselves are the primary source of heating in the plasma, which is necessary to sustain and propagate the burn, enabling high energy gain. After decades of fusion research, here we achieve a burning-plasma state in the laboratory. These experiments were conducted at the US National Ignition Facility, a laser facility delivering up to 1.9 megajoules of energy in pulses with peak powers up to 500 terawatts. We use the lasers to generate X-rays in a radiation cavity to indirectly drive a fuel-containing capsule via the X-ray ablation pressure, which results in the implosion process compressing and heating the fuel via mechanical work. The burning-plasma state was created using a strategy to increase the spatial scale of the capsule(2,3) through two different implosion concepts(4-7). These experiments show fusion self-heating in excess of the mechanical work injected into the implosions, satisfying several burning-plasma metrics(3,8). Additionally, we describe a subset of experiments that appear to have crossed the static self-heating boundary, where fusion heating surpasses the energy losses from radiation and conduction. These results provide an opportunity to study a-particle-dominated plasmas and burning-plasma physics in the laboratory.	[Zylstra, A. B.; Hurricane, O. A.; Callahan, D. A.; Kritcher, A. L.; Ralph, J. E.; Ross, J. S.; Young, C. V.; Baker, K. L.; Casey, D. T.; Doppner, T.; Divol, L.; Hohenberger, M.; Pak, A.; Patel, P. K.; Tommasini, R.; Ali, S. J.; Amendt, P. A.; Atherton, L. J.; Bachmann, B.; Bailey, D.; Benedetti, L. R.; Berzak Hopkins, L.; Bhandarkar, S. D.; Biener, J.; Bionta, R. M.; Bond, E. J.; Bradley, D. K.; Braun, T.; Briggs, T. M.; Bruhn, M. W.; Celliers, P. M.; Chang, B.; Chapman, T.; Chen, H.; Choate, C.; Christopherson, A. R.; Clark, D. S.; Dewald, E. L.; Dittrich, T. R.; Edwards, M. J.; Farmer, W. A.; Field, J. E.; Fittinghoff, D.; Gaffney, J.; Grim, G. P.; Haan, S.; Hahn, K. D.; Hall, G. N.; Hammel, B. A.; Harte, J.; Hartouni, E.; Heebner, J. E.; Hernandez, V. J.; Herrmann, M. C.; Hinkel, D. E.; Ho, D. D.; Holder, J. P.; Hsing, W. W.; Humbird, K. D.; Izumi, N.; Jarrott, L. C.; Jeet, J.; Jones, O.; Kerbel, G. D.; Kerr, S. M.; Khan, S. F.; Koning, J. M.; Kroll, J. J.; Kruse, M. K. G.; Kustowski, B.; Landen, O. L.; Langer, S.; Larson, D.; Lemos, N. C.; Lindl, J. D.; Ma, T.; MacDonald, M. J.; MacGowan, B. J.; Mackinnon, A. J.; MacLaren, S. A.; MacPhee, A. G.; Marinak, M. M.; Mariscal, D. A.; Marley, E. V.; Masse, L.; Meezan, N. B.; Michel, P. A.; Millot, M.; Milovich, J. L.; Moody, J. D.; Moore, A. S.; Newman, K.; Di Nicola, J. -M. G.; Nikroo, A.; Nora, R.; Patel, M. V.; Pelz, L. J.; Peterson, J. L.; Ping, Y.; Pollock, B. B.; Rosen, M.; Salmonson, J. D.; Sater, J.; Schiaffino, S.; Schlossberg, D. J.; Schneider, M. B.; Schroeder, C. R.; Scott, H. A.; Sepke, S. M.; Sherlock, M. W.; Shin, S.; Smalyuk, V. A.; Spears, B. K.; Springer, P. T.; Stadermann, M.; Stoupin, S.; Strozzi, D. J.; Suter, L. J.; Town, R. P. J.; Tubman, E. R.; Weber, C. R.; Widmann, K.; Van Wonterghem, B. M.; Woods, D. T.; Woodworth, B. N.; Yamaguchi, M.; Yang, S. T.; Zimmerman, G. B.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Robey, H. F.; Birge, N. W.; Herrmann, H.; Kim, Y.; Geppert Kleinrath, H.; Geppert Kleinrath, V.; Meaney, K.; Murphy, T.; Volegov, P. L.; Wilde, C. H.] Los Alamos Natl Lab, Los Alamos, NM USA; [Le Pape, S.] Ecole Polytech, Lab Utilisat Lasers Intenses Chez, Palaiseau, France; [Betti, R.; Rinderknecht, H.; Thomas, C. A.] Univ Rochester, Lab Laser Energet, Rochester, NY USA; [Crippen, J. W.; Kilkenny, J.; Kong, C.; Ratledge, M.; Rice, N. G.; Sequoia, K.] Genom Atom, San Diego, CA USA; [Frenje, J.; Gatu Johnson, M.; Huang, H.; Morton, J. W.; Rubery, M. S.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Glenzer, S. H.] SLAC Natl Accelerator Lab, Menlo Pk, CA USA; [Morton, J. W.; Rubery, M. S.] Atom Weap Estab, Aldermaston, England; [Wild, C.] Diamond Mat, Freiburg, Germany	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Institut Polytechnique de Paris; University of Rochester; Massachusetts Institute of Technology (MIT); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Zylstra, AB; Hurricane, OA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	zylstra1@llnl.gov; hurricane1@llnl.gov	Hohenberger, Matthias/AAX-6682-2020; Casey, Daniel/AAX-3022-2020; Murphy, Thomas J/F-3101-2014; Khan, Shahab/GSO-1694-2022; MILLOT, Marius/GOE-5797-2022; Schlossberg, Dave/GRS-1220-2022; Landen, Otto/AEX-9890-2022; tommasini, riccardo/A-8214-2009	Casey, Daniel/0000-0003-2125-677X; Murphy, Thomas J/0000-0002-6137-9873; Landen, Otto/0000-0002-1499-8217; Holder, Joe/0000-0003-1833-4001; MacDonald, Michael/0000-0002-6295-6978; Masse, Laurent/0000-0002-3587-9671; Schlossberg, David/0000-0002-8713-9448; Marley, Edward/0000-0001-7030-944X; Volegov, Petr/0000-0003-0361-7500; Young, Christopher/0000-0002-8075-7550; Ping, Yuan/0000-0002-4879-9072; Khan, Shahab/0000-0003-0898-9178; Geppert-Kleinrath, Verena/0000-0002-6869-5772; Hall, Gareth/0000-0002-5081-7890; Hernandez, Vincent J./0000-0003-0572-7324; Zylstra, Alex/0000-0003-0489-7479; Nikroo, Abbas/0000-0002-8855-0378; Widmann, Klaus/0000-0001-5623-6619; Bachmann, Benjamin/0000-0001-7992-0018; tommasini, riccardo/0000-0002-1070-3565; Millot, Marius/0000-0003-4414-3532	US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; agency of the US government	US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); agency of the US government	We thank B.Coppi (MIT), S.C. Cowley (PPPL), D.Whyte (MIT), J.Hammer (LLNL), M.Farrell (GA) and J.Kline (LANL) for discussions. The contributions of NIF operations and target fabrication teams to the success of these experiments are acknowledged. This work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. This document was prepared as an account of work sponsored by an agency of the US government. Neither the US government nor Lawrence Livermore National Security, LLC, nor any of their employees makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favouring by the US government or Lawrence Livermore National Security, LLC. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US government or Lawrence Livermore National Security, LLC, and shall not be used for advertising or product endorsement purposes. Document release number: LLNL-JRNL-819741-DRAFT.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Albright B., 2021, PHYS PLASMAS, V26; Amendt P, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5099934; Atzeni S, 2004, PHYS INERTIAL FUSION; Baker KL, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.023210; Baker KL, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.135001; Betti R, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.255003; BOSCH HS, 1992, NUCL FUSION, V32, P611, DOI 10.1088/0029-5515/32/4/I07; Callahan DA, 2018, PHYS PLASMAS, V25, DOI 10.1063/1.5020057; Casey DT, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.025002; Casey DT, 2018, PHYS PLASMAS, V25, DOI 10.1063/1.5019741; Cerjan C, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802196; Christopherson AR, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.021201; Coppi B., 2021, ACAD AD SAKHAROV SCI; de Souza RS, 2019, PHYS REV C, V99, DOI 10.1103/PhysRevC.99.014619; Doppner T, 2020, PHYS PLASMAS, V27, DOI 10.1063/1.5135921; Glenzer SH, 2010, SCIENCE, V327, P1228, DOI 10.1126/science.1185634; Green BJ, 2003, PLASMA PHYS CONTR F, V45, P687, DOI 10.1088/0741-3335/45/5/312; Hohenberger M, 2020, PHYS PLASMAS, V27, DOI 10.1063/5.0019083; Hopkins LB, 2019, PLASMA PHYS CONTR F, V61, DOI 10.1088/1361-6587/aad97e; Hurricane OA, 2020, PHYS PLASMAS, V27, DOI 10.1063/5.0001335; Hurricane OA, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5087256; Hurricane OA, 2019, PLASMA PHYS CONTR F, V61, DOI 10.1088/1361-6587/aaed71; Hurricane OA, 2017, PHYS PLASMAS, V24, DOI 10.1063/1.4994856; Hurricane OA, 2016, NAT PHYS, V12, P800, DOI [10.1038/NPHYS3720, 10.1038/nphys3720]; Hurricane OA, 2014, NATURE, V506, P343, DOI 10.1038/nature13008; Keilhacker M, 1999, NUCL FUSION, V39, P209, DOI 10.1088/0029-5515/39/2/306; Kritcher A., NAT PHYS; Landen OL, 2020, HIGH ENERG DENS PHYS, V36, DOI 10.1016/j.hedp.2020.100755; Landen OL, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3592170; LAWSON JD, 1957, P PHYS SOC LOND B, V70, P6, DOI 10.1088/0370-1301/70/1/303; Le Pape S, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.245003; LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025; LLNL, 2021, LAWRENCE LIVERMORE N; Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740; Meezan NB, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4803915; Michel P, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3325733; Moses EI, 2016, J PHYS CONF SER, V688, DOI 10.1088/1742-6596/688/1/012073; National Academies of Sciences Engineering and Medicine, 2019, FIN REP COMM STRAT P; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Pak A, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.145001; Patel PK, 2020, PHYS PLASMAS, V27, DOI 10.1063/5.0003298; Rinderknecht HG, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.145002; Robey HF, 2018, PHYS PLASMAS, V25, DOI 10.1063/1.5010922; Ross J., 2021, PREPRINT; Spears BK, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3696743; Tommasini R, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.155003; Zylstra AB, 2021, PHYS REV LETT, V126, DOI 10.1103/PhysRevLett.126.025001; Zylstra AB, 2019, PHYS PLASMAS, V26, DOI 10.1063/1.5101074	49	73	72	47	95	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2022	601	7894					542	+		10.1038/s41586-021-04281-w	http://dx.doi.org/10.1038/s41586-021-04281-w			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YQ8HX	35082418	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000749546400021
J	Taylor, L				Taylor, Luke			Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], NEW YORK TIMES; Clemens SAC, LANCET, V2022; PUrez-Then E., 2021, IMMUNOGENICITY HETER, DOI [10.1101/2021.12.27.21268459, DOI 10.1101/2021.12.27.21268459]	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o210	10.1136/bmj.o210	http://dx.doi.org/10.1136/bmj.o210			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078762	Bronze			2022-12-28	WOS:000759189200003
J	Adams, R				Adams, Rachel			Urgent care: disability, pandemic, and the value of a life	LANCET			English	Editorial Material									[Adams, Rachel] Columbia Univ, Dept English & Comparat Literature, New York, NY 10027 USA	Columbia University	Adams, R (corresponding author), Columbia Univ, Dept English & Comparat Literature, New York, NY 10027 USA.	rea15@columbia.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2022	399	10323					430	431						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9YU	35093220	Green Published, Bronze			2022-12-28	WOS:000755141600014
J	Caeymaex, L; Astruc, D; Biran, V; Marcus, L; Flamein, F; Le Bouedec, S; Guillois, B; Remichi, R; Harbi, F; Durrmeyer, X; Casagrande, F; Le Sache, N; Todorova, D; Bilal, A; Olivier, D; Reynaud, A; Jacquin, C; Roze, JC; Layese, R; Danan, C; Jung, C; Decobert, F; Audureau, E				Caeymaex, Laurence; Astruc, Dominique; Biran, Valerie; Marcus, Leila; Flamein, Florence; Le Bouedec, Stephane; Guillois, Bernard; Remichi, Radia; Harbi, Faiza; Durrmeyer, Xavier; Casagrande, Florence; Le Sache, Nolwenn; Todorova, Darina; Bilal, Ali; Olivier, Damien; Reynaud, Audrey; Jacquin, Cecile; Roze, Jean-Christophe; Layese, Richard; Danan, Claude; Jung, Camille; Decobert, Fabrice; Audureau, Etienne			An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trial	LANCET			English	Article							ADVERSE EVENTS; HARM	Background Patients in neonatal intensive care units (NICUs) are at high risk of adverse events. The effects of medical and paramedical education programmes to reduce these have not yet been assessed. Methods In this multicentre, stepped-wedge, cluster-randomised controlled trial done in France, we randomly assigned 12 NICUs to three clusters of four units. Eligible neonates were inpatients in a participating unit for at least 2 days, with a postmenstrual age of 42 weeks or less on admission. Each cluster followed a 4-month multifaceted programme including education about root-cause analysis and care bundles. The primary outcome was the rate of adverse events per 1000 patient-days, measured with a retrospective trigger-tool based chart review masked to allocation of randomly selected files. Analyses used mixed-effects Poisson modelling that adjusted for time. This trial is registered with ClinicalTrials.gov, NCT02598609. Findings Between Nov 23, 2015, and Nov 2, 2017, event rates were analysed for 3454 patients of these 12 NICUs for 65 830 patient-days. The event rate per 1000 patient-days reduced significantly from the control to the intervention period (33.9 vs 22.6; incidence rate ratio 0.67; 95% CI 0.50-0.88; p=0.0048). Interpretation A multiprofessional safety-promoting programme in NICUs reduced the rate of adverse events and severe and preventable adverse events in highly vulnerable patients. This programme could significantly improve care offered to critically ill neonates. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Caeymaex, Laurence; Durrmeyer, Xavier; Jacquin, Cecile; Danan, Claude; Decobert, Fabrice] Ctr Hosp Intercommunal Creteil, Neonatal Intens Care Unit, Creteil, France; [Caeymaex, Laurence; Durrmeyer, Xavier; Danan, Claude; Jung, Camille] Ctr Hosp Intercommunal Creteil, Clin Res Ctr, Creteil, France; [Caeymaex, Laurence; Durrmeyer, Xavier] Univ Paris Est Creteil, Fac Med, Creteil, France; [Layese, Richard; Audureau, Etienne] Univ Paris Est Creteil, INSERM, IMRB, CEpiATeam, Creteil, France; [Astruc, Dominique] Univ Hosp Strasbourg, Dept Neonatal Med, Strasbourg, France; [Biran, Valerie] CHU Robert Debre, AP HP, Neonatal Intens Care Unit, Paris, France; [Biran, Valerie] Univ Paris, Sorbonne Paris Cite, Inserm U1141, Paris, France; [Marcus, Leila] Ctr Hosp Univ Grenoble, Neonatal Intens Care Unit, Grenoble, France; [Flamein, Florence; Olivier, Damien] CHU Lille, Neonatal Intens Care Unit, Lille, France; [Flamein, Florence] Clin Invest Ctr, CIC 1403, Lille, France; [Le Bouedec, Stephane] Ctr Hosp Univ Angers, Neonatal Intens Care Unit, Angers, France; [Guillois, Bernard] Ctr Hosp Univ Caen, Neonatal Intens Care Unit, Caen, France; [Guillois, Bernard] Univ Caen Normandie, Caen, France; [Remichi, Radia] Ctr Hosp Intercommunal Poissy St Germain, Neonatal Intens Care Unit, Poissy, France; [Harbi, Faiza] Ctr Hosp Delafontaine, Neonatal Intens Care Unit, St Denis, France; [Casagrande, Florence] Ctr Hosp Univ Nice, Neonatal Intens Care Unit, Nice, France; [Le Sache, Nolwenn] Bicetre Hosp, AP HP, Pediat Intens Care & Neonatal Med, Le Kremlin Bicetre, France; [Le Sache, Nolwenn] Paris Saclay Univ, Le Kremlin Bicetre, France; [Todorova, Darina] Ctr Hosp Rene Dubos, Neonatal Intens Care Unit, Cergy Pontoise, France; [Bilal, Ali] Ctr Hosp Troyes, Neonatal Intens Care Unit, Troyes, France; [Olivier, Damien] Ctr Hosp Luxembourg, Neonatal Intens Care Unit, Luxembourg, Luxembourg; [Reynaud, Audrey] Assoc SOS Prema, Boulogne Billancourt, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Layese, Richard; Audureau, Etienne] Hop Henri Mondor, AP HP, Unite Rech Clin URC Mondor, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Hospital Chi of Poissy Saint Germain; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Rene Dubos, Pontoise; Luxembourg Hospital Center; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Caeymaex, L (corresponding author), Ctr Hosp Intercommunal Creteil, Neonatal Intens Care Unit, Creteil, France.; Caeymaex, L (corresponding author), Ctr Hosp Intercommunal Creteil, Clin Res Ctr, Creteil, France.	laurence.caeymaex@chicreteil.fr	Biran, Valerie/GQY-8192-2022; Audureau, Etienne/AHE-2826-2022; LAYESE, Richard/R-4395-2018	Audureau, Etienne/0000-0002-6166-149X; LAYESE, Richard/0000-0002-2855-4908; JUNG, Camille/0000-0001-8486-8939	Health Ministry, France	Health Ministry, France	Solidarity and Health Ministry, France	Agency for Healthcare Research and Quality, COMPR UN SAF PROGR C; Alleman BW, 2013, PEDIATRICS, V132, pE175, DOI 10.1542/peds.2012-3707; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Caeymaex L, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020912; Chow S, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00225; De Luca D, 2021, SEMIN FETAL NEONAT M, V26, DOI 10.1016/j.siny.2021.101230; Debouck F, 2012, CANCER RADIOTHER, V16, P201, DOI 10.1016/j.canrad.2011.12.002; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Hemming K, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1833-7; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Jacob J, 2015, PEDIATRICS, V135, pE59, DOI 10.1542/peds.2014-2967; Kanter David E, 2004, Pediatr Crit Care Med, V5, P119; Kugelman A, 2008, PEDIATRICS, V122, P550, DOI 10.1542/peds.2007-2729; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Ligi I, 2008, LANCET, V371, P404, DOI 10.1016/S0140-6736(08)60204-4; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; McEwan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169604; Nabhan M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-128; *NAT COORD COUNC M, TAX MED ERR; Okuyama A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-61; Panagos PG, 2017, CLIN PERINATOL, V44, P645, DOI 10.1016/j.clp.2017.05.006; Raju TNK, 2011, PEDIATR RES, V70, P109, DOI 10.1203/PDR.0b013e3182182853; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Snijders C, 2007, ARCH DIS CHILD-FETAL, V92, P391, DOI 10.1136/adc.2006.106419; Stevens TP, 2012, ACTA PAEDIATR, V101, P11, DOI 10.1111/j.1651-2227.2011.02547.x; TeamSTEPPS, AFHRAQ; Thomas L, 2013, BMJ QUAL SAF, V22, P425, DOI 10.1136/bmjqs-2012-001011; Woods D, 2005, PEDIATRICS, V115, P155, DOI 10.1542/peds.2004-0410; Zeitlin J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i2976; Zingg W, 2017, LANCET INFECT DIS, V17, P381, DOI 10.1016/S1473-3099(16)30517-5	32	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					384	392						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YL7CQ	35065786				2022-12-28	WOS:000746046100021
J	Mahase, E				Mahase, Elisabeth			NICE recommends weight loss drug semaglutide for obese adults	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2022, SEM MAN OV OB; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183	2	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2022	376								o340	10.1136/bmj.o340	http://dx.doi.org/10.1136/bmj.o340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZF8EL	35135753				2022-12-28	WOS:000759803000001
J	Kentish-Barnes, N; Chevret, S; Valade, S; Jaber, S; Kerhuel, L; Guisset, O; Martin, M; Mazaud, A; Papazian, L; Argaud, L; Demoule, A; Schnell, D; Lebas, E; Ethuin, F; Hammad, E; Merceron, S; Audibert, J; Blayau, C; Delannoy, PY; Lautrette, A; Lesieur, O; Renault, A; Reuter, D; Terzi, N; Philippon-Jouve, B; Fiancette, M; Ramakers, M; Rigaud, JP; Souppart, V; Asehnoune, K; Champigneulle, B; Goldgran-Toledano, D; Dubost, JL; Bollaert, PE; Chouquer, R; Pochard, F; Cariou, A; Azoulay, E				Kentish-Barnes, Nancy; Chevret, Sylvie; Valade, Sandrine; Jaber, Samir; Kerhuel, Lionel; Guisset, Olivier; Martin, Maelle; Mazaud, Amelie; Papazian, Laurent; Argaud, Laurent; Demoule, Alexandre; Schnell, David; Lebas, Eddy; Ethuin, Frederic; Hammad, Emmanuelle; Merceron, Sybille; Audibert, Juliette; Blayau, Clarisse; Delannoy, Pierre-Yves; Lautrette, Alexandre; Lesieur, Olivier; Renault, Anne; Reuter, Danielle; Terzi, Nicolas; Philippon-Jouve, Benedicte; Fiancette, Maud; Ramakers, Michel; Rigaud, Jean-Philippe; Souppart, Virginie; Asehnoune, Karim; Champigneulle, Benoit; Goldgran-Toledano, Dany; Dubost, Jean-Louis; Bollaert, Pierre-Edouard; Chouquer, Renaud; Pochard, Frederic; Cariou, Alain; Azoulay, Elie			A three-step support strategy for relatives of patients dying in the intensive care unit: a cluster randomised trial	LANCET			English	Article							OF-LIFE CARE; BEREAVED FAMILY-MEMBERS; PALLIATIVE CARE; COMPLICATED GRIEF; COMMUNICATION; DEATH; QUALITY; SYMPTOMS; OUTCOMES; INTERVENTION	Background In relatives of patients dying in intensive care units (ICUs), inadequate team support can increase the prevalence of prolonged grief and other psychological harm. We aimed to evaluate whether a proactive communication and support intervention would improve relatives' outcomes. Methods We undertook a prospective, multicentre, cluster randomised controlled trial in 34 ICUs in France, to compare standard care with a physician-driven, nurse-aided, three-step support strategy for families throughout the dying process, following a decision to withdraw or withhold life support. Inclusion criteria were relatives of patients older than 18 years with an ICU length of stay 2 days or longer. Participating ICUs were randomly assigned (1:1 ratio) into an intervention cluster and a control cluster. The randomisation scheme was generated centrally by a statistician not otherwise involved in the study, using permutation blocks of non-released size. In the intervention group, three meetings were held with relatives: a family conference to prepare the relatives for the imminent death, an ICU-room visit to provide active support, and a meeting after the patient's death to offer condolences and closure. ICUs randomly assigned to the control group applied their best standard of care in terms of support and communication with relatives of dying patients. The primary endpoint was the proportion of relatives with prolonged grief (measured with PG-13, score >= 30) 6 months after the death. Analysis was by intention to treat, with the bereaved relatives as the unit of observation. The study is registered with ClinicalTrials.gov, NCT02955992. Findings Between Feb 23, 2017, and Oct 8, 2019, we enrolled 484 relatives of ICU patients to the intervention group and 391 to the control group. 379 (78%) relatives in the intervention group and 309 (79%) in the control group completed the 6-month interview to measure the primary endpoint. The intervention significantly reduced the number of relatives with prolonged grief symptoms (66 [21%] vs 57 [15%]; p=0.035) and the median PG-13 score was significantly lower in the intervention group than in the control group (19 [IQR 14-26] vs 21 [15-29], mean difference 2.5, 95% CI 1.04-3.95). Interpretation Among relatives of patients dying in the ICU, a physician-driven, nurse-aided, three-step support strategy significantly reduced prolonged grief symptoms. Copyright (C) 2022 Published by Elsevier Ltd. All rights reserved.	[Kentish-Barnes, Nancy; Valade, Sandrine; Kerhuel, Lionel; Souppart, Virginie; Pochard, Frederic; Azoulay, Elie] St Louis Hosp, AP HP Nord, Med Intens Care, Famirea Res Grp, Paris, France; [Chevret, Sylvie; Azoulay, Elie] Paris Univ, St Louis Hosp, AP HP, UMR 1153,ECSTRRA Team,INSERM,Dept Biostat & Med I, Paris, France; [Valade, Sandrine; Cariou, Alain] Cochin Hosp, AP HP Ctr, Med Intens Care, Paris, France; [Cariou, Alain] Paris Univ, Paris, France; [Jaber, Samir] St Eloi Univ Hosp, Dept Anesthesia & Crit Care Med, Montpellier, France; [Jaber, Samir] Univ Montpellier, INSERM, CNRS, PhyMedExp, Montpellier, France; [Guisset, Olivier] St Andre Univ Hosp, Med Intens Care, Bordeaux, France; [Martin, Maelle] Hotel Dieu Univ Hosp, Med Intens Care, Nantes, France; [Mazaud, Amelie] Hosp Civils Lyon, Edouard Herriot Univ Hosp, Surg Intens Care, Lyon, France; [Papazian, Laurent] Hop Nord Marseille, AP HM, Med Intens Care, Marseille, France; [Papazian, Laurent] Aix Marseille Univ, Fac Sci Med & Paramed, Ctr Etud & Rech Sur, Serv Sante & Qualite Vie EA 3279, Marseille, France; [Argaud, Laurent] Hosp Civils Lyon, Edouard Herriot Hosp, Med Intens Care, Lyon, France; [Argaud, Laurent] Univ Lyon, Lyon, France; [Demoule, Alexandre] Sorbonne Univ, La Pitie Salpetriere Univ Hosp, AP HP, Med Intens Care Unit, Paris, France; [Demoule, Alexandre] Sorbonne Univ, INSERM, UMRS11S8, Neurophysiol Resp Expt & Clin, Paris, France; [Schnell, David] Angouleme Hosp, Med & Surg Intens Care, Angouleme, France; [Lebas, Eddy] Bretagne Atlantique Hosp, Med & Surg Intens Care, Vannes, France; [Ethuin, Frederic] Cote Nacre Univ Hosp, Surg Intens Care, Caen, France; [Hammad, Emmanuelle] Hosp Nord, AP HM, Anaesthesia & Intens Care, Marseille, France; [Merceron, Sybille] Andre Mignot Hosp, Med Intens Care, Le Chesnay, France; [Audibert, Juliette] Louis Pasteur Hosp, Med & Surg Intens Care, Chartres, Eure & Loir, France; [Blayau, Clarisse] Sorbonne Univ, Tenon Hosp, AP HP, Med Intens Care, Paris, France; [Delannoy, Pierre-Yves] Chatilliez Hosp, Med & Surg Intens Care, Tourcoing, France; [Lautrette, Alexandre] Gabriel Montpied Univ Hosp, Med Intens Care, Clermont Ferrand, France; [Lesieur, Olivier] La Rochelle Hosp, Med & Surg Intens Care, La Rochelle, France; [Renault, Anne] Cavale Blanche Univ Hosp, Med Intens Care, Brest, France; [Reuter, Danielle] Sud Francilien Hosp, Med & Surg Intens Care, Evry, France; [Terzi, Nicolas] Grenoble Alpes Univ Hosp, Med Intens Care, Grenoble, France; [Philippon-Jouve, Benedicte] Roanne Hosp, Med & Surg Intens Care, Roanne, France; [Fiancette, Maud] Les Oudairies Hosp, Med & Surg Intens Care, La Roche Sur Yon, France; [Ramakers, Michel] St Lo Hosp, Med & Surg Intens Care, St Lo, France; [Rigaud, Jean-Philippe] Dieppe Hosp, Med & Surg Intens Care, Paris, France; [Asehnoune, Karim] Hotel Dieu Univ Hosp, Dept Anesthesia & Crit Care, Nantes, France; [Champigneulle, Benoit] Hop Europeen Georges Pompidou, AP HP Ctr, Dept Aaesthesia & Crit Care, Paris, France; [Goldgran-Toledano, Dany] Montfermeil Hosp, Med & Surg Intens Care, Montfermeil, France; [Dubost, Jean-Louis] Rene Dubos Hosp, Med & Surg Intens Care, Pontoise, France; [Bollaert, Pierre-Edouard] Univ Hosp Cent, Med Intens Care, Nancy, France; [Chouquer, Renaud] Annecy Hosp, Med & Surg Intens Care, Annecy, France; [Pochard, Frederic] Fernand Widal Hosp, AP HP Nord, DMU Neurosdences, Dept Psychiat & Med Addictol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU Bordeaux; Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre Hospitalier de Versailles; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; CHU Brest; Centre Hospitalier Sud Francilien; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHD Vendee; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Rene Dubos, Pontoise; Centre Hospitalier Annecy Genevois; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Kentish-Barnes, N (corresponding author), Hop St Louis, Med ICU, F-75010 Paris, France.	nancy.kentish@aphp.fr	Carmen, Team3/Y-7384-2019	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236	French Ministry of Health	French Ministry of Health	French Ministry of Health	Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Carson SS, 2016, JAMA-J AM MED ASSOC, V316, P51, DOI 10.1001/jama.2016.8474; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2013, JAMA-J AM MED ASSOC, V310, P2271, DOI 10.1001/jama.2013.282081; Curtis JR, 2011, AM J RESP CRIT CARE, V183, P348, DOI 10.1164/rccm.201006-1004OC; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Curtis JR, 2005, AM J RESP CRIT CARE, V171, P844, DOI 10.1164/rccm.200409-1267OC; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; Davidson JE, 2017, CRIT CARE MED, V45, P103, DOI 10.1097/CCM.0000000000002169; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Kentish-Barnes N, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3084-7; Kentish-Barnes N, 2017, INTENS CARE MED, V43, P473, DOI 10.1007/s00134-016-4669-9; Kentish-Barnes N, 2016, INTENS CARE MED, V42, P995, DOI 10.1007/s00134-016-4260-4; Kentish-Barnes N, 2015, CRIT CARE MED, V43, P1839, DOI 10.1097/CCM.0000000000001092; Kentish-Barnes N, 2015, EUR RESPIR J, V45, P1341, DOI 10.1183/09031936.00160014; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Little P, 2015, BRIT J GEN PRACT, V65, pE351, DOI 10.3399/bjgp15X685237; Meakin R, 2002, FAM PRACT, V19, P257, DOI 10.1093/fampra/19.3.257; Nelson JE, 2006, QUAL SAF HEALTH CARE, V15, P264, DOI 10.1136/qshc.2005.017707; Nelson JE, 2012, J PALLIAT MED, V15, P168, DOI 10.1089/jpm.2011.9599; Nelson JE, 2010, CRIT CARE MED, V38, P808, DOI 10.1097/CCM.0b013e3181c5887c; Otani H, 2017, J PAIN SYMPTOM MANAG, V54, P273, DOI 10.1016/j.jpainsymman.2017.07.010; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Selph RB, 2008, J GEN INTERN MED, V23, P1311, DOI 10.1007/s11606-008-0643-8; Shear MK, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0406-z; TILDEN VP, 1995, ARCH INTERN MED, V155, P633, DOI 10.1001/archinte.155.6.633; White DB, 2018, NEW ENGL J MED, V378, P2365, DOI 10.1056/NEJMoa1802637; Wilson JP, 2004, ASSESSING PSYCHOL TR, V2nd	30	9	9	14	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					656	664		10.1016/S0140-6736(21)02176-0	http://dx.doi.org/10.1016/S0140-6736(21)02176-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY1RO	35065008	Green Submitted			2022-12-28	WOS:000754571600023
J	Samarasekera, U				Samarasekera, Udani			Ayoade Alakija: advancing equity in the COVID-19 response	LANCET			English	Biographical-Item																			0	1	1	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					511	511						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY9ZX	35123683	Green Published			2022-12-28	WOS:000755144500013
J	Dyer, O				Dyer, Owen			Protests erupt in Poland as woman dies after hospital refuses to remove dead fetus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Blessed Virgin Mary Provincial Specialist Hospital, 2022, HOSP MANAGEMENT STAT; Dyer O, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2698; Theus J., 2022, DEATH 37 YEAR OLD AG	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o250	10.1136/bmj.o250	http://dx.doi.org/10.1136/bmj.o250			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091429				2022-12-28	WOS:000749313200011
J	Gates, K				Gates, Khalilah			Sitting in Our Discomfort	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BIAS; RACE		[Gates, Khalilah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gates, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Haider AH, 2015, JAMA SURG, V150, P457, DOI 10.1001/jamasurg.2014.4038; Nelson AR, 2003, ANN THORAC SURG, V76, pS1377, DOI 10.1016/S0003-4975(03)01205-0; Ruiz JG, 2015, GERONTOL GERIATR EDU, V36, P58, DOI 10.1080/02701960.2014.966904; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806	5	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4								10.1056/NEJMpv2119290	http://dx.doi.org/10.1056/NEJMpv2119290			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081287	Bronze			2022-12-28	WOS:000753548900003
J	Patel, A; Tillman, BF				Patel, Ameet; Tillman, Benjamin F.			Spur-Cell Hemolytic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patel, Ameet; Tillman, Benjamin F.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Tillman, BF (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	benjamin.f.tillman@vumc.org							0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2022	386	4								10.1056/NEJMicm2101673	http://dx.doi.org/10.1056/NEJMicm2101673			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6UB	35081282				2022-12-28	WOS:000753548900002
J	Hahn, J; Cook, NR; Alexander, EK; Friedman, S; Walter, J; Bubes, V; Kotler, G; Lee, IM; Manson, JE; Costenbader, KH				Hahn, Jill; Cook, Nancy R.; Alexander, Erik K.; Friedman, Sonia; Walter, Joseph; Bubes, Vadim; Kotler, Gregory; Lee, I-Min; Manson, JoAnn E.; Costenbader, Karen H.			Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; PREVENTION	OBJECTIVE To investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk. DESIGN Vitamin D and omega 3 trial (VITAL), a nationwide, randomized, double blind, placebo controlled trial with a two-by-two factorial design. SETTING Nationwide in the United States. PARTICIPANTS 25 871 participants, consisting of 12 786 men >= 50 years and 13 085 women >= 55 years at enrollment. INTERVENTIONS Vitamin D (2000 IU/day) or matched placebo, and omega 3 fatty acids (1000 mg/day) or matched placebo. Participants self-reported all incident autoimmune diseases from baseline to a median of 5.3 years of follow-up; these diseases were confirmed by extensive medical record review. Cox proportional hazard models were used to test the effects of vitamin D and omega 3 fatty acids on autoimmune disease incidence. MAIN OUTCOME MEASURES The primary endpoint was all incident autoimmune diseases confirmed by medical record review: rheumatoid arthritis, polymyalgia rheumatica, autoimmune thyroid disease, psoriasis, and all others. RESULTS 25 871 participants were enrolled and followed for a median of 5.3 years. 18 046 self-identified as non-Hispanic white, 5106 as black, and 2152 as other racial and ethnic groups. The mean age was 67.1 years. For the vitamin D arm, 123 participants in the treatment group and 155 in the placebo group had a confirmed autoimmune disease (hazard ratio 0.78, 95% confidence interval 0.61 to 0.99, P=0.05). In the omega 3 fatty acids arm, 130 participants in the treatment group and 148 in the placebo group had a confirmed autoimmune disease (0.85, 0.67 to 1.08, P=0.19). Compared with the reference arm (vitamin D placebo and omega 3 fatty acid placebo; 88 with confirmed autoimmune disease), 63 participants who received vitamin D and omega 3 fatty acids (0.69, 0.49 to 0.96), 60 who received only vitamin D (0.68, 0.48 to 0.94), and 67 who received only omega 3 fatty acids (0.74, 0.54 to 1.03) had confirmed autoimmune disease. CONCLUSIONS Vitamin D supplementation for five years, with or without omega 3 fatty acids, reduced autoimmune disease by 22%, while omega 3 fatty acid supplementation with or without vitamin D reduced the autoimmune disease rate by 15% (not statistically significant). Both treatment arms showed larger effects than the reference arm (vitamin D placebo and omega 3 fatty acid placebo).	[Hahn, Jill; Cook, Nancy R.; Lee, I-Min; Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hahn, Jill; Costenbader, Karen H.] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA; [Hahn, Jill] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cook, Nancy R.; Walter, Joseph; Bubes, Vadim; Kotler, Gregory; Lee, I-Min; Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Cook, Nancy R.; Walter, Joseph; Bubes, Vadim; Kotler, Gregory; Lee, I-Min; Manson, JoAnn E.] Harvard Med Sch, Boston, MA 02115 USA; [Alexander, Erik K.] Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Friedman, Sonia] Brigham & Womens Hosp, Ctr Crohns & Colitis, Div Gastroenterol Hepatol & Endoscopy, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Costenbader, KH (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA.	kcostenbader@bwh.harvard.edu			National Institutes of Health [R01 AR059086, U01 CA138962, R01 CA138962]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health grants R01 AR059086, U01 CA138962, R01 CA138962. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Akbar U, 2017, JCR-J CLIN RHEUMATOL, V23, P330, DOI 10.1097/RHU.0000000000000563; Althouse AD, 2021, CIRCULATION, V144, pE70, DOI 10.1161/CIRCULATIONAHA.121.055393; Altieri B, 2017, REV ENDOCR METAB DIS, V18, P335, DOI 10.1007/s11154-016-9405-9; Bassuk SS, 2016, CONTEMP CLIN TRIALS, V47, P235, DOI 10.1016/j.cct.2015.12.022; Bouillon R, 2019, ENDOCR REV, V40, P1109, DOI 10.1210/er.2018-00126; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Clark CCT, 2019, CLIN RHEUMATOL, V38, P977, DOI 10.1007/s10067-019-04456-x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Costenbader KH, 2008, ARCH INTERN MED, V168, P1664, DOI 10.1001/archinte.168.15.1664; Costenbader KH, 2019, CLIN CHEM, V65, P1508, DOI 10.1373/clinchem.2019.306902; Dankers W, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00697; Dillon CF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226516; Ding Y, 2017, J CELL MOL MED, V21, P975, DOI 10.1111/jcmm.13037; Fisher SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222313; Gallo D, 2020, J ENDOCRINOL INVEST, V43, P413, DOI 10.1007/s40618-019-01123-5; Giustina A, 2020, REV ENDOCR METAB DIS, V21, P89, DOI 10.1007/s11154-019-09532-w; Grenon SM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002034; Gysemans CA, 2005, ENDOCRINOLOGY, V146, P1956, DOI 10.1210/en.2004-1322; Hayter SM, 2012, AUTOIMMUN REV, V11, P754, DOI 10.1016/j.autrev.2012.02.001; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Kriegel MA, 2011, SEMIN ARTHRITIS RHEU, V40, P512, DOI 10.1016/j.semarthrit.2010.07.009; Li KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088103; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Manson JE, 2019, NEW ENGL J MED, V380, P23, DOI 10.1056/NEJMoa1811403; Murdaca G, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102350; Pedersen M, 2005, J RHEUMATOL, V32, P1249; Pittas AG, 2019, NEW ENGL J MED, V381, P520, DOI 10.1056/NEJMoa1900906; Radzikowska U, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122990; Ramirez JL, 2019, J SURG RES, V238, P164, DOI 10.1016/j.jss.2019.01.038; Roberts MH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102423; Rose NR, 2016, AM J EPIDEMIOL, V183, P403, DOI 10.1093/aje/kwv292; Scragg R, 2018, J STEROID BIOCHEM, V177, P6, DOI 10.1016/j.jsbmb.2017.06.006; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Skaaby T, 2015, ENDOCRINE, V50, P231, DOI 10.1007/s12020-015-0547-4; Sparks JA, 2014, RHEUM DIS CLIN N AM, V40, P637, DOI 10.1016/j.rdc.2014.07.005; Stockinger B, 2007, IMMUNOL CELL BIOL, V85, P83, DOI 10.1038/sj.icb.7100035; Yamamoto E, 2019, J AUTOIMMUN, V100, P7, DOI 10.1016/j.jaut.2019.03.002; Zhang Y, 2020, DIABETES CARE, V43, P1650, DOI 10.2337/dc19-1708	39	44	44	13	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								e066452	10.1136/bmj-2021-066452	http://dx.doi.org/10.1136/bmj-2021-066452			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082139	Green Published, hybrid			2022-12-28	WOS:000748440900009
J	McLachlan, G; Penfold, R; Magee, L; Knight, K; Al-Hadithy, N				McLachlan, Greta; Penfold, Rose; Magee, Lucia; Knight, Katie; Al-Hadithy, Nada			Sexual assault and harassment in medicine: we need actions not words	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NUMBER-METOO; DISCRIMINATION; WOMEN		[McLachlan, Greta] Kent Surrey & Sussex Deanery, London, England; [Penfold, Rose] Kings Coll London, Guys & St Thomas NHS Fdn Trust, London, England; [Knight, Katie] North Middlesex Hosp, London, England; [Al-Hadithy, Nada] Oxford Univ Hosp, Oxford, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	McLachlan, G (corresponding author), Kent Surrey & Sussex Deanery, London, England.			Penfold, Rose/0000-0001-7023-7108				Acholonu R, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l987; Dis J, HARVARD BUS REV; Fleming S., 2021, B R COLL SURG ENGL, V103, P282, DOI [10.1308/rcsbull.2021.106, DOI 10.1308/RCSBULL.2021.106]; Hanson LLM, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2984; Jackson P, SEXUAL ASSAULT SURG, DOI [10.1308/rcsbull.2022.5, DOI 10.1308/RCSBULL.2022.5]; Jaijee SK, 2021, HEART, V107, P895, DOI 10.1136/heartjnl-2020-317837; Launer J, 2018, POSTGRAD MED J, V94, P129, DOI 10.1136/postgradmedj-2018-135554; Liang R, 2019, LANCET, V393, P541, DOI 10.1016/S0140-6736(18)32612-6; Lu DW, 2020, WEST J EMERG MED, V21, P252, DOI 10.5811/westjem.2019.11.44592; Minkina N, 2019, LANCET, V394, P383, DOI [10.1016/S0140-6736(19)31716-7, 10.1016/S0140-6736(19)31731-3]; Online GP, ON 5 GPS HAV BEEN SE; Royal College of Surgeons of England, STAT RESP SEX ASS SU; Royal College of Surgeons of England, WE WILL PUT DIV HEAR; Sayburn A., 2017, B R COLL SURG ENGL, V100, P16, DOI [10.1308/rcsbull.2018.16, DOI 10.1308/RCSBULL.2018.16]; Siad Fartoon M, 2021, CJC Open, V3, pS174, DOI 10.1016/j.cjco.2021.08.018	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o229	10.1136/bmj.o229	http://dx.doi.org/10.1136/bmj.o229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082117	Bronze			2022-12-28	WOS:000748440900011
J	Sulser, RB; Patterson, BD; Urban, DJ; Neander, AI; Luo, ZX				Sulser, R. Benjamin; Patterson, Bruce D.; Urban, Daniel J.; Neander, April I.; Luo, Zhe-Xi			Evolution of inner ear neuroanatomy of bats and implications for echolocation	NATURE			English	Article							DUTY CYCLE ECHOLOCATION; SPIRAL GANGLION; FLIGHT; COCHLEA; SIGNALS; ORIGIN	Phylogenomics of bats suggests that their echolocation either evolved separately in the bat suborders Yinpterochiroptera and Yangochiroptera, or had a single origin in bat ancestors and was later lost in some yinpterochiropterans(1-6). Hearing for echolocation behaviour depends on the inner ear, of which the spiral ganglion is an essential structure. Here we report the observation of highly derived structures of the spiral ganglion in yangochiropteran bats: a trans-oticganglion with a wall-less Rosenthal's canal. This neuroanatomical arrangement permits a larger ganglion with more neurons, higher innervation density of neurons and denser clustering of cochlear nerve fascicles(7-13). This differs from the plesiomorphic neuroanatomy of Yinpterochiroptera and non-chi ropteran mammals. The osteological correlates of these derived ganglion features can now be traced into bat phylogeny, providing direct evidence of how Yangochiroptera differentiated from Yinpterochiroptera in spiral ganglion neuroanatomy. These features are highly variable across major clades and between species of Yangochiroptera, and in morphospace, exhibit much greater disparity in Yangochiroptera than Yinpterochiroptera. These highly variable ganglion features may be a neuroanatomical evolutionary driver for their diverse echolocating strategies(4,14-17) and are associated with the explosive diversification of yangochiropterans, which include most bat families, genera and species.	[Sulser, R. Benjamin] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Patterson, Bruce D.] Field Museum Nat Hist, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA; [Urban, Daniel J.] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Urban, Daniel J.] Univ Calif Los Angeles, Dept Ecol & Evolut, Sears Lab, Los Angeles, CA USA; [Neander, April I.; Luo, Zhe-Xi] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago); University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of Chicago	Sulser, RB (corresponding author), Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.; Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	rsulser@amnh.org; zxluo@uchicago.edu		Neander, April/0000-0001-6816-2872; Urban, Daniel/0000-0002-2672-8468; Patterson, Bruce/0000-0002-2249-7260	UChicago Metcalf Fellowship; NSF; AMNH; Postdoctoral Fellowships from NSF; University of Illinois; Field Museum Brown Mammal Research Fund; JRS Biodiversity Foundation; UChicago Biological Sciences Division	UChicago Metcalf Fellowship; NSF(National Science Foundation (NSF)); AMNH; Postdoctoral Fellowships from NSF; University of Illinois; Field Museum Brown Mammal Research Fund; JRS Biodiversity Foundation; UChicago Biological Sciences Division	This research was supported by UChicago Metcalf Fellowship and Graduate Fellowships from NSF and AMNH (to R.B.S.), by Postdoctoral Fellowships from NSF and University of Illinois (to D.J.U.), Field Museum Brown Mammal Research Fund and grant from JRS Biodiversity Foundation (to B.D.P.) and UChicago Biological Sciences Division and NSF fundings (to Z.-X.L.). We thank J. Schultz, K. Sears, N. Simmons, G. Manley, R. MacPhee and J. Flynn for discussion; K. Sears and E. Rodriguez for access to histological sectioning facilities. Full acknowledgements are presented in the Supplementary Information.	Arbour JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09951-y; Bruns V., 1984, MYOTIS, V21, P52; Carter RT, 2014, ANAT REC, V297, P1270, DOI 10.1002/ar.22934; Dabdoub A, 2016, SPRINGER HANDB AUDIT, V52, P1, DOI 10.1007/978-1-4939-3031-9; Davies KTJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-2; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Echteler SM, 2000, J COMP NEUROL, V425, P436; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; Fenton MB, 1999, ACTA CHIROPTEROL, V1, P127; Gacek RR, 2012, ORL-J OTO-RHIN-LARYN, V74, P22, DOI 10.1159/000334530; Goodrich LV, 2016, SPRINGER HANDB AUDIT, V52, P11, DOI 10.1007/978-1-4939-3031-9_2; Gunnell GF, 2012, CAM STUD MORPHOL MOL, P1, DOI 10.1017/CBO9781139045599; Hedrick BP, 2020, J MAMM EVOL, V27, P563, DOI 10.1007/s10914-019-09472-x; Henson O. W., 1988, ANIMAL SONAR PROCESS, P301; Hsiao CJ, 2015, NEUROREPORT, V26, P478, DOI 10.1097/WNR.0000000000000375; Jacobs DS, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030085; Jebb D, 2020, NATURE, V583, P578, DOI 10.1038/s41586-020-2486-3; Johnson SB, 2011, HEARING RES, V278, P34, DOI 10.1016/j.heares.2011.02.008; Jones G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00117; KOSSL M, 1985, J COMP PHYSIOL A, V157, P687, DOI 10.1007/BF01351362; Lazure L, 2011, J EXP BIOL, V214, P1131, DOI 10.1242/jeb.048967; Luo Z-X., 2020, SENSES A COMPREHENSI, P207, DOI DOI 10.1016/B978-0-12-805408-6.00033-6; Luo ZX, 2012, ZOOL J LINN SOC-LOND, V166, P433, DOI 10.1111/j.1096-3642.2012.00852.x; Maltby A, 2010, HBK BEHAV NEUROSCI, V19, P37, DOI 10.1016/B978-0-12-374593-4.0005-X; Neuweiler G, 2003, J COMP PHYSIOL A, V189, P245, DOI 10.1007/s00359-003-0406-2; NEUWEILER G, 1990, PHYSIOL REV, V70, P615, DOI 10.1152/physrev.1990.70.3.615; Nojiri T, 2021, CURR BIOL, V31, P1353, DOI 10.1016/j.cub.2020.12.043; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; R Development Core Team, 2009, R LANG ENV STAT COMP; RAMPRASHAD F, 1978, J COMP NEUROL, V178, P347, DOI 10.1002/cne.901780209; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rojas D, 2016, SYST BIOL, V65, P432, DOI 10.1093/sysbio/syw011; Schnitzler HU, 2011, J COMP PHYSIOL A, V197, P541, DOI 10.1007/s00359-010-0569-6; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Shi JJ, 2015, EVOLUTION, V69, P1528, DOI 10.1111/evo.12681; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons NB, 2010, NATURE, V466, pE8, DOI 10.1038/nature09219; SPOENDLIN H, 1985, AM J OTOLARYNG, V6, P453, DOI 10.1016/S0196-0709(85)80026-0; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thiagavel J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02532-x; Vater M, 1995, HEARING RES, V91, P178, DOI 10.1016/0378-5955(95)00188-3; Vater M., 1988, ANIMAL SONAR, P225; Vater Marianne, 2000, P137, DOI 10.1017/CBO9780511541872.005; Veselka N, 2010, NATURE, V463, P939, DOI 10.1038/nature08737; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002	48	6	6	19	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2022	602	7897					449	+		10.1038/s41586-021-04335-z	http://dx.doi.org/10.1038/s41586-021-04335-z		JAN 2022	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZB5PA	35082447				2022-12-28	WOS:000750881700003
J	Krumholz, HM; Massey, DS; Dorsey, KB				Krumholz, Harlan M.; Massey, Daisy S.; Dorsey, Karen B.			Racism as a leading cause of death in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; DISPARITIES; RACE		[Krumholz, Harlan M.; Massey, Daisy S.; Dorsey, Karen B.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Dorsey, Karen B.] Yale Sch Med, Dept Pediat, New Haven, CT USA	Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.							Centers for Disease Control and Prevention, NAT CTR HLTH STAT RE; Churchwell K, 2020, CIRCULATION, V142, pE454, DOI 10.1161/CIR.0000000000000936; Cogburn CD, 2019, MILBANK Q, V97, P736, DOI 10.1111/1468-0009.12411; Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616; Kitagawa EM, 1973, VITAL HLTH STAT MONO, DOI [10.4159/harvard.9780674188471/html, DOI 10.4159/HARVARD.9780674188471/HTML]; Mahajan S, 2021, JAMA-J AM MED ASSOC, V326, P637, DOI 10.1001/jama.2021.9907; Massey D, MEDRXIV2021202108302, V2021, DOI [10.1101/2021.08.30.21262732, DOI 10.1101/2021.08.30.21262732]; Rossen LM, 2021, MMWR-MORBID MORTAL W, V70, P1114, DOI 10.15585/mmwr.mm7033a2; United States Department of Health and Human Services, 1985, REPORT SECRETARYS TA; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787	10	2	2	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2022	376								o213	10.1136/bmj.o213	http://dx.doi.org/10.1136/bmj.o213			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9IB	35078777	Bronze			2022-12-28	WOS:000759189200002
J	Thornburg, ZR; Bianchi, DM; Brier, TA; Gilbert, BR; Earnest, TM; Melo, MCR; Safronova, N; Saenz, JP; Cook, AT; Wise, KS; Hutchison, CA; Smith, HO; Glass, JI; Luthey-Schulten, Z				Thornburg, Zane R.; Bianchi, David M.; Brier, Troy A.; Gilbert, Benjamin R.; Earnest, Tyler M.; Melo, Marcelo C. R.; Safronova, Nataliya; Saenz, James P.; Cook, Andras T.; Wise, Kim S.; Hutchison, Clyde A.; Smith, Hamilton O.; Glass, John, I; Luthey-Schulten, Zaida			Fundamental behaviors emerge from simulations of a living minimal cell	CELL			English	Article							GLYCOSE PHOSPHOTRANSFERASE SYSTEM; ELECTROCHEMICAL PROTON GRADIENT; TRANSIENT STATE KINETICS; 2ND-ORDER RATE CONSTANTS; RATE-LIMITING STEP; ESCHERICHIA-COLI; STOCHASTIC SIMULATION; RIBOSOME BIOGENESIS; HIGH-THROUGHPUT; PHOSPHOENOLPYRUVATE	We present a whole-cell fully dynamical kinetic model (WCM) of JCVI-syn3A, a minimal cell with a reduced genome of 493 genes that has retained few regulatory proteins or small RNAs. Cryo-electron tomograms provide the cell geometry and ribosome distributions. Time-dependent behaviors of concentrations and reaction fluxes from stochastic-deterministic simulations over a cell cycle reveal how the cell balances demands of its metabolism, genetic information processes, and growth, and offer insight into the principles of life for this minimal cell. The energy economy of each process including active transport of amino acids, nucleosides, and ions is analyzed. WCM reveals how emergent imbalances lead to slowdowns in the rates of transcription and translation. Integration of experimental data is critical in building a kinetic model from which emerges a genome-wide distribution of mRNA half-lives, multiple DNA replication events that can be compared to qPCR results, and the experimentally observed doubling behavior.	[Thornburg, Zane R.; Bianchi, David M.; Brier, Troy A.; Gilbert, Benjamin R.; Earnest, Tyler M.; Melo, Marcelo C. R.; Luthey-Schulten, Zaida] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Safronova, Nataliya; Saenz, James P.] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01307 Dresden, Germany; [Cook, Andras T.; Wise, Kim S.; Hutchison, Clyde A.; Smith, Hamilton O.; Glass, John, I] J Craig Venter Inst, La Jolla, CA 92037 USA; [Luthey-Schulten, Zaida] NSF Ctr Phys Living Cells, Urbana, IL 61801 USA; [Luthey-Schulten, Zaida] NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Technische Universitat Dresden; J. Craig Venter Institute	Luthey-Schulten, Z (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Luthey-Schulten, Z (corresponding author), NSF Ctr Phys Living Cells, Urbana, IL 61801 USA.; Luthey-Schulten, Z (corresponding author), NIH Ctr Macromol Modeling & Bioinformat, Urbana, IL 61801 USA.	zan@illinois.edu	Glass, John/A-6572-2015	Glass, John/0000-0002-3784-5301; Safronova, Nataliya/0000-0001-7372-3857; Gilbert, Benjamin/0000-0002-9344-5521	NSF [MCB 1818344, 1840320]; Center for the Physics of Living Cells (NSF) [PHY 1430124]; NSF Physics of Living Systems [PHY 1505008]; German Federal Ministry of Education and Research BMBF [03Z22EN12]; VW Foundation "Life"grant [93090]; NIH Center for Macromolecular Modeling and Bioinformatics [P41-GM104601]	NSF(National Science Foundation (NSF)); Center for the Physics of Living Cells (NSF); NSF Physics of Living Systems; German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); VW Foundation "Life"grant; NIH Center for Macromolecular Modeling and Bioinformatics	We thank Julio Maia for significant assistance in modifying jLM and John Stone for making it possible to visualize the RDME simulations and the cryo-electron tomogram reconstructions in VMD. All authors received partial support from NSF MCB 1818344 and 1840320. Z.R.T., DM..B., T.A.B., B.R.G., and Z.L.-S. were supported by the Center for the Physics of Living Cells (NSF PHY 1430124) and NSF Physics of Living Systems (PHY 1505008) . N.S. and J.P.S. were supported by German Federal Ministry of Education and Research BMBF grant (to J.P.S., project 03Z22EN12) and VW Foundation "Life"grant (to J.P.S., project 93090) . Z.L.-S. is partially supported by the NIH Center for Macromolecular Modeling and Bioinformatics (P41-GM104601) .	Agozzino L, 2020, ANNU REV CHEM BIOMOL, V11, P155, DOI 10.1146/annurev-chembioeng-011720-103410; Alberty R. A., 2003, THERMODYNAMICS BIOCH; Beaudoin G.A.W., 2021, METABOLITE DAMAGE DA, DOI [10.1101/2021.12.01.470718, DOI 10.1101/2021.12.01.470718]; BENYOUCEF M, 1981, EUR J BIOCHEM, V113, P499, DOI 10.1111/j.1432-1033.1981.tb05091.x; BENYOUCEF M, 1981, EUR J BIOCHEM, V113, P491, DOI 10.1111/j.1432-1033.1981.tb05090.x; Bianchi DM, 2018, IET SYST BIOL, V12, P170, DOI 10.1049/iet-syb.2017.0070; Blotz C, 2017, FEMS MICROBIOL REV, V41, P640, DOI 10.1093/femsre/fux033; BOSCA L, 1984, TRENDS BIOCHEM SCI, V9, P372, DOI 10.1016/0968-0004(84)90214-7; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Bremer Hans, 2008, EcoSal Plus, V3, DOI 10.1128/ecosal.5.2.3; Breuer M, 2019, ELIFE, V8, DOI 10.7554/eLife.36842; Castellanos M, 2007, BIOTECHNOL BIOENG, V97, P397, DOI 10.1002/bit.21251; Catipovic MA, 2020, EMBO REP, V21, DOI 10.15252/embr.202050905; Chang A, 2021, NUCLEIC ACIDS RES, V49, pD498, DOI 10.1093/nar/gkaa1025; Chen Y, 2015, J MOL BIOL, V427, P2348, DOI 10.1016/j.jmb.2015.05.003; Cheng HM, 2015, NUCLEIC ACIDS RES, V43, P396, DOI 10.1093/nar/gku1284; Cho KH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00154; CLEJAN S, 1984, J BIOL CHEM, V259, P823; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dai XF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.231; Daubenspeck JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143362; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Earnest TM, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aaae2c; Earnest TM, 2016, BIOPOLYMERS, V105, P735, DOI 10.1002/bip.22892; Earnest TM, 2015, BIOPHYS J, V109, P1117, DOI 10.1016/j.bpj.2015.07.030; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Facchetti Giuseppe, 2017, Curr Opin Syst Biol, V5, P86, DOI 10.1016/j.coisb.2017.08.010; Fazal FM, 2015, P NATL ACAD SCI USA, V112, P15101, DOI 10.1073/pnas.1514028112; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gilbert BR, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.644133; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Hallock MJ, 2014, PARALLEL COMPUT, V40, P86, DOI 10.1016/j.parco.2014.03.009; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Hindmarsh AC, 1983, IMACS T SCI COMPUTAT, V1, P55; Hofmeyr JHS, 2013, FEBS LETT, V587, P2868, DOI 10.1016/j.febslet.2013.07.011; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Ibba M., 2005, AMINOACYL TRNA SYNTH; IWAMI Y, 1980, ARCH ORAL BIOL, V25, P163, DOI 10.1016/0003-9969(80)90015-1; Jeckelmann JM, 2019, SUBCELL BIOCHEM, V92, P223, DOI 10.1007/978-3-030-18768-2_8; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Johnson GE, 2020, NATURE, V585, P124, DOI 10.1038/s41586-020-2638-5; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321; KIRK RG, 1969, AM J VET RES, V30, P287; Kitamura S, 2021, J BIOSCI BIOENG, V131, P271, DOI 10.1016/j.jbiosc.2020.10.008; Kornspan JD, 2012, J LIPIDS, V2012, DOI 10.1155/2012/640762; Lachance JC, 2021, MOL SYST BIOL, V17, DOI 10.15252/msb.202010099; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41; Liebermeister W, 2010, BIOINFORMATICS, V26, P1528, DOI 10.1093/bioinformatics/btq141; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lonnfors M, 2011, BIOPHYS J, V100, P2633, DOI 10.1016/j.bpj.2011.03.066; Lubitz T, 2019, BIOINFORMATICS, V35, P3857, DOI 10.1093/bioinformatics/btz129; Lubitz T, 2010, J PHYS CHEM B, V114, P16298, DOI 10.1021/jp108764b; Luthey-Schulten Z, 2021, NAT METHODS, V18, P441, DOI 10.1038/s41592-021-01150-2; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Macklin DN, 2020, SCIENCE, V369, P390, DOI 10.1126/science.aav3751; Marucci L, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00942; Matteau D, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209844; MCELWAIN MC, 1987, J BACTERIOL, V169, P3647, DOI 10.1128/jb.169.8.3647-3653.1987; Meadow ND, 2005, J BIOL CHEM, V280, P41872, DOI 10.1074/jbc.M501440200; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; MOROWITZ HJ, 1984, ISRAEL J MED SCI, V20, P750; NEALE GAM, 1983, J BACTERIOL, V156, P1001, DOI 10.1128/JB.156.3.1001-1005.1983; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Nielsen HJ, 2007, J BACTERIOL, V189, P8660, DOI 10.1128/JB.01212-07; Noor E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005167; Pappas A, 1999, BIOCHEMISTRY-US, V38, P16671, DOI 10.1021/bi9920127; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Pelletier JF, 2021, CELL, V184, P2430, DOI 10.1016/j.cell.2021.03.008; Peterson JR, 2015, P NATL ACAD SCI USA, V112, P15886, DOI 10.1073/pnas.1516246112; PETZOLD L, 1983, SIAM J SCI STAT COMP, V4, P136, DOI 10.1137/0904010; PLACKETT P, 1967, BIOCHEMISTRY-US, V6, P2746, DOI 10.1021/bi00861a015; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; RAZIN S, 1970, J BACTERIOL, V102, P306, DOI 10.1128/JB.102.2.306-310.1970; Roberts E, 2013, J COMPUT CHEM, V34, P245, DOI 10.1002/jcc.23130; Rodwell A.W., 1983, METHODS MYCOPLASMOLO, P163; Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200; Saenz JP, 2012, P NATL ACAD SCI USA, V109, P14236, DOI 10.1073/pnas.1212141109; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Santos JA, 2018, ELIFE, V7, DOI 10.7554/eLife.35828; Schieck E, 2016, MOL MICROBIOL, V99, P55, DOI 10.1111/mmi.13213; Scull CE, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.607158; Serdiuk T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6824; STOUTHAMER AH, 1973, A VAN LEEUW J MICROB, V39, P545, DOI 10.1007/BF02578899; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thornburg ZR, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00130; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Wallden M, 2016, CELL, V166, P729, DOI 10.1016/j.cell.2016.06.052; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Webb AJ, 2006, J BACTERIOL, V188, P8005, DOI 10.1128/JB.01101-06; Werner A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq808; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; WILLIAMSON DL, 1975, SCIENCE, V188, P1018, DOI 10.1126/science.188.4192.1018; Wittig U, 2012, NUCLEIC ACIDS RES, V40, pD790, DOI 10.1093/nar/gkr1046; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	116	13	13	4	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					345	+		10.1016/j.cell.2021.12.025	http://dx.doi.org/10.1016/j.cell.2021.12.025			45	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8WY	35063075	Green Published, hybrid			2022-12-28	WOS:000746168800002
J	Metz, TD; Clifton, RG; Hughes, BL; Sandoval, GJ; Grobman, WA; Saade, GR; Manuck, TA; Longo, M; Sowles, A; Clark, K; Simhan, HN; Rouse, DJ; Mendez-Figueroa, H; Gyamfi-Bannerman, C; Bailit, JL; Costantine, MM; Sehdev, HM; Tita, ATN; Macones, GA				Metz, Torri D.; Clifton, Rebecca G.; Hughes, Brenna L.; Sandoval, Grecio J.; Grobman, William A.; Saade, George R.; Manuck, Tracy A.; Longo, Monica; Sowles, Amber; Clark, Kelly; Simhan, Hyagriv N.; Rouse, Dwight J.; Mendez-Figueroa, Hector; Gyamfi-Bannerman, Cynthia; Bailit, Jennifer L.; Costantine, Maged M.; Sehdev, Harish M.; Tita, Alan T. N.; Macones, George A.		Eunice Kennedy Shriver Natl Inst C	Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material								Importance It remains unknown whether SARS-CoV-2 infection specifically increases the risk of serious obstetric morbidity. Objective To evaluate the association of SARS-CoV-2 infection with serious maternal morbidity or mortality from common obstetric complications. Design, Setting, and Participants Retrospective cohort study of 14 104 pregnant and postpartum patients delivered between March 1, 2020, and December 31, 2020 (with final follow-up to February 11, 2021), at 17 US hospitals participating in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Gestational Research Assessments of COVID-19 (GRAVID) Study. All patients with SARS-CoV-2 were included and compared with those without a positive SARS-CoV-2 test result who delivered on randomly selected dates over the same period. Exposures SARS-CoV-2 infection was based on a positive nucleic acid or antigen test result. Secondary analyses further stratified those with SARS-CoV-2 infection by disease severity. Main Outcomes and Measures The primary outcome was a composite of maternal death or serious morbidity related to hypertensive disorders of pregnancy, postpartum hemorrhage, or infection other than SARS-CoV-2. The main secondary outcome was cesarean birth. Results Of the 14 104 included patients (mean age, 29.7 years), 2352 patients had SARS-CoV-2 infection and 11 752 did not have a positive SARS-CoV-2 test result. Compared with those without a positive SARS-CoV-2 test result, SARS-CoV-2 infection was significantly associated with the primary outcome (13.4% vs 9.2%; difference, 4.2% [95% CI, 2.8%-5.6%]; adjusted relative risk [aRR], 1.41 [95% CI, 1.23-1.61]). All 5 maternal deaths were in the SARS-CoV-2 group. SARS-CoV-2 infection was not significantly associated with cesarean birth (34.7% vs 32.4%; aRR, 1.05 [95% CI, 0.99-1.11]). Compared with those without a positive SARS-CoV-2 test result, moderate or higher COVID-19 severity (n = 586) was significantly associated with the primary outcome (26.1% vs 9.2%; difference, 16.9% [95% CI, 13.3%-20.4%]; aRR, 2.06 [95% CI, 1.73-2.46]) and the major secondary outcome of cesarean birth (45.4% vs 32.4%; difference, 12.8% [95% CI, 8.7%-16.8%]; aRR, 1.17 [95% CI, 1.07-1.28]), but mild or asymptomatic infection (n = 1766) was not significantly associated with the primary outcome (9.2% vs 9.2%; difference, 0% [95% CI, -1.4% to 1.4%]; aRR, 1.11 [95% CI, 0.94-1.32]) or cesarean birth (31.2% vs 32.4%; difference, -1.4% [95% CI, -3.6% to 0.8%]; aRR, 1.00 [95% CI, 0.93-1.07]). Conclusions and Relevance Among pregnant and postpartum individuals at 17 US hospitals, SARS-CoV-2 infection was associated with an increased risk for a composite outcome of maternal mortality or serious morbidity from obstetric complications. Question Among pregnant and postpartum individuals, is SARS-CoV-2 infection associated with increased risk of maternal mortality or serious morbidity from obstetric complications? Findings In this retrospective cohort study that included 14 104 patients, a composite outcome of maternal death or serious morbidity related to hypertensive disorders of pregnancy, postpartum hemorrhage, or infection other than SARS-CoV-2 occurred significantly more frequently in individuals with SARS-CoV-2 infection compared with individuals without SARS-CoV-2 infection (13.4% vs 9.2%, respectively). Meaning Among pregnant and postpartum individuals, SARS-CoV-2 infection was associated with increased risk of a composite outcome of maternal mortality or serious morbidity from obstetric complications. This cohort study evaluates the association of SARS-CoV-2 infection with serious maternal morbidity or mortality related to hypertensive disorders of pregnancy, postpartum hemorrhage, or infection other than SARS-CoV-2.	[Metz, Torri D.; Sowles, Amber] Univ Utah Hlth, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA; [Clifton, Rebecca G.; Sandoval, Grecio J.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Hughes, Brenna L.; Manuck, Tracy A.; Clark, Kelly] Univ N Carolina, Div Maternal Fetal Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Grobman, William A.] Northwestern Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chicago, IL USA; [Saade, George R.] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Galveston, TX USA; [Longo, Monica] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Simhan, Hyagriv N.] Univ Pittsburgh, Dept Obstet & Gynecol, Div Maternal Fetal Med, Pittsburgh, PA USA; [Rouse, Dwight J.] Brown Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Providence, RI USA; [Mendez-Figueroa, Hector] Univ Texas Hlth Sci Ctr Houston, Childrens Mem Hermann Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX USA; [Gyamfi-Bannerman, Cynthia] Columbia Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY USA; [Bailit, Jennifer L.] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Cleveland, OH USA; [Costantine, Maged M.] Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Columbus, OH USA; [Sehdev, Harish M.] Univ Penn, Dept Obstet & Gynecol, Div Maternal Fetal Med, Philadelphia, PA USA; [Tita, Alan T. N.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Maternal Fetal Med, Birmingham, AL USA; [Macones, George A.] Univ Texas Austin, Dept Womens Hlth, Austin, TX USA	Utah System of Higher Education; University of Utah; George Washington University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; University of Texas System; University of Texas Health Science Center Houston; Columbia University; Case Western Reserve University; MetroHealth System; University System of Ohio; Ohio State University; University of Pennsylvania; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Austin	Metz, TD (corresponding author), Univ Utah Hlth, Dept Obstet & Gynecol, Div Maternal Fetal Med, Salt Lake City, UT 84132 USA.			Sandoval, Grecio/0000-0002-3601-6712					0	37	38	7	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	AUG	2022	77	8					457	459		10.1097/01.ogx.0000852884.16321.fd	http://dx.doi.org/10.1097/01.ogx.0000852884.16321.fd			3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	3I0UT	35129581				2022-12-28	WOS:000832442600005
J	Reincke, SM; Yuan, M; Kornau, HC; Corman, VM; van Hoof, S; Sanchez-Sendin, E; Ramberger, M; Yu, WL; Hua, YZ; Tien, H; Schmidt, ML; Schwarz, T; Jeworowski, LM; Brandl, SE; Rasmussen, HF; Homeyer, MA; Stoffler, L; Barner, M; Kunkel, D; Huo, SF; Horler, J; von Wardenburg, N; Kroidl, I; Eser, TM; Wieser, A; Geldmacher, C; Hoelscher, M; Ganzer, H; Weiss, G; Schmitz, D; Drosten, C; Pruss, H; Wilson, IA; Kreye, J				Reincke, S. Momsen; Yuan, Meng; Kornau, Hans-Christian; Corman, Victor M.; van Hoof, Scott; Sanchez-Sendin, Elisa; Ramberger, Melanie; Yu, Wenli; Hua, Yuanzi; Tien, Henry; Schmidt, Marie Luisa; Schwarz, Tatjana; Jeworowski, Lara Maria; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Barner, Martin; Kunkel, Desiree; Huo, Shufan; Horler, Johannes; von Wardenburg, Niels; Kroidl, Inge; Eser, Tabea M.; Wieser, Andreas; Geldmacher, Christof; Hoelscher, Michael; Ganzer, Hannes; Weiss, Gunter; Schmitz, Dietmar; Drosten, Christian; Pruss, Harald; Wilson, Ian A.; Kreye, Jakob			SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies	SCIENCE			English	Article								Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC) resists neutralization by major classes of antibodies from COVID-19 patients and vaccinated individuals. In this study, serum of Beta-infected patients revealed reduced cross-neutralization of wild-type virus. From these patients, we isolated Beta-specific and cross-reactive receptor-binding domain (RBD) antibodies. The Beta-specificity results from recruitment of VOC-specific clonotypes and accommodation of mutations present in Beta and Omicron into a major antibody class that is normally sensitive to these mutations. The Beta-elicited cross-reactive antibodies share genetic and structural features with wild type-elicited antibodies, including a public VH1-58 clonotype that targets the RBD ridge. These findings advance our understanding of the antibody response to SARS-CoV-2 shaped by antigenic drift, with implications for design of next-generation vaccines and therapeutics.	[Reincke, S. Momsen; van Hoof, Scott; Sanchez-Sendin, Elisa; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Huo, Shufan; Horler, Johannes; von Wardenburg, Niels; Pruss, Harald; Kreye, Jakob] Charite Univ Med Berlin, Dept Neurol & Expt Neurol, Berlin, Germany; [Reincke, S. Momsen; Kornau, Hans-Christian; Corman, Victor M.; van Hoof, Scott; Sanchez-Sendin, Elisa; Schmidt, Marie Luisa; Schwarz, Tatjana; Jeworowski, Lara Maria; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Huo, Shufan; Horler, Johannes; von Wardenburg, Niels; Schmitz, Dietmar; Drosten, Christian; Pruss, Harald; Kreye, Jakob] Free Univ Berlin, Berlin, Germany; [Reincke, S. Momsen; Kornau, Hans-Christian; Corman, Victor M.; van Hoof, Scott; Sanchez-Sendin, Elisa; Schmidt, Marie Luisa; Schwarz, Tatjana; Jeworowski, Lara Maria; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Huo, Shufan; Horler, Johannes; von Wardenburg, Niels; Schmitz, Dietmar; Drosten, Christian; Pruss, Harald; Kreye, Jakob] Humboldt Univ, Berlin, Germany; [Reincke, S. Momsen; Kornau, Hans-Christian; van Hoof, Scott; Sanchez-Sendin, Elisa; Ramberger, Melanie; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Horler, Johannes; von Wardenburg, Niels; Schmitz, Dietmar; Pruss, Harald; Kreye, Jakob] German Ctr Neurodegenerat Dis DZNE Berlin, Berlin, Germany; [Reincke, S. Momsen; van Hoof, Scott; Sanchez-Sendin, Elisa; Ramberger, Melanie; Brandl, Sarah E.; Rasmussen, Helle Foverskov; Homeyer, Marie A.; Stoffler, Laura; Barner, Martin; Horler, Johannes; von Wardenburg, Niels; Pruss, Harald; Kreye, Jakob] Helmholtz Innovat Lab BaoBab Brain Antibody Omics, Berlin, Germany; [Yuan, Meng; Yu, Wenli; Hua, Yuanzi; Tien, Henry; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kornau, Hans-Christian; Schmitz, Dietmar] Charite Univ Med Berlin, Cluster NeuroCure, Neurosci Res Ctr NWFZ, Berlin, Germany; [Corman, Victor M.; Schmidt, Marie Luisa; Schwarz, Tatjana; Jeworowski, Lara Maria; Drosten, Christian] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Corman, Victor M.; Schmidt, Marie Luisa; Schwarz, Tatjana; Jeworowski, Lara Maria; Drosten, Christian] German Ctr Infect Res DZIF, Berlin, Germany; [Corman, Victor M.] Lab Berlin Charite Vivantes GmbH, Berlin, Germany; [Kunkel, Desiree] Charite Univ Med Berlin, Flow & Mass Cytometry Core Facil, Berlin Inst Hlth, Berlin, Germany; [Kroidl, Inge; Eser, Tabea M.; Wieser, Andreas; Geldmacher, Christof; Hoelscher, Michael] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Kroidl, Inge; Eser, Tabea M.; Wieser, Andreas; Geldmacher, Christof; Hoelscher, Michael] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Ganzer, Hannes] BKH Schwaz, Dept Internal Med, Schwaz, Austria; [Weiss, Gunter] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kreye, Jakob] Charite Univ Med Berlin, Dept Pediat Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Scripps Research Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Labor Berlin - Charite Vivantes GmbH; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; German Center for Infection Research; Medical University of Innsbruck; Scripps Research Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reincke, SM; Pruss, H; Kreye, J (corresponding author), Charite Univ Med Berlin, Dept Neurol & Expt Neurol, Berlin, Germany.; Reincke, SM; Pruss, H; Kreye, J (corresponding author), Free Univ Berlin, Berlin, Germany.; Reincke, SM; Pruss, H; Kreye, J (corresponding author), Humboldt Univ, Berlin, Germany.; Reincke, SM; Pruss, H; Kreye, J (corresponding author), German Ctr Neurodegenerat Dis DZNE Berlin, Berlin, Germany.; Reincke, SM; Pruss, H; Kreye, J (corresponding author), Helmholtz Innovat Lab BaoBab Brain Antibody Omics, Berlin, Germany.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.; Kreye, J (corresponding author), Charite Univ Med Berlin, Dept Pediat Neurol, Berlin, Germany.	momsen.reincke@charite.de; harald.pruess@charite.de; wilson@scripps.edu; jakob.kreye@charite.de	Corman, Victor M/K-1319-2019; Kreye, Jakob/F-3038-2015	Corman, Victor M/0000-0002-3605-0136; Tien, Henry/0000-0001-7584-5989; Jeworowski, Lara/0000-0002-4159-4189; Reincke, Momsen/0000-0002-8132-3527; Schwarz, Tatjana/0000-0002-6054-4750; Kreye, Jakob/0000-0003-2913-1015; Schmitz, Dietmar/0000-0003-2741-5241; Huo, Shufan/0000-0002-0119-7517; Foverskov Rasmussen, Helle/0000-0002-6923-875X; van Hoof, Scott/0000-0002-2091-0904	Bill and Melinda Gates Foundation [INV-004923]; Bavarian State Ministry of Science and the Arts; Ludwig-Maximilians-Universitat Munich; German Ministry for Education and Research [01KI20271, 01GM1908D]; Helmholtz Association [ExNet0009-Phase2-3, HIL-A03]; German Research Foundation (DFG) [FOR3004 SYNABS, PR1274/3-1, PR1274/5-1]; Austrian Science Fund [FWF J4157-B30]; European Union [GA101003589]; German Ministry of Research [01KI2021]; NaFoUniMedCovid19-COVIM [FKZ: 01KX2021]; US Department of Energy (DOE) Office of Science User Facility [DE-AC02-05CH11231]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bavarian State Ministry of Science and the Arts; Ludwig-Maximilians-Universitat Munich; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); German Research Foundation (DFG)(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); European Union(European Commission); German Ministry of Research; NaFoUniMedCovid19-COVIM; US Department of Energy (DOE) Office of Science User Facility(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Bill and Melinda Gates Foundation INV-004923 (I.A.W.); the Bavarian State Ministry of Science and the Arts; University Hospital; Ludwig-Maximilians-Universitat Munich; German Ministry for Education and Research (project 01KI20271, M.H.; ConnectGenerate 01GM1908D, H.P.); the Helmholtz Association (ExNet0009-Phase2-3, D.S.; HIL-A03, H.P.); the German Research Foundation (DFG) (FOR3004 SYNABS, PR1274/3-1, and PR1274/5-1, H.P.); and the Austrian Science Fund (FWF J4157-B30, M.R.). Parts of the work were funded by the European Union's Horizon 2020 research and innovation program through project RECOVER (GA101003589) to C.D.; the German Ministry of Research through the projects VARIPath (01KI2021) to V.M.C and NaFoUniMedCovid19-COVIM, FKZ: 01KX2021 to C.D. and V.M.C. This research used resources of the Advanced Light Source, which is a US Department of Energy (DOE) Office of Science User Facility under contract DE-AC02-05CH11231. Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1038/s41586-021-04386-2, 10.1101/2021.12.12.472269]; Cevik M, 2021, CELL, V184, P5077, DOI 10.1016/j.cell.2021.09.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hillus D, 2021, LANCET RESP MED, V9, P1255, DOI 10.1016/S2213-2600(21)00357-X; Hoffmann M, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109415; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kreye J, 2016, BRAIN, V139, P2641, DOI 10.1093/brain/aww208; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu HJ, 2021, CELL HOST MICROBE, V29, P806, DOI 10.1016/j.chom.2021.04.005; Lucas C, 2021, NATURE, V600, P523, DOI 10.1038/s41586-021-04085-y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otto SP, 2021, CURR BIOL, V31, pR918, DOI 10.1016/j.cub.2021.06.049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Rapp M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108950; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Reincke SM, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03741-w; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Spencer A. J., 2021, 447308 BIORXIV; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Widera M, 2021, J INFECT DIS, V224, P1109, DOI 10.1093/infdis/jiab355; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wu NC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108274; Ying BL, 2022, SCI TRANSL MED, V14, DOI [10.1101/2021.08.25.457693, 10.1126/scitranslmed.abm3302]; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	45	11	12	8	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2022	375	6582					782	+		10.1126/science.abm5835	http://dx.doi.org/10.1126/science.abm5835			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZD4AQ	35076281	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000758142600049
J	Gonzalez, H; Mei, WB; Robles, I; Hagerling, C; Allen, BM; Okholm, TLH; Nanjaraj, A; Verbeek, T; Kalavacherla, S; van Gogh, M; Georgiou, S; Daras, M; Phillips, JJ; Spitzer, MH; Roose, JP; Werb, Z				Gonzalez, Hugo; Mei, Wenbin; Robles, Isabella; Hagerling, Catharina; Allen, Breanna M.; Okholm, Trine Line Hauge; Nanjaraj, Ankitha; Verbeek, Tamara; Kalavacherla, Sandhya; van Gogh, Merel; Georgiou, Stephen; Daras, Mariza; Phillips, Joanna J.; Spitzer, Matthew H.; Roose, Jeroen P.; Werb, Zena			Cellular architecture of human brain metastases	CELL			English	Article							SINGLE-CELL; DIFFUSION MAPS; CANCER; LANDSCAPE; ATLAS; DIFFERENTIATION; HETEROGENEITY; VISUALIZATION; GENOMICS; SURVIVAL	Brain metastasis (BrM) is the most common form of brain cancer, characterized by neurologic disability and an abysmal prognosis. Unfortunately, our understanding of the biology underlying human BrMs remains rudimentary. Here, we present an integrative analysis of >100,000 malignant and non-malignant cells from 15 human parenchymal BrMs, generated by single-cell transcriptomics, mass cytometry, and complemented with mouse model-and in silico approaches. We interrogated the composition of BrM niches, molecularly defined the blood-tumor interface, and revealed stromal immunosuppressive states enriched with infiltrated T cells and macrophages. Specific single-cell interrogation of metastatic tumor cells provides a framework of 8 functional cell programs that coexist or anticorrelate. Collectively, these programs delineate two functional BrM archetypes, one proliferative and the other inflammatory, that are evidently shaped through tumor-immune interactions. Our resource provides a foundation to understand the molecular basis of BrM in patients with tumor cell-intrinsic and host environmental traits.	[Gonzalez, Hugo; Mei, Wenbin; Robles, Isabella; Hagerling, Catharina; Nanjaraj, Ankitha; Verbeek, Tamara; Kalavacherla, Sandhya; van Gogh, Merel; Georgiou, Stephen; Roose, Jeroen P.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Hagerling, Catharina] Lund Univ, Dept Lab Med, Div Clin Genet, SE-22185 Lund, Sweden; [Allen, Breanna M.; Spitzer, Matthew H.] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA USA; [Allen, Breanna M.; Okholm, Trine Line Hauge; Spitzer, Matthew H.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, Dept Otolaryngol Head & Neck Surg, Chan Zuckerberg Biohub, San Francisco, CA USA; [Phillips, Joanna J.; Spitzer, Matthew H.; Werb, Zena] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Daras, Mariza; Phillips, Joanna J.] Univ Calif San Francisco, Dept Neurol Surg, 1450 3rd St, San Francisco, CA 94158 USA; [Mei, Wenbin] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Kalavacherla, Sandhya] MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; Lund University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Rockefeller University; Massachusetts Institute of Technology (MIT)	Gonzalez, H; Roose, JP (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	hugo.gonzalezvelozo@ucsf.edu; jeroen.roose@ucsf.edu		van Gogh, Merel/0000-0002-5826-5066; Robles, Isabella/0000-0003-1016-7210; Kalavacherla, Sandhya/0000-0003-0485-9042; Roose, Jeroen/0000-0003-4746-2811	National Cancer Institute [CA057621, CA180039, CA199315, CA190851, 5U01CA199315-05]; NIH Office of the Director [OD023056]; Oncology Research Fund; NIH/NCI [R01-CA187318]; NIH/NIAID [R01-AI104789, P01-AI091580]; NIH/NHLBI [R01-HL120724]; Mark Foundation for Cancer Research Endeavor Program [A136299]; California Breast Cancer Research [B26IB1494]; Becas Chile Post-Doctoral Fellowship; Parker Institute for Immunotherapy; Emerson Collective Cancer Research Fund; National Institutes of Health [5P50CA097257-18]; Swedish Society of Medicine; Gunnar Nilsson Cancer Foundation; Swedish Society for Medical Research; National Health Services (ALF); The Carlsberg Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oncology Research Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mark Foundation for Cancer Research Endeavor Program; California Breast Cancer Research; Becas Chile Post-Doctoral Fellowship; Parker Institute for Immunotherapy; Emerson Collective Cancer Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Society of Medicine; Gunnar Nilsson Cancer Foundation; Swedish Society for Medical Research; National Health Services (ALF); The Carlsberg Foundation(Carlsberg Foundation)	This study is dedicated to the memory of our friend, teacher, and mentor, Zena Werb, who first envisioned the potential of this study. Our deepest gratitude for her encouragement, support, brilliance, and kindness. We thank the patients and their families for their generosity in contributing to this study, the surgeons and all members of the UCSF Brain Tumor SPORE Biorepository, and patient advocate Susan Samson for insightful discussions. This study was supported by grants from the National Cancer Institute (CA057621, CA180039, CA199315, CA190851, and 5U01CA199315-05 to Z.W.), the NIH Office of the Director (OD023056 to M.H.S.), and the Oncology Research Fund (to Z.W. and H.G.). General infrastructure in the Roose lab has been supported by grants from the NIH/NCI (R01-CA187318), NIH/NIAID (R01-AI104789 and P01-AI091580), and the NIH/NHLBI (R01-HL120724) (all to J.P.R.). This specific project was supported by a Mark Foundation for Cancer Research Endeavor Program grant (A136299) and California Breast Cancer Research grants (B26IB1494) (both to J.P.R.). The Becas Chile Post-Doctoral Fellowship (to H.G.) and the Parker Institute for Immunotherapy (to M.H.S. and Z.W.); the Emerson Collective Cancer Research Fund (to H.G and Z.W.); the National Institutes of Health (5P50CA097257-18) (to J.J.P.); by funds from Swedish Society of Medicine, Gunnar Nilsson Cancer Foundation, Swedish Society for Medical Research, and governmental funding of clinical research within the National Health Services (ALF) (to C.H.). The Carlsberg Foundation (to T.L.H.O.).	Achrol AS, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-018-0055-y; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Arvanitis CD, 2020, NAT REV CANCER, V20, P26, DOI 10.1038/s41568-019-0205-x; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bae SK, 2000, DEVELOPMENT, V127, P2933; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bova GS, 2017, NATURE, V548, P287, DOI 10.1038/nature23535; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Friebel E, 2020, CELL, V181, P1626, DOI 10.1016/j.cell.2020.04.055; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Gonzalez H, 2018, FEBS J, V285, P654, DOI 10.1111/febs.14325; Gonzalez H, 2013, J IMMUNOL, V190, P5048, DOI 10.4049/jimmunol.1203121; Gril B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05030-w; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hagerling C, 2019, P NATL ACAD SCI USA, V116, P21704, DOI 10.1073/pnas.1907660116; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Hall WA, 2000, MED ONCOL, V17, P279, DOI 10.1007/BF02782192; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Ishii S, 2017, ONCOTARGET, V8, P74567, DOI 10.18632/oncotarget.20209; Kamp MA, 2018, NEUROSURG REV, V41, P77, DOI 10.1007/s10143-016-0760-5; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16164-1; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Kwak T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108571; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Li XR, 2016, INT J ONCOL, V48, P1933, DOI 10.3892/ijo.2016.3406; Luo N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02630-w; Maeda K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22288; Muller S, 2018, BIOINFORMATICS, V34, P3217, DOI 10.1093/bioinformatics/bty316; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Nieblas-Bedolla E, 2021, ONCOLOGIST, V26, P231, DOI 10.1002/onco.13575; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pedersen IS, 1999, CANCER RES, V59, P5449; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Priego N, 2018, NAT MED, V24, P1024, DOI 10.1038/s41591-018-0044-4; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Reiter JG, 2020, NAT GENET, V52, P692, DOI 10.1038/s41588-020-0633-2; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rozenblatt-Rosen O, 2020, CELL, V181, P236, DOI 10.1016/j.cell.2020.03.053; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Shapovalova M, 2019, CANCER RES, V79, P5668, DOI 10.1158/0008-5472.CAN-19-2181; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shen M, 2019, CANCER CELL, V35, P64, DOI 10.1016/j.ccell.2018.11.016; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Sprowls SA, 2019, TRENDS CANCER, V5, P495, DOI 10.1016/j.trecan.2019.06.003; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Venteicher AS, 2017, SCIENCE, V355, DOI 10.1126/science.aai8478; Vidal AC, 2014, CLIN TRANSL ONCOL, V16, P266, DOI 10.1007/s12094-013-1067-4; Wagner NB, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0828-1; Watson MJ, 2021, NATURE, V591, P645, DOI 10.1038/s41586-020-03045-2; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu SZ, 2021, NAT GENET, V53, P1334, DOI 10.1038/s41588-021-00911-1; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zeng QQ, 2019, NATURE, V573, P526, DOI 10.1038/s41586-019-1576-6; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zhao Q, 2018, CANCER RES, V78, P2370, DOI 10.1158/0008-5472.CAN-17-2728; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	82	11	11	18	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 17	2022	185	4					729	+		10.1016/j.cell.2021.12.043	http://dx.doi.org/10.1016/j.cell.2021.12.043			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ZF7CM	35063085				2022-12-28	WOS:000759723100002
J	Tewari, KS; Monk, BJ; Vergote, I; Miller, A; de Melo, AC; Kim, HS; Kim, YM; Lisyanskaya, A; Samouelian, V; Lorusso, D; Damian, F; Chang, CL; Gotovkin, EA; Takahashi, S; Ramone, D; Pikiel, J; Mackowiak-Matejczyk, B; Alia, EMG; Colombo, N; Makarova, Y; Rischin, D; Lheureux, S; Hasegawa, K; Fujiwara, K; Li, J; Jamil, S; Jankovic, V; Chen, CI; Seebach, F; Weinreich, DM; Yancopoulos, GD; Lowy, I; Mathias, M; Fury, MG; Oaknin, A				Tewari, K. S.; Monk, B. J.; Vergote, I; Miller, A.; de Melo, A. C.; Kim, H-S; Kim, Y. M.; Lisyanskaya, A.; Samouelian, V; Lorusso, D.; Damian, F.; Chang, C-L; Gotovkin, E. A.; Takahashi, S.; Ramone, D.; Pikiel, J.; Mackowiak-Matejczyk, B.; Alia, E. M. Guerra; Colombo, N.; Makarova, Y.; Rischin, D.; Lheureux, S.; Hasegawa, K.; Fujiwara, K.; Li, J.; Jamil, S.; Jankovic, V; Chen, C-, I; Seebach, F.; Weinreich, D. M.; Yancopoulos, G. D.; Lowy, I; Mathias, M.; Fury, M. G.; Oaknin, A.		Investigators GOG Protocol 3016; ENGOT Protocol En-Cx9	Survival with Cemiplimab in Recurrent Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPEN-LABEL; MODELS; PD-L1	BACKGROUND Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this population. METHODS In this phase 3 trial, we enrolled patients who had disease progression after first-line platinum-containing chemotherapy, regardless of their programmed cell death ligand 1 (PD-L1) status. Women were randomly assigned (1:1) to receive cemiplimab (350 mg every 3 weeks) or the investigator's choice of single-agent chemotherapy. The primary end point was overall survival. Progression-free survival and safety were also assessed. RESULTS A total of 608 women were enrolled (304 in each group). In the overall trial population, median overall survival was longer in the cemiplimab group than in the chemotherapy group (12.0 months vs. 8.5 months; hazard ratio for death, 0.69; 95% confidence interval [CI], 0.56 to 0.84; two-sided P<0.001). The overall survival benefit was consistent in both histologic subgroups (squamous-cell carcinoma and adenocarcinoma [including adenosquamous carcinoma]). Progression-free survival was also longer in the cemiplimab group than in the chemotherapy group in the overall population (hazard ratio for disease progression or death, 0.75; 95% CI, 0.63 to 0.89; two-sided P<0.001). In the overall population, an objective response occurred in 16.4% (95% CI, 12.5 to 21.1) of the patients in the cemiplimab group, as compared with 6.3% (95% CI, 3.8 to 9.6) in the chemotherapy group. An objective response occurred in 18% (95% CI, 11 to 28) of the cemiplimab-treated patients with PD-L1 expression greater than or equal to 1% and in 11% (95% CI, 4 to 25) of those with PD-L1 expression of less than 1%. Overall, grade 3 or higher adverse events occurred in 45.0% of the patients who received cemiplimab and in 53.4% of those who received chemotherapy. CONCLUSIONS Survival was significantly longer with cemiplimab than with single-agent chemotherapy among patients with recurrent cervical cancer after first-line platinum-containing chemotherapy.	[Tewari, K. S.] Univ Calif Irvine, Dept Gynecol & Obstet, Div Gynecol Oncol, City Tower,333 City Blvd West,Suite 1400, Orange, CA 92868 USA; [Monk, B. J.] Univ Arizona, Arizona Oncol, Div Gynecol Oncol, Phoenix, AZ USA; [Monk, B. J.] Creighton Univ, Phoenix, AZ USA; [Vergote, I] Katholieke Univ Leuven, Univ Hosp, Dept Gynecol & Obstet, Div Gynecol Oncol, Leuven, Belgium; [Miller, A.] Roswell Pk Comprehens Canc Ctr, Dept Biostarist & Bioinformat, Buffalo, NY USA; [Li, J.; Jamil, S.; Jankovic, V; Chen, C-, I; Seebach, F.; Weinreich, D. M.; Yancopoulos, G. D.; Lowy, I; Mathias, M.; Fury, M. G.] Regeneron Pharmaceut, Tarrytown, NY USA; [de Melo, A. C.] Brazilian Natl Canc Inst, Div Clin Res & Technol Dev, Rio De Janeiro, Brazil; [Damian, F.] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Ctr Pesquisa Oncol, Porto Alegre, RS, Brazil; [Ramone, D.] Pio XII Fdn, Barretos Canc Hosp, Dept Clin Oncol, Sao Paulo, Brazil; [Kim, H-S] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Y. M.] Univ Ulsan, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lisyanskaya, A.] St Petersburg State Budgetary Inst Hlth Care, St Petersburg, Russia; [Gotovkin, E. A.] State Budget Hlth Care Inst Ivanovo Reg Oncol Dis, Ivanovna, Russia; [Makarova, Y.] Clin Oncol Dispensary 1, State Budgetary Inst Hlth Care, Krasnodar, Russia; [Samouelian, V] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech Ctr Hosp Univ Montreal, Div Gynecol Oncol,Dept Obstet & Gynecol, Montreal, PQ, Canada; [Lorusso, D.] Fdn Policin Univ Gemelli A IRCCS, Div Gynecol Oncol, Dept Women & Child & Lealth, Rome, Italy; [Lorusso, D.] Univ Cattolica Sacro Cuore, Dept Life Sci & Publ Hlth, Largo Agostino Gemelli, Rome, Italy; [Chang, C-L] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chang, C-L] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Takahashi, S.] Canc Inst Hosp Japanese Fdn Canc Res, Dept Med Oncol, Tokyo, Japan; [Hasegawa, K.; Fujiwara, K.] Saitama Med Univ Int Med Ctr, Dept Gynecol Oncol, Hidaka, Japan; [Pikiel, J.] Szpitale Pomorskie, Dept Oncol, Gdynia, Poland; [Mackowiak-Matejczyk, B.] Bialostockie Ctr Onkol, Dept Gynecol Oncol, Bialostockie, Poland; [Alia, E. M. Guerra] Hosp Ramon & Cajal, Dept Med Oncol, Madrid, Spain; [Colombo, N.] Univ Milano Bicocca, Dept Gynecol Oncol, Milan, Italy; [Colombo, N.] Ist Europeo Oncol IRCCS, Milan, Italy; [Rischin, D.] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia; [Lheureux, S.] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Oaknin, A.] Hosp Univ Vali dHebron, Vali dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol, Gynecol Canc Program, Barcelona, Spain	University of California System; University of California Irvine; University of Arizona; Creighton University; KU Leuven; Regeneron; National Cancer Institute (Inca); Pontificia Universidade Catolica Do Rio Grande Do Sul; Hospital de Cancer de Barretos; Seoul National University (SNU); University of Ulsan; Asan Medical Center; Universite de Montreal; Catholic University of the Sacred Heart; Mackay Memorial Hospital; Mackay Medical College; Japanese Foundation for Cancer Research; Saitama Medical University; Hospital Universitario Ramon y Cajal; University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO); Peter Maccallum Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Vall d'Hebron Institut d'Oncologia (VHIO)	Tewari, KS (corresponding author), Univ Calif Irvine, Dept Gynecol & Obstet, Div Gynecol Oncol, City Tower,333 City Blvd West,Suite 1400, Orange, CA 92868 USA.	ktewari@uci.edu	Tarnawski, Rafal/N-7526-2016; Lisyanskaya, Alla/CAG-2889-2022; de Melo, Andreia/C-8133-2019	Tarnawski, Rafal/0000-0001-6802-5093; Lisyanskaya, Alla/0000-0002-4495-9681; de Melo, Andreia/0000-0002-1201-4333; OAKNIN, ANA/0000-0002-3592-7194	Regeneron Pharmaceuticals; Sanofi	Regeneron Pharmaceuticals(Regeneron); Sanofi	Supported by Regeneron Pharmaceuticals and Sanofi. Editorial assistance with an earlier version of the manuscript was funded by Regeneron Pharmaceuticals and Sanofi in accordance with Good Publication Practice guidelines.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bhatla N, 2019, INT J GYNECOL OBSTET, V145, P129, DOI 10.1002/ijgo.12749; Chung HC, 2019, J CLIN ONCOL, V37, P1470, DOI 10.1200/JCO.18.01265; COX DR, 1972, J R STAT SOC B, V34, P187; Detry MA, 2016, JAMA-J AM MED ASSOC, V315, P407, DOI 10.1001/jama.2015.19394; Diggle P., 1993, ANAL LONGITUDINAL DA; Jones HE, 2011, CLIN TRIALS, V8, P129, DOI 10.1177/1740774510396933; Kitagawa R, 2015, J CLIN ONCOL, V33, P2129, DOI 10.1200/JCO.2014.58.4391; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Migden MR, 2018, NEW ENGL J MED, V379, P341, DOI 10.1056/NEJMoa1805131; Migden MR, 2020, LANCET ONCOL, V21, P294, DOI 10.1016/S1470-2045(19)30728-4; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Papadopoulos KP, 2020, CLIN CANCER RES, V26, P1025, DOI 10.1158/1078-0432.CCR-19-2609; Rischin D, 2020, GYNECOL ONCOL, V159, P322, DOI 10.1016/j.ygyno.2020.08.026; Sezer A, 2021, LANCET, V397, P592, DOI 10.1016/S0140-6736(21)00228-2; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Smith J, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0494-2; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Tewari KS, 2019, J CLIN ONCOL, V37, P2472, DOI 10.1200/JCO.18.02303; Tewari KS, 2017, LANCET, V390, P1654, DOI 10.1016/S0140-6736(17)31607-0; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Vergote I, 2019, INT J GYNECOL CANCER, V29, P1094, DOI 10.1136/ijgc-2019-000441; WIEAND S, 1994, STAT MED, V13, P1453, DOI 10.1002/sim.4780131321	26	41	41	12	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2022	386	6					544	555		10.1056/NEJMoa2112187	http://dx.doi.org/10.1056/NEJMoa2112187			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW0GW	35139273				2022-12-28	WOS:000753100900010
J	Ham, C				Ham, Chris			Six million patients wait as politicians argue over the elective recovery plan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], TIMES; [Anonymous], PUBLIC PERCEPTIONS N	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2022	376								o337	10.1136/bmj.o337	http://dx.doi.org/10.1136/bmj.o337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE9JI	35131840	Bronze			2022-12-28	WOS:000759192600002
J	Lauvaux, T; Giron, C; Mazzolini, M; d'Aspremont, A; Duren, R; Cusworth, D; Shindell, D; Ciais, P				Lauvaux, T.; Giron, C.; Mazzolini, M.; d'Aspremont, A.; Duren, R.; Cusworth, D.; Shindell, D.; Ciais, P.			Global assessment of oil and gas methane ultra-emitters	SCIENCE			English	Article							NATURAL-GAS; SATELLITE-OBSERVATIONS; POINT SOURCES; EMISSIONS; TROPOMI	Methane emissions from oil and gas (O&G) production and transmission represent a considerable contribution to climate change. These emissions comprise sporadic releases of large amounts of methane during maintenance operations or equipment failures not accounted for in current inventory estimates. We collected and analyzed hundreds of very large releases from atmospheric methane images sampled by the TROPOspheric Monitoring Instrument (TROPOMI) between 2019 and 2020. Ultra-emitters are primarily detected over the largest O&G basins throughout the world. With a total contribution equivalent to 8 to 12% (similar to 8 million metric tons of methane per year) of the global O&G production methane emissions, mitigation of ultra-emitters is largely achievable at low costs and would lead to robust net benefits in billions of US dollars for the six major O&G-producing countries when considering societal costs of methane.	[Lauvaux, T.; Ciais, P.] Univ Saclay, Lab Sci Climat & Environm, IPSL, Saclay, France; [Giron, C.; Mazzolini, M.; d'Aspremont, A.] Kayrros, 33 Rue Lafayette, F-75009 Paris, France; [d'Aspremont, A.] Ecole Normale Super, CNRS, Paris, France; [d'Aspremont, A.] Ecole Normale Super, DI, Paris, France; [Duren, R.] Univ Arizona, Off Res Innovat & Impact, Tucson, AZ USA; [Duren, R.] Carbon Mapper, 12 S Raymond St,Suite B, Pasadena, CA 91105 USA; [Cusworth, D.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Shindell, D.] Duke Univ, Nicholas Sch Environm, Earth & Climate Sci Div, Durham, NC 27708 USA; [Shindell, D.] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel; [Shindell, D.] Climate & Clean Air Coalit, 1 Rue Miollis,Bldg 7, F-75015 Paris, France; [Ciais, P.] Cyprus Inst CyI, Climate & Atmosphere Res Ctr, CY-2121 Nicosia, Cyprus	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Duke University; Tel Aviv University	Lauvaux, T (corresponding author), Univ Saclay, Lab Sci Climat & Environm, IPSL, Saclay, France.	thomas.lauvaux@lsce.ipsl.fr	Shindell, Drew/D-4636-2012	Shindell, Drew/0000-0003-1552-4715; Lauvaux, Thomas/0000-0002-7697-742X; Cusworth, Daniel/0000-0003-0158-977X	CNRS Make Our Planet Great Again French program CIUDAD project; NASA GISS grant [80NSSC19M0138]; ANR Investissements d'avenir program [PRAIRIE: ANR-19-P3IA0001]; European Space Agency ESTEC contract [4000134070/21/NL/MM/gm]; NASA Carbon Monitoring System (CMS) program; NASA Jet Propulsion Laboratory; High Tide Foundation	CNRS Make Our Planet Great Again French program CIUDAD project; NASA GISS grant; ANR Investissements d'avenir program(French National Research Agency (ANR)); European Space Agency ESTEC contract; NASA Carbon Monitoring System (CMS) program; NASA Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); High Tide Foundation	This research was supported by CNRS Make Our Planet Great Again French program CIUDAD project (to T. L. and P.C.); NASA GISS grant 80NSSC19M0138 (to D.S.); ANR Investissements d'avenir program grant PRAIRIE: ANR-19-P3IA0001 (to A.A.); European Space Agency ESTEC contract (4000134070/21/NL/MM/gm) (to A.A. and T.L.); NASA Carbon Monitoring System (CMS) program (to R.D. and D.C.); and the High Tide Foundation and NASA Jet Propulsion Laboratory (to R.D.)	Alvarez RA, 2018, SCIENCE, V361, P186, DOI 10.1126/science.aar7204; Barre J, 2021, ATMOS CHEM PHYS, V21, P5117, DOI 10.5194/acp-21-5117-2021; Beucher S., 1992, SCANNING MICROSC, V1992, P28; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chan E, 2020, ENVIRON SCI TECHNOL, V54, P14899, DOI 10.1021/acs.est.0c04117; Conley S, 2016, SCIENCE, V351, P1317, DOI 10.1126/science.aaf2348; Cusworth DH, 2021, ENVIRON SCI TECH LET, V8, P567, DOI 10.1021/acs.estlett.1c00173; Cusworth DH, 2021, GEOPHYS RES LETT, V48, DOI 10.1029/2020GL090864; de Gouw JA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57678-4; Duren RM, 2019, NATURE, V575, P180, DOI 10.1038/s41586-019-1720-3; E. P. A. Global, 2019, NONCO2 GREENH GAS EM; EdgeTech, 2021, TRAP TRACK; Frankenberg C, 2016, P NATL ACAD SCI USA, V113, P9734, DOI 10.1073/pnas.1605617113; Hmiel B, 2020, NATURE, V578, P409, DOI 10.1038/s41586-020-1991-8; Hoglund-Isaksson L, 2020, ENVIRON RES COMMUN, V2, DOI 10.1088/2515-7620/ab7457; Hu H, 2018, GEOPHYS RES LETT, V45, P3682, DOI 10.1002/2018GL077259; Jackson RB, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab9ed2; Karion A, 2015, ENVIRON SCI TECHNOL, V49, P8124, DOI 10.1021/acs.est.5b00217; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Kuuskraa V. A., 2013, EIA TECHNICALLY RECO; Lyon DR, 2021, ATMOS CHEM PHYS, V21, P6605, DOI 10.5194/acp-21-6605-2021; Maasakkers JD, 2019, ATMOS CHEM PHYS, V19, P7859, DOI 10.5194/acp-19-7859-2019; Matthews HD, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014010; Mayfield EN, 2017, ENVIRON SCI TECHNOL, V51, P4772, DOI 10.1021/acs.est.6b05052; Nisbet EG, 2020, REV GEOPHYS, V58, DOI 10.1029/2019RG000675; Nisbet EG, 2019, GLOBAL BIOGEOCHEM CY, V33, P318, DOI 10.1029/2018GB006009; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Omara M, 2016, ENVIRON SCI TECHNOL, V50, P2099, DOI 10.1021/acs.est.5b05503; Pandey S, 2019, P NATL ACAD SCI USA, V116, P26376, DOI 10.1073/pnas.1908712116; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Propp A. M., 2017, AGU FALL M ABSTR; Rigby M, 2017, P NATL ACAD SCI USA, V114, P5373, DOI 10.1073/pnas.1616426114; Saunois M, 2020, EARTH SYST SCI DATA, V12, P1561, DOI 10.5194/essd-12-1561-2020; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; Schneising O, 2020, ATMOS CHEM PHYS, V20, P9169, DOI 10.5194/acp-20-9169-2020; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Student, 1907, BIOMETRIKA, V5, P351; UNEP/CCAC, 2021, GLOB METH ASS BEN CO; Varon DJ, 2019, GEOPHYS RES LETT, V46, P13507, DOI 10.1029/2019GL083798; Varon DJ, 2021, ATMOS MEAS TECH, V14, P2771, DOI 10.5194/amt-14-2771-2021; Varon DJ, 2018, ATMOS MEAS TECH, V11, P5673, DOI 10.5194/amt-11-5673-2018; Veefkind JP, 2012, REMOTE SENS ENVIRON, V120, P70, DOI 10.1016/j.rse.2011.09.027; Zavala-Araiza D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14012; Zavala-Araiza D, 2015, P NATL ACAD SCI USA, V112, P15597, DOI 10.1073/pnas.1522126112; Zhang YZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz5120; Zhao YH, 2020, ATMOS CHEM PHYS, V20, P9525, DOI 10.5194/acp-20-9525-2020	46	23	22	26	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2022	375	6580					557	+		10.1126/science.abj4351	http://dx.doi.org/10.1126/science.abj4351			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YX2VG	35113691	Green Submitted			2022-12-28	WOS:000753965100042
J	Wise, J				Wise, Jacqui			Specialist surgical mesh centres are not working, MPs are told	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cumberlege J, 2020, 1 NO HARM REPORT IND; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4589; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2726; Scottish Government, 2022, MESH REIMB SCHEM BE	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2022	376								o314	10.1136/bmj.o314	http://dx.doi.org/10.1136/bmj.o314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YW6VN	35121626				2022-12-28	WOS:000753552800012
J	Anguita, R; Veas, R				Anguita, Rodrigo; Veas, Ricardo			Lisch Nodules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anguita, Rodrigo; Veas, Ricardo] Moorfields Eye Hosp, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Anguita, R (corresponding author), Moorfields Eye Hosp, London, England.	rodrigoanguita@gmail.com		Anguita, Rodrigo/0000-0003-2382-1111					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2022	386	5					478	478		10.1056/NEJMicm2106711	http://dx.doi.org/10.1056/NEJMicm2106711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YR1JU	35108472				2022-12-28	WOS:000749755800012
J	Abbar, M; Demattei, C; El-Hage, W; Llorca, PM; Samalin, L; Demaricourt, P; Gaillard, R; Courtet, P; Vaiva, G; Gorwood, P; Fabbro, P; Jollant, F				Abbar, Mocrane; Demattei, Christophe; El-Hage, Wissam; Llorca, Pierre-Michel; Samalin, Ludovic; Demaricourt, Pierre; Gaillard, Raphael; Courtet, Philippe; Vaiva, Guillaume; Gorwood, Philip; Fabbro, Pascale; Jollant, Fabrice			Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							D-ASPARTATE ANTAGONIST; MAJOR DEPRESSION; INTRAVENOUS KETAMINE; BIPOLAR DEPRESSION; RATING-SCALE; RISK-FACTORS; ESKETAMINE; DISORDERS; MIDAZOLAM; THOUGHTS	OBJECTIVE To confirm the rapid onset anti-suicidal benefits of ketamine in the short term and at six weeks, overall and according to diagnostic group. DESIGN Prospective, double blind, superiority, randomised placebo controlled trial. SETTING Seven French teaching hospitals between 13 April 2015 and 12 March 2019. Eligibility criteria for participants Aged 18 or older with current suicidal ideation, admitted to hospital voluntarily. Exclusion criteria included a history of schizophrenia or other psychotic disorders, substance dependence, and contraindications for ketamine. PARTICIPANTS 156 participants were recruited and randomised to placebo (n=83) or ketamine (n=73), stratified by centre and diagnosis: bipolar, depressive, or other disorders. Intervention Two 40 minute intravenous infusions of ketamine (0.5 mg/kg) or placebo (saline) were administered at baseline and 24 hours, in addition to usual treatment. MAIN OUTCOME MEASURES The primary outcome was the rate of patients in full suicidal remission at day 3, according to the scale for suicidal ideation total score <= 3. Analyses were conducted on an intention-to-treat basis.	[Abbar, Mocrane; Jollant, Fabrice] Univ Montpellier, Acad Hosp CHU Nimes, Dept Psychiat, Nimes, France; [Demattei, Christophe] Univ Montpellier, CHU Nimes, Dept Biostat Epidemiol Publ Hlth & Innovat Method, Nimes, France; [El-Hage, Wissam] Univ Tours, Natl Inst Hlth & Med Res INSERM, CHRU Tours Res Unit UMR 1253, iBrain, Tours, France; [Llorca, Pierre-Michel] Univ Clermont Auvergne, CHU Clermont Ferrand, Inst Pascal, Dept Psychiat, Clermont Ferrand, France; [Demaricourt, Pierre; Gaillard, Raphael; Gorwood, Philip; Jollant, Fabrice] Univ Paris, Sch Med, Paris, France; [Demaricourt, Pierre; Gaillard, Raphael; Gorwood, Philip; Jollant, Fabrice] Sainte Anne Hosp, Sch Med, Paris, France; [Courtet, Philippe] Univ Montpellier, Ctr Epidemiol & Clin Res Psychiat PSNREC, INSERM, CHU Montpellier, Montpellier, France; [Courtet, Philippe] CHU Montpellier, Lapeyronie Hosp, Dept Emergency Psychiat & Acute Care, Montpellier, France; [Vaiva, Guillaume] CHU Lille, Dept Psychiat, Lille, France; [Vaiva, Guillaume] Univ Lille, INSERM U1172, LilNCog Lille Neurosci, Lille, France; [Jollant, Fabrice] McGill Univ, McGill Grp Suicide Studies, Dept Psychiat, Montreal, PQ, Canada; [Jollant, Fabrice] Epidemiol & Populat Hlth Res Ctr CESP, Moods Team, INSERM, UMR 1178, Le Kremlin Bicetre, France; [Jollant, Fabrice] Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany	Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Friedrich Schiller University of Jena	Jollant, F (corresponding author), Univ Montpellier, Acad Hosp CHU Nimes, Dept Psychiat, Nimes, France.; Jollant, F (corresponding author), Univ Paris, Sch Med, Paris, France.; Jollant, F (corresponding author), Sainte Anne Hosp, Sch Med, Paris, France.; Jollant, F (corresponding author), McGill Univ, McGill Grp Suicide Studies, Dept Psychiat, Montreal, PQ, Canada.; Jollant, F (corresponding author), Epidemiol & Populat Hlth Res Ctr CESP, Moods Team, INSERM, UMR 1178, Le Kremlin Bicetre, France.; Jollant, F (corresponding author), Univ Hosp Jena, Dept Psychiat & Psychotherapy, Jena, Germany.	jollantf@gmail.com			Programme Hospitalier de Recherche Clinique National (PHRC-N)	Programme Hospitalier de Recherche Clinique National (PHRC-N)	Funded by Programme Hospitalier de Recherche Clinique National (PHRC-N) 2013. The study funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The researchers are independent of the funders and all authors had full access to all the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Chung DT, 2017, JAMA PSYCHIAT, V74, P694, DOI 10.1001/jamapsychiatry.2017.1044; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Ducasse D, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.16r10732; Grunebaum MF, 2018, AM J PSYCHIAT, V175, P327, DOI 10.1176/appi.ajp.2017.17060647; Grunebaum MF, 2017, BIPOLAR DISORD, V19, P176, DOI 10.1111/bdi.12487; Hawton K, 2016, LANCET PSYCHIAT, V3, P740, DOI 10.1016/S2215-0366(16)30070-0; Hu YD, 2016, PSYCHOL MED, V46, P623, DOI 10.1017/S0033291715002159; Jollant F, 2020, PROG NEURO-PSYCHOPH, V100, DOI 10.1016/j.pnpbp.2020.109909; McIntyre RS, 2021, AM J PSYCHIAT, V178, P383, DOI 10.1176/appi.ajp.2020.20081251; Milev RV, 2016, CAN J PSYCHIAT, V61, P561, DOI 10.1177/0706743716660033; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Olie E, 2010, J AFFECT DISORDERS, V120, P226, DOI 10.1016/j.jad.2009.03.013; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Phillips JL, 2020, NEUROPSYCHOPHARMACOL, V45, P606, DOI 10.1038/s41386-019-0570-x; Pompili M, 2013, BIPOLAR DISORD, V15, P457, DOI 10.1111/bdi.12087; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sheehan DV., MINI INT NEUROPSYCHI; Siegel AN, 2021, J PSYCHIATR RES, V137, P426, DOI 10.1016/j.jpsychires.2021.03.009; Wilkinson ST, 2018, AM J PSYCHIAT, V175, P150, DOI 10.1176/appi.ajp.2017.17040472; Williams NR, 2018, AM J PSYCHIAT, V175, P1205, DOI 10.1176/appi.ajp.2018.18020138; Witt K, 2020, AUST NZ J PSYCHIAT, V54, P29, DOI 10.1177/0004867419883341; World Health Statistics, 2016, MON HLTH SUST DEV GO; Xiong JQ, 2021, J PSYCHIATR RES, V134, P57, DOI 10.1016/j.jpsychires.2020.12.038; Yatham LN, 2018, BIPOLAR DISORD, V20, P97, DOI 10.1111/bdi.12609; Yoon G, 2019, JAMA PSYCHIAT, V76, P337, DOI 10.1001/jamapsychiatry.2018.3990; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yovell Y, 2016, AM J PSYCHIAT, V173, P491, DOI 10.1176/appi.ajp.2015.15040535; Zalsman G, 2016, LANCET PSYCHIAT, V3, P646, DOI 10.1016/S2215-0366(16)30030-X; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010	36	13	13	4	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2022	376								e067194	10.1136/bmj-2021-067194	http://dx.doi.org/10.1136/bmj-2021-067194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZE1XC	35110300	Green Published, hybrid			2022-12-28	WOS:000758682200007
J	Sester, M; Becker, SL				Sester, Martina; Becker, Soeren L.			Boosting immunity after CoronaVac Comment	LANCET			English	Editorial Material									[Sester, Martina] Saarland Univ, Dept Transplant & Infect Immunol, D-66421 Homburg, Germany; [Becker, Soeren L.] Saarland Univ, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Sester, M (corresponding author), Saarland Univ, Dept Transplant & Infect Immunol, D-66421 Homburg, Germany.	martina.sester@uks.eu		Becker, Soeren/0000-0003-3634-8802				Chemaitelly H, 2021, NEW ENGL J MED, V385, pE83, DOI 10.1056/NEJMoa2114114; Clemens SAC, 2022, LANCET, V399, P521, DOI 10.1016/S0140-6736(22)00094-0; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Kwok SLL, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.2.2101197; Liu Jinyan, 2022, medRxiv, DOI 10.1101/2022.01.02.22268634; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3; Schmidt T, 2021, AM J TRANSPLANT, V21, P3990, DOI 10.1111/ajt.16818; Schmidt T, 2021, NAT MED, V27, P1530, DOI 10.1038/s41591-021-01464-w; World Health Organization, 2021, INT REC HET COVID 19; Zeng G, 2022, LANCET INFECT DIS, V22, P483, DOI 10.1016/S1473-3099(21)00681-2	12	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10324					496	497		10.1016/S0140-6736(22)00095-2	http://dx.doi.org/10.1016/S0140-6736(22)00095-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YY9ZX	35074137	Green Published			2022-12-28	WOS:000755144500002
J	Mahase, E				Mahase, Elisabeth			Omicron sub-lineage BA.2 may have "substantial growth advantage, " UKHSA reports	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2022, SARS COV2 VARIANTS C	1	21	23	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 31	2022	376								o263	10.1136/bmj.o263	http://dx.doi.org/10.1136/bmj.o263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS2TM	35101887	Bronze			2022-12-28	WOS:000750534900004
J	Hupfeld, K				Hupfeld, Kathleen			Paying it forward	SCIENCE			English	Editorial Material									[Hupfeld, Kathleen] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Hupfeld, K (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	SciCareerEditor@aaas.org		Hupfeld, Kathleen/0000-0001-5086-4841					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					466	466						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS8CI	35084956				2022-12-28	WOS:000750899500043
J	Nelms, B; Walbot, V				Nelms, Brad; Walbot, Virginia			Gametophyte genome activation occurs at pollen mitosis I in maize	SCIENCE			English	Article							SELECTION; GENES; TRANSCRIPTION; RECOMBINATION; MICROSPORES; TRANSITION; EXPRESSION; REVEALS; TUBE; SEED	Flowering plants alternate between multicellular haploid (gametophyte) and diploid (sporophyte) generations. Pollen actively transcribes its haploid genome, providing phenotypic diversity even among pollen grains from a single plant. In this study, we used allele-specific RNA sequencing of single pollen precursors to follow the shift to haploid expression in maize pollen. We observed widespread biallelic expression for 11 days after meiosis, indicating that transcripts synthesized by the diploid sporophyte persist long into the haploid phase. Subsequently, there was a rapid and global conversion to monoallelic expression at pollen mitosis I, driven by active new transcription from the haploid genome. Genes showed evidence of increased purifying selection if they were expressed after (but not before) pollen mitosis I. This work establishes the timing during which haploid selection may act in pollen.	[Nelms, Brad] Univ Georgia, Dept Plant Biol, Athens, GA 30606 USA; [Walbot, Virginia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University System of Georgia; University of Georgia; Stanford University	Nelms, B (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30606 USA.	nelms@uga.edu	Zhang, Lu/HGB-5048-2022	Nelms, Bradlee/0000-0002-2381-2170; Walbot, Virginia/0000-0002-1596-7279	National Science Foundation [17540974]; NSF PGRP postdoctoral fellowship	National Science Foundation(National Science Foundation (NSF)); NSF PGRP postdoctoral fellowship	This work was supported by National Science Foundation award 17540974. B.N. was supported by an NSF PGRP postdoctoral fellowship.	Armbruster WS, 2004, AM J BOT, V91, P1939, DOI 10.3732/ajb.91.11.1939; Arunkumar R, 2013, MOL BIOL EVOL, V30, P2475, DOI 10.1093/molbev/mst149; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Beaudry FEG, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100115; BEDINGER PA, 1990, PLANT PHYSIOL, V92, P474, DOI 10.1104/pp.92.2.474; Bhutani K, 2021, SCIENCE, V371, P1008, DOI 10.1126/science.abb1723; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Borg M, 2015, PLANT J, V83, P177, DOI 10.1111/tpj.12856; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Chettoor A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0414-2; Clarke HJ, 2004, EUPHYTICA, V139, P65, DOI 10.1007/s10681-004-2466-y; DAWE RK, 1994, CELL, V76, P901, DOI 10.1016/0092-8674(94)90364-6; EADY C, 1995, PLANT CELL, V7, P65, DOI 10.1105/tpc.7.1.65; Glockle B, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.152645; Gossmann TI, 2014, MOL BIOL EVOL, V31, P574, DOI 10.1093/molbev/mst226; Griffiths JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05083-x; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; HARRIS B, 1978, BIOCHEMISTRY-US, V17, P3250, DOI 10.1021/bi00609a012; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; HSU SY, 1988, MAYDICA, V33, P77; Immler S, 2019, ANNU REV ECOL EVOL S, V50, P219, DOI 10.1146/annurev-ecolsys-110218-024709; Jia HY, 2014, WIRES DEV BIOL, V3, P135, DOI 10.1002/wdev.126; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; KHUSH GS, 1967, GENETICA, V38, P74, DOI 10.1007/BF01507450; Kianian PMA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04562-5; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; KINDIGER B, 1991, GENOME, V34, P579, DOI 10.1139/g91-089; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Krueger Felix, 2016, F1000Res, V5, P1479, DOI 10.12688/f1000research.9037.2; Lenormand T, 2005, PLOS BIOL, V3, P396, DOI 10.1371/journal.pbio.0030063; Lin GF, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02396-x; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MULCAHY DL, 1974, NATURE, V249, P491, DOI 10.1038/249491a0; MULCAHY DL, 1979, SCIENCE, V206, P20, DOI 10.1126/science.206.4414.20; Nelms B, 2019, SCIENCE, V364, P52, DOI 10.1126/science.aav6428; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Sandler G, 2018, EVOL LETT, V2, P368, DOI 10.1002/evl3.60; Schulz KN, 2019, NAT REV GENET, V20, P221, DOI 10.1038/s41576-018-0087-x; Sidhu GK, 2015, P NATL ACAD SCI USA, V112, P15982, DOI 10.1073/pnas.1514265112; Sinha R, 2017, BIORXIV, DOI [10.1101/125724, DOI 10.1101/125724]; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; TANKSLEY SD, 1981, SCIENCE, V213, P453, DOI 10.1126/science.213.4506.453; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Valdivia ER, 2007, PLANT PHYSIOL, V143, P1269, DOI 10.1104/pp.106.092544; Zhai JX, 2015, P NATL ACAD SCI USA, V112, P3146, DOI 10.1073/pnas.1418918112; Zhang J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.79	49	8	8	18	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2022	375	6579					424	+		10.1126/science.abl7392	http://dx.doi.org/10.1126/science.abl7392			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS8CI	35084965	Green Submitted			2022-12-28	WOS:000750899500034
J	Sivan, M; Wright, S; Hughes, S; Calvert, M				Sivan, Manoj; Wright, Shaney; Hughes, Sarah; Calvert, Melanie			Using condition specific patient reported outcome measures for long covid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sivan, Manoj] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Sivan, Manoj] Leeds Community Healthcare NHS Long Covid Serv, Leeds, W Yorkshire, England; [Hughes, Sarah] Univ Birmingham, Ctr Patient Reported Outcome Res, Birmingham, W Midlands, England; [Hughes, Sarah] Swansea Univ, Fac Med Hlth & Life Sci, Swansea, W Glam, Wales; [Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England	University of Leeds; University of Birmingham; Swansea University; University of Birmingham	Sivan, M (corresponding author), Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England.; Sivan, M (corresponding author), Leeds Community Healthcare NHS Long Covid Serv, Leeds, W Yorkshire, England.			Hughes, Sarah/0000-0001-5656-1198				Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Briggs A, 2021, NATURE, V593, P502, DOI 10.1038/d41586-021-01392-2; Brown DA, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-007004; Calvert M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5267; Evans RA, 2021, LANCET RESP MED, V9, P1275, DOI 10.1016/S2213-2600(21)00383-0; Heightman M, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2021-001041; Hirschtick JL, 2021, CLIN INFECT DIS, V73, P2055, DOI 10.1093/cid/ciab408; NHSEngland, 2021, NAT GUID POST COVID; O Connor RJ, 2021, J MED VIROL; Parkin A, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/21501327211010994; Patel K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186476; Sivan M, 2022, J MED VIROL, V94, P1419, DOI 10.1002/jmv.27456; Sivan M, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n853; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Whitaker M., 2021, PERSISTENT SYMPTOMS; World Health Organisation, 2021, SUPP REH SELF MAN CO	16	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o257	10.1136/bmj.o257	http://dx.doi.org/10.1136/bmj.o257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091425	Bronze			2022-12-28	WOS:000749313200002
J	Wise, J				Wise, Jacqui			Sixty seconds on . . . Shigella	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2022	376								o253	10.1136/bmj.o253	http://dx.doi.org/10.1136/bmj.o253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YQ4XR	35091394				2022-12-28	WOS:000749313200010
J	Saul, H; Gursul, D; Powell, M; McCarthy, M				Saul, Helen; Gursul, Deniz; Powell, Martha; McCarthy, Michelle			Adults with learning disabilities want loving relationships, but may need support	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Helen; Gursul, Deniz; Powell, Martha] NIHR Ctr Engagement Disseminat, Twickenham, England; [McCarthy, Michelle] Univ Kent, Canterbury, Kent, England	University of Kent	Saul, H (corresponding author), NIHR Ctr Engagement Disseminat, Twickenham, England.	NIHRAlerts@nihr.ac.uk						Bates C, 2020, INT J CARE CARING, V5, P3; Bates C, 2020, BRIT J LEARN DISABIL, V48, P261, DOI 10.1111/bld.12320; McCarthy M, 2020, SEX DISABIL, V38, P3, DOI 10.1007/s11195-020-09619-2	3	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2022	376								o134	10.1136/bmj.o134	http://dx.doi.org/10.1136/bmj.o134			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP2FD	35082137				2022-12-28	WOS:000748440900001
J	Sun, XL; O'Shea, DJ; Golub, MD; Trautmann, EM; Vyas, S; Ryu, SI; Shenoy, KV				Sun, Xulu; O'Shea, Daniel J.; Golub, Matthew D.; Trautmann, Eric M.; Vyas, Saurabh; Ryu, Stephen I.; Shenoy, Krishna V.			Cortical preparatory activity indexes learned motor memories	NATURE			English	Article							BRAIN-COMPUTER INTERFACE; DYNAMICS; CORTEX; ADAPTATION; MOVEMENT; REPRESENTATION; COMPUTATION; SYSTEMS	The brain's remarkable ability to learn and execute various motor behaviours harnesses the capacity of neural populations to generate a variety of activity patterns. Here we explore systematic changes in preparatory activity in motor cortex that accompany motor learning. We trained rhesus monkeys to learn an arm-reaching task(1) in a curl force field that elicited new muscle forces for some, but not all, movement directions(2,3). We found that in a neural subspace predictive of hand forces, changes in preparatory activity tracked the learned behavioural modifications and reassociated(4 )existing activity patterns with updated movements. Along a neural population dimension orthogonal to the force-predictive subspace, we discovered that preparatory activity shifted uniformly for all movement directions, including those unaltered by learning. During a washout period when the curl field was removed, preparatory activity gradually reverted in the force-predictive subspace, but the uniform shift persisted. These persistent preparatory activity patterns may retain a motor memory of the learned field(5,6) and support accelerated relearning of the same curl field. When a set of distinct curl fields was learned in sequence, we observed a corresponding set of field-specific uniform shifts which separated the associated motor memories in the neural state space(7-9). The precise geometry of these uniform shifts in preparatory activity could serve to index motor memories, facilitating the acquisition, retention and retrieval of a broad motor repertoire.	[Sun, Xulu] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Sun, Xulu; O'Shea, Daniel J.; Golub, Matthew D.; Trautmann, Eric M.; Vyas, Saurabh; Shenoy, Krishna V.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [O'Shea, Daniel J.; Golub, Matthew D.; Trautmann, Eric M.; Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Vyas, Saurabh; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA 94301 USA; [Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Sun, XL (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Sun, XL; Shenoy, KV (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.; Shenoy, KV (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Shenoy, KV (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Shenoy, KV (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Shenoy, KV (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.; Shenoy, KV (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	xulu.sun@ucsf.edu; shenoy-work@stanford.edu		Shenoy, Krishna/0000-0003-1534-9240; O'Shea, Daniel/0000-0002-1366-1743; Sun, Xulu/0000-0003-3076-0994; Golub, Matthew/0000-0003-4508-0537	Stanford Interdisciplinary Graduate Fellowship; Stanford Bio-X Honorary Fellowship; Stanford Department of Biology Funding; US National Science Foundation graduate research fellowship; Stanford Graduate Fellowship; NIH [K99/R00, NIMH-K99MH121533]; NIH NRSA [1F31NS089376-01]; NSF IGERT [0734683]; NIH F31 Ruth L. Kirschstein National Research Service Award [1F31NS103409-01]; NSF Graduate Research Fellowship; Ric Weiland Stanford Graduate Fellowship; NIH Director's Pioneer Award [8DP1HD075623]; Defense Advanced Research Projects Agency (DARPA) Biological Technology Office (BTO) 'NeuroFAST' award [W911NF-14-2-0013]; Simons Foundation Collaboration on the Global Brain [543045]; Office of Naval Research [N000141812158]; Howard Hughes Medical Institute	Stanford Interdisciplinary Graduate Fellowship; Stanford Bio-X Honorary Fellowship; Stanford Department of Biology Funding; US National Science Foundation graduate research fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT(National Science Foundation (NSF)); NIH F31 Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Ric Weiland Stanford Graduate Fellowship; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (DARPA) Biological Technology Office (BTO) 'NeuroFAST' award; Simons Foundation Collaboration on the Global Brain; Office of Naval Research(Office of Naval Research); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank the members of the Shenoy laboratory at Stanford University for comments and discussions on the methods and results; T. Fisher for help with experiments; M. Risch, M. Wechsler and R. Reeder for expert veterinary care; B. Davis for administrative support; and W. L. Gore for donating Preclude artificial dura used as part of the chronic electrode array implantation procedure. X.S. was supported by a Stanford Interdisciplinary Graduate Fellowship, a Stanford Bio-X Honorary Fellowship and Stanford Department of Biology Funding. D.J.O. was supported by a US National Science Foundation graduate research fellowship and a Stanford Graduate Fellowship. M.D.G. was supported by an NIH K99/R00 award NIMH-K99MH121533. E.M.T. was supported by an NIH NRSA grant 1F31NS089376-01, a Stanford Graduate Fellowship and an NSF IGERT grant 0734683. S.V. was supported by an NIH F31 Ruth L. Kirschstein National Research Service Award 1F31NS103409-01, an NSF Graduate Research Fellowship and a Ric Weiland Stanford Graduate Fellowship. K.V.S. was supported by the following awards: NIH Director's Pioneer Award 8DP1HD075623, Defense Advanced Research Projects Agency (DARPA) Biological Technology Office (BTO) 'NeuroFAST' award W911NF-14-2-0013, the Simons Foundation Collaboration on the Global Brain awards 543045, the Office of Naval Research N000141812158 and the Howard Hughes Medical Institute.	Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Arce F, 2010, J NEUROSCI, V30, P9189, DOI 10.1523/JNEUROSCI.1603-10.2010; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Donchin O, 2003, J NEUROSCI, V23, P9032; Even-Chen N, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006808; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Golub MD, 2018, NAT NEUROSCI, V21, P607, DOI 10.1038/s41593-018-0095-3; Heald JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34737-5; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; Howard IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131268; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Hwang EJ, 2013, CURR BIOL, V23, P353, DOI 10.1016/j.cub.2013.01.027; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Krakauer JW, 2019, COMPR PHYSIOL, V9, P613, DOI 10.1002/cphy.c170043; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Oby ER, 2019, P NATL ACAD SCI USA, V116, P15210, DOI 10.1073/pnas.1820296116; Perich MG, 2018, NEURON, V100, P964, DOI 10.1016/j.neuron.2018.09.030; Richardson AG, 2012, J NEUROPHYSIOL, V107, P3144, DOI 10.1152/jn.00477.2011; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Russo AA, 2018, NEURON, V97, P953, DOI 10.1016/j.neuron.2018.01.004; Sakellaridi S, 2019, NEURON, V102, P694, DOI 10.1016/j.neuron.2019.02.012; Sauerbrei BA, 2020, NATURE, V577, P386, DOI 10.1038/s41586-019-1869-9; Schween R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53543-1; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sheahan HR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32606-9; Sheahan HR, 2016, NEURON, V92, P773, DOI 10.1016/j.neuron.2016.10.017; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Stavisky SD, 2017, J NEUROSCI, V37, P1721, DOI 10.1523/JNEUROSCI.1091-16.2016; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Vyas Saurabh, 2018, Neuron, V97, P1177, DOI 10.1016/j.neuron.2018.01.040; Vyas S, 2020, ANNU REV NEUROSCI, V43, P249, DOI 10.1146/annurev-neuro-092619-094115; Vyas S, 2020, NEURON, V106, P329, DOI 10.1016/j.neuron.2020.01.019; Xiao J, 2005, EUR J NEUROSCI, V22, P3266, DOI 10.1111/j.1460-9568.2005.04474.x	37	3	3	4	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2022	602	7896					274	+		10.1038/s41586-021-04329-x	http://dx.doi.org/10.1038/s41586-021-04329-x		JAN 2022	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YW6UU	35082444	Green Submitted			2022-12-28	WOS:000750881700001
J	Shuai, HP; Chan, JFW; Hu, BJ; Chai, Y; Yuen, TTT; Yin, FF; Huang, XE; Yoon, CM; Hu, JC; Liu, H; Shi, JL; Liu, YC; Zhu, TRZ; Zhang, JJ; Hou, YX; Wang, YX; Lu, L; Cai, JP; Zhang, AJX; Zhou, J; Yuan, SF; Brindley, MA; Zhang, BZ; Huang, JD; To, KKW; Yuen, KY; Chu, H				Shuai, Huiping; Chan, Jasper Fuk-Woo; Hu, Bingjie; Chai, Yue; Yuen, Terrence Tsz-Tai; Yin, Feifei; Huang, Xiner; Yoon, Chaemin; Jing-Chu Hu; Liu, Huan; Shi, Jialu; Liu, Yuanchen; Zhu, Tianrenzheng; Zhang, Jinjin; Hou, Yuxin; Wang, Yixin; Lu, Lu; Jian-Piao Cai; Zhang, Anna Jinxia; Zhou, Jie; Yuan, Shuofeng; Brindley, Melinda A.; Bao-Zhong Zhang; Jian-Dong Huang; To, Kelvin Kai-Wang; Kwok-Yung Yuen; Chu, Hin			Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron	NATURE			English	Article								The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly spreading among the human population(1). Although recent reports reveal that the Omicron variant robustly escapes vaccine-associated and therapeutic neutralization antibodies(2-10), the pathogenicity of the virus remains unknown. Here we show that the replication of Omicron is substantially attenuated in human Calu3 and Caco2 cells. Further mechanistic investigations reveal that Omicron is inefficient in its use of transmembrane serine protease 2 (TMPRSS2) compared with wild-type SARS-CoV-2 (HKU-001a) and previous variants, which may explain its reduced replication in Calu3 and Caco2 cells. The replication of Omicron is markedly attenuated in both the upper and lower respiratory tracts of infected K18-hACE2 mice compared with that of the wild-type strain and Delta (B.1.617.2) variant, resulting in its substantially ameliorated lung pathology. Compared with wild-type SARS-CoV-2 and the Alpha (B.1.1.7), Beta (1.351) and Delta variants, infection by Omicron causes the lowest reduction in body weight and the lowest mortality rate. Overall, our study demonstrates that the replication and pathogenicity of the Omicron variant of SARS-CoV-2 in mice is attenuated compared with the wild-type strain and other variants.	[Shuai, Huiping; Chan, Jasper Fuk-Woo; Hu, Bingjie; Chai, Yue; Yuen, Terrence Tsz-Tai; Huang, Xiner; Yoon, Chaemin; Liu, Huan; Shi, Jialu; Liu, Yuanchen; Zhu, Tianrenzheng; Zhang, Jinjin; Hou, Yuxin; Wang, Yixin; Lu, Lu; Jian-Piao Cai; Zhang, Anna Jinxia; Zhou, Jie; Yuan, Shuofeng; To, Kelvin Kai-Wang; Kwok-Yung Yuen; Chu, Hin] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, State Key Lab Emerging Infect Dis,Pokfulam, Hong Kong, Peoples R China; [Shuai, Huiping; Chan, Jasper Fuk-Woo; Hu, Bingjie; Chai, Yue; Yuen, Terrence Tsz-Tai; Huang, Xiner; Yoon, Chaemin; Liu, Huan; Shi, Jialu; Liu, Yuanchen; Zhu, Tianrenzheng; Zhang, Jinjin; Hou, Yuxin; Wang, Yixin; Lu, Lu; Jian-Piao Cai; Zhang, Anna Jinxia; Zhou, Jie; Yuan, Shuofeng; To, Kelvin Kai-Wang; Kwok-Yung Yuen; Chu, Hin] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China; [Yin, Feifei] Hainan Med Univ, Key Lab Trop TransLat Med, Minist Educ, Haikou, Hainan, Peoples R China; [Yin, Feifei; Kwok-Yung Yuen] Hainan Med Univ, Academician Workstn Hainan Prov, Haikou, Hainan, Peoples R China; [Yin, Feifei; Kwok-Yung Yuen] Univ Hong Kong, Hainan Med Univ, Univ Hong Kong Joint Lab Trop Infect Dis, Hong Kong, Peoples R China; [Jing-Chu Hu; Bao-Zhong Zhang] Chinese Acad Sci, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol, CAS Key Lab Quantitat Engn Biol, Shenzhen, Peoples R China; [Zhang, Anna Jinxia; Zhou, Jie; Yuan, Shuofeng; To, Kelvin Kai-Wang; Kwok-Yung Yuen; Chu, Hin] Ctr Virol Vaccinol & Therapeut, Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China; [Yuan, Shuofeng; To, Kelvin Kai-Wang; Kwok-Yung Yuen; Chu, Hin] Univ Hong Kong, Dept Clin Microbiol & Infect Control, Shenzhen Hosp, Shenzhen, Peoples R China; [Brindley, Melinda A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Dept Populat Hearth, Athens, GA USA; [Jian-Dong Huang] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [To, Kelvin Kai-Wang; Kwok-Yung Yuen] Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China; [To, Kelvin Kai-Wang; Kwok-Yung Yuen] Guangzhou Lab, Guangzhou, Peoples R China	University of Hong Kong; University of Hong Kong; Hainan Medical University; Hainan Medical University; Hainan Medical University; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; University System of Georgia; University of Georgia; University of Hong Kong; University of Hong Kong	Yuen, KY; Chu, H (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, State Key Lab Emerging Infect Dis,Pokfulam, Hong Kong, Peoples R China.; Yuen, KY; Chu, H (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Hainan Med Univ, Academician Workstn Hainan Prov, Haikou, Hainan, Peoples R China.; Yuen, KY (corresponding author), Univ Hong Kong, Hainan Med Univ, Univ Hong Kong Joint Lab Trop Infect Dis, Hong Kong, Peoples R China.; Yuen, KY; Chu, H (corresponding author), Ctr Virol Vaccinol & Therapeut, Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China.; Yuen, KY; Chu, H (corresponding author), Univ Hong Kong, Dept Clin Microbiol & Infect Control, Shenzhen Hosp, Shenzhen, Peoples R China.; Yuen, KY (corresponding author), Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China.; Yuen, KY (corresponding author), Guangzhou Lab, Guangzhou, Peoples R China.	kyyuen@hku.hk; hinchu@hku.hk	Huang, Xiner/GQA-4093-2022; CAI, Jian-Piao/HCI-0096-2022; CAI, Jian-piao/GYD-5763-2022; CHU, HIN/ABU-1193-2022; HUANG, Xiner/AAY-3412-2021; Chan, Jasper F. W./D-8007-2013; Hu, Bingjie/AHC-7141-2022; Shuai, Huiping/AAE-5585-2022; zhang, jin/GXV-9154-2022	CAI, Jian-piao/0000-0003-4077-3852; CHU, HIN/0000-0003-2855-9837; HUANG, Xiner/0000-0002-0154-8372; Chan, Jasper F. W./0000-0001-6336-6657; Shuai, Huiping/0000-0001-8078-4113; Yuan, Shuofeng/0000-0001-7996-1119; Hu, Jingchu/0000-0001-6144-7226; Hu, Bingjie/0000-0002-6677-9454	Health and Medical Research Fund [COVID1903010, 20190652]; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; Research Grants Council, The Government of the Hong Kong Special Administrative Region [17118621, T11-709/21-N]; Health@InnoHK, Innovation and Technology Commission, the Government of the Hong Kong Special Administrative Region; National Natural Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau) [32122001]; National Program on Key Research Project of China [2020YFA0707500, 2020YFA0707504]; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government, Sanming Project of Medicine in [SZSM201911014]; High Level-Hospital Program, Health Commission of Guangdong Province, China; University of Hong Kong Li Ka Shing Faculty of Medicine Enhanced New Staff Start-up Fund; University of Hong Kong Outstanding Young Researcher Award; University of Hong Kong Li Ka Shing Faculty of Medicine Research Output Prize; Major Science and Technology Program of Hainan Province [ZDKJ202003]; research project of Hainan Academician Innovation Platform [YSPTZX202004]; Hainan Talent Development Project [SRC200003)]; Emergency Key Program of Guangzhou Laboratory [EKPG22-01]	Health and Medical Research Fund; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; Research Grants Council, The Government of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Health@InnoHK, Innovation and Technology Commission, the Government of the Hong Kong Special Administrative Region; National Natural Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau); National Program on Key Research Project of China; Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government, Sanming Project of Medicine in; High Level-Hospital Program, Health Commission of Guangdong Province, China; University of Hong Kong Li Ka Shing Faculty of Medicine Enhanced New Staff Start-up Fund; University of Hong Kong Outstanding Young Researcher Award; University of Hong Kong Li Ka Shing Faculty of Medicine Research Output Prize; Major Science and Technology Program of Hainan Province; research project of Hainan Academician Innovation Platform; Hainan Talent Development Project; Emergency Key Program of Guangzhou Laboratory	This work was supported in part by funding from the Health and Medical Research Fund (CID-HKU1-5, COVID1903010, projects 7 and 14, and 20190652), the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region; the General Research Fund (17118621) and the Theme-Based Research Scheme (T11-709/21-N) of Research Grants Council, The Government of the Hong Kong Special Administrative Region; Health@InnoHK, Innovation and Technology Commission, the Government of the Hong Kong Special Administrative Region; National Natural Science Foundation of China Excellent Young Scientists Fund (Hong Kong and Macau) (32122001); National Program on Key Research Project of China (grant no. 2020YFA0707500 and 2020YFA0707504); the Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Diseases and Research Capability on Antimicrobial Resistance for Department of Health of the Hong Kong Special Administrative Region Government, Sanming Project of Medicine in Shenzhen, China (no. SZSM201911014); the High Level-Hospital Program, Health Commission of Guangdong Province, China; the University of Hong Kong Li Ka Shing Faculty of Medicine Enhanced New Staff Start-up Fund; the University of Hong Kong Outstanding Young Researcher Award; the University of Hong Kong Li Ka Shing Faculty of Medicine Research Output Prize; the Major Science and Technology Program of Hainan Province (ZDKJ202003); the research project of Hainan Academician Innovation Platform (YSPTZX202004); the Hainan Talent Development Project (SRC200003); the Emergency Key Program of Guangzhou Laboratory (EKPG22-01); and the donations of the Shaw Foundation Hong Kong, R. Yu and C. Yu, M. T. M. M. Yin, M. S.-K. Tong, the Providence Foundation Limited (in memory of the late L. H. Minh), Lee Wan Keung Charity Foundation Limited, H. Ming, H. Hoy and Chow Sin Lan Charity Fund Limited, Hong Kong Sanatorium & Hospital, the Chan Yin Chuen Memorial Charitable Foundation, M. M.-W. Lee, the Hong Kong Hainan Commercial Association South China Microbiology Research Fund, the Jessie & George Ho Charitable Foundation, Perfect Shape Medical Limited, K. C. Tong, Foo Oi Foundation Limited, T. K. M. Laurence, B. H.-C. Lee, P. C. So and the Lo Ying Shek Chi Wai Foundation. The funding sources had no role in the study design, data collection, analysis, interpretation or writing of the report.	Ai JW, 2022, EMERG MICROBES INFEC, V11, P337, DOI 10.1080/22221751.2021.2022440; [Anonymous], 2021, CLASSIFICATION OMICR; Beumer J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25729-7; Brandal LT, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.50.2101147; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chu H, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8577; Chu H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20457-w; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Dejnirattisai W, 2022, LANCET, V399, P234, DOI 10.1016/S0140-6736(21)02844-0; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Edara Venkata-Viswanadh, 2021, bioRxiv, DOI 10.1101/2021.12.20.473557; Espenhain L, 2021, EUROSURVEILLANCE, V26, DOI [10.2807/1560-7917.ES.2021.26.50.21011462015, 10.2807/1560-7917.ES.2021.26.50.2101146]; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Havranek KE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121465; Hoffmann M, 2022, CELL, V185, P447, DOI 10.1016/j.cell.2021.12.032; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Koch J, 2021, EMBO J, V40, DOI 10.15252/embj.2021107821; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Lamers MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66815; Laporte M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009500; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Liu Y., THESIS, DOI [10.1101/2021.08.12.456173(2021, DOI 10.1101/2021.08.12.456173(2021]; Lu L, 2022, CLIN INFECT DIS, V75, pE822, DOI 10.1093/cid/ciab1041; McCallum M., 2021, PREPRINT, DOI [10.1101/2021.12.28.474380, DOI 10.1101/2021.12.28.474380]; Meng B, 2022, NATURE, V603, P706, DOI 10.1038/s41586-022-04474-x; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Mykytyn AZ, 2021, ELIFE, V10, DOI 10.7554/eLife.64508; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w; Perrine CG, 2021, MMWR-MORBID MORTAL W, V70, P1731, DOI 10.15585/mmwr.mm7050e1; Saito A, 2022, NATURE, V602, P300, DOI 10.1038/s41586-021-04266-9; Shuai HP, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103643; VanBlargan LA, INFECTIOUS SARS COV, DOI [10.1101/2021.12.15.472828, DOI 10.1101/2021.12.15.472828]; Wang YC, 2022, EMERG MICROBES INFEC, V11, P1, DOI 10.1080/22221751.2021.2017757; Yuan SF, 2021, NATURE, V593, P418, DOI 10.1038/s41586-021-03431-4; Zeng Cong, 2021, bioRxiv, DOI 10.1101/2021.12.16.472934; Zhao HJ, 2022, EMERG MICROBES INFEC, V11, P277, DOI 10.1080/22221751.2021.2023329; Zheng J, 2021, NATURE, V589, P603, DOI 10.1038/s41586-020-2943-z; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	42	131	136	61	95	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2022	603	7902					693	+	s41586-022-04442-5	10.1038/s41586-022-04442-5	http://dx.doi.org/10.1038/s41586-022-04442-5		JAN 2022	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZY5YD	35062016	Bronze, Green Submitted			2022-12-28	WOS:000763362000002
J	Besana, M; Ciftci, Y; Makuyana, T				Besana, Matteo; Ciftci, Yusuf; Makuyana, Thabo			The UK's immigration plans threaten the health outcomes of asylum seekers and refugees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Besana, Matteo; Ciftci, Yusuf; Makuyana, Thabo] Doctors World, London, England		Besana, M (corresponding author), Doctors World, London, England.							[Anonymous], 2018, LIV EXP ACC HEALTHC; [Anonymous], 2020, DEL DEST AUD DOCT WO; [Anonymous], 2021, INSP CONT AS ACC HMI; [Anonymous], 2021, POL BRIEF NEW PLAN I; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2018, REG REF STUD ACC GP; Bulman M., 2021, INDEPENDENT; Moore S, 2020, HLTH RESPONSE USE MO; Written evidence submitted by Doctors of the World the Helen Bamber Foundation Forrest Medico -Legal Services and Freedom from Torture (COR0245), 2021, FORR MED LEG SERV FR	9	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2022	376								o165	10.1136/bmj.o165	http://dx.doi.org/10.1136/bmj.o165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YS4LG	35058241	Bronze			2022-12-28	WOS:000750649900007
J	Williams, C				Williams, Charleese			We like neurons	CELL			English	Editorial Material								Charleese Williams is the winner of the 2021 Rising Black Scientists Award for an undergraduate scholar. For this award, we asked emerging Black scientists to tell us about the experiences that sparked their interest in the life sciences, their vision and goals, and how they want to contribute to a more inclusive scientific community. This is her story.	[Williams, Charleese] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Williams, C (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	cwilliams401@student.gsu.edu							0	1	1	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 20	2022	185	2					221	223		10.1016/j.cell.2021.12.019	http://dx.doi.org/10.1016/j.cell.2021.12.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YL8YE	35063067	Bronze			2022-12-28	WOS:000746172100001
J	Burki, T				Burki, Talha			Pig-heart transplantation surgeons look to the next steps	LANCET			English	Editorial Material																			0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					347	347						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065774				2022-12-28	WOS:000746046100008
J	Horton, R				Horton, Richard			Offline: COVID-19 as culture war	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN	2022	399	10322					346	346						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	YL7CQ	35065773	Green Published			2022-12-28	WOS:000746046100007
J	Zheng, ZZ; Deng, WY; Bai, Y; Miao, R; Mei, SL; Zhang, ZB; Pan, YD; Wang, Y; Min, R; Deng, F; Wu, ZY; Li, W; Chen, PC; Ma, TC; Lou, XW; Lieberman, J; Liu, X				Zheng, Zengzhang; Deng, Wanyan; Bai, Yang; Miao, Rui; Mei, Shenglin; Zhang, Zhibin; Pan, Youdong; Wang, Yi; Min, Rui; Deng, Fan; Wu, Zeyu; Li, Wu; Chen, Pengcheng; Ma, Tianchi; Lou, Xiwen; Lieberman, Judy; Liu, Xing			The lysosomal Rag-Ragulator complex licenses RIPK1-and caspase-8-mediated pyroptosis by Yersinia	SCIENCE			English	Article							AMINO-ACID LEVELS; GASDERMIN-D; DEATH DOMAIN; CELL-DEATH; ACTIVATION; MECHANISM; GSDMD; INHIBITION; CASPASE-11; GTPASES		[Zheng, Zengzhang; Deng, Wanyan; Li, Wu; Liu, Xing] Guangzhou Women & Childrens Med Ctr, Joint Ctr Infect & Immun Guangzhou Inst Pediat, Guangzhou 510623, Peoples R China; [Zheng, Zengzhang; Deng, Wanyan; Li, Wu; Liu, Xing] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Zheng, Zengzhang; Deng, Wanyan; Bai, Yang; Min, Rui; Deng, Fan; Wu, Zeyu; Li, Wu; Chen, Pengcheng; Ma, Tianchi; Lou, Xiwen; Liu, Xing] Chinese Acad Sci, Inst Pasteur Shanghai, Ctr Microbes Dev & Hlth, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Bai, Yang; Min, Rui; Deng, Fan; Wu, Zeyu] Univ Chinese Acad Sci, Shanghai 200031, Peoples R China; [Miao, Rui; Zhang, Zhibin; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Miao, Rui; Zhang, Zhibin; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mei, Shenglin] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Pan, Youdong] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Pan, Youdong] Harvard Med Sch, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA; [Wang, Yi] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Liu, X (corresponding author), Guangzhou Women & Childrens Med Ctr, Joint Ctr Infect & Immun Guangzhou Inst Pediat, Guangzhou 510623, Peoples R China.; Liu, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China.; Liu, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Ctr Microbes Dev & Hlth, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Lieberman, J (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	judy.lieberman@childrens.harvard.edu; xingliu@ips.ac.cn		Bai, Yang/0000-0001-8042-9584; Miao, Rui/0000-0002-5541-3852; Zhang, Zhibin/0000-0003-1349-2713; Zheng, Zengzhang/0000-0002-9572-1390	National Key RAMP;D Program of China [2020YFA0509600]; Key Research Program of the Chinese Academy of Sciences [ZDBS-LY-SM008]; National Natural Science Foundation of China [31972897, 31900456]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB29030300]; Shanghai Municipal Science and Technology Major Project [2019SHZDZX02]; NIH [R01 CA240955]	National Key RAMP;D Program of China; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Science and Technology Major Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Key R&D Program of China (2020YFA0509600), Key Research Program of the Chinese Academy of Sciences (ZDBS-LY-SM008), National Natural Science Foundation of China (31972897), Strategic Priority Research Program of Chinese Academy of Sciences (XDB29030300), Shanghai Municipal Science and Technology Major Project (2019SHZDZX02) to X.L, National Natural Science Foundation of China for the Youth (31900456) to Ze.Z., and NIH R01 CA240955 to J.L.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Anderton H, 2019, CELL DEATH DIFFER, V26, P877, DOI 10.1038/s41418-018-0166-8; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; de Vasconcelos NM, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036392; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fu TM, 2016, MOL CELL, V64, P236, DOI 10.1016/j.molcel.2016.09.009; Green DR, 2019, CELL, V177, P1094, DOI 10.1016/j.cell.2019.04.024; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kayagaki N, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax4917; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lawrence RE, 2019, SCIENCE, V366, P971, DOI 10.1126/science.aax0364; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Matsuda I, 2014, J BIOL CHEM, V289, P3876, DOI 10.1074/jbc.M113.506485; Muendlein HI, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20357-z; Muendlein HI, 2020, SCIENCE, V367, P1379, DOI 10.1126/science.aay3878; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Park YH, 2013, BBA-PROTEINS PROTEOM, V1834, P292, DOI 10.1016/j.bbapap.2012.08.013; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shen K, 2019, CELL, V179, P1319, DOI 10.1016/j.cell.2019.10.036; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477	37	23	23	8	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2021	372	6549					1412	+	abg0269	10.1126/science.abg0269	http://dx.doi.org/10.1126/science.abg0269			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY4KW	35058659	Green Accepted			2022-12-28	WOS:000665860000041
J	Murray, CJL; Ikuta, KS; Sharara, F; Swetschinski, L; Aguilar, GR; Gray, A; Han, C; Bisignano, C; Rao, P; Wool, E; Johnson, SC; Browne, AJ; Chipeta, MG; Fell, F; Hackett, S; Haines-Woodhouse, G; Hamadani, BHK; Kumaran, EAP; McManigal, B; Agarwal, R; Akech, S; Albertson, S; Amuasi, J; Andrews, J; Aravkin, A; Ashley, E; Bailey, F; Baker, S; Basnyat, B; Bekker, A; Bender, R; Bethou, A; Bielicki, J; Boonkasidecha, S; Bukosia, J; Carvalheiro, C; Castaneda-Orjuela, C; Chansamouth, V; Chaurasia, S; Chiurchiu, S; Chowdhury, F; Cook, AJ; Cooper, B; Cressey, TR; Criollo-Mora, E; Cunningham, M; Darboe, S; Day, NPJ; De Luca, M; Dokova, K; Dramowski, A; Dunachie, SJ; Eckmanns, T; Eibach, D; Emami, A; Feasey, N; Fisher-Pearson, N; Forrest, K; Garrett, D; Gastmeier, P; Giref, AZ; Greer, RC; Gupta, V; Haller, S; Haselbeck, A; Hay, SI; Holm, M; Hopkins, S; Iregbu, KC; Jacobs, J; Jarovsky, D; Javanmardi, F; Khorana, M; Kissoon, N; Kobeissi, E; Kostyanev, T; Krapp, F; Krumkamp, R; Kumar, A; Kyu, HH; Lim, C; Limmathurotsakul, D; Loftus, MJ; Lunn, M; Ma, J; Mturi, N; Munera-Huertas, T; Musicha, P; Mussi-Pinhata, MM; Nakamura, T; Nanavati, R; Nangia, S; Newton, P; Ngoun, C; Novotney, A; Nwakanma, D; Obiero, CW; Olivas-Martinez, A; Olliaro, P; Ooko, E; Ortiz-Brizuela, E; Peleg, AY; Perrone, C; Plakkal, N; Ponce-de-Leon, A; Raad, M; Ramdin, T; Riddell, A; Roberts, T; VictoriaRobotham, J; Roca, A; Rudd, KE; Russell, N; Schnall, J; Scott, JAG; Shivamallappa, M; Sifuentes-Osornio, J; Steenkeste, N; Stewardson, AJ; Stoeva, T; Tasak, N; Thaiprakong, A; Thwaites, G; Turner, C; Turner, P; van Doorn, HR; Velaphi, S; Vongpradith, A; Vu, H; Walsh, T; Waner, S; Wangrangsimakul, T; Wozniak, T; Zheng, P; Sartorius, B; Lopez, AD; Stergachis, A; Moore, C; Dolecek, C; Naghavi, M				Murray, Christopher J. L.; Ikuta, Kevin Shunji; Sharara, Fablina; Swetschinski, Lucien; Aguilar, Gisela Robles; Gray, Authia; Han, Chieh; Bisignano, Catherine; Rao, Puja; Wool, Eve; Johnson, Sarah C.; Browne, Annie J.; Chipeta, Michael Give; Fell, Frederick; Hackett, Sean; Haines-Woodhouse, Georgina; Hamadani, Bahar H. Kashef; Kumaran, Emmanuelle A. P.; McManigal, Barney; Agarwal, Ramesh; Akech, Samuel; Albertson, Samuel; Amuasi, John; Andrews, Jason; Aravkin, Aleskandr; Ashley, Elizabeth; Bailey, Freddie; Baker, Stephen; Basnyat, Buddha; Bekker, Adrie; Bender, Rose; Bethou, Adhisivam; Bielicki, Julia; Boonkasidecha, Suppawat; Bukosia, James; Carvalheiro, Cristina; Castaneda-Orjuela, Carlos; Chansamouth, Vilada; Chaurasia, Suman; Chiurchiu, Sara; Chowdhury, Fazle; Cook, Aislinn J.; Cooper, Ben; Cressey, Tim R.; Criollo-Mora, Elia; Cunningham, Matthew; Darboe, Saffiatou; Day, Nicholas P. J.; De Luca, Maia; Dokova, Klara; Dramowski, Angela; Dunachie, Susanna J.; Eckmanns, Tim; Eibach, Daniel; Emami, Amir; Feasey, Nicholas; Fisher-Pearson, Natasha; Forrest, Karen; Garrett, Denise; Gastmeier, Petra; Giref, Ababi Zergaw; Greer, Rachel Claire; Gupta, Vikas; Haller, Sebastian; Haselbeck, Andrea; Hay, Simon, I; Holm, Marianne; Hopkins, Susan; Iregbu, Kenneth C.; Jacobs, Jan; Jarovsky, Daniel; Javanmardi, Fatemeh; Khorana, Meera; Kissoon, Niranjan; Kobeissi, Elsa; Kostyanev, Tomislav; Krapp, Fiorella; Krumkamp, Ralf; Kumar, Ajay; Kyu, Hmwe H.; Lim, Cherry; Limmathurotsakul, Direk; Loftus, Michael James; Lunn, Miles; Ma, Jianing; Mturi, Neema; Munera-Huertas, Tatiana; Musicha, Patrick; Mussi-Pinhata, Marisa Marcia; Nakamura, Tomoka; Nanavati, Ruchi; Nangia, Sushma; Newton, Paul; Ngoun, Chanpheaktra; Novotney, Amanda; Nwakanma, Davis; Obiero, Christina W.; Olivas-Martinez, Antonio; Olliaro, Piero; Ooko, Ednah; Ortiz-Brizuela, Edgar; Peleg, Anton Yariv; Perrone, Carlo; Plakkal, Nishad; Ponce-de-Leon, Alfredo; Raad, Mathieu; Ramdin, Tanusha; Riddell, Amy; Roberts, Tamalee; VictoriaRobotham, Julie; Roca, Anna; Rudd, Kristina E.; Russell, Neal; Schnall, Jesse; Scott, John Anthony Gerard; Shivamallappa, Madhusudhan; Sifuentes-Osornio, Jose; Steenkeste, Nicolas; Stewardson, Andrew James; Stoeva, Temenuga; Tasak, Nidanuch; Thaiprakong, Areerat; Thwaites, Guy; Turner, Claudia; Turner, Paul; van Doorn, H. Rogier; Velaphi, Sithembiso; Vongpradith, Avina; Huong Vu; Walsh, Timothy; Waner, Seymour; Wangrangsimakul, Tri; Wozniak, Teresa; Zheng, Peng; Sartorius, Benn; Lopez, Alan D.; Stergachis, Andy; Moore, Catrin; Dolecek, Christiane; Naghavi, Mohsen		Antimicrobial Resistance Collabora	Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis	LANCET			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; UNITED-STATES; SEPSIS; DEFINITIONS; INFECTIONS	Background Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. Methods We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 23 pathogens and 88 pathogen-drug combinations in 204 countries and territories in 2019. We obtained data from systematic literature reviews, hospital systems, surveillance systems, and other sources, covering 471 million individual records or isolates and 7585 study-location-years. We used predictive statistical modelling to produce estimates of AMR burden for all locations, including for locations with no data. Our approach can be divided into five broad components: number of deaths where infection played a role, proportion of infectious deaths attributable to a given infectious syndrome, proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antibiotic of interest, and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden based on two counterfactuals: deaths attributable to AMR (based on an alternative scenario in which all drug-resistant infections were replaced by drug-susceptible infections), and deaths associated with AMR (based on an alternative scenario in which all drug-resistant infections were replaced by no infection). We generated 95% uncertainty intervals (UIs) for final estimates as the 25th and 975th ordered values across 1000 posterior draws, and models were cross-validated for out-of-sample predictive validity. We present final estimates aggregated to the global and regional level. Findings On the basis of our predictive statistical models, there were an estimated 4.95 million (3.62-6.57) deaths associated with bacterial AMR in 2019, including 1.27 million (95% UI 0.911-1.71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western subSaharan Africa, at 27.3 deaths per 100 000 (20.9-35.3), and lowest in Australasia, at 6.5 deaths (4.3-9.4) per 100 000. Lower respiratory infections accounted for more than 1.5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000-1 270 000) deaths attributable to AMR and 3.57 million (2.62-4.78) deaths associated with AMR in 2019. One pathogen-drug combination, meticillin-resistant S aureus, caused more than 100 000 deaths attributable to AMR in 2019, while six more each caused 50 000-100 000 deaths: multidrug-resistant excluding extensively drug-resistant tuberculosis, third-generation cephalosporin-resistant E coli, carbapenem-resistant A baumannii, fluoroquinolone-resistant E coli, carbapenem-resistant K pneumoniae, and third-generation cephalosporin-resistant K pneumoniae. Interpretation To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen-drug combinations contributing to it is crucial to making informed and location-specific policy decisions, particularly about infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics. There are serious data gaps in many low-income settings, emphasising the need to expand microbiology laboratory capacity and data collection systems to improve our understanding of this important human health threat. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.	[Murray, Christopher J. L.; Sharara, Fablina; Swetschinski, Lucien; Gray, Authia; Han, Chieh; Bisignano, Catherine; Rao, Puja; Wool, Eve; Johnson, Sarah C.; Bender, Rose; Cunningham, Matthew; Hay, Simon, I; Kyu, Hmwe H.; Ma, Jianing; Novotney, Amanda; Vongpradith, Avina; Zheng, Peng; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Murray, Christopher J. L.; Hay, Simon, I; Sartorius, Benn; Naghavi, Mohsen] Univ Washington, Sch Med, Dept Hlth Metr Sci, Seattle, WA USA; [Aravkin, Aleskandr] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA; [Ikuta, Kevin Shunji] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Infect Dis, Los Angeles, CA USA; [Ikuta, Kevin Shunji] Univ Calif Los Angeles, Dept Infect Dis, Los Angeles, CA USA; [Aguilar, Gisela Robles; McManigal, Barney; Bailey, Freddie; Fisher-Pearson, Natasha; Kobeissi, Elsa; Lunn, Miles; Olliaro, Piero; Moore, Catrin] Univ Oxford, Big Data Inst, Nuffield Dept Med, Oxford, England; [Kumaran, Emmanuelle A. P.; Chansamouth, Vilada; Cooper, Ben; Lim, Cherry; Limmathurotsakul, Direk; Newton, Paul; Perrone, Carlo; Thwaites, Guy; Wangrangsimakul, Tri; Sartorius, Benn; Dolecek, Christiane] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Walsh, Timothy] Univ Oxford, Ineos Oxford Inst Antimicrobial Res, Oxford, England; [Agarwal, Ramesh] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Akech, Samuel] Kenya Med Res Inst KEMRI Wellcome Trust Res Progr, Hlth Serv Res Unit, Nairobi, Kenya; [Bukosia, James] Kenya Med Res Inst KEMRI Wellcome Trust Res Progr, Nairobi Programme, Nairobi, Kenya; [Amuasi, John] Kwame Nkrumah Univ Sci & Technol, Dept Global Hlth, Kumasi, Ghana; [Amuasi, John] Kumasi Ctr Collaborat Res Trop Med, Global Hlth & Infect Dis, Kumasi, Ghana; [Andrews, Jason] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ashley, Elizabeth; Chansamouth, Vilada; Newton, Paul; Roberts, Tamalee] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Baker, Stephen] Univ Cambridge, Dept Med, Cambridge, England; [Basnyat, Buddha] Univ Oxford, Oxford Univ Clin Res Unit Nepal, Kathmandu, Nepal; [Bekker, Adrie; Dramowski, Angela] Stellenbosch Univ, Dept Paediat & Child Hlth, Cape Town, South Africa; [Bethou, Adhisivam; Plakkal, Nishad] Jawaharlal Inst Postgrad Med Educ & Res, Dept Neonatol, Pondicherry, India; [Bielicki, Julia] Univ Basel, Paediat Infect Dis Dept, Childrens Hosp, Basel, Switzerland; [Bielicki, Julia; Cook, Aislinn J.; Riddell, Amy; Russell, Neal] St Georges Univ London, Paediat Infect Dis Res Grp, London, England; [Munera-Huertas, Tatiana] St Georges Univ London, Inst Infect & Immun, London, England; [Boonkasidecha, Suppawat; Khorana, Meera] Queen Sirikit Natl Inst Child Hlth, Dept Pediat, Bangkok, Thailand; [Carvalheiro, Cristina; Mussi-Pinhata, Marisa Marcia] Univ Sao Paulo, Dept Pediat, Ribeirao Preto, Brazil; [Castaneda-Orjuela, Carlos] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Castaneda-Orjuela, Carlos] Univ Nacl Colombia, Epidemiol & Publ Hlth Evaluat Grp, Bogota, Colombia; [Chaurasia, Suman] All India Inst Med Sci, Dept Neonatol, Rishikesh, India; [Chiurchiu, Sara] Bambino Gesu Pediat Hosp, Immunol & Infect Dis Unit, Acad Dept Pediat, Rome, Italy; [De Luca, Maia] Bambino Gesu Pediat Hosp, Acad Hosp Pediat Dept, Rome, Italy; [Chowdhury, Fazle] Bangabandhu Sheikh Mujib Med Univ, Internal Med, Dhaka, Bangladesh; [Chowdhury, Fazle; Dolecek, Christiane] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Day, Nicholas P. J.; Perrone, Carlo] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Browne, Annie J.; Chipeta, Michael Give; Fell, Frederick; Hackett, Sean; Haines-Woodhouse, Georgina; Hamadani, Bahar H. Kashef; Cooper, Ben] Univ Oxford, Nuffield Dept Med, Oxford, England; [Cressey, Tim R.] Chiang Mai Univ, PHPT AMS Res Unit, Chiang Mai, Thailand; [Cressey, Tim R.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Criollo-Mora, Elia] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pharm, Mexico City, DF, Mexico; [Olivas-Martinez, Antonio; Ortiz-Brizuela, Edgar] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico; [Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Darboe, Saffiatou; Roca, Anna] London Sch Hyg & Trop Med, Med Res Council Unit Gambia, Dis Control & Eliminat Dept, Banjul, Gambia; [Forrest, Karen] London Sch Hyg & Trop Med, Clin Serv Dept, Med Res Council Unit Gambia, Banjul, Gambia; [Nwakanma, Davis] London Sch Hyg & Trop Med, Lab Serv Dept, Med Res Council Unit Gambia, Banjul, Gambia; [Dokova, Klara] Med Univ Varna, Dept Social Med & Hlth Care Org, Varna, Bulgaria; [Stoeva, Temenuga] Med Univ Varna, Dept Microbiol & Virol, Varna, Bulgaria; [Eckmanns, Tim; Haller, Sebastian] Robert Koch Inst, Infect Dis Epidemiol, Berlin, Germany; [Eibach, Daniel; Krumkamp, Ralf] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany; [Emami, Amir; Javanmardi, Fatemeh] Shiraz Univ Med Sci, Microbiol Dept, Shiraz, Iran; [Feasey, Nicholas] Univ Liverpool Liverpool Sch Trop Med, Clin Sci, Liverpool, Merseyside, England; [Feasey, Nicholas] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Garrett, Denise] Sabin Vaccine Inst, Appl Epidemiol Programs, Washington, DC USA; [Gastmeier, Petra] Charite Univ Med Berlin, Inst Hyg, Berlin, Germany; [Giref, Ababi Zergaw] Addis Ababa Univ, Dept Hlth Policy & Management, Addis Ababa, Ethiopia; [Giref, Ababi Zergaw] Ethiopian Publ Hlth Inst, Natl Data Management Ctr, Addis Ababa, Ethiopia; [Greer, Rachel Claire; Wangrangsimakul, Tri] Mahidol Oxford Trop Med Res Unit, Chiangrai Clin Res Unit, Bangkok, Thailand; [Dunachie, Susanna J.; Lim, Cherry; Limmathurotsakul, Direk; Tasak, Nidanuch; Thaiprakong, Areerat] Mahidol Oxford Trop Med Res Unit, Dept Microbiol, Bangkok, Thailand; [Gupta, Vikas] Becton Dickinson & Co, MMS Med Affairs, Franklin Lakes, NJ USA; [Haselbeck, Andrea; Holm, Marianne] Int Vaccine Inst, Epidemiol & Publ Hlth Res Dept, Seoul, South Korea; [Hopkins, Susan] Publ Hlth England, Natl Infect Serv, London, England; [VictoriaRobotham, Julie] Publ Hlth England, Antimicrobrial Resistance Div, London, England; [Iregbu, Kenneth C.] Natl Hosp, Dept Med Microbiol, Abuja, Nigeria; [Iregbu, Kenneth C.] Univ Abuja, Dept Med Microbiol, Abuja, Nigeria; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Jarovsky, Daniel] Santa Casa Sao Paulo, Pediat Infect Dis Dept, Sao Paulo, Brazil; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Kostyanev, Tomislav] Univ Antwerp, Lab Med Microbiol, Antwerp, Belgium; [Krapp, Fiorella] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Kumar, Ajay; Nangia, Sushma] Lady Hardinge Med Coll & Kalawati Sarans Children, Dept Neonatol, New Delhi, India; [Loftus, Michael James; Peleg, Anton Yariv; Stewardson, Andrew James] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Mturi, Neema; Obiero, Christina W.] KEMRI Wellcome Trust Res Programme, Clin Res Dept, Kilifi, Kenya; [Ooko, Ednah] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Musicha, Patrick] Wellcome Sanger Inst, Parasites & Microbes Programme, Cambridge, England; [Nakamura, Tomoka] World Hlth Org, Dept Immunizat Vaccines & Biol, Geneva, Switzerland; [Nakamura, Tomoka; Scott, John Anthony Gerard] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Nanavati, Ruchi] Seth GSMC & KEM Hosp, Dept OfNeonatol, Mumbai, Maharashtra, India; [Ngoun, Chanpheaktra] Angkor Hosp Children, Med Dept, Siem Reap, Cambodia; [Turner, Claudia] Angkor Hosp Children, Execut Off, Siem Reap, Cambodia; [Turner, Paul] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Obiero, Christina W.] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Peleg, Anton Yariv; Stewardson, Andrew James] Alfred Hosp, Infect Dis Dept, Melbourne, Vic, Australia; [Ponce-de-Leon, Alfredo] Univ Panamer, Dept Med, Mexico City, DF, Mexico; [Raad, Mathieu] Fdn Merieux, Int Operat Dept, Lyon, France; [Steenkeste, Nicolas] Fdn Merieux, Int Operat Direct, Lyon, France; [Ramdin, Tanusha] Univ Witwatersrand, Dept Paediat & Child Hlth, Parktown, South Africa; [Rudd, Kristina E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Schnall, Jesse] Austin Hlth, Training, Heidelberg, Vic, Australia; [Scott, John Anthony Gerard] KEMRI Wellcome Trust Res Programme, Dept Epidemiol & Demog, Kilifi, Kenya; [Shivamallappa, Madhusudhan] King Edward Mem Hosp Mumbai, Dept Neonatol, Mumbai, Maharashtra, India; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med, Dept Med, Mexico City, DF, Mexico; [Stoeva, Temenuga] Varna Univ Hosp, Microbiol Lab, Varna, Bulgaria; [Thwaites, Guy; Huong Vu] Univ Oxford, Oxford Univ Clin Res Unit Viet Nam, Ho Chi Minh City, Vietnam; [Turner, Claudia] Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [van Doorn, H. Rogier] Oxford Univ Clin Res Unit, Hanoi, Vietnam; [Velaphi, Sithembiso] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa; [Velaphi, Sithembiso] Chris Hani Baragwanath Acad Hosp, Dept Paediat, Johannesburg, South Africa; [Waner, Seymour] Lancet Labs, Dept Microbiol, Johannesburg, South Africa; [Wozniak, Teresa] Menzies Sch Hlth Res, Dept Global Trop Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of Oxford; University of Oxford; University of Oxford; All India Institute of Medical Sciences (AIIMS) New Delhi; Kenya Medical Research Institute; Kenya Medical Research Institute; Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Stanford University; University of Cambridge; University of Oxford; Stellenbosch University; Jawaharlal Institute of Postgraduate Medical Education & Research; University of Basel; St Georges University London; St Georges University London; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Nacional de Salud (Colombia); Universidad Nacional de Colombia; All India Institute of Medical Sciences (AIIMS) Rishikesh; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Bangabandhu Sheikh Mujib Medical University (BSMMU); Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Oxford; Chiang Mai University; University of Liverpool; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Medical University Varna; Medical University Varna; Robert Koch Institute; Bernhard Nocht Institut fur Tropenmedizin; Shiraz University of Medical Science; Liverpool School of Tropical Medicine; University of Malawi; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Addis Ababa University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol Oxford Tropical Medicine Research Unit (MORU); Becton Dickinson; International Vaccine Institute; Public Health England; Public Health England; Institute of Tropical Medicine (ITM); KU Leuven; University of British Columbia; University of Antwerp; Universidad Peruana Cayetano Heredia; Lady Hardinge Medical College & Hospital; Monash University; Wellcome Trust Sanger Institute; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; University of Amsterdam; Florey Institute of Neuroscience & Mental Health; Universidad Panamericana - Ciudad de Mexico; University of Witwatersrand; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Medical University Varna; University of Oxford; University of Witwatersrand; Charles Darwin University; Menzies School of Health Research	Naghavi, M (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	nagham@uw.edu	DARBOE, SAFFIATOU/AAY-6423-2021; Ikuta, Kevin S/HHZ-6411-2022; Hay, Simon Iain/F-8967-2015; Jacobs, Jan/GRX-7316-2022; Emami, Amir/H-1024-2016; Carvalheiro, Cristina G/K-8040-2012; Olivas-Martinez, Antonio/GNP-3729-2022; Roberts, Tamalee/GOE-6303-2022; Plakkal, Nishad/AAL-2397-2020; Ortiz-Brizuela, Edgar/U-6302-2019; Stewardson, Andrew/ABC-5208-2020; Cooper, Ben/HGC-7082-2022; Haller, Sebastian/P-1634-2014; Castaneda-Orjuela, Carlos/N-2601-2017	DARBOE, SAFFIATOU/0000-0002-4711-3307; Ikuta, Kevin S/0000-0002-3149-3907; Hay, Simon Iain/0000-0002-0611-7272; Emami, Amir/0000-0002-4510-1820; Carvalheiro, Cristina G/0000-0003-1248-472X; Olivas-Martinez, Antonio/0000-0003-2779-0068; Plakkal, Nishad/0000-0003-2729-7310; Ortiz-Brizuela, Edgar/0000-0001-7169-8459; Stewardson, Andrew/0000-0001-6805-1224; Dunachie, Susanna/0000-0001-5665-6293; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Perrone, Carlo/0000-0001-9499-0399; Holm, Marianne/0000-0002-0747-4116; Hackett, Sean/0000-0003-1048-8583; Robotham, Julie/0000-0003-2515-4084; Chipeta, Michael Give/0000-0001-5882-9936; Bender, Rose/0000-0001-8169-0039; Kostyanev, Tomislav/0000-0002-1259-4876; Haller, Sebastian/0000-0001-8242-711X; Kumaran, Emmanuelle/0000-0003-3074-0125; Kissoon, Niranjan/0000-0001-8847-9973; Paredes, Jose Luis/0000-0002-0547-1376; Castaneda-Orjuela, Carlos/0000-0002-8735-6223; Roberts, Tamalee/0000-0001-8599-737X; Turner, Paul/0000-0002-1013-7815; Andrews, Jason/0000-0002-5967-251X; Hopkins, Susan/0000-0001-5179-5702; Cressey, Tim R./0000-0002-8106-0974	Bill & Melinda Gates Foundation; Wellcome Trust; Department of Health and Social Care	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome Trust); Department of Health and Social Care	Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund.	Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2019, Weekly Epidemiological Record, V94, P85; Ashley EA, 2018, J ANTIMICROB CHEMOTH, V73, P1737, DOI 10.1093/jac/dky026; Browne AJ, 2021, LANCET PLANET HEALTH, V5, pE893, DOI 10.1016/S2542-5196(21)00280-1; Burki TK, 2017, LANCET RESP MED, V5, P252, DOI 10.1016/S2213-2600(17)30090-5; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Castro J., 2017, STAT-US; Centers for Medicare and Medicaid Services, 2021, COVID 19 EM DEC BLAN; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Cox JA, 2017, CLIN MICROBIOL INFEC, V23, P812, DOI 10.1016/j.cmi.2017.07.010; de Kraker MEA, 2021, EPIDEMIOL REV, V43, P53, DOI 10.1093/epirev/mxab001; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Delorme T, 2017, INT J INFECT DIS, V54, P50, DOI 10.1016/j.ijid.2016.11.405; Dunachie SJ, 2020, CURR OPIN MICROBIOL, V57, P95, DOI 10.1016/j.mib.2020.09.013; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Hay SI, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1073-z; Hendriksen RS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08853-3; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Humphries RM, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.00203-19, 10.1128/JCM.00203-19]; Institute for Health Metrics and Evaluation, 2021, GLOBAL BURDEN DIS ST; Jansen KU, 2018, NAT MED, V24, P10, DOI 10.1038/nm.4465; Kelesidis T, 2015, CLIN MICROBIOL REV, V28, P443, DOI 10.1128/CMR.00072-14; Klugman KP, 2018, P NATL ACAD SCI USA, V115, P12896, DOI 10.1073/pnas.1721095115; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lim C, 2016, ELIFE, V5, DOI 10.7554/eLife.18082; Limmathurotsakul D, 2019, LANCET INFECT DIS, V19, pE392, DOI 10.1016/S1473-3099(19)30276-2; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Mera RM, 2011, MICROB DRUG RESIST, V17, P321, DOI 10.1089/mdr.2010.0193; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Office for Animal Health, 2016, NOAH RESP FIN ON AMR; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; New York Department of Health, 2020, HOSP ASS INF REP PER; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; O'Neill J., 2014, REV ANTIMICROBIAL RE; Oldenkamp R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013515118; Ombelet S, 2018, LANCET INFECT DIS, V18, pE248, DOI 10.1016/S1473-3099(18)30093-8; Organisation for Economic Co-operation and Development European Centre for Disease Prevention and Control, 2019, ANTIMICROBIAL RESIST; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Ramay BM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70741-4; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rolfe R, 2021, ANTIMICROB RESIST IN, V10, DOI 10.1186/s13756-021-00929-4; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tang KL, 2017, LANCET PLANET HEALTH, V1, pE316, DOI 10.1016/S2542-5196(17)30141-9; Temkin E, 2018, LANCET GLOB HEALTH, V6, pE969, DOI 10.1016/s2214-109x(18)30278-x; ter Kuile BH, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw210; UN, 2020, REP INT EXP GROUP SU; UN, SDG IND GLOB IND FRA; UN, 2017, INT COORD GROUP ANT; US Centers for Disease Control and Prevention, 2019, ANTIBIOTIC RESISTANC; Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944; Vos T, 2020, LANCET, V396, P1562; WHO, 2017, WHO TECH REP SER, V1006, P1; WHO, 2021, ANTIMICROBIAL RESIST; WHO, 2019, 2019 ANTCT AG CLIN D; WHO, 2020, GLOB REP EPID BURD S; WHO, 2020, IND 3 D 2 PERC BLOOD; WHO, 2015, GLOB ACT PLAN ANT RE; WHO, 2021, GLOB LEAD GROUP ANT; WHO, 2018, WHO SEPS TECHN EXP M; World Health Organization, 2017, GLOBAL PRIORITY LIST, DOI DOI 10.1016/S1473-3099(09)70222-1; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392; Zheng P, 2021, J COMPUT GRAPH STAT, V30, P544, DOI 10.1080/10618600.2020.1868303	67	572	573	293	538	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB	2022	399	10325					629	655		10.1016/S0140-6736(21)02724-0	http://dx.doi.org/10.1016/S0140-6736(21)02724-0			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YY1RO	36068104	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000754571600022
